protein_ID,PC1_loadings,PC2_loadings,PC_threshold_pass,ClusterColor,SimpleClusterColor,UniprotID,Protein_names,Protein_fams,Gene_names,GO_terms,GO_bp_IDs,sig_bp_GO,sig_bp_GOslim
CHOYP_LOC581183.1.1.m.49767,-0.023979337425725,0.00360010266109084,Yes,wheat1,pale yellow,Q7ZU45,Tetratricopeptide repeat protein 25 (TPR repeat protein 25),,ttc25,cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cilium assembly [GO:0060271]; determination of heart left/right asymmetry [GO:0061371]; otolith morphogenesis [GO:0032474],GO:0005737; GO:0005856; GO:0032474; GO:0042995; GO:0060271; GO:0061371,GO:0060271; GO:0061371,cellular component assembly; anatomical structure development
CHOYP_LOC100368885.1.1.m.7807,-0.0246969097166161,0.000751646923614513,Yes,wheat1,pale yellow,A0A0R4IFG5,Cilia- and flagella-associated protein 53,CFAP53 family,cfap53,axoneme [GO:0005930]; ciliary base [GO:0097546]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287],GO:0003341; GO:0005930; GO:0007368; GO:0060271; GO:0060287; GO:0097546,GO:0060271; GO:0060287,cellular component assembly; anatomical structure development
CHOYP_BRAFLDRAFT_117858.3.3.m.61651,-0.0238755130298035,-0.00448479993244244,Yes,wheat1,pale yellow,Q5PPV2,Tektin-4,Tektin family,tekt4,motile cilium [GO:0031514]; cell projection organization [GO:0030030],GO:0030030; GO:0031514,GO:0030030,NA
CHOYP_LOC100372889.1.2.m.37506,-0.0239197899423855,0.00355977417532623,Yes,wheat1,pale yellow,P54001,Prolyl 4-hydroxylase subunit alpha-1 (4-PH alpha-1) (EC 1.14.11.2) (Procollagen-proline;2-oxoglutarate-4-dioxygenase subunit alpha-1),P4HA family,P4ha1 P4ha,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; mitochondrion [GO:0005739]; procollagen-proline 4-dioxygenase complex [GO:0016222]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity; acting on single donors with incorporation of molecular oxygen; incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]; collagen fibril organization [GO:0030199]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401],GO:0004656; GO:0005506; GO:0005739; GO:0005783; GO:0005788; GO:0016222; GO:0016702; GO:0018401; GO:0030199; GO:0031418; GO:0042802,GO:0018401; GO:0030199,cellular protein modification process; cellular amino acid metabolic process; extracellular matrix organization; small molecule metabolic process
CHOYP_LOC100377024.2.2.m.63302,-0.0239009639627959,-0.0026251857778659,Yes,wheat1,pale yellow,E9Q7R9,Cilia- and flagella-associated protein 43,CFAP43 family,Cfap43,axoneme [GO:0005930]; motile cilium [GO:0031514]; sperm axoneme assembly [GO:0007288]; sperm motility [GO:0097722],GO:0005930; GO:0007288; GO:0031514; GO:0097722,GO:0007288,reproduction; cytoskeleton organization; cellular component assembly; cell differentiation; locomotion; anatomical structure development; cell motility
CHOYP_BRAFLDRAFT_125670.1.1.m.9555,-0.0236507116248055,0.00740336606507943,Yes,wheat1,pale yellow,Q96N23,Cilia- and flagella-associated protein 54,CFAP54 family,CFAP54 C12orf55 C12orf63,axoneme [GO:0005930]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; spermatogenesis [GO:0007283],GO:0005930; GO:0007283; GO:0030154; GO:0060271; GO:0060294,GO:0007283; GO:0060271; GO:0060294,reproduction; cellular component assembly; locomotion; cell motility
CHOYP_LOC100377392.3.4.m.26363,-0.0236939223830003,0.0078528430312193,Yes,wheat1,pale yellow,Q32KL8,Protein TBATA (Protein SPATIAL) (Stromal protein associated with thymii and lymph node homolog) (Thymus; brain and testes-associated protein),TBATA family,TBATA SPATIAL,cytosol [GO:0005829]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],GO:0005829; GO:0007275; GO:0007283; GO:0030154,GO:0007283,reproduction
CHOYP_LOC100366451.1.1.m.10500,-0.0237483690031043,-0.000537843477151716,Yes,wheat1,pale yellow,B2RW38,Cilia- and flagella-associated protein 58,CFAP58 family,Cfap58,cilium [GO:0005929],GO:0005929,NA,NA
CHOYP_LOC100372505.2.2.m.26614,-0.0239334218399212,0.00353220655200765,Yes,wheat1,pale yellow,P86854,Perlucin-like protein,,,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246],GO:0005576; GO:0030246,NA,NA
CHOYP_NRP.1.4.m.29956,-0.0238266314169623,0.00311608116170128,Yes,wheat1,pale yellow,H2A0M0,Asparagine-rich protein (Prism uncharacterized shell protein 1) (PUSP1),,,extracellular region [GO:0005576],GO:0005576,NA,NA
CHOYP_TNNC2.1.1.m.32533,-0.00241705527944329,0.025582234233587,Yes,wheat1,pale yellow,P02595,Calmodulin (CaM),Calmodulin family,,calcium ion binding [GO:0005509],GO:0005509,NA,NA
CHOYP_LOC100371332.1.6.m.7760,-0.0237705973988838,-0.00558241013870157,Yes,wheat1,pale yellow,Q28864,Tissue factor pathway inhibitor (TFPI) (Extrinsic pathway inhibitor) (EPI) (Lipoprotein-associated coagulation inhibitor) (LACI),,TFPI TFPI1,extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; blood coagulation [GO:0007596],GO:0004867; GO:0005615; GO:0007596,NA,NA
CHOYP_contig_005590.m.6345,-0.0243907501098191,-0.000256305709932994,Yes,wheat1,pale yellow,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024582.m.27943,-0.0239403354052789,0.00345172239032569,Yes,wheat1,pale yellow,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025827.m.29484,-0.0236116147552634,0.00735930796490349,Yes,wheat1,pale yellow,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DMOJ_GI23261.2.2.m.30988,-0.023677268744654,0.00762553872117374,Yes,wheat1,pale yellow,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DWIL_GK12566.1.1.m.26720,-0.0237504614196873,0.00800712345683085,Yes,wheat1,pale yellow,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100376426.1.3.m.28097,-0.0237599394354942,0.00301814173255899,Yes,wheat1,pale yellow,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100905544.1.3.m.6504,-0.0236049931166272,0.0090659519691765,Yes,wheat1,pale yellow,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DPSE_GA19599.1.1.m.64309,0.00455009652821305,-0.0271962623902599,Yes,salmon,salmon,P58365,Cadherin-23 (Otocadherin),,Cdh23,apical part of cell [GO:0045177]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; calcium ion binding [GO:0005509]; protein N-terminus binding [GO:0047485]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; sensory perception of sound [GO:0007605],GO:0005509; GO:0005886; GO:0007156; GO:0007605; GO:0007626; GO:0016021; GO:0032420; GO:0045177; GO:0047485; GO:0060122,GO:0060122,cell differentiation; anatomical structure development
CHOYP_CRE_01395.2.2.m.44269,0.000408386986727626,-0.0269759139425633,Yes,salmon,salmon,P22105,Tenascin-X (TN-X) (Hexabrachion-like protein),Tenascin family,TNXB HXBL TNX TNXB1 TNXB2 XB,collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251],GO:0005178; GO:0005201; GO:0005576; GO:0005615; GO:0005622; GO:0007155; GO:0008201; GO:0030036; GO:0030199; GO:0031012; GO:0032963; GO:0048251; GO:0062023; GO:0070062; GO:0098633,GO:0048251,cellular component assembly; extracellular matrix organization
CHOYP_LOC100369620.1.1.m.13590,0.00130095350334346,-0.0278216323078052,Yes,salmon,salmon,Q5E9Z7,DNA-directed RNA polymerase III subunit RPC4 (RNA polymerase III subunit C4) (DNA-directed RNA polymerase III subunit D),Eukaryotic RPC4/POLR3D RNA polymerase subunit family,POLR3D,RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; transcription by RNA polymerase III [GO:0006383],GO:0003677; GO:0003899; GO:0005666; GO:0006383; GO:0032728; GO:0045087; GO:0045089; GO:0051607,GO:0045089,immune system process; response to stress
CHOYP_LOC100552337.1.1.m.19614,-0.00189338079086752,-0.0268564621231416,Yes,salmon,salmon,Q6ZQ58,La-related protein 1 (La ribonucleoprotein domain family member 1),LARP family,Larp1 Kiaa0731 Larp,cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; polysome [GO:0005844]; TORC1 complex [GO:0031931]; eukaryotic initiation factor 4E binding [GO:0008190]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; RNA cap binding [GO:0000339]; translation activator activity [GO:0008494]; translation initiation factor binding [GO:0031369]; cell proliferation [GO:0008283]; cellular response to rapamycin [GO:0072752]; mRNA stabilization [GO:0048255]; negative regulation of translation [GO:0017148]; positive regulation of macroautophagy [GO:0016239]; positive regulation of viral genome replication [GO:0045070]; response to amino acid starvation [GO:1990928]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]; translational initiation [GO:0006413],GO:0000339; GO:0003730; GO:0005737; GO:0005844; GO:0006413; GO:0008190; GO:0008283; GO:0008494; GO:0010494; GO:0016239; GO:0017148; GO:0031369; GO:0031929; GO:0031931; GO:0038202; GO:0045070; GO:0048027; GO:0048255; GO:0072752; GO:1990928,GO:0038202; GO:0048255,signal transduction; catabolic process; cellular nitrogen compound metabolic process; nucleobase-containing compound catabolic process
CHOYP_LOC753939.1.1.m.44379,-0.00532956921570523,-0.0267624382315616,Yes,salmon,salmon,Q9H845,Acyl-CoA dehydrogenase family member 9; mitochondrial (ACAD-9) (EC 1.3.99.-),Acyl-CoA dehydrogenase family,ACAD9,dendrite [GO:0030425]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; medium-chain-acyl-CoA dehydrogenase activity [GO:0070991]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]; long-chain fatty acid metabolic process [GO:0001676]; medium-chain fatty acid metabolic process [GO:0051791]; mitochondrial respiratory chain complex I assembly [GO:0032981],GO:0000062; GO:0001676; GO:0004466; GO:0005634; GO:0005739; GO:0005743; GO:0017099; GO:0030425; GO:0031966; GO:0032981; GO:0050660; GO:0051791; GO:0070991,GO:0032981; GO:0051791,lipid metabolic process; mitochondrion organization; cellular component assembly; small molecule metabolic process; protein-containing complex assembly
CHOYP_PI3R4.1.1.m.14910,5.22371259580091e-05,-0.0270891434804087,Yes,salmon,salmon,Q99570,Phosphoinositide 3-kinase regulatory subunit 4 (PI3-kinase regulatory subunit 4) (EC 2.7.11.1) (PI3-kinase p150 subunit) (Phosphoinositide 3-kinase adaptor protein),Protein kinase superfamily; Ser/Thr protein kinase family,PIK3R4 VPS15,autophagosome [GO:0005776]; axoneme [GO:0005930]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleus-vacuole junction [GO:0071561]; phagocytic vesicle membrane [GO:0030670]; phosphatidylinositol 3-kinase complex; class III [GO:0035032]; phosphatidylinositol 3-kinase complex; class III; type I [GO:0034271]; phosphatidylinositol 3-kinase complex; class III; type II [GO:0034272]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; autophagy of peroxisome [GO:0030242]; cellular response to glucose starvation [GO:0042149]; late endosome to vacuole transport [GO:0045324]; macroautophagy [GO:0016236]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; protein phosphorylation [GO:0006468]; protein targeting to vacuole [GO:0006623]; receptor catabolic process [GO:0032801]; regulation of cytokinesis [GO:0032465]; toll-like receptor 9 signaling pathway [GO:0034162],GO:0004672; GO:0004674; GO:0005524; GO:0005770; GO:0005776; GO:0005829; GO:0005930; GO:0006468; GO:0006623; GO:0015630; GO:0016020; GO:0016236; GO:0016303; GO:0030242; GO:0030670; GO:0032465; GO:0032801; GO:0034162; GO:0034271; GO:0034272; GO:0035032; GO:0042149; GO:0043231; GO:0043552; GO:0045324; GO:0071561,GO:0032801; GO:0042149; GO:0045324,transport; response to stress; vacuolar transport; catabolic process; vesicle-mediated transport
CHOYP_SC24B.1.2.m.95,-0.00405898299723467,-0.027790520850742,Yes,salmon,salmon,O95487,Protein transport protein Sec24B (SEC24-related protein B),SEC23/SEC24 family; SEC24 subfamily,SEC24B,COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; zinc ion binding [GO:0008270]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; aorta morphogenesis [GO:0035909]; auditory receptor cell stereocilium organization [GO:0060088]; cargo loading into COPII-coated vesicle [GO:0090110]; cochlear nucleus development [GO:0021747]; COPII vesicle coating [GO:0048208]; coronary artery morphogenesis [GO:0060982]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; lung lobe morphogenesis [GO:0060463]; neural tube closure [GO:0001843]; outflow tract morphogenesis [GO:0003151]; pulmonary artery morphogenesis [GO:0061156]; regulation of cargo loading into COPII-coated vesicle [GO:1901301]; regulation of establishment of planar polarity involved in neural tube closure [GO:0090178],GO:0000139; GO:0001843; GO:0002474; GO:0003151; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0008270; GO:0012507; GO:0019886; GO:0021747; GO:0030127; GO:0035909; GO:0048208; GO:0060088; GO:0060463; GO:0060982; GO:0061156; GO:0090110; GO:0090178; GO:1901301,GO:0019886; GO:0035909; GO:0060088; GO:0060982; GO:0061156,cell morphogenesis; immune system process; embryo development; cell differentiation; anatomical structure development
CHOYP_NDUFB9.1.2.m.37494,-0.00810221819685902,-0.0262514429518727,Yes,salmon,salmon,Q02369,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9 (Complex I-B22) (CI-B22) (NADH-ubiquinone oxidoreductase B22 subunit),Complex I LYR family,NDUFB9 UQOR22,mitochondrial respiratory chain complex I [GO:0005747]; mitochondrial electron transport; NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981],GO:0005747; GO:0006120; GO:0032981,GO:0006120; GO:0032981,generation of precursor metabolites and energy; mitochondrion organization; cellular component assembly; cellular nitrogen compound metabolic process; small molecule metabolic process; protein-containing complex assembly
CHOYP_ISCW_ISCW011108.1.1.m.13934,0.00161084690847404,-0.0265680495323371,Yes,salmon,salmon,P62944,AP-2 complex subunit beta (AP105B) (Adaptor protein complex AP-2 subunit beta) (Adaptor-related protein complex 2 subunit beta) (Beta-2-adaptin) (Beta-adaptin) (Clathrin assembly protein complex 2 beta large chain) (Plasma membrane adaptor HA2/AP2 adaptin beta subunit),Adaptor complexes large subunit family,Ap2b1 Clapb1,AP-2 adaptor complex [GO:0030122]; AP-type membrane coat adaptor complex [GO:0030119]; clathrin coat [GO:0030118]; glutamatergic synapse [GO:0098978]; postsynapse [GO:0098794]; cargo receptor activity [GO:0038024]; clathrin binding [GO:0030276]; protein-containing complex binding [GO:0044877]; aorta development [GO:0035904]; clathrin coat assembly [GO:0048268]; coronary vasculature development [GO:0060976]; negative regulation of neuron death [GO:1901215]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein localization to membrane [GO:1905477]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; ventricular septum development [GO:0003281],GO:0003281; GO:0030118; GO:0030119; GO:0030122; GO:0030276; GO:0035904; GO:0038024; GO:0044877; GO:0045807; GO:0048268; GO:0060976; GO:0098794; GO:0098884; GO:0098978; GO:1901215; GO:1905477,GO:0003281; GO:0035904; GO:0048268; GO:0060976; GO:0098884,transport; vesicle-mediated transport; cellular component assembly; anatomical structure development; protein-containing complex assembly
CHOYP_LOC100377501.1.1.m.13155,-0.00724577414596104,-0.0266306402462917,Yes,salmon,salmon,Q7ZWS1,tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like (EC 1.3.1.-) (tRNA-dihydrouridine synthase 3-like),Dus family; Dus3 subfamily,dus3l,flavin adenine dinucleotide binding [GO:0050660]; metal ion binding [GO:0046872]; tRNA dihydrouridine synthase activity [GO:0017150],GO:0017150; GO:0046872; GO:0050660,NA,NA
CHOYP_FABP6.2.2.m.59518,-0.000931459418639534,-0.0270263129557599,Yes,salmon,salmon,O01812,Fatty acid-binding protein homolog 6,Calycin superfamily; Fatty-acid binding protein (FABP) family,lbp-6 W02D3.5,lipid binding [GO:0008289],GO:0008289,NA,NA
CHOYP_BRAFLDRAFT_123969.1.1.m.15145,-0.00218058723366504,-0.0275899283533667,Yes,salmon,salmon,Q9QXT0,Protein canopy homolog 2 (MIR-interacting saposin-like protein) (Putative secreted protein ZSIG9) (Transmembrane protein 4),Canopy family,Cnpy2 Msap Tmem4 Zsig9,endoplasmic reticulum [GO:0005783]; negative regulation of gene expression [GO:0010629]; positive regulation of low-density lipoprotein particle receptor biosynthetic process [GO:0045716]; regulation of low-density lipoprotein particle clearance [GO:0010988],GO:0005783; GO:0010629; GO:0010988; GO:0045716,NA,NA
CHOYP_IPO9.1.4.m.24013,0.00555611597961454,-0.0267059401109911,Yes,salmon,salmon,Q91YE6,Importin-9 (Imp9) (Importin-9a) (Imp9a) (Importin-9b) (Imp9b) (Ran-binding protein 9) (RanBP9),Importin beta family,Ipo9 Imp9 Ranbp9,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; histone binding [GO:0042393]; protein transporter activity [GO:0008565]; Ran GTPase binding [GO:0008536]; protein import into nucleus [GO:0006606]; protein stabilization [GO:0050821]; ribosome biogenesis [GO:0042254],GO:0005635; GO:0005737; GO:0005829; GO:0006606; GO:0008536; GO:0008565; GO:0042254; GO:0042393; GO:0050821,NA,NA
CHOYP_BRAFLDRAFT_283981.1.1.m.7732,-0.00594369842430662,-0.0285984610734006,Yes,salmon,salmon,Q9YHY6,Condensin complex subunit 1 (Chromosome assembly protein XCAP-D2) (Chromosome condensation-related SMC-associated protein 1) (Chromosome-associated protein D2) (Eg7) (Non-SMC condensin I complex subunit D2),CND1 (condensin subunit 1) family,ncapd2 capd2 cnap1 eg7,chromosome [GO:0005694]; cytosol [GO:0005829]; nucleus [GO:0005634]; cell division [GO:0051301]; mitotic chromosome condensation [GO:0007076],GO:0005634; GO:0005694; GO:0005829; GO:0007076; GO:0051301,NA,NA
CHOYP_CLC10.2.5.m.4673,0.000972723626535472,-0.0275174966612345,Yes,salmon,salmon,Q66S03,Galactose-specific lectin nattectin (CTL),True venom lectin family,,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]; inflammatory response [GO:0006954],GO:0005576; GO:0006954; GO:0030246; GO:0046872; GO:0090729,NA,NA
CHOYP_ABCF2.1.2.m.28360,0.000159207691025131,-0.0281273701739575,Yes,salmon,salmon,Q99LE6,ATP-binding cassette sub-family F member 2,ABC transporter superfamily; ABCF family; EF3 subfamily,Abcf2,mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887],GO:0005524; GO:0005739; GO:0016887,NA,NA
CHOYP_CALM.42.50.m.56135,0.00360183549358428,-0.0264794840670549,Yes,salmon,salmon,P0DP35,Calmodulin-2 B,Calmodulin family,calm2-b,calcium ion binding [GO:0005509]; signaling receptor binding [GO:0005102]; calcium-mediated signaling [GO:0019722],GO:0005102; GO:0005509; GO:0019722,NA,NA
CHOYP_XPO7.1.1.m.50167,-0.00530341024151338,-0.0272739051530674,Yes,salmon,salmon,Q5ZLT0,Exportin-7,Exportin family,XPO7 RCJMB04_4p4,cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; nuclear export signal receptor activity [GO:0005049]; Ran GTPase binding [GO:0008536]; protein export from nucleus [GO:0006611],GO:0005049; GO:0005643; GO:0005737; GO:0006611; GO:0008536,NA,NA
CHOYP_contig_007115.m.8183,0.00293459332143836,-0.0276337931292546,Yes,salmon,salmon,Q58DT4,Pyrroline-5-carboxylate reductase 1; mitochondrial (P5C reductase 1) (P5CR 1) (EC 1.5.1.2),Pyrroline-5-carboxylate reductase family,PYCR1,mitochondrion [GO:0005739]; identical protein binding [GO:0042802]; pyrroline-5-carboxylate reductase activity [GO:0004735]; cellular response to oxidative stress [GO:0034599]; L-proline biosynthetic process [GO:0055129]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; proline biosynthetic process [GO:0006561]; regulation of mitochondrial membrane potential [GO:0051881],GO:0004735; GO:0005739; GO:0006561; GO:0034599; GO:0042802; GO:0051881; GO:0055129; GO:1903206,NA,NA
CHOYP_ACSS3.1.1.m.64144,-0.00593080461365859,-0.0276783572531125,Yes,salmon,salmon,Q5REB8,Acyl-CoA synthetase short-chain family member 3; mitochondrial (EC 6.2.1.1),ATP-dependent AMP-binding enzyme family,ACSS3,mitochondrion [GO:0005739]; acetate-CoA ligase activity [GO:0003987]; ATP binding [GO:0005524],GO:0003987; GO:0005524; GO:0005739,NA,NA
CHOYP_AMPD2.1.2.m.1295,-0.00719109583813663,-0.0263696611805351,Yes,salmon,salmon,Q01433,AMP deaminase 2 (EC 3.5.4.6) (AMP deaminase isoform L),Metallo-dependent hydrolases superfamily; Adenosine and AMP deaminases family,AMPD2,cytosol [GO:0005829]; AMP deaminase activity [GO:0003876]; metal ion binding [GO:0046872]; cyclic purine nucleotide metabolic process [GO:0052652]; energy homeostasis [GO:0097009]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264]; purine-containing compound salvage [GO:0043101],GO:0003876; GO:0005829; GO:0006188; GO:0032264; GO:0043101; GO:0046872; GO:0052652; GO:0097009,NA,NA
CHOYP_LOC100379027.1.1.m.27022,-0.00261901092674071,-0.0264301492940636,Yes,salmon,salmon,Q5RK00,39S ribosomal protein L46; mitochondrial (L46mt) (MRP-L46),Mitochondrion-specific ribosomal protein mL46 family,Mrpl46,cell junction [GO:0030054]; mitochondrial large ribosomal subunit [GO:0005762]; nucleoplasm [GO:0005654]; hydrolase activity [GO:0016787]; structural constituent of ribosome [GO:0003735],GO:0003735; GO:0005654; GO:0005762; GO:0016787; GO:0030054,NA,NA
CHOYP_RRP5.1.1.m.7375,-0.00139824412444017,-0.026490454783373,Yes,salmon,salmon,Q14690,Protein RRP5 homolog (NF-kappa-B-binding protein) (NFBP) (Programmed cell death protein 11),,PDCD11 KIAA0185,cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; transcription factor binding [GO:0008134]; mRNA processing [GO:0006397]; rRNA processing [GO:0006364],GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006364; GO:0006397; GO:0008134; GO:0032040,NA,NA
CHOYP_BRAFLDRAFT_123736.1.1.m.48671,0.00954293750342606,-0.0264276725949308,Yes,salmon,salmon,A0A0R4IVV0,Microsomal triglyceride transfer protein large subunit,,mttp mtp,basolateral plasma membrane [GO:0016323]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; phospholipid transporter activity [GO:0005548]; cholesterol homeostasis [GO:0042632]; digestion [GO:0007586]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; long-chain fatty acid transport [GO:0015909]; medium-chain fatty acid transport [GO:0001579]; sprouting angiogenesis [GO:0002040],GO:0001579; GO:0002040; GO:0005319; GO:0005548; GO:0005783; GO:0005794; GO:0006629; GO:0006869; GO:0007586; GO:0008289; GO:0015909; GO:0016323; GO:0042157; GO:0042158; GO:0042632,NA,NA
CHOYP_ZC3HF.1.1.m.39867,-0.00349456858853946,-0.0294300918509305,Yes,salmon,salmon,Q8WU90,Zinc finger CCCH domain-containing protein 15 (DRG family-regulatory protein 1) (Likely ortholog of mouse immediate early response erythropoietin 4),ZC3H15/TMA46 family,ZC3H15 DFRP1 LEREPO4 HSPC303 HT010 MSTP012 PP730,cytosol [GO:0005829]; nucleolus [GO:0005730]; cadherin binding [GO:0045296]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cytokine-mediated signaling pathway [GO:0019221]; cytoplasmic translation [GO:0002181],GO:0000981; GO:0002181; GO:0003723; GO:0005730; GO:0005829; GO:0019221; GO:0045296; GO:0046872,NA,NA
CHOYP_U520.1.1.m.7087,0.00348784354874889,-0.0291333660076899,Yes,salmon,salmon,O75643,U5 small nuclear ribonucleoprotein 200 kDa helicase (EC 3.6.4.13) (Activating signal cointegrator 1 complex subunit 3-like 1) (BRR2 homolog) (U5 snRNP-specific 200 kDa protein) (U5-200KD),Helicase family; SKI2 subfamily,SNRNP200 ASCC3L1 HELIC2 KIAA0788,catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; ATP binding [GO:0005524]; ATP-dependent helicase activity [GO:0008026]; ATP-dependent RNA helicase activity [GO:0004004]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing; via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388],GO:0000354; GO:0000388; GO:0000398; GO:0001649; GO:0003723; GO:0004004; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0008026; GO:0016020; GO:0042802; GO:0046540; GO:0071013; GO:0071014,NA,NA
CHOYP_BRAFLDRAFT_63281.2.2.m.46528,0.00585279944661579,-0.0276573321807968,Yes,salmon,salmon,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004705.m.5404,-0.0053010109004046,-0.0264925748493679,Yes,salmon,salmon,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039363.m.44567,0.00665810292503999,-0.0263374977818059,Yes,salmon,salmon,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039460.m.44676,0.00123000350671541,-0.0278611804362621,Yes,salmon,salmon,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_GACZ.1.1.m.42619,0.000196653378531169,-0.0273758823523035,Yes,salmon,salmon,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MEG10.78.91.m.58715,0.00173739240974885,-0.0268657736153193,Yes,salmon,salmon,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ASB3.1.1.m.51103,0.0240076918041041,-0.00245111833828371,Yes,paleturquoise3,paleturquoise3,P42325,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_BRAFLDRAFT_103544.1.1.m.38439,0.0238746028144481,-0.00734950908164406,Yes,paleturquoise3,paleturquoise3,P0C6B8,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_CAH2.1.1.m.42306,0.023981718792018,0.00376245360503273,Yes,paleturquoise3,paleturquoise3,Q8UWA5,NA,NA,NA,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_contig_004572.m.5255,0.0240563862248838,-0.00333831224614758,Yes,paleturquoise3,paleturquoise3,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015692.m.18358,0.0237926152643556,-0.0074866902648208,Yes,paleturquoise3,paleturquoise3,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016567.m.19514,0.0242126348110974,-0.00489071379991703,Yes,paleturquoise3,paleturquoise3,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048541.m.57541,0.0242780497455522,-0.00501460579931219,Yes,paleturquoise3,paleturquoise3,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DMBT1.13.34.m.27666,0.0237531217120419,-0.00070331456296553,Yes,paleturquoise3,paleturquoise3,Q9UGM3,NA,NA,NA,cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; heparan sulfate binding [GO:1904399]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; signaling pattern recognition receptor activity [GO:0008329]; zymogen binding [GO:0035375]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular protein metabolic process [GO:0044267]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; viral process [GO:0016032],NA,NA,NA
CHOYP_ISCW_ISCW012957.1.2.m.51659,0.0236327363351908,-0.000683765752902354,Yes,paleturquoise3,paleturquoise3,Q9Y5K3,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; choline-phosphate cytidylyltransferase activity [GO:0004105]; phosphatidylcholine binding [GO:0031210]; ovarian follicle development [GO:0001541]; phosphatidylcholine biosynthetic process [GO:0006656]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100376308.1.1.m.60595,0.0244469368601249,-0.00267995997931589,Yes,paleturquoise3,paleturquoise3,O88281,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC100377364.2.2.m.52803,0.0237137860989847,-0.0064830690417333,Yes,paleturquoise3,paleturquoise3,Q9NRC6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; photoreceptor connecting cilium [GO:0032391]; photoreceptor disc membrane [GO:0097381]; spectrin [GO:0008091]; actin binding [GO:0003779]; dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; kinesin binding [GO:0019894]; myosin tail binding [GO:0032029]; protein self-association [GO:0043621]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; spectrin binding [GO:0030507]; actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; lysosomal transport [GO:0007041]; MAPK cascade [GO:0000165]; protein homooligomerization [GO:0051260],NA,NA,NA
CHOYP_LOC100533447.2.3.m.44496,0.023941334625648,0.00443704484504002,Yes,paleturquoise3,paleturquoise3,P22488,NA,NA,NA,cytoplasm [GO:0005737]; intermediate filament [GO:0005882]; structural molecule activity [GO:0005198],NA,NA,NA
CHOYP_LOC101169658.1.3.m.18820,0.0244774861978086,-0.00481491460007855,Yes,paleturquoise3,paleturquoise3,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101169658.2.3.m.20752,0.0247443686894174,-0.000405574959829729,Yes,paleturquoise3,paleturquoise3,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LRRX1.6.11.m.41895,0.0240825207575137,-0.00489286005540092,Yes,paleturquoise3,paleturquoise3,Q7Z5L3,NA,NA,NA,collagen trimer [GO:0005581]; extracellular region [GO:0005576]; identical protein binding [GO:0042802]; protein complex oligomerization [GO:0051259],NA,NA,NA
CHOYP_MATN1.3.5.m.46206,0.0248778455130937,-0.00293620128591217,Yes,paleturquoise3,paleturquoise3,P21941,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix organization [GO:0030198]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]; protein-containing complex assembly [GO:0065003]; regulation of bone mineralization [GO:0030500],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G97278.1.2.m.34546,0.0238656315492526,0.00215799428232442,Yes,paleturquoise3,paleturquoise3,Q9GLK0,NA,NA,NA,membrane [GO:0016020]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; keratinization [GO:0031424]; peptide cross-linking [GO:0018149]; positive regulation of cell cycle [GO:0045787]; positive regulation of keratinocyte proliferation [GO:0010838],NA,NA,NA
CHOYP_NOV.1.2.m.27550,0.0245086647813458,-0.00354993739128841,Yes,paleturquoise3,paleturquoise3,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101067833.2.3.m.25528,-0.00914070088608557,0.0246784627250624,Yes,lightsteelblue,pale purple,Q8TDB6,E3 ubiquitin-protein ligase DTX3L (EC 2.3.2.27) (B-lymphoma- and BAL-associated protein) (Protein deltex-3-like) (RING-type E3 ubiquitin transferase DTX3L) (Rhysin-2) (Rhysin2),Deltex family,DTX3L BBAP,cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; STAT family protein binding [GO:0097677]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; defense response to virus [GO:0051607]; double-strand break repair [GO:0006302]; endosome to lysosome transport [GO:0008333]; histone H2A ubiquitination [GO:0033522]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; innate immune response [GO:0045087]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; Notch signaling pathway [GO:0007219]; positive regulation of chromatin binding [GO:0035563]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of NAD+ ADP-ribosyltransferase activity [GO:1901666]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of receptor catabolic process [GO:2000646]; positive regulation of transcription; DNA-templated [GO:0045893]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000209; GO:0002230; GO:0004842; GO:0004857; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005765; GO:0005829; GO:0006302; GO:0006511; GO:0006974; GO:0007219; GO:0008047; GO:0008333; GO:0010390; GO:0015031; GO:0019899; GO:0031901; GO:0032092; GO:0032991; GO:0033522; GO:0033523; GO:0035563; GO:0042393; GO:0044389; GO:0045087; GO:0045893; GO:0046872; GO:0051444; GO:0051607; GO:0051865; GO:0070936; GO:0097677; GO:1900182; GO:1901666; GO:1902966; GO:2000646; GO:2001034,GO:0070936; GO:1900182,cellular protein modification process
CHOYP_BRAFLDRAFT_109340.1.1.m.30107,0.00190696963520882,0.0265942594775362,Yes,lightsteelblue,pale purple,Q60769,Tumor necrosis factor alpha-induced protein 3 (TNF alpha-induced protein 3) (EC 2.3.2.-) (EC 3.4.19.12) (Putative DNA-binding protein A20) (Zinc finger protein A20),Peptidase C64 family,Tnfaip3 Tnfip3,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; nucleus [GO:0005634]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; kinase binding [GO:0019900]; Lys63-specific deubiquitinase activity [GO:0061578]; protease binding [GO:0002020]; protein self-association [GO:0043621]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; ubiquitin binding [GO:0043130]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; B-1 B cell homeostasis [GO:0001922]; cell migration [GO:0016477]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to lipopolysaccharide [GO:0071222]; cytoskeleton organization [GO:0007010]; establishment of protein localization to vacuole [GO:0072666]; inflammatory response [GO:0006954]; marginal zone B cell differentiation [GO:0002315]; negative regulation of autophagy [GO:0010507]; negative regulation of B cell activation [GO:0050869]; negative regulation of CD40 signaling pathway [GO:2000349]; negative regulation of cell death [GO:0060548]; negative regulation of chronic inflammatory response [GO:0002677]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of granuloma formation [GO:0002632]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-1 beta secretion [GO:0050713]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070429]; negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070433]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; negative regulation of toll-like receptor 5 signaling pathway [GO:0034148]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of Wnt signaling pathway [GO:0030177]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K11-linked deubiquitination [GO:0035871]; protein K29-linked deubiquitination [GO:0035523]; protein K33-linked deubiquitination [GO:1990168]; protein K48-linked deubiquitination [GO:0071108]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked deubiquitination [GO:0070536]; regulation of germinal center formation [GO:0002634]; regulation of immunoglobulin production [GO:0002637]; regulation of innate immune response [GO:0045088]; response to molecule of bacterial origin [GO:0002237]; response to muramyl dipeptide [GO:0032495]; response to wounding [GO:0009611]; tolerance induction to lipopolysaccharide [GO:0072573],GO:0001922; GO:0002020; GO:0002237; GO:0002315; GO:0002632; GO:0002634; GO:0002637; GO:0002677; GO:0003677; GO:0004842; GO:0004843; GO:0005634; GO:0005737; GO:0005764; GO:0006915; GO:0006954; GO:0007010; GO:0008270; GO:0009611; GO:0010507; GO:0016477; GO:0016579; GO:0019900; GO:0030177; GO:0031397; GO:0032088; GO:0032495; GO:0032691; GO:0032703; GO:0032715; GO:0032720; GO:0034115; GO:0034140; GO:0034148; GO:0035523; GO:0035871; GO:0036459; GO:0042802; GO:0043124; GO:0043130; GO:0043231; GO:0043621; GO:0045088; GO:0045732; GO:0045736; GO:0045824; GO:0048662; GO:0050713; GO:0050728; GO:0050869; GO:0060548; GO:0061578; GO:0070301; GO:0070429; GO:0070433; GO:0070530; GO:0070536; GO:0070936; GO:0071108; GO:0071222; GO:0071947; GO:0072573; GO:0072666; GO:1902042; GO:1903364; GO:1990168; GO:2000347; GO:2000349; GO:2000352,GO:0070936,cellular protein modification process
CHOYP_LOC100377460.1.1.m.38781,0.0103314687070166,0.0269679560214615,Yes,lightsteelblue,pale purple,Q3ZBD3,Pterin-4-alpha-carbinolamine dehydratase (PHS) (EC 4.2.1.96) (4-alpha-hydroxy-tetrahydropterin dehydratase) (Dimerization cofactor of hepatocyte nuclear factor 1-alpha) (DCoH) (Dimerization cofactor of HNF1) (Phenylalanine hydroxylase-stimulating protein) (Pterin carbinolamine dehydratase) (PCD),Pterin-4-alpha-carbinolamine dehydratase family,PCBD1,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; 4-alpha-hydroxytetrahydrobiopterin dehydratase activity [GO:0008124]; identical protein binding [GO:0042802]; phenylalanine 4-monooxygenase activity [GO:0004505]; protein heterooligomerization [GO:0051291]; protein homotetramerization [GO:0051289]; tetrahydrobiopterin biosynthetic process [GO:0006729],GO:0004505; GO:0005654; GO:0005829; GO:0006729; GO:0008124; GO:0042802; GO:0051289; GO:0051291,GO:0051289,cellular component assembly; protein-containing complex assembly
CHOYP_PHUM_PHUM536560.2.2.m.59367,-0.00138013763671971,0.0251179946588896,Yes,lightsteelblue,pale purple,P47856,Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 (EC 2.6.1.16) (D-fructose-6-phosphate amidotransferase 1) (Glutamine:fructose-6-phosphate amidotransferase 1) (GFAT 1) (GFAT1) (Hexosephosphate aminotransferase 1),,Gfpt1 Gfpt,amino acid binding [GO:0016597]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]; circadian regulation of gene expression [GO:0032922]; fructose 6-phosphate metabolic process [GO:0006002]; glucosamine biosynthetic process [GO:0006042]; glutamine metabolic process [GO:0006541]; negative regulation of glycogen biosynthetic process [GO:0045719]; protein homotetramerization [GO:0051289]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047],GO:0004360; GO:0006002; GO:0006042; GO:0006047; GO:0006048; GO:0006487; GO:0006541; GO:0016597; GO:0030246; GO:0032922; GO:0045719; GO:0051289; GO:0097367,GO:0051289,cellular component assembly; protein-containing complex assembly
CHOYP_PK3CD.1.1.m.53039,-0.000572857394256496,0.0246886203150669,Yes,lightsteelblue,pale purple,O00329,Phosphatidylinositol 4;5-bisphosphate 3-kinase catalytic subunit delta isoform (PI3-kinase subunit delta) (PI3K-delta) (PI3Kdelta) (PtdIns-3-kinase subunit delta) (EC 2.7.1.153) (Phosphatidylinositol 4;5-bisphosphate 3-kinase 110 kDa catalytic subunit delta) (PtdIns-3-kinase subunit p110-delta) (p110delta),PI3/PI4-kinase family,PIK3CD,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mast cell granule [GO:0042629]; membrane [GO:0016020]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol-4;5-bisphosphate 3-kinase activity [GO:0046934]; adaptive immune response [GO:0002250]; axon guidance [GO:0007411]; B cell activation [GO:0042113]; B cell chemotaxis [GO:0035754]; B cell receptor signaling pathway [GO:0050853]; cell migration [GO:0016477]; cytokine production [GO:0001816]; cytokine-mediated signaling pathway [GO:0019221]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mast cell chemotaxis [GO:0002551]; mast cell degranulation [GO:0043303]; mast cell differentiation [GO:0060374]; natural killer cell activation [GO:0030101]; natural killer cell chemotaxis [GO:0035747]; natural killer cell differentiation [GO:0001779]; negative regulation of gene expression [GO:0010629]; neutrophil chemotaxis [GO:0030593]; neutrophil extravasation [GO:0072672]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; platelet activation [GO:0030168]; positive regulation of cell migration [GO:0030335]; positive regulation of gene expression [GO:0010628]; positive regulation of neutrophil apoptotic process [GO:0033031]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; protein phosphorylation [GO:0006468]; respiratory burst involved in defense response [GO:0002679]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; T cell chemotaxis [GO:0010818]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852],GO:0001779; GO:0001816; GO:0002250; GO:0002551; GO:0002679; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005942; GO:0006468; GO:0006954; GO:0007165; GO:0007411; GO:0010628; GO:0010629; GO:0010818; GO:0014065; GO:0014068; GO:0016020; GO:0016301; GO:0016303; GO:0016310; GO:0016477; GO:0019221; GO:0030101; GO:0030168; GO:0030217; GO:0030335; GO:0030593; GO:0033031; GO:0035004; GO:0035005; GO:0035747; GO:0035754; GO:0036092; GO:0042110; GO:0042113; GO:0042629; GO:0043303; GO:0045087; GO:0046854; GO:0046934; GO:0048015; GO:0050852; GO:0050853; GO:0051897; GO:0060374; GO:0072672,GO:0043303,immune system process; transport; vesicle-mediated transport
CHOYP_LMNB2.1.1.m.55999,-0.00899514487294235,0.0254720617597477,Yes,lightsteelblue,pale purple,P08928,Lamin Dm0,Intermediate filament family,Lam CG6944,cytoplasm [GO:0005737]; lamin filament [GO:0005638]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear lamina [GO:0005652]; nucleus [GO:0005634]; spindle pole [GO:0000922]; chromatin binding [GO:0003682]; signaling receptor binding [GO:0005102]; structural molecule activity [GO:0005198]; adult locomotory behavior [GO:0008344]; cell aging [GO:0007569]; central nervous system development [GO:0007417]; chitin-based cuticle development [GO:0040003]; chromatin silencing [GO:0006342]; compound eye morphogenesis [GO:0001745]; digestive tract morphogenesis [GO:0048546]; gonad morphogenesis [GO:0035262]; heterochromatin maintenance involved in chromatin silencing [GO:0070870]; male meiosis cytokinesis [GO:0007112]; meiosis I cytokinesis [GO:0007110]; mitotic nuclear envelope reassembly [GO:0007084]; negative regulation of cell proliferation [GO:0008285]; negative regulation of immune response [GO:0050777]; nuclear envelope organization [GO:0006998]; nuclear membrane organization [GO:0071763]; nuclear migration [GO:0007097]; nuclear pore distribution [GO:0031081]; nucleus organization [GO:0006997]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cytokinesis; actomyosin contractile ring assembly [GO:2000433]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of spindle assembly [GO:1905832]; protein localization to nuclear envelope [GO:0090435]; spermatocyte division [GO:0048137]; spermatogenesis [GO:0007283]; terminal branching; open tracheal system [GO:0007430],GO:0000922; GO:0001745; GO:0003682; GO:0005102; GO:0005198; GO:0005634; GO:0005635; GO:0005637; GO:0005638; GO:0005652; GO:0005737; GO:0006342; GO:0006997; GO:0006998; GO:0007084; GO:0007097; GO:0007110; GO:0007112; GO:0007283; GO:0007417; GO:0007430; GO:0007569; GO:0008285; GO:0008344; GO:0030838; GO:0031081; GO:0035262; GO:0040003; GO:0048137; GO:0048546; GO:0050777; GO:0070870; GO:0071763; GO:0090435; GO:1900182; GO:1905832; GO:2000433,GO:0030838; GO:1900182,cytoskeleton organization; cellular component assembly; protein-containing complex assembly
CHOYP_LOC100119086.1.1.m.55425,-0.00149297414195482,0.0262504021432225,Yes,lightsteelblue,pale purple,P16591,Tyrosine-protein kinase Fer (EC 2.7.10.2) (Feline encephalitis virus-related kinase FER) (Fujinami poultry sarcoma/Feline sarcoma-related protein Fer) (Proto-oncogene c-Fer) (Tyrosine kinase 3) (p94-Fer),Protein kinase superfamily; Tyr protein kinase family; Fes/fps subfamily,FER TYK3,cell cortex [GO:0005938]; cell junction [GO:0030054]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nucleus [GO:0005634]; ATP binding [GO:0005524]; epidermal growth factor receptor binding [GO:0005154]; lipid binding [GO:0008289]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein phosphatase 1 binding [GO:0008157]; protein tyrosine kinase activity [GO:0004713]; actin cytoskeleton reorganization [GO:0031532]; cell adhesion [GO:0007155]; cell proliferation [GO:0008283]; cell-cell adhesion mediated by cadherin [GO:0044331]; cellular response to insulin stimulus [GO:0032869]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to reactive oxygen species [GO:0034614]; chemotaxis [GO:0006935]; cytokine-mediated signaling pathway [GO:0019221]; diapedesis [GO:0050904]; extracellular matrix-cell signaling [GO:0035426]; Fc-epsilon receptor signaling pathway [GO:0038095]; insulin receptor signaling pathway via phosphatidylinositol 3-kinase [GO:0038028]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular signal transduction [GO:0035556]; Kit signaling pathway [GO:0038109]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; negative regulation of mast cell activation involved in immune response [GO:0033007]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell proliferation [GO:0042127]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of fibroblast migration [GO:0010762]; regulation of lamellipodium assembly [GO:0010591]; regulation of mast cell degranulation [GO:0043304]; regulation of protein phosphorylation [GO:0001932]; response to lipopolysaccharide [GO:0032496]; response to platelet-derived growth factor [GO:0036119]; substrate adhesion-dependent cell spreading [GO:0034446]; tyrosine phosphorylation of STAT protein [GO:0007260],GO:0000226; GO:0000278; GO:0001932; GO:0004713; GO:0004715; GO:0005154; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005938; GO:0006468; GO:0006935; GO:0007155; GO:0007260; GO:0008157; GO:0008283; GO:0008284; GO:0008289; GO:0010591; GO:0010762; GO:0018108; GO:0019221; GO:0030054; GO:0030335; GO:0030838; GO:0031234; GO:0031532; GO:0032496; GO:0032869; GO:0033007; GO:0034446; GO:0034614; GO:0035426; GO:0035556; GO:0036006; GO:0036119; GO:0038028; GO:0038095; GO:0038109; GO:0042058; GO:0042127; GO:0042995; GO:0043304; GO:0044331; GO:0046777; GO:0048008; GO:0050904; GO:0051092; GO:0070102,GO:0030838,cytoskeleton organization; cellular component assembly; protein-containing complex assembly
CHOYP_MLE.1.9.m.15462,0.000791927886365926,0.0268957690985218,Yes,lightsteelblue,pale purple,P07291,Myosin essential light chain; striated adductor muscle (E-LC) (Sulfhydryl light chain) (SHLC),,,myosin complex [GO:0016459]; calcium ion binding [GO:0005509],GO:0005509; GO:0016459,NA,NA
CHOYP_CALM.49.50.m.63320,-0.00881801545859316,0.0261784786024362,Yes,lightsteelblue,pale purple,P02595,Calmodulin (CaM),Calmodulin family,,calcium ion binding [GO:0005509],GO:0005509,NA,NA
CHOYP_CPVL.1.2.m.2978,0.00628411015593761,0.0264995563193764,Yes,lightsteelblue,pale purple,Q9H3G5,Probable serine carboxypeptidase CPVL (EC 3.4.16.-) (Carboxypeptidase; vitellogenic-like) (Vitellogenic carboxypeptidase-like protein) (VCP-like protein) (hVLP),Peptidase S10 family,CPVL VLP PSEC0124 UNQ197/PRO223,extracellular exosome [GO:0070062]; serine-type carboxypeptidase activity [GO:0004185]; proteolysis involved in cellular protein catabolic process [GO:0051603],GO:0004185; GO:0051603; GO:0070062,NA,NA
CHOYP_SMP_078690.5.5.m.64878,0.0107594093644878,0.025025664165788,Yes,lightsteelblue,pale purple,P37397,Calponin-3 (Calponin; acidic isoform) (Calponin; non-muscle isoform),Calponin family,Cnn3,actin filament [GO:0005884]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; actin binding [GO:0003779]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; protein binding; bridging [GO:0030674]; actomyosin structure organization [GO:0031032]; epithelial cell differentiation [GO:0030855]; negative regulation of ATPase activity [GO:0032780],GO:0003779; GO:0005516; GO:0005829; GO:0005874; GO:0005884; GO:0008017; GO:0014069; GO:0030425; GO:0030674; GO:0030855; GO:0031032; GO:0032780; GO:0043025; GO:0043197,NA,NA
CHOYP_MYS.7.7.m.44342,-0.00160388548347727,0.0258244410444625,Yes,lightsteelblue,pale purple,P24733,Myosin heavy chain; striated muscle,TRAFAC class myosin-kinesin ATPase superfamily; Myosin family,,myofibril [GO:0030016]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774],GO:0003774; GO:0005516; GO:0005524; GO:0030016; GO:0032982; GO:0051015,NA,NA
CHOYP_contig_043818.m.50622,-0.00555955982486434,0.0273049007919819,Yes,lightsteelblue,pale purple,Q5TZA2,Rootletin (Ciliary rootlet coiled-coil protein),Rootletin family,CROCC KIAA0445,actin cytoskeleton [GO:0015629]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary rootlet [GO:0035253]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; kinesin binding [GO:0019894]; structural molecule activity [GO:0005198]; centriole-centriole cohesion [GO:0010457]; centrosome cycle [GO:0007098]; ciliary basal body organization [GO:0032053]; epithelial structure maintenance [GO:0010669]; establishment of organelle localization [GO:0051656]; photoreceptor cell maintenance [GO:0045494]; positive regulation of cilium assembly [GO:0045724]; positive regulation of protein localization to cilium [GO:1903566]; protein localization [GO:0008104]; protein localization to organelle [GO:0033365],GO:0001917; GO:0003779; GO:0005198; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0007098; GO:0008104; GO:0010457; GO:0010669; GO:0015629; GO:0019894; GO:0032053; GO:0033365; GO:0035253; GO:0045494; GO:0045724; GO:0051656; GO:0070062; GO:1903566,NA,NA
CHOYP_LOC762871.1.1.m.37896,0.00672997269702039,0.0259319630693697,Yes,lightsteelblue,pale purple,Q5R8Z8,Ras-related protein Rab-14,Small GTPase superfamily; Rab family,RAB14,cytosol [GO:0005829]; early endosome membrane [GO:0031901]; Golgi membrane [GO:0000139]; phagocytic vesicle [GO:0045335]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; defense response to bacterium [GO:0042742]; endocytic recycling [GO:0032456]; fibroblast growth factor receptor signaling pathway [GO:0008543]; Golgi to endosome transport [GO:0006895]; phagosome maturation [GO:0090382]; protein transport [GO:0015031]; regulation of embryonic development [GO:0045995]; regulation of protein localization [GO:0032880],GO:0000139; GO:0003924; GO:0005525; GO:0005802; GO:0005829; GO:0006895; GO:0008543; GO:0015031; GO:0019003; GO:0031901; GO:0032456; GO:0032880; GO:0042742; GO:0045335; GO:0045995; GO:0055037; GO:0090382,NA,NA
CHOYP_BICRD.1.1.m.11088,-0.00538712343072194,0.0274822514249731,Yes,lightsteelblue,pale purple,Q8SWR2,Bicaudal D-related protein homolog (BICD-related protein homolog),BICDR family,CG17365 CG32137,,,NA,NA
CHOYP_contig_025032.m.28479,-0.00635405170079247,0.025167295794646,Yes,lightsteelblue,pale purple,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053582.m.64175,0.00554856542321626,0.0247420234227825,Yes,lightsteelblue,pale purple,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EATER.1.1.m.30042,-0.00557498394898204,0.0276420124845386,Yes,lightsteelblue,pale purple,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MIB1.2.4.m.35815,-0.0034199641938913,0.0293317645243492,Yes,lightsteelblue,pale purple,NA,NA,NA,NA,NA,NA,NA,NA
ALBU_BOVIN,0.00205195042830452,-0.00934116934689426,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAS1_BOVIN,0.00364778592941831,-0.00872052841558097,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_14332.1.2.m.5643,0.00541285573528794,0.000603020059034518,No,NA,NA,Q2F637,NA,NA,NA,cytoplasm [GO:0005737]; protein domain specific binding [GO:0019904],NA,NA,NA
CHOYP_14332.2.2.m.61737,-0.00610381801843818,0.00341911344674545,No,NA,NA,Q2F637,NA,NA,NA,cytoplasm [GO:0005737]; protein domain specific binding [GO:0019904],NA,NA,NA
CHOYP_1433E.1.2.m.3638,0.0115853639905371,-0.00238300859844138,No,NA,NA,P92177,NA,NA,NA,centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; germline ring canal [GO:0045172]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; phosphoserine residue binding [GO:0050815]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; transcription factor binding [GO:0008134]; axon guidance [GO:0007411]; cytoplasmic sequestering of transcription factor [GO:0042994]; determination of adult lifespan [GO:0008340]; DNA damage checkpoint [GO:0000077]; germarium-derived oocyte fate determination [GO:0007294]; imaginal disc development [GO:0007444]; mitotic cell cycle checkpoint [GO:0007093]; oocyte microtubule cytoskeleton polarization [GO:0008103]; pole cell migration [GO:0007280]; positive regulation of growth [GO:0045927]; positive regulation of hippo signaling [GO:0035332]; positive regulation of Ras protein signal transduction [GO:0046579]; regulation of growth [GO:0040008]; regulation of mitotic nuclear division [GO:0007088]; response to radiation [GO:0009314]; response to UV [GO:0009411]; wing disc dorsal/ventral pattern formation [GO:0048190],NA,NA,NA
CHOYP_1433G.2.2.m.63450,0.0166995593233298,0.0043038022238141,No,NA,NA,P68252,NA,NA,NA,cytoplasm [GO:0005737]; insulin-like growth factor receptor binding [GO:0005159]; protein domain specific binding [GO:0019904]; regulation of neuron differentiation [GO:0045664]; regulation of synaptic plasticity [GO:0048167],NA,NA,NA
CHOYP_1433G.2.2.m.63451,0.00363952085853946,0.00980383130021234,No,NA,NA,Q4R979,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; pre-mRNA intronic binding [GO:0097157]; pre-mRNA intronic pyrimidine-rich binding [GO:0097158]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cap-independent translational initiation [GO:0002190]; cell differentiation [GO:0030154]; circadian regulation of translation [GO:0097167]; entrainment of circadian clock by photoperiod [GO:0043153]; IRES-dependent translational initiation of linear mRNA [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translation in response to stress [GO:0032055]; negative regulation of translational initiation [GO:0045947]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_1433Z.1.1.m.17045,0.00390650195873591,-0.0157177002434198,No,NA,NA,Q2F637,NA,NA,NA,cytoplasm [GO:0005737]; protein domain specific binding [GO:0019904],NA,NA,NA
CHOYP_2A5D.2.3.m.32240,-0.00534932543946547,0.00269565515987779,No,NA,NA,Q14738,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase activity [GO:0004722]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; nervous system development [GO:0007399]; positive regulation of protein dephosphorylation [GO:0035307]; protein dephosphorylation [GO:0006470]; regulation of protein autophosphorylation [GO:0031952]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_2A5D.3.3.m.37716,0.00646556234658078,-0.00103824700459865,No,NA,NA,Q14738,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase activity [GO:0004722]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; nervous system development [GO:0007399]; positive regulation of protein dephosphorylation [GO:0035307]; protein dephosphorylation [GO:0006470]; regulation of protein autophosphorylation [GO:0031952]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_2AAA.1.1.m.13306,0.019445427359137,0.00750597282738811,No,NA,NA,P54612,NA,NA,NA,chromosome; centromeric region [GO:0000775]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; lateral plasma membrane [GO:0016328]; protein phosphatase type 2A complex [GO:0000159]; protein phosphatase regulator activity [GO:0019888]; chromosome segregation [GO:0007059]; protein dephosphorylation [GO:0006470]; protein-containing complex assembly [GO:0065003],NA,NA,NA
CHOYP_2AAA.1.1.m.13307,0.00313434933825209,0.000707885025146481,No,NA,NA,P54612,NA,NA,NA,chromosome; centromeric region [GO:0000775]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; lateral plasma membrane [GO:0016328]; protein phosphatase type 2A complex [GO:0000159]; protein phosphatase regulator activity [GO:0019888]; chromosome segregation [GO:0007059]; protein dephosphorylation [GO:0006470]; protein-containing complex assembly [GO:0065003],NA,NA,NA
CHOYP_3BP2.2.3.m.19302,-0.0117840187678984,-0.00112785624279877,No,NA,NA,Q06649,NA,NA,NA,phosphotyrosine residue binding [GO:0001784]; SH3 domain binding [GO:0017124]; SH3/SH2 adaptor activity [GO:0005070]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_41.2.3.m.31169,0.00679757959216022,-0.00115266428138832,No,NA,NA,Q9WV92,NA,NA,NA,cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; juxtaparanode region of axon [GO:0044224]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; actin binding [GO:0003779]; structural constituent of cytoskeleton [GO:0005200]; actomyosin structure organization [GO:0031032]; apoptotic process [GO:0006915]; cortical actin cytoskeleton organization [GO:0030866]; cortical cytoskeleton organization [GO:0030865]; cytoskeletal anchoring at plasma membrane [GO:0007016]; myelin maintenance [GO:0043217]; neuron projection morphogenesis [GO:0048812]; paranodal junction assembly [GO:0030913]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; protein localization to plasma membrane [GO:0072659]; regulation of cell growth [GO:0001558]; regulation of cell shape [GO:0008360],NA,NA,NA
CHOYP_4EBP1.1.1.m.12045,0.0139996983982387,0.000366837086967216,No,NA,NA,Q13541,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic initiation factor 4E binding [GO:0008190]; translation repressor activity [GO:0030371]; cellular response to dexamethasone stimulus [GO:0071549]; G1/S transition of mitotic cell cycle [GO:0000082]; insulin receptor signaling pathway [GO:0008286]; IRES-dependent translational initiation of linear mRNA [GO:0002192]; negative regulation of translational initiation [GO:0045947]; positive regulation of mitotic cell cycle [GO:0045931]; TOR signaling [GO:0031929],NA,NA,NA
CHOYP_4ET.1.1.m.1941,-0.0126315432413562,-0.0197538418613603,No,NA,NA,Q9NRA8,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; P-body [GO:0000932]; PML body [GO:0016605]; mRNA binding [GO:0003729]; protein transporter activity [GO:0008565]; RNA binding [GO:0003723]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of translation [GO:0017148]; stem cell population maintenance [GO:0019827],NA,NA,NA
CHOYP_5HTR.1.1.m.64867,0.00771081330299199,-0.00913916289310523,No,NA,NA,Q25414,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930],NA,NA,NA
CHOYP_5NT3.1.1.m.24925,-0.0110352964398183,-0.00933355775432751,No,NA,NA,Q5ZKF6,NA,NA,NA,cytoplasm [GO:0005737]; hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; dephosphorylation [GO:0016311]; nucleotide metabolic process [GO:0009117],NA,NA,NA
CHOYP_A1CF.1.2.m.8145,0.00265153133358446,-0.025440209746798,No,NA,NA,Q5R9H4,NA,NA,NA,apolipoprotein B mRNA editing enzyme complex [GO:0030895]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; single-stranded RNA binding [GO:0003727]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_A2M.2.3.m.54214,-0.0140180637208613,-0.00544489775835907,No,NA,NA,P20742,NA,NA,NA,blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; female pregnancy [GO:0007565],NA,NA,NA
CHOYP_A4.2.3.m.7550,-0.00931700054019845,-0.0159057933521554,No,NA,NA,Q10651,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; heparin binding [GO:0008201]; transition metal ion binding [GO:0046914]; body morphogenesis [GO:0010171]; cell differentiation [GO:0030154]; ecdysis; collagen and cuticulin-based cuticle [GO:0042395]; nematode larval development [GO:0002119]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_A4.3.3.m.22262,-0.00191822143756884,0.00514339026423021,No,NA,NA,Q8CH02,NA,NA,NA,nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_AACS.1.1.m.66267,-0.0135038296271284,0.00436760616894779,No,NA,NA,Q28BL6,NA,NA,NA,cytosol [GO:0005829]; acetoacetate-CoA ligase activity [GO:0030729]; ATP binding [GO:0005524]; fatty acid metabolic process [GO:0006631],NA,NA,NA
CHOYP_AADAT.1.1.m.12672,0.0086892103984643,0.0034750824164027,No,NA,NA,Q8N5Z0,NA,NA,NA,mitochondrial matrix [GO:0005759]; 2-aminoadipate transaminase activity [GO:0047536]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]; 2-oxoglutarate metabolic process [GO:0006103]; alpha-amino acid metabolic process [GO:1901605]; biosynthetic process [GO:0009058]; glutamate metabolic process [GO:0006536]; kynurenine metabolic process [GO:0070189]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; lysine catabolic process [GO:0006554]; tryptophan catabolic process [GO:0006569],NA,NA,NA
CHOYP_AAEL_AAEL000057.1.1.m.36013,0.00205195042830452,-0.00934116934689426,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL001424.1.1.m.40785,-0.0129999535844236,-0.00496013567189429,No,NA,NA,Q2KI92,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane peptidase complex [GO:0042720]; serine-type peptidase activity [GO:0008236]; blood circulation [GO:0008015]; brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; cerebellum vasculature development [GO:0061300]; mitochondrial respiratory chain complex assembly [GO:0033108]; ovarian follicle development [GO:0001541]; ovulation [GO:0030728]; protein processing involved in protein targeting to mitochondrion [GO:0006627]; respiratory electron transport chain [GO:0022904]; signal peptide processing [GO:0006465]; spermatogenesis [GO:0007283]; superoxide metabolic process [GO:0006801],NA,NA,NA
CHOYP_AAEL_AAEL001503.1.1.m.10649,-0.00664205134354817,0.00740531826304885,No,NA,NA,P48763,NA,NA,NA,apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; potassium ion transmembrane transport [GO:0071805]; protein localization [GO:0008104]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719],NA,NA,NA
CHOYP_AAEL_AAEL001706.1.1.m.43821,-0.0128431132862894,-0.0218888486956745,No,NA,NA,Q5ZLH0,NA,NA,NA,cytoplasm [GO:0005737]; nuclear pore central transport channel [GO:0044613]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein transporter activity [GO:0008565]; mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein import into nucleus [GO:0006606],NA,NA,NA
CHOYP_AAEL_AAEL002456.1.1.m.35591,0.0182911210723181,-0.0106594386817325,No,NA,NA,Q8BYM7,NA,NA,NA,axoneme [GO:0005930]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; radial spoke [GO:0001534]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341],NA,NA,NA
CHOYP_AAEL_AAEL002467.1.2.m.47358,0.00966286802969589,0.0207032214262638,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL003539.1.1.m.16619,-0.0117918319448309,0.0172152943026415,No,NA,NA,Q8BHJ5,NA,NA,NA,histone deacetylase complex [GO:0000118]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; histone binding [GO:0042393]; protein N-terminus binding [GO:0047485]; transcription corepressor activity [GO:0003714]; transcription regulatory region DNA binding [GO:0044212]; adipose tissue development [GO:0060612]; blastocyst hatching [GO:0001835]; fat pad development [GO:0060613]; histone deacetylation [GO:0016575]; lipid catabolic process [GO:0016042]; multicellular organism growth [GO:0035264]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of triglyceride metabolic process [GO:0090207]; response to dietary excess [GO:0002021]; white fat cell differentiation [GO:0050872],NA,NA,NA
CHOYP_AAEL_AAEL003853.1.2.m.39529,0.00720951496115733,0.000281821105321817,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL004399.1.1.m.3003,-0.00657857402170264,-0.00918685295250935,No,NA,NA,P47799,NA,NA,NA,integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; follicle-stimulating hormone receptor activity [GO:0004963]; G protein-coupled peptide receptor activity [GO:0008528]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; follicle-stimulating hormone signaling pathway [GO:0042699]; G protein-coupled receptor signaling pathway [GO:0007186]; hormone-mediated signaling pathway [GO:0009755]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of protein kinase A signaling [GO:0010738],NA,NA,NA
CHOYP_AAEL_AAEL004839.1.1.m.13815,-0.0182821321988827,0.00411885649317285,No,NA,NA,Q7TQK0,NA,NA,NA,cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; 7SK snRNA binding [GO:0097322]; chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; RNA polymerase binding [GO:0070063]; transcription coactivator binding [GO:0001223]; cell cycle [GO:0007049]; cell division [GO:0051301]; early viral transcription [GO:0019085]; late viral transcription [GO:0019086]; positive regulation of DNA-templated transcription; elongation [GO:0032786]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of muscle cell differentiation [GO:0051147]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle tissue development [GO:0007519]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_AAEL_AAEL005197.1.1.m.59507,0.00794058832768384,-0.00060654990182357,No,NA,NA,Q9HB90,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; EGO complex [GO:0034448]; Gtr1-Gtr2 GTPase complex [GO:1990131]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; nucleus [GO:0005634]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]; apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; cellular protein localization [GO:0034613]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to starvation [GO:0009267]; positive regulation of TOR signaling [GO:0032008]; regulation of autophagy [GO:0010506]; regulation of macroautophagy [GO:0016241]; regulation of TOR signaling [GO:0032006]; regulation of TORC1 signaling [GO:1903432]; response to amino acid [GO:0043200]; RNA splicing [GO:0008380]; small GTPase mediated signal transduction [GO:0007264]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_AAEL_AAEL006854.1.1.m.13363,-0.0136821502884113,0.00277490249644619,No,NA,NA,P79345,NA,NA,NA,endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cholesterol binding [GO:0015485]; cholesterol transporter activity [GO:0017127]; enzyme binding [GO:0019899]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; response to virus [GO:0009615],NA,NA,NA
CHOYP_AAEL_AAEL006988.1.1.m.49733,0.0043598084688083,0.00362080013799353,No,NA,NA,Q91857,NA,NA,NA,MLL1 complex [GO:0071339]; SAGA complex [GO:0000124]; SLIK (SAGA-like) complex [GO:0046695]; transcription factor TFIID complex [GO:0005669]; protein heterodimerization activity [GO:0046982]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation from RNA polymerase II promoter [GO:0006367],NA,NA,NA
CHOYP_AAEL_AAEL007173.1.1.m.41471,0.0012126085831207,0.0153313184329557,No,NA,NA,O43399,NA,NA,NA,cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; catalytic activity [GO:0003824]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; regulation of cell proliferation [GO:0042127],NA,NA,NA
CHOYP_AAEL_AAEL007437.1.1.m.29443,0.00202806839156309,-0.0148196248165978,No,NA,NA,P86948,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_AAEL_AAEL007549.1.1.m.13827,-0.0135725579708753,0.00388604629968508,No,NA,NA,Q9D9G2,NA,NA,NA,lysosome [GO:0005764],NA,NA,NA
CHOYP_AAEL_AAEL007787.1.1.m.13188,-0.00732257425115647,-0.0146642504795315,No,NA,NA,P13195,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 5-aminolevulinate synthase activity [GO:0003870]; pyridoxal phosphate binding [GO:0030170]; cellular response to insulin stimulus [GO:0032869]; cellular response to organic cyclic compound [GO:0071407]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to cAMP [GO:0051591]; response to cobalt ion [GO:0032025]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to gonadotropin [GO:0034698]; response to herbicide [GO:0009635]; response to hypoxia [GO:0001666]; response to nickel cation [GO:0010045]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to platinum ion [GO:0070541],NA,NA,NA
CHOYP_AAEL_AAEL008069.1.2.m.58164,0.0189571278358316,-0.006224521576325,No,NA,NA,P0C6B8,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_AAEL_AAEL008069.2.2.m.60920,0.0225370770279194,0.00967730891449748,No,NA,NA,P46531,NA,NA,NA,acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; Notch binding [GO:0005112]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transmembrane signaling receptor activity [GO:0004888]; animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell cycle arrest [GO:0007050]; cell differentiation in spinal cord [GO:0021515]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 secretion [GO:0072602]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of growth rate [GO:0045967]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; neural tube development [GO:0021915]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of JAK-STAT cascade [GO:0046427]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription; DNA-templated [GO:0045893]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; pulmonary valve morphogenesis [GO:0003184]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; regulation of transcription; DNA-templated [GO:0006355]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; tissue regeneration [GO:0042246]; transcription initiation from RNA polymerase II promoter [GO:0006367]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222],NA,NA,NA
CHOYP_AAEL_AAEL008069.2.2.m.60921,0.00936201730048594,-0.00305581836978595,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL008257.2.3.m.36861,0.00968946585961669,0.0166180298044024,No,NA,NA,P48809,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P granule [GO:0043186]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; axon guidance [GO:0007411]; negative regulation of oskar mRNA translation [GO:0007319]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of mRNA splicing; via spliceosome [GO:0048026]; positive regulation of translation [GO:0045727]; regulation of mRNA splicing; via spliceosome [GO:0048024]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_AAEL_AAEL009169.1.1.m.24699,-0.0147091911747256,-0.00330228193088716,No,NA,NA,Q3TZZ7,NA,NA,NA,endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of plasma membrane [GO:0005887]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; organelle membrane contact site [GO:0044232]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]; endocytosis [GO:0006897]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869],NA,NA,NA
CHOYP_AAEL_AAEL009187.1.1.m.25730,2.06819537055031e-05,-0.0124196373299533,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL009387.1.1.m.66163,-0.00408415910740583,0.00329166332060274,No,NA,NA,Q9NFT7,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]; cellular glucose homeostasis [GO:0001678]; fructose metabolic process [GO:0006000]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; mannose metabolic process [GO:0006013],NA,NA,NA
CHOYP_AAEL_AAEL009414.1.1.m.639,-0.00894291432603468,-0.00168859213131435,No,NA,NA,Q5BK63,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; NADH dehydrogenase activity [GO:0003954]; protein-containing complex binding [GO:0044877]; circadian rhythm [GO:0007623]; mitochondrial respiratory chain complex I assembly [GO:0032981]; response to glucose [GO:0009749]; ubiquinone-6 biosynthetic process [GO:1901006],NA,NA,NA
CHOYP_AAEL_AAEL010339.1.1.m.63259,-0.0109411326615898,0.00488861312949134,No,NA,NA,Q8R035,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; aminoacyl-tRNA hydrolase activity [GO:0004045]; translation release factor activity; codon nonspecific [GO:0016150]; mitochondrial translational termination [GO:0070126],NA,NA,NA
CHOYP_AAEL_AAEL010626.1.1.m.52019,0.0065883263884642,0.0180931628217626,No,NA,NA,P56719,NA,NA,NA,integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; orexin receptor activity [GO:0016499]; peptide hormone binding [GO:0017046]; circadian sleep/wake cycle process [GO:0022410]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of circadian sleep/wake cycle; wakefulness [GO:0010840]; regulation of cytosolic calcium ion concentration [GO:0051480],NA,NA,NA
CHOYP_AAEL_AAEL010939.1.1.m.64870,-0.0123311822221413,0.0124461897166779,No,NA,NA,Q66HY8,NA,NA,NA,endoplasmic reticulum [GO:0005783]; carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; sphinganine-1-phosphate aldolase activity [GO:0008117]; ameboidal-type cell migration [GO:0001667]; carboxylic acid metabolic process [GO:0019752]; sphingolipid catabolic process [GO:0030149]; sphingolipid metabolic process [GO:0006665],NA,NA,NA
CHOYP_AAEL_AAEL011273.1.1.m.12717,0.0108678977200967,-0.0054910232064387,No,NA,NA,Q9NWZ5,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; uridine kinase activity [GO:0004849]; CTP salvage [GO:0044211]; pyrimidine nucleoside salvage [GO:0043097]; UMP salvage [GO:0044206]; viral process [GO:0016032],NA,NA,NA
CHOYP_AAEL_AAEL011391.1.1.m.10090,0.00618279507491205,-0.0126981804827876,No,NA,NA,Q58DQ5,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462]; translation [GO:0006412],NA,NA,NA
CHOYP_AAEL_AAEL011527.1.1.m.20909,0.0131345363113451,-0.0104528724189718,No,NA,NA,Q99L45,NA,NA,NA,cytoplasm [GO:0005737]; eukaryotic translation initiation factor 2 complex [GO:0005850]; metal ion binding [GO:0046872]; translation initiation factor activity [GO:0003743]; in utero embryonic development [GO:0001701]; male germ cell proliferation [GO:0002176]; male gonad development [GO:0008584],NA,NA,NA
CHOYP_AAEL_AAEL011814.1.1.m.48797,-0.00102330611145051,-0.0134449812549459,No,NA,NA,P82924,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_AAEL_AAEL011979.1.1.m.59057,0.0196010528847892,-0.00896027139457213,No,NA,NA,Q91WQ9,NA,NA,NA,nucleus [GO:0005634]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]; spindle pole body organization [GO:0051300],NA,NA,NA
CHOYP_AAEL_AAEL012012.1.1.m.11873,0.0220667175495212,-0.0102340760916152,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL012950.1.1.m.1373,-0.0113844776830572,-0.0244366865973082,No,NA,NA,P91929,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]; mitochondrial electron transport; NADH to ubiquinone [GO:0006120],NA,NA,NA
CHOYP_AAEL_AAEL013229.1.2.m.30359,-0.0169591047060434,0.00960206869202777,No,NA,NA,P06605,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281],NA,NA,NA
CHOYP_AAEL_AAEL013229.2.2.m.57593,0.000439194760131719,-0.0017034586448507,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL014931.1.1.m.24932,0.0145313622482193,-0.0184344837498797,No,NA,NA,Q6IDD9,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; signaling adaptor activity [GO:0035591]; innate immune response [GO:0045087]; negative regulation of MyD88-independent toll-like receptor signaling pathway [GO:0034128]; regulation of neuron death [GO:1901214]; response to axon injury [GO:0048678]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_AAEL_AAEL015271.1.1.m.56223,-0.0123480459723306,0.00793002007223769,No,NA,NA,P15153,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; nuclear envelope [GO:0005635]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; phosphatidylinositol-4;5-bisphosphate 3-kinase activity [GO:0046934]; protein kinase regulator activity [GO:0019887]; actin filament organization [GO:0007015]; bone resorption [GO:0045453]; cell projection assembly [GO:0030031]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; lymphocyte aggregation [GO:0071593]; neuron projection morphogenesis [GO:0048812]; positive regulation of cell proliferation [GO:0008284]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein targeting to mitochondrion [GO:1903955]; Rac protein signal transduction [GO:0016601]; regulation of cell-substrate adhesion [GO:0010810]; regulation of hydrogen peroxide metabolic process [GO:0010310]; regulation of mast cell chemotaxis [GO:0060753]; regulation of mast cell degranulation [GO:0043304]; regulation of neutrophil migration [GO:1902622]; regulation of respiratory burst [GO:0060263]; regulation of small GTPase mediated signal transduction [GO:0051056]; regulation of T cell proliferation [GO:0042129]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_AAK1.1.1.m.14768,-0.00840622109614076,-0.023390391993875,No,NA,NA,Q2M2I8,NA,NA,NA,cell leading edge [GO:0031252]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; nucleus [GO:0005634]; terminal bouton [GO:0043195]; AP-2 adaptor complex binding [GO:0035612]; ATP binding [GO:0005524]; Notch binding [GO:0005112]; protein serine/threonine kinase activity [GO:0004674]; endocytosis [GO:0006897]; membrane organization [GO:0061024]; positive regulation of Notch signaling pathway [GO:0045747]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of clathrin-dependent endocytosis [GO:2000369]; regulation of endocytosis [GO:0030100]; regulation of protein localization [GO:0032880],NA,NA,NA
CHOYP_AAK1.1.1.m.14769,0.00160726467355595,0.00902471189384735,No,NA,NA,Q9UBL3,NA,NA,NA,histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL3/4 complex [GO:0044666]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]; beta-catenin binding [GO:0008013]; euchromatin binding [GO:1990188]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; beta-catenin-TCF complex assembly [GO:1904837]; cellular response to DNA damage stimulus [GO:0006974]; hemopoiesis [GO:0030097]; histone H3-K4 methylation [GO:0051568]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of transcription; DNA-templated [GO:0006355]; response to estrogen [GO:0043627]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_AAKG2.1.1.m.55638,0.0112925270307352,0.0103620064755728,No,NA,NA,Q9UGJ0,NA,NA,NA,cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; ADP binding [GO:0043531]; AMP binding [GO:0016208]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; cAMP-dependent protein kinase regulator activity [GO:0008603]; phosphorylase kinase regulator activity [GO:0008607]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; ATP biosynthetic process [GO:0006754]; cell cycle arrest [GO:0007050]; fatty acid biosynthetic process [GO:0006633]; glycogen metabolic process [GO:0005977]; intracellular signal transduction [GO:0035556]; macroautophagy [GO:0016236]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein kinase activity [GO:0045860]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of fatty acid metabolic process [GO:0019217]; regulation of fatty acid oxidation [GO:0046320]; regulation of glucose import [GO:0046324]; regulation of glycolytic process [GO:0006110]; sterol biosynthetic process [GO:0016126],NA,NA,NA
CHOYP_AAMP.1.1.m.13698,0.0016655345453976,0.016716328203916,No,NA,NA,Q13685,NA,NA,NA,cell surface [GO:0009986]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; heparin binding [GO:0008201]; unfolded protein binding [GO:0051082]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; positive regulation of endothelial cell migration [GO:0010595]; ribosomal large subunit biogenesis [GO:0042273]; smooth muscle cell migration [GO:0014909],NA,NA,NA
CHOYP_AASI_1435.2.35.m.17918,0.00510957344075131,-0.000770873568960176,No,NA,NA,Q99NH0,NA,NA,NA,chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275],NA,NA,NA
CHOYP_AASI_1435.28.35.m.60443,-0.00500893770365976,0.0118487283515762,No,NA,NA,O70511,NA,NA,NA,axon initial segment [GO:0043194]; cell surface [GO:0009986]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding; bridging [GO:0030674]; spectrin binding [GO:0030507]; cellular response to magnesium ion [GO:0071286]; magnesium ion homeostasis [GO:0010960]; membrane assembly [GO:0071709]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_AASI_1435.35.35.m.65339,0.00214784734152193,-0.000872101574343081,No,NA,NA,Q4UMH6,NA,NA,NA,guanosine tetraphosphate metabolic process [GO:0015969],NA,NA,NA
CHOYP_AATF.1.1.m.34004,-2.07664155134811e-05,-0.0134878536078055,No,NA,NA,Q5ZIM6,NA,NA,NA,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; leucine zipper domain binding [GO:0043522]; cell adhesion [GO:0007155]; cellular response to DNA damage stimulus [GO:0006974]; embryonic cleavage [GO:0040016]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of apoptotic process [GO:0043066]; negative regulation of superoxide anion generation [GO:0032929]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitotic cell cycle [GO:0007346]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_AATM.1.1.m.32176,0.0189541059759173,-0.00960100262151469,No,NA,NA,Q28F67,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; biosynthetic process [GO:0009058]; glutamate metabolic process [GO:0006536],NA,NA,NA
CHOYP_ABCA1.1.3.m.6501,0.0042652500802365,-0.0132926490761424,No,NA,NA,P41233,NA,NA,NA,cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; anion transmembrane transporter activity [GO:0008509]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; ATPase binding [GO:0051117]; cholesterol transporter activity [GO:0017127]; high-density lipoprotein particle binding [GO:0008035]; lipid transporter activity [GO:0005319]; phosphatidylcholine-translocating ATPase activity [GO:0090554]; phosphatidylserine-translocating ATPase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; syntaxin binding [GO:0019905]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipid transport [GO:0006869]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis; engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691],NA,NA,NA
CHOYP_ABCA1.3.3.m.56453,0.00151253339735992,-0.0129490092460305,No,NA,NA,P41233,NA,NA,NA,cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; anion transmembrane transporter activity [GO:0008509]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; ATPase binding [GO:0051117]; cholesterol transporter activity [GO:0017127]; high-density lipoprotein particle binding [GO:0008035]; lipid transporter activity [GO:0005319]; phosphatidylcholine-translocating ATPase activity [GO:0090554]; phosphatidylserine-translocating ATPase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; syntaxin binding [GO:0019905]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipid transport [GO:0006869]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis; engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691],NA,NA,NA
CHOYP_ABCA3.2.6.m.4295,-0.0135725579708753,0.00388604629968508,No,NA,NA,Q99758,NA,NA,NA,alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; lipid transporter activity [GO:0005319]; transporter activity [GO:0005215]; cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085],NA,NA,NA
CHOYP_ABCA3.5.6.m.54787,-0.00639594577434199,-0.00422707033842507,No,NA,NA,Q99758,NA,NA,NA,alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; lipid transporter activity [GO:0005319]; transporter activity [GO:0005215]; cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085],NA,NA,NA
CHOYP_ABCA4.1.1.m.31461,0.00569746642867594,-0.000846254052187188,No,NA,NA,P41233,NA,NA,NA,cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; anion transmembrane transporter activity [GO:0008509]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; ATPase binding [GO:0051117]; cholesterol transporter activity [GO:0017127]; high-density lipoprotein particle binding [GO:0008035]; lipid transporter activity [GO:0005319]; phosphatidylcholine-translocating ATPase activity [GO:0090554]; phosphatidylserine-translocating ATPase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; syntaxin binding [GO:0019905]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipid transport [GO:0006869]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis; engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691],NA,NA,NA
CHOYP_ABCB6.2.3.m.11344,0.00181286259258919,0.0192654195189296,No,NA,NA,O94760,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; amino acid binding [GO:0016597]; catalytic activity [GO:0003824]; dimethylargininase activity [GO:0016403]; metal ion binding [GO:0046872]; arginine catabolic process [GO:0006527]; arginine metabolic process [GO:0006525]; citrulline metabolic process [GO:0000052]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of vascular permeability [GO:0043116]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of angiogenesis [GO:0045766]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of systemic arterial blood pressure [GO:0003073],NA,NA,NA
CHOYP_ABCB6.3.3.m.53101,0.00678620130084429,0.00878741825264137,No,NA,NA,Q08D64,NA,NA,NA,endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626],NA,NA,NA
CHOYP_ABCE1.1.2.m.7437,0.00447222632446958,0.0133609820040408,No,NA,NA,P61222,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; endoribonuclease inhibitor activity [GO:0060698]; iron ion binding [GO:0005506]; ribosomal small subunit binding [GO:0043024]; negative regulation of endoribonuclease activity [GO:0060702]; ribosomal subunit export from nucleus [GO:0000054]; translational initiation [GO:0006413]; translational termination [GO:0006415],NA,NA,NA
CHOYP_ABCE1.2.2.m.42246,-0.00387336303228706,-0.00309837843764422,No,NA,NA,P61222,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; endoribonuclease inhibitor activity [GO:0060698]; iron ion binding [GO:0005506]; ribosomal small subunit binding [GO:0043024]; negative regulation of endoribonuclease activity [GO:0060702]; ribosomal subunit export from nucleus [GO:0000054]; translational initiation [GO:0006413]; translational termination [GO:0006415],NA,NA,NA
CHOYP_ABCF2.1.2.m.28362,0.00304675990507579,-0.0226369152245569,No,NA,NA,P79781,NA,NA,NA,cytoplasm [GO:0005737]; cytosolic small ribosomal subunit [GO:0022627]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein tag [GO:0031386]; structural constituent of ribosome [GO:0003735]; ubiquitin protein ligase binding [GO:0031625]; DNA repair [GO:0006281]; modification-dependent protein catabolic process [GO:0019941]; protein ubiquitination [GO:0016567]; translation [GO:0006412],NA,NA,NA
CHOYP_ABCG8.1.1.m.3707,0.00394536801625317,0.00291369700370642,No,NA,NA,Q9H222,NA,NA,NA,apical plasma membrane [GO:0016324]; ATP-binding cassette (ABC) transporter complex [GO:0043190]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; cholesterol transporter activity [GO:0017127]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; excretion [GO:0007588]; intestinal cholesterol absorption [GO:0030299]; negative regulation of intestinal cholesterol absorption [GO:0045796]; negative regulation of intestinal phytosterol absorption [GO:0010949]; response to drug [GO:0042493]; response to ionizing radiation [GO:0010212]; response to nutrient [GO:0007584]; transmembrane transport [GO:0055085],NA,NA,NA
CHOYP_ABHD2.2.2.m.32276,-0.00509932701445558,-0.00529577396612805,No,NA,NA,Q9QXM0,NA,NA,NA,acrosomal membrane [GO:0002080]; acrosomal vesicle [GO:0001669]; integral component of membrane [GO:0016021]; sperm flagellum [GO:0036126]; sperm plasma membrane [GO:0097524]; acylglycerol lipase activity [GO:0047372]; hormone binding [GO:0042562]; lipase activity [GO:0016298]; short-chain carboxylesterase activity [GO:0034338]; steroid hormone receptor activity [GO:0003707]; acrosome reaction [GO:0007340]; acylglycerol catabolic process [GO:0046464]; cellular lipid metabolic process [GO:0044255]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty acid catabolic process [GO:0051793]; negative regulation of cell migration [GO:0030336]; response to progesterone [GO:0032570]; response to wounding [GO:0009611]; sperm capacitation [GO:0048240]; steroid hormone mediated signaling pathway [GO:0043401],NA,NA,NA
CHOYP_ABI2.2.2.m.65629,-0.0108355079463781,0.00598640062581216,No,NA,NA,Q9QZM5,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; protein tyrosine kinase activator activity [GO:0030296]; SH3 domain binding [GO:0017124]; transcription factor binding [GO:0008134]; actin polymerization or depolymerization [GO:0008154]; postsynapse to nucleus signaling pathway [GO:0099527],NA,NA,NA
CHOYP_ABL1.1.1.m.55647,-0.00126908296662862,0.0115247140528816,No,NA,NA,P00522,NA,NA,NA,adherens junction [GO:0005912]; apical cortex [GO:0045179]; axon [GO:0030424]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; muscle tendon junction [GO:0005927]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; axis elongation [GO:0003401]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; branchiomotor neuron axon guidance [GO:0021785]; cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; compound eye development [GO:0048749]; cytoplasmic transport; nurse cell to oocyte [GO:0007303]; dendrite morphogenesis [GO:0048813]; dorsal closure [GO:0007391]; epithelial cell morphogenesis [GO:0003382]; learning or memory [GO:0007611]; morphogenesis of an epithelium [GO:0002009]; motor neuron axon guidance [GO:0008045]; negative regulation of neuron projection development [GO:0010977]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; neuron migration [GO:0001764]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; photoreceptor cell axon guidance [GO:0072499]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of protein export from nucleus [GO:0046827]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of cell proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ventral cord development [GO:0007419]; ventral furrow formation [GO:0007370],NA,NA,NA
CHOYP_ACA1_060860.1.1.m.52568,0.00553482353085891,-0.00138545099165183,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACA1_091870.1.1.m.43726,-0.014087636213527,-0.0226023029807344,No,NA,NA,Q6R520,NA,NA,NA,calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722],NA,NA,NA
CHOYP_ACA1_394750.1.2.m.54181,0.0115697627185466,0.015550017158337,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACAA2.1.1.m.30666,0.0114394113791706,-0.00843208935687764,No,NA,NA,Q3T0R7,NA,NA,NA,mitochondrion [GO:0005739]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; cellular response to hypoxia [GO:0071456]; fatty acid beta-oxidation [GO:0006635]; negative regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902109]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029],NA,NA,NA
CHOYP_ACAC.1.2.m.16888,0.00204834979311556,-0.0141830029287765,No,NA,NA,P11029,NA,NA,NA,cell [GO:0005623]; cytoplasm [GO:0005737]; acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin carboxylase activity [GO:0004075]; DBD domain binding [GO:0050692]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]; sterol response element binding [GO:0032810]; thyroid hormone receptor binding [GO:0046966]; fatty acid biosynthetic process [GO:0006633]; malonyl-CoA biosynthetic process [GO:2001295]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of biological quality [GO:0065008]; regulation of gene expression; epigenetic [GO:0040029]; response to carbohydrate [GO:0009743]; response to fatty acid [GO:0070542]; response to thyroid hormone [GO:0097066]; transport [GO:0006810],NA,NA,NA
CHOYP_ACAC.2.2.m.58115,-0.00430894344577715,-0.00631540690244347,No,NA,NA,P11029,NA,NA,NA,cell [GO:0005623]; cytoplasm [GO:0005737]; acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin carboxylase activity [GO:0004075]; DBD domain binding [GO:0050692]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]; sterol response element binding [GO:0032810]; thyroid hormone receptor binding [GO:0046966]; fatty acid biosynthetic process [GO:0006633]; malonyl-CoA biosynthetic process [GO:2001295]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of biological quality [GO:0065008]; regulation of gene expression; epigenetic [GO:0040029]; response to carbohydrate [GO:0009743]; response to fatty acid [GO:0070542]; response to thyroid hormone [GO:0097066]; transport [GO:0006810],NA,NA,NA
CHOYP_ACAD8.1.1.m.9135,-0.0131994291743921,0.00754614016052274,No,NA,NA,Q9D7B6,NA,NA,NA,mitochondrion [GO:0005739]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; lipid metabolic process [GO:0006629]; valine catabolic process [GO:0006574],NA,NA,NA
CHOYP_ACADL.1.1.m.5508,0.0107938472038812,-0.0159585228854162,No,NA,NA,P51174,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; palmitoyl-CoA oxidase activity [GO:0016401]; carnitine catabolic process [GO:0042413]; carnitine metabolic process; CoA-linked [GO:0019254]; cellular lipid catabolic process [GO:0044242]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty acid catabolic process [GO:0009062]; long-chain fatty acid catabolic process [GO:0042758]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; oxidation-reduction process [GO:0055114]; positive regulation of cold-induced thermogenesis [GO:0120162]; protein homotetramerization [GO:0051289]; regulation of cholesterol metabolic process [GO:0090181]; response to cold [GO:0009409]; temperature homeostasis [GO:0001659],NA,NA,NA
CHOYP_ACBD5.1.2.m.16744,0.00285721448177987,-0.0160442250248811,No,NA,NA,Q5T8D3,NA,NA,NA,integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; fatty-acyl-CoA binding [GO:0000062]; lipid binding [GO:0008289]; autophagy of peroxisome [GO:0030242]; fatty acid catabolic process [GO:0009062],NA,NA,NA
CHOYP_ACBP.1.4.m.15501,0.00321769576970641,-0.00592534984219981,No,NA,NA,Q9PRL8,NA,NA,NA,endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; fatty-acyl-CoA binding [GO:0000062]; lipid binding [GO:0008289],NA,NA,NA
CHOYP_ACDOPBH.1.9.m.8787,-0.0141816091754927,0.010040411887292,No,NA,NA,Q7Z0T3,NA,NA,NA,extracellular region [GO:0005576]; pheromone activity [GO:0005186],NA,NA,NA
CHOYP_ACDOPBH.5.9.m.42992,0.0222704727120319,-0.0107397066353212,No,NA,NA,Q7Z0T3,NA,NA,NA,extracellular region [GO:0005576]; pheromone activity [GO:0005186],NA,NA,NA
CHOYP_ACDOPBH.8.9.m.52946,0.000686232728993107,-0.0107331332691118,No,NA,NA,Q7Z0T3,NA,NA,NA,extracellular region [GO:0005576]; pheromone activity [GO:0005186],NA,NA,NA
CHOYP_ACDOPBH.9.9.m.63296,0.00217997094733793,-0.00807271368859912,No,NA,NA,Q98ST7,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; reduced ascorbate as one donor; and incorporation of one atom of oxygen [GO:0016715]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589],NA,NA,NA
CHOYP_ACE.2.4.m.5302,0.0175960137409608,0.0142156748230214,No,NA,NA,Q10751,NA,NA,NA,extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carboxypeptidase activity [GO:0004180]; dipeptidyl-peptidase activity [GO:0008239]; exopeptidase activity [GO:0008238]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; zinc ion binding [GO:0008270]; cell proliferation [GO:0008283]; positive regulation of blood pressure [GO:0045777]; positive regulation of systemic arterial blood pressure [GO:0003084]; primitive erythrocyte differentiation [GO:0060319]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081],NA,NA,NA
CHOYP_ACE.4.4.m.17563,-0.0135725579708753,0.00388604629968508,No,NA,NA,P09470,NA,NA,NA,basal plasma membrane [GO:0009925]; brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225]; vesicle [GO:0031982]; actin binding [GO:0003779]; bradykinin receptor binding [GO:0031711]; carboxypeptidase activity [GO:0004180]; chloride ion binding [GO:0031404]; dipeptidyl-peptidase activity [GO:0008239]; drug binding [GO:0008144]; endopeptidase activity [GO:0004175]; exopeptidase activity [GO:0008238]; metallodipeptidase activity [GO:0070573]; metallopeptidase activity [GO:0008237]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase kinase binding [GO:0031434]; peptidase activity [GO:0008233]; peptidyl-dipeptidase activity [GO:0008241]; tripeptidyl-peptidase activity [GO:0008240]; zinc ion binding [GO:0008270]; amyloid-beta metabolic process [GO:0050435]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; animal organ regeneration [GO:0031100]; arachidonic acid secretion [GO:0050482]; bradykinin catabolic process [GO:0010815]; cell proliferation in bone marrow [GO:0071838]; eating behavior [GO:0042755]; embryo development ending in birth or egg hatching [GO:0009792]; heart contraction [GO:0060047]; hormone catabolic process [GO:0042447]; kidney development [GO:0001822]; lung alveolus development [GO:0048286]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of calcium ion import [GO:0090281]; negative regulation of gap junction assembly [GO:1903597]; negative regulation of gene expression [GO:0010629]; negative regulation of glucose import [GO:0046325]; negative regulation of protein binding [GO:0032091]; negative regulation of renal sodium excretion [GO:0035814]; neutrophil mediated immunity [GO:0002446]; peptide catabolic process [GO:0043171]; peptide metabolic process [GO:0006518]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood pressure [GO:0045777]; positive regulation of inflammatory response [GO:0050729]; positive regulation of neurogenesis [GO:0050769]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein binding [GO:0032092]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of systemic arterial blood pressure [GO:0003084]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of angiotensin metabolic process [GO:0060177]; regulation of blood pressure [GO:0008217]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of smooth muscle cell migration [GO:0014910]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; response to lipopolysaccharide [GO:0032496]; sensory perception of pain [GO:0019233]; spermatogenesis [GO:0007283]; vasoconstriction [GO:0042310],NA,NA,NA
CHOYP_ACH5.1.1.m.3951,0.00205195042830453,-0.00934116934689426,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACH7.2.2.m.66217,-0.00755848869026006,-0.00986736846256615,No,NA,NA,Q27218,NA,NA,NA,cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; inorganic cation transmembrane transport [GO:0098662]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of locomotion [GO:0040012]; regulation of membrane potential [GO:0042391]; regulation of oviposition [GO:0046662]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_ACIN1A.2.2.m.51408,-0.00646612286748514,-0.0119179427625798,No,NA,NA,Q9JIX8,NA,NA,NA,ASAP complex [GO:0061574]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; nucleic acid binding [GO:0003676]; apoptotic chromosome condensation [GO:0030263]; apoptotic process [GO:0006915]; erythrocyte differentiation [GO:0030218]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; positive regulation of apoptotic process [GO:0043065]; positive regulation of monocyte differentiation [GO:0045657]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_ACL6B.1.1.m.62588,-0.00138239049053797,-0.0220375767098788,No,NA,NA,O94805,NA,NA,NA,nBAF complex [GO:0071565]; nucleolus [GO:0005730]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; structural constituent of cytoskeleton [GO:0005200]; transcription coactivator activity [GO:0003713]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord development [GO:0021510],NA,NA,NA
CHOYP_ACLA_093460.1.1.m.41459,0.00615540794812729,0.000977991926744791,No,NA,NA,O36022,NA,NA,NA,alpha-1;6-mannosyltransferase complex [GO:0000136]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; cell wall mannoprotein biosynthetic process [GO:0000032]; mannosylation [GO:0097502]; protein N-linked glycosylation [GO:0006487],NA,NA,NA
CHOYP_ACLY.1.1.m.65081,0.00441018900111353,-0.000956248173712807,No,NA,NA,Q91V92,NA,NA,NA,citrate lyase complex [GO:0009346]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; cofactor binding [GO:0048037]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA metabolic process [GO:0006084]; citrate metabolic process [GO:0006101]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]; oxaloacetate metabolic process [GO:0006107],NA,NA,NA
CHOYP_ACO13.1.1.m.30659,-0.00422199242854285,-0.000836489480175725,No,NA,NA,Q5R833,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; spindle [GO:0005819]; acyl-CoA hydrolase activity [GO:0047617],NA,NA,NA
CHOYP_ACON.1.1.m.61060,0.00609217637260524,-0.00659953702328229,No,NA,NA,Q99798,NA,NA,NA,cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; 3 iron; 4 sulfur cluster binding [GO:0051538]; 4 iron; 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; iron ion binding [GO:0005506]; citrate metabolic process [GO:0006101]; generation of precursor metabolites and energy [GO:0006091]; isocitrate metabolic process [GO:0006102]; liver development [GO:0001889]; response to isolation stress [GO:0035900]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_ACOX1.3.3.m.26948,-0.00464343905357238,0.000885918742514805,No,NA,NA,Q9R0H0,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; palmitoyl-CoA oxidase activity [GO:0016401]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; signaling receptor binding [GO:0005102]; cholesterol homeostasis [GO:0042632]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid oxidation [GO:0019395]; generation of precursor metabolites and energy [GO:0006091]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; peroxisome fission [GO:0016559]; prostaglandin metabolic process [GO:0006693]; spermatogenesis [GO:0007283]; very long-chain fatty acid metabolic process [GO:0000038],NA,NA,NA
CHOYP_ACOX3.1.1.m.60111,-0.00294666820547375,-0.000785859778151655,No,NA,NA,O15254,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; pristanoyl-CoA oxidase activity [GO:0016402]; signaling receptor binding [GO:0005102]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; lipid homeostasis [GO:0055088]; protein targeting to peroxisome [GO:0006625],NA,NA,NA
CHOYP_ACSA.1.1.m.61294,0.0194266642447696,0.00570355405414451,No,NA,NA,Q9VP61,NA,NA,NA,cytoplasm [GO:0005737]; acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; short-chain fatty acid-CoA ligase activity [GO:0031955]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; behavioral response to ethanol [GO:0048149]; fatty acid biosynthetic process [GO:0006633],NA,NA,NA
CHOYP_ACSF2.2.4.m.30204,-0.0226647746948131,0.0103356298718091,No,NA,NA,Q0P4F7,NA,NA,NA,mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ligase activity [GO:0016874]; fatty acid metabolic process [GO:0006631],NA,NA,NA
CHOYP_ACSF3.1.1.m.14825,-0.0226585903554283,0.00565677411699104,No,NA,NA,Q58DN7,NA,NA,NA,mitochondrion [GO:0005739]; ATP binding [GO:0005524]; malonyl-CoA synthetase activity [GO:0090409]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; fatty acid biosynthetic process [GO:0006633]; malonate catabolic process [GO:0090410],NA,NA,NA
CHOYP_ACSL1.1.1.m.685,0.0118541115358069,-0.0186685420551857,No,NA,NA,Q9JID6,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; mitochondrial outer membrane [GO:0005741]; peroxisomal membrane [GO:0005778]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467],NA,NA,NA
CHOYP_ACSL1.1.1.m.686,-0.00454411661318094,0.00786254898255953,No,NA,NA,Q54TR1,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; negative regulation of asexual reproduction [GO:1903665]; positive regulation of chemorepellent activity [GO:1903669]; protein localization to plasma membrane [GO:0072659]; proteolysis involved in cellular protein catabolic process [GO:0051603]; sorocarp morphogenesis [GO:0031288]; sporulation resulting in formation of a cellular spore [GO:0030435],NA,NA,NA
CHOYP_ACSL4.1.1.m.24576,-0.0120513075346553,0.00437967362441195,No,NA,NA,Q9QUJ7,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; dendritic spine development [GO:0060996]; embryonic process involved in female pregnancy [GO:0060136]; fatty acid transport [GO:0015908]; lipid biosynthetic process [GO:0008610]; lipid metabolic process [GO:0006629]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; negative regulation of prostaglandin secretion [GO:0032307]; neuron differentiation [GO:0030182]; positive regulation of cell growth [GO:0030307]; regulation of fatty acid metabolic process [GO:0019217]; response to interleukin-15 [GO:0070672]; response to nutrient [GO:0007584]; triglyceride biosynthetic process [GO:0019432],NA,NA,NA
CHOYP_ACSM3.1.1.m.23686,0.0124853054070081,0.0180426098096687,No,NA,NA,Q3UNX5,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acyl-CoA ligase activity [GO:0003996]; ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; metal ion binding [GO:0046872]; acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633],NA,NA,NA
CHOYP_ACT.13.27.m.39351,0.00657604145551256,0.00140449348657484,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACT.19.27.m.53936,0.0149471750643559,0.00706405289095721,No,NA,NA,Q5R9Z1,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; late endosome [GO:0005770]; retromer complex [GO:0030904]; metal ion binding [GO:0046872]; protein transport [GO:0015031]; retrograde transport; endosome to Golgi [GO:0042147]; retrograde transport; endosome to plasma membrane [GO:1990126],NA,NA,NA
CHOYP_ACT.22.27.m.58204,0.00657610534144891,0.00140565484153229,No,NA,NA,P10994,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_ACT.23.27.m.58454,0.000528370147298741,0.00425406425257451,No,NA,NA,O17320,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_ACT.4.27.m.14034,0.010958415045818,-0.015804395195185,No,NA,NA,Q93129,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_ACT.5.27.m.15585,-0.0135725579708752,0.00388604629968508,No,NA,NA,Q26065,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_ACT.6.27.m.15622,0.00418284563392256,-0.00825949738878815,No,NA,NA,Q92193,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_ACT1.3.7.m.25836,-0.00508213007207559,-0.0113795713020634,No,NA,NA,P53470,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_ACT1.4.7.m.29125,-0.00351634936923041,-0.0113926921186719,No,NA,NA,P02578,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_ACT3.1.3.m.23292,0.0065883263884642,0.0180931628217626,No,NA,NA,P41340,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_ACT3.3.3.m.66907,0.00385921382805755,0.00792494932385967,No,NA,NA,Q25010,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_ACT3A.1.1.m.25941,-0.0048524541200354,-0.0105234460288928,No,NA,NA,O17320,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_ACT3A.1.1.m.25943,0.00562676436762251,-0.00463295435182343,No,NA,NA,P52503,NA,NA,NA,mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; cardiovascular system development [GO:0072358]; fatty acid metabolic process [GO:0006631]; mitochondrial electron transport; NADH to ubiquinone [GO:0006120]; mitochondrion morphogenesis [GO:0070584]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; muscle contraction [GO:0006936]; reproductive system development [GO:0061458]; respiratory electron transport chain [GO:0022904],NA,NA,NA
CHOYP_ACT5.3.3.m.41147,0.00505457496322762,-0.00579646574533394,No,NA,NA,P53505,NA,NA,NA,cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_ACTC.2.6.m.15315,-0.00981646347672255,0.00149419801211368,No,NA,NA,Q93129,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_ACTC.3.6.m.21571,0.000545635823452151,-0.000655691924546722,No,NA,NA,P17126,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_ACTN.1.2.m.15252,0.016778644994095,0.0111879327685404,No,NA,NA,L7UZ85,NA,NA,NA,actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; IgE binding [GO:0019863]; actin filament bundle assembly [GO:0051017],NA,NA,NA
CHOYP_ACTN.2.2.m.63975,0.00394536801625317,0.00291369700370642,No,NA,NA,P18091,NA,NA,NA,focal adhesion [GO:0005925]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; cytoskeletal anchoring at plasma membrane [GO:0007016]; sarcomere organization [GO:0045214],NA,NA,NA
CHOYP_ACTP1.1.1.m.30455,0.00638157298335478,-0.00621502572338691,No,NA,NA,Q5UCA8,NA,NA,NA,extrinsic component of membrane [GO:0019898]; pore complex [GO:0046930]; channel activity [GO:0015267]; cation transport [GO:0006812]; hemolysis in other organism involved in symbiotic interaction [GO:0052331]; pore complex assembly [GO:0046931],NA,NA,NA
CHOYP_ACTZ.1.1.m.12877,0.0123681604985206,0.0223827908772083,No,NA,NA,P85515,NA,NA,NA,cell cortex region [GO:0099738]; centriole [GO:0005814]; centrosome [GO:0005813]; COPI-coated vesicle [GO:0030137]; dynactin complex [GO:0005869]; manchette [GO:0002177]; myelin sheath [GO:0043209]; ATP binding [GO:0005524]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_ADA.1.1.m.5625,0.0228387066678412,0.000797030773259247,No,NA,NA,Q6DG22,NA,NA,NA,cell junction [GO:0030054]; cytoplasmic vesicle lumen [GO:0060205]; cytosol [GO:0005829]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; adenosine deaminase activity [GO:0004000]; zinc ion binding [GO:0008270]; adenosine catabolic process [GO:0006154]; hypoxanthine salvage [GO:0043103]; inosine biosynthetic process [GO:0046103]; nucleotide metabolic process [GO:0009117]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168],NA,NA,NA
CHOYP_ADA17.1.3.m.798,-0.00113348829386878,0.00883946016973278,No,NA,NA,Q568K2,NA,NA,NA,nucleus [GO:0005634]; protein phosphatase 1 binding [GO:0008157]; protein serine/threonine phosphatase inhibitor activity [GO:0004865]; ubiquitin protein ligase activity [GO:0061630]; defense response to Gram-positive bacterium [GO:0050830]; negative regulation of cytokine secretion [GO:0050710]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of protein dephosphorylation [GO:0035308]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_ADA17.3.3.m.54971,0.00957176764858472,-0.0177976981803299,No,NA,NA,P27169,NA,NA,NA,blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; intracellular membrane-bounded organelle [GO:0043231]; spherical high-density lipoprotein particle [GO:0034366]; acyl-L-homoserine-lactone lactonohydrolase activity [GO:0102007]; aryldialkylphosphatase activity [GO:0004063]; arylesterase activity [GO:0004064]; calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]; protein homodimerization activity [GO:0042803]; aromatic compound catabolic process [GO:0019439]; carboxylic acid catabolic process [GO:0046395]; cholesterol metabolic process [GO:0008203]; lipoxygenase pathway [GO:0019372]; organophosphate catabolic process [GO:0046434]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of binding [GO:0051099]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of transporter activity [GO:0032411]; response to fatty acid [GO:0070542]; response to fluoride [GO:1902617]; response to nutrient levels [GO:0031667]; response to toxic substance [GO:0009636],NA,NA,NA
CHOYP_ADAL.1.1.m.57556,-0.00622709792888637,0.0156398514842057,No,NA,NA,Q4V9P6,NA,NA,NA,adenosine deaminase activity [GO:0004000]; metal ion binding [GO:0046872]; adenosine catabolic process [GO:0006154]; inosine biosynthetic process [GO:0046103]; nucleotide metabolic process [GO:0009117],NA,NA,NA
CHOYP_ADAMTS12.1.2.m.29930,-0.0175718313270308,0.00883632994904679,No,NA,NA,Q9UKP5,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976],NA,NA,NA
CHOYP_ADAMTS16.1.1.m.28149,-0.0148114634474016,-0.013738985419592,No,NA,NA,Q8TE56,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; nucleic acid binding [GO:0003676],NA,NA,NA
CHOYP_ADAMTS18.1.2.m.4932,0.0100120906543174,-0.0100212408566399,No,NA,NA,Q69Z28,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; branching involved in ureteric bud morphogenesis [GO:0001658]; male gamete generation [GO:0048232]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073],NA,NA,NA
CHOYP_ADAR.2.3.m.45677,-0.0223552689223268,0.0106337810899947,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ADD.2.5.m.15081,-0.0093675833853554,-0.0110753436251031,No,NA,NA,Q02645,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; female germline ring canal inner rim [GO:0035183]; fusome [GO:0045169]; germline ring canal [GO:0045172]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; spectrosome [GO:0045170]; actin filament binding [GO:0051015]; spectrin binding [GO:0030507]; structural molecule activity [GO:0005198]; actin filament bundle assembly [GO:0051017]; actin filament bundle organization [GO:0061572]; adult somatic muscle development [GO:0007527]; axon guidance [GO:0007411]; barbed-end actin filament capping [GO:0051016]; centrosome cycle [GO:0007098]; cystoblast division [GO:0007282]; female germ-line cyst formation [GO:0048135]; female germline ring canal formation; actin assembly [GO:0008302]; fusome organization [GO:0045478]; germ-line cyst formation [GO:0048134]; germarium-derived oocyte fate determination [GO:0007294]; meiotic spindle organization [GO:0000212]; oogenesis [GO:0048477]; ovarian fusome organization [GO:0030723]; photoreceptor cell axon guidance [GO:0072499]; sarcomere organization [GO:0045214]; testicular fusome organization [GO:0030724],NA,NA,NA
CHOYP_ADD.3.5.m.17639,0.0124127828250095,0.00607421681401,No,NA,NA,Q02645,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; female germline ring canal inner rim [GO:0035183]; fusome [GO:0045169]; germline ring canal [GO:0045172]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; spectrosome [GO:0045170]; actin filament binding [GO:0051015]; spectrin binding [GO:0030507]; structural molecule activity [GO:0005198]; actin filament bundle assembly [GO:0051017]; actin filament bundle organization [GO:0061572]; adult somatic muscle development [GO:0007527]; axon guidance [GO:0007411]; barbed-end actin filament capping [GO:0051016]; centrosome cycle [GO:0007098]; cystoblast division [GO:0007282]; female germ-line cyst formation [GO:0048135]; female germline ring canal formation; actin assembly [GO:0008302]; fusome organization [GO:0045478]; germ-line cyst formation [GO:0048134]; germarium-derived oocyte fate determination [GO:0007294]; meiotic spindle organization [GO:0000212]; oogenesis [GO:0048477]; ovarian fusome organization [GO:0030723]; photoreceptor cell axon guidance [GO:0072499]; sarcomere organization [GO:0045214]; testicular fusome organization [GO:0030724],NA,NA,NA
CHOYP_ADHX.1.1.m.60159,0.0155201895002575,-0.00310935708914187,No,NA,NA,P81431,NA,NA,NA,cytoplasm [GO:0005737]; alcohol dehydrogenase (NAD) activity [GO:0004022]; S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]; ethanol oxidation [GO:0006069],NA,NA,NA
CHOYP_AFG32.1.1.m.59372,0.0158968649835711,-0.00444723698803914,No,NA,NA,Q9Y4W6,NA,NA,NA,m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; axonogenesis [GO:0007409]; calcium import into the mitochondrion [GO:0036444]; cristae formation [GO:0042407]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; muscle fiber development [GO:0048747]; myelination [GO:0042552]; nerve development [GO:0021675]; neuromuscular junction development [GO:0007528]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of multicellular organism growth [GO:0040014]; righting reflex [GO:0060013],NA,NA,NA
CHOYP_AFG32.1.1.m.59373,0.0232192008672767,-0.00567060967249501,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AFUA_1G01020.33.50.m.43179,-0.00419413713711313,-0.00470678109842901,No,NA,NA,P16157,NA,NA,NA,axolemma [GO:0030673]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_AFUA_1G01020.7.50.m.19296,-0.0226643852735943,0.0103395651289736,No,NA,NA,Q8Q0U0,NA,NA,NA,,NA,NA,NA
CHOYP_AFURIN2.1.1.m.59865,-0.00762908749931632,-0.00740120844998631,No,NA,NA,Q92824,NA,NA,NA,extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; secretory granule [GO:0030141]; trans-Golgi network [GO:0005802]; endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; serine-type endopeptidase activity [GO:0004252]; anterior/posterior pattern specification [GO:0009952]; cardiac septum development [GO:0003279]; cell-cell signaling [GO:0007267]; coronary vasculature development [GO:0060976]; cytokine biosynthetic process [GO:0042089]; determination of left/right symmetry [GO:0007368]; embryo implantation [GO:0007566]; embryonic digestive tract development [GO:0048566]; embryonic skeletal system development [GO:0048706]; heart development [GO:0007507]; kidney development [GO:0001822]; limb morphogenesis [GO:0035108]; peptide biosynthetic process [GO:0043043]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485]; regulation of lipoprotein lipase activity [GO:0051004]; renin secretion into blood stream [GO:0002001]; respiratory tube development [GO:0030323]; signal peptide processing [GO:0006465]; viral life cycle [GO:0019058],NA,NA,NA
CHOYP_AGAP_AGAP000232.1.1.m.1999,-0.0138853875389344,0.0209374978236086,No,NA,NA,Q9Z2H2,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; GTPase activator activity [GO:0005096]; protein domain specific binding [GO:0019904]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron differentiation [GO:0045666],NA,NA,NA
CHOYP_AGAP_AGAP000991.1.1.m.5123,-1.95457754253842e-05,-0.0134879144259917,No,NA,NA,Q9JJL8,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; serine-tRNA ligase activity [GO:0004828]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434],NA,NA,NA
CHOYP_AGAP_AGAP002199.1.1.m.25337,-0.0157024433050191,-0.0149608192786797,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AGAP_AGAP002350.1.1.m.37286,0.0198344077607077,-0.0049635471565442,No,NA,NA,Q9XZ71,NA,NA,NA,troponin complex [GO:0005861]; regulation of muscle contraction [GO:0006937],NA,NA,NA
CHOYP_AGAP_AGAP002350.1.1.m.37287,0.0209717404248646,0.00717045008780549,No,NA,NA,P53683,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; abscisic acid-activated signaling pathway [GO:0009738]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777],NA,NA,NA
CHOYP_AGAP_AGAP002739.1.5.m.19925,0.015306895358271,-0.0177572076560795,No,NA,NA,P10079,NA,NA,NA,apical lamina of hyaline layer [GO:0032579]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_AGAP_AGAP002739.3.5.m.47030,0.0127209610421702,0.0211914120554459,No,NA,NA,A2RUV0,NA,NA,NA,integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_AGAP_AGAP002739.4.5.m.55695,0.00126796539837398,0.00327973651652605,No,NA,NA,P21783,NA,NA,NA,integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793],NA,NA,NA
CHOYP_AGAP_AGAP002739.5.5.m.60925,0.00767248748857586,-0.00811318854912628,No,NA,NA,P46531,NA,NA,NA,acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; Notch binding [GO:0005112]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transmembrane signaling receptor activity [GO:0004888]; animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell cycle arrest [GO:0007050]; cell differentiation in spinal cord [GO:0021515]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 secretion [GO:0072602]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of growth rate [GO:0045967]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; neural tube development [GO:0021915]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of JAK-STAT cascade [GO:0046427]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription; DNA-templated [GO:0045893]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; pulmonary valve morphogenesis [GO:0003184]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; regulation of transcription; DNA-templated [GO:0006355]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; tissue regeneration [GO:0042246]; transcription initiation from RNA polymerase II promoter [GO:0006367]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222],NA,NA,NA
CHOYP_AGAP_AGAP004136.1.3.m.24172,-0.00524231273998575,-0.00871322685542995,No,NA,NA,Q8BGS1,NA,NA,NA,cell leading edge [GO:0031252]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; cytoskeletal protein binding [GO:0008092]; protein domain specific binding [GO:0019904]; actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; apical constriction [GO:0003383]; axial mesoderm development [GO:0048318]; axial mesoderm morphogenesis [GO:0048319]; cell morphogenesis involved in differentiation [GO:0000904]; cellular response to transforming growth factor beta stimulus [GO:0071560]; ectoderm development [GO:0007398]; embryonic foregut morphogenesis [GO:0048617]; endoderm development [GO:0007492]; epithelial cell morphogenesis [GO:0003382]; epithelial to mesenchymal transition [GO:0001837]; in utero embryonic development [GO:0001701]; left/right axis specification [GO:0070986]; mesoderm development [GO:0007498]; mesoderm migration involved in gastrulation [GO:0007509]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of protein binding [GO:0032091]; neural plate morphogenesis [GO:0001839]; paraxial mesoderm development [GO:0048339]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of protein binding [GO:0032092]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of establishment of protein localization [GO:0070201]; somite rostral/caudal axis specification [GO:0032525]; somitogenesis [GO:0001756]; substrate-dependent cell migration; cell attachment to substrate [GO:0006931]; unidimensional cell growth [GO:0009826],NA,NA,NA
CHOYP_AGAP_AGAP004136.3.3.m.44418,-0.00461032666688406,0.00517628292991608,No,NA,NA,Q8BGS1,NA,NA,NA,cell leading edge [GO:0031252]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; cytoskeletal protein binding [GO:0008092]; protein domain specific binding [GO:0019904]; actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; apical constriction [GO:0003383]; axial mesoderm development [GO:0048318]; axial mesoderm morphogenesis [GO:0048319]; cell morphogenesis involved in differentiation [GO:0000904]; cellular response to transforming growth factor beta stimulus [GO:0071560]; ectoderm development [GO:0007398]; embryonic foregut morphogenesis [GO:0048617]; endoderm development [GO:0007492]; epithelial cell morphogenesis [GO:0003382]; epithelial to mesenchymal transition [GO:0001837]; in utero embryonic development [GO:0001701]; left/right axis specification [GO:0070986]; mesoderm development [GO:0007498]; mesoderm migration involved in gastrulation [GO:0007509]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of protein binding [GO:0032091]; neural plate morphogenesis [GO:0001839]; paraxial mesoderm development [GO:0048339]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of protein binding [GO:0032092]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of establishment of protein localization [GO:0070201]; somite rostral/caudal axis specification [GO:0032525]; somitogenesis [GO:0001756]; substrate-dependent cell migration; cell attachment to substrate [GO:0006931]; unidimensional cell growth [GO:0009826],NA,NA,NA
CHOYP_AGAP_AGAP004136.3.3.m.44420,0.0165928532397546,0.0024851584236299,No,NA,NA,P62864,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_AGAP_AGAP004179.1.1.m.33303,-0.0147855264111638,0.0201846631890994,No,NA,NA,Q86XE3,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; calcium ion binding [GO:0005509]; mitochondrial calcium ion transmembrane transport [GO:0006851],NA,NA,NA
CHOYP_AGAP_AGAP004481.1.1.m.8676,-0.00796875194566979,-0.015907099275066,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AGAP_AGAP004499.1.1.m.13546,0.00770581669896237,0.00192808908417931,No,NA,NA,Q96JP0,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_AGAP_AGAP004861.2.2.m.54567,0.00127250841070931,-0.0130132162550223,No,NA,NA,P28648,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; multivesicular body; internal vesicle [GO:0097487]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein-containing complex binding [GO:0044877]; cell migration [GO:0016477]; cell surface receptor signaling pathway [GO:0007166]; cell-matrix adhesion [GO:0007160]; endosome to melanosome transport [GO:0035646]; epithelial cell differentiation [GO:0030855]; negative regulation of epithelial cell migration [GO:0010633]; pigment granule maturation [GO:0048757]; positive regulation of cell adhesion [GO:0045785]; positive regulation of endocytosis [GO:0045807]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746],NA,NA,NA
CHOYP_AGAP_AGAP004868.1.1.m.60336,-0.00625662029427278,-0.00875926428651791,No,NA,NA,O43399,NA,NA,NA,cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; catalytic activity [GO:0003824]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; regulation of cell proliferation [GO:0042127],NA,NA,NA
CHOYP_AGAP_AGAP004885.1.1.m.29831,-0.00402682744518654,-0.000813220213035535,No,NA,NA,B1AR13,NA,NA,NA,mitochondrion [GO:0005739]; 2 iron; 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; protein maturation by [2Fe-2S] cluster transfer [GO:0106034],NA,NA,NA
CHOYP_AGAP_AGAP005057.1.1.m.62428,0.0123000715881362,-0.012963476266258,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AGAP_AGAP005942.1.3.m.3157,0.0126042943101295,-0.0182952213164949,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AGAP_AGAP006478.1.1.m.44472,-0.014179408597927,-0.00484261640037666,No,NA,NA,Q80TB8,NA,NA,NA,oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_AGAP_AGAP006590.1.1.m.42108,-0.0056452676468711,-0.00334461631785159,No,NA,NA,P91620,NA,NA,NA,cell junction [GO:0030054]; synapse [GO:0045202]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; actin cytoskeleton organization [GO:0030036]; intracellular signal transduction [GO:0035556]; positive regulation of filopodium assembly [GO:0051491]; regulation of axonogenesis [GO:0050770]; regulation of GTPase activity [GO:0043087]; regulation of Rho protein signal transduction [GO:0035023]; regulation of synapse structure or activity [GO:0050803],NA,NA,NA
CHOYP_AGAP_AGAP006810.1.2.m.12514,-0.00212078832001384,-0.00891837260408135,No,NA,NA,Q68ER9,NA,NA,NA,condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; NuA3a histone acetyltransferase complex [GO:1990467]; NuA3b histone acetyltransferase complex [GO:1990468]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleolus [GO:0005730]; histone H2A acetylation [GO:0043968]; histone H3-K14 acetylation [GO:0044154]; histone H3-K23 acetylation [GO:0043972]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982],NA,NA,NA
CHOYP_AGAP_AGAP007120.1.1.m.57542,0.0134363842390145,0.0202273998659239,No,NA,NA,Q01768,NA,NA,NA,cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; lamellipodium [GO:0030027]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ruffle [GO:0001726]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; drug binding [GO:0008144]; enzyme binding [GO:0019899]; fatty acid binding [GO:0005504]; G-quadruplex DNA binding [GO:0051880]; GDP binding [GO:0019003]; intermediate filament binding [GO:0019215]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; protein histidine kinase activity [GO:0004673]; protein serine/threonine kinase activity [GO:0004674]; transcription coactivator activity [GO:0003713]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; cellular response to oxidative stress [GO:0034599]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myeloid leukocyte differentiation [GO:0002762]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein complex oligomerization [GO:0051259]; regulation of epidermis development [GO:0045682]; response to growth hormone [GO:0060416]; UTP biosynthetic process [GO:0006228],NA,NA,NA
CHOYP_AGAP_AGAP007340.1.2.m.2953,-0.00554267820351206,-0.0124568139784208,No,NA,NA,P11167,NA,NA,NA,apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; cell-cell junction [GO:0005911]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; female pronucleus [GO:0001939]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; melanosome [GO:0042470]; midbody [GO:0030496]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; Z disc [GO:0030018]; D-glucose transmembrane transporter activity [GO:0055056]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; glucose transmembrane transporter activity [GO:0005355]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein self-association [GO:0043621]; xenobiotic transmembrane transporter activity [GO:0042910]; cellular hyperosmotic response [GO:0071474]; cellular response to glucose starvation [GO:0042149]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex development [GO:0021987]; dehydroascorbic acid transport [GO:0070837]; female pregnancy [GO:0007565]; glucose transmembrane transport [GO:1904659]; protein-containing complex assembly [GO:0065003]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to osmotic stress [GO:0006970]; response to Thyroglobulin triiodothyronine [GO:1904016]; xenobiotic transport [GO:0042908],NA,NA,NA
CHOYP_AGAP_AGAP007368.1.1.m.8474,0.00949977936261778,0.000266119802622835,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AGAP_AGAP007681.1.1.m.36727,-0.0135725579708753,0.00388604629968508,No,NA,NA,P55040,NA,NA,NA,cytoplasmic side of plasma membrane [GO:0009898]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233]; calcium channel regulator activity [GO:0005246]; calmodulin binding [GO:0005516]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; cell surface receptor signaling pathway [GO:0007166]; chromosome organization [GO:0051276]; immune response [GO:0006955]; metaphase plate congression [GO:0051310]; mitotic cell cycle [GO:0000278]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_AGAP_AGAP008046.1.1.m.58394,0.0164105973652417,0.000887632658355761,No,NA,NA,Q4V920,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; synapse [GO:0045202]; cytoskeletal protein binding [GO:0008092]; phospholipid binding [GO:0005543]; actin filament organization [GO:0007015]; auditory receptor cell stereocilium organization [GO:0060088]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; neuron projection morphogenesis [GO:0048812]; plasma membrane tubulation [GO:0097320]; positive regulation of dendrite development [GO:1900006],NA,NA,NA
CHOYP_AGAP_AGAP008287.1.1.m.58727,-0.00562148269582489,0.000400122164736522,No,NA,NA,Q8AVR4,NA,NA,NA,Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915],NA,NA,NA
CHOYP_AGAP_AGAP010186.1.1.m.62503,0.00205195042830452,-0.00934116934689426,No,NA,NA,Q8NDA2,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; response to stimulus [GO:0050896],NA,NA,NA
CHOYP_AGAP_AGAP010186.1.1.m.62505,0.00633394062599045,-0.00682201632352521,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AGAP_AGAP010490.1.1.m.51445,-0.0097727659188278,0.0122403843213234,No,NA,NA,Q8TDJ6,NA,NA,NA,cell junction [GO:0030054]; extracellular space [GO:0005615]; RAVE complex [GO:0043291]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; Rab GTPase binding [GO:0017137]; vacuolar acidification [GO:0007035],NA,NA,NA
CHOYP_AGAP_AGAP011617.1.2.m.29071,0.0209635531279933,-0.0129601606898922,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AGAP_AGAP013102.1.1.m.50186,0.00205195042830452,-0.00934116934689426,No,NA,NA,Q29RU1,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412],NA,NA,NA
CHOYP_AGO2.1.1.m.17145,0.0065883263884642,0.0180931628217626,No,NA,NA,Q28298,NA,NA,NA,integral component of endoplasmic reticulum membrane [GO:0030176]; protein transport [GO:0015031]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_AGPS.1.1.m.62910,-0.000918900549668718,-0.00905161545537262,No,NA,NA,P97275,NA,NA,NA,nucleolus [GO:0005730]; peroxisome [GO:0005777]; alkylglycerone-phosphate synthase activity [GO:0008609]; FAD binding [GO:0071949]; oxidoreductase activity [GO:0016491]; ether lipid biosynthetic process [GO:0008611],NA,NA,NA
CHOYP_AGRIN.2.5.m.5339,-0.0116311519633535,-0.00634179927080606,No,NA,NA,P25304,NA,NA,NA,axonal growth cone [GO:0044295]; basement membrane [GO:0005604]; cell junction [GO:0030054]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; BMP binding [GO:0036122]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; heparan sulfate proteoglycan binding [GO:0043395]; sialic acid binding [GO:0033691]; transforming growth factor beta binding [GO:0050431]; chemical synaptic transmission [GO:0007268]; neuromuscular junction development [GO:0007528]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein heterotetramerization [GO:0051290]; receptor clustering [GO:0043113]; regulation of axon guidance [GO:1902667]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of protein phosphorylation [GO:0001932]; regulation of synapse organization [GO:0050807]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse assembly [GO:0007416],NA,NA,NA
CHOYP_AGRIN.3.5.m.5652,-0.0011127659605515,-0.000965619664464837,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AGRIN.4.5.m.27580,-0.0225890139667995,0.0105044263937638,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AGSA.1.1.m.5200,0.00764273865336377,-0.000286446678939722,No,NA,NA,P15287,NA,NA,NA,extracellular space [GO:0005615]; adenosine deaminase activity [GO:0004000]; metal ion binding [GO:0046872]; adenosine catabolic process [GO:0006154],NA,NA,NA
CHOYP_AHCTF1.1.1.m.17461,0.0102172738718351,-0.00848108087937907,No,NA,NA,Q8CJF7,NA,NA,NA,chromatin [GO:0000785]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; cell cycle [GO:0007049]; cell division [GO:0051301]; hemopoiesis [GO:0030097]; mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_AIFM1.1.1.m.1582,0.013958619405117,0.00313440732621938,No,NA,NA,O95831,NA,NA,NA,cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; DNA binding [GO:0003677]; FAD binding [GO:0071949]; NAD(P)H oxidase activity [GO:0016174]; oxidoreductase activity; acting on NAD(P)H [GO:0016651]; protein dimerization activity [GO:0046983]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; cellular response to aldosterone [GO:1904045]; cellular response to estradiol stimulus [GO:0071392]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to nitric oxide [GO:0071732]; cellular response to oxygen-glucose deprivation [GO:0090650]; chromosome condensation [GO:0030261]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; mitochondrial respiratory chain complex I assembly [GO:0032981]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron apoptotic process [GO:0043525]; regulation of apoptotic DNA fragmentation [GO:1902510]; response to ischemia [GO:0002931]; response to L-glutamate [GO:1902065],NA,NA,NA
CHOYP_AIMP1.1.1.m.16360,0.00270076214062073,-0.00730417501034161,No,NA,NA,O54873,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; cytokine activity [GO:0005125]; tRNA binding [GO:0000049]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; inflammatory response [GO:0006954]; positive regulation of glucagon secretion [GO:0070094]; translation [GO:0006412],NA,NA,NA
CHOYP_AJL2.1.1.m.26431,0.00364778592941831,-0.00872052841558097,No,NA,NA,P82596,NA,NA,NA,carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_AK5.1.2.m.7331,-0.0110840497092719,-0.0140297694956243,No,NA,NA,A4IFD0,NA,NA,NA,cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; ATP metabolic process [GO:0046034]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142],NA,NA,NA
CHOYP_AKD1.2.3.m.49697,-0.0146020030629081,0.0105483718986151,No,NA,NA,Q5TCS8,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside kinase activity [GO:0019206]; nucleoside monophosphate kinase activity [GO:0050145]; AMP phosphorylation [GO:0006756]; ATP generation from ADP [GO:0006757]; CDP phosphorylation [GO:0061508]; CMP phosphorylation [GO:0061566]; dADP phosphorylation [GO:0006174]; dAMP phosphorylation [GO:0061565]; dCDP phosphorylation [GO:0061570]; dCMP phosphorylation [GO:0061567]; dGDP phosphorylation [GO:0006186]; GDP phosphorylation [GO:0061568]; nucleobase-containing small molecule interconversion [GO:0015949]; TDP phosphorylation [GO:0061571]; UDP phosphorylation [GO:0061569],NA,NA,NA
CHOYP_AKD1.3.3.m.63103,-0.0179204274391367,-0.0114944836601428,No,NA,NA,Q5TCS8,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside kinase activity [GO:0019206]; nucleoside monophosphate kinase activity [GO:0050145]; AMP phosphorylation [GO:0006756]; ATP generation from ADP [GO:0006757]; CDP phosphorylation [GO:0061508]; CMP phosphorylation [GO:0061566]; dADP phosphorylation [GO:0006174]; dAMP phosphorylation [GO:0061565]; dCDP phosphorylation [GO:0061570]; dCMP phosphorylation [GO:0061567]; dGDP phosphorylation [GO:0006186]; GDP phosphorylation [GO:0061568]; nucleobase-containing small molecule interconversion [GO:0015949]; TDP phosphorylation [GO:0061571]; UDP phosphorylation [GO:0061569],NA,NA,NA
CHOYP_AKP13.1.5.m.12951,-0.00790652310021342,-0.00571637004802836,No,NA,NA,Q12802,NA,NA,NA,actin filament [GO:0005884]; cell cortex [GO:0005938]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; cAMP-dependent protein kinase activity [GO:0004691]; guanyl-nucleotide exchange factor activity [GO:0005085]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; protein kinase A binding [GO:0051018]; protein-containing complex scaffold activity [GO:0032947]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0086023]; adrenergic receptor signaling pathway [GO:0071875]; bone development [GO:0060348]; cardiac muscle cell differentiation [GO:0055007]; cell growth involved in cardiac muscle cell development [GO:0061049]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; nuclear export [GO:0051168]; positive regulation of apoptotic process [GO:0043065]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of glucocorticoid mediated signaling pathway [GO:1900169]; regulation of sarcomere organization [GO:0060297]; regulation of small GTPase mediated signal transduction [GO:0051056],NA,NA,NA
CHOYP_AKT1.2.2.m.51125,-0.00297563637521309,-0.0115670897985382,No,NA,NA,Q8INB9,NA,NA,NA,cell cortex [GO:0005938]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cellular response to insulin stimulus [GO:0032869]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; cholesterol homeostasis [GO:0042632]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration; open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; long-term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of triglyceride catabolic process [GO:0010897]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell proliferation [GO:0008284]; positive regulation of cell size [GO:0045793]; positive regulation of lipid storage [GO:0010884]; positive regulation of organ growth [GO:0046622]; positive regulation of TORC1 signaling [GO:1904263]; protein phosphorylation [GO:0006468]; regulation of dendrite development [GO:0050773]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],NA,NA,NA
CHOYP_AL1A1.1.1.m.24832,0.013693080864648,0.0149449249392899,No,NA,NA,Q8MI17,NA,NA,NA,cytosol [GO:0005829]; aldehyde dehydrogenase (NAD) activity [GO:0004029]; retinal dehydrogenase activity [GO:0001758]; oxidation-reduction process [GO:0055114]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572],NA,NA,NA
CHOYP_AL4A1.1.1.m.28988,-0.0149353414723661,0.0173227684878746,No,NA,NA,Q7SY23,NA,NA,NA,mitochondrial matrix [GO:0005759]; 1-pyrroline-5-carboxylate dehydrogenase activity [GO:0003842]; aldehyde dehydrogenase (NAD) activity [GO:0004029]; identical protein binding [GO:0042802]; proline catabolic process to glutamate [GO:0010133],NA,NA,NA
CHOYP_AL8A1.1.1.m.13904,0.0122488536948111,-0.00418627487912214,No,NA,NA,Q66I21,NA,NA,NA,cytoplasm [GO:0005737]; oxidoreductase activity; acting on the aldehyde or oxo group of donors; NAD or NADP as acceptor [GO:0016620]; liver development [GO:0001889],NA,NA,NA
CHOYP_ALAT2.1.1.m.15163,-0.00300569749337791,0.00878575083117272,No,NA,NA,Q6GM82,NA,NA,NA,L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; L-alanine catabolic process [GO:0042853]; L-alanine metabolic process [GO:0042851],NA,NA,NA
CHOYP_ALDH2.3.3.m.25044,0.0193126798254278,0.006730635194263,No,NA,NA,P20000,NA,NA,NA,mitochondrial matrix [GO:0005759]; aldehyde dehydrogenase (NAD) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; NAD binding [GO:0051287]; ethanol catabolic process [GO:0006068],NA,NA,NA
CHOYP_ALDR.1.1.m.50075,0.0204693645668169,-0.00913782454904891,No,NA,NA,P82125,NA,NA,NA,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; 1;5-anhydro-D-fructose reductase activity [GO:0050571]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_ALF.1.3.m.25601,0.0119960494559451,-0.00537264763919294,No,NA,NA,P53442,NA,NA,NA,fructose-bisphosphate aldolase activity [GO:0004332]; glycolytic process [GO:0006096],NA,NA,NA
CHOYP_ALF.2.3.m.40474,0.00859495587453563,-0.0105125142574505,No,NA,NA,Q9GP32,NA,NA,NA,fructose-bisphosphate aldolase activity [GO:0004332]; glycolytic process [GO:0006096],NA,NA,NA
CHOYP_ALF.3.3.m.66837,0.0181714686783893,0.0133360521794142,No,NA,NA,P53442,NA,NA,NA,fructose-bisphosphate aldolase activity [GO:0004332]; glycolytic process [GO:0006096],NA,NA,NA
CHOYP_ALG1.1.1.m.40067,0.000686232728993107,-0.0107331332691118,No,NA,NA,Q921Q3,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; chitobiosyldiphosphodolichol beta-mannosyltransferase activity [GO:0004578]; protein glycosylation [GO:0006486],NA,NA,NA
CHOYP_ALKB8.1.2.m.27789,0.00342456477269677,-0.00575867096780869,No,NA,NA,Q95K79,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; iron ion binding [GO:0005506]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; 2-oxoglutarate as one donor; and incorporation of one atom each of oxygen into both donors [GO:0016706]; tRNA (uracil) methyltransferase activity [GO:0016300]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; oxidation-reduction process [GO:0055114]; tRNA methylation [GO:0030488]; tRNA wobble uridine modification [GO:0002098],NA,NA,NA
CHOYP_ALPHATUB84D.1.1.m.16562,0.00628662520316491,-0.00997803594642064,No,NA,NA,P06605,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281],NA,NA,NA
CHOYP_ALS2.1.3.m.33568,-0.00668684858197764,0.00551475142452121,No,NA,NA,Q96Q42,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; vesicle [GO:0031982]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activator activity [GO:0043539]; Rab GTPase binding [GO:0017137]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; axonogenesis [GO:0007409]; behavioral fear response [GO:0001662]; cell death [GO:0008219]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; in utero embryonic development [GO:0001701]; locomotory behavior [GO:0007626]; neuromuscular junction development [GO:0007528]; neuron projection morphogenesis [GO:0048812]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of Rac protein signal transduction [GO:0035022]; protein localization [GO:0008104]; Rac protein signal transduction [GO:0016601]; receptor recycling [GO:0001881]; regulation of endosome size [GO:0051036]; regulation of Rho protein signal transduction [GO:0035023]; response to oxidative stress [GO:0006979]; synaptic transmission; glutamatergic [GO:0035249],NA,NA,NA
CHOYP_ALS2.2.3.m.37861,0.00207843336487504,0.0143347619503348,No,NA,NA,P06144,NA,NA,NA,nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; nucleosome assembly [GO:0006334],NA,NA,NA
CHOYP_AMACR.1.1.m.21950,-0.0106019967154699,-0.00993008023015538,No,NA,NA,O09174,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; alpha-methylacyl-CoA racemase activity [GO:0008111]; signaling receptor binding [GO:0005102]; bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; fatty acid metabolic process [GO:0006631]; isoprenoid catabolic process [GO:0008300],NA,NA,NA
CHOYP_AMDHD2.2.2.m.52160,-0.00698515633640505,-0.0245752521304961,No,NA,NA,Q6P0U0,NA,NA,NA,metal ion binding [GO:0046872]; N-acetylgalactosamine-6-phosphate deacetylase activity [GO:0047419]; N-acetylglucosamine-6-phosphate deacetylase activity [GO:0008448]; carbohydrate metabolic process [GO:0005975]; N-acetylglucosamine catabolic process [GO:0006046]; N-acetylneuraminate catabolic process [GO:0019262],NA,NA,NA
CHOYP_AMO.1.5.m.28337,0.00217997094733793,-0.00807271368859912,No,NA,NA,H2A0M3,NA,NA,NA,extracellular region [GO:0005576]; copper ion binding [GO:0005507]; primary amine oxidase activity [GO:0008131]; quinone binding [GO:0048038]; amine metabolic process [GO:0009308],NA,NA,NA
CHOYP_AMO.5.5.m.66428,0.00580271742778296,0.0131622251220235,No,NA,NA,H2A0M3,NA,NA,NA,extracellular region [GO:0005576]; copper ion binding [GO:0005507]; primary amine oxidase activity [GO:0008131]; quinone binding [GO:0048038]; amine metabolic process [GO:0009308],NA,NA,NA
CHOYP_AMPL.1.1.m.27061,-0.0122031196935098,-0.0138206244023044,No,NA,NA,P00727,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; aminopeptidase activity [GO:0004177]; disordered domain specific binding [GO:0097718]; manganese ion binding [GO:0030145]; metalloexopeptidase activity [GO:0008235]; peptidase activity [GO:0008233],NA,NA,NA
CHOYP_AMRP.1.1.m.36070,-0.0110415509331754,-0.0245292814188777,No,NA,NA,P30533,NA,NA,NA,cell surface [GO:0009986]; cis-Golgi network [GO:0005801]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome [GO:0005768]; endosome lumen [GO:0031904]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; rough endoplasmic reticulum lumen [GO:0048237]; amyloid-beta binding [GO:0001540]; heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; receptor antagonist activity [GO:0048019]; signaling receptor binding [GO:0005102]; very-low-density lipoprotein particle receptor binding [GO:0070326]; amyloid-beta clearance by transcytosis [GO:0150093]; extracellular negative regulation of signal transduction [GO:1900116]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of cell death [GO:0060548]; negative regulation of protein binding [GO:0032091]; negative regulation of receptor internalization [GO:0002091]; negative regulation of very-low-density lipoprotein particle clearance [GO:0010916]; positive regulation of amyloid-beta clearance [GO:1900223]; regulation of receptor-mediated endocytosis [GO:0048259],NA,NA,NA
CHOYP_AMY.2.3.m.15473,0.00822839809467208,-0.0230722174838207,No,NA,NA,P91778,NA,NA,NA,alpha-amylase activity [GO:0004556]; alpha-amylase activity (releasing maltohexaose) [GO:0103025]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_AMY.3.3.m.64271,0.0200744641558208,-0.00725188667473269,No,NA,NA,P91778,NA,NA,NA,alpha-amylase activity [GO:0004556]; alpha-amylase activity (releasing maltohexaose) [GO:0103025]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_AN13B.1.1.m.15287,0.00459779930666522,-0.0106479733927458,No,NA,NA,Q6PD24,NA,NA,NA,late endosome [GO:0005770]; plasma membrane [GO:0005886],NA,NA,NA
CHOYP_ANGP4.3.7.m.24608,0.0180876254101897,0.00363605182597548,No,NA,NA,P57756,NA,NA,NA,collagen trimer [GO:0005581]; extracellular region [GO:0005576]; extrinsic component of external side of plasma membrane [GO:0031232]; carbohydrate binding [GO:0030246]; G protein-coupled receptor binding [GO:0001664]; metal ion binding [GO:0046872]; sialic acid binding [GO:0033691]; signaling pattern recognition receptor activity [GO:0008329]; cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation; lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of interleukin-8 secretion [GO:2000484]; protein localization to cell surface [GO:0034394]; recognition of apoptotic cell [GO:0043654],NA,NA,NA
CHOYP_ANGP4.4.7.m.33574,0.0097898718807849,0.0042585487296704,No,NA,NA,Q24K15,NA,NA,NA,extracellular region [GO:0005576]; receptor tyrosine kinase binding [GO:0030971]; angiogenesis [GO:0001525],NA,NA,NA
CHOYP_ANK.2.3.m.19487,-0.00839358679886001,0.00358047220248571,No,NA,NA,G5E8K5,NA,NA,NA,axon [GO:0030424]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; dendrite [GO:0030425]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; protein binding; bridging [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of action potential [GO:0045760]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]; synapse organization [GO:0050808],NA,NA,NA
CHOYP_ANK3.3.9.m.6798,0.00536162637679124,-0.00165865610287358,No,NA,NA,Q01484,NA,NA,NA,A band [GO:0031672]; apical plasma membrane [GO:0016324]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding; bridging [GO:0030674]; protein kinase binding [GO:0019901]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005],NA,NA,NA
CHOYP_ANK3.7.9.m.43272,-0.00350299655168787,-0.00782956480530089,No,NA,NA,Q01484,NA,NA,NA,A band [GO:0031672]; apical plasma membrane [GO:0016324]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding; bridging [GO:0030674]; protein kinase binding [GO:0019901]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005],NA,NA,NA
CHOYP_ANKK1.1.1.m.56194,0.0233766757832703,0.00265499596176775,No,NA,NA,Q9ULJ7,NA,NA,NA,endosome [GO:0005768]; protein transport [GO:0015031]; retrograde transport; endosome to plasma membrane [GO:1990126],NA,NA,NA
CHOYP_ANKMY2.1.1.m.18238,0.00535193133726465,0.00849360228094695,No,NA,NA,Q0VCS9,NA,NA,NA,cilium [GO:0005929]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_ANKRD27.1.1.m.12550,0.000686232728993108,-0.0107331332691118,No,NA,NA,Q5REW9,NA,NA,NA,cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; protein transport [GO:0015031],NA,NA,NA
CHOYP_ANKRD5.1.2.m.11711,-0.0153077150799472,0.0133795604699795,No,NA,NA,Q9D2J7,NA,NA,NA,,NA,NA,NA
CHOYP_ANKY2.2.2.m.44213,0.00990099117331699,-0.00598681479381513,No,NA,NA,Q0VCS9,NA,NA,NA,cilium [GO:0005929]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_ANLN.1.1.m.6530,0.0073922430166684,0.00450002190405702,No,NA,NA,Q801E2,NA,NA,NA,bleb [GO:0032059]; cell cortex region [GO:0099738]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; actin binding [GO:0003779]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of bleb assembly [GO:1904172],NA,NA,NA
CHOYP_ANM12.1.1.m.53881,0.000463018821118919,-0.0183617088628301,No,NA,NA,A2XYY8,NA,NA,NA,methyltransferase activity [GO:0008168]; protein methylation [GO:0006479],NA,NA,NA
CHOYP_ANM3.1.1.m.376,0.00205195042830452,-0.00934116934689426,No,NA,NA,O60678,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; histone-arginine N-methyltransferase activity [GO:0008469]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; nucleic acid binding [GO:0003676]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; ribosome binding [GO:0043022]; histone arginine methylation [GO:0034969]; negative regulation of protein ubiquitination [GO:0031397]; peptidyl-arginine methylation; to asymmetrical-dimethyl arginine [GO:0019919]; protein methylation [GO:0006479]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_ANM5.1.1.m.1529,0.0143699922352742,-0.0111820370826448,No,NA,NA,O14744,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; histone methyltransferase complex [GO:0035097]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; E-box binding [GO:0070888]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; histone-arginine N-methyltransferase activity [GO:0008469]; identical protein binding [GO:0042802]; methyl-CpG binding [GO:0008327]; methyltransferase activity [GO:0008168]; protein heterodimerization activity [GO:0046982]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; ribonucleoprotein complex binding [GO:0043021]; transcription corepressor activity [GO:0003714]; cell proliferation [GO:0008283]; circadian regulation of gene expression [GO:0032922]; DNA-templated transcription; termination [GO:0006353]; endothelial cell activation [GO:0042118]; Golgi ribbon formation [GO:0090161]; histone arginine methylation [GO:0034969]; histone H4-R3 methylation [GO:0043985]; liver regeneration [GO:0097421]; negative regulation of cell differentiation [GO:0045596]; peptidyl-arginine methylation [GO:0018216]; peptidyl-arginine N-methylation [GO:0035246]; positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:1904992]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of DNA methylation [GO:0044030]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of mitotic nuclear division [GO:0007088]; regulation of signal transduction by p53 class mediator [GO:1901796]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_ANR11.1.1.m.56842,-0.00296597666138371,0.00348453400233056,No,NA,NA,Q6UB98,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654],NA,NA,NA
CHOYP_ANR17.1.2.m.772,-0.0124266041275491,-0.0199567193345285,No,NA,NA,Q99NH0,NA,NA,NA,chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275],NA,NA,NA
CHOYP_ANR31.1.1.m.61075,-0.0142845702412216,0.0141687243721656,No,NA,NA,Q8N7Z5,NA,NA,NA,,NA,NA,NA
CHOYP_ANR40.1.1.m.1429,-0.00599732944803901,0.00333378426859288,No,NA,NA,Q5SUE8,NA,NA,NA,,NA,NA,NA
CHOYP_ANS1B.1.1.m.46724,0.0113487630786793,-0.00696235151852551,No,NA,NA,A5PMU4,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; regulation of synaptic plasticity by receptor localization to synapse [GO:1900383],NA,NA,NA
CHOYP_ANT_25430.1.2.m.613,-0.00472425815303406,-0.0218699379062736,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ANT_25430.2.2.m.5862,-0.0154960072638948,0.00410924993036271,No,NA,NA,P55906,NA,NA,NA,extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; cell proliferation [GO:0008283]; extracellular matrix organization [GO:0030198],NA,NA,NA
CHOYP_ANXA4.1.2.m.19913,-0.0228038105013068,0.00557047714869261,No,NA,NA,P08132,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; chondroitin sulfate binding [GO:0035374]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; epithelial cell differentiation [GO:0030855]; Notch signaling pathway [GO:0007219],NA,NA,NA
CHOYP_ANXA7.1.4.m.4514,-0.0201804472828534,0.010947832920181,No,NA,NA,Q07076,NA,NA,NA,chromaffin granule membrane [GO:0042584]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176],NA,NA,NA
CHOYP_AOF.1.1.m.7109,0.00297343633090985,0.00633878651191981,No,NA,NA,Q6NSN2,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; primary amine oxidase activity [GO:0008131]; catecholamine metabolic process [GO:0006584]; cellular biogenic amine catabolic process [GO:0042402]; neurotransmitter catabolic process [GO:0042135],NA,NA,NA
CHOYP_AP1G1.1.1.m.13111,0.011319812693333,-0.0129908054316147,No,NA,NA,P22892,NA,NA,NA,AP-1 adaptor complex [GO:0030121]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; microtubule cytoskeleton [GO:0015630]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; collagen binding [GO:0005518]; GTP-dependent protein binding [GO:0030742]; kinesin binding [GO:0019894]; protein C-terminus binding [GO:0008022]; Rab GTPase binding [GO:0017137]; endosome to melanosome transport [GO:0035646]; Golgi to lysosome transport [GO:0090160]; intracellular protein transport [GO:0006886]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of natural killer cell degranulation [GO:0043323]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_AP1M1.1.1.m.56248,0.00502969758154893,-0.0112508913630378,No,NA,NA,Q9BXS5,NA,NA,NA,clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; trans-Golgi network membrane [GO:0032588]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; endosome to melanosome transport [GO:0035646]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; neutrophil degranulation [GO:0043312]; regulation of defense response to virus by virus [GO:0050690],NA,NA,NA
CHOYP_AP2A2.1.1.m.62726,0.00377666155829164,-0.0124689641695696,No,NA,NA,P17427,NA,NA,NA,AP-2 adaptor complex [GO:0030122]; cytoplasmic vesicle [GO:0031410]; membrane coat [GO:0030117]; secretory granule [GO:0030141]; synaptic vesicle [GO:0008021]; clathrin adaptor activity [GO:0035615]; disordered domain specific binding [GO:0097718]; phosphatidylinositol binding [GO:0035091]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; regulation of hematopoietic stem cell differentiation [GO:1902036]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_AP2M1.1.1.m.25996,0.0197583155645467,-0.00251496985126917,No,NA,NA,Q5ZMP6,NA,NA,NA,clathrin adaptor complex [GO:0030131]; clathrin-coated pit [GO:0005905]; plasma membrane [GO:0005886]; lipid binding [GO:0008289]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_AP2S1.1.1.m.61530,-0.000340543211813623,0.0103176006726798,No,NA,NA,P62744,NA,NA,NA,AP-2 adaptor complex [GO:0030122]; plasma membrane [GO:0005886]; protein transporter activity [GO:0008565]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_AP3M2.1.1.m.43706,0.0112298961899093,-0.0203818855256132,No,NA,NA,Q5R478,NA,NA,NA,axon cytoplasm [GO:1904115]; clathrin adaptor complex [GO:0030131]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; Rab GTPase binding [GO:0017137]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_APBP2.1.1.m.62244,0.00394536801625317,0.00291369700370642,No,NA,NA,A5HK05,NA,NA,NA,cytoplasmic vesicle membrane [GO:0030659]; microtubule [GO:0005874]; nucleus [GO:0005634]; intracellular transport [GO:0046907]; protein transport [GO:0015031],NA,NA,NA
CHOYP_API5.1.1.m.17066,0.00799093769934847,0.00936043035415778,No,NA,NA,Q9BZZ5,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; fibroblast growth factor binding [GO:0017134]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; negative regulation of fibroblast apoptotic process [GO:2000270],NA,NA,NA
CHOYP_APLA.1.2.m.191,0.00635006767079293,-0.00669497120252799,No,NA,NA,O88444,NA,NA,NA,cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; Schaffer collateral - CA1 synapse [GO:0098685]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calcium- and calmodulin-responsive adenylate cyclase activity [GO:0008294]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; axonogenesis [GO:0007409]; brain development [GO:0007420]; cAMP biosynthetic process [GO:0006171]; cAMP-mediated signaling [GO:0019933]; cellular response to calcium ion [GO:0071277]; cellular response to forskolin [GO:1904322]; circadian rhythm [GO:0007623]; long-term memory [GO:0007616]; modulation of chemical synaptic transmission [GO:0050804]; neuroinflammatory response [GO:0150076]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of long-term synaptic potentiation [GO:1900273]; regulation of circadian rhythm [GO:0042752]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to lithium ion [GO:0010226],NA,NA,NA
CHOYP_APLP.1.2.m.5955,-0.0105786187116629,-0.0124626439955876,No,NA,NA,Q9U943,NA,NA,NA,extracellular region [GO:0005576]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_APLP.2.2.m.55987,-0.0143684992127372,-0.00931118193310099,No,NA,NA,Q9U943,NA,NA,NA,extracellular region [GO:0005576]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_APN.1.3.m.316,0.00217997094733793,-0.00807271368859912,No,NA,NA,O57579,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_APPBP2.1.1.m.9093,-0.018947602031284,0.00475222429080239,No,NA,NA,Q92624,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; nucleus [GO:0005634]; microtubule motor activity [GO:0003777]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907],NA,NA,NA
CHOYP_AQR.1.1.m.9127,-0.00723363617341941,-0.0225934996756103,No,NA,NA,O60306,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; transcription-coupled nucleotide-excision repair [GO:0006283],NA,NA,NA
CHOYP_ARALYDRAFT_472154.1.1.m.29819,0.0190718460441863,-0.00305038104830382,No,NA,NA,Q9FSG7,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_ARB_02478.1.1.m.29725,0.0143329592790332,-0.00113857516386301,No,NA,NA,D4B1Z7,NA,NA,NA,extracellular region [GO:0005576]; FAD binding [GO:0071949]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_ARC1A.1.1.m.56262,0.00779047889658168,0.01508211957894,No,NA,NA,Q92747,NA,NA,NA,actin cytoskeleton [GO:0015629]; Arp2/3 protein complex [GO:0005885]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin cytoskeleton organization [GO:0030036]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; ephrin receptor signaling pathway [GO:0048013]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; membrane organization [GO:0061024],NA,NA,NA
CHOYP_ARC1A.1.1.m.56263,0.0126071181566438,0.0176660158788306,No,NA,NA,Q1JP79,NA,NA,NA,Arp2/3 protein complex [GO:0005885]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin filament binding [GO:0051015]; Arp2/3 complex-mediated actin nucleation [GO:0034314],NA,NA,NA
CHOYP_ARF2.1.3.m.10738,-0.00521593753771119,-0.00298351702268793,No,NA,NA,P84082,NA,NA,NA,cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_ARF4.1.2.m.8401,-0.00711564806236196,-0.0261036977832377,No,NA,NA,P51644,NA,NA,NA,Golgi apparatus [GO:0005794]; GTP binding [GO:0005525]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_ARF6.1.2.m.3974,0.00394337136896061,0.0125713291085315,No,NA,NA,P62332,NA,NA,NA,cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; filopodium membrane [GO:0031527]; Flemming body [GO:0090543]; glutamatergic synapse [GO:0098978]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; ruffle [GO:0001726]; GTP binding [GO:0005525]; protein N-terminus binding [GO:0047485]; thioesterase binding [GO:0031996]; actin cytoskeleton organization [GO:0030036]; cellular response to nerve growth factor stimulus [GO:1990090]; cortical actin cytoskeleton organization [GO:0030866]; endocytic recycling [GO:0032456]; establishment of epithelial cell polarity [GO:0090162]; hepatocyte apoptotic process [GO:0097284]; intracellular protein transport [GO:0006886]; liver development [GO:0001889]; maintenance of postsynaptic density structure [GO:0099562]; myeloid cell apoptotic process [GO:0033028]; negative regulation of dendrite development [GO:2000171]; negative regulation of protein localization to cell surface [GO:2000009]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to cell surface [GO:0034394]; protein localization to endosome [GO:0036010]; regulation of dendritic spine development [GO:0060998]; regulation of filopodium assembly [GO:0051489]; regulation of presynapse assembly [GO:1905606]; regulation of Rac protein signal transduction [GO:0035020]; ruffle assembly [GO:0097178]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_ARGI.1.2.m.3263,-0.0150156306192282,0.0152257991049686,No,NA,NA,P49900,NA,NA,NA,arginase activity [GO:0004053]; metal ion binding [GO:0046872]; arginine metabolic process [GO:0006525]; urea cycle [GO:0000050],NA,NA,NA
CHOYP_ARH.2.2.m.25884,-0.0110893206225408,-0.00846015167863943,No,NA,NA,Q801G1,NA,NA,NA,cytoplasm [GO:0005737]; cholesterol metabolic process [GO:0008203]; endocytosis [GO:0006897],NA,NA,NA
CHOYP_ARHG7.3.5.m.37182,0.0118857167322592,0.00406987502126777,No,NA,NA,O55043,NA,NA,NA,cell cortex [GO:0005938]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; GABA-ergic synapse [GO:0098982]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase binding [GO:0019901]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; astrocyte cell migration [GO:0043615]; lamellipodium assembly [GO:0030032]; positive regulation of apoptotic process [GO:0043065]; postsynaptic actin cytoskeleton organization [GO:0098974]; presynaptic actin cytoskeleton organization [GO:0099140]; regulation of Rho protein signal transduction [GO:0035023]; small GTPase mediated signal transduction [GO:0007264],NA,NA,NA
CHOYP_ARHGAP12B.1.2.m.36731,0.0161295082304258,-0.000592111286733278,No,NA,NA,Q8C0D4,NA,NA,NA,cytoplasm [GO:0005737]; phagocytic cup [GO:0001891]; GTPase activator activity [GO:0005096]; actin filament organization [GO:0007015]; morphogenesis of an epithelial sheet [GO:0002011]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; phagocytosis; engulfment [GO:0006911]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_ARHGAP8.1.1.m.25503,-0.00966937597283606,-0.0118632613952297,No,NA,NA,P85298,NA,NA,NA,cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_ARHGEF3.1.1.m.13898,-0.00797514195899861,0.00621452054446955,No,NA,NA,Q9N0A8,NA,NA,NA,cytoplasm [GO:0005737]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; intracellular signal transduction [GO:0035556]; regulation of Rho protein signal transduction [GO:0035023],NA,NA,NA
CHOYP_ARI2.1.1.m.34963,0.00714844121100091,-0.0125178450429907,No,NA,NA,O76924,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_ARI4B.1.1.m.56056,-0.0174165808873582,0.00726279450196021,No,NA,NA,Q9JKB5,NA,NA,NA,nucleus [GO:0005634]; transcription regulatory region DNA binding [GO:0044212]; chromatin organization [GO:0006325]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_ARID3A.1.1.m.55743,0.00864486304764265,-0.0119183127816597,No,NA,NA,Q5XGD9,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_ARIP4.3.3.m.33366,0.0132468857420282,0.0174142026309224,No,NA,NA,A4IHD2,NA,NA,NA,nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386],NA,NA,NA
CHOYP_ARL6.1.2.m.29833,-0.000364746958221676,-0.00231146217282703,No,NA,NA,Q5M9P8,NA,NA,NA,axoneme [GO:0005930]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; gastrulation [GO:0007369]; intracellular protein transport [GO:0006886]; Kupffer's vesicle development [GO:0070121]; melanosome transport [GO:0032402]; pectoral fin development [GO:0033339]; protein localization to cilium [GO:0061512]; regulation of Notch signaling pathway [GO:0008593]; response to stimulus [GO:0050896]; vesicle-mediated transport [GO:0016192]; visual perception [GO:0007601],NA,NA,NA
CHOYP_ARL6IP1.1.1.m.13877,0.0124980337551447,0.00941555360708137,No,NA,NA,Q9JKW0,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; Sec61 translocon complex [GO:0005784]; identical protein binding [GO:0042802]; apoptotic process [GO:0006915]; cotranslational protein targeting to membrane [GO:0006613]; endoplasmic reticulum tubular network formation [GO:0071787]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of L-glutamate import across plasma membrane [GO:0002038],NA,NA,NA
CHOYP_ARL8A.1.1.m.12151,-0.0173478025517935,-0.00297974553002056,No,NA,NA,Q6P8C8,NA,NA,NA,late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; vacuolar membrane [GO:0005774]; GTP binding [GO:0005525]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059],NA,NA,NA
CHOYP_ARMC6.1.1.m.28786,-0.00964434567815598,-0.0108478712966552,No,NA,NA,Q8BNU0,NA,NA,NA,cytosol [GO:0005829]; hematopoietic progenitor cell differentiation [GO:0002244],NA,NA,NA
CHOYP_ARMC9.1.1.m.57265,-0.00140873715383122,-0.00353865641726826,No,NA,NA,Q5R629,NA,NA,NA,ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cilium assembly [GO:0060271],NA,NA,NA
CHOYP_ARNT.1.1.m.19078,-0.00772628108057272,-0.0108749369312532,No,NA,NA,O15945,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription factor complex [GO:0090575]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; myosin binding [GO:0017022]; protein heterodimerization activity [GO:0046982]; sequence-specific DNA binding [GO:0043565]; brain development [GO:0007420]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; central nervous system development [GO:0007417]; glial cell migration [GO:0008347]; insulin receptor signaling pathway [GO:0008286]; limb development [GO:0060173]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of R7 cell differentiation [GO:0045676]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_ARP2.1.1.m.43520,0.00516212292242959,0.00024440908830367,No,NA,NA,Q5BL41,NA,NA,NA,Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; ATP binding [GO:0005524]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_ARP3.1.1.m.6867,0.00909352354203364,-0.0065068323049818,No,NA,NA,Q5R8R1,NA,NA,NA,Arp2/3 protein complex [GO:0005885]; brush border [GO:0005903]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; asymmetric cell division [GO:0008356]; cellular response to interferon-gamma [GO:0071346]; cilium assembly [GO:0060271]; establishment or maintenance of cell polarity [GO:0007163]; meiotic chromosome movement towards spindle pole [GO:0016344]; meiotic cytokinesis [GO:0033206]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spindle localization [GO:0051653],NA,NA,NA
CHOYP_ARP6.1.1.m.17920,-0.0117878144160044,-0.00209571387480701,No,NA,NA,Q9GZN1,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; chromatin remodeling [GO:0006338],NA,NA,NA
CHOYP_ARP8.1.1.m.10729,-2.86941978881579e-05,-0.0166073546436701,No,NA,NA,D2I1E3,NA,NA,NA,centrosome [GO:0005813]; Ino80 complex [GO:0031011]; ATP binding [GO:0005524]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281],NA,NA,NA
CHOYP_ARPC2.1.1.m.50573,0.0109992982197596,0.0159778365805162,No,NA,NA,Q3MHR7,NA,NA,NA,Arp2/3 protein complex [GO:0005885]; cell junction [GO:0030054]; cytosol [GO:0005829]; neuron projection [GO:0043005]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; synapse [GO:0045202]; actin filament binding [GO:0051015]; structural constituent of cytoskeleton [GO:0005200]; actin filament polymerization [GO:0030041]; Arp2/3 complex-mediated actin nucleation [GO:0034314],NA,NA,NA
CHOYP_ARPC4.2.2.m.35677,-0.00328658803692584,0.0121319739013598,No,NA,NA,P59999,NA,NA,NA,Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]; protein binding; bridging [GO:0030674]; structural constituent of cytoskeleton [GO:0005200]; actin filament polymerization [GO:0030041]; Arp2/3 complex-mediated actin nucleation [GO:0034314],NA,NA,NA
CHOYP_ARRB.1.2.m.25932,0.0134905336144167,0.010084859420682,No,NA,NA,Q4R562,NA,NA,NA,clathrin-coated pit [GO:0005905]; cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_ARRD.6.1.1.m.9470,-0.0169591047060434,0.00960206869202777,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ARRD3.2.2.m.64983,0.00778016971667814,0.00270554855838703,No,NA,NA,Q7TPQ9,NA,NA,NA,early endosome [GO:0005769]; endosome [GO:0005768]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; beta-3 adrenergic receptor binding [GO:0031699]; fat pad development [GO:0060613]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071878]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of heat generation [GO:0031651]; negative regulation of locomotion involved in locomotory behavior [GO:0090327]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; skin development [GO:0043588]; temperature homeostasis [GO:0001659],NA,NA,NA
CHOYP_ASCC1.1.1.m.39863,0.00394536801625317,0.00291369700370642,No,NA,NA,Q9D8Z1,NA,NA,NA,neuromuscular junction [GO:0031594]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; RNA binding [GO:0003723]; DNA repair [GO:0006281]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_ASCC2.1.1.m.34978,0.0062270058659687,-0.0148521854148449,No,NA,NA,Q9H1I8,NA,NA,NA,activating signal cointegrator 1 complex [GO:0099053]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA dealkylation involved in DNA repair [GO:0006307]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_ASCC3.1.1.m.51755,-0.00413451163955948,-0.0042225533109441,No,NA,NA,F1NTD6,NA,NA,NA,activating signal cointegrator 1 complex [GO:0099053]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP-dependent 3'-5' DNA helicase activity [GO:0043140]; ATP-dependent helicase activity [GO:0008026]; nucleic acid binding [GO:0003676]; cell proliferation [GO:0008283]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA duplex unwinding [GO:0032508],NA,NA,NA
CHOYP_ASGR2.3.4.m.47793,0.00430740753593083,-0.0131987079110819,No,NA,NA,P82596,NA,NA,NA,carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_ASK1.1.2.m.586,0.000705030051031209,-0.0239334142074503,No,NA,NA,Q6ZN16,NA,NA,NA,ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; activation of MAPKK activity [GO:0000186],NA,NA,NA
CHOYP_ASM.1.1.m.21521,-0.0120038706417286,-0.0122054989618231,No,NA,NA,Q04519,NA,NA,NA,endosome [GO:0005768]; extracellular space [GO:0005615]; lamellar body [GO:0042599]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; acid sphingomyelin phosphodiesterase activity [GO:0061750]; hydrolase activity; acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]; ceramide biosynthetic process [GO:0046513]; negative regulation of MAP kinase activity [GO:0043407]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein dephosphorylation [GO:0035307]; response to cocaine [GO:0042220]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021],NA,NA,NA
CHOYP_ASMTL.1.1.m.20115,0.00351803769018747,-0.0135896077064361,No,NA,NA,O95671,NA,NA,NA,cytosol [GO:0005829]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; O-methyltransferase activity [GO:0008171],NA,NA,NA
CHOYP_ASNA.1.1.m.52208,-0.0128899137268947,-0.00245847409256736,No,NA,NA,B0WEV5,NA,NA,NA,endoplasmic reticulum [GO:0005783]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; protein insertion into ER membrane [GO:0045048],NA,NA,NA
CHOYP_ASPH.1.2.m.35319,-0.000432044540581344,-0.023137186802426,No,NA,NA,Q8BSY0,NA,NA,NA,cortical endoplasmic reticulum [GO:0032541]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcoplasmic reticulum membrane [GO:0033017]; calcium ion binding [GO:0005509]; peptide-aspartate beta-dioxygenase activity [GO:0004597]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of store-operated calcium channel activity [GO:0032237]; calcium ion transmembrane transport [GO:0070588]; cellular response to calcium ion [GO:0071277]; face morphogenesis [GO:0060325]; limb morphogenesis [GO:0035108]; negative regulation of cell proliferation [GO:0008285]; pattern specification process [GO:0007389]; peptidyl-aspartic acid hydroxylation [GO:0042264]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of inositol 1;4;5-trisphosphate-sensitive calcium-release channel activity [GO:0031585]; regulation of protein depolymerization [GO:1901879]; regulation of protein stability [GO:0031647]; response to ATP [GO:0033198]; roof of mouth development [GO:0060021],NA,NA,NA
CHOYP_ASPM.1.4.m.6650,0.0064905687250023,0.00420189587981539,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ASSY.2.4.m.43713,0.00129479434794478,-0.0117442089103818,No,NA,NA,Q66I24,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; argininosuccinate synthase activity [GO:0004055]; ATP binding [GO:0005524]; arginine biosynthetic process [GO:0006526]; argininosuccinate metabolic process [GO:0000053]; urea cycle [GO:0000050],NA,NA,NA
CHOYP_ASUN.1.1.m.6333,0.0121627109797992,0.0222903195072975,No,NA,NA,Q9NVM9,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cell division [GO:0051301]; centrosome localization [GO:0051642]; flagellated sperm motility [GO:0030317]; mitotic spindle organization [GO:0007052]; protein localization to nuclear envelope [GO:0090435]; regulation of fertilization [GO:0080154]; regulation of mitotic cell cycle [GO:0007346]; snRNA transcription by RNA polymerase II [GO:0042795],NA,NA,NA
CHOYP_AT1.1.1.m.66793,-0.00852713351435716,-0.0177356629569014,No,NA,NA,Q9Y345,NA,NA,NA,glycinergic synapse [GO:0098690]; integral component of membrane [GO:0016021]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; synaptic transmission; glycinergic [GO:0060012],NA,NA,NA
CHOYP_AT10A.1.1.m.56662,0.00394536801625317,0.00291369700370642,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AT1A.1.1.m.18017,0.016871155992015,-0.015143745944697,No,NA,NA,Q6RWA9,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; sodium:potassium-exchanging ATPase activity [GO:0005391],NA,NA,NA
CHOYP_AT5F1.1.1.m.12896,0.00393949374441642,0.0124985500912109,No,NA,NA,P24539,NA,NA,NA,membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex; coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proton transmembrane transporter activity [GO:0015078]; transmembrane transporter activity [GO:0022857]; ATP biosynthetic process [GO:0006754]; ATP hydrolysis coupled cation transmembrane transport [GO:0099132]; ATP synthesis coupled proton transport [GO:0015986]; cristae formation [GO:0042407]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; substantia nigra development [GO:0021762],NA,NA,NA
CHOYP_ATC1.1.1.m.5160,0.0171100955899211,0.0145199850503,No,NA,NA,Q7PPA5,NA,NA,NA,integral component of membrane [GO:0016021]; sarcoplasmic reticulum membrane [GO:0033017]; ATP binding [GO:0005524]; calcium-transporting ATPase activity [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity; phosphorylative mechanism [GO:0008553]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874],NA,NA,NA
CHOYP_ATC1.1.1.m.5161,-0.0099241072615481,0.00593918572132599,No,NA,NA,P35224,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cadherin binding [GO:0045296]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_ATE1.1.3.m.6901,-0.0163301617062066,0.000749568371160386,No,NA,NA,Q9Z2A5,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; arginyltransferase activity [GO:0004057]; proteasomal protein catabolic process [GO:0010498]; protein arginylation [GO:0016598],NA,NA,NA
CHOYP_ATG2A.1.1.m.57169,0.00434280854491728,-0.0124101038469864,No,NA,NA,Q96BY7,NA,NA,NA,extrinsic component of membrane [GO:0019898]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422],NA,NA,NA
CHOYP_ATG3.1.1.m.25570,0.0120692614142093,-0.00620284942514938,No,NA,NA,Q5I0S6,NA,NA,NA,cytoplasmic ubiquitin ligase complex [GO:0000153]; cytosol [GO:0005829]; Atg12 transferase activity [GO:0019777]; Atg8 ligase activity [GO:0019776]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; protein transport [GO:0015031],NA,NA,NA
CHOYP_ATG7.1.1.m.34175,0.00532252727233005,-0.0167622386700666,No,NA,NA,Q9D906,NA,NA,NA,axon [GO:0030424]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; phagophore assembly site [GO:0000407]; Atg12 activating enzyme activity [GO:0019778]; Atg8 activating enzyme activity [GO:0019779]; protein homodimerization activity [GO:0042803]; transcription factor binding [GO:0008134]; adult walking behavior [GO:0007628]; amino acid homeostasis [GO:0080144]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of host cells involved in interaction with symbiont [GO:0075044]; autophagy of mitochondrion [GO:0000422]; C-terminal protein lipidation [GO:0006501]; cardiac muscle cell development [GO:0055013]; cellular homeostasis [GO:0019725]; cellular response to hyperoxia [GO:0071455]; cellular response to nitrogen starvation [GO:0006995]; cellular response to reactive oxygen species [GO:0034614]; cellular response to starvation [GO:0009267]; cellular sphingolipid homeostasis [GO:0090156]; central nervous system neuron axonogenesis [GO:0021955]; cerebellar Purkinje cell layer development [GO:0021680]; cerebral cortex development [GO:0021987]; defense response to virus [GO:0051607]; late nucleophagy [GO:0044805]; liver development [GO:0001889]; macroautophagy [GO:0016236]; membrane organization [GO:0061024]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of histone H4-K16 acetylation [GO:2000619]; negative regulation of mitochondrial DNA replication [GO:0090298]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of phagocytosis [GO:0050765]; negative regulation of sphingolipid biosynthetic process [GO:0090155]; negative stranded viral RNA replication [GO:0039689]; nervous system process [GO:0050877]; neuron projection development [GO:0031175]; organelle organization [GO:0006996]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of mucus secretion [GO:0070257]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein modification process [GO:0031401]; post-embryonic development [GO:0009791]; protein catabolic process [GO:0030163]; protein lipidation [GO:0006497]; protein modification by small protein conjugation [GO:0032446]; protein transport [GO:0015031]; pyramidal neuron development [GO:0021860]; regulation of cell development [GO:0060284]; regulation of circadian rhythm [GO:0042752]; regulation of hemopoiesis [GO:1903706]; regulation of neuron death [GO:1901214]; regulation of protein ubiquitination [GO:0031396]; response to starvation [GO:0042594]; suppression by virus of host autophagy [GO:0039521],NA,NA,NA
CHOYP_ATIC.1.1.m.17816,-0.00319638728823568,-0.0207398351063823,No,NA,NA,P31335,NA,NA,NA,cytosol [GO:0005829]; IMP cyclohydrolase activity [GO:0003937]; phosphoribosylaminoimidazolecarboxamide formyltransferase activity [GO:0004643]; protein homodimerization activity [GO:0042803]; 'de novo' IMP biosynthetic process [GO:0006189],NA,NA,NA
CHOYP_ATP13A.1.1.m.10161,-0.00198323547485736,-0.0196148587278054,No,NA,NA,Q9EPE9,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; cation transport [GO:0006812]; cellular calcium ion homeostasis [GO:0006874],NA,NA,NA
CHOYP_ATP2B3.1.1.m.6573,-0.00184312568285256,0.00449428129536434,No,NA,NA,Q16720,NA,NA,NA,extracellular vesicle [GO:1903561]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; ATP binding [GO:0005524]; calcium ion transmembrane transporter activity [GO:0015085]; calcium-transporting ATPase activity [GO:0005388]; calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration [GO:1905056]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; calcium ion export across plasma membrane [GO:1990034]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]; regulation of cardiac conduction [GO:1903779]; regulation of cytosolic calcium ion concentration [GO:0051480],NA,NA,NA
CHOYP_ATP5B.1.1.m.22321,0.0145469196265351,-0.0138005644018438,No,NA,NA,Q05825,NA,NA,NA,mitochondrial proton-transporting ATP synthase complex; catalytic core F(1) [GO:0000275]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity; rotational mechanism [GO:0046933]; proton-transporting ATPase activity; rotational mechanism [GO:0046961]; ATP synthesis coupled proton transport [GO:0015986]; proton transmembrane transport [GO:1902600],NA,NA,NA
CHOYP_ATP5C1.1.1.m.16222,0.00403813305561644,-0.00482614513299603,No,NA,NA,O01666,NA,NA,NA,mitochondrial proton-transporting ATP synthase complex; catalytic core F(1) [GO:0000275]; mitochondrion [GO:0005739]; proton-transporting ATP synthase activity; rotational mechanism [GO:0046933]; ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]; proton transmembrane transport [GO:1902600],NA,NA,NA
CHOYP_ATP5H.1.1.m.22927,0.00713274364033784,-0.00442529771510246,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ATP6AP1.1.1.m.18150,-0.0110168768588252,-0.0191777210571508,No,NA,NA,Q15904,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; proton-transporting two-sector ATPase complex [GO:0016469]; proton-transporting V-type ATPase; V1 domain [GO:0033180]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity; rotational mechanism [GO:0046933]; proton-transporting ATPase activity; rotational mechanism [GO:0046961]; Rab GTPase binding [GO:0017137]; transporter activity [GO:0005215]; ATP hydrolysis coupled proton transport [GO:0015991]; cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; establishment of organelle localization [GO:0051656]; insulin receptor signaling pathway [GO:0008286]; ion transmembrane transport [GO:0034220]; pH reduction [GO:0045851]; positive regulation of bone resorption [GO:0045780]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of exocytosis [GO:0045921]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoclast development [GO:2001206]; proton transmembrane transport [GO:1902600]; regulation of cellular pH [GO:0030641]; transferrin transport [GO:0033572],NA,NA,NA
CHOYP_ATP7A.1.1.m.23099,0.00165709319976171,-0.00747846203603179,No,NA,NA,P70705,NA,NA,NA,apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell leading edge [GO:0031252]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane raft [GO:0045121]; microvillus [GO:0005902]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; copper-dependent protein binding [GO:0032767]; copper-exporting ATPase activity [GO:0004008]; copper-transporting ATPase activity [GO:0043682]; cuprous ion binding [GO:1903136]; Rac GTPase binding [GO:0048365]; cellular copper ion homeostasis [GO:0006878]; cellular response to amino acid stimulus [GO:0071230]; cellular response to antibiotic [GO:0071236]; cellular response to cadmium ion [GO:0071276]; cellular response to cobalt ion [GO:0071279]; cellular response to copper ion [GO:0071280]; cellular response to hypoxia [GO:0071456]; cellular response to iron ion [GO:0071281]; cellular response to lead ion [GO:0071284]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; copper ion export [GO:0060003]; in utero embryonic development [GO:0001701]; lactation [GO:0007595]; liver development [GO:0001889]; negative regulation of iron ion transmembrane transport [GO:0034760]; positive regulation of cell size [GO:0045793]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of response to wounding [GO:1903036]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of cytochrome-c oxidase activity [GO:1904959]; regulation of gene expression [GO:0010468]; response to copper ion [GO:0046688]; response to iron(III) ion [GO:0010041]; response to lead ion [GO:0010288]; response to manganese ion [GO:0010042]; response to zinc ion [GO:0010043],NA,NA,NA
CHOYP_ATPA.1.1.m.50245,0.00232569694693405,-0.00893952458653682,No,NA,NA,P80021,NA,NA,NA,mitochondrial proton-transporting ATP synthase complex; catalytic core F(1) [GO:0000275]; plasma membrane [GO:0005886]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity; rotational mechanism [GO:0046933]; ATP biosynthetic process [GO:0006754]; ATP metabolic process [GO:0046034]; ATP synthesis coupled proton transport [GO:0015986]; electron transport chain [GO:0022900]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_ATPB.1.1.m.21960,-0.00784068152062963,-0.00583366773689221,No,NA,NA,Q25117,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; proton-transporting ATP synthase complex; catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity; rotational mechanism [GO:0046933]; ATP synthesis coupled proton transport [GO:0015986],NA,NA,NA
CHOYP_ATRIP.1.1.m.15992,0.00961384809172579,-0.00365361385192832,No,NA,NA,Q8WXE1,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; DNA damage checkpoint [GO:0000077]; DNA replication [GO:0006260]; interstrand cross-link repair [GO:0036297],NA,NA,NA
CHOYP_ATRP.1.1.m.22451,-0.0094626011994436,-0.00999711366183888,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ATRX.1.1.m.14705,0.000319745545707565,-0.000117074314817687,No,NA,NA,Q7YQM4,NA,NA,NA,condensed nuclear chromosome; centromeric region [GO:0000780]; nuclear chromosome; telomeric region [GO:0000784]; nuclear pericentric heterochromatin [GO:0031618]; nuclear subtelomeric heterochromatin [GO:1990707]; PML body [GO:0016605]; telomeric heterochromatin [GO:0031933]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; DNA binding [GO:0003677]; DNA translocase activity [GO:0015616]; helicase activity [GO:0004386]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; cellular response to hydroxyurea [GO:0072711]; chromatin remodeling [GO:0006338]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA damage response; signal transduction by p53 class mediator [GO:0030330]; DNA repair [GO:0006281]; DNA replication-independent nucleosome assembly [GO:0006336]; forebrain development [GO:0030900]; meiotic spindle organization [GO:0000212]; multicellular organism growth [GO:0035264]; negative regulation of maintenance of mitotic sister chromatid cohesion; telomeric [GO:1904908]; negative regulation of telomeric RNA transcription from RNA pol II promoter [GO:1901581]; nucleosome assembly [GO:0006334]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomeric RNA transcription from RNA pol II promoter [GO:1901582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic forelimb morphogenesis [GO:0035128]; protein localization to chromosome; telomeric region [GO:0070198]; regulation of histone H3-K9 trimethylation [GO:1900112]; replication fork processing [GO:0031297]; seminiferous tubule development [GO:0072520]; Sertoli cell development [GO:0060009]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_ATS10.1.1.m.43473,0.00484405509360238,-0.0177187386416318,No,NA,NA,Q8TE60,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; eye development [GO:0001654]; negative regulation of platelet aggregation [GO:0090331],NA,NA,NA
CHOYP_ATS16.2.4.m.14579,-0.000222454605919936,-0.000403096666833409,No,NA,NA,Q8TE57,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; branching involved in ureteric bud morphogenesis [GO:0001658]; male gamete generation [GO:0048232]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073],NA,NA,NA
CHOYP_ATS2.1.2.m.39791,0.0220508950693359,-0.00791558189687481,No,NA,NA,Q69Z28,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; branching involved in ureteric bud morphogenesis [GO:0001658]; male gamete generation [GO:0048232]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073],NA,NA,NA
CHOYP_ATS20.2.2.m.52571,0.00388255749470422,-0.00313345100763347,No,NA,NA,O15072,NA,NA,NA,extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; endopeptidase activity [GO:0004175]; heparin binding [GO:0008201]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; collagen biosynthetic process [GO:0032964]; collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; protein processing [GO:0016485]; supramolecular fiber organization [GO:0097435]; vascular endothelial growth factor production [GO:0010573],NA,NA,NA
CHOYP_ATS6.3.3.m.56109,-0.0128334574514719,-0.0163528443043395,No,NA,NA,Q69Z28,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; branching involved in ureteric bud morphogenesis [GO:0001658]; male gamete generation [GO:0048232]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073],NA,NA,NA
CHOYP_ATXN10.1.1.m.33209,0.00615966897194063,0.00941964587728867,No,NA,NA,Q5FVB0,NA,NA,NA,perinuclear region of cytoplasm [GO:0048471],NA,NA,NA
CHOYP_AUHM.1.2.m.28847,0.00205195042830452,-0.00934116934689426,No,NA,NA,F1LU71,NA,NA,NA,mitochondrion [GO:0005739]; enoyl-CoA hydratase activity [GO:0004300]; itaconyl-CoA hydratase activity [GO:0050011]; methylglutaconyl-CoA hydratase activity [GO:0004490]; mRNA 3'-UTR binding [GO:0003730]; fatty acid beta-oxidation [GO:0006635]; leucine catabolic process [GO:0006552],NA,NA,NA
CHOYP_AUHM.2.2.m.44102,0.00338666618440743,0.0224758812727497,No,NA,NA,Q3TLP5,NA,NA,NA,mitochondrion [GO:0005739]; enoyl-CoA hydratase activity [GO:0004300]; fatty acid beta-oxidation [GO:0006635],NA,NA,NA
CHOYP_B3GT2.1.1.m.35771,0.00497514875039776,-0.0126986062119701,No,NA,NA,Q9MYM7,NA,NA,NA,Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; protein glycosylation [GO:0006486],NA,NA,NA
CHOYP_BACH1.3.17.m.6935,0.0108546931189753,0.0139199800598535,No,NA,NA,G5ED84,NA,NA,NA,cell junction [GO:0030054]; Cul3-RING ubiquitin ligase complex [GO:0031463]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_BACH1.8.17.m.18006,-0.0181988024682203,0.00352248002432243,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BACOIKO003_21.1.1.m.44123,0.0143208716908062,0.00137747308328422,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BAG1.2.2.m.60616,0.0143323426135932,0.0139164463807699,No,NA,NA,Q99933,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; adenyl-nucleotide exchange factor activity [GO:0000774]; chaperone binding [GO:0051087]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; cell surface receptor signaling pathway [GO:0007166]; chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of apoptotic process [GO:0043066]; regulation of cellular response to heat [GO:1900034],NA,NA,NA
CHOYP_BAG3.1.1.m.15160,-0.00500563888078654,0.000983583602706188,No,NA,NA,O95429,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; adenyl-nucleotide exchange factor activity [GO:0000774]; chaperone binding [GO:0051087]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; negative regulation of phosphatidylinositol-3;4;5-trisphosphate 5-phosphatase activity [GO:2001145]; negative regulation of protein targeting to mitochondrion [GO:1903215]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell adhesion [GO:0045785]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of stress fiber assembly [GO:0051496]; protein folding [GO:0006457]; protein localization to plasma membrane [GO:0072659]; regulation of cellular response to heat [GO:1900034]; ruffle assembly [GO:0097178]; tumor necrosis factor-mediated signaling pathway [GO:0033209],NA,NA,NA
CHOYP_BAG6A.1.1.m.25802,-0.0130328917471502,-0.0208424993990872,No,NA,NA,A3KPW9,NA,NA,NA,BAT3 complex [GO:0071818]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; ribosome binding [GO:0043022]; brain development [GO:0007420]; chromatin organization [GO:0006325]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; ER-associated misfolded protein catabolic process [GO:0071712]; internal peptidyl-lysine acetylation [GO:0018393]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; lung development [GO:0030324]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of proteolysis [GO:0045861]; proteasomal protein catabolic process [GO:0010498]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of embryonic development [GO:0045995]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_BAI1.1.2.m.4434,-0.00366947760527579,0.0061026740086131,No,NA,NA,Q9HAR2,NA,NA,NA,axon [GO:0030424]; cell-cell junction [GO:0005911]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; G protein-coupled receptor signaling pathway [GO:0007186]; locomotion involved in locomotory behavior [GO:0031987]; neuron migration [GO:0001764]; positive regulation of synapse assembly [GO:0051965]; response to cocaine [GO:0042220]; synapse assembly [GO:0007416],NA,NA,NA
CHOYP_BAP18.1.1.m.48944,-0.0107346430257459,-0.0115613320270739,No,NA,NA,Q9DCT6,NA,NA,NA,cytosol [GO:0005829]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; NURF complex [GO:0016589]; DNA binding [GO:0003677]; chromatin organization [GO:0006325],NA,NA,NA
CHOYP_BAP31.1.1.m.62939,-0.00329351069934571,-0.00516139730304644,No,NA,NA,Q5R8H3,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]; apoptotic process [GO:0006915]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BARBAKC583_0145.1.1.m.10555,0.0035913590222173,0.00768558271640648,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BAT1.4.4.m.32273,0.00429495781365513,-0.007963357718782,No,NA,NA,P82251,NA,NA,NA,apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; L-amino acid transmembrane transporter activity [GO:0015179]; L-cystine transmembrane transporter activity [GO:0015184]; neutral amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; L-cystine transport [GO:0015811]; leukocyte migration [GO:0050900]; neutral amino acid transport [GO:0015804]; protein-containing complex assembly [GO:0065003],NA,NA,NA
CHOYP_BAX.1.1.m.30787,-0.00826804775935586,-0.0162814949026438,No,NA,NA,O02703,NA,NA,NA,BAX complex [GO:0097144]; Bcl-2 family protein complex [GO:0097136]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial outer membrane [GO:0005741]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; pore complex [GO:0046930]; BH3 domain binding [GO:0051434]; channel activity [GO:0015267]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; lipid binding [GO:0008289]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097296]; apoptotic mitochondrial changes [GO:0008637]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; apoptotic signaling pathway [GO:0097190]; B cell apoptotic process [GO:0001783]; B cell homeostasis [GO:0001782]; B cell homeostatic proliferation [GO:0002358]; B cell negative selection [GO:0002352]; B cell receptor apoptotic signaling pathway [GO:1990117]; blood vessel remodeling [GO:0001974]; cellular response to organic substance [GO:0071310]; cellular response to UV [GO:0034644]; cerebral cortex development [GO:0021987]; development of secondary sexual characteristics [GO:0045136]; ectopic germ cell programmed cell death [GO:0035234]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; fertilization [GO:0009566]; germ cell development [GO:0007281]; glycosphingolipid metabolic process [GO:0006687]; homeostasis of number of cells within a tissue [GO:0048873]; hypothalamus development [GO:0021854]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial fusion [GO:0008053]; mitochondrion morphogenesis [GO:0070584]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of protein binding [GO:0032091]; neuron apoptotic process [GO:0051402]; neuron migration [GO:0001764]; odontogenesis of dentin-containing tooth [GO:0042475]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in mammary gland involution [GO:0060058]; positive regulation of B cell apoptotic process [GO:0002904]; positive regulation of developmental pigmentation [GO:0048087]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein oligomerization [GO:0032461]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; post-embryonic camera-type eye morphogenesis [GO:0048597]; protein homooligomerization [GO:0051260]; protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:0001844]; regulation of cell cycle [GO:0051726]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of mitochondrial membrane permeability involved in programmed necrotic cell death [GO:1902445]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of nitrogen utilization [GO:0006808]; regulation of protein heterodimerization activity [GO:0043497]; regulation of protein homodimerization activity [GO:0043496]; release of cytochrome c from mitochondria [GO:0001836]; release of matrix enzymes from mitochondria [GO:0032976]; response to axon injury [GO:0048678]; response to gamma radiation [GO:0010332]; response to salt stress [GO:0009651]; response to toxic substance [GO:0009636]; retina development in camera-type eye [GO:0060041]; retinal cell programmed cell death [GO:0046666]; Sertoli cell proliferation [GO:0060011]; spermatid differentiation [GO:0048515]; T cell homeostatic proliferation [GO:0001777]; thymocyte apoptotic process [GO:0070242]; vagina development [GO:0060068],NA,NA,NA
CHOYP_BAZ1A.1.1.m.9485,-0.00554066850630128,-0.00210831320374597,No,NA,NA,Q9NRL2,NA,NA,NA,ACF complex [GO:0016590]; CHRAC [GO:0008623]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; DNA-dependent DNA replication [GO:0006261]; histone acetylation [GO:0016573]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_BAZ1B.1.1.m.24480,-0.00869340572522145,-0.00892852098858011,No,NA,NA,Q9UIG0,NA,NA,NA,condensed chromosome [GO:0000793]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; pericentric heterochromatin [GO:0005721]; ATP binding [GO:0005524]; histone binding [GO:0042393]; histone kinase activity [GO:0035173]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; chromatin assembly or disassembly [GO:0006333]; chromatin remodeling [GO:0006338]; histone phosphorylation [GO:0016572]; positive regulation of gene expression; epigenetic [GO:0045815]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_BBOV_II003210.5.13.m.30678,-0.00853069293016421,-0.00185424192982935,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BBS4.1.1.m.50943,-0.00961748144501452,0.0115615971866686,No,NA,NA,Q96RK4,NA,NA,NA,BBSome [GO:0034464]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytosol [GO:0005829]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; dynactin binding [GO:0034452]; microtubule motor activity [GO:0003777]; RNA polymerase II repressing transcription factor binding [GO:0001103]; adult behavior [GO:0030534]; brain morphogenesis [GO:0048854]; centrosome cycle [GO:0007098]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; dendrite development [GO:0016358]; face development [GO:0060324]; fat cell differentiation [GO:0045444]; fat pad development [GO:0060613]; heart looping [GO:0001947]; hippocampus development [GO:0021766]; intracellular transport [GO:0046907]; maintenance of protein location in nucleus [GO:0051457]; melanosome transport [GO:0032402]; microtubule anchoring at centrosome [GO:0034454]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of gene expression [GO:0010629]; negative regulation of GTPase activity [GO:0034260]; negative regulation of systemic arterial blood pressure [GO:0003085]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of cilium assembly [GO:0045724]; positive regulation of multicellular organism growth [GO:0040018]; protein localization to centrosome [GO:0071539]; protein localization to cilium [GO:0061512]; protein localization to organelle [GO:0033365]; protein localization to photoreceptor outer segment [GO:1903546]; protein transport [GO:0015031]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; regulation of cytokinesis [GO:0032465]; regulation of lipid metabolic process [GO:0019216]; regulation of non-motile cilium assembly [GO:1902855]; regulation of stress fiber assembly [GO:0051492]; retina homeostasis [GO:0001895]; retinal rod cell development [GO:0046548]; sensory perception of smell [GO:0007608]; sensory processing [GO:0050893]; social behavior [GO:0035176]; spermatid development [GO:0007286]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual perception [GO:0007601],NA,NA,NA
CHOYP_BBS5.1.1.m.56560,-0.0169591047060434,0.00960206869202778,No,NA,NA,Q7ZWB7,NA,NA,NA,BBSome [GO:0034464]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; phosphatidylinositol-3-phosphate binding [GO:0032266]; compound eye development [GO:0048749]; compound eye photoreceptor development [GO:0042051]; gastrulation [GO:0007369]; heart looping [GO:0001947]; intracellular transport [GO:0046907]; Kupffer's vesicle development [GO:0070121]; melanosome transport [GO:0032402]; pigment granule aggregation in cell center [GO:0051877]; pronephros formation [GO:0072116],NA,NA,NA
CHOYP_BCAS0157.2.2.m.53484,0.0190044797447429,-0.00600351997162775,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BCAS3.1.1.m.6968,-0.00454436028474302,-0.00815215067561561,No,NA,NA,Q9H6U6,NA,NA,NA,cell leading edge [GO:0031252]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; intermediate filament cytoskeleton [GO:0045111]; nucleolus [GO:0005730]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; acetyltransferase activator activity [GO:0010698]; beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; histone binding [GO:0042393]; nuclear hormone receptor binding [GO:0035257]; transcription factor binding [GO:0008134]; activation of GTPase activity [GO:0090630]; angiogenesis [GO:0001525]; cellular response to estrogen stimulus [GO:0071391]; Golgi organization [GO:0007030]; microtubule organizing center organization [GO:0031023]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of GTPase activity [GO:0034260]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of catalytic activity [GO:0043085]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of establishment of cell polarity [GO:2000114]; response to starvation [GO:0042594]; tube formation [GO:0035148],NA,NA,NA
CHOYP_BCAT1.1.1.m.54127,0.0112958816756175,0.0028064907111577,No,NA,NA,Q5EA40,NA,NA,NA,mitochondrion [GO:0005739]; branched-chain-amino-acid transaminase activity [GO:0004084]; L-isoleucine transaminase activity [GO:0052656]; L-leucine transaminase activity [GO:0052654]; L-valine transaminase activity [GO:0052655]; cellular response to leukemia inhibitory factor [GO:1990830]; isoleucine catabolic process [GO:0006550]; leucine biosynthetic process [GO:0009098]; regulation of hormone levels [GO:0010817]; valine biosynthetic process [GO:0009099],NA,NA,NA
CHOYP_BCKD.2.2.m.60038,-0.0147434625685311,0.00372984350555368,No,NA,NA,O14874,NA,NA,NA,mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; [3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity [GO:0047323]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein serine/threonine kinase activity [GO:0004674]; branched-chain amino acid catabolic process [GO:0009083]; cellular amino acid catabolic process [GO:0009063]; phosphorylation [GO:0016310],NA,NA,NA
CHOYP_BCL3.1.2.m.56007,0.00987623890005584,0.019905783683449,No,NA,NA,P20749,NA,NA,NA,Bcl3-Bcl10 complex [GO:0032996]; Bcl3/NF-kappaB2 complex [GO:0033257]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein binding; bridging [GO:0030674]; transcription factor binding [GO:0008134]; antimicrobial humoral response [GO:0019730]; cellular response to DNA damage stimulus [GO:0006974]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; DNA damage response; signal transduction by p53 class mediator [GO:0030330]; extracellular matrix organization [GO:0030198]; follicular dendritic cell differentiation [GO:0002268]; germinal center formation [GO:0002467]; humoral immune response mediated by circulating immunoglobulin [GO:0002455]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; maintenance of protein location in nucleus [GO:0051457]; marginal zone B cell differentiation [GO:0002315]; negative regulation of apoptotic process [GO:0043066]; negative regulation of interleukin-8 biosynthetic process [GO:0045415]; negative regulation of JAK-STAT cascade [GO:0046426]; negative regulation of transcription; DNA-templated [GO:0045892]; negative regulation of tumor necrosis factor biosynthetic process [GO:0042536]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 biosynthetic process [GO:0045082]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; positive regulation of translation [GO:0045727]; protein import into nucleus; translocation [GO:0000060]; regulation of apoptotic process [GO:0042981]; regulation of DNA binding [GO:0051101]; regulation of NIK/NF-kappaB signaling [GO:1901222]; response to UV-C [GO:0010225]; response to virus [GO:0009615]; spleen development [GO:0048536]; T-helper 1 type immune response [GO:0042088]; T-helper 2 cell differentiation [GO:0045064]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_BCL3.2.2.m.57485,0.000686232728993108,-0.0107331332691118,No,NA,NA,Q9WTK5,NA,NA,NA,Bcl3/NF-kappaB2 complex [GO:0033257]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; aging [GO:0007568]; extracellular matrix organization [GO:0030198]; follicular dendritic cell differentiation [GO:0002268]; germinal center formation [GO:0002467]; lymph node development [GO:0048535]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription; DNA-templated [GO:0006355]; response to cytokine [GO:0034097]; response to lipopolysaccharide [GO:0032496]; rhythmic process [GO:0048511]; spleen development [GO:0048536],NA,NA,NA
CHOYP_BCL7A.1.1.m.29528,0.00373786528250739,0.0125624381446036,No,NA,NA,Q9CXE2,NA,NA,NA,,NA,NA,NA
CHOYP_BDH2.1.2.m.30737,0.0100886763572279,0.0182912965040312,No,NA,NA,D4A1J4,NA,NA,NA,cytoplasm [GO:0005737]; 3-hydroxybutyrate dehydrogenase activity [GO:0003858]; oxidoreductase activity; acting on the CH-CH group of donors; NAD or NADP as acceptor [GO:0016628]; heme metabolic process [GO:0042168]; iron ion homeostasis [GO:0055072]; siderophore biosynthetic process [GO:0019290],NA,NA,NA
CHOYP_BDH2.2.2.m.57286,0.0078799569042993,0.00315046496159162,No,NA,NA,D4A1J4,NA,NA,NA,cytoplasm [GO:0005737]; 3-hydroxybutyrate dehydrogenase activity [GO:0003858]; oxidoreductase activity; acting on the CH-CH group of donors; NAD or NADP as acceptor [GO:0016628]; heme metabolic process [GO:0042168]; iron ion homeostasis [GO:0055072]; siderophore biosynthetic process [GO:0019290],NA,NA,NA
CHOYP_BDHB.1.1.m.9128,-0.0225614845023445,0.00998291852712159,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BET1L.1.1.m.8210,-0.0130773315017343,-0.0169107547505159,No,NA,NA,Q5RBX2,NA,NA,NA,integral component of Golgi membrane [GO:0030173]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BGAL.2.2.m.41942,-0.0100550251043467,-0.00792648950440906,No,NA,NA,O19015,NA,NA,NA,lysosome [GO:0005764]; vacuole [GO:0005773]; beta-galactosidase activity [GO:0004565]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_BH13620.1.1.m.41020,-0.0226594213089892,0.0103709909027595,No,NA,NA,P24928,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II; core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; RNA-directed 5'-3' RNA polymerase activity [GO:0003968]; ubiquitin protein ligase binding [GO:0031625]; 7-methylguanosine mRNA capping [GO:0006370]; DNA-templated transcription; termination [GO:0006353]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing; via spliceosome [GO:0000398]; positive regulation of RNA splicing [GO:0033120]; regulation of gene silencing by miRNA [GO:0060964]; regulation of transcription; DNA-templated [GO:0006355]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283],NA,NA,NA
CHOYP_BICD2.1.1.m.9177,-0.0081120919943887,-0.0237904490387342,No,NA,NA,Q8BR07,NA,NA,NA,centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; host cell viral assembly compartment [GO:0072517]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802]; cytoskeletal adaptor activity [GO:0008093]; dynactin binding [GO:0034452]; dynein complex binding [GO:0070840]; dynein intermediate chain binding [GO:0045505]; protein kinase binding [GO:0019901]; proteinase activated receptor binding [GO:0031871]; Rab GTPase binding [GO:0017137]; microtubule anchoring at microtubule organizing center [GO:0072393]; minus-end-directed organelle transport along microtubule [GO:0072385]; negative regulation of phospholipase C activity [GO:1900275]; negative regulation of phospholipase C-activating G protein-coupled receptor signaling pathway [GO:1900737]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein localization to organelle [GO:0033365]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of proteinase activated receptor activity [GO:1900276]; stress granule assembly [GO:0034063]; viral process [GO:0016032],NA,NA,NA
CHOYP_BIG1.1.3.m.6444,0.00985766951956982,0.00436874968195533,No,NA,NA,G3X9K3,NA,NA,NA,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; small nuclear ribonucleoprotein complex [GO:0030532]; trans-Golgi network [GO:0005802]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; guanyl-nucleotide exchange factor activity [GO:0005085]; myosin binding [GO:0017022]; protein kinase A regulatory subunit binding [GO:0034237]; endomembrane system organization [GO:0010256]; Golgi organization [GO:0007030]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of GTPase activity [GO:0034260]; neuron projection development [GO:0031175]; positive regulation of protein glycosylation in Golgi [GO:0090284]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein transport [GO:0015031]; regulation of ARF protein signal transduction [GO:0032012]; regulation of establishment of cell polarity [GO:2000114]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BIG1.3.3.m.34442,0.00373162188994652,-0.0206894512657283,No,NA,NA,Q9Y6D6,NA,NA,NA,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; small nuclear ribonucleoprotein complex [GO:0030532]; trans-Golgi network [GO:0005802]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; guanyl-nucleotide exchange factor activity [GO:0005085]; myosin binding [GO:0017022]; protein kinase A regulatory subunit binding [GO:0034237]; endomembrane system organization [GO:0010256]; exocytosis [GO:0006887]; Golgi organization [GO:0007030]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of GTPase activity [GO:0034260]; neuron projection development [GO:0031175]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein glycosylation in Golgi [GO:0090284]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein transport [GO:0015031]; regulation of ARF protein signal transduction [GO:0032012]; regulation of establishment of cell polarity [GO:2000114]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BIG3.1.1.m.51447,-0.00212078832001384,-0.00891837260408135,No,NA,NA,Q5TH69,NA,NA,NA,integral component of membrane [GO:0016021]; transport vesicle membrane [GO:0030658]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; negative regulation of phosphatase activity [GO:0010923]; regulation of ARF protein signal transduction [GO:0032012],NA,NA,NA
CHOYP_BIG3.1.1.m.51448,-0.0018749499795255,0.0169335762481332,No,NA,NA,Q9Z2W1,NA,NA,NA,cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_BIR7B.2.2.m.60973,-0.00674617193502438,0.00452333061321164,No,NA,NA,P41436,NA,NA,NA,metal ion binding [GO:0046872],NA,NA,NA
CHOYP_BIRA.1.1.m.18343,-0.010454421144261,-0.0109835732852352,No,NA,NA,P0CI75,NA,NA,NA,ATP binding [GO:0005524]; biotin-[acetyl-CoA-carboxylase] ligase activity [GO:0004077]; DNA binding [GO:0003677]; protein biotinylation [GO:0009305]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_BIRC6.1.2.m.51516,-0.00635368610952413,3.04592451245864e-05,No,NA,NA,Q9NR09,NA,NA,NA,endosome [GO:0005768]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465]; spongiotrophoblast layer development [GO:0060712]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_BIRC7.3.5.m.22702,-0.00103004531478587,0.0132255897959737,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BL1S2.1.1.m.11618,0.0162380870072797,-0.00445480922560981,No,NA,NA,Q66KB9,NA,NA,NA,axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; BORC complex [GO:0099078]; gamma-tubulin complex [GO:0000930]; lysosomal membrane [GO:0005765]; gamma-tubulin binding [GO:0043015]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; endosomal transport [GO:0016197]; lysosome localization [GO:0032418]; negative regulation of lymphoid progenitor cell differentiation [GO:1905457]; negative regulation of Notch signaling pathway [GO:0045746]; neuron projection development [GO:0031175]; positive regulation of hematopoietic stem cell differentiation [GO:1902038]; positive regulation of myeloid progenitor cell differentiation [GO:1905455],NA,NA,NA
CHOYP_BLIMP.1.1.1.m.55502,0.00955621879573251,0.0134505456801469,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BLMH.1.1.m.66065,0.00299607688965311,-0.0160109814909848,No,NA,NA,Q13867,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; carboxypeptidase activity [GO:0004180]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]; homocysteine catabolic process [GO:0043418]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; response to drug [GO:0042493]; response to toxic substance [GO:0009636],NA,NA,NA
CHOYP_BLOC1S4.1.1.m.22903,-0.00930917600611851,0.00587252942938095,No,NA,NA,Q8VED2,NA,NA,NA,axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; cytoplasm [GO:0005737]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; melanosome organization [GO:0032438]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175]; platelet aggregation [GO:0070527],NA,NA,NA
CHOYP_BLVRA.1.1.m.17904,-0.0108929882963532,-0.00599331236182431,No,NA,NA,Q9CY64,NA,NA,NA,cytosol [GO:0005829]; biliverdin reductase activity [GO:0004074]; nucleotide binding [GO:0000166]; zinc ion binding [GO:0008270]; heme catabolic process [GO:0042167]; oxidation-reduction process [GO:0055114],NA,NA,NA
CHOYP_BM1_00205.2.4.m.5170,0.00379158051582153,-0.0256253284291603,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BM1_05690.1.1.m.23253,-0.00413976328397919,-0.0238127311904048,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BM1_24035.1.1.m.40152,0.0188045568278422,-0.00898344282026802,No,NA,NA,P24367,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; protein-containing complex [GO:0032991]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; unfolded protein binding [GO:0051082]; chaperone-mediated protein folding [GO:0061077]; negative regulation of collagen fibril organization [GO:1904027]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026],NA,NA,NA
CHOYP_BM1_57400.5.7.m.58033,-0.00222719722617182,0.00155435181623943,No,NA,NA,A0JM12,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; myofibril assembly [GO:0030239]; phagocytosis [GO:0006909]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_BM8F.1.2.m.3009,0.00544930166450081,-0.0101900514868788,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BM8F.2.2.m.35731,0.0232615407197746,-0.00744382690151193,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BMS1.1.1.m.17619,-0.00230119243886229,-0.0201429982748453,No,NA,NA,Q14692,NA,NA,NA,90S preribosome [GO:0030686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_BN6_64710.1.1.m.52168,-0.0225609246643834,0.00998193467468334,No,NA,NA,Q9X6U2,NA,NA,NA,3-hydroxybutyrate dehydrogenase activity [GO:0003858],NA,NA,NA
CHOYP_BOP1.1.1.m.66373,-0.00673896256868796,-0.0204286338318294,No,NA,NA,A0JMQ0,NA,NA,NA,nucleoplasm [GO:0005654]; PeBoW complex [GO:0070545]; preribosome; large subunit precursor [GO:0030687]; ribonucleoprotein complex binding [GO:0043021]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000463]; regulation of cell cycle [GO:0051726],NA,NA,NA
CHOYP_BPHL.1.1.m.55822,-0.0061798785875176,0.00630401298497698,No,NA,NA,Q8R164,NA,NA,NA,mitochondrion [GO:0005739]; hydrolase activity [GO:0016787],NA,NA,NA
CHOYP_BPTF.1.1.m.25244,-0.00634033501839182,0.00502196729058954,No,NA,NA,Q9W0T1,NA,NA,NA,NURF complex [GO:0016589]; DNA binding [GO:0003677]; lysine-acetylated histone binding [GO:0070577]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; nuclear receptor binding [GO:0016922]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; ecdysone receptor-mediated signaling pathway [GO:0035076]; hemopoiesis [GO:0030097]; negative regulation of innate immune response [GO:0045824]; negative regulation of JAK-STAT cascade [GO:0046426]; nucleosome mobilization [GO:0042766]; positive regulation of Notch signaling pathway [GO:0045747]; pupariation [GO:0035073]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid differentiation [GO:0048515]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_BRAF.2.3.m.21192,-0.0132566749723682,-0.00959713394871969,No,NA,NA,P15056,NA,NA,NA,cell body [GO:0044297]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; MAP kinase kinase kinase activity [GO:0004709]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein heterodimerization activity [GO:0046982]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; animal organ morphogenesis [GO:0009887]; CD4-positive or CD8-positive; alpha-beta T cell lineage commitment [GO:0043369]; CD4-positive; alpha-beta T cell differentiation [GO:0043367]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to nerve growth factor stimulus [GO:1990090]; establishment of protein localization to membrane [GO:0090150]; face development [GO:0060324]; head morphogenesis [GO:0060323]; long-term synaptic potentiation [GO:0060291]; MAPK cascade [GO:0000165]; myeloid progenitor cell differentiation [GO:0002318]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of fibroblast migration [GO:0010764]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; positive regulation of axon regeneration [GO:0048680]; positive regulation of axonogenesis [GO:0050772]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein heterooligomerization [GO:0051291]; protein phosphorylation [GO:0006468]; regulation of cell proliferation [GO:0042127]; regulation of T cell differentiation [GO:0045580]; response to cAMP [GO:0051591]; response to peptide hormone [GO:0043434]; somatic stem cell population maintenance [GO:0035019]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trehalose metabolism in response to stress [GO:0070413]; visual learning [GO:0008542],NA,NA,NA
CHOYP_BRAFLDRAFT_100614.1.1.m.31700,0.00394536801625317,0.00291369700370642,No,NA,NA,Q92636,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; sphingomyelin phosphodiesterase activator activity [GO:0016230]; ceramide metabolic process [GO:0006672]; positive regulation of apoptotic process [GO:0043065]; positive regulation of ceramide biosynthetic process [GO:2000304]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_BRAFLDRAFT_100695.1.1.m.47761,-0.0143276652200591,-0.00570391511850962,No,NA,NA,Q2T9T0,NA,NA,NA,phosphatase binding [GO:0019902],NA,NA,NA
CHOYP_BRAFLDRAFT_101346.1.1.m.1028,-0.0041669638370374,-0.00363105502266671,No,NA,NA,Q6PDY2,NA,NA,NA,mitochondrion [GO:0005739]; cysteamine dioxygenase activity [GO:0047800]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_BRAFLDRAFT_102226.1.1.m.48829,0.00615966897194063,0.00941964587728867,No,NA,NA,O14975,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of peroxisomal membrane [GO:0005779]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; enzyme binding [GO:0019899]; fatty acid transmembrane transporter activity [GO:0015245]; long-chain fatty acid transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; phytanate-CoA ligase activity [GO:0050197]; pristanate-CoA ligase activity [GO:0070251]; signaling receptor binding [GO:0005102]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; bile acid biosynthetic process [GO:0006699]; fatty acid alpha-oxidation [GO:0001561]; fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid import [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; methyl-branched fatty acid metabolic process [GO:0097089]; neutrophil degranulation [GO:0043312]; protein targeting to peroxisome [GO:0006625]; very long-chain fatty acid catabolic process [GO:0042760],NA,NA,NA
CHOYP_BRAFLDRAFT_102424.4.6.m.51652,-0.00741094852402018,-0.0115196834388423,No,NA,NA,P28799,NA,NA,NA,azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosome [GO:0005764]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; RNA binding [GO:0003723]; neutrophil degranulation [GO:0043312]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_BRAFLDRAFT_104092.10.11.m.53767,-0.0113564234889451,-0.000376599576138674,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_104160.1.1.m.29524,0.00761112373731664,0.00374755996960296,No,NA,NA,Q91Z53,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; carboxylic acid binding [GO:0031406]; glycerate dehydrogenase activity [GO:0008465]; glyoxylate reductase (NADP) activity [GO:0030267]; hydroxypyruvate reductase activity [GO:0016618]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; NADPH binding [GO:0070402]; oxidoreductase activity; acting on the CH-OH group of donors; NAD or NADP as acceptor [GO:0016616]; protein homodimerization activity [GO:0042803]; dicarboxylic acid metabolic process [GO:0043648]; excretion [GO:0007588]; glyoxylate metabolic process [GO:0046487]; oxidation-reduction process [GO:0055114]; protein complex oligomerization [GO:0051259],NA,NA,NA
CHOYP_BRAFLDRAFT_104267.1.1.m.52332,0.00929150702791471,0.0031996242479979,No,NA,NA,Q5ZK69,NA,NA,NA,proteasome complex [GO:0000502],NA,NA,NA
CHOYP_BRAFLDRAFT_104472.1.1.m.16220,-0.0047596113314059,-0.00679395290159663,No,NA,NA,Q6P963,NA,NA,NA,mitochondrial matrix [GO:0005759]; hydroxyacylglutathione hydrolase activity [GO:0004416]; metal ion binding [GO:0046872]; methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243],NA,NA,NA
CHOYP_BRAFLDRAFT_104488.3.3.m.2973,-0.00768723094710765,-0.0117855566930636,No,NA,NA,Q9Y535,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; nucleobase-containing compound metabolic process [GO:0006139]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase III promoter [GO:0006384],NA,NA,NA
CHOYP_BRAFLDRAFT_105037.1.1.m.17483,-0.0195808897535499,-0.00308662037852069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_105238.1.1.m.18657,-0.00280511691703738,0.00156780037654167,No,NA,NA,Q9H269,NA,NA,NA,autophagosome [GO:0005776]; axon [GO:0030424]; clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; recycling endosome [GO:0055037]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; autophagosome maturation [GO:0097352]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; regulation of SNARE complex assembly [GO:0035542]; regulation of vacuole fusion; non-autophagic [GO:0032889]; vacuole organization [GO:0007033],NA,NA,NA
CHOYP_BRAFLDRAFT_106560.10.14.m.46985,-0.00377173336102596,-0.00923331838160008,No,NA,NA,A0A0R4IBK5,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_BRAFLDRAFT_106560.13.14.m.62780,-0.0209389402821717,0.00487124478717444,No,NA,NA,A0A0R4IBK5,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_BRAFLDRAFT_106560.13.14.m.62781,-0.018180532204933,-0.00585148432604195,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_106560.4.14.m.5053,0.00555910298847882,-0.0172681150989319,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_107506.1.1.m.15759,0.00981540433910597,-0.00599058674822724,No,NA,NA,Q29M42,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_108193.2.2.m.37878,0.0134265401447631,0.00909377871438802,No,NA,NA,Q86VX2,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; NF-kappaB binding [GO:0051059]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription; DNA-templated [GO:0045892]; tumor necrosis factor-mediated signaling pathway [GO:0033209],NA,NA,NA
CHOYP_BRAFLDRAFT_108792.2.5.m.31493,-0.0178254949088772,0.000623585576848916,No,NA,NA,Q39565,NA,NA,NA,cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_BRAFLDRAFT_108792.3.5.m.34514,-0.0150018565766292,0.00972633524126372,No,NA,NA,Q39565,NA,NA,NA,cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_BRAFLDRAFT_108792.4.5.m.45892,-0.000204349187258542,-0.0243640563258989,No,NA,NA,P0C6F1,NA,NA,NA,dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_BRAFLDRAFT_109077.1.1.m.7494,-0.0169591047060434,0.00960206869202777,No,NA,NA,Q6CEJ6,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_BRAFLDRAFT_109688.1.1.m.59704,-0.0112759515751259,0.000967197996953653,No,NA,NA,P50174,NA,NA,NA,cytoplasm [GO:0005737]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; poly-hydroxybutyrate biosynthetic process [GO:0042619],NA,NA,NA
CHOYP_BRAFLDRAFT_113534.1.1.m.10828,-0.0047303551327175,0.00862049909714427,No,NA,NA,Q03161,NA,NA,NA,carbohydrate binding [GO:0030246]; glucose-6-phosphate 1-epimerase activity [GO:0047938]; cellular carbohydrate metabolic process [GO:0044262],NA,NA,NA
CHOYP_BRAFLDRAFT_113552.1.1.m.29171,0.0180276234171988,0.0160144203013875,No,NA,NA,Q1W374,NA,NA,NA,cytoplasm [GO:0005737]; phosphomannomutase activity [GO:0004615]; GDP-mannose biosynthetic process [GO:0009298],NA,NA,NA
CHOYP_BRAFLDRAFT_113596.1.1.m.53557,-1.48925431771339e-05,0.0145689882503474,No,NA,NA,A4IGP0,NA,NA,NA,cytosol [GO:0005829]; intracellular [GO:0005622]; nucleus [GO:0005634]; Hsp70 protein binding [GO:0030544]; protein transporter activity [GO:0008565]; cellular response to heat [GO:0034605]; protein import into nucleus [GO:0006606]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_113696.1.1.m.54166,0.0010837666163756,-0.00034836109366408,No,NA,NA,P20695,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RNA polymerase II sequence-specific DNA-binding transcription factor binding [GO:0061629]; glial cell proliferation [GO:0014009]; muscle cell differentiation [GO:0042692]; neuroblast proliferation [GO:0007405]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_BRAFLDRAFT_113849.1.1.m.53398,0.00921619517360015,0.0155234439873701,No,NA,NA,Q9D8W5,NA,NA,NA,cytoplasm [GO:0005737]; nuclear proteasome complex [GO:0031595]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle; lid subcomplex [GO:0008541]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_BRAFLDRAFT_113849.1.1.m.53400,0.00910674123326656,0.0130137871770143,No,NA,NA,Q7ZUB2,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_BRAFLDRAFT_113892.1.1.m.44055,0.000458506751569859,-0.00651898612135302,No,NA,NA,P48508,NA,NA,NA,glutamate-cysteine ligase complex [GO:0017109]; enzyme regulator activity [GO:0030234]; glutamate-cysteine ligase activity [GO:0004357]; glutamate-cysteine ligase catalytic subunit binding [GO:0035226]; protein heterodimerization activity [GO:0046982]; aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; hepatic stellate cell activation [GO:0035733]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of glutamate-cysteine ligase activity [GO:0035229]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to human chorionic gonadotropin [GO:0044752]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_BRAFLDRAFT_114006.1.1.m.49056,-0.00931130540454385,0.00377397686540604,No,NA,NA,Q6GNT9,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_114106.1.1.m.28307,-0.00732256325069815,-0.0194616859264258,No,NA,NA,P54921,NA,NA,NA,glutamatergic synapse [GO:0098978]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; SNARE complex [GO:0031201]; synaptobrevin 2-SNAP-25-syntaxin-1a complex [GO:0070044]; terminal bouton [GO:0043195]; vacuolar membrane [GO:0005774]; protein-containing complex binding [GO:0044877]; SNARE binding [GO:0000149]; soluble NSF attachment protein activity [GO:0005483]; syntaxin binding [GO:0019905]; apical protein localization [GO:0045176]; brain development [GO:0007420]; intracellular protein transport [GO:0006886]; membrane fusion [GO:0061025]; neuron differentiation [GO:0030182]; positive regulation of ATPase activity [GO:0032781]; protein-containing complex disassembly [GO:0032984]; regulation of synaptic vesicle priming [GO:0010807]; SNARE complex disassembly [GO:0035494]; synaptic transmission; glutamatergic [GO:0035249]; synaptic vesicle priming [GO:0016082],NA,NA,NA
CHOYP_BRAFLDRAFT_114158.1.1.m.24733,0.0209318266186152,0.000480650278030655,No,NA,NA,Q5R9J9,NA,NA,NA,dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi stack [GO:0005795]; synaptic vesicle [GO:0008021]; TRAPP complex [GO:0030008]; dendrite development [GO:0016358]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_114204.1.1.m.15168,-0.013948585496255,-0.0104624451163815,No,NA,NA,A6QP05,NA,NA,NA,oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_BRAFLDRAFT_114350.1.1.m.14176,-0.0166403595876863,-0.0158519309087714,No,NA,NA,A6H791,NA,NA,NA,nucleus [GO:0005634]; tRNA (m1A) methyltransferase complex [GO:0031515]; mRNA (adenine-N1-)-methyltransferase activity [GO:0061953]; tRNA (adenine-N1-)-methyltransferase activity [GO:0016429]; mRNA methylation [GO:0080009]; tRNA methylation [GO:0030488],NA,NA,NA
CHOYP_BRAFLDRAFT_114379.1.1.m.57424,-0.0167005205382212,0.0123045010253839,No,NA,NA,Q9CRB6,NA,NA,NA,microtubule [GO:0005874]; microtubule bundle [GO:0097427]; perinuclear region of cytoplasm [GO:0048471]; tubulin binding [GO:0015631]; microtubule bundle formation [GO:0001578]; microtubule polymerization [GO:0046785]; positive regulation of protein polymerization [GO:0032273],NA,NA,NA
CHOYP_BRAFLDRAFT_114488.1.1.m.6260,0.00146182727067762,-0.0203405921546638,No,NA,NA,Q9UNX4,NA,NA,NA,nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_BRAFLDRAFT_114510.1.1.m.52252,-0.00959464276658918,-0.0122385928193735,No,NA,NA,Q0VFM0,NA,NA,NA,Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_114633.1.1.m.49577,0.00701034579759186,-0.00556113557759276,No,NA,NA,Q62348,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; endoribonuclease activity [GO:0004521]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697],NA,NA,NA
CHOYP_BRAFLDRAFT_114709.1.1.m.17347,0.0208378159519042,0.000902244382439587,No,NA,NA,Q8IW92,NA,NA,NA,extracellular region [GO:0005576]; vacuole [GO:0005773]; beta-galactosidase activity [GO:0004565]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_BRAFLDRAFT_114843.2.2.m.57232,0.00425684736393747,-0.0183779970868998,No,NA,NA,Q7TP17,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; U2AF [GO:0089701]; metal ion binding [GO:0046872]; pre-mRNA 3'-splice site binding [GO:0030628]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_BRAFLDRAFT_114859.1.1.m.37271,-0.0140676851542057,0.00141619680009395,No,NA,NA,Q15119,NA,NA,NA,cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]; cellular response to nutrient [GO:0031670]; cellular response to reactive oxygen species [GO:0034614]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; insulin receptor signaling pathway [GO:0008286]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of calcium-mediated signaling [GO:0050848]; regulation of cellular ketone metabolic process [GO:0010565]; regulation of gluconeogenesis [GO:0006111]; regulation of glucose metabolic process [GO:0010906]; regulation of pH [GO:0006885],NA,NA,NA
CHOYP_BRAFLDRAFT_114866.1.5.m.6859,0.0140494222587625,0.0143276360577051,No,NA,NA,Q3SZQ6,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_BRAFLDRAFT_114866.4.5.m.35626,0.00364778592941831,-0.00872052841558096,No,NA,NA,Q3SZQ6,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_BRAFLDRAFT_114866.4.5.m.35627,-0.00372398823303288,-0.010491372561369,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_114978.1.1.m.43775,0.0126570602056205,-0.000142262396647059,No,NA,NA,Q5IFJ8,NA,NA,NA,proteasome accessory complex [GO:0022624]; proteasome assembly [GO:0043248],NA,NA,NA
CHOYP_BRAFLDRAFT_115029.1.2.m.8365,0.018019424402098,-0.000751903477442956,No,NA,NA,Q95NI4,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_BRAFLDRAFT_115040.1.1.m.28389,0.0183914551475778,0.0067071320662591,No,NA,NA,Q8VC30,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; FAD-AMP lyase (cyclizing) activity [GO:0034012]; glycerone kinase activity [GO:0004371]; metal ion binding [GO:0046872]; triokinase activity [GO:0050354]; carbohydrate phosphorylation [GO:0046835]; cellular carbohydrate metabolic process [GO:0044262]; fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate [GO:0061624]; glycerol catabolic process [GO:0019563]; glycolytic process through fructose-1-phosphate [GO:0061625]; negative regulation of MDA-5 signaling pathway [GO:0039534]; regulation of innate immune response [GO:0045088],NA,NA,NA
CHOYP_BRAFLDRAFT_115113.1.2.m.31023,-0.0131320157322944,0.0108603891878103,No,NA,NA,Q99417,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; regulation of transcription; DNA-templated [GO:0006355]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_115208.1.1.m.52467,0.0128031243565657,0.00738385669205324,No,NA,NA,A4IIL4,NA,NA,NA,membrane [GO:0016020],NA,NA,NA
CHOYP_BRAFLDRAFT_115265.1.1.m.5158,-0.00929955444933865,-0.00238493877355513,No,NA,NA,Q5R792,NA,NA,NA,autophagosome [GO:0005776]; axoneme [GO:0005930]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; phagophore assembly site membrane [GO:0034045]; aggrephagy [GO:0035973]; antigen processing and presentation of endogenous antigen [GO:0019883]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; autophagy of host cells involved in interaction with symbiont [GO:0075044]; autophagy of mitochondrion [GO:0000422]; blood vessel remodeling [GO:0001974]; cellular homeostasis [GO:0019725]; cellular response to nitrosative stress [GO:0071500]; cellular response to starvation [GO:0009267]; heart contraction [GO:0060047]; negative regulation of apoptotic process [GO:0043066]; negative regulation of histone H4-K16 acetylation [GO:2000619]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative stranded viral RNA replication [GO:0039689]; negative thymic T cell selection [GO:0045060]; otolith development [GO:0048840]; positive regulation of mucus secretion [GO:0070257]; protein lipidation involved in autophagosome assembly [GO:0061739]; regulation of cilium assembly [GO:1902017]; regulation of cytokine secretion involved in immune response [GO:0002739]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to drug [GO:0042493]; response to fungus [GO:0009620]; vasodilation [GO:0042311]; ventricular cardiac muscle cell development [GO:0055015],NA,NA,NA
CHOYP_BRAFLDRAFT_115608.1.1.m.25984,0.020570450039063,-0.00116029304784928,No,NA,NA,Q4R502,NA,NA,NA,mitochondrion [GO:0005739]; isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; 2-oxoglutarate metabolic process [GO:0006103]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_BRAFLDRAFT_115611.1.1.m.33392,0.00857073980355783,-0.00904398556751144,No,NA,NA,Q9DCN1,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; peroxisome [GO:0005777]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; NAD+ diphosphatase activity [GO:0000210]; NADH pyrophosphatase activity [GO:0035529]; NAD catabolic process [GO:0019677]; NADH metabolic process [GO:0006734]; NADP catabolic process [GO:0006742],NA,NA,NA
CHOYP_BRAFLDRAFT_115639.1.1.m.11373,-0.0109059902328069,-0.0101203170638431,No,NA,NA,Q9D287,NA,NA,NA,centrosome [GO:0005813]; DNA replication factor A complex [GO:0005662]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_BRAFLDRAFT_115687.1.1.m.4876,0.0180907661915694,0.00850336610941699,No,NA,NA,O57476,NA,NA,NA,cytoplasm [GO:0005737]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; protein kinase binding [GO:0019901]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_BRAFLDRAFT_115743.1.1.m.61177,0.0136004091822804,-0.0127669299217318,No,NA,NA,Q9WTP6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; sperm flagellum [GO:0036126]; sperm mitochondrial sheath [GO:0097226]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; dATP metabolic process [GO:0046060],NA,NA,NA
CHOYP_BRAFLDRAFT_115771.2.2.m.30817,-0.0163271178890682,-0.00284735089297119,No,NA,NA,Q0MQI9,NA,NA,NA,mitochondrial respiratory chain complex I [GO:0005747]; 2 iron; 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; NADH dehydrogenase activity [GO:0003954]; mitochondrial electron transport; NADH to ubiquinone [GO:0006120],NA,NA,NA
CHOYP_BRAFLDRAFT_115951.1.1.m.22622,0.0155294896050094,0.0208788904275262,No,NA,NA,P17276,NA,NA,NA,iron ion binding [GO:0005506]; phenylalanine 4-monooxygenase activity [GO:0004505]; tryptophan 5-monooxygenase activity [GO:0004510]; eye pigment biosynthetic process [GO:0006726]; L-phenylalanine catabolic process [GO:0006559]; long-term memory [GO:0007616]; serotonin biosynthetic process [GO:0042427]; tyrosine biosynthetic process [GO:0006571],NA,NA,NA
CHOYP_BRAFLDRAFT_116041.1.1.m.3962,-0.0180160150996919,-0.00423305069850797,No,NA,NA,Q5I0D1,NA,NA,NA,mitochondrion [GO:0005739],NA,NA,NA
CHOYP_BRAFLDRAFT_116053.1.1.m.63017,-0.0212987224529008,1.74379191330216e-05,No,NA,NA,P42325,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_BRAFLDRAFT_116088.2.2.m.27531,0.000968381587811192,-0.00284223785007262,No,NA,NA,Q9H0A8,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634],NA,NA,NA
CHOYP_BRAFLDRAFT_116394.1.1.m.57079,0.0166005415133293,-0.000186209971512476,No,NA,NA,Q6NRT5,NA,NA,NA,COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; protein deneddylation [GO:0000338],NA,NA,NA
CHOYP_BRAFLDRAFT_116913.1.1.m.43886,0.00659527026730671,0.00458082874147096,No,NA,NA,Q4QQQ7,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; brain development [GO:0007420]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_BRAFLDRAFT_116988.1.3.m.3947,-0.00303586852274807,-0.0117777455161022,No,NA,NA,P56941,NA,NA,NA,endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of lysosomal membrane [GO:1905103]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319]; bile acid metabolic process [GO:0008206]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; lysosomal transport [GO:0007041]; protein glycosylation [GO:0006486],NA,NA,NA
CHOYP_BRAFLDRAFT_117028.1.1.m.26596,-0.0114578153658727,-0.0209268213020674,No,NA,NA,Q96LR7,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_117068.1.1.m.36193,0.0180789326016007,-0.012141428237807,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_117083.3.3.m.59001,-0.0197316186264288,-0.00174361969358578,No,NA,NA,Q0VB26,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_BRAFLDRAFT_117106.1.1.m.49365,0.00512831389856631,-0.00114525747245376,No,NA,NA,Q0V8F1,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; actin binding [GO:0003779]; actin filament polymerization [GO:0030041]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_117157.1.3.m.7944,-0.0170657509444563,-0.00234850957054542,No,NA,NA,Q502W6,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_BRAFLDRAFT_117158.2.2.m.42430,0.0198440643012996,0.00367420323024036,No,NA,NA,Q9JKR5,NA,NA,NA,endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; recycling endosome membrane [GO:0055038]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein targeting to membrane [GO:0006612],NA,NA,NA
CHOYP_BRAFLDRAFT_117187.2.4.m.3553,0.00394536801625317,0.00291369700370642,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_117216.1.1.m.25201,-0.0200097806294468,-0.00492920532446,No,NA,NA,Q9JMD3,NA,NA,NA,cytosol [GO:0005829]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; microvillus [GO:0005902]; motile cilium [GO:0031514]; lipid binding [GO:0008289]; phospholipid transporter activity [GO:0005548]; bile acid secretion [GO:0032782]; phospholipid transport [GO:0015914]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360],NA,NA,NA
CHOYP_BRAFLDRAFT_117231.1.1.m.4966,0.00205195042830452,-0.00934116934689426,No,NA,NA,P36956,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; enzyme activator activity [GO:0008047]; nuclear receptor activity [GO:0004879]; protein dimerization activity [GO:0046983]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sterol response element binding [GO:0032810]; aging [GO:0007568]; cellular response to fatty acid [GO:0071398]; cellular response to starvation [GO:0009267]; cholesterol metabolic process [GO:0008203]; circadian rhythm [GO:0007623]; fat cell differentiation [GO:0045444]; insulin receptor signaling pathway [GO:0008286]; lipid biosynthetic process [GO:0008610]; lipid metabolic process [GO:0006629]; lung development [GO:0030324]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of insulin secretion [GO:0046676]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of fatty acid metabolic process [GO:0019217]; regulation of heart rate by chemical signal [GO:0003062]; regulation of protein stability [GO:0031647]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cAMP [GO:0051591]; response to food [GO:0032094]; response to glucagon [GO:0033762]; response to glucose [GO:0009749]; response to progesterone [GO:0032570]; response to retinoic acid [GO:0032526],NA,NA,NA
CHOYP_BRAFLDRAFT_117263.1.1.m.28027,-0.002365254199969,0.00258053023616004,No,NA,NA,Q53T59,NA,NA,NA,endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; phosphatidylinositol binding [GO:0035091]; negative regulation of autophagy [GO:0010507]; regulation of apoptotic process [GO:0042981],NA,NA,NA
CHOYP_BRAFLDRAFT_117275.1.1.m.9900,-0.00152681136348387,0.0122338570232844,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_117282.2.6.m.13259,-0.00476607237357508,-0.0112289891201344,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_117283.2.2.m.37544,-0.0169591047060434,0.00960206869202777,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_117284.5.7.m.53216,-0.0114437470691801,-0.0035299105367767,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_117292.1.1.m.19637,0.00606600231346666,0.0139499259642165,No,NA,NA,P53352,NA,NA,NA,chromosome; centromeric region [GO:0000775]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; chromosome segregation [GO:0007059]; mitotic cytokinesis [GO:0000281]; mitotic sister chromatid segregation [GO:0000070]; regulation of mitotic cytokinesis [GO:1902412],NA,NA,NA
CHOYP_BRAFLDRAFT_117315.1.2.m.7247,-0.0186105509117497,0.00547041336575192,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_117365.1.2.m.12413,0.00570965810575379,-0.0115432343415189,No,NA,NA,O43247,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_117365.2.2.m.31681,-0.0195303845171611,0.00934416914031539,No,NA,NA,O43247,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_117560.1.1.m.18467,-0.0136263083180191,-0.0223265985088593,No,NA,NA,Q3U829,NA,NA,NA,AP-5 adaptor complex [GO:0044599]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-strand break repair via homologous recombination [GO:0000724]; endosomal transport [GO:0016197]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_117612.1.1.m.28286,0.0215373758988673,-0.0123195151568736,No,NA,NA,P38024,NA,NA,NA,cytosol [GO:0005829]; 5-amino-4-imidazole carboxylate lyase activity [GO:0043727]; ATP binding [GO:0005524]; phosphoribosylaminoimidazole carboxylase activity [GO:0004638]; phosphoribosylaminoimidazolesuccinocarboxamide synthase activity [GO:0004639]; 'de novo' IMP biosynthetic process [GO:0006189],NA,NA,NA
CHOYP_BRAFLDRAFT_117629.2.2.m.31330,-0.00977285931414793,-0.00790898841773936,No,NA,NA,Q8CE72,NA,NA,NA,ciliary transition zone [GO:0035869]; integral component of membrane [GO:0016021]; cardiac septum development [GO:0003279]; cerebellum development [GO:0021549]; cilium assembly [GO:0060271]; coronary vasculature development [GO:0060976]; embryonic digit morphogenesis [GO:0042733]; establishment of planar polarity [GO:0001736]; heart development [GO:0007507]; kidney development [GO:0001822]; protein localization to ciliary transition zone [GO:1904491]; roof of mouth development [GO:0060021]; ventricular septum development [GO:0003281],NA,NA,NA
CHOYP_BRAFLDRAFT_117631.1.1.m.45793,-0.016020159492267,-0.000487045034120892,No,NA,NA,Q99P25,NA,NA,NA,cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_117675.1.1.m.33772,-0.00239123856973566,-0.00123962159731687,No,NA,NA,Q4V847,NA,NA,NA,nucleus [GO:0005634]; snRNA 3'-end processing [GO:0034472],NA,NA,NA
CHOYP_BRAFLDRAFT_117737.1.1.m.4255,-0.00363099871539117,-0.00283411358438619,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_117750.1.1.m.12162,-0.010070488693237,0.00546213232777929,No,NA,NA,Q7L0X2,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_117811.1.1.m.27127,0.00562443020006784,-0.012725331297207,No,NA,NA,Q86IV5,NA,NA,NA,extracellular region [GO:0005576]; actin filament polymerization [GO:0030041]; cell motility [GO:0048870]; glucose homeostasis [GO:0042593]; multicellular organism development [GO:0007275]; negative regulation of aggregate size involved in sorocarp development [GO:0031158]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cGMP-mediated signaling [GO:0010754]; regulation of cAMP-mediated signaling [GO:0043949]; regulation of glucose-6-phosphatase activity [GO:0032114]; regulation of glycolytic process [GO:0006110]; response to UV-C [GO:0010225],NA,NA,NA
CHOYP_BRAFLDRAFT_117811.1.1.m.27128,0.0130511590116838,0.00353956435922274,No,NA,NA,Q6P823,NA,NA,NA,nucleosome [GO:0000786]; nucleus [GO:0005634]; nucleosomal DNA binding [GO:0031492]; protein heterodimerization activity [GO:0046982]; nucleosome assembly [GO:0006334],NA,NA,NA
CHOYP_BRAFLDRAFT_117821.1.1.m.16201,-5.02500376161469e-05,-0.00341758269032152,No,NA,NA,O88384,NA,NA,NA,cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; vesicle [GO:0031982]; chloride channel inhibitor activity [GO:0019869]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to vacuole transport [GO:0006896]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein targeting to vacuole [GO:0006623]; regulation of protein localization to plasma membrane [GO:1903076]; retrograde transport; endosome to Golgi [GO:0042147]; vesicle fusion with Golgi apparatus [GO:0048280],NA,NA,NA
CHOYP_BRAFLDRAFT_117849.1.3.m.2806,-0.00693652027275649,0.00493604699775032,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_117849.2.3.m.4489,-0.00452539362797088,0.00715824716908958,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_117849.3.3.m.5503,0.00515461163088993,-0.00926183680104686,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_117858.2.3.m.48274,0.00835793701957299,-0.00427129918766174,No,NA,NA,Q8K2Z2,NA,NA,NA,commitment complex [GO:0000243]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; mRNA 5'-splice site recognition [GO:0000395],NA,NA,NA
CHOYP_BRAFLDRAFT_117875.1.1.m.48427,0.00685608372136286,0.00740298043812534,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_117937.1.1.m.18686,-0.0011831738752468,-0.0109802874572463,No,NA,NA,Q6DBY2,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatA complex [GO:0031415]; nucleus [GO:0005634]; H4 histone acetyltransferase activity [GO:0010485]; N-acetyltransferase activity [GO:0008080]; peptide alpha-N-acetyltransferase activity [GO:0004596]; peptidyl-lysine acetyltransferase activity [GO:0052858]; establishment of mitotic sister chromatid cohesion [GO:0034087]; histone acetylation [GO:0016573]; mitotic sister chromatid cohesion [GO:0007064]; mitotic sister chromatid cohesion; centromeric [GO:0071962]; N-terminal protein amino acid acetylation [GO:0006474]; somitogenesis [GO:0001756],NA,NA,NA
CHOYP_BRAFLDRAFT_117940.1.1.m.59223,-0.0169591047060434,0.00960206869202777,No,NA,NA,Q00808,NA,NA,NA,GTP binding [GO:0005525],NA,NA,NA
CHOYP_BRAFLDRAFT_117976.1.3.m.22767,0.00430479720440897,-0.0196130884606727,No,NA,NA,Q4R8T1,NA,NA,NA,nucleus [GO:0005634]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_BRAFLDRAFT_117976.2.3.m.49156,-0.0194189035525735,-0.0097036453914655,No,NA,NA,Q5THR3,NA,NA,NA,nucleoplasm [GO:0005654]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_BRAFLDRAFT_118043.1.1.m.26278,0.00370765940808717,-0.00435728506995286,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_118054.1.1.m.18488,-0.00430894344577715,-0.00631540690244347,No,NA,NA,Q888A4,NA,NA,NA,flavin adenine dinucleotide binding [GO:0050660]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxidoreductase activity; acting on NAD(P)H; oxygen as acceptor [GO:0050664],NA,NA,NA
CHOYP_BRAFLDRAFT_118099.2.6.m.3049,0.00861178198487282,-0.0182237537252098,No,NA,NA,Q6PGL7,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; WASH complex [GO:0071203]; phosphatidylinositol-3;4;5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3;4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3;5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; retromer complex binding [GO:1905394]; protein transport [GO:0015031]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_BRAFLDRAFT_118099.6.6.m.45150,-0.00396807246186407,0.0166605440575513,No,NA,NA,Q80X08,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; plasma membrane [GO:0005886]; WASH complex [GO:0071203]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_BRAFLDRAFT_118103.1.1.m.41767,0.00731590465202929,0.0115504055355782,No,NA,NA,O14523,NA,NA,NA,cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; insulin binding [GO:0043559]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transporter activity [GO:0008526]; phospholipid transporter activity [GO:0005548]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774],NA,NA,NA
CHOYP_BRAFLDRAFT_118108.1.1.m.58962,-0.00333851904302591,0.00170674168873135,No,NA,NA,Q90ZE4,NA,NA,NA,apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; aspartic-type endopeptidase activity [GO:0004190]; endopeptidase activity [GO:0004175]; amyloid-beta formation [GO:0034205]; amyloid-beta metabolic process [GO:0050435]; brain development [GO:0007420]; calcium ion transport [GO:0006816]; melanocyte differentiation [GO:0030318]; membrane protein ectodomain proteolysis [GO:0006509]; neurogenesis [GO:0022008]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; protein processing [GO:0016485]; somite development [GO:0061053],NA,NA,NA
CHOYP_BRAFLDRAFT_118210.1.1.m.51280,0.00205195042830453,-0.00934116934689426,No,NA,NA,B9FAF3,NA,NA,NA,kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_BRAFLDRAFT_118250.1.1.m.11178,-0.00417275817029293,0.0232117647170076,No,NA,NA,O95295,NA,NA,NA,axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; BORC complex [GO:0099078]; cell junction [GO:0030054]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]; secretory granule [GO:0030141]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; SNARE binding [GO:0000149]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; autophagosome maturation [GO:0097352]; cellular protein-containing complex localization [GO:0034629]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; late endosome to lysosome transport [GO:1902774]; lysosomal lumen acidification [GO:0007042]; lysosome localization [GO:0032418]; melanosome organization [GO:0032438]; negative regulation of neuron projection development [GO:0010977]; neuron projection development [GO:0031175]; neurotransmitter secretion [GO:0007269]; positive regulation of late endosome to lysosome transport [GO:1902824]; protein maturation [GO:0051604]; regulation of protein binding [GO:0043393]; regulation of synaptic vesicle exocytosis [GO:2000300]; retrograde axonal transport [GO:0008090]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle transport [GO:0048489]; terminal button organization [GO:0072553]; viral process [GO:0016032],NA,NA,NA
CHOYP_BRAFLDRAFT_118260.1.1.m.13621,-0.00361115090395224,-0.00781351927705347,No,NA,NA,Q5R6L5,NA,NA,NA,cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265],NA,NA,NA
CHOYP_BRAFLDRAFT_118294.2.2.m.15439,-0.0051688445871551,-0.0146727862266909,No,NA,NA,Q9R064,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; cell differentiation [GO:0030154]; establishment of protein localization to plasma membrane [GO:0061951]; Golgi organization [GO:0007030]; organelle organization [GO:0006996]; response to endoplasmic reticulum stress [GO:0034976]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_118310.1.1.m.8287,-0.00231734204624025,-0.0245313855064514,No,NA,NA,P46461,NA,NA,NA,cytoplasm [GO:0005737]; Golgi stack [GO:0005795]; neuromuscular junction [GO:0031594]; neuromuscular junction of somatic muscle [GO:0098527]; presynaptic cytosol [GO:0099523]; terminal bouton [GO:0043195]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; autophagy [GO:0006914]; Golgi organization [GO:0007030]; Golgi to lysosome transport [GO:0090160]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle docking [GO:0048211]; neuromuscular synaptic transmission [GO:0007274]; neuron cellular homeostasis [GO:0070050]; neurotransmitter secretion [GO:0007269]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; SNARE complex disassembly [GO:0035494]; synaptic vesicle cycle [GO:0099504]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082],NA,NA,NA
CHOYP_BRAFLDRAFT_118365.1.1.m.44334,-0.0135725579708753,0.00388604629968508,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_118423.1.3.m.29148,0.00323862052001393,-0.00241531478859696,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_118423.2.3.m.29362,0.0127290796799908,-0.0125836269744849,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_118423.3.3.m.30322,-0.00269166604592005,-0.0125767583197629,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_118430.2.2.m.44188,-0.00430894344577715,-0.00631540690244347,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_118500.1.1.m.46374,-0.00305892086480017,-0.00951159835815833,No,NA,NA,O75131,NA,NA,NA,azurophil granule membrane [GO:0035577]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; protein serine/threonine kinase activity [GO:0004674]; receptor tyrosine kinase binding [GO:0030971]; RNA binding [GO:0003723]; transporter activity [GO:0005215]; cellular response to calcium ion [GO:0071277]; cellular response to growth factor stimulus [GO:0071363]; ERBB2 signaling pathway [GO:0038128]; glycerophospholipid biosynthetic process [GO:0046474]; lipid metabolic process [GO:0006629]; neutrophil degranulation [GO:0043312]; positive regulation of cell migration [GO:0030335]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_118535.3.8.m.35521,0.00887212304110415,0.00365402737496958,No,NA,NA,Q9NZJ4,NA,NA,NA,axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457],NA,NA,NA
CHOYP_BRAFLDRAFT_118535.6.8.m.55199,0.00941819395075321,0.0204008050998375,No,NA,NA,Q9NZJ4,NA,NA,NA,axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457],NA,NA,NA
CHOYP_BRAFLDRAFT_118535.8.8.m.61819,-0.0152459411135398,0.00495457485739064,No,NA,NA,Q9NZJ4,NA,NA,NA,axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457],NA,NA,NA
CHOYP_BRAFLDRAFT_118545.2.2.m.54585,0.00364778592941831,-0.00872052841558097,No,NA,NA,A0JPH4,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; sterol binding [GO:0032934]; cholesterol metabolic process [GO:0008203]; SREBP signaling pathway [GO:0032933],NA,NA,NA
CHOYP_BRAFLDRAFT_118602.2.5.m.17419,0.0174638533844554,0.00552414203229057,No,NA,NA,Q2PC93,NA,NA,NA,extracellular space [GO:0005615]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_BRAFLDRAFT_118602.3.5.m.19626,0.0131603423674296,0.0220227618090707,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_118602.4.5.m.26803,0.00456512915117157,-0.0129918659519454,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_118619.2.2.m.4663,-0.00737847977874859,-0.0013594601586968,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_118645.1.1.m.30629,0.00970158392131194,-0.0166643616582239,No,NA,NA,M4YFG7,NA,NA,NA,FMN binding [GO:0010181]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_BRAFLDRAFT_118680.1.1.m.14225,3.35535650334078e-05,0.0027207344143617,No,NA,NA,Q9CZT4,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase III complex [GO:0005666]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; transcription by RNA polymerase III [GO:0006383],NA,NA,NA
CHOYP_BRAFLDRAFT_118709.2.4.m.41225,0.000137924876347206,0.0118075978278429,No,NA,NA,O15050,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_118709.3.4.m.52468,0.00615966897194063,0.00941964587728867,No,NA,NA,Q8BV79,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_118718.1.1.m.14739,0.000778467106520272,-0.0230848152673654,No,NA,NA,O75594,NA,NA,NA,extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle lumen [GO:0097013]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; N-acetylmuramoyl-L-alanine amidase activity [GO:0008745]; peptidoglycan binding [GO:0042834]; peptidoglycan receptor activity [GO:0016019]; zinc ion binding [GO:0008270]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; antimicrobial humoral response [GO:0019730]; defense response to Gram-positive bacterium [GO:0050830]; detection of bacterium [GO:0016045]; growth of symbiont in host [GO:0044117]; innate immune response [GO:0045087]; killing of cells of other organism [GO:0031640]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of natural killer cell differentiation involved in immune response [GO:0032827]; neutrophil degranulation [GO:0043312]; peptidoglycan catabolic process [GO:0009253]; positive regulation of cytolysis in other organism [GO:0051714],NA,NA,NA
CHOYP_BRAFLDRAFT_118735.1.1.m.6990,0.00784357742052394,-0.00417408603393165,No,NA,NA,Q5RKZ7,NA,NA,NA,molybdopterin synthase complex [GO:0019008]; 4 iron; 4 sulfur cluster binding [GO:0051539]; cyclic pyranopterin monophosphate synthase activity [GO:0061799]; GTP 3';8'-cyclase activity [GO:0061798]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324],NA,NA,NA
CHOYP_BRAFLDRAFT_118736.1.1.m.17458,0.00446703792770783,-0.00555451795882414,No,NA,NA,Q8IYD8,NA,NA,NA,FANCM-MHF complex [GO:0071821]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATP-dependent 3'-5' DNA helicase activity [GO:0043140]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; nuclease activity [GO:0004518]; interstrand cross-link repair [GO:0036297]; positive regulation of protein monoubiquitination [GO:1902527]; replication fork processing [GO:0031297]; resolution of meiotic recombination intermediates [GO:0000712],NA,NA,NA
CHOYP_BRAFLDRAFT_118756.1.2.m.16721,0.0141123556892953,-0.00322122244427071,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_118772.1.1.m.59465,-0.0120525626093309,0.0181701415485295,No,NA,NA,A2RT91,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_BRAFLDRAFT_118789.2.3.m.59829,-0.0160888706862962,0.00248438637614175,No,NA,NA,P52758,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; peroxisome [GO:0005777]; deaminase activity [GO:0019239]; endoribonuclease activity; producing 3'-phosphomonoesters [GO:0016892]; long-chain fatty acid binding [GO:0036041]; platinum binding [GO:1904012]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; transition metal ion binding [GO:0046914]; xenon atom binding [GO:1904013]; brain development [GO:0007420]; G1 to G0 transition [GO:0070314]; kidney development [GO:0001822]; L-threonine catabolic process to glycine [GO:0019518]; lung development [GO:0030324]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of translation [GO:0017148]; organonitrogen compound catabolic process [GO:1901565]; response to lipid [GO:0033993]; response to salt [GO:1902074],NA,NA,NA
CHOYP_BRAFLDRAFT_118790.1.1.m.29970,0.0211417050343139,-0.0110829291617027,No,NA,NA,Q9C6B9,NA,NA,NA,cytoplasm [GO:0005737]; phosphoethanolamine N-methyltransferase activity [GO:0000234]; phosphatidylcholine biosynthetic process [GO:0006656],NA,NA,NA
CHOYP_BRAFLDRAFT_118793.1.1.m.20795,-0.00183643104878127,-0.00457338359765448,No,NA,NA,A4IFB6,NA,NA,NA,CCR4-NOT complex [GO:0030014]; mRNA catabolic process [GO:0006402]; negative regulation of translation [GO:0017148],NA,NA,NA
CHOYP_BRAFLDRAFT_118803.1.1.m.14069,-0.000968170220896889,0.00715502765843969,No,NA,NA,Q9HCD5,NA,NA,NA,actin cytoskeleton [GO:0015629]; extracellular space [GO:0005615]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; glucose homeostasis [GO:0042593]; negative regulation of insulin receptor signaling pathway [GO:0046627],NA,NA,NA
CHOYP_BRAFLDRAFT_118819.1.2.m.29565,-0.0135725579708753,0.00388604629968508,No,NA,NA,O75460,NA,NA,NA,AIP1-IRE1 complex [GO:1990597]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; Ire1 complex [GO:1990332]; IRE1-RACK1-PP2A complex [GO:1990630]; IRE1-TRAF2-ASK1 complex [GO:1990604]; mitochondrion [GO:0005739]; nuclear inner membrane [GO:0005637]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; endoribonuclease activity [GO:0004521]; enzyme binding [GO:0019899]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; platelet-derived growth factor receptor binding [GO:0005161]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; unfolded protein binding [GO:0051082]; activation of JUN kinase activity [GO:0007257]; cell cycle arrest [GO:0007050]; cellular response to glucose stimulus [GO:0071333]; cellular response to unfolded protein [GO:0034620]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endoplasmic reticulum unfolded protein response [GO:0030968]; endothelial cell proliferation [GO:0001935]; insulin metabolic process [GO:1901142]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; mRNA catabolic process [GO:0006402]; mRNA cleavage [GO:0006379]; mRNA cleavage involved in mRNA processing [GO:0098787]; mRNA splicing; via endonucleolytic cleavage and ligation [GO:0070054]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine trans-autophosphorylation [GO:1990579]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of RNA splicing [GO:0033120]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of macroautophagy [GO:0016241]; response to endoplasmic reticulum stress [GO:0034976],NA,NA,NA
CHOYP_BRAFLDRAFT_118867.1.1.m.27944,0.00688439669137662,0.00470558188908102,No,NA,NA,P26221,NA,NA,NA,cellulase activity [GO:0008810]; cellulose binding [GO:0030248]; cellulose catabolic process [GO:0030245],NA,NA,NA
CHOYP_BRAFLDRAFT_118961.1.1.m.8363,-0.0209616709077827,0.00331501876408877,No,NA,NA,Q5RF36,NA,NA,NA,CIA complex [GO:0097361]; 4 iron; 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226],NA,NA,NA
CHOYP_BRAFLDRAFT_119035.1.3.m.6973,-0.00335234693086266,-0.00300302940226961,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_119036.1.1.m.18576,-0.0103049375274881,-0.000787028250915312,No,NA,NA,Q8R3P7,NA,NA,NA,centrosome [GO:0005813]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intracellular membrane-bounded organelle [GO:0043231]; intraciliary transport particle B [GO:0030992]; nucleoplasm [GO:0005654]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; floor plate formation [GO:0021508]; heart looping [GO:0001947]; intraciliary transport [GO:0042073]; left/right pattern formation [GO:0060972]; neural tube closure [GO:0001843]; smoothened signaling pathway [GO:0007224],NA,NA,NA
CHOYP_BRAFLDRAFT_119209.1.1.m.4850,-0.020274202215285,-0.000716811752430819,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_119350.1.1.m.50169,-0.00439391328688726,0.00622956183159049,No,NA,NA,Q5ZKD7,NA,NA,NA,cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleus [GO:0005634]; P granule [GO:0043186]; P-body [GO:0000932]; ATP binding [GO:0005524]; ATP-dependent 5'-3' RNA helicase activity [GO:0032575]; RNA binding [GO:0003723]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; gene silencing by miRNA [GO:0035195]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; negative regulation of transposition; RNA-mediated [GO:0010526]; positive regulation of mRNA catabolic process [GO:0061014]; posttranscriptional gene silencing by RNA [GO:0035194]; regulation of neuron projection arborization [GO:0150011],NA,NA,NA
CHOYP_BRAFLDRAFT_119363.1.1.m.41627,0.00211077578652426,0.0173793139381167,No,NA,NA,Q6KAR6,NA,NA,NA,exocyst [GO:0000145]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; presynaptic membrane [GO:0042734]; secretory granule membrane [GO:0030667]; SNARE binding [GO:0000149]; exocyst localization [GO:0051601]; exocytosis [GO:0006887]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_119367.1.1.m.59963,0.00678620130084429,0.00878741825264137,No,NA,NA,Q3UWM4,NA,NA,NA,nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; histone demethylase activity (H3-K27 specific) [GO:0071558]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; histone demethylase activity (H4-K20 specific) [GO:0035575]; iron ion binding [GO:0005506]; methylated histone binding [GO:0035064]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; 2-oxoglutarate as one donor; and incorporation of one atom each of oxygen into both donors [GO:0016706]; zinc ion binding [GO:0008270]; histone H3-K27 demethylation [GO:0071557]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; histone H4-K20 demethylation [GO:0035574]; midbrain development [GO:0030901]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_BRAFLDRAFT_119424.1.1.m.15350,-0.00430894344577715,-0.00631540690244347,No,NA,NA,Q6DJK9,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_119484.2.3.m.60445,0.0101589725536684,-0.00229460626116726,No,NA,NA,B5DF93,NA,NA,NA,CCR4-NOT complex [GO:0030014]; nuclear speck [GO:0016607]; P-body [GO:0000932]; PML body [GO:0016605]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; cytoplasmic mRNA processing body assembly [GO:0033962]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290],NA,NA,NA
CHOYP_BRAFLDRAFT_119491.1.1.m.58761,-0.00506724797891657,0.00993600393661166,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_119549.1.1.m.56597,-0.022662613255481,0.0103534211514784,No,NA,NA,Q5BK43,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_119616.1.1.m.31670,0.013384466694926,0.000933145957443637,No,NA,NA,P30841,NA,NA,NA,oxidoreductase activity; acting on the aldehyde or oxo group of donors; NAD or NADP as acceptor [GO:0016620]; structural constituent of eye lens [GO:0005212],NA,NA,NA
CHOYP_BRAFLDRAFT_119617.1.1.m.50138,-0.0047589238141393,-0.0112382850685128,No,NA,NA,Q2YDR3,NA,NA,NA,integral component of membrane [GO:0016021]; 3'-nucleotidase activity [GO:0008254]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; metal ion binding [GO:0046872]; inositol biosynthetic process [GO:0006021]; phosphatidylinositol phosphorylation [GO:0046854],NA,NA,NA
CHOYP_BRAFLDRAFT_119774.4.4.m.33349,-0.0106890415253297,-0.00265549310651728,No,NA,NA,Q80ZA4,NA,NA,NA,cilium [GO:0005929]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_BRAFLDRAFT_119799.1.1.m.23765,-0.013838810020526,0.0162384864297013,No,NA,NA,P30044,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; antioxidant activity [GO:0016209]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; peroxynitrite reductase activity [GO:0072541]; protein dimerization activity [GO:0046983]; RNA polymerase III regulatory region DNA binding [GO:0001016]; signaling receptor binding [GO:0005102]; thioredoxin peroxidase activity [GO:0008379]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; inflammatory response [GO:0006954]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of transcription by RNA polymerase III [GO:0016480]; positive regulation of collagen biosynthetic process [GO:0032967]; reactive nitrogen species metabolic process [GO:2001057]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_BRAFLDRAFT_119901.1.1.m.7089,0.00742016705715737,-0.0101686027910306,No,NA,NA,P49916,NA,NA,NA,cytoplasm [GO:0005737]; DNA ligase III-XRCC1 complex [GO:0070421]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; DNA ligase activity [GO:0003909]; zinc ion binding [GO:0008270]; base-excision repair; DNA ligation [GO:0006288]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation [GO:0006266]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via homologous recombination [GO:0000724]; lagging strand elongation [GO:0006273]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of mitochondrial DNA replication [GO:0090298]; nucleotide-excision repair; DNA gap filling [GO:0006297]; transcription-coupled nucleotide-excision repair [GO:0006283],NA,NA,NA
CHOYP_BRAFLDRAFT_119906.1.1.m.45319,-0.0090377265880937,0.00650943924044151,No,NA,NA,B0DOB4,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; non-motile cilium [GO:0097730]; negative regulation of canonical Wnt signaling pathway [GO:0090090],NA,NA,NA
CHOYP_BRAFLDRAFT_119906.1.1.m.45320,-0.00954040314102524,0.00744550497673531,No,NA,NA,Q9CR41,NA,NA,NA,cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein N-terminus binding [GO:0047485]; negative regulation of apoptotic process [GO:0043066]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_BRAFLDRAFT_119955.1.1.m.16485,-0.00637888578931815,0.0149703786932585,No,NA,NA,Q6NU94,NA,NA,NA,nucleus [GO:0005634]; tRNA (guanine-N7-)-methyltransferase activity [GO:0008176]; tRNA binding [GO:0000049]; tRNA modification [GO:0006400],NA,NA,NA
CHOYP_BRAFLDRAFT_119982.1.1.m.62398,-0.00890686682520317,-0.00958150799805483,No,NA,NA,O95243,NA,NA,NA,chromatin [GO:0000785]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA N-glycosylase activity [GO:0019104]; endodeoxyribonuclease activity [GO:0004520]; pyrimidine-specific mismatch base pair DNA N-glycosylase activity [GO:0008263]; satellite DNA binding [GO:0003696]; depyrimidination [GO:0045008]; DNA repair [GO:0006281]; response to estradiol [GO:0032355]; response to radiation [GO:0009314],NA,NA,NA
CHOYP_BRAFLDRAFT_120041.1.1.m.6386,-0.0226530809189636,0.0103953918995187,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_120058.1.1.m.9895,-0.0187974950694949,6.60983094129494e-05,No,NA,NA,Q8WWB3,NA,NA,NA,Set1C/COMPASS complex [GO:0048188]; histone H3-K4 methylation [GO:0051568],NA,NA,NA
CHOYP_BRAFLDRAFT_120093.2.2.m.51468,-0.0062906907541444,0.010373545141951,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_120139.4.5.m.50713,-0.0225695700376456,0.00999735544747356,No,NA,NA,Q60997,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular matrix [GO:0031012]; extrinsic component of membrane [GO:0019898]; integral component of membrane [GO:0016021]; phagocytic vesicle membrane [GO:0030670]; transport vesicle membrane [GO:0030658]; zymogen granule membrane [GO:0042589]; extracellular matrix structural constituent [GO:0005201]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375]; blastocyst development [GO:0001824]; cell differentiation [GO:0030154]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; inner cell mass cell proliferation [GO:0001833]; positive regulation of epithelial cell differentiation [GO:0030858]; protein transport [GO:0015031]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_BRAFLDRAFT_120431.1.1.m.49038,-0.0169591047060434,0.00960206869202777,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_120433.1.1.m.66614,-0.0090723400984585,-0.00745095550462864,No,NA,NA,Q5BJ68,NA,NA,NA,integral component of membrane [GO:0016021]; cytochrome-b5 reductase activity; acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]; response to yeast [GO:0001878]; sterol biosynthetic process [GO:0016126],NA,NA,NA
CHOYP_BRAFLDRAFT_120586.1.1.m.41856,0.00483882495713972,0.00626444248856402,No,NA,NA,Q9ULC5,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; regulation of extrinsic apoptotic signaling pathway [GO:2001236],NA,NA,NA
CHOYP_BRAFLDRAFT_120588.1.1.m.22993,-0.0226489506112481,0.0101852795416494,No,NA,NA,Q9JMB1,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_120607.1.3.m.8455,-0.0232269994688501,-0.00183792458746744,No,NA,NA,Q6Q759,NA,NA,NA,axonemal central apparatus [GO:1990716]; microtubule [GO:0005874]; motile cilium [GO:0031514]; axonemal central apparatus assembly [GO:1904158]; epithelial cilium movement [GO:0003351],NA,NA,NA
CHOYP_BRAFLDRAFT_120767.1.1.m.16005,0.00217997094733793,-0.00807271368859912,No,NA,NA,Q8K1J5,NA,NA,NA,nucleus [GO:0005634]; damaged DNA binding [GO:0003684]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to UV [GO:0034644]; DNA replication [GO:0006260]; protein processing [GO:0016485]; protein ubiquitination [GO:0016567]; regulation of cell cycle arrest [GO:0071156],NA,NA,NA
CHOYP_BRAFLDRAFT_120826.1.1.m.56321,-0.0143569940761794,-0.00278016123533611,No,NA,NA,A1A4L0,NA,NA,NA,cytoplasmic dynein complex [GO:0005868]; early endosome membrane [GO:0031901]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; epidermal growth factor receptor binding [GO:0005154]; insulin receptor binding [GO:0005158]; leptin receptor binding [GO:1990460]; phosphatidylinositol binding [GO:0035091]; transferrin receptor binding [GO:1990459]; endocytic recycling [GO:0032456]; positive regulation of histamine secretion by mast cell [GO:1903595]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_120908.1.1.m.5866,0.00498457319718575,0.022662627991289,No,NA,NA,Q865F7,NA,NA,NA,cytoplasm [GO:0005737]; lipid binding [GO:0008289]; hibernation [GO:0042750],NA,NA,NA
CHOYP_BRAFLDRAFT_120923.3.3.m.58916,0.0209437613257419,0.00874675758341333,No,NA,NA,Q3B8G0,NA,NA,NA,zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_BRAFLDRAFT_120970.1.1.m.63798,0.00618210545460195,-0.0112951732786268,No,NA,NA,O75131,NA,NA,NA,azurophil granule membrane [GO:0035577]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; protein serine/threonine kinase activity [GO:0004674]; receptor tyrosine kinase binding [GO:0030971]; RNA binding [GO:0003723]; transporter activity [GO:0005215]; cellular response to calcium ion [GO:0071277]; cellular response to growth factor stimulus [GO:0071363]; ERBB2 signaling pathway [GO:0038128]; glycerophospholipid biosynthetic process [GO:0046474]; lipid metabolic process [GO:0006629]; neutrophil degranulation [GO:0043312]; positive regulation of cell migration [GO:0030335]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_120990.1.18.m.2376,-0.00807920342153338,-0.00334168283852542,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_120990.10.18.m.51025,0.00205195042830452,-0.00934116934689426,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_120993.1.2.m.41307,0.00960050542291013,0.000276292768826387,No,NA,NA,Q60431,NA,NA,NA,cytoplasm [GO:0005737]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; positive regulation of amyloid-beta formation [GO:1902004]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647],NA,NA,NA
CHOYP_BRAFLDRAFT_121045.1.1.m.55827,-0.0146536924306574,0.00450954433140788,No,NA,NA,Q5XM24,NA,NA,NA,extracellular region [GO:0005576]; protein-containing complex [GO:0032991]; chemorepellent activity [GO:0045499]; peptidase activity [GO:0008233]; signaling receptor binding [GO:0005102]; cell cycle [GO:0007049]; negative chemotaxis [GO:0050919]; negative regulation of asexual reproduction [GO:1903665]; protein localization to plasma membrane [GO:0072659]; regulation of aggregate size involved in sorocarp development [GO:0031157]; sporulation resulting in formation of a cellular spore [GO:0030435],NA,NA,NA
CHOYP_BRAFLDRAFT_121105.1.1.m.41883,-0.0194323402935209,-0.00164199452369348,No,NA,NA,Q32NR4,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_121138.1.1.m.787,-0.00421618264201881,-0.00790770523164119,No,NA,NA,Q95KU9,NA,NA,NA,cytoplasm [GO:0005737]; IkappaB kinase complex [GO:0008385]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ubiquitin ligase complex [GO:0000151]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; linear polyubiquitin binding [GO:1990450]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; cellular response to DNA damage stimulus [GO:0006974]; establishment of vesicle localization [GO:0051650]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_BRAFLDRAFT_121151.1.1.m.59381,-0.00419138967156916,0.00253493557939346,No,NA,NA,Q9Y5X3,NA,NA,NA,brush border [GO:0005903]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of endosome membrane [GO:0031313]; macropinocytic cup [GO:0070685]; phagocytic cup [GO:0001891]; retromer complex [GO:0030904]; retromer; tubulation complex [GO:0030905]; ruffle [GO:0001726]; tubular endosome [GO:0097422]; cadherin binding [GO:0045296]; D1 dopamine receptor binding [GO:0031748]; dynactin binding [GO:0034452]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3;5-bisphosphate binding [GO:0080025]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; protein heterodimerization activity [GO:0046982]; epidermal growth factor catabolic process [GO:0007174]; intracellular protein transport [GO:0006886]; negative regulation of blood pressure [GO:0045776]; pinocytosis [GO:0006907]; positive regulation of renal sodium excretion [GO:0035815]; regulation of macroautophagy [GO:0016241]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_BRAFLDRAFT_121259.1.1.m.2411,-0.00586813058854889,0.00493039542201906,No,NA,NA,Q8BUV8,NA,NA,NA,clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; clathrin heavy chain binding [GO:0032050]; clathrin-dependent endocytosis [GO:0072583],NA,NA,NA
CHOYP_BRAFLDRAFT_121459.1.1.m.21810,0.00213448200744792,-0.0138548295473887,No,NA,NA,Q8N6F8,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_121480.1.1.m.48790,0.0219534627679059,-0.00964442696141945,No,NA,NA,P86789,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_BRAFLDRAFT_121507.1.2.m.30603,-0.018855208212632,-0.0136135507390882,No,NA,NA,Q5TYW6,NA,NA,NA,axoneme [GO:0005930]; cilium [GO:0005929]; kinocilium [GO:0060091]; motile cilium [GO:0031514]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; motile cilium assembly [GO:0044458],NA,NA,NA
CHOYP_BRAFLDRAFT_121562.1.1.m.37267,-0.000354443073090076,0.0216039796457805,No,NA,NA,V5YMB3,NA,NA,NA,dipeptidyl-peptidase activity [GO:0008239]; endopeptidase activity [GO:0004175]; serine-type peptidase activity [GO:0008236]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_BRAFLDRAFT_121562.1.1.m.37268,0.0146054519747836,-0.00132976368032418,No,NA,NA,Q5R9R4,NA,NA,NA,postsynaptic density [GO:0014069]; ribosome [GO:0005840]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_BRAFLDRAFT_121667.1.2.m.12193,-0.0177103708684297,-0.00847880247318572,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_121824.1.1.m.37419,-0.0176610325183588,0.00967672678338481,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_121887.1.1.m.59668,0.000301157199270267,-0.0233678964756418,No,NA,NA,Q99973,NA,NA,NA,chromosome; telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; ribonucleoprotein complex [GO:1990904]; telomerase holoenzyme complex [GO:0005697]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034]; telomere maintenance via recombination [GO:0000722],NA,NA,NA
CHOYP_BRAFLDRAFT_121902.1.1.m.64757,0.020257004285212,-0.00796583711841205,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_121927.1.1.m.47211,-0.0210230076972923,-0.00762648149609798,No,NA,NA,Q6ZTR5,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_122018.1.1.m.21774,-0.00632334876214819,-0.0220818960977195,No,NA,NA,O08658,NA,NA,NA,nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; structural constituent of nuclear pore [GO:0017056]; mitotic cell cycle [GO:0000278]; mRNA export from nucleus [GO:0006406]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056],NA,NA,NA
CHOYP_BRAFLDRAFT_122339.1.1.m.58748,-0.0176242226667212,0.00907037334760603,No,NA,NA,Q9CQ46,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_BRAFLDRAFT_122376.1.1.m.49446,-0.0135725579708753,0.00388604629968508,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_122381.3.4.m.23140,-0.0169591047060434,0.00960206869202778,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_122389.1.1.m.15498,0.00153897440985541,-0.0221043568361392,No,NA,NA,Q11118,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879]; cell cycle [GO:0007049]; chaperone-mediated protein complex assembly [GO:0051131]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457],NA,NA,NA
CHOYP_BRAFLDRAFT_122422.1.2.m.52874,-0.0110178339544879,0.00401269445119132,No,NA,NA,P51610,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; histone acetyltransferase complex [GO:0000123]; membrane [GO:0016020]; MLL1 complex [GO:0071339]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Set1C/COMPASS complex [GO:0048188]; activating transcription factor binding [GO:0033613]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; identical protein binding [GO:0042802]; protein binding; bridging [GO:0030674]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coactivator activity [GO:0003713]; blastocyst hatching [GO:0001835]; cell cycle [GO:0007049]; cellular response to organic cyclic compound [GO:0071407]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; mitochondrion organization [GO:0007005]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle [GO:0045787]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription; DNA-templated [GO:0045893]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of protein complex assembly [GO:0043254]; regulation of transcription; DNA-templated [GO:0006355]; release from viral latency [GO:0019046],NA,NA,NA
CHOYP_BRAFLDRAFT_122572.1.1.m.29320,-0.021993370168228,0.00113933104731016,No,NA,NA,Q5PQ44,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_122634.2.2.m.43678,0.0186717805362797,0.00396528088254227,No,NA,NA,Q9Y6R7,NA,NA,NA,extracellular exosome [GO:0070062],NA,NA,NA
CHOYP_BRAFLDRAFT_122687.1.1.m.47713,-0.00864187881215724,0.00599012906880836,No,NA,NA,Q5XIA2,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_122791.1.6.m.8640,0.00779631511620155,-0.0138311127188408,No,NA,NA,Q9UIF8,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_BRAFLDRAFT_122807.1.1.m.3729,0.0185177765226351,0.00558248151752167,No,NA,NA,Q99MD6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; protein disulfide oxidoreductase activity [GO:0015035]; thioredoxin-disulfide reductase activity [GO:0004791]; blastocyst formation [GO:0001825]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; glutathione metabolic process [GO:0006749]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_122887.1.1.m.62170,0.016293009283163,-0.00183957962394111,No,NA,NA,Q3ULZ2,NA,NA,NA,cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; actin binding [GO:0003779]; microtubule binding [GO:0008017]; cilium assembly [GO:0060271]; Golgi ribbon formation [GO:0090161]; stress fiber assembly [GO:0043149],NA,NA,NA
CHOYP_BRAFLDRAFT_122922.1.1.m.17746,0.00394536801625317,0.00291369700370642,No,NA,NA,Q9UHB4,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity [GO:0016491]; cell death [GO:0008219]; cellular response to menadione [GO:0036245]; iron-sulfur cluster assembly [GO:0016226]; oxidation-reduction process [GO:0055114],NA,NA,NA
CHOYP_BRAFLDRAFT_122927.1.1.m.51870,-0.00653674780969367,-0.0163858835380363,No,NA,NA,Q66J69,NA,NA,NA,chromosome [GO:0005694]; MLL1 complex [GO:0071339]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; histone H2A-K119 monoubiquitination [GO:0036353]; negative regulation of transcription by RNA polymerase II [GO:0000122],NA,NA,NA
CHOYP_BRAFLDRAFT_122970.1.1.m.52022,-0.0115949485709425,-0.00371142354258725,No,NA,NA,Q5VVH5,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955],NA,NA,NA
CHOYP_BRAFLDRAFT_123087.1.2.m.6329,-0.016699146478688,0.00298857110179678,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_123087.2.2.m.27308,0.00521910901109537,-0.0152895063667813,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_123202.1.1.m.17267,-0.00415462692468474,-0.0204441172485622,No,NA,NA,P08836,NA,NA,NA,cytoplasm [GO:0005737]; dimethylallyltranstransferase activity [GO:0004161]; geranyltranstransferase activity [GO:0004337]; metal ion binding [GO:0046872]; cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate biosynthetic process [GO:0045337]; geranyl diphosphate biosynthetic process [GO:0033384],NA,NA,NA
CHOYP_BRAFLDRAFT_123291.1.1.m.11923,-0.0175374029531098,0.00951434307919184,No,NA,NA,B6CZ61,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_BRAFLDRAFT_123298.1.1.m.483,-0.00914900717539625,-0.0149126133971664,No,NA,NA,P24386,NA,NA,NA,cytosol [GO:0005829]; Rab-protein geranylgeranyltransferase complex [GO:0005968]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; Rab geranylgeranyltransferase activity [GO:0004663]; Rab GTPase binding [GO:0017137]; post-translational protein modification [GO:0043687]; protein geranylgeranylation [GO:0018344]; protein targeting to membrane [GO:0006612]; regulation of apoptotic process [GO:0042981]; small GTPase mediated signal transduction [GO:0007264]; visual perception [GO:0007601],NA,NA,NA
CHOYP_BRAFLDRAFT_123304.1.1.m.29231,0.00673765036922931,0.00523781988921367,No,NA,NA,Q6GQJ2,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; apoptotic process [GO:0006915],NA,NA,NA
CHOYP_BRAFLDRAFT_123389.1.1.m.57156,-0.00525348550142789,-0.0103291238010231,No,NA,NA,Q05AL1,NA,NA,NA,cytoplasm [GO:0005737]; GID complex [GO:0034657]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_BRAFLDRAFT_123397.1.1.m.42218,-0.0144554143397326,-0.000882679117846979,No,NA,NA,Q8WXR4,NA,NA,NA,cytoplasm [GO:0005737]; myosin complex [GO:0016459]; stereocilium tip [GO:0032426]; actin binding [GO:0003779]; ATP binding [GO:0005524]; motor activity [GO:0003774]; protein serine/threonine kinase activity [GO:0004674]; cochlea morphogenesis [GO:0090103]; response to stimulus [GO:0050896]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601],NA,NA,NA
CHOYP_BRAFLDRAFT_123537.1.2.m.28822,0.00131736662602282,-0.00321700548613351,No,NA,NA,D3YXG0,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_BRAFLDRAFT_123537.2.2.m.50531,-0.0177832620924375,-0.00798706604968738,No,NA,NA,Q9UIF3,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159],NA,NA,NA
CHOYP_BRAFLDRAFT_123540.1.1.m.10582,-0.011836243175843,-0.0120378704379103,No,NA,NA,Q4R5Y0,NA,NA,NA,nucleus [GO:0005634],NA,NA,NA
CHOYP_BRAFLDRAFT_123636.1.1.m.16162,0.0133998422835045,0.00579875788005494,No,NA,NA,Q8C0J2,NA,NA,NA,autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cytosol [GO:0005829]; phagophore assembly site membrane [GO:0034045]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; autophagosome assembly [GO:0000045]; negative stranded viral RNA replication [GO:0039689]; positive regulation of autophagy [GO:0010508]; protein lipidation involved in autophagosome assembly [GO:0061739]; protein localization to phagophore assembly site [GO:0034497]; protein transport [GO:0015031]; xenophagy [GO:0098792],NA,NA,NA
CHOYP_BRAFLDRAFT_123642.2.2.m.55471,0.010523168128883,-0.00481765719719247,No,NA,NA,Q8N6T3,NA,NA,NA,cytosol [GO:0005829]; Golgi membrane [GO:0000139]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; IRE1-mediated unfolded protein response [GO:0036498]; protein transport [GO:0015031]; regulation of ARF protein signal transduction [GO:0032012]; regulation of endocytosis [GO:0030100]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_BRAFLDRAFT_123741.1.1.m.31088,0.0231655929541649,-0.00931222859888712,No,NA,NA,Q7RTY7,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252],NA,NA,NA
CHOYP_BRAFLDRAFT_123768.1.1.m.7223,-0.0184488116853344,0.0175773107289836,No,NA,NA,Q6ZMT9,NA,NA,NA,signal transduction [GO:0007165],NA,NA,NA
CHOYP_BRAFLDRAFT_123909.1.1.m.24337,-0.0141622853636332,0.010142488813065,No,NA,NA,Q3UYG8,NA,NA,NA,centrosome [GO:0005813]; nucleolus [GO:0005730]; nucleus [GO:0005634]; deacetylase activity [GO:0019213]; hydrolase activity; acting on glycosyl bonds [GO:0016798]; brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; protein de-ADP-ribosylation [GO:0051725]; purine nucleoside metabolic process [GO:0042278]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_BRAFLDRAFT_123986.1.1.m.47284,-0.00711763044498725,-0.0260702817348314,No,NA,NA,Q7ZY18,NA,NA,NA,MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; regulation of DNA-dependent DNA replication initiation [GO:0030174],NA,NA,NA
CHOYP_BRAFLDRAFT_124020.1.1.m.22574,0.0155074251426903,0.00753349569009826,No,NA,NA,Q9HBK9,NA,NA,NA,cytosol [GO:0005829]; arsenite methyltransferase activity [GO:0030791]; methylarsonite methyltransferase activity [GO:0030792]; arsonoacetate metabolic process [GO:0018872]; methylation [GO:0032259]; toxin metabolic process [GO:0009404],NA,NA,NA
CHOYP_BRAFLDRAFT_124027.1.2.m.22812,0.0135964971194438,-0.000889848525411653,No,NA,NA,B4JG34,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; dorsal/ventral pattern formation [GO:0009953],NA,NA,NA
CHOYP_BRAFLDRAFT_124027.2.2.m.50286,-0.011561039460631,-0.00374922354891039,No,NA,NA,B4JG34,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; dorsal/ventral pattern formation [GO:0009953],NA,NA,NA
CHOYP_BRAFLDRAFT_124064.1.6.m.5120,-0.00775942477518875,0.00780094758633381,No,NA,NA,Q66IM5,NA,NA,NA,N-acyltransferase activity [GO:0016410]; protein acetylation [GO:0006473],NA,NA,NA
CHOYP_BRAFLDRAFT_124064.3.6.m.38212,0.00942398675772728,0.00672915658996075,No,NA,NA,P35543,NA,NA,NA,high-density lipoprotein particle [GO:0034364]; acute-phase response [GO:0006953],NA,NA,NA
CHOYP_BRAFLDRAFT_124064.5.6.m.41252,0.0115853854667853,0.00128986783664241,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_124069.1.1.m.14145,-0.00455805062235058,-0.00206659555697039,No,NA,NA,Q4R6V2,NA,NA,NA,cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; G-protein beta-subunit binding [GO:0031681]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to virus [GO:0009615]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_BRAFLDRAFT_124130.2.3.m.30247,0.00205195042830453,-0.00934116934689426,No,NA,NA,Q4R8M9,NA,NA,NA,cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_124233.1.1.m.26105,-0.00264142308391231,-0.00194634790613369,No,NA,NA,O43837,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; electron transfer activity [GO:0009055]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_BRAFLDRAFT_124240.1.1.m.8573,-0.00402203799234127,-0.00877343982153469,No,NA,NA,Q76NI1,NA,NA,NA,dendrite [GO:0030425]; guanyl-nucleotide exchange factor complex [GO:0032045]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; cerebellar granule cell differentiation [GO:0021707]; positive regulation of protein phosphorylation [GO:0001934]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; small GTPase mediated signal transduction [GO:0007264],NA,NA,NA
CHOYP_BRAFLDRAFT_124260.1.1.m.8355,-0.0169591047060434,0.00960206869202778,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_124275.1.1.m.8900,0.0128890191257798,0.0173292591950214,No,NA,NA,P13086,NA,NA,NA,mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; succinate-CoA ligase complex (GDP-forming) [GO:0045244]; cofactor binding [GO:0048037]; GDP binding [GO:0019003]; nucleoside diphosphate kinase activity [GO:0004550]; protein heterodimerization activity [GO:0046982]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase (GDP-forming) activity [GO:0004776]; nucleoside triphosphate biosynthetic process [GO:0009142]; succinate metabolic process [GO:0006105]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_BRAFLDRAFT_124284.1.1.m.33673,-0.00481986788824851,-1.15348926732699e-05,No,NA,NA,Q3TNA1,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; xylulokinase activity [GO:0004856]; D-xylose metabolic process [GO:0042732]; phosphorylation [GO:0016310]; xylulose metabolic process [GO:0005997],NA,NA,NA
CHOYP_BRAFLDRAFT_124476.1.4.m.1812,0.00347095005275525,0.000536915819706489,No,NA,NA,Q96I24,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_BRAFLDRAFT_124476.3.4.m.48503,0.00774545461300069,-0.00240609447406861,No,NA,NA,Q96I24,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_BRAFLDRAFT_124523.1.1.m.18960,0.00659406883023615,0.000115121453252223,No,NA,NA,Q9CRA8,NA,NA,NA,cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; RNA binding [GO:0003723]; defense response to virus [GO:0051607]; DNA deamination [GO:0045006]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process; exonucleolytic; 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; RNA catabolic process [GO:0006401]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475],NA,NA,NA
CHOYP_BRAFLDRAFT_124526.1.1.m.25228,-0.0169591047060434,0.00960206869202778,No,NA,NA,Q9BRS2,NA,NA,NA,cytosol [GO:0005829]; methyltransferase complex [GO:0034708]; nucleoplasm [GO:0005654]; preribosome; small subunit precursor [GO:0030688]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; maturation of SSU-rRNA [GO:0030490]; positive regulation of rRNA processing [GO:2000234]; ribosomal small subunit biogenesis [GO:0042274],NA,NA,NA
CHOYP_BRAFLDRAFT_124536.1.2.m.10835,-0.00870371842968214,-0.0063148348671636,No,NA,NA,Q9ESB5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; calcium ion binding [GO:0005509]; blastocyst hatching [GO:0001835]; regulation of amyloid precursor protein biosynthetic process [GO:0042984],NA,NA,NA
CHOYP_BRAFLDRAFT_124611.1.1.m.34341,0.00607659659774759,-0.00874581842085886,No,NA,NA,Q6P9B9,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA processing [GO:0016180]; snRNA transcription by RNA polymerase II [GO:0042795],NA,NA,NA
CHOYP_BRAFLDRAFT_124637.1.1.m.26435,-0.00598307144603663,8.09877662577255e-05,No,NA,NA,Q68FK8,NA,NA,NA,actin cytoskeleton [GO:0015629]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; micro-ribonucleoprotein complex [GO:0035068]; microtubule organizing center [GO:0005815]; nuclear body [GO:0016604]; nuclear stress granule [GO:0097165]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; polysomal ribosome [GO:0042788]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC-loading complex [GO:0070578]; ATP binding [GO:0005524]; ATP-dependent 3'-5' DNA helicase activity [GO:0043140]; ATP-dependent 3'-5' DNA/RNA helicase activity [GO:0033681]; ATP-dependent 3'-5' RNA helicase activity [GO:0034459]; ATP-dependent DNA helicase activity [GO:0004003]; ATP-dependent RNA helicase activity [GO:0004004]; ATPase activity [GO:0016887]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; importin-alpha family protein binding [GO:0061676]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; nucleoside-triphosphatase activity [GO:0017111]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; polysome binding [GO:1905538]; promoter-specific chromatin binding [GO:1990841]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; single-stranded DNA binding [GO:0003697]; single-stranded DNA-dependent ATP-dependent 3'-5' DNA helicase activity [GO:1990518]; single-stranded RNA binding [GO:0003727]; transcription coactivator activity [GO:0003713]; triplex DNA binding [GO:0045142]; alternative mRNA splicing; via spliceosome [GO:0000380]; cellular response to tumor necrosis factor [GO:0071356]; DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; DNA-templated transcription; termination [GO:0006353]; G-quadruplex DNA unwinding [GO:0044806]; mRNA transport [GO:0051028]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of polysome binding [GO:1905698]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cytoplasmic translation [GO:2000765]; regulation of mRNA processing [GO:0050684]; RNA secondary structure unwinding [GO:0010501]; small RNA loading onto RISC [GO:0070922]; targeting of mRNA for destruction involved in RNA interference [GO:0030423],NA,NA,NA
CHOYP_BRAFLDRAFT_124675.1.1.m.61945,0.00360878253936372,0.0140581995211867,No,NA,NA,Q99JG7,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein kinase binding [GO:0019901]; apoptotic process [GO:0006915]; CD40 signaling pathway [GO:0023035]; cellular response to lipopolysaccharide [GO:0071222]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; negative regulation of endothelial cell apoptotic process [GO:2000352]; positive regulation of B cell activation [GO:0050871]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of macrophage activation [GO:0043032]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor 3 signaling pathway [GO:0034138]; toll-like receptor 9 signaling pathway [GO:0034162],NA,NA,NA
CHOYP_BRAFLDRAFT_124686.1.1.m.18409,0.0163228327655151,0.0185052987747645,No,NA,NA,P00504,NA,NA,NA,cytosol [GO:0005829]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; L-cysteine:2-oxoglutarate aminotransferase activity [GO:0047801]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; aspartate biosynthetic process [GO:0006532]; aspartate metabolic process [GO:0006531]; cellular amino acid metabolic process [GO:0006520]; gluconeogenesis [GO:0006094]; glutamate metabolic process [GO:0006536]; glycerol biosynthetic process [GO:0006114],NA,NA,NA
CHOYP_BRAFLDRAFT_124878.1.1.m.55561,0.00581691944613851,0.00401584535454087,No,NA,NA,P35570,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; insulin receptor complex [GO:0005899]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; insulin receptor binding [GO:0005158]; insulin-like growth factor receptor binding [GO:0005159]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; SH2 domain binding [GO:0042169]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; aging [GO:0007568]; cellular response to angiotensin [GO:1904385]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to radiation [GO:0071478]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of insulin secretion [GO:0046676]; negative regulation of somatostatin secretion [GO:0090275]; positive regulation of glucagon secretion [GO:0070094]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphorylation [GO:0042327]; protein heterooligomerization [GO:0051291]; response to activity [GO:0014823]; response to caffeine [GO:0031000]; response to peptide hormone [GO:0043434],NA,NA,NA
CHOYP_BRAFLDRAFT_124950.1.1.m.8139,-7.18024083751616e-05,0.0200901123330732,No,NA,NA,Q8C156,NA,NA,NA,chromosome [GO:0005694]; condensin complex [GO:0000796]; cytosol [GO:0005829]; nuclear condensin complex [GO:0000799]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA topoisomerase (ATP-hydrolyzing) activator activity [GO:0072587]; DNA topoisomerase binding [GO:0044547]; cell division [GO:0051301]; female meiosis chromosome separation [GO:0051309]; female meiotic nuclear division [GO:0007143]; meiotic chromosome condensation [GO:0010032]; meiotic chromosome segregation [GO:0045132]; mitotic chromosome condensation [GO:0007076],NA,NA,NA
CHOYP_BRAFLDRAFT_124962.1.1.m.57433,-0.00265059291148104,-0.0213081249682047,No,NA,NA,O97490,NA,NA,NA,anchored component of membrane [GO:0031225]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; ion transport [GO:0006811]; iron ion homeostasis [GO:0055072],NA,NA,NA
CHOYP_BRAFLDRAFT_124972.1.5.m.3843,0.0219903902796917,-0.0074901922370293,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_124972.1.5.m.3844,0.00965970138746735,-0.0101060314129702,No,NA,NA,Q8HXX6,NA,NA,NA,lysosome [GO:0005764]; enzyme activator activity [GO:0008047]; hydrolase activity [GO:0016787]; ganglioside catabolic process [GO:0006689],NA,NA,NA
CHOYP_BRAFLDRAFT_124972.2.5.m.4101,-0.0206666333126382,-0.00595372872076942,No,NA,NA,Q8HXX6,NA,NA,NA,lysosome [GO:0005764]; enzyme activator activity [GO:0008047]; hydrolase activity [GO:0016787]; ganglioside catabolic process [GO:0006689],NA,NA,NA
CHOYP_BRAFLDRAFT_125037.1.3.m.2939,0.0114047322224162,-0.0157373348762286,No,NA,NA,Q58EK5,NA,NA,NA,cytoplasm [GO:0005737]; P granule [GO:0043186]; pi-body [GO:0071546]; metal ion binding [GO:0046872]; piRNA binding [GO:0034584]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; P granule organization [GO:0030719]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_125037.2.3.m.13981,0.00678620130084428,0.00878741825264137,No,NA,NA,A9CPT4,NA,NA,NA,P granule [GO:0043186]; pi-body [GO:0071546]; metal ion binding [GO:0046872]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_125073.1.1.m.1752,-0.00627192448273425,0.0131618985722855,No,NA,NA,Q99P31,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; adenyl-nucleotide exchange factor activity [GO:0000774]; ubiquitin protein ligase binding [GO:0031625]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398],NA,NA,NA
CHOYP_BRAFLDRAFT_125104.1.1.m.31139,-0.0135725579708752,0.00388604629968508,No,NA,NA,P51909,NA,NA,NA,cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; aging [GO:0007568]; brain development [GO:0007420]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of lipoprotein lipid oxidation [GO:0060588]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of smooth muscle cell-matrix adhesion [GO:2000098]; negative regulation of T cell migration [GO:2000405]; peripheral nervous system axon regeneration [GO:0014012]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to reactive oxygen species [GO:0000302]; tissue regeneration [GO:0042246],NA,NA,NA
CHOYP_BRAFLDRAFT_125119.1.1.m.57550,-0.0199806477190598,0.0134133249456611,No,NA,NA,Q5F201,NA,NA,NA,cytoplasm [GO:0005737]; motile cilium [GO:0031514],NA,NA,NA
CHOYP_BRAFLDRAFT_125234.2.2.m.19033,-0.0113496630573278,0.00322115251786451,No,NA,NA,Q5T6F2,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_BRAFLDRAFT_125263.1.9.m.7394,-0.0155617650406553,0.00354856159207541,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_125265.2.4.m.18968,-0.00212078832001384,-0.00891837260408134,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_125270.1.1.m.2429,0.00205195042830452,-0.00934116934689426,No,NA,NA,Q5TZ24,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; reduced ascorbate as one donor; and incorporation of one atom of oxygen [GO:0016715]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589],NA,NA,NA
CHOYP_BRAFLDRAFT_125327.1.1.m.29699,-0.00157660013654014,0.024229312616213,No,NA,NA,Q91YN5,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802]; UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047],NA,NA,NA
CHOYP_BRAFLDRAFT_125356.3.3.m.35009,-0.00938273834484934,-0.011229121608704,No,NA,NA,Q3V0L5,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_125389.1.1.m.62938,-0.0112007115889385,-0.0122867772326443,No,NA,NA,Q5RFR0,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_125403.1.1.m.30476,-0.0201655233307681,0.00401029457879206,No,NA,NA,Q75J93,NA,NA,NA,COPII vesicle coat [GO:0030127]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; zinc ion binding [GO:0008270]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_BRAFLDRAFT_125405.1.1.m.5741,0.0211066655513642,0.000546725666468452,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_125481.1.1.m.4369,-0.0022167482300864,-0.00417231186690099,No,NA,NA,Q9YGY3,NA,NA,NA,condensed chromosome kinetochore [GO:0000777]; nucleus [GO:0005634]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; meiotic cell cycle [GO:0051321],NA,NA,NA
CHOYP_BRAFLDRAFT_125501.1.1.m.30916,0.015889477221993,-0.0121049267308636,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_125516.1.1.m.13150,0.00364778592941831,-0.00872052841558096,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_125550.1.5.m.9080,-0.0223118038807743,0.00964086952000146,No,NA,NA,P11678,NA,NA,NA,cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule lumen [GO:0034774]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; defense response to bacterium [GO:0042742]; defense response to nematode [GO:0002215]; eosinophil migration [GO:0072677]; hydrogen peroxide catabolic process [GO:0042744]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-5 production [GO:0032714]; neutrophil degranulation [GO:0043312]; positive regulation of interleukin-4 production [GO:0032753]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_BRAFLDRAFT_125634.1.1.m.14767,0.0112225777792736,-0.00314068336481652,No,NA,NA,Q9UI14,NA,NA,NA,cell junction [GO:0030054]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; identical protein binding [GO:0042802]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022],NA,NA,NA
CHOYP_BRAFLDRAFT_125658.1.1.m.27104,0.0137576593782889,0.0161141028023988,No,NA,NA,O00471,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; exocyst [GO:0000145]; midbody [GO:0030496]; protein N-terminus binding [GO:0047485]; Ral GTPase binding [GO:0017160]; epithelial cell apoptotic process [GO:1904019]; establishment of planar polarity [GO:0001736]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; homeostasis of number of cells within a tissue [GO:0048873]; non-motile cilium assembly [GO:1905515]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; vesicle docking [GO:0048278],NA,NA,NA
CHOYP_BRAFLDRAFT_125701.1.3.m.18477,0.00727246392062624,-0.00348568341474415,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_125724.1.1.m.30781,0.00735884792229191,-0.0110297561961225,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_125729.1.1.m.50316,-0.00752589223727713,-0.0025113972664238,No,NA,NA,Q8BN59,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; mRNA 5'-UTR binding [GO:0048027]; myosin binding [GO:0017022]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; RNA processing [GO:0006396],NA,NA,NA
CHOYP_BRAFLDRAFT_125731.1.1.m.6261,-0.016262518081391,-0.00292948167178887,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_125735.1.3.m.26333,-0.00682048505955298,0.0171524881768486,No,NA,NA,P62313,NA,NA,NA,cytoplasm [GO:0005737]; Lsm2-8 complex [GO:0120115]; nucleolus [GO:0005730]; nucleus [GO:0005634]; P-body [GO:0000932]; small nucleolar ribonucleoprotein complex [GO:0005732]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; maturation of SSU-rRNA [GO:0030490]; mRNA catabolic process [GO:0006402]; mRNA splicing; via spliceosome [GO:0000398]; tRNA processing [GO:0008033],NA,NA,NA
CHOYP_BRAFLDRAFT_125780.1.1.m.60450,-0.00319332851694471,0.00137607958690947,No,NA,NA,Q9YH58,NA,NA,NA,centriole [GO:0005814]; Golgi apparatus [GO:0005794]; folic acid binding [GO:0005542]; formimidoyltetrahydrofolate cyclodeaminase activity [GO:0030412]; glutamate formimidoyltransferase activity [GO:0030409]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]; tetrahydrofolate interconversion [GO:0035999],NA,NA,NA
CHOYP_BRAFLDRAFT_125840.1.1.m.58396,-0.0160161207538257,0.0119120453183739,No,NA,NA,Q5RB02,NA,NA,NA,lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234],NA,NA,NA
CHOYP_BRAFLDRAFT_125862.1.1.m.27159,-0.0120186280073956,-0.0140990149034909,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_125880.1.3.m.7081,-0.00407203077089833,-0.0177407049735738,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_125880.3.3.m.26918,-0.0095604438315891,-0.0258692038982666,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_125998.1.1.m.63211,-0.021013155076347,0.00312861534441714,No,NA,NA,Q8NA69,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_125999.1.1.m.24819,0.005598049467153,-0.00454993046844173,No,NA,NA,Q7ZTY7,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_126058.1.1.m.1201,-0.0169591047060434,0.00960206869202778,No,NA,NA,Q503Y4,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; hydrolase activity [GO:0016787]; response to retinoic acid [GO:0032526],NA,NA,NA
CHOYP_BRAFLDRAFT_126152.2.2.m.42694,0.0189360089672263,0.00967658242965098,No,NA,NA,Q7ZUN8,NA,NA,NA,cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; transferase activity [GO:0016740]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_126227.1.1.m.24340,0.00492424364180065,0.00691540814495095,No,NA,NA,O94903,NA,NA,NA,cytoplasm [GO:0005737]; intracellular [GO:0005622]; pyridoxal phosphate binding [GO:0030170],NA,NA,NA
CHOYP_BRAFLDRAFT_126338.1.1.m.59058,-0.00142636007115696,0.00282454350998782,No,NA,NA,Q922C1,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_126352.2.2.m.64882,-0.00797854415396783,0.00366532042279851,No,NA,NA,Q9NXG6,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; 2-oxoglutarate as one donor; and incorporation of one atom each of oxygen into both donors [GO:0016706]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; regulation of erythrocyte differentiation [GO:0045646],NA,NA,NA
CHOYP_BRAFLDRAFT_126371.3.3.m.66053,-0.00339972724026075,-0.00228238621482814,No,NA,NA,Q5XJN2,NA,NA,NA,extracellular region [GO:0005576]; lysosome [GO:0005764]; protein-disulfide reductase activity [GO:0047134]; immune system process [GO:0002376],NA,NA,NA
CHOYP_BRAFLDRAFT_126378.2.2.m.11826,-0.023356522352393,0.0065830147822298,No,NA,NA,A2VDD2,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_126379.1.3.m.5102,-0.0169591047060434,0.00960206869202777,No,NA,NA,A2VDD2,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_126411.1.1.m.49664,0.00493217625243077,-0.00741212469456469,No,NA,NA,Q96J94,NA,NA,NA,chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; dense body [GO:0097433]; nucleus [GO:0005634]; P granule [GO:0043186]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; mRNA cap binding complex binding [GO:0140262]; piRNA binding [GO:0034584]; polysome binding [GO:1905538]; protein kinase binding [GO:0019901]; single-stranded RNA binding [GO:0003727]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; negative regulation of transposition [GO:0010529]; piRNA metabolic process [GO:0034587]; regulation of translation [GO:0006417]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; spermatogenesis; exchange of chromosomal proteins [GO:0035093],NA,NA,NA
CHOYP_BRAFLDRAFT_126506.1.1.m.60629,0.00683031725888355,-0.0101387173805157,No,NA,NA,O02373,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; NAD binding [GO:0051287]; UDP-glucose 6-dehydrogenase activity [GO:0003979]; chondroitin sulfate biosynthetic process [GO:0030206]; epithelial cell migration; open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process; polysaccharide chain biosynthetic process [GO:0015014]; mesoderm migration involved in gastrulation [GO:0007509]; segment polarity determination [GO:0007367]; UDP-glucuronate biosynthetic process [GO:0006065]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_BRAFLDRAFT_126555.2.6.m.5075,0.0182316701343251,-0.00410615421551475,No,NA,NA,P54316,NA,NA,NA,extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; lipase activity [GO:0016298]; triglyceride lipase activity [GO:0004806]; lipid metabolic process [GO:0006629]; pancreas development [GO:0031016]; response to glucocorticoid [GO:0051384]; response to peptide hormone [GO:0043434],NA,NA,NA
CHOYP_BRAFLDRAFT_126555.6.6.m.54234,-0.0225644144686562,0.00998810005196947,No,NA,NA,Q6P8U6,NA,NA,NA,extracellular space [GO:0005615]; lipase activity [GO:0016298]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]; intestinal cholesterol absorption [GO:0030299]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; positive regulation of triglyceride lipase activity [GO:0061365]; post-embryonic development [GO:0009791],NA,NA,NA
CHOYP_BRAFLDRAFT_126596.1.1.m.64385,-0.00871257195664224,-0.00898137969443941,No,NA,NA,Q8WV41,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; cleavage furrow formation [GO:0036089]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; macropinocytosis [GO:0044351]; mitotic cytokinesis [GO:0000281]; negative regulation of endocytosis [GO:0045806]; negative regulation of protein localization to cell surface [GO:2000009]; plasma membrane tubulation [GO:0097320]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of protein localization to cell surface [GO:2000010]; protein import [GO:0017038],NA,NA,NA
CHOYP_BRAFLDRAFT_126603.1.1.m.31078,-0.021672862205729,-0.00887083524369151,No,NA,NA,B2RY50,NA,NA,NA,axoneme [GO:0005930]; ciliary base [GO:0097546]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; outer dynein arm assembly [GO:0036158]; regulation of cilium beat frequency [GO:0003356]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_BRAFLDRAFT_126700.1.2.m.17811,-0.009028697243402,0.000120851040951331,No,NA,NA,G3V9R8,NA,NA,NA,nucleoplasmic periphery of the nuclear pore complex [GO:1990826]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; deaminase binding [GO:1990827]; enzyme inhibitor activity [GO:0004857]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; protein domain specific binding [GO:0019904]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; negative regulation of mRNA modification [GO:0090367],NA,NA,NA
CHOYP_BRAFLDRAFT_126750.1.1.m.40768,0.010000101772569,-0.00556114259558155,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_126756.1.1.m.29611,-0.0179915031802002,-5.5538493679674e-05,No,NA,NA,Q6ZMY6,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_126767.1.3.m.6394,0.016160461725317,-0.00412032008747836,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_126822.1.1.m.14626,-0.014239207693906,-0.0132203858940092,No,NA,NA,O35815,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; nuclear inclusion body [GO:0042405]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATPase binding [GO:0051117]; identical protein binding [GO:0042802]; Lys48-specific deubiquitinase activity [GO:1990380]; Lys63-specific deubiquitinase activity [GO:0061578]; RNA polymerase II regulatory region DNA binding [GO:0001012]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; ubiquitin protein ligase binding [GO:0031625]; actin cytoskeleton organization [GO:0030036]; cellular response to heat [GO:0034605]; cellular response to misfolded protein [GO:0071218]; exploration behavior [GO:0035640]; histone H3 deacetylation [GO:0070932]; intermediate filament cytoskeleton organization [GO:0045104]; microtubule cytoskeleton organization [GO:0000226]; monoubiquitinated protein deubiquitination [GO:0035520]; positive regulation of ERAD pathway [GO:1904294]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; protein localization to cytosolic proteasome complex involved in ERAD pathway [GO:1904379]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; regulation of cell-substrate adhesion [GO:0010810],NA,NA,NA
CHOYP_BRAFLDRAFT_126826.1.1.m.14796,0.00654877260650373,0.00845181883066812,No,NA,NA,Q0P4V4,NA,NA,NA,cytoplasm [GO:0005737]; axonemal dynein complex assembly [GO:0070286]; cilium-dependent cell motility [GO:0060285],NA,NA,NA
CHOYP_BRAFLDRAFT_126856.1.3.m.24519,-0.00796969831463936,-0.00618280113959915,No,NA,NA,P38552,NA,NA,NA,extracellular space [GO:0005615]; carbohydrate binding [GO:0030246]; galactoside binding [GO:0016936],NA,NA,NA
CHOYP_BRAFLDRAFT_126856.2.3.m.30577,-0.00826181064183477,0.000163226525426789,No,NA,NA,Q3MHZ8,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; nucleus [GO:0005634]; carbohydrate binding [GO:0030246]; immune system process [GO:0002376],NA,NA,NA
CHOYP_BRAFLDRAFT_126923.1.1.m.5580,-0.0158831902268551,-0.0125287756848578,No,NA,NA,Q95LS7,NA,NA,NA,cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815],NA,NA,NA
CHOYP_BRAFLDRAFT_126943.1.3.m.6839,0.00985267581914997,-0.0120755880013441,No,NA,NA,Q8N6F8,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_127028.1.1.m.18415,-0.002629586026453,-0.00636963909590223,No,NA,NA,Q9JLJ2,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; 3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; 4-trimethylammoniobutyraldehyde dehydrogenase activity [GO:0047105]; aldehyde dehydrogenase (NAD) activity [GO:0004029]; amine binding [GO:0043176]; aminobutyraldehyde dehydrogenase activity [GO:0019145]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; NAD binding [GO:0051287]; oxidoreductase activity; acting on the aldehyde or oxo group of donors; NAD or NADP as acceptor [GO:0016620]; protein homodimerization activity [GO:0042803]; carnitine biosynthetic process [GO:0045329]; carnitine metabolic process [GO:0009437]; cellular aldehyde metabolic process [GO:0006081]; neurotransmitter biosynthetic process [GO:0042136]; oxidation-reduction process [GO:0055114],NA,NA,NA
CHOYP_BRAFLDRAFT_127065.1.7.m.4586,-0.0022848258272031,-0.00762425738625209,No,NA,NA,Q15063,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; bone regeneration [GO:1990523]; cell adhesion [GO:0007155]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin K [GO:0071307]; extracellular matrix organization [GO:0030198]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; neuron projection extension [GO:1990138]; positive regulation of chemokine (C-C motif) ligand 2 secretion [GO:1904209]; positive regulation of smooth muscle cell migration [GO:0014911]; regulation of Notch signaling pathway [GO:0008593]; regulation of systemic arterial blood pressure [GO:0003073]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to muscle activity [GO:0014850]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_BRAFLDRAFT_127065.2.7.m.5835,-0.00654385697712255,0.0188933276231682,No,NA,NA,Q15063,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; bone regeneration [GO:1990523]; cell adhesion [GO:0007155]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin K [GO:0071307]; extracellular matrix organization [GO:0030198]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; neuron projection extension [GO:1990138]; positive regulation of chemokine (C-C motif) ligand 2 secretion [GO:1904209]; positive regulation of smooth muscle cell migration [GO:0014911]; regulation of Notch signaling pathway [GO:0008593]; regulation of systemic arterial blood pressure [GO:0003073]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to muscle activity [GO:0014850]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_BRAFLDRAFT_127065.3.7.m.15669,-0.0127525151098491,0.0162409997130712,No,NA,NA,Q15063,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; bone regeneration [GO:1990523]; cell adhesion [GO:0007155]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin K [GO:0071307]; extracellular matrix organization [GO:0030198]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; neuron projection extension [GO:1990138]; positive regulation of chemokine (C-C motif) ligand 2 secretion [GO:1904209]; positive regulation of smooth muscle cell migration [GO:0014911]; regulation of Notch signaling pathway [GO:0008593]; regulation of systemic arterial blood pressure [GO:0003073]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to muscle activity [GO:0014850]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_BRAFLDRAFT_127065.4.7.m.28277,-0.0097266247590765,-0.015340172141351,No,NA,NA,P82198,NA,NA,NA,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198],NA,NA,NA
CHOYP_BRAFLDRAFT_127065.5.7.m.28848,-0.0150722067675829,-0.0187300219490967,No,NA,NA,P82198,NA,NA,NA,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198],NA,NA,NA
CHOYP_BRAFLDRAFT_127065.6.7.m.30727,-0.0209582867802498,-0.00762838979032885,No,NA,NA,Q62009,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; bone regeneration [GO:1990523]; cell adhesion [GO:0007155]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin K [GO:0071307]; extracellular matrix organization [GO:0030198]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; neuron projection extension [GO:1990138]; positive regulation of chemokine (C-C motif) ligand 2 secretion [GO:1904209]; positive regulation of smooth muscle cell migration [GO:0014911]; regulation of Notch signaling pathway [GO:0008593]; regulation of systemic arterial blood pressure [GO:0003073]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to muscle activity [GO:0014850]; tissue development [GO:0009888],NA,NA,NA
CHOYP_BRAFLDRAFT_127065.7.7.m.57708,0.000981284468024528,0.0117672206849766,No,NA,NA,P10675,NA,NA,NA,anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_BRAFLDRAFT_127100.1.2.m.2218,0.00230467020597308,0.00147276272942932,No,NA,NA,O08585,NA,NA,NA,clathrin coat [GO:0030118]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin vesicle coat [GO:0030125]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle [GO:0031410]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic endocytic zone [GO:0098843]; postsynaptic endocytic zone cytoplasmic component [GO:0099631]; presynaptic endocytic zone membrane [GO:0098835]; spindle [GO:0005819]; synaptic vesicle membrane [GO:0030672]; clathrin heavy chain binding [GO:0032050]; GTPase binding [GO:0051020]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198]; cell cycle [GO:0007049]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_BRAFLDRAFT_127100.2.2.m.42594,0.0141252942690101,-0.00395839462519948,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_127105.1.1.m.21922,0.0147268041621776,0.00720575899890177,No,NA,NA,Q3ZC89,NA,NA,NA,cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; protein initiator methionine removal [GO:0070084],NA,NA,NA
CHOYP_BRAFLDRAFT_127252.1.1.m.16242,0.00831978321468044,-0.0100197705581858,No,NA,NA,Q8CHI8,NA,NA,NA,NuA4 histone acetyltransferase complex [GO:0035267]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; protein antigen binding [GO:1990405]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967],NA,NA,NA
CHOYP_BRAFLDRAFT_127356.1.2.m.8691,0.00045365523163854,-0.00987084758158346,No,NA,NA,Q5ZIQ3,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_BRAFLDRAFT_127466.1.1.m.62415,-0.0178450564442522,-0.0167406069986036,No,NA,NA,A6PWD2,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_127486.1.1.m.57687,-0.0169591047060434,0.00960206869202777,No,NA,NA,P58340,NA,NA,NA,ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein domain specific binding [GO:0019904]; cell cycle arrest [GO:0007050]; myeloid progenitor cell differentiation [GO:0002318]; regulation of transcription; DNA-templated [GO:0006355]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_BRAFLDRAFT_127497.1.1.m.35445,-0.0067812990337142,0.00310482603360195,No,NA,NA,Q6DEJ5,NA,NA,NA,cytoplasm [GO:0005737]; aminoacyl-tRNA ligase activity [GO:0004812]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; Ser-tRNA(Ala) hydrolase activity [GO:0002196]; regulation of translational fidelity [GO:0006450]; translation [GO:0006412]; tRNA aminoacylation [GO:0043039],NA,NA,NA
CHOYP_BRAFLDRAFT_127510.1.1.m.48935,-0.0224586283128213,0.00982489197191646,No,NA,NA,P00920,NA,NA,NA,apical part of cell [GO:0045177]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; cellular response to fluid shear stress [GO:0071498]; kidney development [GO:0001822]; morphogenesis of an epithelium [GO:0002009]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of bone resorption [GO:0045780]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of synaptic transmission; GABAergic [GO:0032230]; regulation of anion transport [GO:0044070]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to steroid hormone [GO:0048545]; response to zinc ion [GO:0010043]; secretion [GO:0046903],NA,NA,NA
CHOYP_BRAFLDRAFT_127851.1.1.m.10499,0.00829144398321725,-0.0232109731623116,No,NA,NA,P49020,NA,NA,NA,COPI-coated vesicle [GO:0030137]; COPI-coated vesicle membrane [GO:0030663]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; Golgi organization [GO:0007030]; negative regulation of GTPase activity [GO:0034260]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_128029.1.1.m.63515,-0.0157960206631906,0.00018046325083705,No,NA,NA,Q2TBS4,NA,NA,NA,ciliary basal body [GO:0036064]; cytoplasmic vesicle [GO:0031410]; trans-Golgi network [GO:0005802]; cell projection organization [GO:0030030]; positive regulation of kinase activity [GO:0033674]; regulation of cell projection organization [GO:0031344],NA,NA,NA
CHOYP_BRAFLDRAFT_128033.2.2.m.54293,0.0057297705307917,-0.0080775796132845,No,NA,NA,Q70LM4,NA,NA,NA,isomerase activity [GO:0016853]; ligase activity [GO:0016874]; oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177]; antibiotic biosynthetic process [GO:0017000],NA,NA,NA
CHOYP_BRAFLDRAFT_128100.1.1.m.10153,0.00808111139660069,-0.0200638220573809,No,NA,NA,P70279,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; granular component [GO:0001652]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal small subunit biogenesis [GO:0042274]; ribosome assembly [GO:0042255]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_BRAFLDRAFT_128129.1.1.m.63237,-0.0166685756019934,0.00581963305136211,No,NA,NA,Q96J01,NA,NA,NA,nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; RNA export from nucleus [GO:0006405]; RNA splicing [GO:0008380]; viral mRNA export from host cell nucleus [GO:0046784],NA,NA,NA
CHOYP_BRAFLDRAFT_128345.1.1.m.9897,-0.0226423867936605,0.0104242137265839,No,NA,NA,D6REC4,NA,NA,NA,motile cilium [GO:0031514],NA,NA,NA
CHOYP_BRAFLDRAFT_128432.1.1.m.8945,0.0198170886053054,-0.0156461869400921,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_128459.1.3.m.21899,-0.0168302463343419,0.00625823169993699,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_128460.1.2.m.7232,-0.0123218039926656,0.00703053632021533,No,NA,NA,Q7Z4L5,NA,NA,NA,ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intraciliary transport particle A [GO:0030991]; nuclear chromatin [GO:0000790]; forebrain dorsal/ventral pattern formation [GO:0021798]; intraciliary retrograde transport [GO:0035721]; intraciliary transport involved in cilium assembly [GO:0035735]; protein localization to cilium [GO:0061512]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription by RNA polymerase II [GO:0006357]; smoothened signaling pathway [GO:0007224]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_BRAFLDRAFT_128562.2.4.m.33663,-0.0192058548023774,0.0021355623226051,No,NA,NA,Q99973,NA,NA,NA,chromosome; telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; ribonucleoprotein complex [GO:1990904]; telomerase holoenzyme complex [GO:0005697]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034]; telomere maintenance via recombination [GO:0000722],NA,NA,NA
CHOYP_BRAFLDRAFT_128749.1.1.m.56605,-0.00451143970192748,-0.0123698354911246,No,NA,NA,Q8HXW6,NA,NA,NA,axon [GO:0030424]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane raft [GO:0045121]; nucleus [GO:0005634]; synaptic vesicle [GO:0008021]; palmitoyl-(protein) hydrolase activity [GO:0008474]; palmitoyl-CoA hydrolase activity [GO:0016290]; cofactor metabolic process [GO:0051186]; cofactor transport [GO:0051181]; lipid catabolic process [GO:0016042]; lysosomal lumen acidification [GO:0007042]; membrane raft organization [GO:0031579]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; positive regulation of pinocytosis [GO:0048549]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein depalmitoylation [GO:0002084]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_128799.1.1.m.29183,-0.0132964925923681,0.0164276215722435,No,NA,NA,A8MXQ7,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_128825.1.1.m.10785,-0.0129954812793829,0.00582015180009211,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_128828.1.2.m.7356,-0.0107776405644303,-0.0128341802950283,No,NA,NA,Q2T9S4,NA,NA,NA,cytoplasm [GO:0005737]; glycerol-1-phosphatase activity [GO:0000121]; glycerol-3-phosphatase activity [GO:0043136]; magnesium ion binding [GO:0000287]; nucleotide phosphatase activity; acting on free nucleotides [GO:0098519]; phosphatase activity [GO:0016791]; phosphoglycolate phosphatase activity [GO:0008967]; protein tyrosine phosphatase activity [GO:0004725]; dephosphorylation [GO:0016311]; glycerol biosynthetic process [GO:0006114]; glycerophospholipid metabolic process [GO:0006650]; negative regulation of gluconeogenesis [GO:0045721]; peptidyl-tyrosine dephosphorylation [GO:0035335],NA,NA,NA
CHOYP_BRAFLDRAFT_128878.1.1.m.42339,0.00632957023538244,-0.00816418614489054,No,NA,NA,Q9EPB1,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; vesicle [GO:0031982]; dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_BRAFLDRAFT_128887.2.2.m.46965,-0.00518029873831108,0.00990677052670033,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_128944.1.2.m.19981,-0.0138599294292438,-0.0189006552853188,No,NA,NA,Q6NVM2,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; katanin complex [GO:0008352]; microtubule [GO:0005874]; spindle [GO:0005819]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule depolymerization [GO:0007019]; microtubule severing [GO:0051013],NA,NA,NA
CHOYP_BRAFLDRAFT_129004.15.15.m.60150,-0.00238403584953829,-0.00650315705133434,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_129034.1.1.m.17626,0.000133462975853744,-0.0125251716515673,No,NA,NA,Q6DF94,NA,NA,NA,centriole [GO:0005814]; spindle [GO:0005819]; cell division [GO:0051301]; mitotic spindle assembly [GO:0090307]; regulation of centriole replication [GO:0046599],NA,NA,NA
CHOYP_BRAFLDRAFT_129048.1.1.m.1769,0.00769782328289333,0.008387458186323,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_129063.1.1.m.15419,0.00720335245328236,0.00024087375503485,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_129074.1.1.m.25032,-0.00743295029131623,-0.00392971279067744,No,NA,NA,Q497B8,NA,NA,NA,chromosome [GO:0005694]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone demethylase activity (H3-K36 specific) [GO:0051864]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]; G2/M transition of mitotic cell cycle [GO:0000086]; histone H3-K36 demethylation [GO:0070544]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_BRAFLDRAFT_129108.1.2.m.2456,0.00535530567895171,-0.00650860428865134,No,NA,NA,A6QLI0,NA,NA,NA,extracellular region [GO:0005576]; lysosome [GO:0005764]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160],NA,NA,NA
CHOYP_BRAFLDRAFT_129234.1.1.m.10468,0.0124789846589222,-0.0216246738448669,No,NA,NA,Q80Y14,NA,NA,NA,dendrite [GO:0030425]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; 2 iron; 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; glutathione disulfide oxidoreductase activity [GO:0015038]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; hemopoiesis [GO:0030097]; protein lipoylation [GO:0009249],NA,NA,NA
CHOYP_BRAFLDRAFT_129259.1.1.m.9267,0.0229244156349163,-0.00821882181349047,No,NA,NA,Q03460,NA,NA,NA,amyloplast [GO:0009501]; 3 iron; 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; iron ion binding [GO:0005506]; glutamine metabolic process [GO:0006541]; L-glutamate biosynthetic process [GO:0097054],NA,NA,NA
CHOYP_BRAFLDRAFT_129513.1.1.m.51276,0.0155251060771241,-0.000258369108738003,No,NA,NA,O89000,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; 4 iron; 4 sulfur cluster binding [GO:0051539]; dihydropyrimidine dehydrogenase (NADP+) activity [GO:0017113]; dihydrouracil dehydrogenase (NAD+) activity [GO:0004159]; FAD binding [GO:0071949]; iron ion binding [GO:0005506]; iron-sulfur cluster binding [GO:0051536]; NADH dehydrogenase activity [GO:0003954]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; uracil binding [GO:0002058]; aging [GO:0007568]; beta-alanine biosynthetic process [GO:0019483]; circadian rhythm [GO:0007623]; pyrimidine nucleobase catabolic process [GO:0006208]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; response to nutrient [GO:0007584]; response to organic cyclic compound [GO:0014070]; thymidine catabolic process [GO:0006214]; thymine catabolic process [GO:0006210]; uracil catabolic process [GO:0006212]; uracil metabolic process [GO:0019860],NA,NA,NA
CHOYP_BRAFLDRAFT_129759.2.2.m.30082,-0.0227462191567928,0.00121282284402745,No,NA,NA,P86854,NA,NA,NA,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_BRAFLDRAFT_129885.1.2.m.24564,-0.00525676141616969,-0.00210480005413187,No,NA,NA,Q8WUM4,NA,NA,NA,actomyosin [GO:0042641]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; melanosome [GO:0042470]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; calcium-dependent protein binding [GO:0048306]; protein homodimerization activity [GO:0042803]; proteinase activated receptor binding [GO:0031871]; actomyosin contractile ring assembly [GO:0000915]; apoptotic process [GO:0006915]; bicellular tight junction assembly [GO:0070830]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; multivesicular body assembly [GO:0036258]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of extracellular exosome assembly [GO:1903551]; regulation of membrane permeability [GO:0090559]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058],NA,NA,NA
CHOYP_BRAFLDRAFT_129885.2.2.m.34895,-0.00190343553009839,0.0127742627707646,No,NA,NA,Q8WUM4,NA,NA,NA,actomyosin [GO:0042641]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; melanosome [GO:0042470]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; calcium-dependent protein binding [GO:0048306]; protein homodimerization activity [GO:0042803]; proteinase activated receptor binding [GO:0031871]; actomyosin contractile ring assembly [GO:0000915]; apoptotic process [GO:0006915]; bicellular tight junction assembly [GO:0070830]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; multivesicular body assembly [GO:0036258]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of extracellular exosome assembly [GO:1903551]; regulation of membrane permeability [GO:0090559]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058],NA,NA,NA
CHOYP_BRAFLDRAFT_129914.1.3.m.8213,-0.0079768058899619,0.00621531304518546,No,NA,NA,Q8IYJ2,NA,NA,NA,mitochondrion [GO:0005739],NA,NA,NA
CHOYP_BRAFLDRAFT_129932.1.1.m.30332,-0.0140121322220608,-0.00696135124308878,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_129967.1.4.m.4020,-0.0135725579708752,0.00388604629968508,No,NA,NA,B3EWY9,NA,NA,NA,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ErbB-2 class receptor binding [GO:0005176]; extracellular matrix constituent; lubricant activity [GO:0030197]; cell-matrix adhesion [GO:0007160]; epithelial structure maintenance [GO:0010669]; regulation of signaling receptor activity [GO:0010469],NA,NA,NA
CHOYP_BRAFLDRAFT_129967.3.4.m.41916,0.0046439794468094,-0.0123661143775174,No,NA,NA,B3EWY9,NA,NA,NA,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ErbB-2 class receptor binding [GO:0005176]; extracellular matrix constituent; lubricant activity [GO:0030197]; cell-matrix adhesion [GO:0007160]; epithelial structure maintenance [GO:0010669]; regulation of signaling receptor activity [GO:0010469],NA,NA,NA
CHOYP_BRAFLDRAFT_129967.4.4.m.64315,0.0133166288153266,0.00752286357891211,No,NA,NA,B3EWY9,NA,NA,NA,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ErbB-2 class receptor binding [GO:0005176]; extracellular matrix constituent; lubricant activity [GO:0030197]; cell-matrix adhesion [GO:0007160]; epithelial structure maintenance [GO:0010669]; regulation of signaling receptor activity [GO:0010469],NA,NA,NA
CHOYP_BRAFLDRAFT_130097.1.1.m.12458,-0.0226387531867908,-0.00734812227382707,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_130131.1.1.m.11020,0.00580131714747632,-0.00849056503547415,No,NA,NA,Q8N6F8,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_130395.1.1.m.38394,0.00364778592941831,-0.00872052841558096,No,NA,NA,Q6IR74,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_BRAFLDRAFT_130685.1.1.m.63499,-0.0228401438189077,0.00645028987995233,No,NA,NA,Q9ULJ6,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; artery morphogenesis [GO:0048844]; cell aging [GO:0007569]; developmental growth [GO:0048589]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; vasculogenesis [GO:0001570]; vitellogenesis [GO:0007296],NA,NA,NA
CHOYP_BRAFLDRAFT_130809.1.1.m.5127,0.0164520461715312,0.0148161582924271,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_130974.1.1.m.28374,0.0072188736114478,-0.0144229009143499,No,NA,NA,Q27245,NA,NA,NA,cytoplasm [GO:0005737]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloexopeptidase activity [GO:0008235],NA,NA,NA
CHOYP_BRAFLDRAFT_131134.3.3.m.16643,-0.000445931164710725,-0.0217782088324411,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_131151.3.4.m.57848,0.00499315781556454,0.00242727763368559,No,NA,NA,Q8TEU7,NA,NA,NA,apical plasma membrane [GO:0016324]; centrosome [GO:0005813]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; plasma membrane [GO:0005886]; GTP-dependent protein binding [GO:0030742]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidic acid binding [GO:0070300]; Ras GTPase binding [GO:0017016]; microvillus assembly [GO:0030033]; positive regulation of GTPase activity [GO:0043547]; protein localization to plasma membrane [GO:0072659]; Ras protein signal transduction [GO:0007265]; regulation of GTPase activity [GO:0043087],NA,NA,NA
CHOYP_BRAFLDRAFT_131151.4.4.m.58019,-0.00697429244297075,-0.00408345458137188,No,NA,NA,Q8TEU7,NA,NA,NA,apical plasma membrane [GO:0016324]; centrosome [GO:0005813]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; plasma membrane [GO:0005886]; GTP-dependent protein binding [GO:0030742]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidic acid binding [GO:0070300]; Ras GTPase binding [GO:0017016]; microvillus assembly [GO:0030033]; positive regulation of GTPase activity [GO:0043547]; protein localization to plasma membrane [GO:0072659]; Ras protein signal transduction [GO:0007265]; regulation of GTPase activity [GO:0043087],NA,NA,NA
CHOYP_BRAFLDRAFT_131216.1.1.m.8822,0.00205195042830452,-0.00934116934689426,No,NA,NA,Q6P9I7,NA,NA,NA,chromosome; telomeric region [GO:0000781]; PML body [GO:0016605]; Smc5-Smc6 complex [GO:0030915]; ATP binding [GO:0005524]; cellular senescence [GO:0090398]; double-strand break repair via homologous recombination [GO:0000724]; telomere maintenance via recombination [GO:0000722],NA,NA,NA
CHOYP_BRAFLDRAFT_131227.1.1.m.24973,0.0110521738595304,0.0103929377207719,No,NA,NA,Q5ZIT5,NA,NA,NA,cilium [GO:0005929]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; insulin-responsive compartment [GO:0032593]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; endoplasmic reticulum tubular network organization [GO:0071786]; endosomal transport [GO:0016197]; establishment of neuroblast polarity [GO:0045200]; establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; polarized epithelial cell differentiation [GO:0030859]; protein localization to basolateral plasma membrane [GO:1903361]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; Rab protein signal transduction [GO:0032482]; regulation of exocytosis [GO:0017157]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_131414.1.1.m.9300,-0.00685284043576947,-0.000842769103171524,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_131608.1.1.m.44249,0.00386572522866449,-0.00293539680205117,No,NA,NA,Q8R3V6,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_131621.1.1.m.56341,0.0165940498272637,0.000505074003911186,No,NA,NA,P46425,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; TRAF2-GSTP1 complex [GO:0097057]; dinitrosyl-iron complex binding [GO:0035731]; drug binding [GO:0008144]; glutathione binding [GO:0043295]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; protein kinase binding [GO:0019901]; S-nitrosoglutathione binding [GO:0035730]; glutathione metabolic process [GO:0006749],NA,NA,NA
CHOYP_BRAFLDRAFT_131834.1.1.m.29489,-0.0119197640669602,0.00341227668316405,No,NA,NA,Q561R0,NA,NA,NA,endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; integrin activation [GO:0033622]; positive regulation of cell proliferation [GO:0008284]; positive regulation of immunoglobulin biosynthetic process [GO:0002642]; regulation of B cell proliferation [GO:0030888]; regulation of cell proliferation [GO:0042127]; regulation of insulin receptor signaling pathway [GO:0046626],NA,NA,NA
CHOYP_BRAFLDRAFT_132233.1.4.m.13687,0.00184413589184301,-0.00061231760759768,No,NA,NA,Q6AYN9,NA,NA,NA,cytoplasm [GO:0005737]; manchette [GO:0002177]; microtubule [GO:0005874]; sperm flagellum [GO:0036126]; microtubule binding [GO:0008017],NA,NA,NA
CHOYP_BRAFLDRAFT_132336.1.1.m.26677,-0.00675873525465853,-0.0162074677621148,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_132957.1.1.m.51287,-0.0177155038527341,0.0032536338097506,No,NA,NA,Q9GZQ3,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654],NA,NA,NA
CHOYP_BRAFLDRAFT_133135.1.1.m.18788,-0.0226563398861474,0.0103839636932258,No,NA,NA,Q8WYH8,NA,NA,NA,MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; negative regulation of cell proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of transcription; DNA-templated [GO:0045893]; protein acetylation [GO:0006473]; regulation of signal transduction by p53 class mediator [GO:1901796],NA,NA,NA
CHOYP_BRAFLDRAFT_136434.1.1.m.33244,-0.00335207865108768,0.00150942162736441,No,NA,NA,O35737,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; cellular response to interleukin-7 [GO:0098761]; mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_BRAFLDRAFT_140951.1.1.m.40225,0.00274041834049425,0.0105894314460048,No,NA,NA,Q9FMR5,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; SNARE complex [GO:0031201]; vacuole [GO:0005773]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; exocytosis [GO:0006887]; protein transport [GO:0015031]; response to salt stress [GO:0009651]; vesicle fusion [GO:0006906],NA,NA,NA
CHOYP_BRAFLDRAFT_150340.1.4.m.7435,0.00256870735887528,0.0175335993330133,No,NA,NA,Q19QU3,NA,NA,NA,nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_BRAFLDRAFT_151236.1.1.m.30653,-0.0218552973320546,-0.000355551476796554,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_153908.1.2.m.1377,-0.00688165705248472,-0.00835468557646705,No,NA,NA,Q6ZT07,NA,NA,NA,cell [GO:0005623]; calcium ion binding [GO:0005509]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_BRAFLDRAFT_154839.1.1.m.13878,-0.00186824595498125,-0.00437078544330797,No,NA,NA,Q7SXE4,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; protein homodimerization activity [GO:0042803]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; retrograde transport; vesicle recycling within Golgi [GO:0000301],NA,NA,NA
CHOYP_BRAFLDRAFT_161161.1.1.m.39447,-0.00212078832001384,-0.00891837260408135,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_165799.1.1.m.33332,-0.013157791672626,-0.00184721259960106,No,NA,NA,Q80XI3,NA,NA,NA,eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA binding [GO:0003729]; RNA cap binding [GO:0000339]; translation initiation factor activity [GO:0003743]; positive regulation of meiosis I [GO:0060903]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of translation [GO:0045727]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_194931.1.1.m.46966,-0.00974519248754179,-0.0166974214278111,No,NA,NA,Q14790,NA,NA,NA,CD95 death-inducing signaling complex [GO:0031265]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; death-inducing signaling complex [GO:0031264]; membrane raft [GO:0045121]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; ripoptosome [GO:0097342]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; cysteine-type peptidase activity [GO:0008234]; death effector domain binding [GO:0035877]; death receptor binding [GO:0005123]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097296]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; B cell activation [GO:0042113]; cell surface receptor signaling pathway [GO:0007166]; cellular response to mechanical stimulus [GO:0071260]; cellular response to organic cyclic compound [GO:0071407]; death-inducing signaling complex assembly [GO:0071550]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; macrophage differentiation [GO:0030225]; natural killer cell activation [GO:0030101]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of neuron death [GO:1901216]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of proteolysis [GO:0045862]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of necroptotic process [GO:0060544]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; response to cobalt ion [GO:0032025]; response to cold [GO:0009409]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process [GO:0039650]; syncytiotrophoblast cell differentiation involved in labyrinthine layer development [GO:0060715]; T cell activation [GO:0042110]; toll-like receptor 3 signaling pathway [GO:0034138]; TRAIL-activated apoptotic signaling pathway [GO:0036462]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666],NA,NA,NA
CHOYP_BRAFLDRAFT_199108.1.2.m.24078,0.0111896268102628,0.00784166732928571,No,NA,NA,O97902,NA,NA,NA,cell projection membrane [GO:0031253]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; podosome [GO:0002102]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; cilium assembly [GO:0060271]; positive regulation of membrane tubulation [GO:1903527]; positive regulation of podosome assembly [GO:0071803],NA,NA,NA
CHOYP_BRAFLDRAFT_199346.1.3.m.11369,0.0065883263884642,0.0180931628217626,No,NA,NA,Q96QF0,NA,NA,NA,centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; Golgi to plasma membrane transport [GO:0006893]; protein localization to organelle [GO:0033365]; protein targeting to membrane [GO:0006612],NA,NA,NA
CHOYP_BRAFLDRAFT_200206.1.1.m.35419,-0.00937946436295442,0.0169934026642047,No,NA,NA,Q96AB6,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-N-terminal asparagine amidohydrolase activity [GO:0008418]; adult locomotory behavior [GO:0008344]; memory [GO:0007613]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_BRAFLDRAFT_200527.1.1.m.601,0.011065425674667,0.00794166089454822,No,NA,NA,Q8JIS3,NA,NA,NA,cytoplasmic microtubule [GO:0005881]; carbonyl reductase (NADPH) activity [GO:0004090]; erythrulose reductase activity [GO:0047880]; identical protein binding [GO:0042802]; L-xylulose reductase (NAD+) activity [GO:0044105]; L-xylulose reductase (NADP+) activity [GO:0050038]; oxidoreductase activity; acting on NAD(P)H; quinone or similar compound as acceptor [GO:0016655]; D-xylose metabolic process [GO:0042732]; glucose metabolic process [GO:0006006]; protein homotetramerization [GO:0051289]; xylulose metabolic process [GO:0005997],NA,NA,NA
CHOYP_BRAFLDRAFT_201924.1.1.m.30855,-0.0234701017467972,0.00244162713075473,No,NA,NA,P86854,NA,NA,NA,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_BRAFLDRAFT_202318.1.1.m.4330,-0.0148363691397251,-0.00122724921808602,No,NA,NA,Q5R7H0,NA,NA,NA,mitochondrion [GO:0005739]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_BRAFLDRAFT_202721.1.2.m.18687,-0.00808507517748065,0.00097985915898849,No,NA,NA,Q9C005,NA,NA,NA,Golgi apparatus [GO:0005794]; histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]; trans-Golgi network [GO:0005802]; histone-lysine N-methyltransferase activity [GO:0018024]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; endosomal transport [GO:0016197]; histone H3-K4 methylation [GO:0051568]; regulation of megakaryocyte differentiation [GO:0045652],NA,NA,NA
CHOYP_BRAFLDRAFT_202783.1.2.m.21505,0.00465486010159524,-0.00261100655646773,No,NA,NA,C3ZQF9,NA,NA,NA,integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide Y receptor activity [GO:0004983]; cellular response to peptide [GO:1901653],NA,NA,NA
CHOYP_BRAFLDRAFT_203026.1.1.m.61263,0.00744922546433382,0.00555216300347186,No,NA,NA,P97379,NA,NA,NA,cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; mRNA transport [GO:0051028]; small GTPase mediated signal transduction [GO:0007264]; stress granule assembly [GO:0034063],NA,NA,NA
CHOYP_BRAFLDRAFT_203057.1.1.m.47437,-0.00796230675591866,0.00169032109322716,No,NA,NA,Q5ZLS8,NA,NA,NA,integrator complex [GO:0032039]; snRNA processing [GO:0016180],NA,NA,NA
CHOYP_BRAFLDRAFT_203393.1.2.m.16760,-0.00520831727563475,-0.0147601075779162,No,NA,NA,Q15291,NA,NA,NA,histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL3/4 complex [GO:0044666]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]; histone-lysine N-methyltransferase activity [GO:0018024]; methylated histone binding [GO:0035064]; transcription regulatory region DNA binding [GO:0044212]; beta-catenin-TCF complex assembly [GO:1904837]; cellular response to DNA damage stimulus [GO:0006974]; histone H3-K4 methylation [GO:0051568]; post-translational protein modification [GO:0043687]; regulation of megakaryocyte differentiation [GO:0045652]; response to estrogen [GO:0043627],NA,NA,NA
CHOYP_BRAFLDRAFT_203655.1.2.m.10,-0.0217214379046765,0.00490504306717969,No,NA,NA,Q9Y6F1,NA,NA,NA,centriole [GO:0005814]; nucleolus [GO:0005730]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; catalytic activity [GO:0003824]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; negative regulation of telomerase RNA reverse transcriptase activity [GO:1905662]; positive regulation of DNA ligation [GO:0051106]; protein ADP-ribosylation [GO:0006471]; protein localization to site of double-strand break [GO:1990166]; protein poly-ADP-ribosylation [GO:0070212]; regulation of mitotic spindle organization [GO:0060236]; telomere maintenance [GO:0000723],NA,NA,NA
CHOYP_BRAFLDRAFT_203655.2.2.m.20185,-0.0120519520486316,0.00315131410754002,No,NA,NA,Q9Y6F1,NA,NA,NA,centriole [GO:0005814]; nucleolus [GO:0005730]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; catalytic activity [GO:0003824]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; negative regulation of telomerase RNA reverse transcriptase activity [GO:1905662]; positive regulation of DNA ligation [GO:0051106]; protein ADP-ribosylation [GO:0006471]; protein localization to site of double-strand break [GO:1990166]; protein poly-ADP-ribosylation [GO:0070212]; regulation of mitotic spindle organization [GO:0060236]; telomere maintenance [GO:0000723],NA,NA,NA
CHOYP_BRAFLDRAFT_204357.1.1.m.62329,-0.017704824473194,0.000735922952568855,No,NA,NA,P17141,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; germ cell development [GO:0007281]; multicellular organism development [GO:0007275]; regulation of transcription; DNA-templated [GO:0006355]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_204501.1.1.m.910,-0.00213447099510137,-0.00496576717169004,No,NA,NA,Q91YR5,NA,NA,NA,methyltransferase activity [GO:0008168],NA,NA,NA
CHOYP_BRAFLDRAFT_204736.1.2.m.27864,-0.0146087719302392,-0.00851358325394277,No,NA,NA,Q503Q1,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial outer membrane [GO:0005741]; cellular response to DNA damage stimulus [GO:0006974]; mitochondrial protein catabolic process [GO:0035694]; mitophagy by induced vacuole formation [GO:0035695]; response to steroid hormone [GO:0048545],NA,NA,NA
CHOYP_BRAFLDRAFT_204736.2.2.m.63327,0.0078062092629676,-0.0154016977890795,No,NA,NA,Q503Q1,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial outer membrane [GO:0005741]; cellular response to DNA damage stimulus [GO:0006974]; mitochondrial protein catabolic process [GO:0035694]; mitophagy by induced vacuole formation [GO:0035695]; response to steroid hormone [GO:0048545],NA,NA,NA
CHOYP_BRAFLDRAFT_204871.1.1.m.66069,0.0108666285304728,-0.00218093078116014,No,NA,NA,Q4PM12,NA,NA,NA,cytosol [GO:0005829]; ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_BRAFLDRAFT_204923.1.2.m.1690,-0.00460748015057728,-0.0169232500760061,No,NA,NA,P48147,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; endopeptidase activity [GO:0004175]; oligopeptidase activity [GO:0070012]; serine-type endopeptidase activity [GO:0004252]; serine-type exopeptidase activity [GO:0070008]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_BRAFLDRAFT_204923.2.2.m.63877,-0.016475748573434,0.00317844991625217,No,NA,NA,Q9XTA2,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endopeptidase activity [GO:0004175]; oligopeptidase activity [GO:0070012]; serine-type endopeptidase activity [GO:0004252]; serine-type exopeptidase activity [GO:0070008],NA,NA,NA
CHOYP_BRAFLDRAFT_205095.2.2.m.62915,-0.0145418399732066,-0.0154526709983547,No,NA,NA,Q99L04,NA,NA,NA,endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_BRAFLDRAFT_205939.3.3.m.64021,0.00834189196545054,-0.000246763959037711,No,NA,NA,Q96RW7,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],NA,NA,NA
CHOYP_BRAFLDRAFT_206799.1.23.m.3242,0.00205195042830452,-0.00934116934689426,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_206907.11.11.m.60959,-0.00455789446874384,-0.0120849123847614,No,NA,NA,P50429,NA,NA,NA,cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]; anterior head development [GO:0097065]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268],NA,NA,NA
CHOYP_BRAFLDRAFT_206907.11.11.m.60961,0.0190930385998372,-0.00662558081627019,No,NA,NA,Q9Y2V2,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; P granule [GO:0043186]; P-body [GO:0000932]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; mRNA 3'-UTR binding [GO:0003730]; phosphatase binding [GO:0019902]; intracellular signal transduction [GO:0035556]; regulation of mRNA stability [GO:0043488],NA,NA,NA
CHOYP_BRAFLDRAFT_206907.5.11.m.19273,-0.00625691073243858,0.0104596988374594,No,NA,NA,Q9Y383,NA,NA,NA,nuclear speck [GO:0016607]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA splice site selection [GO:0006376],NA,NA,NA
CHOYP_BRAFLDRAFT_206907.6.11.m.30690,0.00156986685887619,0.0130575481140015,No,NA,NA,P50429,NA,NA,NA,cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]; anterior head development [GO:0097065]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268],NA,NA,NA
CHOYP_BRAFLDRAFT_208090.1.1.m.45354,-0.0139335746853434,0.00622695377585491,No,NA,NA,Q61371,NA,NA,NA,acrosomal membrane [GO:0002080]; axonemal basal plate [GO:0097541]; axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; kinocilium [GO:0060091]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; outer acrosomal membrane [GO:0002081]; photoreceptor connecting cilium [GO:0032391]; sperm flagellum [GO:0036126]; trans-Golgi network [GO:0005802]; kinesin binding [GO:0019894]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endothelial cell morphogenesis [GO:0001886]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; non-motile cilium assembly [GO:1905515]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; primary palate development [GO:1903929]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; regulation of smoothened signaling pathway [GO:0008589]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; sperm axoneme assembly [GO:0007288]; spermatid nucleus elongation [GO:0007290]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537],NA,NA,NA
CHOYP_BRAFLDRAFT_208117.3.3.m.56788,0.0125907942676144,-0.00385167372995604,No,NA,NA,P55196,NA,NA,NA,cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; tight junction [GO:0070160]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; protein C-terminus binding [GO:0008022]; Ras GTPase binding [GO:0017016]; adherens junction organization [GO:0034332]; bicellular tight junction assembly [GO:0070830]; cell adhesion [GO:0007155]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell signaling [GO:0007267]; establishment of endothelial intestinal barrier [GO:0090557]; establishment of protein localization to plasma membrane [GO:0061951]; negative regulation of cell migration [GO:0030336]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of GTPase activity [GO:0043547]; regulation of protein localization [GO:0032880]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_BRAFLDRAFT_208160.1.2.m.4498,-0.0053249536426758,-0.013098366568682,No,NA,NA,P86854,NA,NA,NA,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_BRAFLDRAFT_208197.18.21.m.59194,0.00491588973115351,-0.000600714720400964,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208197.2.21.m.9816,-0.000210635196606229,-0.0036911430140964,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208197.5.21.m.21756,-2.00054370871167e-07,-0.0150192601040217,No,NA,NA,Q8K0U4,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208293.10.20.m.53518,0.00466338261020595,0.00654529905630886,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208293.15.20.m.61604,-0.00906085418340783,0.00377244421969007,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208293.6.20.m.36168,-0.00930332125078542,0.00778845787403039,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208436.1.32.m.14239,-0.00560970261248235,0.0175827570101508,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208436.11.32.m.42955,0.00401428922482649,-0.00523119779173752,No,NA,NA,O43301,NA,NA,NA,extracellular exosome [GO:0070062]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208436.18.32.m.58763,-0.00993139946554874,0.0038502047823557,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208436.22.32.m.59131,0.0137643862687186,0.00399948163077482,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208436.25.32.m.60144,-0.00571194741325946,0.00347031639472194,No,NA,NA,O43301,NA,NA,NA,extracellular exosome [GO:0070062]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208436.27.32.m.61232,0.0065883263884642,0.0180931628217626,No,NA,NA,P21613,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_BRAFLDRAFT_208436.28.32.m.61328,-0.00406708165887746,0.011484700108644,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208436.29.32.m.61624,-0.000632037991330819,0.0132784647407765,No,NA,NA,Q8K0U4,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208436.30.32.m.61782,-0.00722326590593699,0.014826909307191,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208436.4.32.m.22687,0.000171685692660095,0.00026340035568302,No,NA,NA,O43301,NA,NA,NA,extracellular exosome [GO:0070062]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208436.4.32.m.22689,-0.00411180478283864,0.0169406452047594,No,NA,NA,P62278,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; synapse [GO:0045202]; 5.8S rRNA binding [GO:1990932]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_BRAFLDRAFT_208436.8.32.m.36574,0.00355814223761823,0.00713352425438231,No,NA,NA,O43301,NA,NA,NA,extracellular exosome [GO:0070062]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208819.1.1.m.61941,-0.00544529250570556,0.00425754904610059,No,NA,NA,Q26619,NA,NA,NA,cAMP-dependent protein kinase complex [GO:0005952]; cytosol [GO:0005829]; 3';5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cAMP binding [GO:0030552]; cAMP-dependent protein kinase regulator activity [GO:0008603]; cGMP-mediated signaling [GO:0019934],NA,NA,NA
CHOYP_BRAFLDRAFT_208819.1.1.m.61942,-0.0161913961435737,-0.00243288019135337,No,NA,NA,C9JJ37,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_209304.2.2.m.63768,0.00217997094733793,-0.00807271368859912,No,NA,NA,Q9QYI4,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; nuclear membrane [GO:0031965]; Hsp70 protein binding [GO:0030544]; cellular protein-containing complex assembly [GO:0034622]; cellular response to misfolded protein [GO:0071218]; chaperone cofactor-dependent protein refolding [GO:0051085]; ERAD pathway [GO:0036503]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_BRAFLDRAFT_209933.1.1.m.29283,0.0158678101841916,0.00316876480300152,No,NA,NA,Q8N2R8,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_210874.1.1.m.28596,-0.00928168627394995,-0.00311149379231713,No,NA,NA,P20351,NA,NA,NA,heme binding [GO:0020037]; metal ion binding [GO:0046872]; tryptophan 2;3-dioxygenase activity [GO:0004833]; compound eye pigmentation [GO:0048072]; kynurenine metabolic process [GO:0070189]; ommochrome biosynthetic process [GO:0006727]; positive regulation of neuron death [GO:1901216]; protein homotetramerization [GO:0051289]; tryptophan catabolic process [GO:0006569]; tryptophan catabolic process to acetyl-CoA [GO:0019442]; tryptophan catabolic process to kynurenine [GO:0019441],NA,NA,NA
CHOYP_BRAFLDRAFT_211853.1.1.m.18681,-0.00457285048675043,0.00511477625475045,No,NA,NA,Q1JQA5,NA,NA,NA,extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; growth factor activity [GO:0008083]; metal ion binding [GO:0046872]; negative regulation of appetite [GO:0032099]; positive regulation of MAPK cascade [GO:0043410],NA,NA,NA
CHOYP_BRAFLDRAFT_212086.1.11.m.20083,0.00106135138244587,0.00613050384775816,No,NA,NA,Q32KR8,NA,NA,NA,cell [GO:0005623]; ADP-ribosylarginine hydrolase activity [GO:0003875]; GTPase activator activity [GO:0005096]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; cellular protein modification process [GO:0006464]; intracellular protein transport [GO:0006886]; protein de-ADP-ribosylation [GO:0051725],NA,NA,NA
CHOYP_BRAFLDRAFT_212086.4.11.m.42448,-0.00871713657698933,0.00623689561290547,No,NA,NA,P54922,NA,NA,NA,cell [GO:0005623]; ADP-ribosylarginine hydrolase activity [GO:0003875]; GTPase activator activity [GO:0005096]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; cellular protein modification process [GO:0006464]; intracellular protein transport [GO:0006886]; protein de-ADP-ribosylation [GO:0051725],NA,NA,NA
CHOYP_BRAFLDRAFT_212086.9.11.m.60590,-0.00738359785126013,0.00500948786325458,No,NA,NA,Q32KR8,NA,NA,NA,cell [GO:0005623]; ADP-ribosylarginine hydrolase activity [GO:0003875]; GTPase activator activity [GO:0005096]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; cellular protein modification process [GO:0006464]; intracellular protein transport [GO:0006886]; protein de-ADP-ribosylation [GO:0051725],NA,NA,NA
CHOYP_BRAFLDRAFT_212438.1.1.m.29117,0.00566729841085466,-0.00153921859561749,No,NA,NA,Q08DF7,NA,NA,NA,mitochondrial matrix [GO:0005759]; exonuclease activity [GO:0004527]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; cellular response to dsRNA [GO:0071359]; cellular response to interferon-alpha [GO:0035457]; cellular response to interferon-gamma [GO:0071346]; mitochondrial mRNA catabolic process [GO:0000958]; mRNA processing [GO:0006397]; negative regulation of cell death [GO:0060548]; negative regulation of oxidative phosphorylation [GO:0090324]; nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:0000288]; positive regulation of viral genome replication [GO:0045070]; regulation of mitochondrial mRNA stability [GO:0044528],NA,NA,NA
CHOYP_BRAFLDRAFT_214346.1.1.m.56462,-0.00762459436504903,-0.0249728200479088,No,NA,NA,Q00988,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex III [GO:0005750]; electron transporter; transferring electrons within CoQH2-cytochrome c reductase complex activity [GO:0045153]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; mitochondrial electron transport; ubiquinol to cytochrome c [GO:0006122],NA,NA,NA
CHOYP_BRAFLDRAFT_214348.1.2.m.42797,-0.00748124302946223,0.0197496565952395,No,NA,NA,O14841,NA,NA,NA,cytosol [GO:0005829]; 5-oxoprolinase (ATP-hydrolyzing) activity [GO:0017168]; ATP binding [GO:0005524]; glutathione biosynthetic process [GO:0006750]; glutathione metabolic process [GO:0006749],NA,NA,NA
CHOYP_BRAFLDRAFT_214348.2.2.m.59996,-0.0082262418847099,0.0194432409405875,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_214790.1.1.m.15955,0.00205195042830453,-0.00934116934689426,No,NA,NA,Q4QR86,NA,NA,NA,intracellular signal transduction [GO:0035556],NA,NA,NA
CHOYP_BRAFLDRAFT_215087.1.1.m.66618,0.00399477702172894,0.00895814436137219,No,NA,NA,Q5ZL74,NA,NA,NA,apical part of cell [GO:0045177]; azurophil granule membrane [GO:0035577]; cell junction [GO:0030054]; cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; pseudopodium [GO:0031143]; SNARE complex [GO:0031201]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; calcium ion regulated exocytosis [GO:0017156]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosome to lysosome transport [GO:0008333]; eosinophil degranulation [GO:0043308]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; natural killer cell degranulation [GO:0043320]; neutrophil degranulation [GO:0043312]; phagocytosis; engulfment [GO:0006911]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of histamine secretion by mast cell [GO:1903595]; regulation of protein targeting to vacuolar membrane [GO:1900483]; SNARE complex assembly [GO:0035493]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_215208.1.1.m.40012,0.000686232728993108,-0.0107331332691118,No,NA,NA,Q0UI56,NA,NA,NA,cytosol [GO:0005829]; 4 iron; 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226],NA,NA,NA
CHOYP_BRAFLDRAFT_215283.1.1.m.1467,0.00109342479809487,0.000722495409643991,No,NA,NA,Q68EZ3,NA,NA,NA,nucleus [GO:0005634]; histone binding [GO:0042393]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H2A-R3 specific) [GO:0070612]; histone methyltransferase activity (H3-R2 specific) [GO:0070611]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; histone-arginine N-methyltransferase activity [GO:0008469]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; DNA repair [GO:0006281]; histone H3-R2 methylation [GO:0034970]; negative regulation of transcription; DNA-templated [GO:0045892]; peptidyl-arginine methylation; to asymmetrical-dimethyl arginine [GO:0019919]; peptidyl-arginine N-methylation [GO:0035246],NA,NA,NA
CHOYP_BRAFLDRAFT_215361.1.1.m.55455,-0.00844977834810532,0.0208883250144399,No,NA,NA,Q3SZH7,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; epoxide hydrolase activity [GO:0004301]; leukotriene-A4 hydrolase activity [GO:0004463]; metalloaminopeptidase activity [GO:0070006]; zinc ion binding [GO:0008270]; cellular lipid metabolic process [GO:0044255]; cellular protein metabolic process [GO:0044267]; leukotriene biosynthetic process [GO:0019370]; peptide catabolic process [GO:0043171],NA,NA,NA
CHOYP_BRAFLDRAFT_215413.1.1.m.2004,0.00753144581314146,0.0118884626080103,No,NA,NA,Q3KRG3,NA,NA,NA,maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462],NA,NA,NA
CHOYP_BRAFLDRAFT_215789.1.1.m.60401,-0.000977036502240041,-0.0166871246171803,No,NA,NA,Q8N2E2,NA,NA,NA,cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856],NA,NA,NA
CHOYP_BRAFLDRAFT_215789.1.1.m.60405,-0.00794076843664824,-0.000674291940490356,No,NA,NA,Q9H0Z9,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; cell cycle [GO:0007049]; cell cycle arrest [GO:0007050]; cell differentiation [GO:0030154]; DNA damage response; signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response; signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; mRNA processing [GO:0006397]; negative regulation of cell proliferation [GO:0008285]; regulation of myotube differentiation [GO:0010830]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_BRAFLDRAFT_216204.1.1.m.30654,-0.00205261954583402,-0.0161191066985703,No,NA,NA,P26697,NA,NA,NA,cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749],NA,NA,NA
CHOYP_BRAFLDRAFT_216893.1.1.m.18940,-0.0130841547069039,-0.00345438405131158,No,NA,NA,Q9NRL2,NA,NA,NA,ACF complex [GO:0016590]; CHRAC [GO:0008623]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; DNA-dependent DNA replication [GO:0006261]; histone acetylation [GO:0016573]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_BRAFLDRAFT_217332.2.2.m.51240,-0.0108085581471599,0.0117710985237979,No,NA,NA,P70665,NA,NA,NA,lysosome [GO:0005764]; sialate O-acetylesterase activity [GO:0001681]; carbohydrate metabolic process [GO:0005975]; regulation of immune system process [GO:0002682],NA,NA,NA
CHOYP_BRAFLDRAFT_217424.2.2.m.44576,-0.00338399891766682,-0.00779505608053661,No,NA,NA,O08590,NA,NA,NA,cell surface [GO:0009986]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; aliphatic-amine oxidase activity [GO:0052595]; aminoacetone:oxygen oxidoreductase(deaminating) activity [GO:0052594]; copper ion binding [GO:0005507]; phenethylamine:oxygen oxidoreductase (deaminating) activity [GO:0052596]; primary amine oxidase activity [GO:0008131]; protein homodimerization activity [GO:0042803]; quinone binding [GO:0048038]; tryptamine:oxygen oxidoreductase (deaminating) activity [GO:0052593]; aging [GO:0007568]; amine metabolic process [GO:0009308]; cell adhesion [GO:0007155]; eating behavior [GO:0042755]; leukocyte migration involved in inflammatory response [GO:0002523]; negative regulation of primary amine oxidase activity [GO:1902283]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of leukocyte migration [GO:0002687]; regulation of blood pressure [GO:0008217]; response to antibiotic [GO:0046677]; response to immobilization stress [GO:0035902],NA,NA,NA
CHOYP_BRAFLDRAFT_217516.1.1.m.18628,-0.00410786714260487,-0.00821175885063001,No,NA,NA,P56518,NA,NA,NA,cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; Sin3-type complex [GO:0070822]; histone deacetylase activity [GO:0004407]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; transcription factor binding [GO:0008134]; chromatin organization [GO:0006325]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_BRAFLDRAFT_218889.2.2.m.58058,-0.0101854515202049,-0.0105192565522581,No,NA,NA,P28749,NA,NA,NA,chromatin [GO:0000785]; nucleoplasm [GO:0005654]; transcription factor complex [GO:0005667]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II regulatory region DNA binding [GO:0001012]; transcription factor binding [GO:0008134]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of cellular senescence [GO:2000773]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell division [GO:0051302]; regulation of lipid kinase activity [GO:0043550]; regulation of mitotic cell cycle [GO:0007346]; viral process [GO:0016032],NA,NA,NA
CHOYP_BRAFLDRAFT_219059.1.1.m.40577,-0.00484176949343069,-0.001705448447324,No,NA,NA,Q5RC46,NA,NA,NA,extracellular space [GO:0005615]; adenosine deaminase activity [GO:0004000]; adenosine receptor binding [GO:0031685]; heparin binding [GO:0008201]; proteoglycan binding [GO:0043394]; zinc ion binding [GO:0008270]; adenosine catabolic process [GO:0006154],NA,NA,NA
CHOYP_BRAFLDRAFT_219059.1.1.m.40578,-0.00210684079087747,0.0123928032586299,No,NA,NA,Q91V57,NA,NA,NA,ephrin receptor binding [GO:0046875]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; motor neuron axon guidance [GO:0008045]; regulation of axonogenesis [GO:0050770]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056],NA,NA,NA
CHOYP_BRAFLDRAFT_219160.1.1.m.58567,-0.00656884368355339,-0.00410947827894497,No,NA,NA,Q7ZXF1,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_BRAFLDRAFT_220284.1.1.m.29545,-0.00317989011538539,0.00847574944167106,No,NA,NA,A2TJ54,NA,NA,NA,cytosol [GO:0005829]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; mannose binding [GO:0005537]; glycosylation [GO:0070085]; positive regulation of GTP binding [GO:1904426]; retrograde transport; endosome to Golgi [GO:0042147]; signal peptide processing [GO:0006465],NA,NA,NA
CHOYP_BRAFLDRAFT_220356.5.6.m.38505,0.013723176409047,0.011087645348048,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_221105.1.2.m.172,0.0141759717899062,0.0103516899968308,No,NA,NA,Q9D2Z4,NA,NA,NA,cysteine-type peptidase activity [GO:0008234]; NEDD8-specific protease activity [GO:0019784],NA,NA,NA
CHOYP_BRAFLDRAFT_221105.2.2.m.18318,-0.00501744485822589,-0.0075252797962491,No,NA,NA,Q8N0U4,NA,NA,NA,cytosol [GO:0005829],NA,NA,NA
CHOYP_BRAFLDRAFT_221115.1.1.m.28512,-0.00692914455363637,-0.000316258174760116,No,NA,NA,Q2M389,NA,NA,NA,early endosome [GO:0005769]; endosome [GO:0005768]; nucleoplasm [GO:0005654]; WASH complex [GO:0071203]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_221294.2.2.m.52722,-0.0169591047060434,0.00960206869202777,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_221898.1.2.m.28353,-0.0135671976172834,0.00552732723512505,No,NA,NA,Q68CZ1,NA,NA,NA,axonemal microtubule [GO:0005879]; axoneme [GO:0005930]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; thromboxane A2 receptor binding [GO:0031870]; camera-type eye development [GO:0043010]; cerebellum development [GO:0021549]; ciliary basal body-plasma membrane docking [GO:0097711]; cochlea development [GO:0090102]; corpus callosum development [GO:0022038]; determination of left/right symmetry [GO:0007368]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; establishment of planar polarity [GO:0001736]; establishment or maintenance of cell polarity [GO:0007163]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; lateral ventricle development [GO:0021670]; liver development [GO:0001889]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; nose development [GO:0043584]; olfactory bulb development [GO:0021772]; pericardium development [GO:0060039]; regulation of smoothened signaling pathway [GO:0008589],NA,NA,NA
CHOYP_BRAFLDRAFT_223290.2.2.m.30918,0.0018472460020644,-0.0176724256168812,No,NA,NA,P86854,NA,NA,NA,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_BRAFLDRAFT_223429.1.2.m.30136,-0.000522694072412083,0.0199345815022006,No,NA,NA,Q13148,NA,NA,NA,cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; ribonucleoprotein complex [GO:1990904]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; sequence-specific double-stranded DNA binding [GO:1990837]; single-stranded RNA binding [GO:0003727]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; positive regulation of protein import into nucleus [GO:0042307]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_BRAFLDRAFT_223429.2.2.m.38659,0.00927426134415875,0.0154984003949452,No,NA,NA,Q28F51,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; double-stranded DNA binding [GO:0003690]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_BRAFLDRAFT_223476.1.1.m.30983,0.00568578065119213,-0.0251044081807943,No,NA,NA,O35125,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829],NA,NA,NA
CHOYP_BRAFLDRAFT_223573.1.1.m.4526,0.00678620130084429,0.00878741825264137,No,NA,NA,P86854,NA,NA,NA,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_BRAFLDRAFT_223623.1.1.m.11202,-0.0102995918495985,-0.0193736359498238,No,NA,NA,Q6ZPT1,NA,NA,NA,Cul3-RING ubiquitin ligase complex [GO:0031463]; midbody [GO:0030496]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein ubiquitination [GO:0016567]; regulation of cytokinesis [GO:0032465],NA,NA,NA
CHOYP_BRAFLDRAFT_223894.1.1.m.7024,-0.00441655429538104,-0.0138127533062453,No,NA,NA,Q9H9Y6,NA,NA,NA,cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; embryo implantation [GO:0007566]; nucleologenesis [GO:0017126]; positive regulation of gene expression; epigenetic [GO:0045815]; rRNA transcription [GO:0009303]; termination of RNA polymerase I transcription [GO:0006363]; transcription initiation from RNA polymerase I promoter [GO:0006361],NA,NA,NA
CHOYP_BRAFLDRAFT_224325.1.3.m.26136,-0.010771485105617,0.000997404795031174,No,NA,NA,Q64516,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; histone binding [GO:0042393]; glucose homeostasis [GO:0042593]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate biosynthetic process [GO:0046167]; phosphorylation [GO:0016310]; regulation of fatty acid metabolic process [GO:0019217]; response to ethanol [GO:0045471]; triglyceride metabolic process [GO:0006641],NA,NA,NA
CHOYP_BRAFLDRAFT_224325.3.3.m.52906,0.00444296977701312,0.00884059964025998,No,NA,NA,Q0IID9,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate biosynthetic process [GO:0046167]; phosphorylation [GO:0016310]; triglyceride metabolic process [GO:0006641],NA,NA,NA
CHOYP_BRAFLDRAFT_224574.18.18.m.65591,0.00747913129269678,0.00915675695967087,No,NA,NA,O75095,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_BRAFLDRAFT_224574.3.18.m.20799,0.00217997094733793,-0.00807271368859912,No,NA,NA,A6BM72,NA,NA,NA,basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842],NA,NA,NA
CHOYP_BRAFLDRAFT_224716.1.2.m.41344,0.00296215577908005,-0.0145743603515574,No,NA,NA,Q6NSW5,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_225253.1.1.m.9264,-0.00539115710308628,-0.0233082643447472,No,NA,NA,O75694,NA,NA,NA,membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore inner ring [GO:0044611]; structural constituent of nuclear pore [GO:0017056]; transporter activity [GO:0005215]; atrial cardiac muscle cell action potential [GO:0086014]; mRNA export from nucleus [GO:0006406]; nuclear envelope organization [GO:0006998]; protein import into nucleus [GO:0006606]; protein localization to nuclear inner membrane [GO:0036228]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]; viral process [GO:0016032],NA,NA,NA
CHOYP_BRAFLDRAFT_225290.1.1.m.5737,-0.000282410821381314,-0.00252785568418791,No,NA,NA,Q6NT55,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; organelle membrane [GO:0031090]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen [GO:0016705]; icosanoid metabolic process [GO:0006690],NA,NA,NA
CHOYP_BRAFLDRAFT_226345.1.1.m.55555,0.0212587265472861,-0.0135163348210536,No,NA,NA,Q9BXB4,NA,NA,NA,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; fat cell differentiation [GO:0045444]; positive regulation of sequestering of triglyceride [GO:0010890],NA,NA,NA
CHOYP_BRAFLDRAFT_226416.1.1.m.56984,-0.0080248105913932,0.00904331787217485,No,NA,NA,Q9H939,NA,NA,NA,actin filament [GO:0005884]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; cytoskeletal protein binding [GO:0008092]; actin filament polymerization [GO:0030041]; cell migration [GO:0016477],NA,NA,NA
CHOYP_BRAFLDRAFT_226506.1.3.m.1062,-0.00575344504174896,-0.0226242122479169,No,NA,NA,Q5H8C4,NA,NA,NA,dense core granule [GO:0031045]; extrinsic component of membrane [GO:0019898]; autophagy [GO:0006914]; locomotory behavior [GO:0007626]; nervous system development [GO:0007399]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]; social behavior [GO:0035176],NA,NA,NA
CHOYP_BRAFLDRAFT_226506.3.3.m.53203,-0.00218927892071002,0.0211887897647246,No,NA,NA,Q5H8C4,NA,NA,NA,dense core granule [GO:0031045]; extrinsic component of membrane [GO:0019898]; autophagy [GO:0006914]; locomotory behavior [GO:0007626]; nervous system development [GO:0007399]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]; social behavior [GO:0035176],NA,NA,NA
CHOYP_BRAFLDRAFT_226942.1.1.m.49751,0.00955924144280816,0.0134485296068771,No,NA,NA,Q9UHJ3,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone binding [GO:0042393]; transcription corepressor activity [GO:0003714]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of muscle organ development [GO:0048635]; negative regulation of transcription; DNA-templated [GO:0045892]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_227287.1.1.m.14669,-0.0156822337521357,0.00239564988384818,No,NA,NA,Q498J9,NA,NA,NA,hydrolase activity [GO:0016787]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_BRAFLDRAFT_227771.1.2.m.60606,0.0202103864448008,0.00201958871761791,No,NA,NA,B3EWZ6,NA,NA,NA,extracellular region [GO:0005576]; membrane [GO:0016020],NA,NA,NA
CHOYP_BRAFLDRAFT_228853.1.1.m.9833,-0.00395857272433042,-0.0111418841340642,No,NA,NA,Q6TH15,NA,NA,NA,eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; mRNA cap binding [GO:0098808]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; cap-dependent translational initiation [GO:0002191]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_BRAFLDRAFT_230143.1.1.m.15015,-0.0101085460127163,0.00455297733209612,No,NA,NA,Q1RMU2,NA,NA,NA,centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; Lys48-specific deubiquitinase activity [GO:1990380]; Lys63-specific deubiquitinase activity [GO:0061578]; proline-rich region binding [GO:0070064]; protein kinase binding [GO:0019901]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]; CD4-positive or CD8-positive; alpha-beta T cell lineage commitment [GO:0043369]; homeostasis of number of cells [GO:0048872]; innate immune response [GO:0045087]; necroptotic process [GO:0070266]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of JNK cascade [GO:0046329]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of p38MAPK cascade [GO:1903753]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; protein linear deubiquitination [GO:1990108]; regulation of B cell differentiation [GO:0045577]; regulation of cilium assembly [GO:1902017]; regulation of inflammatory response [GO:0050727]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of mitotic cell cycle [GO:0007346]; regulation of necroptotic process [GO:0060544]; regulation of protein binding [GO:0043393]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; ripoptosome assembly involved in necroptotic process [GO:1901026]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_BRAFLDRAFT_230181.1.1.m.61583,0.00311857766502993,-0.010572986575175,No,NA,NA,Q8NCC3,NA,NA,NA,extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; calcium-independent phospholipase A2 activity [GO:0047499]; lysophospholipase activity [GO:0004622]; O-acyltransferase activity [GO:0008374]; phospholipid binding [GO:0005543]; ceramide metabolic process [GO:0006672]; fatty acid catabolic process [GO:0009062]; glycerophospholipid metabolic process [GO:0006650]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; phospholipid metabolic process [GO:0006644],NA,NA,NA
CHOYP_BRAFLDRAFT_232705.1.2.m.13912,-0.0198353257265325,-0.00686598084879295,No,NA,NA,A7SG73,NA,NA,NA,cytoplasm [GO:0005737]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; NAD biosynthetic process [GO:0009435]; quinolinate catabolic process [GO:0034213],NA,NA,NA
CHOYP_BRAFLDRAFT_233674.1.1.m.66738,0.0072285742081631,-0.00127224789312752,No,NA,NA,A5PLK2,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]; phosphatase activity [GO:0016791]; protein histidine phosphatase activity [GO:0101006]; dephosphorylation [GO:0016311]; phosphate-containing compound metabolic process [GO:0006796]; protein dephosphorylation [GO:0006470],NA,NA,NA
CHOYP_BRAFLDRAFT_234513.1.1.m.9581,-0.00827236592230094,-0.00232689330236867,No,NA,NA,Q95KG9,NA,NA,NA,Mon1-Ccz1 complex [GO:0035658]; guanyl-nucleotide exchange factor activity [GO:0005085],NA,NA,NA
CHOYP_BRAFLDRAFT_234854.2.2.m.58013,0.00491588973115351,-0.000600714720400961,No,NA,NA,Q9P2E3,NA,NA,NA,chromosome; centromeric region [GO:0000775]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048],NA,NA,NA
CHOYP_BRAFLDRAFT_235412.2.2.m.58139,0.00364778592941831,-0.00872052841558096,No,NA,NA,P22105,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251],NA,NA,NA
CHOYP_BRAFLDRAFT_236936.2.6.m.17168,0.00179866352104804,0.00895594621505133,No,NA,NA,D3YXG0,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_BRAFLDRAFT_236936.3.6.m.29228,0.00349324147922961,-0.0195667246019963,No,NA,NA,Q96RW7,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],NA,NA,NA
CHOYP_BRAFLDRAFT_237339.1.1.m.15256,0.00364778592941831,-0.00872052841558096,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_238139.1.1.m.12224,-0.0169591047060434,0.00960206869202777,No,NA,NA,Q6DGP2,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_BRAFLDRAFT_239751.2.3.m.36889,-0.018265432684164,0.0178158102141474,No,NA,NA,Q28J59,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_240825.1.1.m.43452,0.00470697501772775,-0.00195570019305887,No,NA,NA,Q63186,NA,NA,NA,cytoplasm [GO:0005737]; eukaryotic translation initiation factor 2B complex [GO:0005851]; guanyl-nucleotide exchange factor activity [GO:0005085]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; hippocampus development [GO:0021766]; myelination [GO:0042552]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; oligodendrocyte development [GO:0014003]; ovarian follicle development [GO:0001541]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_BRAFLDRAFT_240864.1.1.m.24434,0.00573627234837368,0.0143178877188892,No,NA,NA,Q5RID7,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; phosphatidylinositol binding [GO:0035091]; intracellular protein transport [GO:0006886]; retrograde transport; endosome to plasma membrane [GO:1990126]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_BRAFLDRAFT_240914.2.3.m.29586,0.0177762238480698,-0.00514235187594748,No,NA,NA,Q96P44,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; growth plate cartilage chondrocyte morphogenesis [GO:0003429],NA,NA,NA
CHOYP_BRAFLDRAFT_241287.1.1.m.5544,-0.000739840958833857,0.00323996167766658,No,NA,NA,F1NUK7,NA,NA,NA,axon terminus [GO:0043679]; axonal growth cone [GO:0044295]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; synaptic membrane [GO:0097060]; chemorepellent activity [GO:0045499]; fibroblast growth factor receptor binding [GO:0005104]; protein homodimerization activity [GO:0042803]; axon guidance [GO:0007411]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; embryonic morphogenesis [GO:0048598]; fibroblast growth factor receptor signaling pathway [GO:0008543]; head development [GO:0060322]; heart development [GO:0007507]; neuron projection development [GO:0031175]; neuron projection extension [GO:1990138]; positive regulation of synapse assembly [GO:0051965]; proepicardium cell migration involved in pericardium morphogenesis [GO:0003345]; response to axon injury [GO:0048678]; synapse assembly [GO:0007416]; synaptic membrane adhesion [GO:0099560],NA,NA,NA
CHOYP_BRAFLDRAFT_241400.1.1.m.44544,0.00530432385010334,0.0204508545231118,No,NA,NA,Q498J9,NA,NA,NA,hydrolase activity [GO:0016787]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_BRAFLDRAFT_241420.1.1.m.61408,0.00204260625767543,-0.0137217139793118,No,NA,NA,Q8CG72,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; poly(ADP-ribose) glycohydrolase activity [GO:0004649]; cellular response to superoxide [GO:0071451],NA,NA,NA
CHOYP_BRAFLDRAFT_241726.22.22.m.52736,-0.00430894344577715,-0.00631540690244347,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_241726.4.22.m.3766,0.00615966897194063,0.00941964587728867,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_244533.1.2.m.40480,0.00918372089124572,-0.00737981238137035,No,NA,NA,Q5FVR2,NA,NA,NA,cytosol [GO:0005829]; phosphorylase activity [GO:0004645]; protein homodimerization activity [GO:0042803]; pyrimidine-nucleoside phosphorylase activity [GO:0016154]; thymidine phosphorylase activity [GO:0009032]; mitochondrial genome maintenance [GO:0000002]; pyrimidine nucleobase metabolic process [GO:0006206]; pyrimidine nucleoside metabolic process [GO:0006213]; regulation of gastric motility [GO:1905333]; regulation of myelination [GO:0031641]; regulation of transmission of nerve impulse [GO:0051969],NA,NA,NA
CHOYP_BRAFLDRAFT_244533.2.2.m.53951,-0.0086098402746259,-0.00263016051727733,No,NA,NA,Q5FVR2,NA,NA,NA,cytosol [GO:0005829]; phosphorylase activity [GO:0004645]; protein homodimerization activity [GO:0042803]; pyrimidine-nucleoside phosphorylase activity [GO:0016154]; thymidine phosphorylase activity [GO:0009032]; mitochondrial genome maintenance [GO:0000002]; pyrimidine nucleobase metabolic process [GO:0006206]; pyrimidine nucleoside metabolic process [GO:0006213]; regulation of gastric motility [GO:1905333]; regulation of myelination [GO:0031641]; regulation of transmission of nerve impulse [GO:0051969],NA,NA,NA
CHOYP_BRAFLDRAFT_245349.1.1.m.45479,-0.0157632261624535,-0.0190988064079402,No,NA,NA,Q6PBA8,NA,NA,NA,motile cilium [GO:0031514]; nucleus [GO:0005634]; cilium organization [GO:0044782]; meiotic cell cycle [GO:0051321],NA,NA,NA
CHOYP_BRAFLDRAFT_246447.1.1.m.30255,-0.0187706230948819,0.00549547093320052,No,NA,NA,P50430,NA,NA,NA,cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268],NA,NA,NA
CHOYP_BRAFLDRAFT_246510.1.1.m.27433,-0.0226627929754949,0.0102533919645495,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_246978.1.1.m.6916,-0.0213735764672613,-0.00456272391093224,No,NA,NA,Q32KU3,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_247007.1.1.m.15096,-0.0135725579708752,0.00388604629968508,No,NA,NA,O14618,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; copper ion binding [GO:0005507]; protein disulfide oxidoreductase activity [GO:0015035]; superoxide dismutase activity [GO:0004784]; superoxide dismutase copper chaperone activity [GO:0016532]; zinc ion binding [GO:0008270]; cellular response to oxidative stress [GO:0034599]; metal ion transport [GO:0030001]; positive regulation of oxidoreductase activity [GO:0051353]; protein maturation by copper ion transfer [GO:0015680]; removal of superoxide radicals [GO:0019430]; superoxide metabolic process [GO:0006801],NA,NA,NA
CHOYP_BRAFLDRAFT_247063.1.1.m.17671,0.00205195042830452,-0.00934116934689426,No,NA,NA,Q80UM7,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mannosyl-oligosaccharide glucosidase activity [GO:0004573]; oligosaccharide metabolic process [GO:0009311]; protein N-linked glycosylation [GO:0006487],NA,NA,NA
CHOYP_BRAFLDRAFT_249141.1.1.m.6974,-0.0114804403785388,-0.00223422535482608,No,NA,NA,Q7ZVC9,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_249506.2.2.m.60314,-0.0114105714261375,0.00432668773988335,No,NA,NA,Q6Q899,NA,NA,NA,actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; regulation of cell migration [GO:0030334]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529],NA,NA,NA
CHOYP_BRAFLDRAFT_251578.1.1.m.15566,-0.00759666824641998,0.0010677723079629,No,NA,NA,Q9V535,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; exon-exon junction complex [GO:0035145]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; establishment of pole plasm mRNA localization [GO:0046595]; germarium-derived oocyte fate determination [GO:0007294]; microtubule cytoskeleton organization [GO:0000226]; mRNA splicing; via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; negative regulation of transposition; DNA-mediated [GO:0000335]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte dorsal/ventral axis specification [GO:0007310]; oocyte nucleus localization involved in oocyte dorsal/ventral axis specification [GO:0051663]; pole plasm oskar mRNA localization [GO:0045451]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of pole plasm oskar mRNA localization [GO:0007317]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_BRAFLDRAFT_251779.1.2.m.6830,-0.00435269740718307,0.0156730934112698,No,NA,NA,Q8CGS6,NA,NA,NA,chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; 5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; identical protein binding [GO:0042802]; single-stranded DNA-dependent ATPase activity [GO:0043142]; base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; protein homooligomerization [GO:0051260]; somatic hypermutation of immunoglobulin genes [GO:0016446],NA,NA,NA
CHOYP_BRAFLDRAFT_251802.1.1.m.66483,0.0142664596752523,0.00430104008972665,No,NA,NA,Q2HJF4,NA,NA,NA,cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; isomerase activity [GO:0016853]; biosynthetic process [GO:0009058]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512],NA,NA,NA
CHOYP_BRAFLDRAFT_255736.1.1.m.62027,-0.0108587882778781,0.00877723448270307,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_258021.1.1.m.6099,-0.0110569950169827,-0.0128425902056929,No,NA,NA,Q2VLG6,NA,NA,NA,external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044]; acute-phase response [GO:0006953],NA,NA,NA
CHOYP_BRAFLDRAFT_259692.1.1.m.44099,-0.000927229226082881,-0.0141818113309969,No,NA,NA,Q3T0V9,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; deoxyribose-phosphate aldolase activity [GO:0004139]; carbohydrate catabolic process [GO:0016052]; deoxyribonucleoside catabolic process [GO:0046121]; deoxyribonucleotide catabolic process [GO:0009264]; deoxyribose phosphate catabolic process [GO:0046386],NA,NA,NA
CHOYP_BRAFLDRAFT_259734.1.1.m.23051,-0.0107385003514434,-0.0205234658154648,No,NA,NA,Q5R5M0,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743],NA,NA,NA
CHOYP_BRAFLDRAFT_259980.1.1.m.17608,-0.00984474354677063,-0.00758983437082482,No,NA,NA,Q8CF89,NA,NA,NA,cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; kinase activator activity [GO:0019209]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; mitogen-activated protein kinase p38 binding [GO:0048273]; protein kinase activator activity [GO:0030295]; protein serine/threonine phosphatase activity [GO:0004722]; protein-containing complex binding [GO:0044877]; activation of MAPKKK activity [GO:0000185]; aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; lung development [GO:0030324]; positive regulation of MAP kinase activity [GO:0043406]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_BRAFLDRAFT_260197.1.1.m.8081,-0.0110205280698103,-0.0237428910416857,No,NA,NA,O43402,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; ER membrane protein complex [GO:0072546]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634],NA,NA,NA
CHOYP_BRAFLDRAFT_260828.1.1.m.16250,0.00513396459763327,-0.010688086429663,No,NA,NA,Q9D2V5,NA,NA,NA,spliceosomal complex [GO:0005681]; spliceosomal tri-snRNP complex assembly [GO:0000244],NA,NA,NA
CHOYP_BRAFLDRAFT_260946.1.2.m.54464,-0.0224409387249817,0.0106030362598753,No,NA,NA,O69060,NA,NA,NA,dioxygenase activity [GO:0051213],NA,NA,NA
CHOYP_BRAFLDRAFT_261406.1.1.m.46291,-0.0171790450392519,-0.00410221284142159,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_261932.1.1.m.23690,-0.00599924876211625,0.00301987579116938,No,NA,NA,Q9Y5Z4,NA,NA,NA,azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; heme binding [GO:0020037]; negative regulation of mitochondrial membrane potential [GO:0010917]; neutrophil degranulation [GO:0043312]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of necrotic cell death [GO:0010940],NA,NA,NA
CHOYP_BRAFLDRAFT_261940.2.2.m.53422,0.00217997094733793,-0.00807271368859912,No,NA,NA,F1NZI4,NA,NA,NA,cell wall [GO:0005618]; cytosol [GO:0005829]; alpha;alpha-trehalase activity [GO:0004555]; protein-glucosylgalactosylhydroxylysine glucosidase activity [GO:0047402]; carbohydrate metabolic process [GO:0005975]; trehalose catabolic process [GO:0005993],NA,NA,NA
CHOYP_BRAFLDRAFT_262219.2.2.m.65564,-0.00871706302558051,-0.0178923919086668,No,NA,NA,Q99JW2,NA,NA,NA,cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; aminoacylase activity [GO:0004046]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; cellular amino acid metabolic process [GO:0006520],NA,NA,NA
CHOYP_BRAFLDRAFT_262219.2.2.m.65565,-0.010959003632358,0.00369758879720658,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_263599.1.1.m.59010,-0.0142721325197141,0.00164921469984836,No,NA,NA,O95995,NA,NA,NA,axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126]; microtubule binding [GO:0008017]; Rab GTPase binding [GO:0017137]; axoneme assembly [GO:0035082]; brain development [GO:0007420]; cellular protein localization [GO:0034613]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement [GO:0003351]; flagellated sperm motility [GO:0030317]; negative regulation of cell proliferation [GO:0008285]; positive regulation of protein localization to cilium [GO:1903566]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of microtubule binding [GO:1904526],NA,NA,NA
CHOYP_BRAFLDRAFT_263599.1.1.m.59011,-0.00200259941034069,0.0118000748731733,No,NA,NA,Q60631,NA,NA,NA,cell-cell junction [GO:0005911]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Grb2-EGFR complex [GO:0070436]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; vesicle membrane [GO:0012506]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; insulin receptor substrate binding [GO:0043560]; neurotrophin TRKA receptor binding [GO:0005168]; phosphoprotein binding [GO:0051219]; phosphotyrosine residue binding [GO:0001784]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; SH3 domain binding [GO:0017124]; SH3/SH2 adaptor activity [GO:0005070]; aging [GO:0007568]; anatomical structure formation involved in morphogenesis [GO:0048646]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; cell differentiation [GO:0030154]; cellular response to ionizing radiation [GO:0071479]; insulin receptor signaling pathway [GO:0008286]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; protein heterooligomerization [GO:0051291]; Ras protein signal transduction [GO:0007265]; receptor internalization [GO:0031623]; regulation of MAPK cascade [GO:0043408]; signal transduction in response to DNA damage [GO:0042770],NA,NA,NA
CHOYP_BRAFLDRAFT_263840.1.1.m.51673,-0.0183477134600772,-0.00482407513221879,No,NA,NA,A2BFC9,NA,NA,NA,cilium [GO:0005929],NA,NA,NA
CHOYP_BRAFLDRAFT_264234.1.2.m.5174,0.0185403887374619,-0.0114364556426604,No,NA,NA,Q58DU5,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex; alpha-subunit complex [GO:0019773]; synapse [GO:0045202]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; ubiquitin protein ligase binding [GO:0031625]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of endopeptidase activity [GO:0052548],NA,NA,NA
CHOYP_BRAFLDRAFT_264234.2.2.m.7063,-0.000867655133086762,0.00649478000661962,No,NA,NA,P27085,NA,NA,NA,cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181],NA,NA,NA
CHOYP_BRAFLDRAFT_264304.1.1.m.35625,0.00678620130084429,0.00878741825264137,No,NA,NA,Q6DF57,NA,NA,NA,condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; nucleic acid binding [GO:0003676],NA,NA,NA
CHOYP_BRAFLDRAFT_264316.1.1.m.29655,-0.00455462816511214,-0.0186595034322602,No,NA,NA,Q08C33,NA,NA,NA,cytoplasm [GO:0005737]; catalytic activity [GO:0003824],NA,NA,NA
CHOYP_BRAFLDRAFT_264461.1.1.m.51481,-0.0156820935941578,-7.25316866634458e-05,No,NA,NA,Q3V0Q6,NA,NA,NA,acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]; microtubule binding [GO:0008017]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_265162.1.3.m.58969,-0.0142520444939687,-0.00385044265051344,No,NA,NA,Q5EAR5,NA,NA,NA,tRNA 2'-phosphotransferase activity [GO:0000215]; tRNA splicing; via endonucleolytic cleavage and ligation [GO:0006388],NA,NA,NA
CHOYP_BRAFLDRAFT_265162.3.3.m.64003,-0.0089799688279134,-0.00208182367655114,No,NA,NA,Q5EAR5,NA,NA,NA,tRNA 2'-phosphotransferase activity [GO:0000215]; tRNA splicing; via endonucleolytic cleavage and ligation [GO:0006388],NA,NA,NA
CHOYP_BRAFLDRAFT_265208.3.7.m.10791,0.00650917765545515,-0.00602125712651008,No,NA,NA,Q91WV7,NA,NA,NA,brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; catalytic activity [GO:0003824]; protein heterodimerization activity [GO:0046982]; amino acid transport [GO:0006865]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_BRAFLDRAFT_265208.6.7.m.52336,0.016163770703438,-0.00199685994331231,No,NA,NA,Q91WV7,NA,NA,NA,brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; catalytic activity [GO:0003824]; protein heterodimerization activity [GO:0046982]; amino acid transport [GO:0006865]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_BRAFLDRAFT_265208.7.7.m.62510,-0.0169591047060434,0.00960206869202778,No,NA,NA,Q91WV7,NA,NA,NA,brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; catalytic activity [GO:0003824]; protein heterodimerization activity [GO:0046982]; amino acid transport [GO:0006865]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_BRAFLDRAFT_265613.1.2.m.14785,0.0133926460298488,-0.000133691720350703,No,NA,NA,Q8BMB3,NA,NA,NA,eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA cap binding complex [GO:0005845]; RNA 7-methylguanosine cap binding [GO:0000340]; translation initiation factor activity [GO:0003743]; ubiquitin protein ligase binding [GO:0031625]; in utero embryonic development [GO:0001701]; negative regulation of translation [GO:0017148],NA,NA,NA
CHOYP_BRAFLDRAFT_265991.1.1.m.58765,-0.00900091045442281,-0.00365357300769827,No,NA,NA,Q9NXS2,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; glutaminyl-peptide cyclotransferase activity [GO:0016603]; zinc ion binding [GO:0008270]; peptidyl-pyroglutamic acid biosynthetic process; using glutaminyl-peptide cyclotransferase [GO:0017186],NA,NA,NA
CHOYP_BRAFLDRAFT_266349.1.1.m.9217,0.00938670248338658,-0.0236776863691728,No,NA,NA,Q3ULD5,NA,NA,NA,methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; coenzyme A metabolic process [GO:0015936]; leucine catabolic process [GO:0006552],NA,NA,NA
CHOYP_BRAFLDRAFT_266781.1.2.m.24880,0.00986551254103774,-0.00341655913234571,No,NA,NA,Q2KI24,NA,NA,NA,cytoplasm [GO:0005737]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_BRAFLDRAFT_266781.1.2.m.24881,0.0166362584845107,0.0086870498887203,No,NA,NA,P62494,NA,NA,NA,axon [GO:0030424]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; kinetochore microtubule [GO:0005828]; multivesicular body [GO:0005771]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; postsynaptic recycling endosome [GO:0098837]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; Schaffer collateral - CA1 synapse [GO:0098685]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; myosin V binding [GO:0031489]; amyloid-beta clearance by transcytosis [GO:0150093]; astral microtubule organization [GO:0030953]; establishment of protein localization to organelle [GO:0072594]; exocytosis [GO:0006887]; exosomal secretion [GO:1990182]; intracellular cholesterol transport [GO:0032367]; intracellular protein transport [GO:0006886]; melanosome transport [GO:0032402]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; multivesicular body assembly [GO:0036258]; neuron projection development [GO:0031175]; neurotransmitter receptor transport; endosome to postsynaptic membrane [GO:0098887]; positive regulation of axon extension [GO:0045773]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; Rab protein signal transduction [GO:0032482]; regulation of cytokinesis [GO:0032465]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of multivesicular body size [GO:0010796]; regulation of protein transport [GO:0051223]; regulation of vesicle-mediated transport [GO:0060627]; vesicle-mediated transport [GO:0016192]; vesicle-mediated transport in synapse [GO:0099003],NA,NA,NA
CHOYP_BRAFLDRAFT_268308.1.1.m.17043,0.00394536801625317,0.00291369700370642,No,NA,NA,P00378,NA,NA,NA,mitochondrion [GO:0005739]; dihydrofolate reductase activity [GO:0004146]; drug binding [GO:0008144]; mRNA binding [GO:0003729]; NADP binding [GO:0050661]; dihydrofolate metabolic process [GO:0046452]; folic acid metabolic process [GO:0046655]; one-carbon metabolic process [GO:0006730]; response to methotrexate [GO:0031427]; tetrahydrofolate biosynthetic process [GO:0046654]; tetrahydrofolate metabolic process [GO:0046653],NA,NA,NA
CHOYP_BRAFLDRAFT_268354.1.1.m.57510,-0.0113466635541421,-0.0137622989870551,No,NA,NA,Q3ZBL4,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_BRAFLDRAFT_268591.1.1.m.59744,0.00150000443023443,0.000644546883077653,No,NA,NA,Q54728,NA,NA,NA,oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_BRAFLDRAFT_268929.1.1.m.35239,0.00823400320452652,0.0165151992810066,No,NA,NA,Q6GN02,NA,NA,NA,mitochondrion [GO:0005739]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_BRAFLDRAFT_268929.1.1.m.35240,-0.0029820024717188,0.0121276789877554,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_269194.1.1.m.53515,0.00430443588580268,-0.0152096027568294,No,NA,NA,Q2PZI1,NA,NA,NA,integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; mannosyltransferase activity [GO:0000030]; protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [GO:0018406],NA,NA,NA
CHOYP_BRAFLDRAFT_269209.1.1.m.4681,0.0214783181051415,0.014229789304558,No,NA,NA,Q9UM22,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160],NA,NA,NA
CHOYP_BRAFLDRAFT_270293.1.3.m.8709,-0.010681687213468,-0.0171935250484337,No,NA,NA,P02720,NA,NA,NA,cytoplasm [GO:0005737]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phospholipid transporter activity [GO:0005548]; phospholipid transport [GO:0015914],NA,NA,NA
CHOYP_BRAFLDRAFT_270300.1.1.m.59680,0.00304652782522345,-0.00137484401114168,No,NA,NA,Q99L13,NA,NA,NA,mitochondrion [GO:0005739]; 3-hydroxyisobutyrate dehydrogenase activity [GO:0008442]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxidoreductase activity; acting on the CH-OH group of donors; NAD or NADP as acceptor [GO:0016616]; valine catabolic process [GO:0006574],NA,NA,NA
CHOYP_BRAFLDRAFT_270517.1.1.m.27028,-0.0220127245535772,-0.00121172616974965,No,NA,NA,B0CM26,NA,NA,NA,cytoplasm [GO:0005737]; non-motile cilium [GO:0097730]; sperm midpiece [GO:0097225]; cell differentiation [GO:0030154]; olfactory behavior [GO:0042048]; positive regulation of fertilization [GO:1905516]; positive regulation of flagellated sperm motility [GO:1902093]; response to odorant [GO:1990834]; sensory perception of smell [GO:0007608]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_270672.1.1.m.25768,0.0107427251984103,-0.0160046734751868,No,NA,NA,Q9Y617,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; O-phospho-L-serine:2-oxoglutarate aminotransferase activity [GO:0004648]; L-serine biosynthetic process [GO:0006564]; pyridoxine biosynthetic process [GO:0008615],NA,NA,NA
CHOYP_BRAFLDRAFT_271463.1.1.m.62869,-0.0203075499780226,-0.00969787722168157,No,NA,NA,Q5JVL4,NA,NA,NA,axoneme [GO:0005930]; centrosome [GO:0005813]; mitotic spindle [GO:0072686]; neuronal cell body [GO:0043025]; spindle pole [GO:0000922]; alpha-tubulin binding [GO:0043014]; calcium ion binding [GO:0005509]; protein C-terminus binding [GO:0008022]; cerebral cortex cell migration [GO:0021795]; mitotic cytokinesis [GO:0000281]; mitotic spindle organization [GO:0007052]; regulation of cell division [GO:0051302],NA,NA,NA
CHOYP_BRAFLDRAFT_272416.1.1.m.56641,0.0149297145281181,0.000309396140481046,No,NA,NA,P43487,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; Ran GTPase binding [GO:0008536]; intracellular transport [GO:0046907]; positive regulation of mitotic centrosome separation [GO:0046604]; signal transduction [GO:0007165]; viral process [GO:0016032],NA,NA,NA
CHOYP_BRAFLDRAFT_273508.1.4.m.5528,0.0198353692033186,0.00547312992806164,No,NA,NA,Q9DFQ7,NA,NA,NA,ribosome [GO:0005840],NA,NA,NA
CHOYP_BRAFLDRAFT_273832.1.1.m.56325,0.00318714987301955,-0.0178766822896064,No,NA,NA,Q0MQI4,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; respirasome [GO:0070469]; 4 iron; 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137],NA,NA,NA
CHOYP_BRAFLDRAFT_274539.3.3.m.49552,-0.0152328047837562,-0.000931297500007083,No,NA,NA,Q86TN4,NA,NA,NA,tRNA 2'-phosphotransferase activity [GO:0000215]; regulation of protein kinase activity [GO:0045859]; tRNA splicing; via endonucleolytic cleavage and ligation [GO:0006388],NA,NA,NA
CHOYP_BRAFLDRAFT_274974.1.1.m.56783,0.011204693191559,-0.00566271335314529,No,NA,NA,Q6DED0,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; SRP-dependent cotranslational protein targeting to membrane; translocation [GO:0006616],NA,NA,NA
CHOYP_BRAFLDRAFT_275083.2.2.m.66604,-0.0205542180410432,0.00279273719226303,No,NA,NA,Q8AVY1,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_BRAFLDRAFT_275293.1.1.m.16192,-0.00953807932322406,-0.00484600731043541,No,NA,NA,A4QNM5,NA,NA,NA,cytosol [GO:0005829]; 4 iron; 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226],NA,NA,NA
CHOYP_BRAFLDRAFT_275517.1.1.m.9720,-0.00310664015908708,0.00965099143387724,No,NA,NA,Q2HJ56,NA,NA,NA,chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleus [GO:0005634]; H4K20me3 modified histone binding [GO:1990889]; histone H4-K20 trimethylation [GO:0034773]; negative regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033140]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_BRAFLDRAFT_275527.1.1.m.12579,0.0113976133328925,0.00616052806740316,No,NA,NA,Q7ZX96,NA,NA,NA,nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; structural constituent of nuclear pore [GO:0017056]; mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_275580.2.2.m.40924,-0.00663206790348121,0.021404168280613,No,NA,NA,Q8QZR1,NA,NA,NA,mitochondrion [GO:0005739]; amino acid binding [GO:0016597]; L-tyrosine:2-oxoglutarate aminotransferase activity [GO:0004838]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; cellular amino acid metabolic process [GO:0006520]; glutamate metabolic process [GO:0006536]; L-phenylalanine catabolic process [GO:0006559]; response to glucocorticoid [GO:0051384]; response to mercury ion [GO:0046689]; response to organic cyclic compound [GO:0014070]; response to oxidative stress [GO:0006979]; tyrosine catabolic process [GO:0006572],NA,NA,NA
CHOYP_BRAFLDRAFT_275667.1.1.m.17353,-0.0174540426029289,-0.00720769210171862,No,NA,NA,Q9P2H3,NA,NA,NA,centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; bone morphogenesis [GO:0060349]; chondrocyte differentiation [GO:0002062]; intraciliary transport involved in cilium assembly [GO:0035735]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; non-motile cilium assembly [GO:1905515]; osteoblast differentiation [GO:0001649]; positive regulation of smoothened signaling pathway [GO:0045880]; smoothened signaling pathway [GO:0007224],NA,NA,NA
CHOYP_BRAFLDRAFT_275724.1.1.m.54178,0.00345347107301996,-0.00631259305731623,No,NA,NA,Q93008,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; co-SMAD binding [GO:0070410]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; ubiquitinyl hydrolase activity [GO:0101005]; axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular protein metabolic process [GO:0044267]; chromosome segregation [GO:0007059]; female gamete generation [GO:0007292]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625]; regulation of circadian rhythm [GO:0042752]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_BRAFLDRAFT_275787.1.2.m.15360,0.0109429607774928,-0.0226203647184858,No,NA,NA,Q5E951,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_BRAFLDRAFT_275787.2.2.m.62313,-0.00885667366238081,0.0160541902211177,No,NA,NA,Q5E951,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_BRAFLDRAFT_275793.1.1.m.9519,0.00364778592941831,-0.00872052841558097,No,NA,NA,Q9H3N1,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; disulfide oxidoreductase activity [GO:0015036]; cell redox homeostasis [GO:0045454]; response to endoplasmic reticulum stress [GO:0034976],NA,NA,NA
CHOYP_BRAFLDRAFT_275870.1.1.m.12895,0.00231217963826552,-0.0232871425390855,No,NA,NA,P36993,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; magnesium ion binding [GO:0000287]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722]; N-terminal protein myristoylation [GO:0006499]; negative regulation of defense response to virus [GO:0050687]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; peptidyl-threonine dephosphorylation [GO:0035970]; protein dephosphorylation [GO:0006470],NA,NA,NA
CHOYP_BRAFLDRAFT_276131.1.1.m.46672,0.0149671512702407,-0.000107111207502798,No,NA,NA,O93327,NA,NA,NA,condensed chromosome [GO:0000793]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleosome [GO:0000786]; pericentric heterochromatin [GO:0005721]; DNA binding [GO:0003677]; double-stranded methylated DNA binding [GO:0010385]; nucleosomal DNA binding [GO:0031492]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; rDNA binding [GO:0000182]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; chromatin organization [GO:0006325]; dosage compensation [GO:0007549]; establishment of protein localization to chromatin [GO:0071169]; negative regulation of cell cycle G2/M phase transition [GO:1902750]; negative regulation of gene expression; epigenetic [GO:0045814]; negative regulation of histone H3-K27 methylation [GO:0061086]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of histone phosphorylation [GO:0033128]; negative regulation of protein localization to chromosome; telomeric region [GO:1904815]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; nucleosome assembly [GO:0006334]; positive regulation of gene expression; epigenetic [GO:0045815]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; regulation of lipid metabolic process [GO:0019216]; regulation of response to oxidative stress [GO:1902882],NA,NA,NA
CHOYP_BRAFLDRAFT_276226.1.2.m.21725,0.00844726709906811,0.0124284777771135,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_276226.2.2.m.64449,-0.0116038405986777,9.59942849853813e-05,No,NA,NA,Q5R806,NA,NA,NA,cytoplasm [GO:0005737]; 13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; prostaglandin metabolic process [GO:0006693],NA,NA,NA
CHOYP_BRAFLDRAFT_276229.1.1.m.37508,-0.00514239749106229,0.00684698360854669,No,NA,NA,Q5ZL12,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_276474.1.1.m.6793,-0.00620382254452204,-0.0158131670782838,No,NA,NA,A1L259,NA,NA,NA,peroxisome [GO:0005777]; 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase activity [GO:0051997]; carboxy-lyase activity [GO:0016831]; allantoin biosynthetic process [GO:0019428]; purine nucleobase metabolic process [GO:0006144]; urate catabolic process [GO:0019628],NA,NA,NA
CHOYP_BRAFLDRAFT_276592.1.1.m.8046,-0.00706155300098256,0.00264408644174269,No,NA,NA,Q8NI36,NA,NA,NA,nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; regulation of axon extension [GO:0030516]; response to stimulus [GO:0050896]; retina homeostasis [GO:0001895]; rRNA processing [GO:0006364]; visual perception [GO:0007601],NA,NA,NA
CHOYP_BRAFLDRAFT_276662.1.1.m.52846,-0.00383905496604455,-0.00995633620048434,No,NA,NA,P60522,NA,NA,NA,autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_276868.1.1.m.27780,-0.00320345225628846,0.00806851365598337,No,NA,NA,Q3U487,NA,NA,NA,perinuclear region of cytoplasm [GO:0048471]; syntaxin binding [GO:0019905]; ubiquitin-protein transferase activity [GO:0004842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_BRAFLDRAFT_276908.1.1.m.28793,-0.00519818213253892,-0.0113639517123365,No,NA,NA,O54774,NA,NA,NA,AP-3 adaptor complex [GO:0030123]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; presynaptic endosome [GO:0098830]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation [GO:0019882]; antigen processing and presentation; exogenous lipid antigen via MHC class Ib [GO:0048007]; endosome to melanosome transport [GO:0035646]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; neurotransmitter receptor transport; postsynaptic endosome to lysosome [GO:0098943]; positive regulation of NK T cell differentiation [GO:0051138]; protein localization to membrane [GO:0072657]; protein localization to organelle [GO:0033365]; protein targeting to vacuole [GO:0006623]; regulation of sequestering of zinc ion [GO:0061088]; synaptic vesicle budding from endosome [GO:0016182]; synaptic vesicle membrane organization [GO:0048499]; vesicle-mediated transport [GO:0016192]; vesicle-mediated transport in synapse [GO:0099003]; zinc ion transport [GO:0006829],NA,NA,NA
CHOYP_BRAFLDRAFT_277055.1.2.m.3095,-0.00105232377316944,-0.0145181245814827,No,NA,NA,Q32LQ6,NA,NA,NA,integral component of membrane [GO:0016021]; transmembrane transport [GO:0055085],NA,NA,NA
CHOYP_BRAFLDRAFT_277055.2.2.m.18714,-0.00476205766407907,-0.0112342625238734,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_277091.1.3.m.1103,-0.00729533782858361,0.00427834564012962,No,NA,NA,P02434,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]; translation [GO:0006412],NA,NA,NA
CHOYP_BRAFLDRAFT_277269.1.1.m.51636,0.00433164248309364,-0.0121232390603943,No,NA,NA,A6H611,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptide metabolic process [GO:0006518]; protein processing involved in protein targeting to mitochondrion [GO:0006627]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_BRAFLDRAFT_277494.2.3.m.57496,-0.00664982938533236,0.012737769842073,No,NA,NA,O43432,NA,NA,NA,cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; translation factor activity; RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; regulation of translational initiation [GO:0006446],NA,NA,NA
CHOYP_BRAFLDRAFT_277494.3.3.m.62602,0.0115547986393341,-0.00748353221442599,No,NA,NA,Q80XI3,NA,NA,NA,eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA binding [GO:0003729]; RNA cap binding [GO:0000339]; translation initiation factor activity [GO:0003743]; positive regulation of meiosis I [GO:0060903]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of translation [GO:0045727]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_277528.1.1.m.10120,-0.0199619201296498,0.00241211881709846,No,NA,NA,Q9H0C1,NA,NA,NA,intracellular [GO:0005622]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_BRAFLDRAFT_277744.1.2.m.5416,-0.00213229599987742,0.00127364101934272,No,NA,NA,P98073,NA,NA,NA,brush border [GO:0005903]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252],NA,NA,NA
CHOYP_BRAFLDRAFT_277775.1.1.m.12736,0.00370894989513866,-0.00932194091858503,No,NA,NA,P07953,NA,NA,NA,6-phosphofructo-2-kinase/fructose-2;6-biphosphatase complex [GO:0043540]; cytosol [GO:0005829]; 6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2;6-bisphosphate 2-phosphatase activity [GO:0004331]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; animal organ regeneration [GO:0031100]; carbohydrate phosphorylation [GO:0046835]; fructose 2;6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]; positive regulation of glucokinase activity [GO:0033133]; response to cAMP [GO:0051591]; response to glucagon [GO:0033762]; response to glucocorticoid [GO:0051384]; response to insulin [GO:0032868]; response to starvation [GO:0042594],NA,NA,NA
CHOYP_BRAFLDRAFT_277775.1.1.m.12737,-0.00290862569252368,0.00773780240800238,No,NA,NA,Q567B1,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin-specific protease activity involved in negative regulation of retrograde protein transport; ER to cytosol [GO:1904265]; endoplasmic reticulum unfolded protein response [GO:0030968]; macroautophagy [GO:0016236]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K27-linked deubiquitination [GO:1990167]; protein K29-linked deubiquitination [GO:0035523]; protein K33-linked deubiquitination [GO:1990168]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_BRAFLDRAFT_277797.1.1.m.26394,-0.00119845495424538,0.00491020988585954,No,NA,NA,O75884,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; hydrolase activity [GO:0016787]; regulation of cell proliferation [GO:0042127],NA,NA,NA
CHOYP_BRAFLDRAFT_277920.1.1.m.28845,0.00107437280033392,-0.00353058256105027,No,NA,NA,Q5E9N0,NA,NA,NA,apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome; small subunit precursor [GO:0030688]; snoRNA binding [GO:0030515]; cell proliferation [GO:0008283]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462]; rRNA processing [GO:0006364]; trophectodermal cell differentiation [GO:0001829],NA,NA,NA
CHOYP_BRAFLDRAFT_278091.1.1.m.7340,-0.0141708863053084,-0.00644716387201555,No,NA,NA,O15067,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylformylglycinamidine synthase activity [GO:0004642]; 'de novo' IMP biosynthetic process [GO:0006189]; anterior head development [GO:0097065]; glutamine metabolic process [GO:0006541]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; response to drug [GO:0042493],NA,NA,NA
CHOYP_BRAFLDRAFT_278625.1.2.m.53120,0.00620377674046704,-0.0155870379543096,No,NA,NA,Q9H3P7,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitochondrion [GO:0005739]; fatty-acyl-CoA binding [GO:0000062]; protein kinase A regulatory subunit binding [GO:0034237]; steroid biosynthetic process [GO:0006694],NA,NA,NA
CHOYP_BRAFLDRAFT_278777.1.1.m.1970,0.0065883263884642,0.0180931628217626,No,NA,NA,Q04281,NA,NA,NA,nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_BRAFLDRAFT_278832.1.1.m.13624,0.00362046721306768,0.0189611461662763,No,NA,NA,P07872,NA,NA,NA,peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; palmitoyl-CoA oxidase activity [GO:0016401]; protein homodimerization activity [GO:0042803]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid oxidation [GO:0019395]; generation of precursor metabolites and energy [GO:0006091]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; prostaglandin metabolic process [GO:0006693]; very long-chain fatty acid metabolic process [GO:0000038],NA,NA,NA
CHOYP_BRAFLDRAFT_278918.1.5.m.13792,0.00249414608871906,-0.00966035250866594,No,NA,NA,Q9FLK4,NA,NA,NA,flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N;N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661],NA,NA,NA
CHOYP_BRAFLDRAFT_278918.2.5.m.16457,-0.00496606821950681,-0.0121719404994452,No,NA,NA,Q9FWW9,NA,NA,NA,flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N;N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; defense response to fungus [GO:0050832],NA,NA,NA
CHOYP_BRAFLDRAFT_278918.3.5.m.38481,-0.0030946100542194,-0.0146236647259598,No,NA,NA,Q9FLK4,NA,NA,NA,flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N;N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661],NA,NA,NA
CHOYP_BRAFLDRAFT_278918.4.5.m.39356,0.00792235119851988,-0.00614377275146847,No,NA,NA,Q8MP06,NA,NA,NA,extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; N;N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; senecionine N-oxygenase activity [GO:0033784]; alkaloid metabolic process [GO:0009820]; oxidation-reduction process [GO:0055114]; protein homotetramerization [GO:0051289],NA,NA,NA
CHOYP_BRAFLDRAFT_278918.5.5.m.48881,-0.0235115862293084,0.00256967577734756,No,NA,NA,Q9C8U0,NA,NA,NA,flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N;N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661],NA,NA,NA
CHOYP_BRAFLDRAFT_278938.1.1.m.38684,-0.00551269200625062,0.004641824910217,No,NA,NA,Q5R605,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; early endosome [GO:0005769]; ESCRT III complex [GO:0000815]; microtubule organizing center [GO:0005815]; nuclear matrix [GO:0016363]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; gene silencing [GO:0016458]; midbody abscission [GO:0061952]; mitotic chromosome condensation [GO:0007076]; mitotic metaphase plate congression [GO:0007080]; negative regulation of cell cycle [GO:0045786]; negative regulation of transcription; DNA-templated [GO:0045892]; nucleus organization [GO:0006997]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; vacuolar transport [GO:0007034]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_279143.1.1.m.50630,0.0032553031991679,-0.0143241724476414,No,NA,NA,Q5PQR5,NA,NA,NA,fibrillar center [GO:0001650]; Mpp10 complex [GO:0034457]; nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; rRNA primary transcript binding [GO:0042134]; snoRNA binding [GO:0030515]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_BRAFLDRAFT_279226.1.1.m.24471,-0.00675274731645721,-0.00571234672993776,No,NA,NA,Q91642,NA,NA,NA,cytoplasm [GO:0005737]; dipeptidase activity [GO:0016805]; serine-type peptidase activity [GO:0008236],NA,NA,NA
CHOYP_BRAFLDRAFT_279360.1.1.m.11115,0.0131040926730285,-0.0203195254816001,No,NA,NA,O35345,NA,NA,NA,cytosol [GO:0005829]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein transporter activity [GO:0008565]; maternal process involved in female pregnancy [GO:0060135]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein import into nucleus [GO:0006606],NA,NA,NA
CHOYP_BRAFLDRAFT_279625.1.1.m.51890,0.021344283640201,-0.00955681119393043,No,NA,NA,P41636,NA,NA,NA,4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]; phenylpropanoid metabolic process [GO:0009698],NA,NA,NA
CHOYP_BRAFLDRAFT_279668.1.1.m.21404,0.00441829318336971,-0.00481713708314483,No,NA,NA,Q9CQP2,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; TRAPP complex [GO:0030008]; ion channel binding [GO:0044325]; transcription factor binding [GO:0008134]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; regulation of transcription; DNA-templated [GO:0006355]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_BRAFLDRAFT_279789.3.3.m.48128,0.0179678986265289,-0.0085468002978804,No,NA,NA,Q26481,NA,NA,NA,nucleus [GO:0005634]; ribosome [GO:0005840]; 5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_BRAFLDRAFT_279923.1.1.m.65663,-0.00171409184251955,-0.0160393874012982,No,NA,NA,P84169,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle; lid subcomplex [GO:0008541]; structural molecule activity [GO:0005198]; meiosis I [GO:0007127]; proteasome assembly [GO:0043248]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_BRAFLDRAFT_279937.1.1.m.49979,0.0191850870610188,-0.00962126308187854,No,NA,NA,Q9QXN5,NA,NA,NA,cytoplasm [GO:0005737]; inclusion body [GO:0016234]; aldo-keto reductase (NADP) activity [GO:0004033]; ferric iron binding [GO:0008199]; inositol oxygenase activity [GO:0050113]; NADP binding [GO:0050661]; oxidoreductase activity [GO:0016491]; oxidoreductase activity; acting on NAD(P)H [GO:0016651]; oxidoreductase activity; acting on single donors with incorporation of molecular oxygen [GO:0016701]; inositol catabolic process [GO:0019310],NA,NA,NA
CHOYP_BRAFLDRAFT_279949.1.1.m.54415,-0.0225685127993663,0.00999544261826621,No,NA,NA,Q9NXB0,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; MKS complex [GO:0036038]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac septum morphogenesis [GO:0060411]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; common bile duct development [GO:0061009]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal system development [GO:0048706]; epithelial structure maintenance [GO:0010669]; head development [GO:0060322]; inner ear receptor cell stereocilium organization [GO:0060122]; motile cilium assembly [GO:0044458]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901620]; regulation of Wnt signaling pathway; planar cell polarity pathway [GO:2000095]; smoothened signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003271],NA,NA,NA
CHOYP_BRAFLDRAFT_279978.1.1.m.30960,-0.0201905307958733,-0.00781742957698686,No,NA,NA,Q9D3W1,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_280249.1.1.m.26508,-0.0135499934988576,0.0134457624785083,No,NA,NA,Q5PPV3,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_280343.1.1.m.41317,-0.00881257524221799,-0.00823267861746857,No,NA,NA,Q9CQC8,NA,NA,NA,cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network transport vesicle [GO:0030140]; CD4 receptor binding [GO:0042609],NA,NA,NA
CHOYP_BRAFLDRAFT_280861.1.2.m.5389,-0.0103658531600115,-0.00340408000233026,No,NA,NA,P12815,NA,NA,NA,COPII vesicle coat [GO:0030127]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; molecular adaptor activity [GO:0060090]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; protein membrane anchor [GO:0043495]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cellular response to heat [GO:0034605]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of protein monoubiquitination [GO:1902527]; response to calcium ion [GO:0051592]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324],NA,NA,NA
CHOYP_BRAFLDRAFT_281070.1.1.m.1319,0.0055196786617617,0.0221873895292798,No,NA,NA,Q9Y2Q3,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular [GO:0005622]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; protein disulfide oxidoreductase activity [GO:0015035]; signaling receptor binding [GO:0005102]; epithelial cell differentiation [GO:0030855]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; protein targeting to peroxisome [GO:0006625],NA,NA,NA
CHOYP_BRAFLDRAFT_281217.1.1.m.15677,0.00288835963421068,-0.0201625375515593,No,NA,NA,P40112,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex; beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_BRAFLDRAFT_281480.1.1.m.22697,-0.0210209829450048,-0.0083137073294282,No,NA,NA,Q8IXY8,NA,NA,NA,cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; unfolded protein binding [GO:0051082]; protein refolding [GO:0042026],NA,NA,NA
CHOYP_BRAFLDRAFT_281490.1.1.m.53995,0.00954879357555064,-0.00489077360736011,No,NA,NA,Q8NFH3,NA,NA,NA,condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear pore outer ring [GO:0031080]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mRNA export from nucleus [GO:0006406]; viral process [GO:0016032],NA,NA,NA
CHOYP_BRAFLDRAFT_281651.2.8.m.5909,-0.00232176979267734,0.00299734962923406,No,NA,NA,Q6RY07,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; apoptotic process [GO:0006915]; chitin catabolic process [GO:0006032]; immune system process [GO:0002376]; polysaccharide catabolic process [GO:0000272]; positive regulation of chemokine secretion [GO:0090197]; production of molecular mediator involved in inflammatory response [GO:0002532],NA,NA,NA
CHOYP_BRAFLDRAFT_281651.5.8.m.25278,-0.0224537241563537,0.000472970230614925,No,NA,NA,Q6RY07,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; apoptotic process [GO:0006915]; chitin catabolic process [GO:0006032]; immune system process [GO:0002376]; polysaccharide catabolic process [GO:0000272]; positive regulation of chemokine secretion [GO:0090197]; production of molecular mediator involved in inflammatory response [GO:0002532],NA,NA,NA
CHOYP_BRAFLDRAFT_281658.1.1.m.6266,-0.0119483498860657,-0.0120168433883309,No,NA,NA,O93257,NA,NA,NA,Ku70:Ku80 complex [GO:0043564]; nonhomologous end joining complex [GO:0070419]; nuclear chromosome; telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; 5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; ATP binding [GO:0005524]; ATP-dependent DNA helicase activity [GO:0004003]; damaged DNA binding [GO:0003684]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; cellular response to gamma radiation [GO:0071480]; cellular response to X-ray [GO:0071481]; DNA recombination [GO:0006310]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of transcription; DNA-templated [GO:0045892]; telomere maintenance [GO:0000723],NA,NA,NA
CHOYP_BRAFLDRAFT_281754.1.1.m.27604,-0.00471467543891475,-0.00692489300608976,No,NA,NA,Q92506,NA,NA,NA,mitochondrial envelope [GO:0005740]; mitochondrial matrix [GO:0005759]; plasma membrane [GO:0005886]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity [GO:0047025]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; NADH binding [GO:0070404]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; androgen metabolic process [GO:0008209]; estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633]; oxidation-reduction process [GO:0055114]; protein heterotetramerization [GO:0051290],NA,NA,NA
CHOYP_BRAFLDRAFT_282065.1.2.m.590,0.00441569579490346,-0.0048333325063644,No,NA,NA,Q6PBY7,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_282105.1.2.m.43460,-0.00257495912164484,0.00305617006010037,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_282135.1.1.m.55919,-0.0106953413145688,-0.00356522353484983,No,NA,NA,Q9HAB8,NA,NA,NA,cytosol [GO:0005829]; phosphopantothenate--cysteine ligase activity [GO:0004632]; coenzyme A biosynthetic process [GO:0015937]; coenzyme biosynthetic process [GO:0009108],NA,NA,NA
CHOYP_BRAFLDRAFT_282200.1.1.m.18115,-0.00699550597819004,0.0139803451898727,No,NA,NA,P79101,NA,NA,NA,mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; 5'-3' exonuclease activity [GO:0008409]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; snoRNA 3'-end processing [GO:0031126]; snoRNA splicing [GO:0034247]; termination of RNA polymerase II transcription [GO:0006369],NA,NA,NA
CHOYP_BRAFLDRAFT_282752.2.2.m.17526,0.00491588973115351,-0.000600714720400964,No,NA,NA,Q8VDT1,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412],NA,NA,NA
CHOYP_BRAFLDRAFT_283093.1.1.m.15039,-0.0141268482721193,-0.0201531007970185,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_283789.1.1.m.40987,-0.0125676581937104,0.00100857377051833,No,NA,NA,E2RQ08,NA,NA,NA,cytosol [GO:0005829]; integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]; rough endoplasmic reticulum [GO:0005791]; dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; protein N-linked glycosylation via asparagine [GO:0018279],NA,NA,NA
CHOYP_BRAFLDRAFT_284130.1.1.m.27065,-0.00569943833532749,-0.00113241840501477,No,NA,NA,P90893,NA,NA,NA,membrane raft [GO:0045121]; dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236]; innate immune response [GO:0045087]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_BRAFLDRAFT_284242.1.1.m.13711,-0.00767050307584814,0.00607777014098201,No,NA,NA,Q9D4P0,NA,NA,NA,cytoplasm [GO:0005737]; trans-Golgi network [GO:0005802]; GTP binding [GO:0005525]; intracellular protein transport [GO:0006886]; protein localization to Golgi membrane [GO:1903292]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_284412.1.1.m.37396,-0.0169591047060434,0.00960206869202777,No,NA,NA,Q05932,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; tetrahydrofolylpolyglutamate synthase activity [GO:0004326]; animal organ regeneration [GO:0031100]; brain development [GO:0007420]; cell proliferation [GO:0008283]; folic acid metabolic process [GO:0046655]; folic acid-containing compound metabolic process [GO:0006760]; glutamate metabolic process [GO:0006536]; liver development [GO:0001889]; nucleobase-containing compound metabolic process [GO:0006139]; one-carbon metabolic process [GO:0006730]; tetrahydrofolylpolyglutamate biosynthetic process [GO:0046901],NA,NA,NA
CHOYP_BRAFLDRAFT_284508.1.1.m.4587,-0.0123302321301046,-0.0074232498725728,No,NA,NA,Q9NR33,NA,NA,NA,Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; epsilon DNA polymerase complex [GO:0008622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; protein heterodimerization activity [GO:0046982]; G1/S transition of mitotic cell cycle [GO:0000082]; histone H3 acetylation [GO:0043966],NA,NA,NA
CHOYP_BRAFLDRAFT_284587.1.3.m.284,-0.000503279631096893,-0.00117236566980367,No,NA,NA,Q5EA79,NA,NA,NA,cytoplasm [GO:0005737]; aldose 1-epimerase activity [GO:0004034]; carbohydrate binding [GO:0030246]; galactose catabolic process via UDP-galactose [GO:0033499]; glucose metabolic process [GO:0006006],NA,NA,NA
CHOYP_BRAFLDRAFT_284587.2.3.m.15867,-0.00299828412198533,-0.0129788035351978,No,NA,NA,Q5EA79,NA,NA,NA,cytoplasm [GO:0005737]; aldose 1-epimerase activity [GO:0004034]; carbohydrate binding [GO:0030246]; galactose catabolic process via UDP-galactose [GO:0033499]; glucose metabolic process [GO:0006006],NA,NA,NA
CHOYP_BRAFLDRAFT_284587.3.3.m.26954,0.0127401955342158,0.0163915839624457,No,NA,NA,Q5EA79,NA,NA,NA,cytoplasm [GO:0005737]; aldose 1-epimerase activity [GO:0004034]; carbohydrate binding [GO:0030246]; galactose catabolic process via UDP-galactose [GO:0033499]; glucose metabolic process [GO:0006006],NA,NA,NA
CHOYP_BRAFLDRAFT_284774.2.3.m.15260,-0.00250184341987944,0.013877775592874,No,NA,NA,P80895,NA,NA,NA,cytoplasm [GO:0005737]; protein-L-isoaspartate (D-aspartate) O-methyltransferase activity [GO:0004719],NA,NA,NA
CHOYP_BRAFLDRAFT_284784.1.1.m.12397,0.00217997094733793,-0.00807271368859912,No,NA,NA,Q6P632,NA,NA,NA,cytoplasm [GO:0005737]; NatB complex [GO:0031416]; nucleus [GO:0005634]; peptide alpha-N-acetyltransferase activity [GO:0004596]; N-terminal peptidyl-methionine acetylation [GO:0017196],NA,NA,NA
CHOYP_BRAFLDRAFT_284846.2.2.m.60100,-0.00541524750175127,0.00218645141883333,No,NA,NA,Q8VHE0,NA,NA,NA,endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; Sec62/Sec63 complex [GO:0031207]; protein transporter activity [GO:0008565]; liver development [GO:0001889]; multicellular organism aging [GO:0010259]; nitrogen compound metabolic process [GO:0006807]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; posttranslational protein targeting to membrane; translocation [GO:0031204]; renal system development [GO:0072001]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614],NA,NA,NA
CHOYP_BRAFLDRAFT_284971.1.1.m.8607,-0.00565657902460873,0.00266279513264705,No,NA,NA,Q99J62,NA,NA,NA,Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; Elg1 RFC-like complex [GO:0031391]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA clamp loader activity [GO:0003689]; enzyme binding [GO:0019899]; single-stranded DNA-dependent ATPase activity [GO:0043142]; DNA-dependent DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264],NA,NA,NA
CHOYP_BRAFLDRAFT_284971.1.1.m.8608,-0.00619058155143903,-0.00804327838320574,No,NA,NA,P41900,NA,NA,NA,nucleus [GO:0005634]; transcription factor TFIIF complex [GO:0005674]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; TFIIF-class transcription factor complex binding [GO:0001096]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367],NA,NA,NA
CHOYP_BRAFLDRAFT_285193.1.1.m.63396,-0.00769949365514763,0.00538173908207964,No,NA,NA,Q9CWZ7,NA,NA,NA,mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; SNARE complex [GO:0031201]; synapse [GO:0045202]; vacuolar membrane [GO:0005774]; soluble NSF attachment protein activity [GO:0005483]; syntaxin binding [GO:0019905]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_285264.1.1.m.52913,-0.00989836388792328,-0.0150047580558833,No,NA,NA,O95861,NA,NA,NA,cytosol [GO:0005829]; 3'(2');5'-bisphosphate nucleotidase activity [GO:0008441]; metal ion binding [GO:0046872]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; nervous system development [GO:0007399]; nucleobase-containing compound metabolic process [GO:0006139]; phosphatidylinositol phosphorylation [GO:0046854],NA,NA,NA
CHOYP_BRAFLDRAFT_285738.1.1.m.21025,0.00691737156442115,0.0172622616572733,No,NA,NA,O95394,NA,NA,NA,cytosol [GO:0005829]; magnesium ion binding [GO:0000287]; phosphoacetylglucosamine mutase activity [GO:0004610]; phosphoglucomutase activity [GO:0004614]; carbohydrate metabolic process [GO:0005975]; glucosamine metabolic process [GO:0006041]; glucose 1-phosphate metabolic process [GO:0019255]; hemopoiesis [GO:0030097]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]; spermatogenesis [GO:0007283]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048],NA,NA,NA
CHOYP_BRAFLDRAFT_285971.1.1.m.18286,-0.000286200773619117,-0.0134150710334555,No,NA,NA,Q6GPV5,NA,NA,NA,metal ion binding [GO:0046872]; transferase activity [GO:0016740]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_BRAFLDRAFT_286243.1.1.m.11085,-0.00411467211655401,0.00557630411406948,No,NA,NA,Q9HD45,NA,NA,NA,integral component of membrane [GO:0016021]; membrane [GO:0016020]; protein localization to membrane [GO:0072657],NA,NA,NA
CHOYP_BRAFLDRAFT_287019.1.1.m.36911,-0.0187631076793601,-0.0147302041561762,No,NA,NA,Q4QQW8,NA,NA,NA,lysosomal lumen [GO:0043202]; hydrolase activity [GO:0016787]; lipid catabolic process [GO:0016042],NA,NA,NA
CHOYP_BRAFLDRAFT_287353.1.1.m.46293,0.0101064460803464,0.017186574170721,No,NA,NA,A6QR56,NA,NA,NA,oxidoreductase activity; acting on the aldehyde or oxo group of donors; NAD or NADP as acceptor [GO:0016620],NA,NA,NA
CHOYP_BRAFLDRAFT_287356.1.1.m.25008,-0.0169587233900979,-0.00418518896409985,No,NA,NA,Q7ZWY2,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_287444.3.5.m.17688,-0.00268287101953371,0.0134440464996599,No,NA,NA,Q6RVV4,NA,NA,NA,chloroplast inner membrane [GO:0009706]; calmodulin binding [GO:0005516]; oxidoreductase activity [GO:0016491]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_287716.1.1.m.51443,-0.0086815882837929,0.0088178705143232,No,NA,NA,P51464,NA,NA,NA,argininosuccinate lyase activity [GO:0004056]; arginine biosynthetic process via ornithine [GO:0042450]; urea cycle [GO:0000050],NA,NA,NA
CHOYP_BRAFLDRAFT_287844.1.1.m.63253,-0.0177783925007299,0.00500077250112458,No,NA,NA,Q6P2Y2,NA,NA,NA,cilium [GO:0005929],NA,NA,NA
CHOYP_BRAFLDRAFT_290492.1.1.m.21887,0.00678620130084428,0.00878741825264137,No,NA,NA,Q9BPW9,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; organelle membrane [GO:0031090]; alcohol dehydrogenase (NAD) activity [GO:0004022]; racemase and epimerase activity [GO:0016854]; retinol dehydrogenase activity [GO:0004745]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; 9-cis-retinoic acid biosynthetic process [GO:0042904]; androgen metabolic process [GO:0008209]; epithelial cell differentiation [GO:0030855]; progesterone metabolic process [GO:0042448]; retinol metabolic process [GO:0042572],NA,NA,NA
CHOYP_BRAFLDRAFT_291364.1.1.m.47990,-0.0225602649020954,0.00998077771884649,No,NA,NA,O18404,NA,NA,NA,cytosol [GO:0005829]; mitochondrial ribonuclease P complex [GO:0030678]; mitochondrion [GO:0005739]; 3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity [GO:0047015]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 7-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0047022]; acetoacetyl-CoA reductase activity [GO:0018454]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; steroid dehydrogenase activity [GO:0016229]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; testosterone dehydrogenase [NAD(P)] activity [GO:0030283]; acyl-CoA metabolic process [GO:0006637]; androgen metabolic process [GO:0008209]; ecdysone metabolic process [GO:0008205]; estrogen metabolic process [GO:0008210]; fatty acid metabolic process [GO:0006631]; mitochondrial tRNA processing [GO:0090646]; RNA phosphodiester bond hydrolysis; endonucleolytic [GO:0090502]; steroid metabolic process [GO:0008202],NA,NA,NA
CHOYP_BRAFLDRAFT_57028.1.1.m.55583,-0.0128589912251065,0.00258698988416687,No,NA,NA,Q9R1R2,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; postsynapse [GO:0098794]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_BRAFLDRAFT_57175.1.1.m.7616,0.00914143424094507,-0.00224614545493163,No,NA,NA,P60027,NA,NA,NA,core TFIIH complex portion of holo TFIIH complex [GO:0000438]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; ATPase activator activity [GO:0001671]; DNA-dependent ATPase activity [GO:0008094]; double-stranded DNA binding [GO:0003690]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; nucleotide-excision repair [GO:0006289]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_BRAFLDRAFT_57176.3.5.m.23440,-0.0065788042404319,-0.0124195053026562,No,NA,NA,O43805,NA,NA,NA,centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; ciliary basal body-plasma membrane docking [GO:0097711]; ciliary receptor clustering involved in smoothened signaling pathway [GO:0060830]; G2/M transition of mitotic cell cycle [GO:0000086]; intraciliary transport [GO:0042073]; regulation of G2/M transition of mitotic cell cycle [GO:0010389],NA,NA,NA
CHOYP_BRAFLDRAFT_57176.5.5.m.54727,-0.00873767350426291,0.0101915497909984,No,NA,NA,Q86UP9,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_BRAFLDRAFT_57258.1.3.m.43523,0.021190617193726,0.00163370563358783,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_57258.2.3.m.48328,0.0123333276503926,-0.00838295839611029,No,NA,NA,Q53FA7,NA,NA,NA,cytosol [GO:0005829]; NADPH binding [GO:0070402]; NADPH:quinone reductase activity [GO:0003960]; protein homodimerization activity [GO:0042803]; quinone binding [GO:0048038]; NADP metabolic process [GO:0006739]; regulation of apoptotic process [GO:0042981],NA,NA,NA
CHOYP_BRAFLDRAFT_57395.1.1.m.9938,0.00478932457379813,0.0100888658924737,No,NA,NA,O75521,NA,NA,NA,cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; dodecenoyl-CoA delta-isomerase activity [GO:0004165]; fatty-acyl-CoA binding [GO:0000062]; signaling receptor binding [GO:0005102]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid catabolic process [GO:0009062]; protein targeting to peroxisome [GO:0006625],NA,NA,NA
CHOYP_BRAFLDRAFT_57407.1.1.m.28838,-0.0141617828682846,-0.0176153091905248,No,NA,NA,O88741,NA,NA,NA,cytosol [GO:0005829]; integral component of mitochondrial outer membrane [GO:0031307]; mitochondrion [GO:0005739]; cellular response to vitamin D [GO:0071305]; mitochondrial fission [GO:0000266]; mitochondrial fusion [GO:0008053]; mitochondrion organization [GO:0007005]; protein targeting to mitochondrion [GO:0006626]; response to retinoic acid [GO:0032526],NA,NA,NA
CHOYP_BRAFLDRAFT_57459.1.1.m.61613,-0.0105682065698362,-0.00693503032263124,No,NA,NA,P10155,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; U2 snRNA binding [GO:0030620]; cilium assembly [GO:0060271]; immune system development [GO:0002520]; response to UV [GO:0009411]; smoothened signaling pathway [GO:0007224]; transcription by RNA polymerase III [GO:0006383],NA,NA,NA
CHOYP_BRAFLDRAFT_57552.1.1.m.8199,-0.00255872586845826,-0.0247811000395564,No,NA,NA,Q9R1C7,NA,NA,NA,cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; proline-rich region binding [GO:0070064]; RNA binding [GO:0003723]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; mRNA cis splicing; via spliceosome [GO:0045292]; mRNA splicing; via spliceosome [GO:0000398]; regulation of cell shape [GO:0008360]; regulation of cytokinesis [GO:0032465],NA,NA,NA
CHOYP_BRAFLDRAFT_57788.3.10.m.31620,-0.0138275821139068,0.0127942132741336,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_57788.6.10.m.45495,0.00491588973115351,-0.000600714720400961,No,NA,NA,O43301,NA,NA,NA,extracellular exosome [GO:0070062]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_57788.8.10.m.49717,0.00941402444134853,0.0203003364404381,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_58035.2.2.m.65814,0.00923201377014635,-0.000166543011037878,No,NA,NA,Q6DQX6,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrial respiratory chain complex I assembly [GO:0032981]; oxidation-reduction process [GO:0055114],NA,NA,NA
CHOYP_BRAFLDRAFT_58194.1.1.m.27050,0.0209564373707539,-0.00733501145176415,No,NA,NA,Q9Y600,NA,NA,NA,cytoplasm [GO:0005737]; aspartate 1-decarboxylase activity [GO:0004068]; pyridoxal phosphate binding [GO:0030170]; sulfinoalanine decarboxylase activity [GO:0004782]; L-cysteine catabolic process to hypotaurine [GO:0019449]; L-cysteine catabolic process to taurine [GO:0019452]; taurine biosynthetic process [GO:0042412],NA,NA,NA
CHOYP_BRAFLDRAFT_58684.1.1.m.13006,0.00932843292315094,-0.0253162557151543,No,NA,NA,Q13367,NA,NA,NA,AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; clathrin-coated vesicle membrane [GO:0030665]; COPI-coated vesicle [GO:0030137]; Golgi apparatus [GO:0005794]; transporter activity [GO:0005215]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; intracellular protein transport [GO:0006886]; post-Golgi vesicle-mediated transport [GO:0006892],NA,NA,NA
CHOYP_BRAFLDRAFT_59014.1.1.m.59709,-0.0207336701196939,-0.00692208150919108,No,NA,NA,Q99NB1,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; propionate biosynthetic process [GO:0019542],NA,NA,NA
CHOYP_BRAFLDRAFT_59154.3.3.m.53255,0.000787617151110711,-0.00290254091149953,No,NA,NA,P61025,NA,NA,NA,cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; SCF ubiquitin ligase complex [GO:0019005]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; histone binding [GO:0042393]; protein kinase binding [GO:0019901]; ubiquitin binding [GO:0043130]; cell division [GO:0051301]; cell proliferation [GO:0008283]; mitotic cell cycle phase transition [GO:0044772]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_BRAFLDRAFT_59647.1.1.m.25700,-0.00222839333042097,0.0167773909783217,No,NA,NA,Q4QRK0,NA,NA,NA,cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; protein initiator methionine removal [GO:0070084],NA,NA,NA
CHOYP_BRAFLDRAFT_59863.1.1.m.24545,-0.0110665767115995,0.00882676888937585,No,NA,NA,O70439,NA,NA,NA,azurophil granule [GO:0042582]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; immunological synapse [GO:0001772]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; tertiary granule [GO:0070820]; vesicle [GO:0031982]; chloride channel inhibitor activity [GO:0019869]; protein-containing complex binding [GO:0044877]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; intracellular protein transport [GO:0006886]; organelle assembly [GO:0070925]; organelle localization [GO:0051640]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; regulation of protein localization to plasma membrane [GO:1903076]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906],NA,NA,NA
CHOYP_BRAFLDRAFT_60200.1.3.m.22201,0.00205195042830452,-0.00934116934689426,No,NA,NA,Q3SX11,NA,NA,NA,nucleolus [GO:0005730]; preribosome; large subunit precursor [GO:0030687]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_BRAFLDRAFT_60200.1.3.m.22202,0.00659689288948995,0.00043685011797537,No,NA,NA,Q8NC51,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; regulation of apoptotic process [GO:0042981]; regulation of mRNA stability [GO:0043488],NA,NA,NA
CHOYP_BRAFLDRAFT_60200.2.3.m.33251,0.00603753831158724,-0.00709231320486191,No,NA,NA,Q63340,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein dephosphorylation [GO:0006470],NA,NA,NA
CHOYP_BRAFLDRAFT_60329.1.1.m.18239,0.0127086529281624,-0.00508889811594355,No,NA,NA,Q6GM65,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; synapse [GO:0045202]; cellular response to lipopolysaccharide [GO:0071222]; macroautophagy [GO:0016236]; negative regulation of protein K63-linked ubiquitination [GO:1900045]; positive regulation of dendrite extension [GO:1903861]; positive regulation of neuron migration [GO:2001224]; positive regulation of phospholipase A2 activity [GO:0032430]; positive regulation of synaptic vesicle recycling [GO:1903423]; prostaglandin metabolic process [GO:0006693]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162],NA,NA,NA
CHOYP_BRAFLDRAFT_60331.1.1.m.34512,-0.0181915465407235,-0.0149252357617849,No,NA,NA,Q8BS45,NA,NA,NA,centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; intraciliary transport particle B binding [GO:0120170]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; manchette assembly [GO:1905198]; photoreceptor cell differentiation [GO:0046530]; photoreceptor cell morphogenesis [GO:0008594]; protein localization to cilium [GO:0061512]; smoothened signaling pathway [GO:0007224]; spermatid development [GO:0007286],NA,NA,NA
CHOYP_BRAFLDRAFT_61250.5.14.m.37733,0.00182905686219694,0.0090236650052628,No,NA,NA,Q6NT55,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; organelle membrane [GO:0031090]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen [GO:0016705]; icosanoid metabolic process [GO:0006690],NA,NA,NA
CHOYP_BRAFLDRAFT_61250.8.14.m.44214,0.00189000871538993,0.00190798417530157,No,NA,NA,Q6NT55,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; organelle membrane [GO:0031090]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen [GO:0016705]; icosanoid metabolic process [GO:0006690],NA,NA,NA
CHOYP_BRAFLDRAFT_61507.1.1.m.52347,-0.00714452496267057,0.0133996435690843,No,NA,NA,Q9WTP7,NA,NA,NA,mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; nucleoside triphosphate adenylate kinase activity [GO:0046899]; ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; AMP phosphorylation [GO:0006756]; ATP metabolic process [GO:0046034]; dATP metabolic process [GO:0046060]; GTP metabolic process [GO:0046039]; ITP metabolic process [GO:0046041]; protein homooligomerization [GO:0051260]; UTP metabolic process [GO:0046051],NA,NA,NA
CHOYP_BRAFLDRAFT_61845.1.1.m.37831,-0.0178689001487466,0.0014576302397325,No,NA,NA,P56597,NA,NA,NA,sperm flagellum [GO:0036126]; nucleoside diphosphate kinase activity [GO:0004550]; cilium assembly [GO:0060271]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_BRAFLDRAFT_62156.1.1.m.47958,0.00947499625405077,-0.0127630974535609,No,NA,NA,Q10725,NA,NA,NA,lyase activity [GO:0016829],NA,NA,NA
CHOYP_BRAFLDRAFT_63199.1.5.m.9045,-0.00543910707725776,0.000216452584194162,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_63199.2.5.m.21288,0.00603843741389237,0.0142637229589657,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_63281.1.2.m.28725,-0.00326540409543414,0.0227866390101293,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_63397.6.8.m.48804,0.00511727814925347,-0.00074185850041891,No,NA,NA,Q9JHA8,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_BRAFLDRAFT_63459.2.3.m.27933,-0.0210776730417244,-0.00220159942347457,No,NA,NA,P49013,NA,NA,NA,extracellular space [GO:0005615]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_BRAFLDRAFT_63471.1.1.m.25619,-0.00162495351232679,0.0165956006931702,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_63652.1.1.m.8021,0.00429186029064947,-0.00797199423266994,No,NA,NA,Q4R9E0,NA,NA,NA,integral component of membrane [GO:0016021]; apoptotic process [GO:0006915]; cilium assembly [GO:0060271]; smoothened signaling pathway [GO:0007224],NA,NA,NA
CHOYP_BRAFLDRAFT_63676.1.1.m.37146,-0.00803435782298283,0.00624270655331438,No,NA,NA,Q6P3R8,NA,NA,NA,ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of striated muscle cell differentiation [GO:0051155],NA,NA,NA
CHOYP_BRAFLDRAFT_63907.1.1.m.14584,0.00719717672448983,-0.0221972266161996,No,NA,NA,Q9P2J5,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; lysosome [GO:0005764]; nuclear body [GO:0016604]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; GTPase activator activity [GO:0005096]; leucine-tRNA ligase activity [GO:0004823]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; glutaminyl-tRNA aminoacylation [GO:0006425]; leucyl-tRNA aminoacylation [GO:0006429]; negative regulation of autophagy [GO:0010507]; positive regulation of GTPase activity [GO:0043547]; positive regulation of TORC1 signaling [GO:1904263]; protein targeting to lysosome [GO:0006622]; regulation of cell size [GO:0008361]; tRNA aminoacylation for protein translation [GO:0006418],NA,NA,NA
CHOYP_BRAFLDRAFT_64071.9.35.m.13313,-0.00891753095171087,-0.000144709597305907,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_64737.1.1.m.40499,-0.0059032723102649,-0.00224625022489053,No,NA,NA,Q9C0B0,NA,NA,NA,cytoplasm [GO:0005737]; polysome [GO:0005844]; metal ion binding [GO:0046872]; mRNA CDS binding [GO:1990715]; polysome binding [GO:1905538]; RNA binding [GO:0003723]; cell morphogenesis involved in neuron differentiation [GO:0048667]; negative regulation of cytoplasmic translation [GO:2000766]; neuron migration [GO:0001764],NA,NA,NA
CHOYP_BRAFLDRAFT_64948.1.1.m.17321,-0.00722261601965975,-0.0216280201396429,No,NA,NA,B9EJR8,NA,NA,NA,cytoplasm [GO:0005737]; dynein intermediate chain binding [GO:0045505]; cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; outer dynein arm assembly [GO:0036158],NA,NA,NA
CHOYP_BRAFLDRAFT_64962.1.1.m.59737,-0.00383257031358825,0.00644045280453817,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_65137.1.1.m.64534,0.00217997094733793,-0.00807271368859912,No,NA,NA,A2AIW0,NA,NA,NA,centrosome [GO:0005813]; ciliary basal body [GO:0036064]; early endosome [GO:0005769]; endosome [GO:0005768]; midbody [GO:0030496]; recycling endosome [GO:0055037]; retromer complex [GO:0030904]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell projection organization [GO:0030030]; positive regulation of cilium assembly [GO:0045724]; positive regulation of protein localization to cilium [GO:1903566]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465]; retrograde transport; endosome to plasma membrane [GO:1990126],NA,NA,NA
CHOYP_BRAFLDRAFT_65518.1.1.m.29803,0.00766228220241324,-0.000186121524535602,No,NA,NA,Q6P3Z3,NA,NA,NA,DNA binding [GO:0003677]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803],NA,NA,NA
CHOYP_BRAFLDRAFT_65562.1.1.m.14267,0.00661935136746525,-0.00435375590220066,No,NA,NA,A4IIK1,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; inflammatory response [GO:0006954]; innate immune response [GO:0045087],NA,NA,NA
CHOYP_BRAFLDRAFT_65681.1.1.m.445,-0.0141992361116649,0.000640486829201642,No,NA,NA,Q9P0W8,NA,NA,NA,axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; photoreceptor cell maintenance [GO:0045494]; protein localization to photoreceptor connecting cilium [GO:1903621]; protein localization to photoreceptor outer segment [GO:1903546]; response to stimulus [GO:0050896]; visual perception [GO:0007601],NA,NA,NA
CHOYP_BRAFLDRAFT_65711.1.1.m.18159,0.0125065134400653,0.010304152418129,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_65861.1.1.m.24624,-0.00284664450569827,-0.0238510041528784,No,NA,NA,Q8NDI1,NA,NA,NA,cytosol [GO:0005829]; endosome [GO:0005768]; plasma membrane [GO:0005886]; endocytosis [GO:0006897]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_65994.1.1.m.40535,0.00394536801625317,0.00291369700370642,No,NA,NA,O00462,NA,NA,NA,azurophil granule membrane [GO:0035577]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; beta-mannosidase activity [GO:0004567]; mannose binding [GO:0005537]; cellular protein modification process [GO:0006464]; glycoprotein catabolic process [GO:0006516]; mannan catabolic process [GO:0046355]; neutrophil degranulation [GO:0043312]; oligosaccharide catabolic process [GO:0009313],NA,NA,NA
CHOYP_BRAFLDRAFT_66204.1.3.m.2589,0.00872360755289029,-0.0031809800016462,No,NA,NA,Q9Y6R7,NA,NA,NA,extracellular exosome [GO:0070062],NA,NA,NA
CHOYP_BRAFLDRAFT_66627.1.1.m.40620,0.0190398875757388,-0.0116891121802385,No,NA,NA,P49696,NA,NA,NA,cytoplasm [GO:0005737]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; valyl-tRNA aminoacylation [GO:0006438],NA,NA,NA
CHOYP_BRAFLDRAFT_66688.1.2.m.2447,0.00108715551507432,-0.00788348564944349,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_66688.2.2.m.10883,-0.0181080102342102,-0.000745807474216866,No,NA,NA,O43345,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_BRAFLDRAFT_66705.1.1.m.47148,-0.0224062676284148,0.0106168720647931,No,NA,NA,P31944,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; keratin filament [GO:0045095]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; endopeptidase activity [GO:0004175]; apoptotic process [GO:0006915]; cornification [GO:0070268]; epidermis development [GO:0008544]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; keratinization [GO:0031424],NA,NA,NA
CHOYP_BRAFLDRAFT_67226.1.1.m.38034,0.0157688008318118,0.00581080239524949,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_67258.9.18.m.34120,-0.0179704669393135,0.00473483725922233,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_67261.1.2.m.16694,0.0210457418256344,0.00010807190324552,No,NA,NA,P86179,NA,NA,NA,cell [GO:0005623]; cortical granule [GO:0060473]; cytoplasm [GO:0005737]; female germ cell nucleus [GO:0001674]; NLS-dependent protein nuclear import complex [GO:0042564]; galactose binding [GO:0005534]; melibiose binding [GO:1903777]; protein homodimerization activity [GO:0042803]; rhamnose binding [GO:0033296],NA,NA,NA
CHOYP_BRAFLDRAFT_67264.4.6.m.42082,-0.00031218694503855,-0.00256108790802506,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_67459.2.2.m.56116,-0.0105624397974112,0.0107853166911476,No,NA,NA,Q8BK67,NA,NA,NA,chromosome; centromeric core domain [GO:0034506]; early endosome membrane [GO:0031901]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; Rac GTPase binding [GO:0048365]; small GTPase binding [GO:0031267]; activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome passenger complex localization to kinetochore [GO:0072356]; establishment of protein localization [GO:0045184]; focal adhesion assembly [GO:0048041]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of GTPase activity [GO:0034260]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; regulation of cell migration [GO:0030334]; regulation of fibroblast migration [GO:0010762]; regulation of ruffle assembly [GO:1900027],NA,NA,NA
CHOYP_BRAFLDRAFT_67483.1.1.m.55096,0.0062407211076028,0.00306613977703392,No,NA,NA,Q9JJP6,NA,NA,NA,cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein domain specific binding [GO:0019904]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; WW domain binding [GO:0050699]; aging [GO:0007568]; cell proliferation [GO:0008283]; chromatin remodeling [GO:0006338]; cloacal septation [GO:0060197]; cranial skeletal system development [GO:1904888]; ectoderm and mesoderm interaction [GO:0007499]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; epidermal cell division [GO:0010481]; epithelial cell development [GO:0002064]; establishment of planar polarity [GO:0001736]; establishment of skin barrier [GO:0061436]; female genitalia morphogenesis [GO:0048807]; hair follicle morphogenesis [GO:0031069]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; keratinocyte differentiation [GO:0030216]; multicellular organism aging [GO:0010259]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of mesoderm development [GO:2000381]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron apoptotic process [GO:0051402]; Notch signaling pathway [GO:0007219]; odontogenesis of dentin-containing tooth [GO:0042475]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of somatic stem cell population maintenance [GO:1904674]; post-anal tail morphogenesis [GO:0036342]; prostatic bud formation [GO:0060513]; protein homotetramerization [GO:0051289]; proximal/distal pattern formation [GO:0009954]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; regulation of epidermal cell division [GO:0010482]; replicative cell aging [GO:0001302]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; spermatogenesis [GO:0007283]; squamous basal epithelial stem cell differentiation involved in prostate gland acinus development [GO:0060529]; sympathetic nervous system development [GO:0048485],NA,NA,NA
CHOYP_BRAFLDRAFT_67520.1.2.m.16093,0.00559646229054686,0.00782127973216074,No,NA,NA,Q6DFV8,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_BRAFLDRAFT_67520.2.2.m.34594,-0.00648694071958245,-0.0230553417716465,No,NA,NA,Q8N2E2,NA,NA,NA,cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856],NA,NA,NA
CHOYP_BRAFLDRAFT_67662.1.1.m.3006,-0.0113131272786393,0.00188982348417294,No,NA,NA,O81884,NA,NA,NA,cytosol [GO:0005829]; L-galactose dehydrogenase activity [GO:0010349]; oxidoreductase activity [GO:0016491]; galactose metabolic process [GO:0006012]; L-ascorbic acid biosynthetic process [GO:0019853],NA,NA,NA
CHOYP_BRAFLDRAFT_67696.3.3.m.54584,-0.0135725579708753,0.00388604629968508,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_67741.2.2.m.37743,0.00394536801625317,0.00291369700370642,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_67911.1.1.m.4174,-0.00212078832001384,-0.00891837260408135,No,NA,NA,Q8L970,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 4-dioxygenase activity [GO:0004656]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401],NA,NA,NA
CHOYP_BRAFLDRAFT_67999.1.1.m.44535,0.00982427975152047,0.0189652900271792,No,NA,NA,Q92485,NA,NA,NA,anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; hydrolase activity; acting on glycosyl bonds [GO:0016798]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685],NA,NA,NA
CHOYP_BRAFLDRAFT_68004.1.1.m.24323,0.0113500583112014,-0.00774795773665035,No,NA,NA,O93610,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; DNA repair [GO:0006281]; DNA replication [GO:0006260],NA,NA,NA
CHOYP_BRAFLDRAFT_68242.2.3.m.26345,0.00745518544695124,-0.0144934646196581,No,NA,NA,Q96RW7,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],NA,NA,NA
CHOYP_BRAFLDRAFT_68488.1.1.m.58466,-0.0166878282372014,0.0124040166409681,No,NA,NA,Q32L27,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; protein K48-linked ubiquitination [GO:0070936],NA,NA,NA
CHOYP_BRAFLDRAFT_68592.1.1.m.53611,0.00945241230918596,0.0044879211313143,No,NA,NA,O13016,NA,NA,NA,early endosome [GO:0005769]; endoplasmic reticulum membrane [GO:0005789]; protein tyrosine phosphatase activity [GO:0004725]; actin cytoskeleton reorganization [GO:0031532]; endoplasmic reticulum unfolded protein response [GO:0030968]; peptidyl-tyrosine dephosphorylation [GO:0035335]; regulation of endocytosis [GO:0030100]; regulation of signal transduction [GO:0009966],NA,NA,NA
CHOYP_BRAFLDRAFT_68766.4.4.m.38248,0.00491588973115351,-0.000600714720400962,No,NA,NA,A0A0R4IBK5,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_BRAFLDRAFT_68867.1.1.m.4095,0.00511649919483421,-0.000744796036562933,No,NA,NA,O14975,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of peroxisomal membrane [GO:0005779]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; enzyme binding [GO:0019899]; fatty acid transmembrane transporter activity [GO:0015245]; long-chain fatty acid transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; phytanate-CoA ligase activity [GO:0050197]; pristanate-CoA ligase activity [GO:0070251]; signaling receptor binding [GO:0005102]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; bile acid biosynthetic process [GO:0006699]; fatty acid alpha-oxidation [GO:0001561]; fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid import [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; methyl-branched fatty acid metabolic process [GO:0097089]; neutrophil degranulation [GO:0043312]; protein targeting to peroxisome [GO:0006625]; very long-chain fatty acid catabolic process [GO:0042760],NA,NA,NA
CHOYP_BRAFLDRAFT_68915.2.7.m.3908,0.00946594106196723,0.0165790756485585,No,NA,NA,O08762,NA,NA,NA,axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195]; peptidase activity [GO:0008233]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; exocytosis [GO:0006887]; proteolysis [GO:0006508]; zymogen activation [GO:0031638],NA,NA,NA
CHOYP_BRAFLDRAFT_68917.1.3.m.16606,0.0186717267769278,-0.00587946612331929,No,NA,NA,Q9UGM3,NA,NA,NA,cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; heparan sulfate binding [GO:1904399]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; signaling pattern recognition receptor activity [GO:0008329]; zymogen binding [GO:0035375]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular protein metabolic process [GO:0044267]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; viral process [GO:0016032],NA,NA,NA
CHOYP_BRAFLDRAFT_68917.2.3.m.28554,-0.0169591047060434,0.00960206869202778,No,NA,NA,A1L4H1,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; intracellular [GO:0005622]; extracellular matrix binding [GO:0050840]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; scavenger receptor activity [GO:0005044]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; detection of bacterial lipoprotein [GO:0042494]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; negative regulation of interleukin-8 secretion [GO:2000483],NA,NA,NA
CHOYP_BRAFLDRAFT_68934.1.2.m.57609,-0.0154772210217064,0.00789964059966397,No,NA,NA,Q5XI68,NA,NA,NA,Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; negative cofactor 2 complex [GO:0017054]; core promoter binding [GO:0001047]; protein heterodimerization activity [GO:0046982]; TBP-class protein binding [GO:0017025]; transcription corepressor activity [GO:0003714]; chromatin remodeling [GO:0006338]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0045898]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_BRAFLDRAFT_68997.1.1.m.56357,-0.0112259727390881,-0.00853782628581387,No,NA,NA,P39429,NA,NA,NA,CD40 receptor complex [GO:0035631]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; IRE1-TRAF2-ASK1 complex [GO:1990604]; membrane raft [GO:0045121]; protein-containing complex [GO:0032991]; TRAF2-GSTP1 complex [GO:0097057]; ubiquitin ligase complex [GO:0000151]; vesicle membrane [GO:0012506]; CD40 receptor binding [GO:0005174]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein-containing complex binding [GO:0044877]; sphingolipid binding [GO:0046625]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; cellular protein-containing complex assembly [GO:0034622]; cellular response to nitric oxide [GO:0071732]; negative regulation of apoptotic process [GO:0043066]; negative regulation of glial cell apoptotic process [GO:0034351]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; programmed necrotic cell death [GO:0097300]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein heterooligomerization [GO:0051291]; protein homotrimerization [GO:0070207]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of immunoglobulin secretion [GO:0051023]; regulation of JNK cascade [GO:0046328]; signal transduction [GO:0007165]; tumor necrosis factor-mediated signaling pathway [GO:0033209],NA,NA,NA
CHOYP_BRAFLDRAFT_69005.1.1.m.26462,0.012877300386759,0.0151891395118933,No,NA,NA,Q2HJH1,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; metalloaminopeptidase activity [GO:0070006]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_BRAFLDRAFT_69120.3.3.m.40386,0.0132497040940863,0.0220324442899824,No,NA,NA,G8HTB6,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_BRAFLDRAFT_69134.2.13.m.10914,0.0038003782642444,0.012396059999294,No,NA,NA,Q86Z23,NA,NA,NA,collagen trimer [GO:0005581]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147],NA,NA,NA
CHOYP_BRAFLDRAFT_69505.3.4.m.52485,-0.0156526521384249,-0.0180140144034277,No,NA,NA,Q0E908,NA,NA,NA,cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_BRAFLDRAFT_69729.1.1.m.683,-0.00631489467210351,0.00329015808365768,No,NA,NA,B2ZZS9,NA,NA,NA,nucleolus [GO:0005730]; eye development [GO:0001654]; head development [GO:0060322]; liver development [GO:0001889]; pharynx development [GO:0060465]; rRNA processing [GO:0006364]; spleen development [GO:0048536]; thymus development [GO:0048538],NA,NA,NA
CHOYP_BRAFLDRAFT_69798.11.22.m.42042,-0.0175731554402101,0.00313829805491503,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_70742.1.1.m.8525,-0.0169591047060434,0.00960206869202777,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_70868.1.1.m.55081,0.00412752759771812,0.00297652966308538,No,NA,NA,Q9H1J1,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA binding [GO:0003723]; structural constituent of nuclear pore [GO:0017056]; telomeric DNA binding [GO:0042162]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; positive regulation of translation [GO:0045727],NA,NA,NA
CHOYP_BRAFLDRAFT_70886.1.1.m.53762,0.00791985861733917,0.000851293242572504,No,NA,NA,Q96P53,NA,NA,NA,early endosome [GO:0005769]; vesicle [GO:0031982]; metal ion binding [GO:0046872]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of protein phosphorylation [GO:0001934],NA,NA,NA
CHOYP_BRAFLDRAFT_70987.2.2.m.58284,-0.0137249308479999,0.00130749950552719,No,NA,NA,Q9HCF6,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; calcium ion transmembrane transport [GO:0070588]; cation transport [GO:0006812]; detection of temperature stimulus [GO:0016048]; protein tetramerization [GO:0051262]; sensory perception of temperature stimulus [GO:0050951],NA,NA,NA
CHOYP_BRAFLDRAFT_71030.1.1.m.31477,-0.0189735161854808,-0.000958341468244071,No,NA,NA,A2A3L6,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_71616.2.3.m.27171,-0.021142123209659,0.00398678823975604,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_71629.1.1.m.65970,0.00491588973115351,-0.000600714720400963,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_72035.1.1.m.48832,-0.0105867462223741,0.00305385963285081,No,NA,NA,Q5R630,NA,NA,NA,clathrin-coated vesicle membrane [GO:0030665]; plasma membrane [GO:0005886]; endocytosis [GO:0006897]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_72273.1.2.m.34499,0.00779149952448084,0.00441912994972626,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_72357.1.1.m.59063,0.0010112995031751,0.00908295796244735,No,NA,NA,Q5VYX0,NA,NA,NA,extracellular region [GO:0005576]; extracellular space [GO:0005615]; epinephrine binding [GO:0051379]; monoamine oxidase activity [GO:0097621]; NADH binding [GO:0070404]; oxidoreductase activity; acting on NAD(P)H [GO:0016651]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of blood pressure [GO:0045776]; negative regulation of heart rate [GO:0010459]; oxidation-reduction process [GO:0055114]; response to epinephrine [GO:0071871]; response to ischemia [GO:0002931]; response to salt [GO:1902074],NA,NA,NA
CHOYP_BRAFLDRAFT_72541.1.2.m.13652,-0.00430894344577715,-0.00631540690244347,No,NA,NA,Q5ZL00,NA,NA,NA,ER membrane protein complex [GO:0072546]; integral component of membrane [GO:0016021]; protein folding in endoplasmic reticulum [GO:0034975],NA,NA,NA
CHOYP_BRAFLDRAFT_72611.1.1.m.61108,0.00140385910116976,-0.0129845796259332,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_72748.1.1.m.27724,0.0166194855935156,0.0142610967292695,No,NA,NA,Q00285,NA,NA,NA,cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364],NA,NA,NA
CHOYP_BRAFLDRAFT_73177.1.1.m.61488,0.0159699337201679,0.00884069392272249,No,NA,NA,Q86VP3,NA,NA,NA,endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; ion channel binding [GO:0044325]; apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; protein localization to phagophore assembly site [GO:0034497]; protein localization to plasma membrane [GO:0072659]; viral process [GO:0016032],NA,NA,NA
CHOYP_BRAFLDRAFT_73486.1.1.m.16417,0.000295497629703281,0.0195770372192078,No,NA,NA,Q93099,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; homogentisate 1;2-dioxygenase activity [GO:0004411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; cellular amino acid metabolic process [GO:0006520]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572],NA,NA,NA
CHOYP_BRAFLDRAFT_73991.2.2.m.60726,0.0231031288284967,0.000694183085494152,No,NA,NA,P49013,NA,NA,NA,extracellular space [GO:0005615]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_BRAFLDRAFT_74063.1.5.m.2740,0.0219608215450326,0.0127093794826812,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_74063.2.5.m.9454,0.00217997094733793,-0.00807271368859912,No,NA,NA,Q9IBG7,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_BRAFLDRAFT_74063.4.5.m.43367,0.00780937268833468,-0.0109208811769431,No,NA,NA,Q3U492,NA,NA,NA,extracellular space [GO:0005615]; hematopoietic progenitor cell differentiation [GO:0002244]; positive regulation of BMP signaling pathway [GO:0030513],NA,NA,NA
CHOYP_BRAFLDRAFT_74469.3.3.m.53818,-0.00534396144460459,0.00252055531739146,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_74594.1.3.m.1187,0.0180928574464124,-0.00878993781686736,No,NA,NA,Q6GMV2,NA,NA,NA,metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168],NA,NA,NA
CHOYP_BRAFLDRAFT_74594.2.3.m.1285,0.00757982096867692,-0.00479168720927318,No,NA,NA,Q6GPQ4,NA,NA,NA,metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168],NA,NA,NA
CHOYP_BRAFLDRAFT_74594.3.3.m.1992,0.00011230781048104,-0.0125317976530634,No,NA,NA,Q5ZIZ2,NA,NA,NA,metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168],NA,NA,NA
CHOYP_BRAFLDRAFT_74861.1.1.m.16599,-0.00430894344577715,-0.00631540690244347,No,NA,NA,Q96IG2,NA,NA,NA,cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; presynapse [GO:0098793]; SCF ubiquitin ligase complex [GO:0019005]; Schaffer collateral - CA1 synapse [GO:0098685]; ubiquitin-protein transferase activity [GO:0004842]; behavioral fear response [GO:0001662]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]; regulation of protein catabolic process at presynapse; modulating synaptic transmission [GO:0099575]; regulation of synaptic vesicle exocytosis [GO:2000300]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_BRAFLDRAFT_74874.1.9.m.3545,-0.0146860910045168,0.017905300987254,No,NA,NA,Q460N5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein poly-ADP-ribosylation [GO:0070212],NA,NA,NA
CHOYP_BRAFLDRAFT_74874.3.9.m.37096,-0.0156489733050195,-0.0135699833634295,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_74874.5.9.m.47033,0.00637022748996578,0.0103089654396062,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_74879.1.6.m.21111,0.00535454733155424,-0.00604703873020696,No,NA,NA,Q2EMV9,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein poly-ADP-ribosylation [GO:0070212],NA,NA,NA
CHOYP_BRAFLDRAFT_74879.3.6.m.24658,0.00322621554444203,0.001220663908209,No,NA,NA,Q460N5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein poly-ADP-ribosylation [GO:0070212],NA,NA,NA
CHOYP_BRAFLDRAFT_75094.1.2.m.24898,0.00217997094733793,-0.00807271368859912,No,NA,NA,Q7Z7G8,NA,NA,NA,protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_75616.1.2.m.9949,-0.0169591047060434,0.00960206869202777,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_75632.1.1.m.60676,-0.00104977732541203,0.015823762833096,No,NA,NA,A4IIK1,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; inflammatory response [GO:0006954]; innate immune response [GO:0045087],NA,NA,NA
CHOYP_BRAFLDRAFT_75707.1.1.m.8533,-0.0135725579708753,0.00388604629968508,No,NA,NA,Q7Z5J8,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_BRAFLDRAFT_75823.1.2.m.2870,-0.00217545371712797,-0.00690285188406384,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_76126.1.1.m.8736,-0.0100433928760522,0.00841574987229905,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_76176.1.1.m.55550,-0.0184603889952889,-0.00428477923338159,No,NA,NA,Q8NE28,NA,NA,NA,ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674],NA,NA,NA
CHOYP_BRAFLDRAFT_76402.1.5.m.22765,0.0147431163919785,-0.00790715664225803,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_76662.3.3.m.61577,-0.0145982364158975,0.00488005664504279,No,NA,NA,Q6ZV70,NA,NA,NA,plasma membrane [GO:0005886]; catalytic activity [GO:0003824],NA,NA,NA
CHOYP_BRAFLDRAFT_76728.1.1.m.17486,0.0154191512294059,0.00914646714644499,No,NA,NA,Q6P8G1,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; transferase activity [GO:0016740]; immune response [GO:0006955]; positive regulation of transcription; DNA-templated [GO:0045893]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_BRAFLDRAFT_76825.1.1.m.2818,-0.0217239249294858,0.00416067227561685,No,NA,NA,P82198,NA,NA,NA,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198],NA,NA,NA
CHOYP_BRAFLDRAFT_76885.1.1.m.20259,0.0159735168636835,-0.0118778246706941,No,NA,NA,P86789,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_BRAFLDRAFT_76943.1.1.m.58001,0.00364778592941831,-0.00872052841558096,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_77063.1.1.m.8252,-0.00907854655958926,-0.0136402183759943,No,NA,NA,Q8D3M4,NA,NA,NA,2-aminoethylphosphonate-pyruvate transaminase activity [GO:0047304]; organic phosphonate catabolic process [GO:0019700],NA,NA,NA
CHOYP_BRAFLDRAFT_77132.1.2.m.5217,-0.00291431485722951,-0.0181738406092498,No,NA,NA,Q9UNH7,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; intracellular [GO:0005622]; nucleus [GO:0005634]; retromer complex [GO:0030904]; retromer; tubulation complex [GO:0030905]; tubular endosome [GO:0097422]; dynactin binding [GO:0034452]; phosphatidylinositol binding [GO:0035091]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; intracellular protein transport [GO:0006886]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of transcription; DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; regulation of macroautophagy [GO:0016241]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_BRAFLDRAFT_77225.1.2.m.29845,0.00473528817630534,-0.0121041941515753,No,NA,NA,P04988,NA,NA,NA,extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; hyperosmotic response [GO:0006972]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_BRAFLDRAFT_77483.1.1.m.56627,-0.000163344012317595,-0.0239430367818895,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_78229.1.1.m.52210,0.010861599593232,0.0207203163786922,No,NA,NA,Q9P2K2,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; cell redox homeostasis [GO:0045454],NA,NA,NA
CHOYP_BRAFLDRAFT_79044.2.2.m.62650,0.00417559612156517,0.00467073713256827,No,NA,NA,B0BNE5,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; carboxylic ester hydrolase activity [GO:0052689]; S-formylglutathione hydrolase activity [GO:0018738]; formaldehyde catabolic process [GO:0046294],NA,NA,NA
CHOYP_BRAFLDRAFT_79377.5.30.m.21330,-0.018545236950024,0.00421659040687773,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_79602.1.1.m.42298,-0.00172467616053636,0.0152897934172162,No,NA,NA,Q8IVI9,NA,NA,NA,cytoskeleton [GO:0005856]; endocytic vesicle membrane [GO:0030666]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; endocytosis [GO:0006897]; negative regulation of transcription; DNA-templated [GO:0045892]; regulation of nitric-oxide synthase activity [GO:0050999],NA,NA,NA
CHOYP_BRAFLDRAFT_79734.1.1.m.15409,-0.00639731546845575,-0.00693793293171331,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_80039.1.1.m.2568,0.0210336005076951,0.000409960635366948,No,NA,NA,Q6PDL0,NA,NA,NA,centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; kinetochore [GO:0000776]; late endosome [GO:0005770]; lysosome [GO:0005764]; microtubule [GO:0005874]; ATP binding [GO:0005524]; dynein heavy chain binding [GO:0045504]; microtubule motor activity [GO:0003777]; cellular response to nerve growth factor stimulus [GO:1990090]; centrosome localization [GO:0051642]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based movement [GO:0007018]; protein homooligomerization [GO:0051260],NA,NA,NA
CHOYP_BRAFLDRAFT_80064.1.1.m.40175,-0.00983056740398421,-0.000909454846752782,No,NA,NA,Q13546,NA,NA,NA,cytosol [GO:0005829]; death-inducing signaling complex [GO:0031264]; endosome membrane [GO:0010008]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; receptor complex [GO:0043235]; ripoptosome [GO:0097342]; ATP binding [GO:0005524]; death domain binding [GO:0070513]; death receptor binding [GO:0005123]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of JUN kinase activity [GO:0007257]; amyloid fibril formation [GO:1990000]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cellular protein catabolic process [GO:0044257]; cellular response to growth factor stimulus [GO:0071363]; cellular response to tumor necrosis factor [GO:0071356]; death-inducing signaling complex assembly [GO:0071550]; extrinsic apoptotic signaling pathway [GO:0097191]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; MAPK cascade [GO:0000165]; MyD88-independent toll-like receptor signaling pathway [GO:0002756]; necroptotic process [GO:0070266]; necroptotic signaling pathway [GO:0097527]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; peptidyl-serine autophosphorylation [GO:0036289]; positive regulation of apoptotic process [GO:0043065]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of hydrogen peroxide-induced cell death [GO:1905206]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of necroptotic process [GO:0060545]; positive regulation of necrotic cell death [GO:0010940]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of programmed cell death [GO:0043068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; protein autophosphorylation [GO:0046777]; protein deubiquitination [GO:0016579]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; regulation of ATP:ADP antiporter activity [GO:0070926]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; response to tumor necrosis factor [GO:0034612]; ripoptosome assembly [GO:0097343]; ripoptosome assembly involved in necroptotic process [GO:1901026]; T cell apoptotic process [GO:0070231]; toll-like receptor 3 signaling pathway [GO:0034138]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032],NA,NA,NA
CHOYP_BRAFLDRAFT_80311.1.3.m.18963,0.0116132863575577,0.014546876398183,No,NA,NA,P86854,NA,NA,NA,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_BRAFLDRAFT_80311.3.3.m.30251,-0.00533641649770036,-0.0186310605058831,No,NA,NA,P98092,NA,NA,NA,carbohydrate binding [GO:0030246]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_BRAFLDRAFT_80394.4.9.m.33604,0.00671065614244832,-0.0062722143580906,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_80432.2.2.m.18322,-0.0138525354787635,-0.00104219701495034,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_80496.1.10.m.12618,0.00308233331362089,-0.0100526634478435,No,NA,NA,Q8N2E2,NA,NA,NA,cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856],NA,NA,NA
CHOYP_BRAFLDRAFT_80496.3.10.m.22837,0.00461399274858947,0.000204696927566023,No,NA,NA,Q8N2E2,NA,NA,NA,cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856],NA,NA,NA
CHOYP_BRAFLDRAFT_80496.6.10.m.29014,0.00558150973556536,-0.0203009207412918,No,NA,NA,Q6DFV8,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_BRAFLDRAFT_80496.8.10.m.49028,0.00245817436954434,-0.00653135817142851,No,NA,NA,Q6DFV8,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_BRAFLDRAFT_80577.2.6.m.24330,0.00491588973115351,-0.000600714720400964,No,NA,NA,Q5BIM1,NA,NA,NA,cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348],NA,NA,NA
CHOYP_BRAFLDRAFT_80919.1.1.m.62047,-0.0139227133833117,-0.00533581665620082,No,NA,NA,Q8C0R9,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_BRAFLDRAFT_80934.1.2.m.23714,-0.00800848017678015,-0.0106188163218566,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_81321.3.10.m.34305,-0.0115641598106126,0.00346875696088767,No,NA,NA,P41241,NA,NA,NA,cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; proline-rich region binding [GO:0070064]; protein kinase A catalytic subunit binding [GO:0034236]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; transferase activity [GO:0016740]; adaptive immune response [GO:0002250]; adherens junction organization [GO:0034332]; brain development [GO:0007420]; cellular response to peptide hormone stimulus [GO:0071375]; intracellular signal transduction [GO:0035556]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of kinase activity [GO:0033673]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of phagocytosis [GO:0050765]; oligodendrocyte differentiation [GO:0048709]; positive regulation of MAP kinase activity [GO:0043406]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; regulation of T cell activation [GO:0050863],NA,NA,NA
CHOYP_BRAFLDRAFT_81321.5.10.m.45062,-0.00855272964398269,0.00614836486585826,No,NA,NA,O22558,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; chloroplast organization [GO:0009658],NA,NA,NA
CHOYP_BRAFLDRAFT_81321.6.10.m.48025,0.00785189648190048,0.00728933498379372,No,NA,NA,P32577,NA,NA,NA,cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; proline-rich region binding [GO:0070064]; protein kinase A catalytic subunit binding [GO:0034236]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; adaptive immune response [GO:0002250]; adherens junction organization [GO:0034332]; brain development [GO:0007420]; cellular response to peptide hormone stimulus [GO:0071375]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of kinase activity [GO:0033673]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of phagocytosis [GO:0050765]; oligodendrocyte differentiation [GO:0048709]; positive regulation of MAP kinase activity [GO:0043406]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368],NA,NA,NA
CHOYP_BRAFLDRAFT_81322.1.2.m.17860,0.00918697036711252,0.0109147167747185,No,NA,NA,B2IZD3,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; lipid binding [GO:0008289],NA,NA,NA
CHOYP_BRAFLDRAFT_81364.2.3.m.30348,-0.02131408037577,-0.00102856298399131,No,NA,NA,A0A1P8AWH8,NA,NA,NA,cell wall [GO:0005618]; extracellular region [GO:0005576]; endo-1;4-beta-xylanase activity [GO:0031176]; xylan catabolic process [GO:0045493],NA,NA,NA
CHOYP_BRAFLDRAFT_81364.3.3.m.30607,0.00322152988091221,-0.00578025904505787,No,NA,NA,O80596,NA,NA,NA,endo-1;4-beta-xylanase activity [GO:0031176]; xylan catabolic process [GO:0045493],NA,NA,NA
CHOYP_BRAFLDRAFT_81509.1.1.m.31565,0.0124285050377656,0.0122664716226313,No,NA,NA,Q9BDK2,NA,NA,NA,actin filament [GO:0005884]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; actin filament bundle assembly [GO:0051017]; actin filament polymerization [GO:0030041]; cellular response to interferon-gamma [GO:0071346]; inflammatory response [GO:0006954]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; negative regulation of smooth muscle cell proliferation [GO:0048662]; phagocytosis; engulfment [GO:0006911]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of smooth muscle cell chemotaxis [GO:0071673]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T cell migration [GO:2000406]; positive regulation of T cell proliferation [GO:0042102]; Rac protein signal transduction [GO:0016601]; ruffle assembly [GO:0097178],NA,NA,NA
CHOYP_BRAFLDRAFT_81532.1.1.m.58865,0.0133923973060182,0.0242047377378879,No,NA,NA,Q05609,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cellular response to iron ion [GO:0071281]; ethylene-activated signaling pathway [GO:0009873]; gibberellin biosynthetic process [GO:0009686]; negative regulation of ethylene-activated signaling pathway [GO:0010105]; protein autophosphorylation [GO:0046777]; regulation of post-embryonic root development [GO:2000069]; regulation of stem cell division [GO:2000035]; regulation of timing of transition from vegetative to reproductive phase [GO:0048510]; response to ethylene [GO:0009723]; response to fructose [GO:0009750]; response to hypoxia [GO:0001666]; response to sucrose [GO:0009744]; sugar mediated signaling pathway [GO:0010182],NA,NA,NA
CHOYP_BRAFLDRAFT_81609.1.1.m.94,0.0195591783709233,0.000269635666276482,No,NA,NA,Q9Y6N5,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; FAD binding [GO:0071949]; quinone binding [GO:0048038]; sulfide:quinone oxidoreductase activity [GO:0070224]; hydrogen sulfide metabolic process [GO:0070813]; sulfide oxidation; using sulfide:quinone oxidoreductase [GO:0070221],NA,NA,NA
CHOYP_BRAFLDRAFT_81733.1.1.m.213,-0.00989435923426184,-0.0142939990834735,No,NA,NA,A4IHY1,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; proteasome binding [GO:0070628]; proteasome assembly [GO:0043248]; proteasome core complex assembly [GO:0080129],NA,NA,NA
CHOYP_BRAFLDRAFT_82353.1.1.m.13454,0.0106242249016215,0.00249732546963439,No,NA,NA,Q9D4D4,NA,NA,NA,cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; transketolase activity [GO:0004802],NA,NA,NA
CHOYP_BRAFLDRAFT_82426.1.20.m.8067,0.000686232728993107,-0.0107331332691118,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_82868.3.5.m.48837,0.00395488249218779,-0.0172928668745387,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_83096.1.1.m.27011,0.000936748654390739,-0.00606505909209808,No,NA,NA,P08472,NA,NA,NA,anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886],NA,NA,NA
CHOYP_BRAFLDRAFT_83552.1.1.m.55255,0.00105571073101812,-0.0183081589454696,No,NA,NA,Q704S8,NA,NA,NA,endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; carnitine O-acetyltransferase activity [GO:0004092]; carnitine metabolic process; CoA-linked [GO:0019254]; fatty acid metabolic process [GO:0006631],NA,NA,NA
CHOYP_BRAFLDRAFT_84054.1.2.m.8523,-0.00673182293051402,-0.00882959398294871,No,NA,NA,Q4R918,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; microtubule binding [GO:0008017]; establishment of spindle orientation [GO:0051294]; microtubule-based movement [GO:0007018]; negative regulation of mitotic centrosome separation [GO:0046603]; nucleus localization [GO:0051647]; protein homotetramerization [GO:0051289],NA,NA,NA
CHOYP_BRAFLDRAFT_84207.2.2.m.36438,-0.0120220373307408,-0.000831053132684422,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_84237.1.1.m.1879,-0.010335056098339,-0.0183135271467572,No,NA,NA,Q9BQG0,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; NLS-dependent protein nuclear import complex [GO:0042564]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; E-box binding [GO:0070888]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; cellular response to glucose starvation [GO:0042149]; circadian regulation of gene expression [GO:0032922]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of transcription; DNA-templated [GO:0045892]; osteoblast differentiation [GO:0001649]; positive regulation of anoikis [GO:2000210]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of gene expression; epigenetic [GO:0045815]; regulation of transcription; DNA-templated [GO:0006355]; respiratory electron transport chain [GO:0022904]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_BRAFLDRAFT_84245.2.2.m.53621,0.00217997094733793,-0.00807271368859912,No,NA,NA,Q9NQG7,NA,NA,NA,BLOC-3 complex [GO:0031085]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; platelet dense granule [GO:0042827]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]; blood coagulation [GO:0007596]; hemostasis [GO:0007599]; lysosome organization [GO:0007040]; melanocyte differentiation [GO:0030318]; melanosome assembly [GO:1903232]; positive regulation of eye pigmentation [GO:0048075]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein stabilization [GO:0050821]; protein targeting [GO:0006605],NA,NA,NA
CHOYP_BRAFLDRAFT_84494.2.5.m.30751,-0.02094749045098,-0.00144539579155577,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_84494.3.5.m.41159,0.00641459887031649,0.00666727480413056,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_84494.4.5.m.44543,0.00696148350687079,-0.0187101925853023,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_84664.1.7.m.3969,0.0065883263884642,0.0180931628217626,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_84838.3.6.m.42355,-0.0050667729841605,-0.00250955237937258,No,NA,NA,Q460N5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein poly-ADP-ribosylation [GO:0070212],NA,NA,NA
CHOYP_BRAFLDRAFT_84941.1.1.m.53224,0.0075860272802512,0.00600711362799493,No,NA,NA,Q3SZE9,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; photoreceptor connecting cilium [GO:0032391]; GTPase activity [GO:0003924]; tubulin binding [GO:0015631]; cell morphogenesis [GO:0000902]; post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021],NA,NA,NA
CHOYP_BRAFLDRAFT_85170.1.1.m.8699,0.00987482918101913,0.0199406005217207,No,NA,NA,Q69Z89,NA,NA,NA,microtubule [GO:0005874]; protein-containing complex [GO:0032991]; multicellular organism development [GO:0007275]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446],NA,NA,NA
CHOYP_BRAFLDRAFT_85206.1.1.m.49234,0.00290893248338518,-0.00338187919973895,No,NA,NA,F5H4B4,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_85506.1.1.m.54726,0.0137907819051231,0.0186762405504415,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_85511.15.23.m.46769,0.00657289243857886,0.00155562943388085,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_85511.17.23.m.55470,-0.0106606503020174,-0.0043533777844608,No,NA,NA,E1BD59,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; interferon-beta production [GO:0032608]; protein K63-linked ubiquitination [GO:0070534]; response to type I interferon [GO:0034340],NA,NA,NA
CHOYP_BRAFLDRAFT_85511.3.23.m.14160,0.0110958669399233,0.0154073007664075,No,NA,NA,Q6PFY8,NA,NA,NA,cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348],NA,NA,NA
CHOYP_BRAFLDRAFT_85664.10.10.m.45430,0.00678620130084429,0.00878741825264137,No,NA,NA,B3EWZ3,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_BRAFLDRAFT_85664.3.10.m.26597,-0.00638636099218725,-0.00219941807321606,No,NA,NA,B3EWZ3,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_BRAFLDRAFT_85664.6.10.m.30553,-0.00259319330934761,-0.00631583910436501,No,NA,NA,Q96RW7,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],NA,NA,NA
CHOYP_BRAFLDRAFT_85822.1.1.m.10102,0.0126892668610872,0.00627160044959285,No,NA,NA,Q9CWK3,NA,NA,NA,cytosol [GO:0005829]; fibrillar center [GO:0001650]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U5 snRNP [GO:0005682]; ribonucleoprotein complex binding [GO:0043021]; mRNA processing [GO:0006397]; negative regulation of phosphatase activity [GO:0010923]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_BRAFLDRAFT_85896.1.1.m.38692,-0.0112139236489038,-0.00284430501855764,No,NA,NA,C0HBB2,NA,NA,NA,integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764],NA,NA,NA
CHOYP_BRAFLDRAFT_85994.3.10.m.7126,0.0108830720754099,-0.0171158012417957,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_85994.7.10.m.36866,0.00743890660734769,0.0138631733566817,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_86052.1.1.m.25460,-0.00805703873307309,-0.0147067117576145,No,NA,NA,Q9CYL5,NA,NA,NA,extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; protein homodimerization activity [GO:0042803]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374],NA,NA,NA
CHOYP_BRAFLDRAFT_86765.1.1.m.54066,-0.00640877333155421,-0.011897791381835,No,NA,NA,R9UTQ8,NA,NA,NA,iron ion binding [GO:0005506]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; 2-oxoglutarate as one donor; and incorporation of one atom each of oxygen into both donors [GO:0016706]; antibiotic biosynthetic process [GO:0017000]; antibiotic metabolic process [GO:0016999],NA,NA,NA
CHOYP_BRAFLDRAFT_86801.1.1.m.27107,0.0168179512563945,-0.0140174309872695,No,NA,NA,E9PV24,NA,NA,NA,blood microparticle [GO:0072562]; cell cortex [GO:0005938]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; platelet alpha granule [GO:0031091]; rough endoplasmic reticulum [GO:0005791]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]; structural molecule activity [GO:0005198]; adaptive immune response [GO:0002250]; blood coagulation [GO:0007596]; blood coagulation; common pathway [GO:0072377]; blood coagulation; fibrin clot formation [GO:0072378]; cell-matrix adhesion [GO:0007160]; cellular protein-containing complex assembly [GO:0034622]; fibrinolysis [GO:0042730]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; plasminogen activation [GO:0031639]; platelet aggregation [GO:0070527]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of exocytosis [GO:0045921]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of peptide hormone secretion [GO:0090277]; positive regulation of protein secretion [GO:0050714]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of vasoconstriction [GO:0045907]; protein polymerization [GO:0051258]; protein-containing complex assembly [GO:0065003]; response to calcium ion [GO:0051592],NA,NA,NA
CHOYP_BRAFLDRAFT_86801.1.1.m.27108,-0.00401043925001775,-0.0159784974154716,No,NA,NA,Q20758,NA,NA,NA,cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; GTP binding [GO:0005525]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_86827.2.4.m.9197,-0.000144914639304632,-0.000876924654760671,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_86827.3.4.m.27276,-0.00923609932845396,-0.00487974884347174,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_86827.4.4.m.61859,-0.0151616143404101,-0.0209688024821121,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_86846.1.3.m.13594,-0.0166516514364682,0.012232728802235,No,NA,NA,P10040,NA,NA,NA,apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; spindle [GO:0005819]; subapical complex [GO:0035003]; calcium ion binding [GO:0005509]; protein kinase C binding [GO:0005080]; spectrin binding [GO:0030507]; adherens junction organization [GO:0034332]; amnioserosa maintenance [GO:0046665]; apical constriction [GO:0003383]; apical protein localization [GO:0045176]; assembly of apicomedial cortex actomyosin [GO:0106036]; cell division [GO:0051301]; cell morphogenesis involved in Malpighian tubule morphogenesis [GO:0061336]; centrosome localization [GO:0051642]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; dorsal closure; amnioserosa morphology change [GO:0046664]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; liquid clearance; open tracheal system [GO:0035002]; maintenance of apical/basal cell polarity [GO:0035090]; Malpighian tubule morphogenesis [GO:0007443]; membrane organization [GO:0061024]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of organ growth [GO:0046621]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nervous system development [GO:0007399]; nuclear chromosome segregation [GO:0098813]; open tracheal system development [GO:0007424]; photoreceptor cell maintenance [GO:0045494]; positive regulation of cell proliferation [GO:0008284]; positive regulation of hippo signaling [GO:0035332]; protein stabilization [GO:0050821]; regulation of imaginal disc growth [GO:0045570]; regulation of intracellular protein transport [GO:0033157]; regulation of protein localization [GO:0032880]; rhabdomere development [GO:0042052]; rhabdomere morphogenesis [GO:0061541]; salivary gland morphogenesis [GO:0007435]; tube morphogenesis [GO:0035239]; zonula adherens assembly [GO:0045186]; zonula adherens maintenance [GO:0045218],NA,NA,NA
CHOYP_BRAFLDRAFT_86846.3.3.m.53453,-0.000655962832889315,0.0203915925943558,No,NA,NA,P10040,NA,NA,NA,apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; spindle [GO:0005819]; subapical complex [GO:0035003]; calcium ion binding [GO:0005509]; protein kinase C binding [GO:0005080]; spectrin binding [GO:0030507]; adherens junction organization [GO:0034332]; amnioserosa maintenance [GO:0046665]; apical constriction [GO:0003383]; apical protein localization [GO:0045176]; assembly of apicomedial cortex actomyosin [GO:0106036]; cell division [GO:0051301]; cell morphogenesis involved in Malpighian tubule morphogenesis [GO:0061336]; centrosome localization [GO:0051642]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; dorsal closure; amnioserosa morphology change [GO:0046664]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; liquid clearance; open tracheal system [GO:0035002]; maintenance of apical/basal cell polarity [GO:0035090]; Malpighian tubule morphogenesis [GO:0007443]; membrane organization [GO:0061024]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of organ growth [GO:0046621]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nervous system development [GO:0007399]; nuclear chromosome segregation [GO:0098813]; open tracheal system development [GO:0007424]; photoreceptor cell maintenance [GO:0045494]; positive regulation of cell proliferation [GO:0008284]; positive regulation of hippo signaling [GO:0035332]; protein stabilization [GO:0050821]; regulation of imaginal disc growth [GO:0045570]; regulation of intracellular protein transport [GO:0033157]; regulation of protein localization [GO:0032880]; rhabdomere development [GO:0042052]; rhabdomere morphogenesis [GO:0061541]; salivary gland morphogenesis [GO:0007435]; tube morphogenesis [GO:0035239]; zonula adherens assembly [GO:0045186]; zonula adherens maintenance [GO:0045218],NA,NA,NA
CHOYP_BRAFLDRAFT_86890.2.4.m.23914,-0.00430894344577715,-0.00631540690244347,No,NA,NA,Q9ESN6,NA,NA,NA,cytoplasm [GO:0005737]; myosin binding [GO:0017022]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523],NA,NA,NA
CHOYP_BRAFLDRAFT_87283.1.1.m.46768,-0.00212078832001384,-0.00891837260408135,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_87294.6.6.m.64622,-0.00212078832001384,-0.00891837260408135,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_87336.4.9.m.23926,-0.0169591047060434,0.00960206869202778,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_87429.1.1.m.43808,-0.010193089463288,-0.00999372773959016,No,NA,NA,Q1RLX4,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi organization [GO:0007030]; lipid homeostasis [GO:0055088]; liver development [GO:0001889]; protein N-linked glycosylation [GO:0006487]; protein secretion [GO:0009306]; regulation of response to endoplasmic reticulum stress [GO:1905897]; retina development in camera-type eye [GO:0060041]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_87630.1.1.m.30352,0.0109020627785532,-0.00044289933724302,No,NA,NA,O43174,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; organelle membrane [GO:0031090]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; NAD(P)H as one donor; and incorporation of one atom of oxygen [GO:0016709]; oxygen binding [GO:0019825]; retinoic acid 4-hydroxylase activity [GO:0008401]; retinoic acid binding [GO:0001972]; kidney development [GO:0001822]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; oxidation-reduction process [GO:0055114]; response to retinoic acid [GO:0032526]; response to vitamin A [GO:0033189]; retinoic acid catabolic process [GO:0034653]; retinoic acid metabolic process [GO:0042573]; sterol metabolic process [GO:0016125]; vitamin metabolic process [GO:0006766]; xenobiotic metabolic process [GO:0006805],NA,NA,NA
CHOYP_BRAFLDRAFT_87634.1.1.m.39992,0.00217997094733793,-0.00807271368859912,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_87662.1.1.m.5474,-0.00340989523019355,0.00460834861715648,No,NA,NA,P17560,NA,NA,NA,N-acylglucosamine 2-epimerase activity [GO:0050121]; peptidase inhibitor activity [GO:0030414]; N-acetylglucosamine metabolic process [GO:0006044]; N-acetylmannosamine metabolic process [GO:0006051]; N-acetylneuraminate catabolic process [GO:0019262],NA,NA,NA
CHOYP_BRAFLDRAFT_87806.1.1.m.28308,0.00263587772175593,-0.00184168436961882,No,NA,NA,Q6EV69,NA,NA,NA,endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; fucosyltransferase activity [GO:0008417]; peptide-O-fucosyltransferase activity [GO:0046922]; angiogenesis [GO:0001525]; fucose metabolic process [GO:0006004]; heart development [GO:0007507]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; protein O-linked glycosylation [GO:0006493]; regulation of Notch signaling pathway [GO:0008593]; somitogenesis [GO:0001756],NA,NA,NA
CHOYP_BRAFLDRAFT_88012.1.1.m.12815,-0.0178446022415902,0.00491689525747366,No,NA,NA,P82861,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; NADPH-adrenodoxin reductase activity [GO:0015039]; cholesterol metabolic process [GO:0008203],NA,NA,NA
CHOYP_BRAFLDRAFT_88018.1.1.m.50147,-0.0146427515918186,-0.0114576648249827,No,NA,NA,O35474,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; multicellular organism development [GO:0007275]; positive regulation of cell-substrate adhesion [GO:0010811],NA,NA,NA
CHOYP_BRAFLDRAFT_88218.8.8.m.64733,0.000514615691178706,0.00249378785610003,No,NA,NA,Q9ESN6,NA,NA,NA,cytoplasm [GO:0005737]; myosin binding [GO:0017022]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523],NA,NA,NA
CHOYP_BRAFLDRAFT_88219.1.5.m.37187,0.00521809595050761,-0.0021819872581162,No,NA,NA,O70277,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; postsynapse [GO:0098794]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_88223.10.22.m.35410,-0.00773980788877781,0.000642055509799213,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_88223.5.22.m.23899,0.00364778592941831,-0.00872052841558097,No,NA,NA,O70277,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; postsynapse [GO:0098794]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_88223.9.22.m.34933,0.00569478639170421,-0.00648259885207726,No,NA,NA,E1BD59,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; interferon-beta production [GO:0032608]; protein K63-linked ubiquitination [GO:0070534]; response to type I interferon [GO:0034340],NA,NA,NA
CHOYP_BRAFLDRAFT_88224.2.11.m.3212,0.00542904648638859,0.0121395965962727,No,NA,NA,O75382,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; protein C-terminus binding [GO:0008022]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; nervous system development [GO:0007399]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_88506.1.1.m.64174,0.00309029922683563,-0.0181706185438187,No,NA,NA,Q3SX22,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_88543.1.2.m.54473,-0.0146260663797494,-0.0060495721771072,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_88566.3.11.m.5108,0.00502916553929159,-0.00520133407809029,No,NA,NA,Q96RW7,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],NA,NA,NA
CHOYP_BRAFLDRAFT_88570.1.2.m.55232,-0.00473712169895168,-0.0139412749674869,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_88583.1.1.m.56300,0.000849183342223103,-0.00587516445646792,No,NA,NA,Q5SSH7,NA,NA,NA,calcium ion binding [GO:0005509]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_BRAFLDRAFT_88596.1.2.m.24206,0.00827013401003247,-0.00912737627431373,No,NA,NA,Q95LU3,NA,NA,NA,integral component of membrane [GO:0016021]; membrane [GO:0016020]; chitin binding [GO:0008061]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_BRAFLDRAFT_89105.1.1.m.2234,-0.00430894344577715,-0.00631540690244348,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_89330.1.1.m.23864,0.000592360138317686,-0.00965485495646453,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_89362.1.1.m.49683,0.00539754101276416,0.00148822062136817,No,NA,NA,A2VDN6,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; U2 snRNP [GO:0005686]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_BRAFLDRAFT_89535.1.1.m.6232,-0.0113900805174433,-0.00373903940333865,No,NA,NA,Q8C4B4,NA,NA,NA,ciliary transition zone [GO:0035869]; lipid binding [GO:0008289]; cilium assembly [GO:0060271]; lipoprotein transport [GO:0042953]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_BRAFLDRAFT_89536.1.1.m.26678,-0.0106972492300179,0.00314720365271506,No,NA,NA,Q96QT6,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; Sin3-type complex [GO:0070822]; transcriptional repressor complex [GO:0017053]; metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892],NA,NA,NA
CHOYP_BRAFLDRAFT_89744.1.1.m.29497,-0.00512122203642986,0.00992214471527021,No,NA,NA,O88280,NA,NA,NA,extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; brain development [GO:0007420]; cell differentiation [GO:0030154]; spinal cord development [GO:0021510],NA,NA,NA
CHOYP_BRAFLDRAFT_89746.1.2.m.29425,-0.011948393662559,-0.0241319016581582,No,NA,NA,Q9R172,NA,NA,NA,integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of transcription; DNA-templated [GO:0006355]; tissue regeneration [GO:0042246]; wound healing [GO:0042060],NA,NA,NA
CHOYP_BRAFLDRAFT_89869.1.3.m.28871,-0.0148287750057416,0.00767799534120953,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_89869.3.3.m.37644,0.00394536801625317,0.00291369700370642,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_89870.1.1.m.15447,0.00435155285575721,0.00860800482327417,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_89920.1.1.m.13963,0.00718552856420226,-0.0221786190336899,No,NA,NA,O15213,NA,NA,NA,nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_BRAFLDRAFT_89952.1.1.m.59629,0.0043283490596692,-0.0124098534225621,No,NA,NA,Q7TQE6,NA,NA,NA,axon [GO:0030424]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection terminus [GO:0044306]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; rough endoplasmic reticulum membrane [GO:0030867]; synapse [GO:0045202]; brain development [GO:0007420]; neuronal signal transduction [GO:0023041],NA,NA,NA
CHOYP_BRAFLDRAFT_89952.1.1.m.59630,0.0100426492337462,0.0139281516700011,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_89961.1.3.m.5717,0.0206670174568858,-0.00821473978062831,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_89961.3.3.m.49198,0.0165880198520639,-0.00608334547382933,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_90098.1.4.m.3841,-0.0100188814548023,-0.0247590137737047,No,NA,NA,Q5M8Z0,NA,NA,NA,cytoplasm [GO:0005737]; betaine-homocysteine S-methyltransferase activity [GO:0047150]; zinc ion binding [GO:0008270]; amino-acid betaine catabolic process [GO:0006579]; methionine biosynthetic process [GO:0009086],NA,NA,NA
CHOYP_BRAFLDRAFT_90098.4.4.m.28113,0.00981593021456862,0.00831483740399391,No,NA,NA,Q5RF32,NA,NA,NA,cytoplasm [GO:0005737]; betaine-homocysteine S-methyltransferase activity [GO:0047150]; zinc ion binding [GO:0008270]; methionine biosynthetic process [GO:0009086],NA,NA,NA
CHOYP_BRAFLDRAFT_90187.1.1.m.30393,-0.0222244275757068,-0.00814432974440804,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_90196.2.2.m.42787,-0.00195468763575567,0.00263578649730884,No,NA,NA,B0JZG0,NA,NA,NA,apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; contractile fiber [GO:0043292]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; L-ascorbate:sodium symporter activity [GO:0008520]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; L-ascorbic acid metabolic process [GO:0019852]; response to oxidative stress [GO:0006979]; transepithelial L-ascorbic acid transport [GO:0070904],NA,NA,NA
CHOYP_BRAFLDRAFT_90332.3.4.m.18933,0.0211568627796529,-0.0131245289591996,No,NA,NA,Q8C6K9,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_BRAFLDRAFT_90405.1.1.m.44167,0.00418538375198719,-0.0213099875259972,No,NA,NA,Q3SZJ4,NA,NA,NA,cytoplasm [GO:0005737]; 13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; 2-alkenal reductase [NAD(P)] activity [GO:0032440],NA,NA,NA
CHOYP_BRAFLDRAFT_90471.1.2.m.30257,-0.0106022847385802,-0.00684547258879123,No,NA,NA,Q9JLQ0,NA,NA,NA,cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; filamentous actin [GO:0031941]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; vascular endothelial growth factor receptor binding [GO:0005172]; actin filament organization [GO:0007015]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; negative regulation of transforming growth factor beta1 production [GO:0032911]; positive regulation of protein localization to nucleus [GO:1900182]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of receptor-mediated endocytosis [GO:0048259]; vesicle organization [GO:0016050],NA,NA,NA
CHOYP_BRAFLDRAFT_90679.1.1.m.33411,0.00217997094733793,-0.00807271368859912,No,NA,NA,O18783,NA,NA,NA,extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; tissue remodeling [GO:0048771],NA,NA,NA
CHOYP_BRAFLDRAFT_90706.2.2.m.29119,-0.0225610607969139,0.00998217373228169,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_90929.1.1.m.54454,-0.00749407986284808,0.00420123826823652,No,NA,NA,E9QAM5,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nuclear receptor transcription coactivator activity [GO:0030374]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_BRAFLDRAFT_90953.1.1.m.48786,-0.0116677770158008,0.0196395234959479,No,NA,NA,P51570,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; ATP binding [GO:0005524]; galactokinase activity [GO:0004335]; galactose binding [GO:0005534]; galactitol metabolic process [GO:0019402]; galactose catabolic process [GO:0019388]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; glycolytic process from galactose [GO:0061623],NA,NA,NA
CHOYP_BRAFLDRAFT_91062.1.1.m.77,-0.0135725579708753,0.00388604629968508,No,NA,NA,Q6XZF7,NA,NA,NA,cell junction [GO:0030054]; cytoskeleton [GO:0005856]; Golgi stack [GO:0005795]; synapse [GO:0045202]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; aging [GO:0007568]; intracellular signal transduction [GO:0035556]; regulation of Rho protein signal transduction [GO:0035023],NA,NA,NA
CHOYP_BRAFLDRAFT_91068.1.1.m.9955,-0.00399285240500713,-0.00301746576637974,No,NA,NA,Q58DT5,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; kinocilium [GO:0060091]; stereocilium [GO:0032420]; positive regulation of GTPase activity [GO:0043547],NA,NA,NA
CHOYP_BRAFLDRAFT_91316.1.1.m.46558,-0.00157114492010693,0.0242651627668263,No,NA,NA,Q3UIR3,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; STAT family protein binding [GO:0097677]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; defense response to virus [GO:0051607]; double-strand break repair [GO:0006302]; endosome to lysosome transport [GO:0008333]; histone H2A ubiquitination [GO:0033522]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; innate immune response [GO:0045087]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; Notch signaling pathway [GO:0007219]; positive regulation of chromatin binding [GO:0035563]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of NAD+ ADP-ribosyltransferase activity [GO:1901666]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of receptor catabolic process [GO:2000646]; positive regulation of transcription; DNA-templated [GO:0045893]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_BRAFLDRAFT_91321.1.10.m.20278,0.00394536801625317,0.00291369700370642,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_91321.10.10.m.59301,-0.0069369802258148,0.00167166833676809,No,NA,NA,Q460N5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein poly-ADP-ribosylation [GO:0070212],NA,NA,NA
CHOYP_BRAFLDRAFT_91321.5.10.m.37054,0.00441655882959771,-0.00482796497058511,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_91321.7.10.m.56158,-0.00480949663866255,-0.00529670861666947,No,NA,NA,Q2EMV9,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein poly-ADP-ribosylation [GO:0070212],NA,NA,NA
CHOYP_BRAFLDRAFT_91394.1.1.m.16068,-0.0109847382233356,-0.0160929370098982,No,NA,NA,Q9CQF9,NA,NA,NA,lysosome [GO:0005764]; plasma membrane [GO:0005886]; very-low-density lipoprotein particle [GO:0034361]; chloride-transporting ATPase activity [GO:0008555]; prenylcysteine oxidase activity [GO:0001735]; chloride transport [GO:0006821]; prenylated protein catabolic process [GO:0030327]; prenylcysteine catabolic process [GO:0030328],NA,NA,NA
CHOYP_BRAFLDRAFT_91441.1.1.m.47971,0.0206237436750054,-0.0104692088563523,No,NA,NA,P08472,NA,NA,NA,anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886],NA,NA,NA
CHOYP_BRAFLDRAFT_91636.1.11.m.28449,-0.0147653168754575,0.00141311373868699,No,NA,NA,Q53G44,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; defense response to virus [GO:0051607]; immune response [GO:0006955],NA,NA,NA
CHOYP_BRAFLDRAFT_91636.4.11.m.45350,-0.00890323463301537,0.00645028500027404,No,NA,NA,P27473,NA,NA,NA,cytoplasm [GO:0005737]; immune response [GO:0006955]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_BRAFLDRAFT_91636.6.11.m.49144,0.00510568953713021,0.0186946438494895,No,NA,NA,Q8BV66,NA,NA,NA,cytoplasm [GO:0005737]; immune response [GO:0006955]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_BRAFLDRAFT_91636.8.11.m.58992,0.00531223837478864,-0.00619289514706651,No,NA,NA,Q8TCB0,NA,NA,NA,cytoplasm [GO:0005737]; immune response [GO:0006955]; response to bacterium [GO:0009617]; response to virus [GO:0009615],NA,NA,NA
CHOYP_BRAFLDRAFT_91695.1.1.m.31423,-0.0126772867683363,-0.0163575286266235,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_91870.3.3.m.62762,0.00491588973115351,-0.000600714720400963,No,NA,NA,P17178,NA,NA,NA,mitochondrial envelope [GO:0005740]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; cholesterol 26-hydroxylase activity [GO:0031073]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen [GO:0016705]; vitamin D3 25-hydroxylase activity [GO:0030343]; cholesterol metabolic process [GO:0008203]; steroid catabolic process [GO:0006706],NA,NA,NA
CHOYP_BRAFLDRAFT_92024.1.1.m.49813,0.00747333379675575,-0.010769279880105,No,NA,NA,O08746,NA,NA,NA,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; axon guidance [GO:0007411]; dendrite regeneration [GO:0031104]; glial cell migration [GO:0008347]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; response to axon injury [GO:0048678],NA,NA,NA
CHOYP_BRAFLDRAFT_92063.1.2.m.677,-0.00363861993691376,-0.00178822172606023,No,NA,NA,Q5ZKI4,NA,NA,NA,early endosome [GO:0005769]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_92084.1.1.m.10643,-0.013492799810615,0.000991905625339694,No,NA,NA,Q8VCY6,NA,NA,NA,nucleolus [GO:0005730]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; snoRNA binding [GO:0030515]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462],NA,NA,NA
CHOYP_BRAFLDRAFT_92365.3.3.m.51160,0.00364778592941831,-0.00872052841558096,No,NA,NA,B3EWY9,NA,NA,NA,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ErbB-2 class receptor binding [GO:0005176]; extracellular matrix constituent; lubricant activity [GO:0030197]; cell-matrix adhesion [GO:0007160]; epithelial structure maintenance [GO:0010669]; regulation of signaling receptor activity [GO:0010469],NA,NA,NA
CHOYP_BRAFLDRAFT_92367.1.4.m.29492,-0.000232006802898787,0.0231900800084289,No,NA,NA,Q0E908,NA,NA,NA,cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_BRAFLDRAFT_92398.1.2.m.15178,-0.00804343533676248,0.00585431109230197,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_92410.1.1.m.36946,0.00657452256584886,0.00153755576531467,No,NA,NA,P42674,NA,NA,NA,cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_BRAFLDRAFT_92601.1.1.m.56157,0.0158820932290389,-0.00939636485368006,No,NA,NA,Q5R7R6,NA,NA,NA,Golgi membrane [GO:0000139]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_92908.1.1.m.36182,-0.00427848038726122,0.00259958403832961,No,NA,NA,Q80YA7,NA,NA,NA,cytosol [GO:0005829]; aminopeptidase activity [GO:0004177]; serine-type peptidase activity [GO:0008236],NA,NA,NA
CHOYP_BRAFLDRAFT_93030.1.1.m.29276,0.00891394391909032,0.0125179009296827,No,NA,NA,Q62261,NA,NA,NA,axolemma [GO:0030673]; cortical cytoskeleton [GO:0030863]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; glutamatergic synapse [GO:0098978]; M band [GO:0031430]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; spectrin [GO:0008091]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; GTPase binding [GO:0051020]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; common-partner SMAD protein phosphorylation [GO:0007182]; Golgi to plasma membrane protein transport [GO:0043001]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 secretion [GO:1900042]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of SMAD protein signal transduction [GO:0060390],NA,NA,NA
CHOYP_BRAFLDRAFT_93247.1.1.m.7558,-0.022566055176484,0.00999102596596335,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_93411.1.3.m.13317,0.0061064797675514,0.0101240033136733,No,NA,NA,O95049,NA,NA,NA,bicellular tight junction [GO:0005923]; nucleus [GO:0005634]; plasma membrane [GO:0005886],NA,NA,NA
CHOYP_BRAFLDRAFT_93411.3.3.m.54402,0.00611815587032324,0.00605728804870846,No,NA,NA,O97758,NA,NA,NA,bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cytoplasmic vesicle [GO:0031410]; gap junction [GO:0005921]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; bicellular tight junction assembly [GO:0070830]; cellular response to calcium ion [GO:0071277],NA,NA,NA
CHOYP_BRAFLDRAFT_93856.2.6.m.20593,0.00722757375180162,-0.0124547227489952,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_93876.1.1.m.8885,0.00520029464154846,0.0120473502300044,No,NA,NA,Q9NPF5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription corepressor activity [GO:0003714]; chromatin remodeling [GO:0006338]; DNA methylation [GO:0006306]; DNA repair [GO:0006281]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of protein import into nucleus [GO:0042307]; regulation of growth [GO:0040008]; response to ethanol [GO:0045471],NA,NA,NA
CHOYP_BRAFLDRAFT_94906.1.1.m.59345,0.0124578822333789,0.0140684957213084,No,NA,NA,P90994,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein deglycase activity [GO:0036524]; cellular response to glyoxal [GO:0036471]; cellular response to methylglyoxal [GO:0097238]; glycolate biosynthetic process [GO:0046295]; glyoxal metabolic process [GO:1903189]; guanine deglycation; glyoxal removal [GO:0106046]; lactate biosynthetic process [GO:0019249]; methylglyoxal metabolic process [GO:0009438]; negative regulation of neuron death [GO:1901215]; protein deglycation; glyoxal removal [GO:0036529]; response to toxic substance [GO:0009636],NA,NA,NA
CHOYP_BRAFLDRAFT_95073.3.9.m.27326,0.00364778592941831,-0.00872052841558097,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_95739.1.2.m.53575,0.00217997094733793,-0.00807271368859912,No,NA,NA,P70193,NA,NA,NA,extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; hair cycle process [GO:0022405]; innervation [GO:0060384]; otolith morphogenesis [GO:0032474]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_BRAFLDRAFT_95739.2.2.m.57592,0.00217997094733793,-0.00807271368859912,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_95868.1.2.m.56034,0.00373045882776171,-0.0174480874937559,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_96254.1.1.m.47860,-0.01246588775676,0.0109173109582463,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_96598.1.1.m.54770,0.00394536801625317,0.00291369700370642,No,NA,NA,Q62283,NA,NA,NA,integral component of plasma membrane [GO:0005887]; cell surface receptor signaling pathway [GO:0007166],NA,NA,NA
CHOYP_BRAFLDRAFT_97410.1.3.m.34739,-0.00174320620612895,0.0159289590686331,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_97676.1.1.m.62102,-0.0119967849649458,-0.0148302190751717,No,NA,NA,Q8N1B4,NA,NA,NA,cytosol [GO:0005829]; EARP complex [GO:1990745]; endosome membrane [GO:0010008]; GARP complex [GO:0000938]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; trans-Golgi network membrane [GO:0032588]; Rab GTPase binding [GO:0017137]; syntaxin binding [GO:0019905]; ectodermal cell differentiation [GO:0010668]; embryonic ectodermal digestive tract development [GO:0048611]; endocytic recycling [GO:0032456]; Golgi to vacuole transport [GO:0006896]; lysosomal transport [GO:0007041]; protein transport [GO:0015031]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_BRAFLDRAFT_97881.1.1.m.46581,-0.0118568777653446,0.00454755174347677,No,NA,NA,O75182,NA,NA,NA,autosome [GO:0030849]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; X chromosome [GO:0000805]; XY body [GO:0001741]; Y chromosome [GO:0000806]; chromatin binding [GO:0003682]; transcription corepressor activity [GO:0003714]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of lipid metabolic process [GO:0019216],NA,NA,NA
CHOYP_BRAFLDRAFT_98499.1.1.m.5718,-0.00896230805152364,0.0120310642004599,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_98740.3.7.m.46571,-0.010662803684984,-0.00379643518280679,No,NA,NA,Q8N2S1,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; glycosaminoglycan binding [GO:0005539]; integrin binding [GO:0005178]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta-activated receptor activity [GO:0005024]; growth hormone secretion [GO:0030252]; multicellular organism development [GO:0007275]; protein folding [GO:0006457]; regulation of cell differentiation [GO:0045595]; regulation of cell growth [GO:0001558]; regulation of proteolysis [GO:0030162]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_BRAFLDRAFT_98740.4.7.m.53694,0.0185400803432511,0.00675923352095667,No,NA,NA,Q61555,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; limb morphogenesis [GO:0035108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583],NA,NA,NA
CHOYP_BRAFLDRAFT_98740.5.7.m.58200,0.00814085638030904,0.00313587615395808,No,NA,NA,P98133,NA,NA,NA,basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; activation of protein kinase A activity [GO:0034199]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; negative regulation of osteoclast development [GO:2001205]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_BRAFLDRAFT_98740.6.7.m.59350,-0.0107720298827285,0.0105861575226441,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_98740.6.7.m.59351,0.0111500750393877,0.00235757958211884,No,NA,NA,P35555,NA,NA,NA,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877]; activation of protein kinase A activity [GO:0034199]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular protein metabolic process [GO:0044267]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; extracellular matrix organization [GO:0030198]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; post-translational protein modification [GO:0043687]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_BRAFLDRAFT_98740.7.7.m.65348,0.0165002652938021,-0.0073838397892663,No,NA,NA,P35555,NA,NA,NA,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877]; activation of protein kinase A activity [GO:0034199]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular protein metabolic process [GO:0044267]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; extracellular matrix organization [GO:0030198]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; post-translational protein modification [GO:0043687]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_BRAFLDRAFT_98895.2.2.m.39575,-0.00528003328545244,-0.0124683991905044,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_98992.1.1.m.62815,0.00789507167243356,-0.00547583904908041,No,NA,NA,P08503,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; acyl-CoA dehydrogenase activity [GO:0003995]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; isomerase activity [GO:0016853]; medium-chain-acyl-CoA dehydrogenase activity [GO:0070991]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; medium-chain fatty acid catabolic process [GO:0051793]; protein homotetramerization [GO:0051289]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; response to hormone [GO:0009725]; response to nutrient [GO:0007584],NA,NA,NA
CHOYP_BRAFLDRAFT_99018.1.1.m.14650,-0.00718335594269299,-0.0134621454257907,No,NA,NA,P55567,NA,NA,NA,hydrolase activity [GO:0016787],NA,NA,NA
CHOYP_BRAFLDRAFT_99073.1.1.m.18282,-0.000625997987774792,0.00814015126429994,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_99083.1.1.m.11705,-0.0133059433329366,0.0187081007463738,No,NA,NA,Q9DAK2,NA,NA,NA,cell body [GO:0044297]; cilium [GO:0005929]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; sperm midpiece [GO:0097225]; vesicle [GO:0031982]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; chaperone binding [GO:0051087]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; ubiquitin protein ligase binding [GO:0031625]; cellular response to unfolded protein [GO:0034620]; negative regulation of cell death [GO:0060548]; spermatid development [GO:0007286],NA,NA,NA
CHOYP_BRAFLDRAFT_99539.1.1.m.55866,0.00394536801625317,0.00291369700370642,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_99630.3.9.m.20020,0.00324613603970812,0.0220096683323931,No,NA,NA,P18460,NA,NA,NA,integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; apoptotic process [GO:0006915]; positive regulation of cell proliferation [GO:0008284]; positive regulation of MAPK cascade [GO:0043410]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_BRAFLDRAFT_99630.5.9.m.36500,0.00205195042830452,-0.00934116934689426,No,NA,NA,P18460,NA,NA,NA,integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; apoptotic process [GO:0006915]; positive regulation of cell proliferation [GO:0008284]; positive regulation of MAPK cascade [GO:0043410]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_BRAFLDRAFT_99630.9.9.m.62562,-0.00430894344577715,-0.00631540690244347,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_99641.1.1.m.63666,-0.00722363711428676,-0.00539363091465173,No,NA,NA,Q2T9I5,NA,NA,NA,metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; negative regulation of phosphatase activity [GO:0010923],NA,NA,NA
CHOYP_BRAFLDRAFT_99974.1.1.m.25083,0.0146869784447671,0.00305342330307221,No,NA,NA,Q9HAY6,NA,NA,NA,cytosol [GO:0005829]; beta-carotene 15;15'-monooxygenase activity [GO:0003834]; carotenoid dioxygenase activity [GO:0010436]; metal ion binding [GO:0046872]; retinal isomerase activity [GO:0004744]; beta-carotene metabolic process [GO:1901810]; carotene catabolic process [GO:0016121]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; vitamin A biosynthetic process [GO:0035238],NA,NA,NA
CHOYP_BRAP.1.1.m.47862,-0.00576395571127486,0.0102265719248823,No,NA,NA,Q7Z569,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; ubiquitin ligase complex [GO:0000151]; identical protein binding [GO:0042802]; nuclear localization sequence binding [GO:0008139]; nucleic acid binding [GO:0003676]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; MAPK cascade [GO:0000165]; negative regulation of signal transduction [GO:0009968]; protein ubiquitination [GO:0016567]; Ras protein signal transduction [GO:0007265],NA,NA,NA
CHOYP_BRCA2.1.2.m.17660,-0.00862626016195461,-0.0127467089952548,No,NA,NA,Q6AZL2,NA,NA,NA,nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; chromatin binding [GO:0003682]; cellular response to DNA damage stimulus [GO:0006974]; centrosome cycle [GO:0007098]; DNA replication [GO:0006260]; regulation of cell cycle [GO:0051726]; response to UV [GO:0009411]; translesion synthesis [GO:0019985],NA,NA,NA
CHOYP_BRCC3.1.1.m.66615,0.00496193580804769,-0.00699892587870461,No,NA,NA,B5X8M4,NA,NA,NA,BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle pole [GO:0000922]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; polyubiquitin modification-dependent protein binding [GO:0031593]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; cell cycle [GO:0007049]; cell division [GO:0051301]; double-strand break repair [GO:0006302]; histone H2A K63-linked deubiquitination [GO:0070537]; positive regulation of DNA repair [GO:0045739]; protein K63-linked deubiquitination [GO:0070536]; response to ionizing radiation [GO:0010212]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425],NA,NA,NA
CHOYP_BRD4.1.1.m.55245,-0.00768054216382849,0.0129675140294658,No,NA,NA,Q91Y44,NA,NA,NA,nucleus [GO:0005634]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; cell differentiation [GO:0030154]; chromatin remodeling [GO:0006338]; histone displacement [GO:0001207]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; mRNA processing [GO:0006397]; positive regulation of transcription involved in meiotic cell cycle [GO:0051039]; regulation of RNA splicing [GO:0043484]; regulation of transcription; DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRD8.1.1.m.244,0.000854706289321691,0.00928468331867764,No,NA,NA,Q8R3B7,NA,NA,NA,mitochondrion [GO:0005739]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; Swr1 complex [GO:0000812]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of growth [GO:0040008],NA,NA,NA
CHOYP_BRX1.1.1.m.30421,-0.00215347404498621,-0.0050355906564763,No,NA,NA,Q3SZZ0,NA,NA,NA,nucleolus [GO:0005730]; ribosomal large subunit assembly [GO:0000027],NA,NA,NA
CHOYP_BT3L4.1.1.m.2144,-0.00267503826272576,0.000627681758303411,No,NA,NA,Q5M8V0,NA,NA,NA,,NA,NA,NA
CHOYP_BTAF1.2.2.m.55086,-0.0076337111787343,-0.00894593677662966,No,NA,NA,O14981,NA,NA,NA,intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; helicase activity [GO:0004386]; negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription; DNA-templated [GO:0045892],NA,NA,NA
CHOYP_BTKL.1.1.m.55270,0.0189467996080679,-0.0184617215505644,No,NA,NA,Q14BI2,NA,NA,NA,axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; neuron projection [GO:0043005]; presynaptic membrane [GO:0042734]; calcium channel regulator activity [GO:0005246]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; glutamate homeostasis [GO:0090461]; glutamate secretion [GO:0014047]; regulation of synaptic transmission; glutamatergic [GO:0051966],NA,NA,NA
CHOYP_BTKL.1.1.m.55271,0.00604913913958138,0.0046228808117652,No,NA,NA,P42680,NA,NA,NA,cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phospholipid binding [GO:0005543]; adaptive immune response [GO:0002250]; B cell receptor signaling pathway [GO:0050853]; cytokine-mediated signaling pathway [GO:0019221]; Fc-epsilon receptor signaling pathway [GO:0038095]; integrin-mediated signaling pathway [GO:0007229]; intracellular signal transduction [GO:0035556]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein phosphorylation [GO:0006468]; regulation of platelet activation [GO:0010543]; T cell receptor signaling pathway [GO:0050852]; tissue regeneration [GO:0042246],NA,NA,NA
CHOYP_BTRC.1.1.m.816,-0.00248812850725416,-0.00931070566845484,No,NA,NA,Q9Y297,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; SCF ubiquitin ligase complex [GO:0019005]; small-subunit processome [GO:0032040]; beta-catenin binding [GO:0008013]; ligase activity [GO:0016874]; protein dimerization activity [GO:0046983]; protein phosphorylated amino acid binding [GO:0045309]; snoRNA binding [GO:0030515]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cellular response to organic cyclic compound [GO:0071407]; G2/M transition of mitotic cell cycle [GO:0000086]; interleukin-1-mediated signaling pathway [GO:0070498]; mammary gland epithelial cell proliferation [GO:0033598]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription; DNA-templated [GO:0045892]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription; DNA-templated [GO:0045893]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein dephosphorylation [GO:0006470]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of circadian rhythm [GO:0042752]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of proteasomal protein catabolic process [GO:0061136]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; signal transduction [GO:0007165]; stress-activated MAPK cascade [GO:0051403]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_BTZ.1.1.m.45914,0.0195025952664628,-0.0146723015673436,No,NA,NA,A5D7H5,NA,NA,NA,cytoplasmic stress granule [GO:0010494]; dendrite [GO:0030425]; exon-exon junction complex [GO:0035145]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; intracellular mRNA localization [GO:0008298]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_BUCC.1.2.m.10972,0.00299297208739118,-0.0035817350607716,No,NA,NA,P20481,NA,NA,NA,extracellular region [GO:0005576]; neuropeptide signaling pathway [GO:0007218],NA,NA,NA
CHOYP_BUD31.3.3.m.64519,0.0110844808181381,0.0142830227141025,No,NA,NA,Q962X9,NA,NA,NA,nucleus [GO:0005634],NA,NA,NA
CHOYP_BUP1.1.1.m.13641,-0.00889811245064795,-0.00484295624517694,No,NA,NA,Q9UBR1,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; beta-ureidopropionase activity [GO:0003837]; metal ion binding [GO:0046872]; beta-alanine biosynthetic process via 3-ureidopropionate [GO:0033396]; beta-alanine metabolic process [GO:0019482]; pyrimidine nucleoside catabolic process [GO:0046135],NA,NA,NA
CHOYP_BZW1.1.1.m.44089,0.0013536328450507,-0.00803121830790967,No,NA,NA,Q5ZLT7,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_C10.1.2.m.23678,-0.0126575419436386,0.00202784749903664,No,NA,NA,O35127,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; camera-type eye morphogenesis [GO:0048593]; cognition [GO:0050890]; corpus callosum morphogenesis [GO:0021540]; post-embryonic development [GO:0009791]; psychomotor behavior [GO:0036343]; regulation of skeletal muscle contraction [GO:0014819]; third ventricle development [GO:0021678],NA,NA,NA
CHOYP_C102A.1.1.m.23591,-0.00752180750576475,0.0205004168490909,No,NA,NA,A0JNH6,NA,NA,NA,myosin complex [GO:0016459]; motor activity [GO:0003774],NA,NA,NA
CHOYP_C124A.1.1.m.61913,-0.0222145407266491,0.000802588683345541,No,NA,NA,Q68EY7,NA,NA,NA,cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; cell cycle [GO:0007049]; cell division [GO:0051301],NA,NA,NA
CHOYP_C19L1.1.1.m.13954,0.00488430990854386,0.0130729033895022,No,NA,NA,Q5RGJ5,NA,NA,NA,,NA,NA,NA
CHOYP_C1QL2.19.32.m.29743,-0.0051662748706518,-0.0200406986281051,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_C1QL2.32.32.m.64434,0.0120920012660086,0.0139889433495323,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_C1QL4.7.10.m.49245,0.00419997624292739,-0.00286747180993337,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_C1QL4L.3.7.m.5967,-0.00630358930825441,-0.00527726680023325,No,NA,NA,Q5RJ80,NA,NA,NA,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; dorsal/ventral pattern formation [GO:0009953]; negative regulation of translation [GO:0017148]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification [GO:2000055]; regulation of growth [GO:0040008],NA,NA,NA
CHOYP_C1QL4L.3.7.m.5968,-0.00316495404549243,0.00306173179661299,No,NA,NA,Q86Z23,NA,NA,NA,collagen trimer [GO:0005581]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147],NA,NA,NA
CHOYP_C1QL4L.6.7.m.26358,0.00692159914203869,-0.00051996677166449,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_C1QT3.4.8.m.22821,0.00394536801625317,0.00291369700370642,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_C1QT4.2.5.m.28767,0.0198605006055522,0.00206223994612224,No,NA,NA,Q8R066,NA,NA,NA,extracellular space [GO:0005615]; cytokine activity [GO:0005125]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of tumor necrosis factor secretion [GO:1904469],NA,NA,NA
CHOYP_C1QT4.3.5.m.46406,0.0117369380435613,0.000160681885188933,No,NA,NA,Q4ZJM9,NA,NA,NA,collagen trimer [GO:0005581]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147],NA,NA,NA
CHOYP_C1TC.1.1.m.28294,0.0212397686461334,0.00779247239358678,No,NA,NA,P27653,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity [GO:0004486]; 10-formyltetrahydrofolate biosynthetic process [GO:0009257]; histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; nucleotide metabolic process [GO:0009117]; one-carbon metabolic process [GO:0006730]; purine nucleobase biosynthetic process [GO:0009113]; purine nucleotide biosynthetic process [GO:0006164]; response to nitrogen dioxide [GO:0035713]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653],NA,NA,NA
CHOYP_C2CD5.1.1.m.9675,-0.00467086611250018,-0.00451664320388611,No,NA,NA,Q28BX9,NA,NA,NA,cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; cellular response to insulin stimulus [GO:0032869]; insulin receptor signaling pathway via phosphatidylinositol 3-kinase [GO:0038028]; intracellular protein transmembrane transport [GO:0065002]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of vesicle fusion [GO:0031340],NA,NA,NA
CHOYP_C2D1.1.1.m.8807,0.0195924742396274,-0.00722848183337119,No,NA,NA,Q9VKJ9,NA,NA,NA,apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; phospholipid binding [GO:0005543]; compound eye development [GO:0048749]; endosomal transport [GO:0016197]; female germ-line stem cell asymmetric division [GO:0048132]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; intracellular protein transport [GO:0006886]; mitotic cytokinesis [GO:0000281]; multivesicular body organization [GO:0036257]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of protein catabolic process [GO:0045732]; regulation of endocytosis [GO:0030100]; regulation of Notch signaling pathway [GO:0008593]; sensory organ development [GO:0007423]; sensory organ precursor cell division [GO:0045035]; wing disc morphogenesis [GO:0007472],NA,NA,NA
CHOYP_C3ORF38.1.1.m.59043,-0.00705028555643348,-0.00454332774050391,No,NA,NA,Q5JPI3,NA,NA,NA,nucleus [GO:0005634]; apoptotic process [GO:0006915]; positive regulation of apoptotic process [GO:0043065],NA,NA,NA
CHOYP_C43BP.1.1.m.62099,-0.00727818779363983,-0.00760788468601463,No,NA,NA,Q6VVX2,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intermembrane ceramide transfer activity [GO:0120017]; phosphatidylinositol-4-phosphate binding [GO:0070273]; ER to Golgi ceramide transport [GO:0035621],NA,NA,NA
CHOYP_CA050.1.2.m.10226,0.000151223855854973,-0.0236929426857769,No,NA,NA,Q5PQ76,NA,NA,NA,,NA,NA,NA
CHOYP_CA14.1.1.m.30677,-0.00515095205654542,-0.022541460851758,No,NA,NA,Q9ULX7,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; bicarbonate transport [GO:0015701],NA,NA,NA
CHOYP_CA2.1.1.m.27846,-0.0177123535092581,-0.00446377907076949,No,NA,NA,Q8UWA5,NA,NA,NA,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_CAB32.1.1.m.52444,-0.00772321032266167,-0.00223655969511581,No,NA,NA,P41044,NA,NA,NA,cytosol [GO:0005829]; dendrite [GO:0030425]; neuron projection [GO:0043005]; nucleus [GO:0005634]; synapse [GO:0045202]; type II terminal bouton [GO:0061175]; type III terminal bouton [GO:0097467]; calcium ion binding [GO:0005509]; negative regulation of response to wounding [GO:1903035]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509],NA,NA,NA
CHOYP_CAD1.2.2.m.61448,-0.0169591047060434,0.00960206869202777,No,NA,NA,Q6X862,NA,NA,NA,integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of phosphatase activity [GO:0010923],NA,NA,NA
CHOYP_CAD89.1.1.m.14552,0.00347312116780458,0.0161145314866223,No,NA,NA,Q9VAF5,NA,NA,NA,apical plasma membrane [GO:0016324]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; calcium ion binding [GO:0005509]; myosin binding [GO:0017022]; apical protein localization [GO:0045176]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-mediated signaling [GO:0019722]; cell-cell adhesion mediated by cadherin [GO:0044331]; chorion-containing eggshell formation [GO:0007304]; follicle cell microvillus organization [GO:0032529]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; mucosal immune response [GO:0002385]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; regulation of follicle cell microvillus length [GO:0032533]; tube morphogenesis [GO:0035239]; vitelline membrane formation involved in chorion-containing eggshell formation [GO:0007305],NA,NA,NA
CHOYP_CADM3.4.4.m.45272,-0.00553584460565526,0.00221630076019054,No,NA,NA,Q7ZXX1,NA,NA,NA,cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_CADM4.1.1.m.60661,0.00400758308732047,-0.0116872246254802,No,NA,NA,Q7ZXX1,NA,NA,NA,cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_CADM4.1.1.m.60662,-0.000916157616688359,0.0143169679326101,No,NA,NA,Q0P5A1,NA,NA,NA,centrosome [GO:0005813]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; midbody [GO:0030496]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; cytoskeleton-dependent cytokinesis [GO:0061640]; microtubule-based process [GO:0007017],NA,NA,NA
CHOYP_CADN.2.3.m.19237,0.0132935804177767,0.000211231994695899,No,NA,NA,O15943,NA,NA,NA,axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; axonal fasciculation [GO:0007413]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290],NA,NA,NA
CHOYP_CAH1.1.2.m.24247,0.00679185418755165,-0.00456909844188649,No,NA,NA,P83299,NA,NA,NA,cytoplasm [GO:0005737]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_CAHD1.5.6.m.53893,0.00364778592941831,-0.00872052841558097,No,NA,NA,Q5VU97,NA,NA,NA,voltage-gated calcium channel complex [GO:0005891]; voltage-gated calcium channel activity [GO:0005245],NA,NA,NA
CHOYP_CAL6303_3579.1.1.m.59031,0.0029708395072235,-0.0201893199485187,No,NA,NA,P28034,NA,NA,NA,caffeoyl-CoA O-methyltransferase activity [GO:0042409]; metal ion binding [GO:0046872]; lignin biosynthetic process [GO:0009809],NA,NA,NA
CHOYP_CAL7507_4591.1.1.m.49532,0.00598148534630126,0.012056909003687,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CALCR.1.6.m.856,-0.0169591047060434,0.00960206869202777,No,NA,NA,O08893,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcitonin receptor activity [GO:0004948]; cell surface receptor signaling pathway [GO:0007166],NA,NA,NA
CHOYP_CALM.11.50.m.28106,0.0111843214993008,0.00446713964646726,No,NA,NA,Q8STF0,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_CALM.15.50.m.30007,0.0146858019616861,-0.00288347819024138,No,NA,NA,Q9LIK5,NA,NA,NA,nucleus [GO:0005634]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]; spindle pole body organization [GO:0051300],NA,NA,NA
CHOYP_CALM.22.50.m.31010,0.00426699789719913,0.0118684405842963,No,NA,NA,Q95NR9,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_CALM.31.50.m.48469,-0.0135725579708753,0.00388604629968508,No,NA,NA,P20397,NA,NA,NA,nucleolus [GO:0005730]; DNA binding [GO:0003677]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_CALM.32.50.m.48894,-0.0169591047060434,0.00960206869202778,No,NA,NA,O16305,NA,NA,NA,cell periphery [GO:0071944]; centrosome [GO:0005813]; mitotic spindle [GO:0072686]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; apoptotic cell clearance [GO:0043277]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; embryo development ending in birth or egg hatching [GO:0009792]; establishment of meiotic spindle orientation [GO:0051296]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of protein localization [GO:0032880]; spindle pole body organization [GO:0051300],NA,NA,NA
CHOYP_CALM.35.50.m.49987,-0.0120436215817399,0.001203338128402,No,NA,NA,P23286,NA,NA,NA,calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722],NA,NA,NA
CHOYP_CALM.37.50.m.52385,0.000382152644638038,-0.0133715784974772,No,NA,NA,P02594,NA,NA,NA,calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722],NA,NA,NA
CHOYP_CALM.44.50.m.56751,0.0107394812245771,-0.0155269760434453,No,NA,NA,Q95NR9,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_CALM.45.50.m.57163,0.000502960821185309,-0.0108010200568741,No,NA,NA,O96102,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_CALM.50.50.m.67046,0.00707013801580482,-0.0107231649431889,No,NA,NA,Q95NR9,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_CALM.7.50.m.12029,0.00171390641916182,-0.0118741359394016,No,NA,NA,Q7T3T2,NA,NA,NA,calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722],NA,NA,NA
CHOYP_CALMB.1.1.m.41570,-0.00755175433353052,0.0140400882753731,No,NA,NA,P05932,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_CALRL.2.3.m.42463,0.00870251460843786,0.000909019449133305,No,NA,NA,O42602,NA,NA,NA,integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; corticotrophin-releasing factor receptor activity [GO:0015056]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; cellular response to corticotropin-releasing hormone stimulus [GO:0071376]; corticotropin secretion [GO:0051458]; regulation of corticosterone secretion [GO:2000852],NA,NA,NA
CHOYP_CALUB.1.2.m.57842,0.00349273572027181,0.00692177014437606,No,NA,NA,B5X4E0,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_CALUB.2.2.m.58007,0.0112887551767923,0.0205293994958911,No,NA,NA,Q6XLQ7,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_CALX.1.1.m.12010,-0.00535939142082147,0.00199138715511327,No,NA,NA,Q5R440,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; presynapse [GO:0098793]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; unfolded protein binding [GO:0051082]; clathrin-dependent endocytosis [GO:0072583]; protein folding [GO:0006457]; synaptic vesicle endocytosis [GO:0048488],NA,NA,NA
CHOYP_CAMK4.1.1.m.30431,-0.020871005370652,0.004714047972308,No,NA,NA,Q16566,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; adaptive immune response [GO:0002250]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; long-term memory [GO:0007616]; myeloid dendritic cell differentiation [GO:0043011]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of transcription; DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of osteoclast differentiation [GO:0045670]; regulation of T cell differentiation in thymus [GO:0033081]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_CAN5.1.1.m.42242,-0.0135725579708753,0.00388604629968508,No,NA,NA,O15484,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; proteolysis [GO:0006508]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_CAN5.1.1.m.42243,-0.0168544141486944,0.00814726569577045,No,NA,NA,P80404,NA,NA,NA,4-aminobutyrate transaminase complex [GO:0032144]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; (S)-3-amino-2-methylpropionate transaminase activity [GO:0047298]; 4-aminobutyrate transaminase activity [GO:0003867]; 4-aminobutyrate:2-oxoglutarate transaminase activity [GO:0034386]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; succinate-semialdehyde dehydrogenase binding [GO:0032145]; aging [GO:0007568]; behavioral response to cocaine [GO:0048148]; cerebellum development [GO:0021549]; copulation [GO:0007620]; exploration behavior [GO:0035640]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; gamma-aminobutyric acid catabolic process [GO:0009450]; locomotory behavior [GO:0007626]; negative regulation of blood pressure [GO:0045776]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of platelet aggregation [GO:0090331]; neurotransmitter catabolic process [GO:0042135]; positive regulation of aspartate secretion [GO:1904450]; positive regulation of dopamine metabolic process [GO:0045964]; positive regulation of heat generation [GO:0031652]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of insulin secretion [GO:0032024]; positive regulation of prolactin secretion [GO:1902722]; positive regulation of uterine smooth muscle contraction [GO:0070474]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039]; response to nicotine [GO:0035094],NA,NA,NA
CHOYP_CAN8.1.2.m.21091,0.00205195042830452,-0.00934116934689426,No,NA,NA,O35920,NA,NA,NA,cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; digestion [GO:0007586]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_CAOG_00801.1.2.m.1579,-0.0137526436796979,0.0033163263028418,No,NA,NA,Q9D9B4,NA,NA,NA,melanocyte differentiation [GO:0030318],NA,NA,NA
CHOYP_CAOG_01182.1.1.m.8019,-0.0226620041458632,0.010357285886736,No,NA,NA,Q717B4,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_CAOG_01521.1.1.m.28103,0.0161554823663962,0.011142623742639,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CAOG_02976.1.2.m.41292,-0.00187823515259737,-0.0101214998658517,No,NA,NA,O83041,NA,NA,NA,cytoplasm [GO:0005737]; aminopeptidase activity [GO:0004177],NA,NA,NA
CHOYP_CAOG_02976.2.2.m.56777,-0.00790136828752616,0.00563494505377839,No,NA,NA,O83041,NA,NA,NA,cytoplasm [GO:0005737]; aminopeptidase activity [GO:0004177],NA,NA,NA
CHOYP_CAOG_03463.1.1.m.16746,0.022523815580458,-0.00239810330297908,No,NA,NA,Q6P1C6,NA,NA,NA,cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; otolith morphogenesis [GO:0032474],NA,NA,NA
CHOYP_CAOG_04006.1.1.m.5403,-0.00245684897271116,0.00638548952195998,No,NA,NA,Q5JI69,NA,NA,NA,cytoplasm [GO:0005737]; amino acid binding [GO:0016597]; L-threonine 3-dehydrogenase activity [GO:0008743]; NAD+ binding [GO:0070403]; zinc ion binding [GO:0008270]; L-threonine catabolic process to glycine [GO:0019518]; protein homotetramerization [GO:0051289]; threonine metabolic process [GO:0006566],NA,NA,NA
CHOYP_CAOG_04643.2.2.m.50992,-0.00807121184738096,-0.0183334368229742,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CAOG_04686.2.2.m.28117,0.0123923553551618,-0.00682679591929439,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CAOG_05733.1.2.m.29878,0.00217997094733793,-0.00807271368859912,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CAP.1.2.m.22123,0.0129819682480505,-0.0093967617981991,No,NA,NA,P40122,NA,NA,NA,plasma membrane [GO:0005886]; actin binding [GO:0003779]; cell morphogenesis [GO:0000902]; cytoskeleton organization [GO:0007010],NA,NA,NA
CHOYP_CAPLA.1.2.m.51979,0.00293769442973348,0.00376964101012822,No,NA,NA,P12370,NA,NA,NA,cell body [GO:0044297]; cytosol [GO:0005829]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein serine/threonine kinase activity [GO:0004674]; anesthesia-resistant memory [GO:0007615]; anterior/posterior pattern specification; imaginal disc [GO:0007448]; behavioral response to ethanol [GO:0048149]; cAMP-mediated signaling [GO:0019933]; cellular response to ethanol [GO:0071361]; compound eye development [GO:0048749]; imaginal disc-derived wing morphogenesis [GO:0007476]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of nucleocytoplasmic transport [GO:0046823]; negative regulation of smoothened signaling pathway [GO:0045879]; olfactory learning [GO:0008355]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oogenesis [GO:0048477]; positive regulation of gene expression [GO:0010628]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of smoothened signaling pathway [GO:0045880]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of apoptotic process [GO:0042981]; regulation of bicoid mRNA localization [GO:0008359]; regulation of circadian sleep/wake cycle; sleep [GO:0045187]; regulation of pole plasm oskar mRNA localization [GO:0007317]; rhythmic behavior [GO:0007622]; sprouting of injured axon [GO:0048682]; thermosensory behavior [GO:0040040],NA,NA,NA
CHOYP_CAPSLB.1.1.m.58887,0.00757925003585761,-0.00803733661231031,No,NA,NA,Q6P8Y1,NA,NA,NA,cytoplasm [GO:0005737]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_CAPZB.1.1.m.5762,-0.0102793373944694,0.00154608826642891,No,NA,NA,Q5XI32,NA,NA,NA,actin filament [GO:0005884]; dendritic spine [GO:0043197]; F-actin capping protein complex [GO:0008290]; neuronal cell body [GO:0043025]; sarcomere [GO:0030017]; WASH complex [GO:0071203]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin cytoskeleton organization [GO:0030036]; barbed-end actin filament capping [GO:0051016]; cell morphogenesis [GO:0000902]; cytoskeleton organization [GO:0007010]; negative regulation of filopodium assembly [GO:0051490]; regulation of cell morphogenesis [GO:0022604]; regulation of lamellipodium assembly [GO:0010591],NA,NA,NA
CHOYP_CARNS1.1.6.m.2227,0.0126706705629762,0.00553808510452206,No,NA,NA,A5YM72,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; carnosine synthase activity [GO:0047730]; FMN binding [GO:0010181]; homocarnosine synthase activity [GO:0102102]; metal ion binding [GO:0046872]; carnosine biosynthetic process [GO:0035499]; histidine catabolic process [GO:0006548],NA,NA,NA
CHOYP_CARNS1.2.6.m.3531,-0.0088966502426331,-0.0122717828007179,No,NA,NA,Q9BT30,NA,NA,NA,mitochondrial matrix [GO:0005759]; dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]; cellular response to DNA damage stimulus [GO:0006974]; fatty acid metabolic process [GO:0006631]; regulation of lipid storage [GO:0010883]; regulation of mitochondrial membrane permeability involved in programmed necrotic cell death [GO:1902445],NA,NA,NA
CHOYP_CARNS1.4.6.m.40244,-0.0224534673683899,0.00174224082891492,No,NA,NA,A5YM72,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; carnosine synthase activity [GO:0047730]; FMN binding [GO:0010181]; homocarnosine synthase activity [GO:0102102]; metal ion binding [GO:0046872]; carnosine biosynthetic process [GO:0035499]; histidine catabolic process [GO:0006548],NA,NA,NA
CHOYP_CARNS1.5.6.m.63614,-0.00797589511892867,-0.0028306114774435,No,NA,NA,Q80TZ9,NA,NA,NA,histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; PML body [GO:0016605]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; RNA polymerase II transcription factor binding [GO:0001085]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; branching morphogenesis of a nerve [GO:0048755]; cerebellar granule cell precursor proliferation [GO:0021930]; cerebellar Purkinje cell layer maturation [GO:0021691]; cerebellum development [GO:0021549]; chromatin remodeling [GO:0006338]; dendrite morphogenesis [GO:0048813]; radial glia guided migration of Purkinje cell [GO:0021942]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_CASP10.4.7.m.45631,-0.0142170855361991,0.00951027135758854,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CASP10.5.7.m.49889,-0.0122955046556908,0.0102773938140137,No,NA,NA,Q92851,NA,NA,NA,CD95 death-inducing signaling complex [GO:0031265]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ripoptosome [GO:0097342]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; death effector domain binding [GO:0035877]; ubiquitin protein ligase binding [GO:0031625]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cell surface receptor signaling pathway [GO:0007166]; execution phase of apoptosis [GO:0097194]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of apoptotic process [GO:0042981],NA,NA,NA
CHOYP_CASP2.5.5.m.35953,-0.00302719171622941,0.00703096471524672,No,NA,NA,P29594,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; aging [GO:0007568]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; brain development [GO:0007420]; cellular response to mechanical stimulus [GO:0071260]; DNA damage response; signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; ectopic germ cell programmed cell death [GO:0035234]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; luteolysis [GO:0001554]; negative regulation of apoptotic process [GO:0043066]; neural retina development [GO:0003407]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485],NA,NA,NA
CHOYP_CASP3.1.3.m.23354,-0.0119054610971331,0.00886888339553181,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CASP3.2.3.m.24896,0.00394536801625317,0.00291369700370642,No,NA,NA,P70677,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; death-inducing signaling complex [GO:0031264]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; aspartic-type endopeptidase activity [GO:0004190]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; death receptor binding [GO:0005123]; peptidase activity [GO:0008233]; phospholipase A2 activator activity [GO:0016005]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; serine-type endopeptidase activity [GO:0004252]; apoptotic process [GO:0006915]; axonal fasciculation [GO:0007413]; B cell homeostasis [GO:0001782]; cell fate commitment [GO:0045165]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to organic substance [GO:0071310]; cellular response to staurosporine [GO:0072734]; erythrocyte differentiation [GO:0030218]; execution phase of apoptosis [GO:0097194]; glial cell apoptotic process [GO:0034349]; heart development [GO:0007507]; hippocampus development [GO:0021766]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; intrinsic apoptotic signaling pathway in response to osmotic stress [GO:0008627]; keratinocyte differentiation [GO:0030216]; learning or memory [GO:0007611]; leukocyte apoptotic process [GO:0071887]; luteolysis [GO:0001554]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of apoptotic process [GO:0043066]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cell cycle [GO:0045786]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]; response to amino acid [GO:0043200]; response to cobalt ion [GO:0032025]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to organic substance [GO:0010033]; response to UV [GO:0009411]; response to wounding [GO:0009611]; response to X-ray [GO:0010165]; sensory perception of sound [GO:0007605]; striated muscle cell differentiation [GO:0051146]; T cell homeostasis [GO:0043029]; wound healing [GO:0042060],NA,NA,NA
CHOYP_CASP7.11.23.m.26574,-0.0137702423369577,-0.000804333377573624,No,NA,NA,P97864,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; aspartic-type endopeptidase activity [GO:0004190]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; aging [GO:0007568]; apoptotic process [GO:0006915]; cellular response to staurosporine [GO:0072734]; execution phase of apoptosis [GO:0097194]; heart development [GO:0007507]; leukocyte apoptotic process [GO:0071887]; neuron apoptotic process [GO:0051402]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to UV [GO:0009411]; striated muscle cell differentiation [GO:0051146],NA,NA,NA
CHOYP_CASP7.16.23.m.50828,-0.00856799551719188,0.0123824106449737,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CASP7.17.23.m.52767,-0.00997904171787918,-0.0195504871695299,No,NA,NA,P97864,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; aspartic-type endopeptidase activity [GO:0004190]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; aging [GO:0007568]; apoptotic process [GO:0006915]; cellular response to staurosporine [GO:0072734]; execution phase of apoptosis [GO:0097194]; heart development [GO:0007507]; leukocyte apoptotic process [GO:0071887]; neuron apoptotic process [GO:0051402]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to UV [GO:0009411]; striated muscle cell differentiation [GO:0051146],NA,NA,NA
CHOYP_CASP7.18.23.m.52787,0.00410529319584404,-0.0229697515534836,No,NA,NA,Q60431,NA,NA,NA,cytoplasm [GO:0005737]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; positive regulation of amyloid-beta formation [GO:1902004]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647],NA,NA,NA
CHOYP_CASP7.2.23.m.5415,-0.0141232161764324,0.000544696117209382,No,NA,NA,P55214,NA,NA,NA,cytoplasm [GO:0005737]; cysteine-type endopeptidase activity [GO:0004197]; apoptotic process [GO:0006915],NA,NA,NA
CHOYP_CASP7.21.23.m.63852,-0.0135725579708753,0.00388604629968508,No,NA,NA,P97864,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; aspartic-type endopeptidase activity [GO:0004190]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; aging [GO:0007568]; apoptotic process [GO:0006915]; cellular response to staurosporine [GO:0072734]; execution phase of apoptosis [GO:0097194]; heart development [GO:0007507]; leukocyte apoptotic process [GO:0071887]; neuron apoptotic process [GO:0051402]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to UV [GO:0009411]; striated muscle cell differentiation [GO:0051146],NA,NA,NA
CHOYP_CASP7.22.23.m.66704,0.00230841690341235,-0.000502403540471343,No,NA,NA,P97864,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; aspartic-type endopeptidase activity [GO:0004190]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; aging [GO:0007568]; apoptotic process [GO:0006915]; cellular response to staurosporine [GO:0072734]; execution phase of apoptosis [GO:0097194]; heart development [GO:0007507]; leukocyte apoptotic process [GO:0071887]; neuron apoptotic process [GO:0051402]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to UV [GO:0009411]; striated muscle cell differentiation [GO:0051146],NA,NA,NA
CHOYP_CASP7.5.23.m.12847,-0.00137964188472962,0.00104481266888402,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CASP7.8.23.m.23670,0.00649177483141644,0.00185133731463109,No,NA,NA,O89094,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; keratin filament [GO:0045095]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; peptidase activity [GO:0008233]; apoptotic process [GO:0006915]; cornification [GO:0070268]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630],NA,NA,NA
CHOYP_CASP7.9.23.m.25523,-0.0103788124158573,-0.0232443924366834,No,NA,NA,P55210,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; apoptotic process [GO:0006915]; cellular response to staurosporine [GO:0072734]; execution phase of apoptosis [GO:0097194]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_CAT.1.1.m.57038,0.0182471208290041,-0.0191430520249675,No,NA,NA,P00432,NA,NA,NA,peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; aminoacylase activity [GO:0004046]; catalase activity [GO:0004096]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; aerobic respiration [GO:0009060]; cholesterol metabolic process [GO:0008203]; hemoglobin metabolic process [GO:0020027]; hydrogen peroxide catabolic process [GO:0042744]; negative regulation of apoptotic process [GO:0043066]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; oxidation-reduction process [GO:0055114]; positive regulation of cell division [GO:0051781]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; protein homotetramerization [GO:0051289]; response to hydrogen peroxide [GO:0042542]; triglyceride metabolic process [GO:0006641]; UV protection [GO:0009650],NA,NA,NA
CHOYP_CATA.1.3.m.11120,-0.000545040836951044,0.00137285953608575,No,NA,NA,Q9PWF7,NA,NA,NA,peroxisome [GO:0005777]; catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_CATA.2.3.m.18454,0.0131923294202569,-0.0150333223643037,No,NA,NA,P04040,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial intermembrane space [GO:0005758]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]; aminoacylase activity [GO:0004046]; antioxidant activity [GO:0016209]; catalase activity [GO:0004096]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; oxidoreductase activity; acting on peroxide as acceptor [GO:0016684]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; aerobic respiration [GO:0009060]; aging [GO:0007568]; cellular response to growth factor stimulus [GO:0071363]; cellular response to oxidative stress [GO:0034599]; cholesterol metabolic process [GO:0008203]; hemoglobin metabolic process [GO:0020027]; hydrogen peroxide catabolic process [GO:0042744]; negative regulation of apoptotic process [GO:0043066]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; neutrophil degranulation [GO:0043312]; osteoblast differentiation [GO:0001649]; positive regulation of cell division [GO:0051781]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; protein homotetramerization [GO:0051289]; protein targeting to peroxisome [GO:0006625]; protein tetramerization [GO:0051262]; response to activity [GO:0014823]; response to cadmium ion [GO:0046686]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to inactivity [GO:0014854]; response to insulin [GO:0032868]; response to L-ascorbic acid [GO:0033591]; response to lead ion [GO:0010288]; response to light intensity [GO:0009642]; response to ozone [GO:0010193]; response to phenylpropanoid [GO:0080184]; response to reactive oxygen species [GO:0000302]; response to vitamin A [GO:0033189]; response to vitamin E [GO:0033197]; triglyceride metabolic process [GO:0006641]; ureteric bud development [GO:0001657]; UV protection [GO:0009650],NA,NA,NA
CHOYP_CATA.3.3.m.21642,0.0214218990168475,-0.0131064487027084,No,NA,NA,Q9PWF7,NA,NA,NA,peroxisome [GO:0005777]; catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_CATB.1.2.m.5440,-0.016707452762858,0.0137740181780636,No,NA,NA,A1E295,NA,NA,NA,extracellular space [GO:0005615]; lysosome [GO:0005764]; melanosome [GO:0042470]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of catalytic activity [GO:0050790],NA,NA,NA
CHOYP_CATL1.1.1.m.56906,-0.00866615230214198,0.00954186740526301,No,NA,NA,P25782,NA,NA,NA,cysteine-type peptidase activity [GO:0008234],NA,NA,NA
CHOYP_CATS.1.1.m.45218,-0.00819866761700801,0.0115390754911872,No,NA,NA,O60911,NA,NA,NA,apical part of cell [GO:0045177]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; microvillus [GO:0005902]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; secretory granule [GO:0030141]; aminopeptidase activity [GO:0004177]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; kininogen binding [GO:0030984]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; serine-type endopeptidase activity [GO:0004252]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; autophagic cell death [GO:0048102]; cellular response to starvation [GO:0009267]; decidualization [GO:0046697]; extracellular matrix disassembly [GO:0022617]; multicellular organism aging [GO:0010259]; nerve development [GO:0021675]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of keratinocyte differentiation [GO:0045616]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to gonadotropin [GO:0034698]; response to odorant [GO:1990834]; Sertoli cell differentiation [GO:0060008]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_CB044.1.1.m.53539,0.00929721987098495,-0.00370386500748528,No,NA,NA,Q5RFV8,NA,NA,NA,,NA,NA,NA
CHOYP_CBG09799.1.1.m.44038,0.00157297708538548,-0.0132497709856058,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CBG11254.1.1.m.9107,-0.0213888494394249,0.00377671623031078,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CBG11292.1.1.m.12957,-0.00877660126960671,-0.0169197366534003,No,NA,NA,Q8ISH7,NA,NA,NA,extracellular region [GO:0005576]; neuropeptide hormone activity [GO:0005184]; neuropeptide signaling pathway [GO:0007218],NA,NA,NA
CHOYP_CBG18730.1.1.m.2611,-3.2670905010267e-05,0.00143539021376872,No,NA,NA,Q80T91,NA,NA,NA,basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842],NA,NA,NA
CHOYP_CBG20816.1.1.m.49333,0.00678620130084429,0.00878741825264137,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CBG22657.2.2.m.28802,0.00122045092560886,-0.0156721554955336,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CBLN3.1.2.m.29253,-0.00273883679985268,-0.0254220893926078,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CBP.2.4.m.11401,-0.00534534082827362,0.00453732134867721,No,NA,NA,Q6JHU9,NA,NA,NA,cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; nuclear body [GO:0016604]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor complex [GO:0005667]; acetyltransferase activity [GO:0016407]; activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; histone acetyltransferase activity [GO:0004402]; MRF binding [GO:0043426]; peroxisome proliferator activated receptor binding [GO:0042975]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; cell proliferation [GO:0008283]; cellular response to UV [GO:0034644]; histone acetylation [GO:0016573]; positive regulation of cell adhesion molecule production [GO:0060355]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; protein destabilization [GO:0031648]; regulation of transcription; DNA-templated [GO:0006355]; response to interleukin-1 [GO:0070555]; rhythmic process [GO:0048511],NA,NA,NA
CHOYP_CBPC1.1.1.m.30713,0.00675992773841761,-0.00146214980801539,No,NA,NA,Q5REG1,NA,NA,NA,Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone binding [GO:0042393]; U6 snRNA binding [GO:0017070]; U6atac snRNA binding [GO:0030624]; mRNA splicing; via spliceosome [GO:0000398]; nucleosome assembly [GO:0006334]; positive regulation of histone deubiquitination [GO:1903586]; spliceosomal snRNP assembly [GO:0000387]; spliceosomal tri-snRNP complex assembly [GO:0000244],NA,NA,NA
CHOYP_CBPQ.1.1.m.58629,-0.0145840885380519,-0.000994959572942789,No,NA,NA,Q6GQ29,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; protein homodimerization activity [GO:0042803]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_CBR.GLY.5.1.1.m.26441,0.00429419672153481,0.0130852228402541,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CBR.LET.2.2.2.m.44681,-0.0126904991411995,-0.0199242133440412,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CBR.LET.2.2.2.m.44682,0.00900856888916949,0.0122797993290445,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CBR.LIN.24.1.1.m.5076,-0.0147836342838041,-0.00443558193279479,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CBS.2.2.m.65898,-0.00549036135109562,-0.00257197100301953,No,NA,NA,Q91WT9,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; carbon monoxide binding [GO:0070025]; cystathionine beta-synthase activity [GO:0004122]; cysteine synthase activity [GO:0004124]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; modified amino acid binding [GO:0072341]; nitric oxide binding [GO:0070026]; nitrite reductase (NO-forming) activity [GO:0050421]; oxygen binding [GO:0019825]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; S-adenosyl-L-methionine binding [GO:1904047]; ubiquitin protein ligase binding [GO:0031625]; blood vessel remodeling [GO:0001974]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cellular response to hypoxia [GO:0071456]; cerebellum morphogenesis [GO:0021587]; cysteine biosynthetic process [GO:0019344]; cysteine biosynthetic process from serine [GO:0006535]; cysteine biosynthetic process via cystathionine [GO:0019343]; endochondral ossification [GO:0001958]; homocysteine catabolic process [GO:0043418]; homocysteine metabolic process [GO:0050667]; hydrogen sulfide biosynthetic process [GO:0070814]; L-serine metabolic process [GO:0006563]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of apoptotic process [GO:0043066]; regulation of blood vessel size [GO:0050880]; regulation of JUN kinase activity [GO:0043506]; regulation of nitric oxide mediated signal transduction [GO:0010749]; response to folic acid [GO:0051593]; superoxide metabolic process [GO:0006801]; transsulfuration [GO:0019346],NA,NA,NA
CHOYP_CBWD1.1.1.m.6825,-0.0118330333153798,-0.00924817953836681,No,NA,NA,Q8IUF1,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_CBX1.1.4.m.5390,0.00223827872208104,-0.00308869152840818,No,NA,NA,Q61686,NA,NA,NA,chromocenter [GO:0010369]; heterochromatin [GO:0000792]; histone deacetylase complex [GO:0000118]; histone methyltransferase complex [GO:0035097]; kinetochore [GO:0000776]; nuclear chromosome; telomeric region [GO:0000784]; nuclear heterochromatin [GO:0005720]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; site of DNA damage [GO:0090734]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; methylated histone binding [GO:0035064]; protein binding; bridging [GO:0030674]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; repressing transcription factor binding [GO:0070491]; ribonucleoprotein complex binding [GO:0043021]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892],NA,NA,NA
CHOYP_CBX1.3.4.m.27106,0.0098116610145509,0.0113491549997151,No,NA,NA,Q61686,NA,NA,NA,chromocenter [GO:0010369]; heterochromatin [GO:0000792]; histone deacetylase complex [GO:0000118]; histone methyltransferase complex [GO:0035097]; kinetochore [GO:0000776]; nuclear chromosome; telomeric region [GO:0000784]; nuclear heterochromatin [GO:0005720]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; site of DNA damage [GO:0090734]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; methylated histone binding [GO:0035064]; protein binding; bridging [GO:0030674]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; repressing transcription factor binding [GO:0070491]; ribonucleoprotein complex binding [GO:0043021]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892],NA,NA,NA
CHOYP_CC136.1.1.m.64302,-0.00853714201203973,-0.0138183418508379,No,NA,NA,Q01844,NA,NA,NA,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_CC171.1.1.m.55237,-0.00867903714092577,-0.00288592922649018,No,NA,NA,E9Q1U1,NA,NA,NA,,NA,NA,NA
CHOYP_CC1G_13336.1.3.m.23079,-0.00174989127075814,-0.0160842513047495,No,NA,NA,O94581,NA,NA,NA,mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrial respiratory chain complex IV assembly [GO:0033617],NA,NA,NA
CHOYP_CCAR1.1.1.m.25430,-0.0130879870731924,0.00501561921211716,No,NA,NA,Q641G3,NA,NA,NA,perinuclear region of cytoplasm [GO:0048471]; cell cycle [GO:0007049]; regulation of transcription; DNA-templated [GO:0006355]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_CCBL1.1.1.m.30637,-0.0161377026491713,0.00191413382260388,No,NA,NA,Q7T3E5,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; cysteine-S-conjugate beta-lyase activity [GO:0047804]; kynurenine-glyoxylate transaminase activity [GO:0047315]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; pyridoxal phosphate binding [GO:0030170]; biosynthetic process [GO:0009058]; cellular amino acid metabolic process [GO:0006520]; kynurenine metabolic process [GO:0070189],NA,NA,NA
CHOYP_CCD22.1.1.m.6639,0.000431770287194508,0.0122380629515793,No,NA,NA,A7RNG8,NA,NA,NA,cullin family protein binding [GO:0097602]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060],NA,NA,NA
CHOYP_CCD43.1.1.m.63636,-0.00629539758430365,-0.0100268148354862,No,NA,NA,Q6PFL6,NA,NA,NA,,NA,NA,NA
CHOYP_CCD53.1.1.m.6684,0.0013391777916315,0.0112034044365507,No,NA,NA,Q5RGJ6,NA,NA,NA,WASH complex [GO:0071203]; actin filament polymerization [GO:0030041]; exocytosis [GO:0006887],NA,NA,NA
CHOYP_CCD73.1.2.m.21485,-0.00311482943823609,-0.0103253741656851,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CCDC146.1.1.m.11347,-0.0169591047060434,0.00960206869202777,No,NA,NA,Q8IYE0,NA,NA,NA,centriole [GO:0005814],NA,NA,NA
CHOYP_CCDC150.1.1.m.58800,-0.00149069617218707,-0.0106465609623128,No,NA,NA,Q8NCX0,NA,NA,NA,,NA,NA,NA
CHOYP_CCDC6.1.1.m.13918,0.00987576134678698,-0.00195199482869303,No,NA,NA,Q16204,NA,NA,NA,cytoskeleton [GO:0005856]; cytosol [GO:0005829]; SH3 domain binding [GO:0017124]; structural constituent of cytoskeleton [GO:0005200],NA,NA,NA
CHOYP_CCHCR1.1.1.m.59142,-0.00890132569981275,0.00883419096309595,No,NA,NA,Q566U4,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; arylformamidase activity [GO:0004061]; 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; tryptophan catabolic process to kynurenine [GO:0019441],NA,NA,NA
CHOYP_CCHL.2.2.m.66608,0.000686232728993108,-0.0107331332691118,No,NA,NA,Q5F339,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; holocytochrome-c synthase activity [GO:0004408]; metal ion binding [GO:0046872]; cytochrome c-heme linkage [GO:0018063],NA,NA,NA
CHOYP_CCKAR.4.6.m.43964,0.00491588973115351,-0.000600714720400964,No,NA,NA,P70031,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930],NA,NA,NA
CHOYP_CCNB.2.2.m.16936,-0.0225665594713063,0.00999192889377058,No,NA,NA,Q5XIK8,NA,NA,NA,phosphoprotein phosphatase activity [GO:0004721],NA,NA,NA
CHOYP_CCNL1.1.2.m.9018,-0.00942478965373355,-0.00954344950623587,No,NA,NA,Q6GN15,NA,NA,NA,nuclear speck [GO:0016607]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of transcription; DNA-templated [GO:0006355]; RNA processing [GO:0006396],NA,NA,NA
CHOYP_CD033.1.1.m.25350,0.00308579665995723,0.000599120041817783,No,NA,NA,Q8BGN2,NA,NA,NA,,NA,NA,NA
CHOYP_CD109.1.2.m.7033,-0.00462022156613356,-0.0115877347420854,No,NA,NA,Q6YHK3,NA,NA,NA,anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616],NA,NA,NA
CHOYP_CD11B.1.1.m.51509,-0.00280127703226191,-0.0145186869209242,No,NA,NA,P21127,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; cell proliferation [GO:0008283]; mitotic cell cycle [GO:0000278]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of mRNA processing [GO:0050684]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_CD36_40650.1.1.m.47015,-0.00168539322411456,0.0131354584444642,No,NA,NA,O35601,NA,NA,NA,actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; lipid binding [GO:0008289]; protein-containing complex binding [GO:0044877]; immune response [GO:0006955]; integrin-mediated signaling pathway [GO:0007229]; protein localization to plasma membrane [GO:0072659]; T cell receptor signaling pathway [GO:0050852],NA,NA,NA
CHOYP_CDC14A.1.1.m.18068,0.00297983243308073,0.00314759471694291,No,NA,NA,Q9UNH5,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinociliary basal body [GO:1902636]; kinocilium [GO:0060091]; mitotic spindle [GO:0072686]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; stereocilium tip [GO:0032426]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; cell division [GO:0051301]; cell proliferation [GO:0008283]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; mitotic cell cycle arrest [GO:0071850]; positive regulation of cytokinesis [GO:0032467]; regulation of exit from mitosis [GO:0007096]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_CDC23.1.1.m.6463,-0.00831898987345843,-0.00418757059370242,No,NA,NA,A1A4R8,NA,NA,NA,anaphase-promoting complex [GO:0005680]; cell division [GO:0051301]; mitotic metaphase plate congression [GO:0007080]; protein K11-linked ubiquitination [GO:0070979]; regulation of mitotic metaphase/anaphase transition [GO:0030071],NA,NA,NA
CHOYP_CDC42.1.11.m.324,0.0189470544913882,0.0060562829555977,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CDC42.11.11.m.60002,-0.0169591047060434,0.00960206869202778,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CDC42.11.11.m.60004,-0.0157510639120698,0.0114681197996711,No,NA,NA,Q29HY3,NA,NA,NA,adherens junction [GO:0005912]; apical part of cell [GO:0045177]; cell cortex [GO:0005938]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; axon extension [GO:0048675]; branching involved in open tracheal system development [GO:0060446]; cell projection assembly [GO:0030031]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; establishment of neuroblast polarity [GO:0045200]; exocyst localization [GO:0051601]; hemocyte migration [GO:0035099]; imaginal disc-derived wing hair outgrowth [GO:0035318]; maintenance of cell polarity [GO:0030011]; maintenance of protein location [GO:0045185]; melanotic encapsulation of foreign target [GO:0035011]; motor neuron axon guidance [GO:0008045]; nephrocyte filtration [GO:0097206]; neuromuscular synaptic transmission [GO:0007274]; ommatidial rotation [GO:0016318]; phagocytosis [GO:0006909]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of JNK cascade [GO:0046330]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of wound healing [GO:0090303]; protein localization to plasma membrane [GO:0072659]; regulation of actin filament polymerization [GO:0030833]; regulation of axonogenesis [GO:0050770]; regulation of cell shape [GO:0008360]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; Rho protein signal transduction [GO:0007266]; sensory perception of touch [GO:0050975]; spermatid development [GO:0007286]; wound healing [GO:0042060],NA,NA,NA
CHOYP_CDC5L.1.1.m.25107,-0.0204556346438286,-0.00875738054524092,No,NA,NA,O08837,NA,NA,NA,DNA replication factor A complex [GO:0005662]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-DNA complex [GO:0032993]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; leucine zipper domain binding [GO:0043522]; protein kinase binding [GO:0019901]; protein phosphatase 1 binding [GO:0008157]; RNA binding [GO:0003723]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor binding [GO:0001222]; WD40-repeat domain binding [GO:0071987]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to interleukin-2 [GO:0071352]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to prolactin [GO:1990646]; cellular response to wortmannin [GO:1904568]; DNA repair [GO:0006281]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; mRNA splicing; via spliceosome [GO:0000398]; regulation of transcription; DNA-templated [GO:0006355]; signal transduction involved in DNA damage checkpoint [GO:0072422],NA,NA,NA
CHOYP_CDC73.1.1.m.36157,-0.00777518406698731,-0.00179797346672426,No,NA,NA,Q5ZLM0,NA,NA,NA,Cdc73/Paf1 complex [GO:0016593]; nucleus [GO:0005634]; RNA polymerase II complex binding [GO:0000993]; cell cycle [GO:0007049]; cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; histone modification [GO:0016570]; mRNA polyadenylation [GO:0006378]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of Wnt signaling pathway [GO:0030177]; recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex [GO:0034402]; regulation of cell growth [GO:0001558]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368],NA,NA,NA
CHOYP_CDK13.1.1.m.59965,-0.00193408664203835,-0.00585690402807892,No,NA,NA,Q9NYV4,NA,NA,NA,chromosome [GO:0005694]; cyclin K-CDK12 complex [GO:0002944]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; fibrillar center [GO:0001650]; nuclear chromatin [GO:0000790]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; mRNA processing [GO:0006397]; negative regulation of stem cell differentiation [GO:2000737]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of MAP kinase activity [GO:0043405]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; transcription elongation from RNA polymerase II promoter [GO:0006368],NA,NA,NA
CHOYP_CDK5.1.1.m.25495,-0.0122165394791994,-0.00467805314072716,No,NA,NA,P49615,NA,NA,NA,axon [GO:0030424]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule [GO:0005874]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; protein kinase 5 complex [GO:0016533]; Schaffer collateral - CA1 synapse [GO:0098685]; acetylcholine receptor activator activity [GO:0030549]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cytoskeletal protein binding [GO:0008092]; ephrin receptor binding [GO:0046875]; ErbB-2 class receptor binding [GO:0005176]; ErbB-3 class receptor binding [GO:0043125]; Hsp90 protein binding [GO:0051879]; kinase activity [GO:0016301]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels [GO:0099635]; apoptotic process [GO:0006915]; associative learning [GO:0008306]; axonogenesis [GO:0007409]; behavioral response to cocaine [GO:0048148]; calcium ion import [GO:0070509]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cellular response to amyloid-beta [GO:1904646]; central nervous system neuron development [GO:0021954]; cerebellar cortex development [GO:0021695]; cerebellar cortex formation [GO:0021697]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; corpus callosum development [GO:0022038]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; excitatory postsynaptic potential [GO:0060079]; exocytosis [GO:0006887]; forebrain development [GO:0030900]; hippocampus development [GO:0021766]; histone phosphorylation [GO:0016572]; intracellular protein transport [GO:0006886]; layer formation in cerebral cortex [GO:0021819]; mitochondrion organization [GO:0007005]; motor neuron axon guidance [GO:0008045]; negative regulation of axon extension [GO:0030517]; negative regulation of cell cycle [GO:0045786]; negative regulation of neuron death [GO:1901215]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of synaptic plasticity [GO:0031914]; negative regulation of transcription; DNA-templated [GO:0045892]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; nucleocytoplasmic transport [GO:0006913]; oligodendrocyte differentiation [GO:0048709]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of glial cell apoptotic process [GO:0034352]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron death [GO:1901216]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein targeting to membrane [GO:0090314]; protein autophosphorylation [GO:0046777]; protein localization to synapse [GO:0035418]; protein phosphorylation [GO:0006468]; receptor catabolic process [GO:0032801]; receptor clustering [GO:0043113]; regulated exocytosis [GO:0045055]; regulation of cell migration [GO:0030334]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of postsynaptic membrane potential [GO:0060078]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission; glutamatergic [GO:0051966]; response to cocaine [GO:0042220]; response to wounding [GO:0009611]; rhythmic process [GO:0048511]; Schwann cell development [GO:0014044]; sensory perception of pain [GO:0019233]; serine phosphorylation of STAT protein [GO:0042501]; skeletal muscle tissue development [GO:0007519]; synapse assembly [GO:0007416]; synapse pruning [GO:0098883]; synaptic transmission; dopaminergic [GO:0001963]; synaptic transmission; glutamatergic [GO:0035249]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle transport [GO:0048489]; telencephalon development [GO:0021537]; visual learning [GO:0008542],NA,NA,NA
CHOYP_CDO1.1.4.m.26663,0.01228816031807,0.0165176122223356,No,NA,NA,Q6NWZ9,NA,NA,NA,cysteine dioxygenase activity [GO:0017172]; iron ion binding [GO:0005506]; taurine biosynthetic process [GO:0042412],NA,NA,NA
CHOYP_CDPK5.1.1.m.6214,0.0192944058050688,0.000615309076284976,No,NA,NA,P04630,NA,NA,NA,nucleus [GO:0005634]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]; spindle pole body organization [GO:0051300],NA,NA,NA
CHOYP_CDPKM.1.1.m.58179,0.0101989061030094,-9.11328383984027e-05,No,NA,NA,P23286,NA,NA,NA,calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722],NA,NA,NA
CHOYP_CE112.1.2.m.11508,0.00798086201070086,0.000714341065721911,No,NA,NA,Q8N8E3,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; inhibitory synapse [GO:0060077]; plasma membrane [GO:0005886]; receptor localization to synapse [GO:0097120],NA,NA,NA
CHOYP_CE120.1.2.m.19214,-0.0145187350727862,-0.00797281667830697,No,NA,NA,Q8N960,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; protein C-terminus binding [GO:0008022]; astral microtubule organization [GO:0030953]; centrosome cycle [GO:0007098]; cerebral cortex development [GO:0021987]; interkinetic nuclear migration [GO:0022027]; neurogenesis [GO:0022008]; positive regulation of centriole elongation [GO:1903724]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of cilium assembly [GO:0045724]; positive regulation of establishment of protein localization [GO:1904951],NA,NA,NA
CHOYP_CEBPZ.1.1.m.12869,-0.0147107930863935,-0.0182740809933348,No,NA,NA,P53569,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; positive regulation of transcription by RNA polymerase II [GO:0045944]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_CECR2.2.3.m.13613,0.00726331504356434,-0.0123946612585214,No,NA,NA,Q9BXF3,NA,NA,NA,CERF complex [GO:0090537]; nucleus [GO:0005634]; apoptotic DNA fragmentation [GO:0006309]; ATP-dependent chromatin remodeling [GO:0043044]; cytoskeleton organization [GO:0007010]; cytoskeleton-dependent cytokinesis [GO:0061640]; execution phase of apoptosis [GO:0097194]; neural tube development [GO:0021915]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_CECR2.3.3.m.59311,0.0057518665764431,-0.0155504242234991,No,NA,NA,Q9BXF3,NA,NA,NA,CERF complex [GO:0090537]; nucleus [GO:0005634]; apoptotic DNA fragmentation [GO:0006309]; ATP-dependent chromatin remodeling [GO:0043044]; cytoskeleton organization [GO:0007010]; cytoskeleton-dependent cytokinesis [GO:0061640]; execution phase of apoptosis [GO:0097194]; neural tube development [GO:0021915]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_CED1.20.29.m.45054,-0.00430894344577715,-0.00631540690244347,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CED1.22.29.m.48193,0.00441962396690306,-0.0051203424976495,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CED1.26.29.m.53629,-0.0169591047060434,0.00960206869202778,No,NA,NA,O75095,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_CED1.9.29.m.29470,-0.0223833920835252,0.010624910862693,No,NA,NA,A0JM12,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; myofibril assembly [GO:0030239]; phagocytosis [GO:0006909]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_CEG1A.1.6.m.815,0.0102857279417343,-0.00320176996692566,No,NA,NA,Q6NRL1,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; protein transport [GO:0015031],NA,NA,NA
CHOYP_CEL.2.3.m.27351,-0.00305735013927204,-0.0121489872452812,No,NA,NA,P07882,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]; synapse [GO:0045202]; zymogen granule [GO:0042588]; carboxylic ester hydrolase activity [GO:0052689]; glycosphingolipid binding [GO:0043208]; lysophospholipase activity [GO:0004622]; neurexin family protein binding [GO:0042043]; protein-containing complex binding [GO:0044877]; retinyl-palmitate esterase activity [GO:0050253]; signaling receptor activity [GO:0038023]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]; modulation of chemical synaptic transmission [GO:0050804]; neuron cell-cell adhesion [GO:0007158]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; synaptic vesicle endocytosis [GO:0048488],NA,NA,NA
CHOYP_CELA1.1.3.m.14531,0.00202313429339194,-0.0148249795191659,No,NA,NA,P00773,NA,NA,NA,extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_CELA1.2.3.m.27287,-0.00357592236073357,0.00290302203872618,No,NA,NA,Q7SIG3,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252],NA,NA,NA
CHOYP_CELE_F01D5.5.1.1.m.4263,0.0183713388480261,0.0131195110011489,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CELE_F01D5.5.1.1.m.4265,0.0168602546692844,0.0179184665611914,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CELE_Y64G10A.7.3.4.m.53262,0.00364778592941831,-0.00872052841558097,No,NA,NA,A0JM12,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; myofibril assembly [GO:0030239]; phagocytosis [GO:0006909]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_CELF2.2.4.m.22506,0.0162367907034065,-0.0033163562158468,No,NA,NA,Q6P0B1,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA splice site selection [GO:0006376]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],NA,NA,NA
CHOYP_CELF4.1.1.m.22429,-0.0102014560288983,0.00111087754476111,No,NA,NA,Q6DGV1,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA splice site selection [GO:0006376]; positive regulation of mRNA splicing; via spliceosome [GO:0048026]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],NA,NA,NA
CHOYP_CELR2.3.8.m.29505,-0.0131583778300733,-0.00184657849927864,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CENPJ.1.1.m.49318,0.00205195042830452,-0.00934116934689426,No,NA,NA,Q569L8,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; tubulin binding [GO:0015631]; astral microtubule nucleation [GO:0030954]; cell division [GO:0051301]; centriole assembly [GO:0098534]; centriole elongation [GO:0061511]; centriole replication [GO:0007099]; centrosome duplication [GO:0051298]; microtubule polymerization [GO:0046785]; mitotic spindle pole body duplication [GO:1903087]; motile cilium assembly [GO:0044458]; non-motile cilium assembly [GO:1905515]; positive regulation of centriole elongation [GO:1903724]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of JAK-STAT cascade [GO:0046427]; positive regulation of non-motile cilium assembly [GO:1902857]; regulation of centriole replication [GO:0046599]; smoothened signaling pathway [GO:0007224],NA,NA,NA
CHOYP_CENTRIN.1.1.m.59526,0.0177808772866654,0.0144124972686481,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CEP164.1.1.m.40330,-0.00269427369580662,0.0103788752759664,No,NA,NA,Q9UPV0,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; cell division [GO:0051301]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; DNA repair [GO:0006281]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of G2/M transition of mitotic cell cycle [GO:0010389],NA,NA,NA
CHOYP_CEP192.1.2.m.7869,0.00774629309963527,0.00207928328404454,No,NA,NA,Q8TEP8,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; pericentriolar material [GO:0000242]; phosphatase binding [GO:0019902]; centrosome duplication [GO:0051298]; centrosome-templated microtubule nucleation [GO:0090222]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic spindle assembly [GO:0090307]; negative regulation of phosphatase activity [GO:0010923]; protein localization to centrosome [GO:0071539]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_CEP290.1.1.m.58767,-0.00227784758801489,-0.0119440664638335,No,NA,NA,O15078,NA,NA,NA,centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; MKS complex [GO:0036038]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; protein-containing complex [GO:0032991]; specific granule lumen [GO:0035580]; identical protein binding [GO:0042802]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; eye photoreceptor cell development [GO:0042462]; G2/M transition of mitotic cell cycle [GO:0000086]; hindbrain development [GO:0030902]; neutrophil degranulation [GO:0043312]; otic vesicle formation [GO:0030916]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of transcription; DNA-templated [GO:0045893]; pronephros development [GO:0048793]; protein transport [GO:0015031]; regulation of establishment of protein localization [GO:0070201]; regulation of G2/M transition of mitotic cell cycle [GO:0010389],NA,NA,NA
CHOYP_CEP350.1.1.m.4119,-0.000638204464315374,0.0033887714827567,No,NA,NA,E9Q309,NA,NA,NA,cell projection [GO:0042995]; centriole [GO:0005814]; centrosome [GO:0005813]; nucleus [GO:0005634]; spindle [GO:0005819]; microtubule binding [GO:0008017]; microtubule anchoring [GO:0034453],NA,NA,NA
CHOYP_CEP63.2.2.m.35716,-0.000526983105764102,0.00488209859023435,No,NA,NA,Q86X83,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_CEP76.1.1.m.6264,0.00170433519892022,0.0115784930881104,No,NA,NA,Q28DH9,NA,NA,NA,centriole [GO:0005814]; regulation of centriole replication [GO:0046599],NA,NA,NA
CHOYP_CEP89.1.2.m.14339,-0.0043499829086317,-0.00855171661421107,No,NA,NA,Q9CZX2,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; chemical synaptic transmission [GO:0007268]; cilium assembly [GO:0060271]; mitochondrion organization [GO:0007005]; non-motile cilium assembly [GO:1905515],NA,NA,NA
CHOYP_CERS6.1.1.m.5214,0.0222307280646754,-0.0130646220760492,No,NA,NA,Q9D6K9,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; DNA binding [GO:0003677]; sphingosine N-acyltransferase activity [GO:0050291]; ceramide biosynthetic process [GO:0046513]; sphingolipid biosynthetic process [GO:0030148],NA,NA,NA
CHOYP_CETN1.1.3.m.15199,-0.0101770627819205,0.0020922683941715,No,NA,NA,Q9R1K9,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; XPC complex [GO:0071942]; calcium ion binding [GO:0005509]; G-protein beta/gamma-subunit complex binding [GO:0031683]; heterotrimeric G-protein binding [GO:0032795]; microtubule binding [GO:0008017]; calcium-mediated signaling [GO:0019722]; centriole replication [GO:0007099]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; nucleotide-excision repair [GO:0006289]; regulation of centrosome duplication [GO:0010824]; regulation of cytokinesis [GO:0032465]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_CF106.1.1.m.14354,0.000686232728993107,-0.0107331332691118,No,NA,NA,Q3TT38,NA,NA,NA,autophagosome [GO:0005776]; phagophore assembly site [GO:0000407]; ubiquitin binding [GO:0043130]; macroautophagy [GO:0016236],NA,NA,NA
CHOYP_CG057.1.1.m.45912,-0.00994707222712759,0.00166491988564023,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CG14207.1.1.m.41523,0.0130972391491823,0.0222183960076846,No,NA,NA,Q9EPF3,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; structural constituent of eye lens [GO:0005212],NA,NA,NA
CHOYP_CG17147.1.1.m.28107,-0.0151234887121513,0.00582500334842874,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CG34417.1.2.m.18203,-0.00269406043086957,0.0120860442619813,No,NA,NA,A8MU46,NA,NA,NA,contractile fiber [GO:0043292]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; I band [GO:0031674]; M band [GO:0031430]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; calmodulin binding [GO:0005516]; protein phosphatase 1 binding [GO:0008157]; tropomyosin binding [GO:0005523]; actin cytoskeleton organization [GO:0030036]; negative regulation of blood vessel diameter [GO:0097756]; positive regulation of vasoconstriction [GO:0045907],NA,NA,NA
CHOYP_CG42749.1.1.m.30138,0.01742169502802,-0.0142996873078304,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CGD4_750.1.1.m.29180,0.00966087217413188,0.0103147172662396,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CGL.1.2.m.31960,0.00699860611724635,0.022280603067376,No,NA,NA,Q60HG7,NA,NA,NA,cytoplasm [GO:0005737]; calmodulin binding [GO:0005516]; cystathionine gamma-lyase activity [GO:0004123]; L-cysteine desulfhydrase activity [GO:0080146]; L-cystine L-cysteine-lyase (deaminating) [GO:0044540]; pyridoxal phosphate binding [GO:0030170]; cysteine biosynthetic process [GO:0019344]; hydrogen sulfide biosynthetic process [GO:0070814]; negative regulation of apoptotic process [GO:0043066]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein sulfhydration [GO:0044524]; protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine [GO:0018272],NA,NA,NA
CHOYP_CH60.1.1.m.26967,0.0132345368320374,-0.0088405671459552,No,NA,NA,O02649,NA,NA,NA,cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; 'de novo' protein folding [GO:0006458]; apoptotic mitochondrial changes [GO:0008637]; cellular response to heat [GO:0034605]; mitochondrion organization [GO:0007005]; protein import into mitochondrial intermembrane space [GO:0045041]; protein refolding [GO:0042026]; protein targeting to mitochondrion [GO:0006626],NA,NA,NA
CHOYP_CHCHD1.1.1.m.25210,-0.00119425598893371,0.0226819176030402,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CHD2.1.1.m.36132,0.00153640380189646,-0.00988606883455704,No,NA,NA,B6ZLK2,NA,NA,NA,chromosome; centromeric region [GO:0000775]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386],NA,NA,NA
CHOYP_CHD5.2.2.m.28708,-0.0170402690637592,0.00071300789952778,No,NA,NA,D3ZD32,NA,NA,NA,heterochromatin [GO:0000792]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; H3K27me3 modified histone binding [GO:0061628]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; cerebral cortex neuron differentiation [GO:0021895]; histone H3-K27 trimethylation [GO:0098532]; histone H4 acetylation [GO:0043967]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; regulation of transcription involved in cell fate commitment [GO:0060850]; spermatogenesis; exchange of chromosomal proteins [GO:0035093]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_CHD7.2.2.m.14418,-0.00598602423380899,-0.0144504684966901,No,NA,NA,Q8BYH8,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; chromatin organization [GO:0006325],NA,NA,NA
CHOYP_CHER.1.1.m.63350,-0.000540786824191481,0.0116373466725378,No,NA,NA,Q9VEN1,NA,NA,NA,actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; female germline ring canal outer rim [GO:0035182]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; actin binding [GO:0003779]; behavioral response to ethanol [GO:0048149]; cytoplasmic transport; nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation; actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sarcomere organization [GO:0045214],NA,NA,NA
CHOYP_CHERP.1.1.m.22401,0.000103987995095955,-0.00944738715955164,No,NA,NA,Q8CGZ0,NA,NA,NA,cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; sarcoplasmic reticulum membrane [GO:0033017]; ion channel binding [GO:0044325]; RNA binding [GO:0003723]; cellular calcium ion homeostasis [GO:0006874]; negative regulation of cell proliferation [GO:0008285]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; release of sequestered calcium ion into cytosol [GO:0051209]; RNA processing [GO:0006396],NA,NA,NA
CHOYP_CHGG_10233.1.1.m.39238,0.0173391484853431,0.0131299933462912,No,NA,NA,Q4I963,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; actin binding [GO:0003779]; actin filament depolymerization [GO:0030042]; cell cycle [GO:0007049]; cell division [GO:0051301],NA,NA,NA
CHOYP_CHI1.1.1.m.40259,0.00394536801625317,0.00291369700370642,No,NA,NA,H2A0L4,NA,NA,NA,extracellular region [GO:0005576]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_CHKA.1.1.m.25454,-0.000871084733032961,-0.00667960429869515,No,NA,NA,Q9Y259,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; choline kinase activity [GO:0004103]; ethanolamine kinase activity [GO:0004305]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646],NA,NA,NA
CHOYP_CHL1.2.2.m.65829,0.0054209288641852,-0.00608907274151806,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CHM2A.1.1.m.59752,-0.00424686891332051,0.0184772708240357,No,NA,NA,Q7ZW25,NA,NA,NA,ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]; nuclear envelope [GO:0005635]; endosome transport via multivesicular body sorting pathway [GO:0032509]; exit from mitosis [GO:0010458]; late endosome to vacuole transport [GO:0045324]; nuclear envelope reassembly [GO:0031468]; protein transport [GO:0015031],NA,NA,NA
CHOYP_CHM4B.1.1.m.19057,0.00162310055990434,0.00637920501820385,No,NA,NA,Q5XGW6,NA,NA,NA,cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; exit from mitosis [GO:0010458]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; nuclear envelope reassembly [GO:0031468]; protein transport [GO:0015031]; vacuolar transport [GO:0007034],NA,NA,NA
CHOYP_CHMP3.1.1.m.65684,8.65898100884434e-05,-0.0071734821310797,No,NA,NA,Q8CGS4,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; ESCRT III complex [GO:0000815]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; midbody [GO:0030496]; multivesicular body [GO:0005771]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; cell cycle [GO:0007049]; cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to vacuole transport [GO:0045324]; positive regulation of cytokinesis [GO:0032467]; protein transport [GO:0015031]; regulation of endosome size [GO:0051036],NA,NA,NA
CHOYP_CHMP5.1.1.m.66827,-0.0147337258147147,-0.00645572730125666,No,NA,NA,Q4QQV8,NA,NA,NA,cytosol [GO:0005829]; endosome membrane [GO:0010008]; nucleus [GO:0005634]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to muramyl dipeptide [GO:0071225]; endosome to lysosome transport [GO:0008333]; lysosome organization [GO:0007040]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body sorting pathway [GO:0071985]; nucleus organization [GO:0006997]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; regulation of receptor recycling [GO:0001919]; viral budding [GO:0046755],NA,NA,NA
CHOYP_CHMP7.1.1.m.15221,0.00370641017008542,0.0166374180423543,No,NA,NA,Q7T0X5,NA,NA,NA,ESCRT III complex [GO:0000815]; nuclear envelope [GO:0005635]; protein transporter activity [GO:0008565]; exit from mitosis [GO:0010458]; late endosome to vacuole transport [GO:0045324]; nuclear envelope reassembly [GO:0031468],NA,NA,NA
CHOYP_CHRD1.1.1.m.42143,0.016235341865752,-0.00795492426907341,No,NA,NA,Q7T3F7,NA,NA,NA,metal ion binding [GO:0046872]; regulation of centrosome duplication [GO:0010824],NA,NA,NA
CHOYP_CHRO_0413.1.2.m.16023,-0.0183623038065071,0.00550992553293632,No,NA,NA,A6QLH5,NA,NA,NA,3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; DNA catabolic process; exonucleolytic [GO:0000738]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000467],NA,NA,NA
CHOYP_CHS.2.1.1.m.37794,0.00784462031363254,-0.0114002767556212,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CHS1.1.4.m.4755,-0.0139574282856996,-0.00172139089794657,No,NA,NA,G5EBQ8,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063],NA,NA,NA
CHOYP_CHS2.1.1.m.63783,0.00678620130084428,0.00878741825264137,No,NA,NA,G5EBQ8,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063],NA,NA,NA
CHOYP_CHSS2.1.1.m.19314,0.00394536801625317,0.00291369700370642,No,NA,NA,Q6IQX7,NA,NA,NA,cytosol [GO:0005829]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; mitochondrial matrix [GO:0005759]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; metal ion binding [GO:0046872]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO:0050510]; transferase activity; transferring glycosyl groups [GO:0016757]; chondroitin sulfate biosynthetic process [GO:0030206],NA,NA,NA
CHOYP_CHTOP.1.1.m.35404,-0.00751543361997754,-0.00316596744860194,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CI064.1.1.m.9517,-0.00878231485419325,-0.017927363821203,No,NA,NA,Q1JP73,NA,NA,NA,tRNA-guanine transglycosylation [GO:0101030],NA,NA,NA
CHOYP_CIAO1.1.1.m.48324,0.00986116473944769,-0.000984088651382454,No,NA,NA,A7RWD2,NA,NA,NA,CIA complex [GO:0097361]; iron-sulfur cluster assembly [GO:0016226],NA,NA,NA
CHOYP_CIC.1.2.m.57436,0.00559402286800436,-0.00635248559437883,No,NA,NA,Q96RK0,NA,NA,NA,intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; brain development [GO:0007420]; learning [GO:0007612]; lung alveolus development [GO:0048286]; memory [GO:0007613]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; social behavior [GO:0035176],NA,NA,NA
CHOYP_CIR1.1.2.m.16126,-0.0104181704481524,-0.00888533203794046,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CIR1A.1.1.m.11568,0.00413625868279585,-0.000495014429367506,No,NA,NA,Q969X6,NA,NA,NA,90S preribosome [GO:0030686]; chromosome [GO:0005694]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; t-UTP complex [GO:0034455]; RNA binding [GO:0003723]; maturation of SSU-rRNA [GO:0030490]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462]; regulation of transcription; DNA-templated [GO:0006355]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_CISD2.1.1.m.26823,-0.00922932906597183,-0.01780705908939,No,NA,NA,C1C524,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; 2 iron; 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; autophagy of mitochondrion [GO:0000422]; multicellular organism aging [GO:0010259]; regulation of autophagy [GO:0010506],NA,NA,NA
CHOYP_CISY.1.1.m.36666,-0.00728901835517975,-0.0166000827845557,No,NA,NA,Q7ZVY5,NA,NA,NA,mitochondrial matrix [GO:0005759]; citrate (Si)-synthase activity [GO:0004108]; carbohydrate metabolic process [GO:0005975]; response to activity [GO:0014823]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_CKAP5.1.1.m.10679,-0.0155484415912802,0.0043067555223476,No,NA,NA,Q14008,NA,NA,NA,centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]; cadherin binding [GO:0045296]; microtubule plus-end binding [GO:0051010]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; centrosome duplication [GO:0051298]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule depolymerization [GO:0007019]; microtubule polymerization [GO:0046785]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; RNA transport [GO:0050658]; spindle organization [GO:0007051],NA,NA,NA
CHOYP_CKLF4.1.1.m.55295,-0.00769521327470958,-0.00144440782895257,No,NA,NA,Q8IZR5,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_CLAP1.4.6.m.39950,-0.00128767862016808,0.00196394864009968,No,NA,NA,A1A5G0,NA,NA,NA,condensed chromosome kinetochore [GO:0000777]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; kinetochore microtubule [GO:0005828]; microtubule organizing center [GO:0005815]; kinetochore binding [GO:0043515]; microtubule plus-end binding [GO:0051010]; cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule anchoring [GO:0034453]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023],NA,NA,NA
CHOYP_CLAP1.6.6.m.57823,0.00187914602742441,0.00171851399479476,No,NA,NA,Q7Z460,NA,NA,NA,basal cortex [GO:0045180]; cell cortex [GO:0005938]; centrosomal corona [GO:0031592]; centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cortical microtubule cytoskeleton [GO:0030981]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; membrane [GO:0016020]; microtubule plus-end [GO:0035371]; spindle microtubule [GO:0005876]; dystroglycan binding [GO:0002162]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; astral microtubule organization [GO:0030953]; cell division [GO:0051301]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment of epithelial cell polarity [GO:0090162]; establishment of mitotic spindle localization [GO:0040001]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of cell polarity [GO:0007163]; exit from mitosis [GO:0010458]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi organization [GO:0007030]; microtubule anchoring [GO:0034453]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of microtubule polymerization or depolymerization [GO:0031111]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of wound healing; spreading of epidermal cells [GO:1903690]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of exocytosis [GO:0045921]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of microtubule polymerization [GO:0031116]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of focal adhesion assembly [GO:0051893]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of gastrulation [GO:0010470]; regulation of microtubule cytoskeleton organization [GO:0070507]; vesicle targeting [GO:0006903],NA,NA,NA
CHOYP_CLASR.1.2.m.27688,-0.0169591047060434,0.00960206869202777,No,NA,NA,Q5HZB6,NA,NA,NA,nucleoplasm [GO:0005654]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_CLCN3.1.1.m.21245,-0.00933150883780593,-0.00524460328738769,No,NA,NA,P51791,NA,NA,NA,apical plasma membrane [GO:0016324]; axon terminus [GO:0043679]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; inhibitory synapse [GO:0060077]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of synaptic vesicle membrane [GO:0030285]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; specific granule [GO:0042581]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; vesicle membrane [GO:0012506]; antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride channel activity [GO:0005254]; chloride ion binding [GO:0031404]; ion channel activity [GO:0005216]; PDZ domain binding [GO:0030165]; protein heterodimerization activity [GO:0046982]; solute:proton antiporter activity [GO:0015299]; voltage-gated chloride channel activity [GO:0005247]; voltage-gated ion channel activity [GO:0005244]; adult locomotory behavior [GO:0008344]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transport [GO:0006811]; negative regulation of cell volume [GO:0045794]; neuron cellular homeostasis [GO:0070050]; phagocytosis; engulfment [GO:0006911]; photoreceptor cell maintenance [GO:0045494]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; synaptic transmission; GABAergic [GO:0051932]; synaptic transmission; glutamatergic [GO:0035249]; synaptic vesicle lumen acidification [GO:0097401],NA,NA,NA
CHOYP_CLCN7.2.3.m.47039,0.00394536801625317,0.00291369700370642,No,NA,NA,O70496,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; antiporter activity [GO:0015297]; ATP binding [GO:0005524]; voltage-gated chloride channel activity [GO:0005247]; chloride transmembrane transport [GO:1902476]; response to pH [GO:0009268],NA,NA,NA
CHOYP_CLCN7.3.3.m.51894,0.00615966897194063,0.00941964587728867,No,NA,NA,O70496,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; antiporter activity [GO:0015297]; ATP binding [GO:0005524]; voltage-gated chloride channel activity [GO:0005247]; chloride transmembrane transport [GO:1902476]; response to pH [GO:0009268],NA,NA,NA
CHOYP_CLEC10A.3.3.m.27236,-0.0117074605484506,-0.0196811731428172,No,NA,NA,P82596,NA,NA,NA,carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_CLEC17A.1.1.m.28486,0.0187835270585943,0.00884639372396541,No,NA,NA,Q6ZS10,NA,NA,NA,cell surface [GO:0009986]; integral component of membrane [GO:0016021]; fucose binding [GO:0042806]; mannose binding [GO:0005537]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_CLH1.2.2.m.22327,0.0215370811119139,-0.00466585106073761,No,NA,NA,P49951,NA,NA,NA,clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin-coated endocytic vesicle [GO:0045334]; melanosome [GO:0042470]; membrane coat [GO:0030117]; mitochondrion [GO:0005739]; spindle [GO:0005819]; arrestin family protein binding [GO:1990763]; clathrin light chain binding [GO:0032051]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; structural molecule activity [GO:0005198]; autophagy [GO:0006914]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; intracellular protein transport [GO:0006886]; mitotic cell cycle [GO:0000278]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; receptor-mediated endocytosis [GO:0006898],NA,NA,NA
CHOYP_CLK2.1.1.m.3081,0.0104385894334987,-0.0113504390898705,No,NA,NA,P49760,NA,NA,NA,nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; negative regulation of gluconeogenesis [GO:0045721]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of RNA splicing [GO:0043484]; response to ionizing radiation [GO:0010212]; response to retinoic acid [GO:0032526],NA,NA,NA
CHOYP_CLK2.1.1.m.3082,-0.00143301775241919,-0.0010412270967392,No,NA,NA,Q91ZA3,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; propionyl-CoA carboxylase activity [GO:0004658],NA,NA,NA
CHOYP_CLP1.1.1.m.11641,0.00882633586672091,-0.0124288880142802,No,NA,NA,Q5ZJL4,NA,NA,NA,cytosol [GO:0005829]; mRNA cleavage factor complex [GO:0005849]; nucleus [GO:0005634]; tRNA-intron endonuclease complex [GO:0000214]; ATP binding [GO:0005524]; ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity [GO:0051736]; polydeoxyribonucleotide kinase activity [GO:0051733]; cerebellar cortex development [GO:0021695]; mRNA polyadenylation [GO:0006378]; siRNA loading onto RISC involved in RNA interference [GO:0035087]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]; tRNA splicing; via endonucleolytic cleavage and ligation [GO:0006388],NA,NA,NA
CHOYP_CLPB.1.3.m.14233,0.00579038507514402,-0.00932968655010749,No,NA,NA,Q60649,NA,NA,NA,mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; cellular response to heat [GO:0034605],NA,NA,NA
CHOYP_CLPT1.1.1.m.50172,-0.0169591047060434,0.00960206869202777,No,NA,NA,Q2NL17,NA,NA,NA,integral component of membrane [GO:0016021]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_CLPX.1.2.m.12748,-0.00422905581875555,-0.0191251680854363,No,NA,NA,Q5U2U0,NA,NA,NA,cytosol [GO:0005829]; endopeptidase Clp complex [GO:0009368]; mitochondrial endopeptidase Clp complex [GO:0009841]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metal ion binding [GO:0046872]; peptidase activator activity [GO:0016504]; unfolded protein binding [GO:0051082]; ATP metabolic process [GO:0046034]; protein catabolic process [GO:0030163]; protein folding [GO:0006457]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_CLPX.2.2.m.49273,-0.00382902148549241,-0.00672768767216508,No,NA,NA,Q9JHS4,NA,NA,NA,cytosol [GO:0005829]; endopeptidase Clp complex [GO:0009368]; mitochondrial endopeptidase Clp complex [GO:0009841]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; peptidase activator activity [GO:0016504]; unfolded protein binding [GO:0051082]; ATP metabolic process [GO:0046034]; protein catabolic process [GO:0030163]; protein folding [GO:0006457]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_CLSTN1.1.1.m.55323,0.0111020735481252,0.0164377031968977,No,NA,NA,O94985,NA,NA,NA,cell junction [GO:0030054]; cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; integral component of postsynaptic density membrane [GO:0099061]; integral component of spine apparatus membrane [GO:0099065]; nucleus [GO:0005634]; postsynaptic endosome [GO:0098845]; postsynaptic membrane [GO:0045211]; amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; kinesin binding [GO:0019894]; X11-like protein binding [GO:0042988]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurotransmitter receptor transport to postsynaptic membrane [GO:0098969]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission [GO:0050806]; regulation of cell growth [GO:0001558]; regulation of synapse maturation [GO:0090128]; vesicle-mediated transport in synapse [GO:0099003],NA,NA,NA
CHOYP_CLU.1.1.m.8566,0.012177592408274,-0.020646911684952,No,NA,NA,Q17N71,NA,NA,NA,cytoplasm [GO:0005737]; intracellular distribution of mitochondria [GO:0048312],NA,NA,NA
CHOYP_CML1.1.1.m.30763,-0.0226661346406256,0.0102977510395923,No,NA,NA,P0DH96,NA,NA,NA,nucleus [GO:0005634]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722],NA,NA,NA
CHOYP_CML8.1.1.m.37436,-0.0129500163802331,-0.0137159510842746,No,NA,NA,P24044,NA,NA,NA,calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722],NA,NA,NA
CHOYP_CN166.1.1.m.14529,-0.00795780016397421,-0.00939016343967929,No,NA,NA,Q5R8I2,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; tRNA-splicing ligase complex [GO:0072669]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of transcription by RNA polymerase II [GO:0045944]; tRNA splicing; via endonucleolytic cleavage and ligation [GO:0006388],NA,NA,NA
CHOYP_CNA1.1.1.m.65403,-0.0033077581762012,-0.0235928539096484,No,NA,NA,P63329,NA,NA,NA,calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; sarcolemma [GO:0042383]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; Z disc [GO:0030018]; calcium-dependent protein serine/threonine phosphatase activity [GO:0004723]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; cyclosporin A binding [GO:0016018]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]; protein heterodimerization activity [GO:0046982]; protein serine/threonine phosphatase activity [GO:0004722]; brain development [GO:0007420]; calcineurin-mediated signaling [GO:0097720]; calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endocytosis [GO:0045807]; positive regulation of transcription by RNA polymerase II [GO:0045944]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883],NA,NA,NA
CHOYP_CNDP2.1.4.m.11722,0.0109290174118578,-0.00262784474307909,No,NA,NA,Q96KP4,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; alanylglutamate dipeptidase activity [GO:0103046]; carboxypeptidase activity [GO:0004180]; cytosolic dipeptidase activity [GO:0102008]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; glutathione biosynthetic process [GO:0006750],NA,NA,NA
CHOYP_CNDP2.3.4.m.30467,0.0156576337926071,0.0112719567523091,No,NA,NA,Q9D1A2,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; alanylglutamate dipeptidase activity [GO:0103046]; carboxypeptidase activity [GO:0004180]; cytosolic dipeptidase activity [GO:0102008]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_CNDP2.4.4.m.56870,-0.0141462025288656,-0.0156130292155918,No,NA,NA,Q5R432,NA,NA,NA,cytoplasm [GO:0005737]; alanylglutamate dipeptidase activity [GO:0103046]; carboxypeptidase activity [GO:0004180]; cytosolic dipeptidase activity [GO:0102008]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237],NA,NA,NA
CHOYP_CNE_1C34780.3.3.m.30615,0.00785975713500461,-0.0237019083237349,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CNOT1.1.1.m.12104,-0.00817737765569613,-0.0206601821169581,No,NA,NA,Q6ZQ08,NA,NA,NA,CCR4-NOT complex [GO:0030014]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; armadillo repeat domain binding [GO:0070016]; estrogen receptor binding [GO:0030331]; protein domain specific binding [GO:0019904]; protein-containing complex scaffold activity [GO:0032947]; retinoic acid receptor binding [GO:0042974]; gene silencing by miRNA [GO:0035195]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of stem cell population maintenance [GO:2000036]; RNA phosphodiester bond hydrolysis; exonucleolytic [GO:0090503]; trophectodermal cell differentiation [GO:0001829],NA,NA,NA
CHOYP_CNOT1.1.1.m.12106,-0.00325191942289379,0.0168685001506296,No,NA,NA,O54879,NA,NA,NA,cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA binding; bending [GO:0008301]; four-way junction DNA binding [GO:0000400]; RNA binding [GO:0003723]; transcription factor binding [GO:0008134]; chromatin remodeling [GO:0006338]; DNA geometric change [GO:0032392]; DNA recombination [GO:0006310]; innate immune response [GO:0045087]; negative regulation of B cell differentiation [GO:0045578]; negative regulation of myeloid cell differentiation [GO:0045638]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_CNOT2.1.2.m.47530,-0.00757928376399754,-0.0182130380616588,No,NA,NA,Q9NZN8,NA,NA,NA,CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; RNA polymerase II transcription corepressor binding [GO:0001226]; transcription coregulator activity [GO:0003712]; DNA damage response; signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; gene silencing by RNA [GO:0031047]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA phosphodiester bond hydrolysis; exonucleolytic [GO:0090503]; trophectodermal cell differentiation [GO:0001829],NA,NA,NA
CHOYP_CNOT3.1.1.m.62322,-0.000279009203467374,0.00126438191841407,No,NA,NA,Q8K0V4,NA,NA,NA,CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; nucleus [GO:0005634]; P-body [GO:0000932]; gene silencing by RNA [GO:0031047]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of translation [GO:0017148]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription; DNA-templated [GO:0006355]; trophectodermal cell differentiation [GO:0001829],NA,NA,NA
CHOYP_CNOT7.1.2.m.7497,-0.011168823947816,-0.0124868468407736,No,NA,NA,Q60809,NA,NA,NA,CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytoplasm [GO:0005737]; host cell PML body [GO:0075341]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; P-body [GO:0000932]; 3'-5'-exoribonuclease activity [GO:0000175]; exoribonuclease activity [GO:0004532]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; cytoplasmic mRNA processing body assembly [GO:0033962]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; defense response to virus [GO:0051607]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; gene silencing by RNA [GO:0031047]; negative regulation of cell proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cell proliferation [GO:0008284]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral genome replication [GO:0045070]; regulation of tyrosine phosphorylation of STAT protein [GO:0042509],NA,NA,NA
CHOYP_CNOT7.2.2.m.35718,0.00344460871405296,-0.0194315636351684,No,NA,NA,Q8CHS8,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; ESCRT I complex [GO:0000813]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; nucleoplasm [GO:0005654]; endosome transport via multivesicular body sorting pathway [GO:0032509]; protein targeting to membrane [GO:0006612]; protein targeting to vacuole [GO:0006623]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162],NA,NA,NA
CHOYP_CNTN5.4.5.m.44639,-0.00471326329046329,0.00201128641998024,No,NA,NA,A2AJ76,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; response to stimulus [GO:0050896],NA,NA,NA
CHOYP_CNTN6.1.2.m.781,-0.00735477800271229,0.00265701912109768,No,NA,NA,A2AJ76,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; response to stimulus [GO:0050896],NA,NA,NA
CHOYP_CNTRL.1.1.m.8381,-0.0139372585272142,-0.00823782213273495,No,NA,NA,A2AL36,NA,NA,NA,centriolar subdistal appendage [GO:0120103]; centrosome [GO:0005813]; cytosol [GO:0005829]; Flemming body [GO:0090543]; microtubule organizing center [GO:0005815]; mitotic spindle pole [GO:0097431]; perinuclear region of cytoplasm [GO:0048471]; cytoskeletal protein binding [GO:0008092]; aorta development [GO:0035904]; cardiac septum development [GO:0003279]; cell division [GO:0051301]; coronary vasculature development [GO:0060976]; mitotic cell cycle [GO:0000278]; regulation of cytoskeleton organization [GO:0051493]; ventricular septum development [GO:0003281],NA,NA,NA
CHOYP_CNTROB.1.1.m.11584,-0.00212078832001384,-0.00891837260408135,No,NA,NA,Q8CB62,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; protein domain specific binding [GO:0019904]; centriole replication [GO:0007099]; centrosome separation [GO:0051299]; mitotic cytokinetic process [GO:1902410]; regulation of cilium assembly [GO:1902017],NA,NA,NA
CHOYP_CO1A1.1.1.m.32133,0.0226433244395011,-0.00579449310597908,No,NA,NA,Q30D77,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; extracellular matrix organization [GO:0030198]; hematopoietic progenitor cell differentiation [GO:0002244],NA,NA,NA
CHOYP_CO2A1.1.1.m.62996,0.021314660973843,-0.00666521552170007,No,NA,NA,P02466,NA,NA,NA,collagen type I trimer [GO:0005584]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]; cellular response to organic substance [GO:0071310]; cellular response to retinoic acid [GO:0071300]; cellular response to thyroid hormone stimulus [GO:0097067]; extracellular matrix organization [GO:0030198]; response to norepinephrine [GO:0071873],NA,NA,NA
CHOYP_CO4A1.1.2.m.36472,0.000943117843036186,0.0142264998047212,No,NA,NA,P27393,NA,NA,NA,basement membrane [GO:0005604]; collagen trimer [GO:0005581]; extracellular matrix structural constituent [GO:0005201],NA,NA,NA
CHOYP_CO4A2.1.2.m.14631,-0.0176250151912822,-0.00287140022850349,No,NA,NA,P08120,NA,NA,NA,basement membrane [GO:0005604]; collagen type IV trimer [GO:0005587]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; cardiac muscle cell development [GO:0055013]; dorsal closure [GO:0007391]; extracellular matrix organization [GO:0030198]; intestinal epithelial structure maintenance [GO:0060729]; oviduct morphogenesis [GO:0035848]; post-embryonic digestive tract morphogenesis [GO:0048621],NA,NA,NA
CHOYP_CO5A2.1.1.m.28030,-0.0232798810671952,0.0018986565948888,No,NA,NA,Q5UNS9,NA,NA,NA,virion [GO:0019012],NA,NA,NA
CHOYP_CO6A3.2.5.m.39533,0.0114499035753809,0.0109999041875931,No,NA,NA,P15989,NA,NA,NA,collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]; growth plate cartilage chondrocyte morphogenesis [GO:0003429],NA,NA,NA
CHOYP_CO6A3.3.5.m.39796,0.00615966897194063,0.00941964587728867,No,NA,NA,P12111,NA,NA,NA,collagen type VI trimer [GO:0005589]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; sarcolemma [GO:0042383]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]; muscle organ development [GO:0007517],NA,NA,NA
CHOYP_CO6A5.1.6.m.5838,0.0234495832778498,-0.00395954518770108,No,NA,NA,A8TX70,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_CO6A5.1.6.m.5840,0.00386040049782138,-0.0241627830804817,No,NA,NA,P27080,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; transmembrane transporter activity [GO:0022857],NA,NA,NA
CHOYP_CO9A1.1.1.m.62338,-0.000321047172755862,-0.00257096448537173,No,NA,NA,P27393,NA,NA,NA,basement membrane [GO:0005604]; collagen trimer [GO:0005581]; extracellular matrix structural constituent [GO:0005201],NA,NA,NA
CHOYP_COCA1.3.6.m.49360,-0.0231826971038821,0.00622283578321554,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_COG2.1.2.m.12604,0.0169177605345584,-0.00305760043101621,No,NA,NA,Q14746,NA,NA,NA,cytosol [GO:0005829]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; Golgi transport complex [GO:0017119]; trans-Golgi network membrane [GO:0032588]; protein transporter activity [GO:0008565]; protein-containing complex binding [GO:0044877]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891],NA,NA,NA
CHOYP_COG3.1.1.m.35921,0.00982777793502474,0.00352277206870015,No,NA,NA,Q96JB2,NA,NA,NA,cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; protein transporter activity [GO:0008565]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; protein glycosylation [GO:0006486]; protein localization to organelle [GO:0033365]; protein stabilization [GO:0050821]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_COG5.1.1.m.13833,-0.00432951190178587,0.00534850154249317,No,NA,NA,Q9UP83,NA,NA,NA,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; trans-Golgi network membrane [GO:0032588]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031],NA,NA,NA
CHOYP_COG6.1.1.m.57008,0.00635082677765399,0.011037859513393,No,NA,NA,Q9Y2V7,NA,NA,NA,Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; trans-Golgi network membrane [GO:0032588]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; glycosylation [GO:0070085]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031],NA,NA,NA
CHOYP_COG8.1.1.m.10907,0.00421530133312141,-0.00220802272682078,No,NA,NA,Q96MW5,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; membrane [GO:0016020]; trans-Golgi network membrane [GO:0032588]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031],NA,NA,NA
CHOYP_COIL.1.1.m.18070,-0.00986028182513241,-0.00178656649254563,No,NA,NA,Q09003,NA,NA,NA,sphere organelle [GO:0071601],NA,NA,NA
CHOYP_COL4A4.1.1.m.30919,-0.0211858883137891,0.00356364604138187,No,NA,NA,Q5UQ13,NA,NA,NA,virion [GO:0019012],NA,NA,NA
CHOYP_COL6A6.1.2.m.39071,0.00704300078291582,-0.00688594456133967,No,NA,NA,A3DC27,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cellulose binding [GO:0030248]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_contig_000003.m.1,0.0065883263884642,0.0180931628217626,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_000121.m.127,0.00217997094733793,-0.00807271368859912,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_000189.m.198,0.00107912507893345,-0.0146476074946013,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_000227.m.218,-0.00708852835225928,-0.00629112736454785,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_000437.m.416,-0.00410845156384341,0.0179059931538876,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_001114.m.1165,-0.00942152163988152,-0.0184428856933976,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_001129.m.1188,-0.0109728991161083,-0.0107941746457517,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_001251.m.1283,0.00394536801625317,0.00291369700370642,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_001305.m.1337,0.00106275024607652,0.0145968467734235,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_001317.m.1351,-0.0139451414047841,-0.0141497019799749,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_001413.m.1466,0.00205195042830453,-0.00934116934689426,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_001477.m.1562,0.00769888627157519,0.00209305833444552,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_001544.m.1660,0.00191165933247933,0.0117248336569076,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_001740.m.1863,0.00748650218300219,0.00917933034618519,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_001932.m.2147,-0.00304934814350264,0.00185859236628312,No,NA,NA,Q09575,NA,NA,NA,nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074],NA,NA,NA
CHOYP_contig_002228.m.2410,-0.000278591675639429,-0.00252358873649289,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002245.m.2431,0.0174535166840746,-0.00653208318737547,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002279.m.2484,0.0213934059787198,-0.0139098926107975,No,NA,NA,Q5RA22,NA,NA,NA,cytoplasm [GO:0005737]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; nucleotide metabolic process [GO:0009117],NA,NA,NA
CHOYP_contig_002305.m.2519,0.000686232728993107,-0.0107331332691118,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002327.m.2549,0.00789693283407267,-0.00605072572198191,No,NA,NA,B3EWY9,NA,NA,NA,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ErbB-2 class receptor binding [GO:0005176]; extracellular matrix constituent; lubricant activity [GO:0030197]; cell-matrix adhesion [GO:0007160]; epithelial structure maintenance [GO:0010669]; regulation of signaling receptor activity [GO:0010469],NA,NA,NA
CHOYP_contig_002369.m.2605,0.00716934226846373,-0.0170804498109438,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002417.m.2661,0.0124298995629213,0.00514973739751876,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002558.m.2814,-0.018621426154372,-0.00102404695299956,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002568.m.2819,-0.0107711892557413,0.0136887547959706,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002597.m.2856,0.00205195042830452,-0.00934116934689426,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002691.m.2966,0.00205195042830452,-0.00934116934689426,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002715.m.2994,0.00589331413524918,0.0138188257123802,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002718.m.2999,0.00961673760231462,-0.00553107584252206,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002734.m.3017,-0.011525494599769,-0.000264516716152865,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002762.m.3056,0.000686232728993108,-0.0107331332691118,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002806.m.3116,0.00394536801625317,0.00291369700370642,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002826.m.3144,0.02088653853638,0.00566611945305775,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002896.m.3210,-0.00929351567397456,0.000178913514124063,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002989.m.3291,0.00491588973115351,-0.000600714720400962,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002999.m.3300,0.00587065282077404,-0.0164783558913906,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003050.m.3358,0.00246271322293011,-0.0160591404512627,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003161.m.3509,0.0065883263884642,0.0180931628217626,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003213.m.3589,-0.00430894344577715,-0.00631540690244347,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003275.m.3667,0.00604667469316182,0.0045965161091957,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003319.m.3735,0.00608581606075228,0.000155284478284972,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003356.m.3782,0.000686232728993108,-0.0107331332691118,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003460.m.3916,0.00944411489256717,0.0110407411522613,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003549.m.4007,0.00992669040327624,-0.0165149290718198,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003595.m.4058,0.0095488074339429,0.0133144955991473,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003670.m.4147,0.0169293248524891,-0.00921728986622284,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003695.m.4176,-0.0109768534494858,0.000160029048827186,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003840.m.4375,-0.00350833865514518,0.0170338283107179,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003882.m.4416,0.00830038399200344,-0.0146295576072722,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003956.m.4511,0.00670765747149452,-0.0261096421246361,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004011.m.4571,0.00364778592941831,-0.00872052841558097,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004045.m.4615,0.00361259312683475,-0.0186311562374427,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004193.m.4802,0.00394536801625317,0.00291369700370642,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004202.m.4814,-0.00872247102101568,-0.000782845858658366,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004338.m.4955,-0.00104396005300051,-0.0145231371769969,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004401.m.5025,0.0129093179164011,0.00965533327512585,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004461.m.5117,0.000686232728993107,-0.0107331332691118,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004474.m.5130,-0.0163191797384386,-0.00931203772948774,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004504.m.5173,1.08522397578674e-05,-0.012773784353461,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004513.m.5183,0.00678620130084428,0.00878741825264137,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004594.m.5279,0.0197509846981705,-0.0147541101446587,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004609.m.5296,0.0177299415224285,0.012207013845047,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004652.m.5338,-0.00915122234325571,0.00676730054748459,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004751.m.5446,0.000686232728993108,-0.0107331332691118,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004756.m.5453,0.000360951671912743,-0.0151042617144354,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004795.m.5507,0.0180423467879891,0.0100793171544939,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004820.m.5529,0.00998644341381967,-0.0142641417862396,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004853.m.5555,0.0160018838432462,0.00635995222335431,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004869.m.5573,-0.00584695523121987,-0.00818049656831966,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004890.m.5604,-0.0138850897350083,-0.00804242304461163,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004925.m.5642,0.0143445360873519,0.00495870507453136,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004972.m.5699,-0.00550664904603897,-0.00686941933548351,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004987.m.5716,0.00430453092365758,-0.0218687721424492,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004993.m.5721,0.0206980226512968,-0.00136028697038973,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_005029.m.5761,-0.00706614901467839,-0.00425124181990722,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_005134.m.5869,0.00510416765757106,0.00755577252139743,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_005396.m.6126,0.0120694034433665,0.00622694482326184,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_005454.m.6186,0.00491588973115351,-0.000600714720400963,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_005583.m.6332,0.0182422626428238,-0.000152595172017263,No,NA,NA,P21399,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; 3 iron; 4 sulfur cluster binding [GO:0051538]; 4 iron; 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; iron-responsive element binding [GO:0030350]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cellular iron ion homeostasis [GO:0006879]; citrate metabolic process [GO:0006101]; intestinal absorption [GO:0050892]; post-embryonic development [GO:0009791]; regulation of translation [GO:0006417]; response to iron(II) ion [GO:0010040]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_contig_005659.m.6448,-0.00259426487861227,0.00701685053870826,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_005830.m.6680,-0.0169591047060434,0.00960206869202777,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_005858.m.6708,-0.000760862909747721,0.0166958710568119,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_005908.m.6759,-0.0219912524196254,0.00930669641707316,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_005913.m.6764,-0.0120091115134428,-0.000845945755133005,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_006063.m.6910,-0.00103773723158666,0.00284013179727104,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_006084.m.6928,-0.00183446909804031,-0.0196608653450755,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_006214.m.7057,0.00253224606487003,0.00687806559249619,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_006293.m.7131,-0.0226437570729452,0.0101672765859108,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_006299.m.7138,0.000686232728993107,-0.0107331332691118,No,NA,NA,Q96EY1,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; postsynaptic membrane [GO:0045211]; ATP binding [GO:0005524]; GTPase regulator activity [GO:0030695]; Hsp70 protein binding [GO:0030544]; IkappaB kinase complex binding [GO:0106137]; interferon-gamma receptor binding [GO:0005133]; metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; transcription factor binding [GO:0008134]; unfolded protein binding [GO:0051082]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation-induced cell death of T cells [GO:0006924]; cell aging [GO:0007569]; mitochondrial DNA replication [GO:0006264]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of programmed cell death [GO:0043069]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuromuscular junction development [GO:0007528]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell proliferation [GO:0042102]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]; response to interferon-gamma [GO:0034341]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; small GTPase mediated signal transduction [GO:0007264]; T cell differentiation in thymus [GO:0033077],NA,NA,NA
CHOYP_contig_006359.m.7206,0.00603215645832307,-0.00711081644647752,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_006364.m.7211,-0.0232818775676262,0.00667208485861734,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_006560.m.7472,-0.0155511184455951,-0.0137863120608831,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_006640.m.7557,-0.00907483678947257,-0.00190989131409566,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_006758.m.7690,0.0035618126135868,-0.0200895059775535,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_006775.m.7711,-0.014182709602029,0.000619576837014182,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_007032.m.8066,0.00342287500947869,-0.00576576767734686,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_007082.m.8119,0.00369640434197759,0.0156716609132068,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_007164.m.8244,0.0119798362264129,-0.00333793672306148,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_007754.m.8963,0.000126482963781803,-0.0125274308017898,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_007858.m.9121,-0.0156630489282184,0.00289944183670778,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_007998.m.9259,-0.0225033217401186,0.000548195073767329,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008002.m.9263,-0.0228089269676292,0.00105291938380972,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008016.m.9273,-0.0169591047060434,0.00960206869202778,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008030.m.9291,0.00615966897194063,0.00941964587728867,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008101.m.9378,0.00725473818059557,0.013104355199293,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008102.m.9380,0.00725558541635857,0.0131077204956768,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008114.m.9394,-0.0135725579708753,0.00388604629968508,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008181.m.9453,0.0105368765781613,-0.00739359594473145,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008261.m.9575,-0.0225657692788492,0.00999051483140124,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008262.m.9576,-0.00268770976670113,-0.0125803302617046,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008307.m.9640,-0.0220062092466337,0.00450680559321428,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008452.m.9831,-0.0143685853420938,-0.00623865598973419,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008503.m.9899,-0.0227578076859537,0.00550779213008442,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008795.m.10231,-0.00180718374653781,0.00636844108622309,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008923.m.10388,-0.0135725579708753,0.00388604629968508,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008926.m.10391,0.00764108644375982,-0.000294801276411914,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008975.m.10444,-0.00701122808897908,0.00914273683571367,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_009176.m.10652,0.00132272063735177,0.0208341892866637,No,NA,NA,Q9NR12,NA,NA,NA,actin cytoskeleton [GO:0015629]; cell-cell adherens junction [GO:0005913]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; ruffle [GO:0001726]; stress fiber [GO:0001725]; metal ion binding [GO:0046872]; actin cytoskeleton organization [GO:0030036]; axon guidance [GO:0007411]; ossification [GO:0001503]; positive regulation of osteoblast differentiation [GO:0045669]; receptor-mediated endocytosis [GO:0006898],NA,NA,NA
CHOYP_contig_009196.m.10701,-0.0208543421719723,0.00713463062456803,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_009315.m.10833,-0.00842697993403513,0.0117188334634711,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_009651.m.11212,-0.00870317392199018,0.00449132499055333,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_009697.m.11280,0.00678620130084429,0.00878741825264137,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_009806.m.11429,0.0065883263884642,0.0180931628217626,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_009817.m.11438,0.0031042113305195,0.000640314834817004,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_009870.m.11509,0.00439980043654243,0.0125364929168202,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_009887.m.11524,-0.0169591047060434,0.00960206869202778,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010011.m.11666,0.0101126946076857,0.00157481161192512,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010154.m.11827,0.00963979742815571,-0.00704664738597626,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010181.m.11866,-0.0190720404587408,0.00535973380010797,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010226.m.11916,0.0165914326178601,-0.0198655508099465,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010233.m.11921,-0.0169591047060434,0.00960206869202778,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010276.m.11960,-0.00715755270453725,-0.00274361035508807,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010354.m.12065,-0.0095185709665969,0.0019826317749665,No,NA,NA,Q9CRB3,NA,NA,NA,mitochondrion [GO:0005739]; peroxisome [GO:0005777]; hydrolase activity [GO:0016787]; hydroxyisourate hydrolase activity [GO:0033971]; purine nucleobase metabolic process [GO:0006144]; urate catabolic process [GO:0019628],NA,NA,NA
CHOYP_contig_010487.m.12180,-0.0226322194484064,0.0101328032286251,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010532.m.12231,-0.015576670411784,0.0129012834493788,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010639.m.12333,0.021192546016071,-0.0136087211098658,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010659.m.12347,-0.00152029549222237,-0.01063966131012,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010674.m.12365,-0.0224480535479409,0.00981044305147316,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010687.m.12382,-0.0119931393656308,-0.0149768222497422,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010861.m.12544,-0.00134572758223508,0.0078180888702551,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_011170.m.12887,-0.0122120325952366,0.00237603838980439,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_011268.m.13012,0.00743041665468056,-0.00505323813258569,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_011571.m.13308,-0.00157145546021433,-0.000916932874170292,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_012045.m.13814,-0.0190721271547775,-0.00307472512814353,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_012068.m.13831,-0.00820023972458607,0.0147029410303434,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_012079.m.13839,-0.00770747430080188,0.0116635349627016,No,NA,NA,P74897,NA,NA,NA,,NA,NA,NA
CHOYP_contig_012255.m.14080,-0.00595588509953977,0.00994465457074033,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_012395.m.14264,-0.00530179290790676,-0.00934095376809217,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_012437.m.14312,-0.00430894344577715,-0.00631540690244347,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_012819.m.14744,-0.0135725579708753,0.00388604629968508,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_012962.m.14885,0.00986499098135584,0.00664148055859722,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_013437.m.15402,0.00780228191103431,0.015647036925547,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_013551.m.15499,-0.00200496745350891,-0.00771263461213345,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_013622.m.15553,-0.0134657034953448,-0.0164805205164315,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_013738.m.15666,0.0224773083069452,-0.0105939288645071,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_013751.m.15674,-0.0150693261947149,0.0111186807989252,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_013806.m.15731,0.0115235156867149,-0.0106256447339677,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_013837.m.15768,0.00559798504821053,0.00129119454033455,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014109.m.16087,0.0065883263884642,0.0180931628217626,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014152.m.16145,0.0177263366199754,-0.00824955947652099,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014205.m.16198,-0.00446024041645216,-0.0192825040768235,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014279.m.16311,0.00987562345100447,0.0199220544700917,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014296.m.16345,0.0165398921337723,-0.0181982588579929,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014354.m.16426,-0.00505569870549401,-0.00614622789578685,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014357.m.16429,-0.0162341394116545,0.00528602606042361,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014469.m.16593,-0.022563183506361,0.00998591643872037,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014479.m.16604,0.0225569527441194,-0.0106351598275775,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014529.m.16671,0.00814157431830068,0.00624829488022073,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014863.m.17135,0.00491588973115351,-0.000600714720400963,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014867.m.17143,0.00764890214170294,-0.000255109016878116,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014877.m.17157,0.00656940755357297,0.00158558383088422,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014947.m.17245,0.0166871780811228,-0.00699678619804385,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014958.m.17266,0.0158992804361786,-0.013349467526239,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015023.m.17360,-0.00791762981477072,0.00866085337622815,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015209.m.17650,0.00964008186415664,-0.0102305707575784,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015341.m.17864,-0.0129137140746827,0.00298253744742585,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015391.m.17937,0.000499014139966903,0.00320104819729658,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015430.m.17979,-0.00472678789302398,-0.0127693339578603,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015439.m.17989,-0.0110103886113443,-0.0085118545164145,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015543.m.18138,0.0229228126427512,-0.0083990474130146,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015712.m.18387,0.0110863889380142,-0.00719520604874459,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015857.m.18578,0.00888516369358305,0.00770382748796386,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015918.m.18639,-0.0222561082915061,0.0095778483266396,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015923.m.18643,-0.0137741176181267,-0.0148334692651295,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015931.m.18654,0.00394536801625317,0.00291369700370642,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016010.m.18750,-0.0135725579708753,0.00388604629968508,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016017.m.18760,-0.00649942876619818,0.00241414629410047,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016020.m.18768,-0.01331447432907,0.00469962403541472,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016120.m.18916,-0.01001249679397,0.00668043678477831,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016292.m.19158,0.00655498565422742,0.00236367407329203,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016370.m.19270,0.0180349979514505,0.0116824901821019,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016375.m.19279,0.00728447515327847,-0.00859699652205333,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016405.m.19312,0.0154648297017582,-0.0184703482060218,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016540.m.19484,0.00987571108792398,0.0199198538745471,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016554.m.19499,0.0166480375374964,-0.0145360249181437,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016559.m.19503,-0.00621124686555993,-0.0223868777455053,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016589.m.19530,0.000905750340119355,0.00427152661353688,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016628.m.19586,-0.00439191511349862,0.00308116243545604,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016637.m.19603,0.00632027584525102,0.0142974924057118,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016752.m.19715,0.00794565203222886,0.00868334334937409,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016762.m.19724,-0.0225918946019839,0.0100398308010428,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016854.m.19834,-0.000378004120773767,0.00960018572293825,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_017060.m.20058,-0.00439451831716885,0.0181295766628772,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_017672.m.20677,-0.00832201663789911,-0.00418506379173529,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_017941.m.21005,0.0220272013533766,-0.0139603643062481,No,NA,NA,B3EWY9,NA,NA,NA,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ErbB-2 class receptor binding [GO:0005176]; extracellular matrix constituent; lubricant activity [GO:0030197]; cell-matrix adhesion [GO:0007160]; epithelial structure maintenance [GO:0010669]; regulation of signaling receptor activity [GO:0010469],NA,NA,NA
CHOYP_contig_018098.m.21196,-0.0169591047060434,0.00960206869202777,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_018118.m.21239,0.00615966897194063,0.00941964587728867,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_018645.m.21889,0.0230367027790527,-0.00756476625463955,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_018676.m.21920,-0.0125932264423315,-0.00667858969898961,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_018822.m.22082,-0.0113218588082708,-0.0203536623226917,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_018956.m.22217,0.0156662539009336,-0.00800646580742944,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_018978.m.22243,0.00491588973115351,-0.000600714720400962,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_019122.m.22406,0.00312624999398502,-0.0128507224494602,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_019189.m.22478,-0.014154517819222,0.000584017434767232,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_019238.m.22546,0.00284573123521182,0.00840499520850304,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_019263.m.22580,0.00586549709733835,-0.0032766292011478,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_019436.m.22745,0.00438489334186944,0.0104324298302568,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_019571.m.22867,0.0177748482081347,-0.00269931992355627,No,NA,NA,A0MSJ1,NA,NA,NA,collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]; bone mineralization [GO:0030282]; extracellular matrix organization [GO:0030198]; notochord morphogenesis [GO:0048570]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_contig_019914.m.23170,0.00678620130084429,0.00878741825264137,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_020023.m.23276,0.00730346638212777,0.0155733347986746,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_020370.m.23576,0.00205195042830452,-0.00934116934689426,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_020390.m.23600,-0.0154675057473727,-0.0155284454707745,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_020392.m.23606,-0.00475907913048221,0.000171574404619054,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_020442.m.23651,0.00205195042830452,-0.00934116934689426,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_021278.m.24464,-0.00156131505508431,-0.00774102998346603,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_021455.m.24647,-0.0135725579708753,0.00388604629968508,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_021478.m.24670,0.0065883263884642,0.0180931628217626,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_021494.m.24691,0.00678620130084429,0.00878741825264137,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_021632.m.24849,0.00213651768159452,-0.0138505119938171,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_021664.m.24884,0.00394536801625317,0.00291369700370642,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_021811.m.25040,-0.00675644106134228,-0.0198267723758607,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_021858.m.25098,0.0112755743858857,-0.00716520530519668,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_022142.m.25369,-0.00240488943650354,-0.0144752626991573,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_022641.m.25871,0.0065883263884642,0.0180931628217626,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_022643.m.25874,0.00138995359288093,-0.0198640891649978,No,NA,NA,Q96HC4,NA,NA,NA,actin cytoskeleton [GO:0015629]; cell-cell adherens junction [GO:0005913]; cytosol [GO:0005829]; membrane [GO:0016020]; neuron projection [GO:0043005]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; actin binding [GO:0003779]; actinin binding [GO:0042805]; cadherin binding involved in cell-cell adhesion [GO:0098641]; metal ion binding [GO:0046872]; protein kinase C binding [GO:0005080]; protein N-terminus binding [GO:0047485]; cell growth involved in cardiac muscle cell development [GO:0061049]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of synapse assembly [GO:0051963],NA,NA,NA
CHOYP_contig_022826.m.26063,0.00491588973115351,-0.000600714720400962,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_022851.m.26077,-0.0135725579708753,0.00388604629968508,No,NA,NA,Q9VT65,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; border follicle cell migration [GO:0007298]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_contig_022855.m.26082,-0.00309162298215701,0.0112807021003654,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_022863.m.26088,0.00637707349556929,0.0112348679631581,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023043.m.26235,0.001892875312775,0.00191188829832231,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023172.m.26349,-0.0224661190984872,0.0105915068253667,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023259.m.26467,0.00491588973115351,-0.000600714720400962,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023399.m.26635,0.00637953066364695,-0.00628706708795101,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023445.m.26685,0.0058531603372244,-0.010190736993572,No,NA,NA,Q66HG4,NA,NA,NA,cytoplasm [GO:0005737]; aldose 1-epimerase activity [GO:0004034]; carbohydrate binding [GO:0030246]; galactose catabolic process via UDP-galactose [GO:0033499]; glucose metabolic process [GO:0006006],NA,NA,NA
CHOYP_contig_023474.m.26716,-0.0169591047060434,0.00960206869202778,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023538.m.26787,-0.0226471091092814,0.00633402121346086,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023655.m.26913,-0.0225946253698106,0.0100453453388935,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023660.m.26915,0.00728261819341852,-0.0135679049472783,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023673.m.26924,0.0165601527675873,0.0136157953046692,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023675.m.26925,-0.0169591047060434,0.00960206869202778,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023710.m.26965,0.0139990042720981,-0.0164765077637079,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023723.m.26983,0.00423608414434268,-0.0133241448925617,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023724.m.26984,-0.0120197674557671,-0.0152672809765399,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023752.m.27015,0.0196663035101847,-0.00227770400742443,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023763.m.27021,-0.00246123978562838,0.00489156296573968,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023792.m.27044,0.00419359815128107,0.00104463373746421,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023811.m.27063,0.021443396943668,-0.00117440895823653,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023814.m.27068,-0.00200821982957483,-0.0105017666864106,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023887.m.27194,0.00543345489739008,-0.0136161420634181,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023888.m.27197,-0.0226370896715545,0.0101466302762944,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023897.m.27203,-0.0187773835984625,-0.000874046476740315,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023932.m.27233,0.0123220586732308,0.0224532045370204,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023945.m.27245,-0.0225097599555004,0.000568957365614048,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023964.m.27264,0.00955920063569175,0.0134485620273267,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024012.m.27306,-0.0214570607258527,-0.00696456060404034,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024035.m.27331,0.0100769583114983,0.00419428662546785,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024046.m.27342,-0.00641904410162465,0.00546157258684561,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024156.m.27442,-0.0226651406099912,0.0103313774215562,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024166.m.27453,-0.00850229861948393,-0.020784737792683,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024175.m.27461,0.0163465928782063,-0.00417901089472386,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024218.m.27505,0.00758420104440841,-0.00510419777307044,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024219.m.27509,-0.00101120273852142,-0.0148072609052151,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024342.m.27673,0.0131932080751763,0.0215736793111722,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024357.m.27696,-0.00618957682076705,-0.00853187632934572,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024372.m.27722,-0.0232041223291872,0.00627365983254743,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024418.m.27769,-0.0218720685617216,-0.00212805097707898,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024424.m.27774,-0.0181953636357842,0.0141902578100292,No,NA,NA,Q8WZ42,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_contig_024498.m.27853,-0.0225914499890125,0.0100389404623617,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024504.m.27855,-0.0228673052130439,0.00568030502641124,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024602.m.27966,-0.00467855036930947,-0.00409053873049877,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024605.m.27976,0.00205195042830452,-0.00934116934689426,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024653.m.28033,-0.00566692847754284,-0.0236216283984153,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024662.m.28044,-0.00430894344577715,-0.00631540690244347,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024665.m.28048,-0.0169591047060434,0.00960206869202778,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024679.m.28057,0.0160936106531462,0.00828707889455136,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024697.m.28081,-0.0132408715102496,-0.0166941744500937,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024706.m.28101,-0.00701811359996518,0.00809663627547268,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024730.m.28114,-0.0169591047060434,0.00960206869202778,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024739.m.28119,-0.022642505093694,0.0101632176477431,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024742.m.28122,0.00363204695297983,-0.0108845748698099,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024846.m.28258,0.00661862395149177,-0.0077604352326046,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024858.m.28270,0.022572062487552,-0.0079613228729506,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024935.m.28365,0.00364778592941831,-0.00872052841558097,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025014.m.28472,-0.0225565335191694,0.00997428417588304,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025058.m.28495,-0.0169591047060434,0.00960206869202778,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025076.m.28535,-0.0146019666575988,-0.0223048900483336,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025149.m.28635,-0.0218003442610972,0.000131486294097717,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025167.m.28650,0.0150026617305568,-0.00814165046474819,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025192.m.28699,-0.00212078832001384,-0.00891837260408135,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025210.m.28720,-0.0168049732680203,0.0103986130856115,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025272.m.28780,-0.0204846838179868,-0.00806404547445464,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025311.m.28826,-0.0226304292029787,0.0101279326482687,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025377.m.28903,-0.00575057277005319,-0.0225259491923089,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025391.m.28934,-0.0222422184589996,0.0095625486606188,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025398.m.28945,-0.0121917629203633,8.25759849814213e-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025411.m.28960,-0.0225586189010087,0.00997790294462301,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025422.m.28978,0.000515965874548544,-0.0175185384306042,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025639.m.29255,0.00615966897194063,0.00941964587728867,No,NA,NA,Q5UNS9,NA,NA,NA,virion [GO:0019012],NA,NA,NA
CHOYP_contig_025679.m.29295,-0.0230323422797298,0.0015026447797707,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025684.m.29301,-0.01672768224616,-0.0139157659465745,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025702.m.29329,-0.0219932681435523,-0.000167789831164032,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025725.m.29348,0.00395010544889472,0.0187259087766195,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025759.m.29400,-0.0155467946112033,-0.00520891237883484,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025810.m.29463,-0.00324306351411139,-0.0165770286050564,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025861.m.29521,-0.022655861804309,0.0103857615271675,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025862.m.29523,-0.0218105873098661,0.00447458430608238,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025865.m.29527,-0.0198571764608185,0.00557352955024542,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025897.m.29562,0.0128677489805206,-0.00941101525734233,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025962.m.29619,-0.00203157550533408,-0.0141238409437425,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026106.m.29754,-0.0225985148228576,0.0100533437527919,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026129.m.29781,-0.0217556878558435,-0.000436298210163981,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026140.m.29796,-0.0169591047060434,0.00960206869202777,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026147.m.29805,0.00213412867196757,-0.0138555708146644,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026238.m.29873,0.0036212280313036,-0.0201072256183336,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026328.m.29985,-0.0232861699107231,0.00642976119348576,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026389.m.30064,-0.0226502287758163,0.0101900607530219,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026398.m.30077,-0.0226607626727078,0.010239442773684,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026477.m.30166,-0.0233687953130168,0.00252242303991386,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026494.m.30182,-0.0225782931320337,0.000738209822840963,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026567.m.30260,0.0206999594998637,0.0079868596074616,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026627.m.30320,-0.0083262558129947,-0.0122731224377674,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026644.m.30335,-0.0169591047060434,0.00960206869202777,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026676.m.30376,-0.0135725579708753,0.00388604629968508,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026679.m.30379,-0.0169591047060434,0.00960206869202777,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026684.m.30387,-0.00066889641983254,-0.0105411418208103,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026696.m.30395,-0.0214580909966947,0.0112886282337118,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026700.m.30399,-0.0209135238534638,-0.0113023832559585,No,NA,NA,P35555,NA,NA,NA,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877]; activation of protein kinase A activity [GO:0034199]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular protein metabolic process [GO:0044267]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; extracellular matrix organization [GO:0030198]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; post-translational protein modification [GO:0043687]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_contig_026723.m.30427,-0.0227160045193865,0.000916405775217094,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026816.m.30541,0.0146391079503222,-0.00988505673909183,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026852.m.30581,0.00678620130084429,0.00878741825264137,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026871.m.30597,0.0065883263884642,0.0180931628217626,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026910.m.30632,-0.00506015379331411,0.0117098052452944,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026915.m.30635,-0.0231281197643681,0.00617563992108545,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026949.m.30663,0.00487104248141345,-0.00233824821398744,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026959.m.30676,-0.0228111104317381,0.00122132665404152,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026975.m.30698,-0.0226049083924922,-0.00455472104910059,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_027060.m.30790,0.0172738749497695,0.0135302487490317,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_027196.m.30937,0.0034868082241246,0.00360837626031391,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_027213.m.30953,-0.0193477544049993,-0.00246436912779278,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_027260.m.31007,0.012854434206601,-0.00556003194114459,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_027304.m.31034,-0.0225309713453958,0.000606816131041269,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_027327.m.31055,-0.0223874127049864,0.00973166900588301,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_027342.m.31071,-0.0225665930063268,0.0105261499719911,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_027379.m.31113,-0.0225837584214863,0.0100238484035862,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_027593.m.31285,0.0233604981826729,-0.00699608845670519,No,NA,NA,O42350,NA,NA,NA,collagen trimer [GO:0005581]; extracellular region [GO:0005576]; extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_contig_027703.m.31406,-0.00430894344577715,-0.00631540690244347,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_027730.m.31434,0.00823177401706928,-0.008356917651872,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_027976.m.31727,-0.00786203321870314,0.0159675066693914,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_028013.m.31792,0.00696514926064426,-0.00101287312125843,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_028016.m.31798,0.00386275102417839,-0.00478703188375967,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_028143.m.32002,0.000686232728993108,-0.0107331332691118,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_028227.m.32131,0.0122386828304877,0.0237326941221861,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_028345.m.32285,0.0185157018565071,0.00145278838106656,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_028370.m.32304,0.00517558062176806,-0.00508909392413317,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_028488.m.32431,0.001620550196974,-0.0105408351394877,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_028566.m.32498,0.00615966897194063,0.00941964587728867,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_028737.m.32661,0.0065883263884642,0.0180931628217626,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_029139.m.33073,0.00491588973115351,-0.000600714720400962,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_029222.m.33159,0.0085599896980684,-0.0104054659675279,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_029279.m.33207,0.00545478882425267,-0.0083495653677692,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_029445.m.33401,0.00918657794669523,-0.000140970246104897,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_029710.m.33698,-0.000864645660980113,-0.0101846481187752,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_030340.m.34527,-0.0156617942972757,0.00237009955425951,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_030366.m.34550,0.00697139537637915,-0.0143765027461599,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_030528.m.34754,-0.0226050737088357,0.0104858727455245,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_030621.m.34884,0.00576247557225773,0.0125405023881071,No,NA,NA,Q80T91,NA,NA,NA,basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842],NA,NA,NA
CHOYP_contig_030692.m.34979,-0.00449387393169465,0.00545797279328551,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_030744.m.35041,0.00987688037789897,0.0198862426346358,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_030748.m.35048,-0.011040872293577,-0.0100294751987893,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_030819.m.35130,-0.0135725579708752,0.00388604629968508,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_030869.m.35200,0.000930847081609977,-0.01933912280717,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_030888.m.35216,-0.00437740660133288,-0.00120495431993214,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_030959.m.35312,-0.00527014116495361,0.0103418605440107,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_031003.m.35364,-0.0135725579708753,0.00388604629968508,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_031126.m.35509,-0.0225932044751053,0.000684272485260218,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_031244.m.35665,-0.0226043359963171,0.0104867950171119,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_031272.m.35693,0.00955895482817697,0.0134487539587945,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_031279.m.35700,0.00678620130084429,0.00878741825264137,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_031433.m.35919,0.00394536801625317,0.00291369700370642,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_031485.m.35969,-0.00222021506962546,-0.00242972919191829,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_031486.m.35972,0.00394536801625317,0.00291369700370642,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_031630.m.36105,-0.0225597247449577,0.00997983250100463,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_031802.m.36287,0.0065883263884642,0.0180931628217626,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_031987.m.36469,0.000686232728993108,-0.0107331332691118,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_032098.m.36603,0.0115078657536258,0.0162352876614846,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_032567.m.37185,-0.00674387723750827,-0.00823282035141478,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_032576.m.37192,-0.00612376942251467,-0.0203089155206607,No,NA,NA,Q8CI51,NA,NA,NA,actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cytosol [GO:0005829]; membrane [GO:0016020]; neuron projection [GO:0043005]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; Z disc [GO:0030018]; actin binding [GO:0003779]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; protein kinase C binding [GO:0005080]; protein N-terminus binding [GO:0047485]; cell growth involved in cardiac muscle cell development [GO:0061049]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of synapse assembly [GO:0051963],NA,NA,NA
CHOYP_contig_032616.m.37244,0.00205188296129269,0.0123071220603231,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_032666.m.37309,-0.0169591047060434,0.00960206869202777,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_032690.m.37333,0.00205195042830452,-0.00934116934689426,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_032916.m.37612,0.0110185351821869,0.0191895339084464,No,NA,NA,P49446,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein homodimerization activity [GO:0042803]; protein tyrosine phosphatase activity [GO:0004725]; negative regulation of insulin receptor signaling pathway [GO:0046627]; regulation of mast cell activation [GO:0033003]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185],NA,NA,NA
CHOYP_contig_032947.m.37658,-0.0107462121328948,-0.0105780569160243,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_033072.m.37776,0.0065883263884642,0.0180931628217626,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_033090.m.37804,0.0049591799037738,0.0118694610140215,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_033147.m.37856,-0.0226634121858246,0.0103477736666299,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_033179.m.37880,-0.0126979022452647,-0.00799331388757221,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_033285.m.37973,0.0157723902175426,-0.0030308067923712,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_033346.m.38026,-0.0226659012324561,0.010289700451002,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_033356.m.38032,0.0203556941547684,-0.00495865241981882,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_033663.m.38288,0.00678620130084429,0.00878741825264137,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_033740.m.38360,0.0154067068396567,0.0155465919026317,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_033822.m.38452,0.00766775025877555,0.0153720109537256,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_033899.m.38537,0.0182559460579771,0.00449764641201482,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_033976.m.38613,0.00932387598081802,-0.0182154808369155,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_034345.m.39015,0.00394536801625317,0.00291369700370642,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_034390.m.39050,0.00353724631305624,8.61950288765024e-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_034410.m.39066,0.0193223671137358,-0.0104005937835962,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_034686.m.39375,-0.00481072135721124,0.0164712491459623,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_034695.m.39383,-0.00619172329200614,0.00526366413395967,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_034750.m.39458,0.0229715519185575,0.00218687120719645,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_034847.m.39553,0.0210866829237707,0.00256182050190635,No,NA,NA,P95896,NA,NA,NA,amidase activity [GO:0004040]; indoleacetamide hydrolase activity [GO:0043864],NA,NA,NA
CHOYP_contig_034890.m.39584,0.0132034335222482,0.0146588300020064,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_034934.m.39632,0.00731925119014025,-0.0176814280339982,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_034987.m.39710,0.00737868549877265,0.0136084488842289,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_035123.m.39896,-0.00212078832001384,-0.00891837260408135,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_035291.m.40069,0.0102731472500796,0.00699904545841266,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_035372.m.40130,-0.000955214180956771,-0.00422306353322748,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_035380.m.40136,0.0124072684560984,0.0181862235895574,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_035493.m.40257,-0.00212282817555504,0.00828468015887489,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_035545.m.40311,0.0203531257233761,-0.0154071485480553,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_035578.m.40341,-0.0121898398665667,0.0114295095734402,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_035697.m.40446,0.00193550854937767,-0.0148524068664478,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_035767.m.40509,-0.00406940693795887,-0.0253756101567041,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_035889.m.40603,-0.0123550098741652,0.00393513482069724,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_035951.m.40680,0.0193992615326656,0.00357608461886915,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_036103.m.40829,0.00780204521045518,0.0156456249283963,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_036280.m.40985,-0.0153480224670315,-0.0105110507001878,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_036283.m.40992,0.00256372852095183,-0.0217479319591566,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_036657.m.41264,-0.00248928550645082,-0.0144363117038349,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_036790.m.41410,0.0222142807876188,-0.0109216538338008,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_036886.m.41498,0.0210310479822471,-0.00546506030237857,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_036899.m.41515,0.00153178766488241,-0.0219390787987607,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_036935.m.41573,-0.01933535237027,0.00564238155750449,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_036974.m.41637,0.00675366434724778,0.00904025996924363,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_037000.m.41674,0.0129127406101507,-0.00986937352840617,No,NA,NA,A0A1I9LN01,NA,NA,NA,integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; hydrolase activity; acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; de-etiolation [GO:0009704]; response to far red light [GO:0010218]; seed germination [GO:0009845],NA,NA,NA
CHOYP_contig_037038.m.41727,0.00797242729599563,-0.00784555459036331,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_037467.m.42206,-0.0114885643728992,-0.0122696209285854,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_037561.m.42354,-0.00430894344577715,-0.00631540690244347,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_037644.m.42447,0.0117523936385831,-0.0146761933772138,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_037727.m.42549,0.00205195042830453,-0.00934116934689426,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_037785.m.42603,0.00750021946652855,-0.0228426830456878,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_037938.m.42800,0.00315667748513404,0.0118949417459125,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_037956.m.42826,-0.0169591047060434,0.00960206869202778,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_037959.m.42830,0.0173253909085817,-0.0163373198800185,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038058.m.42964,0.00202432672100025,-0.0148237301159161,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038126.m.43051,0.00491588973115352,-0.000600714720400963,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038160.m.43103,-0.0189579958737764,0.00869063775270115,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038218.m.43194,-0.0157832573170205,-0.00990316312787083,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038370.m.43386,0.0220058188633413,-0.00941929489290787,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038408.m.43447,0.00202310253894512,-0.0148250124062436,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038478.m.43530,0.0157531181428809,-0.01592211709803,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038486.m.43547,-0.00226995180643421,0.0119198922959332,No,NA,NA,Q9BXM0,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; axon ensheathment [GO:0008366]; regulation of RNA splicing [GO:0043484],NA,NA,NA
CHOYP_contig_038513.m.43619,0.0191910842768699,0.00737237977623576,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038550.m.43669,0.00646395165208615,-0.00157134212781126,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038579.m.43695,0.0219732215472251,-0.00913261041504511,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038691.m.43809,-0.00662348827891451,0.00864706793797422,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038703.m.43817,-0.00918458909092358,-0.0121493950129429,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038765.m.43871,0.00205195042830452,-0.00934116934689427,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038766.m.43872,0.00941570833005288,0.0203340311759335,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038806.m.43911,0.0106263515424385,-0.0117035133176504,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038817.m.43926,-0.0135725579708752,0.00388604629968508,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038859.m.43982,-0.0148101573365325,-0.00898792113433008,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038869.m.43996,0.0184053907551703,-0.000184611477347993,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038921.m.44081,0.0169908774617207,-0.014072781616161,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038946.m.44119,0.000198255785120562,0.00210963820086957,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039058.m.44237,0.0199203542678835,0.00799546110959417,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039068.m.44246,0.00656146458862421,-0.00027710433149141,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039097.m.44266,-0.00212078832001384,-0.00891837260408135,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039100.m.44268,0.00740136125387596,-0.0118715579982955,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039169.m.44357,0.0185221958640549,-0.018925489252354,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039208.m.44410,0.00802442251098356,0.00246586350766731,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039283.m.44494,-0.0226850942346957,0.00539185920489499,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039285.m.44499,0.0228248371203647,0.000224241862846381,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039330.m.44540,0.021986965910385,-0.0107187154156894,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039366.m.44569,0.0216607067360588,-0.0122210873615048,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039465.m.44679,0.00364778592941831,-0.00872052841558096,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039575.m.44801,-0.00405816354437191,-0.000149853894365514,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039595.m.44817,0.00491588973115351,-0.000600714720400963,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039638.m.44850,0.00364778592941831,-0.00872052841558097,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039715.m.44911,0.0215617042928008,-0.0129326018487832,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039741.m.44927,-0.00335352887985792,-0.00174384345373058,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039966.m.45203,0.0189133553136392,-0.0109070837007661,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_040048.m.45313,-0.0109780614749705,0.000161230259267878,No,NA,NA,P04323,NA,NA,NA,aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074],NA,NA,NA
CHOYP_contig_040238.m.45604,0.00596320007290531,0.000457587662215138,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_040334.m.45722,-0.00910068527528099,1.22792521360358e-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_040433.m.45856,-0.00608595101767134,-0.019973284201568,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_040481.m.45927,0.00987604287935545,0.0199111854194293,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_040503.m.45959,0.00364778592941831,-0.00872052841558096,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_040577.m.46077,-0.0143037548852374,-0.0206160387344515,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_040623.m.46145,-0.00381479612143209,-0.0179042204552418,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_040750.m.46306,-0.00424435494494902,-0.0136679682231543,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_040887.m.46494,0.00339607814009578,-0.00587676478534646,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_040962.m.46595,0.0107065905197075,0.00603439351275844,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_040975.m.46616,0.0011200706286262,-0.00466043927839817,No,NA,NA,B3EWY9,NA,NA,NA,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ErbB-2 class receptor binding [GO:0005176]; extracellular matrix constituent; lubricant activity [GO:0030197]; cell-matrix adhesion [GO:0007160]; epithelial structure maintenance [GO:0010669]; regulation of signaling receptor activity [GO:0010469],NA,NA,NA
CHOYP_contig_040978.m.46621,-0.0226453064245948,0.0101724375489053,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041025.m.46710,4.57540933844022e-06,-0.0134886034032561,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041068.m.46778,0.00997473582130196,0.0122756497726564,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041073.m.46786,0.00394536801625317,0.00291369700370642,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041193.m.46961,0.0109191161629098,0.0130090092759492,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041218.m.46991,0.00251624759830502,-0.0154207806292299,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041288.m.47081,0.0028206490202405,-0.0178716534410434,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041298.m.47095,0.0144391505155083,0.00443423702812192,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041336.m.47149,-0.00430894344577715,-0.00631540690244347,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041380.m.47215,0.00491588973115351,-0.000600714720400962,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041554.m.47492,0.00494928679891632,-0.00355976129469972,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041605.m.47590,0.00747514562191087,-0.000546266492472205,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041673.m.47688,-0.00884874787544542,0.00574691486559324,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041706.m.47739,-0.0226658861509606,0.0103190934942626,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041712.m.47757,0.00576655795787299,-0.00573134264495121,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041717.m.47768,0.00615966897194063,0.00941964587728867,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041765.m.47848,0.00678620130084429,0.00878741825264137,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041782.m.47874,0.00145197377748767,0.00682809350244781,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041876.m.48001,-0.0147530704033584,-0.00233846574264304,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041950.m.48134,-0.00442912095310999,-0.00194307566298725,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041958.m.48141,0.0209484962648774,-0.00797001302232629,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042054.m.48295,-0.010465977034224,-0.013695942607655,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042130.m.48414,-0.0135725579708753,0.00388604629968508,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042244.m.48592,-0.00389338694006916,0.00540425086661624,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042249.m.48611,-0.0225605614833674,0.00998129746875855,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042362.m.48774,-0.0135725579708753,0.00388604629968508,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042378.m.48796,0.00364778592941831,-0.00872052841558097,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042449.m.48875,-0.0169591047060434,0.00960206869202778,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042540.m.49007,0.00678620130084429,0.00878741825264137,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042557.m.49033,0.0205944365120438,-0.00168755630183595,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042616.m.49103,0.00394536801625317,0.00291369700370642,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042690.m.49166,-0.0131183718436654,-0.0157268743241987,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042697.m.49175,0.0134176469714377,0.0149415164119145,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042766.m.49278,-0.0135725579708753,0.00388604629968508,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042815.m.49366,0.00205195042830452,-0.00934116934689426,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042864.m.49442,-0.00430894344577715,-0.00631540690244347,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042901.m.49495,0.0065883263884642,0.0180931628217626,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043041.m.49677,-0.0226152980651099,0.0100901877488959,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043053.m.49693,0.00685539960244303,0.0121302867260575,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043057.m.49706,0.0041230906387668,0.0121710853242981,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043072.m.49721,-0.000949387492312271,0.00384393961819449,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043212.m.49892,0.00394536801625317,0.00291369700370642,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043231.m.49931,0.0124805449914736,0.0173120708756285,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043238.m.49940,0.0229224766047199,-0.0082697855967612,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043280.m.49983,0.00729501967474646,0.00386336703176801,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043301.m.50018,0.00309227281699892,0.000613599750191957,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043488.m.50266,-0.0169591047060434,0.00960206869202777,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043510.m.50295,0.0153945911264395,-0.0198268102061394,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043576.m.50359,0.0109080055190827,0.0189737192492381,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043813.m.50619,-0.00073558644038434,0.00569304354456427,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043845.m.50665,-0.0226622403864927,0.0102492788647196,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043862.m.50684,0.0195968972148073,-0.0148539856048666,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043874.m.50696,-0.00326092751656605,0.0173123589625853,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043898.m.50728,0.00217997094733793,-0.00807271368859912,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043909.m.50738,-0.0135725579708753,0.00388604629968508,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_044078.m.50900,0.00886189636048031,-0.00539515458140389,No,NA,NA,Q01484,NA,NA,NA,A band [GO:0031672]; apical plasma membrane [GO:0016324]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding; bridging [GO:0030674]; protein kinase binding [GO:0019901]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005],NA,NA,NA
CHOYP_contig_044225.m.51129,0.00205195042830453,-0.00934116934689426,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_044310.m.51269,-0.00430894344577715,-0.00631540690244347,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_044503.m.51534,-0.00242800387129112,0.00294132287420368,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_044612.m.51675,0.000757514380385932,-0.0049097296684553,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_044629.m.51700,-0.000304669103193319,-0.0111538058248467,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_044640.m.51719,-0.00156520229143003,0.0230505944502148,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_044678.m.51771,0.00615966897194063,0.00941964587728867,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_044692.m.51797,-0.0184085403953979,0.00532375312631124,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_044795.m.51952,0.00217997094733793,-0.00807271368859912,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_044803.m.51967,-0.00433779094590674,0.0220375175503334,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_044824.m.51993,-0.00181247338534714,0.0232258661520788,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_045072.m.52344,-0.00370734684064897,0.00921302723998849,No,NA,NA,Q3ZBG9,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; CD4 receptor binding [GO:0042609]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; epidermal growth factor receptor binding [GO:0005154]; phospholipid scramblase activity [GO:0017128]; SH3 domain binding [GO:0017124]; apoptotic process [GO:0006915]; defense response to virus [GO:0051607]; negative regulation of viral genome replication [GO:0045071]; plasma membrane phospholipid scrambling [GO:0017121]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of innate immune response [GO:0045089]; response to interferon-beta [GO:0035456],NA,NA,NA
CHOYP_contig_045193.m.52491,-0.0170778167553385,0.0142173195810398,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_045205.m.52522,0.00387628001616726,0.00746956155559228,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_045248.m.52574,-0.00717567666912918,-0.0221065442084382,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_045427.m.52825,-0.000310606030374694,-0.0111524226443098,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_045550.m.53021,0.0228056921151831,-0.0122383058554093,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_045552.m.53024,-0.00185077204784228,0.00704356920842079,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_045655.m.53199,0.00624027144496603,-0.0185312879402401,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_045662.m.53210,-0.0159161550526992,-0.00390843422543812,No,NA,NA,Q14686,NA,NA,NA,cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; nuclear receptor transcription coactivator activity [GO:0030374]; retinoid X receptor binding [GO:0046965]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA-templated transcription; initiation [GO:0006352]; glucocorticoid receptor signaling pathway [GO:0042921]; heart development [GO:0007507]; intracellular estrogen receptor signaling pathway [GO:0030520]; myeloid cell differentiation [GO:0030099]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of lipid metabolic process [GO:0019216]; response to hormone [GO:0009725],NA,NA,NA
CHOYP_contig_045946.m.53656,-0.00332606877402983,-0.00308290264549728,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_046319.m.54200,-0.00574188549781264,-0.00132990679749113,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_046503.m.54505,0.00950818766106399,0.0156636916344614,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_046530.m.54559,-0.021965161484993,0.00446565562196124,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_046551.m.54588,0.002838779387977,-0.00126991458128976,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_046706.m.54827,-0.0164524077115882,0.00854282634562843,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_046854.m.55054,0.00813554412912173,0.00621211089160538,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_046883.m.55107,-0.0169591047060434,0.00960206869202778,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047016.m.55305,-0.000811413784876423,-0.000532221192909747,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047066.m.55375,0.000686232728993108,-0.0107331332691118,No,NA,NA,Q6MG82,NA,NA,NA,cell junction [GO:0030054]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic membrane [GO:0099055]; membrane [GO:0016020],NA,NA,NA
CHOYP_contig_047135.m.55497,0.00941714221503925,0.0203685961474296,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047190.m.55575,0.0209943689942612,-4.18200656389275e-07,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047214.m.55631,0.011450895920993,0.0106680939473483,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047294.m.55755,0.00364778592941831,-0.00872052841558096,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047333.m.55799,-0.00430894344577715,-0.00631540690244347,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047394.m.55871,-0.0095793155674934,0.00923326247711309,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047449.m.55959,-0.0143590718459542,-0.00133023727517373,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047498.m.56019,0.00394536801625317,0.00291369700370642,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047569.m.56118,0.00845051456747915,-0.00911541670910859,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047668.m.56271,0.0021625480660377,0.00940278942018578,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047685.m.56291,-0.0218636028860924,0.000253365242549082,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047707.m.56320,-0.0137380190518495,0.00909964098074163,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047731.m.56360,-0.016901885486558,0.00521870902272919,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047828.m.56501,0.00491588973115351,-0.000600714720400962,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047907.m.56621,-0.00430894344577715,-0.00631540690244347,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047908.m.56622,0.00856165010696366,-0.00909061680895355,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047916.m.56635,0.00952807273815132,0.00626686368234919,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047982.m.56715,0.00239295049825376,0.0170222870180534,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048122.m.56947,0.00615966897194063,0.00941964587728867,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048134.m.56964,0.00491588973115351,-0.000600714720400964,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048148.m.56980,0.00217997094733793,-0.00807271368859912,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048267.m.57131,-0.0123736078047325,0.0130279625476599,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048274.m.57147,0.00780234428497855,0.0156474091070796,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048277.m.57151,-0.0197468360250599,-0.0100512212200033,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048369.m.57273,-0.00985197770662363,-0.00190380601349801,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048457.m.57397,0.00149176767264575,0.00248035342810629,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048495.m.57473,0.0213501033138506,0.00199665638628362,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048603.m.57625,0.00807709650106613,0.00590472045864508,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048626.m.57669,-0.014123527560796,0.000545086454532351,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048667.m.57735,0.00231961937540456,-0.00568745562574983,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048706.m.57793,0.00225247960810097,-0.0155165043538407,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048721.m.57810,0.0211993790128042,0.000419515241091186,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048781.m.57879,-0.00958900605668228,0.00923637096447118,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048805.m.57897,-0.0197099758688795,-0.00463073510868899,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048887.m.57987,-0.00756022983711231,0.00548475820138256,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048930.m.58050,-0.0150021874078062,0.0145617977557139,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048973.m.58107,-0.0184200775910934,-0.00566610909081162,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048994.m.58122,0.00794082277188391,0.00867317263796936,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_049099.m.58219,0.0065883263884642,0.0180931628217626,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_049136.m.58269,-0.0198358015997331,0.00458859085596077,No,NA,NA,Q8N7X0,NA,NA,NA,calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; heme binding [GO:0020037]; oxygen binding [GO:0019825],NA,NA,NA
CHOYP_contig_049345.m.58557,0.0106129204433404,0.0055995254758717,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_049353.m.58568,-0.000573992081248928,-0.0119800748061216,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_049367.m.58596,-0.00482457969179009,0.0164619764031892,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_049413.m.58667,-0.00707570768008106,0.00502001209413898,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_049548.m.58834,0.00848093117876494,-0.00702186705923408,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_049586.m.58876,-0.00720597059007709,0.0139947162836301,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_049619.m.58908,-0.0232219158938461,0.0063026039138916,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050044.m.59512,-0.0135725579708753,0.00388604629968508,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050158.m.59641,-0.00971416216779144,0.00702630411694611,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050222.m.59713,-0.00932168816586145,0.000203376904741405,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050253.m.59761,-0.0129678336426137,-0.00476521139422751,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050301.m.59822,0.00205195042830453,-0.00934116934689426,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050355.m.59899,0.0065883263884642,0.0180931628217626,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050388.m.59942,0.00182558085411291,0.00901592444270456,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050483.m.60085,-0.0107007726020213,-0.00551584567134283,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050507.m.60115,0.00678620130084429,0.00878741825264137,No,NA,NA,Q6H236,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; apoptotic process [GO:0006915],NA,NA,NA
CHOYP_contig_050515.m.60136,0.00615966897194063,0.00941964587728867,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050645.m.60289,-0.0169591047060434,0.00960206869202778,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050710.m.60376,-0.00139418071239689,-0.00209168228203674,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050842.m.60581,0.00205195042830452,-0.00934116934689426,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050863.m.60613,-0.00474179143684445,0.0165170772134912,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050942.m.60734,-0.00210377899816512,0.0178618406352604,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_051171.m.61058,0.0123262176533972,0.00604975985658452,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_051254.m.61184,-0.0124631365841378,0.0082258635142627,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_051254.m.61185,-0.0226644127700305,0.0102677764808777,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_051311.m.61287,0.000118757214652261,-0.00163530140998928,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_051346.m.61337,0.0078157495698468,0.0157284067307701,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_051433.m.61487,0.00205195042830452,-0.00934116934689426,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_051499.m.61590,0.0053554875433877,0.00890645571888348,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_051534.m.61634,0.00980063626962188,0.00802660786620814,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_051787.m.61994,-0.00497964595945641,0.0220967581802396,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_051794.m.62013,0.00615966897194063,0.00941964587728867,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_051943.m.62221,0.00326305832303579,-0.0176057583515961,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_052015.m.62309,-0.0137029888755258,-0.00237657534196021,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_052081.m.62393,0.000243254436954061,-0.00665517768970777,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_052083.m.62396,0.0199927724440114,-0.0160372708248223,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_052147.m.62461,0.0107475852664478,0.0131385226268682,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_052383.m.62773,0.0103982309615287,-0.0194834355633321,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_052396.m.62799,-0.00503665699133132,-0.00557629776477639,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_052416.m.62821,0.0048530628716076,-0.0129283928171069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_052441.m.62852,-0.0139154586835135,0.00597396419949498,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_052658.m.63135,0.000686232728993108,-0.0107331332691118,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_052729.m.63227,0.00394536801625317,0.00291369700370642,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_052748.m.63243,-0.0108331581199685,0.016986955086922,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_052993.m.63573,-0.00271465478455959,0.0133273156558241,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053017.m.63597,0.0114839854158597,0.00723895089866883,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053024.m.63605,0.00351204518087221,0.00179443031083121,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053133.m.63737,-0.00761844417398843,0.0140420650929065,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053329.m.63915,0.00116309807623484,0.0130459868573869,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053371.m.63972,-0.0122207106063503,-0.0169421577646855,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053627.m.64220,0.000686232728993107,-0.0107331332691118,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053683.m.64287,0.0218423774355944,0.00530066881602256,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053687.m.64290,0.00748124316684143,0.0171954091673658,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053787.m.64362,0.0231193510257664,-0.0097175126631735,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053912.m.64506,0.0080660004950062,-0.0062762742471128,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053977.m.64571,0.0173822565837198,-0.0033293694189674,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053989.m.64582,0.00944747315469455,0.0134060284953922,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053995.m.64585,-0.000666186262555117,0.0120861160032727,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_054223.m.64734,-0.0135725579708753,0.00388604629968508,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_054409.m.64895,0.02025334443411,-0.0104905755317514,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_054622.m.65176,-0.00968044498186728,-0.00185349061143607,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_054868.m.65463,-0.00847508996979289,0.0103722615114067,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_054901.m.65508,-0.00330417325496079,0.0144865281074619,No,NA,NA,A8XZB0,NA,NA,NA,mitochondrion [GO:0005739]; ATPase binding [GO:0051117]; ATPase inhibitor activity [GO:0042030]; heme biosynthetic process [GO:0006783]; negative regulation of ATPase activity [GO:0032780],NA,NA,NA
CHOYP_contig_055102.m.65741,0.00598238102142344,-0.0149062665674872,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_055225.m.65857,0.00256013526749018,-0.0124626607653645,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_055303.m.65981,-0.0084022287224428,-0.00411831005894906,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_055335.m.66005,0.00496777461367335,-0.0127210395676003,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_055359.m.66029,-0.0135725579708752,0.00388604629968508,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_055404.m.66082,-0.00752023716775799,-0.000225133226207936,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_055406.m.66084,-0.0128713747338172,-0.00930881564689862,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_055822.m.66445,0.00621273967519185,-0.0136671181586523,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_055842.m.66464,0.00355245530412,0.000116718649894669,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_055984.m.66583,0.0149879713079285,-0.000298484902233285,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_056008.m.66602,0.00947549437064853,-0.0240194627693266,No,NA,NA,P51958,NA,NA,NA,cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; cell cycle [GO:0007049]; cell division [GO:0051301],NA,NA,NA
CHOYP_contig_056033.m.66621,-0.0157595473115941,0.00682046840213848,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_056499.m.66997,0.00112390646828499,-0.0170066469900852,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_COPA.1.1.m.31888,0.00439727158848118,-0.0088536358340278,No,NA,NA,Q27954,NA,NA,NA,COPI vesicle coat [GO:0030126]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; hormone activity [GO:0005179]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_COPA.1.1.m.31889,0.00205195042830452,-0.00934116934689426,No,NA,NA,Q9JLR1,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; Sec61 translocon complex [GO:0005784]; protein transmembrane transporter activity [GO:0008320]; ribosome binding [GO:0043022]; signal sequence binding [GO:0005048]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; SRP-dependent cotranslational protein targeting to membrane; translocation [GO:0006616],NA,NA,NA
CHOYP_COPB.1.1.m.16988,0.0206290892007896,-0.00230867213882467,No,NA,NA,P23514,NA,NA,NA,COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; plasma membrane [GO:0005886]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_COPB2.1.1.m.11046,0.0113503007251271,-0.0229323963051784,No,NA,NA,P35606,NA,NA,NA,COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; transport vesicle [GO:0030133]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_COPD.1.1.m.37389,0.00621513103090527,0.0044235178558149,No,NA,NA,Q5ZL57,NA,NA,NA,COPI vesicle coat [GO:0030126]; COPI-coated vesicle [GO:0030137]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi localization [GO:0051645]; protein transport [GO:0015031]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_COPD.1.1.m.37390,-0.0147320360496162,0.00695242346524485,No,NA,NA,Q9DCM4,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; motor activity [GO:0003774]; microtubule-based process [GO:0007017]; positive regulation of ATP-dependent microtubule motor activity; plus-end-directed [GO:2000582],NA,NA,NA
CHOYP_COPE.1.1.m.48265,0.0185165195333079,0.00511767885692009,No,NA,NA,Q5ZIK9,NA,NA,NA,COPI vesicle coat [GO:0030126]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_COPG2.1.1.m.60836,0.0200093482705422,-0.00280029402000814,No,NA,NA,Q9I8E6,NA,NA,NA,COPI vesicle coat [GO:0030126]; Golgi membrane [GO:0000139]; structural molecule activity [GO:0005198]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_COQ4.1.1.m.6843,-0.010048811092098,-0.00354525229907602,No,NA,NA,Q16FT5,NA,NA,NA,extrinsic component of mitochondrial inner membrane [GO:0031314]; ubiquinone biosynthetic process [GO:0006744],NA,NA,NA
CHOYP_COQ9.1.2.m.4620,-0.0104728464228234,-0.00554005113218028,No,NA,NA,O75208,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; lipid binding [GO:0008289]; protein homodimerization activity [GO:0042803]; mitochondrial electron transport; NADH to ubiquinone [GO:0006120]; ubiquinone biosynthetic process [GO:0006744],NA,NA,NA
CHOYP_CORIN.2.2.m.40858,0.0128686751276005,0.0036832198756751,No,NA,NA,Q9Y5Q5,NA,NA,NA,actin cytoskeleton [GO:0015629]; cell surface [GO:0009986]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; female pregnancy [GO:0007565]; peptide hormone processing [GO:0016486]; regulation of blood pressure [GO:0008217]; regulation of cardiac conduction [GO:1903779]; regulation of renal sodium excretion [GO:0035813]; regulation of systemic arterial blood pressure by atrial natriuretic peptide [GO:0003050],NA,NA,NA
CHOYP_COX1.1.15.m.3193,-0.0199359746196992,-0.00412071071409767,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_COX1.5.15.m.24406,-0.00558753587501385,0.0137828695152648,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_COX1.6.15.m.25748,-0.00472759873372736,-0.00547895325989529,No,NA,NA,Q9BYJ9,NA,NA,NA,cytoplasm [GO:0005737]; N6-methyladenosine-containing RNA binding [GO:1990247]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948],NA,NA,NA
CHOYP_COX5B.1.3.m.20245,0.00217997094733793,-0.00807271368859912,No,NA,NA,Q710D6,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; cytochrome-c oxidase activity [GO:0004129]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_COX5B.3.3.m.38557,0.000680491505413629,-0.0184665009952976,No,NA,NA,P00428,NA,NA,NA,mitochondrial respiratory chain complex IV [GO:0005751]; respiratory chain complex IV [GO:0045277]; cytochrome-c oxidase activity [GO:0004129]; metal ion binding [GO:0046872]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport; cytochrome c to oxygen [GO:0006123],NA,NA,NA
CHOYP_CP080.1.1.m.24911,-0.0212235646592474,-0.0105364776289192,No,NA,NA,Q8BTU1,NA,NA,NA,centriole [GO:0005814]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; microtubule [GO:0005874]; nucleus [GO:0005634]; cilium assembly [GO:0060271]; positive regulation of cell motility [GO:2000147]; positive regulation of feeding behavior [GO:2000253]; protein polyglutamylation [GO:0018095]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296],NA,NA,NA
CHOYP_CP096.1.1.m.35853,0.00843795885175281,-0.0053882526167515,No,NA,NA,Q9H0J4,NA,NA,NA,,NA,NA,NA
CHOYP_CP2BA.1.1.m.38084,0.014617851603977,0.00152321011453668,No,NA,NA,O46658,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; organelle membrane [GO:0031090]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; reduced flavin or flavoprotein as one donor; and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; arachidonic acid metabolic process [GO:0019369]; exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805],NA,NA,NA
CHOYP_CP3AB.4.4.m.47872,-0.00674219390300604,-0.00808862194747956,No,NA,NA,Q64459,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; organelle membrane [GO:0031090]; aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; testosterone 6-beta-hydroxylase activity [GO:0050649]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_CP3AO.1.1.m.63459,0.0034326631107353,0.00718994119936722,No,NA,NA,P51538,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; organelle membrane [GO:0031090]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; steroid hydroxylase activity [GO:0008395]; female pregnancy [GO:0007565]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to zinc ion [GO:0010043]; sensory perception of smell [GO:0007608],NA,NA,NA
CHOYP_CP4F2.1.1.m.7803,-0.0138027253851808,-0.00542848768936334,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CPE.1.1.m.53041,-0.00873939738854014,-0.0106707885386241,No,NA,NA,P37892,NA,NA,NA,extracellular region [GO:0005576]; transport vesicle membrane [GO:0030658]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_CPIB.2.3.m.44557,0.0065883263884642,0.0180931628217626,No,NA,NA,Q65YR7,NA,NA,NA,cytosol [GO:0005829]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_CPIB.3.3.m.46138,-0.0121335313373485,-0.0163730664067229,No,NA,NA,Q65YR7,NA,NA,NA,cytosol [GO:0005829]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_CPIPJ_CPIJ000723.1.1.m.7190,-0.0226542962103744,0.0102065394363183,No,NA,NA,P27393,NA,NA,NA,basement membrane [GO:0005604]; collagen trimer [GO:0005581]; extracellular matrix structural constituent [GO:0005201],NA,NA,NA
CHOYP_CPIPJ_CPIJ001623.1.1.m.19531,0.0128118835109787,0.013043163380737,No,NA,NA,Q9UMY4,NA,NA,NA,early endosome [GO:0005769]; membrane [GO:0016020]; enzyme binding [GO:0019899]; phosphatidylinositol binding [GO:0035091]; negative regulation of early endosome to late endosome transport [GO:2000642]; negative regulation of gene expression [GO:0010629]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein processing [GO:0010955]; negative regulation of protein transport [GO:0051224]; protein transport [GO:0015031]; regulation of endocytosis [GO:0030100],NA,NA,NA
CHOYP_CPIPJ_CPIJ003599.1.1.m.61267,-0.0135725579708753,0.00388604629968508,No,NA,NA,Q9NRH2,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; myeloid cell differentiation [GO:0030099]; protein phosphorylation [GO:0006468],NA,NA,NA
CHOYP_CPIPJ_CPIJ003871.1.1.m.147,0.011784912868794,-0.00268453526456106,No,NA,NA,P49024,NA,NA,NA,cell [GO:0005623]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; metal ion binding [GO:0046872]; vinculin binding [GO:0017166]; cell-matrix adhesion [GO:0007160]; response to muscle stretch [GO:0035994],NA,NA,NA
CHOYP_CPIPJ_CPIJ004440.1.1.m.62518,-0.00566982603254327,0.000395559480204319,No,NA,NA,Q9HC07,NA,NA,NA,early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588]; cellular calcium ion homeostasis [GO:0006874]; Golgi calcium ion transport [GO:0032472]; protein N-linked glycosylation [GO:0006487]; regulation of lysosomal lumen pH [GO:0035751],NA,NA,NA
CHOYP_CPIPJ_CPIJ004536.3.3.m.52790,0.00486049981632321,0.0106817689013675,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CPIPJ_CPIJ004840.1.1.m.3309,-0.00673612072325866,-0.00393453299780791,No,NA,NA,Q5EA45,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; oxidoreductase activity [GO:0016491]; mitochondrial respiratory chain complex I assembly [GO:0032981],NA,NA,NA
CHOYP_CPIPJ_CPIJ005489.1.1.m.43655,0.00615569378003726,0.000979244535436948,No,NA,NA,P13668,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule [GO:0005874]; neuron projection [GO:0043005]; tubulin binding [GO:0015631]; axonogenesis [GO:0007409]; brain development [GO:0007420]; establishment of skin barrier [GO:0061436]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; intracellular signal transduction [GO:0035556]; microtubule depolymerization [GO:0007019]; mitotic cytokinesis [GO:0000281]; mitotic spindle organization [GO:0007052]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of thrombin-activated receptor signaling pathway [GO:0070495]; neuron projection development [GO:0031175]; positive regulation of cellular component movement [GO:0051272]; regulation of cytoskeleton organization [GO:0051493]; regulation of microtubule polymerization or depolymerization [GO:0031110]; response to virus [GO:0009615],NA,NA,NA
CHOYP_CPIPJ_CPIJ007723.1.4.m.5854,-0.00161157536566217,0.0137303749699435,No,NA,NA,P48166,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_CPIPJ_CPIJ007723.3.4.m.30316,0.0183479968986956,-0.0161706728945439,No,NA,NA,Q6GL69,NA,NA,NA,nucleolus [GO:0005730]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_CPIPJ_CPIJ007723.4.4.m.64973,-0.0176664682522095,-0.0181784540166288,No,NA,NA,Q4V886,NA,NA,NA,Cdc73/Paf1 complex [GO:0016593]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; membrane [GO:0016020]; transcriptionally active chromatin [GO:0035327]; chromatin binding [GO:0003682]; RNA polymerase II complex binding [GO:0000993]; cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; mRNA polyadenylation [GO:0006378]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome positioning [GO:0016584]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of histone methylation [GO:0031062]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein localization to nucleus [GO:0034504]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_CPIPJ_CPIJ007907.1.1.m.45771,0.00492821425581818,-0.00974466525265022,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CPIPJ_CPIJ008112.1.1.m.51524,0.0113160026461165,-0.00644889944517297,No,NA,NA,Q05695,NA,NA,NA,axon [GO:0030424]; axonal growth cone [GO:0044295]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendritic growth cone [GO:0044294]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; axon guidance receptor activity [GO:0008046]; PDZ domain binding [GO:0030165]; axon development [GO:0061564]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to ethanol [GO:0071361]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to thyroxine stimulus [GO:0097069]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dopaminergic neuron differentiation [GO:0071542]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; modulation of chemical synaptic transmission [GO:0050804]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; positive regulation of axon extension [GO:0045773]; positive regulation of cell-substrate adhesion [GO:0010811]; regulation of ERK1 and ERK2 cascade [GO:0070372]; response to activity [GO:0014823]; response to thyroid hormone [GO:0097066]; synapse organization [GO:0050808],NA,NA,NA
CHOYP_CPIPJ_CPIJ008190.1.1.m.21761,0.0135488551901263,0.0226260935555645,No,NA,NA,Q7ZUH5,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_CPIPJ_CPIJ008492.1.1.m.6934,-0.010921782346179,0.00817103587836881,No,NA,NA,P83565,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761],NA,NA,NA
CHOYP_CPIPJ_CPIJ011304.2.2.m.43130,-0.010934357823365,-0.00254955930275908,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CPIPJ_CPIJ011346.2.2.m.44999,0.00734279916481219,0.00137889732951762,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CPIPJ_CPIJ012408.1.1.m.10724,-0.0139126859940467,0.000646722883305959,No,NA,NA,Q6PV61,NA,NA,NA,nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; defense response to bacterium [GO:0042742],NA,NA,NA
CHOYP_CPIPJ_CPIJ015079.1.1.m.39675,-0.00733674551652845,-0.0187390573695186,No,NA,NA,P42029,NA,NA,NA,mitochondrial intermembrane space [GO:0005758]; mitochondrial respiratory chain complex I [GO:0005747]; protein-containing complex binding [GO:0044877]; mitochondrial electron transport; NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981],NA,NA,NA
CHOYP_CPIPJ_CPIJ016910.1.1.m.62713,-0.0146964851466273,0.000694291979063568,No,NA,NA,P07686,NA,NA,NA,acrosomal vesicle [GO:0001669]; azurophil granule [GO:0042582]; azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]; acetylglucosaminyltransferase activity [GO:0008375]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; astrocyte cell migration [GO:0043615]; cellular calcium ion homeostasis [GO:0006874]; cellular protein metabolic process [GO:0044267]; chondroitin sulfate catabolic process [GO:0030207]; ganglioside catabolic process [GO:0006689]; glycosphingolipid metabolic process [GO:0006687]; hyaluronan catabolic process [GO:0030214]; keratan sulfate catabolic process [GO:0042340]; lipid storage [GO:0019915]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; male courtship behavior [GO:0008049]; myelination [GO:0042552]; neuromuscular process controlling balance [GO:0050885]; neutrophil degranulation [GO:0043312]; oligosaccharide catabolic process [GO:0009313]; oogenesis [GO:0048477]; penetration of zona pellucida [GO:0007341]; phospholipid biosynthetic process [GO:0008654]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell shape [GO:0008360]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_CPNE8.2.2.m.58380,0.00838477192011554,-0.0150923415021819,No,NA,NA,Q78ZA7,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; nucleosome binding [GO:0031491]; nucleosome assembly [GO:0006334],NA,NA,NA
CHOYP_CPSF1.1.1.m.27767,-0.01464609412412,-0.0039259602338418,No,NA,NA,Q10569,NA,NA,NA,mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA polyadenylation [GO:0006378],NA,NA,NA
CHOYP_CPSF2.1.1.m.13908,-0.0124282550747086,0.0052897342814719,No,NA,NA,O35218,NA,NA,NA,mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; RNA binding [GO:0003723]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378],NA,NA,NA
CHOYP_CPSF5.1.2.m.59012,-0.00561677678411136,0.00733388330908563,No,NA,NA,Q7T3C6,NA,NA,NA,cytoplasm [GO:0005737]; mRNA cleavage factor complex [GO:0005849]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; AU-rich element binding [GO:0017091]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; cell differentiation [GO:0030154]; messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA alternative polyadenylation [GO:0110104]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; positive regulation of mRNA cleavage [GO:0031439]; positive regulation of mRNA polyadenylation [GO:1900365]; positive regulation of pro-B cell differentiation [GO:2000975]; positive regulation of stem cell differentiation [GO:2000738]; posttranscriptional regulation of gene expression [GO:0010608]; protein heterotetramerization [GO:0051290],NA,NA,NA
CHOYP_CPT1A.1.1.m.53985,-0.0151782632244767,-0.00838493391554865,No,NA,NA,Q9R0P6,NA,NA,NA,integral component of membrane [GO:0016021]; organelle membrane [GO:0031090]; signal peptidase complex [GO:0005787]; peptidase activity [GO:0008233]; serine-type peptidase activity [GO:0008236]; signal peptide processing [GO:0006465],NA,NA,NA
CHOYP_CPT2.1.1.m.16349,-0.00775237310467359,0.0057185634037286,No,NA,NA,P23786,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; carnitine O-palmitoyltransferase activity [GO:0004095]; carnitine shuttle [GO:0006853]; fatty acid beta-oxidation [GO:0006635]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of lipid metabolic process [GO:0019216],NA,NA,NA
CHOYP_CPVL.2.2.m.62669,-0.0166527614461239,-0.0142484590531261,No,NA,NA,Q9H3G5,NA,NA,NA,extracellular exosome [GO:0070062]; serine-type carboxypeptidase activity [GO:0004185]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_CRADD.1.2.m.27800,0.00846279904008468,-0.00908800386797214,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CRE_02254.1.1.m.12455,-0.00108811066353659,-0.00522823965176668,No,NA,NA,Q9V0D5,NA,NA,NA,cytoplasm [GO:0005737]; L-malate dehydrogenase activity [GO:0030060]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_CRE_06881.1.1.m.62783,0.00394536801625317,0.00291369700370642,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CRE_13958.1.1.m.31239,0.00572009008694833,-0.00590059029253527,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CRE_16884.1.1.m.28203,-0.00477918991228592,-0.00113944967978778,No,NA,NA,Q19673,NA,NA,NA,copper ion binding [GO:0005507]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; another compound as one donor; and incorporation of one atom of oxygen [GO:0016716]; melanin biosynthetic process [GO:0042438],NA,NA,NA
CHOYP_CRE_18961.1.1.m.30942,-0.00210099604839435,-0.0150565706345139,No,NA,NA,O60218,NA,NA,NA,cytosol [GO:0005829]; extracellular region [GO:0005576]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; geranylgeranyl reductase activity [GO:0045550]; indanol dehydrogenase activity [GO:0047718]; oxidoreductase activity [GO:0016491]; retinal dehydrogenase activity [GO:0001758]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; farnesol catabolic process [GO:0016488]; retinoid metabolic process [GO:0001523],NA,NA,NA
CHOYP_CRE_20365.1.3.m.20889,0.0104453748427162,-0.00668906044902797,No,NA,NA,Q21828,NA,NA,NA,integral component of mitochondrial inner membrane [GO:0031305]; pyruvate transmembrane transporter activity [GO:0050833]; mitochondrial pyruvate transmembrane transport [GO:0006850],NA,NA,NA
CHOYP_CRE_21950.1.1.m.55,-0.0135725579708752,0.00388604629968508,No,NA,NA,Q9VZW5,NA,NA,NA,integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204],NA,NA,NA
CHOYP_CRE_25145.1.1.m.8177,-0.0203745142058018,-0.0147659532076428,No,NA,NA,Q9D9T0,NA,NA,NA,Set1C/COMPASS complex [GO:0048188]; histone H3-K4 methylation [GO:0051568],NA,NA,NA
CHOYP_CRE_29942.1.1.m.48587,0.00567724128765144,0.00173863828109103,No,NA,NA,Q05695,NA,NA,NA,axon [GO:0030424]; axonal growth cone [GO:0044295]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendritic growth cone [GO:0044294]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; axon guidance receptor activity [GO:0008046]; PDZ domain binding [GO:0030165]; axon development [GO:0061564]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to ethanol [GO:0071361]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to thyroxine stimulus [GO:0097069]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dopaminergic neuron differentiation [GO:0071542]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; modulation of chemical synaptic transmission [GO:0050804]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; positive regulation of axon extension [GO:0045773]; positive regulation of cell-substrate adhesion [GO:0010811]; regulation of ERK1 and ERK2 cascade [GO:0070372]; response to activity [GO:0014823]; response to thyroid hormone [GO:0097066]; synapse organization [GO:0050808],NA,NA,NA
CHOYP_CRE.DIG.1.1.1.m.26794,0.0205157131781595,-0.00695096135254826,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CRE.GST.7.1.1.m.30139,-0.0193595217988188,-0.00892910852174509,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CRE.HIM.4.1.1.m.55343,-0.000146139710061201,-0.0047977172385975,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CRE.UNC.89.1.3.m.20277,0.0101986587151112,0.00689523002442513,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CRE.UNC.89.3.3.m.61234,-0.0135725579708753,0.00388604629968508,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CREM.1.1.m.12267,0.0024840112613178,0.000614547880281562,No,NA,NA,P79145,NA,NA,NA,nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; glycosphingolipid metabolic process [GO:0006687]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_CRI9333_2800.1.1.m.5332,0.00768955520267195,0.00997226710393919,No,NA,NA,Q9BXB1,NA,NA,NA,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]; transmembrane signaling receptor activity [GO:0004888]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; bone mineralization [GO:0030282]; bone remodeling [GO:0046849]; canonical Wnt signaling pathway involved in metanephric kidney development [GO:0061290]; cell differentiation involved in metanephros development [GO:0072202]; circadian regulation of gene expression [GO:0032922]; digestive tract development [GO:0048565]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; hair follicle development [GO:0001942]; hormone-mediated signaling pathway [GO:0009755]; innate immune response [GO:0045087]; intestinal stem cell homeostasis [GO:0036335]; male genitalia development [GO:0030539]; metanephric glomerulus development [GO:0072224]; metanephric nephron tubule morphogenesis [GO:0072282]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of cytokine secretion [GO:0050710]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transcription; DNA-templated [GO:0045892]; osteoblast differentiation [GO:0001649]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription; DNA-templated [GO:0045893]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_CRIM1.1.3.m.5078,0.0194860323997498,-0.0110043908630803,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CRIM1.2.3.m.5811,0.0185388213179596,0.0156891051304065,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CRLF3.1.2.m.8760,0.0138615751074827,0.00441286104977885,No,NA,NA,Q568M3,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677],NA,NA,NA
CHOYP_CRNL1.1.1.m.2792,-0.00655892346307357,-0.00243029455305563,No,NA,NA,Q9BZJ0,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; spliceosomal complex assembly [GO:0000245],NA,NA,NA
CHOYP_CRYAB.1.5.m.2659,-0.00929942779072995,-0.0219521013206345,No,NA,NA,Q91312,NA,NA,NA,metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; structural constituent of eye lens [GO:0005212],NA,NA,NA
CHOYP_CRYAB.5.5.m.49919,-0.0065445166303689,-0.00708324177704196,No,NA,NA,Q91312,NA,NA,NA,metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; structural constituent of eye lens [GO:0005212],NA,NA,NA
CHOYP_CRYM.1.1.m.8544,0.0221943520837964,-0.00622435324270261,No,NA,NA,O54983,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; hormone binding [GO:0042562]; NADP binding [GO:0050661]; oxidoreductase activity; acting on the CH-NH2 group of donors; NAD or NADP as acceptor [GO:0016639]; protein homodimerization activity [GO:0042803]; thiomorpholine-carboxylate dehydrogenase activity [GO:0047127]; thyroid hormone binding [GO:0070324]; transcription corepressor activity [GO:0003714]; mitochondrial transport [GO:0006839]; negative regulation of transcription by RNA polymerase II [GO:0000122]; sensory perception of sound [GO:0007605]; thyroid hormone metabolic process [GO:0042403]; thyroid hormone transport [GO:0070327],NA,NA,NA
CHOYP_CRYZ.2.2.m.65927,0.0180496164158882,-0.00441177929177974,No,NA,NA,Q08257,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mRNA 3'-UTR binding [GO:0003730]; NADPH binding [GO:0070402]; NADPH:quinone reductase activity [GO:0003960]; zinc ion binding [GO:0008270]; protein homotetramerization [GO:0051289]; visual perception [GO:0007601]; xenobiotic catabolic process [GO:0042178],NA,NA,NA
CHOYP_CS066.1.3.m.44165,-0.0128482734380944,0.0134991922424851,No,NA,NA,Q32L09,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA binding [GO:0003723]; defense response to virus [GO:0051607]; negative regulation of viral genome replication [GO:0045071]; response to interferon-gamma [GO:0034341]; response to type I interferon [GO:0034340]; response to type III interferon [GO:0034342],NA,NA,NA
CHOYP_CS081.1.1.m.48577,0.00212936954902875,-0.0138653241735822,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CSAD.1.1.m.40056,0.0214536939172207,-0.00749555103329451,No,NA,NA,Q9Y600,NA,NA,NA,cytoplasm [GO:0005737]; aspartate 1-decarboxylase activity [GO:0004068]; pyridoxal phosphate binding [GO:0030170]; sulfinoalanine decarboxylase activity [GO:0004782]; L-cysteine catabolic process to hypotaurine [GO:0019449]; L-cysteine catabolic process to taurine [GO:0019452]; taurine biosynthetic process [GO:0042412],NA,NA,NA
CHOYP_CSK.1.1.m.55145,-0.000145511089023655,0.0112288940732607,No,NA,NA,P32577,NA,NA,NA,cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; proline-rich region binding [GO:0070064]; protein kinase A catalytic subunit binding [GO:0034236]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; adaptive immune response [GO:0002250]; adherens junction organization [GO:0034332]; brain development [GO:0007420]; cellular response to peptide hormone stimulus [GO:0071375]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of kinase activity [GO:0033673]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of phagocytosis [GO:0050765]; oligodendrocyte differentiation [GO:0048709]; positive regulation of MAP kinase activity [GO:0043406]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368],NA,NA,NA
CHOYP_CSK21.1.2.m.19313,-0.0151119927794229,-0.019679198011518,No,NA,NA,P21868,NA,NA,NA,nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; rhythmic process [GO:0048511]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_CSK2B.1.1.m.37285,-0.00257663712875563,-0.0242125846821998,No,NA,NA,P28021,NA,NA,NA,protein kinase CK2 complex [GO:0005956]; metal ion binding [GO:0046872]; protein kinase regulator activity [GO:0019887]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_CSKI2.1.1.m.29327,3.94454510326325e-06,-0.0134885978167172,No,NA,NA,Q8VHK2,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; protein domain specific binding [GO:0019904]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_CSKP.1.2.m.20832,0.00758899503800001,-0.000948029462595428,No,NA,NA,O14936,NA,NA,NA,actin cytoskeleton [GO:0015629]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; vesicle [GO:0031982]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; guanylate kinase activity [GO:0004385]; neurexin family protein binding [GO:0042043]; protein serine/threonine kinase activity [GO:0004674]; calcium ion import [GO:0070509]; cell adhesion [GO:0007155]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cellular response to growth factor stimulus [GO:0090288]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of wound healing [GO:0061045]; neurotransmitter secretion [GO:0007269]; positive regulation of calcium ion import [GO:0090280]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of synaptic vesicle exocytosis [GO:2000300],NA,NA,NA
CHOYP_CSN2.1.1.m.28636,0.00598345513022859,0.0089944479401865,No,NA,NA,Q6IR75,NA,NA,NA,COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737],NA,NA,NA
CHOYP_CSN3.1.1.m.10996,-0.0124062733742108,0.00327905248237554,No,NA,NA,Q6P2U9,NA,NA,NA,COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_CSN4.1.1.m.18561,-0.000843012697467673,-0.0111961259814113,No,NA,NA,O88544,NA,NA,NA,cell junction [GO:0030054]; COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; synaptic vesicle [GO:0008021]; protein deneddylation [GO:0000338],NA,NA,NA
CHOYP_CSN5.1.1.m.52330,0.00967854964722751,0.0105766732378468,No,NA,NA,Q6PC30,NA,NA,NA,cell junction [GO:0030054]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synaptic vesicle [GO:0008021]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; NEDD8-specific protease activity [GO:0019784]; negative regulation of apoptotic process [GO:0043066]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; protein deneddylation [GO:0000338]; vestibular receptor cell development [GO:0060118],NA,NA,NA
CHOYP_CSN8.1.1.m.14798,-0.0114067326704008,0.00349410737594386,No,NA,NA,Q6GQA6,NA,NA,NA,COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; COP9 signalosome assembly [GO:0010387]; protein deneddylation [GO:0000338],NA,NA,NA
CHOYP_CSPA_C15740.1.1.m.59258,-0.0107267154618104,-0.0090996394754696,No,NA,NA,Q27237,NA,NA,NA,cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; patched binding [GO:0005113]; unfolded protein binding [GO:0051082]; mitochondrion organization [GO:0007005]; multicellular organism development [GO:0007275]; negative regulation of smoothened signaling pathway [GO:0045879]; protein folding [GO:0006457]; response to heat [GO:0009408],NA,NA,NA
CHOYP_CSPP1.11.14.m.54546,-0.000122795481962136,-0.0237114687513489,No,NA,NA,Q1MSJ5,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; spindle [GO:0005819]; spindle pole [GO:0000922]; positive regulation of cell division [GO:0051781]; positive regulation of cytokinesis [GO:0032467],NA,NA,NA
CHOYP_CSTA.1.3.m.6422,-0.0225592680620742,0.00997903474743216,No,NA,NA,P80416,NA,NA,NA,cytosol [GO:0005829]; cysteine-type endopeptidase inhibitor activity [GO:0004869],NA,NA,NA
CHOYP_CSTF3.1.1.m.10636,-0.0051809750932352,-0.00468238126178935,No,NA,NA,Q12996,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378]; mRNA splicing; via spliceosome [GO:0000398]; RNA 3'-end processing [GO:0031123]; termination of RNA polymerase II transcription [GO:0006369],NA,NA,NA
CHOYP_CTBL1.1.1.m.22983,0.00886599886631037,0.0053446949392434,No,NA,NA,O62703,NA,NA,NA,nucleus [GO:0005634]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; apoptotic process [GO:0006915]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_CTBS.1.1.m.54468,0.00205195042830452,-0.00934116934689426,No,NA,NA,Q8R242,NA,NA,NA,lysosome [GO:0005764]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; chitin catabolic process [GO:0006032]; oligosaccharide catabolic process [GO:0009313],NA,NA,NA
CHOYP_CTK2.3.3.m.51999,0.00875387819361284,-7.78947821600344e-05,No,NA,NA,P20480,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; meiotic spindle [GO:0072687]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; mitotic spindle microtubule [GO:1990498]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein homodimerization activity [GO:0042803]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; distributive segregation [GO:0032837]; meiotic spindle organization [GO:0000212]; microtubule bundle formation [GO:0001578]; microtubule-based movement [GO:0007018]; minus-end directed microtubule sliding [GO:0031534]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle elongation [GO:0000022]; mitotic spindle organization [GO:0007052]; mRNA transport [GO:0051028]; regulation of mitotic spindle assembly [GO:1901673]; regulation of mitotic spindle elongation [GO:0032888]; spindle assembly involved in female meiosis [GO:0007056]; spindle assembly involved in meiosis [GO:0090306]; spindle organization [GO:0007051],NA,NA,NA
CHOYP_CTL2.1.2.m.3858,-0.00164302075572743,-0.00281918586687367,No,NA,NA,Q642H9,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; brain development [GO:0007420]; chordate embryonic development [GO:0043009]; translation [GO:0006412],NA,NA,NA
CHOYP_CTND2.1.1.m.12206,-0.00734533591028737,0.00168229409090959,No,NA,NA,P98203,NA,NA,NA,cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_CTR1.2.4.m.39987,0.00642501296201372,0.00204025738215879,No,NA,NA,Q05609,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cellular response to iron ion [GO:0071281]; ethylene-activated signaling pathway [GO:0009873]; gibberellin biosynthetic process [GO:0009686]; negative regulation of ethylene-activated signaling pathway [GO:0010105]; protein autophosphorylation [GO:0046777]; regulation of post-embryonic root development [GO:2000069]; regulation of stem cell division [GO:2000035]; regulation of timing of transition from vegetative to reproductive phase [GO:0048510]; response to ethylene [GO:0009723]; response to fructose [GO:0009750]; response to hypoxia [GO:0001666]; response to sucrose [GO:0009744]; sugar mediated signaling pathway [GO:0010182],NA,NA,NA
CHOYP_CTR9.1.1.m.18832,-0.00573943234132164,-0.0154020104746097,No,NA,NA,Q4QR29,NA,NA,NA,Cdc73/Paf1 complex [GO:0016593]; transcriptionally active chromatin [GO:0035327]; histone H3-K4 trimethylation [GO:0080182]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968],NA,NA,NA
CHOYP_CTRA.1.2.m.26705,-0.0220958834229718,0.0106808384806869,No,NA,NA,P80646,NA,NA,NA,extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586],NA,NA,NA
CHOYP_CTRL.1.1.m.48654,0.00863490384464599,-0.00556772400155832,No,NA,NA,P35003,NA,NA,NA,extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252],NA,NA,NA
CHOYP_CTSL2.1.2.m.2936,-0.00123160619644405,0.00892811541308276,No,NA,NA,Q9GL24,NA,NA,NA,extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_CTTN.1.1.m.22042,0.00596193715863561,0.00595435223852611,No,NA,NA,Q14247,NA,NA,NA,cell cortex [GO:0005938]; clathrin-coated pit [GO:0005905]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; mitotic spindle midzone [GO:1990023]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; voltage-gated potassium channel complex [GO:0008076]; cadherin binding [GO:0045296]; profilin binding [GO:0005522]; actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; cell motility [GO:0048870]; dendritic spine maintenance [GO:0097062]; focal adhesion assembly [GO:0048041]; intracellular protein transport [GO:0006886]; lamellipodium organization [GO:0097581]; membrane organization [GO:0061024]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; neuron projection morphogenesis [GO:0048812]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of smooth muscle contraction [GO:0045987]; receptor-mediated endocytosis [GO:0006898]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of axon extension [GO:0030516]; substrate-dependent cell migration; cell extension [GO:0006930],NA,NA,NA
CHOYP_CTU2.1.1.m.43200,0.00327586590908695,-0.0143042972592222,No,NA,NA,Q6DC53,NA,NA,NA,cytosol [GO:0005829]; nucleotidyltransferase activity [GO:0016779]; sulfurtransferase activity [GO:0016783]; tRNA binding [GO:0000049]; protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098],NA,NA,NA
CHOYP_CTXA.1.2.m.31637,0.00236066714159076,-0.00666129573529452,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CUL1.1.1.m.13087,0.00858537678888112,-0.00361556559215195,No,NA,NA,Q9WTX6,NA,NA,NA,cullin-RING ubiquitin ligase complex [GO:0031461]; nucleoplasm [GO:0005654]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; cell proliferation [GO:0008283]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032],NA,NA,NA
CHOYP_CUL2.1.1.m.59278,-0.0124523197537378,-0.0196962274379408,No,NA,NA,Q9D4H8,NA,NA,NA,Cul2-RING ubiquitin ligase complex [GO:0031462]; cullin-RING ubiquitin ligase complex [GO:0031461]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]; VCB complex [GO:0030891]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_CUL3B.1.1.m.61643,0.003755406056428,-0.00915164605345177,No,NA,NA,Q6GPF3,NA,NA,NA,Cul3-RING ubiquitin ligase complex [GO:0031463]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; polar microtubule [GO:0005827]; ubiquitin protein ligase binding [GO:0031625]; cell migration [GO:0016477]; COPII vesicle coating [GO:0048208]; embryonic cleavage [GO:0040016]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; integrin-mediated signaling pathway [GO:0007229]; mitotic metaphase plate congression [GO:0007080]; negative regulation of Rho protein signal transduction [GO:0035024]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; stem cell division [GO:0017145]; stress fiber assembly [GO:0043149],NA,NA,NA
CHOYP_CUL3B.1.1.m.61644,0.00261803242721302,-0.0111187523165105,No,NA,NA,A3RLT6,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412],NA,NA,NA
CHOYP_CUL4B.1.1.m.6652,0.00529212729562565,0.0135234734651568,No,NA,NA,Q13619,NA,NA,NA,Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cullin-RING ubiquitin ligase complex [GO:0031461]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin protein ligase binding [GO:0031625]; cell cycle arrest [GO:0007050]; cellular response to DNA damage stimulus [GO:0006974]; DNA damage response; detection of DNA damage [GO:0042769]; G1/S transition of mitotic cell cycle [GO:0000082]; global genome nucleotide-excision repair [GO:0070911]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of cell proliferation [GO:0008285]; negative regulation of granulocyte differentiation [GO:0030853]; nucleotide-excision repair; DNA damage recognition [GO:0000715]; nucleotide-excision repair; DNA incision [GO:0033683]; nucleotide-excision repair; DNA incision; 5'-to lesion [GO:0006296]; nucleotide-excision repair; preincision complex assembly [GO:0006294]; nucleotide-excision repair; preincision complex stabilization [GO:0006293]; positive regulation of cell proliferation [GO:0008284]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of nucleotide-excision repair [GO:2000819]; regulation of protein metabolic process [GO:0051246]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; somatic stem cell population maintenance [GO:0035019]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032],NA,NA,NA
CHOYP_CUX1.1.2.m.10448,0.00984934781490683,-0.000350961026061257,No,NA,NA,Q13948,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; intra-Golgi vesicle-mediated transport [GO:0006891],NA,NA,NA
CHOYP_CWC22.1.1.m.29270,-0.00783125083067972,-0.0108090984693342,No,NA,NA,Q9VJ87,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_CX6A2.1.1.m.47963,0.00116785208343711,-0.0229657735404536,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CYB5.1.2.m.2195,0.00922927421890299,-0.0226578834961232,No,NA,NA,P56395,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; organelle membrane [GO:0031090]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; stearoyl-CoA 9-desaturase activity [GO:0004768]; fatty acid metabolic process [GO:0006631]; response to cadmium ion [GO:0046686],NA,NA,NA
CHOYP_CYC.1.5.m.5663,0.0188059761616697,0.000661165590667665,No,NA,NA,Q6QLW4,NA,NA,NA,mitochondrial intermembrane space [GO:0005758]; respirasome [GO:0070469]; electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_CYH1.1.1.m.66676,0.00891758174463433,-0.00537138893860623,No,NA,NA,Q15438,NA,NA,NA,adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; lipid binding [GO:0008289]; establishment of epithelial cell polarity [GO:0090162]; regulation of ARF protein signal transduction [GO:0032012]; regulation of cell adhesion [GO:0030155]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_CYIIB.2.2.m.64544,0.0110120254528832,0.00776918986894257,No,NA,NA,P02637,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_CYIIB.2.2.m.64545,0.0052650492708264,-0.00827055088667028,No,NA,NA,Q11212,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_CYPL.1.1.m.25000,0.0188143375626512,0.00611860062272226,No,NA,NA,Q9D0W5,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; cyclosporin A binding [GO:0016018]; disordered domain specific binding [GO:0097718]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; mRNA splicing; via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413],NA,NA,NA
CHOYP_CYT5.1.1.m.29960,0.00615966897194063,0.00941964587728867,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CYT5.1.1.m.29962,0.00735635636856922,0.0073792537073411,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CYTA.1.1.m.10540,-0.0233808254399332,0.0066943105621872,No,NA,NA,P01040,NA,NA,NA,cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; protease binding [GO:0002020]; protein binding; bridging [GO:0030674]; structural molecule activity [GO:0005198]; cell-cell adhesion [GO:0098609]; cornification [GO:0070268]; keratinocyte differentiation [GO:0030216]; negative regulation of peptidase activity [GO:0010466]; negative regulation of proteolysis [GO:0045861]; peptide cross-linking [GO:0018149],NA,NA,NA
CHOYP_CYTB.1.6.m.7874,-0.0127537999719017,0.00810221303098205,No,NA,NA,Q6DRC3,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; motile cilium assembly [GO:0044458]; pronephros development [GO:0048793]; pronephros morphogenesis [GO:0072114]; regulation of cilium movement [GO:0003352],NA,NA,NA
CHOYP_CZH5ORF51.1.1.m.25147,-0.00212078832001384,-0.00891837260408135,No,NA,NA,A8Y5U1,NA,NA,NA,,NA,NA,NA
CHOYP_D39U1.1.1.m.29364,-0.00110553345514344,0.00846402889463427,No,NA,NA,Q17QH8,NA,NA,NA,coenzyme binding [GO:0050662]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_DAB2.1.1.m.22396,0.0122066344293856,-0.010012318087668,No,NA,NA,P98081,NA,NA,NA,axon [GO:0030424]; cytosol [GO:0005829]; presynapse [GO:0098793]; sevenless binding [GO:0005118]; SH3 domain binding [GO:0017124]; cellularization [GO:0007349]; clathrin-dependent endocytosis [GO:0072583]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; motor neuron axon guidance [GO:0008045]; positive regulation of sevenless signaling pathway [GO:0045874]; synaptic vesicle endocytosis [GO:0048488],NA,NA,NA
CHOYP_DANA_GF10165.1.1.m.59230,-0.0112299453776209,0.000927505172602452,No,NA,NA,Q68FA2,NA,NA,NA,,NA,NA,NA
CHOYP_DANA_GF10776.1.1.m.18533,-0.00521976155703726,-0.0178236740214086,No,NA,NA,Q2TBS2,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735],NA,NA,NA
CHOYP_DANA_GF14191.1.1.m.11942,0.0195589732824321,0.00111861857486234,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DANA_GF15280.1.2.m.4538,0.0118291924094897,0.0162221742426904,No,NA,NA,Q5ZHW4,NA,NA,NA,early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]; regulation of endocytosis [GO:0030100],NA,NA,NA
CHOYP_DANA_GF15955.1.1.m.44177,0.00961475894029161,0.0151539515003446,No,NA,NA,Q66KY3,NA,NA,NA,response to metal ion [GO:0010038],NA,NA,NA
CHOYP_DANA_GF15955.1.1.m.44178,0.00528993744854203,-0.00793076344343417,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DANA_GF16638.1.1.m.10255,-0.00210982405469131,-0.0247354337779452,No,NA,NA,C4N147,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; lipid binding [GO:0008289],NA,NA,NA
CHOYP_DANA_GF18010.1.1.m.6864,0.0071915201776017,-0.0108598795533801,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DANA_GF20914.1.1.m.14747,-0.0110803856682096,0.00138614302781806,No,NA,NA,O76902,NA,NA,NA,apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; late endosome [GO:0005770]; metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333],NA,NA,NA
CHOYP_DANA_GF24303.1.1.m.33639,0.00076791416339284,-0.00864355305525625,No,NA,NA,P17671,NA,NA,NA,nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; heme binding [GO:0020037]; nuclear receptor activity [GO:0004879]; nuclear receptor transcription coactivator activity [GO:0030374]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; antimicrobial humoral response [GO:0019730]; cell differentiation [GO:0030154]; ecdysis; chitin-based cuticle [GO:0018990]; hormone-mediated signaling pathway [GO:0009755]; molting cycle; chitin-based cuticle [GO:0007591]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of ecdysteroid metabolic process [GO:0007553]; regulation of gene expression [GO:0010468]; response to ecdysone [GO:0035075]; response to lipid [GO:0033993],NA,NA,NA
CHOYP_DAR1.2.4.m.29583,-0.0121802562949351,-0.00230355783253469,No,NA,NA,Q9GZT4,NA,NA,NA,apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; D-serine ammonia-lyase activity [GO:0008721]; glycine binding [GO:0016594]; L-serine ammonia-lyase activity [GO:0003941]; magnesium ion binding [GO:0000287]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine racemase activity [GO:0030378]; threonine racemase activity [GO:0018114]; aging [GO:0007568]; brain development [GO:0007420]; D-serine biosynthetic process [GO:0070179]; D-serine metabolic process [GO:0070178]; L-serine biosynthetic process [GO:0006564]; L-serine metabolic process [GO:0006563]; protein homotetramerization [GO:0051289]; pyruvate biosynthetic process [GO:0042866]; response to lipopolysaccharide [GO:0032496]; response to morphine [GO:0043278]; serine family amino acid metabolic process [GO:0009069],NA,NA,NA
CHOYP_DARS2.1.1.m.43847,0.00251925062188164,0.0131434593300082,No,NA,NA,A6QPU5,NA,NA,NA,mitochondrial matrix [GO:0005759]; aspartate-tRNA ligase activity [GO:0004815]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; mitochondrial asparaginyl-tRNA aminoacylation [GO:0070145],NA,NA,NA
CHOYP_DBP2.2.2.m.55820,0.00755480214565256,0.000273843758327932,No,NA,NA,Q59LU0,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_DBT.1.1.m.4866,-0.0118143435488721,-0.0132193548387662,No,NA,NA,P11181,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; acetyltransferase activity [GO:0016407]; dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity [GO:0043754]; lipoic acid binding [GO:0031405]; ubiquitin protein ligase binding [GO:0031625],NA,NA,NA
CHOYP_DC1I2.1.3.m.25743,-0.00710516578616133,-0.0103035062819832,No,NA,NA,O88487,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; microtubule [GO:0005874]; vesicle [GO:0031982]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; motor activity [GO:0003774]; protein-containing complex binding [GO:0044877]; microtubule-based movement [GO:0007018]; negative regulation of neuron projection development [GO:0010977],NA,NA,NA
CHOYP_DC1I2.2.3.m.54049,0.00678620130084428,0.00878741825264137,No,NA,NA,Q0III3,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; microtubule [GO:0005874]; vesicle [GO:0031982]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; motor activity [GO:0003774]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_DCA15.1.1.m.11376,-0.0135725579708753,0.00388604629968508,No,NA,NA,A2BDA5,NA,NA,NA,protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_DCAF7.1.1.m.51583,0.0065703548737189,0.00157822708919477,No,NA,NA,P61963,NA,NA,NA,Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_DCDC2.3.7.m.36589,0.0103404926119976,-0.00449895434893109,No,NA,NA,Q5DU00,NA,NA,NA,axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; kinocilium [GO:0060091]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; kinesin binding [GO:0019894]; cilium assembly [GO:0060271]; dendrite morphogenesis [GO:0048813]; intracellular signal transduction [GO:0035556]; neuron migration [GO:0001764]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of cilium assembly [GO:1902017]; regulation of Wnt signaling pathway [GO:0030111]; sensory perception of sound [GO:0007605]; visual learning [GO:0008542],NA,NA,NA
CHOYP_DCDC2.7.7.m.46807,-0.0118527435080598,-0.0133078154400463,No,NA,NA,Q9UHG0,NA,NA,NA,axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinocilium [GO:0060091]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; kinesin binding [GO:0019894]; cellular defense response [GO:0006968]; cilium assembly [GO:0060271]; dendrite morphogenesis [GO:0048813]; intracellular signal transduction [GO:0035556]; neuron migration [GO:0001764]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of cilium assembly [GO:1902017]; regulation of Wnt signaling pathway [GO:0030111]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_DCNL4.1.2.m.36826,0.01712657718626,-0.00333297828564374,No,NA,NA,Q8CCA0,NA,NA,NA,nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; cullin family protein binding [GO:0097602]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein binding [GO:0032182]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein neddylation [GO:0045116],NA,NA,NA
CHOYP_DCTN1.2.2.m.40900,-0.00216936846627173,-0.00255743942192736,No,NA,NA,Q14203,NA,NA,NA,axon [GO:0030424]; cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; dynein complex [GO:0030286]; intermediate filament cytoskeleton [GO:0045111]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule plus-end [GO:0035371]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; spindle [GO:0005819]; spindle pole [GO:0000922]; dynein complex binding [GO:0070840]; microtubule binding [GO:0008017]; motor activity [GO:0003774]; protein kinase binding [GO:0019901]; tau protein binding [GO:0048156]; tubulin binding [GO:0015631]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cell division [GO:0051301]; centriole-centriole cohesion [GO:0010457]; ciliary basal body-plasma membrane docking [GO:0097711]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of mitotic spindle orientation [GO:0000132]; G2/M transition of mitotic cell cycle [GO:0000086]; IRE1-mediated unfolded protein response [GO:0036498]; maintenance of synapse structure [GO:0099558]; microtubule anchoring at centrosome [GO:0034454]; mitotic cell cycle [GO:0000278]; motor behavior [GO:0061744]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neuromuscular process [GO:0050905]; neuron cellular homeostasis [GO:0070050]; neuron projection maintenance [GO:1990535]; non-motile cilium assembly [GO:1905515]; nuclear envelope disassembly [GO:0051081]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neuromuscular junction development [GO:1904398]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of mitotic spindle organization [GO:0060236]; retrograde transport; endosome to Golgi [GO:0042147]; transport along microtubule [GO:0010970]; ventral spinal cord development [GO:0021517],NA,NA,NA
CHOYP_DCTN2.1.1.m.1084,-0.00884460629902173,-0.0169710501472374,No,NA,NA,Q99KJ8,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; dynein complex [GO:0030286]; growth cone [GO:0030426]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; vesicle [GO:0031982]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; protein kinase binding [GO:0019901]; spectrin binding [GO:0030507]; cell proliferation [GO:0008283]; melanosome transport [GO:0032402]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; protein localization to centrosome [GO:0071539],NA,NA,NA
CHOYP_DCTN4.1.1.m.29541,0.0141624074812242,0.00529314677434022,No,NA,NA,Q9UJW0,NA,NA,NA,cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; focal adhesion [GO:0005925]; kinetochore [GO:0000776]; nucleus [GO:0005634]; sarcomere [GO:0030017]; spindle pole [GO:0000922]; stress fiber [GO:0001725]; protein N-terminus binding [GO:0047485]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; nuclear migration [GO:0007097],NA,NA,NA
CHOYP_DCUP.1.1.m.7527,0.00144299241294373,-0.0255529120188595,No,NA,NA,P06132,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; uroporphyrinogen decarboxylase activity [GO:0004853]; heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782],NA,NA,NA
CHOYP_DD19A.1.1.m.57641,-0.0142671671546104,0.0114069198234634,No,NA,NA,Q3ZBV2,NA,NA,NA,cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; mRNA transport [GO:0051028]; protein transport [GO:0015031],NA,NA,NA
CHOYP_DDB_G0275195.1.1.m.47584,-0.0155516523663382,-0.00525963443691546,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DDB1.1.1.m.59135,-0.0150718186984215,-0.00980451928524358,No,NA,NA,Q805F9,NA,NA,NA,Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cullin family protein binding [GO:0097602]; damaged DNA binding [GO:0003684]; protein binding; bridging [GO:0030674]; protein-containing complex binding [GO:0044877]; WD40-repeat domain binding [GO:0071987]; DNA repair [GO:0006281]; histone H2A monoubiquitination [GO:0035518]; interaction with symbiont [GO:0051702]; negative regulation of apoptotic process [GO:0043066]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of viral genome replication [GO:0045070]; positive regulation of viral release from host cell [GO:1902188]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of mitotic cell cycle phase transition [GO:1901990]; UV-damage excision repair [GO:0070914]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_DDX1.1.1.m.46908,-0.0142556372789479,-0.0200949469048331,No,NA,NA,Q90WU3,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669]; ATP binding [GO:0005524]; ATP-dependent helicase activity [GO:0008026]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA/RNA helicase activity [GO:0033677]; exonuclease activity [GO:0004527]; nuclease activity [GO:0004518]; poly(A) binding [GO:0008143]; transcription coregulator activity [GO:0003712]; DNA duplex unwinding [GO:0032508]; double-strand break repair [GO:0006302]; mRNA processing [GO:0006397]; tRNA splicing; via endonucleolytic cleavage and ligation [GO:0006388],NA,NA,NA
CHOYP_DDX10.1.1.m.17783,0.0175441949345416,-0.00454717758595495,No,NA,NA,Q9D7V9,NA,NA,NA,cytoplasm [GO:0005737]; lysosome [GO:0005764]; hydrolase activity; acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; transcription factor binding [GO:0008134]; lipid metabolic process [GO:0006629],NA,NA,NA
CHOYP_DDX18.1.2.m.12567,-0.0119789408812625,-0.00559507730030425,No,NA,NA,Q9NVP1,NA,NA,NA,chromosome [GO:0005694]; membrane [GO:0016020]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; RNA binding [GO:0003723]; cellular response to estradiol stimulus [GO:0071392],NA,NA,NA
CHOYP_DDX18.2.2.m.51768,-0.00577515391449948,-0.00981511767067631,No,NA,NA,Q9NVP1,NA,NA,NA,chromosome [GO:0005694]; membrane [GO:0016020]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; RNA binding [GO:0003723]; cellular response to estradiol stimulus [GO:0071392],NA,NA,NA
CHOYP_DDX21.1.2.m.3695,-0.00479315249479298,-0.0114120845895918,No,NA,NA,Q99MJ9,NA,NA,NA,nucleolus [GO:0005730]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_DDX23.1.1.m.20195,-0.00822829859959057,0.00689563379963013,No,NA,NA,Q9BUQ8,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U5 snRNP [GO:0005682]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; RNA binding [GO:0003723]; cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing; via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing; via transesterification reactions [GO:0000375],NA,NA,NA
CHOYP_DDX23.1.1.m.20196,-0.00356121438627239,-0.00967356835567956,No,NA,NA,Q6DF67,NA,NA,NA,cytoplasm [GO:0005737]; catalytic activity [GO:0003824],NA,NA,NA
CHOYP_DDX24.1.1.m.6330,-0.0133565106036271,-0.0115261359743621,No,NA,NA,Q9GZR7,NA,NA,NA,membrane [GO:0016020]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA metabolic process [GO:0016070],NA,NA,NA
CHOYP_DDX3Y.1.1.m.3679,-0.00390580919562287,-0.00895968522255806,No,NA,NA,P24346,NA,NA,NA,ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_DDX41.1.1.m.16719,0.000187267588212254,0.0183292452443765,No,NA,NA,Q91VN6,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; cell proliferation [GO:0008283]; cellular response to interferon-beta [GO:0035458]; defense response to virus [GO:0051607]; mRNA splicing; via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_DDX42.2.2.m.54450,0.00304360381644214,-0.0220610683175743,No,NA,NA,Q7ZY47,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_DDX46.1.1.m.52473,-0.010283758182082,-0.00354031534344046,No,NA,NA,Q4TVV3,NA,NA,NA,Cajal body [GO:0015030]; nuclear speck [GO:0016607]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; brain development [GO:0007420]; definitive hemopoiesis [GO:0060216]; digestive tract morphogenesis [GO:0048546]; exocrine pancreas development [GO:0031017]; liver morphogenesis [GO:0072576]; mRNA splicing; via spliceosome [GO:0000398]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of hematopoietic stem cell differentiation [GO:1902038]; positive regulation of lymphocyte differentiation [GO:0045621],NA,NA,NA
CHOYP_DDX47.1.1.m.11144,-0.0103155807193567,-0.0043244770879599,No,NA,NA,Q9CWX9,NA,NA,NA,nucleolus [GO:0005730]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_DDX58.1.9.m.822,-0.00661549797049427,-0.00586017542836487,No,NA,NA,Q6Q899,NA,NA,NA,actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; regulation of cell migration [GO:0030334]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529],NA,NA,NA
CHOYP_DDX58.7.9.m.58168,-0.0161549421203122,0.000183366259014744,No,NA,NA,Q6Q899,NA,NA,NA,actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; regulation of cell migration [GO:0030334]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529],NA,NA,NA
CHOYP_DDX58.9.9.m.62757,-0.0160890412078783,0.0198849656992478,No,NA,NA,O95786,NA,NA,NA,actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to exogenous dsRNA [GO:0071360]; cytoplasmic pattern recognition receptor signaling pathway in response to virus [GO:0039528]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; negative regulation of type I interferon production [GO:0032480]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; protein deubiquitination [GO:0016579]; regulation of cell migration [GO:0030334]; regulation of type III interferon production [GO:0034344]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529]; viral process [GO:0016032],NA,NA,NA
CHOYP_DDX58.9.9.m.62758,-0.0095793848022861,-2.20451439179127e-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DECR2.1.2.m.29687,0.00172369186569329,-0.00502308419493528,No,NA,NA,Q6NV34,NA,NA,NA,peroxisome [GO:0005777]; 2;4-dienoyl-CoA reductase (NADPH) activity [GO:0008670]; fatty acid metabolic process [GO:0006631],NA,NA,NA
CHOYP_DEK.1.1.m.40646,0.0122640468924559,-0.0175813655510119,No,NA,NA,Q6AXS3,NA,NA,NA,contractile fiber [GO:0043292]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone binding [GO:0042393]; chromatin organization [GO:0006325]; regulation of double-strand break repair [GO:2000779]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032],NA,NA,NA
CHOYP_DENND4A.1.1.m.342,0.00835473596960433,-0.00578210598597391,No,NA,NA,Q7Z401,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_DEP1A.1.1.m.50111,0.0107860403654833,0.0135587326213352,No,NA,NA,Q803Q4,NA,NA,NA,GTPase activator activity [GO:0005096]; intracellular signal transduction [GO:0035556],NA,NA,NA
CHOYP_DERE_GG18317.1.1.m.44727,0.000324588416375425,-0.0141825627131712,No,NA,NA,Q9NFT7,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]; cellular glucose homeostasis [GO:0001678]; fructose metabolic process [GO:0006000]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; mannose metabolic process [GO:0006013],NA,NA,NA
CHOYP_DERE_GG18317.1.1.m.44730,-0.0224041220547051,0.00975275583858269,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DFA_00978.1.1.m.17875,0.00377479382677818,-0.00393662703593395,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DFA_05420.1.1.m.25051,0.00386894667192078,0.00620136719972647,No,NA,NA,O42646,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_DFA_06569.1.1.m.9782,-0.022673831078857,0.00622974218660685,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DFER_5601.1.1.m.49215,0.0123452055769602,-0.0161758341657587,No,NA,NA,Q8J0I9,NA,NA,NA,extracellular region [GO:0005576]; extracellular space [GO:0005615]; glucan endo-1;6-beta-glucosidase activity [GO:0046557]; glucosylceramidase activity [GO:0004348]; hydrolase activity; acting on glycosyl bonds [GO:0016798]; polysaccharide metabolic process [GO:0005976]; sphingolipid metabolic process [GO:0006665],NA,NA,NA
CHOYP_DFPA.1.1.m.29402,-0.00446597956203007,-0.0256416824945015,No,NA,NA,Q7SIG4,NA,NA,NA,calcium ion binding [GO:0005509]; diisopropyl-fluorophosphatase activity [GO:0047862],NA,NA,NA
CHOYP_DGKD.2.2.m.9520,0.00435783290624166,-0.00778184156481716,No,NA,NA,Q16760,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; diacylglycerol binding [GO:0019992]; diacylglycerol kinase activity [GO:0004143]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; diacylglycerol metabolic process [GO:0046339]; endocytosis [GO:0006897]; epidermal growth factor receptor signaling pathway [GO:0007173]; glycerolipid metabolic process [GO:0046486]; lipid phosphorylation [GO:0046834]; multicellular organism development [GO:0007275]; platelet activation [GO:0030168]; protein homooligomerization [GO:0051260]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein transport [GO:0015031]; response to organic substance [GO:0010033]; second-messenger-mediated signaling [GO:0019932]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_DGKZA.1.2.m.29620,0.00762825150778709,-0.000359060177387655,No,NA,NA,O08560,NA,NA,NA,cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; phosphatidic acid biosynthetic process [GO:0006654]; positive regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0090216]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205],NA,NA,NA
CHOYP_DGRI_GH10893.1.1.m.27211,-0.00959639133533545,-0.0221680403967546,No,NA,NA,Q6DGW9,NA,NA,NA,Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; calcium channel activity [GO:0005262]; calcium ion transmembrane transport [GO:0070588]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; ER overload response [GO:0006983],NA,NA,NA
CHOYP_DGRI_GH12278.1.1.m.5056,-0.0102668618295774,0.000512321513744007,No,NA,NA,Q9Y2S2,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; L-gulonate 3-dehydrogenase activity [GO:0050104]; NAD+ binding [GO:0070403]; protein homodimerization activity [GO:0042803]; fatty acid metabolic process [GO:0006631]; glucuronate catabolic process to xylulose 5-phosphate [GO:0019640],NA,NA,NA
CHOYP_DGRI_GH13197.1.1.m.35578,0.00615966897194063,0.00941964587728867,No,NA,NA,O17482,NA,NA,NA,nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; rhythmic process [GO:0048511],NA,NA,NA
CHOYP_DGRI_GH14833.1.1.m.14206,-0.00483695033703678,-0.0182570702881902,No,NA,NA,Q9VUJ0,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; nucleotide binding [GO:0000166]; structural constituent of ribosome [GO:0003735]; gene silencing by RNA [GO:0031047]; mitochondrial translation [GO:0032543]; regulation of translation [GO:0006417]; translation [GO:0006412],NA,NA,NA
CHOYP_DGRI_GH14972.1.1.m.64210,0.00652584209557787,0.00112995415788878,No,NA,NA,P31396,NA,NA,NA,nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; metamorphosis [GO:0007552]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of development; heterochronic [GO:0040034],NA,NA,NA
CHOYP_DGRI_GH15313.1.1.m.5763,0.00831448476037075,0.011255973756096,No,NA,NA,C4N147,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; lipid binding [GO:0008289],NA,NA,NA
CHOYP_DGRI_GH15575.1.1.m.49170,0.00907451908725505,-0.0148559316258685,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DGRI_GH19122.1.1.m.1378,0.00481089766602302,-0.00905343724585097,No,NA,NA,Q2TBK2,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_DGRI_GH20300.1.1.m.57587,0.013273041159365,0.00951673024161482,No,NA,NA,Q63ZH8,NA,NA,NA,,NA,NA,NA
CHOYP_DGRI_GH22804.1.1.m.12160,-0.00323091405778582,-0.0149997080487011,No,NA,NA,Q9HCB6,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; LBD domain binding [GO:0050693]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]; negative regulation of amyloid-beta formation [GO:1902430]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of protein binding [GO:0032092]; positive regulation of protein processing [GO:0010954],NA,NA,NA
CHOYP_DGRI_GH22876.2.3.m.54068,-0.0169591047060434,0.00960206869202778,No,NA,NA,Q761V0,NA,NA,NA,glycinergic synapse [GO:0098690]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; glycine transmembrane transporter activity [GO:0015187]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; glycine import across plasma membrane [GO:1903804]; glycine transport [GO:0015816]; neurotransmitter reuptake [GO:0098810]; neurotransmitter uptake [GO:0001504]; synaptic transmission; glycinergic [GO:0060012],NA,NA,NA
CHOYP_DGRI_GH23100.1.1.m.44142,-0.00161969458923625,0.00506651522447369,No,NA,NA,O60500,NA,NA,NA,cell projection [GO:0042995]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057]; myosin binding [GO:0017022]; cell adhesion [GO:0007155]; excretion [GO:0007588]; glomerular basement membrane development [GO:0032836]; glomerular visceral epithelial cell development [GO:0072015]; JNK cascade [GO:0007254]; myoblast fusion [GO:0007520]; positive regulation of actin filament polymerization [GO:0030838]; protein localization to synapse [GO:0035418]; regulation of excretion [GO:0044062]; skeletal muscle tissue development [GO:0007519],NA,NA,NA
CHOYP_DGRI_GH24618.1.2.m.1995,0.00205195042830452,-0.00934116934689426,No,NA,NA,Q7KVW5,NA,NA,NA,integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; photoreceptor activity [GO:0009881]; small conductance calcium-activated potassium channel activity [GO:0016286]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of membrane potential in photoreceptor cell [GO:0016057],NA,NA,NA
CHOYP_DHB12.1.1.m.62534,0.0065883263884642,0.0180931628217626,No,NA,NA,Q28IU1,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 3-oxo-arachidoyl-CoA reductase activity [GO:0102339]; 3-oxo-behenoyl-CoA reductase activity [GO:0102340]; 3-oxo-cerotoyl-CoA reductase activity [GO:0102342]; 3-oxo-lignoceroyl-CoA reductase activity [GO:0102341]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633],NA,NA,NA
CHOYP_DHB14.1.1.m.13441,-0.00110828707945983,0.0214005660496619,No,NA,NA,Q9MYP6,NA,NA,NA,cytosol [GO:0005829]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; identical protein binding [GO:0042802]; testosterone 17-beta-dehydrogenase (NADP+) activity [GO:0047045]; steroid catabolic process [GO:0006706],NA,NA,NA
CHOYP_DHB4.1.2.m.13985,0.0106056274227122,0.0038920020231456,No,NA,NA,P51659,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3alpha;7alpha;12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity [GO:0033989]; isomerase activity [GO:0016853]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; alpha-linolenic acid metabolic process [GO:0036109]; androgen metabolic process [GO:0008209]; bile acid biosynthetic process [GO:0006699]; estrogen metabolic process [GO:0008210]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; medium-chain fatty-acyl-CoA metabolic process [GO:0036112]; osteoblast differentiation [GO:0001649]; protein targeting to peroxisome [GO:0006625]; Sertoli cell development [GO:0060009]; very long-chain fatty acid metabolic process [GO:0000038]; very long-chain fatty-acyl-CoA metabolic process [GO:0036111],NA,NA,NA
CHOYP_DHB4.2.2.m.19618,-0.000492473955174477,-0.0119459243024708,No,NA,NA,P97852,NA,NA,NA,peroxisome [GO:0005777]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; 3alpha;7alpha;12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity [GO:0033989]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; isomerase activity [GO:0016853]; protein homodimerization activity [GO:0042803]; testosterone dehydrogenase [NAD(P)] activity [GO:0030283]; aging [GO:0007568]; cellular response to organic cyclic compound [GO:0071407]; cholesterol metabolic process [GO:0008203]; fatty acid beta-oxidation [GO:0006635]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to steroid hormone [GO:0048545],NA,NA,NA
CHOYP_DHC6.1.1.m.22887,-0.0223229488592236,0.00965383734802812,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DHE4.1.1.m.48536,-0.021172989211112,0.00367476881623433,No,NA,NA,P00367,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; glutamate dehydrogenase (NAD+) activity [GO:0004352]; glutamate dehydrogenase [NAD(P)+] activity [GO:0004353]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; leucine binding [GO:0070728]; NAD+ binding [GO:0070403]; cellular amino acid biosynthetic process [GO:0008652]; glutamate biosynthetic process [GO:0006537]; glutamate catabolic process [GO:0006538]; glutamine metabolic process [GO:0006541]; positive regulation of insulin secretion [GO:0032024]; substantia nigra development [GO:0021762]; tricarboxylic acid metabolic process [GO:0072350],NA,NA,NA
CHOYP_DHPS.1.1.m.55870,0.00312937620961247,-0.0207267684415801,No,NA,NA,P49366,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; deoxyhypusine synthase activity [GO:0034038]; identical protein binding [GO:0042802]; peptidyl-lysine modification to peptidyl-hypusine [GO:0008612]; positive regulation of cell proliferation [GO:0008284]; spermidine metabolic process [GO:0008216]; translation [GO:0006412],NA,NA,NA
CHOYP_DHR.1.1.1.m.43819,0.00615966897194063,0.00941964587728867,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DHR11.2.2.m.36445,-0.0226467720593625,0.0101774747023232,No,NA,NA,Q71R50,NA,NA,NA,extracellular region [GO:0005576]; 17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; 17-beta-ketosteroid reductase activity [GO:0072555]; 3-keto sterol reductase activity [GO:0000253]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; nucleotide binding [GO:0000166]; estrogen biosynthetic process [GO:0006703],NA,NA,NA
CHOYP_DHSAB.1.1.m.25026,-0.00251810942906715,-0.012601504428675,No,NA,NA,Q801S2,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; flavin adenine dinucleotide binding [GO:0050660]; succinate dehydrogenase (ubiquinone) activity [GO:0008177]; electron transport chain [GO:0022900]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_DHSB.1.1.m.3993,-0.0151111309294088,-0.0138341721537296,No,NA,NA,P21912,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex II; succinate dehydrogenase complex (ubiquinone) [GO:0005749]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; 2 iron; 2 sulfur cluster binding [GO:0051537]; 3 iron; 4 sulfur cluster binding [GO:0051538]; 4 iron; 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; succinate dehydrogenase (ubiquinone) activity [GO:0008177]; ubiquinone binding [GO:0048039]; aerobic respiration [GO:0009060]; respiratory electron transport chain [GO:0022904]; succinate metabolic process [GO:0006105]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_DHSO.1.2.m.5409,-0.0145571045956075,-0.00805371852419053,No,NA,NA,P27867,NA,NA,NA,extracellular exosome [GO:0070062]; mitochondrial membrane [GO:0031966]; motile cilium [GO:0031514]; identical protein binding [GO:0042802]; L-iditol 2-dehydrogenase activity [GO:0003939]; NAD binding [GO:0051287]; zinc ion binding [GO:0008270]; flagellated sperm motility [GO:0030317]; fructose biosynthetic process [GO:0046370]; L-xylitol catabolic process [GO:0051160]; response to cadmium ion [GO:0046686]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to hormone [GO:0009725]; response to nutrient levels [GO:0031667]; response to osmotic stress [GO:0006970]; sorbitol catabolic process [GO:0006062],NA,NA,NA
CHOYP_DHSO.2.2.m.29745,0.0107475947136067,-0.00275972252747813,No,NA,NA,P0DMQ6,NA,NA,NA,mitochondrial membrane [GO:0031966]; motile cilium [GO:0031514]; protein-containing complex [GO:0032991]; L-iditol 2-dehydrogenase activity [GO:0003939]; NAD binding [GO:0051287]; zinc ion binding [GO:0008270]; fructose biosynthetic process [GO:0046370]; fructose metabolic process [GO:0006000]; NADH oxidation [GO:0006116]; NADH regeneration [GO:0006735]; sorbitol biosynthetic process [GO:0006061]; sorbitol catabolic process [GO:0006062],NA,NA,NA
CHOYP_DHTK1.1.1.m.8425,0.00518255689128744,0.00124436621938192,No,NA,NA,Q5EAR5,NA,NA,NA,tRNA 2'-phosphotransferase activity [GO:0000215]; tRNA splicing; via endonucleolytic cleavage and ligation [GO:0006388],NA,NA,NA
CHOYP_DHX15.2.2.m.62441,-0.00294975592044374,-0.00170821813839431,No,NA,NA,O43143,NA,NA,NA,nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]; ATP binding [GO:0005524]; ATP-dependent 3'-5' RNA helicase activity [GO:0034459]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA processing [GO:0006397]; mRNA splicing; via spliceosome [GO:0000398]; response to alkaloid [GO:0043279]; response to toxic substance [GO:0009636]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_DHX57.2.2.m.45703,0.0065883263884642,0.0180931628217626,No,NA,NA,Q9R0X0,NA,NA,NA,mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; ubiquitin ligase complex [GO:0000151]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; protein ubiquitination [GO:0016567]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle cell differentiation [GO:0035914],NA,NA,NA
CHOYP_DHX8.2.3.m.55112,-0.0114877058374915,-0.0253645130918685,No,NA,NA,Q14562,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; ATP binding [GO:0005524]; ATP-dependent 3'-5' RNA helicase activity [GO:0034459]; ATP-dependent RNA helicase activity [GO:0004004]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; spliceosomal complex disassembly [GO:0000390],NA,NA,NA
CHOYP_DHX8.2.3.m.55114,0.0110711954684926,-0.00527416892935798,No,NA,NA,P38542,NA,NA,NA,nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031],NA,NA,NA
CHOYP_DI3L2.1.1.m.61980,0.000127400062374349,0.0165390259568711,No,NA,NA,Q0V9R3,NA,NA,NA,cytoplasm [GO:0005737]; exosome (RNase complex) [GO:0000178]; P-body [GO:0000932]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cell cycle [GO:0007049]; cell division [GO:0051301]; miRNA catabolic process [GO:0010587]; nuclear-transcribed mRNA catabolic process; exonucleolytic [GO:0000291]; nuclear-transcribed mRNA catabolic process; exonucleolytic; 3'-5' [GO:0034427]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; RNA catabolic process [GO:0006401]; rRNA processing [GO:0006364]; stem cell population maintenance [GO:0019827],NA,NA,NA
CHOYP_DIAP2.1.1.m.25706,0.0108467106375946,-0.00732455337203386,No,NA,NA,Q9Z207,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; actin binding [GO:0003779]; Rho GTPase binding [GO:0017048]; actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; cytoskeleton organization [GO:0007010]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_DIAPH1.1.1.m.55416,0.0197704139906763,-0.000834206521139404,No,NA,NA,O70566,NA,NA,NA,actin binding [GO:0003779]; Rho GTPase binding [GO:0017048]; actin filament polymerization [GO:0030041]; multicellular organism development [GO:0007275]; oogenesis [GO:0048477],NA,NA,NA
CHOYP_DICER.1.3.m.9936,-0.00212078832001384,-0.00891837260408134,No,NA,NA,Q9VCU9,NA,NA,NA,cytoplasm [GO:0005737]; micro-ribonucleoprotein complex [GO:0035068]; nucleus [GO:0005634]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; ATP binding [GO:0005524]; bidentate ribonuclease III activity [GO:0016443]; deoxyribonuclease I activity [GO:0004530]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; pre-miRNA binding [GO:0070883]; ribonuclease III activity [GO:0004525]; single-stranded RNA binding [GO:0003727]; apoptotic DNA fragmentation [GO:0006309]; dendrite morphogenesis [GO:0048813]; dsRNA transport [GO:0033227]; germ-line stem cell division [GO:0042078]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; mitotic cell cycle; embryonic [GO:0045448]; pole cell formation [GO:0007279]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; production of siRNA involved in RNA interference [GO:0030422]; response to starvation [GO:0042594]; RNA interference [GO:0016246]; segment polarity determination [GO:0007367]; siRNA loading onto RISC involved in RNA interference [GO:0035087],NA,NA,NA
CHOYP_DICPUDRAFT_147269.1.1.m.34818,-0.000277581709277407,-0.00828462021874394,No,NA,NA,Q54P70,NA,NA,NA,cysteine-type peptidase activity [GO:0008234],NA,NA,NA
CHOYP_DICPUDRAFT_81027.1.1.m.5425,0.0150152140646768,-0.00786193485879482,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DICPUDRAFT_93011.1.1.m.30650,-0.0233079112365266,0.00660293290575777,No,NA,NA,P24044,NA,NA,NA,calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722],NA,NA,NA
CHOYP_DIS3.1.1.m.6724,-5.18834956181456e-05,0.00646533008949163,No,NA,NA,Q9CSH3,NA,NA,NA,cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; endonuclease activity [GO:0004519]; guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]; CUT catabolic process [GO:0071034]; RNA catabolic process [GO:0006401]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_DJC13.1.1.m.46117,-0.000420242553595291,-0.00764606472802196,No,NA,NA,O75165,NA,NA,NA,azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; endosome organization [GO:0007032]; neutrophil degranulation [GO:0043312]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954],NA,NA,NA
CHOYP_DKC1.1.1.m.10978,-0.0061727252282286,-0.00595160583594818,No,NA,NA,Q9ESX5,NA,NA,NA,box H/ACA snoRNP complex [GO:0031429]; box H/ACA telomerase RNP complex [GO:0090661]; Cajal body [GO:0015030]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; box H/ACA snoRNA binding [GO:0034513]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034]; box H/ACA snoRNA 3'-end processing [GO:0000495]; box H/ACA snoRNA metabolic process [GO:0033979]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; mRNA pseudouridine synthesis [GO:1990481]; positive regulation of cell proliferation [GO:0008284]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of telomerase RNA localization to Cajal body [GO:1904872]; rRNA pseudouridine synthesis [GO:0031118]; scaRNA localization to Cajal body [GO:0090666]; snoRNA guided rRNA pseudouridine synthesis [GO:0000454]; snRNA pseudouridine synthesis [GO:0031120]; telomerase RNA stabilization [GO:0090669]; telomere maintenance via telomerase [GO:0007004],NA,NA,NA
CHOYP_DLAT.1.1.m.64812,0.00900310722733719,-0.00259206341637996,No,NA,NA,Q19749,NA,NA,NA,mitochondrial matrix [GO:0005759]; pyruvate dehydrogenase complex [GO:0045254]; dihydrolipoyllysine-residue acetyltransferase activity [GO:0004742]; glycolytic process [GO:0006096],NA,NA,NA
CHOYP_DLDH.1.1.m.31018,-0.000606635306832613,0.00905394504925304,No,NA,NA,P09623,NA,NA,NA,acrosomal vesicle [GO:0001669]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; dihydrolipoyl dehydrogenase activity [GO:0004148]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; cell redox homeostasis [GO:0045454]; histone succinylation [GO:0106077],NA,NA,NA
CHOYP_DLGP1.3.3.m.44296,0.0184690309971009,-0.00341421946491484,No,NA,NA,O14490,NA,NA,NA,cell junction [GO:0030054]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; protein-containing complex binding [GO:0044877]; chemical synaptic transmission [GO:0007268],NA,NA,NA
CHOYP_DLL1.1.1.m.4589,0.00678620130084428,0.00878741825264137,No,NA,NA,P78504,NA,NA,NA,adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; growth factor activity [GO:0008083]; Notch binding [GO:0005112]; phospholipid binding [GO:0005543]; structural molecule activity [GO:0005198]; angiogenesis [GO:0001525]; aorta morphogenesis [GO:0035909]; aortic valve morphogenesis [GO:0003180]; blood vessel remodeling [GO:0001974]; cardiac neural crest cell development involved in outflow tract morphogenesis [GO:0061309]; cardiac right ventricle morphogenesis [GO:0003215]; cardiac septum morphogenesis [GO:0060411]; cell fate determination [GO:0001709]; ciliary body morphogenesis [GO:0061073]; distal tubule development [GO:0072017]; endocardial cushion cell development [GO:0061444]; endothelial cell differentiation [GO:0045446]; glomerular visceral epithelial cell development [GO:0072015]; hemopoiesis [GO:0030097]; inner ear auditory receptor cell differentiation [GO:0042491]; keratinocyte differentiation [GO:0030216]; loop of Henle development [GO:0072070]; morphogenesis of an epithelial sheet [GO:0002011]; myoblast differentiation [GO:0045445]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of stem cell differentiation [GO:2000737]; nephron development [GO:0072006]; nervous system development [GO:0007399]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of myeloid cell differentiation [GO:0045639]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pulmonary artery morphogenesis [GO:0061156]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell proliferation [GO:0042127]; response to muramyl dipeptide [GO:0032495]; T cell mediated immunity [GO:0002456],NA,NA,NA
CHOYP_DLL4.1.1.m.40197,0.0218782238178865,-0.00462157573676366,No,NA,NA,D3ZHH1,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; blood vessel lumenization [GO:0072554]; blood vessel remodeling [GO:0001974]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac atrium morphogenesis [GO:0003209]; dorsal aorta morphogenesis [GO:0035912]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling involved in heart development [GO:0061314]; pericardium morphogenesis [GO:0003344]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of neural retina development [GO:0061074]; regulation of neurogenesis [GO:0050767]; T cell differentiation [GO:0030217]; ventricular trabecula myocardium morphogenesis [GO:0003222],NA,NA,NA
CHOYP_DLP.1.1.m.31353,0.0132561332539252,-0.0104982833517919,No,NA,NA,Q5GN48,NA,NA,NA,actin filament [GO:0005884]; actin filament bundle [GO:0032432]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; actin filament binding [GO:0051015]; dystroglycan binding [GO:0002162]; zinc ion binding [GO:0008270]; actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639],NA,NA,NA
CHOYP_DLP1.1.1.m.40279,-0.0094504923842416,-0.0100079733138445,No,NA,NA,Q86YH6,NA,NA,NA,cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; transferase complex [GO:1990234]; protein heterodimerization activity [GO:0046982]; trans-hexaprenyltranstransferase activity [GO:0000010]; trans-octaprenyltranstransferase activity [GO:0050347]; isoprenoid biosynthetic process [GO:0008299]; protein heterotetramerization [GO:0051290]; regulation of body fluid levels [GO:0050878]; ubiquinone biosynthetic process [GO:0006744],NA,NA,NA
CHOYP_DMBT1.11.34.m.22620,0.00748733192729377,0.00918189563303786,No,NA,NA,Q9UGM3,NA,NA,NA,cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; heparan sulfate binding [GO:1904399]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; signaling pattern recognition receptor activity [GO:0008329]; zymogen binding [GO:0035375]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular protein metabolic process [GO:0044267]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; viral process [GO:0016032],NA,NA,NA
CHOYP_DMBT1.15.34.m.29008,-0.00887916979550401,-0.0257825548084524,No,NA,NA,B3EWZ5,NA,NA,NA,extracellular region [GO:0005576]; membrane [GO:0016020],NA,NA,NA
CHOYP_DMBT1.3.34.m.3602,0.0017504121599781,0.0120290929885952,No,NA,NA,Q86VB7,NA,NA,NA,endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; scavenger receptor activity [GO:0005044]; acute-phase response [GO:0006953]; receptor-mediated endocytosis [GO:0006898],NA,NA,NA
CHOYP_DMOJ_GI11203.1.1.m.24977,-0.0110619776253359,-0.00377100348303423,No,NA,NA,Q9VXK0,NA,NA,NA,mitochondrion [GO:0005739],NA,NA,NA
CHOYP_DMOJ_GI12418.1.1.m.49398,-0.017944357106643,0.0025708547671399,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DMOJ_GI12939.1.3.m.5732,0.0065883263884642,0.0180931628217626,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DMOJ_GI12939.2.3.m.20888,0.00491588973115351,-0.000600714720400964,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DMOJ_GI17052.1.1.m.4566,-0.00212078832001384,-0.00891837260408135,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DMOJ_GI17690.1.1.m.48369,-0.00346548286514295,-0.00562565093880473,No,NA,NA,B7YZV4,NA,NA,NA,extracellular space [GO:0005615]; 3';5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3';5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; calcium- and calmodulin-regulated 3';5'-cyclic-GMP phosphodiesterase activity [GO:0048101]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; cAMP metabolic process [GO:0046058]; cGMP metabolic process [GO:0046068]; male mating behavior [GO:0060179]; multicellular organism reproduction [GO:0032504]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_DMOJ_GI18492.1.1.m.8902,-2.88746552353675e-05,-0.0112759558214184,No,NA,NA,Q95ZJ1,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation via threonine [GO:0018243],NA,NA,NA
CHOYP_DMOJ_GI18492.1.1.m.8903,0.0154321120448534,0.0109799962614898,No,NA,NA,Q95ZJ1,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation via threonine [GO:0018243],NA,NA,NA
CHOYP_DMOJ_GI18925.1.1.m.37775,-0.00948494044753413,0.00153945239798822,No,NA,NA,D3YXG0,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_DMOJ_GI19977.1.1.m.66449,-0.0103048142951904,0.00945778731777433,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DMOJ_GI23261.1.2.m.12269,-0.0170711736730081,0.00446942373243747,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DNAH12.2.3.m.32353,-0.014938164077041,0.0040232504638657,No,NA,NA,Q63170,NA,NA,NA,dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_DNAH12.3.3.m.63246,-0.00528046371705375,-0.0110610197852392,No,NA,NA,Q63170,NA,NA,NA,dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_DNAH5.1.2.m.56799,0.0116472512362242,0.0174187780716528,No,NA,NA,Q8TE73,NA,NA,NA,9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158],NA,NA,NA
CHOYP_DNAH5.2.2.m.61452,-0.0220552511925385,-0.00522131933151233,No,NA,NA,Q8TE73,NA,NA,NA,9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158],NA,NA,NA
CHOYP_DNAH6.2.3.m.21512,-0.0206739665525098,-0.0072763192119469,No,NA,NA,Q9C0G6,NA,NA,NA,axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_DNAH7.1.2.m.19685,-0.00960872131838278,-0.00841121691716888,No,NA,NA,Q63170,NA,NA,NA,dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_DNAH7.2.2.m.46648,-0.0208733601678874,-0.00778295056765237,No,NA,NA,Q8WXX0,NA,NA,NA,axonemal dynein complex [GO:0005858]; cilium [GO:0005929]; cytosol [GO:0005829]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_DNAJ.11.1.1.m.18882,0.0215330355038501,-0.00869755414902747,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DNAJB6B.1.2.m.1265,0.00394536801625317,0.00291369700370642,No,NA,NA,O35723,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737],NA,NA,NA
CHOYP_DNAL1.1.1.m.11822,-0.00633501413839099,0.013677597024255,No,NA,NA,Q05A62,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; alpha-tubulin binding [GO:0043014]; dynein heavy chain binding [GO:0045504]; motor activity [GO:0003774]; outer dynein arm assembly [GO:0036158],NA,NA,NA
CHOYP_DNER.1.1.m.28378,0.000117158516090616,-0.0125303366634411,No,NA,NA,Q07008,NA,NA,NA,acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ruffle [GO:0001726]; calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; Notch binding [GO:0005112]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transmembrane signaling receptor activity [GO:0004888]; animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac vascular smooth muscle cell development [GO:0060948]; cell cycle arrest [GO:0007050]; cell differentiation in spinal cord [GO:0021515]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart looping [GO:0001947]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 secretion [GO:0072602]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of growth rate [GO:0045967]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of JAK-STAT cascade [GO:0046427]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription; DNA-templated [GO:0045893]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell proliferation [GO:0042127]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222],NA,NA,NA
CHOYP_DNJA2.2.2.m.51791,0.0188388725950806,0.0128467920848018,No,NA,NA,Q2HJ94,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; protein refolding [GO:0042026]; response to heat [GO:0009408],NA,NA,NA
CHOYP_DNJA3.1.1.m.15026,-0.0141716036035998,-0.0171928758138995,No,NA,NA,Q96EY1,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; postsynaptic membrane [GO:0045211]; ATP binding [GO:0005524]; GTPase regulator activity [GO:0030695]; Hsp70 protein binding [GO:0030544]; IkappaB kinase complex binding [GO:0106137]; interferon-gamma receptor binding [GO:0005133]; metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; transcription factor binding [GO:0008134]; unfolded protein binding [GO:0051082]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation-induced cell death of T cells [GO:0006924]; cell aging [GO:0007569]; mitochondrial DNA replication [GO:0006264]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of programmed cell death [GO:0043069]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuromuscular junction development [GO:0007528]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell proliferation [GO:0042102]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]; response to interferon-gamma [GO:0034341]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; small GTPase mediated signal transduction [GO:0007264]; T cell differentiation in thymus [GO:0033077],NA,NA,NA
CHOYP_DNJC2.1.1.m.8941,-0.0133545450306244,-0.00516701346468236,No,NA,NA,Q7TQ20,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; ubiquitin modification-dependent histone binding [GO:0061649]; chromatin organization [GO:0006325]; negative regulation of cell growth [GO:0030308]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_DNJC3.1.1.m.52309,-0.0111772880244817,-0.00800010544347175,No,NA,NA,Q27968,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; chaperone binding [GO:0051087]; misfolded protein binding [GO:0051787]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; unfolded protein binding [GO:0051082]; cellular response to cold [GO:0070417]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; protein folding in endoplasmic reticulum [GO:0034975]; response to unfolded protein [GO:0006986],NA,NA,NA
CHOYP_DNJC5.1.1.m.52453,-0.00212078832001384,-0.00891837260408135,No,NA,NA,P56101,NA,NA,NA,membrane [GO:0016020],NA,NA,NA
CHOYP_DNJC7.1.1.m.8987,-0.0134343808344414,-0.00594045544518489,No,NA,NA,Q99615,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATPase activator activity [GO:0001671]; heat shock protein binding [GO:0031072]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein folding [GO:0006457]; regulation of cellular response to heat [GO:1900034],NA,NA,NA
CHOYP_DNJC9.1.1.m.12688,-0.00494752950625797,-0.0146182072086165,No,NA,NA,Q91WN1,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; heat shock protein binding [GO:0031072]; positive regulation of ATPase activity [GO:0032781]; social behavior [GO:0035176],NA,NA,NA
CHOYP_DNLI1.1.2.m.19123,-0.0169591047060434,0.00960206869202777,No,NA,NA,P51892,NA,NA,NA,nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation involved in DNA repair [GO:0051103]; DNA recombination [GO:0006310]; DNA replication [GO:0006260],NA,NA,NA
CHOYP_DNMT1.1.1.m.54990,-0.00143423217916291,-0.0163555211106185,No,NA,NA,Q92072,NA,NA,NA,nucleus [GO:0005634]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270]; DNA methylation on cytosine within a CG sequence [GO:0010424]; maintenance of DNA methylation [GO:0010216]; positive regulation of methylation-dependent chromatin silencing [GO:0090309]; Ras protein signal transduction [GO:0007265],NA,NA,NA
CHOYP_DNPH1.1.1.m.28418,-0.00362392077544139,-0.00362104184131307,No,NA,NA,Q80VJ3,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; deoxyribonucleoside 5'-monophosphate N-glycosidase activity [GO:0070694]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; deoxyribonucleoside monophosphate catabolic process [GO:0009159]; epithelial cell differentiation [GO:0030855]; nucleoside metabolic process [GO:0009116]; nucleotide metabolic process [GO:0009117]; positive regulation of cell growth [GO:0030307],NA,NA,NA
CHOYP_DOCK1.2.2.m.61345,-0.00322083385860214,0.00547852266818124,No,NA,NA,Q14185,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; guanyl-nucleotide exchange factor complex [GO:0032045]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; SH3 domain binding [GO:0017124]; apoptotic process [GO:0006915]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; integrin-mediated signaling pathway [GO:0007229]; phagocytosis; engulfment [GO:0006911]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],NA,NA,NA
CHOYP_DOCK3.1.2.m.49353,0.00214186310388424,-0.0138387875394464,No,NA,NA,Q8N1I0,NA,NA,NA,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; PDZ domain binding [GO:0030165]; Rac GTPase binding [GO:0048365]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]; cell chemotaxis [GO:0060326]; negative regulation of vascular smooth muscle contraction [GO:1904694]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; small GTPase mediated signal transduction [GO:0007264],NA,NA,NA
CHOYP_DOCK7.1.3.m.1197,0.0131391695980152,-0.00770426111929934,No,NA,NA,Q96N67,NA,NA,NA,axon [GO:0030424]; basal part of cell [GO:0045178]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; neuron projection [GO:0043005]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rac GTPase binding [GO:0048365]; activation of GTPase activity [GO:0090630]; axonogenesis [GO:0007409]; establishment of neuroblast polarity [GO:0045200]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of cold-induced thermogenesis [GO:0120163]; neuron projection development [GO:0031175]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of neurogenesis [GO:0050767]; small GTPase mediated signal transduction [GO:0007264],NA,NA,NA
CHOYP_DOCK9.1.2.m.7649,-0.00836836821755214,-0.00687616279835933,No,NA,NA,Q9BZ29,NA,NA,NA,cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]; cadherin binding [GO:0045296]; guanyl-nucleotide exchange factor activity [GO:0005085]; blood coagulation [GO:0007596]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264],NA,NA,NA
CHOYP_DOME.2.2.m.62360,-0.0117834849556713,0.00882953566949852,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DP13A.2.3.m.10746,-0.00600362974367459,-0.0016891276215627,No,NA,NA,Q9UKG1,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; vesicle membrane [GO:0012506]; identical protein binding [GO:0042802]; protein kinase B binding [GO:0043422]; protein-containing complex binding [GO:0044877]; cell cycle [GO:0007049]; cell proliferation [GO:0008283]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; insulin receptor signaling pathway [GO:0008286]; regulation of glucose import [GO:0046324]; regulation of protein localization to plasma membrane [GO:1903076]; signal transduction [GO:0007165]; signaling [GO:0023052],NA,NA,NA
CHOYP_DPER_GL17438.1.1.m.11680,0.00778253266483163,0.0177776658668259,No,NA,NA,Q0E908,NA,NA,NA,cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_DPER_GL17448.1.1.m.54836,0.000912783429834976,-0.00480523246003066,No,NA,NA,P20273,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; carbohydrate binding [GO:0030246]; CD4 receptor binding [GO:0042609]; IgM binding [GO:0001791]; protein phosphatase binding [GO:0019903]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102]; B cell activation [GO:0042113]; cell adhesion [GO:0007155]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of calcium-mediated signaling [GO:0050849]; negative regulation of immunoglobulin secretion [GO:0051025]; regulation of B cell proliferation [GO:0030888]; regulation of endocytosis [GO:0030100]; regulation of immune response [GO:0050776],NA,NA,NA
CHOYP_DPER_GL24378.1.1.m.64285,0.00164424299603099,0.0171714398321673,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DPER_GL26275.1.2.m.885,0.0118750536094023,0.00536313246546601,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DPER_GL26275.2.2.m.17886,-0.0034009836797759,0.00275385546754332,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DPF2.1.2.m.6678,0.00063850478686392,-0.00121508072323831,No,NA,NA,Q61103,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; intracellular membrane-bounded organelle [GO:0043231]; nBAF complex [GO:0071565]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; H3K9me3 modified histone binding [GO:0062072]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; apoptotic process [GO:0006915]; negative regulation of myeloid progenitor cell differentiation [GO:1905454]; negative regulation of transcription; DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_DPOLB.1.1.m.15375,-0.0118843344123181,0.00475132532516021,No,NA,NA,O57383,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; lyase activity [GO:0016829]; metal ion binding [GO:0046872]; base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260],NA,NA,NA
CHOYP_DPOLZ.1.1.m.49299,0.00217997094733793,-0.00807271368859912,No,NA,NA,Q61493,NA,NA,NA,nucleolus [GO:0005730]; zeta DNA polymerase complex [GO:0016035]; 4 iron; 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-prone translesion synthesis [GO:0042276]; nucleic acid phosphodiester bond hydrolysis [GO:0090305],NA,NA,NA
CHOYP_DPSE_GA10259.1.1.m.36297,0.0146023505188913,-0.0168968157900675,No,NA,NA,Q6NW29,NA,NA,NA,,NA,NA,NA
CHOYP_DPSE_GA10675.1.1.m.23860,0.00685649011830323,0.00994317354954231,No,NA,NA,Q23023,NA,NA,NA,axon [GO:0030424]; cytosol [GO:0005829]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; phagophore assembly site [GO:0000407]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; apoptotic cell clearance [GO:0043277]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cell migration [GO:0016477]; dauer larval development [GO:0040024]; determination of adult lifespan [GO:0008340]; embryo development ending in birth or egg hatching [GO:0009792]; nematode male tail tip morphogenesis [GO:0045138]; programmed cell death [GO:0012501]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of autophagy [GO:0010506]; regulation of axon extension [GO:0030516]; regulation of cell size [GO:0008361]; regulation of multicellular organism growth [GO:0040014]; regulation of protein localization [GO:0032880],NA,NA,NA
CHOYP_DPSE_GA15574.1.1.m.62967,-0.0051039189238536,-0.00375307481548384,No,NA,NA,Q9NFT7,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]; cellular glucose homeostasis [GO:0001678]; fructose metabolic process [GO:0006000]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; mannose metabolic process [GO:0006013],NA,NA,NA
CHOYP_DPSE_GA16367.1.1.m.22618,-0.00552065053180657,0.00778240309081737,No,NA,NA,B5X4E0,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_DPSE_GA17283.3.3.m.59446,0.00355468029062618,-0.00152850408586952,No,NA,NA,Q868Z9,NA,NA,NA,basement membrane [GO:0005604]; extracellular matrix structural constituent [GO:0005201]; peptidase activity [GO:0008233]; serine-type endopeptidase inhibitor activity [GO:0004867]; extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_DPSE_GA25136.1.1.m.66680,-0.0169591047060434,0.00960206869202777,No,NA,NA,Q8MRC9,NA,NA,NA,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; multicellular organism reproduction [GO:0032504]; protein O-linked glycosylation [GO:0006493],NA,NA,NA
CHOYP_DPSE_GA27121.1.1.m.6089,0.0223664636990008,-0.00206586755203673,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DPSE_GA28568.3.9.m.19206,-0.0177291571748419,0.0149082958125435,No,NA,NA,Q8TCU4,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; spindle pole [GO:0000922]; alpha-actinin binding [GO:0051393]; ciliary basal body-plasma membrane docking [GO:0097711]; endosomal transport [GO:0016197]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of centriole replication [GO:0046599]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of stress fiber assembly [GO:0051492],NA,NA,NA
CHOYP_DPSE_GA28568.5.9.m.33670,-0.00768867624143189,0.00432593826791432,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DPSE_GA30097.1.1.m.24050,0.00754421530987302,-0.00480302324586375,No,NA,NA,Q5R8Z6,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; calcium ion binding [GO:0005509]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_DPSE_GA30464.1.1.m.65390,-0.00754696017783454,-0.00804604637856587,No,NA,NA,Q3T094,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; hydrolase activity; acting on ester bonds [GO:0016788]; iron ion binding [GO:0005506]; sulfur dioxygenase activity [GO:0050313]; glutathione metabolic process [GO:0006749]; hydrogen sulfide metabolic process [GO:0070813],NA,NA,NA
CHOYP_DPY19L3.1.1.m.7532,0.00312689214538949,-0.0177570989019004,No,NA,NA,Q71B07,NA,NA,NA,integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; mannosyltransferase activity [GO:0000030]; protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [GO:0018406],NA,NA,NA
CHOYP_DRE2.2.2.m.41479,-0.0112706043462868,-0.0104901429216706,No,NA,NA,Q5EAC7,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial intermembrane space [GO:0005758]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 2 iron; 2 sulfur cluster binding [GO:0051537]; 4 iron; 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; apoptotic process [GO:0006915]; hemopoiesis [GO:0030097]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of apoptotic process [GO:0043066],NA,NA,NA
CHOYP_DRG1.1.1.m.28901,0.0024524251904227,-0.0184128053295867,No,NA,NA,P32234,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; cytoplasmic translation [GO:0002181],NA,NA,NA
CHOYP_DRG2.1.1.m.14009,0.00520881225290491,-0.0218143576673761,No,NA,NA,P55039,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; GTP binding [GO:0005525]; cytoplasmic translation [GO:0002181]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_DRPR.1.2.m.58255,-0.00212078832001384,-0.00891837260408135,No,NA,NA,Q9W0A0,NA,NA,NA,axon [GO:0030424]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; phosphatidylserine binding [GO:0001786]; apoptotic cell clearance [GO:0043277]; cell competition in a multicellular organism [GO:0035212]; defense response to bacterium [GO:0042742]; engulfment of apoptotic cell [GO:0043652]; larval locomotory behavior [GO:0008345]; neuron remodeling [GO:0016322]; phagocytosis [GO:0006909]; phagocytosis; engulfment [GO:0006911]; positive regulation of phagocytosis; engulfment [GO:0060100]; regulation of neuromuscular junction development [GO:1904396]; response to axon injury [GO:0048678]; salivary gland cell autophagic cell death [GO:0035071]; wing disc dorsal/ventral pattern formation [GO:0048190],NA,NA,NA
CHOYP_DRPR.2.2.m.62931,-0.0026930121234525,-0.0125755383235594,No,NA,NA,Q9W0A0,NA,NA,NA,axon [GO:0030424]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; phosphatidylserine binding [GO:0001786]; apoptotic cell clearance [GO:0043277]; cell competition in a multicellular organism [GO:0035212]; defense response to bacterium [GO:0042742]; engulfment of apoptotic cell [GO:0043652]; larval locomotory behavior [GO:0008345]; neuron remodeling [GO:0016322]; phagocytosis [GO:0006909]; phagocytosis; engulfment [GO:0006911]; positive regulation of phagocytosis; engulfment [GO:0060100]; regulation of neuromuscular junction development [GO:1904396]; response to axon injury [GO:0048678]; salivary gland cell autophagic cell death [GO:0035071]; wing disc dorsal/ventral pattern formation [GO:0048190],NA,NA,NA
CHOYP_DS.1.1.m.62106,0.001593906666152,-0.0129151042718204,No,NA,NA,Q24292,NA,NA,NA,apicolateral plasma membrane [GO:0016327]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell morphogenesis involved in differentiation [GO:0000904]; cell proliferation [GO:0008283]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of hippo signaling [GO:0035331]; peptide cross-linking [GO:0018149]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251]; Wnt signaling pathway; planar cell polarity pathway [GO:0060071],NA,NA,NA
CHOYP_DSCAM.3.3.m.65848,0.00492874482753611,0.000337812674712858,No,NA,NA,Q96RW7,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],NA,NA,NA
CHOYP_DSEC_GM10209.1.1.m.49171,0.0065883263884642,0.0180931628217626,No,NA,NA,P27701,NA,NA,NA,extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cell surface receptor signaling pathway [GO:0007166],NA,NA,NA
CHOYP_DSEC_GM12928.1.1.m.11933,0.00702338812115864,-0.0149304337407509,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DSEC_GM16292.1.1.m.12184,-0.0149406510311479,-0.00472008283613328,No,NA,NA,Q868Z9,NA,NA,NA,basement membrane [GO:0005604]; extracellular matrix structural constituent [GO:0005201]; peptidase activity [GO:0008233]; serine-type endopeptidase inhibitor activity [GO:0004867]; extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_DSEC_GM19691.1.1.m.30070,0.0046999857080131,0.00667679809709295,No,NA,NA,P19803,NA,NA,NA,cytosol [GO:0005829]; immunological synapse [GO:0001772]; membrane [GO:0016020]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]; Rho GDP-dissociation inhibitor activity [GO:0005094]; regulation of protein localization [GO:0032880]; Rho protein signal transduction [GO:0007266]; semaphorin-plexin signaling pathway [GO:0071526],NA,NA,NA
CHOYP_DSEC_GM21767.1.1.m.63020,0.0174775955868355,-0.007123818668415,No,NA,NA,O16011,NA,NA,NA,cytoplasm [GO:0005737]; H zone [GO:0031673]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; compound eye photoreceptor cell differentiation [GO:0001751]; eye development [GO:0001654]; muscle cell cellular homeostasis [GO:0046716]; muscle organ development [GO:0007517]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of female receptivity [GO:0045924]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; rhabdomere development [GO:0042052]; visual perception [GO:0007601],NA,NA,NA
CHOYP_DSIM_GD11682.1.1.m.30804,0.00283738951022884,0.00385220094672449,No,NA,NA,Q8WTC1,NA,NA,NA,mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; regulation of growth [GO:0040008]; translation [GO:0006412],NA,NA,NA
CHOYP_DSIM_GD13062.1.1.m.3175,0.0110628106545549,0.00471286049729683,No,NA,NA,Q9NFP5,NA,NA,NA,SH3 domain binding [GO:0017124],NA,NA,NA
CHOYP_DSIM_GD13354.1.1.m.6235,-0.00997111694306805,-0.00229741365819452,No,NA,NA,O75489,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nuclear body [GO:0016604]; electron transfer activity [GO:0009055]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]; mitochondrial electron transport; NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; reactive oxygen species metabolic process [GO:0072593]; substantia nigra development [GO:0021762],NA,NA,NA
CHOYP_DSIM_GD24875.1.1.m.66201,-0.0114652292674377,-0.0116720051165062,No,NA,NA,Q3T149,NA,NA,NA,axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]; identical protein binding [GO:0042802]; protein binding involved in protein folding [GO:0044183]; protein homodimerization activity [GO:0042803]; anterograde axonal protein transport [GO:0099641]; chaperone-mediated protein folding [GO:0061077]; regulation of protein phosphorylation [GO:0001932],NA,NA,NA
CHOYP_DSIM_GD25210.1.1.m.29275,-0.0169591047060434,0.00960206869202777,No,NA,NA,Q5XIS2,NA,NA,NA,cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886]; ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transporter activity [GO:1902388]; intermembrane lipid transfer activity [GO:0120013]; lipid binding [GO:0008289]; phospholipid binding [GO:0005543]; phospholipid transporter activity [GO:0005548]; ceramide 1-phosphate transport [GO:1902389]; ceramide transport [GO:0035627]; intermembrane lipid transfer [GO:0120009]; negative regulation of autophagy [GO:0010507]; negative regulation of interleukin-1 beta secretion [GO:0050713]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226],NA,NA,NA
CHOYP_DSPP.5.8.m.37255,0.00615966897194063,0.00941964587728867,No,NA,NA,Q460N5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein poly-ADP-ribosylation [GO:0070212],NA,NA,NA
CHOYP_DSPP.6.8.m.47723,-0.00299565504462265,-0.00932282613990103,No,NA,NA,Q80WT5,NA,NA,NA,AP-1 adaptor complex [GO:0030121]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; trans-Golgi network membrane [GO:0032588]; clathrin binding [GO:0030276]; protein transporter activity [GO:0008565]; intracellular transport [GO:0046907],NA,NA,NA
CHOYP_DSPP.8.8.m.65419,0.00973599940123033,0.00579554081371566,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DSRAD.1.4.m.4228,-0.0177577638312722,0.00482246973719187,No,NA,NA,P55265,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530]; DNA binding [GO:0003677]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251]; adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; mRNA processing [GO:0006397]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; positive regulation of viral genome replication [GO:0045070]; pre-miRNA processing [GO:0031054]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; response to interferon-alpha [GO:0035455]; response to virus [GO:0009615]; RNA processing [GO:0006396]; type I interferon signaling pathway [GO:0060337],NA,NA,NA
CHOYP_DSRAD.2.4.m.5410,-0.0113438477334163,0.00775224643633392,No,NA,NA,P55265,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530]; DNA binding [GO:0003677]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251]; adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; mRNA processing [GO:0006397]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; positive regulation of viral genome replication [GO:0045070]; pre-miRNA processing [GO:0031054]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; response to interferon-alpha [GO:0035455]; response to virus [GO:0009615]; RNA processing [GO:0006396]; type I interferon signaling pathway [GO:0060337],NA,NA,NA
CHOYP_DSRAD.3.4.m.24850,0.0134308982719586,0.0122696939962635,No,NA,NA,Q99MU3,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; left-handed Z-DNA binding [GO:0003692]; metal ion binding [GO:0046872]; tRNA-specific adenosine deaminase activity [GO:0008251]; adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; definitive hemopoiesis [GO:0060216]; erythrocyte differentiation [GO:0030218]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell homeostasis [GO:0061484]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of RNA interference [GO:1900369]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of viral genome replication [GO:0045071]; osteoblast differentiation [GO:0001649]; positive regulation of viral genome replication [GO:0045070]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; response to interferon-alpha [GO:0035455]; response to virus [GO:0009615]; RNA processing [GO:0006396]; somatic diversification of immune receptors via somatic mutation [GO:0002566],NA,NA,NA
CHOYP_DTNBP1.1.1.m.66644,0.00771568238338028,0.00862444460506017,No,NA,NA,Q96EV8,NA,NA,NA,axon [GO:0030424]; axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; melanosome membrane [GO:0033162]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle membrane [GO:0030672]; actin cytoskeleton reorganization [GO:0031532]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; blood coagulation [GO:0007596]; dendrite morphogenesis [GO:0048813]; melanosome organization [GO:0032438]; negative regulation of protein binding [GO:0032091]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; platelet dense granule organization [GO:0060155]; positive regulation of gene expression [GO:0010628]; positive regulation of neurotransmitter secretion [GO:0001956]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of dopamine secretion [GO:0014059]; regulation of JUN kinase activity [GO:0043506]; regulation of synaptic vesicle exocytosis [GO:2000300],NA,NA,NA
CHOYP_DTX3.3.3.m.64703,-0.00801936695612065,0.00701380242542599,No,NA,NA,Q5REG4,NA,NA,NA,cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_DTX3L.2.4.m.51200,-0.00706584106202905,0.00813428427619509,No,NA,NA,Q3UIR3,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; STAT family protein binding [GO:0097677]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; defense response to virus [GO:0051607]; double-strand break repair [GO:0006302]; endosome to lysosome transport [GO:0008333]; histone H2A ubiquitination [GO:0033522]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; innate immune response [GO:0045087]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; Notch signaling pathway [GO:0007219]; positive regulation of chromatin binding [GO:0035563]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of NAD+ ADP-ribosyltransferase activity [GO:1901666]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of receptor catabolic process [GO:2000646]; positive regulation of transcription; DNA-templated [GO:0045893]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_DUOX1.1.4.m.14284,-0.00542645782171652,0.00729362167924779,No,NA,NA,Q58EK5,NA,NA,NA,cytoplasm [GO:0005737]; P granule [GO:0043186]; pi-body [GO:0071546]; metal ion binding [GO:0046872]; piRNA binding [GO:0034584]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; P granule organization [GO:0030719]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_DUOX1.1.4.m.14285,-0.0166847588858877,0.0103848752167397,No,NA,NA,Q8HZK2,NA,NA,NA,apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; heme binding [GO:0020037]; NAD(P)H oxidase activity [GO:0016174]; peroxidase activity [GO:0004601]; cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590],NA,NA,NA
CHOYP_DUOX1.2.4.m.33964,-0.0135909547637754,0.00962923452080349,No,NA,NA,Q8HZK2,NA,NA,NA,apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; heme binding [GO:0020037]; NAD(P)H oxidase activity [GO:0016174]; peroxidase activity [GO:0004601]; cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590],NA,NA,NA
CHOYP_DUOX1.3.4.m.34160,0.00767858415095581,-0.011029484796183,No,NA,NA,Q9VQH2,NA,NA,NA,endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; heme binding [GO:0020037]; NAD(P)H oxidase activity [GO:0016174]; peroxidase activity [GO:0004601]; adult chitin-based cuticle development [GO:0008365]; adult chitin-containing cuticle pigmentation [GO:0048085]; cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; defense response to bacterium [GO:0042742]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; imaginal disc-derived wing morphogenesis [GO:0007476]; mucosal immune response [GO:0002385]; negative regulation of apoptotic process [GO:0043066]; reactive oxygen species metabolic process [GO:0072593]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; wing disc development [GO:0035220],NA,NA,NA
CHOYP_DUOX1.4.4.m.44613,-0.00790750892926098,-0.0240687357471035,No,NA,NA,Q01105,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; histone binding [GO:0042393]; protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]; DNA replication [GO:0006260]; negative regulation of histone acetylation [GO:0035067]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription; DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; regulation of mRNA stability [GO:0043488]; viral process [GO:0016032],NA,NA,NA
CHOYP_DVIR_GJ11008.1.1.m.11917,0.00475760242016363,-0.0191155373257964,No,NA,NA,P20073,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; RNA binding [GO:0003723]; autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176],NA,NA,NA
CHOYP_DVIR_GJ11267.1.1.m.29991,-0.0168678960470711,0.00252673679598269,No,NA,NA,O60218,NA,NA,NA,cytosol [GO:0005829]; extracellular region [GO:0005576]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; geranylgeranyl reductase activity [GO:0045550]; indanol dehydrogenase activity [GO:0047718]; oxidoreductase activity [GO:0016491]; retinal dehydrogenase activity [GO:0001758]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; farnesol catabolic process [GO:0016488]; retinoid metabolic process [GO:0001523],NA,NA,NA
CHOYP_DVIR_GJ13593.1.1.m.18124,-0.0064070954109821,-0.00874225036448239,No,NA,NA,P37193,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 2 iron; 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; positive regulation of ecdysteroid biosynthetic process [GO:0045998],NA,NA,NA
CHOYP_DVIR_GJ14588.1.1.m.25420,-0.00554088276586473,0.00256793291976948,No,NA,NA,Q8IZ73,NA,NA,NA,pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455],NA,NA,NA
CHOYP_DVIR_GJ17679.2.3.m.46443,-0.000174047020675547,-0.00435489856403997,No,NA,NA,A2RU49,NA,NA,NA,mitochondrial matrix [GO:0005759]; hydroxylysine kinase activity [GO:0047992]; lysine catabolic process [GO:0006554],NA,NA,NA
CHOYP_DVIR_GJ20612.1.1.m.14542,0.00160165847318452,-0.0138997036542336,No,NA,NA,Q291A0,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; ribonucleoprotein complex [GO:1990904]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_DVIR_GJ21252.1.1.m.10086,-0.000524084961436386,0.0160947301784184,No,NA,NA,P80311,NA,NA,NA,endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA polymerase binding [GO:0070063]; unfolded protein binding [GO:0051082]; bone development [GO:0060348]; chaperone-mediated protein folding [GO:0061077]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of multicellular organism growth [GO:0040018]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_DVIR_GJ22204.1.1.m.17270,0.018468946959704,-0.00762291892797694,No,NA,NA,Q642M9,NA,NA,NA,D-xylose 1-dehydrogenase (NADP+) activity [GO:0047837]; trans-1;2-dihydrobenzene-1;2-diol dehydrogenase activity [GO:0047115],NA,NA,NA
CHOYP_DVIR_GJ23521.1.1.m.2757,-0.0138115174135467,-0.00230492805683769,No,NA,NA,P0C1H5,NA,NA,NA,nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; nucleosome assembly [GO:0006334],NA,NA,NA
CHOYP_DVL.2.2.m.40553,-0.000402370794842809,-0.0209839237569717,No,NA,NA,Q6DKE2,NA,NA,NA,cytoplasm [GO:0005737]; beta-catenin binding [GO:0008013]; ciliary basal body organization [GO:0032053]; cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; multicellular organism development [GO:0007275]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_DWIL_GK10341.1.1.m.21304,-0.0156881654921576,-0.00577917488122165,No,NA,NA,Q3ZBX6,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_DWIL_GK10525.1.1.m.56074,0.00986101109573875,0.0121779644456145,No,NA,NA,P15330,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; subsynaptic reticulum [GO:0071212]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; high mobility group box 1 binding [GO:0070379]; identical protein binding [GO:0042802]; repressing transcription factor binding [GO:0070491]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; anterior/posterior pattern specification [GO:0009952]; defense response [GO:0006952]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; ectoderm development [GO:0007398]; ectodermal cell fate specification [GO:0001715]; gastrulation involving germ band extension [GO:0010004]; germ cell migration [GO:0008354]; heart development [GO:0007507]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955]; inflammatory response [GO:0006954]; melanization defense response [GO:0035006]; mesoderm development [GO:0007498]; mesodermal cell fate specification [GO:0007501]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; NIK/NF-kappaB signaling [GO:0038061]; peripheral nervous system neuron development [GO:0048935]; plasmatocyte differentiation [GO:0042387]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria [GO:0006964]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of hemocyte proliferation [GO:0035206]; regulation of transcription; DNA-templated [GO:0006355]; response to cytokine [GO:0034097]; Toll signaling pathway [GO:0008063]; ventral cord development [GO:0007419],NA,NA,NA
CHOYP_DWIL_GK11849.1.1.m.12344,0.00446531813599503,-0.00440714374061333,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DWIL_GK15715.1.1.m.52399,-0.00839131455769182,-0.00743359700150974,No,NA,NA,Q924N4,NA,NA,NA,axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; potassium ion transmembrane transporter activity [GO:0015079]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901]; cell volume homeostasis [GO:0006884]; cellular hypotonic response [GO:0071476]; cellular hypotonic salinity response [GO:0071477]; chemical synaptic transmission [GO:0007268]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; ion transport [GO:0006811]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573],NA,NA,NA
CHOYP_DWIL_GK17319.1.1.m.58968,-0.0147902992968907,0.0152192141929203,No,NA,NA,Q90879,NA,NA,NA,nucleus [GO:0005634]; ubiquitin conjugating enzyme activity [GO:0061631]; postreplication repair [GO:0006301]; protein K63-linked ubiquitination [GO:0070534],NA,NA,NA
CHOYP_DWIL_GK23042.1.1.m.38792,0.00710073275134644,-0.0175605389521771,No,NA,NA,Q92539,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; lipid metabolic process [GO:0006629]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432],NA,NA,NA
CHOYP_DWIL_GK24328.1.1.m.16490,0.0147716626554726,-4.99228584354065e-05,No,NA,NA,Q32PI6,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_DWIL_GK25045.1.2.m.9225,0.0159064525758791,0.0139498489925951,No,NA,NA,Q8WQA4,NA,NA,NA,apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; nucleus [GO:0005634]; chloride channel activity [GO:0005254]; voltage-gated ion channel activity [GO:0005244]; epithelial cell development [GO:0002064]; regulation of ion transmembrane transport [GO:0034765]; regulation of tube size [GO:0035150],NA,NA,NA
CHOYP_DWIL_GK25256.1.1.m.7275,-0.00843900579037757,-0.0108776539723757,No,NA,NA,Q8MV48,NA,NA,NA,endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486],NA,NA,NA
CHOYP_DX39B.2.3.m.18241,-0.00353859851470181,-0.021810949146195,No,NA,NA,Q5RE47,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; transcription export complex [GO:0000346]; U4 snRNP [GO:0005687]; U6 snRNP [GO:0005688]; ATP binding [GO:0005524]; ATP-dependent protein binding [GO:0043008]; ATP-dependent RNA helicase activity [GO:0004004]; identical protein binding [GO:0042802]; U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]; mRNA export from nucleus [GO:0006406]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of DNA-templated transcription; elongation [GO:0032786]; RNA secondary structure unwinding [GO:0010501]; spliceosomal complex assembly [GO:0000245]; viral mRNA export from host cell nucleus [GO:0046784],NA,NA,NA
CHOYP_DYAK_GE11656.1.2.m.34706,0.00205195042830452,-0.00934116934689426,No,NA,NA,O16011,NA,NA,NA,cytoplasm [GO:0005737]; H zone [GO:0031673]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; compound eye photoreceptor cell differentiation [GO:0001751]; eye development [GO:0001654]; muscle cell cellular homeostasis [GO:0046716]; muscle organ development [GO:0007517]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of female receptivity [GO:0045924]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; rhabdomere development [GO:0042052]; visual perception [GO:0007601],NA,NA,NA
CHOYP_DYAK_GE21870.1.1.m.28467,-0.0135725579708753,0.00388604629968508,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DYAK_GE25081.2.3.m.43232,0.0174531852327048,-0.0126960025942887,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DYAK_GE25484.1.1.m.6273,0.0065883263884642,0.0180931628217626,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DYH1.1.1.m.46156,-0.0227571644583727,-0.000653621349489815,No,NA,NA,E9Q8T7,NA,NA,NA,axoneme [GO:0005930]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; sperm flagellum [GO:0036126]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium movement involved in cell motility [GO:0060294]; epithelial cilium movement [GO:0003351]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]; sperm axoneme assembly [GO:0007288],NA,NA,NA
CHOYP_DYH2.1.1.m.28905,-0.0214430547450563,-0.00314686507385728,No,NA,NA,P0C6F1,NA,NA,NA,dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_DYH8.2.2.m.45091,0.00784658871099139,0.0162691575873972,No,NA,NA,Q91XQ0,NA,NA,NA,dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]; sperm principal piece [GO:0097228]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158],NA,NA,NA
CHOYP_DYHC.1.3.m.10664,-0.0216089680464938,-0.00346438463032034,No,NA,NA,P23098,NA,NA,NA,cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_DYHC1.1.1.m.2432,0.00729806162410003,-0.0147830575739525,No,NA,NA,Q14204,NA,NA,NA,azurophil granule lumen [GO:0035578]; centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; dynein complex [GO:0030286]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium [GO:0030175]; membrane [GO:0016020]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; RNA binding [GO:0003723]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cell division [GO:0051301]; ciliary basal body-plasma membrane docking [GO:0097711]; cytoplasmic microtubule organization [GO:0031122]; cytoplasmic mRNA processing body assembly [GO:0033962]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitotic spindle organization [GO:0007052]; neutrophil degranulation [GO:0043312]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; stress granule assembly [GO:0034063],NA,NA,NA
CHOYP_DYHC2.2.2.m.31941,-0.0164643118573243,-0.0123018682228458,No,NA,NA,Q27802,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_DYN1.2.3.m.30771,-0.0030312847441967,-0.00235515764451365,No,NA,NA,P21575,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; membrane coat [GO:0030117]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone membrane [GO:0098844]; postsynaptic membrane [GO:0045211]; presynaptic endocytic zone membrane [GO:0098835]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; varicosity [GO:0043196]; D2 dopamine receptor binding [GO:0031749]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; nitric-oxide synthase binding [GO:0050998]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; clathrin-dependent endocytosis [GO:0072583]; endosome organization [GO:0007032]; G protein-coupled receptor internalization [GO:0002031]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of synaptic vesicle recycling [GO:1903423]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of synapse structure or activity [GO:0050803]; regulation of synaptic vesicle endocytosis [GO:1900242]; response to amyloid-beta [GO:1904645]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_DYNLL2.2.2.m.37356,-0.00867128355344095,0.0113845116258607,No,NA,NA,Q78P75,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; glutamatergic synapse [GO:0098978]; microtubule [GO:0005874]; myosin V complex [GO:0031475]; postsynaptic density [GO:0014069]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; motor activity [GO:0003774]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; microtubule-based process [GO:0007017]; positive regulation of ATP-dependent microtubule motor activity; plus-end-directed [GO:2000582],NA,NA,NA
CHOYP_E_R_.1.1.m.63122,-0.00484675408444705,0.00272028074102017,No,NA,NA,Q93104,NA,NA,NA,cell cycle [GO:0007049]; positive regulation of Notch signaling pathway [GO:0045747]; pyrimidine nucleotide biosynthetic process [GO:0006221],NA,NA,NA
CHOYP_E2F4.1.1.m.25398,-0.0136088477840949,0.00110705403823699,No,NA,NA,Q6DE14,NA,NA,NA,nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein dimerization activity [GO:0046983]; centriole assembly [GO:0098534]; mitotic cell cycle [GO:0000278]; motile cilium assembly [GO:0044458]; multi-ciliated epithelial cell differentiation [GO:1903251]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_E41L3.2.2.m.57999,-0.00351321413092016,-0.025229074699125,No,NA,NA,Q9WV92,NA,NA,NA,cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; juxtaparanode region of axon [GO:0044224]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; actin binding [GO:0003779]; structural constituent of cytoskeleton [GO:0005200]; actomyosin structure organization [GO:0031032]; apoptotic process [GO:0006915]; cortical actin cytoskeleton organization [GO:0030866]; cortical cytoskeleton organization [GO:0030865]; cytoskeletal anchoring at plasma membrane [GO:0007016]; myelin maintenance [GO:0043217]; neuron projection morphogenesis [GO:0048812]; paranodal junction assembly [GO:0030913]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; protein localization to plasma membrane [GO:0072659]; regulation of cell growth [GO:0001558]; regulation of cell shape [GO:0008360],NA,NA,NA
CHOYP_EBNA1BP2.1.1.m.63216,-0.0112456803976585,-0.00837621910347046,No,NA,NA,Q9D903,NA,NA,NA,nuclear periphery [GO:0034399]; nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome; large subunit precursor [GO:0030687]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_ECD.1.1.m.61798,0.0132633997591736,-0.0195076036996185,No,NA,NA,O95905,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; cell proliferation [GO:0008283]; mRNA processing [GO:0006397]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of glycolytic process [GO:0006110]; RNA splicing [GO:0008380]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_ECH1.1.1.m.29110,0.000438245185833241,-0.00638457301826767,No,NA,NA,Q62651,NA,NA,NA,mitochondrion [GO:0005739]; peroxisome [GO:0005777]; delta3;5-delta2;4-dienoyl-CoA isomerase activity [GO:0051750]; signaling receptor binding [GO:0005102]; fatty acid beta-oxidation [GO:0006635],NA,NA,NA
CHOYP_ECHM.1.1.m.38462,0.00225881713061301,0.00567541419686439,No,NA,NA,Q8BH95,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; enoyl-CoA hydratase activity [GO:0004300]; fatty acid beta-oxidation [GO:0006635],NA,NA,NA
CHOYP_ECHVI_0367.2.2.m.16808,0.0179825979552898,-0.00238745587763048,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ECM29.1.1.m.48083,0.000158513571816861,-0.0240835738281356,No,NA,NA,Q6PDI5,NA,NA,NA,centrosome [GO:0005813]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; late endosome [GO:0005770]; multivesicular body [GO:0005771]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome binding [GO:0070628]; protein-containing complex scaffold activity [GO:0032947]; proteasome assembly [GO:0043248]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_ECMB.1.3.m.2566,5.19349499298284e-05,-0.00267162036844826,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ECR.1.1.m.28368,-0.00550968720098786,0.0141989504020404,No,NA,NA,P49880,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; ecdysone binding [GO:0035100]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; ecdysone receptor-mediated signaling pathway [GO:0035076],NA,NA,NA
CHOYP_EDEM1.1.1.m.12175,0.0044901812504512,0.0105492082491019,No,NA,NA,Q925U4,NA,NA,NA,aggresome [GO:0016235]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of endoplasmic reticulum membrane [GO:0030176]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1;2-alpha-mannosidase activity [GO:0004571]; misfolded protein binding [GO:0051787]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; positive regulation of retrograde protein transport; ER to cytosol [GO:1904154]; response to unfolded protein [GO:0006986]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent glycoprotein ERAD pathway [GO:0097466],NA,NA,NA
CHOYP_EDI_002780.1.1.m.31041,-0.0225594802079368,0.00997940517489838,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EDI_048910.1.2.m.31504,0.00933387738269379,0.00407354287689441,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EDRF1.2.2.m.45353,0.00323524376228217,-0.00588073905111163,No,NA,NA,Q5R9R1,NA,NA,NA,nucleus [GO:0005634],NA,NA,NA
CHOYP_EEA1.1.1.m.9573,0.00806451244180038,0.00429081861980672,No,NA,NA,Q8BL66,NA,NA,NA,axonal spine [GO:0044308]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extrinsic component of plasma membrane [GO:0019897]; recycling endosome [GO:0055037]; serine-pyruvate aminotransferase complex [GO:0005969]; 1-phosphatidylinositol binding [GO:0005545]; GTP-dependent protein binding [GO:0030742]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; endocytosis [GO:0006897]; vesicle fusion [GO:0006906]; viral RNA genome replication [GO:0039694],NA,NA,NA
CHOYP_EEF1A.2.3.m.20692,-0.00907727031310081,0.0139797174377613,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EEF1A.3.3.m.37430,-0.00229208542731047,-0.00229386264009871,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EEF2.1.2.m.44023,0.00205195042830452,-0.00934116934689426,No,NA,NA,P29691,NA,NA,NA,cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; defense response to Gram-negative bacterium [GO:0050829]; negative regulation of gene expression [GO:0010629]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_EEF2.1.2.m.44025,-0.00916568400228148,-0.0198770324550989,No,NA,NA,Q8WZA0,NA,NA,NA,beta-catenin binding [GO:0008013]; response to ionizing radiation [GO:0010212],NA,NA,NA
CHOYP_EF.1A.6.9.m.43621,-0.00483176558641773,0.00632006767120884,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EF.1A.9.9.m.63037,-0.0142940546954547,-0.00100252811097883,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EF1A.2.4.m.50858,0.0203947735131497,0.0054313026593857,No,NA,NA,Q92005,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation [GO:0006412]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_EF1A.3.4.m.63413,0.0144385641952958,0.00107009335497949,No,NA,NA,Q5RKI1,NA,NA,NA,perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; translation initiation factor activity [GO:0003743]; cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of RNA-directed 5'-3' RNA polymerase activity [GO:1900260],NA,NA,NA
CHOYP_EF1A.3.4.m.63416,-0.00915419537219546,-0.0156050055816603,No,NA,NA,P54353,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; transcription factor binding [GO:0008134]; positive regulation of protein ubiquitination [GO:0031398]; regulation of locomotor rhythm [GO:1904059],NA,NA,NA
CHOYP_EF1A.4.4.m.65743,-0.0179454565431809,-0.00423987878187534,No,NA,NA,Q92630,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; cellular response to DNA damage stimulus [GO:0006974]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; positive regulation of glycogen biosynthetic process [GO:0045725]; protein phosphorylation [GO:0006468]; regulation of signal transduction by p53 class mediator [GO:1901796]; smoothened signaling pathway [GO:0007224],NA,NA,NA
CHOYP_EF1A2.1.3.m.30022,-0.00314264132619869,0.00260051302017351,No,NA,NA,Q92005,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation [GO:0006412]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_EF1A2.2.3.m.37043,0.00217997094733793,-0.00807271368859912,No,NA,NA,P27634,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746],NA,NA,NA
CHOYP_EF1B.1.7.m.26504,0.0138266026828275,-0.00984222584798517,No,NA,NA,P30151,NA,NA,NA,eukaryotic translation elongation factor 1 complex [GO:0005853]; translation elongation factor activity [GO:0003746],NA,NA,NA
CHOYP_EF1B.2.7.m.30853,0.0109101771250898,-0.0211641635932385,No,NA,NA,P30151,NA,NA,NA,eukaryotic translation elongation factor 1 complex [GO:0005853]; translation elongation factor activity [GO:0003746],NA,NA,NA
CHOYP_EF1B.3.7.m.35082,0.00217997094733793,-0.00807271368859912,No,NA,NA,P30151,NA,NA,NA,eukaryotic translation elongation factor 1 complex [GO:0005853]; translation elongation factor activity [GO:0003746],NA,NA,NA
CHOYP_EF1G.1.3.m.12909,-0.00740261250361411,-0.0166344518099928,No,NA,NA,P63100,NA,NA,NA,cytosol [GO:0005829]; sarcolemma [GO:0042383]; calcium ion binding [GO:0005509]; phosphoprotein phosphatase activity [GO:0004721]; protein dephosphorylation [GO:0006470],NA,NA,NA
CHOYP_EF1G.2.3.m.50676,0.0162904823226193,-0.00271491697642396,No,NA,NA,P29694,NA,NA,NA,translation elongation factor activity [GO:0003746],NA,NA,NA
CHOYP_EF1G.3.3.m.63510,0.0220320666025329,0.00516859272088765,No,NA,NA,P12261,NA,NA,NA,translation elongation factor activity [GO:0003746],NA,NA,NA
CHOYP_EF2.1.5.m.1541,-0.00867944284645428,-0.0212056120108389,No,NA,NA,P24156,NA,NA,NA,membrane [GO:0016020]; mitochondrion [GO:0005739]; cellular response to hypoxia [GO:0071456]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_EF2.4.5.m.30185,-0.00616722855120434,0.0102170821607295,No,NA,NA,Q05086,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; brain development [GO:0007420]; positive regulation of protein ubiquitination [GO:0031398]; progesterone receptor signaling pathway [GO:0050847]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; regulation of circadian rhythm [GO:0042752]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; response to progesterone [GO:0032570]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032],NA,NA,NA
CHOYP_EF2.4.5.m.30186,0.0211773689828044,-0.00696227841113034,No,NA,NA,P29691,NA,NA,NA,cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; defense response to Gram-negative bacterium [GO:0050829]; negative regulation of gene expression [GO:0010629]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_EF2.5.5.m.39855,-0.0140872305891139,-0.0219029402114468,No,NA,NA,P29691,NA,NA,NA,cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; defense response to Gram-negative bacterium [GO:0050829]; negative regulation of gene expression [GO:0010629]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_EF2.5.5.m.39856,-0.0162931347697135,-0.0147531795472346,No,NA,NA,Q7QC84,NA,NA,NA,mitochondrion [GO:0005739]; malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]; thymine catabolic process [GO:0006210]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573],NA,NA,NA
CHOYP_EFCAB1.1.1.m.43342,0.0118990290247981,-0.000423959022206556,No,NA,NA,Q3KQ77,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_EFCAB7.1.1.m.17862,-0.0131909068483975,-0.0104467989096599,No,NA,NA,Q6DCF6,NA,NA,NA,ciliary membrane [GO:0060170]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_EFGM.1.1.m.16632,0.00231723384338983,-0.0172001448832443,No,NA,NA,Q7Q1K8,NA,NA,NA,mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; mitochondrial translational elongation [GO:0070125],NA,NA,NA
CHOYP_EFHD2.1.1.m.22844,-0.00925326548846385,0.0124243438301164,No,NA,NA,Q4FZY0,NA,NA,NA,membrane raft [GO:0045121]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_EFTS.2.2.m.66393,0.00255671809148966,-0.0153501194923225,No,NA,NA,Q17PI0,NA,NA,NA,mitochondrion [GO:0005739]; translation elongation factor activity [GO:0003746],NA,NA,NA
CHOYP_EGF1.1.2.m.46366,0.00844723345444238,0.012428173509741,No,NA,NA,P10079,NA,NA,NA,apical lamina of hyaline layer [GO:0032579]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_EGFR.1.3.m.30285,0.0112561169791189,-0.0113813488075752,No,NA,NA,P0CY46,NA,NA,NA,integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; multicellular organism development [GO:0007275]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_EGFR.2.3.m.61781,0.00205195042830452,-0.00934116934689426,No,NA,NA,Q01279,NA,NA,NA,apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; multivesicular body; internal vesicle lumen [GO:0097489]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; synapse [GO:0045202]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; epidermal growth factor binding [GO:0048408]; epidermal growth factor-activated receptor activity [GO:0005006]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; kinase activity [GO:0016301]; nitric-oxide synthase regulator activity [GO:0030235]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane signaling receptor activity [GO:0004888]; ubiquitin protein ligase binding [GO:0031625]; activation of MAPKK activity [GO:0000186]; astrocyte activation [GO:0048143]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; cell proliferation [GO:0008283]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to amino acid stimulus [GO:0071230]; cellular response to cadmium ion [GO:0071276]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to estradiol stimulus [GO:0071392]; cellular response to growth factor stimulus [GO:0071363]; cellular response to mechanical stimulus [GO:0071260]; cellular response to reactive oxygen species [GO:0034614]; cerebral cortex cell migration [GO:0021795]; circadian rhythm [GO:0007623]; digestive tract morphogenesis [GO:0048546]; diterpenoid metabolic process [GO:0016101]; embryonic placenta development [GO:0001892]; epidermal growth factor receptor signaling pathway [GO:0007173]; epidermis development [GO:0008544]; eyelid development in camera-type eye [GO:0061029]; hair follicle development [GO:0001942]; hydrogen peroxide metabolic process [GO:0042743]; intracellular signal transduction [GO:0035556]; learning or memory [GO:0007611]; liver regeneration [GO:0097421]; lung development [GO:0030324]; magnesium ion homeostasis [GO:0010960]; midgut development [GO:0007494]; morphogenesis of an epithelial fold [GO:0060571]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiocyte differentiation [GO:1905208]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of protein catabolic process [GO:0042177]; neuron projection morphogenesis [GO:0048812]; ovulation cycle [GO:0042698]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of bone resorption [GO:0045780]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of inflammatory response [GO:0050729]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide mediated signal transduction [GO:0010750]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphorylation [GO:0042327]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; positive regulation of prolactin secretion [GO:1902722]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein kinase C activity [GO:1900020]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of synaptic transmission; glutamatergic [GO:0051968]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; positive regulation of vasoconstriction [GO:0045907]; protein autophosphorylation [GO:0046777]; receptor-mediated endocytosis [GO:0006898]; regulation of cell proliferation [GO:0042127]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of JNK cascade [GO:0046328]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; response to calcium ion [GO:0051592]; response to cobalamin [GO:0033590]; response to hydroxyisoflavone [GO:0033594]; response to osmotic stress [GO:0006970]; response to UV-A [GO:0070141]; salivary gland morphogenesis [GO:0007435]; signal transduction [GO:0007165]; tongue development [GO:0043586]; translation [GO:0006412]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060],NA,NA,NA
CHOYP_EHHADH.1.1.m.26459,-0.00985644356978344,-0.018497489553933,No,NA,NA,Q6NYL3,NA,NA,NA,peroxisome [GO:0005777]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; dodecenoyl-CoA delta-isomerase activity [GO:0004165]; enoyl-CoA hydratase activity [GO:0004300]; fatty acid beta-oxidation [GO:0006635],NA,NA,NA
CHOYP_EHI_072050.2.8.m.16931,-0.014708415021882,-0.00423969983919674,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EHI_072050.5.8.m.47580,-0.00427116349227152,0.00487885886685915,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EHI_072050.7.8.m.61373,0.00132914091109684,-0.0130027632665584,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EHI_153670.1.2.m.21885,-0.0109062579464586,0.00401775455777019,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EHMT2.1.1.m.263,0.00315310978959292,0.000750040833660386,No,NA,NA,Q9H9B1,NA,NA,NA,chromosome [GO:0005694]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; C2H2 zinc finger domain binding [GO:0070742]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; methyltransferase activity [GO:0008168]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; DNA methylation [GO:0006306]; histone methylation [GO:0016571]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of embryonic development [GO:0045995]; response to fungicide [GO:0060992],NA,NA,NA
CHOYP_EIF1A.1.1.m.30303,0.00743973391399627,0.0134268189696105,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EIF1A.1.1.m.30304,0.0110368482739239,-0.0113006351689994,No,NA,NA,Q0V9J5,NA,NA,NA,nucleus [GO:0005634]; translation initiation factor activity [GO:0003743],NA,NA,NA
CHOYP_EIF1B.1.3.m.29107,-0.0115184205230201,-0.00118009547599754,No,NA,NA,P42678,NA,NA,NA,eukaryotic 43S preinitiation complex [GO:0016282]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_EIF2A.1.1.m.12752,0.00754641558541169,0.00290793258440669,No,NA,NA,Q5ZKC1,NA,NA,NA,cytoplasm [GO:0005737]; cytosolic small ribosomal subunit [GO:0022627]; eukaryotic translation initiation factor 2 complex [GO:0005850]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]; tRNA binding [GO:0000049]; regulation of translation [GO:0006417]; ribosome assembly [GO:0042255],NA,NA,NA
CHOYP_EIF3B.1.1.m.12232,0.017458752256792,-0.0108629002350081,No,NA,NA,P55884,NA,NA,NA,cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex; eIF3m [GO:0071541]; extracellular exosome [GO:0070062]; synapse [GO:0045202]; protein-containing complex scaffold activity [GO:0032947]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525],NA,NA,NA
CHOYP_EIF3C.1.1.m.7991,0.0152908636704294,-0.0121541362765308,No,NA,NA,Q6PFQ2,NA,NA,NA,eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_EIF3E.1.1.m.27167,-0.00807394101077253,-0.0178386217725237,No,NA,NA,Q641X8,NA,NA,NA,eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex; eIF3e [GO:0071540]; nucleus [GO:0005634]; PML body [GO:0016605]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_EIF3G.1.1.m.29464,-0.00236343690603297,0.0156900680239939,No,NA,NA,Q6DRC4,NA,NA,NA,eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_EIF3I.1.1.m.56504,0.0132248194639099,0.00594481186605388,No,NA,NA,B5FZ19,NA,NA,NA,eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_EIF3K.1.1.m.59650,-0.00338152106849183,-0.0111772961806856,No,NA,NA,Q28C65,NA,NA,NA,eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; nucleus [GO:0005634]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_EIF3L.1.1.m.7542,-0.0039378649688844,-0.0252777626046268,No,NA,NA,Q5F428,NA,NA,NA,eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525],NA,NA,NA
CHOYP_EIF4BB.1.1.m.51065,-0.0142970006892761,-0.0175708045378617,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EIF4BB.1.1.m.51066,0.0175647382704396,-0.00324648087903974,No,NA,NA,Q8BGD9,NA,NA,NA,cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; polysome [GO:0005844]; postsynapse [GO:0098794]; ribosomal small subunit binding [GO:0043024]; RNA strand annealing activity [GO:0033592]; RNA strand-exchange activity [GO:0034057]; translation initiation factor activity [GO:0003743]; cytoplasmic translation [GO:0002181]; eukaryotic translation initiation factor 4F complex assembly [GO:0097010]; formation of translation preinitiation complex [GO:0001731],NA,NA,NA
CHOYP_EIF4H.3.3.m.57962,0.0103504101750455,-0.00508567154166443,No,NA,NA,Q15056,NA,NA,NA,cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; cadherin binding [GO:0045296]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA strand annealing activity [GO:0033592]; RNA strand-exchange activity [GO:0034057]; translation factor activity; RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; cytoplasmic translation [GO:0002181]; developmental growth [GO:0048589]; eukaryotic translation initiation factor 4F complex assembly [GO:0097010]; formation of translation preinitiation complex [GO:0001731]; regulation of translational initiation [GO:0006446]; sexual reproduction [GO:0019953]; translational initiation [GO:0006413]; viral process [GO:0016032],NA,NA,NA
CHOYP_EIF5A.1.3.m.22684,0.000930592171124377,-0.00127168851397305,No,NA,NA,P10160,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; nuclear pore [GO:0005643]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; mRNA transport [GO:0051028]; positive regulation of translation [GO:0045727]; positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; protein transport [GO:0015031]; translational frameshifting [GO:0006452],NA,NA,NA
CHOYP_EIN_155680.4.6.m.52358,-0.0125889673150176,0.010034611341006,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EIN_155680.6.6.m.56323,-0.00723113364970365,0.0206004755631941,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EIN_201030.1.3.m.20334,0.0191550222124984,0.00791556742399582,No,NA,NA,Q6NZL8,NA,NA,NA,cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; positive regulation of smoothened signaling pathway [GO:0045880]; protein homooligomerization [GO:0051260],NA,NA,NA
CHOYP_ELDP2.1.2.m.39081,0.0212242340872748,-0.0113896503774999,No,NA,NA,B3A0R6,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_ELDP2.2.2.m.40194,0.0188239272390223,-0.0120959184007222,No,NA,NA,P86954,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_ELMO1.1.1.m.59285,0.00104919057289985,0.00946766820925503,No,NA,NA,Q96JJ3,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]; apoptotic process [GO:0006915]; cell chemotaxis [GO:0060326]; cell-cell adhesion [GO:0098609]; cytoskeleton organization [GO:0007010]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],NA,NA,NA
CHOYP_ELOB.1.1.m.56270,0.0124436934261076,-0.000505379507821686,No,NA,NA,P62870,NA,NA,NA,elongin complex [GO:0070449]; transcription factor complex [GO:0005667]; VCB complex [GO:0030891]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; transcription elongation from RNA polymerase II promoter [GO:0006368],NA,NA,NA
CHOYP_ELOC.1.1.m.1299,-0.00460195111648182,-0.0037041748209705,No,NA,NA,P83941,NA,NA,NA,elongin complex [GO:0070449]; VCB complex [GO:0030891]; protein-containing complex binding [GO:0044877]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_ELOV4.3.3.m.64203,0.000686232728993107,-0.0107331332691118,No,NA,NA,Q9JLJ4,NA,NA,NA,endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; 3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; transferase activity; transferring acyl groups other than amino-acyl groups [GO:0016747]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; fatty acid elongation; monounsaturated fatty acid [GO:0034625]; fatty acid elongation; polyunsaturated fatty acid [GO:0034626]; fatty acid elongation; saturated fatty acid [GO:0019367]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]; very long-chain fatty acid metabolic process [GO:0000038],NA,NA,NA
CHOYP_ELP1.2.2.m.29114,-0.000882737067776674,-0.0132072897207491,No,NA,NA,O95163,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; Elongator holoenzyme complex [GO:0033588]; nucleolus [GO:0005730]; transcription elongation factor complex [GO:0008023]; phosphorylase kinase regulator activity [GO:0008607]; immune response [GO:0006955]; positive regulation of cell migration [GO:0030335]; protein phosphorylation [GO:0006468]; protein-containing complex assembly [GO:0065003]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368]; tRNA wobble uridine modification [GO:0002098],NA,NA,NA
CHOYP_ELP2.1.1.m.18394,0.00678620130084429,0.00878741825264137,No,NA,NA,Q05AM5,NA,NA,NA,cytoplasm [GO:0005737]; Elongator holoenzyme complex [GO:0033588]; proteasome complex [GO:0000502]; transcription elongation factor complex [GO:0008023]; endopeptidase activator activity [GO:0061133]; proteasome assembly [GO:0043248]; transcription elongation from RNA polymerase II promoter [GO:0006368]; tRNA wobble uridine modification [GO:0002098],NA,NA,NA
CHOYP_EMAL1.1.1.m.58030,-0.00244627764751172,0.0111002569629015,No,NA,NA,O00423,NA,NA,NA,cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole [GO:0097431]; perinuclear region of cytoplasm [GO:0048471]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; tubulin binding [GO:0015631]; brain development [GO:0007420]; hematopoietic progenitor cell differentiation [GO:0002244]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]; neuroblast proliferation [GO:0007405],NA,NA,NA
CHOYP_EMAL6.1.1.m.6370,-0.0187614183366623,0.00409764113201891,No,NA,NA,Q6ZMW3,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule binding [GO:0008017],NA,NA,NA
CHOYP_EMC2.2.2.m.21018,-0.00731722324096556,-0.0196058174430047,No,NA,NA,Q6TGY8,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; ER membrane protein complex [GO:0072546]; nucleus [GO:0005634]; protein folding in endoplasmic reticulum [GO:0034975],NA,NA,NA
CHOYP_ENGASE.1.1.m.54655,0.0107137563826024,-0.001135500171236,No,NA,NA,Q8BX80,NA,NA,NA,cytosol [GO:0005829]; mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity [GO:0033925]; protein deglycosylation [GO:0006517],NA,NA,NA
CHOYP_ENO.1.2.m.7680,-0.00636802464380966,-0.0052040087631802,No,NA,NA,Q5ZK62,NA,NA,NA,endosome membrane [GO:0010008]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; cellular response to nerve growth factor stimulus [GO:1990090]; endocytic recycling [GO:0032456],NA,NA,NA
CHOYP_ENO.1.2.m.7681,0.0149899476153757,0.0150518565086142,No,NA,NA,O02654,NA,NA,NA,phosphopyruvate hydratase complex [GO:0000015]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; glycolytic process [GO:0006096],NA,NA,NA
CHOYP_ENOPH.1.4.m.8576,0.0111770550206772,0.00850327457196334,No,NA,NA,Q69ZR9,NA,NA,NA,chromosome [GO:0005694]; nucleoplasm [GO:0005654],NA,NA,NA
CHOYP_ENOPH.3.4.m.51956,-0.0158976461077363,-0.0128010716978887,No,NA,NA,Q0VD27,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; 2;3-diketo-5-methylthiopentyl-1-phosphate enolase activity [GO:0043715]; 2-hydroxy-3-keto-5-methylthiopentenyl-1-phosphate phosphatase activity [GO:0043716]; acireductone synthase activity [GO:0043874]; magnesium ion binding [GO:0000287]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284],NA,NA,NA
CHOYP_ENOX2.1.1.m.7197,-0.00185205530857544,-0.0152141536825529,No,NA,NA,Q8TC92,NA,NA,NA,external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; nucleic acid binding [GO:0003676]; oxidoreductase activity [GO:0016491]; ultradian rhythm [GO:0007624],NA,NA,NA
CHOYP_ENPEP.1.1.m.12765,-0.0135725579708752,0.00388604629968508,No,NA,NA,P50123,NA,NA,NA,brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; angiotensin maturation [GO:0002003]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081],NA,NA,NA
CHOYP_ENPL.3.4.m.39476,0.00371470096745018,-0.0251501468552789,No,NA,NA,Q66HD0,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; perinuclear region of cytoplasm [GO:0048471]; smooth endoplasmic reticulum [GO:0005790]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; cellular response to manganese ion [GO:0071287]; protein folding [GO:0006457]; response to hypoxia [GO:0001666]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_ENPL.4.4.m.47194,-0.00101617932899438,0.0243110718021567,No,NA,NA,Q66HD0,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; perinuclear region of cytoplasm [GO:0048471]; smooth endoplasmic reticulum [GO:0005790]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; cellular response to manganese ion [GO:0071287]; protein folding [GO:0006457]; response to hypoxia [GO:0001666]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_ENPP3.1.1.m.13519,0.00814342089472999,0.00213744017410727,No,NA,NA,J3SBP3,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]; nucleic acid binding [GO:0003676]; phosphodiesterase I activity [GO:0004528]; polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044]; toxin activity [GO:0090729]; immune response [GO:0006955],NA,NA,NA
CHOYP_ENS.1.3.m.25925,0.00799618044391623,0.00759591296531395,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ENTPD4.1.1.m.15533,-0.00481550898347174,0.00636591260579198,No,NA,NA,Q28CF8,NA,NA,NA,cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_EP15R.1.1.m.14260,0.00594377120563098,-0.00594048387370042,No,NA,NA,Q9UBC2,NA,NA,NA,clathrin coat of coated pit [GO:0030132]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; endocytosis [GO:0006897]; membrane organization [GO:0061024]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059],NA,NA,NA
CHOYP_EPDR2.1.1.m.33988,0.0171451828426504,-0.000256790621161645,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EPN2.1.1.m.23660,-0.0110831287165235,0.010391495943282,No,NA,NA,Q9Z1Z3,NA,NA,NA,clathrin coat of endocytic vesicle [GO:0030128]; lipid binding [GO:0008289]; endocytosis [GO:0006897]; regulation of endocytosis [GO:0030100],NA,NA,NA
CHOYP_EPN4.1.3.m.10807,-0.010217773705114,-0.0162161275314951,No,NA,NA,A7Z035,NA,NA,NA,clathrin-coated vesicle [GO:0030136]; Golgi-associated vesicle [GO:0005798]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802]; clathrin binding [GO:0030276]; lipid binding [GO:0008289]; endocytosis [GO:0006897],NA,NA,NA
CHOYP_EPN4.2.3.m.66030,0.0126665058147077,0.00123432559116636,No,NA,NA,A7Z035,NA,NA,NA,clathrin-coated vesicle [GO:0030136]; Golgi-associated vesicle [GO:0005798]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802]; clathrin binding [GO:0030276]; lipid binding [GO:0008289]; endocytosis [GO:0006897],NA,NA,NA
CHOYP_EPRS.1.1.m.35443,0.00486277689935012,0.00319702053423151,No,NA,NA,Q8CGC7,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GAIT complex [GO:0097452]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; glutamate-tRNA ligase activity [GO:0004818]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; proline-tRNA ligase activity [GO:0004827]; protein homodimerization activity [GO:0042803]; RNA stem-loop binding [GO:0035613]; zinc ion binding [GO:0008270]; cellular response to insulin stimulus [GO:0032869]; cellular response to interferon-gamma [GO:0071346]; glutamyl-tRNA aminoacylation [GO:0006424]; long-chain fatty acid import [GO:0044539]; negative regulation of translation [GO:0017148]; prolyl-tRNA aminoacylation [GO:0006433],NA,NA,NA
CHOYP_EPS.8.1.1.m.17522,0.00649686993256134,0.00667333045458745,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ER.1.2.m.14189,-0.0226499447499375,0.010188984161319,No,NA,NA,P81559,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; estrogen receptor activity [GO:0030284]; sequence-specific DNA binding [GO:0043565]; steroid binding [GO:0005496]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_ERD22.1.1.m.12383,0.00155635875934482,-0.0184657699895962,No,NA,NA,Q6PEH1,NA,NA,NA,cis-Golgi network [GO:0005801]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; ER retention sequence binding [GO:0046923]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein retention in ER lumen [GO:0006621]; protein transport [GO:0015031],NA,NA,NA
CHOYP_ERF1.1.1.m.37539,0.0107647203644607,0.00658836744973277,No,NA,NA,Q9GR88,NA,NA,NA,cytoplasm [GO:0005737]; translation release factor activity [GO:0003747],NA,NA,NA
CHOYP_ERF1.1.1.m.37540,-0.00421253113262374,-0.0249336608937193,No,NA,NA,P81004,NA,NA,NA,mitochondrial outer membrane [GO:0005741]; pore complex [GO:0046930]; nucleotide binding [GO:0000166]; porin activity [GO:0015288]; voltage-gated anion channel activity [GO:0008308],NA,NA,NA
CHOYP_ERF3A.1.1.m.57282,0.00675999552433502,-0.0202363329737568,No,NA,NA,Q8R050,NA,NA,NA,cytosol [GO:0005829]; translation release factor complex [GO:0018444]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation release factor activity [GO:0003747]; cytoplasmic translational termination [GO:0002184]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; protein methylation [GO:0006479]; translation [GO:0006412],NA,NA,NA
CHOYP_ERGI1.1.1.m.9684,0.00370390230349575,-0.0245416231720009,No,NA,NA,Q969X5,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_ERL2B.1.1.m.187,-0.013330774409491,-0.010223803267075,No,NA,NA,Q6DKC0,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin protein ligase binding [GO:0031625]; cholesterol metabolic process [GO:0008203]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_ERP44.1.1.m.3853,0.00796737951568486,-0.0253623241270888,No,NA,NA,Q3T0L2,NA,NA,NA,cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986],NA,NA,NA
CHOYP_ERR3.1.1.m.25316,0.00686474134862351,0.000564693204473993,No,NA,NA,P62510,NA,NA,NA,nucleus [GO:0005634]; AF-2 domain binding [GO:0050682]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid binding [GO:0005496]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of transcription; DNA-templated [GO:0006355]; retinoic acid receptor signaling pathway [GO:0048384],NA,NA,NA
CHOYP_ES1.1.1.m.66406,-0.00476444779375132,0.00398106454711738,No,NA,NA,Q9D172,NA,NA,NA,mitochondrion [GO:0005739],NA,NA,NA
CHOYP_ESF1.1.1.m.15088,-0.00026538818629945,0.0198119479607763,No,NA,NA,Q3V1V3,NA,NA,NA,nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_EST1A.1.1.m.59161,0.0107390770339125,-0.0174141569328074,No,NA,NA,P61406,NA,NA,NA,chromosome; telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nucleolus [GO:0005730]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; DNA polymerase binding [GO:0070182]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162]; negative regulation of telomere capping [GO:1904354]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; regulation of RNA stability [GO:0043487]; regulation of telomere maintenance [GO:0032204]; telomere maintenance via telomerase [GO:0007004],NA,NA,NA
CHOYP_ETFD.1.1.m.6881,-0.00313941454741062,-0.0171934592865652,No,NA,NA,Q921G7,NA,NA,NA,integral component of mitochondrial inner membrane [GO:0031305]; membrane [GO:0016020]; mitochondrial electron transfer flavoprotein complex [GO:0017133]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; 4 iron; 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxidoreductase activity; oxidizing metal ions with flavin as acceptor [GO:0043783]; quinone binding [GO:0048038]; ubiquinone binding [GO:0048039]; electron transport chain [GO:0022900]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_EVI1.1.1.m.62064,0.00608570272025726,-0.017263116740037,No,NA,NA,Q03112,NA,NA,NA,cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; hematopoietic stem cell proliferation [GO:0071425]; negative regulation of JNK cascade [GO:0046329]; negative regulation of programmed cell death [GO:0043069]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726],NA,NA,NA
CHOYP_EVL.1.1.m.57134,0.000473401512755249,0.000947338296898525,No,NA,NA,P70460,NA,NA,NA,bicellular tight junction [GO:0005923]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; filopodium membrane [GO:0031527]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; profilin binding [GO:0005522]; SH3 domain binding [GO:0017124]; actin cytoskeleton organization [GO:0030036]; actin polymerization or depolymerization [GO:0008154]; axon guidance [GO:0007411]; neural tube closure [GO:0001843]; positive regulation of actin filament polymerization [GO:0030838]; protein homotetramerization [GO:0051289],NA,NA,NA
CHOYP_EXC6B.1.1.m.38489,0.00941547401305402,0.0203289914655459,No,NA,NA,Q9Y2D4,NA,NA,NA,exocyst [GO:0000145]; membrane [GO:0016020]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031]; vesicle docking involved in exocytosis [GO:0006904],NA,NA,NA
CHOYP_EXOC1.1.2.m.60,-0.0013880674224418,0.0136227621673902,No,NA,NA,Q9NV70,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; GTP-Rho binding [GO:0017049]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; defense response to virus [GO:0051607]; exocyst localization [GO:0051601]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of protein secretion [GO:0050714]; protein transport [GO:0015031]; regulation of macroautophagy [GO:0016241]; viral process [GO:0016032],NA,NA,NA
CHOYP_EXOC2.1.3.m.360,0.00327644672104621,-0.0143037060172299,No,NA,NA,Q96KP1,NA,NA,NA,cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; Ral GTPase binding [GO:0017160]; exocyst assembly [GO:0001927]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031]; regulation of entry of bacterium into host cell [GO:2000535],NA,NA,NA
CHOYP_EXOC4.1.2.m.4421,0.0196960341480824,-0.00787706691542248,No,NA,NA,Q62824,NA,NA,NA,cell leading edge [GO:0031252]; dendritic shaft [GO:0043198]; exocyst [GO:0000145]; Flemming body [GO:0090543]; growth cone [GO:0030426]; growth cone membrane [GO:0032584]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; chemical synaptic transmission [GO:0007268]; establishment of cell polarity [GO:0030010]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; Golgi to transport vesicle transport [GO:0055108]; membrane biogenesis [GO:0044091]; oligodendrocyte differentiation [GO:0048709]; positive regulation of calcium-mediated signaling [GO:0050850]; protein targeting to membrane [GO:0006612]; regulation of protein transport [GO:0051223]; vesicle docking involved in exocytosis [GO:0006904]; vesicle targeting [GO:0006903]; vesicle tethering involved in exocytosis [GO:0090522],NA,NA,NA
CHOYP_EXOS3.1.1.m.10596,-0.0175479063237419,-0.0157225134280197,No,NA,NA,Q9NQT5,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; 3'-5'-exoribonuclease activity [GO:0000175]; RNA binding [GO:0003723]; CUT catabolic process [GO:0071034]; DNA deamination [GO:0045006]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000467]; isotype switching [GO:0045190]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription [GO:0071049]; nuclear-transcribed mRNA catabolic process; exonucleolytic; 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of isotype switching [GO:0045830]; regulation of mRNA stability [GO:0043488]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475],NA,NA,NA
CHOYP_EXOS7.1.1.m.3323,0.00289350903276702,-0.0156505648959974,No,NA,NA,Q15024,NA,NA,NA,cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 3'-5'-exoribonuclease activity [GO:0000175]; AU-rich element binding [GO:0017091]; RNA binding [GO:0003723]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process; exonucleolytic; 3'-5' [GO:0034427]; regulation of mRNA stability [GO:0043488]; RNA catabolic process [GO:0006401]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476],NA,NA,NA
CHOYP_EXOS9.1.1.m.12468,0.0157965187200729,0.0032367910617701,No,NA,NA,Q5XJQ5,NA,NA,NA,cytoplasmic exosome (RNase complex) [GO:0000177]; nuclear exosome (RNase complex) [GO:0000176]; AU-rich element binding [GO:0017091]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process; exonucleolytic; 3'-5' [GO:0034427]; rRNA catabolic process [GO:0016075]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476],NA,NA,NA
CHOYP_EXOSC10.1.1.m.39774,-0.0176139918641945,-0.00278332569157479,No,NA,NA,Q01780,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; membrane [GO:0016020]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; 3'-5'-exoribonuclease activity [GO:0000175]; exoribonuclease activity [GO:0004532]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; CUT catabolic process [GO:0071034]; dosage compensation by inactivation of X chromosome [GO:0009048]; histone mRNA catabolic process [GO:0071044]; maturation of 5.8S rRNA [GO:0000460]; negative regulation of telomere maintenance via telomerase [GO:0032211]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear retention of unspliced pre-mRNA at the site of transcription [GO:0071048]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; regulation of telomerase RNA localization to Cajal body [GO:1904872]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_EXOSC2.1.1.m.9530,-0.00989194461428023,-0.0107151012726833,No,NA,NA,Q2KID0,NA,NA,NA,cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; CUT catabolic process [GO:0071034]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000467]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription [GO:0071049]; nuclear-transcribed mRNA catabolic process; exonucleolytic; 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of cell growth [GO:0030307]; U4 snRNA 3'-end processing [GO:0034475],NA,NA,NA
CHOYP_EZH2.1.1.m.47916,-0.00226989453418862,-0.00715307224425644,No,NA,NA,Q28D84,NA,NA,NA,ESC/E(Z) complex [GO:0035098]; histone-lysine N-methyltransferase activity [GO:0018024]; promoter-specific chromatin binding [GO:1990841]; negative regulation of gene expression; epigenetic [GO:0045814]; rhythmic process [GO:0048511],NA,NA,NA
CHOYP_F10A1.2.4.m.11805,0.0114719380726605,-0.00803679367978919,No,NA,NA,Q5ZLF0,NA,NA,NA,cytoplasm [GO:0005737]; protein dimerization activity [GO:0046983]; chaperone cofactor-dependent protein refolding [GO:0051085],NA,NA,NA
CHOYP_F10A1.4.4.m.44752,-0.00472798206813435,0.0114231929771055,No,NA,NA,Q5ZLF0,NA,NA,NA,cytoplasm [GO:0005737]; protein dimerization activity [GO:0046983]; chaperone cofactor-dependent protein refolding [GO:0051085],NA,NA,NA
CHOYP_F172A.2.2.m.58797,-0.0182809684046018,-0.00236283738414606,No,NA,NA,Q3TNH5,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; chromatin silencing by small RNA [GO:0031048]; mRNA processing [GO:0006397]; neural crest cell development [GO:0014032]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_F179B.1.1.m.45817,0.00770013866500896,-0.0119149843710433,No,NA,NA,Q8BMI3,NA,NA,NA,early endosome [GO:0005769]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; ADP-ribosylation factor binding [GO:0030306]; ubiquitin binding [GO:0043130]; endocytic recycling [GO:0032456]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; negative regulation of amyloid-beta formation [GO:1902430]; positive regulation of protein catabolic process [GO:0045732]; protein destabilization [GO:0031648]; protein localization to cell surface [GO:0034394]; protein localization to lysosome [GO:0061462]; regulation of protein stability [GO:0031647],NA,NA,NA
CHOYP_F188B.1.1.m.8460,-0.00300688849517083,0.0228933490494839,No,NA,NA,Q3UQI9,NA,NA,NA,thiol-dependent ubiquitinyl hydrolase activity [GO:0036459],NA,NA,NA
CHOYP_F48E3.8.1.1.m.46349,0.00364778592941831,-0.00872052841558097,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_F91A1.1.1.m.52980,0.00488999216528869,-0.0141165824957818,No,NA,NA,Q3UVG3,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; trans-Golgi network [GO:0005802]; intracellular protein transport [GO:0006886]; vesicle tethering to Golgi [GO:0099041],NA,NA,NA
CHOYP_FA13A.1.2.m.296,0.00656899037701414,-0.000247561090043017,No,NA,NA,Q8HYW0,NA,NA,NA,,NA,NA,NA
CHOYP_FA13A.1.2.m.297,-0.00430894344577715,-0.00631540690244347,No,NA,NA,Q6TH47,NA,NA,NA,cleavage furrow [GO:0032154]; endosome [GO:0005768]; membrane [GO:0016020]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536],NA,NA,NA
CHOYP_FA49B.1.1.m.294,0.00496314921824918,0.0213581043071005,No,NA,NA,Q9NUQ9,NA,NA,NA,cilium [GO:0005929]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; platelet alpha granule lumen [GO:0031093]; MHC class Ib protein binding; via antigen binding groove [GO:0023030]; platelet degranulation [GO:0002576]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of memory T cell activation [GO:2000568]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated cytotoxicity [GO:0001916],NA,NA,NA
CHOYP_FA63B.1.1.m.52872,-0.0148795121986652,0.00325756836730863,No,NA,NA,Q2KI23,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; cysteine-type carboxypeptidase activity [GO:0016807]; K11-linked polyubiquitin modification-dependent protein binding [GO:0071795]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; K6-linked polyubiquitin modification-dependent protein binding [GO:0071796]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein K48-linked deubiquitination [GO:0071108],NA,NA,NA
CHOYP_FA65A.1.1.m.24019,0.00678620130084429,0.00878741825264137,No,NA,NA,Q96MK2,NA,NA,NA,,NA,NA,NA
CHOYP_FAAA.1.1.m.7653,-0.0111960416180293,-0.00590099276995167,No,NA,NA,A5PKH3,NA,NA,NA,cytosol [GO:0005829]; fumarylacetoacetase activity [GO:0004334]; metal ion binding [GO:0046872]; homogentisate catabolic process [GO:1902000]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572],NA,NA,NA
CHOYP_FABP.1.2.m.51611,0.00904817531655782,0.00494565639724641,No,NA,NA,O01814,NA,NA,NA,nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; fatty acid binding [GO:0005504],NA,NA,NA
CHOYP_FABP2.1.2.m.5800,-0.00120478220532323,-0.0132865500693586,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_FABP6.1.2.m.49858,0.0141646207990755,0.01669321015907,No,NA,NA,O01812,NA,NA,NA,lipid binding [GO:0008289],NA,NA,NA
CHOYP_FABP7.1.2.m.22674,0.00396539413943629,0.0095457854862881,No,NA,NA,Q09139,NA,NA,NA,cell periphery [GO:0071944]; cell projection [GO:0042995]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; lipid binding [GO:0008289]; cell proliferation in forebrain [GO:0021846]; neurogenesis [GO:0022008]; prepulse inhibition [GO:0060134],NA,NA,NA
CHOYP_FABP7.2.2.m.29096,0.0228240446377563,-0.00305334821923723,No,NA,NA,Q09139,NA,NA,NA,cell periphery [GO:0071944]; cell projection [GO:0042995]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; lipid binding [GO:0008289]; cell proliferation in forebrain [GO:0021846]; neurogenesis [GO:0022008]; prepulse inhibition [GO:0060134],NA,NA,NA
CHOYP_FACE1.1.1.m.13875,0.00553492458447765,-0.00138512578406016,No,NA,NA,Q80W54,NA,NA,NA,integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; protein-containing complex [GO:0032991]; double-stranded DNA binding [GO:0003690]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; adult walking behavior [GO:0007628]; bone mineralization [GO:0030282]; CAAX-box protein processing [GO:0071586]; calcium ion import into sarcoplasmic reticulum [GO:1990036]; CAMKK-AMPK signaling cascade [GO:0061762]; cardiac conduction [GO:0061337]; cardiac muscle fiber development [GO:0048739]; cardiac ventricle development [GO:0003231]; cellular lipid metabolic process [GO:0044255]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; chromatin organization [GO:0006325]; chromosome organization [GO:0051276]; determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; epidermis development [GO:0008544]; growth plate cartilage development [GO:0003417]; hair follicle development [GO:0001942]; heart morphogenesis [GO:0003007]; histone H2A phosphorylation [GO:1990164]; histone H2B acetylation [GO:0043969]; histone H2B-K5 acetylation [GO:0043979]; hypomethylation of CpG island [GO:0044029]; inflammatory cell apoptotic process [GO:0006925]; kidney morphogenesis [GO:0060993]; liver development [GO:0001889]; maintenance of rDNA [GO:0043007]; multicellular organism growth [GO:0035264]; negative regulation of gene expression [GO:0010629]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; neuromuscular process [GO:0050905]; nuclear envelope organization [GO:0006998]; nucleus organization [GO:0006997]; positive regulation of gene expression [GO:0010628]; prenylated protein catabolic process [GO:0030327]; protein processing [GO:0016485]; regulation of autophagy [GO:0010506]; regulation of blood circulation [GO:1903522]; regulation of bone mineralization [GO:0030500]; regulation of cell shape [GO:0008360]; regulation of cellular senescence [GO:2000772]; regulation of defense response to virus [GO:0050688]; regulation of DNA damage response; signal transduction by p53 class mediator [GO:0043516]; regulation of DNA methylation [GO:0044030]; regulation of fibroblast proliferation [GO:0048145]; regulation of glucose metabolic process [GO:0010906]; regulation of heart contraction [GO:0008016]; regulation of histone H4 acetylation [GO:0090239]; regulation of histone H4-K16 acetylation [GO:2000618]; regulation of hormone metabolic process [GO:0032350]; regulation of lipid metabolic process [GO:0019216]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic cell cycle DNA replication [GO:1903463]; regulation of multicellular organism growth [GO:0040014]; regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1903025]; regulation of stress-activated protein kinase signaling cascade [GO:0070302]; regulation of termination of RNA polymerase I transcription [GO:2000730]; regulation of TOR signaling [GO:0032006]; regulation of transcription; DNA-templated [GO:0006355]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to DNA damage checkpoint signaling [GO:0072423]; thymus development [GO:0048538]; ventricular cardiac muscle tissue development [GO:0003229],NA,NA,NA
CHOYP_FAF1.1.1.m.35621,0.0120514408334993,0.0143484036942905,No,NA,NA,Q9UNN5,NA,NA,NA,CD95 death-inducing signaling complex [GO:0031265]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; heat shock protein binding [GO:0031072]; NF-kappaB binding [GO:0051059]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; cell death [GO:0008219]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell death [GO:0010942]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of DNA replication [GO:0045740]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of protein complex assembly [GO:0031334]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell adhesion [GO:0030155]; regulation of protein catabolic process [GO:0042176],NA,NA,NA
CHOYP_FAF1.1.1.m.35623,0.00394536801625317,0.00291369700370642,No,NA,NA,Q92193,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_FAF2.1.1.m.54271,0.00297587560598678,0.0184269190532683,No,NA,NA,P30568,NA,NA,NA,cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364],NA,NA,NA
CHOYP_FAIM1.1.1.m.36651,-0.00538056443564464,-0.00113329028768891,No,NA,NA,Q0IIF6,NA,NA,NA,cytoplasm [GO:0005737]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066],NA,NA,NA
CHOYP_FAM122B.1.1.m.7361,-0.000169862035561032,-0.00672519487752929,No,NA,NA,Q5ZLN7,NA,NA,NA,protein serine/threonine phosphatase inhibitor activity [GO:0004865]; positive regulation of cell growth [GO:0030307]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436],NA,NA,NA
CHOYP_FAM193A.1.1.m.66343,-0.00245764310098658,-0.00439065889287193,No,NA,NA,P78312,NA,NA,NA,,NA,NA,NA
CHOYP_FAM50.1.1.m.17123,-0.000894753263916259,0.00316397078493089,No,NA,NA,Q9VAY7,NA,NA,NA,nucleoplasm [GO:0005654]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_FANCJ.1.1.m.17513,0.00436542276619614,-0.00573886378449497,No,NA,NA,Q3YK19,NA,NA,NA,cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 4 iron; 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; ATP-dependent DNA helicase activity [GO:0004003]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; chiasma assembly [GO:0051026]; DNA repair [GO:0006281]; double-strand break repair involved in meiotic recombination [GO:1990918]; meiotic DNA double-strand break processing involved in reciprocal meiotic recombination [GO:0010705]; nucleotide-excision repair [GO:0006289]; regulation of transcription by RNA polymerase II [GO:0006357]; seminiferous tubule development [GO:0072520]; spermatid development [GO:0007286]; spermatogonial cell division [GO:0007284],NA,NA,NA
CHOYP_FARP2.1.1.m.9404,-0.015692718239053,-0.00831128239416408,No,NA,NA,Q91VS8,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; cytoskeletal protein binding [GO:0008092]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; actin cytoskeleton reorganization [GO:0031532]; cell adhesion [GO:0007155]; hair cycle process [GO:0022405]; neuron remodeling [GO:0016322]; osteoclast differentiation [GO:0030316]; podosome assembly [GO:0071800]; Rac protein signal transduction [GO:0016601]; regulation of integrin activation [GO:0033623]; regulation of Rho protein signal transduction [GO:0035023]; semaphorin-plexin signaling pathway [GO:0071526],NA,NA,NA
CHOYP_FAS2.1.1.m.41201,0.0207532189476339,0.00804311321076125,No,NA,NA,P13596,NA,NA,NA,glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; cytoskeletal protein binding [GO:0008092]; fibroblast growth factor receptor binding [GO:0005104]; heparin binding [GO:0008201]; LRR domain binding [GO:0030275]; phosphatase binding [GO:0019902]; aging [GO:0007568]; animal organ regeneration [GO:0031100]; axonal fasciculation [GO:0007413]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; modulation of chemical synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; response to activity [GO:0014823]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794],NA,NA,NA
CHOYP_FASN.3.4.m.60278,-0.00392861096101983,-0.0197699375129043,No,NA,NA,P12276,NA,NA,NA,cell [GO:0005623]; (3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activity [GO:0008659]; 3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [GO:0047451]; 3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; [acyl-carrier-protein] S-acetyltransferase activity [GO:0004313]; [acyl-carrier-protein] S-malonyltransferase activity [GO:0004314]; enoyl-[acyl-carrier-protein] reductase (NADPH; A-specific) activity [GO:0047117]; fatty acid synthase activity [GO:0004312]; myristoyl-[acyl-carrier-protein] hydrolase activity [GO:0016295]; oleoyl-[acyl-carrier-protein] hydrolase activity [GO:0004320]; palmitoyl-[acyl-carrier-protein] hydrolase activity [GO:0016296]; phosphopantetheine binding [GO:0031177]; single-stranded DNA binding [GO:0003697]; fatty acid biosynthetic process [GO:0006633]; lactate metabolic process [GO:0006089]; positive regulation of appetite [GO:0032100],NA,NA,NA
CHOYP_FAT1.2.4.m.36735,0.00641233713433347,0.00665334198971112,No,NA,NA,Q14517,NA,NA,NA,apical plasma membrane [GO:0016324]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; actin filament organization [GO:0007015]; anatomical structure morphogenesis [GO:0009653]; camera-type eye morphogenesis [GO:0048593]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; epithelial cell morphogenesis [GO:0003382]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],NA,NA,NA
CHOYP_FAT1.4.4.m.63315,-0.00259261133701992,-0.0104879274932987,No,NA,NA,Q6V0I7,NA,NA,NA,apical part of cell [GO:0045177]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307],NA,NA,NA
CHOYP_FAT4.8.10.m.44748,0.00982099797581341,-0.0189091199279649,No,NA,NA,Q14517,NA,NA,NA,apical plasma membrane [GO:0016324]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; actin filament organization [GO:0007015]; anatomical structure morphogenesis [GO:0009653]; camera-type eye morphogenesis [GO:0048593]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; epithelial cell morphogenesis [GO:0003382]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],NA,NA,NA
CHOYP_FBLN2.1.1.m.25187,0.0193256211763102,-0.0173575654963338,No,NA,NA,P37889,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811],NA,NA,NA
CHOYP_FBX22.1.1.m.35385,-0.0174875754845565,0.000761597017430954,No,NA,NA,Q5RE08,NA,NA,NA,Z disc [GO:0030018],NA,NA,NA
CHOYP_FBX42.1.1.m.11569,-0.00953525453535241,-0.00218382348332831,No,NA,NA,Q6PDJ6,NA,NA,NA,,NA,NA,NA
CHOYP_FBX9.1.1.m.49865,-0.00277296745240779,0.00436929194433653,No,NA,NA,Q3ZBT2,NA,NA,NA,cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin-protein transferase activity [GO:0004842]; fat cell differentiation [GO:0045444]; innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of TOR signaling [GO:0032006]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],NA,NA,NA
CHOYP_FCHO2.1.1.m.46242,-0.00260519420883073,0.00884718990848926,No,NA,NA,Q3UQN2,NA,NA,NA,AP-2 adaptor complex [GO:0030122]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]; presynaptic endocytic zone membrane [GO:0098835]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; phospholipid binding [GO:0005543]; tubulin binding [GO:0015631]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; plasma membrane tubulation [GO:0097320]; protein localization to plasma membrane [GO:0072659]; synaptic vesicle endocytosis [GO:0048488],NA,NA,NA
CHOYP_FCL.1.1.m.13504,-0.00983462124882319,0.00435315900900507,No,NA,NA,Q8K3X2,NA,NA,NA,coenzyme binding [GO:0050662]; GDP-L-fucose synthase activity [GO:0050577]; GDP-mannose 3;5-epimerase activity [GO:0047918]; identical protein binding [GO:0042802]; 'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; T cell mediated cytotoxicity [GO:0001913],NA,NA,NA
CHOYP_FEN1.1.1.m.66181,-0.0038187223894724,-0.00750383265130136,No,NA,NA,A7RRJ0,NA,NA,NA,mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 5'-3' exonuclease activity [GO:0008409]; 5'-flap endonuclease activity [GO:0017108]; DNA binding [GO:0003677]; flap endonuclease activity [GO:0048256]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; apoptotic DNA fragmentation [GO:0006309]; base-excision repair [GO:0006284]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication; removal of RNA primer [GO:0043137]; positive regulation of sister chromatid cohesion [GO:0045876],NA,NA,NA
CHOYP_FGD1.1.2.m.11030,0.011945023907147,0.0147730330182759,No,NA,NA,P98174,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; ruffle [GO:0001726]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; small GTPase binding [GO:0031267]; actin cytoskeleton organization [GO:0030036]; animal organ morphogenesis [GO:0009887]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; G protein-coupled receptor signaling pathway [GO:0007186]; multicellular organism development [GO:0007275]; positive regulation of apoptotic process [GO:0043065]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_FGFR2.1.3.m.20151,-0.00253257568967623,-0.00103812170723974,No,NA,NA,Q03142,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; transport vesicle [GO:0030133]; ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; heparin binding [GO:0008201]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; alveolar secondary septum development [GO:0061144]; cell migration [GO:0016477]; cholesterol homeostasis [GO:0042632]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glucose homeostasis [GO:0042593]; lung development [GO:0030324]; negative regulation of fibroblast growth factor production [GO:0090272]; negative regulation of gene expression [GO:0010629]; nervous system development [GO:0007399]; organ induction [GO:0001759]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphate ion homeostasis [GO:0055062]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell proliferation [GO:0008284]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of parathyroid hormone secretion [GO:2000830]; positive regulation of proteolysis [GO:0045862]; protein autophosphorylation [GO:0046777]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of lipid metabolic process [GO:0019216]; regulation of phosphate transport [GO:0010966]; regulation of phosphorus metabolic process [GO:0051174]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vitamin D3 metabolic process [GO:0070640],NA,NA,NA
CHOYP_FGFR2.2.3.m.53947,-0.0169591047060434,0.00960206869202777,No,NA,NA,Q8JG38,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; apoptotic process [GO:0006915]; cell proliferation in midbrain [GO:0033278]; cilium assembly [GO:0060271]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; digestive tract development [GO:0048565]; midbrain development [GO:0030901]; positive regulation of cell proliferation [GO:0008284]; regulation of hematopoietic stem cell differentiation [GO:1902036]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_FGL1.1.6.m.30450,0.00843667838161297,0.0123343335811855,No,NA,NA,Q9R045,NA,NA,NA,extracellular space [GO:0005615],NA,NA,NA
CHOYP_FHOD3.2.2.m.44837,-0.0203810010532514,0.0148898884384601,No,NA,NA,Q2V2M9,NA,NA,NA,striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; negative regulation of actin filament polymerization [GO:0030837]; sarcomere organization [GO:0045214],NA,NA,NA
CHOYP_FIBP.1.1.m.36402,0.00615966897194063,0.00941964587728867,No,NA,NA,Q9JI19,NA,NA,NA,endomembrane system [GO:0012505]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; fibroblast growth factor binding [GO:0017134],NA,NA,NA
CHOYP_FKBP12.1.1.m.32709,-0.00388127156769104,-0.00713413503636532,No,NA,NA,Q9Z2I2,NA,NA,NA,calcium channel complex [GO:0034704]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; Z disc [GO:0030018]; calcium channel inhibitor activity [GO:0019855]; cyclic nucleotide binding [GO:0030551]; FK506 binding [GO:0005528]; ion channel binding [GO:0044325]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; signaling receptor binding [GO:0005102]; chaperone-mediated protein folding [GO:0061077]; insulin secretion [GO:0030073]; negative regulation of heart rate [GO:0010459]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of release of sequestered calcium ion into cytosol [GO:0051280]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; neuronal action potential propagation [GO:0019227]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of sequestering of calcium ion [GO:0051284]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of heart rate [GO:0002027]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; release of sequestered calcium ion into cytosol [GO:0051209]; release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0014808]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to redox state [GO:0051775]; response to vitamin E [GO:0033197]; smooth muscle contraction [GO:0006939]; T cell proliferation [GO:0042098],NA,NA,NA
CHOYP_FKBP13.1.1.m.43694,0.019205973558662,-0.0138581626214622,No,NA,NA,Q9Y680,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; calcium ion binding [GO:0005509]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755],NA,NA,NA
CHOYP_FKBP14.1.1.m.7244,-0.0123450602797586,-0.000339852053383488,No,NA,NA,P59024,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; calcium ion binding [GO:0005509]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755],NA,NA,NA
CHOYP_FKBP1AA.1.1.m.26101,0.0121936227407379,0.00928459029300288,No,NA,NA,O42123,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic side of membrane [GO:0098562]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of organelle membrane [GO:0031312]; membrane [GO:0016020]; ryanodine receptor complex [GO:1990425]; sarcoplasmic reticulum membrane [GO:0033017]; terminal cisterna [GO:0014802]; Z disc [GO:0030018]; activin binding [GO:0048185]; calcium channel inhibitor activity [GO:0019855]; drug binding [GO:0008144]; FK506 binding [GO:0005528]; ion channel binding [GO:0044325]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein homodimerization activity [GO:0042803]; SMAD binding [GO:0046332]; amyloid fibril formation [GO:1990000]; cytokine-mediated signaling pathway [GO:0019221]; heart morphogenesis [GO:0003007]; heart trabecula formation [GO:0060347]; muscle contraction [GO:0006936]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of release of sequestered calcium ion into cytosol [GO:0051280]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein binding [GO:0032092]; positive regulation of protein ubiquitination [GO:0031398]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of activin receptor signaling pathway [GO:0032925]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of immune response [GO:0050776]; regulation of protein localization [GO:0032880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; release of sequestered calcium ion into cytosol [GO:0051209]; response to caffeine [GO:0031000]; SMAD protein complex assembly [GO:0007183]; supramolecular fiber organization [GO:0097435]; T cell proliferation [GO:0042098]; ventricular cardiac muscle tissue morphogenesis [GO:0055010],NA,NA,NA
CHOYP_FKBP4.1.1.m.15147,0.00887290619657673,-0.000777616280563243,No,NA,NA,Q9TRY0,NA,NA,NA,axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; FK506 binding [GO:0005528]; heat shock protein binding [GO:0031072]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; chaperone-mediated protein folding [GO:0061077]; negative regulation of microtubule polymerization or depolymerization [GO:0031111]; negative regulation of neuron projection development [GO:0010977]; protein peptidyl-prolyl isomerization [GO:0000413],NA,NA,NA
CHOYP_FL2D.1.1.m.62439,-0.00664641502544797,0.00605965808688315,No,NA,NA,Q7SXL7,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; cell cycle [GO:0007049]; mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; multicellular organism development [GO:0007275]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of apoptotic process [GO:0042981]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_FLELI_3104.1.1.m.46432,0.0178088554389928,-0.00821621377348242,No,NA,NA,Q30NT6,NA,NA,NA,ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphotransferase activity; alcohol group as acceptor [GO:0016773]; 1;6-anhydro-N-acetyl-beta-muramic acid catabolic process [GO:0097175]; amino sugar metabolic process [GO:0006040]; carbohydrate metabolic process [GO:0005975]; peptidoglycan turnover [GO:0009254],NA,NA,NA
CHOYP_FLNA.1.6.m.11089,-0.00180893423045525,-0.00918491521638574,No,NA,NA,Q80X90,NA,NA,NA,brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; identical protein binding [GO:0042802]; actin cytoskeleton organization [GO:0030036]; cellular response to interferon-gamma [GO:0071346]; epithelial cell morphogenesis [GO:0003382]; keratinocyte development [GO:0003334]; skeletal muscle tissue development [GO:0007519],NA,NA,NA
CHOYP_FLNA.2.6.m.11845,0.0131828492906667,0.000160820576151148,No,NA,NA,Q9VEN1,NA,NA,NA,actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; female germline ring canal outer rim [GO:0035182]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; actin binding [GO:0003779]; behavioral response to ethanol [GO:0048149]; cytoplasmic transport; nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation; actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sarcomere organization [GO:0045214],NA,NA,NA
CHOYP_FLNA.6.6.m.37383,-0.00857285960920001,0.0112008492302167,No,NA,NA,Q80X90,NA,NA,NA,brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; identical protein binding [GO:0042802]; actin cytoskeleton organization [GO:0030036]; cellular response to interferon-gamma [GO:0071346]; epithelial cell morphogenesis [GO:0003382]; keratinocyte development [GO:0003334]; skeletal muscle tissue development [GO:0007519],NA,NA,NA
CHOYP_FLNC.2.5.m.37450,-0.00390242930275585,-0.00499431468893334,No,NA,NA,P21333,NA,NA,NA,actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; Myb complex [GO:0031523]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; mu-type opioid receptor binding [GO:0031852]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; Rac GTPase binding [GO:0048365]; Ral GTPase binding [GO:0017160]; Rho GTPase binding [GO:0017048]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transcription factor binding [GO:0008134]; actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; cell junction assembly [GO:0034329]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; defense response to virus [GO:0051607]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; semaphorin-plexin signaling pathway [GO:0071526]; wound healing; spreading of cells [GO:0044319],NA,NA,NA
CHOYP_FLNC.3.5.m.38669,0.00409703760629486,0.00644176867581582,No,NA,NA,P21333,NA,NA,NA,actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; Myb complex [GO:0031523]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; mu-type opioid receptor binding [GO:0031852]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; Rac GTPase binding [GO:0048365]; Ral GTPase binding [GO:0017160]; Rho GTPase binding [GO:0017048]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transcription factor binding [GO:0008134]; actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; cell junction assembly [GO:0034329]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; defense response to virus [GO:0051607]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; semaphorin-plexin signaling pathway [GO:0071526]; wound healing; spreading of cells [GO:0044319],NA,NA,NA
CHOYP_FLNC.5.5.m.40834,0.00941734562305369,0.0206003600053242,No,NA,NA,D3ZHA0,NA,NA,NA,costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; muscle fiber development [GO:0048747],NA,NA,NA
CHOYP_FLOT1.1.2.m.21435,0.00364778592941831,-0.00872052841558097,No,NA,NA,O61491,NA,NA,NA,cytoplasm [GO:0005737]; flotillin complex [GO:0016600]; structural molecule activity [GO:0005198]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_FLOT1.2.2.m.59727,-0.0101594719706314,0.0142164739805368,No,NA,NA,O61491,NA,NA,NA,cytoplasm [GO:0005737]; flotillin complex [GO:0016600]; structural molecule activity [GO:0005198]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_FMRF.1.4.m.26285,0.00766793759458674,-0.00244620218655832,No,NA,NA,P08021,NA,NA,NA,extracellular region [GO:0005576]; neuropeptide signaling pathway [GO:0007218],NA,NA,NA
CHOYP_FMRF.2.4.m.37051,0.0107257982137972,0.0112482618889324,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_FMRF.4.4.m.62077,-0.00925787182144619,-0.00147800139693149,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_FMRP.1.2.m.37742,-0.0143550313970616,-0.00364265969407721,No,NA,NA,Q5XI81,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; dendritic spine [GO:0043197]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; polysome [GO:0005844]; postsynaptic density [GO:0014069]; ribonucleoprotein granule [GO:0035770]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA strand annealing activity [GO:0033592]; translation regulator activity [GO:0045182]; cell differentiation [GO:0030154]; muscle organ development [GO:0007517]; negative regulation of translation [GO:0017148]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of translation [GO:0045727]; regulation of mRNA stability [GO:0043488],NA,NA,NA
CHOYP_FND2.1.4.m.8542,-0.00874398236497047,-0.0248775518465245,No,NA,NA,H2A0L8,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_FND2.3.4.m.40482,0.0224999763795628,-0.0105385238937664,No,NA,NA,H2A0L8,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_FND2.4.4.m.44570,0.0124766712414012,0.000313818759658984,No,NA,NA,H2A0L8,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_FNTA.1.1.m.40996,-0.00447329893729811,-0.00163431617689234,No,NA,NA,P49354,NA,NA,NA,CAAX-protein geranylgeranyltransferase complex [GO:0005953]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; plasma membrane [GO:0005886]; protein farnesyltransferase complex [GO:0005965]; acetylcholine receptor regulator activity [GO:0030548]; alpha-tubulin binding [GO:0043014]; CAAX-protein geranylgeranyltransferase activity [GO:0004662]; microtubule binding [GO:0008017]; protein farnesyltransferase activity [GO:0004660]; protein geranylgeranyltransferase activity [GO:0004661]; Rab geranylgeranyltransferase activity [GO:0004663]; receptor tyrosine kinase binding [GO:0030971]; neurotransmitter receptor metabolic process [GO:0045213]; positive regulation of deacetylase activity [GO:0090045]; positive regulation of tubulin deacetylation [GO:0090044]; protein farnesylation [GO:0018343]; protein geranylgeranylation [GO:0018344]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_FNTB.1.1.m.45546,0.0163025603952515,-0.00956991339904917,No,NA,NA,P49355,NA,NA,NA,protein farnesyltransferase complex [GO:0005965]; farnesyltranstransferase activity [GO:0004311]; protein farnesyltransferase activity [GO:0004660]; zinc ion binding [GO:0008270]; negative regulation of cell proliferation [GO:0008285]; positive regulation of fibroblast proliferation [GO:0048146]; protein farnesylation [GO:0018343]; protein prenylation [GO:0018342]; wound healing [GO:0042060],NA,NA,NA
CHOYP_FOCAD.2.2.m.52366,-0.0102452972219286,-0.00895279586679429,No,NA,NA,Q5VW36,NA,NA,NA,focal adhesion [GO:0005925]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_FOXF1.1.1.m.4194,-0.0135725579708753,0.00388604629968508,No,NA,NA,Q61080,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region DNA binding [GO:0044212]; animal organ morphogenesis [GO:0009887]; blood vessel development [GO:0001568]; cardiac left ventricle morphogenesis [GO:0003214]; cell-cell adhesion [GO:0098609]; cellular response to cytokine stimulus [GO:0071345]; cellular response to organic cyclic compound [GO:0071407]; detection of wounding [GO:0014822]; determination of left/right symmetry [GO:0007368]; digestive tract development [GO:0048565]; ductus arteriosus closure [GO:0097070]; embryonic digestive tract development [GO:0048566]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic ectodermal digestive tract morphogenesis [GO:0048613]; embryonic foregut morphogenesis [GO:0048617]; endocardial cushion development [GO:0003197]; epithelial cell differentiation involved in mammary gland alveolus development [GO:0061030]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment of epithelial cell apical/basal polarity [GO:0045198]; extracellular matrix organization [GO:0030198]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; lateral mesodermal cell differentiation [GO:0048371]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; lung lobe morphogenesis [GO:0060463]; lung morphogenesis [GO:0060425]; lung vasculature development [GO:0060426]; mesenchyme migration [GO:0090131]; mesoderm development [GO:0007498]; midgut development [GO:0007494]; morphogenesis of a branching structure [GO:0001763]; negative regulation of inflammatory response [GO:0050728]; negative regulation of mast cell degranulation [GO:0043305]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pancreas development [GO:0031016]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of smooth muscle cell differentiation [GO:0051150]; renal system development [GO:0072001]; respiratory tube development [GO:0030323]; right lung morphogenesis [GO:0060461]; smooth muscle cell differentiation [GO:0051145]; smoothened signaling pathway [GO:0007224]; somitogenesis [GO:0001756]; trachea development [GO:0060438]; ureter development [GO:0072189]; vasculogenesis [GO:0001570]; venous blood vessel development [GO:0060841],NA,NA,NA
CHOYP_FOXK2.1.1.m.56318,-0.00950764199025673,0.0141932514950253,No,NA,NA,Q7ZX03,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; magnesium ion binding [GO:0000287]; sequence-specific DNA binding [GO:0043565]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_FOXN2_3.1.1.m.8518,0.000263175962820065,0.00344903402625848,No,NA,NA,Q33BP8,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; cell cycle [GO:0007049],NA,NA,NA
CHOYP_FREM1.1.1.m.55119,0.00360697823790764,-0.00628798885594827,No,NA,NA,Q5H8C1,NA,NA,NA,basement membrane [GO:0005604]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; cell communication [GO:0007154]; cell-matrix adhesion [GO:0007160]; craniofacial suture morphogenesis [GO:0097094],NA,NA,NA
CHOYP_FREM2.1.1.m.31430,-0.0135725579708753,0.00388604629968508,No,NA,NA,Q9GV77,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]; cell communication [GO:0007154]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_FRIS.10.11.m.66055,0.00302597247345217,0.00346302087104694,No,NA,NA,P42577,NA,NA,NA,cytoplasm [GO:0005737]; ferric iron binding [GO:0008199]; ferroxidase activity [GO:0004322]; cellular iron ion homeostasis [GO:0006879]; iron ion transport [GO:0006826],NA,NA,NA
CHOYP_FRIS.6.11.m.44036,-0.00193639178836236,-0.00386882742871428,No,NA,NA,P42577,NA,NA,NA,cytoplasm [GO:0005737]; ferric iron binding [GO:0008199]; ferroxidase activity [GO:0004322]; cellular iron ion homeostasis [GO:0006879]; iron ion transport [GO:0006826],NA,NA,NA
CHOYP_FRIS.9.11.m.53958,-0.00342309990281466,0.00439543579864711,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_FRIY.1.1.m.5052,0.0176045304172953,-0.0185640163485681,No,NA,NA,P42578,NA,NA,NA,cell [GO:0005623]; extracellular region [GO:0005576]; ferric iron binding [GO:0008199]; ferroxidase activity [GO:0004322]; cellular iron ion homeostasis [GO:0006879]; iron ion transport [GO:0006826],NA,NA,NA
CHOYP_FRM4B.1.1.m.2249,-0.0034493022298881,-0.0246797575848754,No,NA,NA,Q8BIE6,NA,NA,NA,adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; protein binding; bridging [GO:0030674]; establishment of epithelial cell polarity [GO:0090162],NA,NA,NA
CHOYP_FRRS1.2.3.m.41025,0.0217651771439916,-0.00297421481897573,No,NA,NA,A4QP81,NA,NA,NA,integral component of membrane [GO:0016021]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_FUCL1.1.1.m.28893,-0.0169591047060434,0.00960206869202777,No,NA,NA,Q9I931,NA,NA,NA,extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; fucose binding [GO:0042806]; regulation of cellular defense response [GO:0010185]; regulation of complement activation; lectin pathway [GO:0001868]; regulation of innate immune response [GO:0045088],NA,NA,NA
CHOYP_FUCO.1.2.m.58756,0.00314340369760134,-0.0160063581891714,No,NA,NA,C3YWU0,NA,NA,NA,extracellular region [GO:0005576]; lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139],NA,NA,NA
CHOYP_FUCO.2.2.m.58905,-0.00235601580140013,-0.0124794349765367,No,NA,NA,C3YWU0,NA,NA,NA,extracellular region [GO:0005576]; lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139],NA,NA,NA
CHOYP_FUCO2.1.1.m.64139,-0.00191523997075725,-0.020225973775568,No,NA,NA,Q9BTY2,NA,NA,NA,azurophil granule lumen [GO:0035578]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; cellular protein metabolic process [GO:0044267]; fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139]; neutrophil degranulation [GO:0043312]; post-translational protein modification [GO:0043687]; regulation of entry of bacterium into host cell [GO:2000535]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_FUK.1.1.m.17020,-0.000520599939731893,-0.00651198691988612,No,NA,NA,Q8N0W3,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; fucokinase activity [GO:0050201]; carbohydrate phosphorylation [GO:0046835]; GDP-L-fucose salvage [GO:0042352]; response to dopamine [GO:1903350],NA,NA,NA
CHOYP_FUMH.2.2.m.55401,-0.00480914459724782,-0.00499809535304713,No,NA,NA,O17214,NA,NA,NA,mitochondrion [GO:0005739]; tricarboxylic acid cycle enzyme complex [GO:0045239]; fumarate hydratase activity [GO:0004333]; fumarate metabolic process [GO:0006106]; malate metabolic process [GO:0006108]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_FUT2.4.5.m.54048,0.00678620130084428,0.00878741825264137,No,NA,NA,Q28113,NA,NA,NA,Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486],NA,NA,NA
CHOYP_FUT8.1.1.m.9231,-0.00955084010860266,-0.00269860028568682,No,NA,NA,Q659X0,NA,NA,NA,Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->6)-fucosyltransferase activity [GO:0046921]; glycoprotein 6-alpha-L-fucosyltransferase activity [GO:0008424]; SH3 domain binding [GO:0017124]; GDP-L-fucose metabolic process [GO:0046368]; N-glycan fucosylation [GO:0036071]; protein glycosylation in Golgi [GO:0033578]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279],NA,NA,NA
CHOYP_FUTSC.1.4.m.10187,-0.0130345840181911,-0.00197761103779143,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_FUTSC.3.4.m.18545,-0.0187073911417096,0.0045434439613578,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_FUTSC.4.4.m.59503,-0.0100033712976652,-0.0230764367905782,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_FYN.1.1.m.44312,0.00538681690567935,0.0145462556219164,No,NA,NA,Q9CPW4,NA,NA,NA,Arp2/3 protein complex [GO:0005885]; cytoplasm [GO:0005737]; endosome [GO:0005768]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin filament binding [GO:0051015]; structural constituent of cytoskeleton [GO:0005200]; actin filament network formation [GO:0051639]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; cell migration [GO:0016477]; lamellipodium organization [GO:0097581]; maintenance of cell polarity [GO:0030011]; microtubule organizing center localization [GO:0061842]; orbitofrontal cortex development [GO:0021769]; smooth muscle cell migration [GO:0014909],NA,NA,NA
CHOYP_FYNA.1.1.m.63901,0.00364778592941831,-0.00872052841558096,No,NA,NA,P00523,NA,NA,NA,cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; connexin binding [GO:0071253]; growth factor receptor binding [GO:0070851]; heme binding [GO:0020037]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; epidermal growth factor receptor signaling pathway [GO:0007173]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; progesterone receptor signaling pathway [GO:0050847]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_FYV1.1.1.m.41923,0.00647450134234974,0.0073927874819387,No,NA,NA,Q9Z1T6,NA,NA,NA,cell-cell junction [GO:0005911]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; vesicle membrane [GO:0012506]; 1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; zinc ion binding [GO:0008270]; intracellular signal transduction [GO:0035556]; myelin assembly [GO:0032288]; protein localization to nucleus [GO:0034504]; regulation of autophagosome assembly [GO:2000785]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_FZD7A.1.1.m.29589,0.00696216323459725,-0.00440969074911282,No,NA,NA,Q9I9M5,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; Wnt-activated receptor activity [GO:0042813]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_G6PD.1.2.m.38380,-0.00114332075114706,-0.0100756638533898,No,NA,NA,P05370,NA,NA,NA,cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; carbohydrate binding [GO:0030246]; glucose binding [GO:0005536]; glucose-6-phosphate dehydrogenase activity [GO:0004345]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADP metabolic process [GO:0006739]; NADPH regeneration [GO:0006740]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt; oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390],NA,NA,NA
CHOYP_G6PD.2.2.m.46923,-0.00884445613741146,0.00941542770160761,No,NA,NA,P05370,NA,NA,NA,cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; carbohydrate binding [GO:0030246]; glucose binding [GO:0005536]; glucose-6-phosphate dehydrogenase activity [GO:0004345]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADP metabolic process [GO:0006739]; NADPH regeneration [GO:0006740]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt; oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390],NA,NA,NA
CHOYP_GABPA.1.1.m.15077,-0.00285544502927117,0.00535333756999245,No,NA,NA,Q06546,NA,NA,NA,nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription regulatory region DNA binding [GO:0044212]; blastocyst formation [GO:0001825]; cell differentiation [GO:0030154]; cellular response to dopamine [GO:1903351]; mitochondrion organization [GO:0007005]; negative regulation of megakaryocyte differentiation [GO:0045653]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_GADL1.1.1.m.14433,0.0019966450007812,0.00099658860656385,No,NA,NA,Q9Y600,NA,NA,NA,cytoplasm [GO:0005737]; aspartate 1-decarboxylase activity [GO:0004068]; pyridoxal phosphate binding [GO:0030170]; sulfinoalanine decarboxylase activity [GO:0004782]; L-cysteine catabolic process to hypotaurine [GO:0019449]; L-cysteine catabolic process to taurine [GO:0019452]; taurine biosynthetic process [GO:0042412],NA,NA,NA
CHOYP_GAK.1.1.m.7017,-0.00954660945506749,0.00296223869278594,No,NA,NA,O14976,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]; vesicle [GO:0031982]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; clathrin binding [GO:0030276]; cyclin binding [GO:0030332]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; chaperone cofactor-dependent protein refolding [GO:0051085]; clathrin coat disassembly [GO:0072318]; clathrin-coated pit assembly [GO:1905224]; clathrin-dependent endocytosis [GO:0072583]; endoplasmic reticulum organization [GO:0007029]; Golgi organization [GO:0007030]; Golgi to lysosome transport [GO:0090160]; membrane organization [GO:0061024]; negative regulation of neuron projection development [GO:0010977]; protein localization to Golgi apparatus [GO:0034067]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis [GO:0006898]; synaptic vesicle uncoating [GO:0016191],NA,NA,NA
CHOYP_GALK2.1.2.m.5222,0.00792337436438217,0.0191292761875796,No,NA,NA,Q5XIG6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; galactokinase activity [GO:0004335]; galactose binding [GO:0005534]; N-acetylgalactosamine kinase activity [GO:0033858]; galactose catabolic process via UDP-galactose [GO:0033499],NA,NA,NA
CHOYP_GALNS.1.1.m.66165,-0.0219452663863686,0.00041579862767416,No,NA,NA,Q32KH5,NA,NA,NA,lysosome [GO:0005764]; metal ion binding [GO:0046872]; N-acetylgalactosamine-6-sulfatase activity [GO:0043890],NA,NA,NA
CHOYP_GALT1.1.1.m.33853,0.00653385781861992,-0.000384221714779708,No,NA,NA,Q29121,NA,NA,NA,extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation [GO:0006493],NA,NA,NA
CHOYP_GALT2.1.1.m.54493,-0.00416850195469044,0.017462998012978,No,NA,NA,Q10471,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; immunoglobulin biosynthetic process [GO:0002378]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243],NA,NA,NA
CHOYP_GAR1.1.2.m.9449,-0.0117580244773667,0.00396835712235558,No,NA,NA,Q9CY66,NA,NA,NA,box H/ACA snoRNP complex [GO:0031429]; box H/ACA telomerase RNP complex [GO:0090661]; Cajal body [GO:0015030]; dense fibrillar component [GO:0001651]; fibrillar center [GO:0001650]; nuclear chromosome; telomeric region [GO:0000784]; telomerase holoenzyme complex [GO:0005697]; box H/ACA snoRNA binding [GO:0034513]; snoRNA binding [GO:0030515]; telomerase RNA binding [GO:0070034]; snoRNA guided rRNA pseudouridine synthesis [GO:0000454]; telomere maintenance via telomerase [GO:0007004],NA,NA,NA
CHOYP_GATA1.1.2.m.16576,0.00612083964453189,0.000320294779802924,No,NA,NA,P52168,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II repressing transcription factor binding [GO:0001103]; RNA polymerase II transcription factor binding [GO:0001085]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; blastoderm segmentation [GO:0007350]; cardioblast cell fate determination [GO:0007510]; cardioblast differentiation [GO:0010002]; cardiocyte differentiation [GO:0035051]; cell differentiation [GO:0030154]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; digestive tract development [GO:0048565]; dorsal closure [GO:0007391]; ectoderm development [GO:0007398]; embryonic heart tube development [GO:0035050]; endoderm development [GO:0007492]; heart contraction [GO:0060047]; heart development [GO:0007507]; lymph gland development [GO:0048542]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; pattern specification process [GO:0007389]; pericardial nephrocyte differentiation [GO:0061320]; pigment metabolic process [GO:0042440]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of antimicrobial peptide biosynthetic process [GO:0002805]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_GATAD1.1.1.m.50020,0.0221382008317183,-0.00275141107517383,No,NA,NA,Q1L8G7,NA,NA,NA,I band [GO:0031674]; nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_GATC.1.2.m.2975,-0.00716835498915521,-0.00720928825074393,No,NA,NA,C3XVM1,NA,NA,NA,glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]; glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]; regulation of translational fidelity [GO:0006450],NA,NA,NA
CHOYP_GBB.2.2.m.35274,-0.00418986251579486,0.00832875474466694,No,NA,NA,Q17902,NA,NA,NA,nuclear envelope [GO:0005635]; 3'-5' exonuclease activity [GO:0008408]; nucleic acid binding [GO:0003676],NA,NA,NA
CHOYP_GBLP.3.7.m.20931,0.0168622166687695,-0.0162024282037471,No,NA,NA,O42249,NA,NA,NA,ribosome [GO:0005840]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of gastrulation [GO:2000543]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880],NA,NA,NA
CHOYP_GBLP.6.7.m.57427,0.019702341988443,0.0141436474286716,No,NA,NA,Q9W2N0,NA,NA,NA,actin cortical patch [GO:0030479]; apical plasma membrane [GO:0016324]; dynactin complex [GO:0005869]; F-actin capping protein complex [GO:0008290]; WASH complex [GO:0071203]; actin filament binding [GO:0051015]; protein heterodimerization activity [GO:0046982]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; barbed-end actin filament capping [GO:0051016]; cell morphogenesis [GO:0000902]; germarium-derived oocyte fate determination [GO:0007294]; microtubule-based movement [GO:0007018]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of JNK cascade [GO:0046329]; regulation of filopodium assembly [GO:0051489]; regulation of lamellipodium assembly [GO:0010591]; wing disc development [GO:0035220],NA,NA,NA
CHOYP_GCC2.1.1.m.17251,-0.0101520623007342,-0.00293958386027801,No,NA,NA,Q8CHG3,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; trans-Golgi network [GO:0005802]; identical protein binding [GO:0042802]; Golgi ribbon formation [GO:0090161]; late endosome to Golgi transport [GO:0034499]; microtubule anchoring [GO:0034453]; microtubule organizing center organization [GO:0031023]; protein localization to Golgi apparatus [GO:0034067]; protein targeting to lysosome [GO:0006622]; recycling endosome to Golgi transport [GO:0071955]; regulation of protein exit from endoplasmic reticulum [GO:0070861]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_GCKR.1.1.m.51743,-0.00440216102725798,-0.0198214013857596,No,NA,NA,Q91754,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; fructose-6-phosphate binding [GO:0070095]; carbohydrate derivative metabolic process [GO:1901135]; carbohydrate metabolic process [GO:0005975]; negative regulation of glucokinase activity [GO:0033132],NA,NA,NA
CHOYP_GCN1L.1.1.m.1352,0.0129444841067532,-0.0157269880255319,No,NA,NA,E9PVA8,NA,NA,NA,cytosol [GO:0005829]; polysome [GO:0005844]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; ribosome binding [GO:0043022]; cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_GCP2.1.1.m.23103,0.00394536801625317,0.00291369700370642,No,NA,NA,Q921G8,NA,NA,NA,centrosome [GO:0005813]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin small complex [GO:0008275]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; gamma-tubulin binding [GO:0043015]; structural constituent of cytoskeleton [GO:0005200]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation by interphase microtubule organizing center [GO:0051415]; mitotic cell cycle [GO:0000278]; spindle assembly [GO:0051225],NA,NA,NA
CHOYP_GCSP.1.1.m.46644,-0.0211838573515542,0.00438417044035998,No,NA,NA,P23378,NA,NA,NA,glycine cleavage complex [GO:0005960]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; electron transfer activity [GO:0009055]; enzyme binding [GO:0019899]; glycine binding [GO:0016594]; glycine dehydrogenase (decarboxylating) activity [GO:0004375]; lyase activity [GO:0016829]; protein homodimerization activity [GO:0042803]; pyridoxal binding [GO:0070280]; pyridoxal phosphate binding [GO:0030170]; cellular response to leukemia inhibitory factor [GO:1990830]; glycine catabolic process [GO:0006546]; glycine decarboxylation via glycine cleavage system [GO:0019464]; response to lipoic acid [GO:1903442]; response to methylamine [GO:0036255],NA,NA,NA
CHOYP_GCST.1.1.m.16047,-0.00582860017486144,0.0181474461537671,No,NA,NA,P48728,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; aminomethyltransferase activity [GO:0004047]; transaminase activity [GO:0008483]; glycine catabolic process [GO:0006546]; glycine decarboxylation via glycine cleavage system [GO:0019464],NA,NA,NA
CHOYP_GCY.2.4.m.33243,-1.43842968104699e-06,-0.0134885229890727,No,NA,NA,P18293,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; intracellular signal transduction [GO:0035556]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood vessel size [GO:0050880]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_GD1L1.1.1.m.11963,0.0080547026489315,-0.0044410343735176,No,NA,NA,A6QQZ0,NA,NA,NA,cytosol [GO:0005829]; integral component of mitochondrial outer membrane [GO:0031307]; mitochondrion [GO:0005739]; mitochondrial fission [GO:0000266]; mitochondrial fusion [GO:0008053]; mitochondrion organization [GO:0007005]; protein targeting to mitochondrion [GO:0006626]; response to retinoic acid [GO:0032526],NA,NA,NA
CHOYP_GDAP2.1.1.m.57049,-0.0156857628913613,0.00240007121809485,No,NA,NA,A7T167,NA,NA,NA,,NA,NA,NA
CHOYP_GDE.1.1.m.54948,0.00418331659570917,-0.00368175701421977,No,NA,NA,P35573,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; inclusion body [GO:0016234]; isoamylase complex [GO:0043033]; nucleus [GO:0005634]; sarcoplasmic reticulum [GO:0016529]; secretory granule lumen [GO:0034774]; 4-alpha-glucanotransferase activity [GO:0004134]; amylo-alpha-1;6-glucosidase activity [GO:0004135]; beta-maltose 4-alpha-glucanotransferase activity [GO:0102500]; glycogen debranching enzyme activity [GO:0004133]; polysaccharide binding [GO:0030247]; polyubiquitin modification-dependent protein binding [GO:0031593]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]; neutrophil degranulation [GO:0043312]; response to glucocorticoid [GO:0051384]; response to nutrient [GO:0007584],NA,NA,NA
CHOYP_GDS1B.1.1.m.52257,0.0133745844015913,-4.29078875788125e-05,No,NA,NA,Q5PPZ9,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; GTPase activator activity [GO:0005096]; Ral GTPase binding [GO:0017160]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264],NA,NA,NA
CHOYP_GEK.1.1.m.4939,0.0188033497802022,-0.0113729445972531,No,NA,NA,O54874,NA,NA,NA,actomyosin [GO:0042641]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton reorganization [GO:0031532]; actomyosin structure organization [GO:0031032]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of small GTPase mediated signal transduction [GO:0051056],NA,NA,NA
CHOYP_GELS2.2.2.m.30443,0.0145500117933949,0.0220929259039035,No,NA,NA,Q8MPM1,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin filament binding [GO:0051015]; actin filament capping [GO:0051693],NA,NA,NA
CHOYP_GEMIN5.2.2.m.59078,0.00585163581772612,-0.00753337978845737,No,NA,NA,Q8BX17,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; SMN complex [GO:0032797]; SMN-Gemin2 complex [GO:0034718]; SMN-Sm protein complex [GO:0034719]; mRNA 3'-UTR binding [GO:0003730]; ribosome binding [GO:0043022]; RNA 7-methylguanosine cap binding [GO:0000340]; snRNA binding [GO:0017069]; U1 snRNA binding [GO:0030619]; U4 snRNA binding [GO:0030621]; U4atac snRNA binding [GO:0030622]; regulation of translation [GO:0006417]; spliceosomal snRNP assembly [GO:0000387]; translation [GO:0006412],NA,NA,NA
CHOYP_GEPH.1.2.m.49093,-0.0153973344605212,-0.00552079517928317,No,NA,NA,Q9NQX3,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; postsynaptic specialization [GO:0099572]; postsynaptic specialization membrane [GO:0099634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; molybdopterin adenylyltransferase activity [GO:0061598]; molybdopterin cofactor binding [GO:0043546]; molybdopterin molybdotransferase activity [GO:0061599]; nitrate reductase activity [GO:0008940]; establishment of synaptic specificity at neuromuscular junction [GO:0007529]; gamma-aminobutyric acid receptor clustering [GO:0097112]; glycine receptor clustering [GO:0072579]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdenum incorporation into molybdenum-molybdopterin complex [GO:0018315]; molybdopterin cofactor biosynthetic process [GO:0032324]; postsynaptic neurotransmitter receptor diffusion trapping [GO:0098970]; response to metal ion [GO:0010038],NA,NA,NA
CHOYP_GFM2.1.1.m.18396,-0.0180984096825334,-0.0147458942956647,No,NA,NA,A6QNM2,NA,NA,NA,mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; mitochondrial translation [GO:0032543]; ribosome disassembly [GO:0032790],NA,NA,NA
CHOYP_GGPPS.1.1.m.12124,0.00967736513804254,0.0113185013701072,No,NA,NA,O95749,NA,NA,NA,cytosol [GO:0005829]; dimethylallyltranstransferase activity [GO:0004161]; farnesyltranstransferase activity [GO:0004311]; geranyltranstransferase activity [GO:0004337]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate biosynthetic process [GO:0045337]; geranyl diphosphate biosynthetic process [GO:0033384]; geranylgeranyl diphosphate biosynthetic process [GO:0033386]; isoprenoid metabolic process [GO:0006720]; regulation of cholesterol biosynthetic process [GO:0045540],NA,NA,NA
CHOYP_GIGA2.1.1.m.44916,0.0216402335045034,-0.0111531483504121,No,NA,NA,P86785,NA,NA,NA,,NA,NA,NA
CHOYP_GIGA3.1.1.m.42774,0.021383601485811,0.00382654861194097,No,NA,NA,P86786,NA,NA,NA,,NA,NA,NA
CHOYP_GIGA4.1.3.m.10521,0.0065883263884642,0.0180931628217626,No,NA,NA,P86787,NA,NA,NA,,NA,NA,NA
CHOYP_GIGA4.2.3.m.41265,0.00187817098494284,-0.0177316033999937,No,NA,NA,P86787,NA,NA,NA,,NA,NA,NA
CHOYP_GIGA5.3.4.m.17227,0.00678620130084428,0.00878741825264137,No,NA,NA,P86788,NA,NA,NA,,NA,NA,NA
CHOYP_GIGA5.4.4.m.39598,0.000686232728993108,-0.0107331332691118,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_GIGA6.1.1.m.38687,0.0209002119875702,-0.00992208703437002,No,NA,NA,P86789,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_GIMA4.4.7.m.42250,0.0129291984002246,-0.0127274477401825,No,NA,NA,Q8K3K9,NA,NA,NA,cytosol [GO:0005829]; GTP binding [GO:0005525],NA,NA,NA
CHOYP_GINS3.1.1.m.18574,-0.0154739837857545,-0.0154353936506662,No,NA,NA,Q9CY94,NA,NA,NA,nucleoplasm [GO:0005654]; DNA replication [GO:0006260],NA,NA,NA
CHOYP_GIPC1.1.1.m.60630,0.0078717620266368,-0.0200645993814986,No,NA,NA,Q9Z254,NA,NA,NA,brush border [GO:0005903]; cell cortex [GO:0005938]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endocytic vesicle [GO:0030139]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021]; vesicle membrane [GO:0012506]; actin binding [GO:0003779]; myosin binding [GO:0017022]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; cellular response to interleukin-7 [GO:0098761]; chemical synaptic transmission [GO:0007268]; endothelial cell migration [GO:0043542]; glutamate secretion [GO:0014047]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of cytokinesis [GO:0032467]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein targeting [GO:0006605]; regulation of protein stability [GO:0031647]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic vesicle exocytosis [GO:2000300],NA,NA,NA
CHOYP_GIT1.1.2.m.26059,0.0159354578491964,-0.000998573223870065,No,NA,NA,Q9Y2X7,NA,NA,NA,calyx of Held [GO:0044305]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; membrane [GO:0016020]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; ephrin receptor signaling pathway [GO:0048013]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of cytokinesis [GO:0032465]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of synaptic vesicle exocytosis [GO:2000300],NA,NA,NA
CHOYP_GKAP1.1.1.m.18792,0.00868487230094236,-0.0188986599400921,No,NA,NA,Q6NWC9,NA,NA,NA,Golgi apparatus [GO:0005794]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_GLB1L2.1.1.m.5029,0.0165297191075261,0.0140483590103941,No,NA,NA,Q3UPY5,NA,NA,NA,extracellular region [GO:0005576]; vacuole [GO:0005773]; beta-galactosidase activity [GO:0004565]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_GLCM.2.3.m.40511,-0.00654588834346377,0.016822803824157,No,NA,NA,P17439,NA,NA,NA,extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; glucosylceramidase activity [GO:0004348]; hydrolase activity [GO:0016787]; scavenger receptor binding [GO:0005124]; signaling receptor binding [GO:0005102]; autophagosome organization [GO:1905037]; beta-glucoside catabolic process [GO:1901805]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; glucosylceramide catabolic process [GO:0006680]; negative regulation of cellular protein metabolic process [GO:0032269]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron death [GO:1901215]; negative regulation of protein homooligomerization [GO:0032463]; positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization [GO:1904925]; positive regulation of neuronal action potential [GO:1904457]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein complex disassembly [GO:0043243]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein lipidation [GO:1903061]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; regulation of cellular protein metabolic process [GO:0032268]; regulation of protein metabolic process [GO:0051246]; regulation of water loss via skin [GO:0033561]; response to dexamethasone [GO:0071548]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to testosterone [GO:0033574]; response to thyroid hormone [GO:0097066]; skin morphogenesis [GO:0043589]; sphingosine biosynthetic process [GO:0046512]; termination of signal transduction [GO:0023021],NA,NA,NA
CHOYP_GLIPR1L1.1.1.m.41745,0.0228445285474946,-0.00140873071962492,No,NA,NA,Q7T141,NA,NA,NA,extracellular space [GO:0005615]; peptidase inhibitor activity [GO:0030414]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_GLMN.1.1.m.17085,-0.0141360978364489,0.000560857800721128,No,NA,NA,Q8BZM1,NA,NA,NA,Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul3-RING ubiquitin ligase complex [GO:0031463]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; hepatocyte growth factor receptor binding [GO:0005171]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase inhibitor activity [GO:0055105]; cell surface receptor signaling pathway [GO:0007166]; circulatory system development [GO:0072359]; muscle cell differentiation [GO:0042692]; negative regulation of cell proliferation [GO:0008285]; negative regulation of T cell proliferation [GO:0042130]; neural tube closure [GO:0001843]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of interleukin-2 biosynthetic process [GO:0045086]; positive regulation of phosphorylation [GO:0042327]; regulation of gene expression; epigenetic [GO:0040029]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; vasculogenesis [GO:0001570],NA,NA,NA
CHOYP_GLNA.1.5.m.1591,0.00217997094733793,-0.00807271368859912,No,NA,NA,P20478,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; glutamate catabolic process [GO:0006538]; glutamine biosynthetic process [GO:0006542]; neurotransmitter receptor metabolic process [GO:0045213]; synapse assembly [GO:0007416],NA,NA,NA
CHOYP_GLNA2.1.4.m.4133,0.0196686620960474,0.0067779378541158,No,NA,NA,P20478,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; glutamate catabolic process [GO:0006538]; glutamine biosynthetic process [GO:0006542]; neurotransmitter receptor metabolic process [GO:0045213]; synapse assembly [GO:0007416],NA,NA,NA
CHOYP_GLNA2.1.4.m.4134,0.0095805618097341,-0.00336283040675882,No,NA,NA,Q86UP9,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_GLO1.1.1.m.32382,-0.0104055445872633,-0.0167992353649623,No,NA,NA,Q6P7Q4,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; lactoylglutathione lyase activity [GO:0004462]; zinc ion binding [GO:0008270]; carbohydrate metabolic process [GO:0005975]; glutathione metabolic process [GO:0006749]; methylglyoxal metabolic process [GO:0009438]; negative regulation of apoptotic process [GO:0043066]; osteoclast differentiation [GO:0030316]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_GLOD5.1.1.m.25831,-0.0082851926894799,0.00636169825375415,No,NA,NA,Q502D1,NA,NA,NA,,NA,NA,NA
CHOYP_GLRX2.1.1.m.19246,-0.00911592823013912,0.00562883474564515,No,NA,NA,Q5RC53,NA,NA,NA,mitochondrion [GO:0005739]; 2 iron; 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454],NA,NA,NA
CHOYP_GLRX3.1.1.m.63529,0.000265712083235457,0.00624449685571538,No,NA,NA,Q28ID3,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; electron transfer activity [GO:0009055]; glutathione disulfide oxidoreductase activity [GO:0015038]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]; [2Fe-2S] cluster assembly [GO:0044571]; cell redox homeostasis [GO:0045454]; cellular iron ion homeostasis [GO:0006879]; protein maturation by iron-sulfur cluster transfer [GO:0097428],NA,NA,NA
CHOYP_GLT13.2.2.m.10604,-0.00266618782393688,-0.0047504381629545,No,NA,NA,O08912,NA,NA,NA,extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243],NA,NA,NA
CHOYP_GM2A.2.3.m.19346,0.00998087494391679,0.0135581466046311,No,NA,NA,Q60648,NA,NA,NA,apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; beta-N-acetylgalactosaminidase activity [GO:0032428]; beta-N-acetylhexosaminidase activity [GO:0004563]; enzyme activator activity [GO:0008047]; lipid transporter activity [GO:0005319]; phospholipase activator activity [GO:0016004]; ganglioside catabolic process [GO:0006689]; learning or memory [GO:0007611]; lipid storage [GO:0019915]; nervous system process [GO:0050877]; neuromuscular process controlling balance [GO:0050885]; oligosaccharide catabolic process [GO:0009313]; positive regulation of hydrolase activity [GO:0051345],NA,NA,NA
CHOYP_GMCLL.1.1.m.15031,0.00719740197822396,0.00020182434544551,No,NA,NA,Q96IK5,NA,NA,NA,nuclear matrix [GO:0016363]; identical protein binding [GO:0042802]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_GMDS.1.1.m.28602,-0.0087609001380887,-0.000710437330157512,No,NA,NA,Q8K0C9,NA,NA,NA,cytoplasm [GO:0005737]; GDP-mannose 4;6-dehydratase activity [GO:0008446]; identical protein binding [GO:0042802]; NADP+ binding [GO:0070401]; 'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; Notch signaling pathway [GO:0007219],NA,NA,NA
CHOYP_GMEB1.1.1.m.8284,-0.000753787827961793,-0.0231831273542297,No,NA,NA,O88873,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_GMFB.2.2.m.54955,0.00434472156646161,-0.02193632426359,No,NA,NA,Q5R6P6,NA,NA,NA,actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; growth factor activity [GO:0008083]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316],NA,NA,NA
CHOYP_GMPAA.1.1.m.1432,0.0177008896823804,-0.019149801317967,No,NA,NA,Q6GMK8,NA,NA,NA,GTP binding [GO:0005525]; mannose-1-phosphate guanylyltransferase activity [GO:0004475]; GDP-mannose biosynthetic process [GO:0009298],NA,NA,NA
CHOYP_GMPR2.1.1.m.63274,0.00490437750239415,-0.0115231347395955,No,NA,NA,Q9P2T1,NA,NA,NA,cytosol [GO:0005829]; GMP reductase complex [GO:1902560]; GMP reductase activity [GO:0003920]; metal ion binding [GO:0046872]; GMP metabolic process [GO:0046037]; purine nucleobase metabolic process [GO:0006144]; purine ribonucleotide interconversion [GO:0015951]; purine-containing compound salvage [GO:0043101],NA,NA,NA
CHOYP_GNA1.1.1.m.39198,-0.0122733131981489,0.00386461460697634,No,NA,NA,Q9VAI0,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; glucosamine 6-phosphate N-acetyltransferase activity [GO:0004343]; monosaccharide binding [GO:0048029]; N-acetylglucosamine biosynthetic process [GO:0006045]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048],NA,NA,NA
CHOYP_GNAI.1.1.m.26096,-0.00356354380377607,0.0137080011088001,No,NA,NA,P30682,NA,NA,NA,G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188],NA,NA,NA
CHOYP_GNAO.1.1.m.37355,-0.00269920844305145,0.0164072779851505,No,NA,NA,P30683,NA,NA,NA,G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188],NA,NA,NA
CHOYP_GNAQ.1.1.m.20698,-0.0116454472842679,-0.0127473869289542,No,NA,NA,O15975,NA,NA,NA,G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; G protein-coupled receptor signaling pathway [GO:0007186],NA,NA,NA
CHOYP_GNAS.3.3.m.55756,0.00142758695111039,-0.015363863217929,No,NA,NA,P30684,NA,NA,NA,G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; G protein-coupled receptor signaling pathway [GO:0007186],NA,NA,NA
CHOYP_GNBPB3.1.1.m.55379,0.0217471777596606,0.00398895580106534,No,NA,NA,Q8N0N3,NA,NA,NA,extracellular region [GO:0005576]; (1->3)-beta-D-glucan binding [GO:0001872]; hydrolase activity; hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087],NA,NA,NA
CHOYP_GNPI2.1.1.m.55897,-0.0181373333072587,-0.0158452760615681,No,NA,NA,A4IHW6,NA,NA,NA,cytoplasm [GO:0005737]; glucosamine-6-phosphate deaminase activity [GO:0004342]; identical protein binding [GO:0042802]; carbohydrate metabolic process [GO:0005975]; glucosamine catabolic process [GO:0006043]; N-acetylglucosamine catabolic process [GO:0006046]; N-acetylneuraminate catabolic process [GO:0019262]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048],NA,NA,NA
CHOYP_GOGB1.1.2.m.26408,-0.00617760814490294,0.00367003005592886,No,NA,NA,Q27421,NA,NA,NA,,NA,NA,NA
CHOYP_GOGB1.2.2.m.66418,0.00953185143543469,0.00784792488971226,No,NA,NA,Q27421,NA,NA,NA,,NA,NA,NA
CHOYP_GOLGA4.1.3.m.4761,-0.0133180518647923,-0.000960241805673422,No,NA,NA,Q91VW5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; GTPase binding [GO:0051020]; Golgi to plasma membrane protein transport [GO:0043001]; positive regulation of axon extension [GO:0045773],NA,NA,NA
CHOYP_GOLGA4.3.3.m.55461,0.00706384140381883,-0.020494463026329,No,NA,NA,Q13439,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network [GO:0005802]; GTPase binding [GO:0051020]; Golgi to plasma membrane protein transport [GO:0043001]; positive regulation of axon extension [GO:0045773]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_GOLI4.2.4.m.15493,0.0134636371938029,0.000570796986323146,No,NA,NA,O00461,NA,NA,NA,cis-Golgi network [GO:0005801]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; transport vesicle [GO:0030133],NA,NA,NA
CHOYP_GOLI4.3.4.m.29146,-0.00242743676817382,0.00302600363967124,No,NA,NA,O00461,NA,NA,NA,cis-Golgi network [GO:0005801]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; transport vesicle [GO:0030133],NA,NA,NA
CHOYP_GOLP3.1.1.m.52389,-0.00589541208046158,0.0107136421628548,No,NA,NA,Q9VQ93,NA,NA,NA,cleavage furrow [GO:0032154]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; Rab GTPase binding [GO:0017137]; actomyosin contractile ring assembly [GO:0000915]; cleavage furrow formation [GO:0036089]; Golgi organization [GO:0007030]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle budding [GO:0048194]; male meiosis cytokinesis [GO:0007112]; meiosis I cytokinesis [GO:0007110]; meiosis II cytokinesis [GO:0007111]; mitotic cytokinesis [GO:0000281]; mitotic spindle assembly [GO:0090307]; retrograde transport; vesicle recycling within Golgi [GO:0000301]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890]; spindle assembly [GO:0051225]; spindle assembly involved in male meiosis [GO:0007053],NA,NA,NA
CHOYP_GOPC.1.1.m.45489,0.00322414926034434,-0.00322449556843742,No,NA,NA,Q8BH60,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; trans-Golgi network transport vesicle [GO:0030140]; frizzled binding [GO:0005109]; GTPase regulator activity [GO:0030695]; ion channel binding [GO:0044325]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; syntaxin binding [GO:0019905]; autophagy [GO:0006914]; cytoplasmic sequestering of CFTR protein [GO:0043004]; negative regulation of anion channel activity [GO:0010360]; negative regulation of protein localization to cell surface [GO:2000009]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; spermatid nucleus differentiation [GO:0007289],NA,NA,NA
CHOYP_GPAT4.1.1.m.56178,-0.00773307145841777,0.0140448922875315,No,NA,NA,Q5R6J7,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]; acyl-CoA metabolic process [GO:0006637]; CDP-diacylglycerol biosynthetic process [GO:0016024]; diacylglycerol metabolic process [GO:0046339]; fatty acid metabolic process [GO:0006631]; glandular epithelial cell maturation [GO:0002071]; lactation [GO:0007595]; lipid biosynthetic process [GO:0008610]; phosphatidylcholine biosynthetic process [GO:0006656]; regulation of multicellular organism growth [GO:0040014]; triglyceride biosynthetic process [GO:0019432],NA,NA,NA
CHOYP_GPC6.1.1.m.64926,-0.00570554910586368,-0.0138929309917533,No,NA,NA,Q9R087,NA,NA,NA,anchored component of plasma membrane [GO:0046658]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; cell migration [GO:0016477]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of signal transduction [GO:0009966],NA,NA,NA
CHOYP_GPCP1.1.1.m.11490,-0.00892399993498119,0.000432683156753983,No,NA,NA,Q9NPB8,NA,NA,NA,cytosol [GO:0005829]; glycerophosphocholine phosphodiesterase activity [GO:0047389]; starch binding [GO:2001070]; glycerophospholipid catabolic process [GO:0046475]; skeletal muscle tissue development [GO:0007519],NA,NA,NA
CHOYP_GPDA.1.2.m.6967,-0.00684800522793425,0.00892427258429807,No,NA,NA,O35077,NA,NA,NA,cytosol [GO:0005829]; glycerol-3-phosphate dehydrogenase complex [GO:0009331]; glycerol-3-phosphate dehydrogenase (quinone) activity [GO:0004368]; glycerol-3-phosphate dehydrogenase [NAD(P)+] activity [GO:0047952]; glycerol-3-phosphate dehydrogenase [NAD+] activity [GO:0004367]; NAD binding [GO:0051287]; protein homodimerization activity [GO:0042803]; carbohydrate metabolic process [GO:0005975]; cellular response to cAMP [GO:0071320]; cellular response to tumor necrosis factor [GO:0071356]; gluconeogenesis [GO:0006094]; glycerol-3-phosphate catabolic process [GO:0046168]; glycerol-3-phosphate metabolic process [GO:0006072]; glycerolipid metabolic process [GO:0046486]; glycerophosphate shuttle [GO:0006127]; NADH metabolic process [GO:0006734]; NADH oxidation [GO:0006116]; positive regulation of glycolytic process [GO:0045821],NA,NA,NA
CHOYP_GPDA.2.2.m.30755,0.010320046044758,-0.0041160405245411,No,NA,NA,Q27928,NA,NA,NA,glycerol-3-phosphate dehydrogenase complex [GO:0009331]; glycerol-3-phosphate dehydrogenase [NAD+] activity [GO:0004367]; NAD binding [GO:0051287]; protein homodimerization activity [GO:0042803]; carbohydrate metabolic process [GO:0005975]; glycerol-3-phosphate catabolic process [GO:0046168]; glycerophospholipid metabolic process [GO:0006650],NA,NA,NA
CHOYP_GPM6A.1.1.m.41817,0.00433715905298464,0.0116578127595887,No,NA,NA,P35803,NA,NA,NA,integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; extracellular matrix assembly [GO:0085029]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of serotonin uptake [GO:0051612]; neuron projection development [GO:0031175]; ossification [GO:0001503]; positive regulation of bone mineralization [GO:0030501]; protein transport [GO:0015031]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of focal adhesion assembly [GO:0051893],NA,NA,NA
CHOYP_GPMA.1.1.m.35689,9.66778402658273e-06,0.0216653047606611,No,NA,NA,Q54NE6,NA,NA,NA,cytosol [GO:0005829]; phagocytic vesicle [GO:0045335]; bisphosphoglycerate mutase activity [GO:0004082]; hydrolase activity [GO:0016787]; phosphoglycerate mutase activity [GO:0004619]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096],NA,NA,NA
CHOYP_GPN3.1.2.m.6649,0.00343702932829545,-0.00668932433818744,No,NA,NA,O15145,NA,NA,NA,actin cytoskeleton [GO:0015629]; Arp2/3 protein complex [GO:0005885]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; growth cone leading edge [GO:0061850]; lamellipodium [GO:0030027]; membrane [GO:0016020]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; structural constituent of cytoskeleton [GO:0005200]; actin polymerization-dependent cell motility [GO:0070358]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; cellular response to nerve growth factor stimulus [GO:1990090]; ephrin receptor signaling pathway [GO:0048013]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; membrane organization [GO:0061024],NA,NA,NA
CHOYP_GPR98.4.5.m.21296,0.00794102604542552,0.00867359965191838,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_GPSM2.1.1.m.58301,-0.0206010090723666,-0.00883880906315262,No,NA,NA,P81274,NA,NA,NA,cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; mitotic spindle pole [GO:0097431]; protein-containing complex [GO:0032991]; dynein complex binding [GO:0070840]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein self-association [GO:0043621]; cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; G protein-coupled receptor signaling pathway [GO:0007186]; maintenance of centrosome location [GO:0051661]; mitotic spindle organization [GO:0007052]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of spindle assembly [GO:1905832]; Ran protein signal transduction [GO:0031291]; regulation of mitotic spindle organization [GO:0060236],NA,NA,NA
CHOYP_GPSM2.1.1.m.58302,0.00862770036929069,-0.0166822443513541,No,NA,NA,O42387,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_GPX1.1.4.m.11300,0.0163731686988292,-0.000830212051884936,No,NA,NA,Q8MJ14,NA,NA,NA,cytoplasm [GO:0005737]; glutathione peroxidase activity [GO:0004602]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_GPX3.1.2.m.24838,-0.00995377173369689,-0.0102831550864599,No,NA,NA,G9JJU2,NA,NA,NA,glutathione peroxidase activity [GO:0004602]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_GPX4.A.1.1.m.257,0.000286889000523173,0.00938882778036244,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_GR101.3.3.m.43507,-0.0135725579708752,0.00388604629968508,No,NA,NA,P46023,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930],NA,NA,NA
CHOYP_GRAP1.1.1.m.45768,0.00714746273442258,0.00424065663642269,No,NA,NA,Q8VD04,NA,NA,NA,axon [GO:0030424]; cell junction [GO:0030054]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of postsynaptic early endosome membrane [GO:0098998]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038]; neurotransmitter receptor transport; endosome to postsynaptic membrane [GO:0098887]; regulation of modification of synaptic structure [GO:1905244]; regulation of neurotransmitter receptor transport; endosome to postsynaptic membrane [GO:0099152]; regulation of recycling endosome localization within postsynapse [GO:0099158],NA,NA,NA
CHOYP_GRDN.1.5.m.12675,-0.0135725579708753,0.00388604629968508,No,NA,NA,Q3V6T2,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; membrane [GO:0016020]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; dynein light intermediate chain binding [GO:0051959]; microtubule binding [GO:0008017]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]; protein kinase B binding [GO:0043422]; activation of protein kinase B activity [GO:0032148]; cell migration [GO:0016477]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; DNA replication [GO:0006260]; lamellipodium assembly [GO:0030032]; membrane organization [GO:0061024]; positive regulation of cilium assembly [GO:0045724]; positive regulation of protein localization to cilium [GO:1903566]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell proliferation [GO:0042127]; regulation of DNA replication [GO:0006275]; regulation of neuron projection development [GO:0010975]; regulation of protein phosphorylation [GO:0001932]; TOR signaling [GO:0031929],NA,NA,NA
CHOYP_GRIA3.1.1.m.44173,0.00200006949103911,-0.0163915052785668,No,NA,NA,Q91756,NA,NA,NA,cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; ionotropic glutamate receptor activity [GO:0004970],NA,NA,NA
CHOYP_GRK5.1.1.m.6617,0.00278722721746214,-0.00289734337913467,No,NA,NA,P43249,NA,NA,NA,cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor kinase activity [GO:0004703]; lipid binding [GO:0008289]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; fat cell differentiation [GO:0045444]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell proliferation [GO:0008284]; protein autophosphorylation [GO:0046777]; regulation of cell cycle [GO:0051726]; tachykinin receptor signaling pathway [GO:0007217]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_GRM1.2.2.m.65835,0.0189419171544347,-0.013492165269483,No,NA,NA,Q14416,NA,NA,NA,axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; calcium channel regulator activity [GO:0005246]; G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; G protein-coupled receptor signaling pathway [GO:0007186]; glutamate homeostasis [GO:0090461]; glutamate secretion [GO:0014047]; negative regulation of adenylate cyclase activity [GO:0007194]; regulation of synaptic transmission; glutamatergic [GO:0051966],NA,NA,NA
CHOYP_GRP75.1.1.m.11678,0.0103147358688868,-0.0191693124691457,No,NA,NA,Q3ZCH0,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity; coupled [GO:0042623]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein binding involved in protein folding [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; erythrocyte differentiation [GO:0030218]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; negative regulation of hemopoiesis [GO:1903707]; protein export from nucleus [GO:0006611]; protein refolding [GO:0042026]; regulation of erythrocyte differentiation [GO:0045646]; response to unfolded protein [GO:0006986],NA,NA,NA
CHOYP_GRP78.2.5.m.33058,0.0118759238886022,-0.00629193518881018,No,NA,NA,Q16956,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787],NA,NA,NA
CHOYP_GSH1.1.1.m.8927,-0.00391267819693077,0.00652868480625014,No,NA,NA,P19468,NA,NA,NA,cytosol [GO:0005829]; glutamate-cysteine ligase complex [GO:0017109]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; coenzyme binding [GO:0050662]; glutamate binding [GO:0016595]; glutamate-cysteine ligase activity [GO:0004357]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]; aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410],NA,NA,NA
CHOYP_GSHB.1.1.m.27512,0.00464600809573028,-0.0104371826507782,No,NA,NA,Q5EAC2,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; glutathione binding [GO:0043295]; glutathione synthase activity [GO:0004363]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803],NA,NA,NA
CHOYP_GSK3B.1.1.m.62139,-0.01010947416733,-0.0205217824369704,No,NA,NA,Q9WV60,NA,NA,NA,axon [GO:0030424]; beta-catenin destruction complex [GO:0030877]; cell body [GO:0044297]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; membrane [GO:0016020]; membrane raft [GO:0045121]; membrane-bounded organelle [GO:0043227]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; Schaffer collateral - CA1 synapse [GO:0098685]; Wnt signalosome [GO:1990909]; ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; dynactin binding [GO:0034452]; dynein complex binding [GO:0070840]; integrin binding [GO:0005178]; ionotropic glutamate receptor binding [GO:0035255]; kinase activity [GO:0016301]; NF-kappaB binding [GO:0051059]; p53 binding [GO:0002039]; protease binding [GO:0002020]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II transcription factor binding [GO:0001085]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; animal organ morphogenesis [GO:0009887]; axonogenesis [GO:0007409]; bone remodeling [GO:0046849]; canonical Wnt signaling pathway [GO:0060070]; cell growth involved in cardiac muscle cell development [GO:0061049]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to amyloid-beta [GO:1904646]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to interleukin-3 [GO:0036016]; cellular response to mechanical stimulus [GO:0071260]; circadian rhythm [GO:0007623]; cytoskeleton organization [GO:0007010]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; establishment or maintenance of cell polarity [GO:0007163]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fat cell differentiation [GO:0045444]; glycogen metabolic process [GO:0005977]; hepatic stellate cell activation [GO:0035733]; hepatocyte apoptotic process [GO:0097284]; hippocampus development [GO:0021766]; hypermethylation of CpG island [GO:0044027]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; maintenance of cell polarity [GO:0030011]; myoblast fusion [GO:0007520]; myotube differentiation [GO:0014902]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of dendrite development [GO:2000171]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron death [GO:1901215]; negative regulation of neuron maturation [GO:0014043]; negative regulation of neuron migration [GO:2001223]; negative regulation of neuron projection development [GO:0010977]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein binding [GO:0032091]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of protein localization to centrosome [GO:1904780]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; negative regulation of TOR signaling [GO:0032007]; neuron projection development [GO:0031175]; neuron projection retraction [GO:0106028]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of axon extension [GO:0045773]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of mitochondrion organization [GO:0010822]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron death [GO:1901216]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of osteoclast proliferation [GO:0090290]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; protein export from nucleus [GO:0006611]; protein localization to microtubule [GO:0035372]; protein phosphorylation [GO:0006468]; re-entry into mitotic cell cycle [GO:0000320]; regulation of apoptotic process [GO:0042981]; regulation of axon extension [GO:0030516]; regulation of axonogenesis [GO:0050770]; regulation of dendrite morphogenesis [GO:0048814]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule-based process [GO:0032886]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of neuron projection development [GO:0010975]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of osteoblast differentiation [GO:0045667]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to zinc ion [GO:0010043]; superior temporal gyrus development [GO:0071109]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_GSLG1.3.3.m.66468,-0.00222703798108804,-0.00211645792725899,No,NA,NA,Q61543,NA,NA,NA,extracellular matrix [GO:0031012]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; fibroblast growth factor binding [GO:0017134]; bone morphogenesis [GO:0060349]; negative regulation of protein processing [GO:0010955]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; regulation of chondrocyte differentiation [GO:0032330],NA,NA,NA
CHOYP_GSPATT00009499001.1.1.m.34366,0.000763595430161521,-0.00490570038309887,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_GSPATT00037947001.1.1.m.24620,-0.00662450116711883,0.0134592092007217,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_GST7.1.1.m.59335,-0.0204630082392854,-0.0111503313697923,No,NA,NA,P46088,NA,NA,NA,cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364],NA,NA,NA
CHOYP_GSTO1.1.2.m.14745,-0.00072708455417472,-0.000907444646776801,No,NA,NA,P78417,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; methylarsonate reductase activity [GO:0050610]; oxidoreductase activity [GO:0016491]; cellular response to arsenic-containing substance [GO:0071243]; glutathione derivative biosynthetic process [GO:1901687]; interleukin-12-mediated signaling pathway [GO:0035722]; L-ascorbic acid metabolic process [GO:0019852]; methylation [GO:0032259]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; oxidation-reduction process [GO:0055114]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014810]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; xenobiotic catabolic process [GO:0042178],NA,NA,NA
CHOYP_GSTO1.2.2.m.26202,0.00117099284273321,-0.00551565126137973,No,NA,NA,Q9VSL3,NA,NA,NA,cytoplasm [GO:0005737]; glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; protein homodimerization activity [GO:0042803]; pyrimidodiazepine synthase activity [GO:0004734]; transferase activity; transferring sulfur-containing groups [GO:0016782]; eye pigment biosynthetic process [GO:0006726]; glutathione metabolic process [GO:0006749]; oxidation-reduction process [GO:0055114]; pteridine biosynthetic process [GO:0006728],NA,NA,NA
CHOYP_GSTO2.1.1.m.36486,0.00118118722497506,0.0187223522313635,No,NA,NA,P78417,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; methylarsonate reductase activity [GO:0050610]; oxidoreductase activity [GO:0016491]; cellular response to arsenic-containing substance [GO:0071243]; glutathione derivative biosynthetic process [GO:1901687]; interleukin-12-mediated signaling pathway [GO:0035722]; L-ascorbic acid metabolic process [GO:0019852]; methylation [GO:0032259]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; oxidation-reduction process [GO:0055114]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014810]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; xenobiotic catabolic process [GO:0042178],NA,NA,NA
CHOYP_GSTP1.1.2.m.29677,-0.00102370503087624,0.00124815407997091,No,NA,NA,P19157,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; TRAF2-GSTP1 complex [GO:0097057]; dinitrosyl-iron complex binding [GO:0035731]; drug binding [GO:0008144]; glutathione binding [GO:0043295]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; JUN kinase binding [GO:0008432]; kinase regulator activity [GO:0019207]; protein kinase binding [GO:0019901]; S-nitrosoglutathione binding [GO:0035730]; animal organ regeneration [GO:0031100]; cellular response to cell-matrix adhesion [GO:0071460]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to insulin stimulus [GO:0032869]; cellular response to lipopolysaccharide [GO:0071222]; common myeloid progenitor cell proliferation [GO:0035726]; glutathione metabolic process [GO:0006749]; negative regulation of acute inflammatory response [GO:0002674]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of leukocyte proliferation [GO:0070664]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of neutrophil aggregation [GO:2000429]; negative regulation of nitric-oxide synthase biosynthetic process [GO:0051771]; negative regulation of peroxidase activity [GO:2000469]; negative regulation of stress-activated MAPK cascade [GO:0032873]; negative regulation of tumor necrosis factor production [GO:0032720]; oligodendrocyte development [GO:0014003]; positive regulation of superoxide anion generation [GO:0032930]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of stress-activated MAPK cascade [GO:0032872]; response to amino acid [GO:0043200]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to L-ascorbic acid [GO:0033591]; response to nutrient levels [GO:0031667]; response to reactive oxygen species [GO:0000302]; response to toxic substance [GO:0009636]; xenobiotic metabolic process [GO:0006805],NA,NA,NA
CHOYP_GSTP1.2.2.m.30099,-0.00393726462696969,-0.0166053856190258,No,NA,NA,P81942,NA,NA,NA,mitochondrion [GO:0005739]; nucleus [GO:0005634]; glutathione transferase activity [GO:0004364],NA,NA,NA
CHOYP_GSTS8.1.1.m.12434,-0.00242968969138367,-0.0065390097118985,No,NA,NA,O73888,NA,NA,NA,cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; glutathione transferase activity [GO:0004364]; magnesium ion binding [GO:0000287]; prostaglandin-D synthase activity [GO:0004667]; protein homodimerization activity [GO:0042803]; negative regulation of male germ cell proliferation [GO:2000255]; prostaglandin biosynthetic process [GO:0001516]; prostaglandin metabolic process [GO:0006693],NA,NA,NA
CHOYP_GSTUL.1.1.m.35986,-0.00248429325371819,-0.00843459763583096,No,NA,NA,Q9ZRW8,NA,NA,NA,chloroplast [GO:0009507]; chloroplast stroma [GO:0009570]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; peroxidase activity [GO:0004601]; cellular response to water deprivation [GO:0042631]; glutathione metabolic process [GO:0006749]; response to cadmium ion [GO:0046686]; response to oxidative stress [GO:0006979]; toxin catabolic process [GO:0009407],NA,NA,NA
CHOYP_GSTZ1.1.1.m.56540,0.00749059050404968,-0.0104860450697327,No,NA,NA,Q9VHD2,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; glutathione transferase activity [GO:0004364]; maleylacetoacetate isomerase activity [GO:0016034]; glutathione metabolic process [GO:0006749]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572],NA,NA,NA
CHOYP_GTPB1.1.1.m.66453,-0.011584725902288,-0.0167256424093378,No,NA,NA,O08582,NA,NA,NA,cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; GTP metabolic process [GO:0046039]; positive regulation of mRNA catabolic process [GO:0061014]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_GTR1.1.1.m.25509,0.00656668437814228,0.00160456837427986,No,NA,NA,P27674,NA,NA,NA,apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; female pronucleus [GO:0001939]; integral component of plasma membrane [GO:0005887]; melanosome [GO:0042470]; membrane raft [GO:0045121]; midbody [GO:0030496]; D-glucose transmembrane transporter activity [GO:0055056]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; glucose transmembrane transporter activity [GO:0005355]; identical protein binding [GO:0042802]; protein self-association [GO:0043621]; cellular response to glucose starvation [GO:0042149]; glucose import [GO:0046323]; glucose transmembrane transport [GO:1904659]; protein-containing complex assembly [GO:0065003],NA,NA,NA
CHOYP_GUAA.1.1.m.18809,0.000681323252864919,0.00136375753196262,No,NA,NA,Q5RA96,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; GMP synthase (glutamine-hydrolyzing) activity [GO:0003922]; pyrophosphatase activity [GO:0016462]; glutamine metabolic process [GO:0006541]; GMP biosynthetic process [GO:0006177],NA,NA,NA
CHOYP_GUAD.1.1.m.33511,-0.00725531033982942,0.0178006982200181,No,NA,NA,Q5RAV9,NA,NA,NA,guanine deaminase activity [GO:0008892]; zinc ion binding [GO:0008270]; guanine catabolic process [GO:0006147],NA,NA,NA
CHOYP_GUK1.1.1.m.48140,0.00309159568686837,-0.00317131687665153,No,NA,NA,P15454,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385]; GDP biosynthetic process [GO:0046711]; purine nucleotide metabolic process [GO:0006163],NA,NA,NA
CHOYP_GULP1.1.1.m.44407,-0.00987160378643236,-0.00619065952114327,No,NA,NA,Q32PV0,NA,NA,NA,cytoplasm [GO:0005737]; apoptotic process [GO:0006915]; phagocytosis [GO:0006909],NA,NA,NA
CHOYP_GUN.1.2.m.26883,-0.0133532834827969,-0.000907601166824257,No,NA,NA,P82186,NA,NA,NA,cellulase activity [GO:0008810]; cellulose catabolic process [GO:0030245],NA,NA,NA
CHOYP_GUN.2.2.m.46462,0.0235824279654715,-0.000107767801075474,No,NA,NA,P82186,NA,NA,NA,cellulase activity [GO:0008810]; cellulose catabolic process [GO:0030245],NA,NA,NA
CHOYP_GZF1.1.2.m.7747,0.0124052044896731,-0.000322419827941777,No,NA,NA,P18737,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_H2AV.1.7.m.12182,-0.0126703709961326,0.000404564700547403,No,NA,NA,Q5BJ65,NA,NA,NA,nuclear chromatin [GO:0000790]; nucleosome [GO:0000786]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; chromatin organization [GO:0006325],NA,NA,NA
CHOYP_H2BL3.1.1.m.16594,0.00752714046924886,0.000151847803707765,No,NA,NA,P0C1H5,NA,NA,NA,nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; nucleosome assembly [GO:0006334],NA,NA,NA
CHOYP_H3.1.2.m.3829,-0.0148558317689653,-0.00797044666181778,No,NA,NA,P84239,NA,NA,NA,nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982],NA,NA,NA
CHOYP_HAAF.11.13.m.44366,0.00491588973115351,-0.000600714720400964,No,NA,NA,Q01528,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_HAAF.3.13.m.8849,-0.0115661531056465,-0.0037435432362971,No,NA,NA,Q01528,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_HACE1.1.2.m.24806,-0.00842390027116367,-0.0124288122653618,No,NA,NA,Q28BK1,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; Rab GTPase binding [GO:0017137]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle [GO:0007049]; Golgi organization [GO:0007030]; membrane fusion [GO:0061025]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of cell migration [GO:0030334]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_HACL1.1.1.m.6578,0.0178775365958633,-0.013900271418771,No,NA,NA,Q9UJ83,NA,NA,NA,cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; carbon-carbon lyase activity [GO:0016830]; cofactor binding [GO:0048037]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; signaling receptor binding [GO:0005102]; thiamine pyrophosphate binding [GO:0030976]; fatty acid alpha-oxidation [GO:0001561]; protein complex oligomerization [GO:0051259]; protein targeting to peroxisome [GO:0006625],NA,NA,NA
CHOYP_HAND1.1.1.m.10874,0.00364778592941831,-0.00872052841558096,No,NA,NA,P57102,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; cardiac muscle cell differentiation [GO:0055007]; cardioblast differentiation [GO:0010002]; cardiocyte differentiation [GO:0035051]; cardiogenic plate morphogenesis [GO:0003142]; determination of intestine left/right asymmetry [GO:0071908]; embryonic heart tube formation [GO:0003144]; embryonic pectoral fin morphogenesis [GO:0035118]; embryonic viscerocranium morphogenesis [GO:0048703]; heart contraction [GO:0060047]; heart looping [GO:0001947]; heart morphogenesis [GO:0003007]; noradrenergic neuron differentiation [GO:0003357]; polarized epithelial cell differentiation [GO:0030859]; proepicardium development [GO:0003342]; sympathetic nervous system development [GO:0048485]; thyroid gland development [GO:0030878],NA,NA,NA
CHOYP_HBS1L.1.2.m.14311,-0.0127169246089191,-0.0202721813984361,No,NA,NA,Q9Y450,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; signal transduction [GO:0007165]; translation [GO:0006412],NA,NA,NA
CHOYP_HBX5.1.1.m.11081,0.00394536801625317,0.00291369700370642,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_HD.1.1.m.56119,0.00420500406681684,-0.0109265038094619,No,NA,NA,P42859,NA,NA,NA,autophagosome [GO:0005776]; axon [GO:0030424]; centriole [GO:0005814]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; inclusion body [GO:0016234]; late endosome [GO:0005770]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; neuronal ribonucleoprotein granule [GO:0071598]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic cytosol [GO:0099524]; postsynaptic density [GO:0014069]; presynaptic cytosol [GO:0099523]; protein-containing complex [GO:0032991]; synaptic membrane [GO:0097060]; beta-tubulin binding [GO:0048487]; diazepam binding [GO:0050809]; dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; p53 binding [GO:0002039]; profilin binding [GO:0005522]; signaling receptor binding [GO:0005102]; transcription factor binding [GO:0008134]; anatomical structure morphogenesis [GO:0009653]; anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; associative learning [GO:0008306]; axo-dendritic transport [GO:0008088]; brain development [GO:0007420]; cell aging [GO:0007569]; central nervous system development [GO:0007417]; citrulline metabolic process [GO:0000052]; determination of adult lifespan [GO:0008340]; dopamine receptor signaling pathway [GO:0007212]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; establishment of mitotic spindle orientation [GO:0000132]; gastrulation [GO:0007369]; Golgi organization [GO:0007030]; grooming behavior [GO:0007625]; hormone metabolic process [GO:0042445]; insulin secretion [GO:0030073]; iron ion homeostasis [GO:0055072]; L-glutamate import [GO:0051938]; lactate biosynthetic process from pyruvate [GO:0019244]; learning [GO:0007612]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; mitochondrial transport [GO:0006839]; mitochondrion organization [GO:0007005]; mRNA transport [GO:0051028]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity [GO:2000117]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; neural plate formation [GO:0021990]; neurogenesis [GO:0022008]; neuron apoptotic process [GO:0051402]; neuron development [GO:0048666]; olfactory lobe development [GO:0021988]; paraxial mesoderm formation [GO:0048341]; peptide hormone secretion [GO:0030072]; positive regulation of aggrephagy [GO:1905337]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of cilium assembly [GO:0045724]; positive regulation of inositol 1;4;5-trisphosphate-sensitive calcium-release channel activity [GO:0031587]; positive regulation of lipophagy [GO:1904504]; positive regulation of motile cilium assembly [GO:1905505]; positive regulation of non-motile cilium assembly [GO:1902857]; postsynapse to nucleus signaling pathway [GO:0099527]; protein destabilization [GO:0031648]; protein localization to centrosome [GO:0071539]; protein localization to nucleus [GO:0034504]; quinolinate biosynthetic process [GO:0019805]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of gene expression [GO:0010468]; regulation of intracellular mRNA localization [GO:1904580]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of neuron apoptotic process [GO:0043523]; regulation of phosphoprotein phosphatase activity [GO:0043666]; regulation of protein localization to nucleus [GO:1900180]; regulation of synaptic plasticity [GO:0048167]; response to calcium ion [GO:0051592]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890]; social behavior [GO:0035176]; spermatogenesis [GO:0007283]; striatum development [GO:0021756]; urea cycle [GO:0000050]; vesicle transport along microtubule [GO:0047496]; visual learning [GO:0008542]; vocal learning [GO:0042297],NA,NA,NA
CHOYP_HEAT1.1.1.m.11228,0.0118672132491844,-0.0131450651096578,No,NA,NA,Q7SY48,NA,NA,NA,90S preribosome [GO:0030686]; small-subunit processome [GO:0032040]; t-UTP complex [GO:0034455]; snoRNA binding [GO:0030515]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; regulation of RNA stability [GO:0043487],NA,NA,NA
CHOYP_HEATR3.1.1.m.33423,-0.00456045526786281,0.00544057590701637,No,NA,NA,Q7Z4Q2,NA,NA,NA,cell [GO:0005623]; unfolded protein binding [GO:0051082]; protein import into nucleus [GO:0006606]; ribosomal large subunit biogenesis [GO:0042273],NA,NA,NA
CHOYP_HECD1.1.1.m.27759,-0.00139923833408682,0.00603619192576743,No,NA,NA,Q9ULT8,NA,NA,NA,metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; protein K63-linked ubiquitination [GO:0070534],NA,NA,NA
CHOYP_HELZ.2.2.m.43303,-0.00281816837137008,-0.0151302527547342,No,NA,NA,Q6NYU2,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; P granule [GO:0043186]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; posttranscriptional gene silencing by RNA [GO:0035194],NA,NA,NA
CHOYP_HEM2.1.1.m.6789,-0.00154298950217786,0.00558476176163273,No,NA,NA,Q58DK5,NA,NA,NA,cytosol [GO:0005829]; identical protein binding [GO:0042802]; porphobilinogen synthase activity [GO:0004655]; zinc ion binding [GO:0008270]; cellular response to interleukin-4 [GO:0071353]; heme biosynthetic process [GO:0006783]; negative regulation of proteasomal protein catabolic process [GO:1901799]; protein homooligomerization [GO:0051260]; protoporphyrinogen IX biosynthetic process [GO:0006782],NA,NA,NA
CHOYP_HEM3.1.1.m.28414,-0.00673544371978925,0.00567471984636119,No,NA,NA,Q2KIN5,NA,NA,NA,cytoplasm [GO:0005737]; hydroxymethylbilane synthase activity [GO:0004418]; heme biosynthetic process [GO:0006783]; peptidyl-pyrromethane cofactor linkage [GO:0018160]; protoporphyrinogen IX biosynthetic process [GO:0006782],NA,NA,NA
CHOYP_HEM6.1.1.m.17205,0.00420584834860548,-0.0109613379299852,No,NA,NA,Q9V3D2,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; coproporphyrinogen oxidase activity [GO:0004109]; protein homodimerization activity [GO:0042803]; heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process from glutamate [GO:0019353],NA,NA,NA
CHOYP_HERC1.2.2.m.51367,0.00205195042830452,-0.00934116934689426,No,NA,NA,Q15751,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; ubiquitin-protein transferase activity [GO:0004842]; cerebellar Purkinje cell differentiation [GO:0021702]; negative regulation of autophagy [GO:0010507]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175],NA,NA,NA
CHOYP_HERC2.1.1.m.65153,0.0110407168609946,-0.0057499317031128,No,NA,NA,O95714,NA,NA,NA,centriole [GO:0005814]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via nonhomologous end joining [GO:0006303]; intracellular protein transport [GO:0006886]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_HES1.2.3.m.27001,0.00491588973115351,-0.000600714720400964,No,NA,NA,Q90Z12,NA,NA,NA,nucleus [GO:0005634]; bHLH transcription factor binding [GO:0043425]; protein dimerization activity [GO:0046983]; sequence-specific DNA binding [GO:0043565]; BMP signaling pathway [GO:0030509]; cell proliferation [GO:0008283]; floor plate development [GO:0033504]; lens development in camera-type eye [GO:0002088]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; neural crest formation [GO:0014029]; prechordal plate formation [GO:0021501],NA,NA,NA
CHOYP_HEX.1.1.m.43068,0.0221038517943185,-0.00623657740039082,No,NA,NA,H2A0L6,NA,NA,NA,extracellular region [GO:0005576]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; polysaccharide binding [GO:0030247]; carbohydrate metabolic process [GO:0005975]; chitin catabolic process [GO:0006032],NA,NA,NA
CHOYP_HGFAC.1.1.m.5902,0.00205195042830452,-0.00934116934689426,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_HHEX.2.2.m.19527,-0.0131444295408724,-0.0018616311455665,No,NA,NA,O88271,NA,NA,NA,basement membrane [GO:0005604]; condensed chromosome kinetochore [GO:0000777]; cell adhesion [GO:0007155]; multicellular organism development [GO:0007275]; negative regulation of fibroblast apoptotic process [GO:2000270]; regulation of cell proliferation [GO:0042127]; regulation of cell shape [GO:0008360],NA,NA,NA
CHOYP_HIF1N.1.1.m.53726,0.00500644992520633,0.0168282446219846,No,NA,NA,Q9NWT6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; ankyrin repeat binding [GO:0071532]; carboxylic acid binding [GO:0031406]; cofactor binding [GO:0048037]; hypoxia-inducible factor-asparagine oxygenase activity [GO:0102113]; iron ion binding [GO:0005506]; NF-kappaB binding [GO:0051059]; Notch binding [GO:0005112]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; 2-oxoglutarate as one donor; and incorporation of one atom each of oxygen into both donors [GO:0016706]; oxygen sensor activity [GO:0019826]; peptidyl-asparagine 3-dioxygenase activity [GO:0036140]; peptidyl-histidine dioxygenase activity [GO:0036139]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; oxidation-reduction process [GO:0055114]; peptidyl-asparagine hydroxylation [GO:0042265]; peptidyl-aspartic acid hydroxylation [GO:0042264]; peptidyl-histidine hydroxylation [GO:0036138]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of vasculogenesis [GO:2001214]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418],NA,NA,NA
CHOYP_HINT1.1.1.m.53526,-0.00315851768850482,0.00547333942130724,No,NA,NA,P80912,NA,NA,NA,cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; purine ribonucleotide catabolic process [GO:0009154]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_HIP1.1.1.m.31791,0.000692860044769766,0.0136526529538917,No,NA,NA,O00291,NA,NA,NA,actin cortical patch [GO:0030479]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of postsynaptic membrane [GO:0098890]; extrinsic component of presynaptic membrane [GO:0098888]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; postsynapse [GO:0098794]; presynapse [GO:0098793]; actin filament binding [GO:0051015]; AP-2 adaptor complex binding [GO:0035612]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; clathrin light chain binding [GO:0032051]; epidermal growth factor receptor binding [GO:0005154]; glutamate receptor binding [GO:0035254]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3;4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3;5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; structural constituent of cytoskeleton [GO:0005200]; actin filament organization [GO:0007015]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cell differentiation [GO:0030154]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; membrane organization [GO:0061024]; neurotransmitter receptor transport [GO:0099637]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000588]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of endocytosis [GO:0030100],NA,NA,NA
CHOYP_HIRA.1.1.m.19212,-0.00224305391512563,0.0183254605477899,No,NA,NA,O42611,NA,NA,NA,nucleus [GO:0005634]; chromatin organization [GO:0006325]; regulation of transcription; DNA-templated [GO:0006355]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_HMBS.1.1.m.31422,-0.0127494179259638,0.0110046135794062,No,NA,NA,Q2KIN5,NA,NA,NA,cytoplasm [GO:0005737]; hydroxymethylbilane synthase activity [GO:0004418]; heme biosynthetic process [GO:0006783]; peptidyl-pyrromethane cofactor linkage [GO:0018160]; protoporphyrinogen IX biosynthetic process [GO:0006782],NA,NA,NA
CHOYP_HMCN1.19.44.m.39500,0.0117376959373394,-0.025048626491619,No,NA,NA,Q96RW7,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],NA,NA,NA
CHOYP_HMCN1.23.44.m.42684,0.0220568305356187,-0.0121728534206147,No,NA,NA,D3YXG0,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_HMCN1.28.44.m.47379,0.0207516479521752,0.00885932306451392,No,NA,NA,D3YXG0,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_HMCN1.32.44.m.58935,0.00806916441079791,0.0045811249877723,No,NA,NA,Q96RW7,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],NA,NA,NA
CHOYP_HMCN1.33.44.m.58938,0.0137964270043612,0.0102214070639665,No,NA,NA,P98160,NA,NA,NA,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; integrin binding [GO:0005178]; low-density lipoprotein particle receptor binding [GO:0050750]; protein C-terminus binding [GO:0008022]; angiogenesis [GO:0001525]; brain development [GO:0007420]; cardiovascular system development [GO:0072358]; cell differentiation [GO:0030154]; cellular protein metabolic process [GO:0044267]; extracellular matrix organization [GO:0030198]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan catabolic process [GO:0006027]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell death [GO:0060548]; receptor-mediated endocytosis [GO:0006898]; retinoid metabolic process [GO:0001523],NA,NA,NA
CHOYP_HMCN1.39.44.m.61047,-0.0135725579708753,0.00388604629968508,No,NA,NA,Q8WZ42,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_HMCN1.5.44.m.7236,-0.0105197692830507,0.0176211022534297,No,NA,NA,Q8WZ42,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_HMCN2.10.12.m.49343,-0.022659411543928,0.010231495327724,No,NA,NA,Q24372,NA,NA,NA,anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; protein homodimerization activity [GO:0042803]; cell adhesion involved in heart morphogenesis [GO:0061343]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity; open tracheal system [GO:0035160]; morphogenesis of embryonic epithelium [GO:0016331]; open tracheal system development [GO:0007424]; regulation of tube size; open tracheal system [GO:0035151]; septate junction assembly [GO:0019991],NA,NA,NA
CHOYP_HMCN2.11.12.m.51619,0.00615966897194063,0.00941964587728867,No,NA,NA,Q9W6R5,NA,NA,NA,extracellular region [GO:0005576]; plasma membrane [GO:0005886]; lipid binding [GO:0008289]; cell adhesion [GO:0007155]; response to stimulus [GO:0050896]; visual perception [GO:0007601],NA,NA,NA
CHOYP_HMCN2.3.12.m.26811,0.0145339186323414,-0.00780271179003075,No,NA,NA,Q5UNS9,NA,NA,NA,virion [GO:0019012],NA,NA,NA
CHOYP_HMCN2.6.12.m.33452,-0.0033745206100812,-0.0129811605967569,No,NA,NA,Q96RW7,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],NA,NA,NA
CHOYP_HMCN2.8.12.m.39297,0.00176902231169472,-0.00976232364601077,No,NA,NA,A2AJ76,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; response to stimulus [GO:0050896],NA,NA,NA
CHOYP_HMCN2.9.12.m.44986,0.0199364497935127,-0.016258034327768,No,NA,NA,Q8WZ42,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_HN1L.2.2.m.9837,-0.0097338661544051,0.0137236247491223,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_HNRPR.1.2.m.44125,0.0174416975764026,0.0155704017894291,No,NA,NA,O43390,NA,NA,NA,axon terminus [GO:0043679]; catalytic step 2 spliceosome [GO:0071013]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; circadian rhythm [GO:0007623]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; mRNA splicing; via spliceosome [GO:0000398]; negative regulation of catalytic activity [GO:0043086]; RNA metabolic process [GO:0016070],NA,NA,NA
CHOYP_HNRPR.1.2.m.44126,0.00678620130084428,0.00878741825264137,No,NA,NA,P07291,NA,NA,NA,myosin complex [GO:0016459]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_HOIL1.2.3.m.54310,0.0116220308586292,-0.0093566676831126,No,NA,NA,A9JTG5,NA,NA,NA,LUBAC complex [GO:0071797]; metal ion binding [GO:0046872]; ubiquitin binding [GO:0043130]; ubiquitin-protein transferase activity [GO:0004842]; embryonic cranial skeleton morphogenesis [GO:0048701]; otic vesicle morphogenesis [GO:0071600]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein linear polyubiquitination [GO:0097039],NA,NA,NA
CHOYP_HOOK3.1.1.m.14456,-0.00833906299305758,-0.0192680266606278,No,NA,NA,Q86VS8,NA,NA,NA,centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; FHF complex [GO:0070695]; microtubule [GO:0005874]; pericentriolar material [GO:0000242]; dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; Golgi localization [GO:0051645]; interkinetic nuclear migration [GO:0022027]; lysosome organization [GO:0007040]; microtubule anchoring at centrosome [GO:0034454]; negative regulation of neurogenesis [GO:0050768]; neuronal stem cell population maintenance [GO:0097150]; protein localization to centrosome [GO:0071539]; protein transport [GO:0015031],NA,NA,NA
CHOYP_HOW.5.5.m.58452,0.0169110518541739,-0.00646045801157802,No,NA,NA,O01367,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; single-stranded RNA binding [GO:0003727]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon ensheathment [GO:0008366]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; germ-line stem cell population maintenance [GO:0030718]; glial cell migration [GO:0008347]; mesoderm development [GO:0007498]; mesodermal cell migration [GO:0008078]; muscle attachment [GO:0016203]; muscle cell fate determination [GO:0007521]; muscle organ development [GO:0007517]; oenocyte development [GO:0007438]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of embryonic development [GO:0045995]; regulation of heart contraction [GO:0008016]; regulation of translation [GO:0006417]; sarcomere organization [GO:0045214]; somatic muscle development [GO:0007525]; spermatogonial cell division [GO:0007284],NA,NA,NA
CHOYP_HPGD.1.3.m.50258,0.0213680836830759,0.00423108355262765,No,NA,NA,Q8VCC1,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; protein homodimerization activity [GO:0042803]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_HPRT.1.1.m.61881,0.0196636979147406,-0.0129729462122363,No,NA,NA,P47959,NA,NA,NA,cytoplasm [GO:0005737]; guanine phosphoribosyltransferase activity [GO:0052657]; hypoxanthine phosphoribosyltransferase activity [GO:0004422]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; protein homodimerization activity [GO:0042803]; GMP catabolic process [GO:0046038]; guanine salvage [GO:0006178]; hypoxanthine metabolic process [GO:0046100]; hypoxanthine salvage [GO:0043103]; IMP metabolic process [GO:0046040]; IMP salvage [GO:0032264]; positive regulation of dopamine metabolic process [GO:0045964]; protein homotetramerization [GO:0051289]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside salvage [GO:0006166],NA,NA,NA
CHOYP_HS12A.10.33.m.38139,-0.00393605499227432,0.0135772092957365,No,NA,NA,Q9CZJ2,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HS12A.12.33.m.39763,-0.00303144130845125,0.00581739237006782,No,NA,NA,Q8K0U4,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HS12A.14.33.m.41988,0.00610868512494737,0.00414191418309988,No,NA,NA,Q9CZJ2,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HS12A.20.33.m.55554,-0.00102883692536367,-0.020944189050728,No,NA,NA,Q8K0U4,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HS12A.24.33.m.60051,0.014227160031732,-0.00117784351992012,No,NA,NA,Q9CZJ2,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HS12A.25.33.m.60352,-0.00117450222701425,0.000134165221979721,No,NA,NA,Q9CZJ2,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HS12B.10.14.m.59859,-0.0158614474011519,0.00752436062084796,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HS12B.2.14.m.19896,-0.00103234895483394,0.017022069535415,No,NA,NA,Q8K0U4,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HS12B.7.14.m.40600,0.00583475069331907,0.011261069814844,No,NA,NA,Q8K0U4,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HS12B.7.14.m.40601,0.00881770701301404,-0.00532763596268408,No,NA,NA,Q5EAE6,NA,NA,NA,death domain binding [GO:0070513]; apoptotic signaling pathway [GO:0097190]; autophagy [GO:0006914]; cellular response to amino acid starvation [GO:0034198]; negative regulation of autophagy [GO:0010507],NA,NA,NA
CHOYP_HS74L.1.1.m.24610,0.0175570881507905,-0.00699994136929369,No,NA,NA,O95757,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein folding [GO:0006457]; response to unfolded protein [GO:0006986],NA,NA,NA
CHOYP_HS90A.1.3.m.7725,0.0229930915907888,0.000757932215160867,No,NA,NA,O14562,NA,NA,NA,cadherin binding [GO:0045296]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_HS90A.3.3.m.28299,0.00091584591526021,-0.0131394564919704,No,NA,NA,Q90474,NA,NA,NA,A band [GO:0031672]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; melanosome [GO:0042470]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Z disc [GO:0030018]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; disordered domain specific binding [GO:0097718]; nitric-oxide synthase regulator activity [GO:0030235]; protein homodimerization activity [GO:0042803]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]; response to metal ion [GO:0010038]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_HS90A.3.3.m.28300,0.0110277918910495,-0.0209933695498304,No,NA,NA,P24539,NA,NA,NA,membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex; coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proton transmembrane transporter activity [GO:0015078]; transmembrane transporter activity [GO:0022857]; ATP biosynthetic process [GO:0006754]; ATP hydrolysis coupled cation transmembrane transport [GO:0099132]; ATP synthesis coupled proton transport [GO:0015986]; cristae formation [GO:0042407]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; substantia nigra development [GO:0021762],NA,NA,NA
CHOYP_HSC70.1.1.m.335,0.00864941227238993,0.00542504678574992,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_HSF1.2.2.m.38636,-0.0136230407823879,0.00203121545553779,No,NA,NA,P38529,NA,NA,NA,centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; mitotic spindle pole [GO:0097431]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; chromatin DNA binding [GO:0031490]; core promoter sequence-specific DNA binding [GO:0001046]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; heat shock protein binding [GO:0031072]; promoter-specific chromatin binding [GO:1990841]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; cellular response to cadmium ion [GO:0071276]; cellular response to gamma radiation [GO:0071480]; cellular response to heat [GO:0034605]; DNA repair [GO:0006281]; MAPK cascade [GO:0000165]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of cell cycle G2/M phase transition [GO:1902751]; positive regulation of cell proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of mRNA polyadenylation [GO:1900365]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to heat stress [GO:0061408]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; regulation of protein heterodimerization activity [GO:0043497]; response to heat [GO:0009408]; response to light stimulus [GO:0009416],NA,NA,NA
CHOYP_HSP21.4.1.1.m.8171,-0.0106647762499172,0.00566812465557518,No,NA,NA,P12812,NA,NA,NA,,NA,NA,NA
CHOYP_HSP70.1.1.m.61727,-0.0131403251984345,-0.00186604602066304,No,NA,NA,P41827,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HSP7D.2.3.m.34782,0.0196387295896989,0.00345081852916471,No,NA,NA,Q9U639,NA,NA,NA,nucleus [GO:0005634]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_HSP7D.2.3.m.34785,-0.0173820580401602,-0.0143979104688239,No,NA,NA,Q3T022,NA,NA,NA,ASAP complex [GO:0061574]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_HSP7D.3.3.m.41778,0.00711540479584833,0.0116996371445102,No,NA,NA,O18373,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; selenide; water dikinase activity [GO:0004756]; cell cycle [GO:0007049]; cell proliferation [GO:0008283]; glutamine metabolic process [GO:0006541]; imaginal disc development [GO:0007444]; mitochondrion organization [GO:0007005]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; positive regulation of cell proliferation [GO:0008284]; selenium compound metabolic process [GO:0001887]; selenocysteine biosynthetic process [GO:0016260]; tRNA seleno-modification [GO:0070329],NA,NA,NA
CHOYP_HSP7E.1.1.m.13730,-0.000632985566325558,-0.00226981645735687,No,NA,NA,Q2YDD0,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; polysome [GO:0005844]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity; coupled [GO:0042623]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein binding involved in protein folding [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; cytoplasmic translation [GO:0002181]; protein refolding [GO:0042026]; regulation of translational fidelity [GO:0006450]; response to unfolded protein [GO:0006986],NA,NA,NA
CHOYP_HSP90AA1.1.1.m.14867,0.0202658560673078,0.00645110888169188,No,NA,NA,Q90474,NA,NA,NA,A band [GO:0031672]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; melanosome [GO:0042470]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Z disc [GO:0030018]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; disordered domain specific binding [GO:0097718]; nitric-oxide synthase regulator activity [GO:0030235]; protein homodimerization activity [GO:0042803]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]; response to metal ion [GO:0010038]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_HSPA12A.10.27.m.35252,0.0142022186697376,0.0177960868505917,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HSPA12A.15.27.m.45635,0.0107657932755584,0.0192726105737255,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HSPA12A.16.27.m.48207,0.0037832986858635,0.00438708983149957,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HSPA12A.2.27.m.15188,-0.0043702464030639,0.0024426924369841,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_HSPA12A.21.27.m.57005,-0.00828672573990935,0.0110669001278714,No,NA,NA,Q8K0U4,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HSPA12A.5.27.m.21251,0.00655558476248317,0.00124722242640648,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HSPA12A.9.27.m.34375,-0.00121393632574686,0.0140917684055402,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HSPA12B.1.1.m.36165,0.00678620130084428,0.00878741825264137,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HSPG2.1.4.m.1496,-0.00421509230481708,-0.00864391242844127,No,NA,NA,P98158,NA,NA,NA,apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023]; steroid hormone receptor binding [GO:0035258]; aging [GO:0007568]; animal organ regeneration [GO:0031100]; coronary artery morphogenesis [GO:0060982]; endocytic hemoglobin import [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; hormone secretion [GO:0046879]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of endopeptidase activity [GO:0010951]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to drug [GO:0042493]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; vitamin metabolic process [GO:0006766],NA,NA,NA
CHOYP_HTF4.1.5.m.16262,-0.00656359167593962,0.0129141413165436,No,NA,NA,Q99081,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; transcription factor complex [GO:0005667]; bHLH transcription factor binding [GO:0043425]; cAMP response element binding [GO:0035497]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; enhancer binding [GO:0035326]; HMG box domain binding [GO:0071837]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; SMAD binding [GO:0046332]; transcription factor binding [GO:0008134]; immune response [GO:0006955]; muscle organ development [GO:0007517]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_HTR2B.1.1.m.121,-0.00627636990733939,0.00908830983123365,No,NA,NA,P41595,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synapse [GO:0045202]; drug binding [GO:0008144]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; neurotransmitter receptor activity [GO:0030594]; serotonin binding [GO:0051378]; activation of phospholipase C activity [GO:0007202]; behavior [GO:0007610]; calcium-mediated signaling [GO:0019722]; cardiac muscle hypertrophy [GO:0003300]; cellular calcium ion homeostasis [GO:0006874]; cellular response to temperature stimulus [GO:0071502]; cGMP-mediated signaling [GO:0019934]; chemical synaptic transmission [GO:0007268]; embryonic morphogenesis [GO:0048598]; ERK1 and ERK2 cascade [GO:0070371]; G protein-coupled receptor internalization [GO:0002031]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway; coupled to cyclic nucleotide second messenger [GO:0007187]; heart morphogenesis [GO:0003007]; intestine smooth muscle contraction [GO:0014827]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cell death [GO:0060548]; neural crest cell differentiation [GO:0014033]; neural crest cell migration [GO:0001755]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphorylation [GO:0016310]; positive regulation of cell division [GO:0051781]; positive regulation of cell proliferation [GO:0008284]; positive regulation of cytokine production [GO:0001819]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of phosphatidylinositol biosynthetic process [GO:0010513]; protein kinase C signaling [GO:0070528]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of behavior [GO:0050795]; release of sequestered calcium ion into cytosol [GO:0051209]; response to drug [GO:0042493]; serotonin receptor signaling pathway [GO:0007210]; vasoconstriction [GO:0042310],NA,NA,NA
CHOYP_HTR5B.1.1.m.39330,-0.00790617008726624,-0.0148253837925662,No,NA,NA,A1A5F2,NA,NA,NA,cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endocytosis [GO:0006897]; protein localization [GO:0008104]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_HTT.1.1.m.33803,0.0115894879219057,0.000761121874766574,No,NA,NA,P42858,NA,NA,NA,autophagosome [GO:0005776]; axon [GO:0030424]; centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; inclusion body [GO:0016234]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523]; protein-containing complex [GO:0032991]; beta-tubulin binding [GO:0048487]; dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; p53 binding [GO:0002039]; profilin binding [GO:0005522]; apoptotic process [GO:0006915]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of aggrephagy [GO:1905337]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of cilium assembly [GO:0045724]; positive regulation of inositol 1;4;5-trisphosphate-sensitive calcium-release channel activity [GO:0031587]; positive regulation of lipophagy [GO:1904504]; protein destabilization [GO:0031648]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of phosphoprotein phosphatase activity [GO:0043666]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890]; vesicle transport along microtubule [GO:0047496]; vocal learning [GO:0042297],NA,NA,NA
CHOYP_HUTH.1.1.m.30350,0.00423090166106781,-0.00470962548878103,No,NA,NA,P21213,NA,NA,NA,cytosol [GO:0005829]; histidine ammonia-lyase activity [GO:0004397]; histidine catabolic process [GO:0006548]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]; histidine metabolic process [GO:0006547],NA,NA,NA
CHOYP_HUWE1.1.2.m.566,0.00258233797897812,-0.0252523016459921,No,NA,NA,Q7Z6Z7,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; histone ubiquitination [GO:0016574]; neutrophil degranulation [GO:0043312]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_HVCN1.1.4.m.8888,0.00491588973115351,-0.000600714720400963,No,NA,NA,Q5F4C0,NA,NA,NA,integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; voltage-gated proton channel activity [GO:0030171]; cellular response to pH [GO:0071467]; cellular response to zinc ion [GO:0071294]; proton transmembrane transport [GO:1902600]; regulation of ion transmembrane transport [GO:0034765]; response to pH [GO:0009268]; response to zinc ion [GO:0010043],NA,NA,NA
CHOYP_HVCN1.2.4.m.29334,0.0065883263884642,0.0180931628217626,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_HX1.1.1.m.23716,0.00797594308295835,0.00182081799524966,No,NA,NA,Q8IWF2,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_HXD3.1.1.m.40287,0.00657006132349411,0.00158055710362243,No,NA,NA,P50901,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_HYI.1.1.m.10528,-0.00782853735081915,-0.0210647951027164,No,NA,NA,Q7T3H9,NA,NA,NA,hydroxypyruvate isomerase activity [GO:0008903]; racemase and epimerase activity; acting on carbohydrates and derivatives [GO:0016857],NA,NA,NA
CHOYP_HYOU1.1.3.m.163,0.00333220554461561,-0.00844792601925833,No,NA,NA,Q7ZUW2,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; ATP binding [GO:0005524]; cellular response to hypoxia [GO:0071456]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298],NA,NA,NA
CHOYP_HYOU1.2.3.m.12568,0.019658688790791,-0.0140585921256078,No,NA,NA,Q7ZUW2,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; ATP binding [GO:0005524]; cellular response to hypoxia [GO:0071456]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298],NA,NA,NA
CHOYP_IARS.1.1.m.27559,0.0129134577227074,-0.0164189480475399,No,NA,NA,P41252,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; GTPase binding [GO:0051020]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]; isoleucyl-tRNA aminoacylation [GO:0006428]; osteoblast differentiation [GO:0001649]; tRNA aminoacylation for protein translation [GO:0006418],NA,NA,NA
CHOYP_IDE.1.3.m.8450,-0.00484604419544961,-0.0154747268947825,No,NA,NA,P35559,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; beta-endorphin binding [GO:0031626]; insulin binding [GO:0043559]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; ubiquitin-dependent protein binding [GO:0140036]; zinc ion binding [GO:0008270]; amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; bradykinin catabolic process [GO:0010815]; cellular protein catabolic process [GO:0044257]; determination of adult lifespan [GO:0008340]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; negative regulation of proteolysis [GO:0045861]; peptide catabolic process [GO:0043171]; positive regulation of protein oligomerization [GO:0032461]; protein heterooligomerization [GO:0051291]; protein homotetramerization [GO:0051289]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of aerobic respiration [GO:1903715]; ubiquitin recycling [GO:0010992],NA,NA,NA
CHOYP_IDHC.1.1.m.7041,0.0156668681286686,0.00285867807053298,No,NA,NA,Q9Z2K9,NA,NA,NA,cytosol [GO:0005829]; isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; 2-oxoglutarate metabolic process [GO:0006103]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_IDLC.1.1.m.63624,-0.0156004551849181,-0.0123343879285135,No,NA,NA,Q26630,NA,NA,NA,axoneme [GO:0005930]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; filopodium [GO:0030175]; dynein heavy chain binding [GO:0045504]; motor activity [GO:0003774]; inner dynein arm assembly [GO:0036159],NA,NA,NA
CHOYP_IF122.2.2.m.59794,-0.0175801975248881,0.00341628274009897,No,NA,NA,A8WGF4,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intraciliary transport particle A [GO:0030991]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; multicellular organism development [GO:0007275]; negative regulation of smoothened signaling pathway [GO:0045879]; protein localization to cilium [GO:0061512],NA,NA,NA
CHOYP_IF2A.1.1.m.13279,-0.0096347825843449,0.00748665898713059,No,NA,NA,P68101,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 2 complex [GO:0005850]; eukaryotic translation initiation factor 2B complex [GO:0005851]; glial limiting end-foot [GO:0097451]; multi-eIF complex [GO:0043614]; nucleus [GO:0005634]; synapse [GO:0045202]; translation initiation ternary complex [GO:0044207]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]; aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to oxidative stress [GO:0034599]; cellular response to UV [GO:0034644]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; stress granule assembly [GO:0034063],NA,NA,NA
CHOYP_IF2H.1.1.m.18253,0.00996104368687871,-0.00193237315504004,No,NA,NA,C9WPN6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2 complex [GO:0005850]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation initiation factor activity [GO:0003743]; formation of translation preinitiation complex [GO:0001731],NA,NA,NA
CHOYP_IF4A3.1.1.m.30424,-0.00376609713330459,-0.016623688507106,No,NA,NA,Q7ZVA6,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_IF4E.1.1.m.56823,0.0138339753050533,-0.0185775596146662,No,NA,NA,P48597,NA,NA,NA,eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA cap binding complex [GO:0005845]; protein-containing complex [GO:0032991]; translation initiation factor activity [GO:0003743]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_IF4G2.1.1.m.62766,-0.0125530577418302,-0.0189810539917692,No,NA,NA,Q62448,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; postsynaptic density [GO:0014069]; mRNA binding [GO:0003729]; translation factor activity; RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; cellular macromolecule biosynthetic process [GO:0034645]; negative regulation of autophagy [GO:0010507]; positive regulation of axon extension [GO:0045773]; positive regulation of cell growth [GO:0030307]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of translation [GO:0045727]; regulation of translational initiation [GO:0006446],NA,NA,NA
CHOYP_IF6.1.1.m.22685,-0.00736421884907124,0.00953655534134327,No,NA,NA,O55135,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; lamin filament [GO:0005638]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome; large subunit precursor [GO:0030687]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]; assembly of large subunit precursor of preribosome [GO:1902626]; gene silencing by miRNA [GO:0035195]; mature ribosome assembly [GO:0042256]; miRNA mediated inhibition of translation [GO:0035278]; positive regulation of translation [GO:0045727]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of glycolytic process [GO:0006110]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to insulin [GO:0032868]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal subunit export from nucleus [GO:0000054],NA,NA,NA
CHOYP_IFIH1.10.14.m.60393,-0.0121886154521586,0.00155268879035416,No,NA,NA,Q8R5F7,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; ribonucleoprotein complex binding [GO:0043021]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; MDA-5 signaling pathway [GO:0039530]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of tumor necrosis factor secretion [GO:1904469]; protein sumoylation [GO:0016925]; response to virus [GO:0009615],NA,NA,NA
CHOYP_IFIH1.3.14.m.24387,-0.00303431868108478,0.00158317206720876,No,NA,NA,Q6Q899,NA,NA,NA,actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; regulation of cell migration [GO:0030334]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529],NA,NA,NA
CHOYP_IFIH1.7.14.m.46974,-0.00897544790591035,0.0043459909891951,No,NA,NA,Q6Q899,NA,NA,NA,actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; regulation of cell migration [GO:0030334]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529],NA,NA,NA
CHOYP_IFIH1.9.14.m.54678,-0.0023048715178765,0.0057979234260008,No,NA,NA,Q6Q899,NA,NA,NA,actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; regulation of cell migration [GO:0030334]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529],NA,NA,NA
CHOYP_IFT140.1.1.m.61053,-0.0171596622449142,0.00147456904242185,No,NA,NA,E9PY46,NA,NA,NA,axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]; non-motile cilium [GO:0097730]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; heart development [GO:0007507]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; limb morphogenesis [GO:0035108]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; photoreceptor cell outer segment organization [GO:0035845]; protein localization to cilium [GO:0061512]; regulation of cilium assembly [GO:1902017]; regulation of smoothened signaling pathway [GO:0008589]; renal system development [GO:0072001]; retina development in camera-type eye [GO:0060041]; skeletal system morphogenesis [GO:0048705],NA,NA,NA
CHOYP_IFT57.1.1.m.13249,-0.0170332733345579,-0.00419380513532352,No,NA,NA,Q5EA95,NA,NA,NA,axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; dendrite terminus [GO:0044292]; Golgi apparatus [GO:0005794]; intraciliary transport particle B [GO:0030992]; photoreceptor connecting cilium [GO:0032391]; DNA binding [GO:0003677]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; heart looping [GO:0001947]; intraciliary transport [GO:0042073]; left/right pattern formation [GO:0060972]; motile cilium assembly [GO:0044458]; negative regulation of epithelial cell proliferation [GO:0050680]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; regulation of apoptotic process [GO:0042981]; smoothened signaling pathway [GO:0007224],NA,NA,NA
CHOYP_IKBZ.1.1.m.23083,0.0167249468121412,0.000861076276445105,No,NA,NA,G5EDE9,NA,NA,NA,transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_IKZF.1.1.m.55498,0.000686232728993108,-0.0107331332691118,No,NA,NA,A4IFJ6,NA,NA,NA,nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; protein domain specific binding [GO:0019904]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein heterooligomerization [GO:0051291],NA,NA,NA
CHOYP_IMA2.1.2.m.35753,-0.0013214539917008,0.017277686830809,No,NA,NA,F4KF65,NA,NA,NA,cytosol [GO:0005829]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein transporter activity [GO:0008565]; NLS-bearing protein import into nucleus [GO:0006607],NA,NA,NA
CHOYP_IMA2.2.2.m.49279,-0.00100638094078354,-0.0236022991571862,No,NA,NA,P52170,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; protein transporter activity [GO:0008565]; protein import into nucleus [GO:0006606],NA,NA,NA
CHOYP_IMDH3.1.1.m.51789,-0.000752456757813823,-0.0181459614328127,No,NA,NA,B0UXP9,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; circadian rhythm [GO:0007623]; GMP biosynthetic process [GO:0006177]; GTP biosynthetic process [GO:0006183],NA,NA,NA
CHOYP_IMG5_109580.1.1.m.27791,-0.0224867451253123,0.0105809453992809,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_IMG5_163910.1.1.m.46747,-0.00343857394129161,0.00416095619040972,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_IMSP5.1.2.m.5157,-0.0118457325213617,-0.0243101469705393,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_IMSP5.2.2.m.17779,0.0142599947530921,0.00530465715854025,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_INF2.3.5.m.13728,0.00526385537540816,-0.00693236579773019,No,NA,NA,Q27J81,NA,NA,NA,perinuclear region of cytoplasm [GO:0048471]; actin binding [GO:0003779]; Rho GTPase binding [GO:0017048]; actin cytoskeleton organization [GO:0030036]; regulation of mitochondrial fission [GO:0090140],NA,NA,NA
CHOYP_INO1A.1.1.m.91,-0.00545305724152358,-0.0145528336567435,No,NA,NA,Q6DDT1,NA,NA,NA,cytoplasm [GO:0005737]; inositol-3-phosphate synthase activity [GO:0004512]; inositol biosynthetic process [GO:0006021]; phospholipid biosynthetic process [GO:0008654],NA,NA,NA
CHOYP_INO80.1.2.m.1270,-0.00825177208385158,-0.00751344752950161,No,NA,NA,Q9ULG1,NA,NA,NA,cytoplasm [GO:0005737]; Ino80 complex [GO:0031011]; intermediate filament cytoskeleton [GO:0045111]; microtubule [GO:0005874]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; histone binding [GO:0042393]; ATP-dependent chromatin remodeling [GO:0043044]; cell division [GO:0051301]; cellular response to ionizing radiation [GO:0071479]; cellular response to UV [GO:0034644]; chromatin remodeling [GO:0006338]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; mitotic sister chromatid segregation [GO:0000070]; nucleosome mobilization [GO:0042766]; positive regulation of cell growth [GO:0030307]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; spindle assembly [GO:0051225]; transcription; DNA-templated [GO:0006351]; UV-damage excision repair [GO:0070914],NA,NA,NA
CHOYP_INSI2.1.1.m.59456,0.0050156289934356,0.0145850581907571,No,NA,NA,P49230,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779],NA,NA,NA
CHOYP_INT11.1.1.m.29494,-0.0140366549646947,-0.00419479665383849,No,NA,NA,Q5ZIH0,NA,NA,NA,cytosol [GO:0005829]; integrator complex [GO:0032039]; hydrolase activity [GO:0016787]; regulation of RNA splicing [GO:0043484]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180],NA,NA,NA
CHOYP_INT2.1.1.m.52909,0.00205195042830452,-0.00934116934689426,No,NA,NA,Q9H0H0,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; intracellular [GO:0005622]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]; snRNA transcription by RNA polymerase II [GO:0042795],NA,NA,NA
CHOYP_INT6.1.1.m.13005,-0.00169135601806407,-0.0153824147703918,No,NA,NA,Q6PCM2,NA,NA,NA,actin cytoskeleton [GO:0015629]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180],NA,NA,NA
CHOYP_INT7.1.1.m.14480,0.00419955574581584,-0.0109644074915307,No,NA,NA,Q5ZL91,NA,NA,NA,chromosome [GO:0005694]; integrator complex [GO:0032039]; cellular response to DNA damage stimulus [GO:0006974]; snRNA 3'-end processing [GO:0034472],NA,NA,NA
CHOYP_INT9.1.1.m.11703,-0.0108373286697753,-0.00826550071574118,No,NA,NA,Q9NV88,NA,NA,NA,cytosol [GO:0005829]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA processing [GO:0016180]; snRNA transcription by RNA polymerase II [GO:0042795],NA,NA,NA
CHOYP_INVS.2.6.m.8331,-0.0169591047060434,0.00960206869202777,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_IP6K1.1.1.m.54347,-0.00430894344577715,-0.00631540690244347,No,NA,NA,Q9ESM0,NA,NA,NA,cytosol [GO:0005829]; fibrillar center [GO:0001650]; ATP binding [GO:0005524]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol phosphate biosynthetic process [GO:0032958]; negative regulation of cold-induced thermogenesis [GO:0120163]; phosphatidylinositol phosphorylation [GO:0046854],NA,NA,NA
CHOYP_IPO11.1.1.m.10815,0.00534747477908208,-0.00655044431694591,No,NA,NA,Q9UI26,NA,NA,NA,cytosol [GO:0005829]; fibrillar center [GO:0001650]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; protein transporter activity [GO:0008565]; Ran GTPase binding [GO:0008536]; protein import into nucleus [GO:0006606]; ribosomal protein import into nucleus [GO:0006610],NA,NA,NA
CHOYP_IPO5.1.1.m.25693,0.0175361752197063,-0.0179045474664234,No,NA,NA,O00410,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nucleolus [GO:0005730]; nucleus [GO:0005634]; GTPase inhibitor activity [GO:0005095]; nuclear localization sequence binding [GO:0008139]; protein transporter activity [GO:0008565]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; cellular response to amino acid stimulus [GO:0071230]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of protein import into nucleus [GO:0042307]; ribosomal protein import into nucleus [GO:0006610]; viral process [GO:0016032],NA,NA,NA
CHOYP_IPO7.1.1.m.16806,0.00988984258511644,-0.0242303691849112,No,NA,NA,Q9EPL8,NA,NA,NA,cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; histone binding [GO:0042393]; protein transporter activity [GO:0008565]; Ran GTPase binding [GO:0008536]; SMAD binding [GO:0046332]; innate immune response [GO:0045087]; protein import into nucleus [GO:0006606],NA,NA,NA
CHOYP_IQCA1.1.3.m.4290,-0.0194881893703561,-0.00556393886247509,No,NA,NA,Q86XH1,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_IQGA1.1.1.m.47731,0.0125418881302572,-0.0079181426985201,No,NA,NA,P46940,NA,NA,NA,actin filament [GO:0005884]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lateral plasma membrane [GO:0016328]; membrane raft [GO:0045121]; microtubule [GO:0005874]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; secretory granule membrane [GO:0030667]; slit diaphragm [GO:0036057]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; GTPase inhibitor activity [GO:0005095]; mitogen-activated protein kinase binding [GO:0051019]; phosphatidylinositol-3;4;5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activator activity [GO:0043539]; protein-containing complex binding [GO:0044877]; protein-containing complex scaffold activity [GO:0032947]; Rac GTPase binding [GO:0048365]; S100 protein binding [GO:0044548]; small GTPase binding [GO:0031267]; cell migration [GO:0016477]; cellular response to calcium ion [GO:0071277]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glomerular visceral epithelial cell development [GO:0072015]; negative regulation of dephosphorylation [GO:0035305]; neuron projection extension [GO:1990138]; neutrophil degranulation [GO:0043312]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of dendrite development [GO:1900006]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of cytokine production [GO:0001817]; regulation of mitotic cell cycle [GO:0007346]; response to angiotensin [GO:1990776]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_IRAK4.1.1.m.23405,-0.00528874669692053,0.00565340338936069,No,NA,NA,Q8R4K2,NA,NA,NA,cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; interleukin-1 receptor binding [GO:0005149]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cytokine production [GO:0001816]; cytokine-mediated signaling pathway [GO:0019221]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of smooth muscle cell proliferation [GO:0048661],NA,NA,NA
CHOYP_IRF1.1.3.m.52606,-0.0124406384540568,-0.0227580628230943,No,NA,NA,Q8R4E0,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; transcription regulatory region DNA binding [GO:0044212]; cell proliferation [GO:0008283],NA,NA,NA
CHOYP_IRF5.1.1.m.58123,-0.00445519257756512,-0.000394804105420797,No,NA,NA,Q90871,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; myeloid cell differentiation [GO:0030099]; negative regulation of growth of symbiont in host [GO:0044130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phagocytosis [GO:0006909]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_IRO.4.4.m.24034,0.00605985999399903,-0.0147508045170996,No,NA,NA,P54269,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; compound eye morphogenesis [GO:0001745]; equator specification [GO:0045317]; imaginal disc-derived wing vein specification [GO:0007474]; muscle cell fate commitment [GO:0042693]; negative regulation of growth [GO:0045926]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitotic cell cycle [GO:0007346],NA,NA,NA
CHOYP_ISCA1.1.2.m.17578,0.00529047975164602,-0.00626156381766871,No,NA,NA,Q80W96,NA,NA,NA,mitochondrion [GO:0005739]; 2 iron; 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; structural molecule activity [GO:0005198]; endocrine process [GO:0050886]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by iron-sulfur cluster transfer [GO:0097428],NA,NA,NA
CHOYP_ISCU.1.1.m.37414,0.0124337665621001,-0.008403147466756,No,NA,NA,Q9D7P6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 2 iron; 2 sulfur cluster binding [GO:0051537]; 4 iron; 4 sulfur cluster binding [GO:0051539]; ferrous iron binding [GO:0008198]; iron-sulfur transferase activity [GO:0036455]; protein-containing complex scaffold activity [GO:0032947]; cellular iron ion homeostasis [GO:0006879]; iron-sulfur cluster assembly [GO:0016226],NA,NA,NA
CHOYP_ISCW_ISCW000210.4.4.m.38490,0.0109679166941438,0.0194902583890452,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ISCW_ISCW000642.1.1.m.4065,0.00939450295535014,0.0047652425413446,No,NA,NA,Q8WVN8,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_ISCW_ISCW000704.1.1.m.38250,-0.00963696299846469,-0.0186385744430186,No,NA,NA,Q08E52,NA,NA,NA,actin filament [GO:0005884]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; invadopodium [GO:0071437]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; collagen binding [GO:0005518]; protein serine/threonine kinase activity [GO:0004674]; Rac GTPase binding [GO:0048365]; actin cytoskeleton reorganization [GO:0031532]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration [GO:0016477]; exocytosis [GO:0006887]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of MAPK cascade [GO:0043408]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]; wound healing [GO:0042060],NA,NA,NA
CHOYP_ISCW_ISCW001190.1.1.m.26579,-0.00929992814127456,0.0183242390976044,No,NA,NA,Q7ZV80,NA,NA,NA,Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_ISCW_ISCW001487.2.2.m.61505,-0.00139693565304604,-3.48070826473299e-05,No,NA,NA,Q96DR7,NA,NA,NA,cytosol [GO:0005829]; ruffle [GO:0001726]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; endothelial cell morphogenesis [GO:0001886]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; ruffle assembly [GO:0097178],NA,NA,NA
CHOYP_ISCW_ISCW001592.1.2.m.20852,-0.00788151268355608,-0.0193431195898306,No,NA,NA,O75439,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial processing peptidase complex [GO:0017087]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; aerobic respiration [GO:0009060]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial electron transport; ubiquinol to cytochrome c [GO:0006122]; protein processing involved in protein targeting to mitochondrion [GO:0006627],NA,NA,NA
CHOYP_ISCW_ISCW003477.1.1.m.37800,0.0130143056451764,-0.0149687223749007,No,NA,NA,Q28619,NA,NA,NA,apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; filopodium [GO:0030175]; membrane [GO:0016020]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; ruffle [GO:0001726]; sperm midpiece [GO:0097225]; chloride channel regulator activity [GO:0017081]; protein-containing complex scaffold activity [GO:0032947]; bile acid secretion [GO:0032782]; glutathione transport [GO:0034635]; negative regulation of cell motility [GO:2000146]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein kinase B signaling [GO:0051898]; regulation of protein kinase activity [GO:0045859]; renal absorption [GO:0070293]; renal phosphate ion absorption [GO:0097291]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_ISCW_ISCW003928.1.1.m.18079,-0.0116032491698885,0.0163105330597928,No,NA,NA,Q6P5H6,NA,NA,NA,adherens junction [GO:0005912]; cytoskeleton [GO:0005856]; cytoskeletal protein binding [GO:0008092]; integrin binding [GO:0005178]; protein kinase binding [GO:0019901]; actomyosin structure organization [GO:0031032]; negative regulation of cell motility [GO:2000146]; positive regulation of cell adhesion [GO:0045785]; regulation of cell migration [GO:0030334],NA,NA,NA
CHOYP_ISCW_ISCW004420.1.8.m.5439,-0.00377003811210723,-0.0108774817160452,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ISCW_ISCW004725.1.1.m.9722,-0.000377625156524417,0.00927788889053534,No,NA,NA,Q09506,NA,NA,NA,,NA,NA,NA
CHOYP_ISCW_ISCW005083.2.2.m.40343,0.00432605660397559,-0.00584105148282591,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ISCW_ISCW005292.1.1.m.11066,0.0050461204671403,0.00211609687880673,No,NA,NA,Q9QXD6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; AMP binding [GO:0016208]; fructose 1;6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; carbohydrate metabolic process [GO:0005975]; cellular response to drug [GO:0035690]; cellular response to magnesium ion [GO:0071286]; dephosphorylation [GO:0016311]; fructose 1;6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; negative regulation of cell growth [GO:0030308]; negative regulation of glycolytic process [GO:0045820]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein homotetramerization [GO:0051289]; regulation of gluconeogenesis [GO:0006111]; sucrose biosynthetic process [GO:0005986],NA,NA,NA
CHOYP_ISCW_ISCW005596.1.1.m.60561,-0.00566246249042957,0.00706860683942438,No,NA,NA,O94812,NA,NA,NA,cytosol [GO:0005829]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588]; calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; dense core granule maturation [GO:1990502]; exocytosis [GO:0006887]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of neurotransmitter secretion [GO:0001956]; regulation of dense core granule exocytosis [GO:1905413]; regulation of synaptic transmission; GABAergic [GO:0032228]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_ISCW_ISCW005651.1.1.m.49000,-0.0151868136010718,-0.0174830921436696,No,NA,NA,P42669,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; DNA replication factor A complex [GO:0005662]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; double-stranded telomeric DNA binding [GO:0003691]; purine-rich negative regulatory element binding [GO:0032422]; RNA binding [GO:0003723]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; SMAD binding [GO:0046332]; transcription factor binding [GO:0008134]; translation repressor activity; mRNA regulatory element binding [GO:0000900]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cell proliferation [GO:0008283]; dendritic transport of messenger ribonucleoprotein complex [GO:0098963]; DNA unwinding involved in DNA replication [GO:0006268]; mitotic cell cycle checkpoint [GO:0007093]; negative regulation of transcription; DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of cell proliferation [GO:0008284],NA,NA,NA
CHOYP_ISCW_ISCW005791.1.1.m.53514,-0.000852482555487539,0.0116892961234494,No,NA,NA,P23880,NA,NA,NA,cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein phosphatase type 1 complex [GO:0000164]; PTW/PP1 phosphatase complex [GO:0072357]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; positive regulation of establishment of cell polarity regulating cell shape [GO:2000784]; regulation of cell cycle [GO:0051726]; regulation of mitotic cell cycle [GO:0007346],NA,NA,NA
CHOYP_ISCW_ISCW005878.1.1.m.39374,0.00609518806851895,0.000198974416390602,No,NA,NA,Q9D773,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412],NA,NA,NA
CHOYP_ISCW_ISCW006091.2.2.m.61313,-0.017388169139706,-0.00469394540934362,No,NA,NA,Q503Y7,NA,NA,NA,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; spindle [GO:0005819]; DNA binding [GO:0003677]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755],NA,NA,NA
CHOYP_ISCW_ISCW006277.2.2.m.66212,0.00431960868987414,-0.0124081166723291,No,NA,NA,Q5M8V0,NA,NA,NA,,NA,NA,NA
CHOYP_ISCW_ISCW006831.1.1.m.23820,0.00143049591260999,-0.0176570453394011,No,NA,NA,Q9NTZ6,NA,NA,NA,nucleoplasm [GO:0005654]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_ISCW_ISCW007151.1.2.m.41781,0.0132907461289682,0.00552106514137448,No,NA,NA,Q6BEA0,NA,NA,NA,integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; axon guidance [GO:0007411]; axonal defasciculation [GO:0007414]; morphogenesis of a branching structure [GO:0001763]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287],NA,NA,NA
CHOYP_ISCW_ISCW007151.2.2.m.41979,0.00615966897194063,0.00941964587728867,No,NA,NA,Q9HCM2,NA,NA,NA,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; anterior commissure morphogenesis [GO:0021960]; chemorepulsion of branchiomotor axon [GO:0021793]; facial nerve structural organization [GO:0021612]; glossopharyngeal nerve morphogenesis [GO:0021615]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axonogenesis [GO:0050772]; postganglionic parasympathetic fiber development [GO:0021784]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of negative chemotaxis [GO:0050923]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sympathetic nervous system development [GO:0048485]; trigeminal nerve structural organization [GO:0021637]; vagus nerve morphogenesis [GO:0021644],NA,NA,NA
CHOYP_ISCW_ISCW007158.2.2.m.53689,-0.0169591047060434,0.00960206869202778,No,NA,NA,Q99MK9,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle pole [GO:0000922]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; cell cycle arrest [GO:0007050]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation of cell cycle arrest [GO:0071157]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; Ras protein signal transduction [GO:0007265]; regulation of microtubule cytoskeleton organization [GO:0070507],NA,NA,NA
CHOYP_ISCW_ISCW007158.2.2.m.53690,-0.00679112348060669,0.00668033575831639,No,NA,NA,Q9QXV3,NA,NA,NA,nucleus [GO:0005634]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; cell cycle [GO:0007049]; negative regulation of cell proliferation [GO:0008285]; positive regulation of transcription; DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]; regulation of cell death [GO:0010941],NA,NA,NA
CHOYP_ISCW_ISCW007303.1.1.m.42263,0.00491588973115351,-0.000600714720400964,No,NA,NA,P41095,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027],NA,NA,NA
CHOYP_ISCW_ISCW008174.1.2.m.8360,-0.00881045560040985,0.00091695375283551,No,NA,NA,O08740,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II; core complex [GO:0005665]; DNA binding [GO:0003677]; LRR domain binding [GO:0030275]; protein dimerization activity [GO:0046983]; RNA polymerase II activity [GO:0001055]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_ISCW_ISCW008219.1.2.m.46822,0.00755571812681756,0.0229280324064537,No,NA,NA,P08228,NA,NA,NA,axon cytoplasm [GO:1904115]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; dense core granule [GO:0031045]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]; chaperone binding [GO:0051087]; copper ion binding [GO:0005507]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein phosphatase 2B binding [GO:0030346]; Rac GTPase binding [GO:0048365]; superoxide dismutase activity [GO:0004784]; superoxide dismutase copper chaperone activity [GO:0016532]; zinc ion binding [GO:0008270]; activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226],NA,NA,NA
CHOYP_ISCW_ISCW008316.1.3.m.11997,0.0109737987083456,0.0189589417927841,No,NA,NA,Q8MQI6,NA,NA,NA,transcription elongation factor complex [GO:0008023]; metal ion binding [GO:0046872]; RNA polymerase II complex binding [GO:0000993]; chromatin-mediated maintenance of transcription [GO:0048096]; transcription elongation from RNA polymerase II promoter [GO:0006368],NA,NA,NA
CHOYP_ISCW_ISCW008555.1.1.m.40873,0.0117471804370768,-0.00945993304278248,No,NA,NA,Q8AXV0,NA,NA,NA,cell junction [GO:0030054]; cell projection [GO:0042995]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; glutamatergic synapse [GO:0098978]; podosome [GO:0002102]; presynapse [GO:0098793]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; synaptic vesicle uncoating [GO:0016191],NA,NA,NA
CHOYP_ISCW_ISCW008596.2.2.m.44077,0.00396115456592692,-0.0142039192907174,No,NA,NA,Q3SZ76,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; sodium ion transport [GO:0006814],NA,NA,NA
CHOYP_ISCW_ISCW008669.1.1.m.20227,0.00180434413579818,-0.0105851015511423,No,NA,NA,Q8BK35,NA,NA,NA,cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; rDNA heterochromatin [GO:0033553]; 5S rRNA binding [GO:0008097]; identical protein binding [GO:0042802]; p53 binding [GO:0002039]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; DNA repair [GO:0006281]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein K63-linked deubiquitination [GO:1903006]; protein localization to nucleolus [GO:1902570]; protein localization to nucleoplasm [GO:1990173]; protein stabilization [GO:0050821]; regulation of aerobic respiration [GO:1903715]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of protein phosphorylation [GO:0001932]; regulation of RIG-I signaling pathway [GO:0039535]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_ISCW_ISCW009103.1.1.m.24140,-0.000272868439790227,0.0117354075073398,No,NA,NA,O70133,NA,NA,NA,actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; micro-ribonucleoprotein complex [GO:0035068]; nuclear body [GO:0016604]; nuclear stress granule [GO:0097165]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; polysomal ribosome [GO:0042788]; polysome [GO:0005844]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; RISC-loading complex [GO:0070578]; ATP binding [GO:0005524]; ATP-dependent 3'-5' DNA helicase activity [GO:0043140]; ATP-dependent 3'-5' DNA/RNA helicase activity [GO:0033681]; ATP-dependent 3'-5' RNA helicase activity [GO:0034459]; ATP-dependent DNA helicase activity [GO:0004003]; ATP-dependent RNA helicase activity [GO:0004004]; ATPase activity [GO:0016887]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; importin-alpha family protein binding [GO:0061676]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; nucleoside-triphosphatase activity [GO:0017111]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; polysome binding [GO:1905538]; promoter-specific chromatin binding [GO:1990841]; regulatory region RNA binding [GO:0001069]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; single-stranded DNA binding [GO:0003697]; single-stranded DNA-dependent ATP-dependent 3'-5' DNA helicase activity [GO:1990518]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; triplex DNA binding [GO:0045142]; alternative mRNA splicing; via spliceosome [GO:0000380]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to heat [GO:0034605]; cellular response to tumor necrosis factor [GO:0071356]; circadian rhythm [GO:0007623]; CRD-mediated mRNA stabilization [GO:0070934]; DNA duplex unwinding [GO:0032508]; DNA-templated transcription; termination [GO:0006353]; DNA-templated viral transcription [GO:0039695]; G-quadruplex DNA unwinding [GO:0044806]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mRNA transport [GO:0051028]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of inflammatory response [GO:0050729]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-18 production [GO:0032741]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of polysome binding [GO:1905698]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; positive regulation of viral transcription [GO:0050434]; positive regulation of viral translation [GO:1904973]; protein localization to cytoplasmic stress granule [GO:1903608]; pyroptosis [GO:0070269]; regulation of cytoplasmic translation [GO:2000765]; regulation of defense response to virus by host [GO:0050691]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA secondary structure unwinding [GO:0010501]; small RNA loading onto RISC [GO:0070922]; targeting of mRNA for destruction involved in RNA interference [GO:0030423],NA,NA,NA
CHOYP_ISCW_ISCW009328.2.2.m.65633,0.0175554611996943,-0.000352037241330751,No,NA,NA,Q1L673,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; calcitriol binding [GO:1902098]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; nuclear receptor transcription coactivator activity [GO:0030374]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; vitamin D binding [GO:0005499]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; heart jogging [GO:0003146]; heart looping [GO:0001947]; inner ear receptor cell development [GO:0060119]; multicellular organism development [GO:0007275]; otic vesicle development [GO:0071599]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_ISCW_ISCW010143.1.3.m.17397,-0.00713927085553073,0.00495742976115263,No,NA,NA,Q9UBB5,NA,NA,NA,cytosol [GO:0005829]; heterochromatin [GO:0000792]; histone deacetylase complex [GO:0000118]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; C2H2 zinc finger domain binding [GO:0070742]; chromatin binding [GO:0003682]; methyl-CpG binding [GO:0008327]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; satellite DNA binding [GO:0003696]; siRNA binding [GO:0035197]; aging [GO:0007568]; ATP-dependent chromatin remodeling [GO:0043044]; cellular protein-containing complex assembly [GO:0034622]; cellular response to organic cyclic compound [GO:0071407]; chromatin silencing at rDNA [GO:0000183]; embryonic organ development [GO:0048568]; heart development [GO:0007507]; maternal behavior [GO:0042711]; methylation-dependent chromatin silencing [GO:0006346]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of chromatin binding [GO:0035563]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of cell proliferation [GO:0042127]; regulation of DNA methylation [GO:0044030]; response to estradiol [GO:0032355]; response to mechanical stimulus [GO:0009612]; response to nutrient levels [GO:0031667],NA,NA,NA
CHOYP_ISCW_ISCW010143.3.3.m.61542,0.00820517376852536,-0.0111886133261637,No,NA,NA,P41236,NA,NA,NA,protein phosphatase inhibitor activity [GO:0004864]; protein serine/threonine phosphatase inhibitor activity [GO:0004865]; generation of precursor metabolites and energy [GO:0006091]; glycogen metabolic process [GO:0005977]; regulation of phosphoprotein phosphatase activity [GO:0043666]; regulation of signal transduction [GO:0009966],NA,NA,NA
CHOYP_ISCW_ISCW010532.1.4.m.11493,0.000683547579846861,-0.017763497390025,No,NA,NA,Q9NL98,NA,NA,NA,cell [GO:0005623]; antioxidant activity [GO:0016209]; peroxidase activity [GO:0004601]; thioredoxin peroxidase activity [GO:0008379]; cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_ISCW_ISCW010532.2.4.m.35454,0.00230073249075403,0.0186363693245792,No,NA,NA,Q9NL98,NA,NA,NA,cell [GO:0005623]; antioxidant activity [GO:0016209]; peroxidase activity [GO:0004601]; thioredoxin peroxidase activity [GO:0008379]; cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_ISCW_ISCW011328.1.1.m.8861,0.00189972297570082,0.0019212147706125,No,NA,NA,Q6AXX4,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; brain development [GO:0007420]; chromatin organization [GO:0006325]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462],NA,NA,NA
CHOYP_ISCW_ISCW011341.1.1.m.18728,-0.0149385530791038,-0.00814974460945225,No,NA,NA,B4NYV0,NA,NA,NA,nucleoplasm [GO:0005654]; conversion of ds siRNA to ss siRNA involved in RNA interference [GO:0033168]; defense response to Gram-negative bacterium [GO:0050829]; mRNA processing [GO:0006397]; negative regulation of viral genome replication [GO:0045071]; primary miRNA processing [GO:0031053]; RNA interference [GO:0016246],NA,NA,NA
CHOYP_ISCW_ISCW012010.1.1.m.27251,0.0100257354525123,-0.0153487825313042,No,NA,NA,P38117,NA,NA,NA,cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539],NA,NA,NA
CHOYP_ISCW_ISCW012036.1.1.m.27987,0.00106147007443691,0.00423616485953641,No,NA,NA,Q24297,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; small nucleolar ribonucleoprotein complex [GO:0005732]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_ISCW_ISCW012228.1.2.m.57884,-0.01439715108544,-0.0110145164469365,No,NA,NA,Q3T100,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; organelle membrane [GO:0031090]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; leukotriene-C4 synthase activity [GO:0004464]; leukotriene biosynthetic process [GO:0019370]; lipid metabolic process [GO:0006629],NA,NA,NA
CHOYP_ISCW_ISCW012232.1.1.m.38746,-0.00302994776882086,0.000117223001991786,No,NA,NA,A8WHP3,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412],NA,NA,NA
CHOYP_ISCW_ISCW012366.1.1.m.3690,-0.00772991990115205,-0.00753957589756084,No,NA,NA,P53563,NA,NA,NA,cell junction [GO:0030054]; centrosome [GO:0005813]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial envelope [GO:0005740]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; postsynapse [GO:0098794]; presynapse [GO:0098793]; synaptic vesicle membrane [GO:0030672]; BH domain binding [GO:0051400]; clathrin binding [GO:0030276]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; GTPase binding [GO:0051020]; MDM2/MDM4 family protein binding [GO:0097371]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; transcription factor binding [GO:0008134]; aging [GO:0007568]; apoptotic process [GO:0006915]; cellular response to astaxanthin [GO:1905218]; cellular response to cAMP [GO:0071320]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to drug [GO:0035690]; cellular response to erythropoietin [GO:0036018]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-1 [GO:0071347]; cellular response to prolactin [GO:1990646]; cellular response to thapsigargin [GO:1904579]; cellular response to tumor necrosis factor [GO:0071356]; cerebral cortex development [GO:0021987]; endocytosis [GO:0006897]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mitotic cell cycle checkpoint [GO:0007093]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of execution phase of apoptosis [GO:1900118]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of synaptic vesicle clustering [GO:2000809]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of synaptic vesicle exocytosis [GO:2000302]; regulation of apoptotic process [GO:0042981]; regulation of cytokinesis [GO:0032465]; regulation of long-term synaptic depression [GO:1900452]; response to drug [GO:0042493]; response to electrical stimulus [GO:0051602]; response to erythropoietin [GO:0036017]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to inorganic substance [GO:0010035]; response to ischemia [GO:0002931]; response to lead ion [GO:0010288]; response to lipopolysaccharide [GO:0032496]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; response to oxidative stress [GO:0006979]; response to peptide hormone [GO:0043434]; synaptic vesicle recycling via endosome [GO:0036466],NA,NA,NA
CHOYP_ISCW_ISCW012366.1.1.m.3691,0.00389619916941378,-0.0233421566456724,No,NA,NA,O75489,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nuclear body [GO:0016604]; electron transfer activity [GO:0009055]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]; mitochondrial electron transport; NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; reactive oxygen species metabolic process [GO:0072593]; substantia nigra development [GO:0021762],NA,NA,NA
CHOYP_ISCW_ISCW012442.1.1.m.8441,0.0191793387411419,0.00271654518550422,No,NA,NA,Q5RBX7,NA,NA,NA,signal recognition particle; endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614],NA,NA,NA
CHOYP_ISCW_ISCW012623.1.1.m.26452,0.00317131011923394,-0.0146455705084173,No,NA,NA,P49256,NA,NA,NA,COPI-coated vesicle [GO:0030137]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; exocytic vesicle [GO:0070382]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; protein transport [GO:0015031],NA,NA,NA
CHOYP_ISCW_ISCW013289.2.2.m.18741,-0.00453106697040212,-0.0184813586255142,No,NA,NA,O22703,NA,NA,NA,nuclear speck [GO:0016607]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; DNA binding [GO:0003677]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of mRNA splicing; via spliceosome [GO:0048026]; response to cold [GO:0009409]; response to water deprivation [GO:0009414],NA,NA,NA
CHOYP_ISCW_ISCW013378.2.3.m.11858,-0.000725866765969756,0.00153199153718291,No,NA,NA,Q8CJG0,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; micro-ribonucleoprotein complex [GO:0035068]; mitochondrion [GO:0005739]; mRNA cap binding complex [GO:0005845]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; core promoter binding [GO:0001047]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; endoribonuclease activity; cleaving miRNA-paired mRNA [GO:0090624]; endoribonuclease activity; cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA binding [GO:0003729]; mRNA cap binding [GO:0098808]; protein C-terminus binding [GO:0008022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; mRNA cleavage involved in gene silencing by siRNA [GO:0090625]; negative regulation of translational initiation [GO:0045947]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of trophoblast cell migration [GO:1901165]; post-embryonic development [GO:0009791]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; RNA secondary structure unwinding [GO:0010501]; siRNA loading onto RISC involved in RNA interference [GO:0035087],NA,NA,NA
CHOYP_ISCW_ISCW013378.3.3.m.20296,-0.00471078502296098,0.0017974715903058,No,NA,NA,Q8CJG0,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; micro-ribonucleoprotein complex [GO:0035068]; mitochondrion [GO:0005739]; mRNA cap binding complex [GO:0005845]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; core promoter binding [GO:0001047]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; endoribonuclease activity; cleaving miRNA-paired mRNA [GO:0090624]; endoribonuclease activity; cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA binding [GO:0003729]; mRNA cap binding [GO:0098808]; protein C-terminus binding [GO:0008022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; mRNA cleavage involved in gene silencing by siRNA [GO:0090625]; negative regulation of translational initiation [GO:0045947]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of trophoblast cell migration [GO:1901165]; post-embryonic development [GO:0009791]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; RNA secondary structure unwinding [GO:0010501]; siRNA loading onto RISC involved in RNA interference [GO:0035087],NA,NA,NA
CHOYP_ISCW_ISCW013556.1.1.m.26406,-0.00212078832001384,-0.00891837260408135,No,NA,NA,Q7T0M6,NA,NA,NA,nucleus [GO:0005634]; chromatin assembly or disassembly [GO:0006333],NA,NA,NA
CHOYP_ISCW_ISCW013767.1.1.m.29335,0.00314175294086275,0.020018291939756,No,NA,NA,O08807,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; smooth endoplasmic reticulum [GO:0005790]; protein homodimerization activity [GO:0042803]; thioredoxin peroxidase activity [GO:0008379]; 4-hydroxyproline metabolic process [GO:0019471]; cell redox homeostasis [GO:0045454]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; male gonad development [GO:0008584]; negative regulation of male germ cell proliferation [GO:2000255]; oxidation-reduction process [GO:0055114]; protein maturation by protein folding [GO:0022417]; reactive oxygen species metabolic process [GO:0072593]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_ISCW_ISCW013795.1.1.m.12153,-0.0153672195719128,-0.00973968799373486,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ISCW_ISCW013810.2.2.m.19882,-0.00225838491707099,0.0175824797494057,No,NA,NA,P36241,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181],NA,NA,NA
CHOYP_ISCW_ISCW014398.1.3.m.15838,0.00206427301843509,0.0193711273756523,No,NA,NA,Q5ZML3,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; RNA binding [GO:0003723]; mRNA cis splicing; via spliceosome [GO:0045292]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],NA,NA,NA
CHOYP_ISCW_ISCW014398.1.3.m.15839,0.00170551798649962,-0.0045248409129572,No,NA,NA,Q5ZML3,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; RNA binding [GO:0003723]; mRNA cis splicing; via spliceosome [GO:0045292]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],NA,NA,NA
CHOYP_ISCW_ISCW014481.1.1.m.61217,0.00380862190469847,-0.00484954332906391,No,NA,NA,P56524,NA,NA,NA,A band [GO:0031672]; actomyosin [GO:0042641]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; Z disc [GO:0030018]; activating transcription factor binding [GO:0033613]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; potassium ion binding [GO:0030955]; promoter-specific chromatin binding [GO:1990841]; protein deacetylase activity [GO:0033558]; protein kinase binding [GO:0019901]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]; SUMO transferase activity [GO:0019789]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; B cell activation [GO:0042113]; B cell differentiation [GO:0030183]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to mechanical stimulus [GO:0071260]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to tumor necrosis factor [GO:0071356]; chromatin remodeling [GO:0006338]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; inflammatory response [GO:0006954]; negative regulation of cell proliferation [GO:0008285]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of glycolytic process [GO:0045820]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; nervous system development [GO:0007399]; osteoblast development [GO:0002076]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of cell proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; protein deacetylation [GO:0006476]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of gene expression; epigenetic [GO:0040029]; regulation of protein binding [GO:0043393]; regulation of skeletal muscle fiber development [GO:0048742]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to drug [GO:0042493]; response to interleukin-1 [GO:0070555]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_ISCW_ISCW014579.2.2.m.5327,0.000820369574951505,-0.00818635667722574,No,NA,NA,Q8VHF0,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; establishment of cell polarity [GO:0030010]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of hippo signaling [GO:0035331]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of protein binding [GO:0032092]; protein phosphorylation [GO:0006468],NA,NA,NA
CHOYP_ISCW_ISCW014726.5.5.m.47210,-0.01125055846997,0.00651901038936724,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ISCW_ISCW014880.1.1.m.27977,-0.000108471194682469,-0.020706796674822,No,NA,NA,Q7L7X3,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; kinase activity [GO:0016301]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; transferase activity [GO:0016740]; activation of JUN kinase activity [GO:0007257]; activation of MAPK activity [GO:0000187]; activation of MAPKK activity [GO:0000186]; activation of protein kinase activity [GO:0032147]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; execution phase of apoptosis [GO:0097194]; microtubule cytoskeleton organization [GO:0000226]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of microtubule depolymerization [GO:0007026]; neuron cellular homeostasis [GO:0070050]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein acetylation [GO:1901985]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cytoskeleton organization [GO:0051493]; regulation of microtubule cytoskeleton organization [GO:0070507]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_ISCW_ISCW015061.1.1.m.51,-0.0112073334186849,-0.00580693357365317,No,NA,NA,O08662,NA,NA,NA,cytoplasm [GO:0005737]; Golgi-associated vesicle membrane [GO:0030660]; membrane [GO:0016020]; plasma membrane [GO:0005886]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-mediated signaling [GO:0048015],NA,NA,NA
CHOYP_ISCW_ISCW015295.1.1.m.22192,-0.0148952882788077,0.00063074331403748,No,NA,NA,O88986,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; glycine C-acetyltransferase activity [GO:0008890]; pyridoxal phosphate binding [GO:0030170]; biosynthetic process [GO:0009058]; L-threonine catabolic process to glycine [GO:0019518],NA,NA,NA
CHOYP_ISCW_ISCW016148.3.6.m.54385,-0.00346089012975424,0.0130851942789952,No,NA,NA,P31674,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412],NA,NA,NA
CHOYP_ISCW_ISCW016212.1.2.m.2539,0.00156077608007049,-0.00752074149048004,No,NA,NA,Q9W5U2,NA,NA,NA,extracellular region [GO:0005576]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272],NA,NA,NA
CHOYP_ISCW_ISCW016212.2.2.m.46221,-0.00686663660444662,-0.00195683626109279,No,NA,NA,Q9W5U2,NA,NA,NA,extracellular region [GO:0005576]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272],NA,NA,NA
CHOYP_ISCW_ISCW016254.2.5.m.38599,-0.0112842053303358,0.00498502154317377,No,NA,NA,Q9W141,NA,NA,NA,mitochondrial proton-transporting ATP synthase complex; coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]; ATP biosynthetic process [GO:0006754]; proton transmembrane transport [GO:1902600],NA,NA,NA
CHOYP_ISCW_ISCW016289.1.1.m.12312,-0.0115312860246775,-0.0079950210525386,No,NA,NA,P57721,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; C-rich single-stranded DNA binding [GO:1990829]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; mRNA metabolic process [GO:0016071],NA,NA,NA
CHOYP_ISCW_ISCW016328.1.1.m.10256,0.0065883263884642,0.0180931628217626,No,NA,NA,Q9R1C6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; modulation of chemical synaptic transmission [GO:0050804]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205],NA,NA,NA
CHOYP_ISCW_ISCW017188.1.1.m.23179,-0.0101636783596054,0.00711310880937447,No,NA,NA,Q8WVM7,NA,NA,NA,chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome; centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; regulation of mitotic spindle assembly [GO:1901673],NA,NA,NA
CHOYP_ISCW_ISCW017350.1.1.m.11950,-0.0054291219474516,0.0161189505035415,No,NA,NA,Q24537,NA,NA,NA,cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; DNA binding; bending [GO:0008301]; single-stranded DNA binding [GO:0003697]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]; chromatin remodeling [GO:0006338]; developmental process [GO:0032502]; DNA recombination [GO:0006310]; DNA unwinding involved in DNA replication [GO:0006268]; leg disc development [GO:0035218]; negative regulation of antimicrobial humoral response [GO:0008348]; negative regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0017055]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of DNA binding [GO:0043388]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; segment specification [GO:0007379],NA,NA,NA
CHOYP_ISCW_ISCW017474.1.1.m.18280,0.00325964054766292,-0.0143201486020453,No,NA,NA,Q4PJX1,NA,NA,NA,integral component of membrane [GO:0016021]; protein localization [GO:0008104],NA,NA,NA
CHOYP_ISCW_ISCW017519.1.2.m.935,0.0117552193576561,-0.0112809754288792,No,NA,NA,Q5R5V4,NA,NA,NA,focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674],NA,NA,NA
CHOYP_ISCW_ISCW017526.2.2.m.57044,0.0107109190765934,0.00137445471633301,No,NA,NA,Q9VZZ9,NA,NA,NA,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; SH2 domain binding [GO:0042169]; anterior/posterior axis specification; embryo [GO:0008595]; antimicrobial humoral response [GO:0019730]; photoreceptor cell development [GO:0042461]; R7 cell fate commitment [GO:0007465]; regulation of Ras protein signal transduction [GO:0046578]; sevenless signaling pathway [GO:0045500]; torso signaling pathway [GO:0008293],NA,NA,NA
CHOYP_ISCW_ISCW017652.1.1.m.49306,-0.00363782211467457,-0.0257001392705087,No,NA,NA,Q32PI8,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; mitochondrial ribosome binding [GO:0097177]; rRNA binding [GO:0019843]; tRNA binding [GO:0000049]; cell proliferation [GO:0008283]; positive regulation of mitochondrial translation [GO:0070131],NA,NA,NA
CHOYP_ISCW_ISCW017655.1.1.m.22914,0.00674527773879049,0.00177853114448818,No,NA,NA,Q95WA0,NA,NA,NA,large ribosomal subunit [GO:0015934]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_ISCW_ISCW017707.1.1.m.58329,0.0128401562191597,-0.00569758381616163,No,NA,NA,Q9Y2H1,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; actin binding [GO:0003779]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of cellular component organization [GO:0051128],NA,NA,NA
CHOYP_ISCW_ISCW017709.1.1.m.30040,-0.0126458255358153,-0.0236358148322899,No,NA,NA,Q04757,NA,NA,NA,membrane [GO:0016020],NA,NA,NA
CHOYP_ISCW_ISCW017872.2.2.m.60293,0.00507005343699399,0.0127451232008201,No,NA,NA,P70365,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuron projection [GO:0043005]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; aryl hydrocarbon receptor binding [GO:0017162]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone acetyltransferase activity [GO:0004402]; nuclear hormone receptor binding [GO:0035257]; nuclear receptor binding [GO:0016922]; nuclear receptor transcription coactivator activity [GO:0030374]; progesterone receptor binding [GO:0033142]; protein dimerization activity [GO:0046983]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; retinoic acid receptor binding [GO:0042974]; retinoid X receptor binding [GO:0046965]; RNA polymerase II regulatory region DNA binding [GO:0001012]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; cellular response to hormone stimulus [GO:0032870]; cellular response to Thyroglobulin triiodothyronine [GO:1904017]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; estrous cycle [GO:0044849]; hippocampus development [GO:0021766]; histone H4 acetylation [GO:0043967]; hypothalamus development [GO:0021854]; labyrinthine layer morphogenesis [GO:0060713]; lactation [GO:0007595]; male gonad development [GO:0008584]; male mating behavior [GO:0060179]; positive regulation of apoptotic process [GO:0043065]; positive regulation of female receptivity [GO:0045925]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter by galactose [GO:0000435]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of cellular response to drug [GO:2001038]; regulation of RNA biosynthetic process [GO:2001141]; regulation of thyroid hormone mediated signaling pathway [GO:0002155]; response to estradiol [GO:0032355]; response to progesterone [GO:0032570]; response to retinoic acid [GO:0032526]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_ISCW_ISCW018108.1.1.m.43365,-0.00608622912344548,-0.0116026631935559,No,NA,NA,Q9C0D3,NA,NA,NA,Cul2-RING ubiquitin ligase complex [GO:0031462]; ubiquitin-protein transferase activity [GO:0004842]; regulation of ubiquitin-protein transferase activity [GO:0051438],NA,NA,NA
CHOYP_ISCW_ISCW018298.1.1.m.741,-0.00192728901770842,0.000351755408486094,No,NA,NA,Q12893,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; negative regulation of cell proliferation [GO:0008285]; protein glycosylation [GO:0006486]; protein transport [GO:0015031]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_ISCW_ISCW018425.1.1.m.35608,0.0211795558962184,-0.00175528428290509,No,NA,NA,P81623,NA,NA,NA,cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; activation of MAPK activity [GO:0000187]; negative regulation of gene expression [GO:0010629]; negative regulation of protein secretion [GO:0050709]; positive regulation of gene expression [GO:0010628]; protein secretion [GO:0009306]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235],NA,NA,NA
CHOYP_ISCW_ISCW018501.2.2.m.61797,-0.0104951371908547,-0.0212683473238277,No,NA,NA,Q5F452,NA,NA,NA,nuclear envelope [GO:0005635]; phosphatidylinositol-3;5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein tyrosine phosphatase activity [GO:0004725]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of autophagy [GO:0010506],NA,NA,NA
CHOYP_ISCW_ISCW018536.1.1.m.56336,0.00746606664188788,-0.00349161263823579,No,NA,NA,Q8C0E2,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; late endosome [GO:0005770]; phagocytic vesicle [GO:0045335]; retromer complex [GO:0030904]; protein transporter activity [GO:0008565]; cellular response to interferon-gamma [GO:0071346]; intracellular protein transport [GO:0006886]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_ISCW_ISCW018656.1.1.m.51893,-0.0158156086615956,-0.016604511512227,No,NA,NA,Q6PGW3,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_ISCW_ISCW019027.2.2.m.66984,0.0134175632623342,0.0118236506119105,No,NA,NA,Q2PFW9,NA,NA,NA,nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_ISCW_ISCW019130.1.2.m.10722,-0.00233035031582327,-0.00679360670340168,No,NA,NA,Q3SZ90,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; GAIT complex [GO:0097452]; ribosome [GO:0005840]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; negative regulation of formation of translation preinitiation complex [GO:1901194]; negative regulation of translation [GO:0017148]; translation [GO:0006412],NA,NA,NA
CHOYP_ISCW_ISCW019177.2.4.m.56600,-0.0158272500583603,0.00200451695010462,No,NA,NA,Q9CYL5,NA,NA,NA,extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; protein homodimerization activity [GO:0042803]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374],NA,NA,NA
CHOYP_ISCW_ISCW019177.4.4.m.63940,-0.0226661861626121,0.0103068364735051,No,NA,NA,Q9CYL5,NA,NA,NA,extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; protein homodimerization activity [GO:0042803]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374],NA,NA,NA
CHOYP_ISCW_ISCW019590.1.1.m.30707,-0.000184157194302277,0.0127185041096646,No,NA,NA,Q7KRY7,NA,NA,NA,apicolateral plasma membrane [GO:0016327]; basolateral part of cell [GO:1990794]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; fusome [GO:0045169]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; postsynaptic density [GO:0014069]; septate junction [GO:0005918]; synapse [GO:0045202]; ionotropic glutamate receptor binding [GO:0035255]; anterior/posterior axis specification; follicular epithelium [GO:0030714]; basal protein localization [GO:0045175]; cell fate commitment involved in pattern specification [GO:0060581]; cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; cell proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; compound eye development [GO:0048749]; dorsal closure [GO:0007391]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; Malpighian tubule development [GO:0072002]; memory [GO:0007613]; morphogenesis of a polarized epithelium [GO:0001738]; morphogenesis of embryonic epithelium [GO:0016331]; morphogenesis of follicular epithelium [GO:0016333]; morphogenesis of larval imaginal disc epithelium [GO:0016335]; negative regulation of cell proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurotransmitter receptor transport postsynaptic membrane to endosome [GO:0098968]; neurotransmitter receptor transport; endosome to postsynaptic membrane [GO:0098887]; olfactory behavior [GO:0042048]; ovarian follicle cell development [GO:0030707]; pole plasm protein localization [GO:0007318]; R3/R4 cell fate commitment [GO:0007464]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of cell cycle [GO:0051726]; regulation of endocytosis [GO:0030100]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of JAK-STAT cascade [GO:0046425]; regulation of Notch signaling pathway [GO:0008593]; regulation of synapse structure or activity [GO:0050803]; sensory perception of smell [GO:0007608]; septate junction assembly [GO:0019991]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; wing disc morphogenesis [GO:0007472]; zonula adherens assembly [GO:0045186],NA,NA,NA
CHOYP_ISCW_ISCW019991.1.5.m.8713,-0.00841903973516341,-0.0152398528304008,No,NA,NA,Q6DFR2,NA,NA,NA,cytoplasm [GO:0005737]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; phosphotyrosine residue binding [GO:0001784]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase activity [GO:0061630]; cell surface receptor signaling pathway [GO:0007166]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_ISCW_ISCW020028.1.1.m.57937,0.0193598406737618,-0.0114282593488231,No,NA,NA,Q9I7F7,NA,NA,NA,ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; dorsal closure; amnioserosa morphology change [GO:0046664]; head involution [GO:0008258]; myosin filament assembly [GO:0031034]; protein phosphorylation [GO:0006468],NA,NA,NA
CHOYP_ISCW_ISCW020302.1.1.m.37564,0.00799069045058067,-0.0125924828355723,No,NA,NA,Q17QJ7,NA,NA,NA,mitochondrion [GO:0005739]; pyrroline-5-carboxylate reductase activity [GO:0004735]; cellular response to oxidative stress [GO:0034599]; L-proline biosynthetic process [GO:0055129]; proline biosynthetic process [GO:0006561],NA,NA,NA
CHOYP_ISCW_ISCW020550.2.2.m.18099,0.0147035863600666,-0.00111427200170888,No,NA,NA,O35796,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; presynaptic active zone [GO:0048786]; adrenergic receptor binding [GO:0031690]; complement component C1q binding [GO:0001849]; hyaluronic acid binding [GO:0005540]; kininogen binding [GO:0030984]; mitochondrial ribosome binding [GO:0097177]; mRNA binding [GO:0003729]; protein kinase C binding [GO:0005080]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; translation activator activity [GO:0008494]; apoptotic process [GO:0006915]; complement activation; classical pathway [GO:0006958]; immune response [GO:0006955]; innate immune response [GO:0045087]; mature ribosome assembly [GO:0042256]; mRNA processing [GO:0006397]; negative regulation of defense response to virus [GO:0050687]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of MDA-5 signaling pathway [GO:0039534]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell adhesion [GO:0045785]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of mitochondrial translation [GO:0070131]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of trophoblast cell migration [GO:1901165]; regulation of complement activation [GO:0030449]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_ISCW_ISCW021350.1.1.m.10332,-0.00968435479255309,0.00958217642639821,No,NA,NA,Q01105,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; histone binding [GO:0042393]; protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]; DNA replication [GO:0006260]; negative regulation of histone acetylation [GO:0035067]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription; DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; regulation of mRNA stability [GO:0043488]; viral process [GO:0016032],NA,NA,NA
CHOYP_ISCW_ISCW021457.1.1.m.31134,-0.0126815824925978,-0.0219169051228671,No,NA,NA,Q5XIH7,NA,NA,NA,cytoplasm [GO:0005737]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]; cellular response to hypoxia [GO:0071456]; cellular response to retinoic acid [GO:0071300]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription; DNA-templated [GO:0045892]; response to wounding [GO:0009611],NA,NA,NA
CHOYP_ISCW_ISCW021476.1.1.m.29578,-0.0073529517724365,-0.00133774571412388,No,NA,NA,Q66KE3,NA,NA,NA,mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; pre-mRNA cleavage required for polyadenylation [GO:0098789],NA,NA,NA
CHOYP_ISCW_ISCW021545.1.1.m.25379,0.00180656071018493,0.00897354986813137,No,NA,NA,P35555,NA,NA,NA,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877]; activation of protein kinase A activity [GO:0034199]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular protein metabolic process [GO:0044267]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; extracellular matrix organization [GO:0030198]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; post-translational protein modification [GO:0043687]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_ISCW_ISCW021591.1.1.m.13969,0.00343066803817184,0.0124544401824005,No,NA,NA,Q5RE70,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; SOSS complex [GO:0070876]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; mitotic cell cycle checkpoint [GO:0007093]; response to ionizing radiation [GO:0010212],NA,NA,NA
CHOYP_ISCW_ISCW021591.1.1.m.13970,0.011542498447894,-0.0157661986868524,No,NA,NA,Q2KJG3,NA,NA,NA,cytoplasm [GO:0005737]; asparagine-tRNA ligase activity [GO:0004816]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; asparaginyl-tRNA aminoacylation [GO:0006421],NA,NA,NA
CHOYP_ISCW_ISCW021601.2.2.m.20304,0.0171746434349369,-0.0170171242320553,No,NA,NA,Q6INR1,NA,NA,NA,eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732],NA,NA,NA
CHOYP_ISCW_ISCW022021.1.1.m.53168,0.0162932254003581,0.0135354909973452,No,NA,NA,A2AVA0,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_ISCW_ISCW022029.1.1.m.9014,0.000590823210639743,-0.0123750543090194,No,NA,NA,P61258,NA,NA,NA,centrosome [GO:0005813]; chromatin [GO:0000785]; nuclear body [GO:0016604]; nuclear replication fork [GO:0043596]; PCNA complex [GO:0043626]; PCNA-p21 complex [GO:0070557]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; dinucleotide insertion or deletion binding [GO:0032139]; DNA polymerase binding [GO:0070182]; DNA polymerase processivity factor activity [GO:0030337]; histone acetyltransferase binding [GO:0035035]; identical protein binding [GO:0042802]; MutLalpha complex binding [GO:0032405]; purine-specific mismatch base pair DNA N-glycosylase activity [GO:0000701]; receptor tyrosine kinase binding [GO:0030971]; cellular response to UV [GO:0034644]; DNA replication [GO:0006260]; epithelial cell differentiation [GO:0030855]; mismatch repair [GO:0006298]; positive regulation of deoxyribonuclease activity [GO:0032077]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; translesion synthesis [GO:0019985],NA,NA,NA
CHOYP_ISCW_ISCW022189.1.1.m.8227,-0.00111977454335006,0.0166382137143997,No,NA,NA,Q9XZ71,NA,NA,NA,troponin complex [GO:0005861]; regulation of muscle contraction [GO:0006937],NA,NA,NA
CHOYP_ISCW_ISCW022609.1.1.m.26988,-0.00430894344577715,-0.00631540690244347,No,NA,NA,P97521,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; transmembrane transporter activity [GO:0022857]; carnitine transmembrane transport [GO:1902603],NA,NA,NA
CHOYP_ISCW_ISCW022842.1.1.m.5648,0.00891358632339791,-0.00385125201721442,No,NA,NA,Q8VI63,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuron projection terminus [GO:0044306]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; metal ion binding [GO:0046872]; actin cytoskeleton organization [GO:0030036]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein phosphorylation [GO:0001934],NA,NA,NA
CHOYP_ISCW_ISCW022925.1.2.m.61535,0.0115202757786242,-0.0125645540968714,No,NA,NA,Q9UEW8,NA,NA,NA,apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; cellular hypotonic response [GO:0071476]; cellular response to chemokine [GO:1990869]; chemokine (C-X-C motif) ligand 12 signaling pathway [GO:0038146]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; maintenance of lens transparency [GO:0036438]; negative regulation of creatine transmembrane transporter activity [GO:1905408]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of ion transmembrane transporter activity [GO:0032414]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of T cell chemotaxis [GO:0010820]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; signal transduction by protein phosphorylation [GO:0023014]; signal transduction by trans-phosphorylation [GO:0023016]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_ISCW_ISCW023153.1.1.m.10480,-0.0107328720921963,0.00202430113605627,No,NA,NA,Q96GG9,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; cullin family protein binding [GO:0097602]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein binding [GO:0032182]; positive regulation of protein neddylation [GO:2000436]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; post-translational protein modification [GO:0043687]; protein neddylation [GO:0045116],NA,NA,NA
CHOYP_ISCW_ISCW023180.1.2.m.31255,-0.0106824573212785,-0.0188184456308964,No,NA,NA,Q8WXF0,NA,NA,NA,nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; RS domain binding [GO:0050733]; unfolded protein binding [GO:0051082]; mRNA 5'-splice site recognition [GO:0000395]; mRNA cis splicing; via spliceosome [GO:0045292]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; spliceosomal tri-snRNP complex assembly [GO:0000244],NA,NA,NA
CHOYP_ISCW_ISCW023297.1.1.m.11833,0.0086336152445761,-0.0240043762498784,No,NA,NA,Q9DCD2,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; blastocyst development [GO:0001824]; cerebral cortex development [GO:0021987]; generation of catalytic spliceosome for first transesterification step [GO:0000349]; mRNA splicing; via spliceosome [GO:0000398]; transcription; DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283],NA,NA,NA
CHOYP_ISCW_ISCW023591.1.1.m.9921,0.0108962627621076,0.00135426617095897,No,NA,NA,P38942,NA,NA,NA,transferase activity [GO:0016740]; acetyl-CoA metabolic process [GO:0006084],NA,NA,NA
CHOYP_ISCW_ISCW023973.1.2.m.6506,0.00705419180576983,-0.0123192281968681,No,NA,NA,Q28F07,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; histone-arginine N-methyltransferase activity [GO:0008469]; identical protein binding [GO:0042802]; N-methyltransferase activity [GO:0008170]; protein methyltransferase activity [GO:0008276]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; S-adenosyl-L-methionine binding [GO:1904047]; transcription coactivator activity [GO:0003713]; histone arginine methylation [GO:0034969]; histone H4-R3 methylation [GO:0043985]; histone methylation [GO:0016571]; metamorphosis [GO:0007552]; negative regulation of megakaryocyte differentiation [GO:0045653]; neurogenesis [GO:0022008]; peptidyl-arginine methylation [GO:0018216]; peptidyl-arginine methylation; to asymmetrical-dimethyl arginine [GO:0019919]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription; DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; protein methylation [GO:0006479]; regulation of histone modification [GO:0031056]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_ISL1.1.1.m.10993,-0.00733489441457096,0.0205665440195495,No,NA,NA,P61374,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; enhancer sequence-specific DNA binding [GO:0001158]; estrogen receptor binding [GO:0030331]; metal ion binding [GO:0046872]; nuclear receptor binding [GO:0016922]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; atrial septum morphogenesis [GO:0060413]; axon regeneration [GO:0031103]; cardiac cell fate determination [GO:0060913]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac right ventricle morphogenesis [GO:0003215]; cellular response to glucocorticoid stimulus [GO:0071385]; endocardial cushion morphogenesis [GO:0003203]; heart development [GO:0007507]; innervation [GO:0060384]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of inflammatory response [GO:0050728]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein homodimerization activity [GO:0090074]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell migration [GO:0001755]; outflow tract septum morphogenesis [GO:0003148]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; pharyngeal system development [GO:0060037]; pituitary gland development [GO:0021983]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of granulocyte colony-stimulating factor production [GO:0071657]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of histone acetylation [GO:0035066]; positive regulation of insulin secretion [GO:0032024]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 alpha production [GO:0032730]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of transcription; DNA-templated [GO:0006355]; retinal ganglion cell axon guidance [GO:0031290]; secondary heart field specification [GO:0003139]; sensory system development [GO:0048880]; spinal cord motor neuron cell fate specification [GO:0021520]; trigeminal nerve development [GO:0021559]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; visceral motor neuron differentiation [GO:0021524],NA,NA,NA
CHOYP_ISY1.1.1.m.53545,-0.0194489817117044,0.00833386072653858,No,NA,NA,Q6AYB3,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; post-mRNA release spliceosomal complex [GO:0071014]; post-spliceosomal complex [GO:0071020]; Prp19 complex [GO:0000974]; generation of catalytic spliceosome for second transesterification step [GO:0000350]; mRNA 3'-splice site recognition [GO:0000389],NA,NA,NA
CHOYP_ITA5.1.1.m.55930,-0.00813982232987474,0.00980075851209436,No,NA,NA,P26009,NA,NA,NA,integrin complex [GO:0008305]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; integrin-mediated signaling pathway [GO:0007229]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_ITA7.1.1.m.1060,-0.0150079388780714,-6.73540266446611e-05,No,NA,NA,P23229,NA,NA,NA,basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell surface [GO:0009986]; cell-cell adherens junction [GO:0005913]; external side of plasma membrane [GO:0009897]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; hemidesmosome [GO:0030056]; integrin alpha6-beta4 complex [GO:0034676]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; insulin-like growth factor I binding [GO:0031994]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; neuregulin binding [GO:0038132]; protein-containing complex binding [GO:0044877]; amelogenesis [GO:0097186]; brown fat cell differentiation [GO:0050873]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; cell-substrate junction assembly [GO:0007044]; cellular response to extracellular stimulus [GO:0031668]; cellular response to organic cyclic compound [GO:0071407]; digestive tract development [GO:0048565]; ectodermal cell differentiation [GO:0010668]; extracellular matrix organization [GO:0030198]; filopodium assembly [GO:0046847]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; leukocyte migration [GO:0050900]; nail development [GO:0035878]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transcription by RNA polymerase II [GO:0045944]; renal system development [GO:0072001]; skin development [GO:0043588],NA,NA,NA
CHOYP_ITB1.2.4.m.24270,0.000686232728993107,-0.0107331332691118,No,NA,NA,O54890,NA,NA,NA,alpha9-beta1 integrin-ADAM8 complex [GO:0071133]; alphav-beta3 integrin-HMGB1 complex [GO:0035868]; alphav-beta3 integrin-IGF-1-IGF1R complex [GO:0035867]; alphav-beta3 integrin-PKCalpha complex [GO:0035866]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; filopodium membrane [GO:0031527]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; integral component of synaptic membrane [GO:0099699]; integrin alpha9-beta1 complex [GO:0034679]; integrin alphav-beta3 complex [GO:0034683]; integrin complex [GO:0008305]; lamellipodium membrane [GO:0031258]; melanosome [GO:0042470]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ruffle membrane [GO:0032587]; cell adhesion molecule binding [GO:0050839]; enzyme binding [GO:0019899]; extracellular matrix binding [GO:0050840]; fibrinogen binding [GO:0070051]; fibronectin binding [GO:0001968]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protease binding [GO:0002020]; protein disulfide isomerase activity [GO:0003756]; protein kinase C binding [GO:0005080]; vascular endothelial growth factor receptor 2 binding [GO:0043184]; activation of protein kinase activity [GO:0032147]; apolipoprotein A-I-mediated signaling pathway [GO:0038027]; apoptotic cell clearance [GO:0043277]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell projection morphogenesis [GO:0048858]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; cell-substrate junction assembly [GO:0007044]; cellular response to drug [GO:0035690]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to mechanical stimulus [GO:0071260]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; embryo implantation [GO:0007566]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; negative chemotaxis [GO:0050919]; negative regulation of cell death [GO:0060548]; negative regulation of lipid storage [GO:0010888]; negative regulation of lipid transport [GO:0032369]; negative regulation of lipoprotein metabolic process [GO:0050748]; negative regulation of low-density lipoprotein particle receptor biosynthetic process [GO:0045715]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of adenylate cyclase-inhibiting opioid receptor signaling pathway [GO:1900731]; positive regulation of angiogenesis [GO:0045766]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of glomerular mesangial cell proliferation [GO:0072126]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of T cell migration [GO:2000406]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of extracellular matrix organization [GO:1903053]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of protein tyrosine kinase activity [GO:0061097]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to activity [GO:0014823]; response to radiation [GO:0009314]; smooth muscle cell migration [GO:0014909]; substrate adhesion-dependent cell spreading [GO:0034446]; viral entry into host cell [GO:0046718],NA,NA,NA
CHOYP_ITB1.3.4.m.28565,-0.0103394715999158,0.00626930292398718,No,NA,NA,P11584,NA,NA,NA,apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; costamere [GO:0043034]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; integrin binding [GO:0005178]; protein heterodimerization activity [GO:0046982]; actin filament organization [GO:0007015]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth; open tracheal system [GO:0035001]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity; open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; positive regulation of synapse maturation [GO:0090129]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration; cell extension [GO:0006930]; ventral cord development [GO:0007419]; visual perception [GO:0007601],NA,NA,NA
CHOYP_ITB1B.1.1.m.59423,-0.00197920493794784,0.0127326665939432,No,NA,NA,B0FYY4,NA,NA,NA,cell surface [GO:0009986]; focal adhesion [GO:0005925]; integrin complex [GO:0008305]; invadopodium membrane [GO:0071438]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; recycling endosome [GO:0055037]; ruffle membrane [GO:0032587]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; signaling receptor activity [GO:0038023]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; integrin-mediated signaling pathway [GO:0007229]; positive regulation of protein localization to plasma membrane [GO:1903078]; receptor internalization [GO:0031623]; regulation of collagen catabolic process [GO:0010710],NA,NA,NA
CHOYP_ITF2.1.1.m.1446,0.00701769100380352,-0.012158283601173,No,NA,NA,Q62655,NA,NA,NA,nucleus [GO:0005634]; transcription factor complex [GO:0005667]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; E-box binding [GO:0070888]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_ITIH3.1.3.m.21736,-0.0225602959807724,0.00998083215783538,No,NA,NA,Q8N801,NA,NA,NA,cytoplasm [GO:0005737]; female pronucleus [GO:0001939]; germinal vesicle [GO:0042585]; male pronucleus [GO:0001940]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; C-5 methylation of cytosine [GO:0090116]; chromatin organization [GO:0006325]; DNA demethylation of male pronucleus [GO:0044727]; positive regulation of DNA demethylation [GO:1901537],NA,NA,NA
CHOYP_ITPA.1.1.m.13655,-0.00612895923057486,0.0011454734055942,No,NA,NA,A7RWC9,NA,NA,NA,cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; nucleotide binding [GO:0000166]; deoxyribonucleoside triphosphate catabolic process [GO:0009204]; nucleoside triphosphate catabolic process [GO:0009143]; nucleotide metabolic process [GO:0009117],NA,NA,NA
CHOYP_ITSN1.4.4.m.35131,-0.00527056603787041,0.00124583561452815,No,NA,NA,O42287,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; membrane [GO:0016020]; neuron projection [GO:0043005]; nuclear envelope [GO:0005635]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; endocytosis [GO:0006897]; intracellular signal transduction [GO:0035556]; regulation of Rho protein signal transduction [GO:0035023],NA,NA,NA
CHOYP_IVBI.2.2.m.67049,-0.0225615597109585,0.0099830508472755,No,NA,NA,Q90W98,NA,NA,NA,extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867],NA,NA,NA
CHOYP_IVD.1.2.m.5213,-0.00824756243762374,0.0118687061082515,No,NA,NA,Q9JHI5,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; flavin adenine dinucleotide binding [GO:0050660]; isovaleryl-CoA dehydrogenase activity [GO:0008470]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; leucine catabolic process [GO:0006552],NA,NA,NA
CHOYP_IVD.2.2.m.14522,-0.00935083614938625,0.00060548523003406,No,NA,NA,P34275,NA,NA,NA,plasma membrane [GO:0005886]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; leucine catabolic process [GO:0006552],NA,NA,NA
CHOYP_IWS1.1.1.m.13972,-0.00440038161686579,-0.00525279344361361,No,NA,NA,Q3SWT4,NA,NA,NA,nucleus [GO:0005634]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; regulation of histone H3-K36 trimethylation [GO:2001253]; regulation of histone H4 acetylation [GO:0090239]; regulation of mRNA export from nucleus [GO:0010793]; regulation of mRNA processing [GO:0050684]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_IWS1.1.1.m.13973,0.00678620130084429,0.00878741825264137,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_JIP3.1.1.m.25162,-0.00144817275391381,-0.0247648218532994,No,NA,NA,Q58A65,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; perinuclear region of cytoplasm [GO:0048471]; JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase p38 binding [GO:0048273]; receptor signaling complex scaffold activity [GO:0030159]; activation of JUN kinase activity [GO:0007257]; activation of MAPK activity [GO:0000187]; negative regulation of protein homodimerization activity [GO:0090074]; positive regulation of cell migration [GO:0030335]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron differentiation [GO:0045666]; protein homooligomerization [GO:0051260]; retrograde transport; endosome to Golgi [GO:0042147]; striated muscle cell differentiation [GO:0051146]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_JNK.1.1.m.1540,-0.0116414538928083,-0.0109870242664381,No,NA,NA,P92208,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; JUN kinase activity [GO:0004705]; MAP kinase activity [GO:0004707]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to organic substance [GO:0071310]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; chorion micropyle formation [GO:0046844]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal closure; spreading of leading edge cells [GO:0007395]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc fusion; thorax closure [GO:0046529]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; wound healing [GO:0042060]; wound healing; spreading of epidermal cells [GO:0035313],NA,NA,NA
CHOYP_K0020.1.1.m.1673,-0.00283725819850652,0.00375390841531361,No,NA,NA,Q562C7,NA,NA,NA,chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; regulation of protein ADP-ribosylation [GO:0010835],NA,NA,NA
CHOYP_K11G12.5.1.1.m.55605,0.00364778592941831,-0.00872052841558097,No,NA,NA,Q9UBX3,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; antiporter activity [GO:0015297]; dicarboxylic acid transmembrane transporter activity [GO:0005310]; malate transmembrane transporter activity [GO:0015140]; oxaloacetate transmembrane transporter activity [GO:0015131]; succinate transmembrane transporter activity [GO:0015141]; sulfate transmembrane transporter activity [GO:0015116]; thiosulfate transmembrane transporter activity [GO:0015117]; dicarboxylic acid transport [GO:0006835]; gluconeogenesis [GO:0006094]; ion transport [GO:0006811]; malate transmembrane transport [GO:0071423]; mitochondrial transport [GO:0006839]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; succinate transmembrane transport [GO:0071422]; sulfate transport [GO:0008272]; sulfide oxidation; using sulfide:quinone oxidoreductase [GO:0070221]; thiosulfate transport [GO:0015709],NA,NA,NA
CHOYP_K1239.3.3.m.45453,-0.00912672607553617,0.00147407685600984,No,NA,NA,Q9ULI1,NA,NA,NA,unfolded protein binding [GO:0051082]; ribosomal large subunit biogenesis [GO:0042273],NA,NA,NA
CHOYP_K1468.1.1.m.24917,0.00351973567895213,-0.0201848213894163,No,NA,NA,Q6P6Y1,NA,NA,NA,recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; intracellular cholesterol transport [GO:0032367],NA,NA,NA
CHOYP_K1609.1.1.m.17775,0.0232849810272115,-0.00826091439468538,No,NA,NA,Q5ZJX5,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020],NA,NA,NA
CHOYP_K6PF.1.1.m.46882,0.00963850362591751,0.00495838388004356,No,NA,NA,P52034,NA,NA,NA,6-phosphofructokinase complex [GO:0005945]; 6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; canonical glycolysis [GO:0061621]; fructose 1;6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose catabolic process [GO:0006007]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; myoblast fusion [GO:0007520]; protein complex oligomerization [GO:0051259]; response to sucrose [GO:0009744]; somatic muscle development [GO:0007525],NA,NA,NA
CHOYP_KAL1.1.1.m.60996,0.0179138800512136,-0.017146536231929,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_KALRN.1.2.m.891,0.00983009393176376,0.0046807832654702,No,NA,NA,O60229,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; adult locomotory behavior [GO:0008344]; ephrin receptor signaling pathway [GO:0048013]; G protein-coupled receptor signaling pathway [GO:0007186]; habituation [GO:0046959]; intracellular signal transduction [GO:0035556]; lactation [GO:0007595]; maternal behavior [GO:0042711]; maternal process involved in parturition [GO:0060137]; memory [GO:0007613]; negative regulation of growth hormone secretion [GO:0060125]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; positive regulation of apoptotic process [GO:0043065]; positive regulation of dendritic spine morphogenesis [GO:0061003]; protein phosphorylation [GO:0006468]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; social behavior [GO:0035176]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_KAPR.1.3.m.8246,0.00582316978948611,0.00271993547421588,No,NA,NA,P31319,NA,NA,NA,cAMP-dependent protein kinase complex [GO:0005952]; cAMP binding [GO:0030552]; cAMP-dependent protein kinase regulator activity [GO:0008603],NA,NA,NA
CHOYP_KAPR.2.3.m.56519,-0.00726949337144384,-0.0184440076287073,No,NA,NA,P31319,NA,NA,NA,cAMP-dependent protein kinase complex [GO:0005952]; cAMP binding [GO:0030552]; cAMP-dependent protein kinase regulator activity [GO:0008603],NA,NA,NA
CHOYP_KARG.11.11.m.50800,0.00302022110095908,-0.00590111760365776,No,NA,NA,O15990,NA,NA,NA,arginine kinase activity [GO:0004054]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_KARG.2.11.m.2196,-0.00345777084159622,0.0165979424999357,No,NA,NA,O15990,NA,NA,NA,arginine kinase activity [GO:0004054]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_KARG.3.11.m.2494,-0.0161907163447578,-0.00126821173959558,No,NA,NA,O15990,NA,NA,NA,arginine kinase activity [GO:0004054]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_KARG.4.11.m.5401,0.00768926080247352,0.00827948162937483,No,NA,NA,O15990,NA,NA,NA,arginine kinase activity [GO:0004054]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_KARG.9.11.m.50527,-0.00430894344577715,-0.00631540690244348,No,NA,NA,O15990,NA,NA,NA,arginine kinase activity [GO:0004054]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_KAT3.1.1.m.49207,-0.00580586297441681,0.0061636902044299,No,NA,NA,Q6YP21,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; cysteine-S-conjugate beta-lyase activity [GO:0047804]; kynurenine-glyoxylate transaminase activity [GO:0047315]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; RNA binding [GO:0003723]; 2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; cellular amino acid metabolic process [GO:0006520]; kynurenine metabolic process [GO:0070189],NA,NA,NA
CHOYP_KAT5.1.1.m.9015,-0.00151731125821964,-0.0106403791917365,No,NA,NA,Q99MK2,NA,NA,NA,cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Piccolo NuA4 histone acetyltransferase complex [GO:0032777]; protein-containing complex [GO:0032991]; Swr1 complex [GO:0000812]; chromatin binding [GO:0003682]; H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; phospholipase binding [GO:0043274]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to X-ray [GO:0071481]; DNA damage response; signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; histone acetylation [GO:0016573]; histone H4 acetylation [GO:0043967]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; response to heat [GO:0009408],NA,NA,NA
CHOYP_KAT6B.1.2.m.10955,-0.0169591047060434,0.00960206869202777,No,NA,NA,Q8WML3,NA,NA,NA,MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleosome [GO:0000786]; acetyltransferase activity [GO:0016407]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; metal ion binding [GO:0046872]; transcription factor binding [GO:0008134]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; negative regulation of transcription; DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_KAT8.1.1.m.28310,0.000822121662368452,0.00682504771713368,No,NA,NA,Q9H7Z6,NA,NA,NA,histone acetyltransferase complex [GO:0000123]; kinetochore [GO:0000776]; MLL1 complex [GO:0071339]; MSL complex [GO:0072487]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; acetyltransferase activity [GO:0016407]; enzyme binding [GO:0019899]; histone acetyltransferase activity [GO:0004402]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; transcription factor binding [GO:0008134]; histone acetylation [GO:0016573]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; myeloid cell differentiation [GO:0030099]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of autophagy [GO:0010506],NA,NA,NA
CHOYP_KBP.1.1.m.16212,-0.0148647275739043,0.00359891948801426,No,NA,NA,Q0IIZ5,NA,NA,NA,cytoskeleton [GO:0005856]; mitochondrion [GO:0005739]; cell differentiation [GO:0030154]; mitochondrial transport [GO:0006839]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_KC1A.1.2.m.14719,-0.0169591047060434,0.00960206869202778,No,NA,NA,Q8BK63,NA,NA,NA,beta-catenin destruction complex [GO:0030877]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; keratin filament [GO:0045095]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; peptide binding [GO:0042277]; phosphoprotein binding [GO:0051219]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell morphogenesis [GO:0000902]; Golgi organization [GO:0007030]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein phosphorylation [GO:0006468]; regulation of GTP binding [GO:1904424]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_KC1A.2.2.m.64030,-0.0125996753161854,0.0014855225725066,No,NA,NA,P67963,NA,NA,NA,ciliary basal body [GO:0036064]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; cell division [GO:0051301]; intermediate filament cytoskeleton organization [GO:0045104]; protein phosphorylation [GO:0006468]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_KC1D.1.3.m.12297,0.000764079697848515,-0.00602371514526522,No,NA,NA,Q06486,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle microtubule [GO:0005876]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; peptide binding [GO:0042277]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; cellular response to nerve growth factor stimulus [GO:1990090]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; microtubule nucleation [GO:0007020]; non-motile cilium assembly [GO:1905515]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein phosphorylation [GO:0001934]; protein localization to centrosome [GO:0071539]; protein localization to cilium [GO:0061512]; protein localization to Golgi apparatus [GO:0034067]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_KC1D.3.3.m.61498,0.0107671561506392,0.0135069505801705,No,NA,NA,Q61555,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; limb morphogenesis [GO:0035108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583],NA,NA,NA
CHOYP_KC1G3.1.2.m.18974,0.000686232728993107,-0.0107331332691118,No,NA,NA,Q62762,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; peptide binding [GO:0042277]; phosphoprotein binding [GO:0051219]; protein serine/threonine kinase activity [GO:0004674]; endocytosis [GO:0006897]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_KCIP4.1.1.m.46682,0.0163961471962368,-0.00915098938142607,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_KCMF1.1.1.m.62675,-0.0042102835273548,-0.0240845441209824,No,NA,NA,Q9P0J7,NA,NA,NA,cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleic acid binding [GO:0003676]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; neutrophil degranulation [GO:0043312],NA,NA,NA
CHOYP_KCP.10.13.m.44423,0.00720423496292141,0.000246705607328328,No,NA,NA,Q3U515,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cellular response to virus [GO:0098586],NA,NA,NA
CHOYP_KCP.3.13.m.17018,0.0191318910381269,-0.0103324416776075,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_KCP.6.13.m.26127,0.0111202442069745,-0.0042142910775678,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_KCP.7.13.m.40006,-0.00716642467363923,-0.0150040839205364,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_KCP.8.13.m.40457,0.0223108653369752,-0.010568192777367,No,NA,NA,Q6ZWJ8,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_KCP.9.13.m.43409,0.0232134271198818,-0.00893620525218466,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_KCY.1.1.m.29973,0.0129059098009428,0.00917289260385664,No,NA,NA,Q7ZWE9,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cytidylate kinase activity [GO:0004127]; nucleoside diphosphate kinase activity [GO:0004550]; uridylate kinase activity [GO:0009041]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; pyrimidine nucleotide biosynthetic process [GO:0006221],NA,NA,NA
CHOYP_KDEL1.1.1.m.62729,0.0052505531564301,-0.0070276899241901,No,NA,NA,Q6UW63,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; glucosyltransferase activity [GO:0046527]; UDP-glucosyltransferase activity [GO:0035251]; UDP-xylosyltransferase activity [GO:0035252]; protein O-linked glycosylation via serine [GO:0018242],NA,NA,NA
CHOYP_KDM1A.1.1.m.60229,-0.00207488880874576,-0.0254193232903721,No,NA,NA,O60341,NA,NA,NA,DNA repair complex [GO:1990391]; nuclear chromatin [GO:0000790]; nuclear chromosome; telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor complex [GO:0005667]; androgen receptor binding [GO:0050681]; chromatin binding [GO:0003682]; demethylase activity [GO:0032451]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; histone deacetylase activity [GO:0004407]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-K4 specific) [GO:0032453]; histone demethylase activity (H3-K9 specific) [GO:0032454]; MRF binding [GO:0043426]; nuclear receptor transcription coactivator activity [GO:0030374]; oxidoreductase activity [GO:0016491]; p53 binding [GO:0002039]; telomeric DNA binding [GO:0042162]; telomeric repeat-containing RNA binding [GO:0061752]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; alternative mRNA splicing; via spliceosome [GO:0000380]; blood coagulation [GO:0007596]; cellular response to cAMP [GO:0071320]; cellular response to gamma radiation [GO:0071480]; cellular response to UV [GO:0034644]; cerebral cortex development [GO:0021987]; guanine metabolic process [GO:0046098]; histone H3-K4 demethylation [GO:0034720]; histone H3-K9 demethylation [GO:0033169]; muscle cell development [GO:0055001]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA damage response; signal transduction by p53 class mediator [GO:0043518]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; neuron maturation [GO:0042551]; positive regulation of cell size [GO:0045793]; positive regulation of chromatin binding [GO:0035563]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of histone ubiquitination [GO:0033184]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein demethylation [GO:0006482]; regulation of cellular protein localization [GO:1903827]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of transcription by RNA polymerase II [GO:0006357]; response to fungicide [GO:0060992],NA,NA,NA
CHOYP_KDM1A.1.1.m.60230,0.0054276802074329,0.00164028724033617,No,NA,NA,Q9C0D0,NA,NA,NA,cell junction [GO:0030054]; cytosol [GO:0005829]; nucleus [GO:0005634]; synapse [GO:0045202]; actin binding [GO:0003779]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864]; actin cytoskeleton reorganization [GO:0031532]; actomyosin structure organization [GO:0031032]; cell motility [GO:0048870]; stress fiber assembly [GO:0043149],NA,NA,NA
CHOYP_KDM1B.1.1.m.15843,-0.0213661604477764,-0.000965503037345112,No,NA,NA,Q8NB78,NA,NA,NA,nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; FAD binding [GO:0071949]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-monomethyl-K4 specific) [GO:0034649]; oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270]; DNA methylation involved in gamete generation [GO:0043046]; histone H3-K4 demethylation [GO:0034720]; multicellular organism development [GO:0007275]; protein deubiquitination [GO:0016579]; regulation of DNA methylation [GO:0044030]; regulation of gene expression by genetic imprinting [GO:0006349],NA,NA,NA
CHOYP_KDM2B.1.1.m.58689,-3.89172026663936e-05,-0.0134866542217954,No,NA,NA,Q8N9M1,NA,NA,NA,nucleoplasm [GO:0005654],NA,NA,NA
CHOYP_KDM5A.1.1.m.51935,-0.00989348237531128,-0.0157386388778213,No,NA,NA,P29375,NA,NA,NA,histone methyltransferase complex [GO:0035097]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; core promoter sequence-specific DNA binding [GO:0001046]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 demethylation [GO:0034720]; histone H3-K9 demethylation [GO:0033169]; male gonad development [GO:0008584]; negative regulation of histone deacetylase activity [GO:1901726]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of DNA-binding transcription factor activity [GO:0051090]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_KHDR1.1.1.m.8878,-0.0161825778927362,0.00100577844961815,No,NA,NA,Q0VFL3,NA,NA,NA,nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA processing [GO:0006397],NA,NA,NA
CHOYP_KI11A.1.1.m.14576,-0.0100946076934146,-0.0028347173207028,No,NA,NA,P52732,NA,NA,NA,cytosol [GO:0005829]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; regulation of mitotic centrosome separation [GO:0046602]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890]; spindle organization [GO:0007051],NA,NA,NA
CHOYP_KI16B.1.3.m.42636,0.00179453570456694,0.00177801109927483,No,NA,NA,Q96L93,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; phagocytic vesicle [GO:0045335]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; phosphatidylinositol-3;4;5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3;4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3;5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; Rab GTPase binding [GO:0017137]; cellular response to interferon-gamma [GO:0071346]; early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; microtubule-based movement [GO:0007018]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919],NA,NA,NA
CHOYP_KI21A.1.2.m.43900,0.000978185361199592,-0.0053140938543833,No,NA,NA,Q9QXL2,NA,NA,NA,axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_KIAA1143.1.1.m.1249,-0.00132945747719683,0.00737862385706685,No,NA,NA,Q8K039,NA,NA,NA,,NA,NA,NA
CHOYP_KIF2A.2.2.m.62686,-0.00433170869618496,0.00937794336464653,No,NA,NA,Q5ZKV8,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cell differentiation [GO:0030154]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_KIF2A.2.2.m.62687,0.00780027160269066,-0.00868408284104496,No,NA,NA,P49432,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; pyruvate dehydrogenase complex [GO:0045254]; pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; pyruvate dehydrogenase activity [GO:0004738]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_KIF2A.2.2.m.62688,-0.0112689166453151,-0.00574000793403916,No,NA,NA,Q8VEM8,NA,NA,NA,integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; inorganic phosphate transmembrane transporter activity [GO:0005315]; protein-containing complex binding [GO:0044877]; symporter activity [GO:0015293]; phosphate ion transmembrane transport [GO:0035435],NA,NA,NA
CHOYP_KIF3A.1.1.m.51746,-0.00962408757131871,0.00801021505018441,No,NA,NA,Q4R628,NA,NA,NA,centriole [GO:0005814]; cilium [GO:0005929]; microtubule [GO:0005874]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; centriole-centriole cohesion [GO:0010457]; cilium assembly [GO:0060271]; microtubule anchoring at centrosome [GO:0034454]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_KINH.1.9.m.1032,0.0142494087385884,-0.000451731683863494,No,NA,NA,P21613,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_KINH.6.9.m.42394,-0.00166307416667126,0.0089927898567407,No,NA,NA,P21613,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_KIZ.1.1.m.57618,-0.0169591047060434,0.00960206869202777,No,NA,NA,Q2M2Z5,NA,NA,NA,cell projection [GO:0042995]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; protein kinase binding [GO:0019901]; spindle organization [GO:0007051],NA,NA,NA
CHOYP_KLC.2.3.m.40314,-0.00823581303633546,0.007345860038528,No,NA,NA,P46825,NA,NA,NA,cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule motor activity [GO:0003777],NA,NA,NA
CHOYP_KLH26.1.2.m.8792,-0.0226657268121335,0.0102858094953025,No,NA,NA,Q6ZPT1,NA,NA,NA,Cul3-RING ubiquitin ligase complex [GO:0031463]; midbody [GO:0030496]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein ubiquitination [GO:0016567]; regulation of cytokinesis [GO:0032465],NA,NA,NA
CHOYP_KLH36.1.2.m.12244,0.0101270936243178,0.00254168166190118,No,NA,NA,Q6ZPT1,NA,NA,NA,Cul3-RING ubiquitin ligase complex [GO:0031463]; midbody [GO:0030496]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein ubiquitination [GO:0016567]; regulation of cytokinesis [GO:0032465],NA,NA,NA
CHOYP_KLHDB.3.5.m.46662,0.00833160890663702,-0.0098151892061065,No,NA,NA,O94889,NA,NA,NA,,NA,NA,NA
CHOYP_KLHL24.1.4.m.8833,0.00955632371667922,0.0134504873993676,No,NA,NA,Q6TFL4,NA,NA,NA,adherens junction [GO:0005912]; axon [GO:0030424]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; perikaryon [GO:0043204]; intermediate filament organization [GO:0045109]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of kainate selective glutamate receptor activity [GO:2000312],NA,NA,NA
CHOYP_KLHL24.2.4.m.18433,-0.019301039970972,-0.0145844692813078,No,NA,NA,Q8WZ60,NA,NA,NA,B cell receptor signaling pathway [GO:0050853]; germinal center formation [GO:0002467]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_KLHL7.1.1.m.9444,0.00491588973115352,-0.000600714720400963,No,NA,NA,F1LZ52,NA,NA,NA,Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin binding [GO:0003779]; distal tubule morphogenesis [GO:0072156]; ion homeostasis [GO:0050801]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; renal sodium ion absorption [GO:0070294]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_KLLA0E01035G.1.1.m.13451,0.00394536801625317,0.00291369700370642,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_KMO.1.2.m.17496,0.00600608130576091,-0.0125778556500586,No,NA,NA,Q1RLY6,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; kynurenine 3-monooxygenase activity [GO:0004502]; NAD(P)H oxidase activity [GO:0016174]; 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; glomerular visceral epithelial cell development [GO:0072015]; kynurenine metabolic process [GO:0070189]; NAD metabolic process [GO:0019674]; quinolinate biosynthetic process [GO:0019805]; response to yeast [GO:0001878]; tryptophan catabolic process [GO:0006569],NA,NA,NA
CHOYP_KNOP1.1.1.m.11909,0.00424485737727762,-0.0133165584664845,No,NA,NA,A5D7J3,NA,NA,NA,nucleolus [GO:0005730],NA,NA,NA
CHOYP_KPC1.1.2.m.30648,-0.0020188421148159,-0.0249636404729368,No,NA,NA,Q16974,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein kinase C activity [GO:0004697]; zinc ion binding [GO:0008270]; intracellular signal transduction [GO:0035556],NA,NA,NA
CHOYP_KPC1.2.2.m.37402,0.00722249564754703,-0.00763410828352925,No,NA,NA,Q16974,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein kinase C activity [GO:0004697]; zinc ion binding [GO:0008270]; intracellular signal transduction [GO:0035556],NA,NA,NA
CHOYP_KPC2.1.3.m.22368,0.0018231354924874,-0.000632691534360311,No,NA,NA,Q16975,NA,NA,NA,membrane [GO:0016020]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; intracellular signal transduction [GO:0035556],NA,NA,NA
CHOYP_KPCD3.1.1.m.10808,-0.000897297430470863,-0.00199960117555125,No,NA,NA,O94806,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; sphingolipid biosynthetic process [GO:0030148],NA,NA,NA
CHOYP_KPOL_1058P4.2.2.m.61989,-0.00145698260284439,0.0230925734877401,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_KPRB.1.1.m.17501,-0.00549411042442142,-0.00141704234046166,No,NA,NA,O08618,NA,NA,NA,cytoplasm [GO:0005737]; protein-containing complex [GO:0032991]; ribose phosphate diphosphokinase complex [GO:0002189]; magnesium ion binding [GO:0000287]; ribose phosphate diphosphokinase activity [GO:0004749]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; bone development [GO:0060348]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164],NA,NA,NA
CHOYP_KPYK.2.4.m.19753,0.0161622373379241,0.00431481517156766,No,NA,NA,P00548,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]; cellular response to insulin stimulus [GO:0032869]; glycolytic process [GO:0006096],NA,NA,NA
CHOYP_KPYK.3.4.m.47446,0.00555286849257962,0.00388006648903951,No,NA,NA,P14618,NA,NA,NA,cilium [GO:0005929]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; pyruvate kinase complex [GO:1902912]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MHC class II protein complex binding [GO:0023026]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]; RNA binding [GO:0003723]; thyroid hormone binding [GO:0070324]; animal organ regeneration [GO:0031100]; canonical glycolysis [GO:0061621]; cellular response to insulin stimulus [GO:0032869]; glycolytic process [GO:0006096]; liver development [GO:0001889]; neutrophil degranulation [GO:0043312]; positive regulation of sprouting angiogenesis [GO:1903672]; programmed cell death [GO:0012501]; protein homotetramerization [GO:0051289]; response to gravity [GO:0009629]; response to hypoxia [GO:0001666]; response to muscle inactivity [GO:0014870]; response to nutrient [GO:0007584]; skeletal muscle tissue regeneration [GO:0043403],NA,NA,NA
CHOYP_KPYK.4.4.m.48513,0.0065883263884642,0.0180931628217626,No,NA,NA,P14618,NA,NA,NA,cilium [GO:0005929]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; pyruvate kinase complex [GO:1902912]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MHC class II protein complex binding [GO:0023026]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]; RNA binding [GO:0003723]; thyroid hormone binding [GO:0070324]; animal organ regeneration [GO:0031100]; canonical glycolysis [GO:0061621]; cellular response to insulin stimulus [GO:0032869]; glycolytic process [GO:0006096]; liver development [GO:0001889]; neutrophil degranulation [GO:0043312]; positive regulation of sprouting angiogenesis [GO:1903672]; programmed cell death [GO:0012501]; protein homotetramerization [GO:0051289]; response to gravity [GO:0009629]; response to hypoxia [GO:0001666]; response to muscle inactivity [GO:0014870]; response to nutrient [GO:0007584]; skeletal muscle tissue regeneration [GO:0043403],NA,NA,NA
CHOYP_KPYM.1.1.m.33498,0.0228073918101062,0.000710717833294678,No,NA,NA,P14618,NA,NA,NA,cilium [GO:0005929]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; pyruvate kinase complex [GO:1902912]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MHC class II protein complex binding [GO:0023026]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]; RNA binding [GO:0003723]; thyroid hormone binding [GO:0070324]; animal organ regeneration [GO:0031100]; canonical glycolysis [GO:0061621]; cellular response to insulin stimulus [GO:0032869]; glycolytic process [GO:0006096]; liver development [GO:0001889]; neutrophil degranulation [GO:0043312]; positive regulation of sprouting angiogenesis [GO:1903672]; programmed cell death [GO:0012501]; protein homotetramerization [GO:0051289]; response to gravity [GO:0009629]; response to hypoxia [GO:0001666]; response to muscle inactivity [GO:0014870]; response to nutrient [GO:0007584]; skeletal muscle tissue regeneration [GO:0043403],NA,NA,NA
CHOYP_KRP95.1.1.m.13582,-0.0174657054465016,-0.00487818306206335,No,NA,NA,O15066,NA,NA,NA,axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinesin complex [GO:0005871]; kinesin II complex [GO:0016939]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; plus-end kinesin complex [GO:0005873]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; intraciliary transport particle B binding [GO:0120170]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; Rho GTPase binding [GO:0017048]; anterograde axonal transport [GO:0008089]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; determination of left/right symmetry [GO:0007368]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule-based movement [GO:0007018]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of cytokinesis [GO:0032467]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_KS6A1.1.1.m.38386,0.0210831389366508,-0.00376872490428501,No,NA,NA,P51812,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ribosomal protein S6 kinase activity [GO:0004711]; cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224],NA,NA,NA
CHOYP_KS6A1.1.1.m.38387,0.00248801029244297,0.00488480998852741,No,NA,NA,Q07598,NA,NA,NA,mitochondrion [GO:0005739]; peroxisome [GO:0005777]; lipid binding [GO:0008289]; propanoyl-CoA C-acyltransferase activity [GO:0033814]; lipid transport [GO:0006869]; positive regulation of intracellular cholesterol transport [GO:0032385],NA,NA,NA
CHOYP_KS6A5.1.1.m.51330,-0.0111036437673014,-0.0247027229588835,No,NA,NA,Q5F3L1,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; histone H2A-S1 phosphorylation [GO:0043990]; histone H3-S10 phosphorylation [GO:0043987]; histone H3-S28 phosphorylation [GO:0043988]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468],NA,NA,NA
CHOYP_KS6B1.1.1.m.8274,-0.0128596809129482,0.000611544665403089,No,NA,NA,P67999,NA,NA,NA,cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; peptide binding [GO:0042277]; protein kinase activity [GO:0004672]; protein phosphatase 2A binding [GO:0051721]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]; aging [GO:0007568]; apoptotic process [GO:0006915]; behavioral fear response [GO:0001662]; cell migration [GO:0016477]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hormone stimulus [GO:0032870]; cellular response to insulin stimulus [GO:0032869]; cellular response to interferon-gamma [GO:0071346]; G1/S transition of mitotic cell cycle [GO:0000082]; germ cell development [GO:0007281]; intracellular signal transduction [GO:0035556]; long-chain fatty acid import [GO:0044539]; long-term memory [GO:0007616]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of insulin receptor signaling pathway [GO:0046627]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of skeletal muscle tissue growth [GO:0048633]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of translational initiation [GO:0045948]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; regulation of glucose import [GO:0046324]; response to amino acid [GO:0043200]; response to drug [GO:0042493]; response to electrical stimulus involved in regulation of muscle adaptation [GO:0014878]; response to ethanol [GO:0045471]; response to glucagon [GO:0033762]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to insulin [GO:0032868]; response to leucine [GO:0043201]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to nutrient [GO:0007584]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to organonitrogen compound [GO:0010243]; response to peptide hormone [GO:0043434]; response to testosterone [GO:0033574]; response to toxic substance [GO:0009636]; response to tumor necrosis factor [GO:0034612]; response to wounding [GO:0009611]; skeletal muscle atrophy [GO:0014732]; skeletal muscle contraction [GO:0003009]; TOR signaling [GO:0031929],NA,NA,NA
CHOYP_KSR2.1.1.m.9852,-0.00817992430616711,-0.00491780332193089,No,NA,NA,Q9D0F6,NA,NA,NA,Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA clamp loader activity [GO:0003689]; enzyme binding [GO:0019899]; single-stranded DNA-dependent ATPase activity [GO:0043142]; DNA-dependent DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264],NA,NA,NA
CHOYP_KTNA1.1.2.m.16373,0.00127759580575262,0.0131325576449978,No,NA,NA,O61577,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]; cell cycle [GO:0007049]; cell division [GO:0051301]; cytoplasmic microtubule organization [GO:0031122],NA,NA,NA
CHOYP_KTNA1.2.2.m.63437,0.00150279172359759,-0.017307698895163,No,NA,NA,O08623,NA,NA,NA,aggresome [GO:0016235]; amphisome [GO:0044753]; autolysosome [GO:0044754]; autophagosome [GO:0005776]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; late endosome [GO:0005770]; Lewy body [GO:0097413]; mitochondrion [GO:0005739]; P-body [GO:0000932]; phagophore assembly site [GO:0000407]; PML body [GO:0016605]; sarcomere [GO:0030017]; sperm midpiece [GO:0097225]; ionotropic glutamate receptor binding [GO:0035255]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; SH2 domain binding [GO:0042169]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; aggrephagy [GO:0035973]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; cell differentiation [GO:0030154]; endosome organization [GO:0007032]; immune system process [GO:0002376]; macroautophagy [GO:0016236]; mitochondrion organization [GO:0007005]; mitophagy [GO:0000423]; negative regulation of growth of symbiont in host [GO:0044130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; protein heterooligomerization [GO:0051291]; protein localization to perinuclear region of cytoplasm [GO:1905719]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of protein complex stability [GO:0061635]; response to ischemia [GO:0002931]; response to mitochondrial depolarisation [GO:0098780]; selective autophagy [GO:0061912],NA,NA,NA
CHOYP_L1CAM.2.2.m.49542,2.87977354038683e-05,0.00850905851524017,No,NA,NA,Q05695,NA,NA,NA,axon [GO:0030424]; axonal growth cone [GO:0044295]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendritic growth cone [GO:0044294]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; axon guidance receptor activity [GO:0008046]; PDZ domain binding [GO:0030165]; axon development [GO:0061564]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to ethanol [GO:0071361]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to thyroxine stimulus [GO:0097069]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dopaminergic neuron differentiation [GO:0071542]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; modulation of chemical synaptic transmission [GO:0050804]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; positive regulation of axon extension [GO:0045773]; positive regulation of cell-substrate adhesion [GO:0010811]; regulation of ERK1 and ERK2 cascade [GO:0070372]; response to activity [GO:0014823]; response to thyroid hormone [GO:0097066]; synapse organization [GO:0050808],NA,NA,NA
CHOYP_LA.1.1.m.65962,-0.000832199603530511,-0.0154092683505339,No,NA,NA,P10881,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; poly(U) RNA binding [GO:0008266]; sequence-specific mRNA binding [GO:1990825]; tRNA binding [GO:0000049]; IRES-dependent viral translational initiation [GO:0075522]; nuclear histone mRNA catabolic process [GO:0071045]; protein localization to cytoplasmic stress granule [GO:1903608]; tRNA 3'-end processing [GO:0042780]; tRNA 5'-leader removal [GO:0001682]; tRNA export from nucleus [GO:0006409],NA,NA,NA
CHOYP_LACB2.1.1.m.31957,-0.00707931803936868,-0.00635338168515043,No,NA,NA,Q0V9A9,NA,NA,NA,mitochondrial matrix [GO:0005759]; endoribonuclease activity [GO:0004521]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]; RNA phosphodiester bond hydrolysis; endonucleolytic [GO:0090502],NA,NA,NA
CHOYP_LACBIDRAFT_295117.3.10.m.29879,-0.0169591047060434,0.00960206869202777,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LACH.1.1.m.62529,0.000875239851454715,-0.0229305878963677,No,NA,NA,Q24372,NA,NA,NA,anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; protein homodimerization activity [GO:0042803]; cell adhesion involved in heart morphogenesis [GO:0061343]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity; open tracheal system [GO:0035160]; morphogenesis of embryonic epithelium [GO:0016331]; open tracheal system development [GO:0007424]; regulation of tube size; open tracheal system [GO:0035151]; septate junction assembly [GO:0019991],NA,NA,NA
CHOYP_LAMA2.1.1.m.10439,0.00264656114962099,-0.00905183012592434,No,NA,NA,Q60675,NA,NA,NA,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; dendritic spine [GO:0043197]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; sarcolemma [GO:0042383]; synaptic cleft [GO:0043083]; extracellular matrix structural constituent [GO:0005201]; signaling receptor binding [GO:0005102]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; positive regulation of synaptic transmission; cholinergic [GO:0032224]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; Schwann cell differentiation [GO:0014037],NA,NA,NA
CHOYP_LAMC1.1.1.m.36098,-0.0161862314816744,-0.0160338947173577,No,NA,NA,P11047,NA,NA,NA,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-11 complex [GO:0043260]; extracellular matrix structural constituent [GO:0005201]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; endoderm development [GO:0007492]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; hemidesmosome assembly [GO:0031581]; positive regulation of epithelial cell proliferation [GO:0050679]; post-translational protein modification [GO:0043687]; protein-containing complex assembly [GO:0065003]; substrate adhesion-dependent cell spreading [GO:0034446],NA,NA,NA
CHOYP_LAMP1.2.3.m.16422,0.000697487551942627,-0.00972271269779974,No,NA,NA,P05300,NA,NA,NA,endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886],NA,NA,NA
CHOYP_LAMP1.3.3.m.16600,0.00911898097496813,-0.0119522166013017,No,NA,NA,P05300,NA,NA,NA,endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886],NA,NA,NA
CHOYP_LAR.1.2.m.30133,-0.00862499572019986,-0.00704838463278227,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LARP4.1.1.m.14987,-0.00846736771344722,-0.0102144823663196,No,NA,NA,Q6A0A2,NA,NA,NA,cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleolus [GO:0005730]; polysomal ribosome [GO:0042788]; RNA binding [GO:0003723]; positive regulation of translation [GO:0045727],NA,NA,NA
CHOYP_LARP7.1.1.m.35019,0.00312081081939158,0.000773615546882997,No,NA,NA,Q7ZWE3,NA,NA,NA,nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; cardiac muscle tissue regeneration [GO:0061026]; regulation of cardiac muscle cell proliferation [GO:0060043]; RNA processing [GO:0006396],NA,NA,NA
CHOYP_LC7L3.1.1.m.20705,-0.011817713327613,0.00294976510274116,No,NA,NA,Q5SUF2,NA,NA,NA,nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; mRNA splice site selection [GO:0006376]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LCAZH_2403.1.1.m.47655,0.00678620130084428,0.00878741825264137,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LCP2.12.14.m.40093,0.0123332010188209,0.0105057880279487,No,NA,NA,Q13094,NA,NA,NA,cell-cell junction [GO:0005911]; cytosol [GO:0005829]; plasma membrane raft [GO:0044853]; TCR signalosome [GO:0036398]; cytokine secretion [GO:0050663]; Fc-epsilon receptor signaling pathway [GO:0038095]; immune response [GO:0006955]; intracellular signal transduction [GO:0035556]; mast cell activation [GO:0045576]; platelet activation [GO:0030168]; positive regulation of protein kinase activity [GO:0045860]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_LCP2.3.14.m.8968,-0.00779224322826527,-0.00976622663710646,No,NA,NA,Q60787,NA,NA,NA,cell-cell junction [GO:0005911]; cytosol [GO:0005829]; plasma membrane raft [GO:0044853]; TCR signalosome [GO:0036398]; cytokine secretion [GO:0050663]; intracellular signal transduction [GO:0035556]; mast cell activation [GO:0045576]; positive regulation of protein kinase activity [GO:0045860]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_LDB3.1.1.m.371,-0.00633265417559937,-0.00144305247644419,No,NA,NA,Q5E9E1,NA,NA,NA,cytoskeleton [GO:0005856]; transcription factor complex [GO:0005667]; Z disc [GO:0030018]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LDBPK_300810.1.1.m.29406,0.0087241867546474,0.00662482051528085,No,NA,NA,Q54I71,NA,NA,NA,adherens junction [GO:0005912]; basal cortex [GO:0045180]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; alpha-catenin binding [GO:0045294]; cell adhesion [GO:0007155]; cell motility [GO:0048870]; cellular protein localization [GO:0034613]; centrosome localization [GO:0051642]; culmination involved in sorocarp development [GO:0031154]; epithelial cell morphogenesis [GO:0003382]; establishment or maintenance of bipolar cell polarity [GO:0061245]; Golgi localization [GO:0051645]; multicellular organism development [GO:0007275]; positive regulation of cytoskeleton organization [GO:0051495]; protein secretion [GO:0009306]; regulation of gene expression [GO:0010468]; sorocarp spore cell differentiation [GO:0044671]; sorocarp stalk development [GO:0031150]; sorocarp stalk morphogenesis [GO:0036360],NA,NA,NA
CHOYP_LDLR.6.7.m.57984,0.0183345408839175,-0.00638828223117769,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LECG.3.4.m.29627,-0.00430894344577715,-0.00631540690244347,No,NA,NA,Q66S03,NA,NA,NA,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]; inflammatory response [GO:0006954],NA,NA,NA
CHOYP_LEG4.1.1.m.22079,-0.0115958776295535,0.000954908474446537,No,NA,NA,P38486,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; spliceosomal complex [GO:0005681]; carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; cell differentiation [GO:0030154]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LEMD3.1.1.m.56975,0.0194075182264269,-0.00791098998295833,No,NA,NA,Q9Y2U8,NA,NA,NA,integral component of membrane [GO:0016021]; integral component of nuclear inner membrane [GO:0005639]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]; DNA binding [GO:0003677]; angiogenesis [GO:0001525]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; nuclear envelope organization [GO:0006998]; regulation of intracellular signal transduction [GO:1902531],NA,NA,NA
CHOYP_LEO1.1.1.m.41626,-0.0111632209562756,-0.0204582133590864,No,NA,NA,Q6NYV9,NA,NA,NA,Cdc73/Paf1 complex [GO:0016593]; nucleus [GO:0005634]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; embryonic cranial skeleton morphogenesis [GO:0048701]; glial cell development [GO:0021782]; heart development [GO:0007507]; histone modification [GO:0016570]; melanocyte differentiation [GO:0030318]; neural crest cell development [GO:0014032]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; spinal cord oligodendrocyte cell differentiation [GO:0021529]; transcription elongation from RNA polymerase II promoter [GO:0006368]; xanthophore differentiation [GO:0050936],NA,NA,NA
CHOYP_LGR4.1.2.m.27343,0.0182397165654809,-0.000362984305953392,No,NA,NA,Q9BXB1,NA,NA,NA,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]; transmembrane signaling receptor activity [GO:0004888]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; bone mineralization [GO:0030282]; bone remodeling [GO:0046849]; canonical Wnt signaling pathway involved in metanephric kidney development [GO:0061290]; cell differentiation involved in metanephros development [GO:0072202]; circadian regulation of gene expression [GO:0032922]; digestive tract development [GO:0048565]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; hair follicle development [GO:0001942]; hormone-mediated signaling pathway [GO:0009755]; innate immune response [GO:0045087]; intestinal stem cell homeostasis [GO:0036335]; male genitalia development [GO:0030539]; metanephric glomerulus development [GO:0072224]; metanephric nephron tubule morphogenesis [GO:0072282]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of cytokine secretion [GO:0050710]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transcription; DNA-templated [GO:0045892]; osteoblast differentiation [GO:0001649]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription; DNA-templated [GO:0045893]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LIAS.1.1.m.21693,-0.0186646583034881,-0.00652864539667058,No,NA,NA,Q6GQ48,NA,NA,NA,mitochondrion [GO:0005739]; 4 iron; 4 sulfur cluster binding [GO:0051539]; lipoate synthase activity [GO:0016992]; metal ion binding [GO:0046872]; protein lipoylation [GO:0009249],NA,NA,NA
CHOYP_LIG4.1.1.m.6295,-0.0117247099511419,0.00966945086352812,No,NA,NA,Q8BTF7,NA,NA,NA,condensed chromosome [GO:0000793]; cytoplasmic ribonucleoprotein granule [GO:0036464]; DNA ligase IV complex [GO:0032807]; DNA-dependent protein kinase-DNA ligase 4 complex [GO:0005958]; nonhomologous end joining complex [GO:0070419]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; DNA ligase activity [GO:0003909]; ligase activity [GO:0016874]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell proliferation [GO:0008283]; cellular response to ionizing radiation [GO:0071479]; cellular response to lithium ion [GO:0071285]; central nervous system development [GO:0007417]; chromosome organization [GO:0051276]; DNA biosynthetic process [GO:0071897]; DNA ligation [GO:0006266]; DNA ligation involved in DNA recombination [GO:0051102]; DNA ligation involved in DNA repair [GO:0051103]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair [GO:0006302]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; double-strand break repair via nonhomologous end joining [GO:0006303]; immunoglobulin V(D)J recombination [GO:0033152]; in utero embryonic development [GO:0001701]; isotype switching [GO:0045190]; negative regulation of neuron apoptotic process [GO:0043524]; neuron apoptotic process [GO:0051402]; nucleotide-excision repair; DNA gap filling [GO:0006297]; positive regulation of chromosome organization [GO:2001252]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of neurogenesis [GO:0050769]; pro-B cell differentiation [GO:0002328]; response to gamma radiation [GO:0010332]; response to ionizing radiation [GO:0010212]; response to X-ray [GO:0010165]; single strand break repair [GO:0000012]; somatic stem cell population maintenance [GO:0035019]; T cell differentiation in thymus [GO:0033077]; T cell receptor V(D)J recombination [GO:0033153]; V(D)J recombination [GO:0033151],NA,NA,NA
CHOYP_LIGO2.1.2.m.3525,0.00772521873057533,-0.00739935124728071,No,NA,NA,Q80X72,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; collagen binding [GO:0005518]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of cell migration [GO:0030335]; receptor-mediated virion attachment to host cell [GO:0046813],NA,NA,NA
CHOYP_LIN9.1.1.m.12005,0.00650429732568845,-0.000261074202427775,No,NA,NA,Q5TKA1,NA,NA,NA,nucleoplasm [GO:0005654]; transcriptional repressor complex [GO:0017053]; DNA binding [GO:0003677]; cell cycle [GO:0007049]; DNA biosynthetic process [GO:0071897]; regulation of cell cycle [GO:0051726]; reproduction [GO:0000003]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_LINJ_09_0950.1.1.m.64023,0.00562309134233149,-0.00534052434900331,No,NA,NA,P0CH27,NA,NA,NA,nucleus [GO:0005634]; ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_LIPA1.1.1.m.10892,0.000413262881641254,-0.00912580039127559,No,NA,NA,Q13136,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; presynaptic active zone [GO:0048786]; cell-matrix adhesion [GO:0007160]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of stress fiber assembly [GO:0051497]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LIPB1.1.1.m.35961,-0.00925328599572819,-0.0160281434820383,No,NA,NA,Q8ND30,NA,NA,NA,cytosol [GO:0005829]; extracellular space [GO:0005615]; intracellular [GO:0005622]; presynapse [GO:0098793]; identical protein binding [GO:0042802],NA,NA,NA
CHOYP_LIPR1.2.3.m.4679,-0.00476492399950519,-0.0112305115108519,No,NA,NA,P54316,NA,NA,NA,extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; lipase activity [GO:0016298]; triglyceride lipase activity [GO:0004806]; lipid metabolic process [GO:0006629]; pancreas development [GO:0031016]; response to glucocorticoid [GO:0051384]; response to peptide hormone [GO:0043434],NA,NA,NA
CHOYP_LIS1.1.1.m.56212,0.00317536711792586,-0.00195075477638767,No,NA,NA,C3XVT5,NA,NA,NA,axon cytoplasm [GO:1904115]; cytoplasmic microtubule [GO:0005881]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; microtubule organizing center [GO:0005815]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; dynein complex binding [GO:0070840]; microtubule plus-end binding [GO:0051010]; brain morphogenesis [GO:0048854]; cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; microtubule organizing center organization [GO:0031023]; microtubule sliding [GO:0051012]; nuclear migration [GO:0007097]; regulation of microtubule motor activity [GO:2000574]; retrograde axonal transport [GO:0008090]; vesicle transport along microtubule [GO:0047496],NA,NA,NA
CHOYP_LMBL3.1.1.m.14251,-0.00924937823710343,0.00669768259841269,No,NA,NA,E1C2V1,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325],NA,NA,NA
CHOYP_LMO7.1.1.m.27803,0.00392145080308668,0.00814289566702412,No,NA,NA,Q9UPQ0,NA,NA,NA,cytoplasm [GO:0005737]; stress fiber [GO:0001725]; actin binding [GO:0003779]; metal ion binding [GO:0046872]; myosin II head/neck binding [GO:0032034]; actomyosin structure organization [GO:0031032]; negative regulation of cell migration [GO:0030336]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; regulation of focal adhesion assembly [GO:0051893],NA,NA,NA
CHOYP_LNTL.1.1.2.m.10782,-0.0132182132269034,0.0130933845741077,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOAG_00377.2.4.m.54574,0.00205195042830452,-0.00934116934689426,No,NA,NA,Q20930,NA,NA,NA,basement membrane [GO:0005604]; extracellular space [GO:0005615]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; gonad morphogenesis [GO:0035262]; protein autoprocessing [GO:0016540]; protein localization [GO:0008104]; regulation of cell migration [GO:0030334]; regulation of distal tip cell migration [GO:1903354]; zymogen activation [GO:0031638],NA,NA,NA
CHOYP_LOAG_00625.1.1.m.34418,0.0065883263884642,0.0180931628217626,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOAG_01021.1.4.m.1826,-0.0199693751717511,-0.000317171016024364,No,NA,NA,O01761,NA,NA,NA,A band [GO:0031672]; M band [GO:0031430]; ATP binding [GO:0005524]; MATH domain binding [GO:0090736]; phosphatase binding [GO:0019902]; protein kinase activity [GO:0004672]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; cellular protein localization [GO:0034613]; myosin filament assembly [GO:0031034]; pharyngeal gland morphogenesis [GO:1905905]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion [GO:0040017]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; regulation of Rho protein signal transduction [GO:0035023]; regulation of skeletal muscle contraction by calcium ion signaling [GO:0014722]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_LOAG_05095.2.2.m.58023,0.00478296849739439,0.00761897940472708,No,NA,NA,Q9NJV4,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOAG_05718.1.1.m.48540,-0.0124684161432369,-0.000595917607512234,No,NA,NA,Q5R957,NA,NA,NA,chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; voltage-gated ion channel activity [GO:0005244]; regulation of ion transmembrane transport [GO:0034765],NA,NA,NA
CHOYP_LOAG_05814.1.1.m.56611,-0.0135725579708753,0.00388604629968508,No,NA,NA,Q9JLY7,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; protein tyrosine phosphatase activity [GO:0004725],NA,NA,NA
CHOYP_LOC100005182.1.1.m.53007,0.000598895791636865,0.0118752099237096,No,NA,NA,Q9NUV9,NA,NA,NA,cytosol [GO:0005829]; GTP binding [GO:0005525],NA,NA,NA
CHOYP_LOC100005318.1.1.m.30043,0.00834573180370461,-0.000235341379292921,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100007585.5.7.m.51610,-0.00614977268156889,0.00468456766020479,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100008030.1.1.m.10817,0.00597842216046569,-0.00734921436042913,No,NA,NA,Q6ZSB9,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; cell cycle arrest [GO:0007050]; negative regulation of cell proliferation [GO:0008285]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_LOC100013725.1.2.m.12740,-0.00487194156582074,-0.0101973159882221,No,NA,NA,P07607,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; cofactor binding [GO:0048037]; drug binding [GO:0008144]; folic acid binding [GO:0005542]; mRNA binding [GO:0003729]; nucleotide binding [GO:0000166]; protein homodimerization activity [GO:0042803]; sequence-specific mRNA binding [GO:1990825]; thymidylate synthase activity [GO:0004799]; translation repressor activity; mRNA regulatory element binding [GO:0000900]; aging [GO:0007568]; cartilage development [GO:0051216]; circadian rhythm [GO:0007623]; developmental growth [GO:0048589]; dTMP biosynthetic process [GO:0006231]; dTTP biosynthetic process [GO:0006235]; dUMP metabolic process [GO:0046078]; immortalization of host cell by virus [GO:0019088]; intestinal epithelial cell maturation [GO:0060574]; liver regeneration [GO:0097421]; negative regulation of translation [GO:0017148]; regulation of translation [GO:0006417]; response to cytokine [GO:0034097]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]; response to glucocorticoid [GO:0051384]; response to organophosphorus [GO:0046683]; response to progesterone [GO:0032570]; response to vitamin A [GO:0033189]; tetrahydrofolate interconversion [GO:0035999]; uracil metabolic process [GO:0019860],NA,NA,NA
CHOYP_LOC100017222.1.1.m.19930,0.00348769592287081,0.00736152110662804,No,NA,NA,Q6PGE4,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100017224.1.1.m.26828,-0.00361542669360183,0.00461918555575073,No,NA,NA,Q4VBV9,NA,NA,NA,cytoplasm [GO:0005737]; omega-amidase activity [GO:0050152]; asparagine metabolic process [GO:0006528]; glutamine metabolic process [GO:0006541]; oxaloacetate metabolic process [GO:0006107],NA,NA,NA
CHOYP_LOC100023660.1.1.m.30865,0.00615966897194063,0.00941964587728867,No,NA,NA,Q91766,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; hepatocyte differentiation [GO:0070365]; lipid homeostasis [GO:0055088]; regulation of insulin secretion [GO:0050796]; type B pancreatic cell development [GO:0003323],NA,NA,NA
CHOYP_LOC100024134.1.1.m.61877,0.00712368649556236,0.00666225984417736,No,NA,NA,Q91ZW6,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; iron ion binding [GO:0005506]; oxidoreductase activity; acting on single donors with incorporation of molecular oxygen; incorporation of two atoms of oxygen [GO:0016702]; trimethyllysine dioxygenase activity [GO:0050353]; carnitine biosynthetic process [GO:0045329],NA,NA,NA
CHOYP_LOC100024935.1.1.m.2615,0.00541762761611219,-0.016936896816162,No,NA,NA,Q95108,NA,NA,NA,mitochondrion [GO:0005739]; nucleolus [GO:0005730]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662],NA,NA,NA
CHOYP_LOC100027252.1.1.m.30045,-0.00171040441687323,-0.0165613225796873,No,NA,NA,Q08623,NA,NA,NA,cytosol [GO:0005829]; hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; pseudouridine 5'-phosphatase activity [GO:1990738]; nucleotide metabolic process [GO:0009117]; pyrimidine nucleoside salvage [GO:0043097],NA,NA,NA
CHOYP_LOC100027962.1.1.m.48278,0.0112052241433168,0.0047852775677173,No,NA,NA,Q8R146,NA,NA,NA,cytosol [GO:0005829]; nuclear membrane [GO:0031965]; identical protein binding [GO:0042802]; omega peptidase activity [GO:0008242]; serine-type endopeptidase activity [GO:0004252]; amyloid-beta metabolic process [GO:0050435]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC100028654.1.1.m.62088,0.0193699532583256,-0.00750437387537547,No,NA,NA,A3KPN8,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100030437.1.3.m.5994,0.00809863460946792,-0.0192214254427526,No,NA,NA,A2AX52,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208],NA,NA,NA
CHOYP_LOC100030710.2.4.m.13432,0.00631994313449757,0.00291914673904211,No,NA,NA,A0A0R4IBK5,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100030710.4.4.m.20819,0.00499627470285616,-0.0042542364094625,No,NA,NA,A0A0R4IBK5,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100049762.1.1.m.1777,0.00312621702126178,-0.012851338784774,No,NA,NA,Q1HQF8,NA,NA,NA,extracellular space [GO:0005615]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_LOC100061302.1.1.m.47172,-0.00492597843780595,0.00565091748587152,No,NA,NA,Q96PY6,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of protein kinase activity [GO:0032147]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cilium assembly [GO:0060271]; DNA damage response; detection of DNA damage [GO:0042769]; protein phosphorylation [GO:0006468]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_LOC100068494.1.1.m.8733,-0.00489910105145724,-0.00462417247391191,No,NA,NA,A5PKG7,NA,NA,NA,Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260],NA,NA,NA
CHOYP_LOC100072802.1.1.m.27280,-0.00122510931077739,-0.0147159126896058,No,NA,NA,Q3T0B6,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; adrenergic receptor binding [GO:0031690]; complement component C1q binding [GO:0001849]; hyaluronic acid binding [GO:0005540]; kininogen binding [GO:0030984]; mitochondrial ribosome binding [GO:0097177]; mRNA binding [GO:0003729]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; translation activator activity [GO:0008494]; apoptotic process [GO:0006915]; complement activation; classical pathway [GO:0006958]; innate immune response [GO:0045087]; mature ribosome assembly [GO:0042256]; mRNA processing [GO:0006397]; negative regulation of defense response to virus [GO:0050687]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of MDA-5 signaling pathway [GO:0039534]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell adhesion [GO:0045785]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of mitochondrial translation [GO:0070131]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of trophoblast cell migration [GO:1901165]; regulation of complement activation [GO:0030449]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100079978.1.1.m.18519,0.00424110400431138,-0.0133199797647006,No,NA,NA,Q9WU56,NA,NA,NA,mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; nuclear receptor transcription coactivator activity [GO:0030374]; pseudouridine synthase activity [GO:0009982]; steroid receptor RNA activator RNA binding [GO:0002153]; tRNA binding [GO:0000049]; tRNA pseudouridine synthase activity [GO:0106029]; mRNA pseudouridine synthesis [GO:1990481]; positive regulation of transcription by RNA polymerase II [GO:0045944]; tRNA pseudouridine synthesis [GO:0031119],NA,NA,NA
CHOYP_LOC100080726.1.1.m.59048,0.00712818973816227,-0.00428010520666877,No,NA,NA,A0JPN4,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]; rough endoplasmic reticulum membrane [GO:0030867]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; endoribonuclease activity [GO:0004521]; exoribonuclease activity [GO:0004532]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; nuclease activity [GO:0004518]; ribosome binding [GO:0043022]; RNA stem-loop binding [GO:0035613]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cellular response to chemokine [GO:1990869]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose starvation [GO:0042149]; cellular response to interleukin-1 [GO:0071347]; cellular response to ionomycin [GO:1904637]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to oxidative stress [GO:0034599]; cellular response to sodium arsenite [GO:1903936]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to virus [GO:0098586]; immune response-activating signal transduction [GO:0002757]; inflammatory response [GO:0006954]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of cardiac muscle contraction [GO:0055118]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-gamma secretion [GO:1902714]; negative regulation of interleukin-1 beta secretion [GO:0050713]; negative regulation of interleukin-6 secretion [GO:1900165]; negative regulation of muscle cell apoptotic process [GO:0010656]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of tumor necrosis factor secretion [GO:1904468]; nervous system development [GO:0007399]; nuclear-transcribed mRNA catabolic process; endonucleolytic cleavage-dependent decay [GO:0000294]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of cell death [GO:0010942]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of lipid storage [GO:0010884]; positive regulation of miRNA catabolic process [GO:2000627]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of protein deubiquitination [GO:1903003]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein complex oligomerization [GO:0051259]; protein deubiquitination [GO:0016579]; RNA phosphodiester bond hydrolysis [GO:0090501]; RNA phosphodiester bond hydrolysis; endonucleolytic [GO:0090502]; T cell receptor signaling pathway [GO:0050852],NA,NA,NA
CHOYP_LOC100081619.1.1.m.33744,-0.0092951136509964,0.011703257647432,No,NA,NA,O70480,NA,NA,NA,cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; integral component of presynaptic endosome membrane [GO:0099067]; integral component of synaptic vesicle membrane [GO:0030285]; phagocytic vesicle [GO:0045335]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; cellular response to interferon-gamma [GO:0071346]; Golgi ribbon formation [GO:0090161]; Golgi to plasma membrane protein transport [GO:0043001]; microtubule cytoskeleton organization [GO:0000226]; regulation of Golgi to plasma membrane protein transport [GO:0042996]; regulation of synaptic vesicle endocytosis [GO:1900242]; SNARE complex assembly [GO:0035493]; synaptic vesicle to endosome fusion [GO:0016189]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_LOC100081920.1.4.m.1772,-0.0153136058120879,-0.00174652794430069,No,NA,NA,Q28024,NA,NA,NA,heterotrimeric G-protein complex [GO:0005834]; GTPase activity [GO:0003924]; PDZ domain binding [GO:0030165]; phosphate ion binding [GO:0042301]; cerebral cortex development [GO:0021987]; G protein-coupled receptor signaling pathway [GO:0007186]; response to lipopolysaccharide [GO:0032496],NA,NA,NA
CHOYP_LOC100083076.1.1.m.35327,0.00613057851293024,0.000870260873400847,No,NA,NA,A2RT67,NA,NA,NA,cytoplasm [GO:0005737]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; cellular protein catabolic process [GO:0044257]; endosome to lysosome transport [GO:0008333],NA,NA,NA
CHOYP_LOC100089326.1.1.m.19184,-0.00263270243963114,-0.0104950107516247,No,NA,NA,P70581,NA,NA,NA,nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; protein-containing complex [GO:0032991]; nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056]; mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein heterooligomerization [GO:0051291]; protein heterotetramerization [GO:0051290]; protein heterotrimerization [GO:0070208]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; regulation of protein import into nucleus [GO:0042306],NA,NA,NA
CHOYP_LOC100113561.1.1.m.37903,-0.00543505233212447,-0.00534689810587208,No,NA,NA,P31478,NA,NA,NA,proton-transporting V-type ATPase; V1 domain [GO:0033180]; proton-transporting ATPase activity; rotational mechanism [GO:0046961]; ATP hydrolysis coupled proton transport [GO:0015991],NA,NA,NA
CHOYP_LOC100113671.1.1.m.18491,-0.0188815190248187,-0.00242166029368953,No,NA,NA,Q8R3G1,NA,NA,NA,nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase inhibitor activity [GO:0004865]; cell proliferation [GO:0008283]; mRNA processing [GO:0006397]; multicellular organism development [GO:0007275]; negative regulation of protein dephosphorylation [GO:0035308]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100114159.1.1.m.53867,0.00919677075033335,0.000103915412079769,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100114171.1.1.m.50280,0.00373928267260085,0.0217766585807133,No,NA,NA,O42254,NA,NA,NA,CRD-mediated mRNA stability complex [GO:0070937]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; translation regulator activity [GO:0045182]; CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610],NA,NA,NA
CHOYP_LOC100114247.1.1.m.30717,0.0119833223576209,-0.00844631205607929,No,NA,NA,Q99MN1,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; amino acid binding [GO:0016597]; ATP adenylyltransferase activity [GO:0003877]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; lysine-tRNA ligase activity [GO:0004824]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; tRNA binding [GO:0000049]; activation of MAPK activity [GO:0000187]; basophil activation involved in immune response [GO:0002276]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; ERK1 and ERK2 cascade [GO:0070371]; lysyl-tRNA aminoacylation [GO:0006430]; negative regulation of cell proliferation [GO:0008285]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of cytokine secretion involved in immune response [GO:0002741]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription; DNA-templated [GO:0045893]; response to X-ray [GO:0010165]; tumor necrosis factor-mediated signaling pathway [GO:0033209],NA,NA,NA
CHOYP_LOC100114310.1.2.m.39843,0.0030750440999418,-0.001078230741302,No,NA,NA,Q01082,NA,NA,NA,axolemma [GO:0030673]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; M band [GO:0031430]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; GTPase binding [GO:0051020]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; common-partner SMAD protein phosphorylation [GO:0007182]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to plasma membrane protein transport [GO:0043001]; MAPK cascade [GO:0000165]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 secretion [GO:1900042]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of SMAD protein signal transduction [GO:0060390],NA,NA,NA
CHOYP_LOC100114310.2.2.m.64227,0.01933216333592,0.00215341083527025,No,NA,NA,Q00963,NA,NA,NA,apicolateral plasma membrane [GO:0016327]; axon [GO:0030424]; fusome [GO:0045169]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; spectrosome [GO:0045170]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; cytoskeletal protein binding [GO:0008092]; microtubule binding [GO:0008017]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; photoreceptor cell axon guidance [GO:0072499]; plasma membrane organization [GO:0007009]; regulation of synapse organization [GO:0050807],NA,NA,NA
CHOYP_LOC100114310.2.2.m.64228,0.00604273233495377,0.0209315148108009,No,NA,NA,P36241,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181],NA,NA,NA
CHOYP_LOC100114433.2.4.m.6343,0.0154020099635064,-0.00804420080010696,No,NA,NA,O14974,NA,NA,NA,A band [GO:0031672]; actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; contractile fiber [GO:0043292]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654]; PTW/PP1 phosphatase complex [GO:0072357]; Z disc [GO:0030018]; 14-3-3 protein binding [GO:0071889]; enzyme inhibitor activity [GO:0004857]; phosphatase regulator activity [GO:0019208]; protein kinase binding [GO:0019901]; cellular response to drug [GO:0035690]; centrosome cycle [GO:0007098]; mitotic cell cycle [GO:0000278]; negative regulation of catalytic activity [GO:0043086]; positive regulation of myosin-light-chain-phosphatase activity [GO:0035508]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion [GO:0030155]; regulation of myosin-light-chain-phosphatase activity [GO:0035507]; regulation of nucleocytoplasmic transport [GO:0046822]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100114636.1.1.m.11052,0.00993036497977687,-0.00675802117985377,No,NA,NA,O43396,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; disulfide oxidoreductase activity [GO:0015036]; cell redox homeostasis [GO:0045454],NA,NA,NA
CHOYP_LOC100114736.1.1.m.18266,-0.00473936024543437,0.0103158505774383,No,NA,NA,O18404,NA,NA,NA,cytosol [GO:0005829]; mitochondrial ribonuclease P complex [GO:0030678]; mitochondrion [GO:0005739]; 3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity [GO:0047015]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 7-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0047022]; acetoacetyl-CoA reductase activity [GO:0018454]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; steroid dehydrogenase activity [GO:0016229]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; testosterone dehydrogenase [NAD(P)] activity [GO:0030283]; acyl-CoA metabolic process [GO:0006637]; androgen metabolic process [GO:0008209]; ecdysone metabolic process [GO:0008205]; estrogen metabolic process [GO:0008210]; fatty acid metabolic process [GO:0006631]; mitochondrial tRNA processing [GO:0090646]; RNA phosphodiester bond hydrolysis; endonucleolytic [GO:0090502]; steroid metabolic process [GO:0008202],NA,NA,NA
CHOYP_LOC100115002.1.1.m.45844,-0.000280342428510785,-0.00371317900636595,No,NA,NA,Q9CX00,NA,NA,NA,centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; identical protein binding [GO:0042802]; MIT domain binding [GO:0090541]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; abscission [GO:0009838]; cell division [GO:0051301]; cytoskeleton-dependent cytokinesis [GO:0061640]; establishment of protein localization [GO:0045184]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of proteolysis [GO:0045862]; protein localization [GO:0008104]; protein transport [GO:0015031]; viral capsid secondary envelopment [GO:0046745]; viral release from host cell [GO:0019076],NA,NA,NA
CHOYP_LOC100115298.1.1.m.39207,0.00728828400174674,-0.00397484677592379,No,NA,NA,P35604,NA,NA,NA,COPI vesicle coat [GO:0030126]; Golgi membrane [GO:0000139]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_LOC100115467.1.1.m.51329,0.0165645667810608,0.011022562068116,No,NA,NA,P62323,NA,NA,NA,cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; SMN-Sm protein complex [GO:0034719]; U1 snRNP [GO:0005685]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; histone pre-mRNA DCP binding [GO:0071208]; mRNA splicing; via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_LOC100115577.1.1.m.21791,0.0109461292212106,0.0110659540212779,No,NA,NA,P12613,NA,NA,NA,chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; ovarian follicle cell development [GO:0030707]; protein folding [GO:0006457],NA,NA,NA
CHOYP_LOC100115776.1.1.m.24729,-0.00977843388585731,-0.00596849173879387,No,NA,NA,Q921I2,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100115939.1.1.m.28155,-0.0144719242759311,-0.0154063210343305,No,NA,NA,Q8CHI8,NA,NA,NA,NuA4 histone acetyltransferase complex [GO:0035267]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; protein antigen binding [GO:1990405]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967],NA,NA,NA
CHOYP_LOC100116049.1.1.m.54372,-0.0124014919001265,-0.00148011371418245,No,NA,NA,Q7K556,NA,NA,NA,cytosol [GO:0005829]; GTP binding [GO:0005525]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol binding [GO:0035091]; photoreceptor cell maintenance [GO:0045494]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC100116717.2.2.m.30034,-0.0147012965966902,-0.0080547221949339,No,NA,NA,Q9EPR2,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; calcium ion binding [GO:0005509]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1;2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1;2-dioleoylphosphatidylethanolamine) [GO:0102568]; arachidonic acid secretion [GO:0050482]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644],NA,NA,NA
CHOYP_LOC100116719.1.1.m.58,0.0188666786496893,-0.00531113319343258,No,NA,NA,A4FV97,NA,NA,NA,90S preribosome [GO:0030686]; nucleolus [GO:0005730]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; maturation of LSU-rRNA [GO:0000470]; regulation of apoptotic process [GO:0042981]; regulation of cellular senescence [GO:2000772]; regulation of protein localization [GO:0032880],NA,NA,NA
CHOYP_LOC100116878.1.1.m.11654,-0.000345102769599622,-0.0101760755663301,No,NA,NA,O88665,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; p53 binding [GO:0002039]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; cell cycle [GO:0007049]; negative regulation of cell proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LOC100116878.1.1.m.11655,-0.0127996976841976,-0.00187357169528328,No,NA,NA,Q6NWC6,NA,NA,NA,cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; mRNA cleavage factor complex [GO:0005849]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; perichromatin fibrils [GO:0005726]; mRNA binding [GO:0003729]; messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA alternative polyadenylation [GO:0110104]; mRNA processing [GO:0006397]; positive regulation of RNA export from nucleus [GO:0046833]; protein heterotetramerization [GO:0051290],NA,NA,NA
CHOYP_LOC100117365.1.1.m.37817,0.011522267766229,-0.00982001710725696,No,NA,NA,Q5RA42,NA,NA,NA,translation initiation factor activity [GO:0003743],NA,NA,NA
CHOYP_LOC100117425.1.1.m.1256,-0.00768894417613864,0.0140438896840013,No,NA,NA,O77633,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; postsynaptic density [GO:0014069]; tetraspanin-enriched microdomain [GO:0097197]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; constitutive protein ectodomain proteolysis [GO:0051089]; in utero embryonic development [GO:0001701]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; Notch signaling pathway [GO:0007219]; PMA-inducible membrane protein ectodomain proteolysis [GO:0051088]; positive regulation of cell growth [GO:0030307]; positive regulation of cell proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; postsynapse organization [GO:0099173]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; response to tumor necrosis factor [GO:0034612],NA,NA,NA
CHOYP_LOC100117775.2.2.m.59969,-0.0113202330774337,-0.0229873817814677,No,NA,NA,Q9Y2E4,NA,NA,NA,catalytic activity [GO:0003824],NA,NA,NA
CHOYP_LOC100117917.1.1.m.21225,-0.0056644310222435,0.0134565257807401,No,NA,NA,Q9DC48,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_LOC100118048.1.1.m.62637,-0.00460793137025128,0.018453204839359,No,NA,NA,P53356,NA,NA,NA,ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715],NA,NA,NA
CHOYP_LOC100118048.1.1.m.62638,0.00394536801625317,0.00291369700370642,No,NA,NA,P53013,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation factor activity; RNA binding [GO:0008135]; translation [GO:0006412]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_LOC100118063.2.4.m.29108,-0.00484928606837299,-0.00130243348659269,No,NA,NA,P18172,NA,NA,NA,extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity; acting on CH-OH group of donors [GO:0016614],NA,NA,NA
CHOYP_LOC100118098.1.1.m.14795,-0.00223592291623352,-0.0171743853640879,No,NA,NA,Q5ZL33,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]; signaling receptor binding [GO:0005102]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_LOC100118291.1.1.m.54817,0.00728787936946768,0.00512893240873111,No,NA,NA,Q5M824,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Shc-EGFR complex [GO:0070435]; epidermal growth factor receptor binding [GO:0005154]; phosphoprotein binding [GO:0051219]; phosphotyrosine residue binding [GO:0001784]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; receptor tyrosine kinase binding [GO:0030971]; actin cytoskeleton organization [GO:0030036]; activation of MAPK activity [GO:0000187]; aging [GO:0007568]; angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; cellular response to growth factor stimulus [GO:0071363]; cellular response to insulin stimulus [GO:0032869]; epidermal growth factor receptor signaling pathway [GO:0007173]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; positive regulation of cell proliferation [GO:0008284]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of vasoconstriction [GO:0045907]; regulation of growth [GO:0040008]; regulation of smooth muscle contraction [GO:0006940]; response to endothelin [GO:1990839]; response to glucocorticoid [GO:0051384]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to nicotine [GO:0035094]; response to organic cyclic compound [GO:0014070]; response to toxic substance [GO:0009636],NA,NA,NA
CHOYP_LOC100118354.1.4.m.27048,-0.00759277869328328,-0.024272956511215,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100118354.2.4.m.44636,-0.0196612316966861,-0.00934630321432327,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100118464.1.1.m.33259,0.0131581138999359,-0.0196289174205163,No,NA,NA,Q91ZU6,NA,NA,NA,actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cytoplasmic microtubule organization [GO:0031122]; hemidesmosome assembly [GO:0031581]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060],NA,NA,NA
CHOYP_LOC100118502.1.1.m.57420,0.00874393756851279,0.00787814344347635,No,NA,NA,Q9DCR2,NA,NA,NA,AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; cytoplasmic vesicle membrane [GO:0030659]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC100118811.1.1.m.57633,-0.00592120980779047,-0.0161739316354814,No,NA,NA,P97526,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; GTPase activator activity [GO:0005096]; microtubule binding [GO:0008017]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; syndecan binding [GO:0045545]; actin cytoskeleton organization [GO:0030036]; adrenal gland development [GO:0030325]; artery morphogenesis [GO:0048844]; brain development [GO:0007420]; camera-type eye morphogenesis [GO:0048593]; cell communication [GO:0007154]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to nerve growth factor stimulus [GO:1990090]; cerebral cortex development [GO:0021987]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; forebrain astrocyte development [GO:0021897]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; liver development [GO:0001889]; MAPK cascade [GO:0000165]; metanephros development [GO:0001656]; myelination in peripheral nervous system [GO:0022011]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of protein kinase activity [GO:0006469]; osteoblast differentiation [GO:0001649]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase signaling [GO:0014065]; pigmentation [GO:0043473]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of apoptotic process [GO:0043065]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron projection development [GO:0010976]; Ras protein signal transduction [GO:0007265]; regulation of angiogenesis [GO:0045765]; regulation of bone resorption [GO:0045124]; regulation of cell-matrix adhesion [GO:0001952]; regulation of glial cell differentiation [GO:0045685]; regulation of GTPase activity [GO:0043087]; regulation of neuron differentiation [GO:0045664]; response to hypoxia [GO:0001666]; Schwann cell development [GO:0014044]; Schwann cell differentiation [GO:0014037]; smooth muscle tissue development [GO:0048745]; spinal cord development [GO:0021510]; sympathetic nervous system development [GO:0048485]; visual learning [GO:0008542]; wound healing [GO:0042060],NA,NA,NA
CHOYP_LOC100119008.1.1.m.43229,0.0157958277754932,0.0059722509420473,No,NA,NA,H3ZPL1,NA,NA,NA,L-phenylalanine:2-oxoglutarate aminotransferase activity [GO:0080130]; pyridoxal phosphate binding [GO:0030170]; biosynthetic process [GO:0009058],NA,NA,NA
CHOYP_LOC100119236.1.1.m.22785,-0.00580694039182053,0.00297980828235878,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100119310.1.1.m.22031,0.00479861655028833,0.00709961683006351,No,NA,NA,Q28727,NA,NA,NA,apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; microvillus [GO:0005902]; bile acid:sodium symporter activity [GO:0008508]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_LOC100119310.1.1.m.22032,0.014294243443551,0.00638291837366245,No,NA,NA,P62248,NA,NA,NA,endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_LOC100119577.1.1.m.47861,-0.0163646578228863,-0.00579701907949239,No,NA,NA,Q60676,NA,NA,NA,cell periphery [GO:0071944]; chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; proximal dendrite [GO:1990635]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; G-protein alpha-subunit binding [GO:0001965]; heat shock protein binding [GO:0031072]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; RNA binding [GO:0003723]; cellular response to cadmium ion [GO:0071276]; cellular response to hydrogen peroxide [GO:0070301]; histone dephosphorylation [GO:0016576]; negative regulation of cell death [GO:0060548]; negative regulation of neuron death [GO:1901215]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of glucocorticoid receptor signaling pathway [GO:2000324]; protein complex oligomerization [GO:0051259]; protein dephosphorylation [GO:0006470]; protein heterooligomerization [GO:0051291]; response to arachidonic acid [GO:1904550]; response to lead ion [GO:0010288]; response to morphine [GO:0043278],NA,NA,NA
CHOYP_LOC100119750.1.1.m.7019,-0.0068640177371683,0.00129669008728359,No,NA,NA,Q80YR4,NA,NA,NA,metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; ribosome binding [GO:0043022]; ubiquitin protein ligase activity [GO:0061630]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; rescue of stalled ribosome [GO:0072344],NA,NA,NA
CHOYP_LOC100120123.1.1.m.12979,-0.0141580687406799,-0.0217990067680008,No,NA,NA,P54886,NA,NA,NA,cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; delta1-pyrroline-5-carboxylate synthetase activity [GO:0017084]; glutamate 5-kinase activity [GO:0004349]; glutamate-5-semialdehyde dehydrogenase activity [GO:0004350]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; cellular amino acid biosynthetic process [GO:0008652]; citrulline biosynthetic process [GO:0019240]; glutamate metabolic process [GO:0006536]; L-proline biosynthetic process [GO:0055129]; ornithine biosynthetic process [GO:0006592]; proline biosynthetic process [GO:0006561],NA,NA,NA
CHOYP_LOC100120260.1.1.m.41887,0.0050255609851024,-0.00338956745493145,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100120260.1.1.m.41888,-0.00235533607224539,0.00969505122748578,No,NA,NA,Q62685,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; nuclear receptor transcription coactivator activity [GO:0030374]; protein heterodimerization activity [GO:0046982]; retinoid X receptor binding [GO:0046965]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; cellular response to lipopolysaccharide [GO:0071222]; cholesterol homeostasis [GO:0042632]; insulin receptor signaling pathway [GO:0008286]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; multicellular organism development [GO:0007275]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of inflammatory response [GO:0050728]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of nuclear receptor transcription coactivator activity [GO:2000325],NA,NA,NA
CHOYP_LOC100120440.1.1.m.15371,0.0107509131953341,-0.0131524750789273,No,NA,NA,Q7TN29,NA,NA,NA,cytoplasm [GO:0005737]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100120677.1.1.m.16799,0.00205195042830453,-0.00934116934689426,No,NA,NA,A0JMK9,NA,NA,NA,CAF-1 complex [GO:0033186]; nucleus [GO:0005634]; cell cycle [GO:0007049]; chromatin assembly [GO:0031497]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; nucleosome assembly [GO:0006334],NA,NA,NA
CHOYP_LOC100120994.1.1.m.54109,0.00310111912595652,-0.00621561248533197,No,NA,NA,Q9TUP7,NA,NA,NA,integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; orexin receptor activity [GO:0016499]; circadian sleep/wake cycle process [GO:0022410]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of circadian sleep/wake cycle; wakefulness [GO:0010840]; regulation of cytosolic calcium ion concentration [GO:0051480],NA,NA,NA
CHOYP_LOC100121360.1.1.m.56328,0.000686232728993107,-0.0107331332691118,No,NA,NA,Q99315,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]; aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition; RNA-mediated [GO:0032197],NA,NA,NA
CHOYP_LOC100121363.1.1.m.46369,-0.000125633965456196,0.00745923387923667,No,NA,NA,P97570,NA,NA,NA,cytosol [GO:0005829]; extracellular space [GO:0005615]; microtubule organizing center [GO:0005815]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP-dependent protein binding [GO:0043008]; calcium-independent phospholipase A2 activity [GO:0047499]; calmodulin binding [GO:0005516]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1;2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1;2-dioleoylphosphatidylethanolamine) [GO:0102568]; protein kinase binding [GO:0019901]; serine hydrolase activity [GO:0017171]; antibacterial humoral response [GO:0019731]; cardiolipin biosynthetic process [GO:0032049]; chemotaxis [GO:0006935]; lipid catabolic process [GO:0016042]; maternal process involved in female pregnancy [GO:0060135]; memory [GO:0007613]; negative regulation of synaptic transmission; glutamatergic [GO:0051967]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; regulation of store-operated calcium channel activity [GO:1901339]; response to endoplasmic reticulum stress [GO:0034976]; urinary bladder smooth muscle contraction [GO:0014832],NA,NA,NA
CHOYP_LOC100121425.1.1.m.10532,-0.0142535379546296,0.00601979769117474,No,NA,NA,Q01617,NA,NA,NA,nucleus [GO:0005634]; mRNA binding [GO:0003729]; snRNA stem-loop binding [GO:0035614]; chemical synaptic transmission [GO:0007268]; dormancy process [GO:0022611]; mRNA splicing; via spliceosome [GO:0000398]; multicellular organism development [GO:0007275]; regulation of hemocyte proliferation [GO:0035206],NA,NA,NA
CHOYP_LOC100121687.1.1.m.57141,-0.0127667535138982,-0.0101883921321709,No,NA,NA,Q14202,NA,NA,NA,nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]; cytoskeleton organization [GO:0007010]; multicellular organism development [GO:0007275]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_LOC100121788.1.1.m.28436,0.0226919466318778,-0.00511988205231901,No,NA,NA,Q96HN2,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; neuron projection [GO:0043005]; hydrolase activity [GO:0016787]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine cycle [GO:0033353],NA,NA,NA
CHOYP_LOC100121969.1.1.m.52130,0.00217997094733793,-0.00807271368859912,No,NA,NA,Q5RAY1,NA,NA,NA,clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; endocytosis [GO:0006897]; exocytosis [GO:0006887]; phosphatidylinositol-mediated signaling [GO:0048015],NA,NA,NA
CHOYP_LOC100121991.1.1.m.13778,-0.00430894344577715,-0.00631540690244347,No,NA,NA,Q9NG98,NA,NA,NA,chromosome [GO:0005694]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I activity [GO:0003917]; zinc ion binding [GO:0008270]; developmental growth [GO:0048589]; DNA topological change [GO:0006265]; double-strand break repair via homologous recombination [GO:0000724]; mitochondrial genome maintenance [GO:0000002]; tissue regeneration [GO:0042246],NA,NA,NA
CHOYP_LOC100121999.3.4.m.54805,0.00333374632100331,0.012149634643778,No,NA,NA,O61122,NA,NA,NA,actin cytoskeleton [GO:0015629]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle [GO:0005819]; actin binding [GO:0003779]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; cell cycle [GO:0007049]; cell division [GO:0051301]; hippo signaling [GO:0035329]; hyperosmotic response [GO:0006972]; positive regulation of cell division [GO:0051781]; positive regulation of mitotic cytokinetic process [GO:1903438]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of sorocarp development [GO:0031156]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_LOC100122037.1.1.m.12516,-0.0107169215157978,-0.012247792725921,No,NA,NA,A2BHJ4,NA,NA,NA,CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; gene silencing by RNA [GO:0031047]; mRNA processing [GO:0006397]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_LOC100122067.1.1.m.49811,-0.00551845142968343,-0.0128803747314139,No,NA,NA,Q9BYD6,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; maturation of LSU-rRNA [GO:0000470]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100122208.1.1.m.58545,0.000686232728993107,-0.0107331332691118,No,NA,NA,Q8CC21,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respirasome [GO:0070469]; mitochondrial respiratory chain complex III assembly [GO:0034551]; oxidation-reduction process [GO:0055114],NA,NA,NA
CHOYP_LOC100122211.1.1.m.56146,0.00794162851322759,-0.0022794727477885,No,NA,NA,Q920Q8,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; nucleus [GO:0005634]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of protein ubiquitination [GO:0031397]; response to virus [GO:0009615]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100122269.1.1.m.8408,0.0171158468803641,-0.0155359130173887,No,NA,NA,Q9KPS0,NA,NA,NA,DNA binding [GO:0003677]; regulation of cell shape [GO:0008360],NA,NA,NA
CHOYP_LOC100122293.2.2.m.61265,0.0213550633873502,0.00791033359967058,No,NA,NA,Q96RU3,NA,NA,NA,cell cortex [GO:0005938]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; endocytosis [GO:0006897]; membrane organization [GO:0061024],NA,NA,NA
CHOYP_LOC100122438.2.2.m.60108,0.00217997094733793,-0.00807271368859912,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100122904.1.1.m.45984,0.00394536801625317,0.00291369700370642,No,NA,NA,Q3TLI0,NA,NA,NA,cytosol [GO:0005829]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071]; early endosome to Golgi transport [GO:0034498]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein complex oligomerization [GO:0051259],NA,NA,NA
CHOYP_LOC100123075.1.1.m.8128,0.00991810298556511,0.00652537253880201,No,NA,NA,Q5RBH9,NA,NA,NA,cell cortex [GO:0005938]; endomembrane system [GO:0012505]; lamellipodium [GO:0030027]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein phosphorylation [GO:0006468],NA,NA,NA
CHOYP_LOC100123216.1.1.m.28671,0.0149915756639488,0.00415478715339973,No,NA,NA,Q5RBL1,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; glycine-tRNA ligase activity [GO:0004820]; protein dimerization activity [GO:0046983]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]; tRNA aminoacylation for protein translation [GO:0006418],NA,NA,NA
CHOYP_LOC100123238.1.1.m.27155,-0.0017624764605385,0.00931273221999445,No,NA,NA,Q8C1Z8,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA (guanine(9)-N(1))-methyltransferase activity [GO:0052905]; tRNA (guanine-N1-)-methyltransferase activity [GO:0009019]; tRNA binding [GO:0000049]; magnesium ion homeostasis [GO:0010960]; tRNA methylation [GO:0030488],NA,NA,NA
CHOYP_LOC100123307.1.1.m.13647,-0.00148623171269929,-0.0106475591315987,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100123521.1.2.m.20656,0.00981207841815057,0.0118134115231091,No,NA,NA,Q9UDR5,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; saccharopine dehydrogenase (NAD+; L-glutamate-forming) activity [GO:0047131]; saccharopine dehydrogenase (NADP+; L-lysine-forming) activity [GO:0047130]; saccharopine dehydrogenase activity [GO:0004753]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; lysine biosynthetic process via aminoadipic acid [GO:0019878]; lysine catabolic process [GO:0006554]; protein tetramerization [GO:0051262],NA,NA,NA
CHOYP_LOC100123521.2.2.m.52492,-0.00978994437037825,0.0191442109521422,No,NA,NA,Q9UDR5,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; saccharopine dehydrogenase (NAD+; L-glutamate-forming) activity [GO:0047131]; saccharopine dehydrogenase (NADP+; L-lysine-forming) activity [GO:0047130]; saccharopine dehydrogenase activity [GO:0004753]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; lysine biosynthetic process via aminoadipic acid [GO:0019878]; lysine catabolic process [GO:0006554]; protein tetramerization [GO:0051262],NA,NA,NA
CHOYP_LOC100123553.1.1.m.34041,-0.00844486586247145,-0.0126035830948388,No,NA,NA,Q8I8U7,NA,NA,NA,cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; SAGA complex [GO:0000124]; transcription coregulator activity [GO:0003712]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; histone H3 acetylation [GO:0043966]; mitotic cytokinesis [GO:0000281]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of transcription; DNA-templated [GO:0006355]; transcription; DNA-templated [GO:0006351]; wing disc pattern formation [GO:0035222],NA,NA,NA
CHOYP_LOC100123595.1.2.m.63353,0.00314728514279022,0.0113879006430806,No,NA,NA,O88874,NA,NA,NA,cyclin K-CDK12 complex [GO:0002944]; cyclin K-CDK13 complex [GO:0002945]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; in utero embryonic development [GO:0001701]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of stem cell differentiation [GO:2000737]; positive regulation of DNA-templated transcription; elongation [GO:0032786]; positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues [GO:2001165]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_LOC100123629.1.1.m.841,0.00939804158029619,0.016191476153913,No,NA,NA,P50464,NA,NA,NA,adherens junction [GO:0005912]; basal plasma membrane [GO:0009925]; M band [GO:0031430]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; striated muscle dense body [GO:0055120]; metal ion binding [GO:0046872]; myosin binding [GO:0017022]; cell-cell junction organization [GO:0045216]; mitochondrion organization [GO:0007005]; muscle cell cellular homeostasis [GO:0046716]; muscle organ development [GO:0007517]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; sensory perception of mechanical stimulus [GO:0050954],NA,NA,NA
CHOYP_LOC100123667.1.1.m.22353,-0.0109794606400968,0.000162621648156566,No,NA,NA,P97376,NA,NA,NA,Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; striated muscle dense body [GO:0055120]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; muscle organ development [GO:0007517]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_LOC100123810.2.2.m.52182,-0.00430894344577715,-0.00631540690244347,No,NA,NA,Q7TSH8,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_LOC100123890.1.1.m.11450,0.00160979636406568,-0.00397985419154334,No,NA,NA,B4JSC2,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; glucose homeostasis [GO:0042593]; multicellular organism aging [GO:0010259]; negative regulation of cell growth [GO:0030308]; negative regulation of cell proliferation [GO:0008285]; negative regulation of insulin receptor signaling pathway [GO:0046627]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100123907.1.1.m.2987,-0.0122664413528651,-0.0115285740637564,No,NA,NA,Q7ZWE9,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cytidylate kinase activity [GO:0004127]; nucleoside diphosphate kinase activity [GO:0004550]; uridylate kinase activity [GO:0009041]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; pyrimidine nucleotide biosynthetic process [GO:0006221],NA,NA,NA
CHOYP_LOC100136190.1.1.m.9460,-0.0147961696885489,-0.0150470795328045,No,NA,NA,Q67ER4,NA,NA,NA,nuclear speck [GO:0016607]; U2-type spliceosomal complex [GO:0005684]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; DNA repair [GO:0006281]; isopeptide cross-linking via N6-glycyl-L-lysine [GO:0018276]; mRNA processing [GO:0006397]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; protein ubiquitination [GO:0016567]; snoRNA splicing [GO:0034247],NA,NA,NA
CHOYP_LOC100142119.1.2.m.2339,0.0068606934399024,-0.0127582097547693,No,NA,NA,Q8R003,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; multicellular organism development [GO:0007275]; negative regulation of myoblast differentiation [GO:0045662]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100142249.1.1.m.55762,0.0144403082077602,-0.000318010352515788,No,NA,NA,P58283,NA,NA,NA,cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic endocytic zone [GO:0098843]; Schaffer collateral - CA1 synapse [GO:0098685]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; apoptotic process [GO:0006915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process; modulating synaptic transmission [GO:0099546]; protein K48-linked ubiquitination [GO:0070936]; regulation of defense response to virus by host [GO:0050691]; regulation of interferon-beta production [GO:0032648],NA,NA,NA
CHOYP_LOC100145215.1.1.m.6904,0.000686232728993107,-0.0107331332691118,No,NA,NA,P28285,NA,NA,NA,dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled amine receptor activity [GO:0008227]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; Gi/o-coupled serotonin receptor activity [GO:0001586]; neurotransmitter receptor activity [GO:0030594]; adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; anesthesia-resistant memory [GO:0007615]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway; coupled to cyclic nucleotide second messenger [GO:0007187]; inter-male aggressive behavior [GO:0002121]; male courtship behavior [GO:0008049]; phospholipase C-activating serotonin receptor signaling pathway [GO:0007208]; regulation of circadian sleep/wake cycle; sleep [GO:0045187]; serotonin receptor signaling pathway [GO:0007210],NA,NA,NA
CHOYP_LOC100146233.1.1.m.36400,0.00312663482927925,-0.0128391311157744,No,NA,NA,Q0VH32,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; protein dimerization activity [GO:0046983],NA,NA,NA
CHOYP_LOC100148223.1.1.m.10633,-0.0135725579708753,0.00388604629968508,No,NA,NA,B7Z6K7,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100150876.1.1.m.61100,-0.0140775843183191,-0.0109895421460064,No,NA,NA,Q96NN9,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; 2 iron; 2 sulfur cluster binding [GO:0051537]; flavin adenine dinucleotide binding [GO:0050660]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; execution phase of apoptosis [GO:0097194],NA,NA,NA
CHOYP_LOC100158931.1.1.m.8283,0.00394536801625317,0.00291369700370642,No,NA,NA,Q5RDQ2,NA,NA,NA,bicellular tight junction [GO:0005923]; endomembrane system [GO:0012505]; plasma membrane [GO:0005886]; bicellular tight junction assembly [GO:0070830]; establishment of epithelial cell polarity [GO:0090162],NA,NA,NA
CHOYP_LOC100160077.1.1.m.62645,0.0210262292879741,0.00434119813803984,No,NA,NA,Q62829,NA,NA,NA,cytoplasm [GO:0005737]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; GTPase binding [GO:0051020]; MAP kinase kinase activity [GO:0004708]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; Rac GTPase binding [GO:0048365]; SH3 domain binding [GO:0017124]; activation of protein kinase activity [GO:0032147]; axonogenesis [GO:0007409]; cell migration [GO:0016477]; cellular response to organic cyclic compound [GO:0071407]; dendrite development [GO:0016358]; dendritic spine morphogenesis [GO:0060997]; intracellular signal transduction [GO:0035556]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of neuron apoptotic process [GO:0043525]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament polymerization [GO:0030833]; regulation of axonogenesis [GO:0050770]; regulation of MAPK cascade [GO:0043408]; regulation of neuron projection development [GO:0010975]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_LOC100160385.1.2.m.40193,0.00678620130084429,0.00878741825264137,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100160412.2.2.m.56352,0.0202404907605143,-0.00369213745708798,No,NA,NA,O35115,NA,NA,NA,M band [GO:0031430]; nucleus [GO:0005634]; Z disc [GO:0030018]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription factor binding [GO:0008134]; atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; response to hormone [GO:0009725]; ventricular cardiac muscle cell development [GO:0055015],NA,NA,NA
CHOYP_LOC100161158.1.1.m.14383,-0.00405291054512085,-0.024189947362605,No,NA,NA,Q6NYU7,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; GTP binding [GO:0005525]; uridine kinase activity [GO:0004849],NA,NA,NA
CHOYP_LOC100161360.1.1.m.65809,-0.00771942834166464,0.0020531798267115,No,NA,NA,P23128,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; messenger ribonucleoprotein complex [GO:1990124]; neuronal cell body [GO:0043025]; neuronal ribonucleoprotein granule [GO:0071598]; P granule [GO:0043186]; P-body [GO:0000932]; postsynapse [GO:0098794]; sensory dendrite [GO:0071683]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; cytoplasmic mRNA processing body assembly [GO:0033962]; gene silencing by miRNA [GO:0035195]; habituation [GO:0046959]; messenger ribonucleoprotein complex assembly [GO:1990120]; negative regulation of cytoplasmic translation [GO:2000766]; ovarian follicle cell development [GO:0030707]; pole cell formation [GO:0007279]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of posttranscriptional gene silencing [GO:0060148]; regulation of defense response to virus [GO:0050688]; regulation of neuron projection arborization [GO:0150011]; regulation of olfactory learning [GO:0090328],NA,NA,NA
CHOYP_LOC100162380.1.1.m.23942,0.00678620130084429,0.00878741825264137,No,NA,NA,Q5RH71,NA,NA,NA,integral component of plasma membrane [GO:0005887]; cell surface receptor signaling pathway [GO:0007166],NA,NA,NA
CHOYP_LOC100162439.1.1.m.19182,-0.0225758941271488,0.0100089672352537,No,NA,NA,Q17RP2,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677],NA,NA,NA
CHOYP_LOC100164363.1.1.m.61731,0.0212047526102126,-0.000187189970322817,No,NA,NA,P18155,NA,NA,NA,mitochondrion [GO:0005739]; magnesium ion binding [GO:0000287]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO:0004487]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; phosphate ion binding [GO:0042301]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653],NA,NA,NA
CHOYP_LOC100164899.1.1.m.59665,0.0196853094961972,0.00508278699164584,No,NA,NA,Q8BGT5,NA,NA,NA,mitochondrion [GO:0005739]; L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; L-alanine catabolic process [GO:0042853]; L-alanine metabolic process [GO:0042851],NA,NA,NA
CHOYP_LOC100165317.1.1.m.8504,0.0065883263884642,0.0180931628217626,No,NA,NA,P27398,NA,NA,NA,cytoplasm [GO:0005737]; intracellular [GO:0005622]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; metal ion binding [GO:0046872]; nervous system development [GO:0007399]; proteolysis [GO:0006508]; response to stimulus [GO:0050896]; visual perception [GO:0007601],NA,NA,NA
CHOYP_LOC100165581.1.1.m.18008,-0.0127701275468002,-0.00751309397268585,No,NA,NA,Q5R4B2,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741],NA,NA,NA
CHOYP_LOC100165685.1.1.m.13583,0.0113586921788261,-0.0174829128655453,No,NA,NA,O14639,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; stress fiber [GO:0001725]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; animal organ morphogenesis [GO:0009887]; cilium assembly [GO:0060271]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; visual perception [GO:0007601],NA,NA,NA
CHOYP_LOC100165703.1.1.m.48642,-0.00433312553323825,0.0148439312491398,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100166052.1.1.m.46867,0.00394536801625317,0.00291369700370642,No,NA,NA,A2AAE1,NA,NA,NA,integral component of membrane [GO:0016021]; nucleus [GO:0005634]; presynapse [GO:0098793]; adipose tissue development [GO:0060612]; fat cell differentiation [GO:0045444]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; nucleus localization [GO:0051647]; regulation of cell growth [GO:0001558]; spermatogenesis [GO:0007283]; synaptic vesicle endocytosis [GO:0048488],NA,NA,NA
CHOYP_LOC100166353.1.1.m.4625,-0.00152142873133229,0.00617027713382105,No,NA,NA,Q2NL00,NA,NA,NA,cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749],NA,NA,NA
CHOYP_LOC100166368.1.1.m.44709,0.0182465604822933,-4.85674398084432e-05,No,NA,NA,Q63598,NA,NA,NA,actin filament [GO:0005884]; actin filament bundle [GO:0032432]; cytoplasm [GO:0005737]; stereocilium [GO:0032420]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; inner ear auditory receptor cell differentiation [GO:0042491],NA,NA,NA
CHOYP_LOC100167728.1.2.m.2289,0.0164615431928211,-0.00638806734905957,No,NA,NA,Q3U1T9,NA,NA,NA,clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; phosphatidylinositol phosphate binding [GO:1901981]; Rab GTPase binding [GO:0017137]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; positive regulation of GTPase activity [GO:0043547]; protein transport [GO:0015031]; regulation of immune response [GO:0050776]; T cell receptor signaling pathway [GO:0050852]; T-helper 2 cell cytokine production [GO:0035745],NA,NA,NA
CHOYP_LOC100168017.1.1.m.40316,0.00814157431830068,0.00624829488022073,No,NA,NA,Q26474,NA,NA,NA,anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_LOC100168209.1.1.m.26697,-0.0156825470811019,-0.0141374711751013,No,NA,NA,Q5XI42,NA,NA,NA,plasma membrane [GO:0005886]; 3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; cellular aldehyde metabolic process [GO:0006081]; ethanol catabolic process [GO:0006068],NA,NA,NA
CHOYP_LOC100168368.1.1.m.18551,-0.0172089298399944,-0.000470195393690518,No,NA,NA,P41778,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; adrenal gland development [GO:0030325]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; branching involved in ureteric bud morphogenesis [GO:0001658]; embryonic hemopoiesis [GO:0035162]; embryonic limb morphogenesis [GO:0030326]; embryonic organ development [GO:0048568]; embryonic skeletal system development [GO:0048706]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of cell proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal/distal pattern formation [GO:0009954]; regulation of cell proliferation [GO:0042127]; regulation of ossification [GO:0030278]; sex differentiation [GO:0007548]; spleen development [GO:0048536]; steroid biosynthetic process [GO:0006694]; thymus development [GO:0048538]; urogenital system development [GO:0001655],NA,NA,NA
CHOYP_LOC100168569.1.2.m.11752,0.00690276889216921,-0.00524139015712852,No,NA,NA,Q13188,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein dimerization activity [GO:0046983]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; cell differentiation involved in embryonic placenta development [GO:0060706]; central nervous system development [GO:0007417]; endocardium development [GO:0003157]; hepatocyte apoptotic process [GO:0097284]; hippo signaling [GO:0035329]; intracellular signal transduction [GO:0035556]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell proliferation [GO:0008285]; negative regulation of organ growth [GO:0046621]; neural tube formation [GO:0001841]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase B signaling [GO:0051897]; primitive hemopoiesis [GO:0060215]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of cell differentiation involved in embryonic placenta development [GO:0060800]; signal transduction [GO:0007165]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_LOC100168620.4.4.m.40081,-0.0233899720839929,0.00681337515598701,No,NA,NA,Q0Q028,NA,NA,NA,extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087],NA,NA,NA
CHOYP_LOC100168796.1.1.m.4672,0.0118780172288429,-0.00861172912423705,No,NA,NA,Q60899,NA,NA,NA,synapse [GO:0045202]; RNA binding [GO:0003723]; cellular response to leukemia inhibitory factor [GO:1990830],NA,NA,NA
CHOYP_LOC100168945.1.1.m.37004,0.00720021905041681,-0.00748076296067543,No,NA,NA,P50395,NA,NA,NA,azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; myelin sheath [GO:0043209]; secretory granule lumen [GO:0034774]; synapse [GO:0045202]; vesicle [GO:0031982]; GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; neutrophil degranulation [GO:0043312]; protein transport [GO:0015031]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264],NA,NA,NA
CHOYP_LOC100169229.1.1.m.25981,0.013428940929682,-0.00845610169689392,No,NA,NA,Q7Z6B7,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]; negative regulation of cell migration [GO:0030336]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100169297.1.1.m.48433,0.0056280996361156,-0.00920112079936486,No,NA,NA,G5ECP4,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556],NA,NA,NA
CHOYP_LOC100169460.1.1.m.41302,-0.0103336604894421,-0.0160828821335029,No,NA,NA,Q9UJZ1,NA,NA,NA,cytoskeleton [GO:0005856]; extrinsic component of plasma membrane [GO:0019897]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; cardiolipin binding [GO:1901612]; GTPase binding [GO:0051020]; signaling receptor binding [GO:0005102]; CD4-positive; alpha-beta T cell activation [GO:0035710]; cellular calcium ion homeostasis [GO:0006874]; interleukin-2 production [GO:0032623]; lipid localization [GO:0010876]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; positive regulation of cardiolipin metabolic process [GO:1900210]; positive regulation of mitochondrial DNA replication [GO:0090297]; positive regulation of mitochondrial membrane potential [GO:0010918]; protein complex oligomerization [GO:0051259]; stress-induced mitochondrial fusion [GO:1990046]; T cell receptor signaling pathway [GO:0050852],NA,NA,NA
CHOYP_LOC100174996.1.1.m.27300,-0.011638478390256,0.0163861825021615,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100175021.11.11.m.63958,-0.0225195175647611,0.0105616078079178,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100175021.7.11.m.58378,-0.0226209227835436,0.0104639392189706,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100175702.1.1.m.56240,-0.0169591047060434,0.00960206869202777,No,NA,NA,A2RSX4,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100175722.1.3.m.11427,-0.022836308084121,0.00110576013836782,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100175867.1.1.m.48982,0.0220297716975204,-0.00398486116826211,No,NA,NA,P05099,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; growth plate cartilage chondrocyte morphogenesis [GO:0003429],NA,NA,NA
CHOYP_LOC100175959.1.7.m.1896,0.00592650520697237,0.0170294987050215,No,NA,NA,P90703,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_LOC100175959.4.7.m.28172,0.0158841267455068,0.00378386601342906,No,NA,NA,O61463,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_LOC100176099.1.1.m.40368,-0.0226660731950101,0.0103136371484895,No,NA,NA,Q9P0M2,NA,NA,NA,cytosol [GO:0005829]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; nucleotide binding [GO:0000166]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; modulation of chemical synaptic transmission [GO:0050804]; regulation of protein kinase A signaling [GO:0010738],NA,NA,NA
CHOYP_LOC100176232.1.1.m.24645,-0.0111167728476614,0.012704454148507,No,NA,NA,Q5SSL4,NA,NA,NA,cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density; intracellular component [GO:0099092]; Schaffer collateral - CA1 synapse [GO:0098685]; GTPase activator activity [GO:0005096]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; actin cytoskeleton organization [GO:0030036]; brain development [GO:0007420]; inner ear morphogenesis [GO:0042472]; intracellular signal transduction [GO:0035556]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of blood vessel remodeling [GO:0060313]; negative regulation of cell migration [GO:0030336]; negative regulation of cellular extravasation [GO:0002692]; negative regulation of inflammatory response [GO:0050728]; negative regulation of neutrophil degranulation [GO:0043314]; neuromuscular process controlling balance [GO:0050885]; positive regulation of phagocytosis [GO:0050766]; regulation of Rho protein signal transduction [GO:0035023]; regulation of vascular permeability [GO:0043114]; response to lipopolysaccharide [GO:0032496],NA,NA,NA
CHOYP_LOC100176461.1.1.m.63236,0.00389697115569566,-0.018237162614077,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100176721.6.6.m.66056,0.00364778592941831,-0.00872052841558097,No,NA,NA,P22105,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251],NA,NA,NA
CHOYP_LOC100176799.1.1.m.3132,0.00732147317789014,0.00757536514658319,No,NA,NA,Q60HE9,NA,NA,NA,lysosome [GO:0005764]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; mannose metabolic process [GO:0006013],NA,NA,NA
CHOYP_LOC100177459.1.2.m.48730,-0.0166140425151566,-0.00255346631809479,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100177679.1.1.m.54177,0.0170619495408465,-0.00105096250922477,No,NA,NA,P74148,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100177909.1.1.m.29356,-0.00825870982837165,-0.00569493444874794,No,NA,NA,Q8K3A0,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; [2Fe-2S] cluster assembly [GO:0044571]; iron-sulfur cluster assembly [GO:0016226]; protein complex oligomerization [GO:0051259]; protein maturation by iron-sulfur cluster transfer [GO:0097428],NA,NA,NA
CHOYP_LOC100178034.1.2.m.13282,0.00369389670498532,-0.0221582268669402,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100178081.1.1.m.56365,-0.0110163051006116,-0.00626005013522281,No,NA,NA,O18334,NA,NA,NA,cell junction [GO:0030054]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; synapse [GO:0045202]; vesicle [GO:0031982]; actin binding [GO:0003779]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; axon guidance [GO:0007411]; compound eye morphogenesis [GO:0001745]; defense response to fungus [GO:0050832]; exocytosis [GO:0006887]; germarium-derived egg chamber formation [GO:0007293]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; oocyte microtubule cytoskeleton polarization [GO:0008103]; phototransduction [GO:0007602]; pole plasm oskar mRNA localization [GO:0045451]; R7 cell development [GO:0045467]; Rab protein signal transduction [GO:0032482]; regulation of postsynaptic membrane potential [GO:0060078]; retrograde transport; endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC100178400.1.1.m.4321,0.0121727015873632,0.00566514915705466,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100178700.1.1.m.37554,1.21932944694661e-05,-0.0150189768656922,No,NA,NA,Q497B8,NA,NA,NA,chromosome [GO:0005694]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone demethylase activity (H3-K36 specific) [GO:0051864]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]; G2/M transition of mitotic cell cycle [GO:0000086]; histone H3-K36 demethylation [GO:0070544]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_LOC100178916.1.1.m.26391,0.00144504559436104,0.00241014933159197,No,NA,NA,Q3KQ80,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; apoptotic process [GO:0006915],NA,NA,NA
CHOYP_LOC100179134.1.1.m.23870,0.00205195042830452,-0.00934116934689426,No,NA,NA,Q6NXK5,NA,NA,NA,fibrillar center [GO:0001650]; intercellular bridge [GO:0045171]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; nucleotide phosphatase activity; acting on free nucleotides [GO:0098519]; phosphatase activity [GO:0016791]; polynucleotide 5'-phosphatase activity [GO:0004651]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; RNA binding [GO:0003723]; polynucleotide 5' dephosphorylation [GO:0098507]; protein dephosphorylation [GO:0006470]; RNA metabolic process [GO:0016070],NA,NA,NA
CHOYP_LOC100179300.1.2.m.22734,0.00234157568115589,-0.0226326514171387,No,NA,NA,Q6P8Y1,NA,NA,NA,cytoplasm [GO:0005737]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC100179357.5.6.m.45322,-0.00933607545514702,-0.0131763921759547,No,NA,NA,Q5RHP9,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100179448.1.1.m.8298,0.0145450806052374,-0.0159149470042999,No,NA,NA,P23403,NA,NA,NA,small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100179516.1.2.m.45110,-0.00619205211203462,0.0140005030332395,No,NA,NA,Q6IMH0,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100179516.2.2.m.49937,-0.0188070252011331,-0.011186417132784,No,NA,NA,Q6IMH0,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100180023.1.7.m.11060,0.0187135374063454,0.00835540511622569,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100180023.4.7.m.33650,0.00693617164878211,-0.00437363203359092,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100180023.5.7.m.56825,-0.00140715909295775,0.0184858756909203,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100180543.1.1.m.4746,0.0116080605034459,0.000655133899113222,No,NA,NA,Q90XD2,NA,NA,NA,mitochondrion [GO:0005739]; agmatinase activity [GO:0008783]; metal ion binding [GO:0046872]; putrescine biosynthetic process from arginine [GO:0033388]; spermidine biosynthetic process [GO:0008295],NA,NA,NA
CHOYP_LOC100180636.1.1.m.66440,-0.00707256869157015,-0.0244596125628067,No,NA,NA,Q8CEQ0,NA,NA,NA,ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; heart development [GO:0007507]; protein phosphorylation [GO:0006468]; regulation of cilium assembly [GO:1902017],NA,NA,NA
CHOYP_LOC100180716.1.2.m.860,0.00833787358705474,0.0134771919703949,No,NA,NA,Q9IA76,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100180855.2.4.m.46097,-0.00554095575369029,0.00490069280003891,No,NA,NA,Q8LGG8,NA,NA,NA,plasma membrane [GO:0005886]; AMP binding [GO:0016208],NA,NA,NA
CHOYP_LOC100180855.4.4.m.66721,0.000333889428883075,-0.017478697038703,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100180883.1.1.m.46611,-0.0153814647227071,-0.00926149085224138,No,NA,NA,Q9CQ66,NA,NA,NA,cytoplasmic dynein complex [GO:0005868]; dynein intermediate chain binding [GO:0045505]; cilium assembly [GO:0060271]; regulation of cilium assembly [GO:1902017]; regulation of intraciliary retrograde transport [GO:1905799],NA,NA,NA
CHOYP_LOC100181095.1.1.m.8314,-0.0161517387265149,-0.0136870608112134,No,NA,NA,Q9C093,NA,NA,NA,Golgi apparatus [GO:0005794]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100181159.1.1.m.6127,0.0164050228327432,0.0116739602305524,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100181343.1.1.m.59214,-0.00144464179791636,0.0109420199617183,No,NA,NA,Q9VRV7,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; precatalytic spliceosome [GO:0071011]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; mRNA binding [GO:0003729]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_LOC100181350.1.1.m.2782,0.0107276502576377,-0.00421997911707979,No,NA,NA,P47989,NA,NA,NA,cytosol [GO:0005829]; extracellular space [GO:0005615]; peroxisome [GO:0005777]; sarcoplasmic reticulum [GO:0016529]; 2 iron; 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; protein homodimerization activity [GO:0042803]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; lactation [GO:0007595]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; negative regulation of vasculogenesis [GO:2001213]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; purine nucleotide catabolic process [GO:0006195]; xanthine catabolic process [GO:0009115],NA,NA,NA
CHOYP_LOC100181355.1.1.m.48652,-0.00087029365091398,0.0101755781793627,No,NA,NA,Q9BXF9,NA,NA,NA,acrosomal membrane [GO:0002080]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378],NA,NA,NA
CHOYP_LOC100181607.1.2.m.36709,0.00514855925077097,0.0150303605975186,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100181826.1.1.m.16288,0.016468708714172,-0.013400698681544,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100181873.1.2.m.45633,-0.0161807335044597,0.00575061890310338,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100182131.1.1.m.26023,-0.0104972413773375,-0.00613333714964988,No,NA,NA,Q3T0C9,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; perinuclear region of cytoplasm [GO:0048471]; endocytosis [GO:0006897]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of sprouting angiogenesis [GO:1903671]; regulation of Notch signaling pathway [GO:0008593],NA,NA,NA
CHOYP_LOC100182237.2.2.m.33734,0.0053332714151053,-0.00662314748865823,No,NA,NA,B3EWY9,NA,NA,NA,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ErbB-2 class receptor binding [GO:0005176]; extracellular matrix constituent; lubricant activity [GO:0030197]; cell-matrix adhesion [GO:0007160]; epithelial structure maintenance [GO:0010669]; regulation of signaling receptor activity [GO:0010469],NA,NA,NA
CHOYP_LOC100182352.2.2.m.64092,0.00921854781205281,-0.000385158834362566,No,NA,NA,D3YXS5,NA,NA,NA,intracellular [GO:0005622]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; mitochondrion organization [GO:0007005]; organelle transport along microtubule [GO:0072384],NA,NA,NA
CHOYP_LOC100182585.1.2.m.2597,-0.0115800206619455,0.0138938484965596,No,NA,NA,Q95M12,NA,NA,NA,lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; negative regulation of ERBB signaling pathway [GO:1901185]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; receptor catabolic process [GO:0032801]; renal system process [GO:0003014]; vacuolar protein processing [GO:0006624],NA,NA,NA
CHOYP_LOC100182585.2.2.m.24665,-0.0124394756928235,-0.0105358190793683,No,NA,NA,Q2PFW9,NA,NA,NA,nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_LOC100183353.1.1.m.54920,-0.0208265537843917,-0.00633115194211932,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100183535.2.2.m.10350,0.0064753261328774,-0.0222614413084464,No,NA,NA,Q9LGZ2,NA,NA,NA,lyase activity [GO:0016829],NA,NA,NA
CHOYP_LOC100183583.1.2.m.3863,0.00233262656938684,0.00381988769190555,No,NA,NA,Q9BXW7,NA,NA,NA,mitochondrion [GO:0005739]; glycerophospholipid biosynthetic process [GO:0046474],NA,NA,NA
CHOYP_LOC100183682.1.1.m.61630,-0.00435849065020859,-0.00200182004048557,No,NA,NA,Q8CGC6,NA,NA,NA,nucleolus [GO:0005730]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100183847.1.2.m.12797,0.00877477987889007,-0.0108387434303154,No,NA,NA,P33316,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; dUTP diphosphatase activity [GO:0004170]; magnesium ion binding [GO:0000287]; peroxisome proliferator activated receptor binding [GO:0042975]; pyrimidine deoxyribonucleotide binding [GO:0032556]; receptor inhibitor activity [GO:0030547]; RNA binding [GO:0003723]; DNA replication [GO:0006260]; dUMP biosynthetic process [GO:0006226]; dUTP catabolic process [GO:0046081]; liver development [GO:0001889]; nucleobase-containing compound metabolic process [GO:0006139]; nucleobase-containing small molecule interconversion [GO:0015949]; protein homotrimerization [GO:0070207]; regulation of protein heterodimerization activity [GO:0043497]; response to organic cyclic compound [GO:0014070],NA,NA,NA
CHOYP_LOC100184284.2.2.m.21644,-0.0135699987964098,0.00109585836144133,No,NA,NA,Q5RJI4,NA,NA,NA,extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; multicellular organism growth [GO:0035264]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of chondrocyte differentiation [GO:0032332]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_LOC100184451.1.8.m.30146,-0.0193380952515047,-0.00500261526639804,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100184874.1.1.m.41851,0.00285648003582159,-0.0118696742595288,No,NA,NA,Q2L6K8,NA,NA,NA,extracellular region [GO:0005576]; signaling receptor binding [GO:0005102],NA,NA,NA
CHOYP_LOC100185060.2.2.m.18100,-0.020659010800564,0.00291036886499921,No,NA,NA,Q91ZT9,NA,NA,NA,cytoplasm [GO:0005737]; intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_LOC100185271.1.1.m.19210,-0.0160432327424547,-0.00205026519276218,No,NA,NA,B9EJX3,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100185431.1.1.m.43063,-0.00493178552001811,0.000978118762300835,No,NA,NA,B1WB06,NA,NA,NA,extracellular region [GO:0005576]; methyltransferase activity [GO:0008168],NA,NA,NA
CHOYP_LOC100185443.1.1.m.60976,-0.0136580166859312,-0.0125710148384837,No,NA,NA,A7RR34,NA,NA,NA,apical plasma membrane [GO:0016324]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cilium organization [GO:0044782],NA,NA,NA
CHOYP_LOC100185472.1.1.m.66178,-0.0191216993725732,0.00382578141823075,No,NA,NA,Q810N6,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100185473.1.1.m.5316,-0.0135725579708753,0.00388604629968508,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100185549.1.6.m.31232,-0.0141588325602375,0.0180643552239849,No,NA,NA,Q8LGG8,NA,NA,NA,plasma membrane [GO:0005886]; AMP binding [GO:0016208],NA,NA,NA
CHOYP_LOC100185549.5.6.m.62694,-0.0136318407793091,0.000735247249010064,No,NA,NA,Q57951,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100185846.1.1.m.37884,0.00450979407304396,0.00240188493990222,No,NA,NA,Q6TGV7,NA,NA,NA,regulation of actin filament-based process [GO:0032970],NA,NA,NA
CHOYP_LOC100186070.1.1.m.3415,0.00327263915362653,-0.0199052002194721,No,NA,NA,A2AX52,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208],NA,NA,NA
CHOYP_LOC100186203.1.1.m.7875,0.000974287195793683,-0.0248116642069902,No,NA,NA,Q52KB5,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100186203.1.1.m.7876,0.0177576685914473,-2.35148278220192e-05,No,NA,NA,Q3SYZ4,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]; aspartate-tRNA ligase activity [GO:0004815]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; aspartyl-tRNA aminoacylation [GO:0006422],NA,NA,NA
CHOYP_LOC100186276.4.5.m.12980,0.000686232728993107,-0.0107331332691118,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100186299.6.6.m.52749,-0.00511696217430676,0.00688022320465195,No,NA,NA,Q70FJ1,NA,NA,NA,centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; dendritic branch [GO:0044307]; extrinsic component of postsynaptic density membrane [GO:0099147]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; neuronal cell body [GO:0043025]; pericentriolar material [GO:0000242]; synaptic membrane [GO:0097060]; potassium channel regulator activity [GO:0015459]; protein kinase A regulatory subunit binding [GO:0034237]; protein-containing complex scaffold activity [GO:0032947]; maintenance of centrosome location [GO:0051661]; microtubule nucleation [GO:0007020]; negative regulation of adenylate cyclase activity [GO:0007194]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; regulation of Golgi organization [GO:1903358]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; Sertoli cell development [GO:0060009]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100186360.1.2.m.50759,-0.00914555502450454,-0.00673573459339618,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100186361.3.3.m.66600,0.0146984744170324,-0.00659330649745044,No,NA,NA,P47911,NA,NA,NA,A band [GO:0031672]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; postsynaptic density [GO:0014069]; rough endoplasmic reticulum [GO:0005791]; synapse [GO:0045202]; 5.8S rRNA binding [GO:1990932]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027],NA,NA,NA
CHOYP_LOC100186692.1.1.m.7600,0.00820103450890412,-0.00332121644805976,No,NA,NA,Q6ZWJ8,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_LOC100186733.1.1.m.7066,-0.00409363514267554,0.00657738457568919,No,NA,NA,Q5XIA9,NA,NA,NA,cellularization cleavage furrow [GO:0110070]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; midbody [GO:0030496]; mitotic cytokinetic process [GO:1902410]; mitotic nuclear division [GO:0140014]; nuclear chromosome segregation [GO:0098813],NA,NA,NA
CHOYP_LOC100186936.1.2.m.12235,0.00615966897194063,0.00941964587728867,No,NA,NA,Q6IE24,NA,NA,NA,thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; protein deubiquitination [GO:0016579],NA,NA,NA
CHOYP_LOC100187037.1.1.m.55673,0.00364778592941831,-0.00872052841558096,No,NA,NA,Q0VAA2,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100187348.1.1.m.29904,-0.0221476255289814,0.00946201692822377,No,NA,NA,Q4R6F0,NA,NA,NA,signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100197130.2.2.m.39076,0.0225586458939367,-0.0100202320178978,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100197511.1.1.m.22053,0.00485066861906355,-0.0167099787245624,No,NA,NA,Q5R546,NA,NA,NA,mitochondrial proton-transporting ATP synthase complex [GO:0005753]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex; catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity; rotational mechanism [GO:0046933]; ATP synthesis coupled proton transport [GO:0015986],NA,NA,NA
CHOYP_LOC100197876.1.1.m.45271,-0.0141609238173163,0.000592085466041568,No,NA,NA,P18293,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; intracellular signal transduction [GO:0035556]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood vessel size [GO:0050880]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100198049.1.1.m.13866,-0.00812206323589506,-0.00233107376169546,No,NA,NA,Q9CWP8,NA,NA,NA,cytosol [GO:0005829]; delta DNA polymerase complex [GO:0043625]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA biosynthetic process [GO:0071897]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; positive regulation of endothelial cell proliferation [GO:0001938],NA,NA,NA
CHOYP_LOC100199222.1.1.m.17588,-0.00351645454522816,-0.00166150165379932,No,NA,NA,P0AF48,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100199246.1.1.m.43478,0.00027306542245115,-0.00360830647618735,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100199379.1.2.m.59875,-0.0169591047060434,0.00960206869202778,No,NA,NA,Q8N2E2,NA,NA,NA,cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856],NA,NA,NA
CHOYP_LOC100199379.2.2.m.63866,0.02248670957159,-0.00926640240055931,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100199505.1.2.m.19947,0.0038156662748224,0.00143876481318027,No,NA,NA,P04114,NA,NA,NA,chylomicron [GO:0042627]; chylomicron remnant [GO:0034360]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle lumen [GO:0071682]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endosome lumen [GO:0031904]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; intermediate-density lipoprotein particle [GO:0034363]; intracellular membrane-bounded organelle [GO:0043231]; low-density lipoprotein particle [GO:0034362]; lysosomal lumen [GO:0043202]; mature chylomicron [GO:0034359]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; very-low-density lipoprotein particle [GO:0034361]; cholesterol transporter activity [GO:0017127]; heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; phospholipid binding [GO:0005543]; artery morphogenesis [GO:0048844]; cellular protein metabolic process [GO:0044267]; cellular response to prostaglandin stimulus [GO:0071379]; cellular response to tumor necrosis factor [GO:0071356]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; chylomicron assembly [GO:0034378]; chylomicron remnant clearance [GO:0034382]; chylomicron remodeling [GO:0034371]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; leukocyte migration [GO:0050900]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein catabolic process [GO:0042159]; lipoprotein transport [GO:0042953]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle remodeling [GO:0034374]; membrane organization [GO:0061024]; nervous system development [GO:0007399]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of gene expression [GO:0010628]; positive regulation of lipid storage [GO:0010884]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; post-embryonic development [GO:0009791]; post-translational protein modification [GO:0043687]; receptor-mediated endocytosis [GO:0006898]; regulation of cholesterol biosynthetic process [GO:0045540]; response to carbohydrate [GO:0009743]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to selenium ion [GO:0010269]; response to virus [GO:0009615]; retinoid metabolic process [GO:0001523]; spermatogenesis [GO:0007283]; toll-like receptor signaling pathway [GO:0002224]; triglyceride catabolic process [GO:0019433]; triglyceride mobilization [GO:0006642]; very-low-density lipoprotein particle assembly [GO:0034379]; very-low-density lipoprotein particle clearance [GO:0034447],NA,NA,NA
CHOYP_LOC100199505.2.2.m.25542,-0.00212078832001384,-0.00891837260408135,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100199663.1.1.m.22109,-0.00403777567377234,-0.011296511554083,No,NA,NA,P27659,NA,NA,NA,cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; protein-containing complex [GO:0032991]; ribosome [GO:0005840]; synapse [GO:0045202]; 5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]; cellular response to interleukin-4 [GO:0071353]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100199980.1.2.m.51259,-0.01461979773025,0.00115633755513714,No,NA,NA,Q5AF03,NA,NA,NA,fungal biofilm matrix [GO:0062040]; hyphal cell wall [GO:0030446]; yeast-form cell wall [GO:0030445]; glyoxalase III activity [GO:0019172]; methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243],NA,NA,NA
CHOYP_LOC100199980.2.2.m.62743,0.0142419266575625,-0.00807594452807473,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100199980.2.2.m.62746,0.0150697274016039,0.00508921200621113,No,NA,NA,Q5AF03,NA,NA,NA,fungal biofilm matrix [GO:0062040]; hyphal cell wall [GO:0030446]; yeast-form cell wall [GO:0030445]; glyoxalase III activity [GO:0019172]; methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243],NA,NA,NA
CHOYP_LOC100200137.1.1.m.23041,0.00205195042830452,-0.00934116934689426,No,NA,NA,P19208,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity; coupled [GO:0042623]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein binding involved in protein folding [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_LOC100200424.1.1.m.16669,0.00205195042830452,-0.00934116934689426,No,NA,NA,Q1RMG8,NA,NA,NA,RNA polymerase I complex [GO:0005736]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase III [GO:0006383],NA,NA,NA
CHOYP_LOC100201155.1.1.m.58066,-0.0170061038156037,-0.0129480601615781,No,NA,NA,P42674,NA,NA,NA,cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_LOC100202203.1.1.m.27309,-0.0119090970095578,-0.00785628591018558,No,NA,NA,P29145,NA,NA,NA,serine-type endopeptidase activity [GO:0004252],NA,NA,NA
CHOYP_LOC100202812.1.1.m.31203,0.00205195042830452,-0.00934116934689426,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100204502.1.2.m.26864,0.0164506533869523,-0.011703185302921,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100205674.1.1.m.5810,0.00214458710842414,-0.00437216903510538,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100206475.1.16.m.4004,0.0179015527228967,0.00938493674889615,No,NA,NA,Q02079,NA,NA,NA,extracellular region [GO:0005576]; copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]; lignin catabolic process [GO:0046274],NA,NA,NA
CHOYP_LOC100206557.1.1.m.11857,-0.0169591047060434,0.00960206869202777,No,NA,NA,P61315,NA,NA,NA,Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactose 3-O-sulfotransferase activity [GO:0050694]; galactosylceramide sulfotransferase activity [GO:0001733]; glycolipid biosynthetic process [GO:0009247],NA,NA,NA
CHOYP_LOC100207121.5.9.m.48175,-0.00398316179161544,-0.00721828306499384,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC100207216.2.2.m.28185,-0.0225596172098966,0.0105321518533811,No,NA,NA,Q5EB30,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC100208023.1.8.m.8628,0.00717763100229128,7.53168554730294e-05,No,NA,NA,P18433,NA,NA,NA,extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804],NA,NA,NA
CHOYP_LOC100208023.8.8.m.49917,0.0022483469491002,-0.0134421727423715,No,NA,NA,Q05909,NA,NA,NA,extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of neuron projection development [GO:0010977]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_LOC100208544.1.1.m.54499,0.00221846364240289,0.00471494410248019,No,NA,NA,P26779,NA,NA,NA,extracellular space [GO:0005615]; lysosome [GO:0005764]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; prostate gland growth [GO:0060736]; regulation of lipid metabolic process [GO:0019216]; sphingolipid metabolic process [GO:0006665],NA,NA,NA
CHOYP_LOC100210536.1.1.m.18414,-0.00500391529890689,-0.000360491987248254,No,NA,NA,Q9CX34,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; positive regulation by host of symbiont catalytic activity [GO:0043947]; protein stabilization [GO:0050821]; regulation of protein stability [GO:0031647],NA,NA,NA
CHOYP_LOC100210677.7.8.m.42871,0.0228014491137023,0.00570563624714581,No,NA,NA,D3YXG0,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_LOC100210677.8.8.m.43132,0.0185208695851769,0.00970905250653318,No,NA,NA,Q700K0,NA,NA,NA,extracellular space [GO:0005615]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_LOC100211409.1.1.m.4742,0.0106214250670838,0.011550475639007,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100211409.1.1.m.4743,0.011555782082222,-0.010585169778603,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100212224.1.1.m.37724,0.0119157478046093,0.00859068518565678,No,NA,NA,Q24799,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100212386.1.2.m.33906,0.00609061299464091,0.000177605144994915,No,NA,NA,G5EBQ8,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063],NA,NA,NA
CHOYP_LOC100212698.1.1.m.5807,-0.0126322559015485,-0.00719496258350812,No,NA,NA,P38571,NA,NA,NA,fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; lipase activity [GO:0016298]; sterol esterase activity [GO:0004771]; cell morphogenesis [GO:0000902]; cell proliferation [GO:0008283]; cellular lipid metabolic process [GO:0044255]; cytokine production [GO:0001816]; homeostasis of number of cells within a tissue [GO:0048873]; inflammatory response [GO:0006954]; lipid catabolic process [GO:0016042]; low-density lipoprotein particle clearance [GO:0034383]; lung development [GO:0030324]; sterol metabolic process [GO:0016125]; tissue remodeling [GO:0048771],NA,NA,NA
CHOYP_LOC100213495.2.2.m.51531,0.00491588973115351,-0.000600714720400962,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100213558.1.1.m.45753,0.0094241764632396,0.0159250905153278,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100213744.7.19.m.33062,-0.00670088422987577,-0.0103631497794203,No,NA,NA,Q5BIM1,NA,NA,NA,cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348],NA,NA,NA
CHOYP_LOC100213744.9.19.m.37687,0.000686232728993108,-0.0107331332691118,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100215454.1.1.m.40627,0.0179722463474216,0.0065359097833879,No,NA,NA,P43143,NA,NA,NA,acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; neuron projection [GO:0043005]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; drug binding [GO:0008144]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of dopamine secretion [GO:0033603]; protein heterooligomerization [GO:0051291]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission; cholinergic [GO:0007271],NA,NA,NA
CHOYP_LOC100217869.1.2.m.29774,-0.00138293425579089,-0.0226575046296203,No,NA,NA,Q5U317,NA,NA,NA,mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789],NA,NA,NA
CHOYP_LOC100218754.1.1.m.60778,0.015491898119031,-0.0118361270551007,No,NA,NA,Q14678,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; beta-catenin binding [GO:0008013]; actin cytoskeleton organization [GO:0030036]; cell proliferation [GO:0008283]; glomerular visceral epithelial cell migration [GO:0090521]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of cell migration [GO:0030336]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of lamellipodium morphogenesis [GO:2000393]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of ruffle assembly [GO:1900028]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of wound healing [GO:0090303]; regulation of establishment of cell polarity [GO:2000114]; regulation of Rho protein signal transduction [GO:0035023],NA,NA,NA
CHOYP_LOC100222629.1.1.m.9927,0.00930299404489709,0.006584117964788,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100222774.1.1.m.56990,-0.0115025714649821,-0.0069276568142067,No,NA,NA,Q9V9A7,NA,NA,NA,methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; leucine catabolic process [GO:0006552]; leucine metabolic process [GO:0006551]; regulation of eclosion [GO:0007563],NA,NA,NA
CHOYP_LOC100222774.1.1.m.56992,0.00520142048542606,-0.0045437246948204,No,NA,NA,P61354,NA,NA,NA,cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic large ribosomal subunit [GO:0022625]; ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; response to aldosterone [GO:1904044]; rRNA processing [GO:0006364]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100227090.1.1.m.1313,0.0123535546373295,0.0229854698124728,No,NA,NA,Q8QZZ7,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; EKC/KEOPS complex [GO:0000408]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; tRNA threonylcarbamoyladenosine modification [GO:0002949],NA,NA,NA
CHOYP_LOC100232142.1.1.m.19194,-0.00317554383528994,0.0147154633420946,No,NA,NA,Q96PE7,NA,NA,NA,mitochondrial matrix [GO:0005759]; metal ion binding [GO:0046872]; methylmalonyl-CoA epimerase activity [GO:0004493]; L-methylmalonyl-CoA metabolic process [GO:0046491]; short-chain fatty acid catabolic process [GO:0019626],NA,NA,NA
CHOYP_LOC100232691.1.1.m.15025,-0.00677257770532932,-0.00329256034079238,No,NA,NA,Q924T2,NA,NA,NA,mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial ribosome assembly [GO:0061668]; mitochondrial translation [GO:0032543],NA,NA,NA
CHOYP_LOC100261610.1.1.m.6374,-0.0169591047060434,0.00960206869202777,No,NA,NA,P24044,NA,NA,NA,calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722],NA,NA,NA
CHOYP_LOC100313559.1.1.m.47009,0.0068626344006406,-0.0204228155039895,No,NA,NA,Q8VBW5,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; bone development [GO:0060348],NA,NA,NA
CHOYP_LOC100313569.1.1.m.15201,-0.010660231171205,-0.0213987209553205,No,NA,NA,Q13948,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; intra-Golgi vesicle-mediated transport [GO:0006891],NA,NA,NA
CHOYP_LOC100313573.1.1.m.62977,-0.00385149998520816,-0.00348962297843167,No,NA,NA,O15182,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; half bridge of spindle pole body [GO:0005825]; nucleolus [GO:0005730]; nucleus [GO:0005634]; transcription export complex 2 [GO:0070390]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; calcium-mediated signaling [GO:0019722]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; microtubule nucleation [GO:0007020]; mitotic spindle pole body duplication [GO:1903087]; spindle pole body duplication [GO:0030474],NA,NA,NA
CHOYP_LOC100313589.1.1.m.31479,-0.00822575448370646,-0.0205454549493549,No,NA,NA,Q9JLM8,NA,NA,NA,postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; brain development [GO:0007420]; central nervous system projection neuron axonogenesis [GO:0021952]; dendrite morphogenesis [GO:0048813]; forebrain development [GO:0030900]; intracellular signal transduction [GO:0035556]; negative regulation of protein localization to nucleus [GO:1900181]; neuron migration [GO:0001764]; peptidyl-serine phosphorylation [GO:0018105]; response to virus [GO:0009615],NA,NA,NA
CHOYP_LOC100313617.1.1.m.18024,-0.00430894344577715,-0.00631540690244347,No,NA,NA,O75496,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; animal organ morphogenesis [GO:0009887]; DNA replication preinitiation complex assembly [GO:0071163]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of cell cycle [GO:0045786]; negative regulation of DNA replication [GO:0008156]; negative regulation of DNA-dependent DNA replication [GO:2000104]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of chromatin binding [GO:0035563]; regulation of DNA replication [GO:0006275],NA,NA,NA
CHOYP_LOC100313636.2.3.m.26350,-0.0111245678891853,-0.00109418961558779,No,NA,NA,O88801,NA,NA,NA,apical part of cell [GO:0045177]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; stereocilium tip [GO:0032426]; actin binding [GO:0003779]; G protein-coupled glutamate receptor binding [GO:0035256]; GKAP/Homer scaffold activity [GO:0030160]; glutamate receptor binding [GO:0035254]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; behavioral response to cocaine [GO:0048148]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; chemical homeostasis within a tissue [GO:0048875]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of interleukin-2 production [GO:0032703]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of store-operated calcium entry [GO:2001256]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_LOC100313649.1.1.m.49801,-0.0170735876828999,-0.0110866970616934,No,NA,NA,Q9D5E4,NA,NA,NA,axoneme [GO:0005930]; cytoplasm [GO:0005737]; motile cilium [GO:0031514],NA,NA,NA
CHOYP_LOC100313653.1.1.m.61188,-0.000371158422075522,-0.0104945323003753,No,NA,NA,Q27433,NA,NA,NA,integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; cholesterol binding [GO:0015485]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612],NA,NA,NA
CHOYP_LOC100313655.1.1.m.52035,0.00625815405661304,-0.0132547566553383,No,NA,NA,O88368,NA,NA,NA,nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; bone remodeling [GO:0046849]; camera-type eye development [GO:0043010]; canonical Wnt signaling pathway involved in negative regulation of apoptotic process [GO:0044336]; cell fate commitment [GO:0045165]; melanocyte differentiation [GO:0030318]; negative regulation of cell migration [GO:0030336]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoclast differentiation [GO:0030316]; positive regulation of DNA-templated transcription; initiation [GO:2000144]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of cell proliferation [GO:0042127]; regulation of osteoclast differentiation [GO:0045670]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_LOC100313661.1.1.m.17706,0.00677350595899357,-0.0111141834677933,No,NA,NA,A6QLT2,NA,NA,NA,cytosol [GO:0005829]; early endosome membrane [GO:0031901]; phosphatidylinositol-3;5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein tyrosine phosphatase activity [GO:0004725]; phosphatidylinositol dephosphorylation [GO:0046856],NA,NA,NA
CHOYP_LOC100313664.1.1.m.37913,-0.016346236996088,-0.0136055092660069,No,NA,NA,D3ZSZ3,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; SH2 domain binding [GO:0042169]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; intracellular signal transduction [GO:0035556]; negative regulation of Wnt signaling pathway [GO:0030178]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; protein stabilization [GO:0050821]; regulation of gene expression [GO:0010468]; regulation of transcription; DNA-templated [GO:0006355]; serine phosphorylation of STAT protein [GO:0042501]; transforming growth factor beta receptor signaling pathway [GO:0007179]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LOC100313668.2.6.m.31487,0.00687814836215257,-0.0107539714320471,No,NA,NA,Q24746,NA,NA,NA,nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; mesoderm development [GO:0007498]; nervous system development [GO:0007399]; peripheral nervous system development [GO:0007422]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360],NA,NA,NA
CHOYP_LOC100313676.1.2.m.2193,-0.014810946014327,-0.0116543749248241,No,NA,NA,Q03017,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; transcription factor binding [GO:0008134]; antifungal humoral response [GO:0019732]; antimicrobial humoral response [GO:0019730]; defense response [GO:0006952]; dorsal appendage formation [GO:0046843]; dorsal/ventral axis specification [GO:0009950]; hemopoiesis [GO:0030097]; innate immune response [GO:0045087]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; positive regulation of antifungal peptide biosynthetic process [GO:0006967]; response to fungus [GO:0009620]; Toll signaling pathway [GO:0008063],NA,NA,NA
CHOYP_LOC100313691.1.1.m.290,0.00149341471267199,-0.00398671884163344,No,NA,NA,Q21086,NA,NA,NA,nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; germ cell development [GO:0007281]; nematode larval development [GO:0002119]; regulation of cell proliferation [GO:0042127]; regulation of multicellular organism growth [GO:0040014],NA,NA,NA
CHOYP_LOC100329062.1.2.m.10150,-0.00538202695834002,-0.0233079692889455,No,NA,NA,O88951,NA,NA,NA,basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; MPP7-DLG1-LIN7 complex [GO:0097025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; synapse [GO:0045202]; L27 domain binding [GO:0097016]; PDZ domain binding [GO:0030165]; protein domain specific binding [GO:0019904]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; neurotransmitter secretion [GO:0007269]; protein localization to basolateral plasma membrane [GO:1903361]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC100329062.2.2.m.39235,-0.00188234488980297,-0.0238085032108563,No,NA,NA,Q9CS74,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone acetyltransferase binding [GO:0035035]; cell proliferation [GO:0008283]; mRNA processing [GO:0006397]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100329078.1.3.m.26927,-0.00114872353811025,-0.0150130041118484,No,NA,NA,Q9UM22,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160],NA,NA,NA
CHOYP_LOC100329078.2.3.m.30776,0.0154295965471757,0.00876582524877736,No,NA,NA,Q9UM22,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160],NA,NA,NA
CHOYP_LOC100329955.1.1.m.11340,0.00217997094733793,-0.00807271368859912,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100330792.1.2.m.48676,0.00780246481970625,0.0156481284492041,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100330792.2.2.m.53521,0.0133173774054903,0.0116180964053454,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100331324.2.3.m.40325,0.00719061525222621,0.00999257657854309,No,NA,NA,P55210,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; apoptotic process [GO:0006915]; cellular response to staurosporine [GO:0072734]; execution phase of apoptosis [GO:0097194]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC100332237.1.1.m.18128,0.00217997094733793,-0.00807271368859912,No,NA,NA,Q96RW7,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],NA,NA,NA
CHOYP_LOC100346427.1.1.m.44592,0.0210803975051319,0.000844001242467526,No,NA,NA,Q9UH65,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; actin filament bundle assembly [GO:0051017]; isotype switching [GO:0045190]; negative regulation of actin filament depolymerization [GO:0030835]; negative regulation of cell-cell adhesion mediated by integrin [GO:0033633]; negative regulation of peptidyl-serine dephosphorylation [GO:1902309]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of mast cell chemotaxis [GO:0060754]; regulation of protein localization [GO:0032880],NA,NA,NA
CHOYP_LOC100353582.2.2.m.63483,0.0115807207084793,-0.00511543175073583,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100358262.2.3.m.28381,-0.00612389516796929,0.000589974106178867,No,NA,NA,P35244,NA,NA,NA,DNA replication factor A complex [GO:0005662]; nucleoplasm [GO:0005654]; site of double-strand break [GO:0035861]; damaged DNA binding [GO:0003684]; single-stranded DNA binding [GO:0003697]; base-excision repair [GO:0006284]; DNA damage response; detection of DNA damage [GO:0042769]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; G1/S transition of mitotic cell cycle [GO:0000082]; interstrand cross-link repair [GO:0036297]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair; DNA gap filling [GO:0006297]; nucleotide-excision repair; DNA incision [GO:0033683]; nucleotide-excision repair; DNA incision; 5'-to lesion [GO:0006296]; nucleotide-excision repair; preincision complex assembly [GO:0006294]; nucleotide-excision repair; preincision complex stabilization [GO:0006293]; regulation of cell proliferation [GO:0042127]; regulation of cellular response to heat [GO:1900034]; regulation of mitotic cell cycle [GO:0007346]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985],NA,NA,NA
CHOYP_LOC100366344.1.1.m.7458,-0.0104035587558223,-0.0251439223877917,No,NA,NA,Q8BJ64,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660]; glycine betaine biosynthetic process from choline [GO:0019285],NA,NA,NA
CHOYP_LOC100366380.1.4.m.16838,0.000873782032690358,0.0134677782124207,No,NA,NA,P28799,NA,NA,NA,azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosome [GO:0005764]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; RNA binding [GO:0003723]; neutrophil degranulation [GO:0043312]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100366404.1.2.m.22137,-0.00194466305469707,8.32229704800455e-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100366408.1.1.m.37601,0.00879715757408235,-0.00356936228166485,No,NA,NA,Q38SD2,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; bone resorption [GO:0045453]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; osteoclast development [GO:0036035]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731],NA,NA,NA
CHOYP_LOC100366424.1.1.m.29609,-0.00322674275170981,0.00891649257587843,No,NA,NA,Q9GKS9,NA,NA,NA,metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100366428.1.1.m.3739,-0.0122473288816671,-0.0141525510364307,No,NA,NA,Q7RTY7,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252],NA,NA,NA
CHOYP_LOC100366428.1.1.m.3740,-0.0106896507509997,0.00538826854305136,No,NA,NA,Q504A5,NA,NA,NA,cytoplasm [GO:0005737]; thiopurine S-methyltransferase activity [GO:0008119],NA,NA,NA
CHOYP_LOC100366442.1.4.m.6288,-0.0140906409512256,-0.00995757734701577,No,NA,NA,Q5ZKK5,NA,NA,NA,centriole [GO:0005814]; microtubule [GO:0005874]; sperm flagellum [GO:0036126]; spindle pole [GO:0000922]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100366451.1.1.m.10501,0.0106895995565989,-0.00118670163161102,No,NA,NA,Q9VZI3,NA,NA,NA,cytoplasm [GO:0005737]; cell adhesion molecule binding [GO:0050839]; cardiac muscle tissue development [GO:0048738]; cell-matrix adhesion [GO:0007160]; defense response to Gram-negative bacterium [GO:0050829]; integrin-mediated signaling pathway [GO:0007229],NA,NA,NA
CHOYP_LOC100366455.1.3.m.13543,-0.0131185504354824,0.00528334260412077,No,NA,NA,P16152,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; carbonyl reductase (NADPH) activity [GO:0004090]; oxidoreductase activity; acting on NAD(P)H; quinone or similar compound as acceptor [GO:0016655]; prostaglandin-E2 9-reductase activity [GO:0050221]; cyclooxygenase pathway [GO:0019371]; drug metabolic process [GO:0017144]; epithelial cell differentiation [GO:0030855]; oxidation-reduction process [GO:0055114]; vitamin K metabolic process [GO:0042373],NA,NA,NA
CHOYP_LOC100366455.2.3.m.25037,0.00353352606006319,7.87355489890413e-05,No,NA,NA,Q9CXS4,NA,NA,NA,condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; carbon-sulfur lyase activity [GO:0016846]; ameboidal-type cell migration [GO:0001667]; cell cycle [GO:0007049]; cell division [GO:0051301]; centromere complex assembly [GO:0034508]; pericentric heterochromatin assembly [GO:0031508]; positive regulation of cytokinesis [GO:0032467]; regulation of chromosome organization [GO:0033044],NA,NA,NA
CHOYP_LOC100366455.3.3.m.28840,-0.0162848062760767,-0.013618401683429,No,NA,NA,Q5RCU5,NA,NA,NA,cytoplasm [GO:0005737]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; carbonyl reductase (NADPH) activity [GO:0004090]; prostaglandin-E2 9-reductase activity [GO:0050221]; drug metabolic process [GO:0017144]; vitamin K metabolic process [GO:0042373],NA,NA,NA
CHOYP_LOC100366470.2.2.m.64705,0.0149526736070105,0.013950658159074,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100366482.1.1.m.9777,-0.0188242151965484,0.000960197713957067,No,NA,NA,Q8T773,NA,NA,NA,cell [GO:0005623]; electron transfer activity [GO:0009055]; malate dehydrogenase activity [GO:0016615]; oxidoreductase activity; acting on the CH-OH group of donors; NAD or NADP as acceptor [GO:0016616]; protein disulfide oxidoreductase activity [GO:0015035]; carbohydrate metabolic process [GO:0005975]; cell redox homeostasis [GO:0045454]; malate metabolic process [GO:0006108]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_LOC100366486.1.1.m.15010,-0.00830998584041076,0.0202000647362277,No,NA,NA,Q6P9T8,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278],NA,NA,NA
CHOYP_LOC100366488.1.1.m.56518,-0.0050637868182724,0.0187993618666839,No,NA,NA,Q7ZYG4,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC100366489.1.1.m.21907,-0.0113093061843274,0.00369471543161587,No,NA,NA,A8MWY0,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_LOC100366518.5.6.m.43397,0.00295309229342799,-0.00414569183689337,No,NA,NA,P07207,NA,NA,NA,adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; subapical complex [GO:0035003]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; transmembrane signaling receptor activity [GO:0004888]; actin filament organization [GO:0007015]; anterior/posterior pattern specification [GO:0009952]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell adhesion [GO:0007155]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate specification [GO:0001708]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye cone cell fate commitment [GO:0042676]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral lineage restriction; imaginal disc [GO:0007451]; dorsal/ventral pattern formation; imaginal disc [GO:0007450]; ectoderm development [GO:0007398]; embryonic crystal cell differentiation [GO:0035165]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification; open tracheal system [GO:0035153]; establishment of ommatidial planar polarity [GO:0042067]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland crystal cell differentiation [GO:0035170]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; morphogenesis of follicular epithelium [GO:0016333]; motor neuron axon guidance [GO:0008045]; muscle cell fate determination [GO:0007521]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of JNK cascade [GO:0046329]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; ovarian follicle cell migration [GO:0007297]; ovarian follicle cell stalk formation [GO:0030713]; peripheral nervous system development [GO:0007422]; positive regulation of cell proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell fate commitment [GO:0007464]; R7 cell differentiation [GO:0045466]; R8 cell development [GO:0045463]; R8 cell differentiation [GO:0045465]; R8 cell fate commitment [GO:0007460]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of crystal cell differentiation [GO:0042689]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of R8 cell spacing in compound eye [GO:0045468]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; skeletal muscle tissue development [GO:0007519]; stem cell differentiation [GO:0048863]; ventral cord development [GO:0007419]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]; wing disc proximal/distal pattern formation [GO:0007473],NA,NA,NA
CHOYP_LOC100366536.3.3.m.51739,0.000520867771029602,-0.00406763314208501,No,NA,NA,Q13426,NA,NA,NA,cytosol [GO:0005829]; DNA ligase IV complex [GO:0032807]; DNA-dependent protein kinase-DNA ligase 4 complex [GO:0005958]; nonhomologous end joining complex [GO:0070419]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; cellular response to lithium ion [GO:0071285]; DNA ligation involved in DNA repair [GO:0051103]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; establishment of integrated proviral latency [GO:0075713]; positive regulation of ligase activity [GO:0051351]; response to X-ray [GO:0010165],NA,NA,NA
CHOYP_LOC100366575.1.1.m.29959,-0.0166616320448302,-0.00153819071131744,No,NA,NA,Q9D3N2,NA,NA,NA,9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; beta-tubulin binding [GO:0048487]; calcium ion binding [GO:0005509]; calcium-dependent outer dynein arm binding [GO:0120152]; dynein heavy chain binding [GO:0045504]; cell chemotaxis [GO:0060326]; negative regulation of ATP-dependent microtubule motor activity; minus-end-directed [GO:2000578]; regulation of flagellated sperm motility [GO:1901317],NA,NA,NA
CHOYP_LOC100366577.1.2.m.17884,-0.00758284129582639,0.000685952167977255,No,NA,NA,Q9NRG9,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; fertilization [GO:0009566]; learning [GO:0007612]; mRNA export from nucleus [GO:0006406]; nucleocytoplasmic transport [GO:0006913]; regulation of nucleocytoplasmic transport [GO:0046822]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100366606.1.2.m.47289,-0.0225886050224682,0.0105048616047639,No,NA,NA,Q9Y238,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; negative regulation of cell proliferation [GO:0008285],NA,NA,NA
CHOYP_LOC100366708.1.1.m.19335,0.0176280834473292,0.00318552397015988,No,NA,NA,P77735,NA,NA,NA,cytosol [GO:0005829]; oxidoreductase activity [GO:0016491]; thiamine metabolic process [GO:0006772],NA,NA,NA
CHOYP_LOC100366728.1.1.m.57449,-0.0119121302137912,0.00291789758131725,No,NA,NA,Q0V9S9,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514],NA,NA,NA
CHOYP_LOC100366728.1.1.m.57452,0.0065883263884642,0.0180931628217626,No,NA,NA,P18700,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278],NA,NA,NA
CHOYP_LOC100366734.1.1.m.47271,-0.0174094865193863,-0.0181606900265132,No,NA,NA,O35594,NA,NA,NA,centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; tubulin binding [GO:0015631]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; multicellular organism development [GO:0007275]; regulation of smoothened signaling pathway [GO:0008589]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100366735.1.1.m.52023,-0.0154509322016048,0.00789065285086667,No,NA,NA,Q86YS6,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; trans-Golgi network membrane [GO:0032588]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular response to interferon-gamma [GO:0071346]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; phagosome maturation [GO:0090382]; Rab protein signal transduction [GO:0032482]; retrograde transport; plasma membrane to Golgi [GO:0035526]; toxin transport [GO:1901998]; virion assembly [GO:0019068],NA,NA,NA
CHOYP_LOC100366754.1.1.m.49522,-0.000453671008594565,0.0120655253989264,No,NA,NA,Q9HBI1,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin cytoskeleton reorganization [GO:0031532]; cell projection assembly [GO:0030031]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of cell polarity regulating cell shape [GO:0071963]; lamellipodium assembly [GO:0030032]; substrate adhesion-dependent cell spreading [GO:0034446],NA,NA,NA
CHOYP_LOC100366763.1.1.m.53708,-0.00561221482196302,-0.00981890943867525,No,NA,NA,Q9BYB0,NA,NA,NA,cell junction [GO:0030054]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; neuron projection [GO:0043005]; neuron spine [GO:0044309]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; actin binding [GO:0003779]; GKAP/Homer scaffold activity [GO:0030160]; ionotropic glutamate receptor binding [GO:0035255]; protein C-terminus binding [GO:0008022]; protein self-association [GO:0043621]; receptor signaling complex scaffold activity [GO:0030159]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]; zinc ion binding [GO:0008270]; adult behavior [GO:0030534]; AMPA glutamate receptor clustering [GO:0097113]; axon guidance [GO:0007411]; brain morphogenesis [GO:0048854]; dendritic spine morphogenesis [GO:0060997]; guanylate kinase-associated protein clustering [GO:0097117]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; MAPK cascade [GO:0000165]; memory [GO:0007613]; negative regulation of actin filament bundle assembly [GO:0032232]; negative regulation of cell volume [GO:0045794]; NMDA glutamate receptor clustering [GO:0097114]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of glutamate receptor signaling pathway [GO:1900451]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of synapse structural plasticity [GO:0051835]; positive regulation of synaptic transmission; glutamatergic [GO:0051968]; postsynaptic density assembly [GO:0097107]; regulation of AMPA receptor activity [GO:2000311]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of long-term synaptic depression [GO:1900452]; regulation of long-term synaptic potentiation [GO:1900271]; social behavior [GO:0035176]; striatal medium spiny neuron differentiation [GO:0021773]; synapse assembly [GO:0007416]; synaptic growth at neuromuscular junction [GO:0051124]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625],NA,NA,NA
CHOYP_LOC100366763.1.1.m.53709,0.00394536801625317,0.00291369700370642,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100366766.1.1.m.56292,0.00249508674454481,0.0142982671437821,No,NA,NA,P59083,NA,NA,NA,cytosol [GO:0005829]; calcium channel inhibitor activity [GO:0019855]; ion channel binding [GO:0044325]; protein histidine phosphatase activity [GO:0101006]; negative regulation of ATP citrate synthase activity [GO:2000984]; negative regulation of lyase activity [GO:0051350]; negative regulation of T cell receptor signaling pathway [GO:0050860]; peptidyl-histidine dephosphorylation [GO:0035971]; positive regulation of cell motility [GO:2000147]; regulation of actin cytoskeleton reorganization [GO:2000249],NA,NA,NA
CHOYP_LOC100366770.1.1.m.55784,-0.00672078215785723,-0.0092030443886479,No,NA,NA,Q6P3V7,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC100366787.1.1.m.65795,-0.0176806635490015,0.00314990370648868,No,NA,NA,A8Y5T1,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100366797.1.3.m.20765,0.00342513676928963,-0.00575626601070231,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100366797.2.3.m.54046,0.00364778592941831,-0.00872052841558096,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100366799.1.2.m.37253,0.00557398445975053,-0.00369164629303134,No,NA,NA,Q3ZBD7,NA,NA,NA,ciliary membrane [GO:0060170]; cytosol [GO:0005829]; extracellular space [GO:0005615]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; cytokine activity [GO:0005125]; glucose-6-phosphate isomerase activity [GO:0004347]; intramolecular transferase activity [GO:0016866]; monosaccharide binding [GO:0048029]; ubiquitin protein ligase binding [GO:0031625]; erythrocyte homeostasis [GO:0034101]; gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; in utero embryonic development [GO:0001701]; mesoderm formation [GO:0001707]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of immunoglobulin secretion [GO:0051024],NA,NA,NA
CHOYP_LOC100366813.1.6.m.2829,0.00642323091646591,-0.0112102121816533,No,NA,NA,O57592,NA,NA,NA,ribosome [GO:0005840]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_LOC100366813.4.6.m.31116,0.0113130895761153,-0.00230143251723218,No,NA,NA,O57592,NA,NA,NA,ribosome [GO:0005840]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_LOC100366857.1.1.m.38884,0.00847415333930822,-0.0186416767927448,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100366862.1.1.m.62455,-0.0123041020676138,-0.0147541016746987,No,NA,NA,A5D6U8,NA,NA,NA,extracellular region [GO:0005576]; acid phosphatase activity [GO:0003993]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100366892.2.3.m.51427,0.0065883263884642,0.0180931628217626,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100366906.1.1.m.61901,-0.0209014513465691,3.37217083161502e-05,No,NA,NA,F8WLE0,NA,NA,NA,intracellular [GO:0005622]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; mitochondrion organization [GO:0007005]; organelle transport along microtubule [GO:0072384],NA,NA,NA
CHOYP_LOC100366918.1.1.m.31506,-0.0119707943078713,-0.00335855770698529,No,NA,NA,P11717,NA,NA,NA,cell surface [GO:0009986]; clathrin coat [GO:0030118]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nuclear envelope lumen [GO:0005641]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle [GO:0030133]; enzyme binding [GO:0019899]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor II binding [GO:0031995]; insulin-like growth factor-activated receptor activity [GO:0005010]; kringle domain binding [GO:0036143]; mannose binding [GO:0005537]; phosphoprotein binding [GO:0051219]; retinoic acid binding [GO:0001972]; signaling receptor activity [GO:0038023]; animal organ regeneration [GO:0031100]; G protein-coupled receptor signaling pathway [GO:0007186]; liver development [GO:0001889]; lysosomal transport [GO:0007041]; membrane organization [GO:0061024]; neutrophil degranulation [GO:0043312]; positive regulation of apoptotic process [GO:0043065]; post-embryonic development [GO:0009791]; post-Golgi vesicle-mediated transport [GO:0006892]; receptor-mediated endocytosis [GO:0006898]; response to retinoic acid [GO:0032526]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100366927.1.1.m.6140,-0.00178832080819721,0.0135081590484153,No,NA,NA,P44121,NA,NA,NA,ATP binding [GO:0005524]; DNA ligase (ATP) activity [GO:0003910]; metal ion binding [GO:0046872]; DNA ligation involved in DNA repair [GO:0051103]; DNA recombination [GO:0006310]; DNA replication [GO:0006260],NA,NA,NA
CHOYP_LOC100366932.1.1.m.36598,-0.00915991222249903,-0.0186382516266684,No,NA,NA,Q86UY6,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; H2A histone acetyltransferase activity [GO:0043998]; H4 histone acetyltransferase activity [GO:0010485]; peptide-serine-N-acetyltransferase activity [GO:1990189]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; lipid metabolic process [GO:0006629]; N-terminal protein amino acid acetylation [GO:0006474]; regulation of chromatin silencing at rDNA [GO:0061187],NA,NA,NA
CHOYP_LOC100366957.1.1.m.10938,-0.0169591047060434,0.00960206869202778,No,NA,NA,Q9BGT1,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100366965.1.2.m.40982,-0.00115808628763459,0.0111034618968461,No,NA,NA,Q8C079,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; Rho GTPase binding [GO:0017048]; cortical actin cytoskeleton organization [GO:0030866]; regulation of cell morphogenesis [GO:0022604],NA,NA,NA
CHOYP_LOC100366987.2.2.m.61972,-0.00775500728184124,-0.00522434725124123,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100367001.1.1.m.55663,-0.00975533525915925,0.0139668346550993,No,NA,NA,Q15650,NA,NA,NA,activating signal cointegrator 1 complex [GO:0099053]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; neuromuscular junction [GO:0031594]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; estrogen receptor binding [GO:0030331]; histone acetyltransferase binding [GO:0035035]; nuclear receptor binding [GO:0016922]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; transcription coactivator activity [GO:0003713]; ubiquitin-like protein ligase binding [GO:0044389]; zinc ion binding [GO:0008270]; intracellular estrogen receptor signaling pathway [GO:0030520]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of myoblast differentiation [GO:0045661]; regulation of transcription; DNA-templated [GO:0006355]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_LOC100367006.2.2.m.17211,-0.000811244622207792,-0.00741422388499088,No,NA,NA,Q80U87,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; SH3 domain binding [GO:0017124]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; cellular response to nerve growth factor stimulus [GO:1990090]; endosome organization [GO:0007032]; mitotic cytokinesis [GO:0000281]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; Ras protein signal transduction [GO:0007265]; regulation of protein catabolic process at postsynapse; modulating synaptic transmission [GO:0099576]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100367014.1.1.m.18505,-0.0029720284037452,0.0107364358261081,No,NA,NA,Q08CA1,NA,NA,NA,cytoplasm [GO:0005737]; GDP-D-glucose phosphorylase activity [GO:0080048]; guanyl-nucleotide exchange factor activity [GO:0005085]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; nucleotidyltransferase activity [GO:0016779]; glucose metabolic process [GO:0006006],NA,NA,NA
CHOYP_LOC100367051.1.1.m.13013,-0.0116559660443635,-0.0196300998231298,No,NA,NA,Q8VE97,NA,NA,NA,nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; hematopoietic progenitor cell differentiation [GO:0002244]; mRNA cis splicing; via spliceosome [GO:0045292]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],NA,NA,NA
CHOYP_LOC100367053.1.1.m.18595,-0.00831887123960004,-0.0072764279840176,No,NA,NA,Q9UKZ1,NA,NA,NA,CCR4-NOT complex [GO:0030014]; cytosol [GO:0005829]; nucleus [GO:0005634]; cell proliferation [GO:0008283]; DNA damage response; signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; gene silencing by RNA [GO:0031047]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_LOC100367064.1.1.m.52280,-0.000278791469818845,-0.0230162897173781,No,NA,NA,Q08E40,NA,NA,NA,integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; zinc ion transmembrane transporter activity [GO:0005385]; cellular zinc ion homeostasis [GO:0006882]; regulation of microtubule polymerization [GO:0031113]; regulation of neuron projection development [GO:0010975]; signal transduction [GO:0007165]; zinc ion import across plasma membrane [GO:0071578],NA,NA,NA
CHOYP_LOC100367069.1.1.m.14484,-0.00775475060941416,-0.00172969337414854,No,NA,NA,Q9UHX1,NA,NA,NA,cell junction [GO:0030054]; nucleoplasm [GO:0005654]; cadherin binding [GO:0045296]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_LOC100367071.1.1.m.27695,0.00213697266308254,-0.0138495360079971,No,NA,NA,Q02337,NA,NA,NA,matrix side of mitochondrial inner membrane [GO:0099617]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; 3-hydroxybutyrate dehydrogenase activity [GO:0003858],NA,NA,NA
CHOYP_LOC100367084.12.22.m.48659,-0.0225723716910815,0.0100024629875896,No,NA,NA,Q4LDE5,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_LOC100367084.3.22.m.29143,0.00425114298842969,-0.0133101967351808,No,NA,NA,Q4LDE5,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_LOC100367084.6.22.m.31842,0.00205195042830452,-0.00934116934689426,No,NA,NA,Q9ULL1,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; regulation of Rho protein signal transduction [GO:0035023],NA,NA,NA
CHOYP_LOC100367089.1.4.m.1384,0.00824406699236534,-0.00410889589251823,No,NA,NA,Q9I7U4,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; skeletal muscle tissue development [GO:0007519]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522],NA,NA,NA
CHOYP_LOC100367089.1.4.m.1412,-0.0173653228531232,0.00415945399237692,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100367089.2.4.m.1910,0.00972474093766277,0.0182977601831983,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100367093.1.1.m.63664,0.00194485160203484,-0.021735993298612,No,NA,NA,Q90511,NA,NA,NA,cytoplasm [GO:0005737]; eukaryotic translation initiation factor 2B complex [GO:0005851]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; translation initiation factor activity [GO:0003743]; central nervous system development [GO:0007417]; myelination [GO:0042552]; oligodendrocyte development [GO:0014003]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_LOC100367137.1.1.m.23977,-0.00399629094093004,-0.00131742862011089,No,NA,NA,O08663,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]; N-terminal protein amino acid modification [GO:0031365]; peptidyl-methionine modification [GO:0018206]; protein initiator methionine removal [GO:0070084]; protein processing [GO:0016485],NA,NA,NA
CHOYP_LOC100367144.1.1.m.34153,0.00556952363527755,-0.00495498904406517,No,NA,NA,P49746,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; bone trabecula formation [GO:0060346]; cell-matrix adhesion [GO:0007160]; growth plate cartilage development [GO:0003417]; ossification involved in bone maturation [GO:0043931],NA,NA,NA
CHOYP_LOC100367166.1.1.m.1262,-0.0116468694754092,-0.000298530243667598,No,NA,NA,Q8BT14,NA,NA,NA,CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; ubiquitin-protein transferase activity [GO:0004842]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of megakaryocyte differentiation [GO:0045652]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100367201.2.2.m.61573,-0.00814805561498868,-0.000732269144198063,No,NA,NA,P56812,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; acetyltransferase activator activity [GO:0010698]; beta-tubulin binding [GO:0048487]; DNA binding [GO:0003677]; heparin binding [GO:0008201]; apoptotic process [GO:0006915]; cellular response to transforming growth factor beta stimulus [GO:0071560]; negative regulation of cell proliferation [GO:0008285]; negative regulation of chaperone-mediated protein folding [GO:1903645]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of protein import into mitochondrial outer membrane [GO:1903638]; positive regulation of release of cytochrome c from mitochondria [GO:0090200],NA,NA,NA
CHOYP_LOC100367205.1.1.m.24472,-0.020089982292002,-0.0106926291778327,No,NA,NA,Q7Z4T9,NA,NA,NA,axoneme [GO:0005930]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; cilium movement [GO:0003341],NA,NA,NA
CHOYP_LOC100367232.4.5.m.45036,0.00687113507400853,0.0121663357808887,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100367237.1.2.m.43812,-0.020985716407931,-0.00375875512686863,No,NA,NA,A2ASS6,NA,NA,NA,A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; telethonin binding [GO:0031433]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_LOC100367237.2.2.m.47349,0.00663495676638627,0.00756426388607541,No,NA,NA,A2ASS6,NA,NA,NA,A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; telethonin binding [GO:0031433]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_LOC100367242.1.2.m.48297,0.00654233464525335,-0.000351536994635341,No,NA,NA,Q69Z37,NA,NA,NA,cytoplasm [GO:0005737]; early endosome [GO:0005769]; common myeloid progenitor cell proliferation [GO:0035726]; endosomal vesicle fusion [GO:0034058]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of protein catabolic process [GO:0042176]; spleen development [GO:0048536]; stem cell division [GO:0017145],NA,NA,NA
CHOYP_LOC100367266.1.1.m.10803,0.00205195042830452,-0.00934116934689426,No,NA,NA,Q5R6Q2,NA,NA,NA,Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; SNAP receptor activity [GO:0005484]; Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_LOC100367291.1.1.m.51818,0.00780901930117868,0.0156874851380405,No,NA,NA,O35963,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; presynapse [GO:0098793]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; autophagosome assembly [GO:0000045]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; negative regulation of constitutive secretory pathway [GO:1903434]; protein localization to Golgi apparatus [GO:0034067]; Rab protein signal transduction [GO:0032482]; regulation of Golgi organization [GO:1903358]; regulation of retrograde vesicle-mediated transport; Golgi to ER [GO:2000156]; skeletal system morphogenesis [GO:0048705],NA,NA,NA
CHOYP_LOC100367312.7.13.m.37565,0.00473053002281064,-0.01777811000379,No,NA,NA,Q90Z10,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; regulation of cell cycle [GO:0051726]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100367326.1.1.m.56733,-0.00449456773898228,0.00219041605365014,No,NA,NA,P27447,NA,NA,NA,ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715],NA,NA,NA
CHOYP_LOC100367352.1.1.m.27863,-0.0211801300304403,0.0066207312499721,No,NA,NA,Q4G0U5,NA,NA,NA,axoneme [GO:0005930]; cilium [GO:0005929]; calmodulin binding [GO:0005516]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; motile cilium assembly [GO:0044458],NA,NA,NA
CHOYP_LOC100367353.1.1.m.32092,-0.00670163124055529,0.00181566694937954,No,NA,NA,Q6BWA5,NA,NA,NA,cytoplasm [GO:0005737]; inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]; phosphate-containing compound metabolic process [GO:0006796],NA,NA,NA
CHOYP_LOC100367356.1.1.m.29181,-0.0204312429270951,-0.00552105004723757,No,NA,NA,A4D263,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100367378.1.1.m.25783,-0.0145787937208074,0.0170562763785586,No,NA,NA,Q9UBV8,NA,NA,NA,COPII vesicle coat [GO:0030127]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; molecular adaptor activity [GO:0060090]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; positive regulation of protein monoubiquitination [GO:1902527]; response to calcium ion [GO:0051592],NA,NA,NA
CHOYP_LOC100367394.1.2.m.34992,-0.0124978270406721,0.0125582420182745,No,NA,NA,Q8N4P6,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100367405.1.2.m.10570,-0.0156672732722305,0.00237693914635798,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100367414.1.7.m.21233,-0.0146309912528053,0.00779899950436556,No,NA,NA,Q460N5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein poly-ADP-ribosylation [GO:0070212],NA,NA,NA
CHOYP_LOC100367421.1.1.m.66338,-0.00416625323672424,0.0164811466685112,No,NA,NA,Q5R514,NA,NA,NA,orotate phosphoribosyltransferase activity [GO:0004588]; orotidine-5'-phosphate decarboxylase activity [GO:0004590]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205],NA,NA,NA
CHOYP_LOC100367423.1.1.m.23397,0.0065883263884642,0.0180931628217626,No,NA,NA,H2MTR9,NA,NA,NA,adherens junction [GO:0005912]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; cell adhesion [GO:0007155]; determination of left/right symmetry [GO:0007368],NA,NA,NA
CHOYP_LOC100367436.1.1.m.20579,-0.0169591047060434,0.00960206869202777,No,NA,NA,C3YWU0,NA,NA,NA,extracellular region [GO:0005576]; lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139],NA,NA,NA
CHOYP_LOC100367460.1.1.m.62925,-0.0099770120279339,0.0104440951070377,No,NA,NA,Q8YTC2,NA,NA,NA,ADP binding [GO:0043531]; sequence-specific DNA binding [GO:0043565],NA,NA,NA
CHOYP_LOC100367470.1.1.m.51904,0.0120249788812395,-0.00771553026662998,No,NA,NA,Q4QQY7,NA,NA,NA,mitochondrial outer membrane [GO:0005741]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; queuine tRNA-ribosyltransferase activity [GO:0008479]; tRNA-guanine transglycosylation [GO:0101030],NA,NA,NA
CHOYP_LOC100367535.1.2.m.4730,0.013773234337975,0.0121017176123076,No,NA,NA,Q8R238,NA,NA,NA,mitochondrion [GO:0005739]; identical protein binding [GO:0042802]; L-serine ammonia-lyase activity [GO:0003941]; L-threonine ammonia-lyase activity [GO:0004794]; L-serine catabolic process [GO:0006565]; threonine catabolic process [GO:0006567],NA,NA,NA
CHOYP_LOC100367548.1.1.m.48434,0.0145382142909077,-0.00732010479567393,No,NA,NA,Q5ZKF4,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677],NA,NA,NA
CHOYP_LOC100367581.3.3.m.56472,-0.0183710627672832,-0.0010072522224481,No,NA,NA,Q69Z37,NA,NA,NA,cytoplasm [GO:0005737]; early endosome [GO:0005769]; common myeloid progenitor cell proliferation [GO:0035726]; endosomal vesicle fusion [GO:0034058]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of protein catabolic process [GO:0042176]; spleen development [GO:0048536]; stem cell division [GO:0017145],NA,NA,NA
CHOYP_LOC100367604.1.1.m.52334,-0.0112773429764365,-0.0116740522701033,No,NA,NA,Q9Y366,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; dendrite terminus [GO:0044292]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; photoreceptor connecting cilium [GO:0032391]; protein C-terminus binding [GO:0008022]; cilium assembly [GO:0060271]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; heart looping [GO:0001947]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; negative regulation of epithelial cell proliferation [GO:0050680]; neural tube formation [GO:0001841]; non-motile cilium assembly [GO:1905515]; regulation of protein processing [GO:0070613]; smoothened signaling pathway [GO:0007224],NA,NA,NA
CHOYP_LOC100367612.1.1.m.37487,-0.00229585496599198,-0.00589719276816917,No,NA,NA,Q5XI13,NA,NA,NA,chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA replication origin binding [GO:0003688]; histone binding [GO:0042393]; DNA replication [GO:0006260]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337],NA,NA,NA
CHOYP_LOC100367637.1.1.m.55661,-0.0144647851663873,-0.00125641863421692,No,NA,NA,Q96C86,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; exoribonuclease activity [GO:0004532]; m7G(5')pppN diphosphatase activity [GO:0050072]; RNA 7-methylguanosine cap binding [GO:0000340]; cellular response to menadione [GO:0036245]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; mRNA cis splicing; via spliceosome [GO:0045292]; negative regulation of programmed cell death [GO:0043069]; nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:0000288],NA,NA,NA
CHOYP_LOC100367640.1.1.m.22070,-0.00813689879710664,-0.00493310783144216,No,NA,NA,Q0IHY5,NA,NA,NA,ER membrane protein complex [GO:0072546]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_LOC100367645.1.1.m.29695,-0.000853214721087433,-0.0180166004039029,No,NA,NA,P21839,NA,NA,NA,mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrion [GO:0005739]; 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity [GO:0003863]; alpha-ketoacid dehydrogenase activity [GO:0003826]; branched-chain amino acid catabolic process [GO:0009083]; response to nutrient [GO:0007584],NA,NA,NA
CHOYP_LOC100367659.1.1.m.9232,0.0148787947414865,-0.0153307635814753,No,NA,NA,A1L258,NA,NA,NA,extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; mitochondrion [GO:0005739]; (R)-2-hydroxyglutarate dehydrogenase activity [GO:0051990]; D-lactate dehydrogenase (cytochrome) activity [GO:0004458]; FAD binding [GO:0071949]; lactate oxidation [GO:0019516]; respiratory electron transport chain [GO:0022904],NA,NA,NA
CHOYP_LOC100367705.1.1.m.9297,-0.0137067825130515,-0.00134170011377114,No,NA,NA,Q04859,NA,NA,NA,axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; motile cilium [GO:0031514]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; transcription coactivator activity [GO:0003713]; cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; intraciliary transport [GO:0042073]; negative regulation of non-motile cilium assembly [GO:1902856]; photoreceptor cell maintenance [GO:0045494]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468],NA,NA,NA
CHOYP_LOC100367718.1.1.m.8839,-0.00805482767954613,-0.0154205394465961,No,NA,NA,P84817,NA,NA,NA,endoplasmic reticulum [GO:0005783]; integral component of mitochondrial outer membrane [GO:0031307]; integral component of peroxisomal membrane [GO:0005779]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; apoptotic process [GO:0006915]; autophagy of mitochondrion [GO:0000422]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cellular response to glucose stimulus [GO:0071333]; cellular response to lipid [GO:0071396]; cellular response to peptide [GO:1901653]; cellular response to thapsigargin [GO:1904579]; cellular response to toxic substance [GO:0097237]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial fusion [GO:0008053]; mitochondrion morphogenesis [GO:0070584]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; peroxisome fission [GO:0016559]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein targeting to membrane [GO:0090314]; protein homooligomerization [GO:0051260]; protein targeting to mitochondrion [GO:0006626]; release of cytochrome c from mitochondria [GO:0001836]; response to flavonoid [GO:1905395]; response to fluoride [GO:1902617]; response to hypobaric hypoxia [GO:1990910]; response to muscle activity [GO:0014850]; response to nutrient levels [GO:0031667],NA,NA,NA
CHOYP_LOC100367726.1.2.m.47322,0.0104062491143481,-0.0220451526322087,No,NA,NA,P11498,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pyruvate carboxylase activity [GO:0004736]; biotin metabolic process [GO:0006768]; gluconeogenesis [GO:0006094]; lipid metabolic process [GO:0006629]; negative regulation of gene expression [GO:0010629]; positive regulation by host of viral process [GO:0044794]; positive regulation by host of viral release from host cell [GO:0044791]; pyruvate metabolic process [GO:0006090]; viral RNA genome packaging [GO:0019074],NA,NA,NA
CHOYP_LOC100367736.2.2.m.66862,-0.0225584742723831,0.00997765113334975,No,NA,NA,P20072,NA,NA,NA,chromaffin granule membrane [GO:0042584]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to salt stress [GO:0009651]; social behavior [GO:0035176],NA,NA,NA
CHOYP_LOC100367739.1.1.m.22741,-0.0182709642767798,0.0143205385599698,No,NA,NA,Q9UL16,NA,NA,NA,cilium [GO:0005929]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],NA,NA,NA
CHOYP_LOC100367787.1.1.m.52250,-0.0205467886851633,-0.00454854539326907,No,NA,NA,A8MV24,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100367809.2.2.m.44174,0.0065883263884642,0.0180931628217626,No,NA,NA,Q1HG43,NA,NA,NA,cell leading edge [GO:0031252]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; cellular protein localization [GO:0034613]; hydrogen peroxide metabolic process [GO:0042743]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of neuron differentiation [GO:0045666]; protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of inflammatory response [GO:0050727]; regulation of thyroid hormone generation [GO:2000609],NA,NA,NA
CHOYP_LOC100367837.1.1.m.56015,-0.0102955820149808,0.00353954197756812,No,NA,NA,Q5BJQ6,NA,NA,NA,mRNA cleavage stimulating factor complex [GO:0005848]; mRNA processing [GO:0006397],NA,NA,NA
CHOYP_LOC100367880.1.1.m.12770,-0.00212078832001384,-0.00891837260408135,No,NA,NA,Q9BXW4,NA,NA,NA,autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; microtubule [GO:0005874]; organelle membrane [GO:0031090]; microtubule binding [GO:0008017]; ubiquitin protein ligase binding [GO:0031625]; aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; macroautophagy [GO:0016236],NA,NA,NA
CHOYP_LOC100367908.2.2.m.55212,0.0161305516178634,0.00628526118299902,No,NA,NA,Q5R7A7,NA,NA,NA,early endosome [GO:0005769]; recycling endosome [GO:0055037]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674],NA,NA,NA
CHOYP_LOC100367949.2.3.m.55056,-0.00954273942578824,-0.00549434781414678,No,NA,NA,Q5R6Z6,NA,NA,NA,CCR4-NOT complex [GO:0030014]; nucleus [GO:0005634]; P-body [GO:0000932]; epidermal growth factor receptor binding [GO:0005154]; kinase binding [GO:0019900]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; cytokine-mediated signaling pathway [GO:0019221]; gene silencing by RNA [GO:0031047]; mRNA catabolic process [GO:0006402]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of nuclear receptor transcription coactivator activity [GO:2000327]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_LOC100367949.3.3.m.63228,-0.00255190174755002,0.0037718428924923,No,NA,NA,Q5R6Z6,NA,NA,NA,CCR4-NOT complex [GO:0030014]; nucleus [GO:0005634]; P-body [GO:0000932]; epidermal growth factor receptor binding [GO:0005154]; kinase binding [GO:0019900]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; cytokine-mediated signaling pathway [GO:0019221]; gene silencing by RNA [GO:0031047]; mRNA catabolic process [GO:0006402]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of nuclear receptor transcription coactivator activity [GO:2000327]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_LOC100367951.1.1.m.38662,0.00504991543223022,0.0124550481623778,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100367954.1.2.m.66390,-0.00272344758560115,0.0213525409858337,No,NA,NA,Q9Y426,NA,NA,NA,cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleus [GO:0005634],NA,NA,NA
CHOYP_LOC100367954.2.2.m.66596,0.00836850623129618,0.0106195943186771,No,NA,NA,E9Q3C1,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_LOC100367956.2.2.m.62044,0.00678620130084429,0.00878741825264137,No,NA,NA,Q92113,NA,NA,NA,membrane [GO:0016020]; 17-alpha-hydroxyprogesterone aldolase activity [GO:0047442]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 17-alpha-monooxygenase activity [GO:0004508]; sex differentiation [GO:0007548]; steroid biosynthetic process [GO:0006694],NA,NA,NA
CHOYP_LOC100367974.1.3.m.19352,-0.0227283849665663,-0.00363881862334359,No,NA,NA,Q5R7A7,NA,NA,NA,early endosome [GO:0005769]; recycling endosome [GO:0055037]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674],NA,NA,NA
CHOYP_LOC100368004.1.1.m.62584,-0.0124698680362088,-0.0185415065759363,No,NA,NA,Q5FVB2,NA,NA,NA,metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; embryonic camera-type eye development [GO:0031076]; forebrain development [GO:0030900]; gastrulation [GO:0007369]; mesoderm development [GO:0007498]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_LOC100368022.1.1.m.55588,-0.0228451326941603,-0.00595276549953635,No,NA,NA,Q16959,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motor activity [GO:0003774],NA,NA,NA
CHOYP_LOC100368023.1.1.m.14890,-0.0116322669250683,-0.000971686116690183,No,NA,NA,Q9BSF4,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; TIM22 mitochondrial import inner membrane insertion complex [GO:0042721]; protein import into mitochondrial inner membrane [GO:0045039],NA,NA,NA
CHOYP_LOC100368053.1.1.m.25224,-0.011845172705534,-0.00294557875824661,No,NA,NA,A1L271,NA,NA,NA,membrane [GO:0016020]; heart contraction [GO:0060047]; optokinetic behavior [GO:0007634]; signal transduction [GO:0007165]; swimming behavior [GO:0036269],NA,NA,NA
CHOYP_LOC100368071.1.1.m.6755,-0.0198322590766229,-0.000107137594709599,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100368072.1.1.m.52449,-0.00822811344514297,-0.00848393765780289,No,NA,NA,Q9P2G1,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100368104.1.1.m.22554,-0.00523147069257033,-0.0120939152621859,No,NA,NA,Q8K1N2,NA,NA,NA,basal cortex [GO:0045180]; cell leading edge [GO:0031252]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intermediate filament cytoskeleton [GO:0045111]; plasma membrane [GO:0005886]; establishment of protein localization [GO:0045184]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of wound healing; spreading of epidermal cells [GO:1903690]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of microtubule cytoskeleton organization [GO:0070507],NA,NA,NA
CHOYP_LOC100368109.1.1.m.18734,0.000873891975720855,-0.00339407045613112,No,NA,NA,A6QQM4,NA,NA,NA,metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100368117.1.1.m.27153,-0.00569193403702208,0.00876946050069327,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100368128.1.1.m.9893,-0.00430894344577715,-0.00631540690244347,No,NA,NA,Q3UPW2,NA,NA,NA,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; anatomical structure morphogenesis [GO:0009653]; blastocyst development [GO:0001824]; cell differentiation [GO:0030154]; epithelial cell differentiation [GO:0030855]; extracellular matrix organization [GO:0030198]; inflammatory response [GO:0006954]; mammary gland involution [GO:0060056]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription; DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_LOC100368178.1.3.m.36490,-0.00147009594125747,-0.0106510742372191,No,NA,NA,Q9BYK8,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nuclear receptor transcription coactivator activity [GO:0030374]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of lipid metabolic process [GO:0019216],NA,NA,NA
CHOYP_LOC100368194.1.1.m.59989,0.000937454103990533,-0.00144069306389916,No,NA,NA,Q9CRB9,NA,NA,NA,cytoplasm [GO:0005737]; MICOS complex [GO:0061617]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; phosphatase binding [GO:0019902]; protein-containing complex scaffold activity [GO:0032947]; cristae formation [GO:0042407]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial fusion [GO:0008053]; negative regulation of transcription by RNA polymerase II [GO:0000122],NA,NA,NA
CHOYP_LOC100368219.2.5.m.38385,-0.022758143639733,0.00550067578427931,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100368219.4.5.m.58416,0.00933770087109238,0.0196220368974886,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100368228.3.3.m.54183,-0.00532051694472742,0.00889056580855577,No,NA,NA,Q9W391,NA,NA,NA,phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; catalytic activity [GO:0003824]; glycogen metabolic process [GO:0005977]; protein phosphorylation [GO:0006468],NA,NA,NA
CHOYP_LOC100368238.1.1.m.7505,0.023279981061829,-0.00715563148013266,No,NA,NA,Q13231,NA,NA,NA,extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; endochitinase activity [GO:0008843]; hydrolase activity; hydrolyzing O-glycosyl compounds [GO:0004553]; chitin catabolic process [GO:0006032]; immune response [GO:0006955]; neutrophil degranulation [GO:0043312]; polysaccharide catabolic process [GO:0000272]; polysaccharide digestion [GO:0044245]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_LOC100368251.3.6.m.40053,-0.0156746730505343,0.00238618745188539,No,NA,NA,Q5K651,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; endosomal vesicle fusion [GO:0034058],NA,NA,NA
CHOYP_LOC100368259.1.1.m.39485,0.0186201054408742,-0.0108672185526287,No,NA,NA,Q9VFC8,NA,NA,NA,autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; glycogen (starch) synthase activity [GO:0004373]; cellular response to starvation [GO:0009267]; cellular response to sucrose stimulus [GO:0071329]; glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]; glycophagy [GO:0061723]; positive regulation of glycogen catabolic process [GO:0045819]; response to sucrose [GO:0009744],NA,NA,NA
CHOYP_LOC100368360.1.1.m.9672,-0.021510986411877,-0.0100316886353229,No,NA,NA,Q4KKZ1,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100368376.1.2.m.11023,-0.0025453399161804,-0.00455636467779128,No,NA,NA,Q3EC11,NA,NA,NA,endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein targeting to membrane [GO:0006612],NA,NA,NA
CHOYP_LOC100368394.1.2.m.22888,-0.0196898434112724,-0.000370465332567368,No,NA,NA,Q5T0N1,NA,NA,NA,cilium [GO:0005929]; extracellular exosome [GO:0070062],NA,NA,NA
CHOYP_LOC100368410.2.2.m.44510,-0.0135725579708753,0.00388604629968508,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100368416.1.1.m.58347,-0.00331630444502246,0.00125858727885389,No,NA,NA,Q8VHI3,NA,NA,NA,endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; fucosyltransferase activity [GO:0008417]; peptide-O-fucosyltransferase activity [GO:0046922]; fucose metabolic process [GO:0006004]; fucosylation [GO:0036065]; mesoderm formation [GO:0001707]; protein O-linked fucosylation [GO:0036066]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gene expression [GO:0010468]; regulation of secretion [GO:0051046],NA,NA,NA
CHOYP_LOC100368486.1.1.m.18263,0.00915627562557174,-0.00122069954996892,No,NA,NA,O95433,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; ATPase activator activity [GO:0001671]; cadherin binding [GO:0045296]; chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879]; positive regulation of ATPase activity [GO:0032781],NA,NA,NA
CHOYP_LOC100368495.1.1.m.9879,0.00629501047306543,-0.0138645561358685,No,NA,NA,Q9BVG4,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100368521.3.3.m.41435,0.00217997094733793,-0.00807271368859912,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100368525.1.1.m.62480,-0.00834998199099283,0.0101568549104001,No,NA,NA,Q3UGF1,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intraciliary transport particle A [GO:0030991]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; cell morphogenesis [GO:0000902]; ciliary receptor clustering involved in smoothened signaling pathway [GO:0060830]; cilium assembly [GO:0060271]; digestive system development [GO:0055123]; ear morphogenesis [GO:0042471]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic limb morphogenesis [GO:0030326]; gonad development [GO:0008406]; in utero embryonic development [GO:0001701]; intraciliary retrograde transport [GO:0035721]; myotome development [GO:0061055]; nervous system process [GO:0050877]; protein localization to cilium [GO:0061512]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831],NA,NA,NA
CHOYP_LOC100368576.1.1.m.45391,-0.0149678278618643,0.00859771857916035,No,NA,NA,Q6DMN8,NA,NA,NA,cytoplasm [GO:0005737]; motile cilium [GO:0031514]; nucleus [GO:0005634]; cilium-dependent cell motility [GO:0060285],NA,NA,NA
CHOYP_LOC100368627.1.1.m.13820,0.00622861153398844,-0.0170853713484136,No,NA,NA,Q15061,NA,NA,NA,fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_LOC100368636.1.1.m.6631,-0.0183520877333233,0.00739849651070488,No,NA,NA,Q3UY96,NA,NA,NA,axoneme [GO:0005930]; axoneme assembly [GO:0035082],NA,NA,NA
CHOYP_LOC100368639.1.1.m.56563,0.00266229109492948,-0.0112262297178935,No,NA,NA,Q5PPY6,NA,NA,NA,eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_LOC100368658.1.1.m.16577,-0.0139474777681239,-0.00184738714428258,No,NA,NA,P49139,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; cellular response to DNA damage stimulus [GO:0006974]; inflammatory response [GO:0006954]; macropinocytosis [GO:0044351]; regulation of interleukin-6 production [GO:0032675]; regulation of tumor necrosis factor production [GO:0032680]; response to cytokine [GO:0034097]; response to lipopolysaccharide [GO:0032496]; toll-like receptor signaling pathway [GO:0002224],NA,NA,NA
CHOYP_LOC100368659.1.2.m.15836,0.00139013100244,0.00891064608101363,No,NA,NA,P78316,NA,NA,NA,90S preribosome [GO:0030686]; membrane [GO:0016020]; Noc4p-Nop14p complex [GO:0030692]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; enzyme binding [GO:0019899]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000472]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_LOC100368661.1.1.m.60830,0.000715000632020498,0.0209639525387777,No,NA,NA,Q5F464,NA,NA,NA,cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_LOC100368695.1.1.m.26746,-0.00306863243499075,0.0113392708474823,No,NA,NA,O43301,NA,NA,NA,extracellular exosome [GO:0070062]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC100368715.1.3.m.31823,0.00615966897194063,0.00941964587728867,No,NA,NA,Q5REG4,NA,NA,NA,cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_LOC100368803.1.1.m.12857,-0.0154245018840273,0.000128198823825016,No,NA,NA,Q5JTW2,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium organization [GO:0044782]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of G2/M transition of mitotic cell cycle [GO:0010389],NA,NA,NA
CHOYP_LOC100368820.1.1.m.12090,0.00965806686365871,-0.00244636862986823,No,NA,NA,Q4T2X8,NA,NA,NA,nucleolus [GO:0005730]; RNA binding [GO:0003723]; ribosome assembly [GO:0042255],NA,NA,NA
CHOYP_LOC100368844.1.1.m.45290,-0.0161525390420777,0.0189075704777527,No,NA,NA,B0WYR6,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100368865.1.1.m.48100,-0.00724951301136604,0.0205945340311689,No,NA,NA,Q9D2K4,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100368865.1.1.m.48101,-0.0193856537848232,-0.00799265342132434,No,NA,NA,Q5GIS3,NA,NA,NA,cytoplasm [GO:0005737]; calmodulin binding [GO:0005516]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100368866.1.1.m.6804,0.00130478032541045,0.00101333180307292,No,NA,NA,Q24439,NA,NA,NA,mitochondrial proton-transporting ATP synthase; central stalk [GO:0005756]; mitochondrion [GO:0005739]; proton-transporting ATP synthase activity; rotational mechanism [GO:0046933]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; proton transmembrane transport [GO:1902600],NA,NA,NA
CHOYP_LOC100368907.1.1.m.22004,-0.00184792187265485,0.00331870242526152,No,NA,NA,B5X7E4,NA,NA,NA,cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721],NA,NA,NA
CHOYP_LOC100368913.1.1.m.25628,-0.0130788542586962,-0.00947018900422357,No,NA,NA,B0G143,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; transmembrane transporter activity [GO:0022857]; mitochondrial transport [GO:0006839],NA,NA,NA
CHOYP_LOC100368918.1.2.m.6229,0.00835654224372297,0.00547509833494047,No,NA,NA,Q49AM3,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100368924.1.1.m.5031,-0.00678549327270248,0.0159281313250764,No,NA,NA,Q642C0,NA,NA,NA,nucleus [GO:0005634],NA,NA,NA
CHOYP_LOC100368926.5.5.m.55016,0.00271600863633772,-0.00969186124695218,No,NA,NA,O00370,NA,NA,NA,metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; type II site-specific deoxyribonuclease activity [GO:0009036]; DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition; RNA-mediated [GO:0032197],NA,NA,NA
CHOYP_LOC100368938.2.2.m.53945,-0.0201471945661003,0.000755969811003823,No,NA,NA,Q5M7G4,NA,NA,NA,cytosol [GO:0005829]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; cytidylate kinase activity [GO:0004127]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142],NA,NA,NA
CHOYP_LOC100368976.1.1.m.1873,-0.000735717082827718,-0.00653990791928041,No,NA,NA,A0JNH9,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; 3'-5' exonuclease activity [GO:0008408]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; endodeoxyribonuclease activity [GO:0004520]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; single strand break repair [GO:0000012],NA,NA,NA
CHOYP_LOC100368987.1.1.m.6182,0.000461560351559053,0.0207504250481712,No,NA,NA,Q62165,NA,NA,NA,basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; contractile ring [GO:0070938]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystroglycan complex [GO:0016011]; dystrophin-associated glycoprotein complex [GO:0016010]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; membrane [GO:0016020]; membrane raft [GO:0045121]; node of Ranvier [GO:0033268]; nuclear periphery [GO:0034399]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic cytosol [GO:0099524]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; synapse [GO:0045202]; actin binding [GO:0003779]; alpha-actinin binding [GO:0051393]; calcium ion binding [GO:0005509]; dystroglycan binding [GO:0002162]; laminin binding [GO:0043236]; laminin-1 binding [GO:0043237]; SH2 domain binding [GO:0042169]; structural constituent of muscle [GO:0008307]; tubulin binding [GO:0015631]; vinculin binding [GO:0017166]; aging [GO:0007568]; angiogenesis involved in wound healing [GO:0060055]; axon regeneration [GO:0031103]; basement membrane organization [GO:0071711]; branching involved in salivary gland morphogenesis [GO:0060445]; calcium-dependent cell-matrix adhesion [GO:0016340]; cellular response to cholesterol [GO:0071397]; cellular response to mechanical stimulus [GO:0071260]; commissural neuron axon guidance [GO:0071679]; cytoskeletal anchoring at plasma membrane [GO:0007016]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; membrane protein ectodomain proteolysis [GO:0006509]; microtubule anchoring [GO:0034453]; modulation by virus of host morphology or physiology [GO:0019048]; morphogenesis of an epithelial sheet [GO:0002011]; myelination in peripheral nervous system [GO:0022011]; negative regulation of cell migration [GO:0030336]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of protein kinase B signaling [GO:0051898]; nerve maturation [GO:0021682]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of myelination [GO:0031643]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of protein kinase activity [GO:0045860]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of synapse organization [GO:0050807]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to peptide hormone [GO:0043434]; retrograde trans-synaptic signaling by trans-synaptic protein complex [GO:0098942]; Schwann cell development [GO:0014044]; skeletal muscle tissue regeneration [GO:0043403],NA,NA,NA
CHOYP_LOC100369014.8.9.m.53287,0.00765129965591898,0.00224330537340576,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100369014.9.9.m.53367,-0.00787044399288759,0.0230364734268913,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100369017.1.1.m.27033,-0.00990335888337028,0.00303019394071817,No,NA,NA,Q3V3N7,NA,NA,NA,axoneme [GO:0005930]; BBSome [GO:0034464]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; motile cilium [GO:0031514]; patched binding [GO:0005113]; phosphoprotein binding [GO:0051219]; RNA polymerase II repressing transcription factor binding [GO:0001103]; signaling receptor binding [GO:0005102]; smoothened binding [GO:0005119]; adult behavior [GO:0030534]; brain morphogenesis [GO:0048854]; cartilage development [GO:0051216]; cellular lipid metabolic process [GO:0044255]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; dendrite development [GO:0016358]; fat cell differentiation [GO:0045444]; fertilization [GO:0009566]; Golgi to plasma membrane protein transport [GO:0043001]; hippocampus development [GO:0021766]; hormone metabolic process [GO:0042445]; intraciliary retrograde transport [GO:0035721]; microtubule cytoskeleton organization [GO:0000226]; neural precursor cell proliferation [GO:0061351]; neuron migration [GO:0001764]; non-motile cilium assembly [GO:1905515]; olfactory behavior [GO:0042048]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell morphogenesis [GO:0008594]; protein localization [GO:0008104]; protein localization to cilium [GO:0061512]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; retina homeostasis [GO:0001895]; sensory perception of smell [GO:0007608]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual perception [GO:0007601],NA,NA,NA
CHOYP_LOC100369022.1.1.m.62978,-0.0147041684609543,-0.0210210400736399,No,NA,NA,Q8N0W5,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100369031.1.1.m.19197,0.00610839980993909,0.00315387456200693,No,NA,NA,Q9JK25,NA,NA,NA,cytoplasmic microtubule [GO:0005881]; cytoplasmic vesicle membrane [GO:0030659]; microtubule plus-end [GO:0035371]; ruffle [GO:0001726]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; positive regulation of dendrite development [GO:1900006],NA,NA,NA
CHOYP_LOC100369186.2.9.m.27904,0.00691948073256778,-0.00346164587947721,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100369194.1.1.m.42345,-0.0102973969180838,0.0075107646839788,No,NA,NA,Q5EAJ7,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634],NA,NA,NA
CHOYP_LOC100369232.1.1.m.58420,0.00227216322605123,-0.0168305871133972,No,NA,NA,O93327,NA,NA,NA,condensed chromosome [GO:0000793]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleosome [GO:0000786]; pericentric heterochromatin [GO:0005721]; DNA binding [GO:0003677]; double-stranded methylated DNA binding [GO:0010385]; nucleosomal DNA binding [GO:0031492]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; rDNA binding [GO:0000182]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; chromatin organization [GO:0006325]; dosage compensation [GO:0007549]; establishment of protein localization to chromatin [GO:0071169]; negative regulation of cell cycle G2/M phase transition [GO:1902750]; negative regulation of gene expression; epigenetic [GO:0045814]; negative regulation of histone H3-K27 methylation [GO:0061086]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of histone phosphorylation [GO:0033128]; negative regulation of protein localization to chromosome; telomeric region [GO:1904815]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; nucleosome assembly [GO:0006334]; positive regulation of gene expression; epigenetic [GO:0045815]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; regulation of lipid metabolic process [GO:0019216]; regulation of response to oxidative stress [GO:1902882],NA,NA,NA
CHOYP_LOC100369237.3.3.m.48902,0.00503113890669074,-0.0164925903563836,No,NA,NA,Q3UHR0,NA,NA,NA,chromatin binding [GO:0003682],NA,NA,NA
CHOYP_LOC100369255.1.3.m.17623,-0.0193038176439516,-0.0022694735683554,No,NA,NA,Q9P1Z9,NA,NA,NA,extracellular exosome [GO:0070062],NA,NA,NA
CHOYP_LOC100369259.1.1.m.7509,0.00205195042830452,-0.00934116934689426,No,NA,NA,P23919,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside monophosphate kinase activity [GO:0050145]; thymidylate kinase activity [GO:0004798]; uridylate kinase activity [GO:0009041]; cell proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; dTDP biosynthetic process [GO:0006233]; dTTP biosynthetic process [GO:0006235]; dUDP biosynthetic process [GO:0006227]; myoblast differentiation [GO:0045445]; nucleobase-containing small molecule interconversion [GO:0015949]; response to cadmium ion [GO:0046686]; response to estrogen [GO:0043627],NA,NA,NA
CHOYP_LOC100369270.1.1.m.27019,-0.00325327608952567,0.00892689602790727,No,NA,NA,Q9VFR0,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; mitotic spindle pole [GO:0097431]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; kinase regulator activity [GO:0019207]; protein kinase regulator activity [GO:0019887]; tubulin binding [GO:0015631]; cellular response to DNA damage stimulus [GO:0006974]; establishment of mitotic spindle orientation [GO:0000132]; microtubule anchoring [GO:0034453]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of protein kinase activity [GO:0045859]; ribosomal large subunit export from nucleus [GO:0000055],NA,NA,NA
CHOYP_LOC100369290.1.1.m.66929,0.01209225984297,0.0119880537089011,No,NA,NA,A4IF78,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; positive regulation of apoptotic process [GO:0043065],NA,NA,NA
CHOYP_LOC100369294.2.6.m.22959,0.000686232728993108,-0.0107331332691118,No,NA,NA,Q28298,NA,NA,NA,integral component of endoplasmic reticulum membrane [GO:0030176]; protein transport [GO:0015031]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100369294.3.6.m.24633,0.0155962435642397,0.00184838585864949,No,NA,NA,Q28298,NA,NA,NA,integral component of endoplasmic reticulum membrane [GO:0030176]; protein transport [GO:0015031]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100369302.1.3.m.6808,-0.00833497898443725,-0.00458027279530275,No,NA,NA,Q008S8,NA,NA,NA,Rho guanyl-nucleotide exchange factor activity [GO:0005089]; regulation of Rho protein signal transduction [GO:0035023],NA,NA,NA
CHOYP_LOC100369330.1.1.m.48177,-0.00212078832001384,-0.00891837260408135,No,NA,NA,Q3T0W7,NA,NA,NA,Atg12-Atg5-Atg16 complex [GO:0034274]; phagophore assembly site membrane [GO:0034045]; Atg8 ligase activity [GO:0019776]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; C-terminal protein lipidation [GO:0006501]; innate immune response [GO:0045087],NA,NA,NA
CHOYP_LOC100369333.14.32.m.32582,-0.0135725579708753,0.00388604629968508,No,NA,NA,Q6PFY8,NA,NA,NA,cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348],NA,NA,NA
CHOYP_LOC100369333.22.32.m.39414,0.00205195042830452,-0.00934116934689426,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100369333.28.32.m.53859,0.00394536801625317,0.00291369700370642,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100369340.1.1.m.51639,-0.00902106719429242,0.011037681982005,No,NA,NA,Q80ZX8,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; axonemal dynein complex assembly [GO:0070286]; single fertilization [GO:0007338],NA,NA,NA
CHOYP_LOC100369350.2.6.m.42373,0.00678620130084429,0.00878741825264137,No,NA,NA,P22105,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251],NA,NA,NA
CHOYP_LOC100369378.1.1.m.5391,0.0225949289877759,0.00831865614234659,No,NA,NA,P02640,NA,NA,NA,actin filament bundle [GO:0032432]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; ruffle [GO:0001726]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; lysophosphatidic acid binding [GO:0035727]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; protein homodimerization activity [GO:0042803]; actin filament capping [GO:0051693]; actin filament depolymerization [GO:0030042]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; epidermal growth factor receptor signaling pathway [GO:0007173]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell migration [GO:0010634]; regulation of actin nucleation [GO:0051125]; regulation of cell shape [GO:0008360]; regulation of lamellipodium morphogenesis [GO:2000392]; regulation of wound healing [GO:0061041]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_LOC100369384.1.1.m.47986,-0.016373098381417,0.0125818778499997,No,NA,NA,Q9WTR0,NA,NA,NA,extracellular matrix [GO:0031012]; integral component of plasma membrane [GO:0005887]; metalloaminopeptidase activity [GO:0070006]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; bone development [GO:0060348]; chondrocyte proliferation [GO:0035988]; collagen catabolic process [GO:0030574]; craniofacial suture morphogenesis [GO:0097094]; embryonic cranial skeleton morphogenesis [GO:0048701]; endochondral ossification [GO:0001958]; ossification [GO:0001503]; protein processing [GO:0016485]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC100369402.2.2.m.29002,0.00407349108844753,-0.0173080841470545,No,NA,NA,P45842,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100369411.1.1.m.1071,0.0062101544938292,-0.00295651782435546,No,NA,NA,Q920N2,NA,NA,NA,chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin-[acetyl-CoA-carboxylase] ligase activity [GO:0004077]; biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity [GO:0004078]; biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity [GO:0004079]; biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity [GO:0004080]; biotin-protein ligase activity [GO:0018271]; enzyme binding [GO:0019899]; protein homodimerization activity [GO:0042803]; cell proliferation [GO:0008283]; histone biotinylation [GO:0071110]; histone modification [GO:0016570]; protein biotinylation [GO:0009305]; response to biotin [GO:0070781],NA,NA,NA
CHOYP_LOC100369421.1.2.m.17340,-0.0177403154292062,0.00622316506087425,No,NA,NA,Q2TA16,NA,NA,NA,axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; motile cilium [GO:0031514]; axonemal dynein complex assembly [GO:0070286]; cilium-dependent cell motility [GO:0060285]; regulation of cilium movement [GO:0003352],NA,NA,NA
CHOYP_LOC100369444.1.1.m.18613,-0.00485500291867685,-0.0240571588850946,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100369488.1.1.m.10559,-0.0120109348971597,-0.000843845956848668,No,NA,NA,Q6P0I8,NA,NA,NA,cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process; exonucleolytic; 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475],NA,NA,NA
CHOYP_LOC100369524.1.1.m.8159,-0.00864190723218697,-0.0254765042664194,No,NA,NA,P48818,NA,NA,NA,cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; regulation of cholesterol metabolic process [GO:0090181]; response to cold [GO:0009409]; temperature homeostasis [GO:0001659],NA,NA,NA
CHOYP_LOC100369566.1.1.m.41492,-0.0209081419437818,-0.010327721208122,No,NA,NA,A1A5Q4,NA,NA,NA,motile cilium [GO:0031514]; radial spoke [GO:0001534]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341],NA,NA,NA
CHOYP_LOC100369570.1.1.m.25302,0.00344661920854182,-0.00751369452385155,No,NA,NA,Q8CIG9,NA,NA,NA,SCF ubiquitin ligase complex [GO:0019005]; ubiquitin-protein transferase activity [GO:0004842]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],NA,NA,NA
CHOYP_LOC100369596.1.1.m.7021,0.00691501624532541,-0.00343082932255804,No,NA,NA,Q8IZH2,NA,NA,NA,cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; synapse [GO:0045202]; 5'-3' exoribonuclease activity [GO:0004534]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; cellular response to cycloheximide [GO:0071409]; cellular response to puromycin [GO:1905795]; histone mRNA catabolic process [GO:0071044]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of translation [GO:0017148]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; regulation of mRNA stability [GO:0043488]; response to testosterone [GO:0033574]; RNA phosphodiester bond hydrolysis; exonucleolytic [GO:0090503]; rRNA catabolic process [GO:0016075],NA,NA,NA
CHOYP_LOC100369608.1.3.m.11971,-0.00846224996166321,0.00645370698421018,No,NA,NA,Q8IVV2,NA,NA,NA,stereocilium [GO:0032420]; catalase activity [GO:0004096]; heme binding [GO:0020037]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_LOC100369657.2.2.m.45309,0.020990174272958,-0.0144859513348548,No,NA,NA,P19891,NA,NA,NA,cytosol [GO:0005829]; asparagine synthase (glutamine-hydrolyzing) activity [GO:0004066]; ATP binding [GO:0005524]; cellular response to glucose starvation [GO:0042149]; glutamine metabolic process [GO:0006541]; L-asparagine biosynthetic process [GO:0070981]; negative regulation of apoptotic process [GO:0043066]; positive regulation of mitotic cell cycle [GO:0045931],NA,NA,NA
CHOYP_LOC100369686.2.2.m.30008,0.0065883263884642,0.0180931628217626,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100369689.1.1.m.28663,-0.0211206349420925,0.00348022667552827,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100369695.1.1.m.26973,-0.0154950452381006,0.00532422523243993,No,NA,NA,Q504A5,NA,NA,NA,cytoplasm [GO:0005737]; thiopurine S-methyltransferase activity [GO:0008119],NA,NA,NA
CHOYP_LOC100369712.1.1.m.64282,-0.0129716270827505,-0.0159450561502685,No,NA,NA,O15116,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; Lsm1-7-Pat1 complex [GO:1990726]; messenger ribonucleoprotein complex [GO:1990124]; mRNA cap binding complex [GO:0005845]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; P-body [GO:0000932]; mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; histone mRNA catabolic process [GO:0071044]; mRNA processing [GO:0006397]; negative regulation of neuron differentiation [GO:0045665]; RNA metabolic process [GO:0016070]; RNA splicing [GO:0008380]; RNA splicing; via transesterification reactions [GO:0000375]; stem cell population maintenance [GO:0019827],NA,NA,NA
CHOYP_LOC100369721.1.1.m.17704,0.0197204349024709,0.00338104891567722,No,NA,NA,Q5FW48,NA,NA,NA,aspartate dehydrogenase activity [GO:0033735]; NADP binding [GO:0050661]; NAD biosynthetic process [GO:0009435]; NADP catabolic process [GO:0006742],NA,NA,NA
CHOYP_LOC100369745.1.1.m.18815,-0.00313042691698007,-0.0225172402711387,No,NA,NA,Q5RKI1,NA,NA,NA,perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; translation initiation factor activity [GO:0003743]; cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of RNA-directed 5'-3' RNA polymerase activity [GO:1900260],NA,NA,NA
CHOYP_LOC100369754.6.10.m.53352,0.00424185681321442,-0.0133193151890042,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100369791.1.2.m.8271,-0.00430894344577715,-0.00631540690244347,No,NA,NA,Q14315,NA,NA,NA,costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; cell junction assembly [GO:0034329]; muscle fiber development [GO:0048747],NA,NA,NA
CHOYP_LOC100369816.1.1.m.23060,-0.0174282040198665,0.00551236375153684,No,NA,NA,Q6AXP4,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100369839.2.4.m.27857,-0.0204912332028819,0.0115231139374823,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100369879.3.3.m.59095,0.00205195042830452,-0.00934116934689426,No,NA,NA,P32018,NA,NA,NA,collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; cell adhesion [GO:0007155]; growth plate cartilage chondrocyte morphogenesis [GO:0003429],NA,NA,NA
CHOYP_LOC100369901.1.2.m.9586,-0.00859336810636199,-0.00498942939714533,No,NA,NA,Q8N6D5,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100369929.1.5.m.32680,-0.00212078832001384,-0.00891837260408135,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100369935.1.1.m.40124,-0.0205743582470813,-0.0125876566305667,No,NA,NA,Q96M32,NA,NA,NA,cytosol [GO:0005829]; motile cilium [GO:0031514]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; cytidylate kinase activity [GO:0004127]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside kinase activity [GO:0019206]; cell projection organization [GO:0030030]; nucleobase-containing small molecule interconversion [GO:0015949]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142],NA,NA,NA
CHOYP_LOC100369954.1.1.m.22656,-0.00569207113420604,-0.00335557899690477,No,NA,NA,Q00420,NA,NA,NA,cytoplasmic ribonucleoprotein granule [GO:0036464]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein heterodimerization activity [GO:0046982]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_LOC100369954.1.1.m.22658,-0.00808038984500626,0.0232058321819672,No,NA,NA,B0BNA5,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; actin binding [GO:0003779]; enzyme binding [GO:0019899]; defense response to fungus [GO:0050832],NA,NA,NA
CHOYP_LOC100369985.1.1.m.35628,-0.00927482155683268,-0.00313507410453065,No,NA,NA,A6NNX1,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100370026.1.1.m.42957,-0.017783676088314,-0.00629240308945018,No,NA,NA,Q8JFY9,NA,NA,NA,nucleus [GO:0005634]; endoribonuclease activity [GO:0004521]; manganese ion binding [GO:0030145]; RNA binding [GO:0003723]; snoRNA processing [GO:0043144],NA,NA,NA
CHOYP_LOC100370040.1.2.m.55411,0.00281592723660698,0.00989962636494916,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100370040.2.2.m.55789,0.00689362202969705,-0.00984704503004782,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100370046.1.1.m.18329,-0.0149126517355697,-0.00470375179830446,No,NA,NA,Q9UET6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; tRNA (cytosine-2'-O-)-methyltransferase activity [GO:0052666]; tRNA (guanosine-2'-O-)-methyltransferase activity [GO:0009020]; tRNA methyltransferase activity [GO:0008175]; cytoplasmic translation [GO:0002181]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]; tRNA nucleoside ribose methylation [GO:0002128],NA,NA,NA
CHOYP_LOC100370061.1.1.m.41505,-0.0188958107230597,0.00733585361987919,No,NA,NA,Q9DBB5,NA,NA,NA,eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA cap binding complex [GO:0005845]; RNA 7-methylguanosine cap binding [GO:0000340]; translation initiation factor activity [GO:0003743]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_LOC100370071.1.1.m.46123,-0.0136593195045772,0.0139816565483175,No,NA,NA,Q17GZ9,NA,NA,NA,nucleus [GO:0005634]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; regulation of transcription; DNA-templated [GO:0006355]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_LOC100370080.1.1.m.14971,-0.00145398560795954,0.0109613653954961,No,NA,NA,P36404,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; lateral plasma membrane [GO:0016328]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; nucleolus [GO:0005730]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase inhibitor activity [GO:0005095]; bicellular tight junction assembly [GO:0070830]; centrosome cycle [GO:0007098]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of GTPase activity [GO:0034260]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of microtubule polymerization [GO:0031116]; regulation of insulin secretion [GO:0050796]; regulation of microtubule polymerization [GO:0031113]; tubulin complex assembly [GO:0007021],NA,NA,NA
CHOYP_LOC100370113.2.2.m.56346,0.00374214352143321,0.00752593374180599,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100370122.2.2.m.59310,-0.0226642830935835,0.0102664392095728,No,NA,NA,Q6P2C0,NA,NA,NA,mitochondrial respiratory chain complex I [GO:0005747]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; electron transport chain [GO:0022900],NA,NA,NA
CHOYP_LOC100370136.1.1.m.2170,0.000770699712792339,-0.0248558700434302,No,NA,NA,Q9BZE4,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000463]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of collagen binding [GO:0033342]; negative regulation of DNA replication [GO:0008156]; negative regulation of protein ubiquitination [GO:0031397]; osteoblast differentiation [GO:0001649]; protein stabilization [GO:0050821]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079],NA,NA,NA
CHOYP_LOC100370139.3.4.m.58156,0.00708280275335245,0.0185494268665002,No,NA,NA,Q32P85,NA,NA,NA,cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; dynein intermediate chain binding [GO:0045505]; motor activity [GO:0003774]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_LOC100370154.1.2.m.27385,-0.0137223230526653,-0.0013246943452682,No,NA,NA,Q13637,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; trans-Golgi network [GO:0005802]; AP-1 adaptor complex binding [GO:0035650]; AP-3 adaptor complex binding [GO:0035651]; BLOC-2 complex binding [GO:0036461]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; antigen processing and presentation [GO:0019882]; endosome to melanosome transport [GO:0035646]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; mitochondrion organization [GO:0007005]; phagosome maturation [GO:0090382]; protein localization to membrane [GO:0072657]; Rab protein signal transduction [GO:0032482]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC100370167.1.1.m.15539,0.00588166133592066,0.00372936179758293,No,NA,NA,O04469,NA,NA,NA,peroxisome [GO:0005777]; dodecenoyl-CoA delta-isomerase activity [GO:0004165]; enoyl-CoA hydratase activity [GO:0004300]; fatty acid beta-oxidation [GO:0006635]; fatty acid catabolic process [GO:0009062],NA,NA,NA
CHOYP_LOC100370187.1.1.m.8872,0.00205195042830453,-0.00934116934689426,No,NA,NA,Q07553,NA,NA,NA,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; signaling receptor activity [GO:0038023]; cGMP-mediated signaling [GO:0019934]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100370194.1.1.m.52469,0.00356325207491637,-0.00991401638400665,No,NA,NA,A4IIK1,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; inflammatory response [GO:0006954]; innate immune response [GO:0045087],NA,NA,NA
CHOYP_LOC100370201.1.1.m.974,-0.00976806725213951,-0.0137933566026885,No,NA,NA,Q8BFY6,NA,NA,NA,COPII vesicle coat [GO:0030127]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; molecular adaptor activity [GO:0060090]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; positive regulation of protein monoubiquitination [GO:1902527]; response to calcium ion [GO:0051592],NA,NA,NA
CHOYP_LOC100370218.1.1.m.36701,-0.0181519848910479,0.0124008804837564,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100370236.1.3.m.7766,0.00491588973115351,-0.000600714720400964,No,NA,NA,Q9JKL7,NA,NA,NA,nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; nucleic acid binding [GO:0003676]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100370246.2.2.m.45834,0.00189116186121706,-0.0245921207396894,No,NA,NA,P41824,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100370246.2.2.m.45836,0.0123149677400722,-0.00795897636622251,No,NA,NA,Q13442,NA,NA,NA,cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; cell proliferation [GO:0008283]; neutrophil degranulation [GO:0043312]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100370269.1.1.m.55713,-0.00525135637311913,0.00741278824938036,No,NA,NA,Q640Q5,NA,NA,NA,P-body [GO:0000932]; PAN complex [GO:0031251]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; protein kinase activity [GO:0004672]; RNA binding [GO:0003723]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; protein targeting [GO:0006605],NA,NA,NA
CHOYP_LOC100370323.1.1.m.62024,0.000915165139454371,0.0141046473012847,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100370330.1.1.m.10944,0.00305726788170757,0.00845616415982359,No,NA,NA,Q9NRY5,NA,NA,NA,purine nucleotide binding [GO:0017076],NA,NA,NA
CHOYP_LOC100370334.1.1.m.48934,-0.0104727043619555,-0.00482286369476676,No,NA,NA,Q54RV9,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; sphinganine-1-phosphate aldolase activity [GO:0008117]; actin cytoskeleton organization [GO:0030036]; ameboidal-type cell migration [GO:0001667]; carboxylic acid metabolic process [GO:0019752]; cell death [GO:0008219]; cell motility [GO:0048870]; cellular calcium ion homeostasis [GO:0006874]; ceramide metabolic process [GO:0006672]; chemotaxis [GO:0006935]; locomotion [GO:0040011]; negative regulation of aggregate size involved in sorocarp development [GO:0031158]; negative regulation of lateral pseudopodium assembly [GO:0031276]; positive phototaxis [GO:0046956]; regulation of actin filament polymerization [GO:0030833]; sorocarp development [GO:0030587]; sphingolipid catabolic process [GO:0030149]; sphingolipid metabolic process [GO:0006665]; sporulation resulting in formation of a cellular spore [GO:0030435],NA,NA,NA
CHOYP_LOC100370358.1.1.m.39703,-0.00765627739172379,-0.0114695003633591,No,NA,NA,D3ZY60,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; trans-Golgi network [GO:0005802]; ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transporter activity [GO:1902388]; ceramide binding [GO:0097001]; glycolipid binding [GO:0051861]; glycolipid transporter activity [GO:0017089]; intermembrane lipid transfer activity [GO:0120013]; lipid binding [GO:0008289]; phosphatidylinositol-4-phosphate binding [GO:0070273]; ceramide transport [GO:0035627]; ER to Golgi ceramide transport [GO:0035621]; intermembrane lipid transfer [GO:0120009]; lipid transport [GO:0006869]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC100370401.1.1.m.15416,0.000560275268973744,0.00103935630108174,No,NA,NA,P70195,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex; beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_LOC100370403.1.1.m.11269,0.00364778592941831,-0.00872052841558097,No,NA,NA,C6KFA3,NA,NA,NA,integral component of plasma membrane [GO:0005887]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; G protein-coupled receptor activity [GO:0004930]; laminin binding [GO:0043236]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP-mediated signaling [GO:0019933]; cell surface receptor signaling pathway [GO:0007166]; ear development [GO:0043583]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; myelination of posterior lateral line nerve axons [GO:0048932]; ossification [GO:0001503]; peripheral nervous system myelin formation [GO:0032290]; regulation of sprouting angiogenesis [GO:1903670]; Schwann cell differentiation [GO:0014037]; semicircular canal fusion [GO:0060879],NA,NA,NA
CHOYP_LOC100370410.1.1.m.24212,-0.00117318891328697,0.0119302689722903,No,NA,NA,Q96AT9,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; ribulose-phosphate 3-epimerase activity [GO:0004750]; carbohydrate metabolic process [GO:0005975]; cellular carbohydrate metabolic process [GO:0044262]; pentose catabolic process [GO:0019323]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt; non-oxidative branch [GO:0009052],NA,NA,NA
CHOYP_LOC100370453.1.1.m.48521,-0.0165837266398597,0.000412395170272779,No,NA,NA,Q0VFN8,NA,NA,NA,ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule binding [GO:0008017]; sperm axoneme assembly [GO:0007288],NA,NA,NA
CHOYP_LOC100370463.1.1.m.30276,-0.0226643852735943,0.0103395651289736,No,NA,NA,A6NJI9,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100370478.2.2.m.16291,0.0187622324718467,0.00833157700327279,No,NA,NA,P0DMQ6,NA,NA,NA,mitochondrial membrane [GO:0031966]; motile cilium [GO:0031514]; protein-containing complex [GO:0032991]; L-iditol 2-dehydrogenase activity [GO:0003939]; NAD binding [GO:0051287]; zinc ion binding [GO:0008270]; fructose biosynthetic process [GO:0046370]; fructose metabolic process [GO:0006000]; NADH oxidation [GO:0006116]; NADH regeneration [GO:0006735]; sorbitol biosynthetic process [GO:0006061]; sorbitol catabolic process [GO:0006062],NA,NA,NA
CHOYP_LOC100370504.1.2.m.17506,-0.0226512448780424,0.0101939833050322,No,NA,NA,Q95J53,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100370516.1.1.m.29182,0.00728443880281277,0.0041691588833797,No,NA,NA,B1H1E4,NA,NA,NA,cytoplasm [GO:0005737]; Lewy body [GO:0097413]; nuclear body [GO:0016604]; ubiquitin ligase complex [GO:0000151]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100370520.1.1.m.12258,0.00201665273472454,0.0133927142089483,No,NA,NA,Q8R059,NA,NA,NA,cytosol [GO:0005829]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; UDP-glucose 4-epimerase activity [GO:0003978]; UDP-N-acetylglucosamine 4-epimerase activity [GO:0003974]; galactose catabolic process [GO:0019388]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; glycolytic process from galactose [GO:0061623],NA,NA,NA
CHOYP_LOC100370537.1.1.m.10588,-0.0158200020070447,-0.00173348222528838,No,NA,NA,Q494V2,NA,NA,NA,axonemal outer doublet [GO:0097545]; motile cilium [GO:0031514]; dynein complex binding [GO:0070840]; cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; regulation of microtubule motor activity [GO:2000574],NA,NA,NA
CHOYP_LOC100370537.1.1.m.10589,0.00560081624294671,-0.0108745111850967,No,NA,NA,Q3SZ21,NA,NA,NA,nucleolar ribonuclease P complex [GO:0005655]; ribonuclease P activity [GO:0004526]; RNA binding [GO:0003723]; tRNA processing [GO:0008033],NA,NA,NA
CHOYP_LOC100370551.1.1.m.64375,-0.0215799027383951,-0.00341358048940716,No,NA,NA,Q568D2,NA,NA,NA,motile cilium [GO:0031514]; cilium assembly [GO:0060271],NA,NA,NA
CHOYP_LOC100370552.2.2.m.59438,0.00747163244468508,-0.00274420650163494,No,NA,NA,Q6AYD3,NA,NA,NA,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell differentiation [GO:0045597]; regulation of translation [GO:0006417]; ribosomal large subunit export from nucleus [GO:0000055]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_LOC100370583.1.1.m.56859,-0.0089283537215799,-0.00276504979574557,No,NA,NA,Q05655,NA,NA,NA,azurophil granule lumen [GO:0035578]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium-independent protein kinase C activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; insulin receptor substrate binding [GO:0043560]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cell cycle [GO:0007049]; cellular response to angiotensin [GO:1904385]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular senescence [GO:0090398]; defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; histone phosphorylation [GO:0016572]; immunoglobulin mediated immune response [GO:0016064]; interferon-gamma-mediated signaling pathway [GO:0060333]; interleukin-10 production [GO:0032613]; interleukin-12 production [GO:0032615]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein binding [GO:0032091]; neutrophil activation [GO:0042119]; neutrophil degranulation [GO:0043312]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; platelet activation [GO:0030168]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of phospholipid scramblase activity [GO:1900163]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of mRNA stability [GO:0043488]; regulation of signaling receptor activity [GO:0010469]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; termination of signal transduction [GO:0023021],NA,NA,NA
CHOYP_LOC100370588.15.19.m.60881,0.00957001648661521,0.0134019260773306,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100370600.1.1.m.29572,-0.0176786856151116,-0.0196395087490255,No,NA,NA,Q5ZID0,NA,NA,NA,nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],NA,NA,NA
CHOYP_LOC100370603.1.1.m.51092,0.0189664136439052,0.00306663601921595,No,NA,NA,P40237,NA,NA,NA,integral component of plasma membrane [GO:0005887]; cell surface receptor signaling pathway [GO:0007166],NA,NA,NA
CHOYP_LOC100370625.2.3.m.26929,-0.0129979122938594,0.00260942593862878,No,NA,NA,Q7Z2W4,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of RIG-I signaling pathway [GO:1900246]; response to virus [GO:0009615],NA,NA,NA
CHOYP_LOC100370637.1.2.m.12891,-0.000430240416062524,-0.0144860410669743,No,NA,NA,Q4R5S7,NA,NA,NA,cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; pi-body [GO:0071546]; piP-body [GO:0071547]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; helicase activity [GO:0004386]; nucleic acid binding [GO:0003676]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; multicellular organism development [GO:0007275]; negative regulation of transposition [GO:0010529]; piRNA biosynthetic process [GO:1990511]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100370662.1.3.m.5814,0.00284722623512848,-0.0080394218362548,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100370665.1.1.m.29815,0.00255991138036577,0.00627205651475595,No,NA,NA,F6P3G4,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle; lid subcomplex [GO:0008541]; structural molecule activity [GO:0005198]; proteasome assembly [GO:0043248]; stem cell differentiation [GO:0048863]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100370672.1.1.m.54509,-0.0148887941087244,0.00708752290056104,No,NA,NA,Q505F5,NA,NA,NA,phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_LOC100370673.1.1.m.13161,-0.0222052355813587,0.00320600192168396,No,NA,NA,Q9WV04,NA,NA,NA,cytosol [GO:0005829]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; podosome [GO:0002102]; vesicle [GO:0031982]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein dimerization activity [GO:0046983]; extracellular matrix disassembly [GO:0022617]; microtubule-based movement [GO:0007018]; organelle disassembly [GO:1903008]; regulation of podosome assembly [GO:0071801],NA,NA,NA
CHOYP_LOC100370684.1.2.m.61027,0.00217997094733793,-0.00807271368859912,No,NA,NA,Q6DCG4,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; ammonium transmembrane transporter activity [GO:0008519],NA,NA,NA
CHOYP_LOC100370705.1.2.m.30943,0.0113513109301252,0.00631551669803212,No,NA,NA,O15018,NA,NA,NA,cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; nucleus [GO:0005634]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_LOC100370705.2.2.m.55449,0.00367400633360406,-0.0143598403693191,No,NA,NA,O15018,NA,NA,NA,cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; nucleus [GO:0005634]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_LOC100370716.1.1.m.35654,-0.00363596168278956,-0.0144688665120807,No,NA,NA,Q9H0E3,NA,NA,NA,nuclear speck [GO:0016607]; Sin3-type complex [GO:0070822]; negative regulation of transcription by RNA polymerase II [GO:0000122],NA,NA,NA
CHOYP_LOC100370738.1.1.m.30463,-0.0218925666563102,-0.000254845941501544,No,NA,NA,P51910,NA,NA,NA,cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; aging [GO:0007568]; brain development [GO:0007420]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of lipoprotein lipid oxidation [GO:0060588]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of smooth muscle cell-matrix adhesion [GO:2000098]; negative regulation of T cell migration [GO:2000405]; peripheral nervous system axon regeneration [GO:0014012]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to reactive oxygen species [GO:0000302]; tissue regeneration [GO:0042246],NA,NA,NA
CHOYP_LOC100370747.1.1.m.28315,0.015983078592628,-0.00516628437618997,No,NA,NA,P19623,NA,NA,NA,cytosol [GO:0005829]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; spermidine synthase activity [GO:0004766]; cellular response to leukemia inhibitory factor [GO:1990830]; polyamine biosynthetic process [GO:0006596]; polyamine metabolic process [GO:0006595]; spermidine biosynthetic process [GO:0008295],NA,NA,NA
CHOYP_LOC100370750.2.2.m.52391,-0.0190034299222476,0.00194527506146034,No,NA,NA,Q9MBF8,NA,NA,NA,axoneme [GO:0005930]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cilium movement involved in cell motility [GO:0060294]; inner dynein arm assembly [GO:0036159],NA,NA,NA
CHOYP_LOC100370790.1.1.m.9845,0.00759258111567601,0.020603926969917,No,NA,NA,Q9Z336,NA,NA,NA,axonal growth cone [GO:0044295]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; host cell [GO:0043657]; lamellipodium [GO:0030027]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; secretory vesicle [GO:0099503]; spindle [GO:0005819]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; protein C-terminus binding [GO:0008022]; axon development [GO:0061564]; cell division [GO:0051301]; dendrite development [GO:0016358]; establishment of mitotic spindle orientation [GO:0000132]; intracellular protein transport [GO:0006886]; intracellular transport of viral protein in host cell [GO:0019060]; negative regulation of cell death [GO:0060548]; negative regulation of mitochondrial membrane permeability [GO:0035795]; negative regulation of neurogenesis [GO:0050768]; neuron projection morphogenesis [GO:0048812]; positive regulation of neuron projection development [GO:0010976]; positive regulation of Rac protein signal transduction [GO:0035022]; regulation of cytoskeleton organization [GO:0051493]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of GTPase activity [GO:0043087],NA,NA,NA
CHOYP_LOC100370821.2.2.m.45409,0.00033168242995991,0.00638404280567714,No,NA,NA,A5D6U8,NA,NA,NA,extracellular region [GO:0005576]; acid phosphatase activity [GO:0003993]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100370838.1.1.m.18679,-0.0158831247228485,-0.00982081781160533,No,NA,NA,Q8N9H8,NA,NA,NA,3'-5' exonuclease activity [GO:0008408]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676],NA,NA,NA
CHOYP_LOC100370844.1.2.m.30341,-0.0226248871847263,0.0104576796835953,No,NA,NA,A6NI56,NA,NA,NA,early endosome [GO:0005769],NA,NA,NA
CHOYP_LOC100370879.1.1.m.53699,0.0037107751118232,-0.0187987649610909,No,NA,NA,P49754,NA,NA,NA,AP-3 adaptor complex [GO:0030123]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; protein self-association [GO:0043621]; autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886]; late endosome to lysosome transport [GO:1902774]; regulated exocytosis [GO:0045055]; regulation of SNARE complex assembly [GO:0035542]; vacuole fusion; non-autophagic [GO:0042144],NA,NA,NA
CHOYP_LOC100370896.4.4.m.56380,-0.0182951507313708,0.0169785462454105,No,NA,NA,Q54QQ1,NA,NA,NA,endocytic vesicle membrane [GO:0030666]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; protein serine/threonine kinase activity [GO:0004674]; Ras GTPase binding [GO:0017016]; actin filament organization [GO:0007015]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; cell-substrate adhesion [GO:0031589]; cellular response to nutrient [GO:0031670]; chemotaxis [GO:0006935]; mitotic cytokinesis [GO:0000281]; phagocytosis [GO:0006909]; positive regulation of gene expression [GO:0010628]; positive regulation of STAT cascade [GO:1904894]; protein phosphorylation [GO:0006468]; regulation of filopodium assembly [GO:0051489]; regulation of sorocarp development [GO:0031156]; tyrosine phosphorylation of STAT protein [GO:0007260],NA,NA,NA
CHOYP_LOC100370897.5.5.m.39218,0.0199515871536264,0.0117249544264455,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100370900.1.1.m.20012,-0.0210445501076691,-0.00947339186887139,No,NA,NA,Q5W041,NA,NA,NA,extracellular exosome [GO:0070062],NA,NA,NA
CHOYP_LOC100370907.1.3.m.3187,0.0155552311890377,-0.0135922371641177,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100370907.3.3.m.36832,-0.00430894344577715,-0.00631540690244347,No,NA,NA,Q80VI1,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; interferon-beta production [GO:0032608]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral release from host cell [GO:1902187]; protein K63-linked ubiquitination [GO:0070534]; response to type I interferon [GO:0034340],NA,NA,NA
CHOYP_LOC100370909.1.1.m.30849,-0.0159801222618195,-0.0140421320527291,No,NA,NA,Q9JID1,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; BMP signaling pathway [GO:0030509]; cell aging [GO:0007569]; cellular response to lipopolysaccharide [GO:0071222]; epithelial to mesenchymal transition involved in cardiac fibroblast development [GO:0060940]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of myofibroblast differentiation [GO:1904761]; negative regulation of transcription; DNA-templated [GO:0045892]; negative regulation of vascular smooth muscle cell differentiation [GO:1905064]; negative regulation of vascular smooth muscle cell proliferation [GO:1904706]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of inflammatory response [GO:0050729]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; regulation of protein metabolic process [GO:0051246],NA,NA,NA
CHOYP_LOC100370910.1.1.m.13897,0.00951512734524666,0.00573911007965587,No,NA,NA,Q5R7X9,NA,NA,NA,chromosome [GO:0005694]; nucleoplasm [GO:0005654]; 3'-5' exonuclease activity [GO:0008408]; exodeoxyribonuclease III activity [GO:0008853]; cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; meiotic recombination checkpoint [GO:0051598],NA,NA,NA
CHOYP_LOC100370913.1.1.m.19909,-0.00157147314674624,0.00546761924309574,No,NA,NA,O15084,NA,NA,NA,cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; COPII vesicle coating [GO:0048208],NA,NA,NA
CHOYP_LOC100370941.1.1.m.59883,-0.00356032370204937,-0.00347145628342508,No,NA,NA,Q6ZNA5,NA,NA,NA,integral component of membrane [GO:0016021]; ferric-chelate reductase activity [GO:0000293]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100370957.1.1.m.22435,-0.0121057816904976,-0.000334702846750397,No,NA,NA,Q8N0Z6,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA repair [GO:0006281]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of signal transduction by p53 class mediator [GO:1901796],NA,NA,NA
CHOYP_LOC100370976.1.2.m.17764,-0.00891839913241181,0.0113204471921385,No,NA,NA,Q6IQY5,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802]; cilium assembly [GO:0060271]; regulation of microtubule cytoskeleton organization [GO:0070507],NA,NA,NA
CHOYP_LOC100370989.2.2.m.37995,0.00698943749744514,-0.0194185173049567,No,NA,NA,P62489,NA,NA,NA,nucleus [GO:0005634]; P-body [GO:0000932]; RNA polymerase II; core complex [GO:0005665]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; translation initiation factor binding [GO:0031369]; apoptotic process [GO:0006915]; nuclear-transcribed mRNA catabolic process; exonucleolytic [GO:0000291]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of translational initiation [GO:0045948]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367],NA,NA,NA
CHOYP_LOC100371005.1.2.m.2526,0.0176945533562071,-0.00637357611864186,No,NA,NA,P14618,NA,NA,NA,cilium [GO:0005929]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; pyruvate kinase complex [GO:1902912]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MHC class II protein complex binding [GO:0023026]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]; RNA binding [GO:0003723]; thyroid hormone binding [GO:0070324]; animal organ regeneration [GO:0031100]; canonical glycolysis [GO:0061621]; cellular response to insulin stimulus [GO:0032869]; glycolytic process [GO:0006096]; liver development [GO:0001889]; neutrophil degranulation [GO:0043312]; positive regulation of sprouting angiogenesis [GO:1903672]; programmed cell death [GO:0012501]; protein homotetramerization [GO:0051289]; response to gravity [GO:0009629]; response to hypoxia [GO:0001666]; response to muscle inactivity [GO:0014870]; response to nutrient [GO:0007584]; skeletal muscle tissue regeneration [GO:0043403],NA,NA,NA
CHOYP_LOC100371022.1.1.m.51315,-0.004848222024747,0.0197392790655506,No,NA,NA,Q8K2K6,NA,NA,NA,cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; DNA binding [GO:0003677]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; acrosome assembly [GO:0001675]; intermediate filament organization [GO:0045109]; multicellular organism development [GO:0007275]; spermatid nucleus differentiation [GO:0007289],NA,NA,NA
CHOYP_LOC100371039.1.1.m.18908,-0.00202972201748803,-0.0204786241200039,No,NA,NA,Q64261,NA,NA,NA,centrosome [GO:0005813]; cyclin D2-CDK6 complex [GO:0097132]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ruffle [GO:0001726]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; FBXO family protein binding [GO:0098770]; kinase activity [GO:0016301]; cell cycle [GO:0007049]; cell dedifferentiation [GO:0043697]; cell division [GO:0051301]; gliogenesis [GO:0042063]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hemopoiesis [GO:0030097]; negative regulation of cell cycle [GO:0045786]; negative regulation of cellular senescence [GO:2000773]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of monocyte differentiation [GO:0045656]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; protein phosphorylation [GO:0006468]; regulation of erythrocyte differentiation [GO:0045646]; regulation of gene expression [GO:0010468]; regulation of hematopoietic stem cell differentiation [GO:1902036]; T cell differentiation in thymus [GO:0033077]; type B pancreatic cell development [GO:0003323],NA,NA,NA
CHOYP_LOC100371043.3.5.m.24649,0.00678620130084429,0.00878741825264137,No,NA,NA,Q92113,NA,NA,NA,membrane [GO:0016020]; 17-alpha-hydroxyprogesterone aldolase activity [GO:0047442]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 17-alpha-monooxygenase activity [GO:0004508]; sex differentiation [GO:0007548]; steroid biosynthetic process [GO:0006694],NA,NA,NA
CHOYP_LOC100371058.3.3.m.36497,-0.0146963019010176,-0.0109167546523685,No,NA,NA,Q58DA1,NA,NA,NA,axoneme [GO:0005930]; cytoplasm [GO:0005737]; motile cilium [GO:0031514]; microtubule binding [GO:0008017]; cell migration [GO:0016477]; cilium-dependent cell motility [GO:0060285]; negative regulation of microtubule depolymerization [GO:0007026],NA,NA,NA
CHOYP_LOC100371059.1.1.m.25395,-0.0178993594794328,-0.0110666309233807,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100371074.1.1.m.36435,-0.011972517610497,-0.012942378717718,No,NA,NA,Q5R573,NA,NA,NA,GTP binding [GO:0005525]; GTPase activity [GO:0003924],NA,NA,NA
CHOYP_LOC100371085.1.1.m.44789,2.4227430611865e-05,-0.0134884430081613,No,NA,NA,P42674,NA,NA,NA,cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_LOC100371099.1.1.m.20282,-0.0117738462930054,-0.0118283928937523,No,NA,NA,Q5M7F8,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100371127.1.1.m.23427,0.00217997094733793,-0.00807271368859912,No,NA,NA,Q96S38,NA,NA,NA,early endosome [GO:0005769]; membrane [GO:0016020]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100371143.1.1.m.27046,-0.0169591047060434,0.00960206869202777,No,NA,NA,Q66IC8,NA,NA,NA,cilium assembly [GO:0060271],NA,NA,NA
CHOYP_LOC100371148.1.1.m.47147,-0.0165340071506788,-0.0139870028981821,No,NA,NA,Q8TDX7,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]; spindle assembly [GO:0051225],NA,NA,NA
CHOYP_LOC100371168.1.1.m.54022,-0.0154978067882751,-0.0185120081130259,No,NA,NA,H3BNL1,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100371176.1.1.m.33995,-0.00552178908051201,-0.023557098952061,No,NA,NA,Q58CP0,NA,NA,NA,mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_LOC100371209.1.1.m.49090,-0.0143334948681563,0.00216742443622009,No,NA,NA,A5PLI4,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC100371218.2.3.m.38221,0.00927706230178115,-0.0187042741894349,No,NA,NA,Q8TEW0,NA,NA,NA,adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; axonal growth cone [GO:0044295]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; internode region of axon [GO:0033269]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3;4;5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; protein phosphatase binding [GO:0019903]; asymmetric cell division [GO:0008356]; axonogenesis [GO:0007409]; bicellular tight junction assembly [GO:0070830]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; establishment of cell polarity [GO:0030010]; establishment of centrosome localization [GO:0051660]; establishment of epithelial cell polarity [GO:0090162]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; microtubule cytoskeleton organization [GO:0000226]; myelination in peripheral nervous system [GO:0022011]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; positive regulation of myelination [GO:0031643]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein localization [GO:0008104]; protein targeting to membrane [GO:0006612]; protein-containing complex assembly [GO:0065003]; regulation of cellular localization [GO:0060341]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_LOC100371228.1.4.m.6670,0.00678620130084429,0.00878741825264137,No,NA,NA,P14381,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100371232.1.1.m.25817,0.0016235988447314,-0.0161930382559541,No,NA,NA,Q6P8E9,NA,NA,NA,box C/D snoRNP complex [GO:0031428]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690]; RNA binding [GO:0003723]; U4atac snRNA binding [GO:0030622]; maturation of LSU-rRNA [GO:0000470]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_LOC100371236.1.1.m.62865,0.0110225546705742,-0.0134069039878761,No,NA,NA,P35623,NA,NA,NA,cytosol [GO:0005829]; glycine hydroxymethyltransferase activity [GO:0004372]; pyridoxal phosphate binding [GO:0030170]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine metabolic process [GO:0006563]; protein homotetramerization [GO:0051289]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653],NA,NA,NA
CHOYP_LOC100371248.1.2.m.10238,0.0164525219263935,0.00198863732123806,No,NA,NA,Q5RF32,NA,NA,NA,cytoplasm [GO:0005737]; betaine-homocysteine S-methyltransferase activity [GO:0047150]; zinc ion binding [GO:0008270]; methionine biosynthetic process [GO:0009086],NA,NA,NA
CHOYP_LOC100371248.2.2.m.48460,0.0183614289145769,-0.00389452026579227,No,NA,NA,Q9H2M3,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; betaine-homocysteine S-methyltransferase activity [GO:0047150]; S-methylmethionine-homocysteine S-methyltransferase activity [GO:0061627]; zinc ion binding [GO:0008270]; L-methionine salvage [GO:0071267]; S-adenosylmethionine metabolic process [GO:0046500]; S-methylmethionine metabolic process [GO:0033477]; sulfur amino acid metabolic process [GO:0000096],NA,NA,NA
CHOYP_LOC100371249.1.1.m.63117,0.0203468677157424,0.0146048275832564,No,NA,NA,Q8XBI9,NA,NA,NA,cytoplasm [GO:0005737]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601],NA,NA,NA
CHOYP_LOC100371249.1.1.m.63118,0.00394536801625317,0.00291369700370642,No,NA,NA,Q7JQD3,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; actin filament capping [GO:0051693]; actin filament fragmentation [GO:0030043]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_LOC100371254.1.1.m.1838,-0.0025668600565398,-0.0117100407441749,No,NA,NA,Q6PAM1,NA,NA,NA,cytoplasm [GO:0005737]; syntaxin binding [GO:0019905]; B cell activation [GO:0042113]; exocytosis [GO:0006887],NA,NA,NA
CHOYP_LOC100371275.1.1.m.46896,0.000812269741242866,-0.00298835173277385,No,NA,NA,Q93034,NA,NA,NA,Cul5-RING ubiquitin ligase complex [GO:0031466]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; calcium channel activity [GO:0005262]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle arrest [GO:0007050]; cell proliferation [GO:0008283]; ERBB2 signaling pathway [GO:0038128]; G1/S transition of mitotic cell cycle [GO:0000082]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of cell proliferation [GO:0008285]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100371304.1.1.m.47915,-0.00928462863024979,-0.0105172246646377,No,NA,NA,Q8TBZ9,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100371319.1.1.m.10776,0.0101780512487532,-0.0208868806683892,No,NA,NA,Q23445,NA,NA,NA,COPII vesicle coat [GO:0030127]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; Golgi apparatus [GO:0005794]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; embryo development ending in birth or egg hatching [GO:0009792]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; membrane organization [GO:0061024]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; regulation of COPII vesicle coating [GO:0003400]; vesicle organization [GO:0016050],NA,NA,NA
CHOYP_LOC100371319.1.1.m.10777,0.0106919238271371,0.00197391479581901,No,NA,NA,Q9CQV5,NA,NA,NA,mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543],NA,NA,NA
CHOYP_LOC100371339.1.1.m.4513,-0.01959692499756,-0.00678822492644859,No,NA,NA,P51910,NA,NA,NA,cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; aging [GO:0007568]; brain development [GO:0007420]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of lipoprotein lipid oxidation [GO:0060588]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of smooth muscle cell-matrix adhesion [GO:2000098]; negative regulation of T cell migration [GO:2000405]; peripheral nervous system axon regeneration [GO:0014012]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to reactive oxygen species [GO:0000302]; tissue regeneration [GO:0042246],NA,NA,NA
CHOYP_LOC100371354.1.1.m.47130,0.000913823253771402,0.0147719196185056,No,NA,NA,Q92576,NA,NA,NA,metal ion binding [GO:0046872]; multicellular organism development [GO:0007275]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_LOC100371361.1.1.m.9282,0.00710992393051662,-0.00180287633275514,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100371374.1.1.m.46502,-0.0135725579708753,0.00388604629968508,No,NA,NA,B0SJT4,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; UTP biosynthetic process [GO:0006228],NA,NA,NA
CHOYP_LOC100371390.1.1.m.8047,0.0181722113708275,0.00546329587733408,No,NA,NA,Q99700,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; trans-Golgi network [GO:0005802]; epidermal growth factor receptor binding [GO:0005154]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; cytoplasmic mRNA processing body assembly [GO:0033962]; negative regulation of receptor internalization [GO:0002091]; regulation of cytoplasmic mRNA processing body assembly [GO:0010603]; regulation of translation [GO:0006417]; RNA metabolic process [GO:0016070]; RNA transport [GO:0050658]; stress granule assembly [GO:0034063],NA,NA,NA
CHOYP_LOC100371429.1.1.m.13499,0.00394536801625317,0.00291369700370642,No,NA,NA,P09849,NA,NA,NA,apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; glycosylceramidase activity [GO:0017042]; lactase activity [GO:0000016]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_LOC100371430.1.1.m.61181,-0.00323845700939329,0.0116064282155854,No,NA,NA,Q01460,NA,NA,NA,lysosome [GO:0005764]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; hydrolase activity; acting on glycosyl bonds [GO:0016798]; chitin catabolic process [GO:0006032]; oligosaccharide catabolic process [GO:0009313],NA,NA,NA
CHOYP_LOC100371435.1.1.m.6503,-0.0169591047060434,0.00960206869202778,No,NA,NA,E5RJM6,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100371443.1.1.m.15017,-0.00800012590310244,0.00178198364128585,No,NA,NA,Q66I67,NA,NA,NA,axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; Golgi apparatus [GO:0005794]; intraciliary transport particle B [GO:0030992]; cell differentiation [GO:0030154]; centrosome localization [GO:0051642]; intraciliary transport [GO:0042073]; protein localization to cilium [GO:0061512]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100371457.1.1.m.12814,-0.00494085259327872,-0.0197123144357506,No,NA,NA,O75832,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA damage response; signal transduction by p53 class mediator [GO:0043518]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; post-translational protein modification [GO:0043687]; proteasome regulatory particle assembly [GO:0070682]; protein deubiquitination [GO:0016579],NA,NA,NA
CHOYP_LOC100371468.2.2.m.53875,-0.00214606866730765,-0.00135844678986107,No,NA,NA,Q15058,NA,NA,NA,cytosol [GO:0005829]; Flemming body [GO:0090543]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; tubulin binding [GO:0015631]; activation of protein kinase activity [GO:0032147]; cell division [GO:0051301]; cell proliferation in forebrain [GO:0021846]; cerebellar cortex development [GO:0021695]; cerebellar granular layer structural organization [GO:0021685]; cerebellar Purkinje cell layer structural organization [GO:0021693]; cerebral cortex development [GO:0021987]; establishment of protein localization [GO:0045184]; hippocampus development [GO:0021766]; microtubule-based movement [GO:0007018]; mitotic metaphase plate congression [GO:0007080]; negative regulation of apoptotic process [GO:0043066]; negative regulation of integrin activation [GO:0033624]; negative regulation of neuron apoptotic process [GO:0043524]; olfactory bulb development [GO:0021772]; positive regulation of cell proliferation [GO:0008284]; positive regulation of cytokinesis [GO:0032467]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell adhesion [GO:0030155]; regulation of cell growth [GO:0001558]; regulation of cell maturation [GO:1903429]; regulation of cell migration [GO:0030334]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of myelination [GO:0031641]; regulation of neuron apoptotic process [GO:0043523]; regulation of Rap protein signal transduction [GO:0032487]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; substrate adhesion-dependent cell spreading [GO:0034446],NA,NA,NA
CHOYP_LOC100371500.1.7.m.4423,-0.00482822154518757,0.00602705715969027,No,NA,NA,Q8R151,NA,NA,NA,chromosome; centromeric region [GO:0000775]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048],NA,NA,NA
CHOYP_LOC100371503.1.1.m.62767,0.0065883263884642,0.0180931628217626,No,NA,NA,Q91W67,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100371557.1.1.m.57537,0.0154319994839242,-0.00403779640117198,No,NA,NA,Q9VXK6,NA,NA,NA,cytosol [GO:0005829]; GTP binding [GO:0005525]; translation initiation factor activity [GO:0003743]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_LOC100371571.1.1.m.2417,-0.00786722784949283,-0.0050974294758366,No,NA,NA,Q3TLD5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; phosphatase inhibitor activity [GO:0019212]; phosphoprotein binding [GO:0051219]; protein phosphatase inhibitor activity [GO:0004864]; RNA polymerase II complex binding [GO:0000993]; transcription corepressor activity [GO:0003714]; cellular response to growth factor stimulus [GO:0071363]; cellular response to steroid hormone stimulus [GO:0071383]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cell growth [GO:0001558]; regulation of transcription by RNA polymerase II [GO:0006357]; response to virus [GO:0009615],NA,NA,NA
CHOYP_LOC100371575.1.1.m.10551,-0.0107520322978451,-0.013206746575965,No,NA,NA,P43307,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; cotranslational protein targeting to membrane [GO:0006613]; IRE1-mediated unfolded protein response [GO:0036498]; positive regulation of cell proliferation [GO:0008284],NA,NA,NA
CHOYP_LOC100371590.1.1.m.64405,-0.017623206757069,-0.017078143768138,No,NA,NA,Q2YDN4,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100371597.1.1.m.3330,0.00450128024255207,-0.00394542458546048,No,NA,NA,A7RX26,NA,NA,NA,cytoplasm [GO:0005737]; imidazolonepropionase activity [GO:0050480]; metal ion binding [GO:0046872]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557],NA,NA,NA
CHOYP_LOC100371628.1.1.m.35401,-0.0149977847717455,-0.00837939417429558,No,NA,NA,Q9CPW7,NA,NA,NA,nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_LOC100371637.1.1.m.7833,-0.00614014770041305,0.00181098203942375,No,NA,NA,Q9D024,NA,NA,NA,endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; rough endoplasmic reticulum [GO:0005791]; calcium ion binding [GO:0005509]; calcium ion homeostasis [GO:0055074]; endoplasmic reticulum organization [GO:0007029]; ER overload response [GO:0006983]; post-embryonic development [GO:0009791]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_LOC100371650.1.1.m.4398,-0.00290854757474869,0.00566645439921601,No,NA,NA,Q6IQ20,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane-bounded organelle [GO:0043227]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; photoreceptor outer segment membrane [GO:0042622]; identical protein binding [GO:0042802]; N-acetylphosphatidylethanolamine-hydrolysing phospholipas activity [GO:0102200]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; zinc ion binding [GO:0008270]; aging [GO:0007568]; host-mediated regulation of intestinal microbiota composition [GO:0048874]; N-acylethanolamine metabolic process [GO:0070291]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; negative regulation of eating behavior [GO:1903999]; phospholipid catabolic process [GO:0009395]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of inflammatory response [GO:0050729]; response to isolation stress [GO:0035900]; retinoid metabolic process [GO:0001523]; temperature homeostasis [GO:0001659],NA,NA,NA
CHOYP_LOC100371654.1.1.m.14188,-0.0225651347026281,0.00998938226780422,No,NA,NA,Q9R0M5,NA,NA,NA,ATP binding [GO:0005524]; kinase activity [GO:0016301]; thiamine binding [GO:0030975]; thiamine diphosphokinase activity [GO:0004788]; thiamine diphosphate biosynthetic process [GO:0009229]; thiamine metabolic process [GO:0006772],NA,NA,NA
CHOYP_LOC100371677.1.1.m.122,0.0127746811284133,0.000317201722877476,No,NA,NA,O46037,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; focal adhesion [GO:0005925]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; cytoskeletal anchoring at plasma membrane [GO:0007016],NA,NA,NA
CHOYP_LOC100371695.1.1.m.10063,0.0139779864455486,-0.012185026613163,No,NA,NA,Q9SF85,NA,NA,NA,apoplast [GO:0048046]; chloroplast [GO:0009507]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; adenosine kinase activity [GO:0004001]; ATP binding [GO:0005524]; copper ion binding [GO:0005507]; adenosine salvage [GO:0006169]; AMP salvage [GO:0044209]; response to cadmium ion [GO:0046686]; response to trehalose-6-phosphate [GO:0080094]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100371721.1.1.m.23143,-0.00324848456335101,-0.00173512544531478,No,NA,NA,Q16629,NA,NA,NA,cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; mRNA 3'-end processing [GO:0031124]; mRNA cis splicing; via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; mRNA splicing; via spliceosome [GO:0000398]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; RNA export from nucleus [GO:0006405]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100371750.2.2.m.64949,0.000280137724569128,-0.0199134443538774,No,NA,NA,P07942,NA,NA,NA,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-2 complex [GO:0005607]; laminin-8 complex [GO:0043257]; perinuclear region of cytoplasm [GO:0048471]; extracellular matrix structural constituent [GO:0005201]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; cellular protein metabolic process [GO:0044267]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; neuron projection development [GO:0031175]; neuronal-glial interaction involved in cerebral cortex radial glia guided migration [GO:0021812]; odontogenesis [GO:0042476]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell proliferation [GO:0050679]; post-translational protein modification [GO:0043687]; substrate adhesion-dependent cell spreading [GO:0034446],NA,NA,NA
CHOYP_LOC100371756.1.1.m.24048,-0.0145769445022671,-0.00600114980523628,No,NA,NA,Q26626,NA,NA,NA,kinesin II complex [GO:0016939]; kinesin binding [GO:0019894]; microtubule-based process [GO:0007017],NA,NA,NA
CHOYP_LOC100371761.1.1.m.57462,-0.00161137563640011,0.017690152455961,No,NA,NA,Q6P2W7,NA,NA,NA,late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; Ragulator complex [GO:0071986]; cellular protein localization [GO:0034613]; cellular response to amino acid stimulus [GO:0071230]; cholesterol homeostasis [GO:0042632]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; lysosome localization [GO:0032418]; lysosome organization [GO:0007040]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of TOR signaling [GO:0032008]; regulation of cell growth [GO:0001558]; regulation of cholesterol efflux [GO:0010874]; regulation of cholesterol esterification [GO:0010872]; regulation of cholesterol import [GO:0060620]; regulation of receptor recycling [GO:0001919],NA,NA,NA
CHOYP_LOC100371830.5.6.m.55811,-0.00212078832001384,-0.00891837260408135,No,NA,NA,O73853,NA,NA,NA,membrane [GO:0016020]; 17-alpha-hydroxyprogesterone aldolase activity [GO:0047442]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 17-alpha-monooxygenase activity [GO:0004508]; sex differentiation [GO:0007548]; steroid biosynthetic process [GO:0006694],NA,NA,NA
CHOYP_LOC100371831.1.1.m.11775,0.000310653699203299,0.019696262143607,No,NA,NA,O88327,NA,NA,NA,cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; cell adhesion [GO:0007155]; Rho protein signal transduction [GO:0007266],NA,NA,NA
CHOYP_LOC100371845.3.3.m.62472,0.000851539890196193,-0.00484685238427786,No,NA,NA,P57103,NA,NA,NA,cell junction [GO:0030054]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; intrinsic component of plasma membrane [GO:0031226]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; neuromuscular junction [GO:0031594]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; ion antiporter activity involved in regulation of postsynaptic membrane potential [GO:0099580]; metal ion binding [GO:0046872]; calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; hematopoietic progenitor cell differentiation [GO:0002244]; ion transport [GO:0006811]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; myelination [GO:0042552]; oligodendrocyte differentiation [GO:0048709]; regulation of cardiac conduction [GO:1903779]; regulation of skeletal muscle contraction [GO:0014819]; sodium ion transmembrane transport [GO:0035725]; telencephalon development [GO:0021537],NA,NA,NA
CHOYP_LOC100371875.1.1.m.29467,-0.0136315578329095,-0.00564431875037462,No,NA,NA,P85971,NA,NA,NA,cytoplasm [GO:0005737]; 6-phosphogluconolactonase activity [GO:0017057]; monosaccharide binding [GO:0048029]; carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt; oxidative branch [GO:0009051],NA,NA,NA
CHOYP_LOC100371881.1.2.m.3634,0.0213969851828086,-0.00911760788193646,No,NA,NA,E9PVX6,NA,NA,NA,chromosome; centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]; cell proliferation [GO:0008283]; cholangiocyte proliferation [GO:1990705]; hepatocyte proliferation [GO:0072574]; meiotic cell cycle [GO:0051321]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088],NA,NA,NA
CHOYP_LOC100371885.1.1.m.9427,0.00863972349264541,-0.00488452144018867,No,NA,NA,O61492,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; flotillin complex [GO:0016600]; plasma membrane [GO:0005886]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; melanotic encapsulation of foreign target [GO:0035011]; positive regulation of Wnt protein secretion [GO:0061357]; positive regulation of Wnt signaling pathway by establishment of Wnt protein localization to extracellular region [GO:0035593],NA,NA,NA
CHOYP_LOC100371909.1.1.m.30745,-0.0222805835410431,-0.000450771374361648,No,NA,NA,Q9D180,NA,NA,NA,cilium-dependent cell motility [GO:0060285],NA,NA,NA
CHOYP_LOC100371965.3.4.m.28742,-0.00656896382473893,-0.0083373518539907,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100371977.1.1.m.21628,0.00613723912187587,-0.0241337164252898,No,NA,NA,Q5U312,NA,NA,NA,cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100371983.1.3.m.2863,0.0171356489133326,-0.00338874999246982,No,NA,NA,P9WK87,NA,NA,NA,methyl indole-3-acetate esterase activity [GO:0080030]; short-chain carboxylesterase activity [GO:0034338]; catabolic process [GO:0009056],NA,NA,NA
CHOYP_LOC100371983.2.3.m.48879,0.0090695982000162,0.00803844336659845,No,NA,NA,P9WK87,NA,NA,NA,methyl indole-3-acetate esterase activity [GO:0080030]; short-chain carboxylesterase activity [GO:0034338]; catabolic process [GO:0009056],NA,NA,NA
CHOYP_LOC100371994.1.1.m.50098,0.00943998869891844,-0.0225818511528159,No,NA,NA,Q29RI9,NA,NA,NA,methionine adenosyltransferase complex [GO:0048269]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; methionine adenosyltransferase regulator activity [GO:0048270]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556],NA,NA,NA
CHOYP_LOC100372012.1.1.m.36569,-0.00830375804122484,-0.00420017249474898,No,NA,NA,O14513,NA,NA,NA,microtubule plus-end [GO:0035371]; microtubule bundle formation [GO:0001578]; microtubule depolymerization [GO:0007019],NA,NA,NA
CHOYP_LOC100372020.1.1.m.59998,0.00491588973115351,-0.000600714720400962,No,NA,NA,Q8BVV7,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; spindle pole [GO:0000922],NA,NA,NA
CHOYP_LOC100372028.1.1.m.22341,-0.0123682174475134,0.00797093407546105,No,NA,NA,Q62717,NA,NA,NA,cell junction [GO:0030054]; dense core granule [GO:0031045]; extrinsic component of neuronal dense core vesicle membrane [GO:0098674]; glutamatergic synapse [GO:0098978]; presynapse [GO:0098793]; calcium ion binding [GO:0005509]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; dense core granule exocytosis [GO:1990504]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; regulated exocytosis [GO:0045055]; synaptic vesicle exocytosis [GO:0016079],NA,NA,NA
CHOYP_LOC100372071.1.1.m.14107,0.00933146708202064,0.0210181932340441,No,NA,NA,O14662,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; SNARE complex [GO:0031201]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; Golgi ribbon formation [GO:0090161]; intracellular protein transport [GO:0006886]; retrograde transport; endosome to Golgi [GO:0042147]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906],NA,NA,NA
CHOYP_LOC100372110.1.1.m.11437,0.00435143612376584,0.0111531431002692,No,NA,NA,O00400,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; acetyl-CoA transmembrane transporter activity [GO:0008521]; solute:proton symporter activity [GO:0015295]; BMP signaling pathway [GO:0030509]; SMAD protein signal transduction [GO:0060395]; transmembrane transport [GO:0055085],NA,NA,NA
CHOYP_LOC100372131.1.2.m.36461,0.0152281100098538,0.00666397135264996,No,NA,NA,Q14117,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; amino acid binding [GO:0016597]; dihydropyrimidinase activity [GO:0004157]; phosphoprotein binding [GO:0051219]; thymine binding [GO:0002059]; uracil binding [GO:0002058]; zinc ion binding [GO:0008270]; beta-alanine metabolic process [GO:0019482]; protein homotetramerization [GO:0051289]; pyrimidine nucleobase catabolic process [GO:0006208]; pyrimidine nucleoside catabolic process [GO:0046135]; thymine catabolic process [GO:0006210]; uracil catabolic process [GO:0006212],NA,NA,NA
CHOYP_LOC100372150.1.1.m.7059,0.00849250533431706,0.01292861934997,No,NA,NA,P28289,NA,NA,NA,actin filament [GO:0005884]; cortical cytoskeleton [GO:0030863]; cytosol [GO:0005829]; membrane [GO:0016020]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; tropomyosin binding [GO:0005523]; adult locomotory behavior [GO:0008344]; lens fiber cell development [GO:0070307]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; myofibril assembly [GO:0030239]; pointed-end actin filament capping [GO:0051694],NA,NA,NA
CHOYP_LOC100372183.1.1.m.31741,-0.00801743425133251,0.0105868716697466,No,NA,NA,Q6ZSB9,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; cell cycle arrest [GO:0007050]; negative regulation of cell proliferation [GO:0008285]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_LOC100372197.3.3.m.56377,-0.00333527893579915,0.00779528002908051,No,NA,NA,O35161,NA,NA,NA,integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; protein dimerization activity [GO:0046983]; transmembrane signaling receptor activity [GO:0004888]; anterior/posterior pattern specification [GO:0009952]; apical protein localization [GO:0045176]; cell-cell signaling [GO:0007267]; central nervous system development [GO:0007417]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity of embryonic epithelium [GO:0042249]; G protein-coupled receptor signaling pathway [GO:0007186]; gastrulation with mouth forming second [GO:0001702]; hair follicle development [GO:0001942]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear morphogenesis [GO:0042472]; lateral sprouting involved in lung morphogenesis [GO:0060490]; locomotory behavior [GO:0007626]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; protein localization involved in establishment of planar polarity [GO:0090251]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of neurotransmitter secretion [GO:0046928]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165]; wound healing [GO:0042060],NA,NA,NA
CHOYP_LOC100372208.1.1.m.18397,-0.00497950982236055,0.0130730741322125,No,NA,NA,Q9N5Y2,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; oxidoreductase activity [GO:0016491]; very-long-chain enoyl-CoA reductase activity [GO:0102758]; very long-chain fatty acid biosynthetic process [GO:0042761],NA,NA,NA
CHOYP_LOC100372219.1.1.m.11590,-0.0154696952352779,-0.0117710915133678,No,NA,NA,Q92125,NA,NA,NA,calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544],NA,NA,NA
CHOYP_LOC100372221.2.2.m.48004,0.00851181942803007,0.00145551259343411,No,NA,NA,Q8VCC1,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; protein homodimerization activity [GO:0042803]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_LOC100372236.1.4.m.16991,0.00217997094733793,-0.00807271368859912,No,NA,NA,Q6ITT3,NA,NA,NA,Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-1;3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0008454]; metal ion binding [GO:0046872]; protein glycosylation [GO:0006486],NA,NA,NA
CHOYP_LOC100372239.1.1.m.50390,-0.0203857598966815,0.00339664568862551,No,NA,NA,Q0VFZ6,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100372241.1.1.m.9935,-0.00846252838937592,0.0124831759131291,No,NA,NA,Q9Z265,NA,NA,NA,chromosome; telomeric region [GO:0000781]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; cell division [GO:0051301]; cellular protein catabolic process [GO:0044257]; cellular response to bisphenol A [GO:1903926]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; DNA damage checkpoint [GO:0000077]; DNA damage induced protein phosphorylation [GO:0006975]; DNA damage response; signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; double-strand break repair [GO:0006302]; G2/M transition of mitotic cell cycle [GO:0000086]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mitotic DNA damage checkpoint [GO:0044773]; mitotic spindle assembly [GO:0090307]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of DNA damage checkpoint [GO:2000002]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of anoikis [GO:2000210]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription; DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of protein catabolic process [GO:0042176]; regulation of transcription; DNA-templated [GO:0006355]; replicative cell aging [GO:0001302]; response to gamma radiation [GO:0010332]; response to glycoside [GO:1903416]; signal transduction in response to DNA damage [GO:0042770]; signal transduction involved in intra-S DNA damage checkpoint [GO:0072428],NA,NA,NA
CHOYP_LOC100372245.1.1.m.60270,-0.00837544645649782,-0.000363607354833529,No,NA,NA,Q9NUJ3,NA,NA,NA,microtubule [GO:0005874],NA,NA,NA
CHOYP_LOC100372287.1.1.m.10381,-0.0138613563335728,-0.00641161478366408,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100372290.2.2.m.40459,0.00950795275258709,0.00725693922201644,No,NA,NA,Q5E960,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; zinc ion transmembrane transporter activity [GO:0005385]; cell morphogenesis [GO:0000902]; embryonic cranial skeleton morphogenesis [GO:0048701]; in utero embryonic development [GO:0001701]; limb development [GO:0060173]; T cell homeostasis [GO:0043029]; zinc ion transmembrane transport [GO:0071577],NA,NA,NA
CHOYP_LOC100372298.1.1.m.19547,0.0105855020743232,-0.00267612249595006,No,NA,NA,Q8VDC1,NA,NA,NA,autophagosome [GO:0005776]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; metal ion binding [GO:0046872]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of autophagosome maturation [GO:1901098],NA,NA,NA
CHOYP_LOC100372311.1.1.m.6654,0.00394536801625317,0.00291369700370642,No,NA,NA,Q6ZUK4,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_LOC100372339.1.2.m.5168,0.00484028696059016,0.0190180201556524,No,NA,NA,Q5ZMH1,NA,NA,NA,ciliary membrane [GO:0060170]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; septin complex [GO:0031105]; septin ring [GO:0005940]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein-containing complex scaffold activity [GO:0032947]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; smoothened signaling pathway [GO:0007224],NA,NA,NA
CHOYP_LOC100372340.1.3.m.9116,-0.00530357540821434,-0.00593680164753334,No,NA,NA,Q921X9,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454],NA,NA,NA
CHOYP_LOC100372340.3.3.m.59986,0.010721262141858,-0.00117186882316425,No,NA,NA,Q921X9,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454],NA,NA,NA
CHOYP_LOC100372341.1.1.m.46956,-0.0101668007339995,-0.00845119775495013,No,NA,NA,Q0V9R3,NA,NA,NA,cytoplasm [GO:0005737]; exosome (RNase complex) [GO:0000178]; P-body [GO:0000932]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cell cycle [GO:0007049]; cell division [GO:0051301]; miRNA catabolic process [GO:0010587]; nuclear-transcribed mRNA catabolic process; exonucleolytic [GO:0000291]; nuclear-transcribed mRNA catabolic process; exonucleolytic; 3'-5' [GO:0034427]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; RNA catabolic process [GO:0006401]; rRNA processing [GO:0006364]; stem cell population maintenance [GO:0019827],NA,NA,NA
CHOYP_LOC100372342.1.1.m.63404,-0.00646603829867455,-0.020031671959081,No,NA,NA,P40423,NA,NA,NA,adherens junction [GO:0005912]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; apicomedial cortex [GO:0106037]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; female germline ring canal inner rim [GO:0035183]; midbody [GO:0030496]; myosin II complex [GO:0016460]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233]; calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036]; actin filament-based movement [GO:0030048]; apical constriction involved in gastrulation [GO:0003384]; border follicle cell migration [GO:0007298]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; compartment boundary maintenance [GO:0060289]; cytoskeleton-dependent cytoplasmic transport; nurse cell to oocyte [GO:0019749]; establishment of planar polarity [GO:0001736]; formation of a compartment boundary [GO:0060288]; imaginal disc-derived wing hair organization [GO:0035317]; mitotic cytokinesis [GO:0000281]; myosin II filament assembly [GO:0031036]; nuclear axial expansion [GO:0035191]; ovarian follicle cell development [GO:0030707]; ovarian nurse cell to oocyte transport [GO:0007300]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of tube length; open tracheal system [GO:0035159]; spiracle morphogenesis; open tracheal system [GO:0035277]; tube formation [GO:0035148]; wound healing [GO:0042060],NA,NA,NA
CHOYP_LOC100372388.1.1.m.26623,-0.0156994033149282,-0.0056498332611103,No,NA,NA,Q3UVV9,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100372392.4.8.m.31087,-0.0226479947097112,0.010410346716926,No,NA,NA,A0JPI9,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100372392.6.8.m.56267,-0.0173787545626165,-0.00232427787485936,No,NA,NA,A0JPI9,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100372393.1.1.m.12043,-0.00564587804615119,0.0113847849068565,No,NA,NA,P49116,NA,NA,NA,nucleoplasm [GO:0005654]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription; DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]; transcription initiation from RNA polymerase II promoter [GO:0006367],NA,NA,NA
CHOYP_LOC100372454.1.1.m.56045,0.0222038504571674,-0.00923895860009999,No,NA,NA,Q7ZYC4,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467],NA,NA,NA
CHOYP_LOC100372467.1.1.m.42336,-0.00450141807766191,0.0153760080955795,No,NA,NA,Q8WXA3,NA,NA,NA,cytoplasm [GO:0005737]; endosome [GO:0005768]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; SH3 domain binding [GO:0017124]; regulation of endocytosis [GO:0030100],NA,NA,NA
CHOYP_LOC100372473.1.5.m.7845,-0.0151796043010691,0.00854201921928279,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100372473.2.5.m.35440,-0.008015492254178,-0.00998162198936121,No,NA,NA,Q5UQ35,NA,NA,NA,metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842],NA,NA,NA
CHOYP_LOC100372473.3.5.m.39839,-0.0169383408013307,-0.0142194137778837,No,NA,NA,Q6B9X6,NA,NA,NA,contractile vacuolar membrane [GO:0031164]; contractile vacuole [GO:0000331]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; contractile vacuole discharge [GO:0070177]; contractile vacuole organization [GO:0033298]; hypotonic response [GO:0006971]; mitotic cytokinesis [GO:0000281]; myosin II filament organization [GO:0031038]; peptidyl-serine modification [GO:0018209]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]; regulation of sorocarp development [GO:0031156]; sorocarp morphogenesis [GO:0031288],NA,NA,NA
CHOYP_LOC100372473.4.5.m.48798,-0.0169591047060434,0.00960206869202778,No,NA,NA,Q5UQ35,NA,NA,NA,metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842],NA,NA,NA
CHOYP_LOC100372481.1.1.m.21010,-5.41743797570003e-05,-0.0126652624439055,No,NA,NA,P23727,NA,NA,NA,cell-cell junction [GO:0005911]; cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum membrane [GO:1990578]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex; class IA [GO:0005943]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; ErbB-3 class receptor binding [GO:0043125]; identical protein binding [GO:0042802]; insulin binding [GO:0043559]; insulin receptor binding [GO:0005158]; insulin receptor substrate binding [GO:0043560]; insulin-like growth factor receptor binding [GO:0005159]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphotyrosine residue binding [GO:0001784]; protein heterodimerization activity [GO:0046982]; protein phosphatase binding [GO:0019903]; transcription factor binding [GO:0008134]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; B cell differentiation [GO:0030183]; cellular glucose homeostasis [GO:0001678]; cellular response to insulin stimulus [GO:0032869]; cellular response to UV [GO:0034644]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; growth hormone receptor signaling pathway [GO:0060396]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of osteoclast differentiation [GO:0045671]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphorylation [GO:0046854]; positive regulation of cell migration [GO:0030335]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of glucose import [GO:0046326]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; regulation of stress fiber assembly [GO:0051492]; response to endoplasmic reticulum stress [GO:0034976],NA,NA,NA
CHOYP_LOC100372481.1.1.m.21011,0.00429739090292804,0.0194731145937379,No,NA,NA,Q5RC32,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; microtubule [GO:0005874]; nucleus [GO:0005634]; microtubule binding [GO:0008017]; negative regulation of centriole replication [GO:0046600],NA,NA,NA
CHOYP_LOC100372482.1.1.m.61581,0.00702084242471147,0.00549202263470953,No,NA,NA,Q63HQ0,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; transport vesicle [GO:0030133]; AP-1 adaptor complex binding [GO:0035650]; kinesin binding [GO:0019894]; cellular protein localization [GO:0034613]; negative regulation of cell motility [GO:2000146]; negative regulation of receptor recycling [GO:0001920]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; protein transport [GO:0015031]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; vesicle targeting; trans-Golgi to endosome [GO:0048203],NA,NA,NA
CHOYP_LOC100372487.1.1.m.39712,0.00649529234202988,0.00751685550564314,No,NA,NA,B3EWZ6,NA,NA,NA,extracellular region [GO:0005576]; membrane [GO:0016020],NA,NA,NA
CHOYP_LOC100372505.1.2.m.10260,-0.00712936515209649,-0.0209550443570132,No,NA,NA,Q5FWT1,NA,NA,NA,tRNA-splicing ligase complex [GO:0072669]; protein methyltransferase activity [GO:0008276]; lysosome localization [GO:0032418]; positive regulation of cell proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of ruffle assembly [GO:1900029]; protein methylation [GO:0006479],NA,NA,NA
CHOYP_LOC100372505.1.2.m.10261,-0.011158776982265,-0.0242846704832523,No,NA,NA,Q5RE15,NA,NA,NA,proteasome accessory complex [GO:0022624]; proteasome regulatory particle [GO:0005838]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC100372560.1.1.m.25500,0.00985277398236729,0.0192361129535591,No,NA,NA,P38942,NA,NA,NA,transferase activity [GO:0016740]; acetyl-CoA metabolic process [GO:0006084],NA,NA,NA
CHOYP_LOC100372582.1.2.m.8558,-0.0108195193962848,-0.00126054451427054,No,NA,NA,Q6IQ97,NA,NA,NA,nuclear speck [GO:0016607]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; mRNA cis splicing; via spliceosome [GO:0045292]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],NA,NA,NA
CHOYP_LOC100372601.1.1.m.13567,0.00557221700298119,-0.00126431516686997,No,NA,NA,D2H8V8,NA,NA,NA,centrosome [GO:0005813]; chromosome; telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; 5'-3' exonuclease activity [GO:0008409]; DNA repair [GO:0006281]; mitotic cell cycle checkpoint [GO:0007093]; protection from non-homologous end joining at telomere [GO:0031848]; telomere maintenance [GO:0000723]; telomeric 3' overhang formation [GO:0031860]; telomeric loop formation [GO:0031627],NA,NA,NA
CHOYP_LOC100372607.1.1.m.49009,-0.0185642879381898,-0.00606032089269224,No,NA,NA,Q32KV4,NA,NA,NA,apical part of cell [GO:0045177]; axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; intraciliary transport particle [GO:0030990]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein heavy chain binding [GO:0045504]; determination of left/right symmetry [GO:0007368]; intraciliary retrograde transport [GO:0035721]; intraciliary transport involved in cilium assembly [GO:0035735]; regulation of cilium assembly [GO:1902017],NA,NA,NA
CHOYP_LOC100372616.2.3.m.5692,0.00987676330236649,0.0198900600013704,No,NA,NA,Q16820,NA,NA,NA,extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; meprin A complex [GO:0017090]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; inflammatory response [GO:0006954]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_LOC100372626.1.2.m.8346,0.0118066348658467,0.011044157010081,No,NA,NA,Q5T9S5,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100372693.1.1.m.16279,0.00301856433677636,-0.00496993883865461,No,NA,NA,P13804,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539],NA,NA,NA
CHOYP_LOC100372698.1.1.m.18674,-0.00212078832001384,-0.00891837260408135,No,NA,NA,Q8BTK5,NA,NA,NA,metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168],NA,NA,NA
CHOYP_LOC100372703.1.1.m.29633,-0.0187711088182413,0.00451209810805242,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100372716.5.10.m.31370,0.00320380745078904,0.0150520453508971,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100372803.1.2.m.18615,-0.0083397388832819,-0.0105470644283164,No,NA,NA,Q5RDU7,NA,NA,NA,cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; cell proliferation [GO:0008283],NA,NA,NA
CHOYP_LOC100372845.1.3.m.7734,-0.0200454830772972,0.00499733809159016,No,NA,NA,Q497Q6,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100372867.1.1.m.18083,0.00197218709414068,-0.00659112111392443,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100372879.1.3.m.18886,0.011670356675493,-0.0116240006385969,No,NA,NA,P18142,NA,NA,NA,cell cortex [GO:0005938]; esterosome membrane [GO:0033118]; carboxylic ester hydrolase activity [GO:0052689],NA,NA,NA
CHOYP_LOC100372881.1.1.m.4636,-0.00777033196230601,-0.0122196539415331,No,NA,NA,Q29RK9,NA,NA,NA,metal ion binding [GO:0046872]; regulation of hippo signaling [GO:0035330],NA,NA,NA
CHOYP_LOC100372889.2.2.m.57965,0.0080330570710589,-0.0113225563480491,No,NA,NA,Q7ZU45,NA,NA,NA,cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cilium assembly [GO:0060271]; determination of heart left/right asymmetry [GO:0061371]; otolith morphogenesis [GO:0032474],NA,NA,NA
CHOYP_LOC100372921.2.2.m.56247,-0.0225515578848534,0.00996575146853484,No,NA,NA,Q69ZM6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; transcription factor binding [GO:0008134]; brain development [GO:0007420]; cilium assembly [GO:0060271]; epithelial cilium movement [GO:0003351]; positive regulation of hh target transcription factor activity [GO:0007228]; positive regulation of smoothened signaling pathway [GO:0045880]; post-embryonic development [GO:0009791]; regulation of DNA-binding transcription factor activity [GO:0051090],NA,NA,NA
CHOYP_LOC100372922.1.1.m.12888,-0.00212078832001384,-0.00891837260408135,No,NA,NA,P54254,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear inclusion body [GO:0042405]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; protein C-terminus binding [GO:0008022]; protein self-association [GO:0043621]; RNA binding [GO:0003723]; adult locomotory behavior [GO:0008344]; brain development [GO:0007420]; excitatory postsynaptic potential [GO:0060079]; learning [GO:0007612]; lung alveolus development [GO:0048286]; memory [GO:0007613]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of phosphorylation [GO:0042326]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; nuclear export [GO:0051168]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of transcription by RNA polymerase II [GO:0045944]; social behavior [GO:0035176]; visual learning [GO:0008542],NA,NA,NA
CHOYP_LOC100372926.1.3.m.29881,0.00865430491888447,0.0119289301783137,No,NA,NA,Q3T0K2,NA,NA,NA,cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; pore complex assembly [GO:0046931]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_LOC100372926.2.3.m.61794,0.000967727433360779,-0.0122516091863469,No,NA,NA,Q3T0K2,NA,NA,NA,cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; pore complex assembly [GO:0046931]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_LOC100372942.1.1.m.31119,-0.007686514005096,-0.00319455252062922,No,NA,NA,Q28XE2,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; nucleocytoplasmic transport [GO:0006913],NA,NA,NA
CHOYP_LOC100372945.2.2.m.47110,0.0080650591268015,0.00405248641351555,No,NA,NA,Q810B6,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]; macropinosome [GO:0044354]; membrane [GO:0016020]; retromer complex [GO:0030904]; metal ion binding [GO:0046872]; phosphatidylinositol phosphate binding [GO:1901981]; Rab GTPase binding [GO:0017137]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; Golgi to lysosome transport [GO:0090160]; positive regulation of pinocytosis [GO:0048549]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_LOC100372955.1.1.m.18209,-0.012160244531927,-0.0182410874853704,No,NA,NA,Q14181,NA,NA,NA,alpha DNA polymerase:primase complex [GO:0005658]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; protein heterodimerization activity [GO:0046982]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; telomere maintenance via semi-conservative replication [GO:0032201],NA,NA,NA
CHOYP_LOC100372966.1.1.m.18755,0.00394536801625317,0.00291369700370642,No,NA,NA,Q08DB5,NA,NA,NA,cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; SNARE complex [GO:0031201]; vesicle [GO:0031982]; protein N-terminus binding [GO:0047485]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; early endosome to Golgi transport [GO:0034498]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi disassembly [GO:0090166]; intracellular protein transport [GO:0006886]; positive regulation of protein catabolic process [GO:0045732]; regulation of Golgi organization [GO:1903358]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906],NA,NA,NA
CHOYP_LOC100372967.1.1.m.16378,-0.00396807626891118,-0.00294923193257595,No,NA,NA,Q58EM4,NA,NA,NA,protein carboxyl O-methyltransferase activity [GO:0051998]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; methylation [GO:0032259]; regulation of response to DNA damage stimulus [GO:2001020],NA,NA,NA
CHOYP_LOC100372990.1.1.m.15018,-0.0149150433072245,-0.0144816784587048,No,NA,NA,Q62186,NA,NA,NA,integral component of membrane [GO:0016021]; Sec61 translocon complex [GO:0005784],NA,NA,NA
CHOYP_LOC100373045.1.1.m.16825,-0.0145376962759665,0.00787523399059865,No,NA,NA,P18288,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017],NA,NA,NA
CHOYP_LOC100373083.1.2.m.19986,-0.00212078832001384,-0.00891837260408134,No,NA,NA,Q99758,NA,NA,NA,alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; lipid transporter activity [GO:0005319]; transporter activity [GO:0005215]; cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085],NA,NA,NA
CHOYP_LOC100373083.1.2.m.19987,0.0152648413747147,-0.00412755025040744,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100373083.2.2.m.26841,0.000686232728993107,-0.0107331332691118,No,NA,NA,Q99758,NA,NA,NA,alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; lipid transporter activity [GO:0005319]; transporter activity [GO:0005215]; cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085],NA,NA,NA
CHOYP_LOC100373090.1.1.m.52283,0.0158258276876208,0.00556133269592038,No,NA,NA,Q1LWJ6,NA,NA,NA,lamellipodium [GO:0030027]; directional locomotion [GO:0033058]; negative regulation of actin nucleation [GO:0051126]; negative regulation of cell migration [GO:0030336],NA,NA,NA
CHOYP_LOC100373100.3.4.m.51137,-0.00887559176081835,-0.00605298087160019,No,NA,NA,Q9P2E3,NA,NA,NA,chromosome; centromeric region [GO:0000775]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048],NA,NA,NA
CHOYP_LOC100373100.4.4.m.65650,-0.00937828372243669,-0.00519781577176892,No,NA,NA,Q9P2E3,NA,NA,NA,chromosome; centromeric region [GO:0000775]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048],NA,NA,NA
CHOYP_LOC100373136.1.1.m.6977,-0.00859434708348054,-0.00692497620470768,No,NA,NA,Q5XJS5,NA,NA,NA,nuclear speck [GO:0016607]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; multicellular organism development [GO:0007275]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100373138.1.1.m.23491,-0.00904047592445405,-0.0020454354779431,No,NA,NA,O75886,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; ESCRT-0 complex [GO:0033565]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; macroautophagy [GO:0016236]; membrane organization [GO:0061024]; multivesicular body assembly [GO:0036258]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059],NA,NA,NA
CHOYP_LOC100373141.1.1.m.11194,-0.0083177049522116,-0.0221589666962916,No,NA,NA,Q99K28,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; COPI coating of Golgi vesicle [GO:0048205]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_LOC100373146.1.2.m.13310,-0.00522728904866278,0.00989438823874333,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100373146.2.2.m.27802,-0.0165113606565442,0.00749822759406164,No,NA,NA,Q6ZUG5,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100373169.1.1.m.15573,-0.0181698707247114,0.00279567375248606,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100373170.1.1.m.10994,0.00980425921014579,-0.0155797923386228,No,NA,NA,O57590,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_LOC100373178.1.1.m.61012,0.00205195042830453,-0.00934116934689426,No,NA,NA,A7E3W5,NA,NA,NA,cell junction [GO:0030054]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; synaptic vesicle membrane [GO:0030672]; regulated exocytosis [GO:0045055]; synaptic vesicle membrane organization [GO:0048499],NA,NA,NA
CHOYP_LOC100373186.1.1.m.58981,-0.0100838072712277,-0.00687205522967758,No,NA,NA,Q6AXK4,NA,NA,NA,BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromatin organization [GO:0006325]; double-strand break repair [GO:0006302]; positive regulation of DNA repair [GO:0045739]; protein K63-linked deubiquitination [GO:0070536]; response to ionizing radiation [GO:0010212]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425],NA,NA,NA
CHOYP_LOC100373240.1.1.m.28382,-0.0225227313510363,0.01055951172124,No,NA,NA,Q9I931,NA,NA,NA,extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; fucose binding [GO:0042806]; regulation of cellular defense response [GO:0010185]; regulation of complement activation; lectin pathway [GO:0001868]; regulation of innate immune response [GO:0045088],NA,NA,NA
CHOYP_LOC100373287.1.1.m.36226,-0.0104527047399751,0.0148361255017075,No,NA,NA,Q96DI7,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; small nucleolar ribonucleoprotein complex [GO:0005732]; U2-type catalytic step 2 spliceosome [GO:0071007]; U5 snRNP [GO:0005682]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; RNA splicing; via transesterification reactions [GO:0000375],NA,NA,NA
CHOYP_LOC100373289.1.2.m.7904,-1.14245314337339e-05,-0.00170052366411261,No,NA,NA,Q9CPT5,NA,NA,NA,intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribosomal large subunit biogenesis [GO:0042273],NA,NA,NA
CHOYP_LOC100373317.1.1.m.16740,-0.00721937736667234,-0.00315235233411206,No,NA,NA,Q5HZP1,NA,NA,NA,nucleus [GO:0005634]; ribonuclease H2 complex [GO:0032299]; RNA catabolic process [GO:0006401],NA,NA,NA
CHOYP_LOC100373327.1.13.m.13252,-0.0135725579708752,0.00388604629968508,No,NA,NA,E9PYK3,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; cell death [GO:0008219]; cellular protein modification process [GO:0006464]; inflammatory response [GO:0006954]; protein ADP-ribosylation [GO:0006471]; regulation of telomerase activity [GO:0051972],NA,NA,NA
CHOYP_LOC100373327.2.13.m.16978,0.00758901369887868,-0.000548924195838459,No,NA,NA,E9PYK3,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; cell death [GO:0008219]; cellular protein modification process [GO:0006464]; inflammatory response [GO:0006954]; protein ADP-ribosylation [GO:0006471]; regulation of telomerase activity [GO:0051972],NA,NA,NA
CHOYP_LOC100373339.1.1.m.5653,0.0042932528507307,0.0079743712281732,No,NA,NA,Q5RKJ1,NA,NA,NA,actomyosin contractile ring [GO:0005826]; cytoplasm [GO:0005737]; GID complex [GO:0034657]; integral component of plasma membrane [GO:0005887]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; ubiquitin ligase complex [GO:0000151]; actin binding [GO:0003779]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cytoskeleton organization [GO:0007010]; enucleate erythrocyte development [GO:0048822]; erythrocyte maturation [GO:0043249]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of myeloid cell apoptotic process [GO:0033033]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100373351.1.3.m.49572,-0.0187433098749562,-0.0108680565037116,No,NA,NA,Q6ZN84,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC100373351.2.3.m.58893,-0.00385789507585919,-0.00133084745248392,No,NA,NA,Q6ZN84,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC100373353.1.1.m.50175,-0.00175724936839249,-0.0105777429353016,No,NA,NA,Q0IIF7,NA,NA,NA,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; proteasome binding [GO:0070628]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; innate immune response [GO:0045087]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100373374.1.1.m.7546,-0.00306910178232272,0.0196901085981376,No,NA,NA,Q3ZCL5,NA,NA,NA,cytoplasm [GO:0005737]; trans-Golgi network membrane [GO:0032588]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_LOC100373421.1.1.m.38932,-0.0226507926022706,0.010402472198937,No,NA,NA,A0JPP8,NA,NA,NA,centrosome [GO:0005813],NA,NA,NA
CHOYP_LOC100373427.1.1.m.49648,0.00726028144421506,0.000716540997742145,No,NA,NA,Q8NHP6,NA,NA,NA,integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; chemotaxis [GO:0006935]; neutrophil degranulation [GO:0043312]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of neutrophil chemotaxis [GO:0090023],NA,NA,NA
CHOYP_LOC100373429.1.1.m.10007,-0.0153638701143331,0.0041316532888461,No,NA,NA,F1P4W9,NA,NA,NA,integral component of membrane [GO:0016021]; motile cilium [GO:0031514]; plasma membrane [GO:0005886],NA,NA,NA
CHOYP_LOC100373444.22.79.m.26109,0.00217997094733793,-0.00807271368859912,No,NA,NA,Q9ESN6,NA,NA,NA,cytoplasm [GO:0005737]; myosin binding [GO:0017022]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523],NA,NA,NA
CHOYP_LOC100373444.23.79.m.27899,-0.00904605539071092,0.00765427048325421,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100373444.44.79.m.39021,-0.00926314185487393,0.0174428843447482,No,NA,NA,O70277,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; postsynapse [GO:0098794]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC100373444.59.79.m.54129,0.0105567070360506,0.0129357841349483,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100373444.63.79.m.59147,0.0117111469332389,0.00576523578027113,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100373444.7.79.m.3209,0.00204515757923878,-0.00296594763862214,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100373444.72.79.m.60850,0.0065883263884642,0.0180931628217626,No,NA,NA,A4IF63,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523],NA,NA,NA
CHOYP_LOC100373444.8.79.m.3255,0.00594393912206267,0.00849305827286332,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100373454.1.1.m.59681,-0.0169591047060434,0.00960206869202778,No,NA,NA,Q32LJ3,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100373457.1.1.m.27685,-0.0075214675624803,0.00851399215543057,No,NA,NA,A0MTA1,NA,NA,NA,endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008311]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; phosphodiesterase I activity [GO:0004528]; RNA binding [GO:0003723]; base-excision repair [GO:0006284]; DNA demethylation [GO:0080111]; heart contraction [GO:0060047]; heart looping [GO:0001947]; negative regulation of apoptotic process [GO:0043066]; oxidation-reduction process [GO:0055114]; positive regulation of gene expression [GO:0010628],NA,NA,NA
CHOYP_LOC100373461.1.2.m.30015,0.0185386053379203,-0.00806303818827314,No,NA,NA,Q0VC16,NA,NA,NA,endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lipoprotein transporter activity [GO:0042954]; cargo loading into COPII-coated vesicle [GO:0090110]; cargo loading into vesicle [GO:0035459]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; lipoprotein transport [GO:0042953]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein secretion [GO:0009306]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC100373484.1.1.m.8540,-0.00566980192183902,0.00599799503717562,No,NA,NA,Q96EQ0,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; TRC complex [GO:0072380]; protein-containing complex scaffold activity [GO:0032947]; positive regulation of chaperone-mediated protein folding [GO:1903646]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_LOC100373488.1.1.m.10129,-0.011645549524399,0.00114283252562401,No,NA,NA,P10088,NA,NA,NA,dioxygenase activity [GO:0051213]; L-ascorbic acid binding [GO:0031418]; metal ion binding [GO:0046872]; 2;4-dichlorophenoxyacetic acid catabolic process [GO:0046300],NA,NA,NA
CHOYP_LOC100373492.1.1.m.24527,0.00405112309823037,-0.0180905825788254,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100373522.2.5.m.19698,0.00267777589284329,0.00746749146767928,No,NA,NA,Q95230,NA,NA,NA,membrane [GO:0016020]; binding of sperm to zona pellucida [GO:0007339],NA,NA,NA
CHOYP_LOC100373522.5.5.m.54028,-0.0117796717093639,-0.0122003872508659,No,NA,NA,Q95230,NA,NA,NA,membrane [GO:0016020]; binding of sperm to zona pellucida [GO:0007339],NA,NA,NA
CHOYP_LOC100373569.1.1.m.280,0.00303192780108895,-0.0136366303357195,No,NA,NA,Q96D46,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein binding; bridging [GO:0030674]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of RNA biosynthetic process [GO:1902680]; ribosomal large subunit export from nucleus [GO:0000055],NA,NA,NA
CHOYP_LOC100373578.1.1.m.478,-0.0102357150694445,0.00492140663568988,No,NA,NA,Q5U4F6,NA,NA,NA,axoneme [GO:0005930]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary plasm [GO:0097014]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; dynein complex [GO:0030286]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_LOC100373584.1.1.m.6647,-0.0146808045337492,-0.0118801401945195,No,NA,NA,Q7ZYA5,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; double-stranded RNA binding [GO:0003725]; enzyme activator activity [GO:0008047]; production of siRNA involved in RNA interference [GO:0030422],NA,NA,NA
CHOYP_LOC100373590.1.1.m.51920,0.0018955250990797,-0.0202155023918142,No,NA,NA,P47758,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; GTP binding [GO:0005525]; ubiquitin protein ligase binding [GO:0031625],NA,NA,NA
CHOYP_LOC100373606.1.1.m.29757,-0.000309044456853022,-0.00730122702422044,No,NA,NA,Q6GM78,NA,NA,NA,cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917]; asparaginase activity [GO:0004067]; beta-aspartyl-peptidase activity [GO:0008798]; asparagine catabolic process via L-aspartate [GO:0033345],NA,NA,NA
CHOYP_LOC100373653.3.3.m.56289,0.00339468256595727,-0.0058824674652431,No,NA,NA,P97411,NA,NA,NA,cell junction [GO:0030054]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]; secretory granule membrane [GO:0030667]; synaptic vesicle membrane [GO:0030672]; protein domain specific binding [GO:0019904]; neurotransmitter transport [GO:0006836]; regulation of insulin secretion [GO:0050796]; regulation of neurotransmitter secretion [GO:0046928]; regulation of protein homodimerization activity [GO:0043496],NA,NA,NA
CHOYP_LOC100373656.1.1.m.57144,0.00447474354656512,-0.00585054469517051,No,NA,NA,Q5F356,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-5-phosphate 4-kinase activity [GO:0016309]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC100373657.1.1.m.10366,0.00426380068304664,-0.0179776647946233,No,NA,NA,Q96B26,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; AU-rich element binding [GO:0017091]; identical protein binding [GO:0042802]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process; exonucleolytic; 3'-5' [GO:0034427]; regulation of mRNA stability [GO:0043488]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476],NA,NA,NA
CHOYP_LOC100373670.1.1.m.2427,-0.0110441533011707,0.0149554747728337,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100373694.1.1.m.11753,-0.00900189320289109,-0.010087725116696,No,NA,NA,P0CB97,NA,NA,NA,mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; 4 iron; 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; mitochondrial respiratory chain complex I assembly [GO:0032981]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_LOC100373728.1.1.m.59746,-0.0112464934182823,0.00261772129707806,No,NA,NA,Q8TC84,NA,NA,NA,ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_LOC100373809.1.2.m.35126,-0.0211004290117731,0.00360339973937558,No,NA,NA,Q8C761,NA,NA,NA,ciliary base [GO:0097546]; cilium [GO:0005929]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; interphase microtubule organizing center [GO:0031021]; pericentriolar material [GO:0000242]; spindle pole [GO:0000922]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; cilium assembly [GO:0060271]; embryonic skeletal system morphogenesis [GO:0048704]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_LOC100373842.2.4.m.5139,-0.00964264249878633,-0.0123767545681702,No,NA,NA,Q9WV92,NA,NA,NA,cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; juxtaparanode region of axon [GO:0044224]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; actin binding [GO:0003779]; structural constituent of cytoskeleton [GO:0005200]; actomyosin structure organization [GO:0031032]; apoptotic process [GO:0006915]; cortical actin cytoskeleton organization [GO:0030866]; cortical cytoskeleton organization [GO:0030865]; cytoskeletal anchoring at plasma membrane [GO:0007016]; myelin maintenance [GO:0043217]; neuron projection morphogenesis [GO:0048812]; paranodal junction assembly [GO:0030913]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; protein localization to plasma membrane [GO:0072659]; regulation of cell growth [GO:0001558]; regulation of cell shape [GO:0008360],NA,NA,NA
CHOYP_LOC100373842.4.4.m.40731,0.0186201158719174,0.00730252816511191,No,NA,NA,Q9WV92,NA,NA,NA,cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; juxtaparanode region of axon [GO:0044224]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; actin binding [GO:0003779]; structural constituent of cytoskeleton [GO:0005200]; actomyosin structure organization [GO:0031032]; apoptotic process [GO:0006915]; cortical actin cytoskeleton organization [GO:0030866]; cortical cytoskeleton organization [GO:0030865]; cytoskeletal anchoring at plasma membrane [GO:0007016]; myelin maintenance [GO:0043217]; neuron projection morphogenesis [GO:0048812]; paranodal junction assembly [GO:0030913]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; protein localization to plasma membrane [GO:0072659]; regulation of cell growth [GO:0001558]; regulation of cell shape [GO:0008360],NA,NA,NA
CHOYP_LOC100373864.1.2.m.16543,0.00354963536668582,0.0074342034035688,No,NA,NA,P12955,NA,NA,NA,extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metallocarboxypeptidase activity [GO:0004181]; proline dipeptidase activity [GO:0102009]; cellular amino acid metabolic process [GO:0006520]; collagen catabolic process [GO:0030574]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC100373864.2.2.m.55132,-0.000787691073083112,-0.0144218887733233,No,NA,NA,P12955,NA,NA,NA,extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metallocarboxypeptidase activity [GO:0004181]; proline dipeptidase activity [GO:0102009]; cellular amino acid metabolic process [GO:0006520]; collagen catabolic process [GO:0030574]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC100373888.8.9.m.60548,0.00615966897194063,0.00941964587728867,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100373888.9.9.m.66033,0.0101219911143532,-0.0142416163915393,No,NA,NA,P29590,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; heterochromatin [GO:0000792]; nuclear chromosome; telomeric region [GO:0000784]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; cobalt ion binding [GO:0050897]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; SMAD binding [GO:0046332]; SUMO binding [GO:0032183]; SUMO transferase activity [GO:0019789]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell cycle arrest [GO:0007050]; cell fate commitment [GO:0045165]; cellular response to interleukin-4 [GO:0071353]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular senescence [GO:0090398]; circadian regulation of gene expression [GO:0032922]; common-partner SMAD protein phosphorylation [GO:0007182]; defense response to virus [GO:0051607]; DNA damage response; signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; entrainment of circadian clock by photoperiod [GO:0043153]; extrinsic apoptotic signaling pathway [GO:0097191]; fibroblast migration [GO:0010761]; innate immune response [GO:0045087]; interferon-gamma-mediated signaling pathway [GO:0060333]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; maintenance of protein location in nucleus [GO:0051457]; myeloid cell differentiation [GO:0030099]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of cell proliferation [GO:0008285]; negative regulation of interleukin-1 beta secretion [GO:0050713]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of transcription; DNA-templated [GO:0045892]; negative regulation of translation in response to oxidative stress [GO:0032938]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; negative regulation of viral release from host cell [GO:1902187]; PML body organization [GO:0030578]; positive regulation of apoptotic process involved in mammary gland involution [GO:0060058]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of protein localization to chromosome; telomeric region [GO:1904816]; positive regulation of telomere maintenance [GO:0032206]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein import into nucleus [GO:0006606]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; protein-containing complex assembly [GO:0065003]; regulation of calcium ion transport into cytosol [GO:0010522]; regulation of cell adhesion [GO:0030155]; regulation of circadian rhythm [GO:0042752]; regulation of double-strand break repair [GO:2000779]; regulation of protein phosphorylation [GO:0001932]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription; DNA-templated [GO:0006355]; response to cytokine [GO:0034097]; response to gamma radiation [GO:0010332]; response to hypoxia [GO:0001666]; response to UV [GO:0009411]; retinoic acid receptor signaling pathway [GO:0048384]; transforming growth factor beta receptor signaling pathway [GO:0007179]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100373892.1.2.m.44404,0.00178651454022194,0.00389559335693214,No,NA,NA,Q9CZC8,NA,NA,NA,cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; dipeptidase activity [GO:0016805]; exocytosis [GO:0006887],NA,NA,NA
CHOYP_LOC100373892.2.2.m.55838,-0.0109940905229969,0.0206051958114601,No,NA,NA,Q8VCA8,NA,NA,NA,dipeptidase activity [GO:0016805]; exocytosis [GO:0006887],NA,NA,NA
CHOYP_LOC100373898.1.1.m.24900,-0.00430894344577715,-0.00631540690244347,No,NA,NA,Q86VH2,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cilium assembly [GO:0060271]; epithelial cilium movement [GO:0003351]; microtubule-based movement [GO:0007018]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_LOC100373917.1.1.m.43876,-0.0152157183204884,-0.0061032079517355,No,NA,NA,Q5F457,NA,NA,NA,nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_LOC100373945.1.1.m.53450,-0.018255375015052,-0.000534255542602715,No,NA,NA,Q5EA50,NA,NA,NA,endosome membrane [GO:0010008],NA,NA,NA
CHOYP_LOC100373956.1.1.m.10987,0.0198620425245825,0.0043177330201543,No,NA,NA,A5D989,NA,NA,NA,eukaryotic translation elongation factor 1 complex [GO:0005853]; translation elongation factor activity [GO:0003746],NA,NA,NA
CHOYP_LOC100373985.1.1.m.9302,-0.0120787655907876,0.0227855932061418,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100373990.1.1.m.6259,-0.00983134481867936,0.00226561844655418,No,NA,NA,B4F7A7,NA,NA,NA,centrosome [GO:0005813]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; nucleus [GO:0005634]; fibroblast growth factor binding [GO:0017134]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; fibroblast growth factor receptor signaling pathway [GO:0008543]; microtubule anchoring [GO:0034453]; protein homooligomerization [GO:0051260]; protein import into nucleus; translocation [GO:0000060]; spermatid development [GO:0007286],NA,NA,NA
CHOYP_LOC100374036.1.1.m.65939,-0.0184894369939586,0.00779417494890968,No,NA,NA,Q28IV8,NA,NA,NA,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_LOC100374062.1.1.m.22586,-0.0169233362259392,-0.00130816082867045,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374077.1.1.m.5922,-0.00501382515344729,0.000125943601821756,No,NA,NA,Q5T1M5,NA,NA,NA,actin filament [GO:0005884]; early endosome [GO:0005769]; growth cone [GO:0030426]; membrane [GO:0016020]; actin binding [GO:0003779]; endocytosis [GO:0006897]; negative regulation of phosphatase activity [GO:0010923],NA,NA,NA
CHOYP_LOC100374096.1.1.m.8052,-0.0223157647861502,0.000463095587487337,No,NA,NA,Q8TBP0,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; regulation of receptor recycling [GO:0001919],NA,NA,NA
CHOYP_LOC100374116.1.1.m.37009,0.0065883263884642,0.0180931628217626,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374155.1.1.m.56570,-0.0137874717377547,0.00437637973297596,No,NA,NA,Q08BC4,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100374249.1.1.m.58296,-0.0209735684752398,0.00243972224612712,No,NA,NA,Q4G0X9,NA,NA,NA,axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; motile cilium [GO:0031514]; axonemal dynein complex assembly [GO:0070286]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; epithelial cilium movement [GO:0003351]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; flagellated sperm motility [GO:0030317]; heart looping [GO:0001947]; inner dynein arm assembly [GO:0036159]; lung development [GO:0030324]; motile cilium assembly [GO:0044458]; protein localization to cilium [GO:0061512]; regulation of cilium beat frequency [GO:0003356],NA,NA,NA
CHOYP_LOC100374249.1.1.m.58297,-0.00745652491361463,-0.0247242448888313,No,NA,NA,O14770,NA,NA,NA,nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; DNA binding [GO:0003677]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; eye development [GO:0001654]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pancreas development [GO:0031016]; positive regulation of cardiac muscle myoblast proliferation [GO:0110024]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to growth factor [GO:0070848]; response to mechanical stimulus [GO:0009612]; transcription by RNA polymerase II [GO:0006366]; visual learning [GO:0008542],NA,NA,NA
CHOYP_LOC100374254.1.1.m.22199,-0.0169252398401569,-0.0100583839179146,No,NA,NA,B0BLT0,NA,NA,NA,cell [GO:0005623]; preribosome; large subunit precursor [GO:0030687]; nucleic acid binding [GO:0003676]; ribosomal large subunit binding [GO:0043023]; zinc ion binding [GO:0008270]; ribosomal large subunit export from nucleus [GO:0000055],NA,NA,NA
CHOYP_LOC100374268.1.1.m.58983,-0.00486987550758674,0.00575969123217714,No,NA,NA,Q6P877,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome regulatory particle; lid subcomplex [GO:0008541]; endopeptidase activator activity [GO:0061133]; proteasome binding [GO:0070628]; ubiquitin binding [GO:0043130]; proteasome assembly [GO:0043248]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100374272.3.6.m.53440,-0.00718982941992577,0.0206137203632124,No,NA,NA,O00222,NA,NA,NA,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of synaptic transmission; glutamatergic [GO:0051966]; visual perception [GO:0007601],NA,NA,NA
CHOYP_LOC100374272.5.6.m.57085,0.0174208589309873,-0.0212337457148992,No,NA,NA,Q9QYS2,NA,NA,NA,astrocyte projection [GO:0097449]; axon [GO:0030424]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; calcium channel regulator activity [GO:0005246]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; modulation of chemical synaptic transmission [GO:0050804]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic transmission; glutamatergic [GO:0051966]; sensory perception of pain [GO:0019233]; synaptic transmission; glutamatergic [GO:0035249],NA,NA,NA
CHOYP_LOC100374272.6.6.m.62213,0.00955932242126233,0.0134484647934777,No,NA,NA,Q5RDQ8,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glutamate receptor activity [GO:0008066]; group III metabotropic glutamate receptor activity [GO:0001642]; adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196],NA,NA,NA
CHOYP_LOC100374274.2.3.m.27036,-0.00212078832001384,-0.00891837260408135,No,NA,NA,Q54BA2,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100374277.1.3.m.16275,0.017906552225021,0.00371428754429809,No,NA,NA,Q5ZIJ9,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_LOC100374277.2.3.m.23204,-0.00821300843359816,0.00855122173641457,No,NA,NA,Q5ZIJ9,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_LOC100374280.1.1.m.17385,0.0151944112081261,-0.00333606144589051,No,NA,NA,A0A1D3PCM3,NA,NA,NA,mitochondrion [GO:0005739]; transferase activity; transferring acyl groups other than amino-acyl groups [GO:0016747]; cysteine biosynthetic process [GO:0019344],NA,NA,NA
CHOYP_LOC100374307.1.1.m.29504,0.00239451709621329,-0.00368321653778416,No,NA,NA,Q5RDZ2,NA,NA,NA,cytosol [GO:0005829]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; L-gulonate 3-dehydrogenase activity [GO:0050104]; NAD+ binding [GO:0070403]; protein homodimerization activity [GO:0042803]; fatty acid metabolic process [GO:0006631],NA,NA,NA
CHOYP_LOC100374320.1.1.m.54274,-0.0171658593609348,0.0189866765550362,No,NA,NA,P21369,NA,NA,NA,metal ion binding [GO:0046872]; nicotinamidase activity [GO:0008936]; pyridine nucleotide salvage [GO:0019365],NA,NA,NA
CHOYP_LOC100374338.1.1.m.44584,0.0157665307004432,0.0101628175559292,No,NA,NA,P42620,NA,NA,NA,cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364]; oxidoreductase activity; acting on a sulfur group of donors; quinone or similar compound as acceptor [GO:0016672],NA,NA,NA
CHOYP_LOC100374345.1.2.m.11328,-0.0119633555405562,0.00346927984560706,No,NA,NA,Q8BHJ9,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; pre-mRNA 3'-splice site binding [GO:0030628]; second spliceosomal transesterification activity [GO:0000386]; zinc ion binding [GO:0008270]; alternative mRNA splicing; via spliceosome [GO:0000380]; cellular response to heat [GO:0034605]; intracellular protein transport [GO:0006886]; mRNA 3'-splice site recognition [GO:0000389]; RNA splicing; via transesterification reactions [GO:0000375],NA,NA,NA
CHOYP_LOC100374358.1.1.m.59032,0.00619237266709477,0.00725016059773253,No,NA,NA,Q5ZLW3,NA,NA,NA,Golgi apparatus [GO:0005794]; enzyme binding [GO:0019899]; bone development [GO:0060348]; Golgi organization [GO:0007030],NA,NA,NA
CHOYP_LOC100374370.1.1.m.56335,0.0146675847847081,-0.0108418988139751,No,NA,NA,Q0P4F7,NA,NA,NA,mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ligase activity [GO:0016874]; fatty acid metabolic process [GO:0006631],NA,NA,NA
CHOYP_LOC100374422.1.2.m.26376,-0.0218167291094153,-0.0092847060769142,No,NA,NA,Q8IVF4,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_LOC100374446.1.1.m.29971,-0.0224086684367196,-0.00437903710607107,No,NA,NA,Q9H0I3,NA,NA,NA,centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; cilium assembly [GO:0060271],NA,NA,NA
CHOYP_LOC100374467.1.1.m.31786,-0.0204435415876955,-0.00930092156597952,No,NA,NA,Q4R7Y8,NA,NA,NA,ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; motile cilium assembly [GO:0044458],NA,NA,NA
CHOYP_LOC100374491.1.1.m.6498,-0.0211620692881295,0.00107503204016814,No,NA,NA,Q0V9R4,NA,NA,NA,axoneme [GO:0005930]; axonemal dynein complex assembly [GO:0070286]; cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; inner dynein arm assembly [GO:0036159],NA,NA,NA
CHOYP_LOC100374495.1.1.m.55368,-0.0223311276805666,0.00707975980505452,No,NA,NA,P80311,NA,NA,NA,endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA polymerase binding [GO:0070063]; unfolded protein binding [GO:0051082]; bone development [GO:0060348]; chaperone-mediated protein folding [GO:0061077]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of multicellular organism growth [GO:0040018]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_LOC100374522.1.1.m.66943,-0.0149632499458482,-0.00196775355929868,No,NA,NA,Q9DAM1,NA,NA,NA,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; cell differentiation [GO:0030154],NA,NA,NA
CHOYP_LOC100374527.1.1.m.55214,-0.0171201790865199,-0.00647616488180839,No,NA,NA,O97593,NA,NA,NA,kinetochore [GO:0000776]; meiotic cohesin complex [GO:0030893]; nucleus [GO:0005634]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; cell division [GO:0051301]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid cohesion [GO:0007064]; response to DNA damage checkpoint signaling [GO:0072423]; response to radiation [GO:0009314],NA,NA,NA
CHOYP_LOC100374535.2.3.m.26026,0.00679876340664771,0.0131776584193914,No,NA,NA,O44441,NA,NA,NA,mitochondrion [GO:0005739]; ATPase binding [GO:0051117]; ATPase inhibitor activity [GO:0042030]; heme biosynthetic process [GO:0006783]; negative regulation of ATPase activity [GO:0032780]; negative regulation of nucleotide metabolic process [GO:0045980],NA,NA,NA
CHOYP_LOC100374535.3.3.m.31001,-0.000673283155597638,0.00674952208858266,No,NA,NA,A8XZB0,NA,NA,NA,mitochondrion [GO:0005739]; ATPase binding [GO:0051117]; ATPase inhibitor activity [GO:0042030]; heme biosynthetic process [GO:0006783]; negative regulation of ATPase activity [GO:0032780],NA,NA,NA
CHOYP_LOC100374537.1.1.m.27241,0.00658038913793922,-0.0138099021187836,No,NA,NA,Q19269,NA,NA,NA,extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_LOC100374573.1.1.m.24523,-0.000951289188434258,0.0210702996090602,No,NA,NA,P31689,NA,NA,NA,cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATPase activator activity [GO:0001671]; C3HC4-type RING finger domain binding [GO:0055131]; chaperone binding [GO:0051087]; G protein-coupled receptor binding [GO:0001664]; Hsp70 protein binding [GO:0030544]; low-density lipoprotein particle receptor binding [GO:0050750]; metal ion binding [GO:0046872]; Tat protein binding [GO:0030957]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; androgen receptor signaling pathway [GO:0030521]; DNA damage response; detection of DNA damage [GO:0042769]; flagellated sperm motility [GO:0030317]; negative regulation of apoptotic process [GO:0043066]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; spermatogenesis [GO:0007283]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_LOC100374633.1.2.m.21988,0.0013706236937916,-0.00438961373101372,No,NA,NA,P34714,NA,NA,NA,basement membrane [GO:0005604]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_LOC100374633.1.2.m.21989,-0.00889076330195126,-0.0127145812593671,No,NA,NA,Q9D0C1,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162],NA,NA,NA
CHOYP_LOC100374651.1.4.m.28869,-0.0111348181535714,-0.00256147061590148,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC100374651.3.4.m.52010,0.00205195042830452,-0.00934116934689426,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC100374662.1.6.m.7038,-0.0203746210138344,-0.00595204745069308,No,NA,NA,Q496A3,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100374676.1.1.m.61638,-0.0169591047060434,0.00960206869202777,No,NA,NA,Q9BZ19,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100374685.1.1.m.16061,-0.00637576084562495,-0.00145787845866348,No,NA,NA,Q5M8Z2,NA,NA,NA,cytosol [GO:0005829]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; mitochondrion [GO:0005739]; GPI anchor biosynthetic process [GO:0006506],NA,NA,NA
CHOYP_LOC100374693.1.1.m.62043,0.021982050641455,-0.0116983484568853,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374703.1.1.m.28348,-0.00667875305271401,-0.0121382817407783,No,NA,NA,Q8IV36,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of Golgi membrane [GO:0090498]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi trans cisterna [GO:0000138]; membrane [GO:0016020]; intracellular protein transport [GO:0006886]; response to brefeldin A [GO:0031001],NA,NA,NA
CHOYP_LOC100374741.27.83.m.24541,0.00480787686873852,0.00580711083909556,No,NA,NA,Q9R1R2,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; postsynapse [GO:0098794]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_LOC100374741.30.83.m.32433,0.00280445171369388,0.00310887338646938,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374741.38.83.m.33463,0.0065883263884642,0.0180931628217626,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374741.49.83.m.42424,0.00935658217226809,-0.00178872084313419,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374741.54.83.m.47294,-0.00297246321382397,0.0182884131942511,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374741.61.83.m.53306,0.00733255472028132,0.00496984357378777,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374741.70.83.m.60164,0.0065883263884642,0.0180931628217626,No,NA,NA,Q9ESN6,NA,NA,NA,cytoplasm [GO:0005737]; myosin binding [GO:0017022]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523],NA,NA,NA
CHOYP_LOC100374741.72.83.m.60196,0.0146324682948642,-0.00614877442346504,No,NA,NA,Q9ESN6,NA,NA,NA,cytoplasm [GO:0005737]; myosin binding [GO:0017022]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523],NA,NA,NA
CHOYP_LOC100374741.79.83.m.63217,0.00659373747362854,-0.00494821426624955,No,NA,NA,Q9BRZ2,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; RNA binding [GO:0003723]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; interferon-beta production [GO:0032608]; protein K63-linked ubiquitination [GO:0070534]; regulation of type I interferon production [GO:0032479]; response to type I interferon [GO:0034340],NA,NA,NA
CHOYP_LOC100374742.1.2.m.209,-0.0169591047060434,0.00960206869202778,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374747.1.1.m.54969,0.0151647680022959,-0.014119054473938,No,NA,NA,Q9NZQ3,NA,NA,NA,cytosol [GO:0005829]; intermediate filament [GO:0005882]; nucleus [GO:0005634]; cytoskeletal protein binding [GO:0008092]; SH3 domain binding [GO:0017124]; cytoskeleton organization [GO:0007010]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of neuron projection development [GO:0010976]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100374754.1.1.m.32299,0.012177518463508,-0.0225875104360686,No,NA,NA,Q8R0G9,NA,NA,NA,condensed chromosome outer kinetochore [GO:0000940]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; structural constituent of nuclear pore [GO:0017056]; mRNA export from nucleus [GO:0006406]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; nuclear pore distribution [GO:0031081]; nuclear pore organization [GO:0006999]; paraxial mesoderm development [GO:0048339]; protein import into nucleus [GO:0006606]; somite development [GO:0061053],NA,NA,NA
CHOYP_LOC100374772.1.4.m.30631,0.00818015035897863,0.00321357986013698,No,NA,NA,Q9JIX0,NA,NA,NA,DUBm complex [GO:0071819]; mitochondrion [GO:0005739]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; SAGA complex [GO:0000124]; transcription export complex 2 [GO:0070390]; chromatin binding [GO:0003682]; nuclear receptor transcription coactivator activity [GO:0030374]; transcription coactivator activity [GO:0003713]; histone deubiquitination [GO:0016578]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368],NA,NA,NA
CHOYP_LOC100374785.2.3.m.34677,-0.0202451177843129,-0.00267576833030414,No,NA,NA,Q8IYW2,NA,NA,NA,axoneme [GO:0005930]; axoneme assembly [GO:0035082]; cilium movement involved in cell motility [GO:0060294],NA,NA,NA
CHOYP_LOC100374808.1.1.m.29300,-0.0147304863224566,0.0205444490824574,No,NA,NA,B1H283,NA,NA,NA,mitochondrion [GO:0005739],NA,NA,NA
CHOYP_LOC100374819.2.7.m.48237,0.00205195042830452,-0.00934116934689426,No,NA,NA,Q6PFY8,NA,NA,NA,cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348],NA,NA,NA
CHOYP_LOC100374839.1.1.m.63735,-0.00859933160609916,0.00376564628910686,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374845.1.1.m.49323,-0.0169591047060434,0.00960206869202778,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374849.1.4.m.16004,-0.00650856495384166,-0.0067666919278371,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374909.1.2.m.4076,0.00560283463950467,-0.0154664642210619,No,NA,NA,P91254,NA,NA,NA,glutathione transferase activity [GO:0004364],NA,NA,NA
CHOYP_LOC100374909.2.2.m.57748,0.0108986591533972,-0.00972189491696175,No,NA,NA,P46088,NA,NA,NA,cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364],NA,NA,NA
CHOYP_LOC100374912.1.1.m.51922,-0.00196089964817665,0.015922222864215,No,NA,NA,P52556,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; biliverdin reductase activity [GO:0004074]; riboflavin reductase (NADPH) activity [GO:0042602]; heme catabolic process [GO:0042167],NA,NA,NA
CHOYP_LOC100374960.1.1.m.25267,-0.00935402786651038,-0.020538492860799,No,NA,NA,Q8NHH9,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum tubular network membrane [GO:0098826]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; Golgi organization [GO:0007030]; protein homooligomerization [GO:0051260],NA,NA,NA
CHOYP_LOC100374962.1.1.m.28954,-0.0193065928340217,-0.00498328552782638,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374974.12.16.m.47308,0.00217997094733793,-0.00807271368859912,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374974.15.16.m.58657,0.0013027094650473,-0.0130079959200895,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374981.1.16.m.21258,0.000686232728993108,-0.0107331332691118,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374981.4.16.m.24874,0.00986901058419595,0.0194542109290708,No,NA,NA,O70277,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; postsynapse [GO:0098794]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC100374995.1.3.m.34198,-0.00433833048032665,-0.0199652927388415,No,NA,NA,Q1LUT1,NA,NA,NA,nucleus [GO:0005634]; P-body [GO:0000932]; deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087],NA,NA,NA
CHOYP_LOC100374995.2.3.m.59062,-0.0161955819564755,-0.0192551214885402,No,NA,NA,Q7ZXT3,NA,NA,NA,nucleus [GO:0005634]; P-body [GO:0000932],NA,NA,NA
CHOYP_LOC100375012.1.1.m.11931,-0.0169591047060434,0.00960206869202777,No,NA,NA,Q6NXP6,NA,NA,NA,oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_LOC100375022.1.1.m.3033,-0.00390973976051132,-0.0228292196341028,No,NA,NA,P14685,NA,NA,NA,proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle; lid subcomplex [GO:0008541]; enzyme regulator activity [GO:0030234]; regulation of protein catabolic process [GO:0042176]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100375029.3.10.m.11445,0.00590633415038097,-0.00820436342091524,No,NA,NA,O17389,NA,NA,NA,cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015],NA,NA,NA
CHOYP_LOC100375029.6.10.m.36981,0.0129853036913113,0.0177551596190834,No,NA,NA,O17389,NA,NA,NA,cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015],NA,NA,NA
CHOYP_LOC100375029.8.10.m.60484,0.00294129050769947,-0.00121406075694319,No,NA,NA,O17389,NA,NA,NA,cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015],NA,NA,NA
CHOYP_LOC100375065.1.1.m.7678,-0.00493078470165024,-0.0107946358599875,No,NA,NA,Q9BVG8,NA,NA,NA,centrosome [GO:0005813]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; zonula adherens [GO:0005915]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; epithelial cell-cell adhesion [GO:0090136]; Golgi organization [GO:0007030]; microtubule-based movement [GO:0007018]; visual perception [GO:0007601]; zonula adherens maintenance [GO:0045218],NA,NA,NA
CHOYP_LOC100375089.1.1.m.1341,0.00697605263846572,0.0125742921093731,No,NA,NA,Q3MHN0,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex; beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_LOC100375122.1.1.m.52296,-0.0201232039058423,-0.0161618075227522,No,NA,NA,Q9D581,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC100375141.1.1.m.12655,-0.00579428395115976,0.0182739502623589,No,NA,NA,Q9X6U2,NA,NA,NA,3-hydroxybutyrate dehydrogenase activity [GO:0003858],NA,NA,NA
CHOYP_LOC100375168.1.1.m.23641,0.00204273244278256,-0.0124721952049045,No,NA,NA,Q59E55,NA,NA,NA,nucleus [GO:0005634]; transcription coregulator activity [GO:0003712]; cell proliferation [GO:0008283]; locomotory behavior [GO:0007626]; negative regulation of transcription; DNA-templated [GO:0045892]; neuroblast development [GO:0014019]; neuron development [GO:0048666]; regulation of transcription; DNA-templated [GO:0006355]; wing disc pattern formation [GO:0035222],NA,NA,NA
CHOYP_LOC100375191.1.2.m.9220,-0.0125628559557402,-0.0200858929972664,No,NA,NA,Q86YF9,NA,NA,NA,centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary transition fiber [GO:0097539]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; establishment of protein localization [GO:0045184]; germ cell development [GO:0007281]; multicellular organism development [GO:0007275]; positive regulation of cilium assembly [GO:0045724]; protein localization to cilium [GO:0061512]; regulation of protein binding [GO:0043393]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100375194.5.7.m.46447,-0.0169591047060434,0.00960206869202778,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100375204.2.2.m.21490,-0.00726298890332826,0.00276844718350086,No,NA,NA,Q6NVL7,NA,NA,NA,cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]; endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to vacuole transport [GO:0045324]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC100375204.2.2.m.21491,0.00309885992381353,0.000628336277713606,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100375219.1.1.m.30268,-0.0119677869184261,-0.00130195589088973,No,NA,NA,Q9H4K1,NA,NA,NA,nucleus [GO:0005634],NA,NA,NA
CHOYP_LOC100375219.1.1.m.30269,-0.0152234124723149,-0.0117843490748526,No,NA,NA,Q9DAN9,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100375230.1.1.m.52612,-0.0187019054935341,-0.0154065600746175,No,NA,NA,Q96M69,NA,NA,NA,acrosomal vesicle [GO:0001669]; cell projection [GO:0042995]; cytosol [GO:0005829]; manchette [GO:0002177]; ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385]; axoneme assembly [GO:0035082]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100375232.1.2.m.2686,0.00394536801625317,0.00291369700370642,No,NA,NA,Q9Y2F9,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; cerebral cortex development [GO:0021987]; dendrite morphogenesis [GO:0048813]; neurogenesis [GO:0022008],NA,NA,NA
CHOYP_LOC100375265.2.2.m.11396,-0.00872855141847055,-0.0074296082051752,No,NA,NA,Q9UBQ7,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; peroxisomal matrix [GO:0005782]; carboxylic acid binding [GO:0031406]; glycerate dehydrogenase activity [GO:0008465]; glyoxylate reductase (NADP) activity [GO:0030267]; hydroxypyruvate reductase activity [GO:0016618]; NAD binding [GO:0051287]; NADPH binding [GO:0070402]; oxidoreductase activity; acting on the CH-OH group of donors; NAD or NADP as acceptor [GO:0016616]; protein homodimerization activity [GO:0042803]; cellular nitrogen compound metabolic process [GO:0034641]; dicarboxylic acid metabolic process [GO:0043648]; excretion [GO:0007588]; glyoxylate metabolic process [GO:0046487]; oxidation-reduction process [GO:0055114]; protein complex oligomerization [GO:0051259],NA,NA,NA
CHOYP_LOC100375266.1.1.m.6535,-0.00609846933563533,0.00825416197320116,No,NA,NA,Q9D5R3,NA,NA,NA,centriole [GO:0005814]; ciliary transition fiber [GO:0097539]; Golgi apparatus [GO:0005794]; cilium assembly [GO:0060271]; establishment of centrosome localization [GO:0051660]; protein localization to centrosome [GO:0071539]; vesicle docking [GO:0048278],NA,NA,NA
CHOYP_LOC100375293.2.2.m.58888,-0.0045435627698579,-0.0238033753761274,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100375314.1.1.m.19446,-0.0102595600433897,0.0172324437808825,No,NA,NA,P18142,NA,NA,NA,cell cortex [GO:0005938]; esterosome membrane [GO:0033118]; carboxylic ester hydrolase activity [GO:0052689],NA,NA,NA
CHOYP_LOC100375322.1.1.m.22016,-0.0196970938759126,0.0106019773131541,No,NA,NA,Q74FW6,NA,NA,NA,L-serine ammonia-lyase activity [GO:0003941]; L-threonine ammonia-lyase activity [GO:0004794]; pyridoxal phosphate binding [GO:0030170]; isoleucine biosynthetic process [GO:0009097]; L-serine catabolic process [GO:0006565]; threonine catabolic process [GO:0006567],NA,NA,NA
CHOYP_LOC100375324.1.1.m.45919,-0.014800777160144,0.0141287305231324,No,NA,NA,Q96S44,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; EKC/KEOPS complex [GO:0000408]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; p53 binding [GO:0002039]; protein serine/threonine kinase activity [GO:0004674]; protein phosphorylation [GO:0006468]; regulation of signal transduction by p53 class mediator [GO:1901796]; tRNA processing [GO:0008033]; tRNA threonylcarbamoyladenosine metabolic process [GO:0070525],NA,NA,NA
CHOYP_LOC100375342.2.3.m.30827,-0.0143786056103762,0.00730194430273513,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100375342.3.3.m.40363,-0.0169591047060434,0.00960206869202777,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100375357.1.1.m.46425,-0.00291025884509832,0.019774030403313,No,NA,NA,Q6YHK3,NA,NA,NA,anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616],NA,NA,NA
CHOYP_LOC100375367.1.1.m.10761,-2.378215364477e-06,-0.0134885049401205,No,NA,NA,O60231,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; ATP-dependent 3'-5' RNA helicase activity [GO:0034459]; ATPase activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA splicing; via spliceosome [GO:0000398]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100375395.1.2.m.3613,0.0023756552243161,-0.00434777946369702,No,NA,NA,Q9LJN4,NA,NA,NA,cell wall [GO:0005618]; extracellular region [GO:0005576]; plant-type cell wall [GO:0009505]; alpha-L-arabinofuranosidase activity [GO:0046556]; xylan 1;4-beta-xylosidase activity [GO:0009044]; arabinan catabolic process [GO:0031222]; xylan catabolic process [GO:0045493],NA,NA,NA
CHOYP_LOC100375405.1.1.m.48387,-0.00630732788259141,0.00458825278223732,No,NA,NA,Q9JI92,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; interleukin-5 receptor complex [GO:0005895]; melanosome [GO:0042470]; membrane raft [GO:0045121]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; ephrin receptor binding [GO:0046875]; growth factor binding [GO:0019838]; interleukin-5 receptor binding [GO:0005137]; lipid binding [GO:0008289]; neurexin family protein binding [GO:0042043]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; syndecan binding [GO:0045545]; actin cytoskeleton organization [GO:0030036]; chemical synaptic transmission [GO:0007268]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of receptor internalization [GO:0002091]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; presynapse assembly [GO:0099054]; Ras protein signal transduction [GO:0007265]; regulation of mitotic cell cycle [GO:0007346],NA,NA,NA
CHOYP_LOC100375419.1.1.m.60972,0.0158970455687752,0.00761925438954463,No,NA,NA,O54786,NA,NA,NA,cytosol [GO:0005829]; lipid droplet [GO:0005811]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; deoxyribonuclease inhibitor activity [GO:0060703]; protein binding involved in protein folding [GO:0044183]; protein domain specific binding [GO:0019904]; apoptotic DNA fragmentation [GO:0006309]; chaperone-mediated protein folding [GO:0061077]; negative regulation of apoptotic DNA fragmentation [GO:1902511]; negative regulation of deoxyribonuclease activity [GO:0032076]; negative regulation of execution phase of apoptosis [GO:1900118]; positive regulation of apoptotic process [GO:0043065]; thymocyte apoptotic process [GO:0070242],NA,NA,NA
CHOYP_LOC100375427.1.1.m.6282,0.0221449591962657,-0.00865821028665276,No,NA,NA,Q9ULX7,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; bicarbonate transport [GO:0015701],NA,NA,NA
CHOYP_LOC100375467.1.1.m.42789,0.0036367561102423,-0.000560381074608326,No,NA,NA,Q04721,NA,NA,NA,cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; cell cycle arrest [GO:0007050]; cell fate determination [GO:0001709]; hemopoiesis [GO:0030097]; marginal zone B cell differentiation [GO:0002315]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of growth rate [GO:0045967]; nervous system development [GO:0007399]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of Ras protein signal transduction [GO:0046579]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription; DNA-templated [GO:0006355]; stem cell population maintenance [GO:0019827]; transcription initiation from RNA polymerase II promoter [GO:0006367],NA,NA,NA
CHOYP_LOC100375473.1.1.m.9062,-0.0177895182521654,0.000840213220108407,No,NA,NA,Q4R6T7,NA,NA,NA,cell projection organization [GO:0030030],NA,NA,NA
CHOYP_LOC100375476.1.1.m.33187,0.00143111345079755,0.00238921303687834,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100375481.1.1.m.4496,0.00789898278418907,-0.00683035468367417,No,NA,NA,Q9VY28,NA,NA,NA,mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100375491.1.1.m.11693,-0.0135725579708753,0.00388604629968508,No,NA,NA,Q61909,NA,NA,NA,nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; transcription corepressor activity [GO:0003714]; fat cell differentiation [GO:0045444]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of neuron projection development [GO:0010977]; negative regulation of transcription; DNA-templated [GO:0045892]; regulation of DNA binding [GO:0051101]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100375514.2.6.m.12927,0.00298799379586973,0.00107644298539619,No,NA,NA,Q9Y345,NA,NA,NA,glycinergic synapse [GO:0098690]; integral component of membrane [GO:0016021]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; synaptic transmission; glycinergic [GO:0060012],NA,NA,NA
CHOYP_LOC100375551.1.2.m.27488,-0.0109681730957184,0.00298487128941032,No,NA,NA,Q8VIG3,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; meiotic spindle [GO:0072687]; motile cilium [GO:0031514]; outer dense fiber [GO:0001520]; sperm flagellum [GO:0036126]; axoneme assembly [GO:0035082]; meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286],NA,NA,NA
CHOYP_LOC100375551.1.2.m.27489,-0.000272978997954404,-0.0127165959724975,No,NA,NA,Q9JJW6,NA,NA,NA,cytoplasm [GO:0005737]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100375551.2.2.m.63719,-0.0169591047060434,0.00960206869202777,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100375622.1.1.m.55637,0.0159963910769564,-0.0032943202857334,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100375647.1.2.m.39652,0.00613937018590765,0.000908165720343572,No,NA,NA,P78329,NA,NA,NA,apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; organelle membrane [GO:0031090]; 20-aldehyde-leukotriene B4 20-monooxygenase activity [GO:0097259]; 20-hydroxy-leukotriene B4 omega oxidase activity [GO:0097258]; alkane 1-monooxygenase activity [GO:0018685]; alpha-tocopherol omega-hydroxylase activity [GO:0052871]; arachidonic acid epoxygenase activity [GO:0008392]; arachidonic acid omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; monooxygenase activity [GO:0004497]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; NAD(P)H as one donor; and incorporation of one atom of oxygen [GO:0016709]; tocotrienol omega-hydroxylase activity [GO:0052872]; arachidonic acid metabolic process [GO:0019369]; blood coagulation [GO:0007596]; drug metabolic process [GO:0017144]; epoxygenase P450 pathway [GO:0019373]; icosanoid metabolic process [GO:0006690]; leukotriene B4 catabolic process [GO:0036101]; leukotriene metabolic process [GO:0006691]; long-chain fatty acid metabolic process [GO:0001676]; menaquinone catabolic process [GO:0042361]; negative regulation of icosanoid secretion [GO:0032304]; omega-hydroxylase P450 pathway [GO:0097267]; oxidation-reduction process [GO:0055114]; phylloquinone catabolic process [GO:0042376]; positive regulation of icosanoid secretion [GO:0032305]; pressure natriuresis [GO:0003095]; regulation of blood pressure [GO:0008217]; renal water homeostasis [GO:0003091]; sodium ion homeostasis [GO:0055078]; very long-chain fatty acid metabolic process [GO:0000038]; vitamin E metabolic process [GO:0042360]; vitamin K catabolic process [GO:0042377],NA,NA,NA
CHOYP_LOC100375650.1.1.m.51555,-0.0103980921841991,0.0175732567114169,No,NA,NA,Q98SP7,NA,NA,NA,BBSome [GO:0034464]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; membrane [GO:0016020]; motile cilium [GO:0031514]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; gastrulation [GO:0007369]; intracellular transport [GO:0046907]; Kupffer's vesicle development [GO:0070121]; melanosome transport [GO:0032402]; non-motile cilium assembly [GO:1905515]; pigment granule aggregation in cell center [GO:0051877],NA,NA,NA
CHOYP_LOC100375678.1.1.m.51537,0.00739435300411551,-0.0168599238138871,No,NA,NA,P70541,NA,NA,NA,cytoplasm [GO:0005737]; eukaryotic translation initiation factor 2B complex [GO:0005851]; guanyl-nucleotide exchange factor activity [GO:0005085]; nucleotidyltransferase activity [GO:0016779]; translation initiation factor activity [GO:0003743]; hippocampus development [GO:0021766]; oligodendrocyte development [GO:0014003]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translation [GO:0006412]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_LOC100375699.1.2.m.19738,-0.0147853074101128,-0.00519170313074088,No,NA,NA,Q9TU19,NA,NA,NA,adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cell differentiation [GO:0030154]; cell projection organization [GO:0030030]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100375733.1.1.m.66021,0.0142311560389629,-0.00843036617645485,No,NA,NA,P54961,NA,NA,NA,hydroxymethylglutaryl-CoA synthase activity [GO:0004421]; isoprenoid biosynthetic process [GO:0008299]; sterol biosynthetic process [GO:0016126],NA,NA,NA
CHOYP_LOC100375747.1.1.m.36999,-0.0129019426979007,-0.0208499597060107,No,NA,NA,Q9P209,NA,NA,NA,centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytosol [GO:0005829]; identical protein binding [GO:0042802]; centriole replication [GO:0007099]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; gamma-tubulin complex localization [GO:0033566]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of protein localization to centrosome [GO:1904779]; spindle organization [GO:0007051],NA,NA,NA
CHOYP_LOC100375776.1.3.m.8907,0.011946415118806,0.0209398730144697,No,NA,NA,Q06852,NA,NA,NA,cell wall [GO:0005618]; extracellular region [GO:0005576]; S-layer [GO:0030115]; carbohydrate binding [GO:0030246]; polysaccharide catabolic process [GO:0000272],NA,NA,NA
CHOYP_LOC100375784.2.6.m.7640,-0.0184974197349937,-0.0160501555994386,No,NA,NA,Q4G0P3,NA,NA,NA,axonemal central pair projection [GO:1990718]; axonemal central apparatus assembly [GO:1904158]; cilium movement [GO:0003341]; epithelial cell development [GO:0002064]; trachea development [GO:0060438]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_LOC100375784.3.6.m.12285,-0.00587333495164527,0.00248961389779525,No,NA,NA,Q4G0P3,NA,NA,NA,axonemal central pair projection [GO:1990718]; axonemal central apparatus assembly [GO:1904158]; cilium movement [GO:0003341]; epithelial cell development [GO:0002064]; trachea development [GO:0060438]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_LOC100375784.4.6.m.27594,-0.00989553314854938,0.0166414000917846,No,NA,NA,Q4G0P3,NA,NA,NA,axonemal central pair projection [GO:1990718]; axonemal central apparatus assembly [GO:1904158]; cilium movement [GO:0003341]; epithelial cell development [GO:0002064]; trachea development [GO:0060438]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_LOC100375791.1.1.m.18116,0.00526459248257687,-0.0106051002447666,No,NA,NA,Q6AY40,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; nucleus [GO:0005634]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of glycolytic process [GO:0006110]; regulation of pyruvate kinase activity [GO:1903302],NA,NA,NA
CHOYP_LOC100375797.1.3.m.4166,-0.000958639966310419,0.0162914231262925,No,NA,NA,Q01262,NA,NA,NA,hydrolase activity; acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; cellular amino acid biosynthetic process [GO:0008652],NA,NA,NA
CHOYP_LOC100375820.1.1.m.62640,0.0145143464055108,0.00489222829991251,No,NA,NA,Q924T7,NA,NA,NA,CD40 receptor complex [GO:0035631]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; LUBAC complex [GO:0071797]; metal ion binding [GO:0046872]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; CD40 signaling pathway [GO:0023035]; negative regulation of necroptotic process [GO:0060546]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; T cell receptor signaling pathway [GO:0050852],NA,NA,NA
CHOYP_LOC100375831.1.1.m.24502,-0.00684754639214422,0.00188063412664075,No,NA,NA,Q810J8,NA,NA,NA,autophagosome [GO:0005776]; endoplasmic reticulum [GO:0005783]; extrinsic component of omegasome membrane [GO:0097629]; Golgi stack [GO:0005795]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; omegasome [GO:1990462]; perinuclear region of cytoplasm [GO:0048471]; phagophore assembly site [GO:0000407]; 1-phosphatidylinositol binding [GO:0005545]; metal ion binding [GO:0046872]; phosphatidylinositol-3;4;5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3;4-bisphosphate binding [GO:0043325]; cellular response to starvation [GO:0009267]; macroautophagy [GO:0016236]; negative regulation of phosphatase activity [GO:0010923],NA,NA,NA
CHOYP_LOC100375838.1.1.m.39473,0.00615966897194063,0.00941964587728867,No,NA,NA,Q8K4L0,NA,NA,NA,Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; estrogen receptor binding [GO:0030331]; RNA binding [GO:0003723]; signaling receptor binding [GO:0005102]; transcription corepressor activity [GO:0003714]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396],NA,NA,NA
CHOYP_LOC100375877.1.1.m.16493,-0.000961015974674917,-0.0096913301703094,No,NA,NA,Q9H0A0,NA,NA,NA,membrane [GO:0016020]; midbody [GO:0030496]; nuclear chromosome; telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; ATP binding [GO:0005524]; DNA polymerase binding [GO:0070182]; N-acetyltransferase activity [GO:0008080]; RNA binding [GO:0003723]; rRNA cytidine N-acetyltransferase activity [GO:1990883]; negative regulation of telomere maintenance via telomerase [GO:0032211]; rRNA acetylation involved in maturation of SSU-rRNA [GO:1904812]; rRNA modification [GO:0000154]; tRNA acetylation [GO:0051391],NA,NA,NA
CHOYP_LOC100375888.1.1.m.18951,-0.00563155677808946,-0.000417590019853074,No,NA,NA,Q8K370,NA,NA,NA,mitochondrion [GO:0005739]; flavin adenine dinucleotide binding [GO:0050660]; hydrolase activity [GO:0016787]; oxidoreductase activity; acting on the CH-CH group of donors [GO:0016627],NA,NA,NA
CHOYP_LOC100375890.1.1.m.10490,-0.00402031940245869,-0.00571403907331337,No,NA,NA,Q8CHP8,NA,NA,NA,cytoplasm [GO:0005737]; glycerol-1-phosphatase activity [GO:0000121]; glycerol-3-phosphatase activity [GO:0043136]; magnesium ion binding [GO:0000287]; nucleotide phosphatase activity; acting on free nucleotides [GO:0098519]; phosphatase activity [GO:0016791]; phosphoglycolate phosphatase activity [GO:0008967]; protein tyrosine phosphatase activity [GO:0004725]; dephosphorylation [GO:0016311]; glycerol biosynthetic process [GO:0006114]; glycerophospholipid metabolic process [GO:0006650]; negative regulation of gluconeogenesis [GO:0045721]; peptidyl-tyrosine dephosphorylation [GO:0035335],NA,NA,NA
CHOYP_LOC100375897.1.2.m.14439,-0.00265817938173964,-0.0126063480497452,No,NA,NA,Q4KMD7,NA,NA,NA,nuclear speck [GO:0016607]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; mRNA 3'-UTR binding [GO:0003730]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; RNA uridylyltransferase activity [GO:0050265]; zinc ion binding [GO:0008270]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; snRNA processing [GO:0016180],NA,NA,NA
CHOYP_LOC100375913.1.1.m.9170,-0.0167953029643924,-0.0146678725699756,No,NA,NA,Q0IHI3,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; actin filament polymerization [GO:0030041]; cilium organization [GO:0044782],NA,NA,NA
CHOYP_LOC100375943.1.1.m.9395,0.00418415239307014,0.0167278939479428,No,NA,NA,P57772,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribonucleoprotein complex binding [GO:0043021]; selenocysteine insertion sequence binding [GO:0035368]; translation elongation factor activity [GO:0003746]; tRNA binding [GO:0000049]; selenocysteine incorporation [GO:0001514]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_LOC100375954.4.6.m.32949,-0.0197351397366126,0.00229251769319731,No,NA,NA,Q6PFY8,NA,NA,NA,cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348],NA,NA,NA
CHOYP_LOC100375955.1.1.m.9940,0.00784650380075807,0.0194112481605768,No,NA,NA,Q5F415,NA,NA,NA,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; embryonic brain development [GO:1990403]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_LOC100376045.1.1.m.30010,0.00886941512486566,0.00608676234977953,No,NA,NA,Q96CN5,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],NA,NA,NA
CHOYP_LOC100376049.1.1.m.10489,0.0047263172489955,-0.00413445539598256,No,NA,NA,Q5VWJ9,NA,NA,NA,phosphatidylinositol binding [GO:0035091]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC100376067.3.3.m.62990,-0.0110629175865294,0.00163863642337547,No,NA,NA,O93310,NA,NA,NA,chromosome; centromeric region [GO:0000775]; cohesin complex [GO:0008278]; nuclear chromosome [GO:0000228]; apoptotic process [GO:0006915]; cell division [GO:0051301]; DNA repair [GO:0006281]; protein localization to chromatin [GO:0071168]; sister chromatid cohesion [GO:0007062],NA,NA,NA
CHOYP_LOC100376096.1.1.m.62366,-0.0123603307094843,-0.000142403400978961,No,NA,NA,A1A4V9,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100376151.1.1.m.21094,-0.012074163852774,0.0074187040311799,No,NA,NA,Q7Z5K2,NA,NA,NA,chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome; centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; cell division [GO:0051301]; meiotic chromosome segregation [GO:0045132]; mitotic cell cycle [GO:0000278]; negative regulation of chromatin binding [GO:0035562]; negative regulation of DNA replication [GO:0008156]; negative regulation of sister chromatid cohesion [GO:0045875]; positive regulation of fibroblast proliferation [GO:0048146]; protein localization to chromatin [GO:0071168]; regulation of chromosome condensation [GO:0060623]; regulation of cohesin loading [GO:0071922]; response to toxic substance [GO:0009636]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100376162.1.1.m.48261,-0.0152890175706739,-2.1371142917648e-05,No,NA,NA,P39098,NA,NA,NA,endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1;2-alpha-mannosidase activity [GO:0004571]; glycoprotein metabolic process [GO:0009100]; lung alveolus development [GO:0048286]; N-glycan processing [GO:0006491]; protein glycosylation [GO:0006486]; respiratory gaseous exchange [GO:0007585],NA,NA,NA
CHOYP_LOC100376187.1.2.m.22539,-0.00789607290488623,0.0128820871926492,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100376187.1.2.m.22540,0.0206581302645688,-0.00567881503149743,No,NA,NA,Q03049,NA,NA,NA,aldehyde dehydrogenase (NADP+) activity [GO:0033721]; coenzyme binding [GO:0050662]; oxidoreductase activity [GO:0016491]; oxidoreductase activity; acting on the CH-OH group of donors; NAD or NADP as acceptor [GO:0016616]; response to furfural [GO:1901426],NA,NA,NA
CHOYP_LOC100376187.2.2.m.55240,-0.00300734591578814,0.0128053469026485,No,NA,NA,Q03049,NA,NA,NA,aldehyde dehydrogenase (NADP+) activity [GO:0033721]; coenzyme binding [GO:0050662]; oxidoreductase activity [GO:0016491]; oxidoreductase activity; acting on the CH-OH group of donors; NAD or NADP as acceptor [GO:0016616]; response to furfural [GO:1901426],NA,NA,NA
CHOYP_LOC100376200.1.1.m.19157,-0.00079767406157426,-0.00763539494057215,No,NA,NA,B9EQ30,NA,NA,NA,nucleus [GO:0005634]; SOSS complex [GO:0070876]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; response to ionizing radiation [GO:0010212],NA,NA,NA
CHOYP_LOC100376214.9.11.m.53354,-0.0169591047060434,0.00960206869202777,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100376250.1.1.m.46061,-0.00703071765920371,-0.0171768690578963,No,NA,NA,Q5E9X5,NA,NA,NA,AP-type membrane coat adaptor complex [GO:0030119]; cytosol [GO:0005829]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; endosomal transport [GO:0016197]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC100376265.3.4.m.22693,0.00623761043113155,0.00198041153329097,No,NA,NA,B5X3C1,NA,NA,NA,lysosome [GO:0005764]; galactosylceramidase activity [GO:0004336]; galactosylceramide catabolic process [GO:0006683],NA,NA,NA
CHOYP_LOC100376265.4.4.m.28000,0.00231946382053066,0.0121944910761723,No,NA,NA,Q5SNX7,NA,NA,NA,lysosome [GO:0005764]; galactosylceramidase activity [GO:0004336]; galactosylceramide catabolic process [GO:0006683],NA,NA,NA
CHOYP_LOC100376272.3.4.m.30521,-0.0219832175037525,0.00929900638229095,No,NA,NA,Q40588,NA,NA,NA,extracellular region [GO:0005576]; copper ion binding [GO:0005507]; L-ascorbate oxidase activity [GO:0008447],NA,NA,NA
CHOYP_LOC100376272.3.4.m.30522,0.0190049482681565,-0.00526676463256884,No,NA,NA,Q8HZM5,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; metal ion binding [GO:0046872]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; angiogenesis [GO:0001525]; glutamine biosynthetic process [GO:0006542]; protein palmitoylation [GO:0018345]; regulation of endothelial cell migration [GO:0010594]; regulation of sprouting angiogenesis [GO:1903670],NA,NA,NA
CHOYP_LOC100376274.7.7.m.64553,-0.00611733288276665,-0.00441298632043556,No,NA,NA,Q9MBF8,NA,NA,NA,axoneme [GO:0005930]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cilium movement involved in cell motility [GO:0060294]; inner dynein arm assembly [GO:0036159],NA,NA,NA
CHOYP_LOC100376289.1.1.m.60023,-0.0197795292750613,0.00343175489621049,No,NA,NA,Q5RHH4,NA,NA,NA,axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; cilium assembly [GO:0060271]; photoreceptor cell maintenance [GO:0045494]; pronephros development [GO:0048793]; regulation of TOR signaling [GO:0032006]; retina development in camera-type eye [GO:0060041],NA,NA,NA
CHOYP_LOC100376296.1.1.m.36837,0.00491588973115351,-0.000600714720400961,No,NA,NA,Q96MY1,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654],NA,NA,NA
CHOYP_LOC100376325.1.2.m.1959,-0.00873509785798579,0.00970182734134351,No,NA,NA,Q9NWU2,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; protein homodimerization activity [GO:0042803]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell proliferation [GO:0008284]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LOC100376387.1.1.m.9565,0.014447120830508,-0.00684928991977121,No,NA,NA,O43818,NA,NA,NA,box C/D snoRNP complex [GO:0031428]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; U3 snoRNA binding [GO:0034511]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_LOC100376426.3.3.m.65900,-0.000987260443361756,0.0147619278299422,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100376429.1.1.m.24844,-0.0133462244548246,-0.00482178254286362,No,NA,NA,Q0VCN3,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; sperm flagellum [GO:0036126]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cell differentiation [GO:0030154]; intracellular protein transport [GO:0006886]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; Rab protein signal transduction [GO:0032482]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100376442.1.1.m.40651,-0.0143212318466508,0.00464627666807473,No,NA,NA,A7S8T5,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100376457.1.2.m.11537,0.0103605279184656,0.00372518200269775,No,NA,NA,O73888,NA,NA,NA,cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; glutathione transferase activity [GO:0004364]; magnesium ion binding [GO:0000287]; prostaglandin-D synthase activity [GO:0004667]; protein homodimerization activity [GO:0042803]; negative regulation of male germ cell proliferation [GO:2000255]; prostaglandin biosynthetic process [GO:0001516]; prostaglandin metabolic process [GO:0006693],NA,NA,NA
CHOYP_LOC100376457.2.2.m.51737,0.0209066646265253,0.00569754126813095,No,NA,NA,P18426,NA,NA,NA,structural constituent of eye lens [GO:0005212],NA,NA,NA
CHOYP_LOC100376500.1.1.m.36606,-0.0066190826307058,0.00606810567988473,No,NA,NA,Q08E38,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; DNA replication factor A complex [GO:0005662]; lipid droplet [GO:0005811]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; site of double-strand break [GO:0035861]; spindle [GO:0005819]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; cellular protein localization [GO:0034613]; double-strand break repair via nonhomologous end joining [GO:0006303]; generation of catalytic spliceosome for first transesterification step [GO:0000349]; inner cell mass cell proliferation [GO:0001833]; lipid biosynthetic process [GO:0008610]; mRNA splicing; via spliceosome [GO:0000398]; positive regulation of mRNA splicing; via spliceosome [GO:0048026]; proteasomal protein catabolic process [GO:0010498]; protein K63-linked ubiquitination [GO:0070534]; signal transduction involved in DNA damage checkpoint [GO:0072422]; spliceosomal complex assembly [GO:0000245]; spliceosomal tri-snRNP complex assembly [GO:0000244],NA,NA,NA
CHOYP_LOC100376608.2.4.m.47059,0.0065883263884642,0.0180931628217626,No,NA,NA,Q9R1R2,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; postsynapse [GO:0098794]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_LOC100376608.3.4.m.51379,0.00491588973115351,-0.000600714720400962,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100376610.3.3.m.19687,-0.0140335588165456,-0.0159884244933191,No,NA,NA,Q61656,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ribonucleoprotein granule [GO:0035770]; androgen receptor binding [GO:0050681]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; MH2 domain binding [GO:0035500]; mRNA 3'-UTR binding [GO:0003730]; pre-mRNA binding [GO:0036002]; primary miRNA binding [GO:0070878]; promoter-specific chromatin binding [GO:1990841]; R-SMAD binding [GO:0070412]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; SMAD binding [GO:0046332]; transcription coregulator activity [GO:0003712]; alternative mRNA splicing; via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; BMP signaling pathway [GO:0030509]; circadian rhythm [GO:0007623]; epithelial to mesenchymal transition [GO:0001837]; intracellular estrogen receptor signaling pathway [GO:0030520]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; mRNA transcription [GO:0009299]; myoblast differentiation [GO:0045445]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of DNA damage response; signal transduction by p53 class mediator [GO:0043517]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; positive regulation of transcription; DNA-templated [GO:0045893]; pri-miRNA transcription by RNA polymerase II [GO:0061614]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of osteoblast differentiation [GO:0045667]; regulation of protein import into nucleus; translocation [GO:0033158]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of viral genome replication [GO:0045069],NA,NA,NA
CHOYP_LOC100376688.1.8.m.12067,0.0181807312245552,-0.00208094308028409,No,NA,NA,P84175,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; Golgi apparatus [GO:0005794]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100376708.2.2.m.19660,0.019074256591789,-0.000682927227850933,No,NA,NA,P28668,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; glutamate-tRNA ligase activity [GO:0004818]; metal ion binding [GO:0046872]; proline-tRNA ligase activity [GO:0004827]; RNA binding [GO:0003723]; glutamyl-tRNA aminoacylation [GO:0006424]; prolyl-tRNA aminoacylation [GO:0006433],NA,NA,NA
CHOYP_LOC100376733.1.1.m.12140,0.0112419235127184,0.00276947493135146,No,NA,NA,Q803V5,NA,NA,NA,cytoplasm [GO:0005737]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; positive regulation of TOR signaling [GO:0032008]; regulation of actin cytoskeleton organization [GO:0032956]; TOR signaling [GO:0031929],NA,NA,NA
CHOYP_LOC100376749.1.1.m.27252,-0.00838466187298276,0.00957699217068157,No,NA,NA,Q5FW12,NA,NA,NA,cytosol [GO:0005829]; chordate embryonic development [GO:0043009]; negative regulation of apoptotic process [GO:0043066]; signal transduction [GO:0007165]; TOR signaling [GO:0031929],NA,NA,NA
CHOYP_LOC100376759.2.2.m.59482,-0.0154331851205791,0.0093403893150857,No,NA,NA,Q8WXX7,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; growth cone [GO:0030426]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; actin cytoskeleton reorganization [GO:0031532]; axon extension [GO:0048675]; dendrite extension [GO:0097484]; embryonic viscerocranium morphogenesis [GO:0048703]; forebrain neuron development [GO:0021884]; innate vocalization behavior [GO:0098582]; neuron cellular homeostasis [GO:0070050]; neuron migration [GO:0001764]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H4-K16 acetylation [GO:2000620]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of transcription by RNA polymerase II [GO:0045944]; righting reflex [GO:0060013],NA,NA,NA
CHOYP_LOC100376802.2.2.m.60631,-0.010823680347592,0.00103240332682192,No,NA,NA,O76537,NA,NA,NA,N-acetylmuramoyl-L-alanine amidase activity [GO:0008745]; peptidoglycan binding [GO:0042834]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; peptidoglycan catabolic process [GO:0009253],NA,NA,NA
CHOYP_LOC100376807.1.1.m.22568,-0.0126894066851706,0.00718527910880176,No,NA,NA,Q96DY2,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514],NA,NA,NA
CHOYP_LOC100376827.1.1.m.60291,-0.0147721282285595,-0.0112752264629017,No,NA,NA,Q5RBM1,NA,NA,NA,integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]; protein N-linked glycosylation [GO:0006487],NA,NA,NA
CHOYP_LOC100376857.1.7.m.30171,-0.0182433564013624,-0.0101914578380773,No,NA,NA,Q40588,NA,NA,NA,extracellular region [GO:0005576]; copper ion binding [GO:0005507]; L-ascorbate oxidase activity [GO:0008447],NA,NA,NA
CHOYP_LOC100376857.4.7.m.47467,0.0034485766769227,-0.00607953644607159,No,NA,NA,Q40588,NA,NA,NA,extracellular region [GO:0005576]; copper ion binding [GO:0005507]; L-ascorbate oxidase activity [GO:0008447],NA,NA,NA
CHOYP_LOC100376863.1.1.m.65235,0.0175152271412679,-0.0105610722678173,No,NA,NA,Q04446,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; 1;4-alpha-glucan branching enzyme activity [GO:0003844]; 1;4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis) [GO:0102752]; cation binding [GO:0043169]; hydrolase activity; hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; generation of precursor metabolites and energy [GO:0006091]; glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977],NA,NA,NA
CHOYP_LOC100376864.2.4.m.20389,0.00330481981643524,-0.0109190013148067,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100376880.1.1.m.475,-0.0167228448534308,-0.00575726459906049,No,NA,NA,P70531,NA,NA,NA,dendritic spine [GO:0043197]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; elongation factor-2 kinase activity [GO:0004686]; cellular response to anoxia [GO:0071454]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to insulin stimulus [GO:0032869]; negative regulation of apoptotic process [GO:0043066]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of endocytosis [GO:0045807]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of protein autophosphorylation [GO:0031952]; response to ischemia [GO:0002931]; response to prolactin [GO:1990637],NA,NA,NA
CHOYP_LOC100376902.1.1.m.20390,-0.0204060150004664,-0.014456521864137,No,NA,NA,Q8BYM7,NA,NA,NA,axoneme [GO:0005930]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; radial spoke [GO:0001534]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341],NA,NA,NA
CHOYP_LOC100376908.1.4.m.112,0.00879754908289906,-0.00700064744979269,No,NA,NA,Q8VE97,NA,NA,NA,nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; hematopoietic progenitor cell differentiation [GO:0002244]; mRNA cis splicing; via spliceosome [GO:0045292]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],NA,NA,NA
CHOYP_LOC100376932.1.1.m.12642,0.0169955267278463,-0.00979163554537435,No,NA,NA,Q63569,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle; base subcomplex [GO:0008540]; ATP binding [GO:0005524]; proteasome-activating ATPase activity [GO:0036402]; positive regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0045899]; protein catabolic process [GO:0030163],NA,NA,NA
CHOYP_LOC100376984.1.1.m.15840,-0.00552716616900673,-0.0180172668102826,No,NA,NA,Q5U2Q3,NA,NA,NA,nuclear body [GO:0016604]; hydrolase activity; acting on ester bonds [GO:0016788]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_LOC100377001.1.2.m.10821,-0.000726032734079741,0.00489703839983505,No,NA,NA,A2T7G9,NA,NA,NA,cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; NAD binding [GO:0051287]; oxidoreductase activity; acting on the aldehyde or oxo group of donors; NAD or NADP as acceptor [GO:0016620]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154],NA,NA,NA
CHOYP_LOC100377001.2.2.m.52324,-0.00212078832001384,-0.00891837260408135,No,NA,NA,Q9Z2G9,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; NAD binding [GO:0051287]; oxidoreductase activity; acting on the aldehyde or oxo group of donors; NAD or NADP as acceptor [GO:0016620]; protein serine/threonine kinase activity [GO:0004674]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; import into nucleus [GO:0051170]; positive regulation of programmed cell death [GO:0043068]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; regulation of angiogenesis [GO:0045765],NA,NA,NA
CHOYP_LOC100377034.1.1.m.6251,0.0167451319922491,0.0154768295241412,No,NA,NA,Q6GNL7,NA,NA,NA,cytoplasm [GO:0005737]; formyltetrahydrofolate dehydrogenase activity [GO:0016155]; hydroxymethyl-; formyl- and related transferase activity [GO:0016742]; oxidoreductase activity; acting on the aldehyde or oxo group of donors; NAD or NADP as acceptor [GO:0016620]; 10-formyltetrahydrofolate catabolic process [GO:0009258]; biosynthetic process [GO:0009058]; one-carbon metabolic process [GO:0006730],NA,NA,NA
CHOYP_LOC100377054.1.1.m.8489,0.0174953640737127,0.00716794634924439,No,NA,NA,O35737,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; cellular response to interleukin-7 [GO:0098761]; mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100377058.1.1.m.22299,-0.0186488871603089,-0.00777150226113531,No,NA,NA,M0R2J8,NA,NA,NA,intracellular signal transduction [GO:0035556],NA,NA,NA
CHOYP_LOC100377066.1.2.m.18381,0.00039102932622833,0.00937539430929287,No,NA,NA,Q9EQ06,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; lipid droplet [GO:0005811]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; steroid dehydrogenase activity [GO:0016229]; androgen catabolic process [GO:0006710]; steroid biosynthetic process [GO:0006694],NA,NA,NA
CHOYP_LOC100377077.1.1.m.9907,-0.0168577166161921,-0.0131636120467842,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100377089.1.2.m.5892,0.0074168132118549,0.00708308425790507,No,NA,NA,Q9U943,NA,NA,NA,extracellular region [GO:0005576]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LOC100377100.1.1.m.51994,-0.00116723678054247,-0.0169505030254013,No,NA,NA,Q86WU2,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; D-lactate dehydrogenase (cytochrome) activity [GO:0004458]; D-lactate dehydrogenase activity [GO:0008720]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; lactate catabolic process [GO:1903457],NA,NA,NA
CHOYP_LOC100377119.1.1.m.44037,-0.0225194157781872,0.000516484119740001,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100377154.3.4.m.52896,-0.013122677040094,0.00127954253615314,No,NA,NA,A0A0R4IBK5,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100377160.2.2.m.55835,0.0187264074022147,0.00496872737562719,No,NA,NA,P50867,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; cysteine synthase activity [GO:0004124]; L-cysteine desulfhydrase activity [GO:0080146]; pyridoxal phosphate binding [GO:0030170]; cellular amino acid biosynthetic process [GO:0008652]; cysteine biosynthetic process from serine [GO:0006535],NA,NA,NA
CHOYP_LOC100377173.1.2.m.37698,-0.0189395378701858,-0.00586452944473691,No,NA,NA,Q969V4,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317],NA,NA,NA
CHOYP_LOC100377173.1.2.m.37699,0.00871986692183335,-0.0124047405292886,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100377184.1.1.m.16090,-0.00576730174061532,0.000681197448221138,No,NA,NA,Q9DB15,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial transcription [GO:0006390]; positive regulation of transcription; DNA-templated [GO:0045893]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100377195.1.2.m.28624,-0.0162353079429591,-0.0175770561111948,No,NA,NA,P08472,NA,NA,NA,anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886],NA,NA,NA
CHOYP_LOC100377200.1.2.m.19811,0.0179744019413899,0.0142050501753754,No,NA,NA,Q8R2K1,NA,NA,NA,fucose binding [GO:0042806]; L-fucose mutarotase activity [GO:0036373]; racemase and epimerase activity; acting on carbohydrates and derivatives [GO:0016857]; female mating behavior [GO:0060180]; fucose metabolic process [GO:0006004]; fucosylation [GO:0036065]; negative regulation of neuron differentiation [GO:0045665],NA,NA,NA
CHOYP_LOC100377220.1.1.m.36306,0.000686232728993107,-0.0107331332691118,No,NA,NA,Q6AX59,NA,NA,NA,hydrolase activity [GO:0016787],NA,NA,NA
CHOYP_LOC100377233.1.1.m.30409,-0.0120552648474905,-0.0159376231234841,No,NA,NA,P08962,NA,NA,NA,azurophil granule membrane [GO:0035577]; cell surface [GO:0009986]; endosome lumen [GO:0031904]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; multivesicular body; internal vesicle [GO:0097487]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; cell migration [GO:0016477]; cell surface receptor signaling pathway [GO:0007166]; cell-matrix adhesion [GO:0007160]; cellular protein localization [GO:0034613]; endosome to melanosome transport [GO:0035646]; neutrophil degranulation [GO:0043312]; pigment granule maturation [GO:0048757]; platelet degranulation [GO:0002576]; positive regulation of endocytosis [GO:0045807]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746],NA,NA,NA
CHOYP_LOC100377235.1.2.m.30935,0.016972612419701,0.00456069506690298,No,NA,NA,Q2KIR1,NA,NA,NA,nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; snRNA stem-loop binding [GO:0035614]; U1 snRNA binding [GO:0030619]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_LOC100377243.1.1.m.6500,-0.0159311572774738,-0.00160341303721466,No,NA,NA,Q8T880,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100377244.1.2.m.31458,-0.0208551515722873,-0.000288589459224973,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100377267.1.1.m.49876,0.0141335811335925,-0.00234628877793323,No,NA,NA,A2BG43,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transporter activity [GO:1902388]; intermembrane lipid transfer activity [GO:0120013]; lipid binding [GO:0008289]; ceramide transport [GO:0035627]; intermembrane lipid transfer [GO:0120009],NA,NA,NA
CHOYP_LOC100377311.6.14.m.34688,0.000686232728993108,-0.0107331332691118,No,NA,NA,Q8C525,NA,NA,NA,protein-containing complex binding [GO:0044877],NA,NA,NA
CHOYP_LOC100377323.1.1.m.23683,-0.0103805160230663,-0.00194268904413135,No,NA,NA,D4GU72,NA,NA,NA,dTDP-glucose 4;6-dehydratase activity [GO:0008460]; nucleotide-sugar metabolic process [GO:0009225]; protein glycosylation [GO:0006486]; S-layer organization [GO:0045232],NA,NA,NA
CHOYP_LOC100377347.1.1.m.11235,-0.00880064421492242,0.00578334510525592,No,NA,NA,Q80Y83,NA,NA,NA,axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; neuronal cell body [GO:0043025]; protein-containing complex [GO:0032991]; actin binding [GO:0003779]; gamma-tubulin binding [GO:0043015]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein domain specific binding [GO:0019904]; canonical Wnt signaling pathway [GO:0060070]; cell proliferation in forebrain [GO:0021846]; cerebellar cortex development [GO:0021695]; cerebral cortex cell migration [GO:0021795]; cerebral cortex radially oriented cell migration [GO:0021799]; forebrain ventricular zone progenitor cell division [GO:0021869]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of axonogenesis [GO:0050772]; positive regulation of JNK cascade [GO:0046330]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of microtubule cytoskeleton organization [GO:0070507],NA,NA,NA
CHOYP_LOC100377362.1.1.m.10266,0.00801135687181531,-0.0237936053038404,No,NA,NA,Q99LM2,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cyclin binding [GO:0030332]; MDM2/MDM4 family protein binding [GO:0097371]; mitogen-activated protein kinase binding [GO:0051019]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; ubiquitin-like protein ligase binding [GO:0044389]; apoptotic nuclear changes [GO:0030262]; cell proliferation [GO:0008283]; endoplasmic reticulum unfolded protein response [GO:0030968]; mitotic G2 DNA damage checkpoint [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of cellular protein catabolic process [GO:1903363]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ufmylation [GO:0071569]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic cell cycle [GO:0007346]; regulation of phosphatase activity [GO:0010921],NA,NA,NA
CHOYP_LOC100377364.1.2.m.4828,0.00725862573439894,-0.00592865665257105,No,NA,NA,Q00963,NA,NA,NA,apicolateral plasma membrane [GO:0016327]; axon [GO:0030424]; fusome [GO:0045169]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; spectrosome [GO:0045170]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; cytoskeletal protein binding [GO:0008092]; microtubule binding [GO:0008017]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; photoreceptor cell axon guidance [GO:0072499]; plasma membrane organization [GO:0007009]; regulation of synapse organization [GO:0050807],NA,NA,NA
CHOYP_LOC100377378.1.1.m.64418,-0.0191906400650527,-0.00275691709136109,No,NA,NA,Q32TF8,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100377381.1.2.m.29868,-0.0071779098706571,0.00712297263328197,No,NA,NA,Q99PW8,NA,NA,NA,axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; dendrite cytoplasm [GO:0032839]; intraciliary transport particle B [GO:0030992]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; neuron projection [GO:0043005]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cell projection organization [GO:0030030]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017]; protein-containing complex localization [GO:0031503]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC100377381.2.2.m.49035,-0.0215935458187885,0.00625964645343492,No,NA,NA,Q99PW8,NA,NA,NA,axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; dendrite cytoplasm [GO:0032839]; intraciliary transport particle B [GO:0030992]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; neuron projection [GO:0043005]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cell projection organization [GO:0030030]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017]; protein-containing complex localization [GO:0031503]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC100377392.2.4.m.21904,0.0161224722195905,-0.00899989592574068,No,NA,NA,P05539,NA,NA,NA,collagen trimer [GO:0005581]; collagen type II trimer [GO:0005585]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]; cartilage development [GO:0051216]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to mechanical stimulus [GO:0071260]; cellular response to nicotine [GO:0071316]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to retinoic acid [GO:0071300]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin E [GO:0071306]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; growth plate cartilage development [GO:0003417]; notochord development [GO:0030903]; response to fibroblast growth factor [GO:0071774]; response to mechanical stimulus [GO:0009612]; response to X-ray [GO:0010165]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_LOC100377392.4.4.m.65974,-0.013879864684243,0.00624144949204433,No,NA,NA,Q32KL8,NA,NA,NA,cytosol [GO:0005829]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100377398.1.1.m.44441,0.00453821108838746,-0.00851733237575212,No,NA,NA,Q9N285,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; positive regulation of apoptotic process [GO:0043065],NA,NA,NA
CHOYP_LOC100377412.1.1.m.41404,-0.0231439524794146,-0.00257093512906494,No,NA,NA,Q80Y75,NA,NA,NA,axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; motile cilium [GO:0031514]; sperm connecting piece [GO:0097224]; sperm flagellum [GO:0036126]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; axonemal central apparatus assembly [GO:1904158]; chaperone cofactor-dependent protein refolding [GO:0051085],NA,NA,NA
CHOYP_LOC100377435.1.1.m.46017,-0.00302504820656651,0.00122602324710102,No,NA,NA,Q2KHM9,NA,NA,NA,centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; centriole replication [GO:0007099]; protein localization to centrosome [GO:0071539],NA,NA,NA
CHOYP_LOC100377487.1.1.m.27964,-0.000208843632194346,0.00351032482962255,No,NA,NA,Q91V92,NA,NA,NA,citrate lyase complex [GO:0009346]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; cofactor binding [GO:0048037]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA metabolic process [GO:0006084]; citrate metabolic process [GO:0006101]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]; oxaloacetate metabolic process [GO:0006107],NA,NA,NA
CHOYP_LOC100377495.1.1.m.17707,0.00190966915322839,0.0019347623836219,No,NA,NA,Q03164,NA,NA,NA,cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; AT DNA binding [GO:0003680]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; identical protein binding [GO:0042802]; lysine-acetylated histone binding [GO:0070577]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; transcription regulatory region DNA binding [GO:0044212]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; circadian regulation of gene expression [GO:0032922]; embryonic hemopoiesis [GO:0035162]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; negative regulation of DNA methylation [GO:1905642]; positive regulation of cellular response to drug [GO:2001040]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; positive regulation of transporter activity [GO:0032411]; protein-containing complex assembly [GO:0065003]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of histone H3-K14 acetylation [GO:0071440]; regulation of histone H3-K9 acetylation [GO:2000615]; regulation of megakaryocyte differentiation [GO:0045652]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_LOC100377541.2.4.m.15307,0.00747478227424602,0.00782515601650829,No,NA,NA,P42674,NA,NA,NA,cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_LOC100377560.1.1.m.66612,-0.00235797927133652,-0.00849755988632649,No,NA,NA,O75486,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; STAGA complex [GO:0030914]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription; DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_LOC100377596.1.1.m.7350,-0.00882300295789849,-0.00946769574775651,No,NA,NA,Q571G4,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cell cycle [GO:0007049],NA,NA,NA
CHOYP_LOC100377647.1.2.m.10110,-0.0226635986921017,0.0102600041634246,No,NA,NA,Q5VZQ5,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100377677.1.2.m.23471,-0.0156859004166732,0.00240024356925227,No,NA,NA,P15848,NA,NA,NA,azurophil granule lumen [GO:0035578]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; chondroitin sulfate catabolic process [GO:0030207]; colon epithelial cell migration [GO:0061580]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; neutrophil degranulation [GO:0043312]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268],NA,NA,NA
CHOYP_LOC100377677.2.2.m.27049,-0.00680543693733275,0.00326303725765591,No,NA,NA,P50430,NA,NA,NA,cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268],NA,NA,NA
CHOYP_LOC100377682.1.1.m.31441,-0.00162200710038,0.00588198466945776,No,NA,NA,Q8TDX5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; aminocarboxymuconate-semialdehyde decarboxylase activity [GO:0001760]; hydrolase activity [GO:0016787]; zinc ion binding [GO:0008270]; negative regulation of quinolinate biosynthetic process [GO:1904985]; picolinic acid biosynthetic process [GO:1905004]; protein complex oligomerization [GO:0051259]; regulation of 'de novo' NAD biosynthetic process from tryptophan [GO:1905012]; secondary metabolic process [GO:0019748]; tryptophan catabolic process [GO:0006569],NA,NA,NA
CHOYP_LOC100377736.1.1.m.251,-0.00141713345997059,0.0127322966008336,No,NA,NA,P97478,NA,NA,NA,extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; 2-octoprenyl-3-methyl-6-methoxy-1;4-benzoquinone hydroxylase activity [GO:0008682]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; NAD(P)H as one donor; and incorporation of one atom of oxygen [GO:0016709]; age-dependent response to oxidative stress [GO:0001306]; cellular response to oxidative stress [GO:0034599]; determination of adult lifespan [GO:0008340]; in utero embryonic development [GO:0001701]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; mitochondrion morphogenesis [GO:0070584]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube formation [GO:0001841]; neurogenesis [GO:0022008]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of reactive oxygen species metabolic process [GO:2000377]; respiratory electron transport chain [GO:0022904]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; ubiquinone biosynthetic process [GO:0006744],NA,NA,NA
CHOYP_LOC100377751.1.1.m.26359,-0.0225273999049101,-0.00865583171719464,No,NA,NA,Q8TBY9,NA,NA,NA,axoneme [GO:0005930]; motile cilium [GO:0031514]; cilium movement [GO:0003341],NA,NA,NA
CHOYP_LOC100377755.1.1.m.1005,0.0163934465171564,-0.00284792579126345,No,NA,NA,O75534,NA,NA,NA,CRD-mediated mRNA stability complex [GO:0070937]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; male gonad development [GO:0008584]; nuclear-transcribed mRNA catabolic process; no-go decay [GO:0070966]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100377755.1.1.m.1006,-0.00915527464544763,0.00505834906803735,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100377759.10.15.m.45798,-0.00167126041024005,-0.0115610673348457,No,NA,NA,A6QPC8,NA,NA,NA,chromosome; telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; Smc5-Smc6 complex [GO:0030915]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of response to DNA damage stimulus [GO:2001022],NA,NA,NA
CHOYP_LOC100377759.15.15.m.64824,0.00394536801625317,0.00291369700370642,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100377771.1.1.m.7044,-0.0118980115898886,-0.00540183537936072,No,NA,NA,Q4R7V3,NA,NA,NA,cell projection [GO:0042995]; centriole [GO:0005814]; cell projection organization [GO:0030030]; microtubule anchoring [GO:0034453],NA,NA,NA
CHOYP_LOC100377780.8.11.m.53259,-0.0159596263379912,-0.000613115489140271,No,NA,NA,Q53G44,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; defense response to virus [GO:0051607]; immune response [GO:0006955],NA,NA,NA
CHOYP_LOC100377783.1.1.m.14549,0.0053293603510292,0.000566164832612529,No,NA,NA,P56399,NA,NA,NA,cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100377801.1.1.m.10929,-0.01432079146323,-0.0223814126407957,No,NA,NA,Q1RML7,NA,NA,NA,nucleolus [GO:0005730]; preribosome; large subunit precursor [GO:0030687],NA,NA,NA
CHOYP_LOC100377837.2.2.m.7996,-0.00410800233326048,-0.0105817876462436,No,NA,NA,Q6P5B0,NA,NA,NA,integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730],NA,NA,NA
CHOYP_LOC100377856.1.2.m.13657,0.00686677622379146,-0.0122719166106925,No,NA,NA,Q9Z221,NA,NA,NA,outer dense fiber [GO:0001520]; sperm connecting piece [GO:0097224]; cytoskeleton organization [GO:0007010]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100377856.2.2.m.43339,-0.0113916303151187,0.0121853457662855,No,NA,NA,Q9Z221,NA,NA,NA,outer dense fiber [GO:0001520]; sperm connecting piece [GO:0097224]; cytoskeleton organization [GO:0007010]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100377864.1.1.m.33298,0.00436135344170002,-0.0230825171448617,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100377872.1.1.m.30372,-0.0171307484323065,-0.00206051966369899,No,NA,NA,Q16513,NA,NA,NA,apical junction complex [GO:0043296]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; GTP-Rho binding [GO:0017049]; histone deacetylase binding [GO:0042826]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; apical junction assembly [GO:0043297]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell projection organization [GO:0030030]; epithelial cell migration [GO:0010631]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of cell motility [GO:2000145]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100377901.1.1.m.7173,0.0181171427537104,0.00707125294136591,No,NA,NA,Q62077,NA,NA,NA,cell projection [GO:0042995]; cell-cell junction [GO:0005911]; clathrin-coated vesicle [GO:0030136]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685]; calcium ion binding [GO:0005509]; glutamate receptor binding [GO:0035254]; insulin receptor binding [GO:0005158]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol phospholipase C activity [GO:0004435]; phosphoprotein binding [GO:0051219]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; epidermal growth factor receptor signaling pathway [GO:0007173]; in utero embryonic development [GO:0001701]; inositol trisphosphate biosynthetic process [GO:0032959]; modulation of chemical synaptic transmission [GO:0050804]; phospholipid catabolic process [GO:0009395]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein secretion [GO:0009306]; regulation of store-operated calcium channel activity [GO:1901339]; T cell receptor signaling pathway [GO:0050852],NA,NA,NA
CHOYP_LOC100377934.1.1.m.48699,-0.0124929987772655,0.00175008583643037,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100377974.1.1.m.6543,-0.0106277468434863,0.000866269153872138,No,NA,NA,Q96LI9,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100377982.1.1.m.43510,-0.0127627865103516,-0.00102694357206237,No,NA,NA,Q9QXE5,NA,NA,NA,endosome [GO:0005768]; lysosome [GO:0005764]; dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC100378002.1.1.m.47564,-0.00642694730684128,-0.00177263747162971,No,NA,NA,Q6DFB8,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; Ski complex [GO:0055087]; transcriptionally active chromatin [GO:0035327]; RNA catabolic process [GO:0006401],NA,NA,NA
CHOYP_LOC100378011.2.2.m.52041,-0.00297009250062627,0.00328611905479972,No,NA,NA,Q5UQ35,NA,NA,NA,metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842],NA,NA,NA
CHOYP_LOC100378054.4.4.m.63855,0.0114013544131331,0.0132698875914861,No,NA,NA,Q9VXX8,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; metal ion binding [GO:0046872]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181],NA,NA,NA
CHOYP_LOC100378071.1.1.m.40488,-0.0233818806752874,-0.00205827260261774,No,NA,NA,Q16960,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motor activity [GO:0003774],NA,NA,NA
CHOYP_LOC100378083.1.3.m.26711,-0.0176065297646173,-0.000861637271301624,No,NA,NA,Q9BYX4,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; ribonucleoprotein complex binding [GO:0043021]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]; cellular response to exogenous dsRNA [GO:0071360]; cytoplasmic pattern recognition receptor signaling pathway in response to virus [GO:0039528]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; MDA-5 signaling pathway [GO:0039530]; negative regulation of type I interferon production [GO:0032480]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of tumor necrosis factor secretion [GO:1904469]; protein deubiquitination [GO:0016579]; protein sumoylation [GO:0016925]; regulation of type III interferon production [GO:0034344]; response to virus [GO:0009615]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100378083.3.3.m.65631,0.0062746129572183,-0.0137522806431073,No,NA,NA,Q6Q899,NA,NA,NA,actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; regulation of cell migration [GO:0030334]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529],NA,NA,NA
CHOYP_LOC100378099.1.1.m.22676,-0.000388562927065871,-0.00405476567941884,No,NA,NA,Q7LBC6,NA,NA,NA,chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; antioxidant activity [GO:0016209]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K9 specific) [GO:0032454]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; histone H3-K9 demethylation [GO:0033169]; response to cisplatin [GO:0072718],NA,NA,NA
CHOYP_LOC100378099.1.1.m.22677,0.00693559252584697,0.0102327697953403,No,NA,NA,P81942,NA,NA,NA,mitochondrion [GO:0005739]; nucleus [GO:0005634]; glutathione transferase activity [GO:0004364],NA,NA,NA
CHOYP_LOC100378116.1.3.m.22707,0.00217997094733793,-0.00807271368859912,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100378116.3.3.m.60538,0.00546343908002832,0.00811601272937205,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100378195.1.1.m.46024,-0.0110007357699891,0.00226618585904385,No,NA,NA,Q1LV46,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; hydrolase activity [GO:0016787],NA,NA,NA
CHOYP_LOC100378204.1.1.m.40064,-0.000628450515922055,-0.0193363696551867,No,NA,NA,Q7ZUX6,NA,NA,NA,cofactor binding [GO:0048037]; deoxyhypusine monooxygenase activity [GO:0019135]; iron ion binding [GO:0005506]; peptidyl-lysine modification to peptidyl-hypusine [GO:0008612],NA,NA,NA
CHOYP_LOC100378209.1.2.m.7335,-0.0130470394186973,-0.0238795024733831,No,NA,NA,P25490,NA,NA,NA,cytoplasm [GO:0005737]; Ino80 complex [GO:0031011]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; enhancer sequence-specific DNA binding [GO:0001158]; four-way junction DNA binding [GO:0000400]; histone deacetylase binding [GO:0042826]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA binding [GO:0003723]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]; anterior/posterior pattern specification [GO:0009952]; camera-type eye morphogenesis [GO:0048593]; cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to interleukin-1 [GO:0071347]; cellular response to UV [GO:0034644]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; regulation of transcription by RNA polymerase II [GO:0006357]; response to prostaglandin F [GO:0034696]; response to UV-C [GO:0010225]; RNA localization [GO:0006403]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100378221.1.1.m.29052,0.00537277252312283,0.0009105002629619,No,NA,NA,Q8K4K5,NA,NA,NA,axon [GO:0030424]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; Golgi cis cisterna [GO:0000137]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; axonogenesis [GO:0007409]; cortical actin cytoskeleton organization [GO:0030866]; establishment of spindle orientation [GO:0051294]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of Notch signaling pathway [GO:0008593],NA,NA,NA
CHOYP_LOC100378252.1.1.m.16877,0.00849455277290798,0.00618344777089613,No,NA,NA,Q5ZIQ3,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100378255.1.1.m.63185,-0.0180161088851191,-0.00741026959634379,No,NA,NA,Q8NHU2,NA,NA,NA,axoneme [GO:0005930]; motile cilium [GO:0031514]; cilium movement [GO:0003341]; cilium organization [GO:0044782],NA,NA,NA
CHOYP_LOC100378269.1.2.m.12226,-0.0172567423478759,0.00906072364280548,No,NA,NA,Q2NL11,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100378295.1.4.m.3278,0.00394536801625317,0.00291369700370642,No,NA,NA,P22897,NA,NA,NA,cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898],NA,NA,NA
CHOYP_LOC100378322.1.1.m.16268,0.00127871717255661,0.00807465512364506,No,NA,NA,Q4V8C9,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100378331.1.1.m.47480,-0.0225563643520131,0.00385733089157849,No,NA,NA,Q8TD57,NA,NA,NA,axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_LOC100378364.1.1.m.53053,0.0133159195451812,-0.00416892881960456,No,NA,NA,Q0V8S0,NA,NA,NA,cytosol [GO:0005829]; early endosome membrane [GO:0031901]; ESCRT-0 complex [GO:0033565]; lysosome [GO:0005764]; multivesicular body membrane [GO:0032585]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; ubiquitin-like protein ligase binding [GO:0044389]; membrane invagination [GO:0010324]; negative regulation of angiogenesis [GO:0016525]; negative regulation of JAK-STAT cascade [GO:0046426]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; protein localization to membrane [GO:0072657]; protein targeting to lysosome [GO:0006622]; regulation of MAP kinase activity [GO:0043405],NA,NA,NA
CHOYP_LOC100378410.1.1.m.18106,-0.0122487809293996,-0.0241718876860828,No,NA,NA,Q8IZL8,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; MLL1 complex [GO:0071339]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; transcription factor binding [GO:0008134]; cellular response to estrogen stimulus [GO:0071391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_LOC100378414.1.1.m.34038,-0.00194889212142522,-0.0210471438706713,No,NA,NA,B4PZ52,NA,NA,NA,mitochondrion [GO:0005739]; iron ion binding [GO:0005506]; iron-sulfur cluster binding [GO:0051536]; iron-sulfur cluster assembly [GO:0016226],NA,NA,NA
CHOYP_LOC100378430.1.1.m.63142,-0.0224722453727327,0.000991266387486461,No,NA,NA,P21783,NA,NA,NA,integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793],NA,NA,NA
CHOYP_LOC100378445.1.1.m.7111,0.00130734830602802,-0.00489140189724398,No,NA,NA,Q5SSI6,NA,NA,NA,nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleus [GO:0005634]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_LOC100378487.1.1.m.64108,-0.00345427882127635,-0.0119491924838282,No,NA,NA,Q7SXN4,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; messenger ribonucleoprotein complex [GO:1990124]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; mRNA 3'-UTR binding [GO:0003730]; ribosome binding [GO:0043022]; translation factor activity; RNA binding [GO:0008135]; translation repressor activity; mRNA regulatory element binding [GO:0000900]; cellular response to amino acid stimulus [GO:0071230]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to glucose starvation [GO:0042149]; ionotropic glutamate receptor signaling pathway [GO:0035235]; negative regulation of cytoplasmic translation [GO:2000766]; negative regulation of neuron apoptotic process [GO:0043524]; response to ischemia [GO:0002931],NA,NA,NA
CHOYP_LOC100378510.1.1.m.9865,0.0226082520492586,0.00390895345282326,No,NA,NA,Q14318,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; apoptotic process [GO:0006915]; camera-type eye development [GO:0043010]; cell fate specification [GO:0001708]; dorsal/ventral neural tube patterning [GO:0021904]; intracellular signal transduction [GO:0035556]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of BMP signaling pathway [GO:0030513]; smoothened signaling pathway [GO:0007224]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100378526.1.1.m.16747,0.0103792565006014,0.00547447157075598,No,NA,NA,Q5ZJU4,NA,NA,NA,cytosol [GO:0005829]; sulfur carrier activity [GO:0097163]; protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble uridine modification [GO:0002098],NA,NA,NA
CHOYP_LOC100378553.1.1.m.7444,-0.0110715025861843,-0.00237303248693958,No,NA,NA,Q8BMQ3,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; endochondral bone growth [GO:0003416]; mesenchyme development [GO:0060485]; roof of mouth development [GO:0060021]; tongue development [GO:0043586],NA,NA,NA
CHOYP_LOC100378570.1.1.m.25501,-0.0155234147083246,0.0135333452528068,No,NA,NA,O15527,NA,NA,NA,mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; 8-oxo-7;8-dihydroguanine DNA N-glycosylase activity [GO:0034039]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; endonuclease activity [GO:0004519]; microtubule binding [GO:0008017]; oxidized purine DNA binding [GO:0032357]; oxidized purine nucleobase lesion DNA N-glycosylase activity [GO:0008534]; acute inflammatory response [GO:0002526]; aging [GO:0007568]; base-excision repair [GO:0006284]; base-excision repair; AP site formation [GO:0006285]; cellular response to cadmium ion [GO:0071276]; cellular response to DNA damage stimulus [GO:0006974]; depurination [GO:0045007]; depyrimidination [GO:0045008]; negative regulation of apoptotic process [GO:0043066]; negative regulation of double-strand break repair via single-strand annealing [GO:1901291]; nucleotide-excision repair; DNA incision [GO:0033683]; regulation of transcription; DNA-templated [GO:0006355]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]; response to light stimulus [GO:0009416]; response to oxidative stress [GO:0006979]; response to radiation [GO:0009314],NA,NA,NA
CHOYP_LOC100378584.1.3.m.38091,-0.00879539882457985,7.70896823743657e-05,No,NA,NA,Q28I85,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856],NA,NA,NA
CHOYP_LOC100378607.1.2.m.17330,-0.00697984487962853,0.00501443490884678,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100378615.1.2.m.25321,0.00678620130084428,0.00878741825264137,No,NA,NA,Q9NRA2,NA,NA,NA,cell junction [GO:0030054]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; carbohydrate:proton symporter activity [GO:0005351]; sialic acid transmembrane transporter activity [GO:0015136]; sialic acid:proton symporter activity [GO:0015538]; amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739],NA,NA,NA
CHOYP_LOC100378618.1.1.m.48704,-0.0111610752527419,-0.0126787619862032,No,NA,NA,Q6ZU80,NA,NA,NA,centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; spindle pole [GO:0000922]; protein localization [GO:0008104],NA,NA,NA
CHOYP_LOC100378619.1.2.m.21468,-0.00119162907131067,0.0103646984175126,No,NA,NA,Q8N9Z9,NA,NA,NA,cytoplasm [GO:0005737]; intermediate filament [GO:0005882]; nuclear envelope [GO:0005635]; structural molecule activity [GO:0005198]; cell proliferation [GO:0008283],NA,NA,NA
CHOYP_LOC100378619.2.2.m.36047,-0.0169010640090465,-0.0194552772589266,No,NA,NA,Q8N9Z9,NA,NA,NA,cytoplasm [GO:0005737]; intermediate filament [GO:0005882]; nuclear envelope [GO:0005635]; structural molecule activity [GO:0005198]; cell proliferation [GO:0008283],NA,NA,NA
CHOYP_LOC100378642.1.1.m.54868,0.00563846246297976,-0.0060052842497602,No,NA,NA,Q503L9,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; protein-disulfide reductase activity [GO:0047134]; cardiovascular system development [GO:0072358]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LOC100378644.2.2.m.58497,-0.0143425074179692,0.00662997377471151,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100378652.1.1.m.5656,-0.0139237103858076,0.00507616770100699,No,NA,NA,Q8BKE9,NA,NA,NA,centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; intraciliary transport particle B [GO:0030992]; nucleus [GO:0005634]; beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; epidermis development [GO:0008544]; heart development [GO:0007507]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; keratinocyte development [GO:0003334]; negative regulation of epithelial cell proliferation [GO:0050680]; non-motile cilium assembly [GO:1905515]; Notch signaling pathway [GO:0007219]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_LOC100378652.1.1.m.5657,-0.0054190190777033,-0.0208481121936123,No,NA,NA,O75197,NA,NA,NA,endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; adipose tissue development [GO:0060612]; anterior/posterior pattern specification [GO:0009952]; bone marrow development [GO:0048539]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cholesterol homeostasis [GO:0042632]; endocytosis [GO:0006897]; gastrulation with mouth forming second [GO:0001702]; glucose catabolic process [GO:0006007]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; osteoblast development [GO:0002076]; positive regulation of cell proliferation [GO:0008284]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of blood pressure [GO:0008217]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; retina morphogenesis in camera-type eye [GO:0060042]; retinal blood vessel morphogenesis [GO:0061304]; toxin transport [GO:1901998]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LOC100378652.1.1.m.5658,-0.0105944722106502,0.00196710641502673,No,NA,NA,O75096,NA,NA,NA,cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; BMP signaling pathway [GO:0030509]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein heterotetramerization [GO:0051290]; proximal/distal pattern formation [GO:0009954]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LOC100378653.1.3.m.42107,-0.00430894344577715,-0.00631540690244347,No,NA,NA,P47967,NA,NA,NA,carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_LOC100378658.1.1.m.38454,0.00364778592941831,-0.00872052841558097,No,NA,NA,Q5EAD5,NA,NA,NA,CAAX-protein geranylgeranyltransferase complex [GO:0005953]; CAAX-protein geranylgeranyltransferase activity [GO:0004662]; protein geranylgeranyltransferase activity [GO:0004661]; zinc ion binding [GO:0008270]; protein geranylgeranylation [GO:0018344]; protein prenylation [GO:0018342],NA,NA,NA
CHOYP_LOC100378676.3.8.m.43012,0.00405743066969324,-0.0180002236780634,No,NA,NA,Q6ZRF8,NA,NA,NA,perinuclear region of cytoplasm [GO:0048471]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; ion channel binding [GO:0044325]; zinc ion binding [GO:0008270]; cell-cell signaling involved in cardiac conduction [GO:0086019]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of gene expression [GO:0010628]; positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:1903954]; positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903762]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart looping [GO:1901207],NA,NA,NA
CHOYP_LOC100378691.2.2.m.40118,-0.00604468911069124,-0.00893629687273373,No,NA,NA,Q2KI56,NA,NA,NA,COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC100378714.2.4.m.30802,0.0158511957654265,0.00379638177420124,No,NA,NA,Q8IT98,NA,NA,NA,ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100378719.1.1.m.7367,-0.00264022116903132,-0.00771628900655287,No,NA,NA,Q6UUV9,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; cAMP response element binding protein binding [GO:0008140]; energy homeostasis [GO:0097009]; entrainment of circadian clock by photoperiod [GO:0043153]; memory [GO:0007613]; negative regulation of membrane hyperpolarization [GO:1902631]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendrite development [GO:1900006]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of transcription by RNA polymerase II [GO:0045944]; postsynapse to nucleus signaling pathway [GO:0099527]; protein homotetramerization [GO:0051289]; rhythmic process [GO:0048511]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100378760.1.1.m.37015,-0.00158142168468572,0.00597575753997106,No,NA,NA,P68037,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; transcription coactivator activity [GO:0003713]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activator activity [GO:0097027]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle phase transition [GO:0044770]; cell proliferation [GO:0008283]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to steroid hormone stimulus [GO:0071383]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein K11-linked ubiquitination [GO:0070979]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of transcription; DNA-templated [GO:0006355]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100378816.1.1.m.10997,-0.0212552554811293,-0.00167453213577254,No,NA,NA,Q4R642,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; sperm flagellum [GO:0036126]; flagellated sperm motility [GO:0030317],NA,NA,NA
CHOYP_LOC100378818.2.2.m.27217,0.00588001422881198,-0.00380476593748244,No,NA,NA,O95671,NA,NA,NA,cytosol [GO:0005829]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; O-methyltransferase activity [GO:0008171],NA,NA,NA
CHOYP_LOC100378821.1.1.m.8967,0.00437861168859399,-0.0112116115146933,No,NA,NA,Q4R6F0,NA,NA,NA,signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100378839.1.1.m.21328,-0.0209354568823474,-0.0109380978673496,No,NA,NA,Q86UC2,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856],NA,NA,NA
CHOYP_LOC100378844.1.4.m.7322,-0.0216127064484304,-0.0107797592879814,No,NA,NA,B5X5D0,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100378848.1.1.m.29949,-0.00145210949764666,0.00326071414089195,No,NA,NA,Q96JC1,NA,NA,NA,AP-3 adaptor complex [GO:0030123]; HOPS complex [GO:0030897]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; late endosome to lysosome transport [GO:1902774]; retrograde transport; endosome to plasma membrane [GO:1990126]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC100378849.1.1.m.21445,-0.00526733273931215,0.000324612673029811,No,NA,NA,Q8BJM3,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100378873.3.3.m.30410,-0.020286175354004,-0.00743574585635705,No,NA,NA,Q9H0J4,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100378881.1.1.m.29212,-0.0180862551727644,0.00864796792870785,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100378892.1.1.m.41502,0.00393614644359693,-0.00232064373709413,No,NA,NA,Q7ZYB4,NA,NA,NA,cytoplasm [GO:0005737]; RNA binding [GO:0003723]; translation activator activity [GO:0008494],NA,NA,NA
CHOYP_LOC100378901.1.2.m.29418,-0.00593503783774831,-0.0140364905952695,No,NA,NA,P31331,NA,NA,NA,extracellular region [GO:0005576]; hemoglobin complex [GO:0005833]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344],NA,NA,NA
CHOYP_LOC100378967.1.1.m.62298,-0.0106900194771425,-0.00773514115300039,No,NA,NA,B0BM24,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; photoreceptor connecting cilium [GO:0032391]; cilium organization [GO:0044782],NA,NA,NA
CHOYP_LOC100378969.2.2.m.31240,0.0179363372221294,0.00122545417306496,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100378993.1.1.m.13997,0.00643165645164635,0.00677295690606276,No,NA,NA,Q13029,NA,NA,NA,Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; histone-lysine N-methyltransferase activity [GO:0018024]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; determination of adult lifespan [GO:0008340]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100378999.1.1.m.36850,-0.0222846295196967,0.0096097682926102,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100379008.4.4.m.54023,-0.000953904365751256,-0.00950727101084526,No,NA,NA,Q12912,NA,NA,NA,azurophil granule membrane [GO:0035577]; chromosome [GO:0005694]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; neutrophil degranulation [GO:0043312]; single fertilization [GO:0007338]; vesicle fusion [GO:0006906]; vesicle targeting [GO:0006903],NA,NA,NA
CHOYP_LOC100379049.1.1.m.51860,-0.0100888438195303,-0.0112803096288751,No,NA,NA,A6N6J5,NA,NA,NA,axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle A [GO:0030991]; phosphatidylinositol binding [GO:0035091]; cellular response to glucose stimulus [GO:0071333]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to paclitaxel [GO:1905705]; cellular response to tumor necrosis factor [GO:0071356]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; liver regeneration [GO:0097421]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein localization to cilium [GO:0061512]; response to lipopolysaccharide [GO:0032496]; response to paclitaxel [GO:1901555]; response to toxic substance [GO:0009636],NA,NA,NA
CHOYP_LOC100402577.1.1.m.44548,0.022868998216413,0.00112689403182422,No,NA,NA,P0DMW7,NA,NA,NA,extracellular region [GO:0005576]; nematocyst [GO:0042151]; serine-type endopeptidase inhibitor activity [GO:0004867]; toxin activity [GO:0090729],NA,NA,NA
CHOYP_LOC100459096.3.3.m.45135,0.0196444396233555,0.0112528464164766,No,NA,NA,F1QYJ6,NA,NA,NA,sulfotransferase activity [GO:0008146]; cellular response to xenobiotic stimulus [GO:0071466],NA,NA,NA
CHOYP_LOC100462678.2.2.m.28619,0.00394536801625317,0.00291369700370642,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100465916.1.1.m.44328,0.00205195042830453,-0.00934116934689426,No,NA,NA,Q5R8X6,NA,NA,NA,extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; tissue remodeling [GO:0048771],NA,NA,NA
CHOYP_LOC100471656.2.2.m.34266,0.00346260542512605,-0.00669377454456029,No,NA,NA,Q6P360,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; endoplasmic reticulum unfolded protein response [GO:0030968]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_LOC100472408.1.1.m.17281,0.0101044353306797,-0.0227572561937004,No,NA,NA,Q562D6,NA,NA,NA,RNA binding [GO:0003723]; tRNA (adenine-N6-)-methyltransferase activity [GO:0016430]; tRNA methylation [GO:0030488],NA,NA,NA
CHOYP_LOC100476601.1.1.m.9343,0.0101781379392537,0.00423341101434977,No,NA,NA,A6H619,NA,NA,NA,metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; RNA polymerase binding [GO:0070063]; mRNA processing [GO:0006397]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_LOC100485159.1.1.m.30340,-0.0165902717913932,-0.0140104004323028,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100485247.1.1.m.37690,0.0168145222728974,-0.00264753026370644,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100485356.1.1.m.21339,0.00678620130084429,0.00878741825264137,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100485383.1.1.m.52650,-0.0168177913795548,-0.00307455817330687,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100485485.1.1.m.27961,-0.0232986770596317,0.00645636085285687,No,NA,NA,P86854,NA,NA,NA,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_LOC100485536.1.1.m.48204,0.00653160006907346,0.00076789044778639,No,NA,NA,A7SCH8,NA,NA,NA,cytoplasm [GO:0005737]; kynureninase activity [GO:0030429]; pyridoxal phosphate binding [GO:0030170]; 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; L-kynurenine catabolic process [GO:0097053]; quinolinate biosynthetic process [GO:0019805]; tryptophan catabolic process to kynurenine [GO:0019441],NA,NA,NA
CHOYP_LOC100485604.1.1.m.45268,-0.0135725579708753,0.00388604629968508,No,NA,NA,O43903,NA,NA,NA,actin filament [GO:0005884]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule binding [GO:0008017]; antral ovarian follicle growth [GO:0001547]; apoptotic process [GO:0006915]; basement membrane organization [GO:0071711]; cell cycle arrest [GO:0007050]; initiation of primordial ovarian follicle growth [GO:0001544]; ovulation [GO:0030728]; regulation of cell shape [GO:0008360]; regulation of Notch signaling pathway [GO:0008593],NA,NA,NA
CHOYP_LOC100486001.1.1.m.6209,-0.0169591047060434,0.00960206869202778,No,NA,NA,Q8IX29,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100486063.2.9.m.5918,-0.0169099338225148,0.00668987251765225,No,NA,NA,A2AX52,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208],NA,NA,NA
CHOYP_LOC100486063.5.9.m.39538,0.0186711024982663,-0.00551395630254064,No,NA,NA,P12111,NA,NA,NA,collagen type VI trimer [GO:0005589]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; sarcolemma [GO:0042383]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]; muscle organ development [GO:0007517],NA,NA,NA
CHOYP_LOC100486063.6.9.m.44250,0.00205195042830452,-0.00934116934689426,No,NA,NA,A2AX52,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208],NA,NA,NA
CHOYP_LOC100486063.9.9.m.65186,0.0224199216099063,-0.00127341521100677,No,NA,NA,A2AX52,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208],NA,NA,NA
CHOYP_LOC100486357.1.1.m.51050,-0.00685099386170593,-0.00762624442697182,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100486738.1.2.m.63464,0.0044020248076675,0.0238740640639842,No,NA,NA,Q99KF0,NA,NA,NA,cytoplasm [GO:0005737]; CARD domain binding [GO:0050700]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein phosphorylation [GO:0001934]; tumor necrosis factor-mediated signaling pathway [GO:0033209],NA,NA,NA
CHOYP_LOC100487213.2.4.m.53374,0.00615376813661639,-0.00852163310531925,No,NA,NA,E7F568,NA,NA,NA,cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; actin monomer binding [GO:0003785]; auditory receptor cell stereocilium organization [GO:0060088]; cilium assembly [GO:0060271]; heart jogging [GO:0003146]; heart looping [GO:0001947],NA,NA,NA
CHOYP_LOC100488715.1.1.m.61241,-0.0169591047060434,0.00960206869202778,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100488894.1.5.m.4048,0.000597305888274662,0.00390926367973692,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC100489126.1.1.m.18822,0.0095589343164564,0.0134487697178468,No,NA,NA,Q0V8M0,NA,NA,NA,90S preribosome [GO:0030686]; nucleolus [GO:0005730]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000447],NA,NA,NA
CHOYP_LOC100489926.1.3.m.3642,-0.0105594924330985,0.00774745043911074,No,NA,NA,Q14676,NA,NA,NA,chromosome [GO:0005694]; focal adhesion [GO:0005925]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; FHA domain binding [GO:0070975]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; double-strand break repair via nonhomologous end joining [GO:0006303]; intra-S DNA damage checkpoint [GO:0031573],NA,NA,NA
CHOYP_LOC100489929.1.1.m.51437,0.022513687457474,-0.00894906367793133,No,NA,NA,O73746,NA,NA,NA,extracellular region [GO:0005576]; metalloendopeptidase inhibitor activity [GO:0008191]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_LOC100490321.2.2.m.54266,-0.00959091944765583,0.00923698439823022,No,NA,NA,O88281,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC100490454.1.1.m.64455,-0.00432038878901585,0.00710569203074803,No,NA,NA,Q9DBL7,NA,NA,NA,cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; dephospho-CoA kinase activity [GO:0004140]; pantetheine-phosphate adenylyltransferase activity [GO:0004595]; coenzyme A biosynthetic process [GO:0015937],NA,NA,NA
CHOYP_LOC100491753.1.3.m.45589,0.00217997094733793,-0.00807271368859912,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100491886.1.1.m.26703,-0.0234320215231274,0.00688979868321512,No,NA,NA,P55113,NA,NA,NA,extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; pharyngeal pumping [GO:0043050]; pharynx development [GO:0060465],NA,NA,NA
CHOYP_LOC100492442.1.1.m.16466,-0.0170652625697216,-0.00924753572154105,No,NA,NA,Q08379,NA,NA,NA,cis-Golgi network [GO:0005801]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; importin-alpha family protein binding [GO:0061676]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; syntaxin binding [GO:0019905]; asymmetric cell division [GO:0008356]; centrosome cycle [GO:0007098]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi disassembly [GO:0090166]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; microtubule nucleation [GO:0007020]; mitotic spindle assembly [GO:0090307]; negative regulation of autophagy [GO:0010507]; negative regulation of protein binding [GO:0032091]; positive regulation of protein glycosylation [GO:0060050]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein glycosylation [GO:0006486]; protein homotetramerization [GO:0051289]; protein transport [GO:0015031]; spindle assembly [GO:0051225]; spindle assembly involved in meiosis [GO:0090306],NA,NA,NA
CHOYP_LOC100492576.1.1.m.7775,0.0196884647358877,-0.00328448274550263,No,NA,NA,Q14697,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; glucosidase II complex [GO:0017177]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; carbohydrate binding [GO:0030246]; glucan 1;3-alpha-glucosidase activity [GO:0033919]; RNA binding [GO:0003723]; carbohydrate metabolic process [GO:0005975]; N-glycan processing [GO:0006491],NA,NA,NA
CHOYP_LOC100492683.1.1.m.63753,-0.000835599140776184,-0.00735526821890988,No,NA,NA,Q8VC31,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100493179.5.15.m.32003,-0.00816203249672717,-0.0043163772966188,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100493440.1.2.m.17291,0.00641078138403357,0.0066437689250837,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100493600.1.1.m.58682,-0.0162044830767547,2.25490641645663e-07,No,NA,NA,Q3U5Q7,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; cytidylate kinase activity [GO:0004127]; nucleoside diphosphate kinase activity [GO:0004550]; thymidylate kinase activity [GO:0004798]; UMP kinase activity [GO:0033862]; uridylate kinase activity [GO:0009041]; cellular response to lipopolysaccharide [GO:0071222]; dTDP biosynthetic process [GO:0006233]; dTTP biosynthetic process [GO:0006235]; dUDP biosynthetic process [GO:0006227]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142],NA,NA,NA
CHOYP_LOC100495846.1.1.m.11305,-0.0170576009030838,0.007987891338917,No,NA,NA,O88554,NA,NA,NA,nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; base-excision repair [GO:0006284]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of neuron death [GO:1901215]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; protein poly-ADP-ribosylation [GO:0070212],NA,NA,NA
CHOYP_LOC100496973.2.8.m.19997,0.00935526955097735,0.0209657289606751,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100496973.4.8.m.55256,-0.017266941137786,0.013670548045841,No,NA,NA,Q9H0J9,NA,NA,NA,nucleus [GO:0005634]; metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_LOC100497129.3.8.m.32060,-0.00381672940721852,0.00550085313516024,No,NA,NA,Q2PC93,NA,NA,NA,extracellular space [GO:0005615]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_LOC100497129.6.8.m.41866,-0.0225270192946478,0.0099255056993495,No,NA,NA,Q2PC93,NA,NA,NA,extracellular space [GO:0005615]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_LOC100497129.7.8.m.41875,0.0201950547177896,-0.00917831806821437,No,NA,NA,Q2PC93,NA,NA,NA,extracellular space [GO:0005615]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_LOC100498109.3.3.m.55841,-0.0225649595114965,0.00998907006467744,No,NA,NA,Q96DM1,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100502592.1.1.m.27996,-0.0225632312728739,0.00998600098931444,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100524481.1.1.m.14740,0.0138309193739426,0.0166179337602256,No,NA,NA,Q99PL6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of membrane [GO:0019898]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; macroautophagy [GO:0016236],NA,NA,NA
CHOYP_LOC100533218.1.1.m.56993,-0.00331499815021764,-0.0185842844294075,No,NA,NA,O55173,NA,NA,NA,cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; 3-phosphoinositide-dependent protein kinase activity [GO:0004676]; ATP binding [GO:0005524]; insulin receptor binding [GO:0005158]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase B activity [GO:0032148]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; epidermal growth factor receptor signaling pathway [GO:0007173]; extrinsic apoptotic signaling pathway [GO:0097191]; focal adhesion assembly [GO:0048041]; hyperosmotic response [GO:0006972]; intracellular signal transduction [GO:0035556]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mast cell degranulation [GO:0043304]; type B pancreatic cell development [GO:0003323],NA,NA,NA
CHOYP_LOC100533220.2.2.m.13989,0.00868202898084496,0.00583952173356759,No,NA,NA,Q9Z139,NA,NA,NA,axon [GO:0030424]; axon terminus [GO:0043679]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stress fiber [GO:0001725]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; anatomical structure development [GO:0048856]; astrocyte development [GO:0014002]; inner ear development [GO:0048839]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_LOC100533220.2.2.m.13990,-0.0169591047060434,0.00960206869202777,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100533220.2.2.m.13991,-0.0113919116241119,0.00209374541530128,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100533225.1.2.m.36896,-0.000747586827750839,-0.0237572064770302,No,NA,NA,Q6QM28,NA,NA,NA,cell junction [GO:0030054]; cell projection [GO:0042995]; synaptic vesicle [GO:0008021]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; neurotransmitter secretion [GO:0007269],NA,NA,NA
CHOYP_LOC100533245.3.6.m.31982,0.00646331614215119,0.00732666247663683,No,NA,NA,P04755,NA,NA,NA,acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission; cholinergic [GO:0007271],NA,NA,NA
CHOYP_LOC100533245.3.6.m.31983,-0.0169591047060434,0.00960206869202778,No,NA,NA,P04755,NA,NA,NA,acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission; cholinergic [GO:0007271],NA,NA,NA
CHOYP_LOC100533258.6.6.m.48142,0.0230485560181249,-0.00332914629899095,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100533258.6.6.m.48143,0.0234943835662012,-0.00340383055694918,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100533261.1.1.m.36141,0.00123995610236405,-0.0104414941448465,No,NA,NA,P06603,NA,NA,NA,astral microtubule [GO:0000235]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; antimicrobial humoral response [GO:0019730]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint [GO:0007094],NA,NA,NA
CHOYP_LOC100533283.1.1.m.54357,0.0182835258083292,0.00338622778215639,No,NA,NA,Q5ZKI0,NA,NA,NA,cytoplasm [GO:0005737]; neuron projection [GO:0043005]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683],NA,NA,NA
CHOYP_LOC100533284.1.2.m.25143,-0.0135224081878132,-0.0163654753536744,No,NA,NA,F1M7Y5,NA,NA,NA,apical plasma membrane [GO:0016324]; cell leading edge [GO:0031252]; cytosol [GO:0005829]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; Schmidt-Lanterman incisure [GO:0043220]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; cell-cell junction organization [GO:0045216]; cellular protein localization [GO:0034613]; cellular response to insulin stimulus [GO:0032869]; establishment of apical/basal cell polarity [GO:0035089]; eye photoreceptor cell development [GO:0042462]; Golgi vesicle budding [GO:0048194]; intracellular signal transduction [GO:0035556]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of neuron apoptotic process [GO:0043524]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of glucose import [GO:0046326]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein phosphorylation [GO:0006468]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; response to interleukin-1 [GO:0070555]; response to peptide hormone [GO:0043434],NA,NA,NA
CHOYP_LOC100533289.6.6.m.59221,-0.0115958328929752,-0.00371043352598552,No,NA,NA,P24524,NA,NA,NA,cell junction [GO:0030054]; dendrite [GO:0030425]; glycine-gated chloride channel complex [GO:0016935]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission; glycinergic [GO:0060012],NA,NA,NA
CHOYP_LOC100533290.1.1.m.9001,-0.0138056947207619,0.0109826128438667,No,NA,NA,Q9R152,NA,NA,NA,nucleolus [GO:0005730]; site of DNA damage [GO:0090734]; DNA binding [GO:0003677]; NAD binding [GO:0051287]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]; ATP generation from poly-ADP-D-ribose [GO:1990966]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; protein ADP-ribosylation [GO:0006471],NA,NA,NA
CHOYP_LOC100533291.4.7.m.29195,-0.0218654236048453,-0.00025060952946246,No,NA,NA,P18445,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100533294.1.3.m.35108,0.00766785486596205,-0.00909307381538722,No,NA,NA,P15253,NA,NA,NA,sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_LOC100533294.2.3.m.36820,0.00852423474683066,-0.0028770546752809,No,NA,NA,P15253,NA,NA,NA,sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_LOC100533315.1.3.m.40003,-0.00520786216205301,0.0098995238936999,No,NA,NA,Q38PU3,NA,NA,NA,axon [GO:0030424]; cell junction [GO:0030054]; dendritic spine [GO:0043197]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; extracellularly glutamate-gated ion channel activity [GO:0005234]; ionotropic glutamate receptor activity [GO:0004970],NA,NA,NA
CHOYP_LOC100533316.2.2.m.47773,-0.00153825715201038,0.0079446657754103,No,NA,NA,Q8K0U4,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC100533319.1.2.m.46,-0.0020424321542125,-0.0126962336707444,No,NA,NA,P17972,NA,NA,NA,axon [GO:0030424]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; sleep [GO:0030431],NA,NA,NA
CHOYP_LOC100533325.1.1.m.55617,-0.00705263655529553,-0.0103532160999527,No,NA,NA,O75976,NA,NA,NA,extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; zinc ion binding [GO:0008270]; peptide metabolic process [GO:0006518]; protein processing [GO:0016485],NA,NA,NA
CHOYP_LOC100533330.1.2.m.2565,-0.0159448863604866,0.00464022729345523,No,NA,NA,P25228,NA,NA,NA,cell junction [GO:0030054]; endosome [GO:0005768]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; vesicle [GO:0031982]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cytoskeletal matrix organization at active zone [GO:0048789]; intracellular protein transport [GO:0006886]; maintenance of presynaptic active zone structure [GO:0048790]; neurotransmitter secretion [GO:0007269]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; Rab protein signal transduction [GO:0032482]; regulation of exocytosis [GO:0017157]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle fusion to presynaptic active zone membrane [GO:0031630]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC100533341.1.1.m.1846,-2.12146521439709e-05,-0.0119125707382006,No,NA,NA,O35344,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; protein C-terminus binding [GO:0008022]; protein transporter activity [GO:0008565]; protein import into nucleus [GO:0006606],NA,NA,NA
CHOYP_LOC100533349.3.5.m.52212,0.00602895395298125,-0.00309470563232214,No,NA,NA,Q9VF87,NA,NA,NA,apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; SCAR complex [GO:0031209]; synapse [GO:0045202]; RNA 7-methylguanosine cap binding [GO:0000340]; axon guidance [GO:0007411]; cell adhesion mediated by integrin [GO:0033627]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; centripetally migrating follicle cell migration [GO:0060269]; chaeta development [GO:0022416]; compound eye morphogenesis [GO:0001745]; cortical actin cytoskeleton organization [GO:0030866]; positive regulation of filopodium assembly [GO:0051491]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_LOC100533356.6.6.m.63561,-0.00104294383733774,-0.0145237265270155,No,NA,NA,O01393,NA,NA,NA,cell-cell junction [GO:0005911]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; gap junction hemi-channel activity [GO:0055077]; ion transmembrane transport [GO:0034220],NA,NA,NA
CHOYP_LOC100533357.1.2.m.56848,-0.00777754327370722,0.00801952667463238,No,NA,NA,P34121,NA,NA,NA,actin cytoskeleton [GO:0015629]; phagocytic vesicle [GO:0045335]; actin filament binding [GO:0051015]; regulation of actin filament polymerization [GO:0030833]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_LOC100533367.1.1.m.49626,-0.010746898245374,-0.0153228425373038,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100533383.1.2.m.10358,0.0145792563290291,0.00288147548254313,No,NA,NA,P35224,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cadherin binding [GO:0045296]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_LOC100533384.3.5.m.37350,0.00365868650858968,0.013815483942101,No,NA,NA,Q28FX0,NA,NA,NA,RNA binding [GO:0003723]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_LOC100533384.5.5.m.59082,-0.0158836513813704,0.0114828961557853,No,NA,NA,Q28GD4,NA,NA,NA,cell cortex [GO:0005938]; RNA binding [GO:0003723]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_LOC100533384.5.5.m.59083,-0.00817473826219705,-0.0163135626584569,No,NA,NA,Q5RA42,NA,NA,NA,translation initiation factor activity [GO:0003743],NA,NA,NA
CHOYP_LOC100533387.1.1.m.56131,0.000706478632762351,-0.0156416206672696,No,NA,NA,Q14974,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum tubular network [GO:0071782]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; host cell [GO:0043657]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; specific granule lumen [GO:0035580]; enzyme binding [GO:0019899]; Hsp90 protein binding [GO:0051879]; nuclear localization sequence binding [GO:0008139]; protein domain specific binding [GO:0019904]; protein transporter activity [GO:0008565]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; apoptotic DNA fragmentation [GO:0006309]; astral microtubule organization [GO:0030953]; establishment of mitotic spindle localization [GO:0040001]; establishment of protein localization [GO:0045184]; intracellular transport of virus [GO:0075733]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; modulation by virus of host process [GO:0019054]; neutrophil degranulation [GO:0043312]; NLS-bearing protein import into nucleus [GO:0006607]; protein import into nucleus [GO:0006606]; protein import into nucleus; translocation [GO:0000060]; Ran protein signal transduction [GO:0031291]; regulation of cholesterol biosynthetic process [GO:0045540]; ribosomal protein import into nucleus [GO:0006610],NA,NA,NA
CHOYP_LOC100533388.1.6.m.3716,0.00964349069185353,-0.00217316141625403,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100533388.2.6.m.5374,0.0206997302440559,-0.008159256130514,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100533388.4.6.m.45039,0.00780069468914738,0.0156375801023444,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100533388.6.6.m.45695,0.000104861313495577,0.00561269901257643,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100533400.1.4.m.12300,-0.00285623391263679,0.0105371390813134,No,NA,NA,P36975,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; terminal bouton [GO:0043195]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic vesicle docking [GO:0016081]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC100533400.3.4.m.28214,0.00287504003105629,0.0144558459707488,No,NA,NA,P36975,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; terminal bouton [GO:0043195]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic vesicle docking [GO:0016081]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC100533411.1.1.m.37112,0.00450902979587648,-0.00390015727945,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100533437.1.2.m.4596,-0.00864509335168204,0.0183499808631455,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100533444.1.1.m.33578,6.95541148859905e-05,0.0201597627076931,No,NA,NA,Q9XSC1,NA,NA,NA,extracellular space [GO:0005615]; Wnt-protein binding [GO:0017147]; canonical Wnt signaling pathway [GO:0060070]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell proliferation [GO:0008285]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of Wnt signaling pathway [GO:0030178]; negative regulation of Wnt signaling pathway involved in digestive tract morphogenesis [GO:2000057]; non-canonical Wnt signaling pathway [GO:0035567]; regulation of BMP signaling pathway [GO:0030510],NA,NA,NA
CHOYP_LOC100533447.1.3.m.37261,0.0107787383080895,-0.0169759522355536,No,NA,NA,P22488,NA,NA,NA,cytoplasm [GO:0005737]; intermediate filament [GO:0005882]; structural molecule activity [GO:0005198],NA,NA,NA
CHOYP_LOC100533447.2.3.m.44497,-0.00490919509421611,0.0134449142250792,No,NA,NA,O43639,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; postsynaptic density [GO:0014069]; vesicle membrane [GO:0012506]; cytoskeletal adaptor activity [GO:0008093]; phosphotyrosine residue binding [GO:0001784]; protein-containing complex binding [GO:0044877]; receptor signaling complex scaffold activity [GO:0030159]; scaffold protein binding [GO:0097110]; SH3/SH2 adaptor activity [GO:0005070]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; dendritic spine development [GO:0060996]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; immunological synapse formation [GO:0001771]; lamellipodium assembly [GO:0030032]; negative regulation of cell proliferation [GO:0008285]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990441]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; regulation of epidermal growth factor-activated receptor activity [GO:0007176]; signal complex assembly [GO:0007172]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],NA,NA,NA
CHOYP_LOC100533450.1.1.m.54334,-0.0096395666498857,-0.0172358055501827,No,NA,NA,Q3L1C9,NA,NA,NA,neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; mRNA binding [GO:0003729]; regulation of protein localization [GO:0032880],NA,NA,NA
CHOYP_LOC100533455.1.9.m.3607,-0.00833298676245776,-0.0101066215511809,No,NA,NA,P42577,NA,NA,NA,cytoplasm [GO:0005737]; ferric iron binding [GO:0008199]; ferroxidase activity [GO:0004322]; cellular iron ion homeostasis [GO:0006879]; iron ion transport [GO:0006826],NA,NA,NA
CHOYP_LOC100533521.2.2.m.52097,0.0145713401460546,-0.00374524430519866,No,NA,NA,C4N147,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; lipid binding [GO:0008289],NA,NA,NA
CHOYP_LOC100533524.1.1.m.33932,-0.0133262711665425,0.000305735013741758,No,NA,NA,E2RDZ6,NA,NA,NA,cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; NAD+ binding [GO:0070403]; NAD-dependent protein deacetylase activity [GO:0034979]; protein-glutaryllysine deglutarylase activity [GO:0061697]; protein-malonyllysine demalonylase activity [GO:0036054]; protein-succinyllysine desuccinylase activity [GO:0036055]; zinc ion binding [GO:0008270]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; protein demalonylation [GO:0036046]; protein desuccinylation [GO:0036048]; regulation of ketone biosynthetic process [GO:0010566],NA,NA,NA
CHOYP_LOC100533528.2.2.m.26125,0.000556475735374177,0.00669329578842431,No,NA,NA,Q7JQD3,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; actin filament capping [GO:0051693]; actin filament fragmentation [GO:0030043]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_LOC100533537.1.1.m.36,0.0118408899792892,0.00808399940008985,No,NA,NA,Q921J2,NA,NA,NA,cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; spliceosomal complex [GO:0005681]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of TOR signaling [GO:0032008]; regulation of postsynapse organization [GO:0099175]; regulation of TOR signaling [GO:0032006]; regulation of type B pancreatic cell development [GO:2000074]; small GTPase mediated signal transduction [GO:0007264],NA,NA,NA
CHOYP_LOC100535066.1.2.m.15640,-0.00707592294494712,0.00124505890152652,No,NA,NA,O54891,NA,NA,NA,carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_LOC100535716.2.3.m.39162,0.0179396581893553,0.005686095634688,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100536597.1.1.m.52329,-0.00950104198643403,-0.0149511348987782,No,NA,NA,Q14657,NA,NA,NA,cytoplasm [GO:0005737]; EKC/KEOPS complex [GO:0000408]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA processing [GO:0008033],NA,NA,NA
CHOYP_LOC100537361.1.1.m.55516,-0.0154347373324021,-0.00643247349496295,No,NA,NA,P10076,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100538313.1.1.m.64152,0.0229587497274285,-0.00988953583681654,No,NA,NA,P15989,NA,NA,NA,collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]; growth plate cartilage chondrocyte morphogenesis [GO:0003429],NA,NA,NA
CHOYP_LOC100538996.1.1.m.14935,-0.0154873438693607,0.0136054104341464,No,NA,NA,Q5R7P7,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; DNA-templated transcription; initiation [GO:0006352],NA,NA,NA
CHOYP_LOC100539769.1.1.m.36990,0.00867197930444589,0.00849975152271049,No,NA,NA,O60879,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; actin binding [GO:0003779]; Rho GTPase binding [GO:0017048]; signaling receptor binding [GO:0005102]; actin filament organization [GO:0007015]; female gamete generation [GO:0007292]; multicellular organism development [GO:0007275]; oogenesis [GO:0048477],NA,NA,NA
CHOYP_LOC100540539.1.1.m.14519,0.013855906818363,-0.022107208204108,No,NA,NA,Q15643,NA,NA,NA,cilium [GO:0005929]; cis-Golgi network [GO:0005801]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; inner acrosomal membrane [GO:0002079]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; outer acrosomal membrane [GO:0002081]; transport vesicle [GO:0030133]; transcription coactivator activity [GO:0003713]; chondrocyte differentiation involved in endochondral bone morphogenesis [GO:0003413]; Golgi organization [GO:0007030]; inner ear receptor cell stereocilium organization [GO:0060122]; intraciliary transport involved in cilium assembly [GO:0035735]; protein glycosylation [GO:0006486]; transcription by RNA polymerase II [GO:0006366]; ventricular septum development [GO:0003281],NA,NA,NA
CHOYP_LOC100541322.1.1.m.43256,0.00969194179260774,0.0109955198351627,No,NA,NA,Q60631,NA,NA,NA,cell-cell junction [GO:0005911]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Grb2-EGFR complex [GO:0070436]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; vesicle membrane [GO:0012506]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; insulin receptor substrate binding [GO:0043560]; neurotrophin TRKA receptor binding [GO:0005168]; phosphoprotein binding [GO:0051219]; phosphotyrosine residue binding [GO:0001784]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; SH3 domain binding [GO:0017124]; SH3/SH2 adaptor activity [GO:0005070]; aging [GO:0007568]; anatomical structure formation involved in morphogenesis [GO:0048646]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; cell differentiation [GO:0030154]; cellular response to ionizing radiation [GO:0071479]; insulin receptor signaling pathway [GO:0008286]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; protein heterooligomerization [GO:0051291]; Ras protein signal transduction [GO:0007265]; receptor internalization [GO:0031623]; regulation of MAPK cascade [GO:0043408]; signal transduction in response to DNA damage [GO:0042770],NA,NA,NA
CHOYP_LOC100543236.1.2.m.20322,0.00491588973115351,-0.000600714720400963,No,NA,NA,Q24K15,NA,NA,NA,extracellular region [GO:0005576]; receptor tyrosine kinase binding [GO:0030971]; angiogenesis [GO:0001525],NA,NA,NA
CHOYP_LOC100543709.1.1.m.32086,0.00168772193910091,0.00297370402963626,No,NA,NA,O08688,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; synapse [GO:0045202]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC100546924.1.2.m.34506,-0.0155041106686427,-0.00683390072133224,No,NA,NA,Q8BP86,NA,NA,NA,snRNA-activating protein complex [GO:0019185]; DNA binding [GO:0003677]; snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796],NA,NA,NA
CHOYP_LOC100547490.1.1.m.5822,0.0140812111863665,-0.00270547353471949,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100548534.1.1.m.26484,-0.0226661776357601,0.0103078524324617,No,NA,NA,P42674,NA,NA,NA,cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_LOC100548534.1.1.m.26485,-0.0226627086735679,0.0103527846650351,No,NA,NA,Q01177,NA,NA,NA,extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; endopeptidase activity [GO:0004175]; enzyme binding [GO:0019899]; kinase binding [GO:0019900]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; labyrinthine layer blood vessel development [GO:0060716]; mononuclear cell migration [GO:0071674]; muscle cell cellular homeostasis [GO:0046716]; myoblast differentiation [GO:0045445]; proteolysis involved in cellular protein catabolic process [GO:0051603]; tissue regeneration [GO:0042246]; tissue remodeling [GO:0048771]; trans-synaptic signaling by BDNF; modulating synaptic transmission [GO:0099183]; trophoblast giant cell differentiation [GO:0060707],NA,NA,NA
CHOYP_LOC100549486.1.1.m.54965,-0.0225707473076965,0.00999949475758748,No,NA,NA,P70610,NA,NA,NA,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; exocytosis [GO:0006887]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of insulin secretion [GO:0032024]; positive regulation of vesicle fusion [GO:0031340]; protein localization [GO:0008104],NA,NA,NA
CHOYP_LOC100552087.1.1.m.26238,-0.0133763483033536,-0.00676891480395827,No,NA,NA,Q15853,NA,NA,NA,intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; lactation [GO:0007595]; late viral transcription [GO:0019086]; lipid homeostasis [GO:0055088]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter by glucose [GO:0000432]; regulation of transcription from RNA polymerase II promoter by glucose [GO:0000430]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_LOC100552374.1.1.m.21979,-0.004756964699939,-0.0112407588137948,No,NA,NA,Q3T0Y3,NA,NA,NA,cytoplasm [GO:0005737]; aryl sulfotransferase activity [GO:0004062]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; epithelial cell differentiation [GO:0030855]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805],NA,NA,NA
CHOYP_LOC100552730.1.1.m.18699,-0.0135725579708753,0.00388604629968508,No,NA,NA,O35375,NA,NA,NA,axon [GO:0030424]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; semaphorin receptor activity [GO:0017154]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; angiogenesis [GO:0001525]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; cellular response to leukemia inhibitory factor [GO:1990830]; dorsal root ganglion morphogenesis [GO:1904835]; facial nerve structural organization [GO:0021612]; facioacoustic ganglion development [GO:1903375]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; heart development [GO:0007507]; negative chemotaxis [GO:0050919]; nerve development [GO:0021675]; neural crest cell migration [GO:0001755]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; neuron migration [GO:0001764]; outflow tract septum morphogenesis [GO:0003148]; regulation of postsynapse organization [GO:0099175]; semaphorin-plexin signaling pathway involved in neuron projection guidance [GO:1902285]; sensory neuron axon guidance [GO:0097374]; sympathetic ganglion development [GO:0061549]; sympathetic neuron projection extension [GO:0097490]; sympathetic neuron projection guidance [GO:0097491]; trigeminal ganglion development [GO:0061551]; ventral trunk neural crest cell migration [GO:0036486]; vestibulocochlear nerve structural organization [GO:0021649],NA,NA,NA
CHOYP_LOC100553519.1.1.m.20707,-0.0155060053937783,-0.00781552249191401,No,NA,NA,Q8VDM6,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; RNA binding [GO:0003723]; response to virus [GO:0009615]; RNA processing [GO:0006396],NA,NA,NA
CHOYP_LOC100553663.1.1.m.58460,-0.00296226020520712,0.0108154094164344,No,NA,NA,Q6P7A9,NA,NA,NA,lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; alpha-1;4-glucosidase activity [GO:0004558]; carbohydrate binding [GO:0030246]; maltose alpha-glucosidase activity [GO:0032450]; glycogen catabolic process [GO:0005980],NA,NA,NA
CHOYP_LOC100553687.1.1.m.61663,-0.00710739469953206,-0.00694591638563954,No,NA,NA,P0CB49,NA,NA,NA,nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227],NA,NA,NA
CHOYP_LOC100553809.1.1.m.45965,0.00313051687878274,0.0159606371293828,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100554313.1.1.m.20949,-0.0150218843856921,-0.0170378399147997,No,NA,NA,Q6P069,NA,NA,NA,axon [GO:0030424]; axon terminus [GO:0043679]; chromaffin granule membrane [GO:0042584]; cytosol [GO:0005829]; dendritic spine neck [GO:0044326]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcoplasmic reticulum membrane [GO:0033017]; smooth endoplasmic reticulum [GO:0005790]; T-tubule [GO:0030315]; vesicle [GO:0031982]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; protein heterodimerization activity [GO:0046982]; repressing transcription factor binding [GO:0070491]; calcium ion transport [GO:0006816]; cytoplasmic sequestering of transcription factor [GO:0042994]; heart development [GO:0007507]; negative regulation of cardiac muscle contraction [GO:0055118]; negative regulation of heart rate [GO:0010459]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of high voltage-gated calcium channel activity [GO:1901841]; regulation of relaxation of muscle [GO:1901077],NA,NA,NA
CHOYP_LOC100554450.1.1.m.66550,-0.00663868107796367,-0.00931594120227944,No,NA,NA,Q8R3Q6,NA,NA,NA,mitochondrion [GO:0005739],NA,NA,NA
CHOYP_LOC100554578.1.2.m.7421,-0.0169591047060434,0.00960206869202777,No,NA,NA,O15484,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; proteolysis [GO:0006508]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100554670.1.1.m.4865,0.00714786169951409,-0.00802967080521894,No,NA,NA,Q8IZD4,NA,NA,NA,cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; enzyme activator activity [GO:0008047]; hydrolase activity [GO:0016787]; mRNA binding [GO:0003729]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184],NA,NA,NA
CHOYP_LOC100555223.1.1.m.47612,0.0094464495589112,0.0134052705052368,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100555295.1.1.m.51356,-0.00736394537965306,-0.0102840083558854,No,NA,NA,Q9DBU0,NA,NA,NA,autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; autophagy [GO:0006914]; protein localization to membrane [GO:0072657],NA,NA,NA
CHOYP_LOC100555755.1.1.m.58711,0.00491588973115351,-0.000600714720400964,No,NA,NA,A6BM72,NA,NA,NA,basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842],NA,NA,NA
CHOYP_LOC100555907.1.1.m.27452,-0.0222123762628743,0.000144638915211091,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100556034.2.2.m.15378,-0.00387981887940298,0.00698681963346349,No,NA,NA,Q5TFE4,NA,NA,NA,5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100556517.1.1.m.22221,-0.0125651325907097,0.0122630307671457,No,NA,NA,P79942,NA,NA,NA,metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; circadian regulation of gene expression [GO:0032922]; mRNA processing [GO:0006397],NA,NA,NA
CHOYP_LOC100558815.1.1.m.30536,-0.0035094677735101,0.00410307819229214,No,NA,NA,P23193,NA,NA,NA,nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; positive regulation of exoribonuclease activity [GO:1901919]; regulation of transcription; DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription-coupled nucleotide-excision repair [GO:0006283],NA,NA,NA
CHOYP_LOC100558843.1.1.m.14396,-0.0105148324150297,-0.0128844718187091,No,NA,NA,Q5VWZ2,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; carboxylic ester hydrolase activity [GO:0052689]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; protein depalmitoylation [GO:0002084],NA,NA,NA
CHOYP_LOC100559879.1.1.m.8598,0.000426157375360258,-0.0173145475894432,No,NA,NA,Q9D8N6,NA,NA,NA,transcriptional repressor complex [GO:0017053],NA,NA,NA
CHOYP_LOC100559941.1.2.m.12240,-0.00103237195007071,-0.0225650052490568,No,NA,NA,Q3TLH4,NA,NA,NA,cytosol [GO:0005829]; protein C-terminus binding [GO:0008022]; hematopoietic progenitor cell differentiation [GO:0002244],NA,NA,NA
CHOYP_LOC100560334.2.3.m.42997,0.0141366310985854,0.0017533003003544,No,NA,NA,Q9DAG6,NA,NA,NA,acrosomal vesicle [GO:0001669]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; sperm connecting piece [GO:0097224]; binding of sperm to zona pellucida [GO:0007339],NA,NA,NA
CHOYP_LOC100560768.1.1.m.18804,-0.0139799538483894,-0.0048187830717265,No,NA,NA,Q6PBT7,NA,NA,NA,integral component of membrane [GO:0016021]; PAM complex; Tim23 associated import motor [GO:0001405]; ATPase activator activity [GO:0001671]; protein import into mitochondrial matrix [GO:0030150],NA,NA,NA
CHOYP_LOC100561086.1.1.m.13015,-0.0128383582601189,-0.0181278191661337,No,NA,NA,Q7Z9I4,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; oxidoreductase activity [GO:0016491]; cellular detoxification of aldehyde [GO:0110095],NA,NA,NA
CHOYP_LOC100561262.1.1.m.16846,-0.0152046233768395,-0.0136051981818496,No,NA,NA,P47791,NA,NA,NA,cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; glutathione binding [GO:0043295]; glutathione-disulfide reductase activity [GO:0004362]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glutathione metabolic process [GO:0006749]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100561410.1.1.m.58687,-0.00339539774183413,-0.00944971341993303,No,NA,NA,Q9P000,NA,NA,NA,cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; cholesterol homeostasis [GO:0042632]; neutrophil degranulation [GO:0043312]; sodium ion transport [GO:0006814],NA,NA,NA
CHOYP_LOC100561810.1.1.m.8656,-0.00484688822068648,-0.0248374564099887,No,NA,NA,Q80UY1,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; carnosine N-methyltransferase activity [GO:0030735]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; carnosine metabolic process [GO:0035498],NA,NA,NA
CHOYP_LOC100561894.1.1.m.45814,-0.019741262600332,0.0107955099164579,No,NA,NA,P20072,NA,NA,NA,chromaffin granule membrane [GO:0042584]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to salt stress [GO:0009651]; social behavior [GO:0035176],NA,NA,NA
CHOYP_LOC100562697.1.1.m.27375,-0.0012035766918869,0.0198703959966833,No,NA,NA,Q3SZ45,NA,NA,NA,extracellular region [GO:0005576]; membrane [GO:0016020],NA,NA,NA
CHOYP_LOC100562954.1.1.m.27429,-0.000969810489654077,0.00107085130083546,No,NA,NA,O70309,NA,NA,NA,cell leading edge [GO:0031252]; cell surface [GO:0009986]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; integral component of synaptic membrane [GO:0099699]; integrin alphav-beta5 complex [GO:0034684]; integrin complex [GO:0008305]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; integrin binding [GO:0005178]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_LOC100563402.1.1.m.5257,0.00115665407271866,0.000912310924392685,No,NA,NA,P82596,NA,NA,NA,carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_LOC100563554.1.1.m.49953,0.0105773176573203,-0.00575585674637545,No,NA,NA,Q1LY46,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; calcium ion binding [GO:0005509]; calcium:proton antiporter activity [GO:0015369]; ribosome binding [GO:0043022]; calcium export from the mitochondrion [GO:0099093]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260],NA,NA,NA
CHOYP_LOC100563867.1.1.m.11836,0.0112533617366834,0.00494816618114806,No,NA,NA,Q8BGB5,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100563952.1.1.m.30232,0.00908760975989415,0.0228801424231235,No,NA,NA,Q32PA9,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755],NA,NA,NA
CHOYP_LOC100564140.2.2.m.10031,0.00010097112975703,-0.0125350769495233,No,NA,NA,Q92010,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; negative regulation of transcription; DNA-templated [GO:0045892],NA,NA,NA
CHOYP_LOC100564354.1.1.m.46361,0.00462330369460042,-0.00345206442508605,No,NA,NA,Q9NQP4,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457],NA,NA,NA
CHOYP_LOC100564832.1.1.m.43026,-0.00264328780638909,0.0112362048154664,No,NA,NA,Q95JD5,NA,NA,NA,cytoplasm [GO:0005737]; aryl sulfotransferase activity [GO:0004062]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; epithelial cell differentiation [GO:0030855]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805],NA,NA,NA
CHOYP_LOC100565366.1.1.m.49990,0.0124687935229811,-0.0101264002853509,No,NA,NA,Q5SFM8,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; mRNA processing [GO:0006397]; positive regulation of RNA export from nucleus [GO:0046833],NA,NA,NA
CHOYP_LOC100565534.1.3.m.28075,-0.019230072854174,-0.0126509471217789,No,NA,NA,P02597,NA,NA,NA,nucleus [GO:0005634]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]; spindle pole body organization [GO:0051300],NA,NA,NA
CHOYP_LOC100565534.2.3.m.29570,-0.00346996667953164,-0.0143151245505028,No,NA,NA,Q40302,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC100566943.1.2.m.35349,-0.00328675458653285,-0.0136426696389636,No,NA,NA,P02693,NA,NA,NA,apical cortex [GO:0045179]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; fatty acid binding [GO:0005504]; long-chain fatty acid binding [GO:0036041]; long-chain fatty acid transporter activity [GO:0005324]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; intestinal absorption [GO:0050892]; long-chain fatty acid transport [GO:0015909],NA,NA,NA
CHOYP_LOC100566968.1.1.m.15268,0.00855761359848732,0.00567872302711235,No,NA,NA,Q8AXY6,NA,NA,NA,cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt-protein binding [GO:0017147]; anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_LOC100567114.1.1.m.39091,0.0220344922011703,-0.0117089552774152,No,NA,NA,Q3T052,NA,NA,NA,extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; response to cytokine [GO:0034097],NA,NA,NA
CHOYP_LOC100567407.1.1.m.8503,-0.00559499431561679,0.00263768511059237,No,NA,NA,Q5RB75,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100567969.1.1.m.26460,-0.00973097118092192,0.0104240950359201,No,NA,NA,P36876,NA,NA,NA,cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; protein phosphatase type 2A complex [GO:0000159]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase activity [GO:0004722]; protein-containing complex binding [GO:0044877]; tau protein binding [GO:0048156]; mitotic cell cycle [GO:0000278]; peptidyl-serine dephosphorylation [GO:0070262]; response to morphine [GO:0043278],NA,NA,NA
CHOYP_LOC100568234.1.1.m.60837,0.0098693140757101,-0.00106003126834597,No,NA,NA,Q8R0F3,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; cupric ion binding [GO:1903135]; Formylglycine-generating oxidase activity [GO:0120147]; protein homodimerization activity [GO:0042803]; post-translational protein modification [GO:0043687]; protein oxidation [GO:0018158],NA,NA,NA
CHOYP_LOC100571875.1.1.m.48861,-0.0104472992832424,0.00351137216031712,No,NA,NA,Q16595,NA,NA,NA,cytosol [GO:0005829]; L-cysteine desulfurase complex [GO:1990221]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 2 iron; 2 sulfur cluster binding [GO:0051537]; ferric iron binding [GO:0008199]; ferrous iron binding [GO:0008198]; ferroxidase activity [GO:0004322]; iron chaperone activity [GO:0034986]; adult walking behavior [GO:0007628]; aerobic respiration [GO:0009060]; cellular iron ion homeostasis [GO:0006879]; cellular response to hydrogen peroxide [GO:0070301]; embryo development ending in birth or egg hatching [GO:0009792]; heme biosynthetic process [GO:0006783]; ion transport [GO:0006811]; iron incorporation into metallo-sulfur cluster [GO:0018283]; iron-sulfur cluster assembly [GO:0016226]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of organ growth [GO:0046621]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; oxidative phosphorylation [GO:0006119]; positive regulation of aconitate hydratase activity [GO:1904234]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell growth [GO:0030307]; positive regulation of cell proliferation [GO:0008284]; positive regulation of lyase activity [GO:0051349]; positive regulation of succinate dehydrogenase activity [GO:1904231]; proprioception [GO:0019230]; protein autoprocessing [GO:0016540]; regulation of ferrochelatase activity [GO:0010722]; response to iron ion [GO:0010039]; small molecule metabolic process [GO:0044281],NA,NA,NA
CHOYP_LOC100575377.1.10.m.10592,-0.00476977023804366,-0.0112240094111734,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100576447.2.2.m.55515,-0.0169591047060434,0.00960206869202777,No,NA,NA,Q9CR48,NA,NA,NA,apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; photoreceptor inner segment [GO:0001917]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; photoreceptor cell maintenance [GO:0045494]; regulation of autophagy [GO:0010506]; visual perception [GO:0007601],NA,NA,NA
CHOYP_LOC100577801.1.1.m.7007,0.00394536801625317,0.00291369700370642,No,NA,NA,Q9VPQ6,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II transcription factor binding [GO:0001085]; transcription factor binding [GO:0008134]; amnioserosa maintenance [GO:0046665]; chaeta development [GO:0022416]; compound eye development [GO:0048749]; dorsal closure [GO:0007391]; dorsal closure; leading edge cell fate determination [GO:0007393]; ectoderm development [GO:0007398]; germ-band shortening [GO:0007390]; head involution [GO:0008258]; heart development [GO:0007507]; hemopoiesis [GO:0030097]; larval lymph gland hemopoiesis [GO:0035167]; lymph gland crystal cell differentiation [GO:0035170]; lymph gland development [GO:0048542]; lymph gland plasmatocyte differentiation [GO:0035169]; negative regulation of cell fate specification [GO:0009996]; negative regulation of crystal cell differentiation [GO:0042690]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pigment metabolic process [GO:0042440]; regulation of antimicrobial peptide biosynthetic process [GO:0002805]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100617548.1.1.m.64248,-0.00430894344577715,-0.00631540690244347,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100618341.1.1.m.42477,-0.000728252067383906,0.00233674940960615,No,NA,NA,O15394,NA,NA,NA,axon [GO:0030424]; integral component of membrane [GO:0016021]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; axonal fasciculation [GO:0007413]; neuron cell-cell adhesion [GO:0007158]; sensory perception of smell [GO:0007608],NA,NA,NA
CHOYP_LOC100619435.1.2.m.28884,-0.000643013865734995,-0.0180434545117918,No,NA,NA,P97576,NA,NA,NA,mitochondrion [GO:0005739]; PAM complex; Tim23 associated import motor [GO:0001405]; adenyl-nucleotide exchange factor activity [GO:0000774]; ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; chaperone binding [GO:0051087]; protein homodimerization activity [GO:0042803]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; protein import into mitochondrial matrix [GO:0030150],NA,NA,NA
CHOYP_LOC100631809.1.2.m.30895,-0.0130857507551871,0.0155702394301267,No,NA,NA,Q9QXT1,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; PDZ domain binding [GO:0030165]; phosphatidylinositol-3;4;5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3;4-bisphosphate binding [GO:0043325],NA,NA,NA
CHOYP_LOC100632370.1.1.m.25156,-0.00619753442390353,-0.0142850546228021,No,NA,NA,Q9FKK7,NA,NA,NA,endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]; metal ion binding [GO:0046872]; xylose isomerase activity [GO:0009045]; D-xylose metabolic process [GO:0042732],NA,NA,NA
CHOYP_LOC100632618.1.3.m.23426,-0.00212078832001384,-0.00891837260408135,No,NA,NA,Q9FE17,NA,NA,NA,nucleus [GO:0005634]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]; histone H3-K9 acetylation [GO:0043970],NA,NA,NA
CHOYP_LOC100632618.2.3.m.30752,-0.0135725579708753,0.00388604629968508,No,NA,NA,B8ARK7,NA,NA,NA,nucleus [GO:0005634]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]; histone H3-K9 acetylation [GO:0043970],NA,NA,NA
CHOYP_LOC100632738.1.1.m.4911,-0.00455845334068297,0.0144757181352869,No,NA,NA,O14082,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_LOC100632832.1.1.m.45608,-0.0138059299757141,-0.0149849458360691,No,NA,NA,Q9ET47,NA,NA,NA,actin cytoskeleton [GO:0015629]; brush border [GO:0005903]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; filamentous actin [GO:0031941]; microvillus [GO:0005902]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421]; stereocilium tip [GO:0032426]; actin filament binding [GO:0051015]; SH3 domain binding [GO:0017124]; actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; locomotory behavior [GO:0007626]; negative regulation of cytoskeleton organization [GO:0051494]; parallel actin filament bundle assembly [GO:0030046]; positive regulation of filopodium assembly [GO:0051491]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_LOC100633041.1.1.m.35428,0.00768688170634097,-0.0214925063715171,No,NA,NA,Q13423,NA,NA,NA,integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial respirasome [GO:0005746]; mitochondrion [GO:0005739]; NAD binding [GO:0051287]; NAD(P)+ transhydrogenase (B-specific) activity [GO:0003957]; NAD(P)+ transhydrogenase activity [GO:0008746]; NADP binding [GO:0050661]; cell redox homeostasis [GO:0045454]; cellular oxidant detoxification [GO:0098869]; NADPH regeneration [GO:0006740]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein phosphorylation [GO:0001933]; oxidation-reduction process [GO:0055114]; oxygen homeostasis [GO:0032364]; positive regulation of hydrogen peroxide catabolic process [GO:1903285]; positive regulation of mitochondrial membrane potential [GO:0010918]; proton transmembrane transport [GO:1902600]; reactive oxygen species metabolic process [GO:0072593]; response to vitamin [GO:0033273]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_LOC100633059.1.1.m.20098,-0.00481032805098197,0.022479669697967,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100633075.1.4.m.4467,0.0064623664318755,0.00732106750476213,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100633077.1.4.m.4444,-0.00136723303157157,-0.00269824451000815,No,NA,NA,Q503L9,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; protein-disulfide reductase activity [GO:0047134]; cardiovascular system development [GO:0072358]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LOC100633077.4.4.m.62658,0.00444795519618857,0.0181928691384492,No,NA,NA,Q503L9,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; protein-disulfide reductase activity [GO:0047134]; cardiovascular system development [GO:0072358]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LOC100634021.1.1.m.53536,-0.00717763195112787,0.00255218830594178,No,NA,NA,Q8IYJ1,NA,NA,NA,extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; calcium-dependent phospholipid binding [GO:0005544]; cellular response to calcium ion [GO:0071277]; positive regulation of dendrite extension [GO:1903861],NA,NA,NA
CHOYP_LOC100634556.1.1.m.45015,0.00945883888873463,-0.00850486591168104,No,NA,NA,O19015,NA,NA,NA,lysosome [GO:0005764]; vacuole [GO:0005773]; beta-galactosidase activity [GO:0004565]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_LOC100634688.3.6.m.36725,0.0099378324498929,0.0135858710224193,No,NA,NA,P10155,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; U2 snRNA binding [GO:0030620]; cilium assembly [GO:0060271]; immune system development [GO:0002520]; response to UV [GO:0009411]; smoothened signaling pathway [GO:0007224]; transcription by RNA polymerase III [GO:0006383],NA,NA,NA
CHOYP_LOC100634688.6.6.m.63689,-0.00972534096351559,-0.0147857369001911,No,NA,NA,P10155,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; U2 snRNA binding [GO:0030620]; cilium assembly [GO:0060271]; immune system development [GO:0002520]; response to UV [GO:0009411]; smoothened signaling pathway [GO:0007224]; transcription by RNA polymerase III [GO:0006383],NA,NA,NA
CHOYP_LOC100634891.1.1.m.11488,-0.0054596453308008,-0.0174590175073697,No,NA,NA,F6PHZ6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; synaptonemal complex [GO:0000795]; Hsp90 protein binding [GO:0051879]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; piRNA metabolic process [GO:0034587]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100635182.1.1.m.5368,0.012045535512634,0.00855692780432984,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100635245.3.4.m.44747,0.00780933759327587,0.0156894085746062,No,NA,NA,Q54GB3,NA,NA,NA,integral component of membrane [GO:0016021]; SNARE complex [GO:0031201]; transport vesicle membrane [GO:0030658]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; exocytosis [GO:0006887]; vesicle fusion [GO:0006906],NA,NA,NA
CHOYP_LOC100635352.1.1.m.9481,0.00491588973115351,-0.000600714720400964,No,NA,NA,Q2KI83,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA binding [GO:0003723]; negative regulation of transcription by RNA polymerase II [GO:0000122]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_LOC100635487.1.1.m.21915,0.0102407875367797,0.000974307622528125,No,NA,NA,Q0P4P2,NA,NA,NA,integral component of membrane [GO:0016021]; chitin binding [GO:0008061]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100635694.1.1.m.24761,-0.0126893008949772,-0.0205907878124443,No,NA,NA,P55008,NA,NA,NA,actin filament [GO:0005884]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; actin filament bundle assembly [GO:0051017]; actin filament polymerization [GO:0030041]; cellular response to extracellular stimulus [GO:0031668]; cellular response to hormone stimulus [GO:0032870]; cellular response to hydroperoxide [GO:0071447]; cellular response to interferon-gamma [GO:0071346]; cellular response to morphine [GO:0071315]; cerebellum development [GO:0021549]; inflammatory response [GO:0006954]; microglial cell activation [GO:0001774]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; negative regulation of smooth muscle cell proliferation [GO:0048662]; phagocytosis; engulfment [GO:0006911]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of muscle hyperplasia [GO:0014739]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell chemotaxis [GO:0071673]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T cell migration [GO:2000406]; positive regulation of T cell proliferation [GO:0042102]; Rac protein signal transduction [GO:0016601]; response to axon injury [GO:0048678]; response to electrical stimulus [GO:0051602]; response to glucocorticoid [GO:0051384]; ruffle assembly [GO:0097178],NA,NA,NA
CHOYP_LOC100635715.2.9.m.8040,0.0176065490159244,-0.00153539651208068,No,NA,NA,O16277,NA,NA,NA,nucleosome [GO:0000786]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; nucleosomal DNA binding [GO:0031492]; chromosome condensation [GO:0030261]; negative regulation of chromatin silencing [GO:0031936]; negative regulation of DNA recombination [GO:0045910]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100636110.1.2.m.5041,0.00600784369835683,-0.000323267448595563,No,NA,NA,Q04336,NA,NA,NA,mannosyl-oligosaccharide glucosidase activity [GO:0004573]; oligosaccharide metabolic process [GO:0009311],NA,NA,NA
CHOYP_LOC100636340.1.4.m.5143,-0.00311591358339994,-0.0209260146201946,No,NA,NA,Q9UGM3,NA,NA,NA,cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; heparan sulfate binding [GO:1904399]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; signaling pattern recognition receptor activity [GO:0008329]; zymogen binding [GO:0035375]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular protein metabolic process [GO:0044267]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100636340.3.4.m.44279,0.0116177085925235,-0.019202563408975,No,NA,NA,Q9UGM3,NA,NA,NA,cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; heparan sulfate binding [GO:1904399]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; signaling pattern recognition receptor activity [GO:0008329]; zymogen binding [GO:0035375]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular protein metabolic process [GO:0044267]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100636340.4.4.m.50991,0.00618031370104909,0.0010882437867739,No,NA,NA,Q9UGM3,NA,NA,NA,cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; heparan sulfate binding [GO:1904399]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; signaling pattern recognition receptor activity [GO:0008329]; zymogen binding [GO:0035375]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular protein metabolic process [GO:0044267]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100636433.3.4.m.27077,0.0210838291009229,0.00356114909284806,No,NA,NA,O42401,NA,NA,NA,extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; growth plate cartilage chondrocyte morphogenesis [GO:0003429],NA,NA,NA
CHOYP_LOC100636493.1.1.m.65727,0.019417962607518,-0.0179062266355842,No,NA,NA,Q2PZL6,NA,NA,NA,apical part of cell [GO:0045177]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307],NA,NA,NA
CHOYP_LOC100636568.1.1.m.16013,-0.010630088323484,0.00924569253325737,No,NA,NA,P10351,NA,NA,NA,cytosol [GO:0005829]; peroxisome [GO:0005777]; 2 iron; 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; arginine metabolic process [GO:0006525]; compound eye pigmentation [GO:0048072]; determination of adult lifespan [GO:0008340]; glycerophospholipid metabolic process [GO:0006650]; purine nucleobase metabolic process [GO:0006144]; pyrimidine nucleobase metabolic process [GO:0006206]; response to ethanol [GO:0045471]; tryptophan metabolic process [GO:0006568]; xanthine catabolic process [GO:0009115],NA,NA,NA
CHOYP_LOC100636813.1.1.m.19517,-0.0126154375111147,0.00417758913731239,No,NA,NA,Q66J85,NA,NA,NA,DNA binding [GO:0003677]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_LOC100637812.1.1.m.1303,-0.00727408668464633,0.0242100580476766,No,NA,NA,Q8WWF8,NA,NA,NA,cytoplasm [GO:0005737]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC100637925.1.4.m.34491,0.00954046937972415,0.00631988682559241,No,NA,NA,Q61555,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; limb morphogenesis [GO:0035108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583],NA,NA,NA
CHOYP_LOC100637925.3.4.m.48236,0.00716876075186775,0.00687583642171044,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100638337.1.1.m.19693,0.0125083992784102,0.0093222256405895,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100638372.1.1.m.60468,-0.00676678384936242,0.00217001066008049,No,NA,NA,Q75J93,NA,NA,NA,COPII vesicle coat [GO:0030127]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; zinc ion binding [GO:0008270]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100638431.10.10.m.59513,-0.0169591047060434,0.00960206869202777,No,NA,NA,Q5UR67,NA,NA,NA,hydrolase activity; acting on glycosyl bonds [GO:0016798]; metabolic process [GO:0008152],NA,NA,NA
CHOYP_LOC100638431.3.10.m.24462,-0.0132398014229284,-0.0060805562730714,No,NA,NA,Q5UR67,NA,NA,NA,hydrolase activity; acting on glycosyl bonds [GO:0016798]; metabolic process [GO:0008152],NA,NA,NA
CHOYP_LOC100638431.4.10.m.48496,-0.00242081232970543,-0.000927264231167864,No,NA,NA,Q5UR67,NA,NA,NA,hydrolase activity; acting on glycosyl bonds [GO:0016798]; metabolic process [GO:0008152],NA,NA,NA
CHOYP_LOC100638431.8.10.m.58430,-0.00459026651192,0.00536491915387156,No,NA,NA,Q5UR67,NA,NA,NA,hydrolase activity; acting on glycosyl bonds [GO:0016798]; metabolic process [GO:0008152],NA,NA,NA
CHOYP_LOC100638860.2.2.m.44785,-0.00472521252451366,0.0152077230570968,No,NA,NA,O28987,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100638885.1.4.m.28187,-0.0149449047435053,-0.00245587612054804,No,NA,NA,Q95ND5,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; apoptotic process [GO:0006915]; erythrocyte differentiation [GO:0030218]; keratinocyte differentiation [GO:0030216]; neuron differentiation [GO:0030182]; positive regulation of amyloid-beta formation [GO:1902004]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100639369.1.1.m.23669,-0.000782033950351993,0.0109616906513174,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100639574.1.1.m.40201,0.00615966897194063,0.00941964587728867,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100639626.1.1.m.61641,0.00633015760822536,-0.00195909754186981,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100639879.1.1.m.38832,0.0103591185999127,0.00569611054323509,No,NA,NA,Q8WZ64,NA,NA,NA,cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phosphatidylinositol-3;4;5-trisphosphate binding [GO:0005547]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100640001.1.2.m.37241,0.0140753115909274,0.00813438352135127,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100640001.2.2.m.62667,0.0147232531493541,0.014564470406267,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100640206.1.1.m.48266,0.00410901239033212,-0.0188341066337241,No,NA,NA,O35075,NA,NA,NA,endosome [GO:0005768]; protein transporter activity [GO:0008565]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_LOC100640260.1.2.m.21931,-0.0225314172353169,0.0105536402117325,No,NA,NA,P49013,NA,NA,NA,extracellular space [GO:0005615]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC100640618.1.1.m.4378,0.0218776801222328,-0.00573207434259613,No,NA,NA,Q5U3U0,NA,NA,NA,dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100641267.1.2.m.49206,-0.00917180957740498,-0.00436881289518504,No,NA,NA,R9UTQ8,NA,NA,NA,iron ion binding [GO:0005506]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; 2-oxoglutarate as one donor; and incorporation of one atom each of oxygen into both donors [GO:0016706]; antibiotic biosynthetic process [GO:0017000]; antibiotic metabolic process [GO:0016999],NA,NA,NA
CHOYP_LOC100641267.2.2.m.57947,-0.0109950451704668,0.0149542658182439,No,NA,NA,R9UTQ8,NA,NA,NA,iron ion binding [GO:0005506]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; 2-oxoglutarate as one donor; and incorporation of one atom each of oxygen into both donors [GO:0016706]; antibiotic biosynthetic process [GO:0017000]; antibiotic metabolic process [GO:0016999],NA,NA,NA
CHOYP_LOC100641892.1.1.m.56601,0.0105861423124716,0.000296514932007269,No,NA,NA,P19623,NA,NA,NA,cytosol [GO:0005829]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; spermidine synthase activity [GO:0004766]; cellular response to leukemia inhibitory factor [GO:1990830]; polyamine biosynthetic process [GO:0006596]; polyamine metabolic process [GO:0006595]; spermidine biosynthetic process [GO:0008295],NA,NA,NA
CHOYP_LOC100641969.1.1.m.7196,0.0161329901548406,-0.00728536374998392,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100642024.1.2.m.38402,-0.00519914717333733,0.0228546010838915,No,NA,NA,Q8MPM1,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin filament binding [GO:0051015]; actin filament capping [GO:0051693],NA,NA,NA
CHOYP_LOC100642349.1.1.m.53035,0.0108017737872244,-0.0137829496021056,No,NA,NA,Q6DKB0,NA,NA,NA,cytoplasm [GO:0005737]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; nucleotide metabolic process [GO:0009117],NA,NA,NA
CHOYP_LOC100642494.1.1.m.58088,0.00424667047444334,-0.0133148068822201,No,NA,NA,Q3V384,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; mitochondrial electron transport; cytochrome c to oxygen [GO:0006123]; mitochondrial protein catabolic process [GO:0035694]; mitochondrion organization [GO:0007005],NA,NA,NA
CHOYP_LOC100642680.1.1.m.6611,-0.0181761555664149,-0.0111229170453046,No,NA,NA,Q8TCA0,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100642881.1.1.m.14183,0.000714568070749229,-0.00239217671837662,No,NA,NA,Q8NCN5,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; [pyruvate dehydrogenase (lipoamide)] phosphatase activity [GO:0004741]; oxidoreductase activity [GO:0016491]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510],NA,NA,NA
CHOYP_LOC100642891.1.1.m.25638,0.00771854194239825,-0.0173107404970519,No,NA,NA,Q1LZ96,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; proton-transporting ATP synthase complex assembly [GO:0043461],NA,NA,NA
CHOYP_LOC100642891.1.1.m.25639,-0.00446022880851629,-0.018772160104197,No,NA,NA,Q9CPY6,NA,NA,NA,ubiquitin ligase complex [GO:0000151]; ubiquitin protein ligase activity [GO:0061630]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_LOC100642984.1.1.m.28915,0.00560875828625818,-0.00374470102556216,No,NA,NA,Q9UM13,NA,NA,NA,anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein K11-linked ubiquitination [GO:0070979]; regulation of mitotic cell cycle phase transition [GO:1901990],NA,NA,NA
CHOYP_LOC100643070.1.1.m.40176,-0.00843693415174318,-0.00473640371860939,No,NA,NA,Q24498,NA,NA,NA,calcium channel complex [GO:0034704]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasmic reticulum membrane [GO:0033017]; smooth endoplasmic reticulum [GO:0005790]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; calcium-induced calcium release activity [GO:0048763]; ryanodine-sensitive calcium-release channel activity [GO:0005219]; calcium ion transport [GO:0006816]; heart contraction [GO:0060047]; multicellular organism development [GO:0007275]; muscle contraction [GO:0006936]; regulation of hemocyte proliferation [GO:0035206]; release of sequestered calcium ion into cytosol [GO:0051209]; response to anesthetic [GO:0072347],NA,NA,NA
CHOYP_LOC100644321.3.7.m.24037,0.00426642286164858,0.00317919175415788,No,NA,NA,Q9NZN5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266],NA,NA,NA
CHOYP_LOC100644321.6.7.m.56495,-0.00560644620140784,-0.00703258778758936,No,NA,NA,Q9NZN5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266],NA,NA,NA
CHOYP_LOC100644613.1.1.m.55011,0.00540589268581918,-0.0102280954520574,No,NA,NA,A0R5M8,NA,NA,NA,dimethylhistidine N-methyltransferase activity [GO:0030745]; protein methyltransferase activity [GO:0008276]; ergothioneine biosynthesis from histidine via N-alpha;N-alpha;N-alpha-trimethyl-L-histidine [GO:0052704]; N-alpha;N-alpha;N-alpha-trimethyl-L-histidine biosynthesis from histidine [GO:0052707],NA,NA,NA
CHOYP_LOC100644701.2.2.m.54959,-0.0090917413296404,-0.00179599347727337,No,NA,NA,Q9UBI9,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; negative regulation of mitotic cell cycle [GO:0045930]; respiratory tube development [GO:0030323],NA,NA,NA
CHOYP_LOC100644701.2.2.m.54960,-0.00328177680812043,-0.00427436623456992,No,NA,NA,Q5PQP2,NA,NA,NA,Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; secretory granule [GO:0030141]; apoptotic process [GO:0006915],NA,NA,NA
CHOYP_LOC100645183.1.1.m.53488,1.29507154915472e-05,-0.0150051054665415,No,NA,NA,Q6NTN5,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatase regulator activity [GO:0019208]; regulation of GTPase activity [GO:0043087],NA,NA,NA
CHOYP_LOC100645380.1.1.m.14246,0.0229881675487837,0.00327546849682757,No,NA,NA,Q9DBG7,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; signal recognition particle receptor complex [GO:0005785]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; signal recognition particle binding [GO:0005047]; protein targeting [GO:0006605]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614],NA,NA,NA
CHOYP_LOC100645450.1.1.m.39898,0.0102836170169219,0.000860015242701103,No,NA,NA,O60502,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102167]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102571]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102166]; beta-N-acetylglucosaminidase activity [GO:0016231]; hyalurononglucosaminidase activity [GO:0004415]; glycoprotein catabolic process [GO:0006516]; glycoprotein metabolic process [GO:0009100]; N-acetylglucosamine metabolic process [GO:0006044]; protein deglycosylation [GO:0006517]; protein O-linked glycosylation [GO:0006493]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100645706.1.1.m.62733,-0.00236386082462365,-0.0251338618977813,No,NA,NA,A5D794,NA,NA,NA,cytosol [GO:0005829]; endosome [GO:0005768]; membrane [GO:0016020]; GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; endocytosis [GO:0006897]; regulation of protein transport [GO:0051223]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100646524.1.1.m.44445,0.00413721887367651,-0.00968873388973782,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100646535.1.1.m.61774,-0.0038611079737179,-0.00990193853414716,No,NA,NA,Q9W4E2,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; protein kinase A binding [GO:0051018]; compound eye cone cell differentiation [GO:0042675]; eye photoreceptor cell development [GO:0042462]; mushroom body development [GO:0016319]; neuromuscular junction development [GO:0007528]; olfactory learning [GO:0008355]; short-term memory [GO:0007614],NA,NA,NA
CHOYP_LOC100646574.1.1.m.55144,0.0179188751785895,-0.00590597833424524,No,NA,NA,Q7SXN5,NA,NA,NA,cell junction [GO:0030054]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; synaptic vesicle membrane [GO:0030672]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; apoptotic mitochondrial changes [GO:0008637]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; intracellular distribution of mitochondria [GO:0048312]; membrane fusion [GO:0061025]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; peroxisome fission [GO:0016559]; protein complex oligomerization [GO:0051259]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of mitochondrion organization [GO:0010821],NA,NA,NA
CHOYP_LOC100646810.1.1.m.25033,0.00649881388319064,-0.00968542024755994,No,NA,NA,O95045,NA,NA,NA,cytosol [GO:0005829]; type III intermediate filament [GO:0045098]; identical protein binding [GO:0042802]; uridine phosphorylase activity [GO:0004850]; nucleoside metabolic process [GO:0009116]; nucleotide catabolic process [GO:0009166]; pyrimidine nucleoside catabolic process [GO:0046135]; pyrimidine nucleoside salvage [GO:0043097]; UMP salvage [GO:0044206]; uridine metabolic process [GO:0046108],NA,NA,NA
CHOYP_LOC100647135.1.2.m.21531,-0.0126701982014055,0.0100506312982271,No,NA,NA,C9D7C2,NA,NA,NA,voltage-gated calcium channel complex [GO:0005891]; calcium ion binding [GO:0005509]; voltage-gated calcium channel activity [GO:0005245]; regulation of ion transmembrane transport [GO:0034765],NA,NA,NA
CHOYP_LOC100647521.2.2.m.59908,0.00104883573691527,0.0196754072962804,No,NA,NA,P50416,NA,NA,NA,integral component of mitochondrial outer membrane [GO:0031307]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; carnitine O-palmitoyltransferase activity [GO:0004095]; identical protein binding [GO:0042802]; palmitoleoyltransferase activity [GO:1990698]; carnitine metabolic process [GO:0009437]; carnitine shuttle [GO:0006853]; cellular response to fatty acid [GO:0071398]; circadian rhythm [GO:0007623]; eating behavior [GO:0042755]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; glucose metabolic process [GO:0006006]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of fatty acid beta-oxidation [GO:0032000]; protein homooligomerization [GO:0051260]; regulation of insulin secretion [GO:0050796]; regulation of lipid metabolic process [GO:0019216]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; triglyceride metabolic process [GO:0006641],NA,NA,NA
CHOYP_LOC100647948.1.1.m.9650,0.00605256964558612,-0.0258371854057353,No,NA,NA,Q91ZU6,NA,NA,NA,actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cytoplasmic microtubule organization [GO:0031122]; hemidesmosome assembly [GO:0031581]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060],NA,NA,NA
CHOYP_LOC100648051.2.2.m.61174,-0.00332967923891874,-0.0129055598513534,No,NA,NA,Q9V3J1,NA,NA,NA,plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; vacuolar proton-transporting V-type ATPase; V1 domain [GO:0000221]; proton-transporting ATPase activity; rotational mechanism [GO:0046961]; ATP hydrolysis coupled proton transport [GO:0015991]; determination of adult lifespan [GO:0008340]; dsRNA transport [GO:0033227],NA,NA,NA
CHOYP_LOC100648516.1.1.m.64902,0.0215325215670072,-0.00126425491032217,No,NA,NA,P21783,NA,NA,NA,integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793],NA,NA,NA
CHOYP_LOC100649130.1.1.m.58207,0.0215043261071745,0.0124649418755894,No,NA,NA,Q99323,NA,NA,NA,actomyosin contractile ring [GO:0005826]; apical cortex [GO:0045179]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell-cell contact zone [GO:0044291]; cilium [GO:0005929]; cleavage furrow [GO:0032154]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; myosin complex [GO:0016459]; myosin II complex [GO:0016460]; unconventional myosin complex [GO:0016461]; Z disc [GO:0030018]; actin binding [GO:0003779]; ATP binding [GO:0005524]; ATPase activity; coupled [GO:0042623]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; anterior midgut development [GO:0007496]; border follicle cell migration [GO:0007298]; cellular response to mechanical stimulus [GO:0071260]; compartment boundary maintenance [GO:0060289]; cuticle pattern formation [GO:0035017]; dorsal closure [GO:0007391]; dorsal closure; amnioserosa morphology change [GO:0046664]; dorsal closure; leading edge cell differentiation [GO:0046663]; dorsal closure; spreading of leading edge cells [GO:0007395]; establishment of neuroblast polarity [GO:0045200]; establishment of planar polarity [GO:0001736]; eye-antennal disc morphogenesis [GO:0007455]; head involution [GO:0008258]; imaginal disc-derived wing hair organization [GO:0035317]; left/right axis specification [GO:0070986]; maintenance of protein location in cell [GO:0032507]; Malpighian tubule morphogenesis [GO:0007443]; mitotic cytokinesis [GO:0000281]; morphogenesis of an epithelial fold [GO:0060571]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; myosin II filament assembly [GO:0031036]; ommatidial rotation [GO:0016318]; ovarian follicle cell migration [GO:0007297]; positive regulation of border follicle cell migration [GO:1903688]; protein complex oligomerization [GO:0051259]; regulation of myoblast fusion [GO:1901739]; regulation of tube length; open tracheal system [GO:0035159]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; spiracle morphogenesis; open tracheal system [GO:0035277]; wound healing [GO:0042060],NA,NA,NA
CHOYP_LOC100649205.1.1.m.39938,-0.0125593583391341,0.0200956161398696,No,NA,NA,O43257,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; nucleosome binding [GO:0031491]; histone exchange [GO:0043486]; regulation of histone deacetylation [GO:0031063],NA,NA,NA
CHOYP_LOC100649375.1.1.m.21222,0.00441432339407409,-0.00484184013656523,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100650469.1.2.m.42139,-0.0128134311792014,-0.0175803775592063,No,NA,NA,Q9JM52,NA,NA,NA,axon [GO:0030424]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton reorganization [GO:0031532]; activation of protein kinase activity [GO:0032147]; chemical synaptic transmission [GO:0007268]; dendrite morphogenesis [GO:0048813]; MAPK cascade [GO:0000165]; multicellular organism development [GO:0007275]; negative thymic T cell selection [GO:0045060]; neuron cellular homeostasis [GO:0070050]; neuron projection morphogenesis [GO:0048812]; positive regulation of JNK cascade [GO:0046330]; positive regulation of p38MAPK cascade [GO:1900745]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of AMPA receptor activity [GO:2000311]; regulation of cell migration [GO:0030334]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell-matrix adhesion [GO:0001952]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_LOC100650552.1.1.m.44153,-0.00197763984654474,-0.0214808948645866,No,NA,NA,Q9VHN6,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100650613.1.1.m.10270,0.00354917310036108,0.000110127622034743,No,NA,NA,Q9UJX6,NA,NA,NA,anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ubiquitin protein ligase binding [GO:0031625]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic plasticity [GO:0031915]; protein K11-linked ubiquitination [GO:0070979]; regulation of mitotic cell cycle phase transition [GO:1901990],NA,NA,NA
CHOYP_LOC100650648.1.2.m.24726,0.00384127114287245,-0.0125300606888733,No,NA,NA,W0LYS5,NA,NA,NA,ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; molting cycle process [GO:0022404]; protein phosphorylation [GO:0006468],NA,NA,NA
CHOYP_LOC100650709.1.1.m.12958,-0.0115946822694222,-0.00371172163025784,No,NA,NA,Q9CQ90,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100651274.1.1.m.26220,-0.00895287155681836,0.0027782708546472,No,NA,NA,O54941,NA,NA,NA,nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; DNA binding [GO:0003677]; N-acetyltransferase activity [GO:0008080]; nuclear receptor binding [GO:0016922]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; negative regulation of transcription; DNA-templated [GO:0045892]; neurogenesis [GO:0022008]; nucleosome disassembly [GO:0006337],NA,NA,NA
CHOYP_LOC100651327.1.1.m.34619,-0.00328273754864262,0.0090040927370918,No,NA,NA,F1RD40,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; Ran GTPase binding [GO:0008536]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; axon choice point recognition [GO:0016198]; axon guidance [GO:0007411]; central nervous system projection neuron axonogenesis [GO:0021952]; developmental pigmentation [GO:0048066]; habenula development [GO:0021986]; neuromuscular process [GO:0050905]; regulation of axon guidance [GO:1902667]; regulation of pteridine metabolic process [GO:0042068]; retinal ganglion cell axon guidance [GO:0031290],NA,NA,NA
CHOYP_LOC100651687.1.1.m.39884,-0.0135725579708753,0.00388604629968508,No,NA,NA,Q76I76,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; actin binding [GO:0003779]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; actin cytoskeleton organization [GO:0030036]; protein dephosphorylation [GO:0006470]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of axonogenesis [GO:0050770]; regulation of lamellipodium assembly [GO:0010591],NA,NA,NA
CHOYP_LOC100653683.1.1.m.7478,-0.0132663227770922,-0.00514467458918569,No,NA,NA,Q9R0Z7,NA,NA,NA,cytosol [GO:0005829]; nuclear speck [GO:0016607]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC100655005.1.1.m.51334,-0.0085053255725155,-0.00428730361560869,No,NA,NA,Q6P4S8,NA,NA,NA,integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; blastocyst growth [GO:0001832]; inner cell mass cell proliferation [GO:0001833]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; snRNA processing [GO:0016180]; U2 snRNA 3'-end processing [GO:0034474],NA,NA,NA
CHOYP_LOC100656236.1.1.m.27240,0.00482337148703219,0.013657108509177,No,NA,NA,Q8HY12,NA,NA,NA,integral component of membrane [GO:0016021]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; adaptive immune response [GO:0002250]; endocytosis [GO:0006897]; innate immune response [GO:0045087],NA,NA,NA
CHOYP_LOC100658481.1.1.m.8712,0.00589175956800567,-0.00872264420518759,No,NA,NA,Q14978,NA,NA,NA,box C/D snoRNP complex [GO:0031428]; box H/ACA snoRNP complex [GO:0031429]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; box C/D snoRNA binding [GO:0034512]; box C/D snoRNP complex binding [GO:0062064]; box H/ACA snoRNA binding [GO:0034513]; box H/ACA snoRNP complex binding [GO:0062065]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; GTP binding [GO:0005525]; nuclear localization sequence binding [GO:0008139]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; RNA polymerase I core binding [GO:0001042]; transcription factor binding [GO:0008134]; box H/ACA snoRNA metabolic process [GO:0033979]; mitotic cell cycle [GO:0000278]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; nucleolus organization [GO:0007000]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of protein import into nucleus [GO:0042306]; regulation of translation [GO:0006417]; response to osmotic stress [GO:0006970]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_LOC100659825.1.1.m.62706,-0.00645206815007248,-0.00506412887585584,No,NA,NA,Q8K2L8,NA,NA,NA,endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; kinetochore [GO:0000776]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; TRAPP complex [GO:0030008]; endopeptidase activity [GO:0004175]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; metaphase plate congression [GO:0051310]; positive regulation of protein localization to kinetochore [GO:1905342]; protein complex oligomerization [GO:0051259]; regulation of kinetochore assembly [GO:0090234],NA,NA,NA
CHOYP_LOC100668913.1.1.m.6819,-0.0038805239089806,0.00230933581376624,No,NA,NA,Q9WVF8,NA,NA,NA,mitochondrion [GO:0005739]; cell maturation [GO:0048469]; chemokine (C-C motif) ligand 5 production [GO:0071609]; defense response to Gram-negative bacterium [GO:0050829]; inflammatory response [GO:0006954]; interleukin-15 production [GO:0032618]; natural killer cell differentiation [GO:0001779]; negative regulation of interleukin-17 production [GO:0032700]; neutrophil mediated killing of gram-negative bacterium [GO:0070945]; phagocytosis [GO:0006909]; positive regulation of interleukin-10 production [GO:0032733]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to defense-related host reactive oxygen species production [GO:0052567],NA,NA,NA
CHOYP_LOC100669963.1.1.m.57300,0.00840011970695674,-0.0147383314899403,No,NA,NA,Q5RJR8,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial nucleoid [GO:0042645]; nuclear envelope [GO:0005635]; organelle membrane [GO:0031090],NA,NA,NA
CHOYP_LOC100670231.1.1.m.6369,0.00249620275851205,0.00555195256624546,No,NA,NA,Q8BHT6,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; fucose metabolic process [GO:0006004]; protein glycosylation [GO:0006486],NA,NA,NA
CHOYP_LOC100672555.1.1.m.15827,-0.0168467312679898,-0.00415045010905411,No,NA,NA,B6D5P6,NA,NA,NA,axoneme [GO:0005930]; dynein complex binding [GO:0070840]; cilium assembly [GO:0060271]; motile cilium assembly [GO:0044458],NA,NA,NA
CHOYP_LOC100677972.1.1.m.12181,-0.0169591047060434,0.00960206869202778,No,NA,NA,Q60738,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of postsynaptic density membrane [GO:0099061]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; T-tubule [GO:0030315]; calcium channel inhibitor activity [GO:0019855]; zinc ion transmembrane transporter activity [GO:0005385]; cadmium ion transmembrane transport [GO:0070574]; calcium ion import [GO:0070509]; cellular calcium ion homeostasis [GO:0006874]; cellular zinc ion homeostasis [GO:0006882]; detoxification of cadmium ion [GO:0071585]; in utero embryonic development [GO:0001701]; negative regulation of calcium ion import [GO:0090281]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of zinc ion transmembrane import [GO:0071584]; zinc ion transport [GO:0006829],NA,NA,NA
CHOYP_LOC100678100.1.1.m.14602,-0.0119138747260626,-0.0163087322731156,No,NA,NA,B4U7S7,NA,NA,NA,cytoplasm [GO:0005737]; DNA binding [GO:0003677]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100678410.1.1.m.16114,-0.0128449905782374,-0.0149339524087866,No,NA,NA,Q3MII6,NA,NA,NA,autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; regulation of autophagosome maturation [GO:1901096],NA,NA,NA
CHOYP_LOC100679233.1.1.m.21455,-0.00982936030156013,0.0120833447043861,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100679608.1.3.m.1597,-0.00130835038299401,0.00783861963853934,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100679620.1.1.m.66367,-0.0115350010081412,-0.0134828551263958,No,NA,NA,Q6DFN1,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; mitochondrial respiratory chain complex I assembly [GO:0032981],NA,NA,NA
CHOYP_LOC100680210.1.1.m.5750,0.010445600708601,0.00638842829413094,No,NA,NA,Q02427,NA,NA,NA,nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA cis splicing; via spliceosome [GO:0045292]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100681683.1.1.m.60729,-0.00735436441576393,0.00562550415965933,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100689951.1.1.m.56514,0.0119389397903155,-0.00934543239931372,No,NA,NA,P11179,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; dihydrolipoyllysine-residue succinyltransferase activity [GO:0004149]; 2-oxoglutarate metabolic process [GO:0006103]; histone succinylation [GO:0106077]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_LOC100690782.1.1.m.26094,0.00649631291470445,-0.0120684547332113,No,NA,NA,A2VDC2,NA,NA,NA,mitochondrion [GO:0005739]; 3-hydroxyisobutyryl-CoA hydrolase activity [GO:0003860]; valine catabolic process [GO:0006574],NA,NA,NA
CHOYP_LOC100690874.1.2.m.62880,0.00786395378585164,0.00109764167558623,No,NA,NA,O14832,NA,NA,NA,cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; carboxylic acid binding [GO:0031406]; cofactor binding [GO:0048037]; ferrous iron binding [GO:0008198]; L-ascorbic acid binding [GO:0031418]; phytanoyl-CoA dioxygenase activity [GO:0048244]; 2-oxoglutarate metabolic process [GO:0006103]; fatty acid alpha-oxidation [GO:0001561]; isoprenoid metabolic process [GO:0006720]; methyl-branched fatty acid metabolic process [GO:0097089]; protein targeting to peroxisome [GO:0006625],NA,NA,NA
CHOYP_LOC100691034.1.2.m.10976,-0.00357163817825271,-0.00142352038306652,No,NA,NA,Q9D0S9,NA,NA,NA,mitochondrion [GO:0005739]; nucleolus [GO:0005730]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; apoptotic process [GO:0006915]; lipid catabolic process [GO:0016042]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; steroid biosynthetic process [GO:0006694],NA,NA,NA
CHOYP_LOC100691144.1.1.m.47006,0.010498095937336,0.0101142038031817,No,NA,NA,Q4QQW3,NA,NA,NA,mitochondrion [GO:0005739]; alcohol dehydrogenase (NAD) activity [GO:0004022]; hydroxyacid-oxoacid transhydrogenase activity [GO:0047988]; metal ion binding [GO:0046872]; glutamate catabolic process via 2-oxoglutarate [GO:0006539],NA,NA,NA
CHOYP_LOC100691455.1.1.m.3282,0.0118267380475,0.0154653345687476,No,NA,NA,Q505H4,NA,NA,NA,AMPA glutamate receptor complex [GO:0032281]; cell junction [GO:0030054]; extracellular space [GO:0005615]; synapse [GO:0045202]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of neuron differentiation [GO:0045666],NA,NA,NA
CHOYP_LOC100691486.1.1.m.24964,0.00781323997907545,0.0157130856279866,No,NA,NA,Q9Y305,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; acyl-CoA metabolic process [GO:0006637],NA,NA,NA
CHOYP_LOC100691486.1.1.m.24965,-0.00371652271042851,-0.0036953898854117,No,NA,NA,P62255,NA,NA,NA,ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100691601.2.2.m.40748,0.00394536801625317,0.00291369700370642,No,NA,NA,P31597,NA,NA,NA,apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; chloride transmembrane transporter activity [GO:0015108]; cysteine transmembrane transporter activity [GO:0033229]; glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; chloride transmembrane transport [GO:1902476]; cysteine transport [GO:0042883]; D-aspartate import across plasma membrane [GO:0070779]; L-aspartate import across plasma membrane [GO:0140009]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813],NA,NA,NA
CHOYP_LOC100691676.1.1.m.64226,-0.00486091508570501,0.014911032906552,No,NA,NA,Q9UKK9,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular [GO:0005622]; nucleus [GO:0005634]; 8-oxo-dGDP phosphatase activity [GO:0044715]; ADP-ribose diphosphatase activity [GO:0047631]; ADP-sugar diphosphatase activity [GO:0019144]; magnesium ion binding [GO:0000287]; nucleotidyltransferase activity [GO:0016779]; protein homodimerization activity [GO:0042803]; snoRNA binding [GO:0030515]; ATP generation from poly-ADP-D-ribose [GO:1990966]; chromatin remodeling [GO:0006338]; D-ribose catabolic process [GO:0019303]; nucleobase-containing small molecule catabolic process [GO:0034656]; nucleoside phosphate metabolic process [GO:0006753]; nucleotide metabolic process [GO:0009117]; ribonucleoside diphosphate catabolic process [GO:0009191]; ribose phosphate metabolic process [GO:0019693],NA,NA,NA
CHOYP_LOC100692139.1.1.m.27787,-0.013073606001621,-0.00899289913478079,No,NA,NA,O57478,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; 2 iron; 2 sulfur cluster binding [GO:0051537]; ferrochelatase activity [GO:0004325]; metal ion binding [GO:0046872]; heme biosynthetic process [GO:0006783],NA,NA,NA
CHOYP_LOC100692402.2.2.m.49856,0.00491588973115351,-0.000600714720400962,No,NA,NA,Q14624,NA,NA,NA,blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; platelet dense granule lumen [GO:0031089]; endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; platelet degranulation [GO:0002576]; response to cytokine [GO:0034097],NA,NA,NA
CHOYP_LOC100692418.1.1.m.55157,-0.0166669073124503,-0.00550787843267601,No,NA,NA,P45954,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; branched-chain amino acid catabolic process [GO:0009083]; fatty acid metabolic process [GO:0006631],NA,NA,NA
CHOYP_LOC100692418.1.1.m.55158,-0.00642676285530723,-0.00819381427099101,No,NA,NA,Q9D172,NA,NA,NA,mitochondrion [GO:0005739],NA,NA,NA
CHOYP_LOC100692795.2.2.m.50682,0.0131862776320831,0.0107034682599487,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100692883.1.1.m.5437,0.00912384026768386,-0.0171463902651698,No,NA,NA,Q5IS41,NA,NA,NA,extracellular matrix [GO:0031012]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_LOC100692894.1.1.m.10137,0.00615966897194063,0.00941964587728867,No,NA,NA,Q8WWT9,NA,NA,NA,extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; citrate transmembrane transporter activity [GO:0015137]; high-affinity sodium:dicarboxylate symporter activity [GO:0015362]; sodium:dicarboxylate symporter activity [GO:0017153]; succinate transmembrane transporter activity [GO:0015141]; citrate transport [GO:0015746],NA,NA,NA
CHOYP_LOC100693418.1.2.m.990,-0.0183311210055378,-0.00219636071853553,No,NA,NA,P56389,NA,NA,NA,cytosol [GO:0005829]; cytidine deaminase activity [GO:0004126]; identical protein binding [GO:0042802]; nucleoside binding [GO:0001882]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; cytidine deamination [GO:0009972]; negative regulation of cell growth [GO:0030308]; negative regulation of nucleotide metabolic process [GO:0045980]; protein homotetramerization [GO:0051289],NA,NA,NA
CHOYP_LOC100693418.2.2.m.56971,-0.010658062320235,-0.00685660269903692,No,NA,NA,P32320,NA,NA,NA,cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; tertiary granule lumen [GO:1904724]; cytidine deaminase activity [GO:0004126]; nucleoside binding [GO:0001882]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; cell surface receptor signaling pathway [GO:0007166]; cytidine deamination [GO:0009972]; cytosine metabolic process [GO:0019858]; negative regulation of cell growth [GO:0030308]; negative regulation of nucleotide metabolic process [GO:0045980]; neutrophil degranulation [GO:0043312]; protein homotetramerization [GO:0051289]; pyrimidine nucleoside salvage [GO:0043097]; pyrimidine-containing compound salvage [GO:0008655],NA,NA,NA
CHOYP_LOC100693575.1.1.m.19082,-0.00859684636468158,0.0114902032136905,No,NA,NA,Q8K4P0,NA,NA,NA,collagen trimer [GO:0005581]; fibrillar center [GO:0001650]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA polyadenylation [GO:0006378],NA,NA,NA
CHOYP_LOC100693708.1.1.m.7688,-0.00195546273565087,-0.0173444745789711,No,NA,NA,Q5RGU1,NA,NA,NA,extrinsic component of mitochondrial inner membrane [GO:0031314]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphorylation [GO:0016310]; protein phosphorylation [GO:0006468]; ubiquinone biosynthetic process [GO:0006744],NA,NA,NA
CHOYP_LOC100693867.1.1.m.27278,0.0113317695389773,-0.00553120961074212,No,NA,NA,Q03249,NA,NA,NA,cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; UDP-glucose:hexose-1-phosphate uridylyltransferase activity [GO:0008108]; zinc ion binding [GO:0008270]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; glycolytic process from galactose [GO:0061623]; UDP-glucose catabolic process [GO:0006258]; UDP-glucose metabolic process [GO:0006011],NA,NA,NA
CHOYP_LOC100694272.1.1.m.19247,-0.0102853294164486,-0.00817068543634218,No,NA,NA,P78318,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888]; B cell activation [GO:0042113]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of stress-activated MAPK cascade [GO:0032873]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of microtubule-based movement [GO:0060632]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100694623.1.1.m.14876,0.00787693331091573,0.0105570333553785,No,NA,NA,Q80Z30,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; cellular response to drug [GO:0035690]; negative regulation of protein kinase activity [GO:0006469]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of stress fiber assembly [GO:0051496],NA,NA,NA
CHOYP_LOC100694648.1.1.m.18881,0.00294762519182786,-0.0177407384046846,No,NA,NA,Q8K268,NA,NA,NA,ATP binding [GO:0005524]; ATPase activity [GO:0016887]; defense response to virus [GO:0051607],NA,NA,NA
CHOYP_LOC100694901.3.3.m.66949,-0.0104270879320081,-0.00787743116645187,No,NA,NA,Q3SZE2,NA,NA,NA,cytosol [GO:0005829]; prefoldin complex [GO:0016272]; protein binding involved in protein folding [GO:0044183]; unfolded protein binding [GO:0051082],NA,NA,NA
CHOYP_LOC100695151.2.2.m.30573,0.0184633409649137,-0.0122823595804131,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100695307.1.1.m.51209,-0.0107779733787838,-0.00544175078944272,No,NA,NA,A9JS71,NA,NA,NA,mitochondrion [GO:0005739]; catalytic activity [GO:0003824],NA,NA,NA
CHOYP_LOC100695438.1.1.m.8594,0.00644766861305429,0.0068731567523035,No,NA,NA,Q9QYE0,NA,NA,NA,nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; gland morphogenesis [GO:0022612]; multicellular organism growth [GO:0035264]; negative regulation of gene expression [GO:0010629]; organ growth [GO:0035265]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prostate gland growth [GO:0060736]; regulation of transcription; DNA-templated [GO:0006355]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_LOC100696358.1.1.m.27370,-0.00547685372413718,0.00598483192409482,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100696604.1.1.m.40638,0.00611892495381294,0.00283758995392218,No,NA,NA,Q5M9G3,NA,NA,NA,cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; P-body [GO:0000932]; postsynapse [GO:0098794]; RNA binding [GO:0003723]; negative regulation of translation [GO:0017148]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003],NA,NA,NA
CHOYP_LOC100696668.1.1.m.31105,-0.0217029559639057,0.00432933071467724,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100696985.1.1.m.17599,0.00555929940425942,0.0146466189865089,No,NA,NA,O43719,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2 snRNP [GO:0005686]; U2-type spliceosomal complex [GO:0005684]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; regulation of DNA-templated transcription; elongation [GO:0032784]; regulation of transcription by RNA polymerase II [GO:0006357]; viral genome replication [GO:0019079],NA,NA,NA
CHOYP_LOC100697247.1.2.m.37588,0.0118969983297693,-0.0023335926396215,No,NA,NA,Q60438,NA,NA,NA,endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC100697247.2.2.m.56896,0.00234810744416185,-0.0180414429630292,No,NA,NA,Q4V7M2,NA,NA,NA,endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC100697720.1.2.m.5790,0.00450694583589355,-0.00391244190312244,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100697793.5.6.m.62286,0.00491588973115351,-0.000600714720400963,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100697862.1.1.m.27738,-0.0167282463549489,-0.014369756494775,No,NA,NA,O02467,NA,NA,NA,lysosome [GO:0005764]; N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity [GO:0003948]; peptidase activity [GO:0008233],NA,NA,NA
CHOYP_LOC100698013.1.1.m.5420,-0.0138374026533186,0.00611928638762304,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100698240.2.4.m.14964,0.00364778592941831,-0.00872052841558097,No,NA,NA,G5ED84,NA,NA,NA,cell junction [GO:0030054]; Cul3-RING ubiquitin ligase complex [GO:0031463]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100698638.1.1.m.45171,0.00312662884738643,-0.012839486052595,No,NA,NA,A2AJ88,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; mitochondrial membrane [GO:0031966]; nuclear membrane [GO:0031965]; carboxylic ester hydrolase activity [GO:0052689]; lysophospholipase activity [GO:0004622]; lipid catabolic process [GO:0016042],NA,NA,NA
CHOYP_LOC100699093.1.1.m.20134,0.00737429990563872,0.0190134567817796,No,NA,NA,Q2KJC9,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; betaine-aldehyde dehydrogenase activity [GO:0008802]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; L-aminoadipate-semialdehyde dehydrogenase activity [GO:0004043]; glycine betaine biosynthetic process from choline [GO:0019285],NA,NA,NA
CHOYP_LOC100699161.1.1.m.35139,0.017566547986575,-0.00729066567383691,No,NA,NA,Q5U247,NA,NA,NA,exocyst [GO:0000145]; growth cone [GO:0030426]; perinuclear region of cytoplasm [GO:0048471]; exocytosis [GO:0006887]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC100699383.1.1.m.63490,0.0146758693688505,0.0155863101789322,No,NA,NA,Q95VY2,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC100699837.1.1.m.54956,0.00217997094733793,-0.00807271368859912,No,NA,NA,Q5E9P6,NA,NA,NA,integral component of endoplasmic reticulum membrane [GO:0030176]; fat cell differentiation [GO:0045444]; lipid catabolic process [GO:0016042]; lipid droplet organization [GO:0034389]; lipid storage [GO:0019915]; negative regulation of lipid catabolic process [GO:0050995],NA,NA,NA
CHOYP_LOC100699850.1.3.m.3523,-0.0076370304475039,0.0026276388605055,No,NA,NA,P22897,NA,NA,NA,cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898],NA,NA,NA
CHOYP_LOC100700188.1.1.m.30931,-0.0135725579708753,0.00388604629968508,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100700230.1.1.m.57851,-0.00565090790648802,-0.0155619252219612,No,NA,NA,A4IGH4,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; tRNA methyltransferase complex [GO:0043527]; tRNA (guanine-N7)-methylation [GO:0106004]; tRNA modification [GO:0006400],NA,NA,NA
CHOYP_LOC100700626.2.2.m.17262,0.00312665552046706,-0.0128377150549429,No,NA,NA,Q13395,NA,NA,NA,nucleus [GO:0005634]; RNA binding [GO:0003723]; tRNA (guanine) methyltransferase activity [GO:0016423]; regulation of transcription by RNA polymerase II [GO:0006357]; tRNA methylation [GO:0030488],NA,NA,NA
CHOYP_LOC100700757.1.1.m.23394,-0.000177937121919121,0.0200369517033763,No,NA,NA,Q8N0X4,NA,NA,NA,mitochondrion [GO:0005739]; (3S)-citramalyl-CoA lyase activity [GO:0047777]; magnesium ion binding [GO:0000287]; malate synthase activity [GO:0004474]; protein homotrimerization [GO:0070207]; regulation of cobalamin metabolic process [GO:0106064],NA,NA,NA
CHOYP_LOC100701105.1.1.m.56657,-0.00575476826949174,0.00187311026059274,No,NA,NA,Q91XF0,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; FMN binding [GO:0010181]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; pyridoxamine-phosphate oxidase activity [GO:0004733]; pyridoxal phosphate biosynthetic process [GO:0042823]; pyridoxine biosynthetic process [GO:0008615],NA,NA,NA
CHOYP_LOC100701406.1.1.m.23796,-0.0170467295459259,-0.00167809984633418,No,NA,NA,Q6UX04,NA,NA,NA,catalytic step 1 spliceosome [GO:0071012]; catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; mRNA splicing; via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413],NA,NA,NA
CHOYP_LOC100701551.1.7.m.3948,0.00620538221808548,-0.00599802173872107,No,NA,NA,Q9CQR2,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; rough endoplasmic reticulum [GO:0005791]; synapse [GO:0045202]; protein N-terminus binding [GO:0047485]; ribosome binding [GO:0043022]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000461],NA,NA,NA
CHOYP_LOC100701725.1.1.m.54512,0.0147681965547562,0.00228840907467454,No,NA,NA,Q8HXM1,NA,NA,NA,cleavage body [GO:0071920]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789],NA,NA,NA
CHOYP_LOC100702367.1.1.m.62543,-0.00148401386389408,-0.000209859516719261,No,NA,NA,Q5U3V9,NA,NA,NA,ESCRT II complex [GO:0000814]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328],NA,NA,NA
CHOYP_LOC100703090.1.1.m.46433,-0.00912426384048592,-0.0211830109556423,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100703202.1.1.m.10370,0.00785618791087249,-0.0145162719986428,No,NA,NA,Q503I8,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity [GO:0000224]; glycoprotein catabolic process [GO:0006516]; protein deglycosylation [GO:0006517]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515],NA,NA,NA
CHOYP_LOC100703289.1.1.m.53585,0.00466951230567633,-0.00417959334414345,No,NA,NA,Q8CF97,NA,NA,NA,endoplasmic reticulum [GO:0005783]; Golgi stack [GO:0005795]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; endoplasmic reticulum membrane fusion [GO:0016320]; Golgi organization [GO:0007030]; Golgi reassembly [GO:0090168]; mitotic cell cycle [GO:0000278]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_LOC100703423.1.1.m.940,-0.00373354298233327,-0.00916623222363352,No,NA,NA,P40939,NA,NA,NA,mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; enoyl-CoA hydratase activity [GO:0004300]; fatty-acyl-CoA binding [GO:0000062]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; NAD binding [GO:0051287]; protein-containing complex binding [GO:0044877]; fatty acid beta-oxidation [GO:0006635]; response to drug [GO:0042493]; response to insulin [GO:0032868],NA,NA,NA
CHOYP_LOC100703423.1.1.m.941,-0.00468851028202764,-0.0109987895849166,No,NA,NA,O46629,NA,NA,NA,endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; acetyl-CoA C-acyltransferase activity [GO:0003988]; enoyl-CoA hydratase activity [GO:0004300]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; fatty acid beta-oxidation [GO:0006635],NA,NA,NA
CHOYP_LOC100703585.2.4.m.39510,0.0122576422824091,0.0236883574694398,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100703956.1.1.m.31550,0.00491588973115352,-0.000600714720400963,No,NA,NA,Q8CGC6,NA,NA,NA,nucleolus [GO:0005730]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100704039.1.1.m.21695,0.00812222531162523,0.00613580984152279,No,NA,NA,E9PTA2,NA,NA,NA,cytoplasmic vesicle membrane [GO:0030659]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-release channel activity [GO:0015278]; cation channel activity [GO:0005261]; ligand-gated calcium channel activity [GO:0099604]; manganese ion transmembrane transporter activity [GO:0005384]; sodium channel activity [GO:0005272]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane import into cytosol [GO:0097553]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to purine-containing compound [GO:0071415]; cellular response to temperature stimulus [GO:0071502]; dendritic cell chemotaxis [GO:0002407]; dendritic cell differentiation [GO:0097028]; estrous cycle [GO:0044849]; positive regulation of insulin secretion [GO:0032024]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of filopodium assembly [GO:0051489]; release of sequestered calcium ion into cytosol [GO:0051209]; response to heat [GO:0009408]; response to hydroperoxide [GO:0033194]; temperature homeostasis [GO:0001659]; zinc ion transmembrane transport [GO:0071577],NA,NA,NA
CHOYP_LOC100704264.1.1.m.49420,-0.000159432170945898,-0.00602446196499919,No,NA,NA,P52333,NA,NA,NA,cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; cytokine-mediated signaling pathway [GO:0019221]; enzyme linked receptor protein signaling pathway [GO:0007167]; erythrocyte differentiation [GO:0030218]; innate immune response [GO:0045087]; interleukin-15-mediated signaling pathway [GO:0035723]; interleukin-2-mediated signaling pathway [GO:0038110]; interleukin-21-mediated signaling pathway [GO:0038114]; interleukin-4-mediated signaling pathway [GO:0035771]; interleukin-7-mediated signaling pathway [GO:0038111]; interleukin-9-mediated signaling pathway [GO:0038113]; intracellular signal transduction [GO:0035556]; JAK-STAT cascade involved in growth hormone signaling pathway [GO:0060397]; MAPK cascade [GO:0000165]; negative regulation of dendritic cell cytokine production [GO:0002731]; negative regulation of FasL biosynthetic process [GO:0045221]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of T cell activation [GO:0050868]; negative regulation of T-helper 1 cell differentiation [GO:0045626]; negative regulation of thymocyte apoptotic process [GO:0070244]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of T cell proliferation [GO:0042102]; protein phosphorylation [GO:0006468]; regulation of JAK-STAT cascade [GO:0046425]; regulation of T cell apoptotic process [GO:0070232]; response to interleukin-15 [GO:0070672]; response to interleukin-2 [GO:0070669]; response to interleukin-4 [GO:0070670]; response to interleukin-9 [GO:0071104]; T cell homeostasis [GO:0043029]; tyrosine phosphorylation of STAT protein [GO:0007260],NA,NA,NA
CHOYP_LOC100704562.1.1.m.25340,-0.0135396932517149,0.00396295730936893,No,NA,NA,Q8YWD8,NA,NA,NA,peptide-methionine (S)-S-oxide reductase activity [GO:0008113]; cellular protein modification process [GO:0006464],NA,NA,NA
CHOYP_LOC100704819.1.2.m.14210,0.0171709621363278,0.0132441664908692,No,NA,NA,Q9X248,NA,NA,NA,3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; fatty acid elongation [GO:0030497],NA,NA,NA
CHOYP_LOC100704819.2.2.m.49100,-0.0178651288360019,0.0137982358736921,No,NA,NA,Q9X248,NA,NA,NA,3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; fatty acid elongation [GO:0030497],NA,NA,NA
CHOYP_LOC100705265.3.3.m.40296,0.00615966897194063,0.00941964587728867,No,NA,NA,O70244,NA,NA,NA,apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi-associated vesicle [GO:0005798]; ionotropic glutamate receptor complex [GO:0008328]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; channel regulator activity [GO:0016247]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; adult locomotory behavior [GO:0008344]; cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import [GO:0020028]; hyperosmotic response [GO:0006972]; in utero embryonic development [GO:0001701]; positive regulation of synaptic transmission; glutamatergic [GO:0051968]; protein homotrimerization [GO:0070207]; receptor-mediated endocytosis [GO:0006898]; regulation of locomotion [GO:0040012]; response to nutrient [GO:0007584]; thigmotaxis [GO:0001966]; vitamin metabolic process [GO:0006766],NA,NA,NA
CHOYP_LOC100705460.1.3.m.4908,-0.00160040612968233,-0.0151539202891877,No,NA,NA,Q5RJ80,NA,NA,NA,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; dorsal/ventral pattern formation [GO:0009953]; negative regulation of translation [GO:0017148]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification [GO:2000055]; regulation of growth [GO:0040008],NA,NA,NA
CHOYP_LOC100705726.1.1.m.17900,-0.00528102254196845,0.011970583900887,No,NA,NA,Q8JZL3,NA,NA,NA,cytoplasm [GO:0005737]; magnesium ion binding [GO:0000287]; thiamin-triphosphatase activity [GO:0050333]; dephosphorylation [GO:0016311]; thiamine diphosphate metabolic process [GO:0042357]; thiamine metabolic process [GO:0006772],NA,NA,NA
CHOYP_LOC100705966.1.1.m.45957,0.0114136742396275,-0.011335489579453,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100706133.1.1.m.56708,-0.0146676882424621,0.00462132973057053,No,NA,NA,Q28EW0,NA,NA,NA,Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_LOC100706374.1.1.m.51988,-0.00685893324425993,0.00939412869402605,No,NA,NA,Q9UBS3,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; misfolded protein binding [GO:0051787]; B cell differentiation [GO:0030183]; immunoglobulin production [GO:0002377]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_LOC100706747.1.1.m.14818,-0.0159764198945283,0.0147872872478958,No,NA,NA,P23965,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; dodecenoyl-CoA delta-isomerase activity [GO:0004165]; enoyl-CoA hydratase activity [GO:0004300]; identical protein binding [GO:0042802]; fatty acid beta-oxidation [GO:0006635],NA,NA,NA
CHOYP_LOC100707249.1.1.m.15336,-0.00841704308340549,-0.00410591312472567,No,NA,NA,P50219,NA,NA,NA,cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; anatomical structure morphogenesis [GO:0009653]; endocrine pancreas development [GO:0031018]; humoral immune response [GO:0006959]; neuron projection morphogenesis [GO:0048812]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord motor neuron cell fate specification [GO:0021520],NA,NA,NA
CHOYP_LOC100707367.1.1.m.16292,0.00557301569194118,-0.00126171015881744,No,NA,NA,Q9JLV6,NA,NA,NA,mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; double-stranded DNA binding [GO:0003690]; nucleoside monophosphate kinase activity [GO:0050145]; polynucleotide 3'-phosphatase activity [GO:0046403]; dephosphorylation [GO:0016311]; DNA 3' dephosphorylation involved in DNA repair [GO:0098504]; DNA damage response; detection of DNA damage [GO:0042769]; DNA repair [GO:0006281]; negative regulation of protein ADP-ribosylation [GO:0010836]; nucleotide phosphorylation [GO:0046939]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_LOC100707656.1.1.m.10569,-0.0100514455422376,0.000306520417660023,No,NA,NA,Q8VXZ0,NA,NA,NA,chloroplast [GO:0009507]; 8-oxo-dGDP phosphatase activity [GO:0044715]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100707920.1.1.m.27511,0.00585510280536196,0.00260415077935646,No,NA,NA,Q8C4J7,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; snoRNA binding [GO:0030515]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462],NA,NA,NA
CHOYP_LOC100708024.1.2.m.7177,-0.00171267923646645,-0.00448059983061231,No,NA,NA,Q8VC31,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100708054.1.1.m.57813,0.0155851414562801,-0.00122560390542782,No,NA,NA,P42566,NA,NA,NA,aggresome [GO:0016235]; AP-2 adaptor complex [GO:0030122]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; ciliary membrane [GO:0060170]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; identical protein binding [GO:0042802]; polyubiquitin modification-dependent protein binding [GO:0031593]; SH3 domain binding [GO:0017124]; cell proliferation [GO:0008283]; clathrin coat assembly [GO:0048268]; endocytic recycling [GO:0032456]; epidermal growth factor receptor signaling pathway [GO:0007173]; Golgi to endosome transport [GO:0006895]; membrane organization [GO:0061024]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; positive regulation of receptor recycling [GO:0001921]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of cell proliferation [GO:0042127]; vesicle organization [GO:0016050]; viral entry into host cell [GO:0046718],NA,NA,NA
CHOYP_LOC100708199.3.6.m.23799,-0.0135725579708753,0.00388604629968508,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100708199.6.6.m.57028,-0.0135725579708753,0.00388604629968508,No,NA,NA,P10394,NA,NA,NA,aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074],NA,NA,NA
CHOYP_LOC100708329.1.1.m.3319,-0.00455092494964078,-0.0204966669957971,No,NA,NA,P47224,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; guanyl-nucleotide exchange factor activity [GO:0005085]; zinc ion binding [GO:0008270]; membrane fusion [GO:0061025]; post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031]; small GTPase mediated signal transduction [GO:0007264],NA,NA,NA
CHOYP_LOC100708602.1.1.m.65805,-0.0169591047060434,0.00960206869202777,No,NA,NA,Q66IH2,NA,NA,NA,nucleus [GO:0005634]; cell cycle [GO:0007049]; negative regulation of cell proliferation [GO:0008285],NA,NA,NA
CHOYP_LOC100708650.1.3.m.10354,0.0065883263884642,0.0180931628217626,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100708717.1.1.m.5825,-0.0096910190947773,0.00227371653222153,No,NA,NA,P07686,NA,NA,NA,acrosomal vesicle [GO:0001669]; azurophil granule [GO:0042582]; azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]; acetylglucosaminyltransferase activity [GO:0008375]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; astrocyte cell migration [GO:0043615]; cellular calcium ion homeostasis [GO:0006874]; cellular protein metabolic process [GO:0044267]; chondroitin sulfate catabolic process [GO:0030207]; ganglioside catabolic process [GO:0006689]; glycosphingolipid metabolic process [GO:0006687]; hyaluronan catabolic process [GO:0030214]; keratan sulfate catabolic process [GO:0042340]; lipid storage [GO:0019915]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; male courtship behavior [GO:0008049]; myelination [GO:0042552]; neuromuscular process controlling balance [GO:0050885]; neutrophil degranulation [GO:0043312]; oligosaccharide catabolic process [GO:0009313]; oogenesis [GO:0048477]; penetration of zona pellucida [GO:0007341]; phospholipid biosynthetic process [GO:0008654]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell shape [GO:0008360]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_LOC100708991.1.5.m.740,-0.00526856630644217,-0.0116934477682634,No,NA,NA,A6NMZ7,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_LOC100708991.2.5.m.29236,-0.0209264327605715,0.010359530057451,No,NA,NA,A2AX52,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208],NA,NA,NA
CHOYP_LOC100708991.3.5.m.40072,0.0025573172135247,0.0168685426579361,No,NA,NA,A6NMZ7,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_LOC100708991.5.5.m.59991,0.0221649431484844,-0.0105937602561756,No,NA,NA,A6NMZ7,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_LOC100709262.1.2.m.17960,0.00221043944363514,-0.0171472943072257,No,NA,NA,P15989,NA,NA,NA,collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]; growth plate cartilage chondrocyte morphogenesis [GO:0003429],NA,NA,NA
CHOYP_LOC100709316.1.1.m.17221,-0.00766001401373876,-0.00989260128606645,No,NA,NA,Q9TRY0,NA,NA,NA,axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; FK506 binding [GO:0005528]; heat shock protein binding [GO:0031072]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; chaperone-mediated protein folding [GO:0061077]; negative regulation of microtubule polymerization or depolymerization [GO:0031111]; negative regulation of neuron projection development [GO:0010977]; protein peptidyl-prolyl isomerization [GO:0000413],NA,NA,NA
CHOYP_LOC100709493.2.2.m.59425,0.0099273208534125,0.0153408812871197,No,NA,NA,A6NHC0,NA,NA,NA,cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; digestion [GO:0007586]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC100709538.1.2.m.4299,-0.0124910701679618,-0.0223514252084161,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100709617.1.1.m.10644,-0.0163128092311425,0.0197519627025014,No,NA,NA,Q76IC5,NA,NA,NA,cytosol [GO:0005829]; cysteine-type peptidase activity [GO:0008234]; pyroglutamyl-peptidase activity [GO:0016920]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC100709948.1.1.m.9245,-0.0147377863280934,-0.00954677332981564,No,NA,NA,Q5RHP9,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100710392.2.2.m.14004,0.00350342364607748,1.84759896519399e-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100710565.1.1.m.5315,-0.00786856049344802,-0.0110921795674322,No,NA,NA,O46640,NA,NA,NA,cytoplasm [GO:0005737]; amine sulfotransferase activity [GO:0047685],NA,NA,NA
CHOYP_LOC100710578.1.1.m.62426,-0.00659158475266926,-0.00163182668419715,No,NA,NA,Q29448,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; hydroxymethylglutaryl-CoA lyase activity [GO:0004419]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; ketone body biosynthetic process [GO:0046951]; leucine catabolic process [GO:0006552]; lipid metabolic process [GO:0006629]; mitochondrion organization [GO:0007005]; protein tetramerization [GO:0051262],NA,NA,NA
CHOYP_LOC100710612.1.1.m.5449,-0.00866961959337686,-0.0125970756799705,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100710670.1.2.m.7245,-0.000881558078446275,0.0119086058970628,No,NA,NA,Q4R4I6,NA,NA,NA,plasma membrane [GO:0005886]; actin binding [GO:0003779]; actin cytoskeleton organization [GO:0030036]; cell morphogenesis [GO:0000902],NA,NA,NA
CHOYP_LOC100710670.2.2.m.45011,0.0118350738834719,0.0221229557240637,No,NA,NA,Q4R4I6,NA,NA,NA,plasma membrane [GO:0005886]; actin binding [GO:0003779]; actin cytoskeleton organization [GO:0030036]; cell morphogenesis [GO:0000902],NA,NA,NA
CHOYP_LOC100710965.1.1.m.15140,-0.00698927205029367,0.0106347136926174,No,NA,NA,Q99ND9,NA,NA,NA,cytoplasm [GO:0005737]; polysome [GO:0005844]; androgen receptor signaling pathway [GO:0030521]; cell aging [GO:0007569]; cellular response to oxidative stress [GO:0034599]; cellular response to testosterone stimulus [GO:0071394]; cytoplasmic translation [GO:0002181]; positive regulation of androgen receptor activity [GO:2000825],NA,NA,NA
CHOYP_LOC100711334.1.1.m.16928,0.00752222177753988,0.00750227445572981,No,NA,NA,P17078,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; mRNA binding [GO:0003729]; ribonucleoprotein complex binding [GO:0043021]; structural constituent of ribosome [GO:0003735]; cellular response to UV-B [GO:0071493]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000463]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100711559.1.1.m.10313,0.00363100180712209,-0.00874694801358285,No,NA,NA,Q6NW52,NA,NA,NA,mitochondrion [GO:0005739]; actin binding [GO:0003779]; L-methionine-(R)-S-oxide reductase activity [GO:0033745]; metal ion binding [GO:0046872]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; actin filament polymerization [GO:0030041]; cellular response to oxidative stress [GO:0034599]; protein repair [GO:0030091],NA,NA,NA
CHOYP_LOC100711617.1.1.m.9209,-0.00682204354849481,0.00858017125909977,No,NA,NA,Q9D7M8,NA,NA,NA,cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; RNA polymerase II; core complex [GO:0005665]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleotide binding [GO:0000166]; translation initiation factor binding [GO:0031369]; mRNA export from nucleus in response to heat stress [GO:0031990]; nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:0000288]; positive regulation of translational initiation [GO:0045948]; recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex [GO:0034402]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367],NA,NA,NA
CHOYP_LOC100713637.1.1.m.16691,-0.0170820032887548,0.00587946956079828,No,NA,NA,Q5RL51,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],NA,NA,NA
CHOYP_LOC100714922.1.1.m.39817,0.00678620130084429,0.00878741825264137,No,NA,NA,Q9WTN5,NA,NA,NA,endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; NAADP-sensitive calcium-release channel activity [GO:0072345]; voltage-gated calcium channel activity [GO:0005245]; regulation of ion transmembrane transport [GO:0034765],NA,NA,NA
CHOYP_LOC100717261.1.1.m.51839,0.0166939754695776,0.00408749141858845,No,NA,NA,Q8JG30,NA,NA,NA,cytoplasm [GO:0005737]; sulfotransferase activity [GO:0008146]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805],NA,NA,NA
CHOYP_LOC100718468.1.1.m.11334,-0.00742120478735135,0.00213552885467937,No,NA,NA,Q96ER3,NA,NA,NA,extracellular space [GO:0005615]; nucleus [GO:0005634],NA,NA,NA
CHOYP_LOC100720440.1.2.m.11473,0.00194145689197431,-0.020371216613288,No,NA,NA,Q9Y4C0,NA,NA,NA,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; metal ion binding [GO:0046872]; neuroligin family protein binding [GO:0097109]; signaling receptor activity [GO:0038023]; adult behavior [GO:0030534]; axon guidance [GO:0007411]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; social behavior [GO:0035176]; vocalization behavior [GO:0071625],NA,NA,NA
CHOYP_LOC100721364.1.1.m.15879,-6.73488324789208e-05,0.0140568392319827,No,NA,NA,Q8IYB9,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100721584.1.1.m.52602,0.00820190889470985,0.00136035320933365,No,NA,NA,Q2M385,NA,NA,NA,integral component of membrane [GO:0016021]; defense response to bacterium [GO:0042742],NA,NA,NA
CHOYP_LOC100723342.1.1.m.58414,-0.00212078832001384,-0.00891837260408135,No,NA,NA,Q9UHB7,NA,NA,NA,ELL-EAF complex [GO:0032783]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023]; transcriptionally active chromatin [GO:0035327]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; spermatid development [GO:0007286]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368],NA,NA,NA
CHOYP_LOC100725472.1.2.m.5970,0.00561638532611702,-0.0134073693012663,No,NA,NA,Q95KI0,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100726220.1.1.m.8701,-0.0141396874740219,0.0115438949368037,No,NA,NA,Q6PEE2,NA,NA,NA,cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; regulation of translational initiation [GO:0006446],NA,NA,NA
CHOYP_LOC100726448.1.1.m.26536,-0.00482554791395029,0.00198818804316387,No,NA,NA,Q711G3,NA,NA,NA,hydrolase activity; acting on ester bonds [GO:0016788]; lipid catabolic process [GO:0016042],NA,NA,NA
CHOYP_LOC100727159.1.1.m.60272,0.00615966897194063,0.00941964587728867,No,NA,NA,Q5SSZ7,NA,NA,NA,integral component of plasma membrane [GO:0005887]; frizzled binding [GO:0005109]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; limb development [GO:0060173]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of Wnt signaling pathway [GO:0030178]; protein ubiquitination [GO:0016567]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of Wnt signaling pathway; planar cell polarity pathway [GO:2000095]; stem cell proliferation [GO:0072089]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt receptor catabolic process [GO:0038018]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LOC100727208.1.1.m.9365,-0.00430894344577715,-0.00631540690244347,No,NA,NA,Q5U2Z0,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_LOC100727208.1.1.m.9366,0.000231245222690431,0.00278207638860404,No,NA,NA,Q6AXS5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; mRNA 3'-UTR binding [GO:0003730]; regulation of apoptotic process [GO:0042981],NA,NA,NA
CHOYP_LOC100728625.2.2.m.51928,-0.0168309673363552,-0.000430424606731347,No,NA,NA,Q9S9V0,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; abscisic acid-activated signaling pathway [GO:0009738]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; response to salicylic acid [GO:0009751],NA,NA,NA
CHOYP_LOC100729623.1.2.m.6310,0.0061746090207096,0.00106278960224929,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100730443.1.1.m.57698,-0.00527933252423398,0.000582864411119333,No,NA,NA,Q4V348,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100740246.1.1.m.25108,-0.002479091320379,-0.00392089419652863,No,NA,NA,A9C3P0,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_LOC100740578.1.1.m.65702,-0.00924644934117065,-0.0187545572389163,No,NA,NA,Q04870,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; promoter-specific chromatin binding [GO:1990841]; transferase activity [GO:0016740]; negative regulation of protein binding [GO:0032091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; transcription initiation from RNA polymerase II promoter [GO:0006367],NA,NA,NA
CHOYP_LOC100740873.1.1.m.46472,-0.0135725579708752,0.00388604629968508,No,NA,NA,Q14517,NA,NA,NA,apical plasma membrane [GO:0016324]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; actin filament organization [GO:0007015]; anatomical structure morphogenesis [GO:0009653]; camera-type eye morphogenesis [GO:0048593]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; epithelial cell morphogenesis [GO:0003382]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],NA,NA,NA
CHOYP_LOC100741247.2.2.m.27816,-0.00189723858915257,-0.00269549011161288,No,NA,NA,Q9Z1G4,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase; V0 domain [GO:0000220]; ATPase binding [GO:0051117]; proton-transporting ATPase activity; rotational mechanism [GO:0046961]; ATP hydrolysis coupled proton transport [GO:0015991]; regulation of macroautophagy [GO:0016241]; toxin transport [GO:1901998]; vacuolar acidification [GO:0007035],NA,NA,NA
CHOYP_LOC100741250.1.2.m.48951,0.0139523458142009,-0.000320477792456618,No,NA,NA,P79098,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC100741406.1.1.m.29038,0.00087822284746742,-0.00386690988759034,No,NA,NA,Q6PD03,NA,NA,NA,centrosome [GO:0005813]; chromosome; centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; Z disc [GO:0030018]; kinase binding [GO:0019900]; phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase activator activity [GO:0072542]; negative regulation of lipid kinase activity [GO:0090219]; negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of protein dephosphorylation [GO:0035307]; protein dephosphorylation [GO:0006470]; regulation of protein autophosphorylation [GO:0031952]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100742152.1.2.m.4504,0.0123732130203662,-0.0211440976299762,No,NA,NA,Q5ZLR5,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; 2 iron; 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; ubiquinol-cytochrome-c reductase activity [GO:0008121]; mitochondrial electron transport; ubiquinol to cytochrome c [GO:0006122],NA,NA,NA
CHOYP_LOC100742289.1.1.m.25180,0.00990647700219986,-0.0201985721774128,No,NA,NA,Q91447,NA,NA,NA,cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713],NA,NA,NA
CHOYP_LOC100743250.1.1.m.12309,-0.00734858627897417,0.0135751987749185,No,NA,NA,Q14642,NA,NA,NA,membrane [GO:0016020]; plasma membrane [GO:0005886]; inositol-1;3;4;5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1;4;5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; PH domain binding [GO:0042731]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; inositol phosphate-mediated signaling [GO:0048016]; phosphatidylinositol dephosphorylation [GO:0046856],NA,NA,NA
CHOYP_LOC100743251.1.1.m.16814,-0.0162836076496243,0.00272315452326554,No,NA,NA,Q8BMF3,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; malic enzyme activity [GO:0004470]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; oxaloacetate decarboxylase activity [GO:0008948]; malate metabolic process [GO:0006108]; oxidation-reduction process [GO:0055114]; pyruvate metabolic process [GO:0006090],NA,NA,NA
CHOYP_LOC100743492.1.1.m.58896,0.0183730352571574,-0.00241861058677693,No,NA,NA,P49963,NA,NA,NA,signal recognition particle; endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; SRP-dependent cotranslational protein targeting to membrane; signal sequence recognition [GO:0006617]; SRP-dependent cotranslational protein targeting to membrane; translocation [GO:0006616],NA,NA,NA
CHOYP_LOC100743548.1.2.m.18991,0.0174344810444727,0.00633489923995348,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100743601.1.1.m.37797,-0.00768249967529315,-0.00487946038490948,No,NA,NA,Q00963,NA,NA,NA,apicolateral plasma membrane [GO:0016327]; axon [GO:0030424]; fusome [GO:0045169]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; spectrosome [GO:0045170]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; cytoskeletal protein binding [GO:0008092]; microtubule binding [GO:0008017]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; photoreceptor cell axon guidance [GO:0072499]; plasma membrane organization [GO:0007009]; regulation of synapse organization [GO:0050807],NA,NA,NA
CHOYP_LOC100743901.1.1.m.4559,0.0137912681997451,-0.0130716606603304,No,NA,NA,Q6DC04,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-R17 specific) [GO:0035642]; histone-arginine N-methyltransferase activity [GO:0008469]; lysine-acetylated histone binding [GO:0070577]; nuclear receptor transcription coactivator activity [GO:0030374]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; transcription coactivator activity [GO:0003713]; transcription regulatory region DNA binding [GO:0044212]; histone arginine methylation [GO:0034969]; histone H3-R17 methylation [GO:0034971]; peptidyl-arginine methylation; to asymmetrical-dimethyl arginine [GO:0019919]; positive regulation of fat cell differentiation [GO:0045600]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of skeletal muscle fiber development [GO:0048742]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100744089.1.1.m.58530,-0.00714774784004612,-0.000441945011376229,No,NA,NA,Q7ZVK3,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; juxtaparanode region of axon [GO:0044224]; meiotic spindle [GO:0072687]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; myelin sheath [GO:0043209]; nuclear heterochromatin [GO:0005720]; nucleus [GO:0005634]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; Schmidt-Lanterman incisure [GO:0043220]; spindle [GO:0005819]; histone deacetylase activity [GO:0004407]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H4-K16 specific) [GO:0046970]; NAD-dependent protein deacetylase activity [GO:0034979]; transcription factor binding [GO:0008134]; tubulin deacetylase activity [GO:0042903]; zinc ion binding [GO:0008270]; cellular response to caloric restriction [GO:0061433]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; cilium assembly [GO:0060271]; histone H4 deacetylation [GO:0070933]; negative regulation of angiogenesis [GO:0016525]; negative regulation of autophagy [GO:0010507]; negative regulation of cell proliferation [GO:0008285]; negative regulation of oligodendrocyte progenitor proliferation [GO:0070446]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; positive regulation of DNA binding [GO:0043388]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of cell cycle [GO:0051726]; tubulin deacetylation [GO:0090042],NA,NA,NA
CHOYP_LOC100744356.1.1.m.49326,-0.00550556469473111,0.00899078131298866,No,NA,NA,Q9P2K3,NA,NA,NA,nucleus [GO:0005634]; transcription factor complex [GO:0005667]; transcriptional repressor complex [GO:0017053]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212],NA,NA,NA
CHOYP_LOC100744369.1.1.m.56678,-0.00115888954960151,-0.015873298293024,No,NA,NA,Q08509,NA,NA,NA,brush border [GO:0005903]; cell cortex [GO:0005938]; cell junction [GO:0030054]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421]; stereocilium tip [GO:0032426]; synapse [GO:0045202]; actin binding [GO:0003779]; Rac GTPase binding [GO:0048365]; signaling adaptor activity [GO:0035591]; actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; actin polymerization-dependent cell motility [GO:0070358]; adult locomotory behavior [GO:0008344]; barbed-end actin filament capping [GO:0051016]; behavioral response to ethanol [GO:0048149]; cellular response to leukemia inhibitory factor [GO:1990830]; dendritic cell migration [GO:0036336]; exit from mitosis [GO:0010458]; positive regulation of ruffle assembly [GO:1900029]; Rac protein signal transduction [GO:0016601]; regulation of actin filament length [GO:0030832]; regulation of cell shape [GO:0008360]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266],NA,NA,NA
CHOYP_LOC100744506.1.1.m.44043,0.0176019934586567,-0.00740348117031568,No,NA,NA,O46037,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; focal adhesion [GO:0005925]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; cytoskeletal anchoring at plasma membrane [GO:0007016],NA,NA,NA
CHOYP_LOC100745330.1.1.m.65802,0.00190249813200167,0.00192499467269647,No,NA,NA,O35598,NA,NA,NA,cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; synaptic vesicle [GO:0008021]; tetraspanin-enriched microdomain [GO:0097197]; trans-Golgi network [GO:0005802]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; amyloid-beta formation [GO:0034205]; constitutive protein ectodomain proteolysis [GO:0051089]; in utero embryonic development [GO:0001701]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; nucleocytoplasmic transport [GO:0006913]; PMA-inducible membrane protein ectodomain proteolysis [GO:0051088]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; postsynapse organization [GO:0099173]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; response to antineoplastic agent [GO:0097327]; response to tumor necrosis factor [GO:0034612]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100745429.1.1.m.27818,-0.0139230713918028,0.0129379494783088,No,NA,NA,O95758,NA,NA,NA,nucleus [GO:0005634]; RNA binding [GO:0003723]; anatomical structure morphogenesis [GO:0009653]; erythrocyte maturation [GO:0043249]; mRNA processing [GO:0006397]; negative regulation of RNA splicing [GO:0033119]; regulation of cell differentiation [GO:0045595]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100745778.1.1.m.27697,0.0182883688272074,-0.00363743622564504,No,NA,NA,Q7T3N8,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100748006.1.2.m.19013,0.00226736637342933,0.00223432210454184,No,NA,NA,Q6P9H4,NA,NA,NA,apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765],NA,NA,NA
CHOYP_LOC100748395.4.7.m.40663,0.00330087262077678,0.0128125930994097,No,NA,NA,P51989,NA,NA,NA,nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397],NA,NA,NA
CHOYP_LOC100748395.6.7.m.57994,0.0121876765532852,0.0217370817021368,No,NA,NA,P51989,NA,NA,NA,nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397],NA,NA,NA
CHOYP_LOC100748436.1.1.m.33164,-0.00149202268209694,0.00434427253437162,No,NA,NA,P13216,NA,NA,NA,mitochondrial matrix [GO:0005759]; 2 iron; 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; cholesterol metabolic process [GO:0008203]; steroid biosynthetic process [GO:0006694],NA,NA,NA
CHOYP_LOC100748625.1.1.m.24479,-0.00181603996457772,-0.00618511353997867,No,NA,NA,Q9JIH2,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; Ran GTPase binding [GO:0008536]; mRNA transport [GO:0051028]; neural tube formation [GO:0001841]; positive regulation of GTPase activity [GO:0043547]; protein import into nucleus [GO:0006606],NA,NA,NA
CHOYP_LOC100749296.1.1.m.45471,0.00144758837985528,0.00999313073640812,No,NA,NA,A1A4S6,NA,NA,NA,cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; cytoskeleton organization [GO:0007010]; negative regulation of apoptotic process [GO:0043066]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100749463.1.1.m.6770,-0.000719534816706687,-0.004615905040704,No,NA,NA,Q93009,NA,NA,NA,chromosome [GO:0005694]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; cysteine-type endopeptidase activity [GO:0004197]; Lys48-specific deubiquitinase activity [GO:1990380]; p53 binding [GO:0002039]; protein C-terminus binding [GO:0008022]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; ubiquitinyl hydrolase activity [GO:0101005]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; maintenance of DNA methylation [GO:0010216]; monoubiquitinated protein deubiquitination [GO:0035520]; multicellular organism development [GO:0007275]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of protein stability [GO:0031647]; regulation of telomere capping [GO:1904353]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100749506.1.1.m.8950,0.00364778592941831,-0.00872052841558096,No,NA,NA,Q9CWL2,NA,NA,NA,cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of amacrine cell differentiation [GO:1902870]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinal cone cell fate commitment [GO:0060226]; positive regulation of transcription; DNA-templated [GO:0045893]; retinal bipolar neuron differentiation [GO:0060040]; retinal rod cell fate commitment [GO:0060223],NA,NA,NA
CHOYP_LOC100749506.1.1.m.8951,-0.0230901004057711,0.00175880470218819,No,NA,NA,O35125,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829],NA,NA,NA
CHOYP_LOC100749745.1.1.m.11523,0.00394536801625317,0.00291369700370642,No,NA,NA,P48545,NA,NA,NA,external side of plasma membrane [GO:0009897]; T-tubule [GO:0030315]; voltage-gated potassium channel complex [GO:0008076]; G-protein activated inward rectifier potassium channel activity [GO:0015467]; inward rectifier potassium channel activity [GO:0005242]; voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:0086089]; membrane repolarization during atrial cardiac muscle cell action potential [GO:0098914]; potassium ion import across plasma membrane [GO:1990573]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ion transmembrane transport [GO:0034765],NA,NA,NA
CHOYP_LOC100752270.1.1.m.23081,-0.0203300153336894,0.000570234940423199,No,NA,NA,Q5RCU5,NA,NA,NA,cytoplasm [GO:0005737]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; carbonyl reductase (NADPH) activity [GO:0004090]; prostaglandin-E2 9-reductase activity [GO:0050221]; drug metabolic process [GO:0017144]; vitamin K metabolic process [GO:0042373],NA,NA,NA
CHOYP_LOC100755189.1.1.m.33307,-4.53141478927512e-05,0.0121510746538788,No,NA,NA,Q9CQM5,NA,NA,NA,cytosol [GO:0005829]; peroxidase activity [GO:0004601]; protein-disulfide reductase activity [GO:0047134]; tumor necrosis factor-mediated signaling pathway [GO:0033209],NA,NA,NA
CHOYP_LOC100759507.1.1.m.30604,-0.0107112393510834,-0.00618722655495796,No,NA,NA,P17900,NA,NA,NA,apical plasma membrane [GO:0016324]; azurophil granule lumen [GO:0035578]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]; beta-N-acetylgalactosaminidase activity [GO:0032428]; lipid transporter activity [GO:0005319]; phospholipase activator activity [GO:0016004]; sphingolipid activator protein activity [GO:0030290]; ganglioside catabolic process [GO:0006689]; glycosphingolipid metabolic process [GO:0006687]; learning or memory [GO:0007611]; lipid storage [GO:0019915]; neuromuscular process controlling balance [GO:0050885]; neutrophil degranulation [GO:0043312]; oligosaccharide catabolic process [GO:0009313]; positive regulation of hydrolase activity [GO:0051345],NA,NA,NA
CHOYP_LOC100769755.1.1.m.59793,-0.0118326786976954,0.0157952068840656,No,NA,NA,Q8IV20,NA,NA,NA,peroxisome [GO:0005777]; copper ion binding [GO:0005507],NA,NA,NA
CHOYP_LOC100770235.1.1.m.2514,0.00678620130084428,0.00878741825264137,No,NA,NA,Q9R001,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; defense response to bacterium [GO:0042742]; negative regulation of cold-induced thermogenesis [GO:0120163]; tooth eruption [GO:0044691],NA,NA,NA
CHOYP_LOC100770313.1.1.m.3513,0.00848808538594775,-0.00534029817140008,No,NA,NA,O00748,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; carboxylic ester hydrolase activity [GO:0052689]; methyl indole-3-acetate esterase activity [GO:0080030]; methylumbelliferyl-acetate deacetylase activity [GO:0047374]; catabolic process [GO:0009056]; prostaglandin metabolic process [GO:0006693]; xenobiotic metabolic process [GO:0006805],NA,NA,NA
CHOYP_LOC100808508.1.1.m.59055,-0.00614990059205811,0.0165254463436622,No,NA,NA,Q93XW5,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; enzyme regulator activity [GO:0030234]; glucosinolate catabolic process [GO:0019762]; nitrile biosynthetic process [GO:0080028],NA,NA,NA
CHOYP_LOC100841619.1.1.m.40382,0.00205195042830452,-0.00934116934689426,No,NA,NA,P10447,NA,NA,NA,ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715],NA,NA,NA
CHOYP_LOC100862999.1.1.m.11759,0.00355165286235359,0.0137176194587692,No,NA,NA,Q6PEC4,NA,NA,NA,Cul7-RING ubiquitin ligase complex [GO:0031467]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],NA,NA,NA
CHOYP_LOC100863242.1.1.m.9849,0.0080755945149492,-0.0191029593507505,No,NA,NA,Q767L0,NA,NA,NA,cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ribosome binding [GO:0043022]; translation activator activity [GO:0008494]; positive regulation of translation [GO:0045727]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_LOC100863386.1.1.m.37224,-0.00385345698973246,-0.00840638250642401,No,NA,NA,P98156,NA,NA,NA,apical part of cell [GO:0045177]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; receptor complex [GO:0043235]; very-low-density lipoprotein particle [GO:0034361]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; glycoprotein transporter activity [GO:0034437]; reelin receptor activity [GO:0038025]; very-low-density lipoprotein particle binding [GO:0034189]; very-low-density lipoprotein particle receptor activity [GO:0030229]; cellular response to hypoxia [GO:0071456]; cholesterol metabolic process [GO:0008203]; dendrite morphogenesis [GO:0048813]; glycoprotein transport [GO:0034436]; lipid transport [GO:0006869]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of dendrite development [GO:1900006]; positive regulation of protein kinase activity [GO:0045860]; receptor-mediated endocytosis [GO:0006898]; reelin-mediated signaling pathway [GO:0038026]; ventral spinal cord development [GO:0021517]; very-low-density lipoprotein particle clearance [GO:0034447],NA,NA,NA
CHOYP_LOC100863781.1.1.m.33751,0.00343773804411199,0.0147188175468021,No,NA,NA,P20241,NA,NA,NA,bicellular tight junction [GO:0005923]; filopodium [GO:0030175]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; septate junction [GO:0005918]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; axon ensheathment [GO:0008366]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell adhesion [GO:0098609]; central complex development [GO:0048036]; dendrite morphogenesis [GO:0048813]; establishment of glial blood-brain barrier [GO:0060857]; female courtship behavior [GO:0008050]; imaginal disc morphogenesis [GO:0007560]; male courtship behavior [GO:0008049]; melanotic encapsulation of foreign target [GO:0035011]; motor neuron axon guidance [GO:0008045]; mushroom body development [GO:0016319]; nerve maturation [GO:0021682]; neuron cell-cell adhesion [GO:0007158]; photoreceptor cell axon guidance [GO:0072499]; regulation of female receptivity [GO:0045924]; regulation of tube size; open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synapse organization [GO:0050808],NA,NA,NA
CHOYP_LOC100863920.1.1.m.40408,0.00184797344841879,-0.00935235896283785,No,NA,NA,B0W6M9,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100864134.1.1.m.41690,0.0065883263884642,0.0180931628217626,No,NA,NA,Q2PFD7,NA,NA,NA,cell junction [GO:0030054]; membrane [GO:0016020]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; ruffle membrane [GO:0032587]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; ARF protein signal transduction [GO:0032011]; regulation of ARF protein signal transduction [GO:0032012],NA,NA,NA
CHOYP_LOC100864501.1.1.m.7850,-0.0178974549126702,-0.0180078273152354,No,NA,NA,M9PBE2,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; cadherin binding [GO:0045296]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; actin filament organization [GO:0007015]; chitin-based cuticle development [GO:0040003]; dorsal closure [GO:0007391]; epithelial cell migration; open tracheal system [GO:0007427]; epithelium development [GO:0060429]; head involution [GO:0008258]; midgut development [GO:0007494]; protein ubiquitination [GO:0016567]; segmentation [GO:0035282],NA,NA,NA
CHOYP_LOC100864577.1.1.m.8977,-0.00754828373851466,-0.0146672029384766,No,NA,NA,Q9Y4K4,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; activation of JUN kinase activity [GO:0007257]; activation of protein kinase activity [GO:0032147]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_LOC100865129.1.1.m.45329,0.00678620130084428,0.00878741825264137,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100865286.1.1.m.17958,-0.0101652707777023,0.00744048100150496,No,NA,NA,O02695,NA,NA,NA,cell junction [GO:0030054]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]; synaptic vesicle membrane [GO:0030672]; protein tyrosine phosphatase activity [GO:0004725]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; lipid metabolic process [GO:0006629]; neurotransmitter secretion [GO:0007269],NA,NA,NA
CHOYP_LOC100865976.1.1.m.15403,-0.00616880786393252,-0.0031207412367423,No,NA,NA,Q9W445,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; protein-containing complex [GO:0032991]; RNA binding [GO:0003723]; formation of translation preinitiation complex [GO:0001731]; positive regulation of translational initiation [GO:0045948]; translation reinitiation [GO:0002188],NA,NA,NA
CHOYP_LOC100866180.1.1.m.49582,-0.00671626430831061,0.00111565780487086,No,NA,NA,Q8IV50,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100867381.8.8.m.53059,0.00670520112945238,-0.00978130181262155,No,NA,NA,Q62417,NA,NA,NA,cell-cell adherens junction [GO:0005913]; cell-substrate adherens junction [GO:0005924]; centrosome [GO:0005813]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; insulin receptor complex [GO:0005899]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; synapse [GO:0045202]; insulin receptor binding [GO:0005158]; protein kinase binding [GO:0019901]; SH3/SH2 adaptor activity [GO:0005070]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; acetylcholine receptor signaling pathway [GO:0095500]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; insulin receptor signaling pathway [GO:0008286]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904393]; stress fiber assembly [GO:0043149],NA,NA,NA
CHOYP_LOC100867487.2.2.m.65146,0.00646182960565266,0.00696260352633346,No,NA,NA,A0JM12,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; myofibril assembly [GO:0030239]; phagocytosis [GO:0006909]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_LOC100867628.1.1.m.1331,-0.00597867062692231,0.0157512659990976,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100867962.1.1.m.19193,-0.0121013747914564,-0.011954742577335,No,NA,NA,A2AV36,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; histone-arginine N-methyltransferase activity [GO:0008469]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; histone arginine methylation [GO:0034969]; peptidyl-arginine methylation [GO:0018216]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of transcription; DNA-templated [GO:0006355]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_LOC100869188.1.1.m.18952,-0.0134092210108342,-0.0186200296020037,No,NA,NA,Q9CXW2,NA,NA,NA,mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735],NA,NA,NA
CHOYP_LOC100869625.1.1.m.52959,-0.00786559640547303,0.00821168543387116,No,NA,NA,Q8VEG6,NA,NA,NA,CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; gene silencing by RNA [GO:0031047]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:0000288]; positive regulation of cell proliferation [GO:0008284]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606],NA,NA,NA
CHOYP_LOC100870649.1.2.m.13573,-0.0112359296909884,0.00418913490404444,No,NA,NA,Q9UKI8,NA,NA,NA,nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; intracellular protein transport [GO:0006886]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of chromatin assembly or disassembly [GO:0001672],NA,NA,NA
CHOYP_LOC100872239.1.1.m.53052,-0.0125204962792659,0.00383484900502494,No,NA,NA,Q9H9H4,NA,NA,NA,cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; midbody [GO:0030496]; plasma membrane [GO:0005886]; calcium-dependent protein binding [GO:0048306]; endosomal transport [GO:0016197]; endosome transport via multivesicular body sorting pathway [GO:0032509]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; positive regulation of viral release from host cell [GO:1902188]; protein targeting to membrane [GO:0006612]; protein targeting to vacuole [GO:0006623]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058],NA,NA,NA
CHOYP_LOC100872507.1.1.m.21152,0.0154177734981586,0.0041519350025428,No,NA,NA,P00491,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; intracellular [GO:0005622]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; drug binding [GO:0008144]; nucleoside binding [GO:0001882]; phosphate ion binding [GO:0042301]; purine nucleobase binding [GO:0002060]; purine-nucleoside phosphorylase activity [GO:0004731]; immune response [GO:0006955]; inosine catabolic process [GO:0006148]; interleukin-2 secretion [GO:0070970]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; neutrophil degranulation [GO:0043312]; nicotinamide riboside catabolic process [GO:0006738]; nucleobase-containing compound metabolic process [GO:0006139]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of T cell proliferation [GO:0042102]; purine nucleotide catabolic process [GO:0006195]; purine-containing compound salvage [GO:0043101]; response to drug [GO:0042493]; urate biosynthetic process [GO:0034418],NA,NA,NA
CHOYP_LOC100874620.1.1.m.23782,-0.00187958594203468,0.00745526771937822,No,NA,NA,Q01063,NA,NA,NA,apical plasma membrane [GO:0016324]; calcium channel complex [GO:0034704]; centrosome [GO:0005813]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; voltage-gated calcium channel complex [GO:0005891]; 3';5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; ATPase binding [GO:0051117]; cAMP binding [GO:0030552]; drug binding [GO:0008144]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; aging [GO:0007568]; cAMP catabolic process [GO:0006198]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to lipopolysaccharide [GO:0071222]; establishment of endothelial barrier [GO:0061028]; leukocyte migration [GO:0050900]; multicellular organism growth [GO:0035264]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of heart contraction [GO:0045822]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of relaxation of cardiac muscle [GO:1901898]; neutrophil chemotaxis [GO:0030593]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-5 production [GO:0032754]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of heart rate [GO:0002027]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; smooth muscle contraction [GO:0006939]; T cell receptor signaling pathway [GO:0050852],NA,NA,NA
CHOYP_LOC100875369.1.1.m.31446,0.00374090707576626,-0.00470710897483872,No,NA,NA,P20936,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; phosphotyrosine residue binding [GO:0001784]; potassium channel inhibitor activity [GO:0019870]; signaling receptor binding [GO:0005102]; blood vessel morphogenesis [GO:0048514]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; mitotic cytokinesis [GO:0000281]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of Ras protein signal transduction [GO:0046580]; regulation of actin filament polymerization [GO:0030833]; regulation of cell shape [GO:0008360]; regulation of RNA metabolic process [GO:0051252]; signal transduction [GO:0007165]; vasculogenesis [GO:0001570],NA,NA,NA
CHOYP_LOC100875390.1.1.m.24780,-0.012533418799634,-0.00278023920478207,No,NA,NA,Q641Z6,NA,NA,NA,ciliary pocket membrane [GO:0020018]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; lipid droplet [GO:0005811]; myelin sheath [GO:0043209]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet dense tubular network membrane [GO:0031095]; recycling endosome membrane [GO:0055038]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; cellular response to nerve growth factor stimulus [GO:1990090]; cholesterol homeostasis [GO:0042632]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; low-density lipoprotein particle clearance [GO:0034383]; neuron projection development [GO:0031175]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of neuron projection development [GO:0010976]; protein localization to cilium [GO:0061512],NA,NA,NA
CHOYP_LOC100875404.1.1.m.8506,-0.010692911276241,0.00836053257943898,No,NA,NA,Q6AXY7,NA,NA,NA,precatalytic spliceosome [GO:0071011]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100875479.1.2.m.42509,-0.0122939271910327,-0.0110134494161166,No,NA,NA,Q7PHR1,NA,NA,NA,cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; synapse [GO:0045202]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; synaptic vesicle transport [GO:0048489]; vesicle transport along microtubule [GO:0047496]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC100875585.1.1.m.8714,-0.000422651894247929,-0.0193683464092152,No,NA,NA,Q00174,NA,NA,NA,axon [GO:0030424]; basement membrane [GO:0005604]; cell junction [GO:0030054]; presynaptic periactive zone [GO:0036062]; synaptic vesicle [GO:0008021]; signaling receptor binding [GO:0005102]; axon guidance [GO:0007411]; cell adhesion mediated by integrin [GO:0033627]; dorsal trunk growth; open tracheal system [GO:0035001]; female meiosis chromosome segregation [GO:0016321]; heart development [GO:0007507]; melanotic encapsulation of foreign target [GO:0035011]; mesoderm development [GO:0007498]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; substrate adhesion-dependent cell spreading [GO:0034446],NA,NA,NA
CHOYP_LOC100875705.1.1.m.10980,-0.0035353248264904,-0.00311396653338315,No,NA,NA,Q9V9W8,NA,NA,NA,beta-catenin-TCF complex [GO:1990907]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; canonical Wnt signaling pathway [GO:0060070]; chitin-based larval cuticle pattern formation [GO:0035293]; delamination [GO:0060232]; embryonic pattern specification [GO:0009880]; eye-antennal disc development [GO:0035214]; imaginal disc-derived wing expansion [GO:0048526]; positive regulation of transcription by RNA polymerase II [GO:0045944]; segment polarity determination [GO:0007367]; transcription; DNA-templated [GO:0006351]; wing disc morphogenesis [GO:0007472],NA,NA,NA
CHOYP_LOC100875978.1.1.m.34640,-0.0226596454370554,0.0102328149123936,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100875987.1.2.m.7720,-0.0118821930177082,-0.0183821033524189,No,NA,NA,P42026,NA,NA,NA,mitochondrial respiratory chain complex I [GO:0005747]; 4 iron; 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]; aerobic respiration [GO:0009060]; electron transport coupled proton transport [GO:0015990]; mitochondrial respiratory chain complex I assembly [GO:0032981],NA,NA,NA
CHOYP_LOC100876012.1.1.m.8280,-0.00975627816328927,0.0202837438028327,No,NA,NA,Q16831,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; uridine phosphorylase activity [GO:0004850]; cellular response to glucose starvation [GO:0042149]; nucleobase-containing compound metabolic process [GO:0006139]; nucleotide catabolic process [GO:0009166]; pyrimidine nucleoside catabolic process [GO:0046135]; pyrimidine nucleoside salvage [GO:0043097]; UMP salvage [GO:0044206]; uridine catabolic process [GO:0006218],NA,NA,NA
CHOYP_LOC100876515.1.2.m.37063,0.0100861432686012,0.0109329628191571,No,NA,NA,Q8NF91,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynaptic membrane [GO:0045211]; sarcomere [GO:0030017]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; cytoskeletal anchoring at nuclear membrane [GO:0090286]; Golgi organization [GO:0007030]; muscle cell differentiation [GO:0042692]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleus organization [GO:0006997]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100876515.2.2.m.54514,0.00363663909287258,-0.000389400792067276,No,NA,NA,Q8NF91,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynaptic membrane [GO:0045211]; sarcomere [GO:0030017]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; cytoskeletal anchoring at nuclear membrane [GO:0090286]; Golgi organization [GO:0007030]; muscle cell differentiation [GO:0042692]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleus organization [GO:0006997]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100876659.1.1.m.19405,-0.0162793696931166,0.0101103107547596,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100876663.1.1.m.4368,0.00737039907471299,-0.0092948975466525,No,NA,NA,O01404,NA,NA,NA,extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; copper ion binding [GO:0005507]; peptidylamidoglycolate lyase activity [GO:0004598]; peptidylglycine monooxygenase activity [GO:0004504]; memory [GO:0007613]; multicellular organism reproduction [GO:0032504]; peptide amidation [GO:0001519]; regulation of imaginal disc-derived wing size [GO:0044719]; response to fungus [GO:0009620],NA,NA,NA
CHOYP_LOC100877311.1.1.m.25123,0.00203960702579698,-0.0247368012554759,No,NA,NA,Q9NX05,NA,NA,NA,nucleus [GO:0005634]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_LOC100877335.1.1.m.8851,-0.00639188719813873,0.00170330637569972,No,NA,NA,Q61329,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; enzyme binding [GO:0019899]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]; brain development [GO:0007420]; circadian regulation of gene expression [GO:0032922]; muscle organ development [GO:0007517]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of cell adhesion [GO:0045785]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of locomotor rhythm [GO:1904059]; regulation of neuron differentiation [GO:0045664]; response to transforming growth factor beta [GO:0071559],NA,NA,NA
CHOYP_LOC100877393.1.1.m.26310,-0.000728331473512164,-0.0141002599641939,No,NA,NA,Q5F499,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; cardiolipin binding [GO:1901612]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; phosphatidic acid binding [GO:0070300]; apoptotic process [GO:0006915]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; GTP metabolic process [GO:0046039]; membrane fusion [GO:0061025]; membrane tubulation [GO:0097749]; mitochondrial fission [GO:0000266]; mitochondrial fusion [GO:0008053],NA,NA,NA
CHOYP_LOC100877438.2.2.m.37290,-0.00309103702613928,-0.00603109970877355,No,NA,NA,Q7KRY7,NA,NA,NA,apicolateral plasma membrane [GO:0016327]; basolateral part of cell [GO:1990794]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; fusome [GO:0045169]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; postsynaptic density [GO:0014069]; septate junction [GO:0005918]; synapse [GO:0045202]; ionotropic glutamate receptor binding [GO:0035255]; anterior/posterior axis specification; follicular epithelium [GO:0030714]; basal protein localization [GO:0045175]; cell fate commitment involved in pattern specification [GO:0060581]; cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; cell proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; compound eye development [GO:0048749]; dorsal closure [GO:0007391]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; Malpighian tubule development [GO:0072002]; memory [GO:0007613]; morphogenesis of a polarized epithelium [GO:0001738]; morphogenesis of embryonic epithelium [GO:0016331]; morphogenesis of follicular epithelium [GO:0016333]; morphogenesis of larval imaginal disc epithelium [GO:0016335]; negative regulation of cell proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurotransmitter receptor transport postsynaptic membrane to endosome [GO:0098968]; neurotransmitter receptor transport; endosome to postsynaptic membrane [GO:0098887]; olfactory behavior [GO:0042048]; ovarian follicle cell development [GO:0030707]; pole plasm protein localization [GO:0007318]; R3/R4 cell fate commitment [GO:0007464]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of cell cycle [GO:0051726]; regulation of endocytosis [GO:0030100]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of JAK-STAT cascade [GO:0046425]; regulation of Notch signaling pathway [GO:0008593]; regulation of synapse structure or activity [GO:0050803]; sensory perception of smell [GO:0007608]; septate junction assembly [GO:0019991]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; wing disc morphogenesis [GO:0007472]; zonula adherens assembly [GO:0045186],NA,NA,NA
CHOYP_LOC100877549.1.1.m.8321,-0.0135725579708753,0.00388604629968508,No,NA,NA,Q91WD2,NA,NA,NA,integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; ion channel activity [GO:0005216]; metal ion binding [GO:0046872]; calcium ion homeostasis [GO:0055074]; calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; parathyroid hormone secretion [GO:0035898]; protein homotetramerization [GO:0051289]; response to calcium ion [GO:0051592],NA,NA,NA
CHOYP_LOC100877554.2.2.m.34916,0.00569681100188482,-0.0132849262043713,No,NA,NA,P18172,NA,NA,NA,extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity; acting on CH-OH group of donors [GO:0016614],NA,NA,NA
CHOYP_LOC100877618.1.1.m.39871,-0.0169591047060434,0.00960206869202777,No,NA,NA,Q86V88,NA,NA,NA,metal ion binding [GO:0046872]; protein tyrosine phosphatase activity [GO:0004725],NA,NA,NA
CHOYP_LOC100877689.1.2.m.14376,0.0106543758482158,-0.00149270527853895,No,NA,NA,Q9ERG0,NA,NA,NA,actin cytoskeleton [GO:0015629]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; metal ion binding [GO:0046872]; actin filament bundle assembly [GO:0051017]; cell migration [GO:0016477]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; intestinal cholesterol absorption [GO:0030299]; negative regulation of actin filament depolymerization [GO:0030835]; ruffle organization [GO:0031529],NA,NA,NA
CHOYP_LOC100877689.2.2.m.26187,0.00447667051931576,0.0180813035908057,No,NA,NA,Q9BT23,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100877728.1.1.m.19879,-0.00223267693476654,0.00135079613044326,No,NA,NA,Q5ZLS7,NA,NA,NA,nuclear speck [GO:0016607]; DNA binding [GO:0003677]; methylated histone binding [GO:0035064]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_LOC100877749.1.1.m.65236,0.00255426157454181,-0.0164285070888644,No,NA,NA,Q9UBN7,NA,NA,NA,aggresome [GO:0016235]; axon [GO:0030424]; caveola [GO:0005901]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; dendrite [GO:0030425]; histone deacetylase complex [GO:0000118]; inclusion body [GO:0016234]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-catenin binding [GO:0008013]; beta-tubulin binding [GO:0048487]; dynein complex binding [GO:0070840]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; Hsp90 protein binding [GO:0051879]; microtubule binding [GO:0008017]; misfolded protein binding [GO:0051787]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein deacetylase activity [GO:0033558]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; tau protein binding [GO:0048156]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; aggresome assembly [GO:0070842]; autophagy [GO:0006914]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to misfolded protein [GO:0071218]; cellular response to topologically incorrect protein [GO:0035967]; cilium assembly [GO:0060271]; collateral sprouting [GO:0048668]; dendritic spine morphogenesis [GO:0060997]; histone deacetylation [GO:0016575]; Hsp90 deacetylation [GO:0070846]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; mitochondrion localization [GO:0051646]; negative regulation of hydrogen peroxide metabolic process [GO:0010727]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of protein complex disassembly [GO:0043242]; negative regulation of proteolysis [GO:0045861]; negative regulation of transcription; DNA-templated [GO:0045892]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; peptidyl-lysine deacetylation [GO:0034983]; polyubiquitinated misfolded protein transport [GO:0070845]; positive regulation of chaperone-mediated protein complex assembly [GO:0090035]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of hydrogen peroxide-mediated programmed cell death [GO:1901300]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein oligomerization [GO:0032461]; positive regulation of receptor biosynthetic process [GO:0010870]; positive regulation of signal transduction [GO:0009967]; protein deacetylation [GO:0006476]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein-containing complex disassembly [GO:0032984]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of autophagy [GO:0010506]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of establishment of protein localization [GO:0070201]; regulation of fat cell differentiation [GO:0045598]; regulation of gene expression; epigenetic [GO:0040029]; regulation of macroautophagy [GO:0016241]; regulation of microtubule-based movement [GO:0060632]; regulation of protein stability [GO:0031647]; regulation of signaling receptor activity [GO:0010469]; response to growth factor [GO:0070848]; response to misfolded protein [GO:0051788]; response to organic substance [GO:0010033]; response to toxic substance [GO:0009636]; tubulin deacetylation [GO:0090042]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162],NA,NA,NA
CHOYP_LOC100877947.1.1.m.51907,0.00813346754365408,-0.0078630743686461,No,NA,NA,Q6PFX9,NA,NA,NA,chromosome; centromeric region [GO:0000775]; chromosome; telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear chromosome; telomeric region [GO:0000784]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone binding [GO:0042393]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; zinc ion binding [GO:0008270]; cell division [GO:0051301]; cellular response to nutrient [GO:0031670]; mRNA transport [GO:0051028]; negative regulation of maintenance of mitotic sister chromatid cohesion; telomeric [GO:1904908]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomeric DNA binding [GO:1904743]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome; telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LOC100877992.1.1.m.1507,-0.00730492968950918,-0.0201913384100107,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100878123.1.1.m.55730,0.0172140792165894,-0.00097333641164554,No,NA,NA,A5PK45,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; procollagen galactosyltransferase activity [GO:0050211]; positive regulation of collagen fibril organization [GO:1904028],NA,NA,NA
CHOYP_LOC100878391.1.1.m.28644,0.0192098466863274,-0.0125586106834542,No,NA,NA,O35094,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; cardiac muscle cell differentiation [GO:0055007]; intracellular protein transport [GO:0006886]; protein import into mitochondrial matrix [GO:0030150]; response to 3;3';5-triiodo-L-thyronine [GO:1905242],NA,NA,NA
CHOYP_LOC100878601.1.1.m.15486,-0.00823939973374644,0.00124597704960361,No,NA,NA,Q803E1,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA 7-methylguanosine cap binding [GO:0000340]; 7-methylguanosine mRNA capping [GO:0006370]; mRNA transport [GO:0051028],NA,NA,NA
CHOYP_LOC100879052.1.1.m.53743,-0.00430894344577715,-0.00631540690244347,No,NA,NA,A1XBS5,NA,NA,NA,centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; cilium assembly [GO:0060271],NA,NA,NA
CHOYP_LOC100879129.1.1.m.44467,0.0142667207104662,0.00877099986822375,No,NA,NA,Q5DTY9,NA,NA,NA,cell junction [GO:0030054]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; receptor complex [GO:0043235]; protein homooligomerization [GO:0051260]; regulation of G protein-coupled receptor signaling pathway [GO:0008277],NA,NA,NA
CHOYP_LOC100879250.1.1.m.24381,0.00522219602795732,0.0166984171640624,No,NA,NA,Q589R5,NA,NA,NA,cytosol [GO:0005829]; methylglyoxal synthase activity [GO:0008929]; protein homodimerization activity [GO:0042803]; triose-phosphate isomerase activity [GO:0004807]; gluconeogenesis [GO:0006094]; glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; glycerol catabolic process [GO:0019563]; glycolytic process [GO:0006096]; methylglyoxal biosynthetic process [GO:0019242],NA,NA,NA
CHOYP_LOC100879339.1.1.m.20204,-0.00477079090767136,-0.0112226138209431,No,NA,NA,Q8TBG4,NA,NA,NA,mitochondrial matrix [GO:0005759]; ethanolamine-phosphate phospho-lyase activity [GO:0050459]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]; phosphatidylethanolamine biosynthetic process [GO:0006646],NA,NA,NA
CHOYP_LOC100879389.2.2.m.63959,-0.00703149554421917,0.00661426582943188,No,NA,NA,Q92804,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of signal transduction by p53 class mediator [GO:1901796]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367],NA,NA,NA
CHOYP_LOC100879487.1.3.m.20887,-0.00430894344577715,-0.00631540690244347,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100879487.2.3.m.32793,0.00205610099704544,-0.000140242241186594,No,NA,NA,Q8K480,NA,NA,NA,apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; eye photoreceptor cell development [GO:0042462]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601],NA,NA,NA
CHOYP_LOC100879487.3.3.m.33048,-0.0106711486944942,-0.0238704119621522,No,NA,NA,P0C6B8,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_LOC100879487.3.3.m.33049,0.00677882453299633,-0.00048969545661532,No,NA,NA,Q6NZL8,NA,NA,NA,cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; positive regulation of smoothened signaling pathway [GO:0045880]; protein homooligomerization [GO:0051260],NA,NA,NA
CHOYP_LOC100879690.1.1.m.18064,0.00525550683639656,-0.0107706722004595,No,NA,NA,Q6AWC2,NA,NA,NA,cytosol [GO:0005829]; kinase binding [GO:0019900]; protein-containing complex scaffold activity [GO:0032947]; negative regulation of hippo signaling [GO:0035331]; negative regulation of organ growth [GO:0046621]; negative regulation of transcription by RNA polymerase II [GO:0000122],NA,NA,NA
CHOYP_LOC100879804.1.1.m.59833,-0.00246469816356666,-0.0239144946669625,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100879890.1.1.m.4963,0.0223424348053936,-0.00761567830577028,No,NA,NA,O00499,NA,NA,NA,actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon initial segment [GO:0043194]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; I band [GO:0031674]; lipid tube [GO:0060987]; membrane [GO:0016020]; node of Ranvier [GO:0033268]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; T-tubule [GO:0030315]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; chaperone binding [GO:0051087]; clathrin binding [GO:0030276]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; protease binding [GO:0002020]; RNA polymerase binding [GO:0070063]; tau protein binding [GO:0048156]; cell proliferation [GO:0008283]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; lipid tube assembly [GO:0060988]; membrane organization [GO:0061024]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902960]; negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904878]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of ventricular cardiac muscle cell action potential [GO:1903946]; nucleus localization [GO:0051647]; nucleus organization [GO:0006997]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of apoptotic process [GO:0043065]; positive regulation of astrocyte differentiation [GO:0048711]; regulation of cell cycle arrest [GO:0071156]; regulation of endocytosis [GO:0030100]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of neuron differentiation [GO:0045664]; T-tubule organization [GO:0033292]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100879964.1.1.m.1780,0.00961096306778234,-0.0193356671726223,No,NA,NA,Q924I2,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein serine/threonine kinase activity [GO:0004674]; SH3 domain binding [GO:0017124]; activation of protein kinase activity [GO:0032147]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; response to UV [GO:0009411]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_LOC100879981.1.1.m.57826,0.00208220955502394,-0.0161736032519482,No,NA,NA,O75808,NA,NA,NA,cytoplasm [GO:0005737]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; metal ion binding [GO:0046872]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC100880308.1.1.m.6158,-0.00747621618875217,-0.0129458912000272,No,NA,NA,Q5EA98,NA,NA,NA,microfibril [GO:0001527]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_LOC100880757.2.2.m.41249,0.0127667033285662,-0.00206758822660679,No,NA,NA,Q4PIN7,NA,NA,NA,nucleus [GO:0005634]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755],NA,NA,NA
CHOYP_LOC100880815.3.7.m.45911,-0.0135725579708753,0.00388604629968508,No,NA,NA,P20273,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; carbohydrate binding [GO:0030246]; CD4 receptor binding [GO:0042609]; IgM binding [GO:0001791]; protein phosphatase binding [GO:0019903]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102]; B cell activation [GO:0042113]; cell adhesion [GO:0007155]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of calcium-mediated signaling [GO:0050849]; negative regulation of immunoglobulin secretion [GO:0051025]; regulation of B cell proliferation [GO:0030888]; regulation of endocytosis [GO:0030100]; regulation of immune response [GO:0050776],NA,NA,NA
CHOYP_LOC100880815.5.7.m.54594,0.00838251458277603,-0.0157397444848776,No,NA,NA,D3YXG0,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_LOC100880948.1.1.m.25232,-0.00640600660431345,0.017546901928158,No,NA,NA,P52632,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; protein dimerization activity [GO:0046983]; sequence-specific DNA binding [GO:0043565]; acute-phase response [GO:0006953]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth factor stimulus [GO:0071363]; JAK-STAT cascade [GO:0007259]; JAK-STAT cascade involved in growth hormone signaling pathway [GO:0060397]; liver development [GO:0001889]; luteinization [GO:0001553]; positive regulation of cellular component movement [GO:0051272]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription; DNA-templated [GO:0006355]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to peptide hormone [GO:0043434]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_LOC100881280.1.1.m.39133,-0.0101963773902168,0.00521377648371102,No,NA,NA,Q9EQW7,NA,NA,NA,centrosome [GO:0005813]; endosome membrane [GO:0010008]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; trans-Golgi network membrane [GO:0032588]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cargo loading into vesicle [GO:0035459]; cell cycle [GO:0007049]; cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; microtubule-based movement [GO:0007018]; plus-end-directed vesicle transport along microtubule [GO:0072383]; regulation of cytokinesis [GO:0032465],NA,NA,NA
CHOYP_LOC100881316.1.1.m.51540,0.0058773121451841,0.0126746348367599,No,NA,NA,P47812,NA,NA,NA,ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; intracellular signal transduction [GO:0035556]; p38MAPK cascade [GO:0038066]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of myotube differentiation [GO:0010831]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_LOC100881430.1.1.m.4201,-0.00295819879391741,-0.0242715419520192,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100881900.1.3.m.1852,0.0186805784550115,0.00299546954027698,No,NA,NA,P54357,NA,NA,NA,cytosol [GO:0005829]; myosin complex [GO:0016459]; myosin II complex [GO:0016460]; myosin V complex [GO:0031475]; myosin VI complex [GO:0031476]; myosin VII complex [GO:0031477]; calcium ion binding [GO:0005509]; myosin binding [GO:0017022]; myosin heavy chain binding [GO:0032036]; actin filament-based movement [GO:0030048],NA,NA,NA
CHOYP_LOC100882263.1.1.m.48839,-0.00314791743767151,-0.0158569752824391,No,NA,NA,P34611,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; negative regulation of ribosome biogenesis [GO:0090071]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of translation [GO:0006417]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_LOC100882621.1.2.m.25860,-0.0101928847811234,-0.00633908052185736,No,NA,NA,Q8IRG6,NA,NA,NA,cytosol [GO:0005829]; FACT complex [GO:0035101]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome puff [GO:0005703]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-independent nucleosome organization [GO:0034724]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of chromatin assembly or disassembly [GO:0001672]; transcription elongation from RNA polymerase II promoter [GO:0006368],NA,NA,NA
CHOYP_LOC100883123.1.1.m.704,-0.00676070447532109,-0.0237668923533105,No,NA,NA,P62501,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_LOC100883412.1.1.m.25657,-0.0132417910698263,-0.016879310152316,No,NA,NA,O15550,NA,NA,NA,histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K27 specific) [GO:0071558]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; canonical Wnt signaling pathway [GO:0060070]; cardiovascular system development [GO:0072358]; chromatin remodeling [GO:0006338]; heart morphogenesis [GO:0003007]; histone H3-K4 methylation [GO:0051568]; in utero embryonic development [GO:0001701]; mesodermal cell differentiation [GO:0048333]; multicellular organism growth [GO:0035264]; neural tube closure [GO:0001843]; notochord morphogenesis [GO:0048570]; positive regulation of gene expression [GO:0010628]; respiratory system process [GO:0003016]; somite rostral/caudal axis specification [GO:0032525],NA,NA,NA
CHOYP_LOC100883571.1.1.m.42323,-0.00597287095601074,-0.0145305159409667,No,NA,NA,Q9UPY6,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; postsynapse [GO:0098794]; actin binding [GO:0003779]; actin filament polymerization [GO:0030041]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; modification of postsynaptic actin cytoskeleton [GO:0098885]; oligodendrocyte development [GO:0014003]; positive regulation of myelination [GO:0031643]; protein-containing complex assembly [GO:0065003]; regulation of cell shape [GO:0008360],NA,NA,NA
CHOYP_LOC100883586.1.1.m.268,0.00589569789251508,-0.00321357855086578,No,NA,NA,Q641Z2,NA,NA,NA,cytoplasm [GO:0005737]; neuron projection terminus [GO:0044306]; protein tyrosine phosphatase activity [GO:0004725]; negative regulation of neuron projection development [GO:0010977]; positive regulation of protein localization to plasma membrane [GO:1903078],NA,NA,NA
CHOYP_LOC100883864.1.1.m.41791,-0.00485006077787149,-0.00656058602842442,No,NA,NA,Q9WUB3,NA,NA,NA,cytoplasm [GO:0005737]; sarcoplasmic reticulum [GO:0016529]; Z disc [GO:0030018]; AMP binding [GO:0016208]; carbohydrate binding [GO:0030246]; drug binding [GO:0008144]; glycogen phosphorylase activity [GO:0008184]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]; cellular calcium ion homeostasis [GO:0006874]; glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]; response to cAMP [GO:0051591]; response to hypoxia [GO:0001666]; response to organic substance [GO:0010033],NA,NA,NA
CHOYP_LOC100888253.1.1.m.18761,-0.00757397108271757,0.0140407738181541,No,NA,NA,A2RRH5,NA,NA,NA,nucleoplasm [GO:0005654],NA,NA,NA
CHOYP_LOC100888299.1.3.m.3738,-0.00243791440699092,0.00886294076399555,No,NA,NA,Q6MHJ5,NA,NA,NA,ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; telomere maintenance [GO:0000723],NA,NA,NA
CHOYP_LOC100888300.1.2.m.10203,-0.00183802966786367,0.00312839083563327,No,NA,NA,Q92805,NA,NA,NA,acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802],NA,NA,NA
CHOYP_LOC100888608.1.3.m.5445,0.0187084428812366,0.00853778832846147,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100888702.1.1.m.56287,0.00678620130084429,0.00878741825264137,No,NA,NA,P35448,NA,NA,NA,cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; sarcoplasmic reticulum [GO:0016529]; calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; cell adhesion [GO:0007155]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; response to unfolded protein [GO:0006986],NA,NA,NA
CHOYP_LOC100888889.1.1.m.14397,0.00615966897194063,0.00941964587728867,No,NA,NA,Q5HY98,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100888910.1.1.m.64827,0.00987709033014148,0.0198790471907264,No,NA,NA,Q7ZWI4,NA,NA,NA,cytoplasm [GO:0005737]; protein kinase A binding [GO:0051018]; regulation of canonical Wnt signaling pathway [GO:0060828],NA,NA,NA
CHOYP_LOC100888919.1.1.m.1193,-0.00340300706075449,0.018447402629967,No,NA,NA,P25455,NA,NA,NA,cell [GO:0005623]; calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]; entrainment of circadian clock by photoperiod [GO:0043153]; flight behavior [GO:0007629]; intracellular signal transduction [GO:0035556]; lipid catabolic process [GO:0016042]; neuron cellular homeostasis [GO:0070050]; regulation of neuromuscular synaptic transmission [GO:1900073],NA,NA,NA
CHOYP_LOC100888944.1.1.m.45112,0.00297347747397632,0.00791095945652545,No,NA,NA,P53500,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC100889245.1.2.m.999,-0.00430894344577715,-0.00631540690244347,No,NA,NA,A2ALS5,NA,NA,NA,axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; GTPase activator activity [GO:0005096]; protein homodimerization activity [GO:0042803]; Ras GTPase binding [GO:0017016]; cellular response to glial cell derived neurotrophic factor [GO:1990792]; negative regulation of GTP binding [GO:1904425]; negative regulation of microvillus assembly [GO:1903697]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of thyroid gland epithelial cell proliferation [GO:1904442]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phagocytosis [GO:0050766]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056],NA,NA,NA
CHOYP_LOC100889318.1.1.m.61506,0.00491588973115351,-0.000600714720400962,No,NA,NA,Q9VCX1,NA,NA,NA,apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; asymmetric neuroblast division [GO:0055059]; axon ensheathment in central nervous system [GO:0032291]; cell cycle [GO:0007049]; cortical actin cytoskeleton organization [GO:0030866]; cytoplasmic transport; nurse cell to oocyte [GO:0007303]; defense response to fungus [GO:0050832]; dorsal/ventral axis specification; ovarian follicular epithelium [GO:0008069]; embryonic axis specification [GO:0000578]; establishment of endothelial blood-brain barrier [GO:0014045]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; glial cell differentiation [GO:0010001]; heart process [GO:0003015]; oocyte dorsal/ventral axis specification [GO:0007310]; regulation of asymmetric cell division [GO:0009786]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419],NA,NA,NA
CHOYP_LOC100889336.1.1.m.18327,-0.0180071086330211,-0.0143628691403518,No,NA,NA,Q6ZV65,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC100889562.1.1.m.27158,0.00385407700916317,-0.0139558034568862,No,NA,NA,A9VFD6,NA,NA,NA,ATP binding [GO:0005524]; S-methyl-5-thioribose kinase activity [GO:0046522]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284],NA,NA,NA
CHOYP_LOC100889564.1.1.m.17148,0.0112501730369458,-0.0126724145544735,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100889564.1.1.m.17149,-0.0053583426332424,-0.0198239178842435,No,NA,NA,Q6DF46,NA,NA,NA,cell projection [GO:0042995]; extrinsic component of mitochondrial inner membrane [GO:0031314]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; FAD binding [GO:0071949]; oxidoreductase activity [GO:0016491]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; NAD(P)H as one donor; and incorporation of one atom of oxygen [GO:0016709]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; reduced flavin or flavoprotein as one donor; and incorporation of one atom of oxygen [GO:0016712]; ubiquinone biosynthetic process [GO:0006744],NA,NA,NA
CHOYP_LOC100889738.1.1.m.41184,-0.0169361202465736,-0.00244517227152468,No,NA,NA,Q6NXI6,NA,NA,NA,RNA polymerase II; holoenzyme [GO:0016591],NA,NA,NA
CHOYP_LOC100889837.1.2.m.2516,0.00631227326561423,-0.003266766562747,No,NA,NA,Q8N0N3,NA,NA,NA,extracellular region [GO:0005576]; (1->3)-beta-D-glucan binding [GO:0001872]; hydrolase activity; hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087],NA,NA,NA
CHOYP_LOC100889837.2.2.m.31074,0.00755863683935662,0.0143942520805846,No,NA,NA,Q8N0N3,NA,NA,NA,extracellular region [GO:0005576]; (1->3)-beta-D-glucan binding [GO:0001872]; hydrolase activity; hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087],NA,NA,NA
CHOYP_LOC100889942.1.1.m.57041,0.00620748503707494,-0.000354256635352292,No,NA,NA,Q96PN7,NA,NA,NA,cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding; bending [GO:0008301]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; nuclear receptor transcription coactivator activity [GO:0030374]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; cholesterol catabolic process [GO:0006707]; homeostatic process [GO:0042592]; multicellular organism development [GO:0007275]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of hormone biosynthetic process [GO:0046885]; steroid biosynthetic process [GO:0006694],NA,NA,NA
CHOYP_LOC100890015.1.1.m.8302,-0.0145332889837839,0.0141818139425189,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100890099.1.1.m.11505,-0.0015675243480602,0.00203328270573072,No,NA,NA,P53486,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC100890106.1.1.m.40543,0.0168412265294714,-0.00483747006819576,No,NA,NA,Q2M2T5,NA,NA,NA,Cul2-RING ubiquitin ligase complex [GO:0031462]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; nucleus [GO:0005634]; recycling endosome [GO:0055037]; copper ion binding [GO:0005507]; copper ion homeostasis [GO:0055070]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of sodium ion transmembrane transport [GO:1902306]; positive regulation of protein ubiquitination [GO:0031398]; protein transport [GO:0015031]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434],NA,NA,NA
CHOYP_LOC100890342.1.1.m.10194,-0.00312290417087835,-0.0119077781388337,No,NA,NA,O15259,NA,NA,NA,adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; motile cilium [GO:0031514]; photoreceptor connecting cilium [GO:0032391]; structural molecule activity [GO:0005198]; actin cytoskeleton organization [GO:0030036]; cell projection organization [GO:0030030]; cell-cell adhesion [GO:0098609]; ciliary basal body-plasma membrane docking [GO:0097711]; excretion [GO:0007588]; positive regulation of bicellular tight junction assembly [GO:1903348]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; spermatid differentiation [GO:0048515]; visual behavior [GO:0007632],NA,NA,NA
CHOYP_LOC100890433.1.1.m.30609,-0.00705590630740478,0.00950465156652431,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100890512.1.1.m.36422,-0.0221783027458925,-0.00836872677579064,No,NA,NA,Q8IYX7,NA,NA,NA,axonemal microtubule [GO:0005879]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126]; microtubule binding [GO:0008017]; cell projection organization [GO:0030030]; cellular response to cold [GO:0070417]; cold acclimation [GO:0009631]; microtubule anchoring [GO:0034453]; positive regulation of cilium assembly [GO:0045724]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_LOC100890512.1.1.m.36423,0.00761372555024369,-0.00331634361137792,No,NA,NA,Q29L80,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100890517.2.2.m.22207,0.000502489710028837,-0.0212498876089896,No,NA,NA,Q08E31,NA,NA,NA,condensed chromosome kinetochore [GO:0000777]; condensed nuclear chromosome; centromeric region [GO:0000780]; cytosol [GO:0005829]; nBAF complex [GO:0071565]; nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; chromatin organization [GO:0006325]; dendrite development [GO:0016358]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_LOC100890554.1.1.m.28894,-0.0155670011151725,-0.0108049466770696,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100890653.1.1.m.13755,-0.0159363404247875,-0.0163933925208039,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100890753.1.3.m.50299,-0.0125676732288442,-0.0204109636924189,No,NA,NA,Q99M80,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_LOC100890753.2.3.m.53551,0.00205195042830453,-0.00934116934689426,No,NA,NA,Q99M80,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_LOC100890762.1.1.m.31399,-0.00459588026713924,-0.0119331647281527,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100891184.1.1.m.18226,-0.0014986116463063,0.00384405778436734,No,NA,NA,O95477,NA,NA,NA,endocytic vesicle [GO:0030139]; endoplasmic reticulum membrane [GO:0005789]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; anion transmembrane transporter activity [GO:0008509]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; ATPase binding [GO:0051117]; cholesterol binding [GO:0015485]; cholesterol transporter activity [GO:0017127]; high-density lipoprotein particle binding [GO:0008035]; lipid transporter activity [GO:0005319]; phosphatidylcholine-translocating ATPase activity [GO:0090554]; phosphatidylserine-translocating ATPase activity [GO:0090556]; phospholipid binding [GO:0005543]; phospholipid transporter activity [GO:0005548]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; syntaxin binding [GO:0019905]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipid transport [GO:0006869]; lysosome organization [GO:0007040]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; phagocytosis; engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of high-density lipoprotein particle assembly [GO:0090107]; regulation of lipid metabolic process [GO:0019216]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691],NA,NA,NA
CHOYP_LOC100891282.1.1.m.41107,-0.0162240158122988,-0.0046144277900919,No,NA,NA,O00115,NA,NA,NA,extracellular exosome [GO:0070062]; lysosome [GO:0005764]; deoxyribonuclease II activity [GO:0004531]; DNA binding [GO:0003677]; apoptotic DNA fragmentation [GO:0006309]; DNA metabolic process [GO:0006259]; erythrocyte differentiation [GO:0030218]; regulation of immune response [GO:0050776],NA,NA,NA
CHOYP_LOC100891402.2.3.m.27268,-0.00264792577607668,-0.00278912343350632,No,NA,NA,P60897,NA,NA,NA,proteasome complex [GO:0000502]; proteasome regulatory particle; lid subcomplex [GO:0008541]; double-strand break repair via homologous recombination [GO:0000724]; mRNA export from nucleus [GO:0006406]; proteasome assembly [GO:0043248],NA,NA,NA
CHOYP_LOC100891466.2.10.m.9752,0.00491588973115351,-0.000600714720400964,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100891502.1.1.m.14627,-0.00572010735361356,-0.00439664616885726,No,NA,NA,Q3ZBD2,NA,NA,NA,cytoplasm [GO:0005737]; dynactin complex [GO:0005869]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_LOC100891594.2.2.m.54602,0.0165528465343132,-0.0126778552824848,No,NA,NA,Q1MTN8,NA,NA,NA,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_LOC100891656.1.1.m.62466,-0.0194773888424706,-0.000694387576129645,No,NA,NA,Q8YTC2,NA,NA,NA,ADP binding [GO:0043531]; sequence-specific DNA binding [GO:0043565],NA,NA,NA
CHOYP_LOC100891888.1.1.m.20756,-0.00583852364500054,-0.0071171623869779,No,NA,NA,P29218,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; identical protein binding [GO:0042802]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; inositol monophosphate phosphatase activity [GO:0052834]; lithium ion binding [GO:0031403]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]; inositol biosynthetic process [GO:0006021]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; phosphate-containing compound metabolic process [GO:0006796]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphorylation [GO:0046854]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100892150.1.1.m.10319,-0.00212078832001384,-0.00891837260408135,No,NA,NA,A9CPT4,NA,NA,NA,P granule [GO:0043186]; pi-body [GO:0071546]; metal ion binding [GO:0046872]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100892181.1.1.m.49777,0.00641555830121135,-0.00848790293597496,No,NA,NA,Q9ET66,NA,NA,NA,extracellular space [GO:0005615]; peptidase inhibitor activity [GO:0030414]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052],NA,NA,NA
CHOYP_LOC100892193.1.5.m.13369,-0.00598474545474176,-0.000421152946024799,No,NA,NA,Q98943,NA,NA,NA,cytoplasm [GO:0005737]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; apoptotic process [GO:0006915]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; regulation of apoptotic process [GO:0042981],NA,NA,NA
CHOYP_LOC100892193.2.5.m.28130,0.0143905578837099,0.00378116885567268,No,NA,NA,Q98943,NA,NA,NA,cytoplasm [GO:0005737]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; apoptotic process [GO:0006915]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; regulation of apoptotic process [GO:0042981],NA,NA,NA
CHOYP_LOC100892461.2.2.m.55369,0.00962611025941656,0.00727716932791146,No,NA,NA,Q6PK81,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100892516.1.1.m.38152,-0.0169591047060434,0.00960206869202777,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100892637.1.1.m.49164,-0.00426634245479769,-0.00585092591142571,No,NA,NA,Q2NKS3,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100892743.1.1.m.55850,-0.0169591047060434,0.00960206869202777,No,NA,NA,O54926,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; CD27 receptor binding [GO:0005175]; tumor necrosis factor receptor binding [GO:0005164]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; activation-induced cell death of T cells [GO:0006924]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030],NA,NA,NA
CHOYP_LOC100892914.1.1.m.53491,-0.00517077107918146,0.00429587115408688,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100892925.1.2.m.44655,-0.0115453523700754,0.0170511680146103,No,NA,NA,Q5F359,NA,NA,NA,endoplasmic reticulum [GO:0005783]; TRAPP complex [GO:0030008]; TRAPPI protein complex [GO:1990070]; TRAPPII protein complex [GO:1990071]; TRAPPIII protein complex [GO:1990072]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888],NA,NA,NA
CHOYP_LOC100893261.2.3.m.49437,-0.00930130570777372,0.000185674896544554,No,NA,NA,D4AR77,NA,NA,NA,extracellular region [GO:0005576]; serine-type peptidase activity [GO:0008236],NA,NA,NA
CHOYP_LOC100893889.1.2.m.7738,-0.00510022980296708,0.0174692733492765,No,NA,NA,Q8IXR9,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100893889.2.2.m.64935,0.00415041348305534,0.0211896843376863,No,NA,NA,P04113,NA,NA,NA,myosin complex [GO:0016459]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC100893981.1.1.m.56774,0.00394536801625317,0.00291369700370642,No,NA,NA,B0JZV4,NA,NA,NA,cytosol [GO:0005829]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; protein branching point deglutamylation [GO:0035611]; protein deglutamylation [GO:0035608],NA,NA,NA
CHOYP_LOC100897892.1.1.m.1462,0.00120359880822673,-0.00154112174065278,No,NA,NA,P82147,NA,NA,NA,perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; unfolded protein binding [GO:0051082]; chaperone-mediated protein folding [GO:0061077]; multicellular organism development [GO:0007275]; protein refolding [GO:0042026]; regulation of translational initiation by eIF2 alpha phosphorylation [GO:0010998]; response to heat [GO:0009408]; sarcomere organization [GO:0045214],NA,NA,NA
CHOYP_LOC100898095.9.19.m.32685,0.000686232728993107,-0.0107331332691118,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100898860.1.1.m.7386,0.0154735401939242,0.00788880303405009,No,NA,NA,O76387,NA,NA,NA,cytosol [GO:0005829]; aminoacyl-tRNA hydrolase activity [GO:0004045],NA,NA,NA
CHOYP_LOC100899149.1.2.m.6146,-0.0169591047060434,0.00960206869202777,No,NA,NA,Q65YR7,NA,NA,NA,cytosol [GO:0005829]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC100899149.2.2.m.29105,-0.0208762087808021,-0.00580467115979908,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100899229.1.1.m.12157,0.00167245027462036,-0.0213814301897791,No,NA,NA,Q9VRJ2,NA,NA,NA,integral component of endoplasmic reticulum membrane [GO:0030176]; adult locomotory behavior [GO:0008344]; lipid droplet organization [GO:0034389]; lipid storage [GO:0019915]; phospholipid biosynthetic process [GO:0008654]; regulation of dendrite development [GO:0050773]; sensory perception of sound [GO:0007605]; sequestering of triglyceride [GO:0030730],NA,NA,NA
CHOYP_LOC100899437.1.1.m.28953,-0.0152909996303357,-0.010768948975032,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100899732.1.1.m.26595,0.012168183721774,-0.0149606527259369,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100899882.1.3.m.27725,-0.0225648229539982,0.00998882684991015,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC100900162.1.1.m.58237,-0.00055532300510761,-0.0131671956953068,No,NA,NA,Q8AV57,NA,NA,NA,cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; identical protein binding [GO:0042802]; camera-type eye photoreceptor cell differentiation [GO:0060219]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416],NA,NA,NA
CHOYP_LOC100900174.1.1.m.14983,0.00615966897194063,0.00941964587728867,No,NA,NA,A8K0R7,NA,NA,NA,metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676],NA,NA,NA
CHOYP_LOC100900429.1.1.m.13158,-0.0173272110346807,0.0139706067908496,No,NA,NA,Q91756,NA,NA,NA,cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; ionotropic glutamate receptor activity [GO:0004970],NA,NA,NA
CHOYP_LOC100900935.1.1.m.56691,-0.0121349660106029,0.0131918929347115,No,NA,NA,Q6P5E8,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; vesicle membrane [GO:0012506]; activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; phospholipase binding [GO:0043274]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; cAMP-mediated signaling [GO:0019933]; diacylglycerol metabolic process [GO:0046339]; G protein-coupled receptor signaling pathway [GO:0007186]; glycerolipid metabolic process [GO:0046486]; lipid phosphorylation [GO:0046834]; negative regulation of gene expression [GO:0010629]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidic acid biosynthetic process [GO:0006654]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein kinase C signaling [GO:0070528]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of cholesterol metabolic process [GO:0090181]; regulation of cortisol biosynthetic process [GO:2000064]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of gluconeogenesis [GO:0006111]; regulation of progesterone biosynthetic process [GO:2000182]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of TORC1 signaling [GO:1903432]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ATP [GO:0033198]; response to cAMP [GO:0051591]; thrombin-activated receptor signaling pathway [GO:0070493],NA,NA,NA
CHOYP_LOC100900939.1.1.m.15284,-0.0129653808628907,0.00228520588387512,No,NA,NA,P11031,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; activating transcription factor binding [GO:0033613]; DNA helicase activity [GO:0003678]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; identical protein binding [GO:0042802]; sequence-specific double-stranded DNA binding [GO:1990837]; single-stranded DNA binding [GO:0003697]; transcription coactivator activity [GO:0003713]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein homooligomerization [GO:0051260]; regulation of transcription by RNA polymerase II [GO:0006357]; SMAD protein signal transduction [GO:0060395],NA,NA,NA
CHOYP_LOC100901947.1.1.m.7834,-0.01330116059901,0.00224949515227303,No,NA,NA,Q9VA73,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; transmembrane transporter activity [GO:0022857]; aspartate transmembrane transport [GO:0015810]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]; mitochondrial transport [GO:0006839]; wound healing [GO:0042060],NA,NA,NA
CHOYP_LOC100901947.1.1.m.7835,-6.34499423989713e-05,-0.00130405280381146,No,NA,NA,O14929,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nuclear chromosome; telomeric region [GO:0000784]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; chromatin silencing at telomere [GO:0006348]; DNA packaging [GO:0006323]; DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336]; histone H4 acetylation [GO:0043967]; internal protein amino acid acetylation [GO:0006475]; response to nutrient [GO:0007584],NA,NA,NA
CHOYP_LOC100902046.1.1.m.11187,-0.00753057503587311,0.00021169850626814,No,NA,NA,P34611,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; negative regulation of ribosome biogenesis [GO:0090071]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of translation [GO:0006417]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_LOC100902075.1.1.m.10103,0.00491588973115351,-0.000600714720400962,No,NA,NA,Q96FN5,NA,NA,NA,cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_LOC100902565.1.1.m.19044,0.0104630626488409,-0.000863479079655874,No,NA,NA,B2RU80,NA,NA,NA,integral component of membrane [GO:0016021]; receptor complex [GO:0043235]; protein tyrosine phosphatase activity [GO:0004725]; angiogenesis [GO:0001525]; dephosphorylation [GO:0016311],NA,NA,NA
CHOYP_LOC100902628.1.1.m.1200,0.00647401170806341,0.00188752865786841,No,NA,NA,O45947,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein glycosylation [GO:0006486],NA,NA,NA
CHOYP_LOC100902807.1.4.m.12152,0.0138826295790031,-0.0169240866207785,No,NA,NA,Q9VN14,NA,NA,NA,anchored component of membrane [GO:0031225]; axon [GO:0030424]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; cell-cell adhesion mediator activity [GO:0098632]; axon ensheathment [GO:0008366]; axon guidance [GO:0007411]; cell adhesion involved in heart morphogenesis [GO:0061343]; dendrite self-avoidance [GO:0070593]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nerve maturation [GO:0021682]; septate junction assembly [GO:0019991],NA,NA,NA
CHOYP_LOC100902807.4.4.m.59166,-0.00114796880166566,-0.0137661020063627,No,NA,NA,Q9VN14,NA,NA,NA,anchored component of membrane [GO:0031225]; axon [GO:0030424]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; cell-cell adhesion mediator activity [GO:0098632]; axon ensheathment [GO:0008366]; axon guidance [GO:0007411]; cell adhesion involved in heart morphogenesis [GO:0061343]; dendrite self-avoidance [GO:0070593]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nerve maturation [GO:0021682]; septate junction assembly [GO:0019991],NA,NA,NA
CHOYP_LOC100902912.1.1.m.9008,-0.0118942455548021,-0.0217615685704365,No,NA,NA,Q1HCL7,NA,NA,NA,mitochondrion [GO:0005739]; ATP binding [GO:0005524]; NAD+ kinase activity [GO:0003951]; protein homodimerization activity [GO:0042803]; NAD metabolic process [GO:0019674]; NADP biosynthetic process [GO:0006741],NA,NA,NA
CHOYP_LOC100903522.1.3.m.2296,0.014448017864666,-0.000154523624943056,No,NA,NA,Q28DR4,NA,NA,NA,nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; DNA-templated transcription; initiation [GO:0006352]; nucleosome assembly [GO:0006334],NA,NA,NA
CHOYP_LOC100903758.1.1.m.43697,0.00364778592941831,-0.00872052841558096,No,NA,NA,Q47944,NA,NA,NA,flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity; acting on CH-OH group of donors [GO:0016614],NA,NA,NA
CHOYP_LOC100903812.1.1.m.65786,0.0207785808789136,0.00346434801998363,No,NA,NA,Q15149,NA,NA,NA,brush border [GO:0005903]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; hemidesmosome [GO:0030056]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity [GO:0005198]; hemidesmosome assembly [GO:0031581]; intermediate filament cytoskeleton organization [GO:0045104]; wound healing [GO:0042060],NA,NA,NA
CHOYP_LOC100903999.1.1.m.16840,-0.00721784022297456,-0.0124182698379295,No,NA,NA,Q923M0,NA,NA,NA,cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein phosphatase regulator activity [GO:0019888],NA,NA,NA
CHOYP_LOC100904232.1.1.m.38777,-0.000582721100789493,0.0167685550994264,No,NA,NA,Q96L92,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; immunological synapse [GO:0001772]; nucleoplasm [GO:0005654]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3-phosphate binding [GO:0032266]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; establishment of natural killer cell polarity [GO:0001770]; intracellular protein transport [GO:0006886]; retrograde transport; endosome to plasma membrane [GO:1990126]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100904451.3.11.m.13002,0.00344848979480529,-0.0134420734836203,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100904558.2.2.m.26621,-0.0169591047060434,0.00960206869202777,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100905188.1.1.m.2446,0.0141874211234865,0.00423520198310366,No,NA,NA,Q9WYP5,NA,NA,NA,inositol 2-dehydrogenase activity [GO:0050112]; oxidoreductase activity [GO:0016491]; inositol metabolic process [GO:0006020]; NADPH regeneration [GO:0006740],NA,NA,NA
CHOYP_LOC100905387.1.1.m.30579,-0.00973432463616109,0.00709285671656427,No,NA,NA,Q5TM62,NA,NA,NA,cell junction [GO:0030054]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543],NA,NA,NA
CHOYP_LOC100905729.1.3.m.13789,-0.00297817591061635,0.00973958156506024,No,NA,NA,Q8WPI2,NA,NA,NA,extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867],NA,NA,NA
CHOYP_LOC100906408.1.1.m.3002,0.0228325839889872,-0.00696406149855744,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100907253.3.3.m.27327,0.00876832634101828,0.0198188096385842,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100907408.1.1.m.24444,-0.00430894344577715,-0.00631540690244347,No,NA,NA,Q9Z2P6,NA,NA,NA,autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; ciliary pocket membrane [GO:0020018]; cytoplasmic vesicle [GO:0031410]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; terminal bouton [GO:0043195]; SNAP receptor activity [GO:0005484]; syntaxin binding [GO:0019905]; autophagosome maturation [GO:0097352]; cilium assembly [GO:0060271]; exocytosis [GO:0006887]; protein transport [GO:0015031]; regulation of synaptic vesicle cycle [GO:0098693]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; vesicle fusion [GO:0006906],NA,NA,NA
CHOYP_LOC100907708.1.1.m.16095,0.0203686298647537,-0.00136884877529964,No,NA,NA,O13035,NA,NA,NA,extracellular space [GO:0005615]; lysosome [GO:0005764]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; prostate gland growth [GO:0060736]; regulation of lipid metabolic process [GO:0019216]; sphingolipid metabolic process [GO:0006665],NA,NA,NA
CHOYP_LOC100907797.3.4.m.54168,0.00394536801625317,0.00291369700370642,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100907841.1.1.m.39986,0.00600679409065746,0.0162691219517955,No,NA,NA,Q26636,NA,NA,NA,lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_LOC100907845.2.3.m.23111,0.00505969043542622,-0.0123790260594587,No,NA,NA,G5EBQ8,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063],NA,NA,NA
CHOYP_LOC100908241.1.1.m.52509,-0.0115261750124775,0.0183855688797313,No,NA,NA,Q8CJG0,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; micro-ribonucleoprotein complex [GO:0035068]; mitochondrion [GO:0005739]; mRNA cap binding complex [GO:0005845]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; core promoter binding [GO:0001047]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; endoribonuclease activity; cleaving miRNA-paired mRNA [GO:0090624]; endoribonuclease activity; cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA binding [GO:0003729]; mRNA cap binding [GO:0098808]; protein C-terminus binding [GO:0008022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; mRNA cleavage involved in gene silencing by siRNA [GO:0090625]; negative regulation of translational initiation [GO:0045947]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of trophoblast cell migration [GO:1901165]; post-embryonic development [GO:0009791]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; RNA secondary structure unwinding [GO:0010501]; siRNA loading onto RISC involved in RNA interference [GO:0035087],NA,NA,NA
CHOYP_LOC100908688.1.5.m.30293,0.0204311700647296,-0.0143298706463939,No,NA,NA,P35979,NA,NA,NA,cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; nucleolus [GO:0005730]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; large ribosomal subunit rRNA binding [GO:0070180]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100909243.1.1.m.22728,-0.00513248636432248,0.000777384421296161,No,NA,NA,Q99M87,NA,NA,NA,actin filament [GO:0005884]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; ATP binding [GO:0005524]; GTPase regulator activity [GO:0030695]; Hsp70 protein binding [GO:0030544]; IkappaB kinase complex binding [GO:0106137]; interferon-gamma receptor binding [GO:0005133]; metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; receptor tyrosine kinase binding [GO:0030971]; transcription factor binding [GO:0008134]; unfolded protein binding [GO:0051082]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation-induced cell death of T cells [GO:0006924]; apoptotic process [GO:0006915]; cell aging [GO:0007569]; mitochondrial DNA replication [GO:0006264]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of programmed cell death [GO:0043069]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuromuscular junction development [GO:0007528]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell proliferation [GO:0042102]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]; response to interferon-gamma [GO:0034341]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; small GTPase mediated signal transduction [GO:0007264]; T cell differentiation in thymus [GO:0033077],NA,NA,NA
CHOYP_LOC100910862.2.2.m.45085,0.000788672710478516,-0.0179562946376555,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100914852.1.1.m.29079,-0.00251844322149829,-0.0100815282684151,No,NA,NA,Q9W735,NA,NA,NA,apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cilium [GO:0005929]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; prominosome [GO:0071914]; cholesterol binding [GO:0015485],NA,NA,NA
CHOYP_LOC100918713.1.1.m.17833,-0.0169591047060434,0.00960206869202778,No,NA,NA,Q4V348,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100922782.1.1.m.5582,-0.00727542524441065,0.0205861070742264,No,NA,NA,Q8BK48,NA,NA,NA,endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; carboxylic ester hydrolase activity [GO:0052689]; trans-permethrin hydrolase activity [GO:0102209],NA,NA,NA
CHOYP_LOC100927475.1.1.m.28390,-0.00567566815971716,-0.00872607877259388,No,NA,NA,Q8VCT4,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; lipid droplet [GO:0005811]; carboxylic ester hydrolase activity [GO:0052689]; fatty-acyl-ethyl-ester synthase activity [GO:0030339]; methyl indole-3-acetate esterase activity [GO:0080030]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]; acyl-CoA metabolic process [GO:0006637]; acylglycerol catabolic process [GO:0046464]; cholesterol biosynthetic process [GO:0006695]; epithelial cell differentiation [GO:0030855]; lipid catabolic process [GO:0016042]; medium-chain fatty acid metabolic process [GO:0051791]; response to toxic substance [GO:0009636]; short-chain fatty acid catabolic process [GO:0019626]; very-low-density lipoprotein particle assembly [GO:0034379],NA,NA,NA
CHOYP_LOC100929680.1.2.m.17333,0.00566147809165826,0.00323965066826051,No,NA,NA,P15941,NA,NA,NA,apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; nuclear chromatin [GO:0000790]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; p53 binding [GO:0002039]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coregulator activity [GO:0003712]; cytokine-mediated signaling pathway [GO:0019221]; DNA damage response; signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response; signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of transcription by competitive promoter binding [GO:0010944]; O-glycan processing [GO:0016266]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; stimulatory C-type lectin receptor signaling pathway [GO:0002223],NA,NA,NA
CHOYP_LOC100929680.2.2.m.28318,-0.0138808843880002,0.00736160921832296,No,NA,NA,P15941,NA,NA,NA,apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; nuclear chromatin [GO:0000790]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; p53 binding [GO:0002039]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coregulator activity [GO:0003712]; cytokine-mediated signaling pathway [GO:0019221]; DNA damage response; signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response; signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of transcription by competitive promoter binding [GO:0010944]; O-glycan processing [GO:0016266]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; stimulatory C-type lectin receptor signaling pathway [GO:0002223],NA,NA,NA
CHOYP_LOC100929997.1.1.m.23658,0.0107755674028614,-0.00949792597009896,No,NA,NA,Q9H2H8,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; mRNA splicing; via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413],NA,NA,NA
CHOYP_LOC100931580.2.2.m.44310,0.00898598565274973,0.0133353330335396,No,NA,NA,P31944,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; keratin filament [GO:0045095]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; endopeptidase activity [GO:0004175]; apoptotic process [GO:0006915]; cornification [GO:0070268]; epidermis development [GO:0008544]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; keratinization [GO:0031424],NA,NA,NA
CHOYP_LOC100932567.1.1.m.26590,-0.00371196103213614,0.0017474199042277,No,NA,NA,Q5T5Y3,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; spectrin binding [GO:0030507]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton organization [GO:0007010]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule depolymerization [GO:0007026]; neuron projection development [GO:0031175]; regulation of cell morphogenesis [GO:0022604]; regulation of microtubule polymerization [GO:0031113],NA,NA,NA
CHOYP_LOC100933241.16.45.m.30626,-0.0148019350928745,-0.0176031003122477,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100933589.3.3.m.59374,-0.00442597623189133,-0.0137604312596167,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100934353.1.1.m.11772,0.00615966897194063,0.00941964587728867,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101020089.1.1.m.9396,0.0095553969554873,0.0134509769387415,No,NA,NA,P10077,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC101033229.1.1.m.38291,-0.0218933517272351,-0.000252082281682457,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101040300.1.2.m.6533,0.0166323622584846,0.013474206690954,No,NA,NA,P62248,NA,NA,NA,endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_LOC101058182.1.1.m.57909,-0.00212078832001384,-0.00891837260408135,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101060411.1.1.m.54761,0.00394536801625317,0.00291369700370642,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101061101.1.1.m.50165,0.013909459046207,0.00888143888577236,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101061332.1.1.m.25069,0.0227295463994869,-0.00254736442696906,No,NA,NA,Q6PCL9,NA,NA,NA,cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]; RNA polyadenylation [GO:0043631],NA,NA,NA
CHOYP_LOC101061667.1.1.m.8351,0.00811404349851617,0.00910231728369409,No,NA,NA,Q80V24,NA,NA,NA,nucleus [GO:0005634]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC101062323.1.1.m.15918,-0.00481051072352098,-0.0203511806990209,No,NA,NA,P54106,NA,NA,NA,cytoskeleton [GO:0005856]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; plasma membrane [GO:0005886]; cell volume homeostasis [GO:0006884]; chloride transport [GO:0006821]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_LOC101062578.1.1.m.56255,-0.0145519711914307,0.00692015754040732,No,NA,NA,Q9R0D8,NA,NA,NA,microtubule cytoskeleton [GO:0015630]; microtubule binding [GO:0008017],NA,NA,NA
CHOYP_LOC101063181.1.1.m.12864,-0.0051372020658923,-0.00148109722474246,No,NA,NA,Q9EP82,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; tRNA methyltransferase complex [GO:0043527]; tRNA (guanine-N7)-methylation [GO:0106004]; tRNA modification [GO:0006400],NA,NA,NA
CHOYP_LOC101063699.1.1.m.18944,-0.0125014522795143,0.00164310421763945,No,NA,NA,Q9UUI3,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; U2 snRNP [GO:0005686]; U2-type prespliceosome [GO:0071004]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; spliceosomal complex assembly [GO:0000245],NA,NA,NA
CHOYP_LOC101063838.1.1.m.50540,0.00386698342489608,0.00183401240779104,No,NA,NA,Q5BJI9,NA,NA,NA,integral component of membrane [GO:0016021]; organelle membrane [GO:0031090]; signal peptidase complex [GO:0005787]; peptidase activity [GO:0008233]; protein targeting to ER [GO:0045047]; signal peptide processing [GO:0006465],NA,NA,NA
CHOYP_LOC101063890.1.1.m.7895,-0.0140860952217898,0.00902670783009135,No,NA,NA,P50607,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; phosphatidylinositol binding [GO:0035091]; protein-containing complex binding [GO:0044877]; phagocytosis; recognition [GO:0006910]; photoreceptor cell maintenance [GO:0045494]; positive regulation of phagocytosis [GO:0050766]; protein localization to cilium [GO:0061512]; protein localization to photoreceptor outer segment [GO:1903546]; receptor localization to non-motile cilium [GO:0097500]; response to hormone [GO:0009725]; retina development in camera-type eye [GO:0060041]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_LOC101064182.1.1.m.8320,-4.34023088415922e-05,-0.00494383807175667,No,NA,NA,Q5E9S4,NA,NA,NA,mitochondrion [GO:0005739]; ethanolamine-phosphate phospho-lyase activity [GO:0050459]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483],NA,NA,NA
CHOYP_LOC101064328.2.3.m.57090,-0.0154927459456612,-0.000322883997397953,No,NA,NA,Q9Z0T0,NA,NA,NA,cytoplasm [GO:0005737]; thiopurine S-methyltransferase activity [GO:0008119]; response to organic cyclic compound [GO:0014070]; response to testosterone [GO:0033574],NA,NA,NA
CHOYP_LOC101064384.1.1.m.19175,0.00205195042830453,-0.00934116934689426,No,NA,NA,Q8NFH5,NA,NA,NA,nuclear envelope [GO:0005635]; nuclear lamina [GO:0005652]; nuclear membrane [GO:0031965]; nuclear pore central transport channel [GO:0044613]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; phospholipid binding [GO:0005543]; single-stranded DNA binding [GO:0003697]; structural constituent of nuclear pore [GO:0017056]; mRNA export from nucleus [GO:0006406]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore organization [GO:0006999]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC101064472.1.1.m.66819,0.00375221133909242,-0.00408354825157047,No,NA,NA,P13944,NA,NA,NA,collagen type XII trimer [GO:0005595]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; endodermal cell differentiation [GO:0035987]; growth plate cartilage chondrocyte morphogenesis [GO:0003429],NA,NA,NA
CHOYP_LOC101064693.1.2.m.30288,-0.0208636390816914,-0.00189714408789655,No,NA,NA,A8TX70,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_LOC101064793.1.1.m.27191,-0.00461828467364785,0.00307047039669634,No,NA,NA,Q99471,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; transcription corepressor activity [GO:0003714]; unfolded protein binding [GO:0051082]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription; DNA-templated [GO:0045892]; protein folding [GO:0006457]; regulation of transcription; DNA-templated [GO:0006355]; retina development in camera-type eye [GO:0060041],NA,NA,NA
CHOYP_LOC101065149.1.1.m.49591,0.0112692389746999,0.0140449916196841,No,NA,NA,Q6P7S1,NA,NA,NA,lysosome [GO:0005764]; ceramidase activity [GO:0102121]; hydrolase activity; acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; N-acylsphingosine amidohydrolase activity [GO:0017040]; lipid metabolic process [GO:0006629]; lung development [GO:0030324]; response to organic substance [GO:0010033],NA,NA,NA
CHOYP_LOC101065571.1.2.m.36430,-0.0225589012682752,0.00997839493449657,No,NA,NA,P24540,NA,NA,NA,acylphosphatase activity [GO:0003998],NA,NA,NA
CHOYP_LOC101065647.2.2.m.10863,-0.00212078832001384,-0.00891837260408135,No,NA,NA,Q5SZD4,NA,NA,NA,mitochondrion [GO:0005739]; glycine N-acyltransferase activity [GO:0047961],NA,NA,NA
CHOYP_LOC101065695.1.1.m.13611,0.0192254108011448,0.00686586823277104,No,NA,NA,Q6NVR9,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; zinc ion binding [GO:0008270]; mitochondrion organization [GO:0007005],NA,NA,NA
CHOYP_LOC101066074.1.1.m.19291,0.0176451402156078,0.0102086600240165,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101066924.1.1.m.16031,-0.013837639881439,0.00469652702192137,No,NA,NA,A7YY46,NA,NA,NA,membrane [GO:0016020]; mitochondrion [GO:0005739]; hydroxyacylglutathione hydrolase activity [GO:0004416]; metal ion binding [GO:0046872]; methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243]; negative regulation of neurotransmitter secretion [GO:0046929]; neuromuscular process controlling posture [GO:0050884]; regulation of dopamine metabolic process [GO:0042053]; regulation of synaptic transmission; dopaminergic [GO:0032225],NA,NA,NA
CHOYP_LOC101067075.1.2.m.30552,-0.0169591047060434,0.00960206869202778,No,NA,NA,Q6AX44,NA,NA,NA,integral component of membrane [GO:0016021]; chitin binding [GO:0008061]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC101067281.1.2.m.14666,-0.0106308284068582,-0.015788322565525,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101067376.1.1.m.40668,0.0142521329667715,0.00911685465841679,No,NA,NA,Q5ZIJ9,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_LOC101067698.2.2.m.27457,-0.0229879342193372,0.00134462799539653,No,NA,NA,Q5R1U3,NA,NA,NA,cytosol [GO:0005829]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; hyperosmotic response [GO:0006972]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC101067777.1.1.m.52432,-0.00713071475597243,0.0147486053786958,No,NA,NA,Q4QQV2,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; macrophage colony-stimulating factor signaling pathway [GO:0038145]; Ras protein signal transduction [GO:0007265]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_LOC101067857.1.1.m.36995,-0.00829588725597818,0.00445866712553767,No,NA,NA,Q63413,NA,NA,NA,cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; protein-containing complex [GO:0032991]; spliceosomal complex [GO:0005681]; transcription export complex [GO:0000346]; U4 snRNP [GO:0005687]; U6 snRNP [GO:0005688]; ATP binding [GO:0005524]; ATP-dependent protein binding [GO:0043008]; ATP-dependent RNA helicase activity [GO:0004004]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]; liver development [GO:0001889]; mRNA export from nucleus [GO:0006406]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of DNA-templated transcription; elongation [GO:0032786]; positive regulation of translation [GO:0045727]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; RNA secondary structure unwinding [GO:0010501]; spliceosomal complex assembly [GO:0000245]; viral mRNA export from host cell nucleus [GO:0046784],NA,NA,NA
CHOYP_LOC101067905.1.1.m.42386,0.000908302992304153,0.0143883229958461,No,NA,NA,P41214,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; signaling receptor activity [GO:0038023]; translation initiation factor activity [GO:0003743]; formation of translation preinitiation complex [GO:0001731]; intracellular protein transport [GO:0006886]; IRES-dependent viral translational initiation [GO:0075522]; ribosome disassembly [GO:0032790],NA,NA,NA
CHOYP_LOC101068003.1.1.m.14900,-0.0153064212494327,0.00151253493174983,No,NA,NA,Q9NZJ6,NA,NA,NA,extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 2-polyprenyl-6-methoxy-1;4-benzoquinone methyltransferase activity [GO:0008425]; 3-demethylubiquinone-10 3-O-methyltransferase activity [GO:0044596]; 3-demethylubiquinone-9 3-O-methyltransferase activity [GO:0008689]; decaprenyldihydroxybenzoate methyltransferase activity [GO:0044595]; hexaprenyldihydroxybenzoate methyltransferase activity [GO:0004395]; O-methyltransferase activity [GO:0008171]; glycerol metabolic process [GO:0006071]; regulation of ubiquinone biosynthetic process [GO:0010795]; ubiquinone biosynthetic process [GO:0006744],NA,NA,NA
CHOYP_LOC101068028.1.1.m.48693,0.00569781840252749,-0.0137901072749262,No,NA,NA,Q9DCS2,NA,NA,NA,,NA,NA,NA
CHOYP_LOC101068272.1.3.m.40396,0.0220150303578228,-0.0112129446343822,No,NA,NA,Q14162,NA,NA,NA,endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; low-density lipoprotein particle binding [GO:0030169]; scavenger receptor activity [GO:0005044]; transmembrane signaling receptor activity [GO:0004888]; cell adhesion [GO:0007155]; cholesterol catabolic process [GO:0006707]; dendrite development [GO:0016358]; neuron remodeling [GO:0016322]; positive regulation of axon regeneration [GO:0048680]; positive regulation of neuron projection development [GO:0010976]; receptor-mediated endocytosis [GO:0006898],NA,NA,NA
CHOYP_LOC101068378.2.3.m.20090,-0.0111545591338439,-0.00350903526251064,No,NA,NA,Q6DFV8,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_LOC101068378.3.3.m.29759,0.0212813625774474,-0.011906783260636,No,NA,NA,Q8N2E2,NA,NA,NA,cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856],NA,NA,NA
CHOYP_LOC101068677.1.1.m.30685,0.00977851538534769,-0.00950892028116275,No,NA,NA,Q00536,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; microtubule cytoskeleton [GO:0015630]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine/threonine kinase activity [GO:0004674]; exocytosis [GO:0006887]; growth hormone secretion [GO:0030252]; neuron projection development [GO:0031175]; protein phosphorylation [GO:0006468]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC101069006.1.2.m.5484,0.0180879078743123,0.0158819445187,No,NA,NA,Q60648,NA,NA,NA,apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; beta-N-acetylgalactosaminidase activity [GO:0032428]; beta-N-acetylhexosaminidase activity [GO:0004563]; enzyme activator activity [GO:0008047]; lipid transporter activity [GO:0005319]; phospholipase activator activity [GO:0016004]; ganglioside catabolic process [GO:0006689]; learning or memory [GO:0007611]; lipid storage [GO:0019915]; nervous system process [GO:0050877]; neuromuscular process controlling balance [GO:0050885]; oligosaccharide catabolic process [GO:0009313]; positive regulation of hydrolase activity [GO:0051345],NA,NA,NA
CHOYP_LOC101069440.1.3.m.4206,-0.00751995038511348,-0.0166154417577368,No,NA,NA,Q9V0D5,NA,NA,NA,cytoplasm [GO:0005737]; L-malate dehydrogenase activity [GO:0030060]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_LOC101069440.2.3.m.16645,0.00436288974683483,-0.00715307446678374,No,NA,NA,Q9V0D5,NA,NA,NA,cytoplasm [GO:0005737]; L-malate dehydrogenase activity [GO:0030060]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_LOC101069440.3.3.m.28439,0.0168263037453743,-0.00292738486888435,No,NA,NA,Q9V0D5,NA,NA,NA,cytoplasm [GO:0005737]; L-malate dehydrogenase activity [GO:0030060]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_LOC101069588.1.1.m.34189,0.00552365893743058,0.0119647960409872,No,NA,NA,Q6B855,NA,NA,NA,metal ion binding [GO:0046872]; transketolase activity [GO:0004802]; regulation of growth [GO:0040008],NA,NA,NA
CHOYP_LOC101069759.1.1.m.40708,0.0100503490362612,-0.000272358726274206,No,NA,NA,P28024,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex; beta-subunit complex [GO:0019774]; threonine-type endopeptidase activity [GO:0004298]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_LOC101070424.1.1.m.64148,-0.00712663035480059,0.00243177379968024,No,NA,NA,P85834,NA,NA,NA,mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; synapse [GO:0045202]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; mitochondrial translational elongation [GO:0070125]; response to ethanol [GO:0045471]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_LOC101070553.1.1.m.9549,-0.0106535615052148,0.000889743302427862,No,NA,NA,Q9JII1,NA,NA,NA,axoneme [GO:0005930]; cytoplasm [GO:0005737]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; phosphatidylinositol-3;4;5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-4;5-bisphosphate 5-phosphatase activity [GO:0004439]; phosphatidylinositol-4;5-bisphosphate phosphatase activity [GO:0106019]; inositol phosphate dephosphorylation [GO:0046855]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of translation [GO:0017148]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol metabolic process [GO:0046488],NA,NA,NA
CHOYP_LOC101070737.2.3.m.11531,-0.0178547313944021,-0.00189805126270248,No,NA,NA,Q9CQZ5,NA,NA,NA,mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_LOC101071050.1.1.m.38421,0.00317890230822296,-0.0148516141553,No,NA,NA,Q9HCN4,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],NA,NA,NA
CHOYP_LOC101071230.1.1.m.22193,0.00442848183871581,-0.00475237692248001,No,NA,NA,Q99M80,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_LOC101071441.1.1.m.64484,-0.00292363445760728,-0.0185845635649797,No,NA,NA,P60899,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA polymerase II; core complex [GO:0005665]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter [GO:0001193]; mRNA cleavage [GO:0006379]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283],NA,NA,NA
CHOYP_LOC101071891.1.2.m.31440,-0.016159547487956,0.000386674456225953,No,NA,NA,Q68EV6,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735],NA,NA,NA
CHOYP_LOC101071902.1.1.m.49967,-0.00875945244009657,-0.0161187222231867,No,NA,NA,Q9CQE3,NA,NA,NA,mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543],NA,NA,NA
CHOYP_LOC101072178.1.1.m.65566,0.00236026840477939,0.0125215083016922,No,NA,NA,Q6PCJ9,NA,NA,NA,lysosome [GO:0005764]; palmitoyl-(protein) hydrolase activity [GO:0008474],NA,NA,NA
CHOYP_LOC101072591.1.1.m.1861,-0.00945110147316375,-0.00774762376052304,No,NA,NA,Q32LJ2,NA,NA,NA,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; GTP binding [GO:0005525]; gastrulation [GO:0007369]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; protein localization to Golgi apparatus [GO:0034067]; protein localization to organelle [GO:0033365]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_LOC101072646.1.1.m.8800,0.0101257976826849,-0.0186892463783905,No,NA,NA,Q9D3D9,NA,NA,NA,mitochondrial envelope [GO:0005740]; mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex; catalytic core F(1) [GO:0000275]; mitochondrion [GO:0005739]; proton-transporting ATP synthase complex [GO:0045259]; proton-transporting ATP synthase complex; catalytic core F(1) [GO:0045261]; protein-containing complex binding [GO:0044877]; proton transmembrane transporter activity [GO:0015078]; proton-transporting ATP synthase activity; rotational mechanism [GO:0046933]; ATP metabolic process [GO:0046034]; ATP synthesis coupled proton transport [GO:0015986]; proton transmembrane transport [GO:1902600],NA,NA,NA
CHOYP_LOC101072885.1.1.m.63778,-0.00712987967547925,-0.00616051076893445,No,NA,NA,Q93129,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC101072885.1.1.m.63779,-0.0147959597359729,-0.0035575415117271,No,NA,NA,Q25381,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC101073830.1.1.m.42117,-0.0079144352039631,-0.0187406006478763,No,NA,NA,Q9DB91,NA,NA,NA,mediator complex [GO:0016592]; nucleoplasm [GO:0005654],NA,NA,NA
CHOYP_LOC101075536.1.1.m.42991,-0.0117892533728277,-0.0106762036552473,No,NA,NA,Q9GLW9,NA,NA,NA,mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; cell redox homeostasis [GO:0045454],NA,NA,NA
CHOYP_LOC101075808.1.1.m.17712,-0.012116766013899,-0.0093120102376456,No,NA,NA,Q5RE33,NA,NA,NA,endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_LOC101076145.1.1.m.26253,0.0065883263884642,0.0180931628217626,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101076180.1.1.m.41749,0.000705142287135695,-0.0182702374908955,No,NA,NA,Q3SYU1,NA,NA,NA,cytosol [GO:0005829]; Noc1p-Noc2p complex [GO:0030690]; Noc2p-Noc3p complex [GO:0030691]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; apoptotic process [GO:0006915]; cellular response to UV [GO:0034644]; chromatin assembly [GO:0031497]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of histone acetylation [GO:0035067]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal large subunit biogenesis [GO:0042273],NA,NA,NA
CHOYP_LOC101076498.2.2.m.25096,0.00615966897194063,0.00941964587728867,No,NA,NA,P70031,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930],NA,NA,NA
CHOYP_LOC101076790.1.1.m.45316,0.00491588973115351,-0.000600714720400961,No,NA,NA,Q6Q4G4,NA,NA,NA,extracellular space [GO:0005615]; membrane [GO:0016020]; carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241],NA,NA,NA
CHOYP_LOC101077059.1.1.m.57292,-0.0174453448911654,-0.00209674394382345,No,NA,NA,P54864,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; transcription regulatory region DNA binding [GO:0044212]; Ras protein signal transduction [GO:0007265],NA,NA,NA
CHOYP_LOC101077542.1.1.m.58180,-0.00748499274384009,0.0125399322811026,No,NA,NA,Q26636,NA,NA,NA,lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_LOC101077597.2.3.m.25843,-0.00212078832001384,-0.00891837260408135,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101077787.2.3.m.65668,0.000686232728993107,-0.0107331332691118,No,NA,NA,O95149,NA,NA,NA,cytosol [GO:0005829]; nuclear pore [GO:0005643]; nuclear import signal receptor activity [GO:0061608]; RNA cap binding [GO:0000339]; import into nucleus [GO:0051170]; protein import into nucleus [GO:0006606]; snRNA import into nucleus [GO:0061015]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_LOC101078033.1.1.m.42470,-0.000938450286345912,0.00174349721538108,No,NA,NA,P49816,NA,NA,NA,caveola [GO:0005901]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; TSC1-TSC2 complex [GO:0033596]; GTPase activator activity [GO:0005096]; phosphatase binding [GO:0019902]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; aging [GO:0007568]; cell projection organization [GO:0030030]; establishment of cell polarity [GO:0030010]; establishment of protein localization [GO:0045184]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of macroautophagy [GO:0016242]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of pinocytosis [GO:0048550]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of TOR signaling [GO:0032007]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of cell adhesion [GO:0045785]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of neuron projection development [GO:0010976]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; protein localization to cell surface [GO:0034394]; regulation of cell cycle [GO:0051726]; regulation of postsynapse organization [GO:0099175]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; social behavior [GO:0035176],NA,NA,NA
CHOYP_LOC101078145.1.1.m.54616,0.00394536801625317,0.00291369700370642,No,NA,NA,Q9DDT2,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; cellular response to insulin stimulus [GO:0032869]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of inflammatory response [GO:0050727]; regulation of kinase activity [GO:0043549]; regulation of phosphorylation [GO:0042325]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor 7 signaling pathway [GO:0034154]; toll-like receptor 9 signaling pathway [GO:0034162]; TOR signaling [GO:0031929],NA,NA,NA
CHOYP_LOC101078252.1.1.m.39219,-0.00104302304715896,-0.0145236807425539,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101078542.1.1.m.44610,0.0104791471456334,0.0156895704860553,No,NA,NA,Q01518,NA,NA,NA,azurophil granule lumen [GO:0035578]; cortical actin cytoskeleton [GO:0030864]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]; actin polymerization or depolymerization [GO:0008154]; activation of adenylate cyclase activity [GO:0007190]; ameboidal-type cell migration [GO:0001667]; cell morphogenesis [GO:0000902]; establishment or maintenance of cell polarity [GO:0007163]; neutrophil degranulation [GO:0043312]; receptor-mediated endocytosis [GO:0006898]; regulation of adenylate cyclase activity [GO:0045761]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC101078914.1.1.m.34199,-0.0148441824761388,-0.00349627118426369,No,NA,NA,Q148G5,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; FAD binding [GO:0071949]; proline dehydrogenase activity [GO:0004657]; proline catabolic process to glutamate [GO:0010133],NA,NA,NA
CHOYP_LOC101079138.1.4.m.4320,-0.00349074668064472,0.00346076998157526,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101079642.1.1.m.56374,-0.0143787805917661,-0.0100846037956703,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101107626.1.1.m.1051,-0.00865027308270318,-0.00101469473710071,No,NA,NA,Q5TYW1,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cellular response to zinc ion [GO:0071294]; negative regulation of transcription; DNA-templated [GO:0045892]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_LOC101154772.1.1.m.55397,-0.0149737286572313,0.00521448268720035,No,NA,NA,P49442,NA,NA,NA,inositol-1;4-bisphosphate 1-phosphatase activity [GO:0004441]; metal ion binding [GO:0046872]; inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol phosphorylation [GO:0046854],NA,NA,NA
CHOYP_LOC101155522.1.1.m.45101,-0.00508875463982541,-0.017064042112661,No,NA,NA,Q9VU84,NA,NA,NA,axon [GO:0030424]; cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; growth cone [GO:0030426]; neuromuscular junction [GO:0031594]; type Ib terminal bouton [GO:0061176]; type Is terminal bouton [GO:0061177]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; phosphatidylinositol-3;4;5-trisphosphate binding [GO:0005547]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; chaeta development [GO:0022416]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; terminal button organization [GO:0072553],NA,NA,NA
CHOYP_LOC101155562.1.1.m.51414,-0.00890146495864105,-0.00658048542648154,No,NA,NA,Q5TYQ8,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; poly(A) binding [GO:0008143]; negative regulation of mRNA polyadenylation [GO:1900364]; regulation of mRNA stability [GO:0043488],NA,NA,NA
CHOYP_LOC101155629.1.1.m.30633,0.00941654937065892,-0.00462115140582887,No,NA,NA,Q93425,NA,NA,NA,mitochondrial small ribosomal subunit [GO:0005763]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC101156197.1.1.m.31571,0.00678620130084429,0.00878741825264137,No,NA,NA,Q9EQ28,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-dependent DNA replication [GO:0006261]; nucleotide-excision repair; DNA gap filling [GO:0006297],NA,NA,NA
CHOYP_LOC101156767.1.1.m.65605,0.00364778592941831,-0.00872052841558097,No,NA,NA,Q9QYP0,NA,NA,NA,integral component of membrane [GO:0016021]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; BMP signaling pathway [GO:0030509]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of heart left/right asymmetry [GO:0061371]; embryonic heart tube left/right pattern formation [GO:0060971]; embryonic heart tube morphogenesis [GO:0003143]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; fasciculation of sensory neuron axon [GO:0097155]; left/right pattern formation [GO:0060972]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of axon extension involved in axon guidance [GO:0048842]; regulation of gene expression [GO:0010468],NA,NA,NA
CHOYP_LOC101156833.1.1.m.38739,0.0184839622039199,0.00391353193041795,No,NA,NA,O13008,NA,NA,NA,cytoplasm [GO:0005737]; lipid binding [GO:0008289],NA,NA,NA
CHOYP_LOC101156914.1.1.m.30383,-0.0125331036650955,0.00392870861225047,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101156984.2.2.m.22956,0.00242394676893417,0.00913418475211063,No,NA,NA,P54985,NA,NA,NA,cytoplasm [GO:0005737]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457],NA,NA,NA
CHOYP_LOC101157039.2.2.m.54697,0.0141399657389911,0.0108056221075484,No,NA,NA,Q27546,NA,NA,NA,inosine nucleosidase activity [GO:0047724]; metal ion binding [GO:0046872]; uridine nucleosidase activity [GO:0045437]; nucleotide metabolic process [GO:0009117],NA,NA,NA
CHOYP_LOC101157079.2.2.m.7067,-0.00430894344577715,-0.00631540690244347,No,NA,NA,Q9BZA8,NA,NA,NA,integral component of plasma membrane [GO:0005887]; sperm head [GO:0061827]; sperm midpiece [GO:0097225]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of Wnt signaling pathway [GO:0030177]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC101157371.3.3.m.51109,0.0195858208729902,0.00587660337358992,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101157864.1.2.m.9913,-0.00147745766517834,-0.0211097562765678,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101157895.2.2.m.28009,0.00678620130084429,0.00878741825264137,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101158638.1.2.m.5931,0.00309760691773578,0.000625532400029078,No,NA,NA,Q2TAL6,NA,NA,NA,AMPA glutamate receptor complex [GO:0032281]; basement membrane [GO:0005604]; cell junction [GO:0030054]; extracellular space [GO:0005615]; interstitial matrix [GO:0005614]; synapse [GO:0045202]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of neuron differentiation [GO:0045666],NA,NA,NA
CHOYP_LOC101158638.2.2.m.27400,0.0160314551608085,-0.00879015507478566,No,NA,NA,B0UZC8,NA,NA,NA,cell junction [GO:0030054]; extracellular region [GO:0005576]; synapse [GO:0045202]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_LOC101158923.1.2.m.27410,-0.00212078832001384,-0.00891837260408135,No,NA,NA,Q6DIB5,NA,NA,NA,cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; complement component C1q binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast migration [GO:0051451]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_LOC101159074.1.1.m.29872,0.00394536801625317,0.00291369700370642,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101159300.1.1.m.26609,-0.00410989322170257,-0.00780136680193361,No,NA,NA,Q99N92,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC101159719.1.1.m.21443,-0.00212902430316218,-0.0181175772884511,No,NA,NA,A4IGL7,NA,NA,NA,extracellular space [GO:0005615]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_LOC101160004.1.1.m.48946,0.00298150903329614,0.0217688050059363,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101160053.1.1.m.18848,0.00301436300611652,-0.00733755414951727,No,NA,NA,Q6AY09,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_LOC101160063.1.4.m.2465,0.00754740905622885,-0.00607723659430552,No,NA,NA,Q14162,NA,NA,NA,endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; low-density lipoprotein particle binding [GO:0030169]; scavenger receptor activity [GO:0005044]; transmembrane signaling receptor activity [GO:0004888]; cell adhesion [GO:0007155]; cholesterol catabolic process [GO:0006707]; dendrite development [GO:0016358]; neuron remodeling [GO:0016322]; positive regulation of axon regeneration [GO:0048680]; positive regulation of neuron projection development [GO:0010976]; receptor-mediated endocytosis [GO:0006898],NA,NA,NA
CHOYP_LOC101160163.2.2.m.44944,0.00974572471443414,0.0167610916000744,No,NA,NA,Q05695,NA,NA,NA,axon [GO:0030424]; axonal growth cone [GO:0044295]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendritic growth cone [GO:0044294]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; axon guidance receptor activity [GO:0008046]; PDZ domain binding [GO:0030165]; axon development [GO:0061564]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to ethanol [GO:0071361]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to thyroxine stimulus [GO:0097069]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dopaminergic neuron differentiation [GO:0071542]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; modulation of chemical synaptic transmission [GO:0050804]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; positive regulation of axon extension [GO:0045773]; positive regulation of cell-substrate adhesion [GO:0010811]; regulation of ERK1 and ERK2 cascade [GO:0070372]; response to activity [GO:0014823]; response to thyroid hormone [GO:0097066]; synapse organization [GO:0050808],NA,NA,NA
CHOYP_LOC101160363.1.1.m.194,-0.0115538417916058,-0.00375720682624115,No,NA,NA,Q9HAC7,NA,NA,NA,mitochondrion [GO:0005739]; succinate-hydroxymethylglutarate CoA-transferase activity [GO:0047369],NA,NA,NA
CHOYP_LOC101161108.1.1.m.52561,-0.0135725579708753,0.00388604629968508,No,NA,NA,Q9NR21,NA,NA,NA,nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; cell differentiation [GO:0030154]; mRNA transport [GO:0051028]; nuclear envelope organization [GO:0006998]; protein transport [GO:0015031]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC101161976.1.1.m.43986,0.00598778628481343,0.0239397257943466,No,NA,NA,Q9X248,NA,NA,NA,3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; fatty acid elongation [GO:0030497],NA,NA,NA
CHOYP_LOC101162206.1.1.m.53261,-0.00733001113309065,0.0113105776353876,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101162499.1.1.m.47400,-0.0135725579708753,0.00388604629968508,No,NA,NA,O95428,NA,NA,NA,extracellular region [GO:0005576]; peptidase activity [GO:0008233]; serine-type endopeptidase inhibitor activity [GO:0004867],NA,NA,NA
CHOYP_LOC101162528.1.1.m.17841,0.00394536801625317,0.00291369700370642,No,NA,NA,Q5ZJL9,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; dGTP binding [GO:0032567]; dGTPase activity [GO:0008832]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; RNA phosphodiester bond hydrolysis [GO:0090501]; somatic hypermutation of immunoglobulin genes [GO:0016446],NA,NA,NA
CHOYP_LOC101163682.1.1.m.10220,0.00414002543921412,-0.00611562861559133,No,NA,NA,Q6DRD9,NA,NA,NA,mitochondrion [GO:0005739]; hydrolase activity [GO:0016787],NA,NA,NA
CHOYP_LOC101164168.1.1.m.24728,0.00282501910057952,-0.0215087441202403,No,NA,NA,Q9UK41,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; protein-containing complex binding [GO:0044877]; ubiquitin binding [GO:0043130]; endosomal transport [GO:0016197]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058],NA,NA,NA
CHOYP_LOC101164444.1.1.m.42364,-0.0041805263543019,-0.0166895375416714,No,NA,NA,Q6P1J6,NA,NA,NA,apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1;2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1;2-dioleoylphosphatidylethanolamine) [GO:0102568]; retinyl-palmitate esterase activity [GO:0050253]; lipid catabolic process [GO:0016042]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phospholipid metabolic process [GO:0006644]; positive regulation of acrosome reaction [GO:2000344]; retinoid metabolic process [GO:0001523],NA,NA,NA
CHOYP_LOC101164482.1.1.m.44586,0.00544844312462362,-0.00743407466271162,No,NA,NA,Q5SRX1,NA,NA,NA,cell [GO:0005623]; clathrin binding [GO:0030276]; protein kinase binding [GO:0019901]; intracellular protein transport [GO:0006886]; negative regulation of mitotic nuclear division [GO:0045839]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC101165304.1.1.m.54576,-0.0104204455382173,-0.00127572795116125,No,NA,NA,Q9QY36,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatA complex [GO:0031415]; nucleolus [GO:0005730]; nucleus [GO:0005634]; N-acetyltransferase activity [GO:0008080]; peptide alpha-N-acetyltransferase activity [GO:0004596]; peptide-glutamate-N-acetyltransferase activity [GO:1990190]; peptide-serine-N-acetyltransferase activity [GO:1990189]; ribosome binding [GO:0043022]; N-terminal peptidyl-glutamic acid acetylation [GO:0018002]; N-terminal peptidyl-serine acetylation [GO:0017198]; N-terminal protein amino acid acetylation [GO:0006474]; negative regulation of maintenance of mitotic sister chromatid cohesion; centromeric [GO:2000719]; protein acetylation [GO:0006473],NA,NA,NA
CHOYP_LOC101165968.2.7.m.18121,-0.0107090397386023,0.00102469558627808,No,NA,NA,Q53G44,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; defense response to virus [GO:0051607]; immune response [GO:0006955],NA,NA,NA
CHOYP_LOC101165968.3.7.m.49147,0.00961524456718678,0.0144828961207717,No,NA,NA,P27473,NA,NA,NA,cytoplasm [GO:0005737]; immune response [GO:0006955]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_LOC101165968.5.7.m.54243,-0.0194776198915659,0.00172281382792055,No,NA,NA,Q53G44,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; defense response to virus [GO:0051607]; immune response [GO:0006955],NA,NA,NA
CHOYP_LOC101165968.6.7.m.55758,-0.0225640132995737,0.00998738733443257,No,NA,NA,Q53G44,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; defense response to virus [GO:0051607]; immune response [GO:0006955],NA,NA,NA
CHOYP_LOC101166328.1.1.m.14447,-0.0116812373570498,-0.0176496551962926,No,NA,NA,Q9NXZ2,NA,NA,NA,intracellular [GO:0005622]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_LOC101166335.1.1.m.5463,-0.0141927890905037,-0.00103993736970353,No,NA,NA,Q9UM22,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160],NA,NA,NA
CHOYP_LOC101167642.1.1.m.31028,-0.00729095774256934,-0.00109112931265294,No,NA,NA,Q71R50,NA,NA,NA,extracellular region [GO:0005576]; 17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; 17-beta-ketosteroid reductase activity [GO:0072555]; 3-keto sterol reductase activity [GO:0000253]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; nucleotide binding [GO:0000166]; estrogen biosynthetic process [GO:0006703],NA,NA,NA
CHOYP_LOC101167938.1.1.m.27316,0.0125985747987717,0.0159586325156671,No,NA,NA,Q01538,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC101168798.1.1.m.6128,0.00610202926982969,0.000231077734477854,No,NA,NA,Q9D0R4,NA,NA,NA,nucleolus [GO:0005730]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; positive regulation of neuron projection development [GO:0010976]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_LOC101168834.1.1.m.9567,-0.00175883817397862,-0.00400806379868746,No,NA,NA,Q96BK5,NA,NA,NA,chromosome; telomeric region [GO:0000781]; condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; nuclear chromosome [GO:0000228]; nuclear chromosome; telomeric region [GO:0000784]; nucleolus [GO:0005730]; spindle [GO:0005819]; protein-containing complex binding [GO:0044877]; telomerase inhibitor activity [GO:0010521]; telomerase RNA binding [GO:0070034]; mitotic metaphase plate congression [GO:0007080]; negative regulation of cell proliferation [GO:0008285]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of telomeric DNA binding [GO:1904744]; protein localization to chromosome; telomeric region [GO:0070198]; protein localization to nucleolus [GO:1902570]; regulation of protein stability [GO:0031647]; regulation of telomerase activity [GO:0051972]; telomere maintenance via telomerase [GO:0007004],NA,NA,NA
CHOYP_LOC101168891.1.1.m.30839,-0.00690939529780065,0.0071834743640164,No,NA,NA,Q6DRG1,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; lens development in camera-type eye [GO:0002088],NA,NA,NA
CHOYP_LOC101169131.2.2.m.32499,0.00501711847168876,-0.0126190377538161,No,NA,NA,O70277,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; postsynapse [GO:0098794]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC101169402.1.1.m.7122,0.00615785597479523,0.00619920012457882,No,NA,NA,Q9BWU0,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; mRNA binding [GO:0003729],NA,NA,NA
CHOYP_LOC101169524.1.1.m.4630,0.00217033248435378,-0.014310689042423,No,NA,NA,O00566,NA,NA,NA,chromosome [GO:0005694]; Mpp10 complex [GO:0034457]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small nucleolar ribonucleoprotein complex [GO:0005732]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; negative regulation of phosphatase activity [GO:0010923]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; RNA splicing; via transesterification reactions [GO:0000375]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_LOC101169976.1.1.m.55723,-0.00823109141379642,-0.0200805030825978,No,NA,NA,Q91XU0,NA,NA,NA,nuclear chromosome; telomeric region [GO:0000784]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; replisome [GO:0030894]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; enzyme activator activity [GO:0008047]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; single-stranded DNA-dependent ATPase activity [GO:0043142]; DNA recombination [GO:0006310]; DNA replication; Okazaki fragment processing [GO:0033567]; DNA strand renaturation [GO:0000733]; DNA synthesis involved in DNA repair [GO:0000731]; DNA-dependent DNA replication [GO:0006261]; innate immune response [GO:0045087]; regulation of DNA repair [GO:0006282]; regulation of DNA-dependent DNA replication initiation [GO:0030174],NA,NA,NA
CHOYP_LOC101170942.1.1.m.47597,0.00850636065539076,0.0126317641543574,No,NA,NA,P41105,NA,NA,NA,cell body [GO:0044297]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosolic large ribosomal subunit [GO:0022625]; dendrite [GO:0030425]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC101171340.1.1.m.29474,0.0115264928086416,-0.01276043785391,No,NA,NA,A3KPQ7,NA,NA,NA,integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; hyalurononglucosaminidase activity [GO:0004415]; angiogenesis [GO:0001525]; atrioventricular valve formation [GO:0003190]; cardiac muscle tissue morphogenesis [GO:0055008]; cell migration involved in heart formation [GO:0060974]; cell migration to the midline involved in heart development [GO:0003318]; embryonic heart tube morphogenesis [GO:0003143]; endocardial cushion development [GO:0003197]; heart looping [GO:0001947]; hyaluronan catabolic process [GO:0030214]; muscle attachment [GO:0016203]; muscle tissue morphogenesis [GO:0060415]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; regulation of sprouting angiogenesis [GO:1903670],NA,NA,NA
CHOYP_LOC101171379.1.1.m.27459,0.00480262245357757,0.00375500966080718,No,NA,NA,Q08BY0,NA,NA,NA,mitochondrion [GO:0005739]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; chordate embryonic development [GO:0043009]; mitochondrial respiratory chain complex I assembly [GO:0032981]; peptidyl-arginine methylation; to symmetrical-dimethyl arginine [GO:0019918],NA,NA,NA
CHOYP_LOC101173065.1.1.m.11998,0.00811815152898269,0.00611335005216952,No,NA,NA,Q8IY37,NA,NA,NA,nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP-dependent 3'-5' RNA helicase activity [GO:0034459]; RNA binding [GO:0003723]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_LOC101173335.2.4.m.33982,0.0226445587529326,-0.0116926239673351,No,NA,NA,P15989,NA,NA,NA,collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]; growth plate cartilage chondrocyte morphogenesis [GO:0003429],NA,NA,NA
CHOYP_LOC101173335.4.4.m.49816,0.00151952606074026,0.00564076592057954,No,NA,NA,Q24799,NA,NA,NA,,NA,NA,NA
CHOYP_LOC101173404.1.1.m.27554,-0.00732199245083401,0.00142403861628565,No,NA,NA,Q9LZG0,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; adenosine kinase activity [GO:0004001]; ATP binding [GO:0005524]; copper ion binding [GO:0005507]; kinase binding [GO:0019900]; adenosine salvage [GO:0006169]; AMP salvage [GO:0044209]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC101173869.1.1.m.32090,-0.00449069629172991,-0.0024157864255971,No,NA,NA,Q8C5L6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; trans-Golgi network [GO:0005802]; inositol bisphosphate phosphatase activity [GO:0016312]; inositol trisphosphate phosphatase activity [GO:0046030]; inositol-1;3;4;5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1;4;5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; phosphatidylinositol trisphosphate phosphatase activity [GO:0034594]; phosphatidylinositol-3;4;5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-4;5-bisphosphate 5-phosphatase activity [GO:0004439]; vasopressin receptor activity [GO:0005000]; cellular response to cAMP [GO:0071320]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hormone stimulus [GO:0032870]; cellular response to insulin stimulus [GO:0032869]; cellular response to tumor necrosis factor [GO:0071356]; dephosphorylation [GO:0016311]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; in utero embryonic development [GO:0001701]; inositol phosphate dephosphorylation [GO:0046855]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of dephosphorylation [GO:0035305]; negative regulation of glucose transmembrane transport [GO:0010829]; negative regulation of glycogen (starch) synthase activity [GO:2000466]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein targeting to membrane [GO:0090315]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of transcription; DNA-templated [GO:0045892]; neuromuscular junction development; skeletal muscle fiber [GO:0098529]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of renal water transport [GO:2001153]; positive regulation of transcription; DNA-templated [GO:0045893]; positive regulation of urine volume [GO:0035810]; protein localization to plasma membrane [GO:0072659]; regulation of glycogen biosynthetic process [GO:0005979]; response to insulin [GO:0032868]; ruffle assembly [GO:0097178],NA,NA,NA
CHOYP_LOC101174856.1.1.m.47585,-0.00115757862878779,-0.0108148949199921,No,NA,NA,Q9Y6R4,NA,NA,NA,cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; activation of MAPKK activity [GO:0000186]; activation of protein kinase activity [GO:0032147]; chorionic trophoblast cell differentiation [GO:0060718]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_LOC101175128.1.1.m.13811,-0.010060098439762,0.00891431663722041,No,NA,NA,Q99LC9,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; photoreceptor cell cilium [GO:0097733]; photoreceptor outer segment [GO:0001750]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity; coupled [GO:0042623]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix; translocation [GO:0016561]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625],NA,NA,NA
CHOYP_LOC101175542.1.1.m.39653,0.00685313553842354,-0.0108273642344676,No,NA,NA,Q15542,NA,NA,NA,actin cytoskeleton [GO:0015629]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; transcription regulatory region DNA binding [GO:0044212]; chromatin organization [GO:0006325]; DNA-templated transcription; initiation [GO:0006352]; histone acetylation [GO:0016573]; regulation of signal transduction by p53 class mediator [GO:1901796]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC101175582.1.1.m.59321,-0.00910135419198,0.0106115880208542,No,NA,NA,F1LQ48,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; ribonucleoprotein complex [GO:1990904]; ribonucleoprotein granule [GO:0035770]; mRNA 3'-UTR binding [GO:0003730]; mRNA CDS binding [GO:1990715]; pre-mRNA intronic binding [GO:0097157]; transcription regulatory region DNA binding [GO:0044212]; cellular response to amino acid starvation [GO:0034198]; circadian rhythm [GO:0007623]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; response to peptide [GO:1901652],NA,NA,NA
CHOYP_LOC101175670.1.1.m.37,-0.0030969044703059,-0.0110513224193783,No,NA,NA,Q9NFP5,NA,NA,NA,SH3 domain binding [GO:0017124],NA,NA,NA
CHOYP_LOC101234062.1.1.m.27366,-0.0144364897550828,-0.00280593066634202,No,NA,NA,Q2KIR8,NA,NA,NA,mitochondrion [GO:0005739]; coenzyme binding [GO:0050662]; identical protein binding [GO:0042802]; L-threonine 3-dehydrogenase activity [GO:0008743]; L-threonine catabolic process to glycine [GO:0019518]; threonine catabolic process [GO:0006567],NA,NA,NA
CHOYP_LOC101236385.3.6.m.4348,0.0081296440140135,0.00617773518371362,No,NA,NA,B3EWZ3,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_LOC101238350.1.1.m.23002,-0.022562698479569,0.00998505873085593,No,NA,NA,B3EWY8,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_LOC101242114.1.1.m.13149,0.0181106771976476,-0.0084105277791399,No,NA,NA,Q8N7A1,NA,NA,NA,cytosol [GO:0005829],NA,NA,NA
CHOYP_LOC101242248.1.2.m.24785,0.00543066021204457,-0.00368498581478303,No,NA,NA,P0C6F1,NA,NA,NA,dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_LOC101242430.1.2.m.23519,0.00394536801625317,0.00291369700370642,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101345275.1.1.m.1796,0.00437708568143105,-0.0209210825384256,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101384981.1.1.m.53468,0.00394536801625317,0.00291369700370642,No,NA,NA,Q99M80,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_LOC101416772.1.1.m.30815,0.0184387552415087,0.0143625494540839,No,NA,NA,Q9W6X3,NA,NA,NA,mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; chaperone cofactor-dependent protein refolding [GO:0051085],NA,NA,NA
CHOYP_LOC101439509.1.1.m.65851,-0.0107535579658967,-0.0240914628564372,No,NA,NA,P20742,NA,NA,NA,blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; female pregnancy [GO:0007565],NA,NA,NA
CHOYP_LOC373223.1.1.m.48226,-0.0030698532841955,0.012645240509577,No,NA,NA,Q17R14,NA,NA,NA,apical dendrite [GO:0097440]; axolemma [GO:0030673]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endosome [GO:0005768]; myelin sheath [GO:0043209]; myosin complex [GO:0016459]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; smooth endoplasmic reticulum [GO:0005790]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; cellular localization [GO:0051641]; early endosome to recycling endosome transport [GO:0061502]; negative regulation of phosphatase activity [GO:0010923],NA,NA,NA
CHOYP_LOC373229.2.3.m.43412,0.00140026954910849,-0.00433131975270029,No,NA,NA,G5EBQ8,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063],NA,NA,NA
CHOYP_LOC373274.1.1.m.29721,0.0216097547024524,-0.0118184502349298,No,NA,NA,Q8N0N3,NA,NA,NA,extracellular region [GO:0005576]; (1->3)-beta-D-glucan binding [GO:0001872]; hydrolase activity; hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087],NA,NA,NA
CHOYP_LOC373275.4.7.m.47547,0.0114182510805878,0.0242147269701645,No,NA,NA,Q5R481,NA,NA,NA,axoneme [GO:0005930]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; midbody [GO:0030496]; motile cilium [GO:0031514]; septin complex [GO:0031105]; spindle [GO:0005819]; GTP binding [GO:0005525]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; cell division [GO:0051301]; cilium assembly [GO:0060271]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC373275.6.7.m.57854,-0.0116938910880494,-0.00373536776067517,No,NA,NA,P11833,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017],NA,NA,NA
CHOYP_LOC373275.7.7.m.63851,0.00364778592941831,-0.00872052841558097,No,NA,NA,P18700,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278],NA,NA,NA
CHOYP_LOC408431.1.1.m.18046,0.00955907620376788,0.0134486599009413,No,NA,NA,Q9VY77,NA,NA,NA,adherens junction [GO:0005912]; apical cortex [GO:0045179]; apical part of cell [GO:0045177]; cell-cell junction [GO:0005911]; nucleus [GO:0005634]; P-body [GO:0000932]; transcription factor complex [GO:0005667]; actin binding [GO:0003779]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; cytoskeleton organization [GO:0007010]; mitotic cell cycle [GO:0000278]; negative regulation of hippo signaling [GO:0035331]; ovarian follicle cell development [GO:0030707]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of imaginal disc growth [GO:0045572]; protein localization to centrosome [GO:0071539]; response to hypoxia [GO:0001666],NA,NA,NA
CHOYP_LOC408643.1.1.m.50154,0.00794704495114478,-0.0117601921739454,No,NA,NA,Q4J781,NA,NA,NA,alcohol dehydrogenase (NAD) activity [GO:0004022]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_LOC409619.1.4.m.13984,0.0122313602957862,-0.000858048015039984,No,NA,NA,P79098,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC410403.1.1.m.31535,-0.0124154291476112,-0.00991972622733763,No,NA,NA,Q5F3J5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; proteasome activator complex [GO:0008537]; endopeptidase activator activity [GO:0061133]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; p53 binding [GO:0002039]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of endopeptidase activity [GO:0010950]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of proteasomal protein catabolic process [GO:0061136],NA,NA,NA
CHOYP_LOC410511.1.2.m.10509,-0.0108876349587156,-0.00535797185922049,No,NA,NA,Q2KHT3,NA,NA,NA,cytosol [GO:0005829]; endolysosome membrane [GO:0036020]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; vesicle [GO:0031982]; Rab GTPase binding [GO:0017137]; autophagy [GO:0006914]; cellular response to starvation [GO:0009267]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of macroautophagy by TORC1 signaling [GO:1904766]; negative regulation of mitophagy [GO:1901525]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of autophagosome maturation [GO:1901098]; positive regulation of TORC1 signaling [GO:1904263],NA,NA,NA
CHOYP_LOC411194.1.1.m.8502,0.000686232728993108,-0.0107331332691118,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC412116.1.1.m.42829,-0.000222853226292943,-0.0046197378443311,No,NA,NA,Q8BHN5,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_LOC413005.1.1.m.63172,-0.00645109013443183,-0.0194165340055393,No,NA,NA,Q6AYR2,NA,NA,NA,cytoplasm [GO:0005737]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC420515.1.1.m.15613,0.00497100277805513,-0.00348337690929496,No,NA,NA,P22897,NA,NA,NA,cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898],NA,NA,NA
CHOYP_LOC494408.1.1.m.29208,-0.0223734376491397,-0.00174970006925362,No,NA,NA,Q9ET66,NA,NA,NA,extracellular space [GO:0005615]; peptidase inhibitor activity [GO:0030414]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052],NA,NA,NA
CHOYP_LOC496139.1.1.m.39321,-0.00574888718015759,-0.00867303627415891,No,NA,NA,Q9D187,NA,NA,NA,CIA complex [GO:0097361]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; MMXD complex [GO:0071817]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; chromosome segregation [GO:0007059]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by iron-sulfur cluster transfer [GO:0097428],NA,NA,NA
CHOYP_LOC549476.1.1.m.42388,0.001765900933882,0.00857791104271401,No,NA,NA,P62264,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]; mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]; erythrocyte differentiation [GO:0030218]; maturation of SSU-rRNA [GO:0030490]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC551931.1.1.m.9934,0.00409838345684824,0.0170757424434569,No,NA,NA,Q99447,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; ethanolamine-phosphate cytidylyltransferase activity [GO:0004306]; phosphatidylethanolamine biosynthetic process [GO:0006646]; phospholipid biosynthetic process [GO:0008654],NA,NA,NA
CHOYP_LOC552012.1.1.m.65224,-0.0169591047060434,0.00960206869202777,No,NA,NA,Q9NRF2,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; blood coagulation [GO:0007596]; intracellular signal transduction [GO:0035556]; lamellipodium assembly [GO:0030032]; positive regulation of mitotic nuclear division [GO:0045840]; regulation of DNA biosynthetic process [GO:2000278],NA,NA,NA
CHOYP_LOC552024.1.1.m.5290,0.0156027047148235,-0.0136946063918373,No,NA,NA,O05389,NA,NA,NA,oxidoreductase activity [GO:0016491]; NADPH regeneration [GO:0006740],NA,NA,NA
CHOYP_LOC552081.1.1.m.51439,-0.000129212740411392,-0.0123992669722961,No,NA,NA,A4IG32,NA,NA,NA,integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; uniplex complex [GO:1990246]; calcium ion binding [GO:0005509]; calcium ion import [GO:0070509]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of mitochondrial calcium ion concentration [GO:0051561],NA,NA,NA
CHOYP_LOC552559.1.2.m.39702,-0.00298408545185323,-0.0119112077128949,No,NA,NA,Q9VU02,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; commitment complex [GO:0000243]; cytosol [GO:0005829]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN-Sm protein complex [GO:0034719]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U4 snRNP [GO:0005687]; U5 snRNP [GO:0005682]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_LOC552662.1.1.m.15078,0.00955602085589427,0.0134506536005406,No,NA,NA,Q68ED3,NA,NA,NA,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; TRAMP complex [GO:0031499]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; carbohydrate homeostasis [GO:0033500]; cell cycle [GO:0007049]; cell division [GO:0051301]; histone mRNA catabolic process [GO:0071044]; miRNA catabolic process [GO:0010587]; mRNA polyadenylation [GO:0006378]; ncRNA polyadenylation [GO:0043629]; ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process [GO:0043630]; negative regulation of telomere maintenance via telomerase [GO:0032211]; rRNA processing [GO:0006364]; snoRNA polyadenylation [GO:0071050],NA,NA,NA
CHOYP_LOC557305.1.1.m.18011,0.00968329911664722,0.00112659341392505,No,NA,NA,Q86VP3,NA,NA,NA,endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; ion channel binding [GO:0044325]; apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; protein localization to phagophore assembly site [GO:0034497]; protein localization to plasma membrane [GO:0072659]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC558150.4.4.m.53050,-0.00729116489797595,-0.000138386023649251,No,NA,NA,Q9JLC8,NA,NA,NA,cytoplasm [GO:0005737]; low-density lipoprotein particle receptor binding [GO:0050750],NA,NA,NA
CHOYP_LOC558213.1.1.m.27293,8.64544244985969e-05,0.000543160099726191,No,NA,NA,Q4VGL6,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; P-body [GO:0000932]; double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA stem-loop binding [GO:0035613]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; B cell homeostasis [GO:0001782]; cellular response to interleukin-1 [GO:0071347]; cytoplasmic mRNA processing body assembly [GO:0033962]; lymph node development [GO:0048535]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of germinal center formation [GO:0002635]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of T-helper cell differentiation [GO:0045623]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:0000288]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; posttranscriptional regulation of gene expression [GO:0010608]; protein polyubiquitination [GO:0000209]; regulation of gene expression [GO:0010468]; regulation of germinal center formation [GO:0002634]; regulation of miRNA metabolic process [GO:2000628]; regulation of mRNA stability [GO:0043488]; regulation of T cell receptor signaling pathway [GO:0050856]; spleen development [GO:0048536]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]; T follicular helper cell differentiation [GO:0061470],NA,NA,NA
CHOYP_LOC559490.1.1.m.44696,-0.00498863216159983,-0.00673457688983919,No,NA,NA,Q9CRB6,NA,NA,NA,microtubule [GO:0005874]; microtubule bundle [GO:0097427]; perinuclear region of cytoplasm [GO:0048471]; tubulin binding [GO:0015631]; microtubule bundle formation [GO:0001578]; microtubule polymerization [GO:0046785]; positive regulation of protein polymerization [GO:0032273],NA,NA,NA
CHOYP_LOC562156.1.2.m.16403,-0.0198875927667378,0.00242909453655005,No,NA,NA,Q5G265,NA,NA,NA,axon [GO:0030424]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; exocytosis [GO:0006887],NA,NA,NA
CHOYP_LOC564392.1.1.m.29701,0.00413797837088691,-0.0168095796202074,No,NA,NA,Q92485,NA,NA,NA,anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; hydrolase activity; acting on glycosyl bonds [GO:0016798]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685],NA,NA,NA
CHOYP_LOC565211.1.2.m.34982,-0.00102940622768502,-0.0145311731655236,No,NA,NA,Q9JHA8,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_LOC565211.2.2.m.55017,0.00678620130084429,0.00878741825264137,No,NA,NA,Q9JHA8,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_LOC566621.1.1.m.45550,0.00780955152997613,0.015690702041999,No,NA,NA,Q5ZJL9,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; dGTP binding [GO:0032567]; dGTPase activity [GO:0008832]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; RNA phosphodiester bond hydrolysis [GO:0090501]; somatic hypermutation of immunoglobulin genes [GO:0016446],NA,NA,NA
CHOYP_LOC566887.1.1.m.45765,0.0116940347876073,-0.00939022602949612,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC567383.1.1.m.16245,0.00587130279881114,0.0041846261541847,No,NA,NA,Q75NR7,NA,NA,NA,chromosome [GO:0005694]; chromosome; telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; ATP-dependent 3'-5' DNA helicase activity [GO:0043140]; bubble DNA binding [GO:0000405]; DNA binding [GO:0003677]; four-way junction helicase activity [GO:0009378]; oxidized purine DNA binding [GO:0032357]; single-stranded DNA binding [GO:0003697]; telomeric D-loop binding [GO:0061821]; zinc ion binding [GO:0008270]; base-excision repair [GO:0006284]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA strand renaturation [GO:0000733]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of sister chromatid cohesion [GO:0045875]; pigmentation [GO:0043473]; positive regulation of cell proliferation [GO:0008284]; positive regulation of DNA replication [GO:0045740]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820],NA,NA,NA
CHOYP_LOC567820.1.1.m.51203,0.00615966897194063,0.00941964587728867,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC569612.1.1.m.18528,-0.00430894344577715,-0.00631540690244347,No,NA,NA,Q6P9H5,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; GTP binding [GO:0005525],NA,NA,NA
CHOYP_LOC571721.1.3.m.36443,0.00696781157308165,-0.00543994815738404,No,NA,NA,Q52M93,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC571721.2.3.m.53122,-0.0121072477660253,-0.0216669589289826,No,NA,NA,A6NNF4,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC574569.1.1.m.61069,0.000361115286748904,0.0126465419245751,No,NA,NA,O54922,NA,NA,NA,cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; plasma membrane [GO:0005886]; exocytosis [GO:0006887]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC574602.1.1.m.44079,-0.0169591047060434,0.00960206869202778,No,NA,NA,Q9UA35,NA,NA,NA,integral component of plasma membrane [GO:0005887]; nucleoside transmembrane transporter activity [GO:0005337],NA,NA,NA
CHOYP_LOC574740.1.1.m.29924,-0.0155217045683162,-0.012771669336723,No,NA,NA,Q4V8G4,NA,NA,NA,axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; cilium movement [GO:0003341]; hematopoietic progenitor cell differentiation [GO:0002244]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_LOC574855.1.9.m.547,0.0116846858861387,0.0113394811668688,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC574855.4.9.m.22339,0.00781206136694952,0.0157059159308174,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC574855.6.9.m.46549,0.014833893205901,0.0164282373386835,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC574928.1.2.m.48221,0.0129871191335056,0.000870689012235009,No,NA,NA,Q9D5V6,NA,NA,NA,axon [GO:0030424]; cell junction [GO:0030054]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; cell differentiation [GO:0030154]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; TORC2 signaling [GO:0038203],NA,NA,NA
CHOYP_LOC574943.1.1.m.56446,0.00989483766777963,0.00141234971831802,No,NA,NA,P23800,NA,NA,NA,chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; nucleosomal DNA binding [GO:0031492]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; spindle assembly [GO:0051225],NA,NA,NA
CHOYP_LOC575058.1.1.m.9531,0.00466169620635573,-0.00519492053604697,No,NA,NA,Q8WZ42,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_LOC575132.2.2.m.66125,0.00528427893382607,-0.0230671298516989,No,NA,NA,Q9WVM7,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex scaffold activity [GO:0032947]; apoptotic process [GO:0006915]; negative regulation of cell proliferation [GO:0008285]; positive regulation of aminoacyl-tRNA ligase activity [GO:1903632]; positive regulation of protein ubiquitination [GO:0031398]; protein-containing complex assembly [GO:0065003]; translation [GO:0006412]; type II pneumocyte differentiation [GO:0060510],NA,NA,NA
CHOYP_LOC575161.4.5.m.42590,0.0053672042406277,-0.00453776875777972,No,NA,NA,B3EWY9,NA,NA,NA,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ErbB-2 class receptor binding [GO:0005176]; extracellular matrix constituent; lubricant activity [GO:0030197]; cell-matrix adhesion [GO:0007160]; epithelial structure maintenance [GO:0010669]; regulation of signaling receptor activity [GO:0010469],NA,NA,NA
CHOYP_LOC575161.5.5.m.55590,0.000182770610439638,-0.0162561632466668,No,NA,NA,B3EWY9,NA,NA,NA,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ErbB-2 class receptor binding [GO:0005176]; extracellular matrix constituent; lubricant activity [GO:0030197]; cell-matrix adhesion [GO:0007160]; epithelial structure maintenance [GO:0010669]; regulation of signaling receptor activity [GO:0010469],NA,NA,NA
CHOYP_LOC575203.2.6.m.6856,0.0136190883984154,0.00362748638877976,No,NA,NA,Q26636,NA,NA,NA,lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_LOC575203.6.6.m.30705,0.00342655854857603,-0.0162572855373641,No,NA,NA,Q26636,NA,NA,NA,lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_LOC575264.1.1.m.10111,-0.0148978148914776,-0.00681920436409322,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC575405.1.1.m.18640,0.0178315778363629,-0.00804943481108553,No,NA,NA,Q5YLG1,NA,NA,NA,extracellular region [GO:0005576]; cellulase activity [GO:0008810]; cellulose binding [GO:0030248]; cellulose catabolic process [GO:0030245],NA,NA,NA
CHOYP_LOC575478.1.1.m.6923,-0.00102362375345715,-0.0145341259090159,No,NA,NA,Q86U38,NA,NA,NA,RNA binding [GO:0003723],NA,NA,NA
CHOYP_LOC575509.2.2.m.63548,-0.0228050948588361,0.0105202609463934,No,NA,NA,Q7T0Y4,NA,NA,NA,axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; motile cilium [GO:0031514]; axonemal dynein complex assembly [GO:0070286]; cilium-dependent cell motility [GO:0060285],NA,NA,NA
CHOYP_LOC575600.1.1.m.27851,-0.012233869126999,-0.00797722060971141,No,NA,NA,Q9Y5X2,NA,NA,NA,cytosol [GO:0005829]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; early endosome to Golgi transport [GO:0034498]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_LOC575625.1.2.m.50064,0.00347281359551159,0.00153851604279126,No,NA,NA,O95405,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; protein-containing complex [GO:0032991]; 1-phosphatidylinositol binding [GO:0005545]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; serine-type peptidase activity [GO:0008236]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_LOC575793.1.2.m.34690,-0.0019262128547727,-0.0142872232681661,No,NA,NA,Q3T042,NA,NA,NA,nucleus [GO:0005634]; preribosome; small subunit precursor [GO:0030688]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; cleavage involved in rRNA processing [GO:0000469]; maturation of SSU-rRNA [GO:0030490],NA,NA,NA
CHOYP_LOC575793.1.2.m.34691,0.00394536801625317,0.00291369700370642,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC575893.1.1.m.62614,0.00675255745260194,-0.00565749244951293,No,NA,NA,Q3T0Z7,NA,NA,NA,cytoplasm [GO:0005737]; 6;7-dihydropteridine reductase activity [GO:0004155]; NADH binding [GO:0070404]; NADPH binding [GO:0070402]; L-phenylalanine catabolic process [GO:0006559]; tetrahydrobiopterin biosynthetic process [GO:0006729],NA,NA,NA
CHOYP_LOC575944.1.5.m.22547,0.00394536801625317,0.00291369700370642,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC575944.3.5.m.24887,0.00987790842503363,0.00675409620669501,No,NA,NA,P22105,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251],NA,NA,NA
CHOYP_LOC576041.1.1.m.28220,0.00623047670487622,-0.0116583460630281,No,NA,NA,Q92051,NA,NA,NA,carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; carbon dioxide transport [GO:0015670]; hypotonic salinity response [GO:0042539],NA,NA,NA
CHOYP_LOC576200.3.4.m.38681,-0.00469666425877903,0.0130062590596024,No,NA,NA,A6X942,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC576326.1.1.m.49857,0.0151921259315581,0.000187449557429409,No,NA,NA,Q6TLF6,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]; gluconolactonase activity [GO:0004341]; zinc ion binding [GO:0008270]; cellular calcium ion homeostasis [GO:0006874]; L-ascorbic acid biosynthetic process [GO:0019853]; positive regulation of ATPase activity [GO:0032781]; regulation of calcium-mediated signaling [GO:0050848],NA,NA,NA
CHOYP_LOC576341.1.2.m.9414,-0.0116172103016169,-0.00368643505347756,No,NA,NA,Q4AC94,NA,NA,NA,centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; brain development [GO:0007420]; centriole elongation [GO:0061511]; ciliary basal body-plasma membrane docking [GO:0097711]; embryonic digit morphogenesis [GO:0042733]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; neural plate axis specification [GO:0021997]; neural tube development [GO:0021915]; non-motile cilium assembly [GO:1905515]; protein localization to centrosome [GO:0071539]; protein processing [GO:0016485]; regulation of proteolysis [GO:0030162]; regulation of smoothened signaling pathway [GO:0008589],NA,NA,NA
CHOYP_LOC576498.1.1.m.10455,-0.0185993213587269,-0.00764942910667116,No,NA,NA,Q5FWU8,NA,NA,NA,apical plasma membrane [GO:0016324]; centriolar satellite [GO:0034451]; cilium [GO:0005929]; metal ion binding [GO:0046872]; inner dynein arm assembly [GO:0036159]; motile cilium assembly [GO:0044458]; outer dynein arm assembly [GO:0036158]; positive regulation of motile cilium assembly [GO:1905505],NA,NA,NA
CHOYP_LOC576511.1.1.m.53180,-0.00957060544211775,0.0122941532232107,No,NA,NA,Q5RG45,NA,NA,NA,centriole [GO:0005814]; centriole replication [GO:0007099]; centriole-centriole cohesion [GO:0010457],NA,NA,NA
CHOYP_LOC576660.1.1.m.33760,-0.0108329982144729,0.00188019269316336,No,NA,NA,A6QLU1,NA,NA,NA,glycerol-3-phosphate dehydrogenase complex [GO:0009331]; mitochondrion [GO:0005739]; calcium ion binding [GO:0005509]; glycerol-3-phosphate dehydrogenase (quinone) activity [GO:0004368]; glycerol-3-phosphate dehydrogenase [NAD+] activity [GO:0004367]; sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity [GO:0052591]; camera-type eye development [GO:0043010]; gluconeogenesis [GO:0006094]; glycerol catabolic process [GO:0019563]; glycerol-3-phosphate catabolic process [GO:0046168]; multicellular organism growth [GO:0035264],NA,NA,NA
CHOYP_LOC576665.1.2.m.10867,-0.0234125847498799,0.00228528006085606,No,NA,NA,A6QQL5,NA,NA,NA,,NA,NA,NA
CHOYP_LOC576665.1.2.m.10868,-0.0227927964830892,0.00555350874418282,No,NA,NA,Q96L03,NA,NA,NA,cytoplasm [GO:0005737]; calmodulin binding [GO:0005516],NA,NA,NA
CHOYP_LOC576698.1.1.m.32335,-0.0168004057649482,-0.0202120352077712,No,NA,NA,Q3V096,NA,NA,NA,nucleus [GO:0005634]; NF-kappaB binding [GO:0051059]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of NF-kappaB transcription factor activity [GO:0051092],NA,NA,NA
CHOYP_LOC576797.1.1.m.8986,-0.000730355732636531,0.00573577400565699,No,NA,NA,O43822,NA,NA,NA,ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; cytoskeleton organization [GO:0007010]; DNA damage response; detection of DNA damage [GO:0042769]; motile cilium assembly [GO:0044458]; regulation of cell shape [GO:0008360],NA,NA,NA
CHOYP_LOC577063.1.1.m.30814,-0.0200979221569737,-0.00225373362360381,No,NA,NA,P05090,NA,NA,NA,cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319]; aging [GO:0007568]; angiogenesis [GO:0001525]; brain development [GO:0007420]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of lipoprotein lipid oxidation [GO:0060588]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of smooth muscle cell-matrix adhesion [GO:2000098]; negative regulation of T cell migration [GO:2000405]; peripheral nervous system axon regeneration [GO:0014012]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to reactive oxygen species [GO:0000302]; tissue regeneration [GO:0042246],NA,NA,NA
CHOYP_LOC577184.1.1.m.62005,0.0223914991041536,-0.00930056577321163,No,NA,NA,B3EWY9,NA,NA,NA,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ErbB-2 class receptor binding [GO:0005176]; extracellular matrix constituent; lubricant activity [GO:0030197]; cell-matrix adhesion [GO:0007160]; epithelial structure maintenance [GO:0010669]; regulation of signaling receptor activity [GO:0010469],NA,NA,NA
CHOYP_LOC577190.1.1.m.18117,-0.00759970631355888,-0.00540624695537723,No,NA,NA,C3XRY1,NA,NA,NA,nucleus [GO:0005634]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K4 specific) [GO:0032453]; iron ion binding [GO:0005506]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; 2-oxoglutarate as one donor; and incorporation of one atom each of oxygen into both donors [GO:0016706]; histone H3-K36 demethylation [GO:0070544]; histone H3-K4 demethylation [GO:0034720]; negative regulation of transcription; DNA-templated [GO:0045892],NA,NA,NA
CHOYP_LOC577313.2.5.m.45484,-0.018538480591699,0.0106752352274831,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC577338.1.1.m.9819,-0.0154821905114078,-0.00167210899027691,No,NA,NA,Q6GPB8,NA,NA,NA,nucleus [GO:0005634]; RNA lariat debranching enzyme activity [GO:0008419]; mRNA processing [GO:0006397]; RNA splicing; via transesterification reactions [GO:0000375],NA,NA,NA
CHOYP_LOC577351.1.1.m.17664,-0.0189084252946801,-0.00103928638883368,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC577371.1.2.m.46335,-0.0185309446594209,-0.0191660839207467,No,NA,NA,Q8TE73,NA,NA,NA,9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158],NA,NA,NA
CHOYP_LOC577550.1.1.m.36506,-0.0116068324068751,-0.00666337833070837,No,NA,NA,Q28IH8,NA,NA,NA,cytoplasm [GO:0005737]; motile cilium [GO:0031514]; nucleus [GO:0005634],NA,NA,NA
CHOYP_LOC577551.1.1.m.30278,-0.00823112755660602,0.0134968555950262,No,NA,NA,Q8BHL8,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471]; proteasome complex [GO:0000502]; proteasome binding [GO:0070628]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; negative regulation of proteasomal protein catabolic process [GO:1901799]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC577573.1.1.m.13979,-0.00167922609488907,-0.0115572341745326,No,NA,NA,Q9NVE5,NA,NA,NA,cytosol [GO:0005829]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC577730.2.5.m.11065,-0.013877049456228,-0.0150816619191852,No,NA,NA,A7RT29,NA,NA,NA,lysosome [GO:0005764]; Ragulator complex [GO:0071986]; cellular response to amino acid stimulus [GO:0071230]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of TOR signaling [GO:0032008]; protein localization to lysosome [GO:0061462]; regulation of cell size [GO:0008361]; viral genome replication [GO:0019079],NA,NA,NA
CHOYP_LOC577805.1.4.m.9698,-0.0196921558675565,0.00431139463065688,No,NA,NA,Q39575,NA,NA,NA,cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cilium movement involved in cell motility [GO:0060294]; outer dynein arm assembly [GO:0036158],NA,NA,NA
CHOYP_LOC577805.3.4.m.46026,-0.0169591047060434,0.00960206869202777,No,NA,NA,Q96JB1,NA,NA,NA,axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158],NA,NA,NA
CHOYP_LOC577905.1.2.m.2598,0.00890023141486388,0.00594158576273752,No,NA,NA,P40757,NA,NA,NA,mitochondrion [GO:0005739]; allantoinase activity [GO:0004038]; cobalt ion binding [GO:0050897]; zinc ion binding [GO:0008270]; allantoin catabolic process [GO:0000256],NA,NA,NA
CHOYP_LOC577931.3.3.m.35020,-0.00197681060352167,-0.0197307346376615,No,NA,NA,P07589,NA,NA,NA,extracellular region [GO:0005576]; extracellular space [GO:0005615]; disordered domain specific binding [GO:0097718]; heparin binding [GO:0008201]; acute-phase response [GO:0006953]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; regulation of cell shape [GO:0008360],NA,NA,NA
CHOYP_LOC578003.1.1.m.64329,-0.0108717348103443,-0.019433298012201,No,NA,NA,Q5M7D6,NA,NA,NA,protein phosphatase 4 complex [GO:0030289]; protein phosphatase regulator activity [GO:0019888],NA,NA,NA
CHOYP_LOC578045.4.5.m.61073,0.0076342175157378,-0.000329330955281066,No,NA,NA,P28828,NA,NA,NA,cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; positive regulation of blood vessel diameter [GO:0097755]; protein dephosphorylation [GO:0006470]; response to drug [GO:0042493]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC578045.5.5.m.65293,-0.00179601201259726,0.0234113706865216,No,NA,NA,P28827,NA,NA,NA,cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; positive regulation of blood vessel diameter [GO:0097755]; protein dephosphorylation [GO:0006470]; response to drug [GO:0042493]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC578169.1.1.m.63470,-0.0233295643755291,0.00163940576032541,No,NA,NA,Q5T1B0,NA,NA,NA,,NA,NA,NA
CHOYP_LOC578260.1.1.m.21677,0.00849055697245847,-0.0154929528505092,No,NA,NA,Q5R2J2,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity [GO:0004365]; microtubule binding [GO:0008017]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; peptidyl-cysteine S-nitrosylase activity [GO:0035605]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; microtubule cytoskeleton organization [GO:0000226]; neuron apoptotic process [GO:0051402]; peptidyl-cysteine S-trans-nitrosylation [GO:0035606]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_LOC578280.1.1.m.42277,0.00217997094733793,-0.00807271368859912,No,NA,NA,O95490,NA,NA,NA,integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; latrotoxin receptor activity [GO:0016524]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186],NA,NA,NA
CHOYP_LOC578284.1.1.m.30567,0.00232535835283121,0.00408315827433519,No,NA,NA,Q5ZM33,NA,NA,NA,nucleosome [GO:0000786]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; heterochromatin organization [GO:0070828]; nucleosome assembly [GO:0006334]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC578349.1.1.m.51923,-0.00329169969909568,-0.00638351928028039,No,NA,NA,Q9BUH6,NA,NA,NA,nonhomologous end joining complex [GO:0070419]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein-containing complex scaffold activity [GO:0032947]; cellular response to DNA damage stimulus [GO:0006974]; DNA ligation involved in DNA repair [GO:0051103]; double-strand break repair via nonhomologous end joining [GO:0006303],NA,NA,NA
CHOYP_LOC578371.1.1.m.56054,-0.023171928905024,0.000658104842024546,No,NA,NA,Q9P2S6,NA,NA,NA,metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC578464.1.1.m.46553,0.00777516242987542,-0.00518510272478597,No,NA,NA,P49109,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; organelle membrane [GO:0031090]; flavin adenine dinucleotide binding [GO:0050660]; N;N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661],NA,NA,NA
CHOYP_LOC578599.1.8.m.12749,0.00364778592941831,-0.00872052841558097,No,NA,NA,O75581,NA,NA,NA,caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; apolipoprotein binding [GO:0034185]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; anterior/posterior pattern specification [GO:0009952]; axis elongation involved in somitogenesis [GO:0090245]; beta-catenin destruction complex disassembly [GO:1904886]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in neural crest cell differentiation [GO:0044335]; canonical Wnt signaling pathway involved in regulation of cell proliferation [GO:0044340]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; gastrulation with mouth forming second [GO:0001702]; midbrain development [GO:0030901]; midbrain dopaminergic neuron differentiation [GO:1904948]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; response to peptide hormone [GO:0043434]; roof of mouth development [GO:0060021]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; Wnt signaling pathway involved in somitogenesis [GO:0090244],NA,NA,NA
CHOYP_LOC578599.8.8.m.57682,0.00646792687079462,0.00700136328164298,No,NA,NA,O75581,NA,NA,NA,caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; apolipoprotein binding [GO:0034185]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; anterior/posterior pattern specification [GO:0009952]; axis elongation involved in somitogenesis [GO:0090245]; beta-catenin destruction complex disassembly [GO:1904886]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in neural crest cell differentiation [GO:0044335]; canonical Wnt signaling pathway involved in regulation of cell proliferation [GO:0044340]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; gastrulation with mouth forming second [GO:0001702]; midbrain development [GO:0030901]; midbrain dopaminergic neuron differentiation [GO:1904948]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; response to peptide hormone [GO:0043434]; roof of mouth development [GO:0060021]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; Wnt signaling pathway involved in somitogenesis [GO:0090244],NA,NA,NA
CHOYP_LOC578600.1.1.m.45849,0.00670834809117843,-0.0118432814089788,No,NA,NA,P83741,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; ATP binding [GO:0005524]; chloride channel inhibitor activity [GO:0019869]; magnesium ion binding [GO:0000287]; phosphatase binding [GO:0019902]; potassium channel inhibitor activity [GO:0019870]; protein kinase activator activity [GO:0030295]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; cellular response to calcium ion [GO:0071277]; cellular response to chemokine [GO:1990869]; chemokine (C-C motif) ligand 21 signaling pathway [GO:0038116]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; ion transport [GO:0006811]; lymphocyte migration into lymph node [GO:0097022]; negative regulation of cell-cell adhesion mediated by integrin [GO:0033633]; negative regulation of GTPase activity [GO:0034260]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of kinase activity [GO:0033673]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of sodium ion transport [GO:0010766]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of ion transmembrane transporter activity [GO:0032414]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of T cell chemotaxis [GO:0010820]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cellular process [GO:0050794]; regulation of sodium ion transport [GO:0002028]; signal transduction by trans-phosphorylation [GO:0023016]; T cell receptor signaling pathway [GO:0050852],NA,NA,NA
CHOYP_LOC578627.1.1.m.61950,-0.00505579780042903,0.0114930858856919,No,NA,NA,P51147,NA,NA,NA,early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; exocytic vesicle [GO:0070382]; lipid droplet [GO:0005811]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; plasma membrane to endosome transport [GO:0048227]; Rab protein signal transduction [GO:0032482]; regulation of endocytosis [GO:0030100],NA,NA,NA
CHOYP_LOC578656.8.15.m.42294,-0.0154449645780217,-0.0167970592863771,No,NA,NA,O75581,NA,NA,NA,caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; apolipoprotein binding [GO:0034185]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; anterior/posterior pattern specification [GO:0009952]; axis elongation involved in somitogenesis [GO:0090245]; beta-catenin destruction complex disassembly [GO:1904886]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in neural crest cell differentiation [GO:0044335]; canonical Wnt signaling pathway involved in regulation of cell proliferation [GO:0044340]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; gastrulation with mouth forming second [GO:0001702]; midbrain development [GO:0030901]; midbrain dopaminergic neuron differentiation [GO:1904948]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; response to peptide hormone [GO:0043434]; roof of mouth development [GO:0060021]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; Wnt signaling pathway involved in somitogenesis [GO:0090244],NA,NA,NA
CHOYP_LOC578656.9.15.m.53454,0.000686232728993108,-0.0107331332691118,No,NA,NA,Q9JI18,NA,NA,NA,integral component of membrane [GO:0016021]; membrane [GO:0016020]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041]; low-density lipoprotein particle receptor binding [GO:0050750]; in utero embryonic development [GO:0001701],NA,NA,NA
CHOYP_LOC578672.1.2.m.29847,-0.00572946588421829,0.00722432496184716,No,NA,NA,Q9BUJ2,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; response to virus [GO:0009615]; RNA processing [GO:0006396],NA,NA,NA
CHOYP_LOC578672.2.2.m.44884,-0.00413903604972413,-0.0168017400547349,No,NA,NA,Q00839,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; cell surface [GO:0009986]; centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasmic ribonucleoprotein granule [GO:0036464]; dendrite cytoplasm [GO:0032839]; inactive sex chromosome [GO:0098577]; kinetochore [GO:0000776]; membrane [GO:0016020]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; mitotic spindle microtubule [GO:1990498]; mitotic spindle midzone [GO:1990023]; nuclear chromosome [GO:0000228]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; spindle pole [GO:0000922]; telomerase holoenzyme complex [GO:0005697]; actin binding [GO:0003779]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(C) RNA binding [GO:0017130]; poly(G) binding [GO:0034046]; pre-mRNA binding [GO:0036002]; promoter-specific chromatin binding [GO:1990841]; protein-containing complex binding [GO:0044877]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA polymerase II C-terminal domain binding [GO:0099122]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; snRNA binding [GO:0017069]; telomerase RNA binding [GO:0070034]; TFIIH-class transcription factor complex binding [GO:0001097]; transcription corepressor activity [GO:0003714]; adaptive thermogenesis [GO:1990845]; cardiac muscle cell development [GO:0055013]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; CRD-mediated mRNA stabilization [GO:0070934]; dendritic transport of messenger ribonucleoprotein complex [GO:0098963]; dosage compensation by inactivation of X chromosome [GO:0009048]; maintenance of protein location in nucleus [GO:0051457]; mRNA splicing; via spliceosome [GO:0000398]; mRNA stabilization [GO:0048255]; negative regulation of kinase activity [GO:0033673]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; osteoblast differentiation [GO:0001649]; positive regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902425]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to spindle microtubule [GO:1902889]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of chromatin organization [GO:1902275]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic spindle assembly [GO:1901673]; RNA localization to chromatin [GO:1990280]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396],NA,NA,NA
CHOYP_LOC578680.1.1.m.49370,-0.0231731341975946,-0.00387917777115587,No,NA,NA,Q8CDU5,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC578781.1.5.m.2353,-0.00182135376377107,0.00321790194862994,No,NA,NA,O95425,NA,NA,NA,actin cytoskeleton [GO:0015629]; cleavage furrow [GO:0032154]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; invadopodium [GO:0071437]; microtubule minus-end [GO:0036449]; midbody [GO:0030496]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; podosome [GO:0002102]; actin filament binding [GO:0051015]; cytoskeleton organization [GO:0007010]; positive regulation of cytokinesis [GO:0032467]; skeletal muscle tissue development [GO:0007519],NA,NA,NA
CHOYP_LOC578781.2.5.m.8827,0.0121114145994877,0.00408831333185538,No,NA,NA,O95425,NA,NA,NA,actin cytoskeleton [GO:0015629]; cleavage furrow [GO:0032154]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; invadopodium [GO:0071437]; microtubule minus-end [GO:0036449]; midbody [GO:0030496]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; podosome [GO:0002102]; actin filament binding [GO:0051015]; cytoskeleton organization [GO:0007010]; positive regulation of cytokinesis [GO:0032467]; skeletal muscle tissue development [GO:0007519],NA,NA,NA
CHOYP_LOC578858.2.2.m.25157,-0.0134656098507576,4.49059145644338e-05,No,NA,NA,Q6SP97,NA,NA,NA,acrosomal vesicle [GO:0001669]; sperm principal piece [GO:0097228]; calmodulin binding [GO:0005516]; SH3 domain binding [GO:0017124],NA,NA,NA
CHOYP_LOC578881.1.1.m.9743,0.0201092147138705,0.00715986636790151,No,NA,NA,Q9HBU6,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ethanolamine kinase activity [GO:0004305]; phosphatidylethanolamine biosynthetic process [GO:0006646],NA,NA,NA
CHOYP_LOC578897.1.1.m.11932,-0.0226649600739731,0.0102740192905555,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC578968.1.2.m.41294,-0.00539211750248232,-0.0135356631152453,No,NA,NA,Q99M80,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_LOC578968.2.2.m.54316,0.00364778592941831,-0.00872052841558097,No,NA,NA,Q99M80,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_LOC578979.1.1.m.10409,-0.0120747581486862,-0.00756687924707722,No,NA,NA,Q4R6I5,NA,NA,NA,,NA,NA,NA
CHOYP_LOC579012.1.1.m.10830,-0.020356371933158,-0.0105814083472962,No,NA,NA,Q8N865,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC579123.1.1.m.65215,0.0014907265638567,-0.0195014657020505,No,NA,NA,Q9UNS1,NA,NA,NA,nuclear chromatin [GO:0000790]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; branching morphogenesis of an epithelial tube [GO:0048754]; cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; cellular response to bleomycin [GO:1904976]; cellular response to cisplatin [GO:0072719]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; circadian rhythm [GO:0007623]; detection of abiotic stimulus [GO:0009582]; DNA repair [GO:0006281]; DNA replication checkpoint [GO:0000076]; lung development [GO:0030324]; morphogenesis of an epithelium [GO:0002009]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of double-strand break repair [GO:2000781]; regulation of circadian rhythm [GO:0042752]; replication fork arrest [GO:0043111]; replication fork protection [GO:0048478],NA,NA,NA
CHOYP_LOC579332.1.1.m.41750,0.00321568125130628,-0.0242535297282997,No,NA,NA,Q92538,NA,NA,NA,cell leading edge [GO:0031252]; cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; trans-Golgi network [GO:0005802]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol-3;4;5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3;5-bisphosphate binding [GO:0080025]; cell activation involved in immune response [GO:0002263]; cellular response to virus [GO:0098586]; COPI coating of Golgi vesicle [GO:0048205]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endoplasmic reticulum-Golgi intermediate compartment organization [GO:0097111]; establishment of monopolar cell polarity [GO:0061162]; Golgi disassembly [GO:0090166]; Golgi organization [GO:0007030]; Golgi to endosome transport [GO:0006895]; neutrophil chemotaxis [GO:0030593]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to endoplasmic reticulum tubular network [GO:1903420]; protein localization to Golgi apparatus [GO:0034067]; protein transport [GO:0015031]; reactive oxygen species biosynthetic process [GO:1903409]; regulation of ARF protein signal transduction [GO:0032012]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein localization to cell surface [GO:2000008]; retrograde transport; endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC579381.1.1.m.10900,0.00205195042830452,-0.00934116934689426,No,NA,NA,Q8BUG5,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC579644.1.1.m.16828,-0.0156711926866983,0.00238183609919379,No,NA,NA,Q9Z0R0,NA,NA,NA,centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; histone kinase activity (H3-T3 specific) [GO:0072354]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; histone H3-T3 phosphorylation involved in chromosome passenger complex localization to kinetochore [GO:2000751]; intracellular signal transduction [GO:0035556]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; protein localization to chromosome; centromeric region [GO:0071459]; protein phosphorylation [GO:0006468],NA,NA,NA
CHOYP_LOC579656.3.5.m.41908,0.000951212081874114,0.000672462647395784,No,NA,NA,Q9Y3Q0,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; dipeptidyl-peptidase activity [GO:0008239]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; N-formylglutamate deformylase activity [GO:0050129]; serine-type peptidase activity [GO:0008236]; cellular amino acid biosynthetic process [GO:0008652]; neurotransmitter catabolic process [GO:0042135]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC579681.1.1.m.25827,0.00293803344984118,0.0160081552968061,No,NA,NA,Q6IP50,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC579713.1.1.m.17440,0.000977526682492303,-0.0187372663333345,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC579737.1.1.m.14356,0.00935717832851941,-0.0139716790650621,No,NA,NA,Q64350,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2B complex [GO:0005851]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; aging [GO:0007568]; astrocyte development [GO:0014002]; astrocyte differentiation [GO:0048708]; hippocampus development [GO:0021766]; myelination [GO:0042552]; oligodendrocyte development [GO:0014003]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to lithium ion [GO:0010226]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_LOC579832.2.2.m.47454,-0.0136127190017749,0.00192484590296392,No,NA,NA,Q5SUV2,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; cell differentiation [GO:0030154]; chemical synaptic transmission [GO:0007268]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC579833.1.1.m.23271,0.0174808232332675,-0.00745640226053564,No,NA,NA,Q8MP06,NA,NA,NA,extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; N;N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; senecionine N-oxygenase activity [GO:0033784]; alkaloid metabolic process [GO:0009820]; oxidation-reduction process [GO:0055114]; protein homotetramerization [GO:0051289],NA,NA,NA
CHOYP_LOC579914.1.1.m.13347,-0.0152862862434032,-0.00298193543250082,No,NA,NA,Q07DZ5,NA,NA,NA,cell cortex [GO:0005938]; dendritic spine [GO:0043197],NA,NA,NA
CHOYP_LOC579934.1.1.m.59523,-0.0126797065880203,-0.0185314866644308,No,NA,NA,Q6NY77,NA,NA,NA,mitochondrion [GO:0005739]; 4-hydroxy-2-oxoglutarate aldolase activity [GO:0008700]; glyoxylate catabolic process [GO:0009436],NA,NA,NA
CHOYP_LOC579946.11.24.m.42367,-0.00276616720615854,0.0213843263555887,No,NA,NA,O88281,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC579946.17.24.m.53406,-0.00158680477817586,0.000419943863458933,No,NA,NA,O88281,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC579946.20.24.m.55163,0.00597220444428838,-0.00148461235328034,No,NA,NA,Q9W0A0,NA,NA,NA,axon [GO:0030424]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; phosphatidylserine binding [GO:0001786]; apoptotic cell clearance [GO:0043277]; cell competition in a multicellular organism [GO:0035212]; defense response to bacterium [GO:0042742]; engulfment of apoptotic cell [GO:0043652]; larval locomotory behavior [GO:0008345]; neuron remodeling [GO:0016322]; phagocytosis [GO:0006909]; phagocytosis; engulfment [GO:0006911]; positive regulation of phagocytosis; engulfment [GO:0060100]; regulation of neuromuscular junction development [GO:1904396]; response to axon injury [GO:0048678]; salivary gland cell autophagic cell death [GO:0035071]; wing disc dorsal/ventral pattern formation [GO:0048190],NA,NA,NA
CHOYP_LOC579946.7.24.m.39737,0.0225366083396863,-0.00860455316584195,No,NA,NA,P22105,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251],NA,NA,NA
CHOYP_LOC580197.1.1.m.4591,0.00432819967698926,-0.0131037459514193,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC580207.1.1.m.49071,0.00202967160223694,0.00422214234583888,No,NA,NA,Q3MHG0,NA,NA,NA,Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; Golgi organization [GO:0007030]; Golgi vesicle prefusion complex stabilization [GO:0048213]; protein transport [GO:0015031]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_LOC580355.1.1.m.29389,0.00310970923559403,-0.00623312182749671,No,NA,NA,P07314,NA,NA,NA,extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; glutathione hydrolase activity [GO:0036374]; hypoglycin A gamma-glutamyl transpeptidase activity [GO:0102953]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; peptidyltransferase activity [GO:0000048]; transferase activity; transferring amino-acyl groups [GO:0016755]; aging [GO:0007568]; cellular amino acid metabolic process [GO:0006520]; cellular response to oxidative stress [GO:0034599]; cysteine biosynthetic process [GO:0019344]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; glutathione metabolic process [GO:0006749]; peptide modification [GO:0031179]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; spermatogenesis [GO:0007283]; zymogen activation [GO:0031638],NA,NA,NA
CHOYP_LOC580466.1.2.m.18704,0.00591451129552258,-0.000327240477978287,No,NA,NA,Q640V9,NA,NA,NA,nucleus [GO:0005634]; endodeoxyribonuclease activity; producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC580666.1.2.m.21929,-0.00180551712714631,0.0115114399459719,No,NA,NA,B0C431,NA,NA,NA,ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC580669.1.1.m.7758,-0.00842015823146679,-0.00410330358547125,No,NA,NA,Q9Y7Y3,NA,NA,NA,90S preribosome [GO:0030686]; nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; ribosomal small subunit biogenesis [GO:0042274]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_LOC580670.1.6.m.4085,-0.00126394129111171,0.0110895726497324,No,NA,NA,A2AJX4,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; cholesterol homeostasis [GO:0042632]; negative regulation of bile acid biosynthetic process [GO:0070858],NA,NA,NA
CHOYP_LOC580670.5.6.m.34028,0.0221794178342316,-0.00726825551298935,No,NA,NA,B3EWZ5,NA,NA,NA,extracellular region [GO:0005576]; membrane [GO:0016020],NA,NA,NA
CHOYP_LOC580670.6.6.m.40875,0.0118505494866532,-0.0207104660786734,No,NA,NA,B3EWZ6,NA,NA,NA,extracellular region [GO:0005576]; membrane [GO:0016020],NA,NA,NA
CHOYP_LOC580675.1.1.m.44042,0.00491588973115351,-0.000600714720400964,No,NA,NA,Q5ZQU0,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160],NA,NA,NA
CHOYP_LOC580687.1.1.m.1044,0.0138482024653898,0.00305310095923383,No,NA,NA,P82094,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; DNA binding [GO:0003677]; transcription coregulator activity [GO:0003712]; acrosome assembly [GO:0001675]; cellular response to organic cyclic compound [GO:0071407]; defense response to bacterium [GO:0042742]; flagellated sperm motility [GO:0030317]; Leydig cell differentiation [GO:0033327]; luteinizing hormone secretion [GO:0032275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; positive regulation of cytokine production [GO:0001819]; positive regulation of testosterone secretion [GO:2000845]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of transcription; DNA-templated [GO:0006355]; spermatid nucleus differentiation [GO:0007289]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_LOC580832.1.1.m.66146,-0.0078034223081103,0.000380457055986031,No,NA,NA,Q92947,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; lysine catabolic process [GO:0006554]; tryptophan metabolic process [GO:0006568],NA,NA,NA
CHOYP_LOC580840.1.1.m.45392,-0.0163636546395501,-0.0182334741146008,No,NA,NA,Q32L77,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],NA,NA,NA
CHOYP_LOC581113.2.2.m.57598,-0.0201566423359598,-0.00956483638055124,No,NA,NA,Q8AV28,NA,NA,NA,apical part of cell [GO:0045177]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; pericentriolar material [GO:0000242]; protein-containing complex [GO:0032991]; centrosome cycle [GO:0007098]; cilium assembly [GO:0060271]; cytoplasmic microtubule organization [GO:0031122]; interkinetic nuclear migration [GO:0022027]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule anchoring at centrosome [GO:0034454]; negative regulation of neurogenesis [GO:0050768]; neuron migration [GO:0001764]; neuronal stem cell population maintenance [GO:0097150]; non-motile cilium assembly [GO:1905515]; positive regulation of intracellular protein transport [GO:0090316]; protein localization to centrosome [GO:0071539]; social behavior [GO:0035176],NA,NA,NA
CHOYP_LOC581128.1.1.m.46711,0.00364778592941831,-0.00872052841558097,No,NA,NA,P83436,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; nucleolus [GO:0005730]; trans-Golgi network membrane [GO:0032588]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; protein glycosylation [GO:0006486]; protein localization to Golgi apparatus [GO:0034067]; protein localization to organelle [GO:0033365]; protein stabilization [GO:0050821]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_LOC581387.1.1.m.56997,-0.0222292238570598,-0.0074026009958933,No,NA,NA,A8E5W8,NA,NA,NA,,NA,NA,NA
CHOYP_LOC581447.1.1.m.65782,0.0143541607214347,0.0159075819215242,No,NA,NA,P23913,NA,NA,NA,integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; DNA binding [GO:0003677]; oxidoreductase activity; acting on the CH-CH group of donors; NAD or NADP as acceptor [GO:0016628]; sterol biosynthetic process [GO:0016126],NA,NA,NA
CHOYP_LOC581452.2.4.m.25348,0.00394536801625317,0.00291369700370642,No,NA,NA,Q20191,NA,NA,NA,extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_LOC581452.3.4.m.41000,-0.00476097811181646,-0.0112356573956152,No,NA,NA,P42674,NA,NA,NA,cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_LOC581491.1.2.m.56125,-0.0102181996436156,-0.0238057135518147,No,NA,NA,Q9Y283,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; membrane [GO:0016020]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]; calmodulin binding [GO:0005516]; multicellular organism development [GO:0007275]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LOC581508.1.1.m.26966,0.00136608964158437,-0.00439849677109673,No,NA,NA,Q96FN9,NA,NA,NA,cytoplasm [GO:0005737]; Ala-tRNA(Thr) hydrolase activity [GO:0106105]; aminoacyl-tRNA editing activity [GO:0002161]; D-tyrosyl-tRNA(Tyr) deacylase activity [GO:0051500]; tRNA binding [GO:0000049]; aminoacyl-tRNA metabolism involved in translational fidelity [GO:0106074]; tRNA metabolic process [GO:0006399],NA,NA,NA
CHOYP_LOC581594.2.3.m.34837,-0.00416507357135749,-0.00828985049033602,No,NA,NA,Q4FZG9,NA,NA,NA,mitochondrial respiratory chain complex IV [GO:0005751]; electron transport chain [GO:0022900]; proton transmembrane transport [GO:1902600],NA,NA,NA
CHOYP_LOC581711.1.1.m.14276,0.0118224066999208,0.00809462680738002,No,NA,NA,Q9CY21,NA,NA,NA,nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein heterodimerization activity [GO:0046982]; rRNA (guanine) methyltransferase activity [GO:0016435]; chromatin organization [GO:0006325]; positive regulation of rRNA processing [GO:2000234]; rRNA (guanine-N7)-methylation [GO:0070476],NA,NA,NA
CHOYP_LOC581748.1.1.m.47690,0.00342534787397527,-0.00575537808001804,No,NA,NA,P53753,NA,NA,NA,cell septum [GO:0030428]; cell surface [GO:0009986]; extracellular region [GO:0005576]; fungal-type cell wall [GO:0009277]; glucan endo-1;3-beta-D-glucosidase activity [GO:0042973]; glucan endo-1;3-beta-glucanase activity; C-3 substituted reducing group [GO:0052861]; glucan endo-1;4-beta-glucanase activity; C-3 substituted reducing group [GO:0052862]; metabolic process [GO:0008152]; septum digestion after cytokinesis [GO:0000920],NA,NA,NA
CHOYP_LOC581773.1.1.m.56865,-0.00285601180822195,-0.00553221599058192,No,NA,NA,Q9WV48,NA,NA,NA,cell junction [GO:0030054]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; intracellular [GO:0005622]; ionotropic glutamate receptor complex [GO:0008328]; neuron projection [GO:0043005]; neuron spine [GO:0044309]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; ankyrin repeat binding [GO:0071532]; GKAP/Homer scaffold activity [GO:0030160]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; receptor signaling complex scaffold activity [GO:0030159]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]; somatostatin receptor binding [GO:0031877]; adult behavior [GO:0030534]; associative learning [GO:0008306]; brain morphogenesis [GO:0048854]; cytoskeletal anchoring at plasma membrane [GO:0007016]; dendritic spine morphogenesis [GO:0060997]; determination of affect [GO:0050894]; habituation [GO:0046959]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; negative regulation of actin filament bundle assembly [GO:0032232]; neuromuscular process controlling balance [GO:0050885]; olfactory behavior [GO:0042048]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synaptic transmission; glutamatergic [GO:0051968]; postsynaptic density assembly [GO:0097107]; protein localization to synapse [GO:0035418]; protein-containing complex assembly [GO:0065003]; regulation of AMPA receptor activity [GO:2000311]; righting reflex [GO:0060013]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse maturation [GO:0060074]; synaptic growth at neuromuscular junction [GO:0051124]; vocalization behavior [GO:0071625],NA,NA,NA
CHOYP_LOC581886.1.3.m.23639,-0.0169897957815561,0.00415400873695779,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC581927.10.27.m.32671,-0.00364035414404465,-0.0164096463306504,No,NA,NA,Q99NH0,NA,NA,NA,chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275],NA,NA,NA
CHOYP_LOC581927.9.27.m.31886,-0.0131119346089982,-0.00189640759895123,No,NA,NA,Q9ULJ7,NA,NA,NA,endosome [GO:0005768]; protein transport [GO:0015031]; retrograde transport; endosome to plasma membrane [GO:1990126],NA,NA,NA
CHOYP_LOC582121.1.1.m.30176,-0.00530618353373617,0.00527175225680174,No,NA,NA,P23034,NA,NA,NA,cytoplasm [GO:0005737]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; pyridoxal phosphate binding [GO:0030170]; biosynthetic process [GO:0009058],NA,NA,NA
CHOYP_LOC582154.1.1.m.58922,0.0234945452093624,0.00295608330082416,No,NA,NA,P46952,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; 3-hydroxyanthranilate 3;4-dioxygenase activity [GO:0000334]; electron transfer activity [GO:0009055]; ferrous iron binding [GO:0008198]; 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; NAD biosynthetic process [GO:0009435]; neuron cellular homeostasis [GO:0070050]; quinolinate biosynthetic process [GO:0019805]; quinolinate metabolic process [GO:0046874]; response to cadmium ion [GO:0046686]; response to zinc ion [GO:0010043]; tryptophan catabolic process [GO:0006569],NA,NA,NA
CHOYP_LOC582174.2.16.m.16430,-0.0081952326889098,-0.00740611415706054,No,NA,NA,O95613,NA,NA,NA,centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; calmodulin binding [GO:0005516]; protein-containing complex scaffold activity [GO:0032947]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]; positive regulation of intracellular protein transport [GO:0090316]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC582178.1.1.m.42729,-0.00458176287222874,-0.0197655749032982,No,NA,NA,Q91VD9,NA,NA,NA,mitochondrial intermembrane space [GO:0005758]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; plasma membrane respiratory chain complex I [GO:0045272]; 2 iron; 2 sulfur cluster binding [GO:0051537]; 4 iron; 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; apoptotic mitochondrial changes [GO:0008637]; ATP metabolic process [GO:0046034]; ATP synthesis coupled electron transport [GO:0042773]; cellular respiration [GO:0045333]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881],NA,NA,NA
CHOYP_LOC582352.1.1.m.30199,-0.0197618182816571,0.00692904954520153,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC582570.1.1.m.65944,-0.00212078832001384,-0.00891837260408135,No,NA,NA,Q9P2F6,NA,NA,NA,cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC582626.1.1.m.5567,-0.0120858454163303,-0.0237177797301349,No,NA,NA,Q9H9J2,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; double-stranded RNA binding [GO:0003725]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; pre-miRNA processing [GO:0031054]; primary miRNA processing [GO:0031053]; production of siRNA involved in RNA interference [GO:0030422]; RNA processing [GO:0006396],NA,NA,NA
CHOYP_LOC582726.1.1.m.29762,0.00795077318921761,-0.0130739790227764,No,NA,NA,P08183,NA,NA,NA,apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; ceramide-translocating ATPase activity [GO:0099038]; phosphatidylcholine-translocating ATPase activity [GO:0090554]; phosphatidylethanolamine-translocating ATPase activity [GO:0090555]; transporter activity [GO:0005215]; xenobiotic transmembrane transporting ATPase activity [GO:0008559]; ceramide translocation [GO:0099040]; G2/M transition of mitotic cell cycle [GO:0000086]; phospholipid translocation [GO:0045332]; positive regulation of anion channel activity [GO:1901529]; regulation of chloride transport [GO:2001225]; regulation of response to osmotic stress [GO:0047484]; response to drug [GO:0042493]; stem cell proliferation [GO:0072089]; transmembrane transport [GO:0055085],NA,NA,NA
CHOYP_LOC582782.1.4.m.8110,0.0118241334181582,0.00222848256991281,No,NA,NA,Q5UQP2,NA,NA,NA,integral component of membrane [GO:0016021]; hydrolase activity [GO:0016787]; lipid catabolic process [GO:0016042],NA,NA,NA
CHOYP_LOC582782.4.4.m.62807,0.00928959953276109,0.00642579209368078,No,NA,NA,Q5UQP2,NA,NA,NA,integral component of membrane [GO:0016021]; hydrolase activity [GO:0016787]; lipid catabolic process [GO:0016042],NA,NA,NA
CHOYP_LOC582784.1.1.m.53921,-0.0082233902219633,-0.0114000866142312,No,NA,NA,Q9BY77,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of translation [GO:0045727]; RNA export from nucleus [GO:0006405],NA,NA,NA
CHOYP_LOC582874.1.1.m.5135,0.00839869265703417,-0.011944038900074,No,NA,NA,O55096,NA,NA,NA,cytosol [GO:0005829]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; dipeptidyl-peptidase activity [GO:0008239]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC583072.4.25.m.20255,0.00615966897194063,0.00941964587728867,No,NA,NA,P16157,NA,NA,NA,axolemma [GO:0030673]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC583138.1.1.m.8990,-0.017248142715862,0.00531204145896818,No,NA,NA,A9UMP7,NA,NA,NA,phosphopyruvate hydratase complex [GO:0000015]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; glycolytic process [GO:0006096],NA,NA,NA
CHOYP_LOC583253.1.1.m.11773,0.00394536801625317,0.00291369700370642,No,NA,NA,A9ZSZ2,NA,NA,NA,cytoplasm [GO:0005737]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC583472.1.1.m.25642,-0.00730711733736277,0.00734772326245995,No,NA,NA,P13010,NA,NA,NA,cytosol [GO:0005829]; extracellular region [GO:0005576]; Ku70:Ku80 complex [GO:0043564]; membrane [GO:0016020]; nonhomologous end joining complex [GO:0070419]; nuclear chromosome; telomeric region [GO:0000784]; nuclear telomere cap complex [GO:0000783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; ribonucleoprotein complex [GO:1990904]; secretory granule lumen [GO:0034774]; site of DNA damage [GO:0090734]; ATP binding [GO:0005524]; ATP-dependent DNA helicase activity [GO:0004003]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA end binding [GO:0045027]; double-stranded DNA binding [GO:0003690]; enzyme activator activity [GO:0008047]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; transcription regulatory region DNA binding [GO:0044212]; ubiquitin protein ligase binding [GO:0031625]; activation of innate immune response [GO:0002218]; brain development [GO:0007420]; cell proliferation [GO:0008283]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to fatty acid [GO:0071398]; cellular response to gamma radiation [GO:0071480]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to X-ray [GO:0071481]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; establishment of integrated proviral latency [GO:0075713]; hematopoietic stem cell differentiation [GO:0060218]; innate immune response [GO:0045087]; negative regulation of t-circle formation [GO:1904430]; negative regulation of transcription; DNA-templated [GO:0045892]; neutrophil degranulation [GO:0043312]; positive regulation of catalytic activity [GO:0043085]; positive regulation of neurogenesis [GO:0050769]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of type I interferon production [GO:0032481]; protein localization to chromosome; telomeric region [GO:0070198]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of telomere maintenance [GO:0032204]; response to drug [GO:0042493]; telomere maintenance [GO:0000723],NA,NA,NA
CHOYP_LOC583843.1.1.m.11191,0.00896114197054354,0.00752878319709662,No,NA,NA,Q6DCY9,NA,NA,NA,cytoplasm [GO:0005737]; HAUS complex [GO:0070652]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; spindle [GO:0005819]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; spindle assembly [GO:0051225],NA,NA,NA
CHOYP_LOC583865.2.2.m.15485,-0.00225068533305208,-0.00429086367626997,No,NA,NA,Q6NYV5,NA,NA,NA,histone deacetylase complex [GO:0000118]; nucleolus [GO:0005730]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone deacetylase activity [GO:0004407]; non-sequence-specific DNA binding; bending [GO:0044378]; nucleosome binding [GO:0031491]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; zinc ion binding [GO:0008270]; heart looping [GO:0001947]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC583890.1.1.m.14405,0.0197801129192653,0.0143281615588294,No,NA,NA,P12426,NA,NA,NA,cytoplasm [GO:0005737]; adenine binding [GO:0002055]; adenine phosphoribosyltransferase activity [GO:0003999]; AMP binding [GO:0016208]; adenine salvage [GO:0006168]; AMP salvage [GO:0044209]; purine ribonucleoside salvage [GO:0006166],NA,NA,NA
CHOYP_LOC583954.1.1.m.777,-0.0155254865231883,-0.00573648850707303,No,NA,NA,Q8AVG9,NA,NA,NA,glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]; amidase activity [GO:0004040]; ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]; glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543],NA,NA,NA
CHOYP_LOC584001.1.1.m.46452,-0.00160394523111707,-0.0121542811473418,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC584015.1.1.m.10227,-0.00505120377791135,-0.0072141338104261,No,NA,NA,Q5BKR2,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular vesicle [GO:0097708]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; synaptic vesicle membrane [GO:0030672]; identical protein binding [GO:0042802]; lithium:proton antiporter activity [GO:0010348]; sodium:proton antiporter activity [GO:0015385]; clathrin-dependent endocytosis [GO:0072583]; flagellated sperm motility [GO:0030317]; positive regulation of osteoclast development [GO:2001206]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; sodium ion transport [GO:0006814],NA,NA,NA
CHOYP_LOC584052.1.1.m.6375,0.00956004075261557,0.0134478609768578,No,NA,NA,Q6DJN2,NA,NA,NA,cytoplasm [GO:0005737]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122],NA,NA,NA
CHOYP_LOC584058.1.1.m.59244,-0.0169591047060434,0.00960206869202777,No,NA,NA,P55265,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530]; DNA binding [GO:0003677]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251]; adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; mRNA processing [GO:0006397]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; positive regulation of viral genome replication [GO:0045070]; pre-miRNA processing [GO:0031054]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; response to interferon-alpha [GO:0035455]; response to virus [GO:0009615]; RNA processing [GO:0006396]; type I interferon signaling pathway [GO:0060337],NA,NA,NA
CHOYP_LOC584062.1.1.m.62279,-0.016048573686244,0.0035198059466309,No,NA,NA,O00625,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; quercetin 2;3-dioxygenase activity [GO:0008127]; transcription coregulator activity [GO:0003712]; digestion [GO:0007586]; monocyte differentiation [GO:0030224]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_LOC584095.1.1.m.6815,0.0115366789767132,-0.0216445297230817,No,NA,NA,Q9DE46,NA,NA,NA,alpha DNA polymerase:primase complex [GO:0005658]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 4 iron; 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleoside binding [GO:0001882]; nucleotide binding [GO:0000166]; cell proliferation [GO:0008283]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA replication; synthesis of RNA primer [GO:0006269]; DNA strand elongation involved in DNA replication [GO:0006271]; double-strand break repair via nonhomologous end joining [GO:0006303]; lagging strand elongation [GO:0006273]; leading strand elongation [GO:0006272],NA,NA,NA
CHOYP_LOC584238.1.1.m.30307,0.00833675828290646,-0.0196362294836853,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC584270.1.1.m.49225,0.00104778155838986,0.0158777209279511,No,NA,NA,Q9NX08,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654],NA,NA,NA
CHOYP_LOC584281.1.1.m.34958,0.00805960995420664,0.0025725538330621,No,NA,NA,P51650,NA,NA,NA,mitochondrion [GO:0005739]; carboxylic acid binding [GO:0031406]; NAD binding [GO:0051287]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]; central nervous system development [GO:0007417]; gamma-aminobutyric acid catabolic process [GO:0009450]; oxidation-reduction process [GO:0055114]; succinate metabolic process [GO:0006105],NA,NA,NA
CHOYP_LOC584318.1.1.m.35309,0.00950435200996506,0.00715677950673138,No,NA,NA,Q6A098,NA,NA,NA,ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; ribonucleoprotein complex binding [GO:0043021]; selenocysteine insertion sequence binding [GO:0035368]; selenocysteine incorporation [GO:0001514],NA,NA,NA
CHOYP_LOC584333.1.1.m.42540,0.00615966897194063,0.00941964587728867,No,NA,NA,P14133,NA,NA,NA,extracellular region [GO:0005576]; copper ion binding [GO:0005507]; L-ascorbate oxidase activity [GO:0008447],NA,NA,NA
CHOYP_LOC584364.2.2.m.57790,-0.00353909106675786,0.00561074863549568,No,NA,NA,P02553,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017],NA,NA,NA
CHOYP_LOC584368.1.2.m.10628,0.00188264230492634,0.0190544083172746,No,NA,NA,P80513,NA,NA,NA,endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; sarcoplasmic reticulum lumen [GO:0033018]; growth factor activity [GO:0008083]; lipid binding [GO:0008289]; dopaminergic neuron differentiation [GO:0071542]; neuron projection development [GO:0031175]; response to unfolded protein [GO:0006986],NA,NA,NA
CHOYP_LOC584392.1.1.m.24512,-0.0112737671852197,-0.0130373040664892,No,NA,NA,Q32KI9,NA,NA,NA,endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484],NA,NA,NA
CHOYP_LOC584416.1.1.m.34286,-0.00430894344577715,-0.00631540690244347,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC584481.10.10.m.66365,0.00388579924742945,-0.0131278383088568,No,NA,NA,O16025,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; arachidonate 8(R)-lipoxygenase activity [GO:0047677]; catalase activity [GO:0004096]; heme binding [GO:0020037]; hydroperoxide dehydratase activity [GO:0047987]; iron ion binding [GO:0005506]; arachidonic acid metabolic process [GO:0019369]; oxylipin biosynthetic process [GO:0031408],NA,NA,NA
CHOYP_LOC584481.5.10.m.52126,0.00873051949533417,-0.0209903324220433,No,NA,NA,O16025,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; arachidonate 8(R)-lipoxygenase activity [GO:0047677]; catalase activity [GO:0004096]; heme binding [GO:0020037]; hydroperoxide dehydratase activity [GO:0047987]; iron ion binding [GO:0005506]; arachidonic acid metabolic process [GO:0019369]; oxylipin biosynthetic process [GO:0031408],NA,NA,NA
CHOYP_LOC584481.8.10.m.61433,0.00205195042830452,-0.00934116934689426,No,NA,NA,O16025,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; arachidonate 8(R)-lipoxygenase activity [GO:0047677]; catalase activity [GO:0004096]; heme binding [GO:0020037]; hydroperoxide dehydratase activity [GO:0047987]; iron ion binding [GO:0005506]; arachidonic acid metabolic process [GO:0019369]; oxylipin biosynthetic process [GO:0031408],NA,NA,NA
CHOYP_LOC584567.1.1.m.29825,0.0105777426871362,-0.00101806686900306,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC584665.1.1.m.28760,-0.013744299815427,-0.0100015476121398,No,NA,NA,Q6ZMT9,NA,NA,NA,signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC584905.1.1.m.51595,-0.020231586681686,0.0050748349983571,No,NA,NA,Q6P2D8,NA,NA,NA,cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; response to X-ray [GO:0010165],NA,NA,NA
CHOYP_LOC585032.1.2.m.1235,0.00312136134890608,-0.0127390319734311,No,NA,NA,Q15276,NA,NA,NA,early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; growth factor activity [GO:0008083]; GTPase activator activity [GO:0005096]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; endocytosis [GO:0006897]; Golgi to plasma membrane transport [GO:0006893]; membrane fusion [GO:0061025]; protein localization to ciliary membrane [GO:1903441]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC585158.1.2.m.18137,-0.00780988060797224,0.00021182970986039,No,NA,NA,O14095,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; cell redox homeostasis [GO:0045454]; negative regulation of signal transduction [GO:0009968]; protein folding [GO:0006457]; response to pheromone [GO:0019236],NA,NA,NA
CHOYP_LOC585322.1.2.m.8217,-0.0109553064304434,-0.00182476729583793,No,NA,NA,Q4R8T1,NA,NA,NA,nucleus [GO:0005634]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC585438.1.1.m.44017,-0.00387862842168801,-0.0115376746264661,No,NA,NA,Q9NVX2,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; hematopoietic stem cell homeostasis [GO:0061484]; inner cell mass cell differentiation [GO:0001826]; kidney development [GO:0001822]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of mitotic cell cycle [GO:0045930]; Notch signaling pathway [GO:0007219]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; ribosomal large subunit assembly [GO:0000027]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756],NA,NA,NA
CHOYP_LOC585494.1.1.m.64158,-0.00766587221108989,0.0140433226690887,No,NA,NA,Q99LG0,NA,NA,NA,nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; histone binding [GO:0042393]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; transcription coactivator activity [GO:0003713]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; histone deubiquitination [GO:0016578]; histone H2A K63-linked deubiquitination [GO:0070537]; mitotic cell cycle [GO:0000278]; mitotic nuclear division [GO:0140014]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; positive regulation of translational elongation [GO:0045901]; protein homotetramerization [GO:0051289]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC585591.1.1.m.62390,-0.0133904029169995,-0.0131482714457992,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC585638.1.1.m.10100,-0.0131252967266451,-0.00188215613134219,No,NA,NA,Q9NNW5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; cell cycle arrest [GO:0007050]; negative regulation of autophagy [GO:0010507]; negative regulation of cell proliferation [GO:0008285],NA,NA,NA
CHOYP_LOC585734.1.1.m.36212,0.00615966897194063,0.00941964587728867,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC585839.1.1.m.51865,-0.01515156499217,0.00194016434541088,No,NA,NA,Q5XIJ8,NA,NA,NA,axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; motile cilium [GO:0031514]; axonemal dynein complex assembly [GO:0070286]; cilium-dependent cell motility [GO:0060285]; regulation of cilium movement [GO:0003352],NA,NA,NA
CHOYP_LOC585963.1.2.m.36775,-0.00974149063370599,-0.00323382014239513,No,NA,NA,Q27991,NA,NA,NA,brush border [GO:0005903]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; midbody [GO:0030496]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; polysome [GO:0005844]; spindle [GO:0005819]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; mRNA 5'-UTR binding [GO:0048027]; RNA stem-loop binding [GO:0035613]; actin filament-based movement [GO:0030048]; adult heart development [GO:0007512]; aorta development [GO:0035904]; axon guidance [GO:0007411]; cardiac myofibril assembly [GO:0055003]; cardiac septum development [GO:0003279]; cell adhesion [GO:0007155]; cell proliferation [GO:0008283]; cerebellar Purkinje cell layer development [GO:0021680]; coronary vasculature development [GO:0060976]; exocytosis [GO:0006887]; fourth ventricle development [GO:0021592]; in utero embryonic development [GO:0001701]; lateral ventricle development [GO:0021670]; mitotic cytokinesis [GO:0000281]; neuromuscular process controlling balance [GO:0050885]; neuron migration [GO:0001764]; nuclear migration [GO:0007097]; plasma membrane repair [GO:0001778]; positive regulation of protein secretion [GO:0050714]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of cell shape [GO:0008360]; retina development in camera-type eye [GO:0060041]; substrate-dependent cell migration; cell extension [GO:0006930]; third ventricle development [GO:0021678]; ventricular cardiac muscle cell development [GO:0055015],NA,NA,NA
CHOYP_LOC585972.1.1.m.25356,-0.0136207787808561,-0.00183885209653344,No,NA,NA,Q0P5A2,NA,NA,NA,extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; 2-octaprenyl-6-methoxy-1;4-benzoquinone methylase activity [GO:0043333]; ubiquinone biosynthetic process [GO:0006744],NA,NA,NA
CHOYP_LOC586005.1.1.m.63556,0.00949128315488727,0.00820635481260968,No,NA,NA,Q8WVM8,NA,NA,NA,cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; Golgi-associated vesicle [GO:0005798]; plasma membrane [GO:0005886]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; syntaxin binding [GO:0019905]; cell morphogenesis [GO:0000902]; COPII vesicle coating [GO:0048208]; negative regulation of autophagosome assembly [GO:1902902]; post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of protein transport [GO:0051223]; response to hypoxia [GO:0001666]; response to toxic substance [GO:0009636]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]; vesicle docking involved in exocytosis [GO:0006904],NA,NA,NA
CHOYP_LOC586039.1.1.m.27100,0.00784648963411064,0.00724044644587836,No,NA,NA,P81799,NA,NA,NA,ATP binding [GO:0005524]; N-acetylglucosamine kinase activity [GO:0045127]; N-acetylneuraminate catabolic process [GO:0019262],NA,NA,NA
CHOYP_LOC586044.1.1.m.60359,0.00217997094733793,-0.00807271368859912,No,NA,NA,B2RU80,NA,NA,NA,integral component of membrane [GO:0016021]; receptor complex [GO:0043235]; protein tyrosine phosphatase activity [GO:0004725]; angiogenesis [GO:0001525]; dephosphorylation [GO:0016311],NA,NA,NA
CHOYP_LOC586122.3.4.m.63155,0.0142529547711683,0.0148103135878402,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC586471.1.1.m.8913,-0.0135725579708753,0.00388604629968508,No,NA,NA,Q13569,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; ATP binding [GO:0005524]; chloride ion binding [GO:0031404]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA N-glycosylase activity [GO:0019104]; double-stranded DNA binding [GO:0003690]; G/U mismatch-specific uracil-DNA glycosylase activity [GO:0043739]; magnesium ion binding [GO:0000287]; mismatched DNA binding [GO:0030983]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; protein self-association [GO:0043621]; pyrimidine-specific mismatch base pair DNA N-glycosylase activity [GO:0008263]; sodium ion binding [GO:0031402]; SUMO binding [GO:0032183]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; uracil DNA N-glycosylase activity [GO:0004844]; base-excision repair [GO:0006284]; base-excision repair; AP site formation [GO:0006285]; chromatin organization [GO:0006325]; depyrimidination [GO:0045008]; DNA demethylation [GO:0080111]; mismatch repair [GO:0006298]; negative regulation of chromatin binding [GO:0035562]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidative DNA demethylation [GO:0035511]; regulation of DNA N-glycosylase activity [GO:1902544]; regulation of embryonic development [GO:0045995]; regulation of gene expression; epigenetic [GO:0040029],NA,NA,NA
CHOYP_LOC586494.1.1.m.50214,-0.0155233315429324,0.00642153500662965,No,NA,NA,Q96T60,NA,NA,NA,membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; damaged DNA binding [GO:0003684]; double-stranded DNA binding [GO:0003690]; endonuclease activity [GO:0004519]; nucleoside monophosphate kinase activity [GO:0050145]; polynucleotide 3'-phosphatase activity [GO:0046403]; purine nucleotide binding [GO:0017076]; dephosphorylation [GO:0016311]; DNA 3' dephosphorylation involved in DNA repair [GO:0098504]; DNA damage response; detection of DNA damage [GO:0042769]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; negative regulation of protein ADP-ribosylation [GO:0010836]; nucleotide phosphorylation [GO:0046939]; nucleotide-excision repair; DNA damage removal [GO:0000718]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; response to oxidative stress [GO:0006979]; response to radiation [GO:0009314],NA,NA,NA
CHOYP_LOC586604.1.1.m.30509,-0.00353453760819098,-0.0108912859777984,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC586661.1.1.m.56660,-0.0159387924020032,-0.0148053436176992,No,NA,NA,Q9XGA0,NA,NA,NA,mitochondrion [GO:0005739]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; ribose phosphate diphosphokinase activity [GO:0004749]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165],NA,NA,NA
CHOYP_LOC586678.1.1.m.35070,0.00659562412332838,-0.0241328145359119,No,NA,NA,Q8CAQ8,NA,NA,NA,MICOS complex [GO:0061617]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; cristae formation [GO:0042407]; mitochondrial calcium ion homeostasis [GO:0051560],NA,NA,NA
CHOYP_LOC586835.1.1.m.9967,0.00902666329082239,-0.017308489301497,No,NA,NA,Q96MU7,NA,NA,NA,nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]; dosage compensation by inactivation of X chromosome [GO:0009048]; mRNA export from nucleus [GO:0006406]; mRNA splice site selection [GO:0006376]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of mRNA splicing; via spliceosome [GO:0048024],NA,NA,NA
CHOYP_LOC586835.1.1.m.9969,-0.0188798962393362,0.00461823420101788,No,NA,NA,Q28FE4,NA,NA,NA,,NA,NA,NA
CHOYP_LOC586953.1.1.m.19600,0.00615966897194063,0.00941964587728867,No,NA,NA,Q28FY0,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; motile cilium [GO:0031514]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; cytoskeleton organization [GO:0007010]; epithelial cilium movement [GO:0003351]; motile cilium assembly [GO:0044458],NA,NA,NA
CHOYP_LOC587133.1.1.m.61281,0.00839130124412781,0.0086465608920589,No,NA,NA,P72745,NA,NA,NA,,NA,NA,NA
CHOYP_LOC587136.1.3.m.7607,0.00284189011894486,-0.0031537484942522,No,NA,NA,Q8BW94,NA,NA,NA,dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium movement [GO:0003341]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_LOC587346.1.1.m.17791,0.00775587738923878,0.00197905226080419,No,NA,NA,A1A5V9,NA,NA,NA,cytoplasm [GO:0005737]; Elongator holoenzyme complex [GO:0033588]; nucleus [GO:0005634]; positive regulation of cell migration [GO:0030335]; tRNA wobble uridine modification [GO:0002098],NA,NA,NA
CHOYP_LOC587439.1.1.m.45707,-0.0103623059619509,-0.00298022737180411,No,NA,NA,Q5HYI8,NA,NA,NA,cell [GO:0005623]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482],NA,NA,NA
CHOYP_LOC587610.1.3.m.16984,0.0208176025948559,-0.00670944399677681,No,NA,NA,P00687,NA,NA,NA,extracellular space [GO:0005615]; alpha-amylase activity [GO:0004556]; alpha-amylase activity (releasing maltohexaose) [GO:0103025]; amylase activity [GO:0016160]; calcium ion binding [GO:0005509]; chloride ion binding [GO:0031404]; carbohydrate catabolic process [GO:0016052]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_LOC587610.3.3.m.27175,0.0233666269351412,-0.00640628573225517,No,NA,NA,P00687,NA,NA,NA,extracellular space [GO:0005615]; alpha-amylase activity [GO:0004556]; alpha-amylase activity (releasing maltohexaose) [GO:0103025]; amylase activity [GO:0016160]; calcium ion binding [GO:0005509]; chloride ion binding [GO:0031404]; carbohydrate catabolic process [GO:0016052]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_LOC587700.1.1.m.42534,-0.00462023170129458,-0.0244361822789032,No,NA,NA,Q9D6R2,NA,NA,NA,mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; 2-oxoglutarate metabolic process [GO:0006103]; isocitrate metabolic process [GO:0006102]; NADH metabolic process [GO:0006734]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_LOC587705.1.2.m.11702,0.0134983855364192,0.0135203751045957,No,NA,NA,P77735,NA,NA,NA,cytosol [GO:0005829]; oxidoreductase activity [GO:0016491]; thiamine metabolic process [GO:0006772],NA,NA,NA
CHOYP_LOC587705.2.2.m.11817,0.00662873383731117,0.00731356856907734,No,NA,NA,P77735,NA,NA,NA,cytosol [GO:0005829]; oxidoreductase activity [GO:0016491]; thiamine metabolic process [GO:0006772],NA,NA,NA
CHOYP_LOC587740.1.4.m.22830,0.0065655332920147,0.00161184455268312,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC587752.1.1.m.66173,0.00460886694400014,-0.00316740599033621,No,NA,NA,P53369,NA,NA,NA,acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 8-oxo-7;8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity [GO:0035539]; 8-oxo-7;8-dihydroguanosine triphosphate pyrophosphatase activity [GO:0008413]; ATP diphosphatase activity [GO:0047693]; GTP diphosphatase activity [GO:0036219]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; snoRNA binding [GO:0030515]; aging [GO:0007568]; dATP catabolic process [GO:0046061]; dGTP catabolic process [GO:0006203]; DNA protection [GO:0042262]; DNA repair [GO:0006281]; male gonad development [GO:0008584]; purine nucleotide catabolic process [GO:0006195]; response to cadmium ion [GO:0046686],NA,NA,NA
CHOYP_LOC587791.2.3.m.33887,-0.0169591047060434,0.00960206869202777,No,NA,NA,Q86TZ1,NA,NA,NA,,NA,NA,NA
CHOYP_LOC587803.1.1.m.9452,-0.00693815900087895,-0.0089490658703142,No,NA,NA,Q8BYR1,NA,NA,NA,protein C-terminal carboxyl O-methyltransferase activity [GO:0003880]; protein C-terminal leucine carboxyl O-methyltransferase activity [GO:0018423]; tRNA methyltransferase activity [GO:0008175]; C-terminal protein methylation [GO:0006481]; tRNA methylation [GO:0030488]; wybutosine biosynthetic process [GO:0031591],NA,NA,NA
CHOYP_LOC587840.1.1.m.10143,-0.0134873936299558,0.00918834019708627,No,NA,NA,Q90744,NA,NA,NA,cytoplasm [GO:0005737]; lysosome [GO:0005764]; alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456]; glycoside catabolic process [GO:0016139]; glycosylceramide catabolic process [GO:0046477]; oligosaccharide metabolic process [GO:0009311],NA,NA,NA
CHOYP_LOC587946.1.1.m.5037,-0.00966185888963494,0.00925964854608836,No,NA,NA,P46012,NA,NA,NA,,NA,NA,NA
CHOYP_LOC587966.1.1.m.10698,-0.00478892066279081,0.00795004067078047,No,NA,NA,Q9JK84,NA,NA,NA,apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein kinase C binding [GO:0005080]; Rho GTPase binding [GO:0017048]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; establishment or maintenance of cell polarity [GO:0007163]; regulation of cellular localization [GO:0060341],NA,NA,NA
CHOYP_LOC587972.1.2.m.3283,0.0141987486782916,-0.0188378046800448,No,NA,NA,P09848,NA,NA,NA,apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; beta-glucosidase activity [GO:0008422]; glycosylceramidase activity [GO:0017042]; lactase activity [GO:0000016]; carbohydrate metabolic process [GO:0005975]; polysaccharide digestion [GO:0044245],NA,NA,NA
CHOYP_LOC588385.1.2.m.18390,0.00217997094733793,-0.00807271368859912,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC588440.1.1.m.4951,0.0112541839072588,0.00585736136048434,No,NA,NA,Q6TUG0,NA,NA,NA,endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; nucleus [GO:0005634]; signaling receptor binding [GO:0005102]; unfolded protein binding [GO:0051082]; mRNA modification [GO:0016556]; negative regulation of neurogenesis [GO:0050768]; protein folding [GO:0006457]; protein maturation [GO:0051604],NA,NA,NA
CHOYP_LOC588549.1.2.m.1855,0.0089206445513862,-0.0239880329386503,No,NA,NA,O75376,NA,NA,NA,cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; histone deacetylase binding [GO:0042826]; nuclear hormone receptor binding [GO:0035257]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II regulatory region DNA binding [GO:0001012]; sequence-specific DNA binding [GO:0043565]; thyroid hormone receptor binding [GO:0046966]; transcription corepressor activity [GO:0003714]; transcription regulatory region DNA binding [GO:0044212]; chromatin organization [GO:0006325]; circadian rhythm [GO:0007623]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of JNK cascade [GO:0046329]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; regulation of fatty acid transport [GO:2000191]; regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter [GO:0072362]; regulation of lipid metabolic process [GO:0019216]; regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter [GO:0072368]; spindle assembly [GO:0051225]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_LOC588572.1.2.m.17892,-0.0158446104360496,-0.00567102563530344,No,NA,NA,Q52KI8,NA,NA,NA,nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; DNA binding [GO:0003677]; mRNA splicing; via spliceosome [GO:0000398]; RNA splicing; via transesterification reactions [GO:0000375],NA,NA,NA
CHOYP_LOC588827.1.1.m.11601,0.00652497322184502,-0.00894712505885244,No,NA,NA,Q8WV99,NA,NA,NA,anchored component of membrane [GO:0031225]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; proteasome complex [GO:0000502]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein targeting to ER [GO:0045047]; regulation of insulin-like growth factor receptor signaling pathway [GO:0043567]; SRP-dependent cotranslational protein targeting to membrane; translocation [GO:0006616],NA,NA,NA
CHOYP_LOC588883.2.3.m.14590,-0.0160097989873555,-0.0146812143794197,No,NA,NA,E9QAT4,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; organelle membrane [GO:0031090]; perinuclear region of cytoplasm [GO:0048471]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi to plasma membrane CFTR protein transport [GO:0043000]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; response to endoplasmic reticulum stress [GO:0034976],NA,NA,NA
CHOYP_LOC588883.3.3.m.38321,0.00373387507005005,-0.0171194080605683,No,NA,NA,E9QAT4,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; organelle membrane [GO:0031090]; perinuclear region of cytoplasm [GO:0048471]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi to plasma membrane CFTR protein transport [GO:0043000]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; response to endoplasmic reticulum stress [GO:0034976],NA,NA,NA
CHOYP_LOC588932.3.3.m.35464,0.0102529606979362,-0.00940816246042424,No,NA,NA,Q9UMZ2,NA,NA,NA,AP-1 adaptor complex [GO:0030121]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_LOC589108.1.2.m.9688,-0.0192102795308263,-0.0139641227720545,No,NA,NA,Q4V7T8,NA,NA,NA,motile cilium [GO:0031514],NA,NA,NA
CHOYP_LOC589108.2.2.m.48073,0.0195922033034671,-0.00894980196729163,No,NA,NA,Q969T9,NA,NA,NA,cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; estrogen receptor binding [GO:0030331]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; cellular response to estrogen stimulus [GO:0071391]; establishment of protein localization [GO:0045184]; positive regulation of gene expression; epigenetic [GO:0045815]; positive regulation of histone H3-K14 acetylation [GO:0071442]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; response to estrogen [GO:0043627]; response to progesterone [GO:0032570],NA,NA,NA
CHOYP_LOC589177.1.1.m.52878,-0.00689216193383957,-0.0117864698920291,No,NA,NA,Q5U2V4,NA,NA,NA,extracellular space [GO:0005615]; lysosome [GO:0005764]; hydrolase activity [GO:0016787]; lipid catabolic process [GO:0016042],NA,NA,NA
CHOYP_LOC589201.1.1.m.59863,-0.0128415591419401,-0.0187886184907954,No,NA,NA,F1N9Y5,NA,NA,NA,cytosol [GO:0005829]; early phagosome [GO:0032009]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; adaptive immune response [GO:0002250]; B cell receptor signaling pathway [GO:0050853]; blood vessel morphogenesis [GO:0048514]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to molecule of fungal origin [GO:0071226]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular signal transduction [GO:0035556]; leukocyte activation involved in immune response [GO:0002366]; leukocyte cell-cell adhesion [GO:0007159]; lymph vessel development [GO:0001945]; macrophage activation involved in immune response [GO:0002281]; neutrophil activation involved in immune response [GO:0002283]; neutrophil chemotaxis [GO:0030593]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of mast cell degranulation [GO:0043306]; protein phosphorylation [GO:0006468]; regulation of arachidonic acid secretion [GO:0090237]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of neutrophil degranulation [GO:0043313]; regulation of phagocytosis [GO:0050764]; regulation of platelet activation [GO:0010543]; regulation of platelet aggregation [GO:0090330]; regulation of superoxide anion generation [GO:0032928]; serotonin secretion by platelet [GO:0002554],NA,NA,NA
CHOYP_LOC589390.1.1.m.11589,-0.00212078832001384,-0.00891837260408135,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC589479.2.2.m.57247,-0.0213816611024588,-0.00514801852569934,No,NA,NA,Q9JLI7,NA,NA,NA,axonemal central apparatus [GO:1990716]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; sperm principal piece [GO:0097228]; flagellated sperm motility [GO:0030317]; sperm axoneme assembly [GO:0007288]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_LOC589644.2.3.m.21781,-0.00373035188275271,-0.0104601086980068,No,NA,NA,Q96RW7,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],NA,NA,NA
CHOYP_LOC589720.1.1.m.63687,-1.37384649864474e-05,-0.0173580561357096,No,NA,NA,Q9UHV9,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; protein binding involved in protein folding [GO:0044183]; unfolded protein binding [GO:0051082]; positive regulation of cytoskeleton organization [GO:0051495]; protein folding [GO:0006457],NA,NA,NA
CHOYP_LOC589750.3.5.m.42967,-0.0169591047060434,0.00960206869202777,No,NA,NA,Q5F478,NA,NA,NA,,NA,NA,NA
CHOYP_LOC589839.1.1.m.29309,-0.0135725579708752,0.00388604629968508,No,NA,NA,Q5XX13,NA,NA,NA,cytosol [GO:0005829]; ubiquitin-protein transferase activity [GO:0004842]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209],NA,NA,NA
CHOYP_LOC589952.1.5.m.2235,-0.0136522439059571,-0.0160852248319107,No,NA,NA,Q2TBI0,NA,NA,NA,extracellular space [GO:0005615]; membrane [GO:0016020]; lipopolysaccharide binding [GO:0001530]; acute-phase response [GO:0006953]; cellular response to lipopolysaccharide [GO:0071222]; defense response to Gram-negative bacterium [GO:0050829]; innate immune response [GO:0045087]; lipid transport [GO:0006869]; macrophage activation involved in immune response [GO:0002281]; positive regulation of tumor necrosis factor production [GO:0032760],NA,NA,NA
CHOYP_LOC589952.2.5.m.21623,-0.0113959828010069,-0.0135953825205064,No,NA,NA,Q2TBI0,NA,NA,NA,extracellular space [GO:0005615]; membrane [GO:0016020]; lipopolysaccharide binding [GO:0001530]; acute-phase response [GO:0006953]; cellular response to lipopolysaccharide [GO:0071222]; defense response to Gram-negative bacterium [GO:0050829]; innate immune response [GO:0045087]; lipid transport [GO:0006869]; macrophage activation involved in immune response [GO:0002281]; positive regulation of tumor necrosis factor production [GO:0032760],NA,NA,NA
CHOYP_LOC589952.3.5.m.29284,0.000125097758121059,0.00111630762976184,No,NA,NA,Q61805,NA,NA,NA,cell surface [GO:0009986]; extracellular space [GO:0005615]; membrane [GO:0016020]; lipopeptide binding [GO:0071723]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; signaling receptor binding [GO:0005102]; acute-phase response [GO:0006953]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lipoteichoic acid [GO:0071223]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; detection of molecule of bacterial origin [GO:0032490]; innate immune response [GO:0045087]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; lipopolysaccharide transport [GO:0015920]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; macromolecule localization [GO:0033036]; macrophage activation involved in immune response [GO:0002281]; negative regulation of growth of symbiont in host [GO:0044130]; negative regulation of tumor necrosis factor production [GO:0032720]; opsonization [GO:0008228]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytolysis [GO:0045919]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of macrophage activation [GO:0043032]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phagocytosis; engulfment [GO:0060100]; positive regulation of respiratory burst involved in inflammatory response [GO:0060265]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of membrane permeability [GO:0090559]; response to lipopolysaccharide [GO:0032496],NA,NA,NA
CHOYP_LOC589952.4.5.m.31147,-0.0167351685438322,-0.00386340442029203,No,NA,NA,Q61805,NA,NA,NA,cell surface [GO:0009986]; extracellular space [GO:0005615]; membrane [GO:0016020]; lipopeptide binding [GO:0071723]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; signaling receptor binding [GO:0005102]; acute-phase response [GO:0006953]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lipoteichoic acid [GO:0071223]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; detection of molecule of bacterial origin [GO:0032490]; innate immune response [GO:0045087]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; lipopolysaccharide transport [GO:0015920]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; macromolecule localization [GO:0033036]; macrophage activation involved in immune response [GO:0002281]; negative regulation of growth of symbiont in host [GO:0044130]; negative regulation of tumor necrosis factor production [GO:0032720]; opsonization [GO:0008228]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytolysis [GO:0045919]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of macrophage activation [GO:0043032]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phagocytosis; engulfment [GO:0060100]; positive regulation of respiratory burst involved in inflammatory response [GO:0060265]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of membrane permeability [GO:0090559]; response to lipopolysaccharide [GO:0032496],NA,NA,NA
CHOYP_LOC590125.6.7.m.53735,-0.0088882496804022,0.00301232919316045,No,NA,NA,B3EWY9,NA,NA,NA,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ErbB-2 class receptor binding [GO:0005176]; extracellular matrix constituent; lubricant activity [GO:0030197]; cell-matrix adhesion [GO:0007160]; epithelial structure maintenance [GO:0010669]; regulation of signaling receptor activity [GO:0010469],NA,NA,NA
CHOYP_LOC590298.2.3.m.4191,0.00233151825528873,0.0219289159435399,No,NA,NA,P80109,NA,NA,NA,cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; intracellular membrane-bounded organelle [GO:0043231]; glycosylphosphatidylinositol phospholipase D activity [GO:0004621]; sodium channel regulator activity [GO:0017080]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to calcium ion [GO:0071277]; cellular response to cholesterol [GO:0071397]; cellular response to drug [GO:0035690]; cellular response to insulin stimulus [GO:0032869]; cellular response to pH [GO:0071467]; cellular response to triglyceride [GO:0071401]; chondrocyte differentiation [GO:0002062]; complement receptor mediated signaling pathway [GO:0002430]; GPI anchor release [GO:0006507]; insulin receptor signaling pathway [GO:0008286]; negative regulation of cell proliferation [GO:0008285]; negative regulation of triglyceride catabolic process [GO:0010897]; ossification [GO:0001503]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytolysis [GO:0045919]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of high-density lipoprotein particle clearance [GO:0010983]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of secretion [GO:0051047]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of cellular response to insulin stimulus [GO:1900076]; response to glucose [GO:0009749]; transepithelial transport [GO:0070633],NA,NA,NA
CHOYP_LOC590567.1.1.m.29483,-0.00485655477896262,0.0150692818757582,No,NA,NA,O02350,NA,NA,NA,extracellular space [GO:0005615]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; digestion [GO:0007586]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC590568.2.4.m.38593,0.00526284914163069,-0.006936393060848,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC590633.1.1.m.32259,-0.00875172066970843,0.000235045086571636,No,NA,NA,Q3UMR0,NA,NA,NA,cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; tubular endosome [GO:0097422]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rab GTPase binding [GO:0017137]; SNARE binding [GO:0000149]; early endosome to late endosome transport [GO:0045022]; endosome to melanosome transport [GO:0035646]; negative regulation of SNARE complex assembly [GO:0035544]; neuron projection morphogenesis [GO:0048812]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of neuron projection development [GO:0010976]; protein transport [GO:0015031]; retrograde transport; endosome to plasma membrane [GO:1990126],NA,NA,NA
CHOYP_LOC590657.1.1.m.633,-0.00704958541285265,0.0050185217589749,No,NA,NA,Q8BZ25,NA,NA,NA,ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674],NA,NA,NA
CHOYP_LOC590657.1.1.m.634,0.000177443687394508,0.0232784358652027,No,NA,NA,Q6PIP5,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654],NA,NA,NA
CHOYP_LOC590729.1.1.m.35259,-0.0129525898257114,-0.0227155549241501,No,NA,NA,Q2T9T9,NA,NA,NA,PeBoW complex [GO:0070545]; preribosome; large subunit precursor [GO:0030687],NA,NA,NA
CHOYP_LOC590756.2.6.m.28777,0.00889994125583989,0.0204136279713234,No,NA,NA,Q86XZ4,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_LOC590756.3.6.m.40372,-0.0045274468963791,-0.000500763407866877,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC590756.4.6.m.48555,-0.0182502842613284,-0.0119478690534463,No,NA,NA,A7MBP4,NA,NA,NA,centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; cilium assembly [GO:0060271]; determination of ventral identity [GO:0048264]; intraciliary transport [GO:0042073]; pronephros development [GO:0048793]; retina development in camera-type eye [GO:0060041],NA,NA,NA
CHOYP_LOC590931.1.1.m.7446,-0.0146428728382665,-0.0101103836386908,No,NA,NA,Q6PGZ3,NA,NA,NA,centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; microtubule binding [GO:0008017]; camera-type eye development [GO:0043010]; cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; pronephros development [GO:0048793]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule polymerization [GO:0031113],NA,NA,NA
CHOYP_LOC590949.1.2.m.13540,-0.0186689303067946,0.00473614431870742,No,NA,NA,P27987,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; inositol-1;4;5-trisphosphate 3-kinase activity [GO:0008440]; cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; common myeloid progenitor cell proliferation [GO:0035726]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; inositol trisphosphate metabolic process [GO:0032957]; MAPK cascade [GO:0000165]; myeloid cell homeostasis [GO:0002262]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of neutrophil apoptotic process [GO:0033030]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of Ras protein signal transduction [GO:0046579]; positive thymic T cell selection [GO:0045059]; regulation of protein phosphorylation [GO:0001932]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC590969.1.1.m.15822,-0.00393711680820462,-0.00722436892042118,No,NA,NA,Q9Z160,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC590971.1.1.m.30661,0.0153347531475225,0.00813243121383529,No,NA,NA,O43175,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; myelin sheath [GO:0043209]; electron transfer activity [GO:0009055]; L-malate dehydrogenase activity [GO:0030060]; NAD binding [GO:0051287]; phosphoglycerate dehydrogenase activity [GO:0004617]; brain development [GO:0007420]; cellular amino acid metabolic process [GO:0006520]; G1 to G0 transition [GO:0070314]; gamma-aminobutyric acid metabolic process [GO:0009448]; glial cell development [GO:0021782]; glutamine metabolic process [GO:0006541]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; neural tube development [GO:0021915]; neuron projection development [GO:0031175]; regulation of gene expression [GO:0010468]; spinal cord development [GO:0021510]; taurine metabolic process [GO:0019530]; threonine metabolic process [GO:0006566],NA,NA,NA
CHOYP_LOC590989.3.3.m.32047,0.00110184386690916,0.00898511357906542,No,NA,NA,Q6J6I8,NA,NA,NA,BRCA1-A complex [GO:0070531]; BRCA1-BARD1 complex [GO:0031436]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; RNA polymerase binding [GO:0070063]; transcription coactivator activity [GO:0003713]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; chordate embryonic development [GO:0043009]; dosage compensation by inactivation of X chromosome [GO:0009048]; double-strand break repair via homologous recombination [GO:0000724]; fatty acid biosynthetic process [GO:0006633]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of histone acetylation [GO:0035067]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; protein autoubiquitination [GO:0051865]; protein K6-linked ubiquitination [GO:0085020]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_LOC591073.1.1.m.50375,-0.014713850961234,-0.00668663713876092,No,NA,NA,Q5XHC1,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC591084.2.2.m.59355,-0.00939690714934396,0.00880944517626022,No,NA,NA,Q8BRH4,NA,NA,NA,histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; transferase activity; transferring acyl groups [GO:0016746]; eyelid development in camera-type eye [GO:0061029]; histone methylation [GO:0016571]; multicellular organism growth [GO:0035264]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; single fertilization [GO:0007338],NA,NA,NA
CHOYP_LOC591177.1.1.m.1476,0.00326852355901747,0.019890262002182,No,NA,NA,Q8K0U4,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC591426.1.1.m.19353,0.0022333664568907,-0.00799976554217406,No,NA,NA,Q9UGU0,NA,NA,NA,nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC591426.1.1.m.19354,0.00687845695637618,0.000651097131801004,No,NA,NA,Q9Y6D9,NA,NA,NA,centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear pore nuclear basket [GO:0044615]; spindle [GO:0005819]; spindle pole [GO:0000922]; identical protein binding [GO:0042802]; kinetochore binding [GO:0043515]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; mitotic cell cycle checkpoint [GO:0007093]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of T cell proliferation [GO:0042130]; regulation of metaphase plate congression [GO:0090235]; thymus development [GO:0048538],NA,NA,NA
CHOYP_LOC591441.1.1.m.19965,0.00726381133324449,0.00859422820559634,No,NA,NA,Q6PFY8,NA,NA,NA,cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348],NA,NA,NA
CHOYP_LOC591570.1.1.m.4767,-0.0221499111444264,0.0119127561969789,No,NA,NA,Q2T9W3,NA,NA,NA,axoneme [GO:0005930]; cilium movement [GO:0003341]; outer dynein arm assembly [GO:0036158]; spermatid development [GO:0007286],NA,NA,NA
CHOYP_LOC591690.1.1.m.30550,0.00516924187333838,0.00741347862264097,No,NA,NA,Q4R4T9,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; intracellular transport [GO:0046907]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC591797.1.3.m.11526,-0.010739854707852,0.00356171606702619,No,NA,NA,Q60596,NA,NA,NA,ERCC4-ERCC1 complex [GO:0070522]; nuclear chromatin [GO:0000790]; nuclear chromosome; telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; oxidized DNA binding [GO:0032356]; base-excision repair [GO:0006284]; cerebellum morphogenesis [GO:0021587]; DNA repair [GO:0006281]; double-strand break repair via nonhomologous end joining [GO:0006303]; hippocampus development [GO:0021766]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of protein ADP-ribosylation [GO:0010836]; positive regulation of DNA ligase activity [GO:1904877]; positive regulation of single strand break repair [GO:1903518]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; response to drug [GO:0042493]; response to hydroperoxide [GO:0033194]; response to hypoxia [GO:0001666]; response to organic substance [GO:0010033]; single strand break repair [GO:0000012]; telomeric DNA-containing double minutes formation [GO:0061819]; voluntary musculoskeletal movement [GO:0050882],NA,NA,NA
CHOYP_LOC591797.1.3.m.11527,-0.0129810195384853,-0.0117562558076163,No,NA,NA,P22232,NA,NA,NA,nucleolus [GO:0005730]; histone-glutamine methyltransferase activity [GO:1990259]; RNA binding [GO:0003723]; histone glutamine methylation [GO:1990258]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_LOC591898.1.2.m.28918,0.0109772869917866,0.00695745674088388,No,NA,NA,P70684,NA,NA,NA,cytoplasm [GO:0005737]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; prostaglandin metabolic process [GO:0006693]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_LOC591898.2.2.m.29158,0.00921243801085587,-0.00983079893559648,No,NA,NA,P70684,NA,NA,NA,cytoplasm [GO:0005737]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; prostaglandin metabolic process [GO:0006693]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_LOC591926.1.1.m.27235,0.00506550561200594,-0.0210124158306353,No,NA,NA,Q9H0U6,NA,NA,NA,extracellular space [GO:0005615]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; 5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; rRNA import into mitochondrion [GO:0035928]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC591968.1.1.m.37093,0.00453396644011262,-0.00121168006733667,No,NA,NA,Q9DAZ9,NA,NA,NA,centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; midbody [GO:0030496]; metal ion binding [GO:0046872]; phosphatidylinositol-3-phosphate binding [GO:0032266]; abscission [GO:0009838]; cell division [GO:0051301]; mitotic cytokinesis checkpoint [GO:0044878]; negative regulation of cytokinesis [GO:0032466],NA,NA,NA
CHOYP_LOC592001.1.1.m.43470,-0.00160687372468377,-0.0174297760733573,No,NA,NA,Q9UPU5,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC592006.1.1.m.18498,0.00493004107491163,-0.00170907520583274,No,NA,NA,Q96AJ9,NA,NA,NA,autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; neuron projection terminus [GO:0044306]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; autophagy [GO:0006914]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi ribbon formation [GO:0090161]; Golgi to vacuole transport [GO:0006896]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein targeting to vacuole [GO:0006623]; retrograde transport; endosome to Golgi [GO:0042147]; vesicle fusion with Golgi apparatus [GO:0048280]; voluntary musculoskeletal movement [GO:0050882],NA,NA,NA
CHOYP_LOC592013.1.1.m.20072,-0.00665852732905996,0.0133597032811394,No,NA,NA,Q9HAS0,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; trans-Golgi network [GO:0005802]; intracellular protein transport [GO:0006886]; vesicle tethering to Golgi [GO:0099041],NA,NA,NA
CHOYP_LOC592142.4.9.m.49474,-0.0120401514604344,-0.00119528886861206,No,NA,NA,C3YWU0,NA,NA,NA,extracellular region [GO:0005576]; lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139],NA,NA,NA
CHOYP_LOC592142.5.9.m.53066,-0.0103338297664255,0.00933195774190182,No,NA,NA,C3YWU0,NA,NA,NA,extracellular region [GO:0005576]; lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139],NA,NA,NA
CHOYP_LOC592142.6.9.m.54976,-0.0103993373406202,0.000595832376027799,No,NA,NA,C3YWU0,NA,NA,NA,extracellular region [GO:0005576]; lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139],NA,NA,NA
CHOYP_LOC592142.7.9.m.55467,-0.0105511082725837,0.0046238717523729,No,NA,NA,C3YWU0,NA,NA,NA,extracellular region [GO:0005576]; lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139],NA,NA,NA
CHOYP_LOC592209.1.1.m.48009,-0.0217494801162238,-0.00720374034251806,No,NA,NA,Q8IVU9,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; sperm flagellum [GO:0036126]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC592215.1.1.m.34856,0.00566584336672485,-0.0157387397723908,No,NA,NA,Q8R2E9,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; oxidoreductase activity; acting on a sulfur group of donors; disulfide as acceptor [GO:0016671]; protein disulfide isomerase activity [GO:0003756]; protein disulfide oxidoreductase activity [GO:0015035]; 4-hydroxyproline metabolic process [GO:0019471]; cell redox homeostasis [GO:0045454]; extracellular matrix organization [GO:0030198]; glucose homeostasis [GO:0042593]; insulin processing [GO:0030070]; protein folding in endoplasmic reticulum [GO:0034975]; protein maturation by protein folding [GO:0022417],NA,NA,NA
CHOYP_LOC592357.1.1.m.27228,-0.0112786562835344,0.00305789849481217,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC592411.1.1.m.19664,-0.00572465056206159,-0.0182706610176051,No,NA,NA,Q6NUB2,NA,NA,NA,nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_LOC592528.1.2.m.17290,0.0168248302570045,-0.00209246337925066,No,NA,NA,O88545,NA,NA,NA,COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; protein deneddylation [GO:0000338],NA,NA,NA
CHOYP_LOC592585.1.1.m.51309,0.0198862867863234,-0.0045108471229596,No,NA,NA,P16444,NA,NA,NA,anchored component of membrane [GO:0031225]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; microvillus membrane [GO:0031528]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; dipeptidase activity [GO:0016805]; dipeptidyl-peptidase activity [GO:0008239]; GPI anchor binding [GO:0034235]; metallodipeptidase activity [GO:0070573]; metalloexopeptidase activity [GO:0008235]; modified amino acid binding [GO:0072341]; zinc ion binding [GO:0008270]; antibiotic metabolic process [GO:0016999]; cellular lactam catabolic process [GO:0072340]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to nitric oxide [GO:0071732]; glutathione metabolic process [GO:0006749]; homocysteine metabolic process [GO:0050667]; leukotriene metabolic process [GO:0006691]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; xenobiotic metabolic process [GO:0006805],NA,NA,NA
CHOYP_LOC592624.1.1.m.45639,-0.0200113597525571,-8.11348023079487e-05,No,NA,NA,Q32PH2,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrion [GO:0005739],NA,NA,NA
CHOYP_LOC592709.1.1.m.22553,-0.0116571170517698,0.000400010124084432,No,NA,NA,A6NCI4,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_LOC592745.1.1.m.47718,0.00305154294374622,0.00299079395259093,No,NA,NA,Q10002,NA,NA,NA,mitochondrion [GO:0005739]; nucleus [GO:0005634]; 3'-tyrosyl-DNA phosphodiesterase activity [GO:0017005]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008311]; phosphoric diester hydrolase activity [GO:0008081]; zinc ion binding [GO:0008270]; base-excision repair [GO:0006284],NA,NA,NA
CHOYP_LOC592825.1.1.m.43751,-0.00887382924304553,-0.0169842173782656,No,NA,NA,Q5RBB1,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; SUMO-specific isopeptidase activity [GO:0070140]; protein desumoylation [GO:0016926],NA,NA,NA
CHOYP_LOC592857.1.1.m.62834,-0.0190992310255485,-0.0111797724195831,No,NA,NA,B2RC85,NA,NA,NA,,NA,NA,NA
CHOYP_LOC592888.1.1.m.63240,0.00954177946481573,0.0126387977481392,No,NA,NA,Q6DFB7,NA,NA,NA,centriole [GO:0005814]; cell cycle [GO:0007049],NA,NA,NA
CHOYP_LOC592990.1.1.m.17663,0.00781728660755185,-0.0116899341331255,No,NA,NA,Q99L04,NA,NA,NA,endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_LOC593134.1.1.m.29711,0.000293655106884032,-0.0250377717736247,No,NA,NA,O88630,NA,NA,NA,cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; SNARE complex [GO:0031201]; SNAP receptor activity [GO:0005484]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]; regulation of vesicle targeting; to; from or within Golgi [GO:0048209]; retrograde transport; endosome to Golgi [GO:0042147]; vesicle fusion [GO:0006906],NA,NA,NA
CHOYP_LOC593247.1.1.m.56872,-0.00282949663108251,0.018704553282543,No,NA,NA,Q9HU55,NA,NA,NA,cytoplasm [GO:0005737]; electron transfer activity [GO:0009055]; glutathione-disulfide reductase activity [GO:0004362]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599],NA,NA,NA
CHOYP_LOC593338.1.2.m.31413,-0.00795625637260713,-0.00928567057722752,No,NA,NA,Q18297,NA,NA,NA,integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; ion channel activity [GO:0005216]; response to stimulus [GO:0050896],NA,NA,NA
CHOYP_LOC593467.2.4.m.66724,0.00976888756403696,0.00890222848557831,No,NA,NA,P42674,NA,NA,NA,cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_LOC593522.1.2.m.5381,-0.0132327795792187,-0.0135056643718951,No,NA,NA,P23246,NA,NA,NA,chromatin [GO:0000785]; dendrite cytoplasm [GO:0032839]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; RNA polymerase II transcription factor complex [GO:0090575]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; histone deacetylase binding [GO:0042826]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; activation of innate immune response [GO:0002218]; alternative mRNA splicing; via spliceosome [GO:0000380]; dendritic transport of messenger ribonucleoprotein complex [GO:0098963]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC593522.2.2.m.33858,-0.0112523922536741,-0.00312442970947251,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC593529.1.1.m.59343,-0.00102086071939739,-0.0218045784392211,No,NA,NA,Q4KM30,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233],NA,NA,NA
CHOYP_LOC593558.3.4.m.36843,-0.00117525727351952,-0.00329667818638424,No,NA,NA,B6RSP1,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; zonula adherens [GO:0005915]; delta-catenin binding [GO:0070097]; cardiac muscle cell differentiation [GO:0055007]; epithelial cell-cell adhesion [GO:0090136]; regulation of heart contraction [GO:0008016]; zonula adherens maintenance [GO:0045218],NA,NA,NA
CHOYP_LOC593741.1.1.m.11514,-0.0176235716969124,0.0018765908929569,No,NA,NA,Q567I9,NA,NA,NA,metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC594038.1.1.m.8864,0.00649418302607698,0.00140738132411652,No,NA,NA,B0WIW5,NA,NA,NA,,NA,NA,NA
CHOYP_LOC594130.1.1.m.48747,-0.0111242909611631,0.0186744267350276,No,NA,NA,P32755,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; 4-hydroxyphenylpyruvate dioxygenase activity [GO:0003868]; metal ion binding [GO:0046872]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572],NA,NA,NA
CHOYP_LOC594151.1.2.m.7270,-0.0169591047060434,0.00960206869202777,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC594176.1.1.m.9662,-0.0112237566142803,-0.000892714392164524,No,NA,NA,Q14186,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; anoikis [GO:0043276]; cell proliferation [GO:0008283]; DNA damage response; signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; epidermis development [GO:0008544]; negative regulation of fat cell proliferation [GO:0070345]; negative regulation of G0 to G1 transition [GO:0070317]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA biosynthetic process [GO:2000278]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083],NA,NA,NA
CHOYP_LOC594315.1.1.m.28047,0.0203403563642524,-0.00547795811074531,No,NA,NA,Q78PY7,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; dense body [GO:0097433]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; RISC complex [GO:0016442]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; nuclease activity [GO:0004518]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; gene silencing by RNA [GO:0031047]; miRNA catabolic process [GO:0010587]; regulation of cell cycle process [GO:0010564]; RNA catabolic process [GO:0006401],NA,NA,NA
CHOYP_LOC594379.1.1.m.55370,-0.00941606244137595,0.000563248485853506,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC594407.1.1.m.38463,-0.0051245272360153,0.00633751258167974,No,NA,NA,Q8BWQ6,NA,NA,NA,early endosome [GO:0005769]; integral component of membrane [GO:0016021]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC594533.1.1.m.58830,0.0065883263884642,0.0180931628217626,No,NA,NA,Q8IYE1,NA,NA,NA,cell projection [GO:0042995]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleus [GO:0005634]; cellular response to DNA damage stimulus [GO:0006974]; cytoplasmic microtubule organization [GO:0031122]; non-motile cilium assembly [GO:1905515],NA,NA,NA
CHOYP_LOC594590.1.2.m.10772,-0.0128182716103845,-0.0149330908115805,No,NA,NA,B5XGE7,NA,NA,NA,endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888],NA,NA,NA
CHOYP_LOC594665.1.1.m.8448,0.0194028716895752,0.00211127251634687,No,NA,NA,P16435,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; cytochrome-b5 reductase activity; acting on NAD(P)H [GO:0004128]; electron transfer activity [GO:0009055]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; hydrolase activity [GO:0016787]; iron-cytochrome-c reductase activity [GO:0047726]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric oxide dioxygenase activity [GO:0008941]; oxidoreductase activity [GO:0016491]; carnitine metabolic process [GO:0009437]; cellular organofluorine metabolic process [GO:0090346]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to peptide hormone stimulus [GO:0071375]; demethylation [GO:0070988]; fatty acid oxidation [GO:0019395]; flavonoid metabolic process [GO:0009812]; internal peptidyl-lysine acetylation [GO:0018393]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of lipase activity [GO:0060192]; nitrate catabolic process [GO:0043602]; nitric oxide catabolic process [GO:0046210]; oxidation-reduction process [GO:0055114]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of monooxygenase activity [GO:0032770]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of steroid hormone biosynthetic process [GO:0090031]; regulation of growth plate cartilage chondrocyte proliferation [GO:0003420]; response to drug [GO:0042493]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; xenobiotic metabolic process [GO:0006805],NA,NA,NA
CHOYP_LOC594665.1.1.m.8449,0.00318145586046723,-0.00972568438671008,No,NA,NA,O77622,NA,NA,NA,chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; microtubule [GO:0005874]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; WD40-repeat domain binding [GO:0071987]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_LOC594676.1.1.m.8936,0.00590023441562805,0.000162552138907781,No,NA,NA,Q5BKR2,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular vesicle [GO:0097708]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; synaptic vesicle membrane [GO:0030672]; identical protein binding [GO:0042802]; lithium:proton antiporter activity [GO:0010348]; sodium:proton antiporter activity [GO:0015385]; clathrin-dependent endocytosis [GO:0072583]; flagellated sperm motility [GO:0030317]; positive regulation of osteoclast development [GO:2001206]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; sodium ion transport [GO:0006814],NA,NA,NA
CHOYP_LOC654860.3.3.m.63750,-0.0106619425418325,0.00659949947823136,No,NA,NA,Q13492,NA,NA,NA,cell surface [GO:0009986]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome to plasma membrane transport vesicle [GO:0070381]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; intrinsic component of membrane [GO:0031224]; membrane [GO:0016020]; neurofibrillary tangle [GO:0097418]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; vesicle [GO:0031982]; 1-phosphatidylinositol binding [GO:0005545]; amyloid-beta binding [GO:0001540]; cadherin binding [GO:0045296]; clathrin binding [GO:0030276]; clathrin heavy chain binding [GO:0032050]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; Rab GTPase binding [GO:0017137]; tau protein binding [GO:0048156]; amyloid-beta clearance by transcytosis [GO:0150093]; axonogenesis [GO:0007409]; cargo loading into vesicle [GO:0035459]; cell proliferation [GO:0008283]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; dendrite morphogenesis [GO:0048813]; endosomal transport [GO:0016197]; hemopoiesis [GO:0030097]; iron ion homeostasis [GO:0055072]; iron ion import across plasma membrane [GO:0098711]; learning or memory [GO:0007611]; membrane bending [GO:0097753]; membrane organization [GO:0061024]; modulation of age-related behavioral decline [GO:0090647]; negative regulation of gene expression [GO:0010629]; negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902963]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of receptor-mediated endocytosis [GO:0048261]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron death [GO:1901216]; positive regulation of transcription; DNA-templated [GO:0045893]; protein-containing complex assembly [GO:0065003]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902959]; regulation of endocytosis [GO:0030100]; regulation of protein localization [GO:0032880]; regulation of vesicle size [GO:0097494]; synaptic vesicle maturation [GO:0016188]; vesicle budding from membrane [GO:0006900]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC654949.1.1.m.9313,-0.0144927684890047,-0.0202640698801981,No,NA,NA,O74503,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; RNA polymerase I upstream activating factor complex [GO:0000500]; RNA polymerase I general transcription initiation factor activity [GO:0001181]; transcription initiation from RNA polymerase I promoter [GO:0006361],NA,NA,NA
CHOYP_LOC654994.1.1.m.39461,-0.00998944473870816,-0.0119796733536283,No,NA,NA,Q9VLN1,NA,NA,NA,histone methyltransferase complex [GO:0035097]; PTW/PP1 phosphatase complex [GO:0072357]; Set1C/COMPASS complex [GO:0048188]; chromatin binding [GO:0003682]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 trimethylation [GO:0080182],NA,NA,NA
CHOYP_LOC655520.2.2.m.14178,-0.00576277194729878,-0.0176769875437577,No,NA,NA,Q9NQC3,NA,NA,NA,cell projection [GO:0042995]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endoplasmic reticulum tubular network membrane [GO:0098826]; integral component of endoplasmic reticulum membrane [GO:0030176]; intracellular [GO:0005622]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; axonal fasciculation [GO:0007413]; blastocyst formation [GO:0001825]; cardiac epithelial to mesenchymal transition [GO:0060317]; cerebral cortex radial glia guided migration [GO:0021801]; endoplasmic reticulum tubular network formation [GO:0071787]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; endoplasmic reticulum tubular network organization [GO:0071786]; negative regulation of axon extension [GO:0030517]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell growth [GO:0030308]; nuclear pore complex assembly [GO:0051292]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERBB3 signaling pathway [GO:1905580]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of cell migration [GO:0030334],NA,NA,NA
CHOYP_LOC655529.1.3.m.1225,0.010185759619336,-0.00442467986840663,No,NA,NA,Q8NI08,NA,NA,NA,intracellular [GO:0005622]; nucleus [GO:0005634]; nuclear hormone receptor binding [GO:0035257]; nuclear receptor transcription coactivator activity [GO:0030374]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_LOC655570.1.2.m.9210,-0.00835696998878545,-0.00838698225381162,No,NA,NA,Q49GP5,NA,NA,NA,endosome [GO:0005768]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]; endosome organization [GO:0007032]; Golgi organization [GO:0007030]; pectoral fin development [GO:0033339]; phosphatidylinositol phosphorylation [GO:0046854],NA,NA,NA
CHOYP_LOC656201.1.1.m.8657,-0.0125389637991523,-0.0143835181049668,No,NA,NA,Q13148,NA,NA,NA,cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; ribonucleoprotein complex [GO:1990904]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; sequence-specific double-stranded DNA binding [GO:1990837]; single-stranded RNA binding [GO:0003727]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; positive regulation of protein import into nucleus [GO:0042307]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_LOC656402.1.1.m.62053,0.00769394516822901,0.0113286217984967,No,NA,NA,Q9R062,NA,NA,NA,glucose binding [GO:0005536]; glycogenin glucosyltransferase activity [GO:0008466]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]; UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity [GO:0102751]; glycogen biosynthetic process [GO:0005978],NA,NA,NA
CHOYP_LOC656459.1.1.m.34956,-0.0162796771063458,0.00962257654513161,No,NA,NA,B7ZMP1,NA,NA,NA,mitochondrion [GO:0005739]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]; glomerular filtration [GO:0003094]; protein processing [GO:0016485],NA,NA,NA
CHOYP_LOC656615.1.1.m.66274,0.000686232728993106,-0.0107331332691118,No,NA,NA,Q6GPD0,NA,NA,NA,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; GTPase activator activity [GO:0005096]; phosphatidylinositol binding [GO:0035091]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC656702.1.1.m.14425,0.0177460136992485,0.00541293618599137,No,NA,NA,Q13045,NA,NA,NA,brush border [GO:0005903]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin cytoskeleton organization [GO:0030036]; actin filament severing [GO:0051014]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_LOC656741.1.1.m.19820,0.00879000588205336,-0.0181970822901291,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC656867.1.1.m.28658,0.0061719209862814,0.00517084098018165,No,NA,NA,Q6P799,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; serine-tRNA ligase activity [GO:0004828]; negative regulation of angiogenesis [GO:0016525]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular endothelial growth factor production [GO:1904046]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434],NA,NA,NA
CHOYP_LOC656899.1.1.m.15417,-0.00721723100530798,-0.00867417406782862,No,NA,NA,Q6NSR8,NA,NA,NA,cytoplasm [GO:0005737]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloexopeptidase activity [GO:0008235],NA,NA,NA
CHOYP_LOC657235.1.1.m.1711,-0.00403951969875636,0.0128410312479497,No,NA,NA,Q9V3J1,NA,NA,NA,plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; vacuolar proton-transporting V-type ATPase; V1 domain [GO:0000221]; proton-transporting ATPase activity; rotational mechanism [GO:0046961]; ATP hydrolysis coupled proton transport [GO:0015991]; determination of adult lifespan [GO:0008340]; dsRNA transport [GO:0033227],NA,NA,NA
CHOYP_LOC657327.1.1.m.54811,-0.00419651159727546,-0.0113226620860606,No,NA,NA,M9NDE3,NA,NA,NA,adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; tricellular tight junction [GO:0061689]; carbohydrate binding [GO:0030246]; scavenger receptor activity [GO:0005044]; cell-cell junction maintenance [GO:0045217]; establishment of endothelial intestinal barrier [GO:0090557]; liquid clearance; open tracheal system [GO:0035002]; regulation of tube length; open tracheal system [GO:0035159]; response to endoplasmic reticulum stress [GO:0034976]; tricellular tight junction assembly [GO:1904274],NA,NA,NA
CHOYP_LOC657378.1.1.m.14648,0.00177311815860592,-0.0171701172433232,No,NA,NA,Q08509,NA,NA,NA,brush border [GO:0005903]; cell cortex [GO:0005938]; cell junction [GO:0030054]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421]; stereocilium tip [GO:0032426]; synapse [GO:0045202]; actin binding [GO:0003779]; Rac GTPase binding [GO:0048365]; signaling adaptor activity [GO:0035591]; actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; actin polymerization-dependent cell motility [GO:0070358]; adult locomotory behavior [GO:0008344]; barbed-end actin filament capping [GO:0051016]; behavioral response to ethanol [GO:0048149]; cellular response to leukemia inhibitory factor [GO:1990830]; dendritic cell migration [GO:0036336]; exit from mitosis [GO:0010458]; positive regulation of ruffle assembly [GO:1900029]; Rac protein signal transduction [GO:0016601]; regulation of actin filament length [GO:0030832]; regulation of cell shape [GO:0008360]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266],NA,NA,NA
CHOYP_LOC657466.1.1.m.38710,-0.0125424869876458,0.00448574867211157,No,NA,NA,Q95KE5,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543],NA,NA,NA
CHOYP_LOC657473.1.1.m.55374,-0.00629840160567595,-0.0161912345452871,No,NA,NA,O55203,NA,NA,NA,cell leading edge [GO:0031252]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transcription factor complex [GO:0005667]; enzyme binding [GO:0019899]; LIM domain binding [GO:0030274]; RNA polymerase II activating transcription factor binding [GO:0001102]; transcription coregulator activity [GO:0003712]; epithelial structure maintenance [GO:0010669]; hair follicle development [GO:0001942]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of cellular component biogenesis [GO:0044089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell migration [GO:0030334]; regulation of kinase activity [GO:0043549]; somatic stem cell population maintenance [GO:0035019],NA,NA,NA
CHOYP_LOC657674.1.1.m.21821,0.000431917540935081,0.00460388061896372,No,NA,NA,B0FYY4,NA,NA,NA,cell surface [GO:0009986]; focal adhesion [GO:0005925]; integrin complex [GO:0008305]; invadopodium membrane [GO:0071438]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; recycling endosome [GO:0055037]; ruffle membrane [GO:0032587]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; signaling receptor activity [GO:0038023]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; integrin-mediated signaling pathway [GO:0007229]; positive regulation of protein localization to plasma membrane [GO:1903078]; receptor internalization [GO:0031623]; regulation of collagen catabolic process [GO:0010710],NA,NA,NA
CHOYP_LOC657694.1.1.m.34526,0.00354427794924698,0.0063985459915392,No,NA,NA,Q9NFT7,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]; cellular glucose homeostasis [GO:0001678]; fructose metabolic process [GO:0006000]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; mannose metabolic process [GO:0006013],NA,NA,NA
CHOYP_LOC657811.1.1.m.29214,0.00810626290001268,0.00604984499614607,No,NA,NA,Q08D57,NA,NA,NA,chromosome [GO:0005694]; nuclear speck [GO:0016607]; Set1C/COMPASS complex [GO:0048188]; histone-lysine N-methyltransferase activity [GO:0018024]; RNA binding [GO:0003723]; histone H3-K4 methylation [GO:0051568],NA,NA,NA
CHOYP_LOC658003.1.1.m.29101,-0.00225286378653637,0.00811409552342618,No,NA,NA,Q7ZWP1,NA,NA,NA,cytoskeleton [GO:0005856],NA,NA,NA
CHOYP_LOC658092.1.2.m.22901,0.00592650153661092,-0.0205673424241876,No,NA,NA,Q58DA0,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle; base subcomplex [GO:0008540]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome assembly [GO:0043248]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_LOC658092.2.2.m.60940,-0.00458303360263387,-0.00170146837301939,No,NA,NA,Q8WZ42,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_LOC658201.1.1.m.42880,0.0129463950755149,-0.0191383602363696,No,NA,NA,P22488,NA,NA,NA,cytoplasm [GO:0005737]; intermediate filament [GO:0005882]; structural molecule activity [GO:0005198],NA,NA,NA
CHOYP_LOC658242.1.1.m.41709,-0.0103202534195496,-0.011495967265182,No,NA,NA,Q9UQ03,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; membrane [GO:0016020]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin cytoskeleton organization [GO:0030036],NA,NA,NA
CHOYP_LOC658248.1.1.m.11054,-0.0021106331278893,-0.0203817348091313,No,NA,NA,Q5FWY5,NA,NA,NA,aryl hydrocarbon receptor complex [GO:0034751]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; aryl hydrocarbon receptor binding [GO:0017162]; GAF domain binding [GO:0036004]; transcription coregulator activity [GO:0003712]; unfolded protein binding [GO:0051082]; negative regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051344]; protein maturation by protein folding [GO:0022417]; protein targeting to mitochondrion [GO:0006626]; regulation of protein kinase A signaling [GO:0010738]; xenobiotic metabolic process [GO:0006805],NA,NA,NA
CHOYP_LOC658280.1.1.m.18469,-0.0102149488690696,-0.00869476902642809,No,NA,NA,Q6TH22,NA,NA,NA,cytosol [GO:0005829]; aspartic-type endopeptidase activity [GO:0004190]; identical protein binding [GO:0042802]; ubiquitin binding [GO:0043130]; protein processing [GO:0016485],NA,NA,NA
CHOYP_LOC658414.1.3.m.6219,0.00491555665852559,-0.0217831599464322,No,NA,NA,Q9HCD6,NA,NA,NA,glutamatergic synapse [GO:0098978]; postsynaptic density; intracellular component [GO:0099092]; in utero embryonic development [GO:0001701],NA,NA,NA
CHOYP_LOC658593.1.1.m.25202,-0.0107794995948257,-0.010977631609638,No,NA,NA,P56380,NA,NA,NA,mitochondrion [GO:0005739]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; GTP binding [GO:0005525]; apoptotic process [GO:0006915],NA,NA,NA
CHOYP_LOC658611.1.1.m.11239,0.0106850306854814,0.0115360829061233,No,NA,NA,Q96PE2,NA,NA,NA,cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; actin cytoskeleton organization [GO:0030036]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056],NA,NA,NA
CHOYP_LOC658640.1.2.m.36016,0.00553488114995328,-0.0052731770255154,No,NA,NA,A0A0F7YYX3,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_LOC658640.2.2.m.56941,-0.00303204048110156,-0.0141235165230304,No,NA,NA,A0A0F7YYX3,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_LOC658895.1.1.m.20262,0.00787093639761614,-0.00629454944983287,No,NA,NA,Q8BFR5,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; synapse [GO:0045202]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; mitochondrial translational elongation [GO:0070125]; response to ethanol [GO:0045471]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_LOC659024.1.2.m.31136,-0.00332117279830466,0.000332026660632485,No,NA,NA,P70318,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; AU-rich element binding [GO:0017091]; DNA binding [GO:0003677]; apoptotic process [GO:0006915]; germ cell development [GO:0007281]; positive regulation of cell proliferation [GO:0008284]; stem cell division [GO:0017145],NA,NA,NA
CHOYP_LOC659206.1.6.m.3536,0.0142560821026711,-0.00719418773287634,No,NA,NA,P62890,NA,NA,NA,cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; ribosome [GO:0005840]; RNA binding [GO:0003723]; selenocysteine insertion sequence binding [GO:0035368]; structural constituent of ribosome [GO:0003735]; liver regeneration [GO:0097421]; positive regulation of selenocysteine incorporation [GO:1904571]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC659206.6.6.m.43541,0.0235768383586072,-0.00639956262745655,No,NA,NA,P02466,NA,NA,NA,collagen type I trimer [GO:0005584]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]; cellular response to organic substance [GO:0071310]; cellular response to retinoic acid [GO:0071300]; cellular response to thyroid hormone stimulus [GO:0097067]; extracellular matrix organization [GO:0030198]; response to norepinephrine [GO:0071873],NA,NA,NA
CHOYP_LOC659226.1.3.m.16864,0.000366671111736595,-0.0201840430505927,No,NA,NA,Q26636,NA,NA,NA,lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_LOC659306.1.1.m.11580,0.00969019434582695,-0.00742031088978821,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC659398.1.1.m.9611,-0.00709635238586727,-0.0174408316713332,No,NA,NA,Q7ZVR8,NA,NA,NA,nucleus [GO:0005634]; mRNA binding [GO:0003729]; mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC659409.1.1.m.24437,-0.0104094008088679,-0.0161223682382067,No,NA,NA,Q96PX1,NA,NA,NA,cell body [GO:0044297]; cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; negative regulation of apoptotic process [GO:0043066]; positive regulation of dendrite extension [GO:1903861],NA,NA,NA
CHOYP_LOC659512.1.4.m.6122,-0.00969526969807899,-0.0129494594836518,No,NA,NA,Q5R941,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; calcium ion binding [GO:0005509]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755],NA,NA,NA
CHOYP_LOC659512.3.4.m.26463,0.0235107534861843,-0.00134468106135729,No,NA,NA,Q5R941,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; calcium ion binding [GO:0005509]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755],NA,NA,NA
CHOYP_LOC659512.4.4.m.31246,0.0130903516273808,0.000894244360682613,No,NA,NA,Q5R941,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; calcium ion binding [GO:0005509]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755],NA,NA,NA
CHOYP_LOC659617.1.1.m.23473,-0.00552881223353152,0.0134957994036996,No,NA,NA,Q6PB03,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phospholipase D activity [GO:0004630]; lipid catabolic process [GO:0016042],NA,NA,NA
CHOYP_LOC659702.1.1.m.7231,-0.00408210082191422,0.00166640806149004,No,NA,NA,P56377,NA,NA,NA,AP-type membrane coat adaptor complex [GO:0030119]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intracellular protein transport [GO:0006886]; regulation of defense response to virus by virus [GO:0050690]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC659901.1.1.m.348,-0.0131217440487721,-0.00188595187508349,No,NA,NA,Q5C9Z4,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA binding [GO:0003723]; hair follicle maturation [GO:0048820]; ribosomal small subunit biogenesis [GO:0042274],NA,NA,NA
CHOYP_LOC659964.1.1.m.25995,-0.0169591047060434,0.00960206869202778,No,NA,NA,Q9V439,NA,NA,NA,chromatin [GO:0000785]; mediator complex [GO:0016592]; nucleolus [GO:0005730]; nucleus [GO:0005634]; transcription coregulator activity [GO:0003712]; mitotic cell cycle [GO:0000278]; negative regulation of neuroblast proliferation [GO:0007406]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter involved in spermatogenesis [GO:1902064],NA,NA,NA
CHOYP_LOC660067.1.1.m.20126,0.0065262514931044,-0.0188521964426683,No,NA,NA,Q9DBE9,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome; large subunit precursor [GO:0030687]; preribosome; small subunit precursor [GO:0030688]; rRNA (guanine) methyltransferase activity [GO:0016435]; rRNA (uridine-2'-O-)-methyltransferase activity [GO:0008650]; enzyme-directed rRNA 2'-O-methylation [GO:0000453]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000463]; rRNA methylation [GO:0031167],NA,NA,NA
CHOYP_LOC660183.1.1.m.8143,0.00278069959140127,-0.0241091178261306,No,NA,NA,Q62902,NA,NA,NA,COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; mannose binding [GO:0005537]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC660225.1.1.m.35196,0.00394536801625317,0.00291369700370642,No,NA,NA,C3YWU0,NA,NA,NA,extracellular region [GO:0005576]; lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139],NA,NA,NA
CHOYP_LOC660225.1.1.m.35197,-0.00903710102699486,0.000551812530972142,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC660338.1.1.m.33595,0.0157940364700379,-0.0167898593432018,No,NA,NA,Q91W90,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; isomerase activity [GO:0016853]; apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454],NA,NA,NA
CHOYP_LOC660381.1.1.m.6379,-0.00135417836200258,0.0152680631156312,No,NA,NA,Q9VRP9,NA,NA,NA,nucleus [GO:0005634]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; histone modification [GO:0016570]; histone monoubiquitination [GO:0010390]; histone ubiquitination [GO:0016574]; Notch signaling pathway [GO:0007219]; protein monoubiquitination [GO:0006513],NA,NA,NA
CHOYP_LOC660501.1.2.m.5218,-0.020029684391627,0.00168937038389348,No,NA,NA,Q9W436,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC660501.2.2.m.19155,-0.0187295619310379,0.0107090581986176,No,NA,NA,Q9W436,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC660510.1.1.m.56258,0.00845049017902197,0.0122131574452249,No,NA,NA,Q8BHR2,NA,NA,NA,external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; nucleic acid binding [GO:0003676]; oxidoreductase activity [GO:0016491]; ultradian rhythm [GO:0007624],NA,NA,NA
CHOYP_LOC660560.1.4.m.31035,0.0065883263884642,0.0180931628217626,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC660560.1.4.m.31036,0.0184250884960095,0.00359893107567559,No,NA,NA,P39872,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC660560.4.4.m.54542,-0.0169591047060434,0.00960206869202777,No,NA,NA,Q5T0B9,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC660590.1.1.m.26950,-0.000328197981682933,-0.0123405460952077,No,NA,NA,Q2T9U5,NA,NA,NA,nucleolus [GO:0005730]; exonuclease activity [GO:0004527]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_LOC660684.1.1.m.28592,-0.0098708439181527,-0.00695215721537813,No,NA,NA,Q949P2,NA,NA,NA,apoplast [GO:0048046]; chloroplast [GO:0009507]; cytosol [GO:0005829]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptide metabolic process [GO:0006518]; proteolysis [GO:0006508]; response to cadmium ion [GO:0046686],NA,NA,NA
CHOYP_LOC660898.1.1.m.38632,-0.00153035948328068,-0.00848376720970301,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC661043.1.1.m.11553,-0.0037652284212684,-0.0122192379335829,No,NA,NA,P14543,NA,NA,NA,basement membrane [GO:0005604]; cell periphery [GO:0071944]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix structural constituent [GO:0005201]; laminin binding [GO:0043236]; laminin-1 binding [GO:0043237]; proteoglycan binding [GO:0043394]; basement membrane organization [GO:0071711]; cell-matrix adhesion [GO:0007160]; extracellular matrix organization [GO:0030198]; glomerular basement membrane development [GO:0032836]; positive regulation of cell-substrate adhesion [GO:0010811],NA,NA,NA
CHOYP_LOC661226.1.1.m.62936,0.0188113831843927,0.0188714200254146,No,NA,NA,Q16658,NA,NA,NA,actin cytoskeleton [GO:0015629]; cell projection membrane [GO:0031253]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; growth cone [GO:0030426]; invadopodium [GO:0071437]; lamellipodium [GO:0030027]; microspike [GO:0044393]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; podosome [GO:0002102]; ruffle [GO:0001726]; stress fiber [GO:0001725]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; drug binding [GO:0008144]; protein binding; bridging [GO:0030674]; RNA binding [GO:0003723]; actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; cell migration [GO:0016477]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cell-cell junction assembly [GO:0007043]; cytokine-mediated signaling pathway [GO:0019221]; establishment of apical/basal cell polarity [GO:0035089]; establishment or maintenance of cell polarity [GO:0007163]; microspike assembly [GO:0030035]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of podosome assembly [GO:0071803]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of microvillus assembly [GO:0032534],NA,NA,NA
CHOYP_LOC661306.1.3.m.11419,0.0125664604493494,-0.00474167877563121,No,NA,NA,Q9VX32,NA,NA,NA,cytosol [GO:0005829]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; semaphorin receptor binding [GO:0030215]; defasciculation of motor neuron axon [GO:0007415]; mushroom body development [GO:0016319]; negative regulation of cell size [GO:0045792]; regulation of axonogenesis [GO:0050770]; Rho protein signal transduction [GO:0007266],NA,NA,NA
CHOYP_LOC661626.1.1.m.53878,-0.0148833888167345,0.00316397606172891,No,NA,NA,Q8BH75,NA,NA,NA,endoplasmic reticulum tubular network [GO:0071782]; perinuclear region of cytoplasm [GO:0048471]; erythropoietin receptor binding [GO:0005128]; interleukin-3 receptor binding [GO:0005135]; protein domain specific binding [GO:0019904]; Ral GTPase binding [GO:0017160]; receptor tyrosine kinase binding [GO:0030971]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; autophagy [GO:0006914]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of mitophagy [GO:1901525]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; proteasomal protein catabolic process [GO:0010498]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of establishment of cell polarity [GO:2000114]; regulation of gene expression [GO:0010468]; regulation of lymphocyte differentiation [GO:0045619]; regulation of MAPK cascade [GO:0043408]; regulation of myeloid cell differentiation [GO:0045637]; regulation of protein kinase B signaling [GO:0051896]; regulation of reactive oxygen species metabolic process [GO:2000377],NA,NA,NA
CHOYP_LOC661769.1.1.m.10866,0.00979723722407842,-0.00297403584713213,No,NA,NA,Q3SYS1,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; ribosome [GO:0005840]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; negative regulation of translation [GO:0017148]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC661829.1.1.m.64858,-0.0138180130642757,-0.0144027310964453,No,NA,NA,C0H906,NA,NA,NA,cytoplasm [GO:0005737]; nuclear cap binding complex [GO:0005846]; nucleus [GO:0005634]; RNA cap binding [GO:0000339]; 7-methylguanosine mRNA capping [GO:0006370]; gene silencing by RNA [GO:0031047]; mRNA cis splicing; via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_LOC661955.1.1.m.37858,-0.00880378722782378,-0.000894761539070088,No,NA,NA,Q5R4R9,NA,NA,NA,membrane [GO:0016020]; mitochondrion [GO:0005739]; calmodulin binding [GO:0005516]; mitochondrial respiratory chain complex I assembly [GO:0032981],NA,NA,NA
CHOYP_LOC662072.1.1.m.51458,-0.00584135850938538,-0.0120426908679702,No,NA,NA,Q10131,NA,NA,NA,endoplasmic reticulum [GO:0005783]; calcium ion binding [GO:0005509]; calcium ion regulated exocytosis [GO:0017156],NA,NA,NA
CHOYP_LOC662115.2.2.m.15477,0.0203139235659049,-0.00051154107145768,No,NA,NA,O60841,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; regulation of translational initiation [GO:0006446],NA,NA,NA
CHOYP_LOC662190.1.3.m.1532,0.0019391126995671,-0.00423910482478942,No,NA,NA,Q9R050,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; head development [GO:0060322]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_LOC662190.3.3.m.62554,0.011623206220253,-0.0144842029531819,No,NA,NA,Q9R050,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; head development [GO:0060322]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_LOC662211.1.1.m.23378,-0.00490452944446156,-0.0112801720726425,No,NA,NA,Q13905,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; protein-containing complex [GO:0032991]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rap guanyl-nucleotide exchange factor activity [GO:0017034]; SH3 domain binding [GO:0017124]; activation of GTPase activity [GO:0090630]; activation of MAPKK activity [GO:0000186]; blood vessel development [GO:0001568]; cell-cell adhesion [GO:0098609]; cellular response to cAMP [GO:0071320]; cellular response to nerve growth factor stimulus [GO:1990090]; cytokine-mediated signaling pathway [GO:0019221]; establishment of endothelial barrier [GO:0061028]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of Ras protein signal transduction [GO:0046580]; nerve growth factor signaling pathway [GO:0038180]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905451]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; positive regulation of Ras protein signal transduction [GO:0046579]; Rap protein signal transduction [GO:0032486]; regulation of cell junction assembly [GO:1901888]; regulation of JNK cascade [GO:0046328]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_LOC662241.1.1.m.66905,0.00431550512045689,-0.0124069467799306,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC662320.1.2.m.18374,-0.00882853903484356,-0.0159592894508319,No,NA,NA,Q66II8,NA,NA,NA,commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619]; hematopoietic stem cell differentiation [GO:0060218]; mRNA splicing; via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484],NA,NA,NA
CHOYP_LOC662320.2.2.m.19454,-0.00448401224199697,-0.0106578762764617,No,NA,NA,Q42404,NA,NA,NA,commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; mRNA binding [GO:0003729]; U1 snRNA binding [GO:0030619]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_LOC662357.1.1.m.64851,-0.00911825626496424,-0.0106885996720384,No,NA,NA,Q961D9,NA,NA,NA,beta-catenin-TCF complex [GO:1990907]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; canonical Wnt signaling pathway [GO:0060070]; chitin-based larval cuticle pattern formation [GO:0035293]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; leg disc pattern formation [GO:0035223]; segment polarity determination [GO:0007367]; sternite morphogenesis [GO:0007491]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_LOC662408.1.1.m.44393,-0.0131830759038805,-0.0023065711666824,No,NA,NA,Q9GKY8,NA,NA,NA,integral component of membrane [GO:0016021]; junctional membrane complex [GO:0030314]; plasma membrane [GO:0005886]; sarcoplasmic reticulum membrane [GO:0033017],NA,NA,NA
CHOYP_LOC662543.1.1.m.39811,0.0198489405717892,-0.0134304698083927,No,NA,NA,Q14624,NA,NA,NA,blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; platelet dense granule lumen [GO:0031089]; endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; platelet degranulation [GO:0002576]; response to cytokine [GO:0034097],NA,NA,NA
CHOYP_LOC662585.2.2.m.7262,0.00641870100964,0.0117780614547453,No,NA,NA,Q91ZU6,NA,NA,NA,actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cytoplasmic microtubule organization [GO:0031122]; hemidesmosome assembly [GO:0031581]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060],NA,NA,NA
CHOYP_LOC663138.1.1.m.7661,-0.0010516015294796,-0.0145185688722734,No,NA,NA,Q9Y2H2,NA,NA,NA,axon [GO:0030424]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; neuronal cell body [GO:0043025]; recycling endosome [GO:0055037]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; phosphatidylinositol phosphate 4-phosphatase activity [GO:0034596]; phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein homodimerization activity [GO:0042803]; adult locomotory behavior [GO:0008344]; cardiac muscle hypertrophy in response to stress [GO:0014898]; clathrin-dependent endocytosis [GO:0072583]; negative regulation of axon regeneration [GO:0048681]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol catabolic process [GO:0031161]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of receptor recycling [GO:0001921]; regulation of cell motility [GO:2000145]; regulation of endocytic recycling [GO:2001135]; regulation of protein kinase B signaling [GO:0051896],NA,NA,NA
CHOYP_LOC663155.1.1.m.62768,-0.0138421966330877,-0.0117911083740881,No,NA,NA,Q2L969,NA,NA,NA,mitochondrial sorting and assembly machinery complex [GO:0001401]; nucleolus [GO:0005730]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC663249.1.1.m.25441,-0.0124500581064235,-0.00263165425929723,No,NA,NA,P06280,NA,NA,NA,azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; alpha-galactosidase activity [GO:0004557]; catalytic activity [GO:0003824]; galactoside binding [GO:0016936]; hydrolase activity [GO:0016787]; protein homodimerization activity [GO:0042803]; raffinose alpha-galactosidase activity [GO:0052692]; signaling receptor binding [GO:0005102]; glycoside catabolic process [GO:0016139]; glycosphingolipid catabolic process [GO:0046479]; glycosphingolipid metabolic process [GO:0006687]; glycosylceramide catabolic process [GO:0046477]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of nitric-oxide synthase activity [GO:0051001]; neutrophil degranulation [GO:0043312]; oligosaccharide metabolic process [GO:0009311],NA,NA,NA
CHOYP_LOC663261.1.1.m.21784,0.00151353198415282,-0.0107829126953968,No,NA,NA,Q922K7,NA,NA,NA,nucleolus [GO:0005730]; RNA binding [GO:0003723]; rRNA (cytosine-C5-)-methyltransferase activity [GO:0009383]; blastocyst formation [GO:0001825]; positive regulation of cell proliferation [GO:0008284]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; rRNA base methylation [GO:0070475],NA,NA,NA
CHOYP_LOC663375.1.1.m.11969,-0.0104408359837931,-0.0172982555395364,No,NA,NA,Q76IQ7,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA polymerase II transcription factor binding [GO:0001085]; female gonad development [GO:0008585]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to gonadotropin [GO:0034698],NA,NA,NA
CHOYP_LOC663422.1.1.m.57246,-0.0045079187406662,-0.0190747548290189,No,NA,NA,P31396,NA,NA,NA,nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; metamorphosis [GO:0007552]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of development; heterochronic [GO:0040034],NA,NA,NA
CHOYP_LOC663424.1.2.m.49957,-0.0112723475002835,0.0108492582656987,No,NA,NA,D3ZSI8,NA,NA,NA,cytosol [GO:0005829]; lamellipodium [GO:0030027]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nuclear speck [GO:0016607]; ruffle membrane [GO:0032587]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]; kinase binding [GO:0019900]; actin cytoskeleton reorganization [GO:0031532]; activation of GTPase activity [GO:0090630]; cell chemotaxis [GO:0060326]; fibroblast migration [GO:0010761]; focal adhesion assembly [GO:0048041]; phosphatidylinositol biosynthetic process [GO:0006661]; protein localization to plasma membrane [GO:0072659]; ruffle assembly [GO:0097178],NA,NA,NA
CHOYP_LOC663518.1.1.m.11968,-0.00146654140651248,-0.0109526126335439,No,NA,NA,Q7KMJ6,NA,NA,NA,nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; compound eye development [GO:0048749]; mRNA methylation [GO:0080009]; mRNA splicing; via spliceosome [GO:0000398]; negative regulation of stem cell differentiation [GO:2000737]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; sex differentiation [GO:0007548]; wing disc pattern formation [GO:0035222],NA,NA,NA
CHOYP_LOC663776.1.1.m.66113,-0.0039080209630926,0.0151097014778994,No,NA,NA,Q29RP8,NA,NA,NA,chromosome [GO:0005694]; nucleus [GO:0005634]; histone methyltransferase activity (H4-K20 specific) [GO:0042799]; histone-lysine N-methyltransferase activity [GO:0018024]; histone H4-K20 trimethylation [GO:0034773]; muscle organ development [GO:0007517],NA,NA,NA
CHOYP_LOC663838.2.2.m.43318,-0.00548682463224476,-0.00392534330791348,No,NA,NA,P10079,NA,NA,NA,apical lamina of hyaline layer [GO:0032579]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC663855.2.5.m.747,0.0211009858161512,-0.00112262382177078,No,NA,NA,Q9DC07,NA,NA,NA,Z disc [GO:0030018]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; cardiac muscle thin filament assembly [GO:0071691]; muscle fiber development [GO:0048747],NA,NA,NA
CHOYP_LOC663855.5.5.m.51311,-0.0138859326618445,-0.000501723806248798,No,NA,NA,P34416,NA,NA,NA,cell junction [GO:0030054]; striated muscle dense body [GO:0055120]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC664087.1.1.m.19351,0.00926363563729589,-0.000256992360915556,No,NA,NA,Q03112,NA,NA,NA,cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; hematopoietic stem cell proliferation [GO:0071425]; negative regulation of JNK cascade [GO:0046329]; negative regulation of programmed cell death [GO:0043069]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726],NA,NA,NA
CHOYP_LOC664138.1.1.m.26660,-0.0223587383468554,0.000426418585312303,No,NA,NA,Q9VRN5,NA,NA,NA,cytosol [GO:0005829]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; zinc ion binding [GO:0008270]; negative regulation of pre-miRNA processing [GO:2000632]; oogenesis [GO:0048477]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of stem cell proliferation [GO:2000648]; regulation of transcription; DNA-templated [GO:0006355]; symmetric stem cell division [GO:0098724],NA,NA,NA
CHOYP_LOC664527.1.1.m.16232,0.00138247473725375,-0.00804353465219957,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC684934.1.1.m.1807,0.00473679867114316,-0.00878485133454979,No,NA,NA,Q8VC31,NA,NA,NA,,NA,NA,NA
CHOYP_LOC689840.1.1.m.6512,-0.0226202052797727,0.0104650337191011,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC720058.1.1.m.11127,-0.0170624135066409,-0.000384752145746189,No,NA,NA,A0JNB1,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC724172.1.1.m.24081,0.00857172083308949,-0.00428442578430326,No,NA,NA,Q9W4E2,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; protein kinase A binding [GO:0051018]; compound eye cone cell differentiation [GO:0042675]; eye photoreceptor cell development [GO:0042462]; mushroom body development [GO:0016319]; neuromuscular junction development [GO:0007528]; olfactory learning [GO:0008355]; short-term memory [GO:0007614],NA,NA,NA
CHOYP_LOC724467.1.1.m.38548,-0.00551945878624377,0.0174818356272619,No,NA,NA,Q5R788,NA,NA,NA,mitochondrion [GO:0005739]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; structural molecule activity [GO:0005198]; protein maturation by iron-sulfur cluster transfer [GO:0097428],NA,NA,NA
CHOYP_LOC725079.1.1.m.66349,-0.00923734644249631,-0.00771207340282582,No,NA,NA,Q9DCD5,NA,NA,NA,bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; Golgi organization [GO:0007030],NA,NA,NA
CHOYP_LOC725565.1.1.m.19064,0.00711083890738787,-0.00703888451699348,No,NA,NA,Q6P829,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase activity [GO:0061630]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_LOC725703.1.1.m.31182,-0.0217898978192337,-0.00417771776311887,No,NA,NA,P04570,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC726145.1.1.m.27163,-0.0107370386098164,0.000297761563095704,No,NA,NA,P52486,NA,NA,NA,nucleus [GO:0005634]; ATP binding [GO:0005524]; proteasome binding [GO:0070628]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; protein polyubiquitination [GO:0000209],NA,NA,NA
CHOYP_LOC732900.1.1.m.62814,-0.00981040132011644,-0.0258141022476886,No,NA,NA,Q641Y2,NA,NA,NA,mitochondrial respiratory chain complex I [GO:0005747]; nucleoplasm [GO:0005654]; 4 iron; 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase activity [GO:0003954]; quinone binding [GO:0048038]; ubiquitin protein ligase binding [GO:0031625]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_LOC732961.1.1.m.29082,-0.012724373713604,0.0082076139419467,No,NA,NA,O18404,NA,NA,NA,cytosol [GO:0005829]; mitochondrial ribonuclease P complex [GO:0030678]; mitochondrion [GO:0005739]; 3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity [GO:0047015]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 7-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0047022]; acetoacetyl-CoA reductase activity [GO:0018454]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; steroid dehydrogenase activity [GO:0016229]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; testosterone dehydrogenase [NAD(P)] activity [GO:0030283]; acyl-CoA metabolic process [GO:0006637]; androgen metabolic process [GO:0008209]; ecdysone metabolic process [GO:0008205]; estrogen metabolic process [GO:0008210]; fatty acid metabolic process [GO:0006631]; mitochondrial tRNA processing [GO:0090646]; RNA phosphodiester bond hydrolysis; endonucleolytic [GO:0090502]; steroid metabolic process [GO:0008202],NA,NA,NA
CHOYP_LOC751836.2.6.m.25437,0.0185661919548879,-0.00914054314529999,No,NA,NA,P08962,NA,NA,NA,azurophil granule membrane [GO:0035577]; cell surface [GO:0009986]; endosome lumen [GO:0031904]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; multivesicular body; internal vesicle [GO:0097487]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; cell migration [GO:0016477]; cell surface receptor signaling pathway [GO:0007166]; cell-matrix adhesion [GO:0007160]; cellular protein localization [GO:0034613]; endosome to melanosome transport [GO:0035646]; neutrophil degranulation [GO:0043312]; pigment granule maturation [GO:0048757]; platelet degranulation [GO:0002576]; positive regulation of endocytosis [GO:0045807]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746],NA,NA,NA
CHOYP_LOC751836.5.6.m.43257,-0.00569586580225622,0.00225579461312498,No,NA,NA,Q6AYR9,NA,NA,NA,cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; vesicle [GO:0031982]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cell surface receptor signaling pathway [GO:0007166]; positive regulation of endocytosis [GO:0045807]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_LOC752244.2.2.m.45622,0.00878138738368666,-0.00268715651872116,No,NA,NA,Q9UDY4,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of transcription by RNA polymerase II [GO:0000122]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986],NA,NA,NA
CHOYP_LOC752782.1.1.m.53937,-0.00404563225670094,-0.00493001123453894,No,NA,NA,O17320,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC752782.1.1.m.53938,0.00559202621335748,0.00205624384628661,No,NA,NA,Q93129,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC752884.1.1.m.4412,0.00827862720916352,-0.00295638489021553,No,NA,NA,Q8NE09,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; negative regulation of signal transduction [GO:0009968],NA,NA,NA
CHOYP_LOC753176.3.3.m.54259,0.00394536801625317,0.00291369700370642,No,NA,NA,Q6DIB5,NA,NA,NA,cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; complement component C1q binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast migration [GO:0051451]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_LOC753178.2.2.m.60569,-0.0199256915674361,-0.00220406528473711,No,NA,NA,Q4R744,NA,NA,NA,,NA,NA,NA
CHOYP_LOC753709.10.44.m.22246,0.00217997094733793,-0.00807271368859912,No,NA,NA,Q8IWZ3,NA,NA,NA,cytoplasm [GO:0005737]; RNA binding [GO:0003723]; innate immune response [GO:0045087],NA,NA,NA
CHOYP_LOC754102.1.1.m.57575,0.0214642892006865,-0.00350587638486359,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC754102.1.1.m.57578,-0.00800970653146708,0.00738104185625078,No,NA,NA,P02553,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017],NA,NA,NA
CHOYP_LOC754150.1.1.m.29730,-0.0169591047060434,0.00960206869202777,No,NA,NA,Q9P0M2,NA,NA,NA,cytosol [GO:0005829]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; nucleotide binding [GO:0000166]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; modulation of chemical synaptic transmission [GO:0050804]; regulation of protein kinase A signaling [GO:0010738],NA,NA,NA
CHOYP_LOC754355.1.1.m.66745,-0.0149673141846356,-0.00271370112632681,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC754396.1.1.m.39126,0.012563689753212,-0.00399872869552349,No,NA,NA,Q6INX4,NA,NA,NA,mitochondrion [GO:0005739]; isomerase activity [GO:0016853]; L-fuconate dehydratase activity [GO:0050023]; magnesium ion binding [GO:0000287]; cellular carbohydrate catabolic process [GO:0044275],NA,NA,NA
CHOYP_LOC754557.1.2.m.5492,0.0235800731216314,-0.0077119873387172,No,NA,NA,Q6TLF6,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]; gluconolactonase activity [GO:0004341]; zinc ion binding [GO:0008270]; cellular calcium ion homeostasis [GO:0006874]; L-ascorbic acid biosynthetic process [GO:0019853]; positive regulation of ATPase activity [GO:0032781]; regulation of calcium-mediated signaling [GO:0050848],NA,NA,NA
CHOYP_LOC754557.2.2.m.22904,-0.0119213407922232,-0.00315682270390554,No,NA,NA,Q6TLF6,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]; gluconolactonase activity [GO:0004341]; zinc ion binding [GO:0008270]; cellular calcium ion homeostasis [GO:0006874]; L-ascorbic acid biosynthetic process [GO:0019853]; positive regulation of ATPase activity [GO:0032781]; regulation of calcium-mediated signaling [GO:0050848],NA,NA,NA
CHOYP_LOC754728.5.6.m.42237,-0.00277751783724664,0.00135230445397045,No,NA,NA,Q99NH0,NA,NA,NA,chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275],NA,NA,NA
CHOYP_LOC754820.1.1.m.57329,0.00598617947439647,0.0127045065485084,No,NA,NA,Q6NV18,NA,NA,NA,DNA ligase IV complex [GO:0032807]; nonhomologous end joining complex [GO:0070419]; DNA end binding [GO:0045027]; double-strand break repair via nonhomologous end joining [GO:0006303],NA,NA,NA
CHOYP_LOC755229.1.1.m.5006,-0.0123830469737679,-0.0123922324211746,No,NA,NA,P57756,NA,NA,NA,collagen trimer [GO:0005581]; extracellular region [GO:0005576]; extrinsic component of external side of plasma membrane [GO:0031232]; carbohydrate binding [GO:0030246]; G protein-coupled receptor binding [GO:0001664]; metal ion binding [GO:0046872]; sialic acid binding [GO:0033691]; signaling pattern recognition receptor activity [GO:0008329]; cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation; lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of interleukin-8 secretion [GO:2000484]; protein localization to cell surface [GO:0034394]; recognition of apoptotic cell [GO:0043654],NA,NA,NA
CHOYP_LOC755290.2.4.m.31794,-0.00372993278082539,0.00155939867210887,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC755521.5.28.m.32618,0.00784650176828239,0.000395873523596289,No,NA,NA,Q9ULJ7,NA,NA,NA,endosome [GO:0005768]; protein transport [GO:0015031]; retrograde transport; endosome to plasma membrane [GO:1990126],NA,NA,NA
CHOYP_LOC755594.2.6.m.51265,0.00763637730934714,0.00663103557473638,No,NA,NA,Q4UMH6,NA,NA,NA,guanosine tetraphosphate metabolic process [GO:0015969],NA,NA,NA
CHOYP_LOC755594.4.6.m.53187,0.010875000286212,0.0124420868974095,No,NA,NA,Q4UMH6,NA,NA,NA,guanosine tetraphosphate metabolic process [GO:0015969],NA,NA,NA
CHOYP_LOC755594.5.6.m.54446,0.00205195042830452,-0.00934116934689426,No,NA,NA,Q4UMH6,NA,NA,NA,guanosine tetraphosphate metabolic process [GO:0015969],NA,NA,NA
CHOYP_LOC756222.1.2.m.62,0.0169399158646737,0.00574134641019858,No,NA,NA,A8MU46,NA,NA,NA,contractile fiber [GO:0043292]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; I band [GO:0031674]; M band [GO:0031430]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; calmodulin binding [GO:0005516]; protein phosphatase 1 binding [GO:0008157]; tropomyosin binding [GO:0005523]; actin cytoskeleton organization [GO:0030036]; negative regulation of blood vessel diameter [GO:0097756]; positive regulation of vasoconstriction [GO:0045907],NA,NA,NA
CHOYP_LOC756760.1.1.m.1259,-0.00611845353355593,0.0158637544164324,No,NA,NA,Q9BW91,NA,NA,NA,extracellular exosome [GO:0070062]; intracellular [GO:0005622]; mitochondrial matrix [GO:0005759]; adenosine-diphosphatase activity [GO:0043262]; ADP-ribose diphosphatase activity [GO:0047631]; ADP-sugar diphosphatase activity [GO:0019144]; ADP catabolic process [GO:0046032]; IDP catabolic process [GO:0046709]; nucleobase-containing small molecule catabolic process [GO:0034656],NA,NA,NA
CHOYP_LOC756946.1.1.m.49284,0.00514953970375291,-0.00929449385650856,No,NA,NA,Q9C0I9,NA,NA,NA,,NA,NA,NA
CHOYP_LOC756958.1.2.m.17672,-0.0135725579708753,0.00388604629968508,No,NA,NA,Q7Z591,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_LOC757096.1.1.m.9762,-0.0222613136512714,0.00570102059406433,No,NA,NA,Q5THR3,NA,NA,NA,nucleoplasm [GO:0005654]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC762368.1.1.m.8991,0.00394536801625317,0.00291369700370642,No,NA,NA,Q08DU8,NA,NA,NA,axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; cytoplasm [GO:0005737]; endosome [GO:0005768]; extrinsic component of membrane [GO:0019898]; transport vesicle [GO:0030133]; actin filament binding [GO:0051015]; protein homodimerization activity [GO:0042803]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; blood coagulation [GO:0007596]; endosome to melanosome transport [GO:0035646]; melanocyte differentiation [GO:0030318]; melanosome transport [GO:0032402]; membrane fusion [GO:0061025]; neuron projection development [GO:0031175]; positive regulation of natural killer cell activation [GO:0032816]; positive regulation of pigment cell differentiation [GO:0050942]; secretion of lysosomal enzymes [GO:0033299],NA,NA,NA
CHOYP_LOC762575.1.1.m.54012,-0.0148036544195742,0.00423581975810653,No,NA,NA,Q9D2U5,NA,NA,NA,cytoplasm [GO:0005737]; NatC complex [GO:0031417]; nucleus [GO:0005634]; polysome [GO:0005844]; negative regulation of apoptotic process [GO:0043066],NA,NA,NA
CHOYP_LOC762961.3.5.m.46330,-0.00964299671992635,0.00925363741521451,No,NA,NA,O43614,NA,NA,NA,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; orexin receptor activity [GO:0016499]; peptide hormone binding [GO:0017046]; chemical synaptic transmission [GO:0007268]; circadian sleep/wake cycle process [GO:0022410]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of circadian sleep/wake cycle; wakefulness [GO:0010840]; regulation of cytosolic calcium ion concentration [GO:0051480],NA,NA,NA
CHOYP_LOC763087.1.1.m.9110,-0.00660254267161409,-0.00986962273675633,No,NA,NA,Q5EAN7,NA,NA,NA,chromosome; telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Mre11 complex [GO:0030870]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; shelterin complex [GO:0070187]; G-rich strand telomeric DNA binding [GO:0098505]; phosphatase binding [GO:0019902]; negative regulation of DNA recombination at telomere [GO:0048239]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of telomere maintenance [GO:0032205]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein acetylation [GO:1901985]; protein localization to chromosome; telomeric region [GO:0070198]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of transcription; DNA-templated [GO:0006355]; telomere maintenance [GO:0000723]; telomere maintenance via telomere lengthening [GO:0010833],NA,NA,NA
CHOYP_LOC763287.1.1.m.43472,0.0129780024577613,-0.00608273102806669,No,NA,NA,P86880,NA,NA,NA,cytoplasm [GO:0005737]; perikaryon [GO:0043204]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344],NA,NA,NA
CHOYP_LOC763308.3.3.m.63145,0.0201328754830652,0.00623105046690884,No,NA,NA,O35186,NA,NA,NA,cytoplasm [GO:0005737]; extracellular space [GO:0005615]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; fibronectin binding [GO:0001968]; proteoglycan binding [GO:0043394]; bone resorption [GO:0045453]; collagen catabolic process [GO:0030574]; intramembranous ossification [GO:0001957]; negative regulation of cartilage development [GO:0061037]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_LOC763340.1.1.m.60271,-0.0037280366796898,0.00724376644249216,No,NA,NA,Q8VCM3,NA,NA,NA,endosome [GO:0005768]; focal adhesion [GO:0005925]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC763378.1.1.m.7889,-0.00805690176233704,-0.017103706303214,No,NA,NA,Q9C0D2,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; mitotic spindle microtubule [GO:1990498]; plasma membrane [GO:0005886]; microtubule binding [GO:0008017]; positive regulation of centriole elongation [GO:1903724]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of protein acetylation [GO:1901985]; regulation of centriole replication [GO:0046599],NA,NA,NA
CHOYP_LOC763463.1.1.m.1366,-0.0178316018083101,0.00241530540792732,No,NA,NA,Q6GLT8,NA,NA,NA,hydrolase activity [GO:0016787]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC763793.3.7.m.24306,0.0065883263884642,0.0180931628217626,No,NA,NA,O75095,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC763845.1.1.m.35345,0.000686232728993107,-0.0107331332691118,No,NA,NA,Q9ULI1,NA,NA,NA,unfolded protein binding [GO:0051082]; ribosomal large subunit biogenesis [GO:0042273],NA,NA,NA
CHOYP_LOC763960.1.2.m.17062,0.00394536801625317,0.00291369700370642,No,NA,NA,Q5JR59,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803],NA,NA,NA
CHOYP_LOC764565.1.1.m.3966,-0.00977435382695481,0.0193435268083564,No,NA,NA,Q9GKX2,NA,NA,NA,mitochondrion [GO:0005739]; peroxisome [GO:0005777]; carbonyl reductase (NADPH) activity [GO:0004090],NA,NA,NA
CHOYP_LOC764722.1.3.m.16471,0.0235532510524265,-0.00476687447796338,No,NA,NA,Q7YT83,NA,NA,NA,extracellular region [GO:0005576]; peptidase activity [GO:0008233],NA,NA,NA
CHOYP_LOC764722.3.3.m.43616,0.0154582745294644,0.0120052963779513,No,NA,NA,A1BQQ5,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_LOC764806.1.2.m.17636,0.0128434694905075,-0.0136788526182619,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC764850.1.8.m.5396,0.00543494680597649,-0.0116750332003388,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC764898.1.1.m.28118,-0.011614617842313,-0.00152686885409461,No,NA,NA,Q9Y547,NA,NA,NA,centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; heart development [GO:0007507]; intraciliary transport involved in cilium assembly [GO:0035735]; kidney development [GO:0001822]; left/right axis specification [GO:0070986]; lung development [GO:0030324]; skeletal system development [GO:0001501]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC764949.1.1.m.44351,0.0110167530540479,0.00906701462182386,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC769726.1.1.m.26365,0.00392356982072873,-0.0140812354336404,No,NA,NA,G4V4G1,NA,NA,NA,extracellular region [GO:0005576]; insulin-like growth factor binding [GO:0005520]; serine-type endopeptidase inhibitor activity [GO:0004867]; regulation of cell growth [GO:0001558],NA,NA,NA
CHOYP_LOC778718.1.1.m.29230,-0.00587004046686402,-0.00338373396003754,No,NA,NA,O54879,NA,NA,NA,cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA binding; bending [GO:0008301]; four-way junction DNA binding [GO:0000400]; RNA binding [GO:0003723]; transcription factor binding [GO:0008134]; chromatin remodeling [GO:0006338]; DNA geometric change [GO:0032392]; DNA recombination [GO:0006310]; innate immune response [GO:0045087]; negative regulation of B cell differentiation [GO:0045578]; negative regulation of myeloid cell differentiation [GO:0045638]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_LOC794295.1.1.m.42748,0.00394536801625317,0.00291369700370642,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC797197.1.1.m.49426,0.00176185119618567,-0.019338561062125,No,NA,NA,Q8IYF3,NA,NA,NA,central element [GO:0000801]; chiasma assembly [GO:0051026]; fertilization [GO:0009566]; male gonad development [GO:0008584]; male meiosis chromosome segregation [GO:0007060]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; reciprocal meiotic recombination [GO:0007131]; resolution of meiotic recombination intermediates [GO:0000712]; synaptonemal complex assembly [GO:0007130],NA,NA,NA
CHOYP_LONM.1.1.m.7031,0.0124713089008246,-0.0157489198635022,No,NA,NA,Q8CGK3,NA,NA,NA,cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; ATPase activity [GO:0016887]; DNA polymerase binding [GO:0070182]; G-quadruplex DNA binding [GO:0051880]; mitochondrial promoter sequence-specific DNA binding [GO:0001018]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; aging [GO:0007568]; cellular protein-containing complex assembly [GO:0034622]; cellular response to oxidative stress [GO:0034599]; chaperone-mediated protein complex assembly [GO:0051131]; mitochondrion organization [GO:0007005]; oxidation-dependent protein catabolic process [GO:0070407]; protein homooligomerization [GO:0051260]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to aluminum ion [GO:0010044]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666],NA,NA,NA
CHOYP_LR16A.1.3.m.9037,-0.00676564118082317,0.0128116236466468,No,NA,NA,Q6EDY6,NA,NA,NA,cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex binding [GO:0044877]; actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415],NA,NA,NA
CHOYP_LR16A.3.3.m.59538,0.0208197918176444,-0.00903619375707026,No,NA,NA,Q5VZK9,NA,NA,NA,cell leading edge [GO:0031252]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex binding [GO:0044877]; actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415],NA,NA,NA
CHOYP_LR16A.3.3.m.59539,0.000686232728993107,-0.0107331332691118,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LRC40.1.2.m.20043,0.00191126086871203,0.00416406947157067,No,NA,NA,Q7SXW3,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LRCH2.2.2.m.56149,0.000313124256558604,0.00986057501478567,No,NA,NA,Q96II8,NA,NA,NA,cytosol [GO:0005829]; extracellular region [GO:0005576],NA,NA,NA
CHOYP_LRIG1.1.3.m.954,0.0141987309473508,0.0163878991815732,No,NA,NA,F7D3V9,NA,NA,NA,integral component of plasma membrane [GO:0005887]; trans-Golgi network membrane [GO:0032588]; G protein-coupled peptide receptor activity [GO:0008528]; protein-hormone receptor activity [GO:0016500]; transmembrane signaling receptor activity [GO:0004888]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; hormone-mediated signaling pathway [GO:0009755]; positive regulation of canonical Wnt signaling pathway [GO:0090263],NA,NA,NA
CHOYP_LRP1.5.5.m.54869,0.0035704752634003,0.00253302568520842,No,NA,NA,Q91ZX7,NA,NA,NA,basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; receptor complex [GO:0043235]; alpha-2 macroglobulin receptor activity [GO:0016964]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; clathrin heavy chain binding [GO:0032050]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; astrocyte activation involved in immune response [GO:0002265]; cardiac septum development [GO:0003279]; cell proliferation [GO:0008283]; cellular response to amyloid-beta [GO:1904646]; cholesterol metabolic process [GO:0008203]; coronary vasculature development [GO:0060976]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron projection development [GO:0010977]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of cell death [GO:0010942]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein transport [GO:0051222]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cholesterol transport [GO:0032374]; regulation of phospholipase A2 activity [GO:0032429]; transcytosis [GO:0045056],NA,NA,NA
CHOYP_LRP12.1.2.m.30870,0.00876278418596265,-0.0116575123783493,No,NA,NA,Q5R662,NA,NA,NA,clathrin-coated pit [GO:0005905]; integral component of plasma membrane [GO:0005887]; endocytosis [GO:0006897]; neuron migration [GO:0001764]; neuron projection development [GO:0031175],NA,NA,NA
CHOYP_LRP1B.1.2.m.7346,-0.00502709194066359,0.00994619964799963,No,NA,NA,O75581,NA,NA,NA,caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; apolipoprotein binding [GO:0034185]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; anterior/posterior pattern specification [GO:0009952]; axis elongation involved in somitogenesis [GO:0090245]; beta-catenin destruction complex disassembly [GO:1904886]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in neural crest cell differentiation [GO:0044335]; canonical Wnt signaling pathway involved in regulation of cell proliferation [GO:0044340]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; gastrulation with mouth forming second [GO:0001702]; midbrain development [GO:0030901]; midbrain dopaminergic neuron differentiation [GO:1904948]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; response to peptide hormone [GO:0043434]; roof of mouth development [GO:0060021]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; Wnt signaling pathway involved in somitogenesis [GO:0090244],NA,NA,NA
CHOYP_LRP2.6.7.m.41365,0.00746195518416841,-0.000627741852871007,No,NA,NA,P98158,NA,NA,NA,apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023]; steroid hormone receptor binding [GO:0035258]; aging [GO:0007568]; animal organ regeneration [GO:0031100]; coronary artery morphogenesis [GO:0060982]; endocytic hemoglobin import [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; hormone secretion [GO:0046879]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of endopeptidase activity [GO:0010951]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to drug [GO:0042493]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; vitamin metabolic process [GO:0006766],NA,NA,NA
CHOYP_LRP4.5.5.m.48010,0.00779337103835081,-0.0136265311336239,No,NA,NA,Q9QYP1,NA,NA,NA,cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; BMP signaling pathway [GO:0030509]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein heterotetramerization [GO:0051290]; proximal/distal pattern formation [GO:0009954]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LRP5.1.3.m.18025,0.00407743844497065,-0.0024269038028491,No,NA,NA,O75197,NA,NA,NA,endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; adipose tissue development [GO:0060612]; anterior/posterior pattern specification [GO:0009952]; bone marrow development [GO:0048539]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cholesterol homeostasis [GO:0042632]; endocytosis [GO:0006897]; gastrulation with mouth forming second [GO:0001702]; glucose catabolic process [GO:0006007]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; osteoblast development [GO:0002076]; positive regulation of cell proliferation [GO:0008284]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of blood pressure [GO:0008217]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; retina morphogenesis in camera-type eye [GO:0060042]; retinal blood vessel morphogenesis [GO:0061304]; toxin transport [GO:1901998]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LRP6.1.6.m.878,0.00615966897194063,0.00941964587728867,No,NA,NA,O88572,NA,NA,NA,caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; apolipoprotein binding [GO:0034185]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; anterior/posterior pattern specification [GO:0009952]; axis elongation [GO:0003401]; axis elongation involved in somitogenesis [GO:0090245]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in cardiac neural crest cell differentiation involved in heart development [GO:0061310]; canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation [GO:0061324]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex cell migration [GO:0021795]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; forebrain development [GO:0030900]; forebrain generation of neurons [GO:0021872]; forebrain radial glial cell differentiation [GO:0021861]; formation of radial glial scaffolds [GO:0021943]; gastrulation with mouth forming second [GO:0001702]; generation of neurons [GO:0048699]; heart looping [GO:0001947]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mammary placode formation [GO:0060596]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis [GO:2000151]; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis [GO:2000162]; negative regulation of planar cell polarity pathway involved in neural tube closure [GO:2000168]; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis [GO:2000164]; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis [GO:2000166]; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis [GO:2000149]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; post-anal tail morphogenesis [GO:0036342]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cell development [GO:0060284]; regulation of cell proliferation [GO:0042127]; regulation of transcription; DNA-templated [GO:0006355]; response to folic acid [GO:0051593]; retina morphogenesis in camera-type eye [GO:0060042]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in forebrain neuroblast division [GO:0021874]; Wnt signaling pathway involved in somitogenesis [GO:0090244],NA,NA,NA
CHOYP_LRRF2.2.2.m.40846,0.000317684197371734,0.00470426151912969,No,NA,NA,Q2T9W6,NA,NA,NA,regulation of transcription; DNA-templated [GO:0006355]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LS14A.2.3.m.10984,-0.0146204025016646,0.0172084581717165,No,NA,NA,Q8ND56,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; P-body [GO:0000932]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; cytoplasmic mRNA processing body assembly [GO:0033962]; multicellular organism development [GO:0007275]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; regulation of translation [GO:0006417]; RIG-I signaling pathway [GO:0039529],NA,NA,NA
CHOYP_LSAMP.1.1.m.36104,0.0094153415041959,0.0203261994501866,No,NA,NA,Q24372,NA,NA,NA,anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; protein homodimerization activity [GO:0042803]; cell adhesion involved in heart morphogenesis [GO:0061343]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity; open tracheal system [GO:0035160]; morphogenesis of embryonic epithelium [GO:0016331]; open tracheal system development [GO:0007424]; regulation of tube size; open tracheal system [GO:0035151]; septate junction assembly [GO:0019991],NA,NA,NA
CHOYP_LSDA.1.1.m.28040,0.00336198280648217,-0.0194640813164231,No,NA,NA,Q5NAI7,NA,NA,NA,cytoplasm [GO:0005737]; flavin adenine dinucleotide binding [GO:0050660]; N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [GO:0052903]; norspermine:oxygen oxidoreductase activity [GO:0052894]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; spermine:oxygen oxidoreductase (spermidine-forming) activity [GO:0052901]; thermospermine oxidase activity [GO:1990534]; regulation of timing of transition from vegetative to reproductive phase [GO:0048510]; spermine catabolic process [GO:0046208]; thermospermine catabolic process [GO:1903602],NA,NA,NA
CHOYP_LSG1.1.1.m.14762,0.0111550699412623,0.00243442200428508,No,NA,NA,Q6NY89,NA,NA,NA,Cajal body [GO:0015030]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; nuclear export [GO:0051168]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LSM12.1.1.m.24998,0.00754603416935095,0.00483856748331117,No,NA,NA,Q5RAT5,NA,NA,NA,,NA,NA,NA
CHOYP_LSM2.1.2.m.54283,0.0106107387143492,0.0116794356853807,No,NA,NA,O35900,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; Lsm1-7-Pat1 complex [GO:1990726]; Lsm2-8 complex [GO:0120115]; nucleus [GO:0005634]; P-body [GO:0000932]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]; protein kinase binding [GO:0019901]; Ral GTPase binding [GO:0017160]; RNA binding [GO:0003723]; mRNA catabolic process [GO:0006402]; mRNA splicing; via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244],NA,NA,NA
CHOYP_LSM3.1.1.m.9505,-0.00283614173520664,-0.00900112869341294,No,NA,NA,P62311,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; Lsm1-7-Pat1 complex [GO:1990726]; Lsm2-8 complex [GO:0120115]; nucleus [GO:0005634]; P-body [GO:0000932]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]; RNA binding [GO:0003723]; U6 snRNA 3'-end binding [GO:0030629]; cytoplasmic mRNA processing body assembly [GO:0033962]; mRNA splicing; via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process [GO:0000956],NA,NA,NA
CHOYP_LSM4.1.3.m.2601,0.0063350377924898,-0.00323494956917318,No,NA,NA,Q9QXA5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; Lsm2-8 complex [GO:0120115]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; protein-containing complex [GO:0032991]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]; PH domain binding [GO:0042731]; RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070]; cytoplasmic mRNA processing body assembly [GO:0033962]; mRNA splicing; via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process [GO:0000956]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_LSM7.1.1.m.3617,0.00519455061988071,-0.000385929968139556,No,NA,NA,Q9CQQ8,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; Lsm1-7-Pat1 complex [GO:1990726]; Lsm2-8 complex [GO:0120115]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; mRNA catabolic process [GO:0006402]; mRNA splicing; via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process [GO:0000956],NA,NA,NA
CHOYP_LTN1.1.2.m.7693,0.000726594417251791,-0.00375309693895709,No,NA,NA,Q6A009,NA,NA,NA,cytosol [GO:0005829]; RQC complex [GO:1990112]; ribosomal large subunit binding [GO:0043023]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116],NA,NA,NA
CHOYP_LTOR2.2.2.m.61709,-0.00178279646091993,0.00574145957507526,No,NA,NA,B5X7X4,NA,NA,NA,late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; Ragulator complex [GO:0071986]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein-containing complex scaffold activity [GO:0032947]; cellular protein localization [GO:0034613]; cellular response to amino acid stimulus [GO:0071230]; positive regulation of TOR signaling [GO:0032008]; regulation of cell growth [GO:0001558],NA,NA,NA
CHOYP_LTV1.1.1.m.19482,-0.00816271401201214,-0.00328024722607766,No,NA,NA,Q4V838,NA,NA,NA,,NA,NA,NA
CHOYP_LYAM3.2.4.m.3333,-0.00857617964477439,0.0126017505352153,No,NA,NA,P98109,NA,NA,NA,integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; oligosaccharide binding [GO:0070492]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; leukocyte tethering or rolling [GO:0050901],NA,NA,NA
CHOYP_LYPA2.1.1.m.45740,-0.0149010187556992,0.00931230870882746,No,NA,NA,Q9QYL8,NA,NA,NA,cytoplasm [GO:0005737]; Golgi stack [GO:0005795]; carboxylic ester hydrolase activity [GO:0052689]; palmitoyl-(protein) hydrolase activity [GO:0008474]; fatty acid metabolic process [GO:0006631]; protein depalmitoylation [GO:0002084],NA,NA,NA
CHOYP_LYRM4.2.3.m.7011,-0.00257898220179309,0.0169903346589322,No,NA,NA,Q6DCS1,NA,NA,NA,mitochondrion [GO:0005739]; nucleus [GO:0005634],NA,NA,NA
CHOYP_LYS3.1.1.m.31221,0.0157495887736447,0.0212383877779493,No,NA,NA,B3A003,NA,NA,NA,extracellular region [GO:0005576]; lysozyme activity [GO:0003796]; cytolysis [GO:0019835]; defense response to bacterium [GO:0042742]; metabolic process [GO:0008152],NA,NA,NA
CHOYP_M1I1L.1.1.m.4329,-0.00592655355643059,-0.00815238962714309,No,NA,NA,Q9CQ20,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; lipid metabolic process [GO:0006629]; negative regulation of microtubule depolymerization [GO:0007026]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of ligase activity [GO:0051351]; protein polymerization [GO:0051258]; regulation of lipid biosynthetic process [GO:0046890],NA,NA,NA
CHOYP_M2OM.1.1.m.11786,0.00364778592941831,-0.00872052841558097,No,NA,NA,P22292,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; oxoglutarate:malate antiporter activity [GO:0015367],NA,NA,NA
CHOYP_M3K1.1.1.m.7202,0.00205195042830452,-0.00934116934689426,No,NA,NA,Q62925,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; ATP binding [GO:0005524]; JUN kinase binding [GO:0008432]; JUN kinase kinase kinase activity [GO:0004706]; MAP kinase kinase kinase activity [GO:0004709]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein serine/threonine kinase activity [GO:0004674]; sphingolipid binding [GO:0046625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; activation of JNKK activity [GO:0007256]; activation of MAPKK activity [GO:0000186]; activation of protein kinase activity [GO:0032147]; MAPK cascade [GO:0000165]; negative regulation of actin filament bundle assembly [GO:0032232]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral transcription [GO:0050434]; protein autophosphorylation [GO:0046777]; protein complex oligomerization [GO:0051259]; protein phosphorylation [GO:0006468]; protein polyubiquitination [GO:0000209]; response to osmotic stress [GO:0006970]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_M3K7.1.4.m.7880,-0.00997759798300213,-0.00375413267427021,No,NA,NA,P0C8E4,NA,NA,NA,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; activation of MAPKK activity [GO:0000186]; apoptotic process [GO:0006915]; I-kappaB phosphorylation [GO:0007252]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JUN kinase activity [GO:0043507]; protein phosphorylation [GO:0006468],NA,NA,NA
CHOYP_M3K7.2.4.m.17369,-0.00919777120703342,-0.011404571396254,No,NA,NA,Q3U3C9,NA,NA,NA,,NA,NA,NA
CHOYP_M6PR.1.1.m.51635,0.00269040081330328,-0.0176682572667747,No,NA,NA,Q6AY20,NA,NA,NA,integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802]; mannose binding [GO:0005537]; protein domain specific binding [GO:0019904]; retromer complex binding [GO:1905394]; protein targeting to lysosome [GO:0006622]; secretion of lysosomal enzymes [GO:0033299],NA,NA,NA
CHOYP_MA1B1.1.1.m.22675,-0.0136757198070057,-0.00816965189035664,No,NA,NA,B2GUY0,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1;2-alpha-mannosidase activity [GO:0004571]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; N-glycan processing [GO:0006491]; protein glycosylation [GO:0006486]; trimming of terminal mannose on B branch [GO:0036509]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_MA2A1.1.1.m.19620,-0.00742608977531514,-0.00608785694680759,No,NA,NA,P28494,NA,NA,NA,cis-Golgi network [GO:0005801]; extracellular space [GO:0005615]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity; hydrolyzing N-glycosyl compounds [GO:0016799]; mannosyl-oligosaccharide 1;3-1;6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]; in utero embryonic development [GO:0001701]; liver development [GO:0001889]; lung alveolus development [GO:0048286]; mannose metabolic process [GO:0006013]; mitochondrion organization [GO:0007005]; N-glycan processing [GO:0006491]; positive regulation of neurogenesis [GO:0050769]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]; respiratory gaseous exchange [GO:0007585]; retina morphogenesis in camera-type eye [GO:0060042]; vacuole organization [GO:0007033],NA,NA,NA
CHOYP_MA2A2.1.1.m.8261,-0.0119274681615225,0.000302322580759151,No,NA,NA,Q8BRK9,NA,NA,NA,Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity; hydrolyzing N-glycosyl compounds [GO:0016799]; mannosidase activity [GO:0015923]; mannosyl-oligosaccharide 1;3-1;6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]; mannose metabolic process [GO:0006013]; N-glycan processing [GO:0006491]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486],NA,NA,NA
CHOYP_MA2C1.1.1.m.46709,0.00394536801625317,0.00291369700370642,No,NA,NA,Q91W89,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; mannose metabolic process [GO:0006013]; oligosaccharide catabolic process [GO:0009313],NA,NA,NA
CHOYP_MABP1.1.2.m.21698,-0.00908394500236459,-0.00543603532424979,No,NA,NA,Q6DFF9,NA,NA,NA,,NA,NA,NA
CHOYP_MABP1.1.2.m.21699,0.0122466915207928,-0.0164830670095952,No,NA,NA,Q7L2H7,NA,NA,NA,cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex; eIF3m [GO:0071541]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; cytoplasmic translational initiation [GO:0002183]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_MAD1.1.1.m.48542,-0.000163439862483018,-0.0236482077070017,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MAD2L1.1.1.m.10353,-0.0121298633902515,-0.0228639546998763,No,NA,NA,Q13257,NA,NA,NA,chromosome [GO:0005694]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; mitotic cell cycle checkpoint [GO:0007093]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of mitotic cell cycle phase transition [GO:1901990],NA,NA,NA
CHOYP_MAGI1.1.1.m.66921,0.00364778592941831,-0.00872052841558097,No,NA,NA,O88382,NA,NA,NA,bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extrinsic component of postsynaptic membrane [GO:0098890]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; slit diaphragm [GO:0036057]; synapse [GO:0045202]; beta-1 adrenergic receptor binding [GO:0031697]; kinesin binding [GO:0019894]; phosphatase binding [GO:0019902]; protein-containing complex binding [GO:0044877]; receptor signaling complex scaffold activity [GO:0030159]; SMAD binding [GO:0046332]; structural constituent of postsynaptic density [GO:0098919]; structural constituent of postsynaptic specialization [GO:0098879]; type II activin receptor binding [GO:0070699]; cellular response to nerve growth factor stimulus [GO:1990090]; glomerular filtration [GO:0003094]; glomerular visceral epithelial cell development [GO:0072015]; mitotic cell cycle arrest [GO:0071850]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of protein kinase B signaling [GO:0051898]; nerve growth factor signaling pathway [GO:0038180]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of receptor internalization [GO:0002092]; protein heterooligomerization [GO:0051291]; receptor clustering [GO:0043113]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of synaptic membrane adhesion [GO:0099179]; signal transduction [GO:0007165]; SMAD protein signal transduction [GO:0060395],NA,NA,NA
CHOYP_MALT1.1.1.m.53909,0.0143179726680499,0.00564229429025575,No,NA,NA,Q9UDY8,NA,NA,NA,CBM complex [GO:0032449]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; cysteine-type endopeptidase activity [GO:0004197]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; protein self-association [GO:0043621]; ubiquitin-protein transferase activity [GO:0004842]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; B cell activation [GO:0042113]; B-1 B cell differentiation [GO:0001923]; defense response [GO:0006952]; Fc-epsilon receptor signaling pathway [GO:0038095]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of apoptotic process [GO:0043066]; nuclear export [GO:0051168]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; protein complex oligomerization [GO:0051259]; proteolysis [GO:0006508]; regulation of apoptotic process [GO:0042981]; regulation of T cell receptor signaling pathway [GO:0050856]; response to fungus [GO:0009620]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852],NA,NA,NA
CHOYP_MAN2B1.1.1.m.38450,-0.0075217208567997,-0.0036728436806303,No,NA,NA,Q29451,NA,NA,NA,lysosome [GO:0005764]; vacuolar membrane [GO:0005774]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; learning or memory [GO:0007611]; mannose metabolic process [GO:0006013]; protein deglycosylation [GO:0006517],NA,NA,NA
CHOYP_MANBA.2.2.m.47433,0.00394536801625317,0.00291369700370642,No,NA,NA,O00462,NA,NA,NA,azurophil granule membrane [GO:0035577]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; beta-mannosidase activity [GO:0004567]; mannose binding [GO:0005537]; cellular protein modification process [GO:0006464]; glycoprotein catabolic process [GO:0006516]; mannan catabolic process [GO:0046355]; neutrophil degranulation [GO:0043312]; oligosaccharide catabolic process [GO:0009313],NA,NA,NA
CHOYP_MANL.2.9.m.16934,0.00555785531683812,0.00766484175267521,No,NA,NA,P86856,NA,NA,NA,extracellular region [GO:0005576]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_MANL.5.9.m.42622,0.0102759619558284,0.0185886727331904,No,NA,NA,Q90YP3,NA,NA,NA,cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181],NA,NA,NA
CHOYP_MARE3.1.1.m.30069,0.0164659507295783,0.0167109636739141,No,NA,NA,Q9UPY8,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; spindle midzone [GO:0051233]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of microtubule plus-end binding [GO:1903033]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of transcription; DNA-templated [GO:0045893]; protein localization [GO:0008104]; protein localization to microtubule [GO:0035372]; protein localization to microtubule plus-end [GO:1904825]; regulation of microtubule polymerization or depolymerization [GO:0031110]; spindle assembly [GO:0051225],NA,NA,NA
CHOYP_MARH5.1.1.m.45222,0.00364778592941831,-0.00872052841558097,No,NA,NA,Q5ZJ41,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; GTPase binding [GO:0051020]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; negative regulation of cell aging [GO:0090344]; positive regulation of mitochondrial fission [GO:0090141]; protein autoubiquitination [GO:0051865]; protein localization to mitochondrion [GO:0070585]; protein polyubiquitination [GO:0000209]; regulation of mitochondrial fission [GO:0090140],NA,NA,NA
CHOYP_MASP2.1.1.m.3029,0.00642485007630628,0.00673065834843756,No,NA,NA,O70244,NA,NA,NA,apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi-associated vesicle [GO:0005798]; ionotropic glutamate receptor complex [GO:0008328]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; channel regulator activity [GO:0016247]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; adult locomotory behavior [GO:0008344]; cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import [GO:0020028]; hyperosmotic response [GO:0006972]; in utero embryonic development [GO:0001701]; positive regulation of synaptic transmission; glutamatergic [GO:0051968]; protein homotrimerization [GO:0070207]; receptor-mediated endocytosis [GO:0006898]; regulation of locomotion [GO:0040012]; response to nutrient [GO:0007584]; thigmotaxis [GO:0001966]; vitamin metabolic process [GO:0006766],NA,NA,NA
CHOYP_MAST4.1.1.m.25573,-0.0109693588628939,-0.00868251839800933,No,NA,NA,Q811L6,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105],NA,NA,NA
CHOYP_MATN1.2.5.m.45361,0.0185661858318693,0.00933839841508333,No,NA,NA,A2AX52,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208],NA,NA,NA
CHOYP_MB21L.1.1.m.35723,0.000686232728993107,-0.0107331332691118,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MBCDH18.1.1.m.34344,-0.0184716604271393,-0.0192735787030873,No,NA,NA,Q2PZL6,NA,NA,NA,apical part of cell [GO:0045177]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307],NA,NA,NA
CHOYP_MBLK1.1.1.m.51933,0.000307140130691911,0.00465712355103649,No,NA,NA,Q5BJS9,NA,NA,NA,cytoplasm [GO:0005737]; filopodium tip [GO:0032433]; stereocilium tip [GO:0032426]; response to axon injury [GO:0048678],NA,NA,NA
CHOYP_MCA3.1.1.m.5766,0.007209381496308,0.00028092868874701,No,NA,NA,O43324,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; negative regulation of cell proliferation [GO:0008285]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cellular senescence [GO:2000774]; positive regulation of DNA damage response; signal transduction by p53 class mediator [GO:0043517]; tRNA aminoacylation for protein translation [GO:0006418],NA,NA,NA
CHOYP_MCA3A.1.2.m.24375,-0.000134585412983672,0.0108877767792355,No,NA,NA,G3MWR8,NA,NA,NA,cell cortex [GO:0005938]; cell projection [GO:0042995]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; actin binding [GO:0003779]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; NAD(P)H as one donor; and incorporation of one atom of oxygen [GO:0016709]; Rab GTPase binding [GO:0017137]; actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; exocytosis [GO:0006887]; oxidation-reduction process [GO:0055114],NA,NA,NA
CHOYP_MCCA.1.1.m.18170,-0.0124066051989907,-0.0100427351940631,No,NA,NA,Q96RQ3,NA,NA,NA,3-methylcrotonyl-CoA carboxylase complex; mitochondrial [GO:0002169]; cytosol [GO:0005829]; methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin carboxylase activity [GO:0004075]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; biotin metabolic process [GO:0006768]; leucine catabolic process [GO:0006552]; protein heterooligomerization [GO:0051291],NA,NA,NA
CHOYP_MCEE.1.1.m.62224,-0.00094996574146255,0.0195606932177179,No,NA,NA,Q96PE7,NA,NA,NA,mitochondrial matrix [GO:0005759]; metal ion binding [GO:0046872]; methylmalonyl-CoA epimerase activity [GO:0004493]; L-methylmalonyl-CoA metabolic process [GO:0046491]; short-chain fatty acid catabolic process [GO:0019626],NA,NA,NA
CHOYP_MCES.1.2.m.15348,-0.0119047592271087,-0.0102098514402682,No,NA,NA,Q5U2U7,NA,NA,NA,fibrillar center [GO:0001650]; mRNA cap binding complex [GO:0005845]; mRNA cap methyltransferase complex [GO:0031533]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; receptor complex [GO:0043235]; mRNA (guanine-N7-)-methyltransferase activity [GO:0004482]; RNA binding [GO:0003723]; 7-methylguanosine mRNA capping [GO:0006370]; cellular response to leukemia inhibitory factor [GO:1990830],NA,NA,NA
CHOYP_MCM2.1.1.m.14569,-0.00901902418415338,-0.0129782803310691,No,NA,NA,P55861,NA,NA,NA,chromatin [GO:0000785]; MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; negative regulation of DNA helicase activity [GO:1905775]; regulation of DNA-dependent DNA replication initiation [GO:0030174],NA,NA,NA
CHOYP_MCM3.1.1.m.14853,-0.0122092130871081,-0.0250112383092615,No,NA,NA,Q28BS0,NA,NA,NA,MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; cell cycle [GO:0007049]; DNA replication initiation [GO:0006270],NA,NA,NA
CHOYP_MCM4.1.1.m.61253,-0.0113858831679021,-0.0185675858596785,No,NA,NA,Q6GL41,NA,NA,NA,chromatin [GO:0000785]; MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; regulation of DNA-dependent DNA replication initiation [GO:0030174],NA,NA,NA
CHOYP_MCM4.1.1.m.61254,0.0185750209685156,-0.0112941930962149,No,NA,NA,Q9XUY5,NA,NA,NA,sodium:potassium-exchanging ATPase complex [GO:0005890]; ATPase activator activity [GO:0001671]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; potassium ion import across plasma membrane [GO:1990573]; sodium ion export across plasma membrane [GO:0036376],NA,NA,NA
CHOYP_MCM5.1.1.m.48534,-0.0104926773312088,-0.0113981213846907,No,NA,NA,P55862,NA,NA,NA,chromatin [GO:0000785]; cytosol [GO:0005829]; MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA replication origin binding [GO:0003688]; helicase activity [GO:0004386]; cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; regulation of DNA-dependent DNA replication initiation [GO:0030174],NA,NA,NA
CHOYP_MCM7.1.1.m.50070,-0.0132588364971819,-0.013640898077554,No,NA,NA,Q6NX31,NA,NA,NA,chromatin [GO:0000785]; MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; regulation of DNA-dependent DNA replication initiation [GO:0030174],NA,NA,NA
CHOYP_MCMBP.1.2.m.3994,-0.0082599978391214,-0.00993867379985264,No,NA,NA,Q7ZYP6,NA,NA,NA,nucleus [GO:0005634]; chromatin binding [GO:0003682]; cell division [GO:0051301]; DNA-dependent DNA replication [GO:0006261]; sister chromatid cohesion [GO:0007062],NA,NA,NA
CHOYP_MCMBP.2.2.m.18631,0.00664305242552473,-0.021114466104873,No,NA,NA,Q7ZYP6,NA,NA,NA,nucleus [GO:0005634]; chromatin binding [GO:0003682]; cell division [GO:0051301]; DNA-dependent DNA replication [GO:0006261]; sister chromatid cohesion [GO:0007062],NA,NA,NA
CHOYP_MD27A.1.2.m.18338,-0.0130460135649408,-0.00928066329624191,No,NA,NA,Q5XHA1,NA,NA,NA,mediator complex [GO:0016592],NA,NA,NA
CHOYP_MDHC.1.1.m.57053,0.0135459934170479,0.0116683613885428,No,NA,NA,Q5ZME2,NA,NA,NA,cytosol [GO:0005829]; extracellular space [GO:0005615]; L-malate dehydrogenase activity [GO:0030060]; carbohydrate metabolic process [GO:0005975]; malate metabolic process [GO:0006108]; NADH metabolic process [GO:0006734]; oxaloacetate metabolic process [GO:0006107]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_MDHM.1.1.m.43603,0.012819802570146,0.00118539888795182,No,NA,NA,Q5NVR2,NA,NA,NA,mitochondrial matrix [GO:0005759]; L-malate dehydrogenase activity [GO:0030060]; protein homodimerization activity [GO:0042803]; aerobic respiration [GO:0009060]; carbohydrate metabolic process [GO:0005975]; internal protein amino acid acetylation [GO:0006475]; malate metabolic process [GO:0006108]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_MDM1.1.2.m.7535,-0.0111583789297657,-0.0191228909969219,No,NA,NA,Q5RC32,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; microtubule [GO:0005874]; nucleus [GO:0005634]; microtubule binding [GO:0008017]; negative regulation of centriole replication [GO:0046600],NA,NA,NA
CHOYP_MDN1.2.8.m.1779,-0.00476401560036774,-0.011231707798833,No,NA,NA,Q9NU22,NA,NA,NA,cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; unfolded protein binding [GO:0051082]; protein-containing complex assembly [GO:0065003]; ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_MDN1.3.8.m.3846,-0.0138129878256443,-0.0186229867997542,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MDN1.4.8.m.6155,0.00900019963371849,-0.0211878221035299,No,NA,NA,Q9NU22,NA,NA,NA,cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; unfolded protein binding [GO:0051082]; protein-containing complex assembly [GO:0065003]; ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_MDN1.6.8.m.52635,-0.00374890514295382,-0.0162839980908478,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MDN1.7.8.m.63476,0.0107250908645311,-0.00462128988263574,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MDR1A.1.1.m.47026,0.00678620130084428,0.00878741825264137,No,NA,NA,P06795,NA,NA,NA,apical plasma membrane [GO:0016324]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intercellular canaliculus [GO:0046581]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; transporter activity [GO:0005215]; establishment of endothelial blood-brain barrier [GO:0014045]; response to drug [GO:0042493]; Sertoli cell barrier remodeling [GO:0061843],NA,NA,NA
CHOYP_MDR1B.1.2.m.12480,-0.00529258783936677,-0.00765704403592023,No,NA,NA,P21440,NA,NA,NA,actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylcholine-translocating ATPase activity [GO:0090554]; bile acid secretion [GO:0032782]; cellular response to bile acid [GO:1903413]; lipid homeostasis [GO:0055088]; phospholipid translocation [GO:0045332]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of phospholipid translocation [GO:0061092]; positive regulation of phospholipid transport [GO:2001140]; response to fenofibrate [GO:1901557],NA,NA,NA
CHOYP_MDR3.3.3.m.66641,-0.00787528460833932,-0.00757836801476085,No,NA,NA,P08183,NA,NA,NA,apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; ceramide-translocating ATPase activity [GO:0099038]; phosphatidylcholine-translocating ATPase activity [GO:0090554]; phosphatidylethanolamine-translocating ATPase activity [GO:0090555]; transporter activity [GO:0005215]; xenobiotic transmembrane transporting ATPase activity [GO:0008559]; ceramide translocation [GO:0099040]; G2/M transition of mitotic cell cycle [GO:0000086]; phospholipid translocation [GO:0045332]; positive regulation of anion channel activity [GO:1901529]; regulation of chloride transport [GO:2001225]; regulation of response to osmotic stress [GO:0047484]; response to drug [GO:0042493]; stem cell proliferation [GO:0072089]; transmembrane transport [GO:0055085],NA,NA,NA
CHOYP_ME3.1.1.m.58433,-0.00653892312655771,-0.00664169012740252,No,NA,NA,P40927,NA,NA,NA,cytoplasm [GO:0005737]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; oxaloacetate decarboxylase activity [GO:0008948],NA,NA,NA
CHOYP_MEC2.3.4.m.30735,-0.00752389893795428,-0.0075777878274303,No,NA,NA,Q27433,NA,NA,NA,integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; cholesterol binding [GO:0015485]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612],NA,NA,NA
CHOYP_MECR.1.1.m.6989,0.00302552883771985,-0.0201366988905176,No,NA,NA,Q6GQN8,NA,NA,NA,mitochondrion [GO:0005739]; trans-2-enoyl-CoA reductase (NADPH) activity [GO:0019166]; fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631],NA,NA,NA
CHOYP_MED17.1.1.m.1678,0.00205195042830452,-0.00934116934689426,No,NA,NA,Q0VFR9,NA,NA,NA,core mediator complex [GO:0070847]; mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_MED18.1.1.m.28719,0.0065883263884642,0.0180931628217626,No,NA,NA,Q9BUE0,NA,NA,NA,core mediator complex [GO:0070847]; mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]; termination of RNA polymerase II transcription [GO:0006369],NA,NA,NA
CHOYP_MED21.1.1.m.6955,-0.0021369813540942,-0.0106493899386456,No,NA,NA,Q16RX1,NA,NA,NA,mediator complex [GO:0016592],NA,NA,NA
CHOYP_MED24.4.10.m.16708,0.00676989852278153,-0.0115593542344657,No,NA,NA,Q2PW47,NA,NA,NA,mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; enteric nervous system development [GO:0048484]; interstitial cell of Cajal differentiation [GO:0061453]; retinal cone cell development [GO:0046549]; thymus development [GO:0048538],NA,NA,NA
CHOYP_MED25.2.2.m.42845,-0.0169591047060434,0.00960206869202778,No,NA,NA,A4IHD9,NA,NA,NA,nucleus [GO:0005634],NA,NA,NA
CHOYP_MED4.1.1.m.12006,-0.00741794891180959,0.00585093055924069,No,NA,NA,Q7QH62,NA,NA,NA,core mediator complex [GO:0070847]; mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_MED7.1.1.m.48813,-0.0135725579708753,0.00388604629968508,No,NA,NA,Q7PR68,NA,NA,NA,core mediator complex [GO:0070847]; mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_MED8B.1.1.m.7004,-0.0178081924159922,0.00517662908590571,No,NA,NA,Q5HZZ6,NA,NA,NA,mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; protein ubiquitination [GO:0016567]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_MEF2A.1.1.m.21731,-0.00392749386325501,0.0194586717818512,No,NA,NA,A2VDZ3,NA,NA,NA,cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II transcription factor binding [GO:0001085]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; apoptotic process [GO:0006915]; cardiac conduction [GO:0061337]; cellular response to calcium ion [GO:0071277]; dendrite morphogenesis [GO:0048813]; ERK5 cascade [GO:0070375]; MAPK cascade [GO:0000165]; mitochondrial genome maintenance [GO:0000002]; mitochondrion distribution [GO:0048311]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of glucose import [GO:0046326]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription; DNA-templated [GO:0006351]; ventricular cardiac myofibril assembly [GO:0055005],NA,NA,NA
CHOYP_MEG10.11.91.m.21604,0.00217997094733793,-0.00807271368859912,No,NA,NA,Q9W0A0,NA,NA,NA,axon [GO:0030424]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; phosphatidylserine binding [GO:0001786]; apoptotic cell clearance [GO:0043277]; cell competition in a multicellular organism [GO:0035212]; defense response to bacterium [GO:0042742]; engulfment of apoptotic cell [GO:0043652]; larval locomotory behavior [GO:0008345]; neuron remodeling [GO:0016322]; phagocytosis [GO:0006909]; phagocytosis; engulfment [GO:0006911]; positive regulation of phagocytosis; engulfment [GO:0060100]; regulation of neuromuscular junction development [GO:1904396]; response to axon injury [GO:0048678]; salivary gland cell autophagic cell death [GO:0035071]; wing disc dorsal/ventral pattern formation [GO:0048190],NA,NA,NA
CHOYP_MEG10.19.91.m.24289,-0.0176050167040123,0.0031655458741511,No,NA,NA,O88281,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_MEG10.22.91.m.28727,0.00814238109989131,0.00625322260276711,No,NA,NA,Q8VIK5,NA,NA,NA,integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; negative regulation of Notch signaling pathway [GO:0045746]; phosphatidylinositol 3-kinase signaling [GO:0014065]; platelet aggregation [GO:0070527]; protein kinase B signaling [GO:0043491]; recognition of apoptotic cell [GO:0043654],NA,NA,NA
CHOYP_MEG10.47.91.m.45614,0.000686232728993107,-0.0107331332691118,No,NA,NA,Q6DIB5,NA,NA,NA,cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; complement component C1q binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast migration [GO:0051451]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_MEG10.50.91.m.46730,-0.0225636046079795,0.00998666232910421,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MEG10.56.91.m.47515,0.00205195042830452,-0.00934116934689426,No,NA,NA,Q8VIK5,NA,NA,NA,integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; negative regulation of Notch signaling pathway [GO:0045746]; phosphatidylinositol 3-kinase signaling [GO:0014065]; platelet aggregation [GO:0070527]; protein kinase B signaling [GO:0043491]; recognition of apoptotic cell [GO:0043654],NA,NA,NA
CHOYP_MEG10.58.91.m.48257,-0.00559861492905545,0.0183903752557647,No,NA,NA,Q9W0A0,NA,NA,NA,axon [GO:0030424]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; phosphatidylserine binding [GO:0001786]; apoptotic cell clearance [GO:0043277]; cell competition in a multicellular organism [GO:0035212]; defense response to bacterium [GO:0042742]; engulfment of apoptotic cell [GO:0043652]; larval locomotory behavior [GO:0008345]; neuron remodeling [GO:0016322]; phagocytosis [GO:0006909]; phagocytosis; engulfment [GO:0006911]; positive regulation of phagocytosis; engulfment [GO:0060100]; regulation of neuromuscular junction development [GO:1904396]; response to axon injury [GO:0048678]; salivary gland cell autophagic cell death [GO:0035071]; wing disc dorsal/ventral pattern formation [GO:0048190],NA,NA,NA
CHOYP_MEG10.61.91.m.50119,0.00871484597460852,0.00652041322151622,No,NA,NA,A0JM12,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; myofibril assembly [GO:0030239]; phagocytosis [GO:0006909]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_MEG10.67.91.m.52967,-0.0169591047060434,0.00960206869202777,No,NA,NA,A6BM72,NA,NA,NA,basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842],NA,NA,NA
CHOYP_MEG10.70.91.m.54892,0.00796526261669954,0.00244539173351744,No,NA,NA,P22105,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251],NA,NA,NA
CHOYP_MEG10.79.91.m.59237,-0.00497335255709489,0.00578532724356615,No,NA,NA,Q99M80,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_MEG10.80.91.m.60740,0.00743532743076634,0.00255817237335034,No,NA,NA,Q9W0A0,NA,NA,NA,axon [GO:0030424]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; phosphatidylserine binding [GO:0001786]; apoptotic cell clearance [GO:0043277]; cell competition in a multicellular organism [GO:0035212]; defense response to bacterium [GO:0042742]; engulfment of apoptotic cell [GO:0043652]; larval locomotory behavior [GO:0008345]; neuron remodeling [GO:0016322]; phagocytosis [GO:0006909]; phagocytosis; engulfment [GO:0006911]; positive regulation of phagocytosis; engulfment [GO:0060100]; regulation of neuromuscular junction development [GO:1904396]; response to axon injury [GO:0048678]; salivary gland cell autophagic cell death [GO:0035071]; wing disc dorsal/ventral pattern formation [GO:0048190],NA,NA,NA
CHOYP_MEG10.83.91.m.61586,0.00484588092706001,0.0117149426359737,No,NA,NA,P23469,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; negative regulation of insulin receptor signaling pathway [GO:0046627]; protein dephosphorylation [GO:0006470],NA,NA,NA
CHOYP_MEG10.9.91.m.20215,0.00217997094733793,-0.00807271368859912,No,NA,NA,Q80T91,NA,NA,NA,basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842],NA,NA,NA
CHOYP_MEG11.15.25.m.46952,-0.00561432252374775,0.00196514775912177,No,NA,NA,Q14162,NA,NA,NA,endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; low-density lipoprotein particle binding [GO:0030169]; scavenger receptor activity [GO:0005044]; transmembrane signaling receptor activity [GO:0004888]; cell adhesion [GO:0007155]; cholesterol catabolic process [GO:0006707]; dendrite development [GO:0016358]; neuron remodeling [GO:0016322]; positive regulation of axon regeneration [GO:0048680]; positive regulation of neuron projection development [GO:0010976]; receptor-mediated endocytosis [GO:0006898],NA,NA,NA
CHOYP_MEG11.8.25.m.39826,0.00364778592941831,-0.00872052841558096,No,NA,NA,A0JM12,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; myofibril assembly [GO:0030239]; phagocytosis [GO:0006909]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_MEGF10.8.12.m.38635,0.00762395796693942,-0.00799587052318466,No,NA,NA,Q06805,NA,NA,NA,integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; positive regulation of angiogenesis [GO:0045766]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_MEGF6.1.59.m.1169,-0.0169591047060434,0.00960206869202777,No,NA,NA,Q6DIB5,NA,NA,NA,cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; complement component C1q binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast migration [GO:0051451]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_MEGF6.11.59.m.24279,-0.00150754710191468,-0.0106426931202696,No,NA,NA,Q6DIB5,NA,NA,NA,cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; complement component C1q binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast migration [GO:0051451]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_MEGF6.13.59.m.24300,-0.00706438461387684,0.00501936880543666,No,NA,NA,O75095,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_MEGF6.15.59.m.24311,-0.00212078832001384,-0.00891837260408135,No,NA,NA,O88281,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_MEGF6.3.59.m.2378,0.00937891744104974,0.0208916865829283,No,NA,NA,A0JM12,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; myofibril assembly [GO:0030239]; phagocytosis [GO:0006909]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_MEGF6.32.59.m.41698,0.00955604682017322,0.0134506395941004,No,NA,NA,O14522,NA,NA,NA,cell surface [GO:0009986]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_MEGF6.35.59.m.42904,-0.00212078832001384,-0.00891837260408135,No,NA,NA,P22105,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251],NA,NA,NA
CHOYP_MEGF6.36.59.m.43203,0.012881992935354,0.0102915686259502,No,NA,NA,O75095,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_MEGF6.44.59.m.47511,-0.0120223757991271,-0.000830662933237108,No,NA,NA,Q6DIB5,NA,NA,NA,cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; complement component C1q binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast migration [GO:0051451]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_MEGF6.48.59.m.51016,-0.00755889894267206,0.0140403116735985,No,NA,NA,O75095,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_MEGF6.52.59.m.54262,-0.00126153251459577,0.00598768146411213,No,NA,NA,O88281,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_MEGF6.55.59.m.59497,0.0130058684659915,-0.00120537957228217,No,NA,NA,Q5ND28,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; low-density lipoprotein particle binding [GO:0030169]; scavenger receptor activity [GO:0005044]; cell adhesion [GO:0007155]; dendrite development [GO:0016358]; neuron remodeling [GO:0016322]; positive regulation of axon regeneration [GO:0048680]; positive regulation of neuron projection development [GO:0010976],NA,NA,NA
CHOYP_MEGF6.8.59.m.7292,0.0219953248386566,-0.00502055391042505,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MEGF6A.1.2.m.17795,0.00615966897194063,0.00941964587728867,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MEP50.1.1.m.12931,0.000428566826372339,-0.0179705303403698,No,NA,NA,Q5RBZ2,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; methyl-CpG binding [GO:0008327],NA,NA,NA
CHOYP_MERL.1.1.m.1067,-0.00128690243827711,0.0107127528821082,No,NA,NA,P35240,NA,NA,NA,adherens junction [GO:0005912]; apical part of cell [GO:0045177]; cell body [GO:0044297]; cleavage furrow [GO:0032154]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; filopodium membrane [GO:0031527]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; actin binding [GO:0003779]; actin cytoskeleton organization [GO:0030036]; cell-cell junction organization [GO:0045216]; ectoderm development [GO:0007398]; hippocampus development [GO:0021766]; lens fiber cell differentiation [GO:0070306]; mesoderm formation [GO:0001707]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of JAK-STAT cascade [GO:0046426]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of cell differentiation [GO:0045597]; positive regulation of stress fiber assembly [GO:0051496]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of gliogenesis [GO:0014013]; regulation of hippo signaling [GO:0035330]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of protein localization to nucleus [GO:1900180]; regulation of protein stability [GO:0031647]; regulation of stem cell proliferation [GO:0072091]; Schwann cell proliferation [GO:0014010],NA,NA,NA
CHOYP_MESD.1.1.m.52095,0.00492718513051948,-0.0163507251363249,No,NA,NA,A1L243,NA,NA,NA,endoplasmic reticulum [GO:0005783]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; protein folding [GO:0006457]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_MESH1.1.3.m.13824,-0.0115804084065325,0.00833688137358586,No,NA,NA,Q9D114,NA,NA,NA,guanosine-3';5'-bis(diphosphate) 3'-diphosphatase activity [GO:0008893]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_MEST.2.2.m.55065,-0.0219705113155133,-0.0103124739993693,No,NA,NA,Q6GQN0,NA,NA,NA,centriole [GO:0005814]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; tubulin-glutamic acid ligase activity [GO:0070740]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; protein polyglutamylation [GO:0018095]; protein transport [GO:0015031],NA,NA,NA
CHOYP_MET14.1.1.m.5073,-0.00900893660747469,0.00475888716244837,No,NA,NA,Q6NZ22,NA,NA,NA,nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; mRNA (N6-adenosine)-methyltransferase activity [GO:0001734]; mRNA binding [GO:0003729]; forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; mRNA destabilization [GO:0061157]; mRNA methylation [GO:0080009]; mRNA splicing; via spliceosome [GO:0000398]; RNA methylation [GO:0001510]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827],NA,NA,NA
CHOYP_MET14.1.1.m.5074,0.00484129627899433,0.0188573311968052,No,NA,NA,Q9Y6G5,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634],NA,NA,NA
CHOYP_MET23.1.1.m.14359,-0.0135725579708753,0.00388604629968508,No,NA,NA,Q6DJF8,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; methyltransferase activity [GO:0008168],NA,NA,NA
CHOYP_METEV_0975.1.1.m.28991,-0.0147108600321965,-0.00986790619070485,No,NA,NA,P82198,NA,NA,NA,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198],NA,NA,NA
CHOYP_METH.1.1.m.18095,0.00870638927497694,-0.0120636005794386,No,NA,NA,Q4JIJ3,NA,NA,NA,cytosol [GO:0005829]; cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]; pteridine-containing compound metabolic process [GO:0042558],NA,NA,NA
CHOYP_METK.1.2.m.3732,0.0127128516104235,-0.00120748035578107,No,NA,NA,Q2KJC6,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]; methionine catabolic process [GO:0009087]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556],NA,NA,NA
CHOYP_METTL15.1.1.m.14094,-0.00430894344577715,-0.00631540690244347,No,NA,NA,A6NJ78,NA,NA,NA,rRNA (cytosine-N4-)-methyltransferase activity [GO:0071424]; rRNA base methylation [GO:0070475],NA,NA,NA
CHOYP_MF.CPA.1.1.m.3630,0.0210929392237113,-0.0069952125428959,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MFAP4.3.3.m.62664,0.00794836056997581,0.00868907181398131,No,NA,NA,D8VNS8,NA,NA,NA,extracellular region [GO:0005576]; toxin activity [GO:0090729],NA,NA,NA
CHOYP_MGA.2.2.m.66484,-0.00064158134949589,-0.0168770662715927,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MGC154513.1.1.m.20908,-0.00840273371015235,-0.00411788782790586,No,NA,NA,Q9H9L4,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982],NA,NA,NA
CHOYP_MGC78792.1.1.m.45233,0.0142625430782866,-0.0160209475190275,No,NA,NA,Q08288,NA,NA,NA,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; photoreceptor outer segment [GO:0001750]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; erythrocyte development [GO:0048821]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of phagocytosis [GO:0050766]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_MGC81574.1.1.m.8983,0.00780936760919622,0.0156895900201885,No,NA,NA,Q91XN4,NA,NA,NA,integral component of membrane [GO:0016021]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_MGC82409.1.1.m.44657,-0.00947059193268288,-0.0104662497317868,No,NA,NA,P05689,NA,NA,NA,extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_MGC89016.1.2.m.76,0.0170565906705044,0.00604063266496913,No,NA,NA,Q03168,NA,NA,NA,lysosome [GO:0005764]; aspartic-type endopeptidase activity [GO:0004190],NA,NA,NA
CHOYP_MGN2.1.1.m.9330,0.00849992527534145,0.0151502638270916,No,NA,NA,Q96A72,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; exon-exon junction complex [GO:0035145]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing; via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; RNA export from nucleus [GO:0006405]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_MIB.2.3.m.30418,0.00223339568462975,-0.0174402597111554,No,NA,NA,Q8R412,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; nuclear inner membrane [GO:0005637]; aging [GO:0007568]; response to virus [GO:0009615],NA,NA,NA
CHOYP_MIB1.3.4.m.57545,-0.00673392578341152,0.0102124050118551,No,NA,NA,Q86YT6,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; blood vessel development [GO:0001568]; endocytosis [GO:0006897]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; negative regulation of neuron differentiation [GO:0045665]; neural tube formation [GO:0001841]; Notch signaling pathway [GO:0007219]; positive regulation of endocytosis [GO:0045807]; protein ubiquitination [GO:0016567]; somitogenesis [GO:0001756],NA,NA,NA
CHOYP_MIB1.4.4.m.64019,-0.00964079841144192,0.00925293613081418,No,NA,NA,Q5ZIJ9,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_MIB2.2.6.m.23029,0.00424599247943711,0.0236915614442701,No,NA,NA,Q5ZIJ9,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_MIB2.4.6.m.43287,-0.00337716445907012,0.00332265407701596,No,NA,NA,Q5ZIJ9,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_MIB2.5.6.m.43978,-0.00906066298502254,0.00100374205707602,No,NA,NA,Q5ZIJ9,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_MICPUCDRAFT_54866.2.4.m.37897,0.0118557338136706,0.0100969613198493,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MICPUCDRAFT_54866.4.4.m.57185,-0.0170073801279169,0.00143874100432214,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MICPUN_58704.1.1.m.54967,-0.0184915959028051,-0.0114668275545475,No,NA,NA,Q9Y5Z4,NA,NA,NA,azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; heme binding [GO:0020037]; negative regulation of mitochondrial membrane potential [GO:0010917]; neutrophil degranulation [GO:0043312]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of necrotic cell death [GO:0010940],NA,NA,NA
CHOYP_MIF.2.2.m.30795,0.00694129437940069,-0.00505604023186176,No,NA,NA,P80928,NA,NA,NA,cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular space [GO:0005615]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; chemoattractant activity [GO:0042056]; cytokine activity [GO:0005125]; cytokine receptor binding [GO:0005126]; dopachrome isomerase activity [GO:0004167]; identical protein binding [GO:0042802]; phenylpyruvate tautomerase activity [GO:0050178]; protease binding [GO:0002020]; cell aging [GO:0007569]; cell proliferation [GO:0008283]; cell surface receptor signaling pathway [GO:0007166]; DNA damage response; signal transduction by p53 class mediator [GO:0030330]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of cell aging [GO:0090344]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of cellular protein metabolic process [GO:0032269]; negative regulation of DNA damage response; signal transduction by p53 class mediator [GO:0043518]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of macrophage chemotaxis [GO:0010760]; negative regulation of mature B cell apoptotic process [GO:0002906]; negative regulation of myeloid cell apoptotic process [GO:0033033]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of myeloid leukocyte cytokine production involved in immune response [GO:0061081]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of prostaglandin secretion involved in immune response [GO:0061078]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of tumor necrosis factor production [GO:0032760]; prostaglandin biosynthetic process [GO:0001516]; protein homotrimerization [GO:0070207],NA,NA,NA
CHOYP_MINP1.1.1.m.13284,0.00274253118554467,-0.0214507979243074,No,NA,NA,Q9Z2L6,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; plasma membrane [GO:0005886]; acid phosphatase activity [GO:0003993]; bisphosphoglycerate 3-phosphatase activity [GO:0034417]; inositol hexakisphosphate 2-phosphatase activity [GO:0052826]; inositol phosphate phosphatase activity [GO:0052745]; inositol-1;3;4;5;6-pentakisphosphate 3-phosphatase activity [GO:0030351]; inositol-1;4;5;6-tetrakisphosphate 6-phosphatase activity [GO:0030352],NA,NA,NA
CHOYP_MINT.1.1.m.54605,-0.00556171696241082,-0.0103957114393194,No,NA,NA,Q8SX83,NA,NA,NA,nucleus [GO:0005634]; RNA binding [GO:0003723]; axon guidance [GO:0007411]; compound eye development [GO:0048749]; defense response to fungus [GO:0050832]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of thoracic bristle planar orientation [GO:0048106]; glial cell fate determination [GO:0007403]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; maintenance of imaginal disc-derived wing hair orientation [GO:0035321]; neuroblast fate determination [GO:0007400]; peripheral nervous system development [GO:0007422]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of transcription; DNA-templated [GO:0006355]; segment specification [GO:0007379]; transcription; DNA-templated [GO:0006351]; wing disc pattern formation [GO:0035222],NA,NA,NA
CHOYP_MK01.1.1.m.48878,0.00717305896225662,-0.0135219503317895,No,NA,NA,P26696,NA,NA,NA,cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; mitotic spindle assembly checkpoint [GO:0007094]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]; regulation of protein stability [GO:0031647]; response to epidermal growth factor [GO:0070849],NA,NA,NA
CHOYP_ML12B.1.1.m.27220,0.0217993136806887,-0.00442002026190256,No,NA,NA,Q09510,NA,NA,NA,cytoplasm [GO:0005737]; myosin complex [GO:0016459]; calcium ion binding [GO:0005509]; embryonic body morphogenesis [GO:0010172]; establishment of cell polarity [GO:0030010]; meiosis I cytokinesis [GO:0007110]; mitotic cytokinesis [GO:0000281]; nematode larval development [GO:0002119]; protein localization [GO:0008104],NA,NA,NA
CHOYP_MLE.4.9.m.38686,0.0197868216464391,0.00461215651603209,No,NA,NA,P05945,NA,NA,NA,myosin complex [GO:0016459]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_MLL.1.1.m.33426,0.00619959950557787,0.000710398787970373,No,NA,NA,O08550,NA,NA,NA,histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; zinc ion binding [GO:0008270]; gene silencing [GO:0016458]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 trimethylation [GO:0080182]; histone lysine methylation [GO:0034968]; memory [GO:0007613]; oocyte differentiation [GO:0009994]; ovarian follicle development [GO:0001541]; ovulation [GO:0030728]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_MLL3.2.3.m.25295,-0.0139195664708603,-0.00169954625452594,No,NA,NA,Q8NEZ4,NA,NA,NA,histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; transferase activity; transferring acyl groups [GO:0016746]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of megakaryocyte differentiation [GO:0045652],NA,NA,NA
CHOYP_MLP2.4.4.m.62619,0.0171139305282867,0.00531276034696568,No,NA,NA,Q24400,NA,NA,NA,nucleus [GO:0005634]; Z disc [GO:0030018]; metal ion binding [GO:0046872]; structural constituent of muscle [GO:0008307]; muscle organ development [GO:0007517]; muscle tissue development [GO:0060537]; regulation of establishment of planar polarity [GO:0090175]; sarcomere organization [GO:0045214],NA,NA,NA
CHOYP_MLRA.3.3.m.62296,-0.00595749248717768,0.00964936418702865,No,NA,NA,P04113,NA,NA,NA,myosin complex [GO:0016459]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_MMAC.1.1.m.8063,-0.0135975766413536,-0.00678128998571204,No,NA,NA,Q5ZL21,NA,NA,NA,cytoplasm [GO:0005737]; cyanocobalamin reductase (cyanide-eliminating) activity [GO:0033787]; demethylase activity [GO:0032451]; FAD binding [GO:0071949]; glutathione binding [GO:0043295]; oxidoreductase activity [GO:0016491]; cobalamin biosynthetic process [GO:0009236]; cobalamin metabolic process [GO:0009235]; demethylation [GO:0070988]; glutathione metabolic process [GO:0006749]; oxidation-reduction process [GO:0055114],NA,NA,NA
CHOYP_MMS19.1.1.m.18650,-0.00515096533273544,0.00289455507183749,No,NA,NA,Q0V9L1,NA,NA,NA,CIA complex [GO:0097361]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]; cellular response to DNA damage stimulus [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; iron-sulfur cluster assembly [GO:0016226]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; protein maturation by iron-sulfur cluster transfer [GO:0097428],NA,NA,NA
CHOYP_MNB.1.1.m.14023,-0.00464515028135442,0.00931169107419284,No,NA,NA,Q63470,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; tau protein binding [GO:0048156]; amyloid-beta formation [GO:0034205]; circadian rhythm [GO:0007623]; negative regulation of DNA damage response; signal transduction by p53 class mediator [GO:0043518]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of protein deacetylation [GO:0090312]; positive regulation of RNA splicing [GO:0033120]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],NA,NA,NA
CHOYP_MO25.1.1.m.62210,-0.000101712300388415,-0.0225176616834885,No,NA,NA,P91891,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; signal transduction by protein phosphorylation [GO:0023014],NA,NA,NA
CHOYP_MO4L1.1.1.m.8106,-0.0163722838690135,0.00275012245041588,No,NA,NA,Q9Y0I1,NA,NA,NA,histone acetyltransferase complex [GO:0000123]; histone methyltransferase complex [GO:0035097]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; enzyme regulator activity [GO:0030234]; methylated histone binding [GO:0035064]; chromatin silencing [GO:0006342]; chromosome organization [GO:0051276]; chromosome separation [GO:0051304]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone deacetylation [GO:0016575]; histone exchange [GO:0043486]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K36 methylation [GO:0000416],NA,NA,NA
CHOYP_MOB1.1.1.m.19452,0.00640282093910571,-0.0156140526638957,No,NA,NA,Q95RA8,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; apoptotic process [GO:0006915]; cell proliferation [GO:0008283]; chromosome segregation [GO:0007059]; hippo signaling [GO:0035329]; multicellular organism development [GO:0007275]; ovarian follicle cell development [GO:0030707]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_MON2.1.1.m.65761,-0.00651867157660303,-0.00131039389922424,No,NA,NA,Q7Z3U7,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031],NA,NA,NA
CHOYP_MONBRDRAFT_34536.1.1.m.30219,0.00182596358901601,-0.0144063876574156,No,NA,NA,A0KDV2,NA,NA,NA,L-rhamnonate dehydratase activity [GO:0050032]; magnesium ion binding [GO:0000287]; cellular amino acid catabolic process [GO:0009063],NA,NA,NA
CHOYP_MONBRDRAFT_34989.1.1.m.34385,-0.00907477234962416,0.00413090001364727,No,NA,NA,O18823,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; acyloxyacyl hydrolase activity [GO:0050528]; calcium ion binding [GO:0005509]; fatty acid metabolic process [GO:0006631]; lipopolysaccharide catabolic process [GO:0009104]; negative regulation of inflammatory response [GO:0050728],NA,NA,NA
CHOYP_MORC2.1.1.m.6240,-0.00225728202409095,0.0205628181595774,No,NA,NA,Q9Y6X9,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; zinc ion binding [GO:0008270]; fatty acid metabolic process [GO:0006631],NA,NA,NA
CHOYP_MORC3.1.2.m.38178,-0.0117266871285552,-0.00755982261361753,No,NA,NA,Q14149,NA,NA,NA,nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; PML body [GO:0016605]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cell aging [GO:0007569]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of fibroblast proliferation [GO:0048147]; peptidyl-serine phosphorylation [GO:0018105]; post-embryonic development [GO:0009791]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; viral process [GO:0016032],NA,NA,NA
CHOYP_MP2K4.1.1.m.10635,-0.00455187134340325,-0.0260490618606973,No,NA,NA,P47809,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; nucleus [GO:0005634]; perikaryon [GO:0043204]; ATP binding [GO:0005524]; JUN kinase kinase activity [GO:0008545]; MAP kinase kinase activity [GO:0004708]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of JUN kinase activity [GO:0007257]; activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; cell growth involved in cardiac muscle cell development [GO:0061049]; cellular response to mechanical stimulus [GO:0071260]; cellular response to sorbitol [GO:0072709]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; negative regulation of motor neuron apoptotic process [GO:2000672]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA replication [GO:0045740]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; protein phosphorylation [GO:0006468]; response to wounding [GO:0009611]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_MP2K5.1.1.m.45311,0.00837299892351145,-0.0144323816237999,No,NA,NA,Q13163,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; cellular response to growth factor stimulus [GO:0071363]; cellular response to laminar fluid shear stress [GO:0071499]; ERK5 cascade [GO:0070375]; heart development [GO:0007507]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of interleukin-8 biosynthetic process [GO:0045415]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of response to cytokine stimulus [GO:0060761]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of transcription by RNA polymerase II [GO:0045944]; signal transduction [GO:0007165]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_MP2K5.1.1.m.45312,0.0122590344996192,0.0084578499954666,No,NA,NA,P26446,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA binding [GO:0003677]; NAD binding [GO:0051287]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]; ATP generation from poly-ADP-D-ribose [GO:1990966]; double-strand break repair [GO:0006302]; peptidyl-serine ADP-ribosylation [GO:0018312]; protein poly-ADP-ribosylation [GO:0070212],NA,NA,NA
CHOYP_MP2K6.1.1.m.38188,0.022027843962005,0.00199373432970519,No,NA,NA,P52564,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; MAP kinase kinase activity [GO:0004708]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; cardiac muscle contraction [GO:0060048]; cell cycle arrest [GO:0007050]; cellular response to sorbitol [GO:0072709]; DNA damage induced protein phosphorylation [GO:0006975]; negative regulation of cold-induced thermogenesis [GO:0120163]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; ovulation cycle process [GO:0022602]; positive regulation of apoptotic process [GO:0043065]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of prostaglandin secretion [GO:0032308]; response to drug [GO:0042493]; response to ischemia [GO:0002931]; signal transduction [GO:0007165]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_MPDZ.3.3.m.51236,-0.00983678132494754,-0.0147454200523873,No,NA,NA,O75970,NA,NA,NA,apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; Schmidt-Lanterman incisure [GO:0043220]; protein C-terminus binding [GO:0008022]; cell adhesion [GO:0007155]; viral process [GO:0016032],NA,NA,NA
CHOYP_MPEG1.4.5.m.49975,0.00491588973115351,-0.000600714720400962,No,NA,NA,Q2KJC3,NA,NA,NA,integral component of membrane [GO:0016021]; defense response to bacterium [GO:0042742],NA,NA,NA
CHOYP_MPET_1013.1.2.m.36696,-0.0180007972537238,0.00308803892694665,No,NA,NA,Q5I0S8,NA,NA,NA,cytoplasm [GO:0005737]; extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of endopeptidase activity [GO:0010951],NA,NA,NA
CHOYP_MPHOSPH9.1.1.m.9795,-0.00109450535429442,-0.00535728533490497,No,NA,NA,A6H5Y1,NA,NA,NA,centriole [GO:0005814]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139],NA,NA,NA
CHOYP_MPI.1.1.m.35645,0.0105965695887315,0.00986666569693375,No,NA,NA,Q3SZI0,NA,NA,NA,cytoplasm [GO:0005737]; mannose-6-phosphate isomerase activity [GO:0004476]; zinc ion binding [GO:0008270]; carbohydrate metabolic process [GO:0005975]; cell wall mannoprotein biosynthetic process [GO:0000032]; GDP-mannose biosynthetic process [GO:0009298]; protein glycosylation [GO:0006486],NA,NA,NA
CHOYP_MPP2.1.1.m.62101,-0.00474434830132217,0.0178568103257681,No,NA,NA,D3ZAA9,NA,NA,NA,anchored component of postsynaptic density membrane [GO:0099031]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendritic shaft [GO:0043198]; dendritic spine membrane [GO:0032591]; glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069]; Schaffer collateral - CA1 synapse [GO:0098685]; ion channel binding [GO:0044325]; PDZ domain binding [GO:0030165]; structural constituent of postsynaptic density [GO:0098919]; excitatory postsynaptic potential [GO:0060079]; long-term synaptic potentiation [GO:0060291]; protein homooligomerization [GO:0051260],NA,NA,NA
CHOYP_MPPA.2.2.m.18272,0.00692697350016566,-0.0153210951360663,No,NA,NA,Q9DC61,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; protein processing involved in protein targeting to mitochondrion [GO:0006627]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_MPPA.2.2.m.18273,-0.0135725579708753,0.00388604629968508,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MPST.1.1.m.11853,-0.000316292811513957,-0.011151085107166,No,NA,NA,P97532,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; synapse [GO:0045202]; 3-mercaptopyruvate sulfurtransferase activity [GO:0016784]; identical protein binding [GO:0042802]; thiosulfate sulfurtransferase activity [GO:0004792]; hydrogen sulfide biosynthetic process [GO:0070814]; kidney development [GO:0001822]; liver development [GO:0001889]; spinal cord development [GO:0021510]; transsulfuration [GO:0019346],NA,NA,NA
CHOYP_MROH1.1.1.m.24366,-0.00930124263455479,-0.00362152410885571,No,NA,NA,Q8NDA8,NA,NA,NA,,NA,NA,NA
CHOYP_MRP1.10.10.m.64931,-0.0219669616881764,0.00446756579744832,No,NA,NA,Q8CG09,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; drug transmembrane transporter activity [GO:0015238]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; lipid-transporting ATPase activity [GO:0034040]; long-chain fatty acid transporter activity [GO:0005324]; oxidoreductase activity [GO:0016491]; sphingolipid transporter activity [GO:0046624]; xenobiotic transmembrane transporting ATPase activity [GO:0008559]; cell chemotaxis [GO:0060326]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of cell death [GO:0060548]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; positive regulation of drug transmembrane export [GO:1905701]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908],NA,NA,NA
CHOYP_MRP1.4.10.m.27993,0.00255794076571187,-0.0162295298440987,No,NA,NA,Q5F364,NA,NA,NA,basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; transmembrane transport [GO:0055085],NA,NA,NA
CHOYP_MRP1.5.10.m.34368,-0.015460089759643,-0.00896160936601306,No,NA,NA,Q8CG09,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; drug transmembrane transporter activity [GO:0015238]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; lipid-transporting ATPase activity [GO:0034040]; long-chain fatty acid transporter activity [GO:0005324]; oxidoreductase activity [GO:0016491]; sphingolipid transporter activity [GO:0046624]; xenobiotic transmembrane transporting ATPase activity [GO:0008559]; cell chemotaxis [GO:0060326]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of cell death [GO:0060548]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; positive regulation of drug transmembrane export [GO:1905701]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908],NA,NA,NA
CHOYP_MRPL42.1.1.m.61762,0.0164508374800733,-0.00638558611273271,No,NA,NA,Q9CPV3,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886],NA,NA,NA
CHOYP_MRPL45.1.1.m.11763,-0.00462085392868642,0.0104552511387354,No,NA,NA,Q3T142,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739],NA,NA,NA
CHOYP_MRPL55.1.1.m.1120,0.00364778592941831,-0.00872052841558097,No,NA,NA,P0C2B8,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_MRPS28.1.1.m.29259,-0.00908431654359693,0.00210415640228956,No,NA,NA,P82928,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763],NA,NA,NA
CHOYP_MRPS35.1.1.m.20118,-0.00379893987166211,-0.000321248726622379,No,NA,NA,Q2YDF6,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543],NA,NA,NA
CHOYP_MRRF.1.1.m.16730,0.0021760647582519,0.00863409944240565,No,NA,NA,Q0VCQ4,NA,NA,NA,mitochondrion [GO:0005739]; ribosomal large subunit binding [GO:0043023]; translation [GO:0006412],NA,NA,NA
CHOYP_MRT4.1.1.m.1698,0.00706127813824749,0.00729560004974078,No,NA,NA,Q9UKD2,NA,NA,NA,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; nuclear-transcribed mRNA catabolic process [GO:0000956]; ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_MSH2.1.1.m.18340,-0.00265359082416867,-0.0126102897700251,No,NA,NA,Q5XXB5,NA,NA,NA,chromosome [GO:0005694]; MutSalpha complex [GO:0032301]; ATP binding [GO:0005524]; mismatched DNA binding [GO:0030983]; cell cycle [GO:0007049]; mismatch repair [GO:0006298],NA,NA,NA
CHOYP_MSI2H.3.3.m.35858,-0.0180073804603589,-0.0186805152832455,No,NA,NA,Q9VVE5,NA,NA,NA,cytoplasm [GO:0005737]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; stem cell development [GO:0048864],NA,NA,NA
CHOYP_MSMB.4.5.m.40217,0.00644004014788323,0.00300378631118165,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MSRB3.1.4.m.4844,0.000307865044580649,-0.0241348670258318,No,NA,NA,Q5R930,NA,NA,NA,endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; L-methionine-(R)-S-oxide reductase activity [GO:0033745]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]; protein repair [GO:0030091]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_MSRB3.2.4.m.17278,-0.0169591047060434,0.00960206869202777,No,NA,NA,Q8BU85,NA,NA,NA,endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; L-methionine-(R)-S-oxide reductase activity [GO:0033745]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]; cellular response to oxidative stress [GO:0034599]; protein repair [GO:0030091],NA,NA,NA
CHOYP_MT.10.18.m.44063,-0.00100770880781328,0.00275564699232832,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MTA1.1.1.m.12640,-0.0139720909354455,-0.00924722749105352,No,NA,NA,Q13330,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; circadian regulation of gene expression [GO:0032922]; double-strand break repair [GO:0006302]; entrainment of circadian clock by photoperiod [GO:0043153]; histone deacetylation [GO:0016575]; locomotor rhythm [GO:0045475]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein autoubiquitination [GO:1902499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression; epigenetic [GO:0040029]; response to ionizing radiation [GO:0010212]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_MTAP.1.1.m.15433,-0.00187336812208009,-0.00713462667277247,No,NA,NA,Q7ZV22,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; S-methyl-5-thioadenosine phosphorylase activity [GO:0017061]; L-methionine salvage from methylthioadenosine [GO:0019509]; purine ribonucleoside salvage [GO:0006166],NA,NA,NA
CHOYP_MTBP.1.1.m.17026,0.00217997094733793,-0.00807271368859912,No,NA,NA,Q6NRW0,NA,NA,NA,cell cycle arrest [GO:0007050]; regulation of protein ubiquitination [GO:0031396],NA,NA,NA
CHOYP_MTHR.1.1.m.54596,0.00985970193445865,-0.0244510383906001,No,NA,NA,Q5I598,NA,NA,NA,cytosol [GO:0005829]; FAD binding [GO:0071949]; methylenetetrahydrofolate reductase (NAD(P)H) activity [GO:0004489]; methionine biosynthetic process [GO:0009086]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate interconversion [GO:0035999],NA,NA,NA
CHOYP_MTIF2.1.1.m.17935,-0.0115559871387034,-0.00375482878466485,No,NA,NA,P46198,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosomal small subunit binding [GO:0043024]; translation factor activity; RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; mitochondrial translational initiation [GO:0070124]; ribosome disassembly [GO:0032790],NA,NA,NA
CHOYP_MTMR9.1.1.m.26430,-0.00376303598416845,0.0202981536756518,No,NA,NA,Q9Z2D0,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein-containing complex [GO:0032991]; enzyme regulator activity [GO:0030234]; protein phosphatase binding [GO:0019903]; negative regulation of autophagy [GO:0010507]; positive regulation of phosphatase activity [GO:0010922]; protein stabilization [GO:0050821]; regulation of phosphatidylinositol dephosphorylation [GO:0060304],NA,NA,NA
CHOYP_MTNA.1.1.m.1717,-0.00792306839383672,0.00201280917302606,No,NA,NA,Q16I17,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; S-methyl-5-thioribose-1-phosphate isomerase activity [GO:0046523]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284],NA,NA,NA
CHOYP_MTNB.1.1.m.16051,0.0135811739536706,0.0235892558044849,No,NA,NA,Q96GX9,NA,NA,NA,cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; methylthioribulose 1-phosphate dehydratase activity [GO:0046570]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]; negative regulation of apoptotic process [GO:0043066]; protein homotetramerization [GO:0051289]; pyroptosis [GO:0070269]; regulation of ERK1 and ERK2 cascade [GO:0070372],NA,NA,NA
CHOYP_MTND.2.3.m.41824,0.00742557589541178,-0.0209256016369704,No,NA,NA,C3ZAH2,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; acireductone dioxygenase [iron(II)-requiring] activity [GO:0010309]; iron ion binding [GO:0005506]; L-methionine salvage from methylthioadenosine [GO:0019509]; methionine metabolic process [GO:0006555],NA,NA,NA
CHOYP_MTOR.2.2.m.51573,-0.0130057711513071,-0.0140445200607503,No,NA,NA,P42345,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; postsynaptic cytosol [GO:0099524]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; phosphoprotein binding [GO:0051219]; protein domain specific binding [GO:0019904]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ribosome binding [GO:0043022]; RNA polymerase III type 1 promoter DNA binding [GO:0001030]; RNA polymerase III type 2 promoter DNA binding [GO:0001031]; RNA polymerase III type 3 promoter DNA binding [GO:0001032]; TFIIIC-class transcription factor complex binding [GO:0001156]; translation regulator activity [GO:0045182]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; activation of protein kinase B activity [GO:0032148]; anoikis [GO:0043276]; brain development [GO:0007420]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cell aging [GO:0007569]; cell cycle arrest [GO:0007050]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to hypoxia [GO:0071456]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; cellular response to nutrient levels [GO:0031669]; cellular response to starvation [GO:0009267]; energy reserve metabolic process [GO:0006112]; germ cell development [GO:0007281]; heart morphogenesis [GO:0003007]; heart valve morphogenesis [GO:0003179]; long-term memory [GO:0007616]; maternal process involved in female pregnancy [GO:0060135]; mRNA stabilization [GO:0048255]; multicellular organism growth [GO:0035264]; negative regulation of autophagy [GO:0010507]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cell size [GO:0045792]; negative regulation of cholangiocyte apoptotic process [GO:1904193]; negative regulation of iodide transmembrane transport [GO:1904213]; negative regulation of macroautophagy [GO:0016242]; negative regulation of muscle atrophy [GO:0014736]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein ubiquitination [GO:0031397]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of cholangiocyte proliferation [GO:1904056]; positive regulation of cytoplasmic translational initiation [GO:1904690]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of eating behavior [GO:1904000]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of granulosa cell proliferation [GO:1904197]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron maturation [GO:0014042]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of sensory perception of pain [GO:1904058]; positive regulation of skeletal muscle hypertrophy [GO:1904206]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; positive regulation of translation [GO:0045727]; positive regulation of wound healing; spreading of epidermal cells [GO:1903691]; post-embryonic development [GO:0009791]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of brown fat cell differentiation [GO:0090335]; regulation of carbohydrate utilization [GO:0043610]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; regulation of cellular response to heat [GO:1900034]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of GTPase activity [GO:0043087]; regulation of macroautophagy [GO:0016241]; regulation of membrane permeability [GO:0090559]; regulation of myelination [GO:0031641]; regulation of osteoclast differentiation [GO:0045670]; regulation of response to food [GO:0032095]; regulation of translation at synapse; modulating synaptic transmission [GO:0099547]; response to activity [GO:0014823]; response to amino acid [GO:0043200]; response to cocaine [GO:0042220]; response to insulin [GO:0032868]; response to morphine [GO:0043278]; response to nutrient [GO:0007584]; ruffle organization [GO:0031529]; social behavior [GO:0035176]; spinal cord development [GO:0021510]; T-helper 1 cell lineage commitment [GO:0002296]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]; visual learning [GO:0008542]; voluntary musculoskeletal movement [GO:0050882]; wound healing [GO:0042060],NA,NA,NA
CHOYP_MTPN.2.2.m.58730,-0.0121354517505485,0.0023791984343317,No,NA,NA,Q55FM5,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex binding [GO:0044877]; actin cytoskeleton organization [GO:0030036]; negative regulation of barbed-end actin filament capping [GO:2000813],NA,NA,NA
CHOYP_MTR_027S0011.1.1.m.29241,-0.01023202684144,0.0102691864617718,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MTR_7G016900.1.1.m.39323,0.00109466423269599,0.00913869595493661,No,NA,NA,Q9FMB4,NA,NA,NA,HAUS complex [GO:0070652]; phragmoplast [GO:0009524]; spindle microtubule [GO:0005876]; microtubule minus-end binding [GO:0051011]; cell division [GO:0051301]; spindle assembly [GO:0051225],NA,NA,NA
CHOYP_MTR1.1.1.m.59840,-0.0133251727443144,-0.00841910048078279,No,NA,NA,Q803R5,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; mRNA (nucleoside-2'-O-)-methyltransferase activity [GO:0004483]; nucleic acid binding [GO:0003676]; 7-methylguanosine mRNA capping [GO:0006370]; cap1 mRNA methylation [GO:0097309]; mRNA methylation [GO:0080009],NA,NA,NA
CHOYP_MTSS1.1.1.1.m.41595,-0.00770661581884895,0.00361655542916494,No,NA,NA,O43312,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; ruffle [GO:0001726]; actin monomer binding [GO:0003785]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cellular response to fluid shear stress [GO:0071498]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; glomerulus morphogenesis [GO:0072102]; microspike assembly [GO:0030035]; negative regulation of epithelial cell proliferation [GO:0050680]; nephron tubule epithelial cell differentiation [GO:0072160]; plasma membrane organization [GO:0007009]; renal tubule morphogenesis [GO:0061333]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_MTX1.1.1.m.43691,0.00267808697558968,-0.016844164020351,No,NA,NA,Q27HK4,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial sorting and assembly machinery complex [GO:0001401]; protein transport [GO:0015031],NA,NA,NA
CHOYP_MUC1.1.5.m.5910,-0.0174182700574891,-0.0109506788568405,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MUC21.1.1.m.41811,-0.0127930754504569,-0.00846997180781757,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MUC4.1.1.m.41314,0.0181789035023961,-0.0111867389640773,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MUC5A.1.2.m.43407,0.0160962445290131,-0.00953857586580733,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MUC5AC.1.2.m.17430,0.00394536801625317,0.00291369700370642,No,NA,NA,O35276,NA,NA,NA,axon [GO:0030424]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic membrane [GO:0099055]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; semaphorin receptor activity [GO:0017154]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; angiogenesis [GO:0001525]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; cellular response to leukemia inhibitory factor [GO:1990830]; dorsal root ganglion morphogenesis [GO:1904835]; facial nerve structural organization [GO:0021612]; facioacoustic ganglion development [GO:1903375]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; negative chemotaxis [GO:0050919]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; outflow tract septum morphogenesis [GO:0003148]; regulation of postsynapse organization [GO:0099175]; semaphorin-plexin signaling pathway involved in neuron projection guidance [GO:1902285]; sensory neuron axon guidance [GO:0097374]; sympathetic ganglion development [GO:0061549]; sympathetic neuron projection extension [GO:0097490]; sympathetic neuron projection guidance [GO:0097491]; trigeminal ganglion development [GO:0061551]; ventral trunk neural crest cell migration [GO:0036486]; vestibulocochlear nerve structural organization [GO:0021649],NA,NA,NA
CHOYP_MUC5B.1.1.m.15734,-0.0169591047060434,0.00960206869202777,No,NA,NA,Q685J3,NA,NA,NA,apical plasma membrane [GO:0016324]; collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; extracellular matrix constituent; lubricant activity [GO:0030197]; PDZ domain binding [GO:0030165]; cellular homeostasis [GO:0019725]; O-glycan processing [GO:0016266]; stimulatory C-type lectin receptor signaling pathway [GO:0002223],NA,NA,NA
CHOYP_MUG2.1.1.m.55656,-0.00102406665651083,-0.0145339045480918,No,NA,NA,Q6IE52,NA,NA,NA,extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867],NA,NA,NA
CHOYP_MUTA.1.1.m.31799,-0.0163352514150138,-0.00829534663749285,No,NA,NA,P22033,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; cobalamin binding [GO:0031419]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methylmalonyl-CoA mutase activity [GO:0004494]; modified amino acid binding [GO:0072341]; protein homodimerization activity [GO:0042803]; cobalamin metabolic process [GO:0009235]; homocysteine metabolic process [GO:0050667]; positive regulation of GTPase activity [GO:0043547]; post-embryonic development [GO:0009791],NA,NA,NA
CHOYP_MVD1.1.1.m.28700,-0.00970380779854386,-0.00899821027674246,No,NA,NA,Q99JF5,NA,NA,NA,cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; diphosphomevalonate decarboxylase activity [GO:0004163]; Hsp70 protein binding [GO:0030544]; protein homodimerization activity [GO:0042803]; cholesterol biosynthetic process [GO:0006695]; isopentenyl diphosphate biosynthetic process; mevalonate pathway [GO:0019287]; isoprenoid biosynthetic process [GO:0008299]; positive regulation of cell proliferation [GO:0008284],NA,NA,NA
CHOYP_MVP.1.1.m.56230,-0.00645881137593168,0.0138530483220177,No,NA,NA,Q5EAJ7,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634],NA,NA,NA
CHOYP_MYBA.1.1.m.48052,0.00341285528281605,-0.00580760855573271,No,NA,NA,P10242,NA,NA,NA,nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to retinoic acid [GO:0071300]; chromatin remodeling [GO:0006338]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of hepatic stellate cell proliferation [GO:1904899]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K9 methylation [GO:0051574]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T-helper cell differentiation [GO:0045624]; positive regulation of testosterone secretion [GO:2000845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta production [GO:0071636]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of transcription; DNA-templated [GO:0006355]; response to hypoxia [GO:0001666],NA,NA,NA
CHOYP_MYBPP.1.1.m.45264,0.00364778592941831,-0.00872052841558096,No,NA,NA,Q8TBZ2,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; cell differentiation [GO:0030154]; chemical synaptic transmission [GO:0007268]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_MYBV.1.1.m.62683,0.00342052867940324,-0.000490419126409122,No,NA,NA,Q54P70,NA,NA,NA,cysteine-type peptidase activity [GO:0008234],NA,NA,NA
CHOYP_MYBX.3.4.m.53061,0.00364778592941831,-0.00872052841558097,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MYCB2.1.2.m.13017,0.0107843924732787,0.00815178364924947,No,NA,NA,O75592,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein homodimerization activity [GO:0042803]; Ran GTPase binding [GO:0008536]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; branchiomotor neuron axon guidance [GO:0021785]; central nervous system projection neuron axonogenesis [GO:0021952]; negative regulation of protein catabolic process [GO:0042177]; neuromuscular process [GO:0050905]; protein ubiquitination [GO:0016567]; regulation of axon guidance [GO:1902667]; regulation of cytoskeleton organization [GO:0051493]; regulation of protein localization [GO:0032880],NA,NA,NA
CHOYP_MYCBP2.1.1.m.27070,-0.0103712916717882,0.0168685310017092,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MYD88.2.7.m.21423,-0.014123166442939,0.0105713943913458,No,NA,NA,A8QMS7,NA,NA,NA,cytoplasm [GO:0005737]; TIR domain binding [GO:0070976]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123],NA,NA,NA
CHOYP_MYD88.4.7.m.31202,0.00394536801625317,0.00291369700370642,No,NA,NA,Q5XJ85,NA,NA,NA,cytoplasm [GO:0005737]; TIR domain binding [GO:0070976]; activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; monocyte activation [GO:0042117]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; neutrophil activation involved in immune response [GO:0002283]; neutrophil chemotaxis [GO:0030593]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of hematopoietic progenitor cell differentiation [GO:1901532]; response to molecule of bacterial origin [GO:0002237],NA,NA,NA
CHOYP_MYD88.5.7.m.41603,0.00205195042830453,-0.00934116934689426,No,NA,NA,Q99836,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; death receptor binding [GO:0005123]; identical protein binding [GO:0042802]; protein self-association [GO:0043621]; TIR domain binding [GO:0070976]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; apoptotic process [GO:0006915]; cell surface receptor signaling pathway [GO:0007166]; cellular response to mechanical stimulus [GO:0071260]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-23 production [GO:0032747]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of type I interferon production [GO:0032481]; regulation of inflammatory response [GO:0050727]; response to interleukin-1 [GO:0070555]; signal transduction [GO:0007165]; toll-like receptor 9 signaling pathway [GO:0034162]; toll-like receptor signaling pathway [GO:0002224]; type I interferon signaling pathway [GO:0060337],NA,NA,NA
CHOYP_MYEF2.1.1.m.18999,-0.0181039013491208,0.00336528547127341,No,NA,NA,Q8C854,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; ribonucleoprotein complex [GO:1990904]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; mRNA binding [GO:0003729]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of mRNA stability involved in response to oxidative stress [GO:2000815],NA,NA,NA
CHOYP_MYG1.1.1.m.4971,0.0015283814801178,-0.0081025875091683,No,NA,NA,Q9JK81,NA,NA,NA,mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; locomotory exploration behavior [GO:0035641],NA,NA,NA
CHOYP_MYO15.1.1.m.66281,-0.0103299990712134,-0.0193260907790191,No,NA,NA,Q9UKN7,NA,NA,NA,cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; myosin complex [GO:0016459]; stereocilium [GO:0032420]; actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; inner ear morphogenesis [GO:0042472]; locomotory behavior [GO:0007626]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_MYO16.4.4.m.65831,0.00388040044657063,0.0074822379255154,No,NA,NA,Q9Y6X6,NA,NA,NA,cytoplasm [GO:0005737]; myosin complex [GO:0016459]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; motor activity [GO:0003774]; cerebellum development [GO:0021549]; negative regulation of cell proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134],NA,NA,NA
CHOYP_MYO18.1.1.m.3952,0.00593990831430835,0.0157146230420289,No,NA,NA,Q92614,NA,NA,NA,actomyosin [GO:0042641]; cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; myosin complex [GO:0016459]; trans-Golgi network [GO:0005802]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; DNA metabolic process [GO:0006259]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030],NA,NA,NA
CHOYP_MYO1B.1.1.m.53598,-0.0103874318769151,-0.00840790423904721,No,NA,NA,P46735,NA,NA,NA,actin filament [GO:0005884]; apical part of cell [GO:0045177]; brush border [GO:0005903]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; filopodium [GO:0030175]; myosin complex [GO:0016459]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; motor activity [GO:0003774]; phosphatidylinositol-3;4;5-trisphosphate binding [GO:0005547]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; post-Golgi vesicle-mediated transport [GO:0006892]; transferrin transport [GO:0033572],NA,NA,NA
CHOYP_MYO1E.1.1.m.49109,-0.0113444441959971,-0.00334987393989447,No,NA,NA,Q12965,NA,NA,NA,actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; brush border [GO:0005903]; cell-cell junction [GO:0005911]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; myosin complex [GO:0016459]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATPase activity; coupled [GO:0042623]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; motor activity [GO:0003774]; phosphatidylinositol binding [GO:0035091]; actin filament-based movement [GO:0030048]; endocytosis [GO:0006897]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; glomerular visceral epithelial cell development [GO:0072015]; in utero embryonic development [GO:0001701]; nitrogen compound metabolic process [GO:0006807]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic hemopoiesis [GO:0035166]; vasculogenesis [GO:0001570],NA,NA,NA
CHOYP_MYO22.2.2.m.24750,0.00751347135836531,0.00926560298883019,No,NA,NA,Q9U1M8,NA,NA,NA,cell leading edge [GO:0031252]; cytosol [GO:0005829]; filopodium [GO:0030175]; membrane [GO:0016020]; myosin complex [GO:0016459]; phagocytic cup [GO:0001891]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; motor activity [GO:0003774]; protein self-association [GO:0043621]; actin filament-based movement [GO:0030048]; cell morphogenesis [GO:0000902]; cell-substrate adhesion [GO:0031589]; filopodium assembly [GO:0046847]; phagocytosis [GO:0006909]; spore germination [GO:0009847],NA,NA,NA
CHOYP_MYO3.2.2.m.59993,0.00488308046608381,-0.0113957982583247,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MYO3AL.1.1.m.8123,-0.0168687695777937,-0.000674662588887501,No,NA,NA,Q1EG27,NA,NA,NA,cytoplasm [GO:0005737]; filopodium tip [GO:0032433]; myosin complex [GO:0016459]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; stereocilium tip [GO:0032426]; actin binding [GO:0003779]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]; protein serine/threonine kinase activity [GO:0004674]; auditory receptor cell stereocilium organization [GO:0060088]; cochlea morphogenesis [GO:0090103]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of filopodium assembly [GO:0051491]; protein autophosphorylation [GO:0046777]; response to stimulus [GO:0050896]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601],NA,NA,NA
CHOYP_MYO5A.2.4.m.11575,0.00497263548419955,0.0109877210730848,No,NA,NA,Q9Y4I1,NA,NA,NA,actomyosin [GO:0042641]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium tip [GO:0032433]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; insulin-responsive compartment [GO:0032593]; intermediate filament [GO:0005882]; melanosome [GO:0042470]; membrane [GO:0016020]; microtubule plus-end [GO:0035371]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; photoreceptor outer segment [GO:0001750]; postsynapse [GO:0098794]; ruffle [GO:0001726]; smooth endoplasmic reticulum [GO:0005790]; unconventional myosin complex [GO:0016461]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; microfilament motor activity [GO:0000146]; Rab GTPase binding [GO:0017137]; RNA binding [GO:0003723]; actin filament-based movement [GO:0030048]; cellular response to insulin stimulus [GO:0032869]; chemical synaptic transmission [GO:0007268]; establishment of endoplasmic reticulum localization to postsynapse [GO:0099089]; exocytosis [GO:0006887]; hair follicle maturation [GO:0048820]; insulin secretion [GO:0030073]; locomotion involved in locomotory behavior [GO:0031987]; long-chain fatty acid biosynthetic process [GO:0042759]; melanin biosynthetic process [GO:0042438]; melanocyte differentiation [GO:0030318]; melanosome transport [GO:0032402]; myelination [GO:0042552]; odontogenesis [GO:0042476]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to plasma membrane [GO:0072659]; regulation of inositol 1;4;5-trisphosphate-sensitive calcium-release channel activity [GO:0031585]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; secretory granule localization [GO:0032252]; synapse organization [GO:0050808]; vesicle transport along actin filament [GO:0030050]; vesicle-mediated transport [GO:0016192]; visual perception [GO:0007601],NA,NA,NA
CHOYP_MYO6.1.1.m.4131,0.0020773866219555,0.00751975822530909,No,NA,NA,Q9UM54,NA,NA,NA,actin filament [GO:0005884]; apical part of cell [GO:0045177]; cell cortex [GO:0005938]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus [GO:0005902]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; RNA polymerase II; holoenzyme [GO:0016591]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; unconventional myosin complex [GO:0016461]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; minus-end directed microfilament motor activity [GO:0060001]; motor activity [GO:0003774]; actin filament-based movement [GO:0030048]; DNA damage response; signal transduction by p53 class mediator [GO:0030330]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of secretion [GO:0051046]; response to drug [GO:0042493]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_MYO7A.1.3.m.59205,0.00342145703947917,0.00207181093066336,No,NA,NA,Q17LW0,NA,NA,NA,cytoplasm [GO:0005737]; myosin complex [GO:0016459]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; imaginal disc-derived wing hair organization [GO:0035317]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_MYO7A.2.3.m.63360,0.0125334972621585,0.00571606210142734,No,NA,NA,Q17LW0,NA,NA,NA,cytoplasm [GO:0005737]; myosin complex [GO:0016459]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; imaginal disc-derived wing hair organization [GO:0035317]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_MYOF.3.3.m.53228,-0.00916746247796661,-0.00899452086006766,No,NA,NA,Q9ESD7,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; late endosome [GO:0005770]; membrane microdomain [GO:0098857]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; alpha-tubulin binding [GO:0043014]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; microtubule binding [GO:0008017]; phospholipid binding [GO:0005543]; angiogenesis [GO:0001525]; cellular response to osmotic stress [GO:0071470]; cytokine secretion [GO:0050663]; fat cell differentiation [GO:0045444]; glycerol metabolic process [GO:0006071]; lipid storage [GO:0019915]; macrophage activation involved in immune response [GO:0002281]; monocyte activation involved in immune response [GO:0002280]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein polyubiquitination [GO:1902915]; plasma membrane repair [GO:0001778]; positive regulation of cell adhesion [GO:0045785]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of neutrophil chemotaxis [GO:0090023]; regulation of calcium ion import [GO:0090279]; skeletal muscle tissue regeneration [GO:0043403]; T-tubule organization [GO:0033292]; vesicle fusion [GO:0006906],NA,NA,NA
CHOYP_MYPH.1.2.m.36560,0.009222433134119,0.00552412196586685,No,NA,NA,Q24799,NA,NA,NA,,NA,NA,NA
CHOYP_MYS.1.7.m.433,-0.010034244411087,0.00806185918571841,No,NA,NA,P24733,NA,NA,NA,myofibril [GO:0030016]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774],NA,NA,NA
CHOYP_MYS.1.7.m.435,-0.00355685493884137,-0.012280934681398,No,NA,NA,Q32LJ4,NA,NA,NA,calyx of Held [GO:0044305]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; regulation of synaptic transmission; glutamatergic [GO:0051966],NA,NA,NA
CHOYP_MYS.2.7.m.2064,0.00782151940647048,0.0157639227194391,No,NA,NA,Q2VJ60,NA,NA,NA,cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of membrane [GO:0016021]; microtubule organizing center [GO:0005815]; postsynapse [GO:0098794]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; regulation of protein catabolic process at postsynapse; modulating synaptic transmission [GO:0099576]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_MYS.2.7.m.2069,0.00367443530048908,0.00711547998681939,No,NA,NA,P24733,NA,NA,NA,myofibril [GO:0030016]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774],NA,NA,NA
CHOYP_MYS.2.7.m.2070,-0.00228509542130204,-0.0016864449070985,No,NA,NA,P24733,NA,NA,NA,myofibril [GO:0030016]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774],NA,NA,NA
CHOYP_MYS.2.7.m.2075,-0.00861249413694288,-0.00322354303975691,No,NA,NA,P24733,NA,NA,NA,myofibril [GO:0030016]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774],NA,NA,NA
CHOYP_MYS.4.7.m.18188,0.0180799226213361,0.0101801731341672,No,NA,NA,P24733,NA,NA,NA,myofibril [GO:0030016]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774],NA,NA,NA
CHOYP_MYS.7.7.m.44341,-0.0144960418089949,0.0112344653627246,No,NA,NA,P24733,NA,NA,NA,myofibril [GO:0030016]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774],NA,NA,NA
CHOYP_MYS3.1.2.m.31829,-0.022001056574476,0.00450301598008175,No,NA,NA,Q91ZR3,NA,NA,NA,mitochondrion [GO:0005739]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; negative regulation of gene expression; epigenetic [GO:0045814]; negative regulation of transcription; DNA-templated [GO:0045892]; regulation of DNA-binding transcription factor activity [GO:0051090]; response to virus [GO:0009615]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_MYSP.1.9.m.1097,0.00459589864698015,0.0202337579763049,No,NA,NA,O96064,NA,NA,NA,myofibril [GO:0030016]; myosin filament [GO:0032982]; motor activity [GO:0003774],NA,NA,NA
CHOYP_MYSP.1.9.m.1100,0.0167455110229768,5.30406935868422e-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MYSP.4.9.m.2302,0.00474440036624627,-0.0210478412008697,No,NA,NA,O96064,NA,NA,NA,myofibril [GO:0030016]; myosin filament [GO:0032982]; motor activity [GO:0003774],NA,NA,NA
CHOYP_MYSP.5.9.m.28124,0.0039394129979221,0.000493588977179596,No,NA,NA,O96064,NA,NA,NA,myofibril [GO:0030016]; myosin filament [GO:0032982]; motor activity [GO:0003774],NA,NA,NA
CHOYP_MYSP.8.9.m.44813,-0.00313276378965525,-0.00370488805318341,No,NA,NA,O96064,NA,NA,NA,myofibril [GO:0030016]; myosin filament [GO:0032982]; motor activity [GO:0003774],NA,NA,NA
CHOYP_MYSTI_04398.1.1.m.27734,-0.0225582172060778,0.00997720386834903,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_N2F1A.1.1.m.63063,0.0125784516372411,0.0200044319288679,No,NA,NA,Q06725,NA,NA,NA,nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; atrial cardiac muscle cell differentiation [GO:0055011]; cardiac atrium morphogenesis [GO:0003209]; endothelial cell proliferation [GO:0001935]; vasculature development [GO:0001944],NA,NA,NA
CHOYP_NAA15.1.1.m.34959,0.000918058155872833,-0.00242770066979887,No,NA,NA,Q9BXJ9,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; NatA complex [GO:0031415]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; N-terminal peptidyl-methionine acetylation [GO:0017196]; N-terminal protein amino acid acetylation [GO:0006474]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription; DNA-templated [GO:0045893]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_NAA25.1.1.m.11255,0.00393970990151316,-0.00411930517099053,No,NA,NA,Q14CX7,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; NatB complex [GO:0031416]; N-terminal peptidyl-methionine acetylation [GO:0017196],NA,NA,NA
CHOYP_NAA35.1.1.m.60092,-0.00726907374311483,0.00413698083541747,No,NA,NA,Q5ZHV2,NA,NA,NA,cytoplasm [GO:0005737]; NatC complex [GO:0031417]; peptide alpha-N-acetyltransferase activity [GO:0004596]; N-terminal peptidyl-methionine acetylation [GO:0017196]; N-terminal protein amino acid acetylation [GO:0006474]; negative regulation of apoptotic process [GO:0043066]; smooth muscle cell proliferation [GO:0048659],NA,NA,NA
CHOYP_NACA.2.9.m.11875,-0.000801319492858696,0.00604834418802217,No,NA,NA,Q8AWF2,NA,NA,NA,nascent polypeptide-associated complex [GO:0005854]; protein transport [GO:0015031],NA,NA,NA
CHOYP_NAEGRDRAFT_47557.1.1.m.11283,-0.0196535189760324,-0.00204743114905243,No,NA,NA,Q0VD31,NA,NA,NA,mitochondrial intermembrane space [GO:0005758]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_NAEGRDRAFT_49892.1.1.m.10608,0.00364778592941831,-0.00872052841558097,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NAEGRDRAFT_71860.1.1.m.2556,0.000686232728993107,-0.0107331332691118,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NAF1.1.1.m.13716,0.00205195042830452,-0.00934116934689426,No,NA,NA,Q52KK4,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; small nucleolar ribonucleoprotein complex [GO:0005732]; RNA binding [GO:0003723]; box H/ACA snoRNP assembly [GO:0000493]; pseudouridine synthesis [GO:0001522]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_NAGLU.2.2.m.60267,-0.00840691944260361,-0.00732888939355156,No,NA,NA,P54802,NA,NA,NA,extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; alpha-N-acetylglucosaminidase activity [GO:0004561]; cerebellar Purkinje cell layer development [GO:0021680]; glycosaminoglycan catabolic process [GO:0006027]; inner ear receptor cell development [GO:0060119]; locomotor rhythm [GO:0045475]; lysosome organization [GO:0007040]; middle ear morphogenesis [GO:0042474]; nervous system development [GO:0007399]; retinal rod cell development [GO:0046548],NA,NA,NA
CHOYP_NAGT1.1.1.m.8857,0.00941540975251574,0.0203276324288841,No,NA,NA,Q8VCV9,NA,NA,NA,apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; glucose transmembrane transporter activity [GO:0005355]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814],NA,NA,NA
CHOYP_NAS13.1.1.m.30415,-0.0115805313177979,-0.00372753356024931,No,NA,NA,P42674,NA,NA,NA,cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_NASP.2.4.m.13404,-0.00416301054291711,0.00235650078516451,No,NA,NA,Q02508,NA,NA,NA,nucleus [GO:0005634]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_NASP.4.4.m.56613,-0.00345046081190912,-0.0165601352438778,No,NA,NA,P49321,NA,NA,NA,cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; histone binding [GO:0042393]; protein-containing complex binding [GO:0044877]; blastocyst development [GO:0001824]; cell proliferation [GO:0008283]; CENP-A containing nucleosome assembly [GO:0034080]; DNA replication [GO:0006260]; DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336]; G1/S transition of mitotic cell cycle [GO:0000082]; histone exchange [GO:0043486]; male gonad development [GO:0008584]; nucleosome assembly [GO:0006334]; protein transport [GO:0015031]; response to testosterone [GO:0033574],NA,NA,NA
CHOYP_NAV2.1.3.m.9737,0.0057845557663657,-0.00568293782784543,No,NA,NA,Q8IVL1,NA,NA,NA,interstitial matrix [GO:0005614]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; heparin binding [GO:0008201]; glossopharyngeal nerve development [GO:0021563]; locomotory behavior [GO:0007626]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; optic nerve development [GO:0021554]; regulation of systemic arterial blood pressure by baroreceptor feedback [GO:0003025]; sensory perception of smell [GO:0007608]; sensory perception of sound [GO:0007605]; vagus nerve development [GO:0021564],NA,NA,NA
CHOYP_NBEL1.1.1.m.33217,0.00162398375949943,-0.0143612899121165,No,NA,NA,Q6ZS30,NA,NA,NA,,NA,NA,NA
CHOYP_NC2A.1.1.m.22786,-0.0169591047060434,0.00960206869202777,No,NA,NA,Q14919,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_NCAH.1.5.m.8672,-0.00662075517092642,-0.0068168100683545,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NCAH.3.5.m.51972,0.00501946385558127,-6.92348300906596e-05,No,NA,NA,P42325,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_NCBP2.1.1.m.60410,-0.0106093671393217,-0.00417198106318875,No,NA,NA,B4KCD5,NA,NA,NA,nuclear cap binding complex [GO:0005846]; nucleus [GO:0005634]; RNA cap binding [GO:0000339]; mRNA cis splicing; via spliceosome [GO:0045292]; negative regulation of viral genome replication [GO:0045071]; primary miRNA processing [GO:0031053]; production of siRNA involved in RNA interference [GO:0030422],NA,NA,NA
CHOYP_NCDN.1.1.m.58381,-0.00690969907973698,-0.0214269613690871,No,NA,NA,Q640K1,NA,NA,NA,cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; neuron projection development [GO:0031175],NA,NA,NA
CHOYP_NCER_101848.1.1.m.63547,-0.00310483374570488,0.00396353851017558,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NCKP1.1.4.m.24694,-0.000267098870083996,-0.00922092023515294,No,NA,NA,P28660,NA,NA,NA,filamentous actin [GO:0031941]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; postsynapse [GO:0098794]; ruffle [GO:0001726]; SCAR complex [GO:0031209]; protein-containing complex binding [GO:0044877]; apical protein localization [GO:0045176]; basal protein localization [GO:0045175]; cell migration [GO:0016477]; cell migration involved in gastrulation [GO:0042074]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; cortical actin cytoskeleton organization [GO:0030866]; embryonic body morphogenesis [GO:0010172]; embryonic foregut morphogenesis [GO:0048617]; embryonic heart tube development [GO:0035050]; endoderm development [GO:0007492]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; in utero embryonic development [GO:0001701]; lamellipodium assembly [GO:0030032]; mesodermal cell migration [GO:0008078]; neural tube closure [GO:0001843]; neuron projection morphogenesis [GO:0048812]; notochord development [GO:0030903]; notochord morphogenesis [GO:0048570]; paraxial mesoderm development [GO:0048339]; paraxial mesoderm morphogenesis [GO:0048340]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of lamellipodium assembly [GO:0010592]; protein stabilization [GO:0050821]; Rac protein signal transduction [GO:0016601]; regulation of protein localization [GO:0032880]; somitogenesis [GO:0001756]; zygotic determination of anterior/posterior axis; embryo [GO:0007354],NA,NA,NA
CHOYP_NCLIV_053520.1.1.m.8896,-0.00155225865705059,0.00991854490443303,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NCOA4.1.1.m.5549,0.00570429788106889,-0.0162174605074243,No,NA,NA,Q13772,NA,NA,NA,autolysosome [GO:0044754]; nucleus [GO:0005634]; androgen receptor binding [GO:0050681]; transcription coactivator activity [GO:0003713]; androgen receptor signaling pathway [GO:0030521]; cellular iron ion homeostasis [GO:0006879]; male gonad development [GO:0008584]; positive regulation of transcription; DNA-templated [GO:0045893]; protein targeting to lysosome [GO:0006622],NA,NA,NA
CHOYP_NCU02236.1.1.m.28628,-0.0169850955305058,-0.0159658031820791,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ND1.2.5.m.36938,0.014390694107645,0.0192252925048475,No,NA,NA,Q61425,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; NAD+ binding [GO:0070403]; fatty acid beta-oxidation [GO:0006635]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cold-induced thermogenesis [GO:0120162]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to insulin [GO:0032868],NA,NA,NA
CHOYP_ND1.4.5.m.42588,-9.75033826943452e-05,-0.0109677548513276,No,NA,NA,Q9ER88,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; structural constituent of ribosome [GO:0003735]; apoptotic mitochondrial changes [GO:0008637],NA,NA,NA
CHOYP_ND4.3.5.m.19536,-0.00779507413380653,-0.00112863261690674,No,NA,NA,F1LQ48,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; ribonucleoprotein complex [GO:1990904]; ribonucleoprotein granule [GO:0035770]; mRNA 3'-UTR binding [GO:0003730]; mRNA CDS binding [GO:1990715]; pre-mRNA intronic binding [GO:0097157]; transcription regulatory region DNA binding [GO:0044212]; cellular response to amino acid starvation [GO:0034198]; circadian rhythm [GO:0007623]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; response to peptide [GO:1901652],NA,NA,NA
CHOYP_NDK7.1.1.m.64883,-0.0203783001416884,0.00654866355402096,No,NA,NA,Q9Y5B8,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; UTP biosynthetic process [GO:0006228],NA,NA,NA
CHOYP_NDL1A.1.1.m.10230,-0.0024633675588957,0.00604645139365932,No,NA,NA,Q9CZA6,NA,NA,NA,centrosome [GO:0005813]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; spindle [GO:0005819]; spindle pole centrosome [GO:0031616]; synapse [GO:0045202]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904]; cell division [GO:0051301]; cell migration [GO:0016477]; centrosome duplication [GO:0051298]; centrosome localization [GO:0051642]; cerebral cortex development [GO:0021987]; chromosome segregation [GO:0007059]; establishment of chromosome localization [GO:0051303]; establishment of mitotic spindle orientation [GO:0000132]; forebrain development [GO:0030900]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic centrosome separation [GO:0007100]; neuroblast proliferation [GO:0007405]; neuron migration [GO:0001764]; regulation of microtubule motor activity [GO:2000574]; vesicle transport along microtubule [GO:0047496],NA,NA,NA
CHOYP_NDUA5.1.2.m.2750,-0.00430171976031552,0.00471163380450666,No,NA,NA,Q18359,NA,NA,NA,mitochondrial respiratory chain complex I [GO:0005747]; mitochondrial electron transport; NADH to ubiquinone [GO:0006120],NA,NA,NA
CHOYP_NDUFA7.2.2.m.57153,0.00307772918782929,0.00908865611688704,No,NA,NA,Q9Z1P6,NA,NA,NA,mitochondrial respiratory chain complex I [GO:0005747]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; structural constituent of ribosome [GO:0003735]; mitochondrial electron transport; NADH to ubiquinone [GO:0006120]; mitochondrial translation [GO:0032543],NA,NA,NA
CHOYP_NDUFB7.1.1.m.27222,-0.00727935283882329,-0.0167551325165986,No,NA,NA,P90789,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; respirasome [GO:0070469]; NADH dehydrogenase (ubiquinone) activity [GO:0008137],NA,NA,NA
CHOYP_NDUFS4.1.1.m.66417,-0.00398394235498237,-0.00901637807192859,No,NA,NA,P0CB96,NA,NA,NA,mitochondrial respiratory chain complex I [GO:0005747]; oxidoreductase activity; acting on NAD(P)H [GO:0016651]; brain development [GO:0007420]; cAMP-mediated signaling [GO:0019933]; cellular respiration [GO:0045333]; electron transport chain [GO:0022900]; mitochondrial respiratory chain complex I assembly [GO:0032981]; positive regulation of fibroblast proliferation [GO:0048146]; reactive oxygen species metabolic process [GO:0072593]; response to cAMP [GO:0051591],NA,NA,NA
CHOYP_NEC1.1.1.m.63094,-0.00798816646980796,0.00199340469020102,No,NA,NA,P28840,NA,NA,NA,axon terminus [GO:0043679]; dendrite [GO:0030425]; extracellular space [GO:0005615]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; rough endoplasmic reticulum [GO:0005791]; secretory granule [GO:0030141]; secretory granule lumen [GO:0034774]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]; chaperone binding [GO:0051087]; endopeptidase activity [GO:0004175]; insulin binding [GO:0043559]; protein-containing complex binding [GO:0044877]; serine-type endopeptidase activity [GO:0004252]; neurogenesis [GO:0022008]; pancreas development [GO:0031016]; peptide hormone processing [GO:0016486]; pituitary gland development [GO:0021983]; positive regulation of protein secretion [GO:0050714]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to axon injury [GO:0048678]; response to calcium ion [GO:0051592]; response to chlorate [GO:0010157]; response to drug [GO:0042493]; response to fatty acid [GO:0070542]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to inorganic substance [GO:0010035]; response to interleukin-1 [GO:0070555]; response to lipopolysaccharide [GO:0032496]; response to morphine [GO:0043278]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to peptide hormone [GO:0043434],NA,NA,NA
CHOYP_NECA3.1.1.m.106,-0.00798336082941489,-0.0140432420761671,No,NA,NA,Q9ESB5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; calcium ion binding [GO:0005509]; blastocyst hatching [GO:0001835]; regulation of amyloid precursor protein biosynthetic process [GO:0042984],NA,NA,NA
CHOYP_NECX.1.1.m.56979,-0.00601475219827041,0.00447267216414731,No,NA,NA,Q16982,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_NED4L.1.1.m.7792,-0.00204501101025871,-0.0145735532013086,No,NA,NA,Q62940,NA,NA,NA,cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; membrane raft [GO:0045121]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; protein C-terminus binding [GO:0008022]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; immune response [GO:0006955]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; neuromuscular junction development [GO:0007528]; neuron projection development [GO:0031175]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein targeting to lysosome [GO:0006622]; protein ubiquitination [GO:0016567]; receptor catabolic process [GO:0032801]; receptor internalization [GO:0031623]; regulation of dendrite morphogenesis [GO:0048814]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of protein catabolic process at postsynapse; modulating synaptic transmission [GO:0099576]; regulation of synapse organization [GO:0050807]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_NEDD1.1.1.m.10741,0.00370924177268864,-0.0187904514722212,No,NA,NA,P33215,NA,NA,NA,apical part of cell [GO:0045177]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; gamma-tubulin ring complex; centrosomal [GO:0000924]; pericentriolar material [GO:0000242]; spindle pole [GO:0000922]; cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule depolymerization [GO:0007019]; microtubule polymerization or depolymerization [GO:0031109]; protein localization to centrosome [GO:0071539]; regulation of establishment of protein localization [GO:0070201],NA,NA,NA
CHOYP_NEFH.1.2.m.59956,0.0063422437808558,-0.00676016556592867,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEK1.1.5.m.9137,-0.0152453476297712,0.0138226434964998,No,NA,NA,P51954,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of protein kinase activity [GO:0032147]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cilium assembly [GO:0060271]; DNA damage response; detection of DNA damage [GO:0042769]; kidney development [GO:0001822]; multicellular organism growth [GO:0035264]; protein phosphorylation [GO:0006468]; regulation of DNA damage checkpoint [GO:2000001]; response to ionizing radiation [GO:0010212]; signal transduction by protein phosphorylation [GO:0023014]; spermatogenesis [GO:0007283]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_NEK1.4.5.m.32116,-0.00602889040818041,0.0194640872216075,No,NA,NA,P51954,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of protein kinase activity [GO:0032147]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cilium assembly [GO:0060271]; DNA damage response; detection of DNA damage [GO:0042769]; kidney development [GO:0001822]; multicellular organism growth [GO:0035264]; protein phosphorylation [GO:0006468]; regulation of DNA damage checkpoint [GO:2000001]; response to ionizing radiation [GO:0010212]; signal transduction by protein phosphorylation [GO:0023014]; spermatogenesis [GO:0007283]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_NEK9.1.1.m.19497,-0.00755346120499613,-0.00191075579128918,No,NA,NA,Q8TD19,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; cell division [GO:0051301]; mitotic nuclear envelope disassembly [GO:0007077],NA,NA,NA
CHOYP_NELFB.1.2.m.9922,-0.00805817622162848,-0.00288754547602942,No,NA,NA,Q9Y113,NA,NA,NA,chromosome [GO:0005694]; NELF complex [GO:0032021]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; RNA binding [GO:0003723]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_NEMF.1.1.m.57807,-0.00159832304524873,0.00895265657240172,No,NA,NA,Q8CCP0,NA,NA,NA,nucleus [GO:0005634]; RQC complex [GO:1990112]; ribosomal large subunit binding [GO:0043023]; tRNA binding [GO:0000049]; nuclear export [GO:0051168]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G100691.1.2.m.26774,-0.0123436536853827,0.000691411648063393,No,NA,NA,F8WLE0,NA,NA,NA,intracellular [GO:0005622]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; mitochondrion organization [GO:0007005]; organelle transport along microtubule [GO:0072384],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G100691.2.2.m.65547,-0.00445483833454119,-0.00969944481038819,No,NA,NA,F8WLE0,NA,NA,NA,intracellular [GO:0005622]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; mitochondrion organization [GO:0007005]; organelle transport along microtubule [GO:0072384],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G106520.1.1.m.14881,-0.00483985743088122,-0.0243648783524809,No,NA,NA,P50532,NA,NA,NA,chromosome [GO:0005694]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein heterodimerization activity [GO:0046982]; cell division [GO:0051301]; mitotic chromosome condensation [GO:0007076],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G114289.1.1.m.17188,0.0115006160101552,0.00715205041779892,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G120119.1.2.m.6082,0.0143845567577656,-0.00166673992215331,No,NA,NA,P28825,NA,NA,NA,membrane [GO:0016020]; meprin A complex [GO:0017090]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G120526.4.5.m.36926,-0.00943904026716741,-0.0103748375858774,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G122785.1.1.m.57840,-0.0131025757453389,-0.0051166489548704,No,NA,NA,P33450,NA,NA,NA,apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis involved in differentiation [GO:0000904]; cell proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; equator specification [GO:0045317]; establishment of body hair planar orientation [GO:0048105]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; establishment of tissue polarity [GO:0007164]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; negative regulation of cell proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of organ growth [GO:0046621]; peptide cross-linking [GO:0018149]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251]; pupal development [GO:0035209]; regulation of growth [GO:0040008]; regulation of imaginal disc growth [GO:0045570]; regulation of protein localization [GO:0032880]; regulation of tube length; open tracheal system [GO:0035159]; tissue development [GO:0009888]; wing disc development [GO:0035220]; Wnt signaling pathway; planar cell polarity pathway [GO:0060071],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G122840.1.2.m.28819,0.00831760810329906,0.00679880982193452,No,NA,NA,Q4R7T5,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G135670.1.1.m.18689,-0.0171618301318949,0.0156976035875414,No,NA,NA,Q52I78,NA,NA,NA,cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]; cytokine activity [GO:0005125]; nicotinamide phosphoribosyltransferase activity [GO:0047280]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; circadian regulation of gene expression [GO:0032922]; NAD biosynthetic process [GO:0009435],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G140878.1.1.m.18069,-0.0123107019905224,-0.00300398217886659,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G141380.2.4.m.8974,0.00678620130084429,0.00878741825264137,No,NA,NA,P10079,NA,NA,NA,apical lamina of hyaline layer [GO:0032579]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G154303.1.1.m.3521,-0.00449995348720732,-0.0173223386021846,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G154974.1.1.m.44261,0.0159082951820671,-0.00387039915411325,No,NA,NA,Q9Y1A3,NA,NA,NA,mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; metal ion binding [GO:0046872]; P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]; chaperone-mediated protein transport [GO:0072321]; protein targeting to mitochondrion [GO:0006626],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G157638.1.1.m.31214,-0.00627299995108256,-0.0185328904804604,No,NA,NA,Q16820,NA,NA,NA,extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; meprin A complex [GO:0017090]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; inflammatory response [GO:0006954]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G157950.1.1.m.4584,0.00958575662353628,-0.00781972380562008,No,NA,NA,A2VD82,NA,NA,NA,,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G159364.1.1.m.22912,0.00524240792780121,-0.00212456580227655,No,NA,NA,P79781,NA,NA,NA,cytoplasm [GO:0005737]; cytosolic small ribosomal subunit [GO:0022627]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein tag [GO:0031386]; structural constituent of ribosome [GO:0003735]; ubiquitin protein ligase binding [GO:0031625]; DNA repair [GO:0006281]; modification-dependent protein catabolic process [GO:0019941]; protein ubiquitination [GO:0016567]; translation [GO:0006412],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G160170.1.1.m.66042,-0.0226648093180396,0.0103352540377106,No,NA,NA,P0DJG4,NA,NA,NA,,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G162365.1.1.m.8038,0.00951648695329293,-0.0107634418583035,No,NA,NA,Q7JZB4,NA,NA,NA,GTP binding [GO:0005525]; mannose-1-phosphate guanylyltransferase activity [GO:0004475]; GDP-mannose biosynthetic process [GO:0009298]; larval lymph gland hemopoiesis [GO:0035167],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G163820.1.1.m.6391,-0.00364493515046143,0.0155925550321968,No,NA,NA,Q5R5L3,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; oxidoreductase activity; acting on a sulfur group of donors; disulfide as acceptor [GO:0016671]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; protein folding in endoplasmic reticulum [GO:0034975]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G164392.1.3.m.46942,0.0165131216979328,0.0127214704219072,No,NA,NA,P46209,NA,NA,NA,hydrolase activity [GO:0016787],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G164392.3.3.m.59979,0.00615966897194063,0.00941964587728867,No,NA,NA,P46209,NA,NA,NA,hydrolase activity [GO:0016787],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G165338.1.1.m.60296,0.00384090648005012,0.0154444105391236,No,NA,NA,P60517,NA,NA,NA,actin cytoskeleton [GO:0015629]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cell body [GO:0044297]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; lysosome [GO:0005764]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; sperm midpiece [GO:0097225]; beta-tubulin binding [GO:0048487]; GABA receptor binding [GO:0050811]; microtubule binding [GO:0008017]; ubiquitin protein ligase binding [GO:0031625]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; microtubule cytoskeleton organization [GO:0000226]; protein transport [GO:0015031],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G165649.1.1.m.2893,0.0049188868561392,0.0156320416635418,No,NA,NA,Q6DF67,NA,NA,NA,cytoplasm [GO:0005737]; catalytic activity [GO:0003824],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G166546.1.1.m.10454,-0.0167934358547538,-0.00511800707911602,No,NA,NA,O35130,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; rRNA (pseudouridine) methyltransferase activity [GO:0070037]; rRNA binding [GO:0019843]; blastocyst development [GO:0001824]; nucleologenesis [GO:0017126]; rRNA base methylation [GO:0070475],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G167304.1.1.m.10864,0.00457208053485703,-0.00146678129700638,No,NA,NA,P49596,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; presynaptic active zone [GO:0048786]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; MAP kinase serine/threonine phosphatase activity [GO:1990439]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; ubiquitin protein ligase binding [GO:0031625]; cellular response to osmotic stress [GO:0071470]; negative regulation of axon extension [GO:0030517]; negative regulation of stress-activated MAPK cascade [GO:0032873]; positive regulation of synapse assembly [GO:0051965]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G167758.1.1.m.66572,-0.0125044158861841,0.0141062355590543,No,NA,NA,Q5PQQ6,NA,NA,NA,cytoplasm [GO:0005737]; manchette [GO:0002177]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126]; calmodulin binding [GO:0005516]; cilium organization [GO:0044782]; sperm axoneme assembly [GO:0007288]; spermatid development [GO:0007286],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G167835.1.1.m.6190,-0.00822894862861701,0.00830027630348187,No,NA,NA,Q567Y6,NA,NA,NA,cell [GO:0005623]; intraciliary transport particle B [GO:0030992]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G167853.1.2.m.20047,-0.0158458202146137,0.00582871327668133,No,NA,NA,A4FU69,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G168076.2.2.m.56942,-0.00399925055138941,-0.0172068078378081,No,NA,NA,Q54271,NA,NA,NA,phosphonopyruvate decarboxylase activity [GO:0033980]; thiamine pyrophosphate binding [GO:0030976]; antibiotic biosynthetic process [GO:0017000]; organic phosphonate biosynthetic process [GO:0032923],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G168163.1.1.m.63148,0.00910962639022146,0.0118463975215808,No,NA,NA,Q9Z2U1,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex; alpha-subunit complex [GO:0019773]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G168923.1.1.m.29344,0.000353958746973661,-0.00180274264548552,No,NA,NA,O95825,NA,NA,NA,cytosol [GO:0005829]; NADP binding [GO:0050661]; NADPH:quinone reductase activity [GO:0003960]; quinone metabolic process [GO:1901661],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G169195.1.1.m.2476,-0.0071285251927305,0.00785239270184257,No,NA,NA,P50174,NA,NA,NA,cytoplasm [GO:0005737]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; poly-hydroxybutyrate biosynthetic process [GO:0042619],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G169538.1.2.m.18155,-0.0107200673363741,0.000950374419244518,No,NA,NA,O05218,NA,NA,NA,glutathione hydrolase activity [GO:0036374]; hypoglycin A gamma-glutamyl transpeptidase activity [GO:0102953]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; glutathione catabolic process [GO:0006751],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G169538.2.2.m.29703,0.011190859534628,-0.00272498808022706,No,NA,NA,O05218,NA,NA,NA,glutathione hydrolase activity [GO:0036374]; hypoglycin A gamma-glutamyl transpeptidase activity [GO:0102953]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; glutathione catabolic process [GO:0006751],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G171044.1.1.m.44527,0.00884125360806946,0.00430518362042762,No,NA,NA,Q62356,NA,NA,NA,extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; response to starvation [GO:0042594],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G173323.2.2.m.55211,0.00808713749474714,-0.00027799712698531,No,NA,NA,P28075,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex; beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G173435.1.1.m.37344,-0.00841269142588089,0.00541352578443528,No,NA,NA,Q711T7,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; glutaminase activity [GO:0004359]; NAD+ synthase (glutamine-hydrolyzing) activity [GO:0003952]; NAD+ synthase activity [GO:0008795]; NAD biosynthetic process [GO:0009435],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G173950.1.1.m.13511,0.00932091495204911,0.00135050218557694,No,NA,NA,O62742,NA,NA,NA,mitochondrion [GO:0005739]; peroxisome [GO:0005777]; lipid binding [GO:0008289]; propanoyl-CoA C-acyltransferase activity [GO:0033814]; lipid transport [GO:0006869],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G173950.1.1.m.13512,-0.00443627522796517,-0.0094106208139062,No,NA,NA,Q6PAY8,NA,NA,NA,peroxisome [GO:0005777]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G179696.1.1.m.40556,0.0135604706132561,-0.00121373024572137,No,NA,NA,P18426,NA,NA,NA,structural constituent of eye lens [GO:0005212],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G179716.1.1.m.55972,-0.00209852401187085,-0.00317805256398309,No,NA,NA,P15651,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; acyl-CoA dehydrogenase activity [GO:0003995]; butyryl-CoA dehydrogenase activity [GO:0004085]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; butyrate catabolic process [GO:0046359]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; protein homotetramerization [GO:0051289]; response to glucocorticoid [GO:0051384]; response to starvation [GO:0042594],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G180651.1.2.m.2808,0.000595082875756743,-0.00656254471197702,No,NA,NA,P06797,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; lysosome [GO:0005764]; microvillus [GO:0005902]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; vacuole [GO:0005773]; aminopeptidase activity [GO:0004177]; cysteine-type carboxypeptidase activity [GO:0016807]; cysteine-type endopeptidase activity [GO:0004197]; histone binding [GO:0042393]; kininogen binding [GO:0030984]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; autophagic cell death [GO:0048102]; cell communication [GO:0007154]; cellular response to starvation [GO:0009267]; decidualization [GO:0046697]; hair follicle morphogenesis [GO:0031069]; male gonad development [GO:0008584]; multicellular organism aging [GO:0010259]; negative regulation of keratinocyte proliferation [GO:0010839]; nerve development [GO:0021675]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to gonadotropin [GO:0034698]; response to organic cyclic compound [GO:0014070]; Sertoli cell differentiation [GO:0060008]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G181421.1.1.m.3106,-0.00481740687837812,0.0219723212249053,No,NA,NA,P30837,NA,NA,NA,intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; aldehyde dehydrogenase (NAD) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; NAD binding [GO:0051287]; carbohydrate metabolic process [GO:0005975]; ethanol catabolic process [GO:0006068]; ethanol oxidation [GO:0006069],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G182319.1.1.m.5048,-0.00602640895055571,-0.0200080675098718,No,NA,NA,Q5ZIE6,NA,NA,NA,cytoplasm [GO:0005737]; NEDD8 activating enzyme activity [GO:0019781]; protein modification by small protein conjugation [GO:0032446]; protein neddylation [GO:0045116],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G183894.1.1.m.55454,-0.0111312232186858,-0.00541630978394539,No,NA,NA,A5A6H9,NA,NA,NA,mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity [GO:0003863]; alpha-ketoacid dehydrogenase activity [GO:0003826]; metal ion binding [GO:0046872]; branched-chain amino acid catabolic process [GO:0009083],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G185623.1.1.m.62696,-0.00479518148350022,-0.0020963605368443,No,NA,NA,Q54TR1,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; negative regulation of asexual reproduction [GO:1903665]; positive regulation of chemorepellent activity [GO:1903669]; protein localization to plasma membrane [GO:0072659]; proteolysis involved in cellular protein catabolic process [GO:0051603]; sorocarp morphogenesis [GO:0031288]; sporulation resulting in formation of a cellular spore [GO:0030435],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G188927.1.1.m.17076,-0.000248955772282693,-0.00616780852357959,No,NA,NA,O05389,NA,NA,NA,oxidoreductase activity [GO:0016491]; NADPH regeneration [GO:0006740],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G188942.1.1.m.6629,0.0204346635322544,-0.00624013906203739,No,NA,NA,Q9WUA2,NA,NA,NA,phenylalanine-tRNA ligase complex [GO:0009328]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723]; phenylalanyl-tRNA aminoacylation [GO:0006432]; protein heterotetramerization [GO:0051290],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G191841.1.1.m.1745,-0.00699419731711613,-0.00665652997736758,No,NA,NA,P24367,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; protein-containing complex [GO:0032991]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; unfolded protein binding [GO:0051082]; chaperone-mediated protein folding [GO:0061077]; negative regulation of collagen fibril organization [GO:1904027]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G192713.1.1.m.16224,0.00472849649697695,-0.0155927210106792,No,NA,NA,O88696,NA,NA,NA,endopeptidase Clp complex [GO:0009368]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP-dependent peptidase activity [GO:0004176]; ATPase binding [GO:0051117]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; protein homooligomerization [GO:0051260]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G193373.1.2.m.19292,0.00615966897194063,0.00941964587728867,No,NA,NA,Q80VI1,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; interferon-beta production [GO:0032608]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral release from host cell [GO:1902187]; protein K63-linked ubiquitination [GO:0070534]; response to type I interferon [GO:0034340],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G194582.1.2.m.11442,0.0142121526247423,-0.0109871108885239,No,NA,NA,Q8WPW2,NA,NA,NA,pyridoxal 5'-phosphate synthase (glutamine hydrolysing) activity [GO:0036381]; pyridoxal phosphate biosynthetic process [GO:0042823],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G194582.2.2.m.40726,-0.00960419074413277,-0.00303575092680886,No,NA,NA,P23606,NA,NA,NA,intrinsic component of membrane [GO:0031224]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; keratinization [GO:0031424]; peptide cross-linking [GO:0018149]; positive regulation of cell cycle [GO:0045787]; positive regulation of keratinocyte proliferation [GO:0010838],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G197278.1.1.m.45568,0.00509165516471352,0.00202110846761566,No,NA,NA,A6X391,NA,NA,NA,carboxylic ester hydrolase activity [GO:0052689]; deacetylase activity [GO:0019213]; hydrolase activity; acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G197314.1.2.m.61420,0.00162254255536586,0.0212476627451456,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G198667.1.15.m.3453,0.0065883263884642,0.0180931628217626,No,NA,NA,B3EWZ6,NA,NA,NA,extracellular region [GO:0005576]; membrane [GO:0016020],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G198667.12.15.m.51327,0.00615966897194063,0.00941964587728867,No,NA,NA,B3EWZ5,NA,NA,NA,extracellular region [GO:0005576]; membrane [GO:0016020],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G198667.14.15.m.61843,0.019363507040686,-0.00706280248191599,No,NA,NA,B3EWZ6,NA,NA,NA,extracellular region [GO:0005576]; membrane [GO:0016020],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G198846.1.1.m.25649,0.00469183560363764,-0.0151406972829952,No,NA,NA,Q8R2L5,NA,NA,NA,mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G198897.2.6.m.4748,-0.000773442469023039,0.0215796107425808,No,NA,NA,Q56R14,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G198897.4.6.m.52548,0.00657430257227144,0.00154024151918258,No,NA,NA,Q6PFY8,NA,NA,NA,cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G199721.1.1.m.64387,0.0063797794420908,-0.0240940842702323,No,NA,NA,Q9UGM1,NA,NA,NA,acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; cholinergic synapse [GO:0098981]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; calcium channel activity [GO:0005262]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; inner ear morphogenesis [GO:0042472]; ion transmembrane transport [GO:0034220]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; nervous system process [GO:0050877]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G201445.4.5.m.54666,-0.0225627976412991,0.00998523396323424,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G201552.1.6.m.2876,0.00394536801625317,0.00291369700370642,No,NA,NA,Q04786,NA,NA,NA,beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; polysaccharide binding [GO:0030247]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G201552.4.6.m.22239,0.00205195042830452,-0.00934116934689426,No,NA,NA,P13670,NA,NA,NA,cell outer membrane [GO:0009279]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; polysaccharide binding [GO:0030247]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G202687.1.1.m.8886,-0.0116713114397214,-0.00260307958229345,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G203842.1.1.m.60812,-0.0149498897774734,-0.00422287201379378,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G203842.1.1.m.60815,0.00814216357155036,0.0062518918720636,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G204928.1.2.m.15590,0.00801963014085126,-0.00984240038665278,No,NA,NA,Q9R013,NA,NA,NA,extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G204928.2.2.m.27972,0.0131582260175059,-0.000460265155833388,No,NA,NA,Q9R013,NA,NA,NA,extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G206150.1.1.m.39762,0.00177807865294895,0.00891003377263253,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G206950.1.1.m.37574,0.00669044115803802,-0.0088530470831783,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G208725.1.1.m.36498,-0.0224171358219721,0.00976948507527685,No,NA,NA,Q2KIR0,NA,NA,NA,,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G212280.3.3.m.30224,0.0113684613863582,0.00760194588246646,No,NA,NA,E7FAM5,NA,NA,NA,P-body [GO:0000932]; miRNA binding [GO:0035198]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; embryonic body morphogenesis [GO:0010172]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of gene silencing by miRNA [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G212312.2.5.m.45586,-0.0025595238370759,0.0107418497530293,No,NA,NA,Q8K0U4,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G214844.22.34.m.54623,-0.0169591047060434,0.00960206869202778,No,NA,NA,Q9D9R9,NA,NA,NA,,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G214844.25.34.m.55918,0.00657643312707714,0.0015080701571724,No,NA,NA,Q8N2E2,NA,NA,NA,cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G214844.29.34.m.57719,-0.00104968929445307,-0.0145197347388496,No,NA,NA,Q6DFV8,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G214844.9.34.m.28637,0.00364778592941831,-0.00872052841558097,No,NA,NA,Q8N2E2,NA,NA,NA,cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G214960.1.1.m.2485,0.0151981926160029,-0.00104710765873766,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G215851.2.2.m.18129,-0.0147895284114023,0.00445795310551771,No,NA,NA,Q49A92,NA,NA,NA,,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G218264.11.14.m.51529,0.00205195042830452,-0.00934116934689427,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G218914.4.4.m.62116,0.0095564284449158,0.0134504284715859,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G221088.1.1.m.66380,-0.0222031810525165,0.00952033066286353,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G221688.1.1.m.52819,0.00148858510176863,0.0024755716602738,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G224038.3.5.m.31061,-0.0157513404827208,0.00117464617778333,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G224038.4.5.m.31140,-0.0197030712738254,0.000621759681733948,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G224038.5.5.m.50649,0.00729945716400231,0.00577354515623262,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G224392.2.3.m.36325,-0.0103472030067844,-0.00257207397022292,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G226328.1.1.m.11691,0.0108366126941168,-0.0140373429423931,No,NA,NA,Q8IVN8,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular matrix structural constituent [GO:0005201]; polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044]; immune response [GO:0006955],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G229510.4.4.m.47762,-0.00102930922574105,0.00287867838119595,No,NA,NA,Q03650,NA,NA,NA,ciliary pocket [GO:0020016]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endocytosis [GO:0006897],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G230495.1.1.m.61211,0.0160636858859913,-0.00683651515327702,No,NA,NA,P52209,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; NADP binding [GO:0050661]; phosphogluconate dehydrogenase (decarboxylating) activity [GO:0004616]; D-gluconate metabolic process [GO:0019521]; oxidation-reduction process [GO:0055114]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt; oxidative branch [GO:0009051],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G232294.1.1.m.22465,0.0152053356322757,-0.0025544673741638,No,NA,NA,P16230,NA,NA,NA,sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G233184.1.1.m.18285,-0.00986709835232569,-0.0180660325460791,No,NA,NA,Q5RC69,NA,NA,NA,dCMP deaminase activity [GO:0004132]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]; nucleotide biosynthetic process [GO:0009165]; pyrimidine nucleotide metabolic process [GO:0006220],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G233709.6.13.m.49823,-0.0116049365836335,-0.00370022917258378,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G233709.8.13.m.55781,0.00459915960935814,0.0109625537177384,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G234225.1.1.m.49490,0.0201894540529033,0.00878369345149555,No,NA,NA,O77834,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; calcium-independent phospholipase A2 activity [GO:0047499]; glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; phospholipase A2 activity (consuming 1;2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1;2-dioleoylphosphatidylethanolamine) [GO:0102568]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerophospholipid catabolic process [GO:0046475]; hydrogen peroxide catabolic process [GO:0042744]; positive regulation of mRNA splicing; via spliceosome [GO:0048026]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G235461.1.1.m.28341,0.0114347593545289,-0.00432902024126802,No,NA,NA,Q8MP06,NA,NA,NA,extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; N;N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; senecionine N-oxygenase activity [GO:0033784]; alkaloid metabolic process [GO:0009820]; oxidation-reduction process [GO:0055114]; protein homotetramerization [GO:0051289],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G235656.1.1.m.19147,-0.0146542065107856,-0.00838808308893239,No,NA,NA,Q9CQ62,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 2;4-dienoyl-CoA reductase (NADPH) activity [GO:0008670]; NADPH binding [GO:0070402]; fatty acid beta-oxidation [GO:0006635]; positive regulation of cold-induced thermogenesis [GO:0120162]; protein homotetramerization [GO:0051289],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G235656.1.1.m.19149,-0.0083256776169446,0.00545493158522004,No,NA,NA,Q8CEI1,NA,NA,NA,mitochondrion [GO:0005739],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G235970.1.1.m.34141,-0.0160330037393815,-0.0134594566984563,No,NA,NA,Q6DGA6,NA,NA,NA,allantoicase activity [GO:0004037]; allantoin catabolic process [GO:0000256]; purine nucleobase metabolic process [GO:0006144],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G236573.1.2.m.46431,0.00826386211775094,0.00897202970239135,No,NA,NA,P74148,NA,NA,NA,,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G236573.2.2.m.47233,-0.00635418590993168,-0.000903208950510789,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G236653.1.1.m.59422,-0.0121978009700063,0.00236177590223459,No,NA,NA,Q8VBT9,NA,NA,NA,cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extrinsic component of membrane [GO:0019898]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; glucose homeostasis [GO:0042593]; intracellular protein transport [GO:0006886]; positive regulation of protein modification process [GO:0031401]; regulation of glucose import [GO:0046324],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G236658.3.6.m.24704,-0.00128332533500467,0.019551611122044,No,NA,NA,P74148,NA,NA,NA,,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G236658.4.6.m.30181,-0.00999438786616564,-0.020598320803245,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G236658.5.6.m.34525,0.0115951944582532,0.0119550570219358,No,NA,NA,O07552,NA,NA,NA,,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G237029.1.1.m.64370,0.000185221161484493,0.00366949847899844,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G237545.1.1.m.34853,0.000529957602491529,0.0205281037625243,No,NA,NA,Q4KM33,NA,NA,NA,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; phosphatidylinositol-3;4-bisphosphate binding [GO:0043325]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; actin cytoskeleton reorganization [GO:0031532]; cortical actin cytoskeleton organization [GO:0030866]; hematopoietic progenitor cell differentiation [GO:0002244]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of inositol phosphate biosynthetic process [GO:0010920]; phosphatidylinositol metabolic process [GO:0046488]; phospholipase C-inhibiting G protein-coupled receptor signaling pathway [GO:0030845]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of actin filament depolymerization [GO:0030836]; positive regulation of inositol-polyphosphate 5-phosphatase activity [GO:0010925]; positive regulation of integrin activation [GO:0033625]; positive regulation of platelet activation [GO:0010572]; protein kinase C signaling [GO:0070528]; protein secretion by platelet [GO:0070560]; regulation of cell diameter [GO:0060305]; ruffle organization [GO:0031529]; thrombin-activated receptor signaling pathway [GO:0070493]; vesicle docking involved in exocytosis [GO:0006904],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G237598.1.1.m.11619,0.0067064210523228,-0.0115688270096809,No,NA,NA,P38942,NA,NA,NA,transferase activity [GO:0016740]; acetyl-CoA metabolic process [GO:0006084],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G237629.1.1.m.24486,0.0186992676832946,0.00393300914612283,No,NA,NA,Q96PM5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; error-free translesion synthesis [GO:0070987]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G237797.1.1.m.40688,0.00615966897194063,0.00941964587728867,No,NA,NA,Q9BW85,NA,NA,NA,U2-type catalytic step 1 spliceosome [GO:0071006]; mRNA processing [GO:0006397]; negative regulation of DNA damage response; signal transduction by p53 class mediator [GO:0043518]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G237881.1.1.m.10098,-0.00996226831873169,-0.0122135231874413,No,NA,NA,Q5C9L6,NA,NA,NA,cytoplasm [GO:0005737]; (S)-coclaurine-N-methyltransferase activity [GO:0030794],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G238062.3.6.m.5146,0.0193163407489884,-0.0121977295409179,No,NA,NA,P86854,NA,NA,NA,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G238590.1.1.m.49168,-0.00501741568965723,0.0174791962607519,No,NA,NA,Q9QUM7,NA,NA,NA,mismatch repair complex [GO:0032300]; nucleoplasm [GO:0005654]; synaptonemal complex [GO:0000795]; ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; DNA-dependent ATPase activity [GO:0008094]; mismatched DNA binding [GO:0030983]; chiasma assembly [GO:0051026]; female gamete generation [GO:0007292]; homologous chromosome segregation [GO:0045143]; meiosis I [GO:0007127]; mismatch repair [GO:0006298]; reciprocal meiotic recombination [GO:0007131]; synapsis [GO:0007129],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G238593.1.1.m.8407,0.00364778592941831,-0.00872052841558096,No,NA,NA,Q6UPR8,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; ovarian follicle development [GO:0001541],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G238894.7.11.m.61041,0.0110019259967311,0.0190840213350534,No,NA,NA,Q6PDJ1,NA,NA,NA,voltage-gated calcium channel complex [GO:0005891]; voltage-gated calcium channel activity [GO:0005245],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G239043.2.6.m.4886,-0.00527331034145011,0.00601078797758732,No,NA,NA,B3EWZ5,NA,NA,NA,extracellular region [GO:0005576]; membrane [GO:0016020],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G240471.1.1.m.10922,-0.0229173823438651,0.00575084776286853,No,NA,NA,Q8K4F6,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]; rRNA base methylation [GO:0070475],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G240563.1.3.m.5221,-0.00212399304730485,-0.00426281624655957,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G240563.3.3.m.30812,-0.00258774428332425,-0.0105791408389596,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G240887.2.2.m.37649,0.00205195042830452,-0.00934116934689426,No,NA,NA,Q9CPU4,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; organelle membrane [GO:0031090]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; leukotriene-C4 synthase activity [GO:0004464]; leukotriene biosynthetic process [GO:0019370]; lipid metabolic process [GO:0006629]; response to organonitrogen compound [GO:0010243],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G241267.1.1.m.7467,0.00205195042830452,-0.00934116934689426,No,NA,NA,Q6PDZ2,NA,NA,NA,fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I transcription factor complex [GO:0000120]; RNA polymerase I CORE element sequence-specific DNA binding [GO:0001164]; transcription by RNA polymerase I [GO:0006360],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G241446.1.2.m.22601,-0.0169591047060434,0.00960206869202778,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G241446.2.2.m.47394,-0.00430894344577715,-0.00631540690244347,No,NA,NA,Q5FVR2,NA,NA,NA,cytosol [GO:0005829]; phosphorylase activity [GO:0004645]; protein homodimerization activity [GO:0042803]; pyrimidine-nucleoside phosphorylase activity [GO:0016154]; thymidine phosphorylase activity [GO:0009032]; mitochondrial genome maintenance [GO:0000002]; pyrimidine nucleobase metabolic process [GO:0006206]; pyrimidine nucleoside metabolic process [GO:0006213]; regulation of gastric motility [GO:1905333]; regulation of myelination [GO:0031641]; regulation of transmission of nerve impulse [GO:0051969],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G242065.1.1.m.21817,0.0184420756064466,0.00999510604244658,No,NA,NA,O17320,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G242153.2.4.m.15572,-0.0148898946541174,-0.0105088885235602,No,NA,NA,Q57951,NA,NA,NA,,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G242153.4.4.m.60071,0.0121808737841846,0.0104270066533171,No,NA,NA,Q2FXL6,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G243463.1.1.m.49871,-0.0078292263405312,0.0154834737147153,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G244077.1.1.m.14957,-0.00212078832001384,-0.00891837260408135,No,NA,NA,Q17Q97,NA,NA,NA,,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G244113.1.1.m.22167,-0.0128868135141408,-0.00987521790970817,No,NA,NA,Q27802,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G244537.2.3.m.10401,0.0013962048821971,0.00981886640459825,No,NA,NA,P74148,NA,NA,NA,,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G244727.1.1.m.35118,0.00502402300939063,-0.0212056698070371,No,NA,NA,Q9SKC3,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G244806.2.2.m.52012,0.00622246364834972,0.000829247993436222,No,NA,NA,A0A0R4IBK5,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G245101.1.1.m.56451,0.00410197154890825,0.00929957957318539,No,NA,NA,Q497B8,NA,NA,NA,chromosome [GO:0005694]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone demethylase activity (H3-K36 specific) [GO:0051864]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]; G2/M transition of mitotic cell cycle [GO:0000086]; histone H3-K36 demethylation [GO:0070544]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G245280.11.11.m.63026,0.00954050196340434,-0.00266466440446914,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G245280.2.11.m.22482,-0.00441332045954395,0.0168359537170881,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G245280.5.11.m.34248,-0.00320378716205549,0.0178339448405293,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G245744.1.1.m.36806,-0.0156691048007411,0.00237922703701013,No,NA,NA,A0JPI9,NA,NA,NA,,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G245969.1.2.m.347,0.0174324485947147,-0.00649137998879996,No,NA,NA,Q8N6F8,NA,NA,NA,,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G246111.1.2.m.45249,0.00205195042830452,-0.00934116934689427,No,NA,NA,A7SLZ2,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; cyclic-di-GMP binding [GO:0035438]; cyclic-GMP-AMP binding [GO:0061507]; cellular response to exogenous dsRNA [GO:0071360]; cytoplasmic pattern recognition receptor signaling pathway in response to virus [GO:0039528]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; interferon-beta production [GO:0032608]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of type I interferon production [GO:0032481],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G246422.1.1.m.1312,-0.0113351206201785,0.00126516427236189,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G246686.1.1.m.53126,-0.0221900920386209,0.00950641498875865,No,NA,NA,B3EWY7,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G247177.1.1.m.63233,-0.0176640888846379,-0.00263005165336892,No,NA,NA,Q18786,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G247395.1.8.m.5020,-0.00520195289718465,0.00614547520476475,No,NA,NA,Q9JLC8,NA,NA,NA,cytoplasm [GO:0005737]; low-density lipoprotein particle receptor binding [GO:0050750],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G248362.1.1.m.62940,0.0051743720257737,0.0144149330415571,No,NA,NA,Q03958,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; chaperone-mediated protein complex assembly [GO:0051131]; protein folding [GO:0006457],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G52068.2.3.m.36345,-0.00317523000207038,-0.00464359265461198,No,NA,NA,P49013,NA,NA,NA,extracellular space [GO:0005615]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G61368.1.1.m.42775,0.000686232728993107,-0.0107331332691118,No,NA,NA,P15253,NA,NA,NA,sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G69851.3.4.m.5191,0.00217997094733793,-0.00807271368859912,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G73504.1.2.m.17299,0.00908873520955822,-0.0160053886185833,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G73504.2.2.m.38500,0.0134914465261732,-0.0119604992657578,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G79897.1.1.m.52661,0.00488377705917313,0.0234718964954127,No,NA,NA,Q9Z1J2,NA,NA,NA,ciliary basal body [GO:0036064]; ciliary plasm [GO:0097014]; ciliary rootlet [GO:0035253]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; manganese ion binding [GO:0030145]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; mitotic cell cycle [GO:0000278]; positive regulation of transcription; DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of cellular senescence [GO:2000772]; regulation of replicative cell aging [GO:1900062]; regulation of response to DNA damage stimulus [GO:2001020]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G80221.1.1.m.12716,-0.0135725579708753,0.00388604629968508,No,NA,NA,Q8BFR4,NA,NA,NA,lysosome [GO:0005764]; glycosaminoglycan binding [GO:0005539]; metal ion binding [GO:0046872]; N-acetylglucosamine-6-sulfatase activity [GO:0008449]; sulfate binding [GO:0043199]; sulfuric ester hydrolase activity [GO:0008484]; keratan sulfate catabolic process [GO:0042340],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G80846.1.1.m.24713,-0.00295662881300604,-0.009946915715688,No,NA,NA,Q9DCG9,NA,NA,NA,nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; protein heterodimerization activity [GO:0046982]; protein methyltransferase activity [GO:0008276]; rRNA (guanine) methyltransferase activity [GO:0016435]; peptidyl-glutamine methylation [GO:0018364]; positive regulation of rRNA processing [GO:2000234]; rRNA (guanine-N7)-methylation [GO:0070476]; tRNA methylation [GO:0030488],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G83869.3.3.m.30283,-0.0226577309588754,0.0103784364560492,No,NA,NA,Q5YLG1,NA,NA,NA,extracellular region [GO:0005576]; cellulase activity [GO:0008810]; cellulose binding [GO:0030248]; cellulose catabolic process [GO:0030245],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G86312.1.1.m.10844,-0.0183679431787124,-0.00999098325910103,No,NA,NA,Q9Y6J8,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; protein phosphatase binding [GO:0019903]; protein phosphatase inhibitor activity [GO:0004864]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; pseudophosphatase activity [GO:0001691]; intracellular signal transduction [GO:0035556]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of stress granule assembly [GO:0062030]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of neuron projection development [GO:0010976]; regulation of intrinsic apoptotic signaling pathway [GO:2001242],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G92762.1.1.m.1253,0.00491588973115352,-0.000600714720400963,No,NA,NA,Q6ZHE5,NA,NA,NA,mitochondrion [GO:0005739]; D-cysteine desulfhydrase activity [GO:0019148],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G957.1.1.m.27284,0.0153947161838251,0.00275450557408973,No,NA,NA,O11780,NA,NA,NA,extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; cell proliferation [GO:0008283]; extracellular matrix organization [GO:0030198],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G96234.1.1.m.27743,-0.012054370007499,-0.00590257622862154,No,NA,NA,Q8WUA2,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]; regulation of phosphorylation of RNA polymerase II C-terminal domain [GO:1901407],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G97278.2.2.m.63646,-0.0208018978075797,0.011895638389281,No,NA,NA,Q9JLF6,NA,NA,NA,cell-cell adherens junction [GO:0005913]; intrinsic component of membrane [GO:0031224]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; animal organ morphogenesis [GO:0009887]; keratinization [GO:0031424]; keratinocyte differentiation [GO:0030216]; peptide cross-linking [GO:0018149]; positive regulation of cell cycle [GO:0045787]; positive regulation of keratinocyte proliferation [GO:0010838]; protein metabolic process [GO:0019538],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G97278.2.2.m.63648,0.0160534409390334,-0.0117210420295812,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEO1.3.3.m.61836,0.00645781079548542,0.00191755807641707,No,NA,NA,P97798,NA,NA,NA,cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular vesicle [GO:0097708]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; BMP receptor binding [GO:0070700]; cadherin binding [GO:0045296]; co-receptor binding [GO:0039706]; signaling receptor activity [GO:0038023]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; iron ion homeostasis [GO:0055072]; myoblast fusion [GO:0007520]; negative regulation of axon regeneration [GO:0048681]; negative regulation of neuron death [GO:1901215]; negative regulation of protein secretion [GO:0050709]; neuron migration [GO:0001764]; positive regulation of BMP signaling pathway [GO:0030513]; regulation of axon regeneration [GO:0048679]; regulation of neuron migration [GO:2001222]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_NEUL4.2.2.m.54340,-0.0221674580421597,0.0003750705851449,No,NA,NA,A1L0Y2,NA,NA,NA,centriole [GO:0005814],NA,NA,NA
CHOYP_NF70.1.4.m.31159,0.0108849762764174,0.0115902968330112,No,NA,NA,Q01240,NA,NA,NA,intermediate filament [GO:0005882]; structural molecule activity [GO:0005198],NA,NA,NA
CHOYP_NF70.4.4.m.63507,-0.00435830643614091,-0.0168964738557489,No,NA,NA,Q01241,NA,NA,NA,intermediate filament [GO:0005882]; structural molecule activity [GO:0005198],NA,NA,NA
CHOYP_NFH.1.1.m.53607,-0.00738090212166725,0.0107470297340509,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NFIL3.1.1.m.26076,-0.0120223473523739,-0.00083069572820558,No,NA,NA,Q16649,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor activity [GO:0003714]; cellular response to interleukin-4 [GO:0071353]; circadian rhythm [GO:0007623]; immune response [GO:0006955]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; regulation of transcription; DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_NFKB.1.1.m.51558,-0.0113310503613213,-0.00154653097377821,No,NA,NA,Q04861,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; NF-kappaB binding [GO:0051059]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_NFRKB.1.1.m.18027,-0.0169591047060434,0.00960206869202778,No,NA,NA,Q6PIJ4,NA,NA,NA,Ino80 complex [GO:0031011]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protease binding [GO:0002020]; DNA recombination [GO:0006310]; DNA repair [GO:0006281],NA,NA,NA
CHOYP_NFRKB.1.1.m.18028,0.00237475797995185,-0.0230154627944582,No,NA,NA,Q9DCH4,NA,NA,NA,eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex; eIF3m [GO:0071541]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; protein deubiquitination [GO:0016579]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_NFS1.1.1.m.1622,-0.0109245794205265,-0.00743182250951093,No,NA,NA,Q9Z1J3,NA,NA,NA,cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine desulfurase activity [GO:0031071]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; [2Fe-2S] cluster assembly [GO:0044571]; iron incorporation into metallo-sulfur cluster [GO:0018283]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777],NA,NA,NA
CHOYP_NFX1.1.2.m.13487,0.000181275477819285,-0.0125077631329103,No,NA,NA,Q12986,NA,NA,NA,cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; RNA binding [GO:0003723]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; inflammatory response [GO:0006954]; negative regulation of MHC class II biosynthetic process [GO:0045347]; negative regulation of transcription by RNA polymerase II [GO:0000122]; transcription by RNA polymerase II [GO:0006366]; viral process [GO:0016032],NA,NA,NA
CHOYP_NGAP.2.2.m.63455,0.00764084333648491,-0.00668185125439439,No,NA,NA,Q3UHC7,NA,NA,NA,AIP1-IRE1 complex [GO:1990597]; axon [GO:0030424]; cerebellar mossy fiber [GO:0044300]; climbing fiber [GO:0044301]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; parallel fiber [GO:1990032]; plasma membrane [GO:0005886]; 14-3-3 protein binding [GO:0071889]; death receptor binding [GO:0005123]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; mitogen-activated protein kinase kinase binding [GO:0031434]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591]; vascular endothelial growth factor receptor 2 binding [GO:0043184]; activation of JUN kinase activity [GO:0007257]; activation of MAPKKK activity [GO:0000185]; angiogenesis [GO:0001525]; cell cycle [GO:0007049]; cell motility involved in cerebral cortex radial glia guided migration [GO:0021814]; cellular protein catabolic process [GO:0044257]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; I-kappaB phosphorylation [GO:0007252]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; layer formation in cerebral cortex [GO:0021819]; negative regulation of angiogenesis [GO:0016525]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth [GO:0030308]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cellular protein catabolic process [GO:1903363]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of GTPase activity [GO:0034260]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of phosphatidylinositol 3-kinase activity [GO:0043553]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; neuron projection morphogenesis [GO:0048812]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of dendrite development [GO:1900006]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of synapse maturation [GO:0090129]; positive regulation of transcription by RNA polymerase II [GO:0045944]; reelin-mediated signaling pathway [GO:0038026]; regulation of GTPase activity [GO:0043087]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of p38MAPK cascade [GO:1900744]; regulation of protein complex assembly [GO:0043254]; regulation of protein heterodimerization activity [GO:0043497]; response to unfolded protein [GO:0006986]; tube formation [GO:0035148]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324],NA,NA,NA
CHOYP_NHP2.1.1.m.57624,-0.01814098347474,0.00211572943726361,No,NA,NA,Q6P8C4,NA,NA,NA,box H/ACA snoRNP complex [GO:0031429]; small nucleolar ribonucleoprotein complex [GO:0005732]; telomerase holoenzyme complex [GO:0005697]; box H/ACA snoRNA binding [GO:0034513]; RNA binding [GO:0003723]; cleavage involved in rRNA processing [GO:0000469]; maturation of LSU-rRNA [GO:0000470]; rRNA pseudouridine synthesis [GO:0031118]; snRNA pseudouridine synthesis [GO:0031120]; telomere maintenance via telomerase [GO:0007004]; translation [GO:0006412],NA,NA,NA
CHOYP_NID2.1.2.m.5776,-0.00412738112764094,-0.00888184137061556,No,NA,NA,P81439,NA,NA,NA,extracellular region [GO:0005576]; cysteine-type endopeptidase inhibitor activity [GO:0004869],NA,NA,NA
CHOYP_NIF3L.1.2.m.28817,0.0172607903175594,-0.010355030225657,No,NA,NA,Q9GZT8,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; transcription factor binding [GO:0008134]; negative regulation of nucleic acid-templated transcription [GO:1903507]; neuron differentiation [GO:0030182]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_NIPA.1.1.m.13987,0.00716735499178202,-0.00360728769207314,No,NA,NA,Q80YV2,NA,NA,NA,nuclear membrane [GO:0031965]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_NIPLB.1.1.m.11155,-0.00300109861222787,0.0048839414762382,No,NA,NA,Q6KCD5,NA,NA,NA,chromatin [GO:0000785]; integrator complex [GO:0032039]; nuclear chromatin [GO:0000790]; nuclear chromosome [GO:0000228]; nucleus [GO:0005634]; Scc2-Scc4 cohesin loading complex [GO:0090694]; SMC loading complex [GO:0032116]; chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; histone deacetylase binding [GO:0042826]; mediator complex binding [GO:0036033]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; brain development [GO:0007420]; cellular protein localization [GO:0034613]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to X-ray [GO:0071481]; cognition [GO:0050890]; cohesin loading [GO:0071921]; developmental growth [GO:0048589]; double-strand break repair [GO:0006302]; ear morphogenesis [GO:0042471]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic forelimb morphogenesis [GO:0035115]; embryonic viscerocranium morphogenesis [GO:0048703]; establishment of mitotic sister chromatid cohesion [GO:0034087]; establishment of protein localization to chromatin [GO:0071169]; external genitalia morphogenesis [GO:0035261]; eye morphogenesis [GO:0048592]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forelimb morphogenesis [GO:0035136]; gall bladder development [GO:0061010]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; mitotic chromosome condensation [GO:0007076]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; outflow tract morphogenesis [GO:0003151]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of mitotic cohesin loading [GO:1905406]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuron migration [GO:2001224]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rDNA condensation [GO:0070550]; regulation of developmental growth [GO:0048638]; regulation of embryonic development [GO:0045995]; regulation of hair cycle [GO:0042634]; regulation of transcription by RNA polymerase II [GO:0006357]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; sensory perception of sound [GO:0007605]; stem cell population maintenance [GO:0019827]; transcriptional activation by promoter-enhancer looping [GO:0071733]; uterus morphogenesis [GO:0061038],NA,NA,NA
CHOYP_NIPSNAP3A.B.1.1.m.62397,0.0163975332882442,-0.0164200137062283,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NISCH.1.2.m.17955,-0.00813110162921644,0.00917126197270391,No,NA,NA,Q9Y2I1,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; phosphatidylinositol binding [GO:0035091]; protein kinase binding [GO:0019901]; structural constituent of cytoskeleton [GO:0005200]; actin cytoskeleton organization [GO:0030036]; apoptotic process [GO:0006915]; glucose metabolic process [GO:0006006]; negative regulation of cell migration [GO:0030336]; norepinephrine secretion [GO:0048243]; Rac protein signal transduction [GO:0016601]; regulation of blood pressure [GO:0008217]; regulation of synaptic transmission; GABAergic [GO:0032228],NA,NA,NA
CHOYP_NIT2B.1.1.m.18389,0.0102357899696352,0.0237348364957187,No,NA,NA,Q6INI7,NA,NA,NA,cytoplasm [GO:0005737]; omega-amidase activity [GO:0050152]; nitrogen compound metabolic process [GO:0006807],NA,NA,NA
CHOYP_NKRF.1.1.m.61828,-0.0111415828693856,-0.00352895992186056,No,NA,NA,O15226,NA,NA,NA,nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_NKX23.1.1.m.25439,0.00553350288181078,-0.00138970000312741,No,NA,NA,A6NCS4,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; atrial cardiac muscle cell development [GO:0055014]; cell differentiation [GO:0030154]; digestive tract development [GO:0048565]; embryonic heart tube development [GO:0035050]; hypothalamus development [GO:0021854]; negative regulation of apoptotic process [GO:0043066]; pericardium development [GO:0060039]; pharyngeal system development [GO:0060037]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; tongue development [GO:0043586]; ventricular cardiac muscle cell development [GO:0055015],NA,NA,NA
CHOYP_NLRC3.1.1.m.57383,-0.00604171722695935,0.0101328072915405,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NMT2.1.2.m.10421,-0.00836930004875441,-0.0144979955636815,No,NA,NA,O60551,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; Golgi apparatus [GO:0005794]; host cell [GO:0043657]; plasma membrane [GO:0005886]; glycylpeptide N-tetradecanoyltransferase activity [GO:0004379]; intracellular transport of virus [GO:0075733]; N-terminal peptidyl-glycine N-myristoylation [GO:0018008]; regulation of rhodopsin mediated signaling pathway [GO:0022400],NA,NA,NA
CHOYP_NNRE.2.2.m.27199,-0.0169591047060434,0.00960206869202778,No,NA,NA,B7QDG3,NA,NA,NA,mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; NADHX epimerase activity [GO:0052856]; NADPHX epimerase activity [GO:0052857]; nucleotide binding [GO:0000166],NA,NA,NA
CHOYP_NOC41.1.1.m.53790,-0.00978931914677986,-0.0136110886265172,No,NA,NA,Q6NU91,NA,NA,NA,integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_NOG2.1.1.m.41399,0.00214077192305648,-0.00348265618522156,No,NA,NA,Q99LH1,NA,NA,NA,nucleolus [GO:0005730]; GTP binding [GO:0005525]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_NOL10.1.1.m.1606,-0.00559547121236676,-0.020001263709815,No,NA,NA,Q7T0Q5,NA,NA,NA,nucleolus [GO:0005730],NA,NA,NA
CHOYP_NOL11.1.1.m.6423,0.00586959862615178,-0.0153432431220391,No,NA,NA,Q6INI5,NA,NA,NA,nucleolus [GO:0005730]; maturation of SSU-rRNA [GO:0030490]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838],NA,NA,NA
CHOYP_NOL5.1.1.m.49429,0.0103951519901217,0.00531079751602738,No,NA,NA,Q4R779,NA,NA,NA,nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_NOL9.1.2.m.16473,0.00197379144661583,-0.0111153839098396,No,NA,NA,Q3TZX8,NA,NA,NA,intermediate filament cytoskeleton [GO:0045111]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; polynucleotide 5'-hydroxyl-kinase activity [GO:0051731]; RNA binding [GO:0003723]; cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000448]; maturation of 5.8S rRNA [GO:0000460],NA,NA,NA
CHOYP_NOLC1.3.3.m.66629,0.00653868444425822,-0.0130266265959114,No,NA,NA,P41777,NA,NA,NA,box C/D snoRNP complex [GO:0031428]; box H/ACA snoRNP complex [GO:0031429]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; box C/D snoRNA binding [GO:0034512]; box C/D snoRNP complex binding [GO:0062064]; box H/ACA snoRNA binding [GO:0034513]; box H/ACA snoRNP complex binding [GO:0062065]; DNA-binding transcription factor activity [GO:0003700]; GTP binding [GO:0005525]; nuclear localization sequence binding [GO:0008139]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; RNA polymerase I core binding [GO:0001042]; transcription factor binding [GO:0008134]; box H/ACA snoRNA metabolic process [GO:0033979]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; nucleolus organization [GO:0007000]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of protein import into nucleus [GO:0042306]; regulation of translation [GO:0006417]; response to osmotic stress [GO:0006970],NA,NA,NA
CHOYP_NOMO1.2.2.m.46404,-0.013511160999081,-0.0025373797057252,No,NA,NA,Q15155,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_NOP56.1.1.m.55664,-0.00450551056930987,0.015908901262534,No,NA,NA,O00567,NA,NA,NA,box C/D snoRNP complex [GO:0031428]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pre-snoRNP complex [GO:0070761]; small nucleolar ribonucleoprotein complex [GO:0005732]; small-subunit processome [GO:0032040]; cadherin binding [GO:0045296]; histone methyltransferase binding [GO:1990226]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_NOSC.1.1.m.6346,0.00938678132561766,-0.0216763068604458,No,NA,NA,Q9Z0J4,NA,NA,NA,azurophil granule [GO:0042582]; calyx of Held [GO:0044305]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density; intracellular component [GO:0099092]; postsynaptic specialization; intracellular component [GO:0099091]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; synapse [GO:0045202]; T-tubule [GO:0030315]; vesicle membrane [GO:0012506]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cadmium ion binding [GO:0046870]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; ion channel binding [GO:0044325]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric-oxide synthase activity [GO:0004517]; oxidoreductase activity [GO:0016491]; phosphoprotein binding [GO:0051219]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; sodium channel regulator activity [GO:0017080]; arginine catabolic process [GO:0006527]; behavioral response to cocaine [GO:0048148]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to growth factor stimulus [GO:0071363]; cellular response to mechanical stimulus [GO:0071260]; establishment of protein localization [GO:0045184]; exogenous drug catabolic process [GO:0042738]; multicellular organismal response to stress [GO:0033555]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood pressure [GO:0045776]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of heart contraction [GO:0045822]; negative regulation of hydrolase activity [GO:0051346]; negative regulation of insulin secretion [GO:0046676]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of serotonin uptake [GO:0051612]; negative regulation of vasoconstriction [GO:0045906]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0140196]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of guanylate cyclase activity [GO:0031284]; positive regulation of histone acetylation [GO:0035066]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron death [GO:1901216]; positive regulation of sodium ion transmembrane transport [GO:1902307]; positive regulation of the force of heart contraction [GO:0098735]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of heart contraction [GO:0008016]; regulation of neurogenesis [GO:0050767]; regulation of sensory perception of pain [GO:0051930]; regulation of sodium ion transport [GO:0002028]; response to estrogen [GO:0043627]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to peptide hormone [GO:0043434]; retrograde trans-synaptic signaling by nitric oxide [GO:0098924]; striated muscle contraction [GO:0006941]; synaptic signaling by nitric oxide [GO:0099163]; vasodilation [GO:0042311],NA,NA,NA
CHOYP_NOTC3.1.1.m.20877,-0.00547195246411929,-0.00265166906332668,No,NA,NA,P07207,NA,NA,NA,adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; subapical complex [GO:0035003]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; transmembrane signaling receptor activity [GO:0004888]; actin filament organization [GO:0007015]; anterior/posterior pattern specification [GO:0009952]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell adhesion [GO:0007155]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate specification [GO:0001708]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye cone cell fate commitment [GO:0042676]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral lineage restriction; imaginal disc [GO:0007451]; dorsal/ventral pattern formation; imaginal disc [GO:0007450]; ectoderm development [GO:0007398]; embryonic crystal cell differentiation [GO:0035165]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification; open tracheal system [GO:0035153]; establishment of ommatidial planar polarity [GO:0042067]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland crystal cell differentiation [GO:0035170]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; morphogenesis of follicular epithelium [GO:0016333]; motor neuron axon guidance [GO:0008045]; muscle cell fate determination [GO:0007521]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of JNK cascade [GO:0046329]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; ovarian follicle cell migration [GO:0007297]; ovarian follicle cell stalk formation [GO:0030713]; peripheral nervous system development [GO:0007422]; positive regulation of cell proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell fate commitment [GO:0007464]; R7 cell differentiation [GO:0045466]; R8 cell development [GO:0045463]; R8 cell differentiation [GO:0045465]; R8 cell fate commitment [GO:0007460]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of crystal cell differentiation [GO:0042689]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of R8 cell spacing in compound eye [GO:0045468]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; skeletal muscle tissue development [GO:0007519]; stem cell differentiation [GO:0048863]; ventral cord development [GO:0007419]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]; wing disc proximal/distal pattern formation [GO:0007473],NA,NA,NA
CHOYP_NPC2.2.7.m.29742,0.0193771392306667,-0.0115021349034106,No,NA,NA,P79345,NA,NA,NA,endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cholesterol binding [GO:0015485]; cholesterol transporter activity [GO:0017127]; enzyme binding [GO:0019899]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; response to virus [GO:0009615],NA,NA,NA
CHOYP_NPC2.4.7.m.30775,-4.89762668941292e-05,-0.00308831187921834,No,NA,NA,P61917,NA,NA,NA,endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cholesterol binding [GO:0015485]; cholesterol efflux [GO:0033344]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367],NA,NA,NA
CHOYP_NPC2.5.7.m.30911,0.00787571064846793,0.0228303708575426,No,NA,NA,P79345,NA,NA,NA,endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cholesterol binding [GO:0015485]; cholesterol transporter activity [GO:0017127]; enzyme binding [GO:0019899]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; response to virus [GO:0009615],NA,NA,NA
CHOYP_NPC2.6.7.m.31030,0.0197222833017395,-0.0165985154217005,No,NA,NA,P61917,NA,NA,NA,endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cholesterol binding [GO:0015485]; cholesterol efflux [GO:0033344]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367],NA,NA,NA
CHOYP_NPL.1.3.m.4064,-0.00360872890603562,-0.0177377969668769,No,NA,NA,Q66H59,NA,NA,NA,cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; N-acetylneuraminate lyase activity [GO:0008747]; carbohydrate metabolic process [GO:0005975]; N-acetylneuraminate catabolic process [GO:0019262],NA,NA,NA
CHOYP_NPL.3.3.m.29352,-0.00629295331687717,0.0075159360661754,No,NA,NA,Q9DCJ9,NA,NA,NA,cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; N-acetylneuraminate lyase activity [GO:0008747]; carbohydrate metabolic process [GO:0005975]; N-acetylneuraminate catabolic process [GO:0019262],NA,NA,NA
CHOYP_NPL4.1.1.m.62114,-0.00206846330747006,0.0197867429230436,No,NA,NA,P60670,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear outer membrane-endoplasmic reticulum membrane network [GO:0042175]; nucleus [GO:0005634]; UFD1-NPL4 complex [GO:0036501]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; ATPase binding [GO:0051117]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; Golgi organization [GO:0007030]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; retrograde protein transport; ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_NPTN.1.1.m.50315,0.016967408315051,-0.00445176233656056,No,NA,NA,P35613,NA,NA,NA,acrosomal membrane [GO:0002080]; axon [GO:0030424]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; cadherin binding [GO:0045296]; cell-cell adhesion mediator activity [GO:0098632]; mannose binding [GO:0005537]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; axon guidance [GO:0007411]; cell surface receptor signaling pathway [GO:0007166]; decidualization [GO:0046697]; dendrite self-avoidance [GO:0070593]; embryo implantation [GO:0007566]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; leukocyte migration [GO:0050900]; odontogenesis of dentin-containing tooth [GO:0042475]; protein localization to plasma membrane [GO:0072659]; pyruvate metabolic process [GO:0006090]; response to cAMP [GO:0051591]; response to mercury ion [GO:0046689]; response to peptide hormone [GO:0043434],NA,NA,NA
CHOYP_NR1AA.1.1.m.39226,0.0132099793061723,-0.0155678726018396,No,NA,NA,Q9ULB1,NA,NA,NA,cell junction [GO:0030054]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic active zone membrane [GO:0099059]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; vesicle [GO:0031982]; acetylcholine receptor binding [GO:0033130]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; neuroligin family protein binding [GO:0097109]; signaling receptor activity [GO:0038023]; adult behavior [GO:0030534]; axon guidance [GO:0007411]; chemical synaptic transmission [GO:0007268]; gephyrin clustering involved in postsynaptic density assembly [GO:0097116]; learning [GO:0007612]; neuroligin clustering involved in postsynaptic membrane assembly [GO:0097118]; neuromuscular process controlling balance [GO:0050885]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission; glutamatergic [GO:0051968]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; prepulse inhibition [GO:0060134]; regulation of grooming behavior [GO:2000821]; regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]; regulation of synaptic vesicle cycle [GO:0098693]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling by endocannabinoid [GO:0099542]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625],NA,NA,NA
CHOYP_NRDC.1.1.m.28526,0.00169973320033859,-0.0170451109918075,No,NA,NA,Q8BHG1,NA,NA,NA,mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; regulation of endopeptidase activity [GO:0052548],NA,NA,NA
CHOYP_NRG.1.1.m.10622,-0.00519293486529651,-0.0195436022665601,No,NA,NA,P20241,NA,NA,NA,bicellular tight junction [GO:0005923]; filopodium [GO:0030175]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; septate junction [GO:0005918]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; axon ensheathment [GO:0008366]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell adhesion [GO:0098609]; central complex development [GO:0048036]; dendrite morphogenesis [GO:0048813]; establishment of glial blood-brain barrier [GO:0060857]; female courtship behavior [GO:0008050]; imaginal disc morphogenesis [GO:0007560]; male courtship behavior [GO:0008049]; melanotic encapsulation of foreign target [GO:0035011]; motor neuron axon guidance [GO:0008045]; mushroom body development [GO:0016319]; nerve maturation [GO:0021682]; neuron cell-cell adhesion [GO:0007158]; photoreceptor cell axon guidance [GO:0072499]; regulation of female receptivity [GO:0045924]; regulation of tube size; open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synapse organization [GO:0050808],NA,NA,NA
CHOYP_NRP.2.4.m.39720,0.0193973437344713,-0.0110966289213294,No,NA,NA,H2A0M0,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_NRP.4.4.m.44647,0.0217590829138544,-0.00875597782376129,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NRX3A.1.1.m.1705,0.00170100062848391,-0.00371853706334162,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NRX4.1.1.m.8135,0.0204989650737857,-0.00778955483360534,No,NA,NA,Q94887,NA,NA,NA,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; presynaptic active zone [GO:0048786]; septate junction [GO:0005918]; synapse [GO:0045202]; axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size; open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553],NA,NA,NA
CHOYP_NSF1C.1.1.m.62502,0.00812209915663171,0.0124077557353163,No,NA,NA,Q9CZ44,NA,NA,NA,chromosome [GO:0005694]; cytosol [GO:0005829]; Golgi stack [GO:0005795]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; spindle pole centrosome [GO:0031616]; VCP-NSFL1C complex [GO:1990730]; ATPase binding [GO:0051117]; phospholipid binding [GO:0005543]; ubiquitin binding [GO:0043130]; autophagosome assembly [GO:0000045]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; membrane fusion [GO:0061025]; negative regulation of protein localization to centrosome [GO:1904780]; nuclear envelope reassembly [GO:0031468]; positive regulation of mitotic centrosome separation [GO:0046604]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_NSUN2.1.1.m.14138,0.00284555994230563,-0.00262137018541721,No,NA,NA,Q08J23,NA,NA,NA,chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049]; cell division [GO:0051301]; hair follicle maturation [GO:0048820]; meiotic cell cycle checkpoint [GO:0033313]; spermatid development [GO:0007286]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400],NA,NA,NA
CHOYP_NT5M.1.1.m.6188,-0.00268314794854473,-0.0125844234697889,No,NA,NA,Q9NPB1,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotidase activity [GO:0008252]; nucleotide binding [GO:0000166]; DNA replication [GO:0006260]; dUMP catabolic process [GO:0046079]; pyrimidine deoxyribonucleotide catabolic process [GO:0009223]; pyrimidine nucleoside catabolic process [GO:0046135],NA,NA,NA
CHOYP_NTF.2.1.1.m.38498,0.0156653132714168,-0.00544460340313393,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NTM1A.1.1.m.614,0.00270296121375645,-0.00816058027170102,No,NA,NA,Q6NWX7,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; histone methyltransferase activity [GO:0042054]; N-terminal protein N-methyltransferase activity [GO:0071885]; protein methyltransferase activity [GO:0008276]; chromosome segregation [GO:0007059]; histone methylation [GO:0016571]; N-terminal peptidyl-glycine methylation [GO:0018013]; N-terminal peptidyl-proline dimethylation [GO:0018016]; N-terminal peptidyl-serine dimethylation [GO:0035572]; N-terminal peptidyl-serine trimethylation [GO:0035573]; spindle organization [GO:0007051],NA,NA,NA
CHOYP_NU107.1.2.m.46092,-0.00391778959432713,-0.000152981988252238,No,NA,NA,Q8BH74,NA,NA,NA,condensed chromosome kinetochore [GO:0000777]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; structural constituent of nuclear pore [GO:0017056]; female gonad development [GO:0008585]; mRNA export from nucleus [GO:0006406]; nuclear pore complex assembly [GO:0051292]; posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein import into nucleus [GO:0006606],NA,NA,NA
CHOYP_NU160.1.1.m.46155,-0.000612234897854533,0.00237727083115232,No,NA,NA,Q9Z0W3,NA,NA,NA,kinetochore [GO:0000776]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; structural constituent of nuclear pore [GO:0017056]; mRNA export from nucleus [GO:0006406],NA,NA,NA
CHOYP_NU188.2.2.m.51343,0.0123693321482374,-0.0100089741192589,No,NA,NA,Q5SRE5,NA,NA,NA,membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear pore inner ring [GO:0044611]; structural constituent of nuclear pore [GO:0017056]; mRNA export from nucleus [GO:0006406]; protein import into nucleus [GO:0006606]; viral process [GO:0016032],NA,NA,NA
CHOYP_NUBP1.1.1.m.65721,-0.00215151892574943,0.00498178610133302,No,NA,NA,Q6P298,NA,NA,NA,cytosol [GO:0005829]; 4 iron; 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226],NA,NA,NA
CHOYP_NUBPL.1.1.m.15123,-0.000273365916549971,0.00714641827723978,No,NA,NA,Q9CWD8,NA,NA,NA,mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; 4 iron; 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrion morphogenesis [GO:0070584],NA,NA,NA
CHOYP_NUCB2.2.2.m.55289,0.0180984901674737,-0.013272917339001,No,NA,NA,Q9JI85,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi medial cisterna [GO:0005797]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; tumor necrosis factor receptor binding [GO:0005164]; insulin metabolic process [GO:1901142]; negative regulation of appetite [GO:0032099]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of glucagon secretion [GO:0070093]; negative regulation of insulin receptor signaling pathway [GO:0046627]; positive regulation of fatty acid oxidation [GO:0046321]; positive regulation of testosterone secretion [GO:2000845]; response to glucose [GO:0009749]; response to human chorionic gonadotropin [GO:0044752]; response to melanocyte-stimulating hormone [GO:1990680]; response to starvation [GO:0042594],NA,NA,NA
CHOYP_NUCL.1.2.m.19135,0.00331543188102731,-0.0172543569706497,No,NA,NA,P20397,NA,NA,NA,nucleolus [GO:0005730]; DNA binding [GO:0003677]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_NUCL.2.2.m.21719,0.00493726983271459,-0.00577856090688288,No,NA,NA,P20397,NA,NA,NA,nucleolus [GO:0005730]; DNA binding [GO:0003677]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_NUD16.1.2.m.10250,-0.00871938091691873,-0.00854467556865235,No,NA,NA,P0DKY8,NA,NA,NA,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; nucleotide metabolic process [GO:0009117],NA,NA,NA
CHOYP_NUD17.1.1.m.13156,-0.0160150121296543,0.00553783150139351,No,NA,NA,Q4V8V2,NA,NA,NA,cytosol [GO:0005829]; peroxisome [GO:0005777]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]; NAD catabolic process [GO:0019677]; NADH metabolic process [GO:0006734]; NADP catabolic process [GO:0006742],NA,NA,NA
CHOYP_NUDT14.1.1.m.64313,-0.0118013195537614,0.00782167394596401,No,NA,NA,Q05B60,NA,NA,NA,cytoplasm [GO:0005737]; ADP-ribose diphosphatase activity [GO:0047631]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; UDP-sugar diphosphatase activity [GO:0008768]; nucleoside phosphate metabolic process [GO:0006753]; ribose phosphate metabolic process [GO:0019693],NA,NA,NA
CHOYP_NUFIP1.1.1.m.8979,-0.00212078832001384,-0.00891837260408135,No,NA,NA,Q641W3,NA,NA,NA,cytosolic ribosome [GO:0022626]; fibrillar center [GO:0001650]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; pre-snoRNP complex [GO:0070761]; presynaptic active zone [GO:0048786]; transcription elongation factor complex [GO:0008023]; ATPase binding [GO:0051117]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein binding; bridging [GO:0030674]; snoRNA binding [GO:0030515]; box C/D snoRNP assembly [GO:0000492]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein complex oligomerization [GO:0051259],NA,NA,NA
CHOYP_NUMB.1.1.m.19732,-0.0133241102754799,0.0017561665394664,No,NA,NA,P16554,NA,NA,NA,basal cortex [GO:0045180]; basal part of cell [GO:0045178]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; Notch binding [GO:0005112]; asymmetric cell division [GO:0008356]; asymmetric neuroblast division [GO:0055059]; cell fate commitment [GO:0045165]; cell fate determination [GO:0001709]; central nervous system development [GO:0007417]; centrosome localization [GO:0051642]; embryonic heart tube development [GO:0035050]; glial cell migration [GO:0008347]; heart development [GO:0007507]; Malpighian tubule tip cell differentiation [GO:0061382]; muscle cell fate specification [GO:0042694]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of Notch signaling pathway [GO:0045746]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; Notch signaling pathway [GO:0007219]; pericardial nephrocyte differentiation [GO:0061320]; positive regulation of endocytosis [GO:0045807]; protein localization [GO:0008104]; regulation of asymmetric cell division [GO:0009786]; regulation of nervous system development [GO:0051960]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; rhythmic behavior [GO:0007622]; sensory organ precursor cell division [GO:0045035]; sensory organ precursor cell fate determination [GO:0016360]; ventral cord development [GO:0007419],NA,NA,NA
CHOYP_NUP153.1.1.m.34857,0.000973008272418452,0.00714497818952324,No,NA,NA,Q640Z6,NA,NA,NA,nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; structural constituent of nuclear pore [GO:0017056]; mRNA transport [GO:0051028]; protein transport [GO:0015031],NA,NA,NA
CHOYP_NUP205.1.1.m.54932,-0.0142763802220119,-0.0215129391477977,No,NA,NA,Q92621,NA,NA,NA,membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore inner ring [GO:0044611]; structural constituent of nuclear pore [GO:0017056]; mRNA export from nucleus [GO:0006406]; nuclear pore complex assembly [GO:0051292]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; viral process [GO:0016032],NA,NA,NA
CHOYP_NUP214.2.3.m.20892,-0.00119552319151895,0.0110931132536155,No,NA,NA,P35658,NA,NA,NA,cytoplasmic side of nuclear pore [GO:1990876]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear export signal receptor activity [GO:0005049]; nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056]; mitotic cell cycle [GO:0000278]; mRNA export from nucleus [GO:0006406]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; regulation of cell cycle [GO:0051726]; regulation of mRNA stability [GO:0043488]; regulation of nucleocytoplasmic transport [GO:0046822]; viral process [GO:0016032],NA,NA,NA
CHOYP_NUP214.3.3.m.52826,-0.0123537712039715,-0.0162388482085649,No,NA,NA,P35658,NA,NA,NA,cytoplasmic side of nuclear pore [GO:1990876]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear export signal receptor activity [GO:0005049]; nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056]; mitotic cell cycle [GO:0000278]; mRNA export from nucleus [GO:0006406]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; regulation of cell cycle [GO:0051726]; regulation of mRNA stability [GO:0043488]; regulation of nucleocytoplasmic transport [GO:0046822]; viral process [GO:0016032],NA,NA,NA
CHOYP_NUP50.1.1.m.17104,0.00471667761295389,0.00210412395168418,No,NA,NA,Q9UKX7,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Ran GTPase binding [GO:0008536]; mRNA export from nucleus [GO:0006406]; positive regulation of GTPase activity [GO:0043547]; protein import into nucleus [GO:0006606]; viral process [GO:0016032],NA,NA,NA
CHOYP_NUP54.1.1.m.24886,-0.0074040152322679,-0.0202126273109612,No,NA,NA,Q8BTS4,NA,NA,NA,nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore central transport channel [GO:0044613]; protein-containing complex [GO:0032991]; structural constituent of nuclear pore [GO:0017056]; mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; protein heterooligomerization [GO:0051291]; protein heterotetramerization [GO:0051290]; protein heterotrimerization [GO:0070208]; protein homooligomerization [GO:0051260]; protein localization to nuclear inner membrane [GO:0036228]; protein targeting [GO:0006605]; regulation of protein import into nucleus [GO:0042306],NA,NA,NA
CHOYP_NUP62L.1.1.m.15606,0.00530747923397708,0.00644141059067353,No,NA,NA,P17955,NA,NA,NA,annulate lamellae [GO:0005642]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; mitotic spindle [GO:0072686]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore central transport channel [GO:0044613]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; spindle pole [GO:0000922]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; kinesin binding [GO:0019894]; phospholipid binding [GO:0005543]; PTB domain binding [GO:0051425]; receptor signaling complex scaffold activity [GO:0030159]; SH2 domain binding [GO:0042169]; structural constituent of nuclear pore [GO:0017056]; thyroid hormone receptor binding [GO:0046966]; ubiquitin binding [GO:0043130]; cell aging [GO:0007569]; cell death [GO:0008219]; cell surface receptor signaling pathway [GO:0007166]; centriole assembly [GO:0098534]; mitotic cell cycle [GO:0000278]; mitotic centrosome separation [GO:0007100]; mitotic metaphase plate congression [GO:0007080]; mRNA transport [GO:0051028]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of programmed cell death [GO:0043069]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of centriole replication [GO:0046601]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of mitotic cytokinetic process [GO:1903438]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of transcription; DNA-templated [GO:0045893]; protein heterotrimerization [GO:0070208]; protein import into nucleus [GO:0006606]; regulation of mitotic spindle organization [GO:0060236]; regulation of protein import into nucleus [GO:0042306]; spermatogenesis [GO:0007283]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_NUP85.1.1.m.16167,0.0106732965546775,-0.000173004176988013,No,NA,NA,Q6DBY0,NA,NA,NA,nuclear membrane [GO:0031965]; nuclear pore outer ring [GO:0031080]; structural constituent of nuclear pore [GO:0017056]; mRNA export from nucleus [GO:0006406]; positive regulation of transcription; DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606],NA,NA,NA
CHOYP_NUP98.1.1.m.8689,-0.0148130801626648,-0.0163696140563217,No,NA,NA,P49793,NA,NA,NA,kinetochore [GO:0000776]; nuclear body [GO:0016604]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; nuclear localization sequence binding [GO:0008139]; peptide binding [GO:0042277]; promoter-specific chromatin binding [GO:1990841]; RNA binding [GO:0003723]; serine-type peptidase activity [GO:0008236]; structural constituent of nuclear pore [GO:0017056]; transcription coactivator activity [GO:0003713]; DNA replication [GO:0006260]; mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; positive regulation of mRNA splicing; via spliceosome [GO:0048026]; posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein import into nucleus [GO:0006606]; RNA export from nucleus [GO:0006405]; telomere tethering at nuclear periphery [GO:0034398],NA,NA,NA
CHOYP_NUPL2.1.2.m.4693,0.00646419354875342,0.00733183419031029,No,NA,NA,Q8CIC2,NA,NA,NA,cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor outer segment [GO:0001750]; metal ion binding [GO:0046872]; nuclear export signal receptor activity [GO:0005049]; mRNA transport [GO:0051028]; protein export from nucleus [GO:0006611],NA,NA,NA
CHOYP_NXF1.1.2.m.28017,0.00865546504496069,-0.018834283559979,No,NA,NA,Q9UBU9,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear inclusion body [GO:0042405]; nuclear pore [GO:0005643]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]; RNA export from nucleus [GO:0006405]; viral process [GO:0016032],NA,NA,NA
CHOYP_OAT.1.1.m.3069,-0.00571767525786719,0.000256471586504032,No,NA,NA,Q9VW26,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ornithine-oxo-acid transaminase activity [GO:0004587]; pyridoxal phosphate binding [GO:0030170]; arginine catabolic process to glutamate [GO:0019544]; arginine catabolic process to proline via ornithine [GO:0010121]; L-proline biosynthetic process [GO:0055129]; ornithine metabolic process [GO:0006591],NA,NA,NA
CHOYP_OCDH.1.1.m.1284,0.00235877121638047,0.00491868636367368,No,NA,NA,Q9BHM6,NA,NA,NA,coenzyme binding [GO:0050662]; D-octopine dehydrogenase activity [GO:0047830]; nucleotide binding [GO:0000166],NA,NA,NA
CHOYP_OCTC.1.1.m.31819,0.00896645573666516,0.0105521990904521,No,NA,NA,Q9UKG9,NA,NA,NA,cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; carnitine O-octanoyltransferase activity [GO:0008458]; signaling receptor binding [GO:0005102]; carnitine metabolic process [GO:0009437]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; generation of precursor metabolites and energy [GO:0006091]; medium-chain fatty acid metabolic process [GO:0051791]; protein targeting to peroxisome [GO:0006625],NA,NA,NA
CHOYP_ODC1.1.1.m.12032,0.00974659375983088,0.0190737735948011,No,NA,NA,Q04832,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_ODH.1.2.m.1327,-0.0196291563110895,0.00677999529379065,No,NA,NA,Q8N0N9,NA,NA,NA,coenzyme binding [GO:0050662]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_ODH.2.2.m.16624,-0.0181770388834105,0.00544141342012938,No,NA,NA,Q8N0N9,NA,NA,NA,coenzyme binding [GO:0050662]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_ODO1.2.2.m.23540,-0.0023671581416121,-0.0235875207424531,No,NA,NA,Q60HE2,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; 2-oxoglutarate metabolic process [GO:0006103]; generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; histone succinylation [GO:0106077]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_ODPX.1.1.m.29097,-0.00038473435780179,-0.00129961614197847,No,NA,NA,Q8BKZ9,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; pyruvate dehydrogenase complex [GO:0045254]; pyruvate dehydrogenase (NAD+) activity [GO:0034604]; transferase activity; transferring acyl groups [GO:0016746]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732],NA,NA,NA
CHOYP_ODPX.1.1.m.29098,-0.00103985804611887,-0.0145254900583935,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_OFD1.1.1.m.29513,-0.00899730742088135,0.00595047568975771,No,NA,NA,O75665,NA,NA,NA,centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; alpha-tubulin binding [GO:0043014]; gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of G2/M transition of mitotic cell cycle [GO:0010389],NA,NA,NA
CHOYP_OFUT1.1.1.m.41737,-0.00162352060416732,0.00797654200930793,No,NA,NA,Q9V6X7,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; fucosyltransferase activity [GO:0008417]; Notch binding [GO:0005112]; peptide-O-fucosyltransferase activity [GO:0046922]; cell-cell adhesion [GO:0098609]; endocytosis [GO:0006897]; fucose metabolic process [GO:0006004]; negative regulation of Notch signaling pathway [GO:0045746]; Notch signaling pathway [GO:0007219]; O-glycan processing [GO:0016266]; positive regulation of Notch signaling pathway [GO:0045747]; protein catabolic process [GO:0030163]; protein O-linked fucosylation [GO:0036066]; protein O-linked glycosylation [GO:0006493]; regulation of Notch signaling pathway [GO:0008593]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_OGFD1.1.1.m.10563,-0.013125726508418,-0.00188169661895003,No,NA,NA,Q5R4R3,NA,NA,NA,cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; peptidyl-proline 3-dioxygenase activity [GO:0031544]; peptidyl-proline dioxygenase activity [GO:0031543]; cell proliferation [GO:0008283]; protein hydroxylation [GO:0018126]; regulation of translational termination [GO:0006449]; stress granule assembly [GO:0034063],NA,NA,NA
CHOYP_OGFRL1.1.1.m.44422,-0.00381209920032183,0.0118096784419558,No,NA,NA,Q5TC84,NA,NA,NA,membrane [GO:0016020]; opioid receptor activity [GO:0004985],NA,NA,NA
CHOYP_OGT1.3.3.m.54325,-0.00232966659653441,-0.0201482352568379,No,NA,NA,P56558,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; zymogen granule [GO:0042588]; monosaccharide binding [GO:0048029]; peptide binding [GO:0042277]; phosphatidylinositol-3;4;5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to toxic substance [GO:0097237]; circadian regulation of gene expression [GO:0032922]; forebrain development [GO:0030900]; glucosamine metabolic process [GO:0006041]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; intracellular distribution of mitochondria [GO:0048312]; negative regulation of cell death [GO:0060548]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein targeting to membrane [GO:0090315]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cell size [GO:0045793]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of proteolysis [GO:0045862]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein heterotrimerization [GO:0070208]; protein homotrimerization [GO:0070207]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110],NA,NA,NA
CHOYP_OLA1.2.2.m.28588,0.0126276802442977,-0.0132103507732941,No,NA,NA,Q9NTK5,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleolus [GO:0005730]; platelet alpha granule lumen [GO:0031093]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; cadherin binding [GO:0045296]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]; ATP metabolic process [GO:0046034]; platelet degranulation [GO:0002576],NA,NA,NA
CHOYP_ONEC2.1.3.m.22857,-0.0183960061825198,-0.00761682223339788,No,NA,NA,O95948,NA,NA,NA,actin cytoskeleton [GO:0015629]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; cilium assembly [GO:0060271]; endocrine pancreas development [GO:0031018]; epithelial cell development [GO:0002064]; liver development [GO:0001889]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; peripheral nervous system neuron development [GO:0048935]; positive regulation of cell migration [GO:0030335]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell-matrix adhesion [GO:0001952],NA,NA,NA
CHOYP_ORC1.1.2.m.17178,-0.0106095887085099,0.00356091525933473,No,NA,NA,Q5RDD2,NA,NA,NA,nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_OS11G0657400.1.2.m.24816,0.00442719839874049,-0.00168268766535646,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_OSA.1.2.m.6579,0.00572281673966875,0.000868583630977691,No,NA,NA,Q8IN94,NA,NA,NA,brahma complex [GO:0035060]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; chromatin remodeling [GO:0006338]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; negative regulation of neuroblast proliferation [GO:0007406]; neuroblast fate commitment [GO:0014017]; photoreceptor cell differentiation [GO:0046530]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription; DNA-templated [GO:0006355]; segment specification [GO:0007379]; wing disc dorsal/ventral pattern formation [GO:0048190]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_OSBL6.1.1.m.24967,0.00723281313730656,0.000625240539307685,No,NA,NA,Q9BZF3,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; bile acid biosynthetic process [GO:0006699],NA,NA,NA
CHOYP_OSBL8.1.2.m.7583,0.0065883263884642,0.0180931628217626,No,NA,NA,B9EJ86,NA,NA,NA,cortical endoplasmic reticulum [GO:0032541]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; phospholipid transporter activity [GO:0005548]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; activation of protein kinase B activity [GO:0032148]; fat cell differentiation [GO:0045444]; negative regulation of cell migration [GO:0030336]; negative regulation of sequestering of triglyceride [GO:0010891]; phospholipid transport [GO:0015914]; positive regulation of glucose import [GO:0046326]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein kinase B signaling [GO:0051897]; protein localization to nuclear pore [GO:0090204],NA,NA,NA
CHOYP_OSBL9.1.2.m.17667,-0.0119557266801907,-0.0141716487269654,No,NA,NA,Q0IJ05,NA,NA,NA,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248],NA,NA,NA
CHOYP_OSBP1.1.1.m.12788,0.0131447155567743,-0.00349245044236126,No,NA,NA,P22059,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; lipid binding [GO:0008289]; oxysterol binding [GO:0008142]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein domain specific binding [GO:0019904]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; bile acid biosynthetic process [GO:0006699]; intracellular cholesterol transport [GO:0032367]; positive regulation of growth of symbiont in host [GO:0044128]; sterol transport [GO:0015918],NA,NA,NA
CHOYP_OSGEP.1.1.m.29582,-0.00562152381099367,0.00220723887551321,No,NA,NA,A7SXZ6,NA,NA,NA,cytoplasm [GO:0005737]; EKC/KEOPS complex [GO:0000408]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; N(6)-L-threonylcarbamoyladenine synthase activity [GO:0061711]; tRNA threonylcarbamoyladenosine modification [GO:0002949],NA,NA,NA
CHOYP_OSGI2.1.1.m.11055,-0.00212078832001384,-0.00891837260408135,No,NA,NA,Q9Y236,NA,NA,NA,growth factor activity [GO:0008083]; meiotic cell cycle [GO:0051321]; negative regulation of cell growth [GO:0030308],NA,NA,NA
CHOYP_OSHV1_GP010.1.2.m.28852,0.0065576251061469,-0.000292119224766405,No,NA,NA,Q6R7L4,NA,NA,NA,metal ion binding [GO:0046872],NA,NA,NA
CHOYP_OSHV1_GP010.1.2.m.28853,-0.0169591047060434,0.00960206869202777,No,NA,NA,Q6R7L3,NA,NA,NA,,NA,NA,NA
CHOYP_OSHV1_GP010.1.2.m.28854,0.00615966897194063,0.00941964587728867,No,NA,NA,Q6R7L5,NA,NA,NA,,NA,NA,NA
CHOYP_OST48.1.1.m.43513,-0.00317643690502909,0.00319898363631055,No,NA,NA,Q5R501,NA,NA,NA,integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]; protein glycosylation [GO:0006486]; protein N-linked glycosylation via asparagine [GO:0018279],NA,NA,NA
CHOYP_OSTA.1.1.m.11011,0.00678620130084429,0.00878741825264137,No,NA,NA,Q8R000,NA,NA,NA,basolateral plasma membrane [GO:0016323]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; bile acid transmembrane transporter activity [GO:0015125]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transmembrane transporter activity [GO:0022857]; bile acid and bile salt transport [GO:0015721]; bile acid secretion [GO:0032782]; organic substance transport [GO:0071702],NA,NA,NA
CHOYP_OTER_1386.1.1.m.15303,-0.00791632144374518,0.0164838556015939,No,NA,NA,Q5EA79,NA,NA,NA,cytoplasm [GO:0005737]; aldose 1-epimerase activity [GO:0004034]; carbohydrate binding [GO:0030246]; galactose catabolic process via UDP-galactose [GO:0033499]; glucose metabolic process [GO:0006006],NA,NA,NA
CHOYP_OTU5B.1.1.m.6212,0.00199103645874847,0.0171062431630731,No,NA,NA,Q6DHK1,NA,NA,NA,extracellular region [GO:0005576]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; NADHX epimerase activity [GO:0052856]; NADPHX epimerase activity [GO:0052857]; nucleotide binding [GO:0000166],NA,NA,NA
CHOYP_OTU6B.1.2.m.31547,-2.27864244174805e-05,-0.00170403692629686,No,NA,NA,Q7ZV00,NA,NA,NA,thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; protein deubiquitination [GO:0016579],NA,NA,NA
CHOYP_OTUB1.1.1.m.29705,0.00369603576678008,-0.0114608588931186,No,NA,NA,B2RYG6,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; NEDD8-specific protease activity [GO:0019784]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; adaptive immune response [GO:0002250]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to interleukin-1 [GO:0071347]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; protein K48-linked deubiquitination [GO:0071108],NA,NA,NA
CHOYP_OTX5B.1.1.m.10054,-0.0225644602574837,0.00998818146731795,No,NA,NA,Q9PT61,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; anterior/posterior pattern specification [GO:0009952]; eye photoreceptor cell fate commitment [GO:0042706]; positive regulation of rhodopsin gene expression [GO:0045872]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_OX2R.3.3.m.44161,0.000751231457871437,-0.00491388731138581,No,NA,NA,O43614,NA,NA,NA,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; orexin receptor activity [GO:0016499]; peptide hormone binding [GO:0017046]; chemical synaptic transmission [GO:0007268]; circadian sleep/wake cycle process [GO:0022410]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of circadian sleep/wake cycle; wakefulness [GO:0010840]; regulation of cytosolic calcium ion concentration [GO:0051480],NA,NA,NA
CHOYP_OXDD.1.4.m.2688,-0.00351530066557743,-0.0255014905517425,No,NA,NA,P31228,NA,NA,NA,cytosol [GO:0005829]; peroxisome [GO:0005777]; cofactor binding [GO:0048037]; D-amino-acid oxidase activity [GO:0003884]; D-aspartate oxidase activity [GO:0008445]; FAD binding [GO:0071949]; signaling receptor binding [GO:0005102]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; D-amino acid catabolic process [GO:0019478]; D-amino acid metabolic process [GO:0046416],NA,NA,NA
CHOYP_OXSM.1.1.m.30217,0.00205195042830452,-0.00934116934689426,No,NA,NA,Q9NWU1,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; acyl-CoA metabolic process [GO:0006637]; medium-chain fatty acid biosynthetic process [GO:0051792]; short-chain fatty acid biosynthetic process [GO:0051790],NA,NA,NA
CHOYP_P121C.1.1.m.57092,0.00398211018353641,-0.0147009985499016,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_P20D2.1.2.m.9005,0.00388855029061886,0.00552083159844129,No,NA,NA,A3KG59,NA,NA,NA,nucleoplasm [GO:0005654]; dipeptidase activity [GO:0016805]; proteolysis [GO:0006508]; regulation of cellular protein metabolic process [GO:0032268],NA,NA,NA
CHOYP_P20D2.1.2.m.9006,-0.0123529219364733,-0.00939301213793626,No,NA,NA,Q8IYS1,NA,NA,NA,nucleoplasm [GO:0005654]; dipeptidase activity [GO:0016805]; proteolysis [GO:0006508]; regulation of cellular protein metabolic process [GO:0032268],NA,NA,NA
CHOYP_P20D2.2.2.m.47191,-0.00739328018171712,0.0205470339428015,No,NA,NA,Q8IYS1,NA,NA,NA,nucleoplasm [GO:0005654]; dipeptidase activity [GO:0016805]; proteolysis [GO:0006508]; regulation of cellular protein metabolic process [GO:0032268],NA,NA,NA
CHOYP_P3A2.1.3.m.11560,-0.00516303534838974,-0.013321810572865,No,NA,NA,Q04073,NA,NA,NA,nucleus [GO:0005634]; core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_P4HA1.4.5.m.59821,-0.0228762306215681,0.00573434291868412,No,NA,NA,Q10576,NA,NA,NA,cell [GO:0005623]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity; acting on single donors with incorporation of molecular oxygen; incorporation of two atoms of oxygen [GO:0016702]; peptidyl-proline 4-dioxygenase activity [GO:0031545]; procollagen-proline 4-dioxygenase activity [GO:0004656]; collagen and cuticulin-based cuticle development [GO:0040002]; cuticle development involved in collagen and cuticulin-based cuticle molting cycle [GO:0042338]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic body morphogenesis [GO:0010172]; macromolecule modification [GO:0043412]; oxidation-reduction process [GO:0055114]; peptidyl-proline hydroxylation [GO:0019511]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of multicellular organism growth [GO:0040018],NA,NA,NA
CHOYP_P4R3A.1.1.m.1043,-0.0150864560562341,-0.0165318183974739,No,NA,NA,Q5SP90,NA,NA,NA,,NA,NA,NA
CHOYP_P66A.1.1.m.22279,-0.00797980454586623,-0.012348350918022,No,NA,NA,Q86YP4,NA,NA,NA,nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; protein binding; bridging [GO:0030674]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; DNA methylation [GO:0006306]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892],NA,NA,NA
CHOYP_PA1B2.1.2.m.10637,-0.0112203485597868,-0.00706514861272485,No,NA,NA,O35264,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; plasma membrane [GO:0005886]; 1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; platelet-activating factor acetyltransferase activity [GO:0047179]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; brain development [GO:0007420]; lipid catabolic process [GO:0016042]; positive regulation of macroautophagy [GO:0016239]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_PABP2.1.1.m.12768,-0.0181551319342124,-0.0158299658795441,No,NA,NA,Q7KNF2,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]; mRNA splicing; via spliceosome [GO:0000398]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of polynucleotide adenylyltransferase activity [GO:1904247]; positive regulation of protein glycosylation [GO:0060050],NA,NA,NA
CHOYP_PABP4.4.6.m.38167,0.00251885699526234,-0.00442290624383662,No,NA,NA,Q13310,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; blood coagulation [GO:0007596]; myeloid cell development [GO:0061515]; regulation of mRNA stability [GO:0043488]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; translation [GO:0006412],NA,NA,NA
CHOYP_PABP4.5.6.m.38922,-0.0135725579708753,0.00388604629968508,No,NA,NA,Q9EPH8,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; messenger ribonucleoprotein complex [GO:1990124]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; synapse [GO:0045202]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; gene silencing by RNA [GO:0031047]; mRNA processing [GO:0006397]; negative regulation of nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; positive regulation of nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_PACN2.2.2.m.25018,-0.00719896745737234,0.00303216392645171,No,NA,NA,Q9WVE8,NA,NA,NA,caveola [GO:0005901]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; extrinsic component of membrane [GO:0019898]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; phosphatidic acid binding [GO:0070300]; phospholipid binding [GO:0005543]; actin cytoskeleton organization [GO:0030036]; caveola assembly [GO:0070836]; caveolin-mediated endocytosis [GO:0072584]; cell projection morphogenesis [GO:0048858]; cytoskeleton organization [GO:0007010]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of endocytosis [GO:0045806]; plasma membrane tubulation [GO:0097320]; protein localization to endosome [GO:0036010]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_PAGR1.1.1.m.18447,-0.000852529081374972,0.00426804227651665,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PAK1.1.1.m.50796,0.00668394879416591,0.0140419645781025,No,NA,NA,Q08E52,NA,NA,NA,actin filament [GO:0005884]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; invadopodium [GO:0071437]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; collagen binding [GO:0005518]; protein serine/threonine kinase activity [GO:0004674]; Rac GTPase binding [GO:0048365]; actin cytoskeleton reorganization [GO:0031532]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration [GO:0016477]; exocytosis [GO:0006887]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of MAPK cascade [GO:0043408]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]; wound healing [GO:0042060],NA,NA,NA
CHOYP_PAK7.1.1.m.35662,-0.0139189109401273,0.0115820148816922,No,NA,NA,Q5R8Z4,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; learning [GO:0007612]; locomotory behavior [GO:0007626]; memory [GO:0007613],NA,NA,NA
CHOYP_PAN2.1.1.m.44690,0.00644143862796382,-0.0156119723465497,No,NA,NA,A1Z7K9,NA,NA,NA,nucleus [GO:0005634]; P-body [GO:0000932]; PAN complex [GO:0031251]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; poly(A)-specific ribonuclease activity [GO:0004535]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606],NA,NA,NA
CHOYP_PAN2.1.1.m.44691,-0.00772368390355991,0.0177666153659572,No,NA,NA,Q25381,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_PAN2.1.1.m.44693,-0.00779914847970151,-0.0203025513971623,No,NA,NA,Q92193,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_PANG1.1.2.m.10756,-0.00930772341894908,0.00374702308762843,No,NA,NA,P91943,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; beta-catenin binding [GO:0008013]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; kinase binding [GO:0019900]; repressing transcription factor binding [GO:0070491]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; canonical Wnt signaling pathway [GO:0060070]; embryonic pattern specification [GO:0009880]; heart development [GO:0007507]; imaginal disc-derived wing morphogenesis [GO:0007476]; mesodermal cell fate determination [GO:0007500]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription; DNA-templated [GO:0006355]; salivary gland morphogenesis [GO:0007435]; segment polarity determination [GO:0007367]; spiracle morphogenesis; open tracheal system [GO:0035277]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_PAPOG.1.2.m.33182,-0.00258838128428154,0.00652900207764109,No,NA,NA,Q6PCL9,NA,NA,NA,cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]; RNA polyadenylation [GO:0043631],NA,NA,NA
CHOYP_PAPSS.1.1.m.53055,0.00360795961236855,0.013250118392747,No,NA,NA,Q27128,NA,NA,NA,adenylylsulfate kinase activity [GO:0004020]; ATP binding [GO:0005524]; nucleotidyltransferase activity [GO:0016779]; sulfate adenylyltransferase (ATP) activity [GO:0004781]; sulfate assimilation [GO:0000103],NA,NA,NA
CHOYP_PAR14.15.17.m.60687,0.0163716340171692,-0.00903064750039895,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PAR15.2.6.m.21081,0.00233030015162955,-0.00705680108868803,No,NA,NA,O43734,NA,NA,NA,signaling receptor binding [GO:0005102]; B cell apoptotic process [GO:0001783]; humoral immune response [GO:0006959]; immunoglobulin secretion [GO:0048305]; intracellular signal transduction [GO:0035556]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123],NA,NA,NA
CHOYP_PAR15.5.6.m.60634,-0.00430894344577715,-0.00631540690244347,No,NA,NA,Q8BZH4,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; cell division [GO:0051301]; kinetochore assembly [GO:0051382]; mitotic sister chromatid cohesion [GO:0007064]; regulation of gene expression [GO:0010468],NA,NA,NA
CHOYP_PARG.1.1.m.24813,-0.00936916904817588,0.0183451094884363,No,NA,NA,O02776,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; poly(ADP-ribose) glycohydrolase activity [GO:0004649]; ATP generation from poly-ADP-D-ribose [GO:1990966]; carbohydrate metabolic process [GO:0005975]; nucleotide-sugar metabolic process [GO:0009225]; regulation of DNA repair [GO:0006282],NA,NA,NA
CHOYP_PARN.1.1.m.19023,-0.00353245349860563,-0.00952669476258743,No,NA,NA,Q90ZA1,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; cation binding [GO:0043169]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; meiotic cell cycle [GO:0051321]; mRNA catabolic process [GO:0006402],NA,NA,NA
CHOYP_PARP12.1.2.m.42887,-0.0130144906362448,0.005580916349301,No,NA,NA,Q9H0J9,NA,NA,NA,nucleus [GO:0005634]; metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_PARP14.14.22.m.52621,-0.0012723078518811,0.00395723122041644,No,NA,NA,Q460N5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein poly-ADP-ribosylation [GO:0070212],NA,NA,NA
CHOYP_PARP16.1.1.m.1294,0.00762089256734654,0.00228740676146637,No,NA,NA,Q5U2Q4,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; kinase binding [GO:0019900]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein serine/threonine kinase activator activity [GO:0043539]; endoplasmic reticulum unfolded protein response [GO:0030968]; protein ADP-ribosylation [GO:0006471],NA,NA,NA
CHOYP_PARP8.1.1.m.55346,0.00217997094733793,-0.00807271368859912,No,NA,NA,Q8N3A8,NA,NA,NA,intracellular [GO:0005622]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylation [GO:0006471],NA,NA,NA
CHOYP_PAT3.1.4.m.21678,-0.000981689989766561,-0.016682539092557,No,NA,NA,Q27874,NA,NA,NA,basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell surface [GO:0009986]; focal adhesion [GO:0005925]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; M band [GO:0031430]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; striated muscle dense body [GO:0055120]; integrin binding [GO:0005178]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; integrin-mediated signaling pathway [GO:0007229]; mitochondrion organization [GO:0007005]; muscle cell cellular homeostasis [GO:0046716]; muscle cell development [GO:0055001]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; positive regulation of distal tip cell migration [GO:1903356]; positive regulation of locomotion [GO:0040017]; positive regulation of myosin II filament organization [GO:1904901]; positive regulation of ovulation [GO:0060279]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of smooth muscle contraction [GO:0045987]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of distal tip cell migration [GO:1903354]; regulation of vulval development [GO:0040028]; striated muscle cell development [GO:0055002]; vulval cell fate specification [GO:0072327],NA,NA,NA
CHOYP_PAT3.4.4.m.54228,0.00615966897194063,0.00941964587728867,No,NA,NA,Q27874,NA,NA,NA,basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell surface [GO:0009986]; focal adhesion [GO:0005925]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; M band [GO:0031430]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; striated muscle dense body [GO:0055120]; integrin binding [GO:0005178]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; integrin-mediated signaling pathway [GO:0007229]; mitochondrion organization [GO:0007005]; muscle cell cellular homeostasis [GO:0046716]; muscle cell development [GO:0055001]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; positive regulation of distal tip cell migration [GO:1903356]; positive regulation of locomotion [GO:0040017]; positive regulation of myosin II filament organization [GO:1904901]; positive regulation of ovulation [GO:0060279]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of smooth muscle contraction [GO:0045987]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of distal tip cell migration [GO:1903354]; regulation of vulval development [GO:0040028]; striated muscle cell development [GO:0055002]; vulval cell fate specification [GO:0072327],NA,NA,NA
CHOYP_PAX2A.1.2.m.10577,-0.0105021730230357,-0.00856324736655567,No,NA,NA,Q02962,NA,NA,NA,centriolar satellite [GO:0034451]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; microtubule organizing center [GO:0005815]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; proximal promoter sequence-specific DNA binding [GO:0000987]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; aging [GO:0007568]; axonogenesis [GO:0007409]; brain morphogenesis [GO:0048854]; branching involved in ureteric bud morphogenesis [GO:0001658]; camera-type eye development [GO:0043010]; cell fate determination [GO:0001709]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to glucose stimulus [GO:0071333]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to retinoic acid [GO:0071300]; cochlea development [GO:0090102]; cochlea morphogenesis [GO:0090103]; glial cell differentiation [GO:0010001]; inner ear morphogenesis [GO:0042472]; mesenchymal to epithelial transition [GO:0060231]; mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003337]; mesodermal cell fate specification [GO:0007501]; mesonephros development [GO:0001823]; metanephric collecting duct development [GO:0072205]; metanephric distal convoluted tubule development [GO:0072221]; metanephric epithelium development [GO:0072207]; metanephric mesenchymal cell differentiation [GO:0072162]; metanephric mesenchyme development [GO:0072075]; metanephric nephron tubule formation [GO:0072289]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic process involved in metanephric collecting duct development [GO:1900215]; negative regulation of apoptotic process involved in metanephric nephron tubule development [GO:1900218]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of cytolysis [GO:0045918]; negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis [GO:0072305]; negative regulation of mesenchymal cell apoptotic process involved in metanephros development [GO:1900212]; negative regulation of programmed cell death [GO:0043069]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription; DNA-templated [GO:0045892]; nephric duct formation [GO:0072179]; neural tube closure [GO:0001843]; optic chiasma development [GO:0061360]; optic cup morphogenesis involved in camera-type eye development [GO:0002072]; optic nerve development [GO:0021554]; optic nerve morphogenesis [GO:0021631]; optic nerve structural organization [GO:0021633]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0072108]; positive regulation of metanephric DCT cell differentiation [GO:2000594]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of optic nerve formation [GO:2000597]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; pronephric field specification [GO:0039003]; pronephros development [GO:0048793]; protein kinase B signaling [GO:0043491]; reactive oxygen species metabolic process [GO:0072593]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]; regulation of metanephros size [GO:0035566]; response to nutrient levels [GO:0031667]; retinal pigment epithelium development [GO:0003406]; stem cell differentiation [GO:0048863]; transcription by RNA polymerase II [GO:0006366]; transcription; DNA-templated [GO:0006351]; ureter development [GO:0072189]; ureter maturation [GO:0035799]; urogenital system development [GO:0001655]; vestibulocochlear nerve formation [GO:0021650]; visual perception [GO:0007601],NA,NA,NA
CHOYP_PAXB1.1.2.m.42816,0.0023713887124008,0.00761682071694777,No,NA,NA,Q9Z1W9,NA,NA,NA,apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; cellular hypotonic response [GO:0071476]; cellular response to chemokine [GO:1990869]; chemokine (C-X-C motif) ligand 12 signaling pathway [GO:0038146]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; maintenance of lens transparency [GO:0036438]; negative regulation of creatine transmembrane transporter activity [GO:1905408]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of ion transmembrane transporter activity [GO:0032414]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of T cell chemotaxis [GO:0010820]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; signal transduction by protein phosphorylation [GO:0023014]; signal transduction by trans-phosphorylation [GO:0023016]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_PB1.2.6.m.11467,0.00484402381882144,0.007933924674708,No,NA,NA,Q90941,NA,NA,NA,RSC-type complex [GO:0016586]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; ATP-dependent chromatin remodeling [GO:0043044]; nucleosome disassembly [GO:0006337]; transcription elongation from RNA polymerase II promoter [GO:0006368],NA,NA,NA
CHOYP_PC11X.1.2.m.24796,-0.00306591376358094,-0.00596445405552727,No,NA,NA,Q8IW45,NA,NA,NA,mitochondrial matrix [GO:0005759]; ADP-dependent NAD(P)H-hydrate dehydratase activity [GO:0052855]; ATP binding [GO:0005524]; ATP-dependent NAD(P)H-hydrate dehydratase activity [GO:0047453]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356],NA,NA,NA
CHOYP_PC2.1.2.m.34944,-0.00740239466037838,-0.0200619836803666,No,NA,NA,Q8JHV9,NA,NA,NA,cytoplasm [GO:0005737]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; protein autoubiquitination [GO:0051865],NA,NA,NA
CHOYP_PC2.1.2.m.34945,-0.00115066699412332,-0.0225299182786841,No,NA,NA,Q03333,NA,NA,NA,extracellular space [GO:0005615]; membrane [GO:0016020]; neuron projection [GO:0043005]; transport vesicle [GO:0030133]; serine-type endopeptidase activity [GO:0004252]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485],NA,NA,NA
CHOYP_PCCA.2.2.m.45684,-0.00472212045135145,-0.0114996366378325,No,NA,NA,Q91ZA3,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; propionyl-CoA carboxylase activity [GO:0004658],NA,NA,NA
CHOYP_PCCB.1.2.m.3057,-0.0143534651513131,-0.0153028653358506,No,NA,NA,Q13231,NA,NA,NA,extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; endochitinase activity [GO:0008843]; hydrolase activity; hydrolyzing O-glycosyl compounds [GO:0004553]; chitin catabolic process [GO:0006032]; immune response [GO:0006955]; neutrophil degranulation [GO:0043312]; polysaccharide catabolic process [GO:0000272]; polysaccharide digestion [GO:0044245]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_PCCB.1.2.m.3058,-0.00991484708079514,0.00615857919219933,No,NA,NA,P05166,NA,NA,NA,cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; propionyl-CoA carboxylase activity [GO:0004658]; biotin metabolic process [GO:0006768],NA,NA,NA
CHOYP_PCDH1.2.3.m.8055,0.00217997094733793,-0.00807271368859912,No,NA,NA,Q9HC56,NA,NA,NA,cell-cell contact zone [GO:0044291]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],NA,NA,NA
CHOYP_PCDH1.3.3.m.63887,0.00394536801625317,0.00291369700370642,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PCDH7.1.3.m.6236,0.00205195042830452,-0.00934116934689427,No,NA,NA,Q6KEQ9,NA,NA,NA,integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of phosphatase activity [GO:0010923],NA,NA,NA
CHOYP_PCDH9.2.5.m.34196,-0.00156255989643051,-0.00771786269160374,No,NA,NA,Q6WYY1,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of phosphatase activity [GO:0010923],NA,NA,NA
CHOYP_PCDH9.4.5.m.58558,0.0110025269977182,0.00744659405696438,No,NA,NA,Q9HC56,NA,NA,NA,cell-cell contact zone [GO:0044291]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],NA,NA,NA
CHOYP_PCDH9.5.5.m.59488,0.00534520493065609,-0.0079563926649694,No,NA,NA,O95453,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; cation binding [GO:0043169]; metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; nuclease activity [GO:0004518]; poly(A)-specific ribonuclease activity [GO:0004535]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; box H/ACA snoRNA 3'-end processing [GO:0000495]; female gamete generation [GO:0007292]; miRNA catabolic process [GO:0010587]; ncRNA deadenylation [GO:0110008]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of mRNA stability [GO:0043488]; regulation of telomerase RNA localization to Cajal body [GO:1904872]; RNA modification [GO:0009451]; RNA phosphodiester bond hydrolysis; exonucleolytic [GO:0090503]; telomerase RNA stabilization [GO:0090669],NA,NA,NA
CHOYP_PCF11.1.1.m.49191,0.00603962643606558,0.00666805361356913,No,NA,NA,O94913,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; mRNA cleavage factor complex [GO:0005849]; nucleoplasm [GO:0005654]; mRNA binding [GO:0003729]; RNA polymerase II complex binding [GO:0000993]; mRNA 3'-end processing [GO:0031124]; mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378]; mRNA splicing; via spliceosome [GO:0000398]; termination of RNA polymerase II transcription [GO:0006369],NA,NA,NA
CHOYP_PCH2.1.1.m.7113,0.0035684805680491,0.000148929459033914,No,NA,NA,Q6P4W8,NA,NA,NA,chromosome [GO:0005694]; nucleus [GO:0005634]; ATP binding [GO:0005524]; double-strand break repair [GO:0006302]; meiotic recombination checkpoint [GO:0051598]; oogenesis [GO:0048477]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130],NA,NA,NA
CHOYP_PCID2.1.1.m.28679,-0.00493346741814875,-0.013081256210063,No,NA,NA,Q5JVF3,NA,NA,NA,transcription export complex 2 [GO:0070390]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity [GO:2000117]; nuclear retention of pre-mRNA at the site of transcription [GO:0071033]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of transcription; DNA-templated [GO:0045893]; posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; regulation of mRNA stability [GO:0043488]; spleen development [GO:0048536]; transcription elongation from RNA polymerase II promoter [GO:0006368],NA,NA,NA
CHOYP_PCKG.1.2.m.43784,0.00188553752720198,0.00991910935186169,No,NA,NA,P05153,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; DBD domain binding [GO:0050692]; epinephrine binding [GO:0051379]; GTP binding [GO:0005525]; inosine kinase activity [GO:0008906]; malate oxidase activity [GO:0019157]; manganese ion binding [GO:0030145]; mRNA binding [GO:0003729]; nucleoside diphosphate kinase activity [GO:0004550]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; protein-disulfide reductase activity [GO:0047134]; sequence-specific DNA binding [GO:0043565]; adult feeding behavior [GO:0008343]; aging [GO:0007568]; alanine metabolic process [GO:0006522]; aspartate metabolic process [GO:0006531]; cellular response to cAMP [GO:0071320]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to ethanol [GO:0071361]; cellular response to fructose stimulus [GO:0071332]; cellular response to glucagon stimulus [GO:0071377]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to interleukin-1 [GO:0071347]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to retinoic acid [GO:0071300]; cellular response to tumor necrosis factor [GO:0071356]; developmental growth [GO:0048589]; digestion [GO:0007586]; eggshell formation [GO:0030703]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic organ morphogenesis [GO:0048562]; gluconeogenesis [GO:0006094]; glutamate metabolic process [GO:0006536]; glutamine metabolic process [GO:0006541]; glycerol biosynthetic process from pyruvate [GO:0046327]; glycerol catabolic process [GO:0019563]; glycine metabolic process [GO:0006544]; hepatocyte differentiation [GO:0070365]; intestinal absorption [GO:0050892]; kidney interstitial fibroblast differentiation [GO:0072071]; lactate metabolic process [GO:0006089]; lipid catabolic process [GO:0016042]; malate transport [GO:0015743]; NADH regeneration [GO:0006735]; negative regulation of carbohydrate metabolic process [GO:0045912]; oviposition [GO:0018991]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of carbohydrate metabolic process [GO:0045913]; positive regulation of gluconeogenesis [GO:0045722]; proline metabolic process [GO:0006560]; propionate catabolic process [GO:0019543]; pyruvate metabolic process [GO:0006090]; regulation of feeding behavior [GO:0060259]; regulation of gluconeogenesis [GO:0006111]; regulation of transcription by glucose [GO:0046015]; response to cAMP [GO:0051591]; response to cycloheximide [GO:0046898]; response to glucocorticoid [GO:0051384]; response to interleukin-6 [GO:0070741]; response to lipid [GO:0033993]; response to lipopolysaccharide [GO:0032496]; response to methionine [GO:1904640]; response to starvation [GO:0042594]; serine family amino acid metabolic process [GO:0009069]; sexual reproduction [GO:0019953]; vitellogenesis [GO:0007296],NA,NA,NA
CHOYP_PCKG.1.2.m.43785,0.00739989919963719,0.0144949016781256,No,NA,NA,P29190,NA,NA,NA,GTP binding [GO:0005525]; metal ion binding [GO:0046872]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; gluconeogenesis [GO:0006094],NA,NA,NA
CHOYP_PCKG.2.2.m.50139,-0.005105191342264,0.018142197642862,No,NA,NA,P29190,NA,NA,NA,GTP binding [GO:0005525]; metal ion binding [GO:0046872]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; gluconeogenesis [GO:0006094],NA,NA,NA
CHOYP_PCP.1.1.m.59309,-0.0104071960218366,0.00997469109837165,No,NA,NA,Q2TA14,NA,NA,NA,lysosome [GO:0005764]; carboxypeptidase activity [GO:0004180]; dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236]; angiogenesis involved in wound healing [GO:0060055]; negative regulation of systemic arterial blood pressure [GO:0003085]; proteolysis [GO:0006508]; regulation of blood vessel endothelial cell migration [GO:0043535],NA,NA,NA
CHOYP_PCS.1.1.1.m.8305,0.00491588973115351,-0.000600714720400964,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PCX1.1.1.m.55309,-0.00430894344577715,-0.00631540690244347,No,NA,NA,Q96RV3,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_PCYB_062570.1.1.m.58917,0.00205195042830452,-0.00934116934689426,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PDCD2L.1.1.m.43699,0.00213254472543359,-0.013858864475959,No,NA,NA,Q5ZID2,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_PDCL3.1.1.m.7323,0.0170907192056163,-0.00786096461517645,No,NA,NA,Q5RB77,NA,NA,NA,cytoplasm [GO:0005737]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; viral process [GO:0016032],NA,NA,NA
CHOYP_PDDC1.1.1.m.16484,-0.00168386038203362,-0.00634637610565821,No,NA,NA,Q8BFQ8,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_PDE11.1.3.m.8788,0.00491588973115351,-0.000600714720400962,No,NA,NA,Q9VJ79,NA,NA,NA,cytosol [GO:0005829]; 3';5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3';5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; metal ion binding [GO:0046872]; cAMP metabolic process [GO:0046058]; cGMP metabolic process [GO:0046068]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_PDE2A.3.3.m.60225,-0.00211875488266749,-0.00454645726286277,No,NA,NA,P14099,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; 3';5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3';5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; drug binding [GO:0008144]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; cAMP-mediated signaling [GO:0019933]; cellular response to cGMP [GO:0071321]; cellular response to drug [GO:0035690]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to mechanical stimulus [GO:0071260]; cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; establishment of endothelial barrier [GO:0061028]; GMP catabolic process [GO:0046038]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of protein import into nucleus; translocation [GO:0033159]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular permeability [GO:0043116]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of vascular permeability [GO:0043117]; regulation of mitochondrion organization [GO:0010821]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_PDE3A.1.3.m.22256,0.00795161477962726,0.00869597786798292,No,NA,NA,Q14432,NA,NA,NA,cytosol [GO:0005829]; integral component of membrane [GO:0016021]; 3';5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3';5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cGMP-inhibited cyclic-nucleotide phosphodiesterase activity [GO:0004119]; metal ion binding [GO:0046872]; cAMP-mediated signaling [GO:0019933]; cellular response to cGMP [GO:0071321]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cGMP-mediated signaling [GO:0019934]; G protein-coupled receptor signaling pathway [GO:0007186]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of vascular permeability [GO:0043116]; oocyte maturation [GO:0001556]; positive regulation of oocyte development [GO:0060282]; positive regulation of vascular permeability [GO:0043117]; regulation of meiotic nuclear division [GO:0040020]; response to drug [GO:0042493],NA,NA,NA
CHOYP_PDE6D.1.2.m.6439,-0.0101864835584031,-0.0201198583743324,No,NA,NA,O55057,NA,NA,NA,cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; 3';5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; GTPase inhibitor activity [GO:0005095]; Rab GTPase binding [GO:0017137]; phototransduction [GO:0007602]; visual perception [GO:0007601],NA,NA,NA
CHOYP_PDHA.1.1.1.m.67024,-0.00948435987106234,-0.0157257839559412,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PDHA1.1.1.m.42807,0.00702448235977375,-0.00448896158751434,No,NA,NA,P52899,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glycolytic process [GO:0006096],NA,NA,NA
CHOYP_PDIA1.1.1.m.5297,0.0180621074068892,-0.016642150899301,No,NA,NA,P04785,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; melanosome [GO:0042470]; procollagen-proline 4-dioxygenase complex [GO:0016222]; enzyme binding [GO:0019899]; integrin binding [GO:0005178]; peptide disulfide oxidoreductase activity [GO:0015037]; procollagen-proline 4-dioxygenase activity [GO:0004656]; protein disulfide isomerase activity [GO:0003756]; protein heterodimerization activity [GO:0046982]; cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-7 [GO:0098761]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976],NA,NA,NA
CHOYP_PDIA3.1.1.m.60223,0.00104689831395018,-0.00188642339841598,No,NA,NA,Q8JG64,NA,NA,NA,cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470]; MHC class I peptide loading complex [GO:0042824]; myelin sheath [GO:0043209]; identical protein binding [GO:0042802]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]; cellular response to interleukin-7 [GO:0098761]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976],NA,NA,NA
CHOYP_PDIA4.1.1.m.54958,0.0144464423758397,0.000203100547179476,No,NA,NA,P13667,NA,NA,NA,cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; RNA binding [GO:0003723]; cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976],NA,NA,NA
CHOYP_PDIA6.1.2.m.9012,0.015485935765974,0.00816593691022246,No,NA,NA,Q922R8,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular space [GO:0005615]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527],NA,NA,NA
CHOYP_PDIA6.2.2.m.58490,-0.0210743227949229,-0.00117717999704864,No,NA,NA,P38661,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454],NA,NA,NA
CHOYP_PDLI1.2.2.m.2094,0.018887080114584,0.0113748660293559,No,NA,NA,Q5E9E1,NA,NA,NA,cytoskeleton [GO:0005856]; transcription factor complex [GO:0005667]; Z disc [GO:0030018]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_PDS5B.1.1.m.16690,0.0115381263755662,-0.0181475197167734,No,NA,NA,Q4VA53,NA,NA,NA,chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; cell division [GO:0051301]; DNA repair [GO:0006281]; enteric nervous system development [GO:0048484]; lens development in camera-type eye [GO:0002088]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of cell proliferation [GO:0008285]; neuroblast migration [GO:0097402]; regulation of cell proliferation [GO:0042127],NA,NA,NA
CHOYP_PDXDC1.1.1.m.11298,-0.00494371625098158,-0.0217206350658273,No,NA,NA,Q99K01,NA,NA,NA,endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; sphinganine-1-phosphate aldolase activity [GO:0008117]; ameboidal-type cell migration [GO:0001667]; carboxylic acid metabolic process [GO:0019752]; sphingolipid catabolic process [GO:0030149]; sphingolipid metabolic process [GO:0006665],NA,NA,NA
CHOYP_PDXK.1.1.m.14904,0.00627449972313726,0.0167801825122108,No,NA,NA,P82197,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; pyridoxal kinase activity [GO:0008478]; pyridoxal 5'-phosphate salvage [GO:0009443],NA,NA,NA
CHOYP_PDZRN3.1.1.m.18229,0.00678620130084429,0.00878741825264137,No,NA,NA,Q69ZS0,NA,NA,NA,cell junction [GO:0030054]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; neuromuscular junction development [GO:0007528]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_PE2R3.2.2.m.61863,0.00394536801625317,0.00291369700370642,No,NA,NA,O75382,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; protein C-terminus binding [GO:0008022]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; nervous system development [GO:0007399]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031],NA,NA,NA
CHOYP_PEAR1.10.16.m.42850,-0.00212078832001384,-0.00891837260408135,No,NA,NA,O75095,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_PEAR1.6.16.m.37314,0.00394536801625317,0.00291369700370642,No,NA,NA,P59222,NA,NA,NA,integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157],NA,NA,NA
CHOYP_PEAR1.8.16.m.41400,-0.0166281333979896,-0.0199167321086701,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PECR.1.1.m.58859,-0.00380177000273738,0.00607629319660377,No,NA,NA,Q9WVK3,NA,NA,NA,intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; trans-2-enoyl-CoA reductase (NADPH) activity [GO:0019166]; fatty acid biosynthetic process [GO:0006633]; oxidation-reduction process [GO:0055114]; phytol metabolic process [GO:0033306],NA,NA,NA
CHOYP_PELO.1.1.m.14458,0.00298368418405604,0.00047745743191796,No,NA,NA,P48612,NA,NA,NA,cytoplasm [GO:0005737]; Dom34-Hbs1 complex [GO:1990533]; nucleus [GO:0005634]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; ribosome binding [GO:0043022]; compound eye morphogenesis [GO:0001745]; female germ-line stem cell asymmetric division [GO:0048132]; G2/MI transition of meiotic cell cycle [GO:0008315]; germ-line stem cell population maintenance [GO:0030718]; male meiosis I [GO:0007141]; meiotic cell cycle [GO:0051321]; meiotic nuclear envelope disassembly [GO:0051078]; meiotic spindle organization [GO:0000212]; nonfunctional rRNA decay [GO:0070651]; nuclear-transcribed mRNA catabolic process; no-go decay [GO:0070966]; nuclear-transcribed mRNA catabolic process; non-stop decay [GO:0070481]; posttranscriptional gene silencing [GO:0016441]; ribosome disassembly [GO:0032790]; RNA surveillance [GO:0071025]; spermatocyte division [GO:0048137],NA,NA,NA
CHOYP_PEO1.1.1.m.14775,0.00217997094733793,-0.00807271368859912,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PEPM.1.1.m.14235,-0.00272213494212711,-0.0152895101139076,No,NA,NA,P56839,NA,NA,NA,metal ion binding [GO:0046872]; phosphoenolpyruvate mutase activity [GO:0050188]; organic phosphonate biosynthetic process [GO:0032923],NA,NA,NA
CHOYP_PERMA_0370.1.1.m.41998,0.000363164493913934,0.000551159317708471,No,NA,NA,Q9VFD5,NA,NA,NA,ubiquitin-protein transferase activity [GO:0004842]; regulation of ubiquitin-protein transferase activity [GO:0051438],NA,NA,NA
CHOYP_PERQ2.2.2.m.40796,-0.0163503513280505,-0.012567948684624,No,NA,NA,O75420,NA,NA,NA,protein-containing complex [GO:0032991]; insulin-like growth factor receptor signaling pathway [GO:0048009],NA,NA,NA
CHOYP_PESC.1.1.m.16875,0.016442107636419,-0.0201579675372778,No,NA,NA,Q7ZY69,NA,NA,NA,nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; PeBoW complex [GO:0070545]; preribosome; large subunit precursor [GO:0030687]; ribonucleoprotein complex binding [GO:0043021]; cell proliferation [GO:0008283]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000463],NA,NA,NA
CHOYP_PEX2.2.2.m.26981,-0.00215067451294669,-0.0243089296232412,No,NA,NA,P40855,NA,NA,NA,brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; ATPase binding [GO:0051117]; peroxisome membrane class-1 targeting sequence binding [GO:0036105]; protein N-terminus binding [GO:0047485]; chaperone-mediated protein folding [GO:0061077]; chaperone-mediated protein transport [GO:0072321]; establishment of protein localization to peroxisome [GO:0072663]; negative regulation of lipid binding [GO:1900131]; peroxisome fission [GO:0016559]; peroxisome membrane biogenesis [GO:0016557]; peroxisome organization [GO:0007031]; protein import into peroxisome membrane [GO:0045046]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625]; transmembrane transport [GO:0055085],NA,NA,NA
CHOYP_PF10_0308.1.1.m.43529,0.0157224834688262,-0.000285733369008537,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PFB0115W.2.2.m.65461,-0.00695067611489325,0.0019810902912176,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PFD3.1.1.m.56418,0.00607903403945457,-0.00245413186733725,No,NA,NA,Q5RCG9,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; protein folding [GO:0006457],NA,NA,NA
CHOYP_PGBM.2.3.m.44777,0.0154076238507111,-0.0076009566132883,No,NA,NA,Q810U3,NA,NA,NA,axon [GO:0030424]; axon initial segment [GO:0043194]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; myelin sheath [GO:0043209]; node of Ranvier [GO:0033268]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; Schwann cell microvillus [GO:0097454]; septate junction [GO:0005918]; protein binding involved in heterotypic cell-cell adhesion [GO:0086080]; protein domain specific binding [GO:0019904]; axon guidance [GO:0007411]; clustering of voltage-gated sodium channels [GO:0045162]; paranodal junction assembly [GO:0030913]; peripheral nervous system development [GO:0007422]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; protein localization to plasma membrane [GO:0072659]; synapse organization [GO:0050808]; transmission of nerve impulse [GO:0019226],NA,NA,NA
CHOYP_PGDH.3.5.m.36973,-0.0112818376402943,0.0178183955740096,No,NA,NA,Q8VCC1,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; protein homodimerization activity [GO:0042803]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_PGDH.5.5.m.66725,0.0125088687081833,-0.0105400195854625,No,NA,NA,P15428,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; protein homodimerization activity [GO:0042803]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; lipoxin biosynthetic process [GO:2001301]; lipoxygenase pathway [GO:0019372]; long-chain fatty acid biosynthetic process [GO:0042759]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_PGK1.1.1.m.27254,0.0106317669862538,0.0163392112726793,No,NA,NA,Q3T0P6,NA,NA,NA,cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; phosphoglycerate kinase activity [GO:0004618]; protein-disulfide reductase activity [GO:0047134]; cellular response to hypoxia [GO:0071456]; chemical synaptic transmission [GO:0007268]; epithelial cell differentiation [GO:0030855]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; muscle cell cellular homeostasis [GO:0046716]; myoblast fusion [GO:0007520]; negative regulation of angiogenesis [GO:0016525]; plasminogen activation [GO:0031639]; positive regulation of oxidative phosphorylation [GO:1903862]; response to hypoxia [GO:0001666]; somatic muscle development [GO:0007525],NA,NA,NA
CHOYP_PGM1.1.1.m.38482,0.0063959403659889,-0.00959441118598822,No,NA,NA,P36871,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; tertiary granule lumen [GO:1904724]; magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]; galactose catabolic process [GO:0019388]; gluconeogenesis [GO:0006094]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]; glycolytic process [GO:0006096]; neutrophil degranulation [GO:0043312],NA,NA,NA
CHOYP_PGM2.1.1.m.65095,0.00736221543984393,0.000128504907395432,No,NA,NA,Q96G03,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]; phosphopentomutase activity [GO:0008973]; deoxyribose phosphate catabolic process [GO:0046386]; galactose catabolic process [GO:0019388]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]; neutrophil degranulation [GO:0043312]; pentose-phosphate shunt [GO:0006098],NA,NA,NA
CHOYP_PGPS1.1.1.m.10148,-0.0135725579708753,0.00388604629968508,No,NA,NA,Q5ZHN9,NA,NA,NA,endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity [GO:0008444]; cardiolipin biosynthetic process [GO:0032049],NA,NA,NA
CHOYP_PGRMC1.1.1.m.38547,0.00364778592941831,-0.00872052841558096,No,NA,NA,Q5XIU9,NA,NA,NA,integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; steroid binding [GO:0005496],NA,NA,NA
CHOYP_PGTA.1.1.m.43418,0.019066657576556,-0.00164252101577409,No,NA,NA,Q5EA80,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; Rab-protein geranylgeranyltransferase complex [GO:0005968]; Rab geranylgeranyltransferase activity [GO:0004663]; Rab GTPase binding [GO:0017137]; zinc ion binding [GO:0008270]; protein geranylgeranylation [GO:0018344],NA,NA,NA
CHOYP_PGTG_12376.1.2.m.43330,0.00686600634041103,-0.000146178055493085,No,NA,NA,P37167,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; actin binding [GO:0003779]; actin filament depolymerization [GO:0030042],NA,NA,NA
CHOYP_PHATRDRAFT_43152.1.1.m.15003,0.00649354998205218,0.0189861993523439,No,NA,NA,P25007,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; unfolded protein binding [GO:0051082]; protein refolding [GO:0042026],NA,NA,NA
CHOYP_PHC2.1.1.m.48379,-0.0119820181917896,0.00801420199903844,No,NA,NA,Q8QHL5,NA,NA,NA,PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_PHF10.1.1.m.6981,0.00513426427386164,0.0210656538256148,No,NA,NA,Q8WUB8,NA,NA,NA,histone acetyltransferase complex [GO:0000123]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; negative regulation of transcription; DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_PHF14.1.1.m.27257,0.00308877200699681,0.000605771409742143,No,NA,NA,O94880,NA,NA,NA,nucleus [GO:0005634]; metal ion binding [GO:0046872]; lung alveolus development [GO:0048286]; negative regulation of mesenchymal cell proliferation involved in lung development [GO:2000791]; negative regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000584]; negative regulation of transcription by RNA polymerase II [GO:0000122],NA,NA,NA
CHOYP_PHF5A.1.1.m.32389,-0.00836570455329053,-0.0159316870895786,No,NA,NA,P83871,NA,NA,NA,nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_PHLP.1.1.m.25742,9.87439166631837e-05,-0.0191112736241198,No,NA,NA,Q13371,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein-containing complex binding [GO:0044877]; cell projection organization [GO:0030030]; heterotrimeric G-protein complex assembly [GO:1902605]; negative regulation of protein refolding [GO:0061084]; positive regulation of smoothened signaling pathway [GO:0045880]; protein folding [GO:0006457]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; signal transduction [GO:0007165]; visual perception [GO:0007601],NA,NA,NA
CHOYP_PHOCN.1.1.m.40660,-0.0144819614158427,-0.0132322160981177,No,NA,NA,Q9QYW3,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; vesicle budding from membrane [GO:0006900],NA,NA,NA
CHOYP_PHR.1.1.m.7664,-0.0215738947392534,-0.00397848631910476,No,NA,NA,Q28811,NA,NA,NA,deoxyribodipyrimidine photo-lyase activity [GO:0003904]; DNA binding [GO:0003677]; DNA repair [GO:0006281]; protein-chromophore linkage [GO:0018298],NA,NA,NA
CHOYP_PHT4.1.1.m.18841,-0.00876355139552303,-0.000620866042178616,No,NA,NA,O34371,NA,NA,NA,oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_PHUM_PHUM009400.1.1.m.35298,-0.0159850644474533,-0.0175500837515135,No,NA,NA,Q9U943,NA,NA,NA,extracellular region [GO:0005576]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_PHUM_PHUM035190.1.1.m.16675,0.00572145245969491,-0.00184098281444856,No,NA,NA,Q9ERH3,NA,NA,NA,synaptic vesicle [GO:0008021]; hematopoietic progenitor cell differentiation [GO:0002244],NA,NA,NA
CHOYP_PHUM_PHUM049590.1.4.m.14204,0.00364778592941831,-0.00872052841558097,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PHUM_PHUM060390.1.1.m.12993,-0.000430444242088601,0.0164714262330306,No,NA,NA,Q642H7,NA,NA,NA,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; G protein-coupled receptor signaling pathway [GO:0007186],NA,NA,NA
CHOYP_PHUM_PHUM066670.2.3.m.42178,-0.00607453234538832,-0.0190190153026065,No,NA,NA,P98160,NA,NA,NA,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; integrin binding [GO:0005178]; low-density lipoprotein particle receptor binding [GO:0050750]; protein C-terminus binding [GO:0008022]; angiogenesis [GO:0001525]; brain development [GO:0007420]; cardiovascular system development [GO:0072358]; cell differentiation [GO:0030154]; cellular protein metabolic process [GO:0044267]; extracellular matrix organization [GO:0030198]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan catabolic process [GO:0006027]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell death [GO:0060548]; receptor-mediated endocytosis [GO:0006898]; retinoid metabolic process [GO:0001523],NA,NA,NA
CHOYP_PHUM_PHUM068980.4.5.m.56739,-0.00552393018351868,0.00175792460831997,No,NA,NA,Q8NFZ8,NA,NA,NA,integral component of membrane [GO:0016021]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_PHUM_PHUM071280.1.1.m.25507,-0.00608874240806511,0.0026897137566352,No,NA,NA,Q9Y6E0,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; cellular response to starvation [GO:0009267]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; MAPK cascade [GO:0000165]; negative regulation of cell migration [GO:0030336]; neuron projection morphogenesis [GO:0048812]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_PHUM_PHUM075600.1.1.m.35072,0.00443485141333354,-0.013980554110898,No,NA,NA,Q9U6M0,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxidoreductase activity; acting on NAD(P)H [GO:0016651]; innate immune response [GO:0045087]; regulation of oxidoreductase activity [GO:0051341],NA,NA,NA
CHOYP_PHUM_PHUM076810.1.1.m.24070,0.0206455187244105,-0.00776028777922691,No,NA,NA,O75369,NA,NA,NA,actin cytoskeleton [GO:0015629]; brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; actin cytoskeleton organization [GO:0030036]; cellular response to interferon-gamma [GO:0071346]; cytoskeletal anchoring at plasma membrane [GO:0007016]; epithelial cell morphogenesis [GO:0003382]; keratinocyte development [GO:0003334]; signal transduction [GO:0007165]; skeletal muscle tissue development [GO:0007519],NA,NA,NA
CHOYP_PHUM_PHUM092120.1.1.m.33493,0.000474355791703581,-0.0124493123064505,No,NA,NA,Q5JWR5,NA,NA,NA,cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031],NA,NA,NA
CHOYP_PHUM_PHUM122670.1.1.m.38346,0.0065883263884642,0.0180931628217626,No,NA,NA,Q9BKZ9,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; amyloid-beta binding [GO:0001540]; transcription factor binding [GO:0008134]; embryo development ending in birth or egg hatching [GO:0009792]; feeding behavior [GO:0007631]; nematode larval development [GO:0002119]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_PHUM_PHUM125580.1.1.m.47466,0.00147816181256936,-0.0203643701061395,No,NA,NA,P04069,NA,NA,NA,extracellular region [GO:0005576]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_PHUM_PHUM128460.1.7.m.3477,-0.00153148455181844,-0.0146175197211036,No,NA,NA,Q8WV28,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; SH3/SH2 adaptor activity [GO:0005070]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; B cell differentiation [GO:0030183]; humoral immune response [GO:0006959]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PHUM_PHUM128460.3.7.m.27983,-0.0162500736386101,-0.0110384741781566,No,NA,NA,Q8WV28,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; SH3/SH2 adaptor activity [GO:0005070]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; B cell differentiation [GO:0030183]; humoral immune response [GO:0006959]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PHUM_PHUM128460.4.7.m.38295,-0.00174800594139872,-0.000416421041034791,No,NA,NA,Q9QUN3,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; plasma membrane [GO:0005886]; SH3/SH2 adaptor activity [GO:0005070]; B cell activation [GO:0042113]; intracellular signal transduction [GO:0035556]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PHUM_PHUM128460.6.7.m.60989,0.0050671356030265,0.0170768848627477,No,NA,NA,Q9QUN3,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; plasma membrane [GO:0005886]; SH3/SH2 adaptor activity [GO:0005070]; B cell activation [GO:0042113]; intracellular signal transduction [GO:0035556]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PHUM_PHUM135440.1.1.m.40573,-0.00212078832001384,-0.00891837260408135,No,NA,NA,Q8IS64,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; peptide hormone processing [GO:0016486],NA,NA,NA
CHOYP_PHUM_PHUM137710.1.1.m.19548,0.0075734142192279,-0.0220828276016278,No,NA,NA,Q5ZJP5,NA,NA,NA,Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; sarcomere [GO:0030017],NA,NA,NA
CHOYP_PHUM_PHUM169900.2.2.m.61606,-0.0135725579708753,0.00388604629968508,No,NA,NA,Q8C033,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinesin binding [GO:0019894]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; centrosome duplication [GO:0051298]; mitotic spindle assembly [GO:0090307]; myelination in peripheral nervous system [GO:0022011]; positive regulation of stress fiber assembly [GO:0051496]; regulation of Rho protein signal transduction [GO:0035023],NA,NA,NA
CHOYP_PHUM_PHUM174810.1.1.m.31029,-0.0108189141235076,0.00809118739966324,No,NA,NA,Q8N5N7,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126],NA,NA,NA
CHOYP_PHUM_PHUM174820.1.1.m.57391,-0.00358158406245989,0.0130859464784822,No,NA,NA,Q5SWW4,NA,NA,NA,mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; signaling receptor activity [GO:0038023]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; androgen receptor signaling pathway [GO:0030521]; cholesterol homeostasis [GO:0042632]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation from RNA polymerase II promoter [GO:0006367]; triglyceride homeostasis [GO:0070328],NA,NA,NA
CHOYP_PHUM_PHUM176650.1.1.m.13332,-0.0129617740686094,0.00457530299767448,No,NA,NA,Q6P9N1,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; myelination [GO:0042552]; phosphatidylinositol phosphorylation [GO:0046854]; protein localization to plasma membrane [GO:0072659],NA,NA,NA
CHOYP_PHUM_PHUM184790.1.1.m.41715,-0.0220090023745905,0.00341208311205821,No,NA,NA,Q92626,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; heme binding [GO:0020037]; interleukin-1 receptor antagonist activity [GO:0005152]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; immune response [GO:0006955]; oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_PHUM_PHUM215460.1.1.m.33815,0.0051387566740414,-0.00935685170838381,No,NA,NA,Q8JZP9,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytoskeletal adaptor activity [GO:0008093]; microtubule binding [GO:0008017]; thyroid hormone receptor binding [GO:0046966]; cell cycle arrest [GO:0007050]; cellular response to starvation [GO:0009267]; cellular response to thyroid hormone stimulus [GO:0097067]; microtubule bundle formation [GO:0001578]; negative regulation of cell growth [GO:0030308]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of gene expression [GO:0010629]; negative regulation of microtubule depolymerization [GO:0007026]; regulation of cell cycle [GO:0051726],NA,NA,NA
CHOYP_PHUM_PHUM226120.1.7.m.673,0.0065883263884642,0.0180931628217626,No,NA,NA,A2ASS6,NA,NA,NA,A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; telethonin binding [GO:0031433]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_PHUM_PHUM226120.2.7.m.2274,0.0108920674565048,0.00200443185405089,No,NA,NA,Q23551,NA,NA,NA,A band [GO:0031672]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; structural constituent of muscle [GO:0008307]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; muscle contraction [GO:0006936]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_PHUM_PHUM226120.3.7.m.20773,-0.0176579588909651,0.00957046164509952,No,NA,NA,Q23551,NA,NA,NA,A band [GO:0031672]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; structural constituent of muscle [GO:0008307]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; muscle contraction [GO:0006936]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_PHUM_PHUM226120.5.7.m.43551,-0.00306624231200871,0.0034324563590453,No,NA,NA,Q23551,NA,NA,NA,A band [GO:0031672]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; structural constituent of muscle [GO:0008307]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; muscle contraction [GO:0006936]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_PHUM_PHUM226120.6.7.m.48915,0.0135725579708753,-0.00388604629968508,No,NA,NA,Q8WZ42,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_PHUM_PHUM226120.7.7.m.54053,0.00132939398541395,0.00298096553939869,No,NA,NA,Q23551,NA,NA,NA,A band [GO:0031672]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; structural constituent of muscle [GO:0008307]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; muscle contraction [GO:0006936]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_PHUM_PHUM228480.1.1.m.498,0.00678620130084429,0.00878741825264137,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PHUM_PHUM229210.1.1.m.50089,0.00856311369016373,0.0109247501576194,No,NA,NA,Q3T0L3,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_PHUM_PHUM233260.1.1.m.6315,-0.000232020671912771,-0.0177717493651534,No,NA,NA,O08715,NA,NA,NA,endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; mitochondrial crista [GO:0030061]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; postsynaptic membrane [GO:0045211]; beta-tubulin binding [GO:0048487]; microtubule binding [GO:0008017]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; protein phosphatase 2B binding [GO:0030346]; protein phosphatase binding [GO:0019903]; protein-containing complex scaffold activity [GO:0032947]; RNA binding [GO:0003723]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of protein dephosphorylation [GO:0035308]; negative regulation of protein import into nucleus [GO:0042308]; regulation of protein kinase A signaling [GO:0010738],NA,NA,NA
CHOYP_PHUM_PHUM234540.1.1.m.9211,0.00510223515255623,-0.00079842568886481,No,NA,NA,Q5ZHY5,NA,NA,NA,chaperone complex [GO:0101031]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; ubiquitin ligase complex [GO:0000151]; Z disc [GO:0030018]; chaperone binding [GO:0051087]; G protein-coupled receptor binding [GO:0001664]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; misfolded protein binding [GO:0051787]; protein homodimerization activity [GO:0042803]; SMAD binding [GO:0046332]; TPR domain binding [GO:0030911]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; cellular response to misfolded protein [GO:0071218]; DNA repair [GO:0006281]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of protein binding [GO:0032091]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of chaperone-mediated protein complex assembly [GO:0090035]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; regulation of glucocorticoid metabolic process [GO:0031943]; regulation of protein stability [GO:0031647]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579],NA,NA,NA
CHOYP_PHUM_PHUM241330.1.3.m.29132,-0.00505105088481914,-0.00318051147283103,No,NA,NA,Q16629,NA,NA,NA,cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; mRNA 3'-end processing [GO:0031124]; mRNA cis splicing; via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; mRNA splicing; via spliceosome [GO:0000398]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; RNA export from nucleus [GO:0006405]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_PHUM_PHUM244880.1.2.m.691,-0.0130582700112529,-0.00195297514456752,No,NA,NA,Q9VB11,NA,NA,NA,cation channel complex [GO:0034703]; cation channel activity [GO:0005261]; cation homeostasis [GO:0055080]; locomotor rhythm [GO:0045475],NA,NA,NA
CHOYP_PHUM_PHUM244880.2.2.m.41653,-0.000809116605419937,-0.0199281839070988,No,NA,NA,Q9VB11,NA,NA,NA,cation channel complex [GO:0034703]; cation channel activity [GO:0005261]; cation homeostasis [GO:0055080]; locomotor rhythm [GO:0045475],NA,NA,NA
CHOYP_PHUM_PHUM268120.1.1.m.23332,0.0111720794121442,0.0141441356834859,No,NA,NA,Q4LDE5,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_PHUM_PHUM278110.1.1.m.17560,-0.0015045211421738,0.00294543649852122,No,NA,NA,Q6GLE1,NA,NA,NA,,NA,NA,NA
CHOYP_PHUM_PHUM289860.1.1.m.44778,-0.0109298167871557,0.00608832907309041,No,NA,NA,Q6YHK3,NA,NA,NA,anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616],NA,NA,NA
CHOYP_PHUM_PHUM289860.1.1.m.44779,0.0160418144567374,0.00239561162331644,No,NA,NA,P37397,NA,NA,NA,actin filament [GO:0005884]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; actin binding [GO:0003779]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; protein binding; bridging [GO:0030674]; actomyosin structure organization [GO:0031032]; epithelial cell differentiation [GO:0030855]; negative regulation of ATPase activity [GO:0032780],NA,NA,NA
CHOYP_PHUM_PHUM305910.1.2.m.58404,0.0165199783449915,-0.00605457030558489,No,NA,NA,O35867,NA,NA,NA,actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; dendritic spine neck [GO:0044326]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; growth cone lamellipodium [GO:1990761]; lamellipodium [GO:0030027]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic actin cytoskeleton [GO:0098871]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; actin filament binding [GO:0051015]; GTPase binding [GO:0051020]; ion channel binding [GO:0044325]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein phosphatase 1 binding [GO:0008157]; protein-containing complex binding [GO:0044877]; actin filament organization [GO:0007015]; aging [GO:0007568]; calcium-mediated signaling [GO:0019722]; cellular response to toxic substance [GO:0097237]; excitatory postsynaptic potential [GO:0060079]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of spontaneous neurotransmitter secretion [GO:1904049]; negative regulation of stress fiber assembly [GO:0051497]; neuron development [GO:0048666]; neuron projection development [GO:0031175]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein kinase activity [GO:0045860]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of actin filament polymerization [GO:0030833]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of filopodium assembly [GO:0051489]; regulation of synapse assembly [GO:0051963]; regulation of synapse structural plasticity [GO:0051823],NA,NA,NA
CHOYP_PHUM_PHUM310360.1.1.m.21767,0.0065883263884642,0.0180931628217626,No,NA,NA,Q5R7A4,NA,NA,NA,cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; symbiont-containing vacuole [GO:0020003]; trans-Golgi network [GO:0005802]; dynein complex binding [GO:0070840]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; kinesin binding [GO:0019894]; Rab GTPase binding [GO:0017137]; Golgi organization [GO:0007030]; mitochondrion organization [GO:0007005]; multi-organism toxin transport [GO:1990967]; negative regulation of neuron projection development [GO:0010977]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of receptor recycling [GO:0001921]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein localization to membrane [GO:0072657]; protein transport [GO:0015031]; response to bacterium [GO:0009617]; retrograde transport; endosome to Golgi [GO:0042147]; synapse assembly [GO:0007416]; T cell activation [GO:0042110]; viral RNA genome replication [GO:0039694],NA,NA,NA
CHOYP_PHUM_PHUM317840.1.2.m.29476,-0.0145337945851388,-0.00995310866599764,No,NA,NA,O60218,NA,NA,NA,cytosol [GO:0005829]; extracellular region [GO:0005576]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; geranylgeranyl reductase activity [GO:0045550]; indanol dehydrogenase activity [GO:0047718]; oxidoreductase activity [GO:0016491]; retinal dehydrogenase activity [GO:0001758]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; farnesol catabolic process [GO:0016488]; retinoid metabolic process [GO:0001523],NA,NA,NA
CHOYP_PHUM_PHUM317840.2.2.m.36471,-0.0113733638316105,0.0116695994913569,No,NA,NA,O60218,NA,NA,NA,cytosol [GO:0005829]; extracellular region [GO:0005576]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; geranylgeranyl reductase activity [GO:0045550]; indanol dehydrogenase activity [GO:0047718]; oxidoreductase activity [GO:0016491]; retinal dehydrogenase activity [GO:0001758]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; farnesol catabolic process [GO:0016488]; retinoid metabolic process [GO:0001523],NA,NA,NA
CHOYP_PHUM_PHUM319040.1.1.m.54919,0.00135987288831161,0.00867152494745236,No,NA,NA,Q5ZJ39,NA,NA,NA,mRNA binding [GO:0003729]; translation initiation factor activity [GO:0003743]; formation of translation preinitiation complex [GO:0001731]; IRES-dependent viral translational initiation [GO:0075522]; ribosome disassembly [GO:0032790]; translation reinitiation [GO:0002188],NA,NA,NA
CHOYP_PHUM_PHUM328150.1.1.m.8592,0.0123043812141364,0.0223366681712233,No,NA,NA,O76463,NA,NA,NA,bis(5'-adenosyl)-triphosphatase activity [GO:0047710]; hydrolase activity; acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; nucleotide binding [GO:0000166]; nucleobase-containing compound metabolic process [GO:0006139],NA,NA,NA
CHOYP_PHUM_PHUM332570.1.1.m.56283,-0.0100005536095726,0.0126156237055021,No,NA,NA,Q9XYM0,NA,NA,NA,receptor tyrosine kinase binding [GO:0030971]; border follicle cell migration [GO:0007298]; ephrin receptor signaling pathway [GO:0048013]; imaginal disc fusion; thorax closure [GO:0046529]; myoblast fusion [GO:0007520]; phagocytosis; engulfment [GO:0006911]; positive regulation of JNK cascade [GO:0046330]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of GTPase activity [GO:0043087]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],NA,NA,NA
CHOYP_PHUM_PHUM349810.1.2.m.7707,-0.00212361515324784,0.000554283639074155,No,NA,NA,A7SMW7,NA,NA,NA,mitochondrion [GO:0005739]; (S)-2-hydroxy-acid oxidase activity [GO:0003973]; 2-hydroxyglutarate dehydrogenase activity [GO:0047545],NA,NA,NA
CHOYP_PHUM_PHUM350510.1.1.m.44180,0.000146544796902121,-0.0178243702143261,No,NA,NA,Q9UI36,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; cell proliferation [GO:0008283]; development of primary female sexual characteristics [GO:0046545]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; regulation of nuclear cell cycle DNA replication [GO:0033262]; regulation of transcription; DNA-templated [GO:0006355]; respiratory gaseous exchange [GO:0007585]; suckling behavior [GO:0001967],NA,NA,NA
CHOYP_PHUM_PHUM353470.1.1.m.63458,0.00148708726845057,0.00647070952669677,No,NA,NA,A2TLM1,NA,NA,NA,intracellular membrane-bounded organelle [GO:0043231]; ribose-5-phosphate isomerase activity [GO:0004751]; D-ribose metabolic process [GO:0006014]; pentose-phosphate shunt; non-oxidative branch [GO:0009052],NA,NA,NA
CHOYP_PHUM_PHUM361660.1.1.m.63423,-0.0124972463442179,-0.0232980147139093,No,NA,NA,Q7Z3K6,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; histone deacetylase binding [GO:0042826]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription corepressor activity [GO:0003714]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122],NA,NA,NA
CHOYP_PHUM_PHUM370970.1.2.m.40102,-0.00731747684800977,0.00399303726060251,No,NA,NA,P49746,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; bone trabecula formation [GO:0060346]; cell-matrix adhesion [GO:0007160]; growth plate cartilage development [GO:0003417]; ossification involved in bone maturation [GO:0043931],NA,NA,NA
CHOYP_PHUM_PHUM375280.1.2.m.23797,0.0135532340234999,0.0018507215930227,No,NA,NA,Q9W6Z2,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-templated transcription; initiation [GO:0006352]; embryo development ending in birth or egg hatching [GO:0009792]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_PHUM_PHUM377430.1.2.m.29459,-0.0169591047060434,0.00960206869202778,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PHUM_PHUM378040.1.1.m.15341,-0.0135725579708753,0.00388604629968508,No,NA,NA,Q9Y5B0,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]; phosphoprotein phosphatase activity [GO:0004721]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]; Tat protein binding [GO:0030957]; TFIIF-class transcription factor complex binding [GO:0001096]; cell division [GO:0051301]; dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; exit from mitosis [GO:0010458]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; positive regulation by host of viral transcription [GO:0043923]; protein dephosphorylation [GO:0006470]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368],NA,NA,NA
CHOYP_PHUM_PHUM411900.1.1.m.50272,-0.0158649799147773,0.00336074967382364,No,NA,NA,Q9WYG0,NA,NA,NA,oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_PHUM_PHUM423190.1.1.m.18351,-0.0088814016610086,-0.00536621467992417,No,NA,NA,Q8C3P7,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; mRNA (N6-adenosine)-methyltransferase activity [GO:0001734]; mRNA binding [GO:0003729]; protein heterodimerization activity [GO:0046982]; RNA methyltransferase activity [GO:0008173]; S-adenosyl-L-methionine binding [GO:1904047]; adenosine to inosine editing [GO:0006382]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; circadian rhythm [GO:0007623]; dosage compensation by inactivation of X chromosome [GO:0009048]; endothelial to hematopoietic transition [GO:0098508]; forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; mRNA methylation [GO:0080009]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; mRNA splicing; via spliceosome [GO:0000398]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of cap-independent translational initiation [GO:1903679]; primary miRNA methylation [GO:1990744]; primary miRNA processing [GO:0031053]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of meiotic cell cycle [GO:0051445]; regulation of T cell differentiation [GO:0045580]; RNA methylation [GO:0001510]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827],NA,NA,NA
CHOYP_PHUM_PHUM427190.1.1.m.57126,0.00217997094733793,-0.00807271368859911,No,NA,NA,P20273,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; carbohydrate binding [GO:0030246]; CD4 receptor binding [GO:0042609]; IgM binding [GO:0001791]; protein phosphatase binding [GO:0019903]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102]; B cell activation [GO:0042113]; cell adhesion [GO:0007155]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of calcium-mediated signaling [GO:0050849]; negative regulation of immunoglobulin secretion [GO:0051025]; regulation of B cell proliferation [GO:0030888]; regulation of endocytosis [GO:0030100]; regulation of immune response [GO:0050776],NA,NA,NA
CHOYP_PHUM_PHUM445570.1.1.m.18708,0.0149504793882151,0.00153410565856976,No,NA,NA,O15460,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; electron transfer activity [GO:0009055]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity; acting on single donors with incorporation of molecular oxygen; incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401],NA,NA,NA
CHOYP_PHUM_PHUM450820.1.1.m.40803,-0.00965569796762531,-0.0168409252845311,No,NA,NA,Q5R416,NA,NA,NA,actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; extrinsic component of postsynaptic membrane [GO:0098890]; extrinsic component of presynaptic membrane [GO:0098888]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; parallel fiber to Purkinje cell synapse [GO:0098688]; postsynaptic density; intracellular component [GO:0099092]; presynaptic active zone cytoplasmic component [GO:0098831]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; axonogenesis [GO:0007409]; brain morphogenesis [GO:0048854]; cell-cell adhesion [GO:0098609]; dendrite morphogenesis [GO:0048813]; modification of postsynaptic actin cytoskeleton [GO:0098885]; prepulse inhibition [GO:0060134]; radial glia guided migration of Purkinje cell [GO:0021942]; regulation of synapse structural plasticity [GO:0051823],NA,NA,NA
CHOYP_PHUM_PHUM454570.1.1.m.28665,0.0120877152464983,0.00106813006555483,No,NA,NA,Q3UHU5,NA,NA,NA,apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; lateral plasma membrane [GO:0016328]; microtubule bundle [GO:0097427]; midbody [GO:0030496]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; microtubule bundle formation [GO:0001578]; positive regulation of microtubule motor activity [GO:2000576]; positive regulation of protein targeting to membrane [GO:0090314]; regulation of autophagy [GO:0010506],NA,NA,NA
CHOYP_PHUM_PHUM465390.1.1.m.21142,0.00394536801625317,0.00291369700370642,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PHUM_PHUM470230.1.1.m.29432,0.000965300333402068,0.00180661005442618,No,NA,NA,P98158,NA,NA,NA,apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023]; steroid hormone receptor binding [GO:0035258]; aging [GO:0007568]; animal organ regeneration [GO:0031100]; coronary artery morphogenesis [GO:0060982]; endocytic hemoglobin import [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; hormone secretion [GO:0046879]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of endopeptidase activity [GO:0010951]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to drug [GO:0042493]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; vitamin metabolic process [GO:0006766],NA,NA,NA
CHOYP_PHUM_PHUM477110.1.1.m.53813,-0.00821056102508772,0.00770084848928592,No,NA,NA,P20241,NA,NA,NA,bicellular tight junction [GO:0005923]; filopodium [GO:0030175]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; septate junction [GO:0005918]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; axon ensheathment [GO:0008366]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell adhesion [GO:0098609]; central complex development [GO:0048036]; dendrite morphogenesis [GO:0048813]; establishment of glial blood-brain barrier [GO:0060857]; female courtship behavior [GO:0008050]; imaginal disc morphogenesis [GO:0007560]; male courtship behavior [GO:0008049]; melanotic encapsulation of foreign target [GO:0035011]; motor neuron axon guidance [GO:0008045]; mushroom body development [GO:0016319]; nerve maturation [GO:0021682]; neuron cell-cell adhesion [GO:0007158]; photoreceptor cell axon guidance [GO:0072499]; regulation of female receptivity [GO:0045924]; regulation of tube size; open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synapse organization [GO:0050808],NA,NA,NA
CHOYP_PHUM_PHUM477570.1.1.m.2101,0.0163589282803498,0.016797544049751,No,NA,NA,P11240,NA,NA,NA,mitochondrial respiratory chain complex IV [GO:0005751]; myelin sheath [GO:0043209]; cytochrome-c oxidase activity [GO:0004129]; metal ion binding [GO:0046872]; mitochondrial electron transport; cytochrome c to oxygen [GO:0006123],NA,NA,NA
CHOYP_PHUM_PHUM477850.1.1.m.19067,-0.0154324747982144,-0.0109151984811417,No,NA,NA,H2QII6,NA,NA,NA,annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; transferase activity [GO:0016740]; mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of GTPase activity [GO:0043547]; protein folding [GO:0006457]; protein sumoylation [GO:0016925],NA,NA,NA
CHOYP_PHUM_PHUM479110.1.1.m.54103,-0.0169591047060434,0.00960206869202777,No,NA,NA,O95822,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; identical protein binding [GO:0042802]; malonyl-CoA decarboxylase activity [GO:0050080]; signaling receptor binding [GO:0005102]; acetyl-CoA biosynthetic process [GO:0006085]; acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]; fatty acid oxidation [GO:0019395]; malonyl-CoA catabolic process [GO:2001294]; positive regulation of fatty acid oxidation [GO:0046321]; protein targeting to peroxisome [GO:0006625]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of glucose metabolic process [GO:0010906]; response to ischemia [GO:0002931],NA,NA,NA
CHOYP_PHUM_PHUM494500.1.1.m.9430,0.0143528824425531,-0.0105864411621251,No,NA,NA,Q09024,NA,NA,NA,axon [GO:0030424]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; insulin binding [GO:0043559]; insulin-like growth factor binding [GO:0005520]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; determination of adult lifespan [GO:0008340]; entry into reproductive diapause [GO:0055116]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of lipid storage [GO:0010888]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; positive regulation of insulin receptor signaling pathway [GO:0046628]; response to starvation [GO:0042594],NA,NA,NA
CHOYP_PHUM_PHUM498110.1.1.m.60692,0.00435962511623354,0.0232719295348799,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PHUM_PHUM498130.1.1.m.12138,-0.0101118706993417,0.00893756917237793,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PHUM_PHUM500930.1.1.m.21562,0.0027052414377279,-0.0167082214645441,No,NA,NA,P15215,NA,NA,NA,basement membrane [GO:0005604]; basement membrane assembly [GO:0070831]; cell adhesion mediated by integrin [GO:0033627]; endodermal digestive tract morphogenesis [GO:0061031]; extracellular matrix assembly [GO:0085029]; midgut development [GO:0007494]; salivary gland morphogenesis [GO:0007435]; substrate adhesion-dependent cell spreading [GO:0034446],NA,NA,NA
CHOYP_PHUM_PHUM516040.1.1.m.55603,-0.00873768123421484,0.000208299834105843,No,NA,NA,Q5ZIJ9,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_PHUM_PHUM519460.1.1.m.3701,-0.00944542900966777,-0.0125953881669898,No,NA,NA,Q9JHE7,NA,NA,NA,,NA,NA,NA
CHOYP_PHUM_PHUM536560.1.2.m.12360,-0.00589507857478476,-0.00993338029136734,No,NA,NA,P82808,NA,NA,NA,amino acid binding [GO:0016597]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]; cellular response to insulin stimulus [GO:0032869]; circadian regulation of gene expression [GO:0032922]; fructose 6-phosphate metabolic process [GO:0006002]; glucosamine biosynthetic process [GO:0006042]; glutamine metabolic process [GO:0006541]; negative regulation of glycogen biosynthetic process [GO:0045719]; protein homotetramerization [GO:0051289]; protein N-linked glycosylation [GO:0006487]; response to insulin [GO:0032868]; response to sucrose [GO:0009744]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047],NA,NA,NA
CHOYP_PHUM_PHUM537100.1.1.m.62217,-0.0111496796402411,-0.00453271080819465,No,NA,NA,Q80XC3,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; plasma membrane to endosome transport [GO:0048227]; positive regulation of GTPase activity [GO:0043547]; regulation of Golgi organization [GO:1903358]; retrograde transport; plasma membrane to Golgi [GO:0035526]; virion assembly [GO:0019068],NA,NA,NA
CHOYP_PHUM_PHUM538050.1.1.m.56205,-0.0104606980845336,-0.0173232313003104,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PHUM_PHUM538580.1.1.m.43268,0.00943282819225342,0.00578308060180956,No,NA,NA,Q9UBN7,NA,NA,NA,aggresome [GO:0016235]; axon [GO:0030424]; caveola [GO:0005901]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; dendrite [GO:0030425]; histone deacetylase complex [GO:0000118]; inclusion body [GO:0016234]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-catenin binding [GO:0008013]; beta-tubulin binding [GO:0048487]; dynein complex binding [GO:0070840]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; Hsp90 protein binding [GO:0051879]; microtubule binding [GO:0008017]; misfolded protein binding [GO:0051787]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein deacetylase activity [GO:0033558]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; tau protein binding [GO:0048156]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; aggresome assembly [GO:0070842]; autophagy [GO:0006914]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to misfolded protein [GO:0071218]; cellular response to topologically incorrect protein [GO:0035967]; cilium assembly [GO:0060271]; collateral sprouting [GO:0048668]; dendritic spine morphogenesis [GO:0060997]; histone deacetylation [GO:0016575]; Hsp90 deacetylation [GO:0070846]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; mitochondrion localization [GO:0051646]; negative regulation of hydrogen peroxide metabolic process [GO:0010727]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of protein complex disassembly [GO:0043242]; negative regulation of proteolysis [GO:0045861]; negative regulation of transcription; DNA-templated [GO:0045892]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; peptidyl-lysine deacetylation [GO:0034983]; polyubiquitinated misfolded protein transport [GO:0070845]; positive regulation of chaperone-mediated protein complex assembly [GO:0090035]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of hydrogen peroxide-mediated programmed cell death [GO:1901300]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein oligomerization [GO:0032461]; positive regulation of receptor biosynthetic process [GO:0010870]; positive regulation of signal transduction [GO:0009967]; protein deacetylation [GO:0006476]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein-containing complex disassembly [GO:0032984]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of autophagy [GO:0010506]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of establishment of protein localization [GO:0070201]; regulation of fat cell differentiation [GO:0045598]; regulation of gene expression; epigenetic [GO:0040029]; regulation of macroautophagy [GO:0016241]; regulation of microtubule-based movement [GO:0060632]; regulation of protein stability [GO:0031647]; regulation of signaling receptor activity [GO:0010469]; response to growth factor [GO:0070848]; response to misfolded protein [GO:0051788]; response to organic substance [GO:0010033]; response to toxic substance [GO:0009636]; tubulin deacetylation [GO:0090042]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162],NA,NA,NA
CHOYP_PHUM_PHUM544530.1.1.m.38469,0.0070572052553872,-0.0136990096954112,No,NA,NA,Q15428,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type prespliceosome [GO:0071004]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; mRNA 3'-splice site recognition [GO:0000389]; mRNA processing [GO:0006397]; mRNA splicing; via spliceosome [GO:0000398]; positive regulation of neuron projection development [GO:0010976]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245],NA,NA,NA
CHOYP_PHUM_PHUM547410.1.1.m.10964,-0.0226660689567306,0.0102947884874559,No,NA,NA,Q868Z9,NA,NA,NA,basement membrane [GO:0005604]; extracellular matrix structural constituent [GO:0005201]; peptidase activity [GO:0008233]; serine-type endopeptidase inhibitor activity [GO:0004867]; extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_PHUM_PHUM549040.1.1.m.10284,0.00707317419444195,0.0107828742724802,No,NA,NA,O46036,NA,NA,NA,ISWI-type complex [GO:0031010]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; oxidoreductase activity; acting on the CH-OH group of donors; NAD or NADP as acceptor [GO:0016616]; protein homodimerization activity [GO:0042803]; repressing transcription factor binding [GO:0070491]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; ATP-dependent chromatin remodeling [GO:0043044]; chaeta development [GO:0022416]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ precursor cell fate determination [GO:0016360]; wing disc development [GO:0035220],NA,NA,NA
CHOYP_PHUM_PHUM559420.1.1.m.8620,0.00990704979313023,-0.0059170608748918,No,NA,NA,D2GXS7,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; regulation of neuron apoptotic process [GO:0043523],NA,NA,NA
CHOYP_PHUM_PHUM562900.1.1.m.43674,-0.00430894344577715,-0.00631540690244347,No,NA,NA,Q8QFV0,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; intracellular sodium activated potassium channel activity [GO:0005228]; outward rectifier potassium channel activity [GO:0015271]; regulation of membrane potential [GO:0042391],NA,NA,NA
CHOYP_PHUM_PHUM563970.1.1.m.13515,0.00994564406612837,-0.0170822135967308,No,NA,NA,O15381,NA,NA,NA,membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; preribosome binding [GO:1990275]; RNA binding [GO:0003723]; positive regulation of protein binding [GO:0032092]; positive regulation of telomerase activity [GO:0051973]; regulation of protein localization to nucleolus [GO:1904749]; ribosomal large subunit biogenesis [GO:0042273]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_PHUM_PHUM574190.1.1.m.24768,-0.00673502551935289,0.0127409436953833,No,NA,NA,Q05209,NA,NA,NA,cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; podosome [GO:0002102]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; SH3 domain binding [GO:0017124]; cellular response to cytokine stimulus [GO:0071345]; cellular response to epidermal growth factor stimulus [GO:0071364]; ERBB2 signaling pathway [GO:0038128]; negative regulation of ERBB signaling pathway [GO:1901185]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; tissue regeneration [GO:0042246],NA,NA,NA
CHOYP_PHUM_PHUM574550.1.1.m.59401,-0.00352032410135598,-0.00547872151649465,No,NA,NA,Q5XJK1,NA,NA,NA,cytosol [GO:0005829]; Golgi membrane [GO:0000139]; positive regulation of macroautophagy [GO:0016239]; regulation of protein complex stability [GO:0061635],NA,NA,NA
CHOYP_PHUM_PHUM579670.1.1.m.63016,-0.00342682323399259,0.00207451479523143,No,NA,NA,Q8R500,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intrinsic component of mitochondrial outer membrane [GO:0031306]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; protein homodimerization activity [GO:0042803]; proteoglycan binding [GO:0043394]; Ras GTPase binding [GO:0017016]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; cellular response to ionizing radiation [GO:0071479]; cellular response to L-glutamate [GO:1905232]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to manganese ion [GO:0071287]; cellular response to mercaptoethanol [GO:0072705]; cellular response to oxygen-glucose deprivation [GO:0090650]; cellular response to testosterone stimulus [GO:0071394]; intracellular distribution of mitochondria [GO:0048312]; male gonad development [GO:0008584]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial fusion [GO:0008053]; mitochondrial membrane organization [GO:0007006]; mitochondrion localization [GO:0051646]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; mitotic cell cycle [GO:0000278]; mitotic cell cycle arrest [GO:0071850]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell death [GO:0060548]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of mitochondrial fission [GO:0090258]; negative regulation of neuron death [GO:1901215]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of sarcomere organization [GO:0060299]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of vascular smooth muscle cell proliferation [GO:1904706]; positive regulation of cellular respiration [GO:1901857]; positive regulation of chromatin binding [GO:0035563]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of estradiol secretion [GO:2000866]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of ovarian follicle development [GO:2000386]; positive regulation of progesterone secretion [GO:2000872]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; protein targeting to mitochondrion [GO:0006626]; response to axon injury [GO:0048678]; response to cadmium ion [GO:0046686]; response to calcium ion [GO:0051592]; response to D-galactose [GO:1905377]; response to electrical stimulus [GO:0051602]; response to fatty acid [GO:0070542]; response to flavonoid [GO:1905395]; response to hypobaric hypoxia [GO:1990910]; response to L-arginine [GO:1903576]; response to muscle activity [GO:0014850]; response to nutrient levels [GO:0031667]; response to testosterone [GO:0033574]; response to unfolded protein [GO:0006986]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_PHUM_PHUM596890.1.1.m.10989,0.0095605565733543,-0.0201939879151388,No,NA,NA,Q9VGG5,NA,NA,NA,integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],NA,NA,NA
CHOYP_PHUM_PHUM596940.1.1.m.2151,-0.0158566360711242,0.0162351192265302,No,NA,NA,Q91YE8,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018]; 14-3-3 protein binding [GO:0071889]; actin binding [GO:0003779]; alpha-actinin binding [GO:0051393]; filamin binding [GO:0031005]; muscle alpha-actinin binding [GO:0051371]; autophagosome assembly [GO:0000045]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of cell migration [GO:0030335]; regulation of Rho-dependent protein serine/threonine kinase activity [GO:2000298],NA,NA,NA
CHOYP_PHUM_PHUM600390.1.1.m.6641,-0.0131862375872504,-0.00944253560704303,No,NA,NA,Q6DID3,NA,NA,NA,cytoplasm [GO:0005737]; mRNA cleavage factor complex [GO:0005849]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA polymerase binding [GO:0070063]; RNA polymerase core enzyme binding [GO:0043175]; RNA polymerase II complex binding [GO:0000993]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; termination of RNA polymerase II transcription [GO:0006369]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_PHUM_PHUM602670.1.1.m.52487,-0.0126316175454643,0.00129115911615652,No,NA,NA,Q9NZ56,NA,NA,NA,cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; microvillus [GO:0005902]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle [GO:0005819]; actin binding [GO:0003779]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; establishment of meiotic spindle localization [GO:0051295]; formin-nucleated actin cable assembly [GO:0070649]; homologous chromosome movement towards spindle pole involved in homologous chromosome segregation [GO:0051758]; intracellular signal transduction [GO:0035556]; intracellular transport [GO:0046907]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein catabolic process [GO:0042177]; oogenesis [GO:0048477]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of double-strand break repair [GO:2000781]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_PHUM_PHUM616130.1.1.m.47653,-0.000498954159381185,0.00945385018044534,No,NA,NA,P92204,NA,NA,NA,chromosome [GO:0005694]; NELF complex [GO:0032021]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023]; transcriptional repressor complex [GO:0017053]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; negative regulation of DNA-templated transcription; elongation [GO:0032785]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription elongation from RNA polymerase II promoter [GO:0006368],NA,NA,NA
CHOYP_PHYD1.1.2.m.17822,-0.0126001847676143,0.013693137968167,No,NA,NA,Q0IIB1,NA,NA,NA,dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_PI4KB.1.1.m.8669,-0.00154391786399968,-0.0143313742773505,No,NA,NA,B1MTG7,NA,NA,NA,Golgi membrane [GO:0000139]; mitochondrial outer membrane [GO:0005741]; rough endoplasmic reticulum membrane [GO:0030867]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; phosphatidylinositol-mediated signaling [GO:0048015],NA,NA,NA
CHOYP_PIDD.1.1.m.54294,-0.0226119521573992,0.0100824950080966,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PIF.3.6.m.18904,0.0228430320266587,-0.0096406536992365,No,NA,NA,C7G0B5,NA,NA,NA,extracellular region [GO:0005576]; chitin binding [GO:0008061]; chitin metabolic process [GO:0006030],NA,NA,NA
CHOYP_PIF.6.6.m.44699,0.00981830218286734,-0.00482193432036399,No,NA,NA,Q99715,NA,NA,NA,collagen type XII trimer [GO:0005595]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; endodermal cell differentiation [GO:0035987]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_PIGS.1.1.m.18959,-0.0127749407205375,0.0131505170477558,No,NA,NA,Q2HJ98,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; acetylpyruvate hydrolase activity [GO:0018773]; acylpyruvate hydrolase activity [GO:0047621]; fumarylpyruvate hydrolase activity [GO:0034545]; metal ion binding [GO:0046872]; oxaloacetate decarboxylase activity [GO:0008948],NA,NA,NA
CHOYP_PININ.1.1.m.56667,-0.010932036642357,-0.00489476656895209,No,NA,NA,Q9H307,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; cell-cell junction [GO:0005911]; desmosome [GO:0030057]; exon-exon junction complex [GO:0035145]; intermediate filament [GO:0005882]; membrane [GO:0016020]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_PIPNA.1.1.m.37750,0.00173031335079838,-0.0183019826268342,No,NA,NA,P53810,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; myelin sheath [GO:0043209]; fatty-acyl-CoA binding [GO:0000062]; lipid binding [GO:0008289]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transporter activity [GO:0008526]; phospholipid binding [GO:0005543]; stearic acid binding [GO:0070540]; axonogenesis [GO:0007409]; phospholipid transport [GO:0015914],NA,NA,NA
CHOYP_PIR.1.1.m.48663,-0.000700087821323987,0.00039302714115548,No,NA,NA,O00625,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; quercetin 2;3-dioxygenase activity [GO:0008127]; transcription coregulator activity [GO:0003712]; digestion [GO:0007586]; monocyte differentiation [GO:0030224]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_PISD.2.2.m.30086,-0.00430894344577715,-0.00631540690244347,No,NA,NA,P27465,NA,NA,NA,integral component of mitochondrial inner membrane [GO:0031305]; nucleus [GO:0005634]; phosphatidylserine decarboxylase activity [GO:0004609]; phosphatidylethanolamine biosynthetic process [GO:0006646]; protein autoprocessing [GO:0016540],NA,NA,NA
CHOYP_PITG_07096.1.1.m.4922,0.00775559301377225,-0.0112412385083857,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PK1IP.1.1.m.49466,0.0114905500242038,0.00685439523709646,No,NA,NA,Q80VC6,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; tRNA binding [GO:0000049]; selenocysteine incorporation [GO:0001514],NA,NA,NA
CHOYP_PK3C3.1.1.m.13959,-0.00923068586130371,-0.00541237973717977,No,NA,NA,Q6AZN6,NA,NA,NA,midbody [GO:0030496]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524]; autophagy [GO:0006914]; cell cycle [GO:0007049]; cell division [GO:0051301]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of cytokinesis [GO:0032465],NA,NA,NA
CHOYP_PKH_082300.1.1.m.29388,-0.00212078832001384,-0.00891837260408135,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PKH_143120.1.1.m.6777,-0.0183939326445748,-0.00601916514014356,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PKHL1.3.3.m.42452,-0.0215292850960933,0.00997911221059143,No,NA,NA,Q80ZA4,NA,NA,NA,cilium [GO:0005929]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_PLB1.1.1.m.16558,0.00023760657298602,0.00222254481238432,No,NA,NA,Q06HQ7,NA,NA,NA,apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1;2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1;2-dioleoylphosphatidylethanolamine) [GO:0102568]; retinyl-palmitate esterase activity [GO:0050253]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644],NA,NA,NA
CHOYP_PLC.2.5.m.5277,-0.0111726071082333,0.00822038609406715,No,NA,NA,P82596,NA,NA,NA,carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_PLC.3.5.m.7658,0.00438664301111042,-0.0123775521277282,No,NA,NA,P86854,NA,NA,NA,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_PLCB4.1.2.m.1637,-0.0213031832187198,-0.0010390702030213,No,NA,NA,Q15147,NA,NA,NA,cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; parallel fiber to Purkinje cell synapse [GO:0098688]; postsynaptic density [GO:0014069]; smooth endoplasmic reticulum [GO:0005790]; calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; G protein-coupled receptor signaling pathway [GO:0007186]; inositol phosphate metabolic process [GO:0043647]; intracellular signal transduction [GO:0035556]; lipid catabolic process [GO:0016042]; modulation of chemical synaptic transmission [GO:0050804],NA,NA,NA
CHOYP_PLCD1.1.1.m.63908,0.00628827370973882,0.00709069031430847,No,NA,NA,P10688,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; inositol 1;4;5 trisphosphate binding [GO:0070679]; phosphatidylinositol phospholipase C activity [GO:0004435]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; phospholipid binding [GO:0005543]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; lipid catabolic process [GO:0016042]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of inositol trisphosphate biosynthetic process [GO:0032962]; positive regulation of norepinephrine secretion [GO:0010701]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of phospholipase C activity [GO:1900274]; response to aluminum ion [GO:0010044]; response to calcium ion [GO:0051592]; response to hyperoxia [GO:0055093]; response to organonitrogen compound [GO:0010243]; response to peptide hormone [GO:0043434]; response to prostaglandin F [GO:0034696],NA,NA,NA
CHOYP_PLCL2.1.1.m.62311,-0.00110953888536454,0.0124098559374383,No,NA,NA,Q9UPR0,NA,NA,NA,cytoplasm [GO:0005737]; GABA receptor binding [GO:0050811]; inositol 1;4;5 trisphosphate binding [GO:0070679]; phosphatidylinositol phospholipase C activity [GO:0004435]; B cell proliferation involved in immune response [GO:0002322]; B-1a B cell differentiation [GO:0002337]; gamma-aminobutyric acid signaling pathway [GO:0007214]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of receptor binding [GO:1900122]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of synaptic transmission; GABAergic [GO:0032228],NA,NA,NA
CHOYP_PLEKHA1.2.2.m.21816,0.000830649326111308,0.0106513816792729,No,NA,NA,Q9HB19,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; PDZ domain binding [GO:0030165]; phosphatidylinositol-3;4-bisphosphate binding [GO:0043325]; phosphatidylinositol biosynthetic process [GO:0006661]; positive regulation of cell-matrix adhesion [GO:0001954],NA,NA,NA
CHOYP_PLIN2.1.1.m.23758,0.0122304414344707,-0.0236516661188888,No,NA,NA,Q4PLW0,NA,NA,NA,intracellular [GO:0005622]; lipid droplet [GO:0005811]; membrane [GO:0016020],NA,NA,NA
CHOYP_PLK1.1.2.m.26371,0.0109850292121824,-0.00712913091167356,No,NA,NA,P62205,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; cell division [GO:0051301]; mitotic cell cycle [GO:0000278]; protein localization to chromatin [GO:0071168]; protein phosphorylation [GO:0006468]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425],NA,NA,NA
CHOYP_PLMN.1.11.m.5524,-0.00896833487304466,-0.0255718286678561,No,NA,NA,P00765,NA,NA,NA,extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586],NA,NA,NA
CHOYP_PLMN.4.11.m.29150,-0.0169591047060434,0.00960206869202778,No,NA,NA,P06867,NA,NA,NA,extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; interaction with symbiont via secreted substance involved in symbiotic interaction [GO:0052213]; tissue remodeling [GO:0048771],NA,NA,NA
CHOYP_PLOD3.1.1.m.41788,0.0199086036872756,-0.00278669086037437,No,NA,NA,Q5U367,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; rough endoplasmic reticulum [GO:0005791]; trans-Golgi network [GO:0005802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen galactosyltransferase activity [GO:0050211]; procollagen glucosyltransferase activity [GO:0033823]; procollagen-lysine 5-dioxygenase activity [GO:0008475]; basement membrane assembly [GO:0070831]; cellular response to hormone stimulus [GO:0032870]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; endothelial cell morphogenesis [GO:0001886]; epidermis morphogenesis [GO:0048730]; hydroxylysine biosynthetic process [GO:0046947]; in utero embryonic development [GO:0001701]; lung morphogenesis [GO:0060425]; neural tube development [GO:0021915]; peptidyl-lysine hydroxylation [GO:0017185]; protein localization [GO:0008104]; protein O-linked glycosylation [GO:0006493]; vasodilation [GO:0042311],NA,NA,NA
CHOYP_PLRG1.1.1.m.65600,-0.00426262044357038,-0.0186032302327752,No,NA,NA,Q922V4,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; DNA replication factor A complex [GO:0005662]; fibrillar center [GO:0001650]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; mRNA splicing; via spliceosome [GO:0000398]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein localization to nucleus [GO:0034504],NA,NA,NA
CHOYP_PLSP.4.5.m.44386,0.00364778592941831,-0.00872052841558097,No,NA,NA,H2A0M7,NA,NA,NA,extracellular region [GO:0005576]; heme binding [GO:0020037]; peroxidase activity [GO:0004601]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_PLXA3.1.1.m.51322,-0.00147176928581371,-0.0106507164351708,No,NA,NA,O15031,NA,NA,NA,cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; brain development [GO:0007420]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell adhesion [GO:0007162]; neural tube closure [GO:0001843]; neuroblast proliferation [GO:0007405]; positive regulation of axonogenesis [GO:0050772]; positive regulation of neuron projection development [GO:0010976]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of neuron migration [GO:2001222]; regulation of protein phosphorylation [GO:0001932]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287],NA,NA,NA
CHOYP_PLXB2.2.2.m.47843,-0.015068419940252,-0.0106802035073596,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PM20D2.1.1.m.27186,0.0198877976068075,-0.0062533579588573,No,NA,NA,A3KG59,NA,NA,NA,nucleoplasm [GO:0005654]; dipeptidase activity [GO:0016805]; proteolysis [GO:0006508]; regulation of cellular protein metabolic process [GO:0032268],NA,NA,NA
CHOYP_PMAA_001770.1.1.m.11519,0.0113899717904055,0.00135921555819373,No,NA,NA,Q54RA4,NA,NA,NA,dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_PMAR_PMAR003946.2.2.m.31102,-0.00917452159119164,-0.0164616458699821,No,NA,NA,P55142,NA,NA,NA,cytoplasm [GO:0005737]; electron transfer activity [GO:0009055]; glutathione-disulfide reductase activity [GO:0004362]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599],NA,NA,NA
CHOYP_PMAR_PMAR009545.1.1.m.28734,0.00364778592941831,-0.00872052841558097,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PMAR_PMAR019172.1.1.m.2563,-0.00804036121499393,0.00284875340307315,No,NA,NA,B8DKP2,NA,NA,NA,magnesium ion binding [GO:0000287]; phosphonoacetaldehyde hydrolase activity [GO:0050194]; organic phosphonate catabolic process [GO:0019700],NA,NA,NA
CHOYP_PMS2.1.1.m.16450,0.0107008483770755,0.0122738816125822,No,NA,NA,P54278,NA,NA,NA,cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mismatch repair complex [GO:0032300]; MutLalpha complex [GO:0032389]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; single base insertion or deletion binding [GO:0032138]; mismatch repair [GO:0006298]; response to drug [GO:0042493]; somatic hypermutation of immunoglobulin genes [GO:0016446],NA,NA,NA
CHOYP_PMTR.1.1.m.46450,0.00217997094733793,-0.00807271368859912,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PNCB.1.1.m.57201,-0.0170340215961149,-0.00937043154962844,No,NA,NA,Q9VQX4,NA,NA,NA,cytosol [GO:0005829]; metal ion binding [GO:0046872]; nicotinate phosphoribosyltransferase activity [GO:0004516]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; NAD biosynthetic process [GO:0009435]; NAD salvage [GO:0034355]; nicotinate nucleotide salvage [GO:0019358]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_PNO1.1.3.m.2044,-0.00721874512061642,-0.0154376539866917,No,NA,NA,Q6VEU3,NA,NA,NA,nucleolus [GO:0005730]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_PNO1.2.3.m.47801,0.00364778592941831,-0.00872052841558096,No,NA,NA,Q8VCX6,NA,NA,NA,KICSTOR complex [GO:0140007]; lamellipodium [GO:0030027]; lysosomal membrane [GO:0005765]; postsynaptic actin cytoskeleton [GO:0098871]; stereocilium [GO:0032420]; actin filament binding [GO:0051015]; actin filament organization [GO:0007015]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; negative regulation of TORC1 signaling [GO:1904262]; protein localization to lysosome [GO:0061462],NA,NA,NA
CHOYP_PNP5B.1.1.m.21997,-0.00100171406134568,0.024171574579019,No,NA,NA,P00491,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; intracellular [GO:0005622]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; drug binding [GO:0008144]; nucleoside binding [GO:0001882]; phosphate ion binding [GO:0042301]; purine nucleobase binding [GO:0002060]; purine-nucleoside phosphorylase activity [GO:0004731]; immune response [GO:0006955]; inosine catabolic process [GO:0006148]; interleukin-2 secretion [GO:0070970]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; neutrophil degranulation [GO:0043312]; nicotinamide riboside catabolic process [GO:0006738]; nucleobase-containing compound metabolic process [GO:0006139]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of T cell proliferation [GO:0042102]; purine nucleotide catabolic process [GO:0006195]; purine-containing compound salvage [GO:0043101]; response to drug [GO:0042493]; urate biosynthetic process [GO:0034418],NA,NA,NA
CHOYP_PO2F1.1.1.m.11428,-0.00398044420171801,-0.0123577068968307,No,NA,NA,Q9UKI9,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; epidermis development [GO:0008544]; negative regulation by host of viral transcription [GO:0043922]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_POGLUT1.1.1.m.45796,0.00138596131472592,0.019377808092393,No,NA,NA,G3V9D0,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; glucosyltransferase activity [GO:0046527]; protein xylosyltransferase activity [GO:0030158]; UDP-glucosyltransferase activity [GO:0035251]; UDP-xylosyltransferase activity [GO:0035252]; gastrulation [GO:0007369]; muscle tissue development [GO:0060537]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; regulation of gastrulation [GO:0010470],NA,NA,NA
CHOYP_POLD1.1.1.m.61169,-0.00408153661020084,0.0148340811815002,No,NA,NA,P28340,NA,NA,NA,aggresome [GO:0016235]; cytosol [GO:0005829]; delta DNA polymerase complex [GO:0043625]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleus [GO:0005634]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; 4 iron; 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; base-excision repair; gap-filling [GO:0006287]; cellular response to UV [GO:0034644]; DNA damage response; detection of DNA damage [GO:0042769]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; DNA-dependent DNA replication [GO:0006261]; fatty acid homeostasis [GO:0055089]; nucleotide-excision repair; DNA gap filling [GO:0006297]; nucleotide-excision repair; DNA incision [GO:0033683]; nucleotide-excision repair; DNA incision; 5'-to lesion [GO:0006296]; response to UV [GO:0009411]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985],NA,NA,NA
CHOYP_POLR3K.1.1.m.8423,-0.00363400051299976,-0.0173793401624533,No,NA,NA,Q9Y2Y1,NA,NA,NA,cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; termination of RNA polymerase III transcription [GO:0006386]; transcription by RNA polymerase III [GO:0006383]; tRNA 3'-trailer cleavage [GO:0042779],NA,NA,NA
CHOYP_POMGNT1.1.1.m.33377,0.0065883263884642,0.0180931628217626,No,NA,NA,Q5XIN7,NA,NA,NA,integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; beta-1;3-galactosyl-O-glycosyl-glycoprotein beta-1;3-N-acetylglucosaminyltransferase activity [GO:0047223]; manganese ion binding [GO:0030145]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493],NA,NA,NA
CHOYP_POPTRDRAFT_1091519.1.1.m.56854,0.00615966897194063,0.00941964587728867,No,NA,NA,Q8BWF0,NA,NA,NA,mitochondrion [GO:0005739]; carboxylic acid binding [GO:0031406]; NAD binding [GO:0051287]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]; acetate metabolic process [GO:0006083]; central nervous system development [GO:0007417]; galactosylceramide metabolic process [GO:0006681]; gamma-aminobutyric acid catabolic process [GO:0009450]; gamma-aminobutyric acid metabolic process [GO:0009448]; glucose metabolic process [GO:0006006]; glucosylceramide metabolic process [GO:0006678]; glutamate metabolic process [GO:0006536]; glutamine metabolic process [GO:0006541]; glutathione metabolic process [GO:0006749]; glycerophospholipid metabolic process [GO:0006650]; neurotransmitter catabolic process [GO:0042135]; oxidation-reduction process [GO:0055114]; post-embryonic development [GO:0009791]; protein homotetramerization [GO:0051289]; respiratory electron transport chain [GO:0022904]; short-chain fatty acid metabolic process [GO:0046459]; succinate metabolic process [GO:0006105],NA,NA,NA
CHOYP_POPTRDRAFT_655879.1.1.m.46190,0.00609054210092374,-0.00189538509989723,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PP1A.1.1.m.25950,0.00678620130084428,0.00878741825264137,No,NA,NA,P62138,NA,NA,NA,cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; glycogen granule [GO:0042587]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear chromosome; telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; protein phosphatase type 1 complex [GO:0000164]; PTW/PP1 phosphatase complex [GO:0072357]; cadherin binding involved in cell-cell adhesion [GO:0098641]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase 1 binding [GO:0008157]; protein serine/threonine phosphatase activity [GO:0004722]; protein-containing complex binding [GO:0044877]; ribonucleoprotein complex binding [GO:0043021]; branching morphogenesis of an epithelial tube [GO:0048754]; cell cycle [GO:0007049]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; lung development [GO:0030324]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein dephosphorylation [GO:0006470]; regulation of circadian rhythm [GO:0042752]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of glycogen catabolic process [GO:0005981]; response to lead ion [GO:0010288],NA,NA,NA
CHOYP_PP1B.2.3.m.22075,0.00510326398975404,-0.000605018502621646,No,NA,NA,Q5I085,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein phosphatase type 1 complex [GO:0000164]; PTW/PP1 phosphatase complex [GO:0072357]; metal ion binding [GO:0046872]; myosin-light-chain-phosphatase activity [GO:0050115]; protein serine/threonine phosphatase activity [GO:0004722]; cell cycle [GO:0007049]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; glycogen metabolic process [GO:0005977]; regulation of cell adhesion [GO:0030155]; regulation of circadian rhythm [GO:0042752],NA,NA,NA
CHOYP_PP1RA.1.1.m.9915,-0.00705788289649035,0.00837710198748013,No,NA,NA,Q6GLQ4,NA,NA,NA,nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein phosphatase inhibitor activity [GO:0004864],NA,NA,NA
CHOYP_PP4C.1.1.m.10112,-0.00815915512006298,-0.0232165553449897,No,NA,NA,Q5R6K8,NA,NA,NA,cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; regulation of double-strand break repair via homologous recombination [GO:0010569],NA,NA,NA
CHOYP_PP4R1.1.1.m.11682,0.005686649828488,-0.0216973537760646,No,NA,NA,Q8VI02,NA,NA,NA,protein phosphatase 4 complex [GO:0030289]; protein phosphatase regulator activity [GO:0019888]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_PP6R3.1.1.m.43072,-0.00993438405367826,-0.0206990940824908,No,NA,NA,Q5F471,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein phosphatase binding [GO:0019903]; regulation of phosphoprotein phosphatase activity [GO:0043666],NA,NA,NA
CHOYP_PPA5.1.1.m.36087,-0.00817026414957847,0.00412392226992762,No,NA,NA,P09889,NA,NA,NA,extracellular region [GO:0005576]; lysosome [GO:0005764]; acid phosphatase activity [GO:0003993]; ferric iron binding [GO:0008199]; ferrous iron binding [GO:0008198]; bone morphogenesis [GO:0060349]; bone resorption [GO:0045453]; defense response to Gram-positive bacterium [GO:0050830]; ion transport [GO:0006811]; iron ion homeostasis [GO:0055072]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of superoxide anion generation [GO:0032929]; negative regulation of tumor necrosis factor production [GO:0032720]; ossification [GO:0001503]; response to cytokine [GO:0034097]; response to lipopolysaccharide [GO:0032496],NA,NA,NA
CHOYP_PPAC1.1.1.m.51347,-0.00169761107618542,0.000101466221985983,No,NA,NA,P82890,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; acid phosphatase activity [GO:0003993]; protein tyrosine phosphatase activity [GO:0004725]; protein dephosphorylation [GO:0006470],NA,NA,NA
CHOYP_PPAL.2.2.m.32405,-0.0116540597636687,-0.011081063514671,No,NA,NA,Q0P5F0,NA,NA,NA,integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; acid phosphatase activity [GO:0003993]; lysosome organization [GO:0007040]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_PPAN.B.1.1.m.2112,-0.00364019405631301,-0.0138960987618807,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PPBT.1.4.m.5115,-0.00328999837804817,-0.0219370659695754,No,NA,NA,Q29486,NA,NA,NA,anchored component of plasma membrane [GO:0046658]; alkaline phosphatase activity [GO:0004035]; metal ion binding [GO:0046872]; dephosphorylation [GO:0016311],NA,NA,NA
CHOYP_PPIB.2.4.m.40019,-0.0225578608733299,0.00997658454587587,No,NA,NA,O94273,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; Golgi apparatus [GO:0005794]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; unfolded protein binding [GO:0051082]; protein folding in endoplasmic reticulum [GO:0034975]; protein refolding [GO:0042026],NA,NA,NA
CHOYP_PPID.1.1.m.55261,-0.00324155148015846,-0.0129154828040863,No,NA,NA,Q9CR16,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclosporin A binding [GO:0016018]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; FK506 binding [GO:0005528]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; transcription factor binding [GO:0008134]; unfolded protein binding [GO:0051082]; apoptotic process [GO:0006915]; cellular response to UV-A [GO:0071492]; chaperone-mediated protein folding [GO:0061077]; lipid droplet organization [GO:0034389]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein secretion [GO:0050714]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003],NA,NA,NA
CHOYP_PPIE.1.1.m.18580,-0.00318232626717503,-2.63932963499024e-05,No,NA,NA,Q5R723,NA,NA,NA,nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; cyclosporin A binding [GO:0016018]; mRNA binding [GO:0003729]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; poly(A) binding [GO:0008143]; mRNA splicing; via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413],NA,NA,NA
CHOYP_PPIG.1.1.m.63308,0.00604033110025078,-0.0120676985698541,No,NA,NA,P30414,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; unfolded protein binding [GO:0051082]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026],NA,NA,NA
CHOYP_PPIH.1.1.m.18923,0.0120655168633011,-0.00179503910625116,No,NA,NA,O43447,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U4/U6 snRNP [GO:0071001]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; ribonucleoprotein complex binding [GO:0043021]; unfolded protein binding [GO:0051082]; angiogenesis [GO:0001525]; mRNA splicing; via spliceosome [GO:0000398]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]; protein-containing complex assembly [GO:0065003],NA,NA,NA
CHOYP_PPIL2.1.1.m.55184,-0.0135725579708753,0.00388604629968508,No,NA,NA,Q9D787,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; protein folding [GO:0006457]; protein localization to plasma membrane [GO:0072659]; protein peptidyl-prolyl isomerization [GO:0000413]; protein polyubiquitination [GO:0000209],NA,NA,NA
CHOYP_PPM1H.1.1.m.24782,-0.00769543874221906,0.0163321185194918,No,NA,NA,Q5M821,NA,NA,NA,cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722],NA,NA,NA
CHOYP_PPME1.1.1.m.56260,-0.0140823564019595,0.00800044180307228,No,NA,NA,Q8BVQ5,NA,NA,NA,protein C-terminal methylesterase activity [GO:0051722]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase binding [GO:0019903]; protein demethylation [GO:0006482],NA,NA,NA
CHOYP_PPN.2.4.m.44929,0.000750921191101472,-0.00790753537190509,No,NA,NA,Q868Z9,NA,NA,NA,basement membrane [GO:0005604]; extracellular matrix structural constituent [GO:0005201]; peptidase activity [GO:0008233]; serine-type endopeptidase inhibitor activity [GO:0004867]; extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_PPN.3.4.m.50209,-0.00576498189928228,0.00414529318250928,No,NA,NA,Q868Z9,NA,NA,NA,basement membrane [GO:0005604]; extracellular matrix structural constituent [GO:0005201]; peptidase activity [GO:0008233]; serine-type endopeptidase inhibitor activity [GO:0004867]; extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_PPOX.1.1.m.45234,-0.00933092699421737,-0.0174950925491729,No,NA,NA,P56602,NA,NA,NA,intrinsic component of mitochondrial inner membrane [GO:0031304]; mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491]; oxygen-dependent protoporphyrinogen oxidase activity [GO:0004729]; heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782],NA,NA,NA
CHOYP_PPP1CC.1.1.m.13937,-1.78630885477406e-05,-0.00824943797351215,No,NA,NA,P62138,NA,NA,NA,cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; glycogen granule [GO:0042587]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear chromosome; telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; protein phosphatase type 1 complex [GO:0000164]; PTW/PP1 phosphatase complex [GO:0072357]; cadherin binding involved in cell-cell adhesion [GO:0098641]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase 1 binding [GO:0008157]; protein serine/threonine phosphatase activity [GO:0004722]; protein-containing complex binding [GO:0044877]; ribonucleoprotein complex binding [GO:0043021]; branching morphogenesis of an epithelial tube [GO:0048754]; cell cycle [GO:0007049]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; lung development [GO:0030324]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein dephosphorylation [GO:0006470]; regulation of circadian rhythm [GO:0042752]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of glycogen catabolic process [GO:0005981]; response to lead ion [GO:0010288],NA,NA,NA
CHOYP_PPP1R7.1.1.m.37778,0.0156906983891223,0.000760422632417486,No,NA,NA,Q5HZV9,NA,NA,NA,nucleus [GO:0005634],NA,NA,NA
CHOYP_PPP6.1.1.m.16278,0.00768318260602291,-0.0218844181925978,No,NA,NA,Q64620,NA,NA,NA,cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; cell cycle [GO:0007049]; innate immune response [GO:0045087]; protein dephosphorylation [GO:0006470],NA,NA,NA
CHOYP_PPR27.1.1.m.10278,0.00979862051577241,0.00296402066931118,No,NA,NA,Q86WC6,NA,NA,NA,phosphatase binding [GO:0019902]; protein phosphatase inhibitor activity [GO:0004864]; negative regulation of phosphatase activity [GO:0010923],NA,NA,NA
CHOYP_PPR37.1.1.m.27483,-0.00159968149838835,-0.00780576516343664,No,NA,NA,Q1L994,NA,NA,NA,protein phosphatase inhibitor activity [GO:0004864]; negative regulation of phosphatase activity [GO:0010923],NA,NA,NA
CHOYP_PPT2A.1.2.m.30339,0.00746287827562247,-0.0205366463708952,No,NA,NA,Q6PCJ9,NA,NA,NA,lysosome [GO:0005764]; palmitoyl-(protein) hydrolase activity [GO:0008474],NA,NA,NA
CHOYP_PPUTW619_2764.1.1.m.44946,0.0218739048381062,-0.0128357453283574,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PPWD1.1.1.m.48713,0.0074802942076619,-0.0106098826276695,No,NA,NA,Q29RZ2,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; mRNA processing [GO:0006397]; protein peptidyl-prolyl isomerization [GO:0000413]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_PRB2.2.2.m.41331,0.00760637408837512,-0.00823629973637447,No,NA,NA,Q7Z0T3,NA,NA,NA,extracellular region [GO:0005576]; pheromone activity [GO:0005186],NA,NA,NA
CHOYP_PRCC.2.2.m.58572,-0.00141803359610405,-0.00495516489937453,No,NA,NA,Q92733,NA,NA,NA,nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mitotic cell cycle checkpoint [GO:0007093]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_PRG4.1.2.m.7441,0.00491588973115351,-0.000600714720400963,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PRIM.1.1.m.30784,-0.00430894344577715,-0.00631540690244347,No,NA,NA,Q6R7L6,NA,NA,NA,DNA primase activity [GO:0003896],NA,NA,NA
CHOYP_PRKAB1B.1.3.m.19788,-0.0102604630214509,0.0126805786335863,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PRKAB1B.2.3.m.31228,0.0206453635408977,-0.00460903406296448,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PRKAB2.1.1.m.12513,0.0145134937894381,0.00155086987527764,No,NA,NA,O43741,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; cell cycle arrest [GO:0007050]; fatty acid biosynthetic process [GO:0006633]; macroautophagy [GO:0016236]; positive regulation of cold-induced thermogenesis [GO:0120162]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]; regulation of fatty acid biosynthetic process [GO:0042304]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_PRKCSH.1.1.m.28109,0.0131950705287207,-0.00888967285769142,No,NA,NA,P14314,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; glucosidase II complex [GO:0017177]; intracellular [GO:0005622]; intracellular membrane-bounded organelle [GO:0043231]; calcium ion binding [GO:0005509]; ion channel binding [GO:0044325]; phosphoprotein binding [GO:0051219]; protein kinase C binding [GO:0005080]; cellular protein metabolic process [GO:0044267]; intracellular signal transduction [GO:0035556]; N-glycan processing [GO:0006491]; post-translational protein modification [GO:0043687],NA,NA,NA
CHOYP_PRKDC.1.1.m.47256,-0.0188767202303237,-0.00419582976034035,No,NA,NA,Q8QGX4,NA,NA,NA,nonhomologous end joining complex [GO:0070419]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent protein kinase activity [GO:0004677]; kinase activity [GO:0016301]; protein serine/threonine kinase activity [GO:0004674]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; immunoglobulin V(D)J recombination [GO:0033152]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; signal transduction involved in mitotic G1 DNA damage checkpoint [GO:0072431]; telomere maintenance [GO:0000723],NA,NA,NA
CHOYP_PRKN2.1.1.m.54903,0.00205195042830452,-0.00934116934689426,No,NA,NA,Q9JK66,NA,NA,NA,aggresome [GO:0016235]; axon [GO:0030424]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; ubiquitin ligase complex [GO:0000151]; cullin family protein binding [GO:0097602]; F-box domain binding [GO:1990444]; G protein-coupled receptor binding [GO:0001664]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; adult locomotory behavior [GO:0008344]; aggresome assembly [GO:0070842]; autophagy of mitochondrion [GO:0000422]; brain development [GO:0007420]; cellular protein modification process [GO:0006464]; cellular response to hydrogen sulfide [GO:1904881]; cellular response to L-glutamate [GO:1905232]; cellular response to L-glutamine [GO:1904845]; cellular response to manganese ion [GO:0071287]; cellular response to toxic substance [GO:0097237]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of glucokinase activity [GO:0033132]; negative regulation of insulin secretion [GO:0046676]; negative regulation of JNK cascade [GO:0046329]; negative regulation of mitochondrial fission [GO:0090258]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of synaptic transmission; glutamatergic [GO:0051967]; neuron cellular homeostasis [GO:0070050]; positive regulation of apoptotic process [GO:0043065]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of DNA binding [GO:0043388]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of mitochondrial fusion [GO:0010636]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of mitophagy [GO:1901526]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; protein localization to mitochondrion [GO:0070585]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of gene expression [GO:0010468]; regulation of mitochondrion organization [GO:0010821]; response to corticosterone [GO:0051412]; response to curcumin [GO:1904643]; response to drug [GO:0042493]; response to endoplasmic reticulum stress [GO:0034976]; response to muscle activity [GO:0014850]; response to oxidative stress [GO:0006979]; response to unfolded protein [GO:0006986]; ubiquitin-dependent protein catabolic process [GO:0006511]; zinc ion homeostasis [GO:0055069],NA,NA,NA
CHOYP_PROF.2.2.m.41295,-0.0135725579708753,0.00388604629968508,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PROM1.3.3.m.58805,0.0166559574463178,0.0112840324681967,No,NA,NA,O77302,NA,NA,NA,ribosome [GO:0005840],NA,NA,NA
CHOYP_PRP16.1.1.m.19094,0.00447755479278047,-0.00407748198129023,No,NA,NA,Q17R09,NA,NA,NA,spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; ATP-dependent 3'-5' RNA helicase activity [GO:0034459]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_PRP18.1.1.m.2214,-0.00955937343498079,0.0190079924475759,No,NA,NA,Q2HJ41,NA,NA,NA,nuclear speck [GO:0016607]; U2-type post-spliceosomal complex [GO:0071021]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; generation of catalytic spliceosome for second transesterification step [GO:0000350]; nuclear retention of unspliced pre-mRNA at the site of transcription [GO:0071048],NA,NA,NA
CHOYP_PRP31.3.6.m.8812,-0.00541850016977292,-0.0103264160704934,No,NA,NA,Q7SXM7,NA,NA,NA,Cajal body [GO:0015030]; MLL1 complex [GO:0071339]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690]; U4atac snRNA binding [GO:0030622]; mRNA splicing; via spliceosome [GO:0000398]; retina development in camera-type eye [GO:0060041]; spliceosomal tri-snRNP complex assembly [GO:0000244],NA,NA,NA
CHOYP_PRP4B.1.1.m.28423,-0.0134647759270132,-0.00753410150124427,No,NA,NA,Q08DZ2,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; chromosome [GO:0005694]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; mRNA processing [GO:0006397]; protein phosphorylation [GO:0006468]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_PRP6.1.2.m.28600,-0.0101272662296582,-0.0180148032502371,No,NA,NA,A1A5S1,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; androgen receptor binding [GO:0050681]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; mRNA splicing; via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA localization [GO:0006403]; spliceosomal tri-snRNP complex assembly [GO:0000244],NA,NA,NA
CHOYP_PRP6.2.2.m.34365,-0.017770790241639,-0.0111940485443831,No,NA,NA,P30568,NA,NA,NA,cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364],NA,NA,NA
CHOYP_PRP8.1.1.m.51584,-0.0185816642265781,-0.0113113687581546,No,NA,NA,Q99PV0,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; pre-mRNA intronic binding [GO:0097157]; second spliceosomal transesterification activity [GO:0000386]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA splicing; via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244],NA,NA,NA
CHOYP_PRPF3.1.1.m.736,-0.00386228511507197,-0.00312553501860011,No,NA,NA,Q5ZJ85,NA,NA,NA,nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; mRNA splicing; via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244],NA,NA,NA
CHOYP_PRPF4.1.1.m.62194,-0.00409916705334313,-0.00633803611453745,No,NA,NA,O43172,NA,NA,NA,Cajal body [GO:0015030]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; spliceosomal snRNP complex [GO:0097525]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 snRNP [GO:0071001]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]; mRNA splicing; via spliceosome [GO:0000398]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; RNA splicing; via transesterification reactions [GO:0000375],NA,NA,NA
CHOYP_PRPS1.1.1.m.10083,-0.00782516334646331,0.00670042863172252,No,NA,NA,P60892,NA,NA,NA,cytoplasm [GO:0005737]; protein-containing complex [GO:0032991]; ribose phosphate diphosphokinase complex [GO:0002189]; ADP binding [GO:0043531]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; carbohydrate binding [GO:0030246]; GDP binding [GO:0019003]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; ribose phosphate diphosphokinase activity [GO:0004749]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; AMP biosynthetic process [GO:0006167]; animal organ regeneration [GO:0031100]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164]; ribose phosphate metabolic process [GO:0019693],NA,NA,NA
CHOYP_PRRC1.1.1.m.6820,0.0109841424531757,0.00166022015654628,No,NA,NA,A6H8J1,NA,NA,NA,Golgi apparatus [GO:0005794],NA,NA,NA
CHOYP_PRRT1.2.5.m.28553,-0.00430894344577715,-0.00631540690244347,No,NA,NA,Q6MG82,NA,NA,NA,cell junction [GO:0030054]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic membrane [GO:0099055]; membrane [GO:0016020],NA,NA,NA
CHOYP_PRS4.1.1.m.45626,0.00501602162118312,-0.00053301898055846,No,NA,NA,P48601,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle; base subcomplex [GO:0008540]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; proteasome-activating ATPase activity [GO:0036402]; TBP-class protein binding [GO:0017025]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_PRS6B.1.1.m.66735,-0.00976300551095756,0.00155905336826387,No,NA,NA,Q4R7L3,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; ATP binding [GO:0005524]; proteasome-activating ATPase activity [GO:0036402]; blastocyst development [GO:0001824]; protein catabolic process [GO:0030163],NA,NA,NA
CHOYP_PRS7.1.1.m.31825,-0.00701114432307211,0.00577062253222371,No,NA,NA,Q4R4R0,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; proteasome-activating ATPase activity [GO:0036402]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_PRS8.1.1.m.40757,0.00143447874344327,0.00898356125842242,No,NA,NA,P54814,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; ATP binding [GO:0005524]; proteasome-activating ATPase activity [GO:0036402]; protein catabolic process [GO:0030163],NA,NA,NA
CHOYP_PRTG.2.3.m.27411,0.0065883263884642,0.0180931628217626,No,NA,NA,Q2EY13,NA,NA,NA,integral component of membrane [GO:0016021]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_PRUN2.1.1.m.38759,-0.00340024039962489,0.00544813722853511,No,NA,NA,Q5BJR4,NA,NA,NA,cytoplasm [GO:0005737]; exopolyphosphatase activity [GO:0004309]; apoptotic process [GO:0006915]; polyphosphate catabolic process [GO:0006798],NA,NA,NA
CHOYP_PSA.1.1.m.27259,0.0213350291137012,0.00251253474837875,No,NA,NA,Q11011,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_PSA1.1.1.m.44276,0.00858961243085079,0.0149588617231123,No,NA,NA,P25786,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polysome [GO:0005844]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex; alpha-subunit complex [GO:0019773]; endopeptidase activity [GO:0004175]; RNA binding [GO:0003723]; threonine-type endopeptidase activity [GO:0004298]; immune system process [GO:0002376]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579],NA,NA,NA
CHOYP_PSA2.1.1.m.57091,0.0181789008261634,-0.000156536350398566,No,NA,NA,P25787,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex; alpha-subunit complex [GO:0019773]; secretory granule lumen [GO:0034774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; neutrophil degranulation [GO:0043312]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; response to virus [GO:0009615],NA,NA,NA
CHOYP_PSA4.1.1.m.19303,0.00967189856975522,0.0147298609186152,No,NA,NA,P25789,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex; alpha-subunit complex [GO:0019773]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; viral process [GO:0016032],NA,NA,NA
CHOYP_PSA6.1.1.m.30357,-0.00490891522977999,0.00463948717973484,No,NA,NA,P60901,NA,NA,NA,cytoplasm [GO:0005737]; myofibril [GO:0030016]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; proteasome core complex [GO:0005839]; proteasome core complex; alpha-subunit complex [GO:0019773]; sarcomere [GO:0030017]; endopeptidase activity [GO:0004175]; NF-kappaB binding [GO:0051059]; RNA binding [GO:0003723]; threonine-type endopeptidase activity [GO:0004298]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_PSB1.2.2.m.63827,0.00344108144856792,0.0145607733962155,No,NA,NA,Q2TBX6,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex; beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_PSD7.1.1.m.19729,0.0169547336738424,-0.00872361600059371,No,NA,NA,P26270,NA,NA,NA,cytosol [GO:0005829]; dendrite [GO:0030425]; nucleoplasm [GO:0005654]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle; lid subcomplex [GO:0008541]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_PSDE.1.1.m.38562,0.00239297660137074,0.0242479360607067,No,NA,NA,Q9V3H2,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle; lid subcomplex [GO:0008541]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; proteasome binding [GO:0070628]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579],NA,NA,NA
CHOYP_PSIP1.1.1.m.61157,-0.0118737674999837,-0.0167853374516885,No,NA,NA,Q9Y3E1,NA,NA,NA,cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; growth factor activity [GO:0008083]; microtubule binding [GO:0008017]; tubulin binding [GO:0015631]; cell proliferation [GO:0008283]; microtubule polymerization [GO:0046785]; negative regulation of microtubule depolymerization [GO:0007026]; neuron projection development [GO:0031175],NA,NA,NA
CHOYP_PSMB2.1.1.m.62965,0.0164453919128082,-0.00627847043836051,No,NA,NA,P40307,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex; beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243],NA,NA,NA
CHOYP_PSMC6.1.1.m.13888,0.0185493410594113,-0.00431231983237925,No,NA,NA,P62334,NA,NA,NA,cytosolic proteasome complex [GO:0031597]; inclusion body [GO:0016234]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle; base subcomplex [GO:0008540]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; proteasome-activating ATPase activity [GO:0036402]; positive regulation of inclusion body assembly [GO:0090261]; positive regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0045899]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_PSMD1.1.1.m.21682,0.00194171466684264,-0.0220145873197299,No,NA,NA,Q99460,NA,NA,NA,azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle; base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]; enzyme regulator activity [GO:0030234]; ubiquitin protein ligase binding [GO:0031625]; neutrophil degranulation [GO:0043312]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; regulation of protein catabolic process [GO:0042176],NA,NA,NA
CHOYP_PSMD1.1.1.m.21683,-0.0131276161896859,-0.0104092527095059,No,NA,NA,Q99805,NA,NA,NA,endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; protein localization to membrane [GO:0072657],NA,NA,NA
CHOYP_PSMD2.1.3.m.13362,0.0100675569757388,0.00626349597807038,No,NA,NA,P56701,NA,NA,NA,nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle; base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]; enzyme regulator activity [GO:0030234]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176],NA,NA,NA
CHOYP_PSMD2.3.3.m.59657,-0.00635887055339577,-0.0198628118818253,No,NA,NA,Q5VUA4,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; meiotic cell cycle [GO:0051321]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_PSMD2.3.3.m.59658,-0.00682700203568985,-0.00780812560535716,No,NA,NA,Q13200,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle; base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]; secretory granule lumen [GO:0034774]; enzyme regulator activity [GO:0030234]; neutrophil degranulation [GO:0043312]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; regulation of protein catabolic process [GO:0042176],NA,NA,NA
CHOYP_PSMD6.1.1.m.60839,-0.00796983799258451,-0.0251356764918803,No,NA,NA,Q15008,NA,NA,NA,cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; secretory granule lumen [GO:0034774]; ATPase activity [GO:0016887]; enzyme regulator activity [GO:0030234]; neutrophil degranulation [GO:0043312]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_PSMD9.1.1.m.5055,-0.000101595204019572,-0.00813621375716665,No,NA,NA,Q3SZ19,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome regulatory particle; base subcomplex [GO:0008540]; proteasome regulatory particle assembly [GO:0070682],NA,NA,NA
CHOYP_PSME4.1.1.m.18992,-0.00570413400736449,-0.0112250251499628,No,NA,NA,Q6NRP2,NA,NA,NA,cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spermatoproteasome complex [GO:1990111]; lysine-acetylated histone binding [GO:0070577]; peptidase activator activity [GO:0016504]; proteasome binding [GO:0070628]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; spermatogenesis; exchange of chromosomal proteins [GO:0035093],NA,NA,NA
CHOYP_PSMG2.1.1.m.66279,-0.00355196118390023,-0.00382079809873124,No,NA,NA,Q1LXS2,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome assembly [GO:0043248],NA,NA,NA
CHOYP_PSTA_4372.1.1.m.39115,0.00548475539013268,-0.00539125850566387,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PSTA.1.2.m.4739,0.0176765788050012,0.00520838373308479,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PSTA.2.2.m.9655,-0.0186622985764134,-0.00564889340205543,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PSTPIP1.1.1.m.39114,-0.00340415362020821,0.0188703783233166,No,NA,NA,O43586,NA,NA,NA,actin filament [GO:0005884]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; uropod [GO:0001931]; actin filament binding [GO:0051015]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; actin filament polymerization [GO:0030041]; cell adhesion [GO:0007155]; endocytosis [GO:0006897]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_PTCD3.1.1.m.24655,-0.0105575319581909,-0.0111313988418005,No,NA,NA,Q5R8W8,NA,NA,NA,mitochondrion [GO:0005739]; ribosome [GO:0005840]; ribosomal small subunit binding [GO:0043024]; rRNA binding [GO:0019843]; mitochondrial translation [GO:0032543]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_PTEN.1.1.m.5408,-0.0115754291154701,-0.011840987677001,No,NA,NA,P60484,NA,NA,NA,apical plasma membrane [GO:0016324]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; myelin sheath adaxonal region [GO:0035749]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; postsynaptic cytosol [GO:0099524]; postsynaptic membrane [GO:0045211]; Schmidt-Lanterman incisure [GO:0043220]; anaphase-promoting complex binding [GO:0010997]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; inositol-1;3;4;5-tetrakisphosphate 3-phosphatase activity [GO:0051717]; ionotropic glutamate receptor binding [GO:0035255]; lipid binding [GO:0008289]; PDZ domain binding [GO:0030165]; phosphatidylinositol-3;4;5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3;4-bisphosphate 3-phosphatase activity [GO:0051800]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphoprotein phosphatase activity [GO:0004721]; platelet-derived growth factor receptor binding [GO:0005161]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; ubiquitin-specific protease binding [GO:1990381]; adult behavior [GO:0030534]; aging [GO:0007568]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; brain morphogenesis [GO:0048854]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue development [GO:0048738]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to electrical stimulus [GO:0071257]; cellular response to ethanol [GO:0071361]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to leptin stimulus [GO:0044320]; cellular response to nerve growth factor stimulus [GO:1990090]; central nervous system development [GO:0007417]; central nervous system myelin maintenance [GO:0032286]; central nervous system neuron axonogenesis [GO:0021955]; dendritic spine morphogenesis [GO:0060997]; dentate gyrus development [GO:0021542]; endothelial cell migration [GO:0043542]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; learning or memory [GO:0007611]; locomotor rhythm [GO:0045475]; locomotory behavior [GO:0007626]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; male mating behavior [GO:0060179]; maternal behavior [GO:0042711]; memory [GO:0007613]; multicellular organismal response to stress [GO:0033555]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axon regeneration [GO:0048681]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cell aging [GO:0090344]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of keratinocyte migration [GO:0051548]; negative regulation of myelination [GO:0031642]; negative regulation of organ growth [GO:0046621]; negative regulation of phagocytosis [GO:0050765]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of signaling receptor activity [GO:2000272]; negative regulation of synaptic vesicle clustering [GO:2000808]; negative regulation of vascular smooth muscle cell proliferation [GO:1904706]; negative regulation of wound healing; spreading of epidermal cells [GO:1903690]; neuron-neuron synaptic transmission [GO:0007270]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of TRAIL-activated apoptotic signaling pathway [GO:1903984]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; postsynaptic density assembly [GO:0097107]; prepulse inhibition [GO:0060134]; presynaptic membrane assembly [GO:0097105]; prostate gland growth [GO:0060736]; protein dephosphorylation [GO:0006470]; protein deubiquitination [GO:0016579]; protein kinase B signaling [GO:0043491]; protein stabilization [GO:0050821]; regulation of B cell apoptotic process [GO:0002902]; regulation of cellular component size [GO:0032535]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of myeloid cell apoptotic process [GO:0033032]; regulation of neuron projection development [GO:0010975]; regulation of protein stability [GO:0031647]; regulation of synaptic transmission; GABAergic [GO:0032228]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to ATP [GO:0033198]; response to estradiol [GO:0032355]; response to glucose [GO:0009749]; response to zinc ion [GO:0010043]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse maturation [GO:0060074]; transcription initiation from RNA polymerase II promoter [GO:0006367],NA,NA,NA
CHOYP_PTER.1.2.m.28985,0.0129944756792996,0.00728423555163507,No,NA,NA,Q7SZS2,NA,NA,NA,hydrolase activity; acting on ester bonds [GO:0016788]; zinc ion binding [GO:0008270]; catabolic process [GO:0009056],NA,NA,NA
CHOYP_PTGR1.1.1.m.29812,0.00416972111838368,0.0162907960290686,No,NA,NA,Q3SZJ4,NA,NA,NA,cytoplasm [GO:0005737]; 13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; 2-alkenal reductase [NAD(P)] activity [GO:0032440],NA,NA,NA
CHOYP_PTH1R.4.4.m.65130,0.00582321092785221,-0.00359067331532357,No,NA,NA,P25107,NA,NA,NA,integral component of plasma membrane [GO:0005887]; parathyroid hormone receptor activity [GO:0004991]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166],NA,NA,NA
CHOYP_PTHB1.1.1.m.35678,-0.0117901342884793,-0.0127738448041673,No,NA,NA,Q6AX60,NA,NA,NA,BBSome [GO:0034464]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815],NA,NA,NA
CHOYP_PTN11.4.4.m.62827,0.00535008786030914,0.000576428036303342,No,NA,NA,Q90687,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cell adhesion molecule binding [GO:0050839]; insulin receptor binding [GO:0005158]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; peptide hormone receptor binding [GO:0051428]; phosphotyrosine residue binding [GO:0001784]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; SH3/SH2 adaptor activity [GO:0005070]; abortive mitotic cell cycle [GO:0033277]; activation of MAPK activity [GO:0000187]; atrioventricular canal development [GO:0036302]; axonogenesis [GO:0007409]; Bergmann glial cell differentiation [GO:0060020]; cellular response to epidermal growth factor stimulus [GO:0071364]; cerebellar cortex formation [GO:0021697]; DNA damage checkpoint [GO:0000077]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; face morphogenesis [GO:0060325]; genitalia development [GO:0048806]; glucose homeostasis [GO:0042593]; homeostasis of number of cells within a tissue [GO:0048873]; hormone metabolic process [GO:0042445]; hormone-mediated signaling pathway [GO:0009755]; inner ear development [GO:0048839]; integrin-mediated signaling pathway [GO:0007229]; intestinal epithelial cell migration [GO:0061582]; megakaryocyte development [GO:0035855]; microvillus organization [GO:0032528]; multicellular organism growth [GO:0035264]; multicellular organismal reproductive process [GO:0048609]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of cortisol secretion [GO:0051463]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of insulin secretion [GO:0046676]; neurotrophin TRK receptor signaling pathway [GO:0048011]; organ growth [GO:0035265]; platelet formation [GO:0030220]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glucose import [GO:0046326]; positive regulation of hormone secretion [GO:0046887]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of multicellular organism growth [GO:0040014]; regulation of protein complex assembly [GO:0043254]; regulation of protein export from nucleus [GO:0046825]; triglyceride metabolic process [GO:0006641],NA,NA,NA
CHOYP_PTN11.4.4.m.62828,-0.0203754587495212,0.00332337410420803,No,NA,NA,Q20191,NA,NA,NA,extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_PTP10.3.3.m.46720,0.00364778592941831,-0.00872052841558096,No,NA,NA,B2RU80,NA,NA,NA,integral component of membrane [GO:0016021]; receptor complex [GO:0043235]; protein tyrosine phosphatase activity [GO:0004725]; angiogenesis [GO:0001525]; dephosphorylation [GO:0016311],NA,NA,NA
CHOYP_PTPA.1.1.m.18579,-0.00232190947567054,-0.0140430653848694,No,NA,NA,Q2KJ44,NA,NA,NA,calcium channel complex [GO:0034704]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein homodimerization activity [GO:0042803]; protein phosphatase 2A binding [GO:0051721]; protein tyrosine phosphatase activator activity [GO:0008160]; signaling receptor binding [GO:0005102]; mitotic spindle organization [GO:0007052]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; positive regulation of apoptotic process [GO:0043065]; positive regulation of phosphoprotein phosphatase activity [GO:0032516],NA,NA,NA
CHOYP_PTPN23.1.1.m.16408,-0.00637960389861829,-0.00521238439721506,No,NA,NA,Q6PB44,NA,NA,NA,ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; negative regulation of epithelial cell migration [GO:0010633]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of homophilic cell adhesion [GO:1903387]; positive regulation of Wnt protein secretion [GO:0061357]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162],NA,NA,NA
CHOYP_PTPRA.19.22.m.59233,-0.0135725579708753,0.00388604629968508,No,NA,NA,P18433,NA,NA,NA,extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804],NA,NA,NA
CHOYP_PTPRA.2.22.m.3118,0.00217997094733793,-0.00807271368859912,No,NA,NA,Q99M80,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRA.9.22.m.46545,0.00615966897194063,0.00941964587728867,No,NA,NA,Q99M80,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRA.9.22.m.46547,0.00394536801625317,0.00291369700370642,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PTPRB.1.4.m.21615,0.00369024987742866,0.00511544049850617,No,NA,NA,B2RU80,NA,NA,NA,integral component of membrane [GO:0016021]; receptor complex [GO:0043235]; protein tyrosine phosphatase activity [GO:0004725]; angiogenesis [GO:0001525]; dephosphorylation [GO:0016311],NA,NA,NA
CHOYP_PTPRB.3.4.m.52977,0.00298032716367061,-0.00575549047215457,No,NA,NA,B2RU80,NA,NA,NA,integral component of membrane [GO:0016021]; receptor complex [GO:0043235]; protein tyrosine phosphatase activity [GO:0004725]; angiogenesis [GO:0001525]; dephosphorylation [GO:0016311],NA,NA,NA
CHOYP_PTPRB.4.4.m.66782,0.00678620130084428,0.00878741825264137,No,NA,NA,P35992,NA,NA,NA,apical part of cell [GO:0045177]; axon [GO:0030424]; integral component of membrane [GO:0016021]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; branching involved in open tracheal system development [GO:0060446]; central nervous system development [GO:0007417]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; open tracheal system development [GO:0007424]; protein dephosphorylation [GO:0006470],NA,NA,NA
CHOYP_PTPRC.5.14.m.34957,0.00615966897194063,0.00941964587728867,No,NA,NA,O14522,NA,NA,NA,cell surface [GO:0009986]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRE.7.19.m.34309,-0.00430894344577715,-0.00631540690244347,No,NA,NA,P18433,NA,NA,NA,extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804],NA,NA,NA
CHOYP_PTPREA.1.2.m.4823,0.0111648541665806,-0.00111489713051404,No,NA,NA,B9EKR1,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; integral component of postsynaptic density membrane [GO:0099061]; intrinsic component of plasma membrane [GO:0031226]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perineuronal net [GO:0072534]; postsynaptic membrane [GO:0045211]; ruffle membrane [GO:0032587]; synapse [GO:0045202]; fibroblast growth factor binding [GO:0017134]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; axonal fasciculation [GO:0007413]; axonogenesis [GO:0007409]; hematopoietic progenitor cell differentiation [GO:0002244]; learning or memory [GO:0007611]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of dendrite development [GO:2000171]; oligodendrocyte differentiation [GO:0048709]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of cell migration [GO:0030335]; positive regulation of dendrite development [GO:1900006]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of Schwann cell migration [GO:1900149]; protein dephosphorylation [GO:0006470]; regulation of dendrite morphogenesis [GO:0048814]; regulation of oligodendrocyte progenitor proliferation [GO:0070445],NA,NA,NA
CHOYP_PTPRF.2.6.m.17540,-0.0169591047060434,0.00960206869202778,No,NA,NA,P28827,NA,NA,NA,cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; positive regulation of blood vessel diameter [GO:0097755]; protein dephosphorylation [GO:0006470]; response to drug [GO:0042493]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_PTPRF.3.6.m.28841,0.00317159637384166,0.0103362003088132,No,NA,NA,P16621,NA,NA,NA,axon [GO:0030424]; basal plasma membrane [GO:0009925]; cell leading edge [GO:0031252]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; heparin binding [GO:0008201]; protein tyrosine phosphatase activity [GO:0004725]; SAM domain binding [GO:0032093]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon extension [GO:0048675]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; cell adhesion [GO:0007155]; centripetally migrating follicle cell migration [GO:0060269]; motor neuron axon guidance [GO:0008045]; negative regulation of homophilic cell adhesion [GO:1903386]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; peptidyl-tyrosine dephosphorylation [GO:0035335]; photoreceptor cell morphogenesis [GO:0008594]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of plasma membrane bounded cell projection assembly [GO:0120034]; R7 cell development [GO:0045467]; regulation of axon extension involved in axon guidance [GO:0048841]; retinal ganglion cell axon guidance [GO:0031290]; spermatogenesis [GO:0007283]; synaptic growth at neuromuscular junction [GO:0051124],NA,NA,NA
CHOYP_PTPRG.1.3.m.56419,-0.00442088149670203,-0.0113872636258698,No,NA,NA,P18433,NA,NA,NA,extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804],NA,NA,NA
CHOYP_PTPRG.2.3.m.61939,0.00533847649157489,0.000274289534609946,No,NA,NA,P18433,NA,NA,NA,extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804],NA,NA,NA
CHOYP_PTPRG.3.3.m.65311,0.00217997094733793,-0.00807271368859912,No,NA,NA,Q99M80,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRK.10.20.m.31769,-0.00430894344577715,-0.00631540690244347,No,NA,NA,Q99M80,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRK.13.20.m.40023,0.00950697451467116,0.00713835275205081,No,NA,NA,P18433,NA,NA,NA,extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804],NA,NA,NA
CHOYP_PTPRK.17.20.m.60780,0.00432445657208098,-0.0124092128127174,No,NA,NA,Q15262,NA,NA,NA,adherens junction [GO:0005912]; axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; leading edge membrane [GO:0031256]; neuronal cell body [GO:0043025]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription; DNA-templated [GO:0045892]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_PTPRK.18.20.m.62712,0.000285550530839903,-0.00052449443528414,No,NA,NA,P23471,NA,NA,NA,integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; perineuronal net [GO:0072534]; plasma membrane [GO:0005886]; synapse [GO:0045202]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axonogenesis [GO:0007409]; central nervous system development [GO:0007417]; cytokine-mediated signaling pathway [GO:0019221]; hematopoietic progenitor cell differentiation [GO:0002244]; learning or memory [GO:0007611]; oligodendrocyte differentiation [GO:0048709]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of oligodendrocyte progenitor proliferation [GO:0070445],NA,NA,NA
CHOYP_PTPRK.4.20.m.2624,0.0102651939243081,0.0124906752250149,No,NA,NA,Q99M80,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRK.6.20.m.6291,0.0079635965448039,0.00872163648676982,No,NA,NA,Q99M80,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRK.8.20.m.8333,0.0063468973476034,-0.00672233520317961,No,NA,NA,O14522,NA,NA,NA,cell surface [GO:0009986]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRM.11.15.m.52054,0.00657707890972156,0.000365944389990897,No,NA,NA,P23469,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; negative regulation of insulin receptor signaling pathway [GO:0046627]; protein dephosphorylation [GO:0006470],NA,NA,NA
CHOYP_PTPRM.14.15.m.57240,0.0065883263884642,0.0180931628217626,No,NA,NA,Q15262,NA,NA,NA,adherens junction [GO:0005912]; axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; leading edge membrane [GO:0031256]; neuronal cell body [GO:0043025]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription; DNA-templated [GO:0045892]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_PTPRQ.6.8.m.45809,0.00658898646990164,0.000408449931795634,No,NA,NA,P0C5E4,NA,NA,NA,integral component of membrane [GO:0016021]; stereocilium bundle [GO:0032421]; protein tyrosine phosphatase activity [GO:0004725]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; inner ear morphogenesis [GO:0042472]; neuromuscular process controlling balance [GO:0050885]; regulation of fat cell differentiation [GO:0045598]; vestibular receptor cell morphogenesis [GO:0060116],NA,NA,NA
CHOYP_PTPRT.11.45.m.39468,9.12291778089724e-05,0.00819724696865498,No,NA,NA,P28828,NA,NA,NA,cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; positive regulation of blood vessel diameter [GO:0097755]; protein dephosphorylation [GO:0006470]; response to drug [GO:0042493]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_PTPRT.12.45.m.39573,-0.00753233199402199,0.012499918905142,No,NA,NA,O14522,NA,NA,NA,cell surface [GO:0009986]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRT.17.45.m.42361,0.00864826160142024,0.0015189375952693,No,NA,NA,O14522,NA,NA,NA,cell surface [GO:0009986]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRT.22.45.m.47112,0.0122092213947697,-0.0185949693893573,No,NA,NA,O14522,NA,NA,NA,cell surface [GO:0009986]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRT.26.45.m.52045,-0.00790147939891358,-0.0034706483428139,No,NA,NA,P28828,NA,NA,NA,cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; positive regulation of blood vessel diameter [GO:0097755]; protein dephosphorylation [GO:0006470]; response to drug [GO:0042493]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_PTPRT.30.45.m.53464,-0.000100518299627381,-0.00542729837950592,No,NA,NA,P18433,NA,NA,NA,extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804],NA,NA,NA
CHOYP_PTPRT.38.45.m.60044,0.00315630926841679,0.000757237513911048,No,NA,NA,Q99M80,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRT.40.45.m.61584,0.00394536801625317,0.00291369700370642,No,NA,NA,P18433,NA,NA,NA,extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804],NA,NA,NA
CHOYP_PTPRT.6.45.m.24275,-0.00753359334780338,0.0140395078974497,No,NA,NA,Q99M80,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRU.2.2.m.58388,0.00355088676594198,0.0075589263427687,No,NA,NA,P28827,NA,NA,NA,cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; positive regulation of blood vessel diameter [GO:0097755]; protein dephosphorylation [GO:0006470]; response to drug [GO:0042493]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_PTPRZ.1.9.m.12735,0.01235355891224,0.0229870738961299,No,NA,NA,P23471,NA,NA,NA,integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; perineuronal net [GO:0072534]; plasma membrane [GO:0005886]; synapse [GO:0045202]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axonogenesis [GO:0007409]; central nervous system development [GO:0007417]; cytokine-mediated signaling pathway [GO:0019221]; hematopoietic progenitor cell differentiation [GO:0002244]; learning or memory [GO:0007611]; oligodendrocyte differentiation [GO:0048709]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of oligodendrocyte progenitor proliferation [GO:0070445],NA,NA,NA
CHOYP_PTPRZ.4.9.m.21524,-0.00269301195671801,-0.0125755384748241,No,NA,NA,P28827,NA,NA,NA,cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; positive regulation of blood vessel diameter [GO:0097755]; protein dephosphorylation [GO:0006470]; response to drug [GO:0042493]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_PUA1A.1.1.m.6287,-0.0117609745146064,-0.00179488026556704,No,NA,NA,Q561L1,NA,NA,NA,cytoplasm [GO:0005737]; adenylosuccinate synthase activity [GO:0004019]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; 'de novo' AMP biosynthetic process [GO:0044208],NA,NA,NA
CHOYP_PUM1.1.1.m.8674,-0.0127222596590387,-0.0173055771273558,No,NA,NA,Q80U58,NA,NA,NA,cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of RIG-I signaling pathway [GO:1900246]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of chromosome segregation [GO:0051983]; regulation of mRNA stability [GO:0043488]; regulation of translation [GO:0006417]; stress granule assembly [GO:0034063],NA,NA,NA
CHOYP_PUR2.1.1.m.17810,0.0213192907955583,-0.00798553948153017,No,NA,NA,Q64737,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; phosphoribosylglycinamide formyltransferase activity [GO:0004644]; 'de novo' IMP biosynthetic process [GO:0006189]; adenine biosynthetic process [GO:0046084]; brainstem development [GO:0003360]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; glycine metabolic process [GO:0006544]; purine nucleotide biosynthetic process [GO:0006164]; response to inorganic substance [GO:0010035]; response to organic substance [GO:0010033]; ribonucleoside monophosphate biosynthetic process [GO:0009156]; tetrahydrofolate biosynthetic process [GO:0046654],NA,NA,NA
CHOYP_PUR8.1.1.m.2748,-0.00594882630436212,0.010904298566052,No,NA,NA,P21265,NA,NA,NA,cytosol [GO:0005829]; (S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity [GO:0070626]; N6-(1;2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity [GO:0004018]; 'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189],NA,NA,NA
CHOYP_PUS3.1.1.m.9880,-0.0124462929975442,-0.00482186599361757,No,NA,NA,Q9BZE2,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; tRNA pseudouridine synthase activity [GO:0106029]; mRNA pseudouridine synthesis [GO:1990481]; tRNA modification [GO:0006400]; tRNA pseudouridine synthesis [GO:0031119],NA,NA,NA
CHOYP_PUS7.1.1.m.53798,0.0105066324603186,0.00861507408617196,No,NA,NA,Q96PZ0,NA,NA,NA,nucleus [GO:0005634]; enzyme binding [GO:0019899]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; mRNA pseudouridine synthesis [GO:1990481]; negative regulation of translation [GO:0017148]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mesoderm development [GO:2000380]; tRNA pseudouridine synthesis [GO:0031119],NA,NA,NA
CHOYP_PVX_111155.1.1.m.25208,0.0165078288019432,0.00227591650923072,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PWAP.1.1.m.44818,0.022845413391058,-0.00146104953893994,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PWP2.1.1.m.7530,-0.00443409193115375,-0.0100605109657582,No,NA,NA,Q5RFQ3,NA,NA,NA,nucleolus [GO:0005730],NA,NA,NA
CHOYP_PXK.1.1.m.27815,0.00874920720158817,0.0110125940257787,No,NA,NA,Q8BX57,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; actin binding [GO:0003779]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; inflammatory response [GO:0006954]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of ATPase activity [GO:0032780]; negative regulation of ion transport [GO:0043271]; regulation of membrane potential [GO:0042391],NA,NA,NA
CHOYP_PY03350.1.1.m.8097,0.00439432098885822,-0.0107008545826449,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PY03697.1.1.m.58980,0.000765184223941602,-0.00323650696289278,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PY04960.1.1.m.26352,-0.0226219392259189,0.010462369237853,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PYR1.1.1.m.61565,-0.0034743968438666,-0.0118263804414684,No,NA,NA,Q91437,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; amino acid binding [GO:0016597]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; zinc ion binding [GO:0008270]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; glutamine metabolic process [GO:0006541],NA,NA,NA
CHOYP_PYRD2.1.1.m.26691,-0.0106282955558044,0.00338035753221278,No,NA,NA,Q68FT3,NA,NA,NA,oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_PYRG1.1.1.m.13552,-0.0073918417133712,-0.0170755822825613,No,NA,NA,Q6PEI7,NA,NA,NA,cytoophidium [GO:0097268]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; identical protein binding [GO:0042802]; 'de novo' CTP biosynthetic process [GO:0044210]; CTP biosynthetic process [GO:0006241]; glutamine metabolic process [GO:0006541]; pyrimidine nucleobase biosynthetic process [GO:0019856],NA,NA,NA
CHOYP_QARS.2.2.m.18038,0.00594204891993498,-0.0160388024865215,No,NA,NA,P47897,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; brain development [GO:0007420]; glutaminyl-tRNA aminoacylation [GO:0006425]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of stress-activated MAPK cascade [GO:0032873]; negative regulation of transcription; DNA-templated [GO:0045892]; tRNA aminoacylation for protein translation [GO:0006418],NA,NA,NA
CHOYP_QCR2.1.1.m.35612,-0.00734329815087461,-0.0190177882849473,No,NA,NA,P22695,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; protein-containing complex binding [GO:0044877]; aerobic respiration [GO:0009060]; oxidative phosphorylation [GO:0006119]; protein processing involved in protein targeting to mitochondrion [GO:0006627],NA,NA,NA
CHOYP_QCR2.1.1.m.35613,-0.0186339863961458,-0.0139515584760891,No,NA,NA,Q8VIG3,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; meiotic spindle [GO:0072687]; motile cilium [GO:0031514]; outer dense fiber [GO:0001520]; sperm flagellum [GO:0036126]; axoneme assembly [GO:0035082]; meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286],NA,NA,NA
CHOYP_QPCT.1.1.m.38977,0.0121956126964814,0.0084007431789436,No,NA,NA,Q16769,NA,NA,NA,extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; glutaminyl-peptide cyclotransferase activity [GO:0016603]; zinc ion binding [GO:0008270]; cellular protein modification process [GO:0006464]; neutrophil degranulation [GO:0043312]; peptidyl-pyroglutamic acid biosynthetic process; using glutaminyl-peptide cyclotransferase [GO:0017186],NA,NA,NA
CHOYP_QTRTD1.1.1.m.19041,0.00751779199916641,0.00843715396771545,No,NA,NA,Q28DX0,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; queuine tRNA-ribosyltransferase activity [GO:0008479]; tRNA-guanine transglycosylation [GO:0101030],NA,NA,NA
CHOYP_R3HDM1.1.1.m.36018,0.00306012903273715,-0.00598325046813856,No,NA,NA,Q15032,NA,NA,NA,RNA binding [GO:0003723],NA,NA,NA
CHOYP_RAB1A.1.3.m.10036,0.00135322509064518,-0.0129776821835355,No,NA,NA,Q05974,NA,NA,NA,endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_RAB21.1.1.m.56542,0.00529590069012438,-0.00624481337655525,No,NA,NA,P35282,NA,NA,NA,axon cytoplasm [GO:1904115]; cleavage furrow [GO:0032154]; cytoplasmic side of early endosome membrane [GO:0098559]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi cisterna membrane [GO:0032580]; neuron projection [GO:0043005]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; vesicle membrane [GO:0012506]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; anterograde axonal transport [GO:0008089]; intracellular protein transport [GO:0006886]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of receptor-mediated endocytosis [GO:0048260]; Rab protein signal transduction [GO:0032482]; regulation of axon extension [GO:0030516]; regulation of exocytosis [GO:0017157],NA,NA,NA
CHOYP_RAB35.1.1.m.8277,0.0111797791999176,0.0152300967565341,No,NA,NA,Q5U316,NA,NA,NA,anchored component of synaptic vesicle membrane [GO:0098993]; cell projection membrane [GO:0031253]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; intercellular bridge [GO:0045171]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; antigen processing and presentation [GO:0019882]; cellular response to nerve growth factor stimulus [GO:1990090]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; mitotic cytokinesis [GO:0000281]; neuron projection development [GO:0031175]; plasma membrane to endosome transport [GO:0048227]; protein localization to endosome [GO:0036010]; Rab protein signal transduction [GO:0032482],NA,NA,NA
CHOYP_RAB35.1.1.m.8278,0.0146513053305218,0.0118401207515212,No,NA,NA,P62282,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; membrane [GO:0016020]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; osteoblast differentiation [GO:0001649]; translation [GO:0006412],NA,NA,NA
CHOYP_RAB4B.1.1.m.55402,-0.00895680946778922,0.00521972744584719,No,NA,NA,Q68EK7,NA,NA,NA,endosome [GO:0005768]; insulin-responsive compartment [GO:0032593]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]; regulation of endocytosis [GO:0030100],NA,NA,NA
CHOYP_RAB7A.1.2.m.23789,0.00140598749069784,0.00695995652758815,No,NA,NA,Q5D013,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; methyltransferase activity [GO:0008168]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine methylation [GO:0018022],NA,NA,NA
CHOYP_RAB7A.1.2.m.23790,-0.00942689277659543,0.00906865959674563,No,NA,NA,H9BW96,NA,NA,NA,cytosol [GO:0005829]; endosome membrane [GO:0010008]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; lipid catabolic process [GO:0016042]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of viral process [GO:0048524]; protein targeting to lysosome [GO:0006622]; viral process [GO:0016032],NA,NA,NA
CHOYP_RAB8A.2.3.m.33866,-0.00547761948092024,-0.00807016738027743,No,NA,NA,Q4R5P1,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; Golgi apparatus [GO:0005794]; midbody [GO:0030496]; non-motile cilium [GO:0097730]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; Rab GTPase binding [GO:0017137]; autophagy [GO:0006914]; axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; cilium assembly [GO:0060271]; Golgi vesicle fusion to target membrane [GO:0048210]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; regulation of autophagy [GO:0010506]; vesicle docking involved in exocytosis [GO:0006904],NA,NA,NA
CHOYP_RABGAP1.1.1.m.50532,-3.41305903859533e-05,0.00239006704274214,No,NA,NA,A2AWA9,NA,NA,NA,cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; intracellular protein transport [GO:0006886]; regulation of GTPase activity [GO:0043087],NA,NA,NA
CHOYP_RABP2.1.1.m.29597,0.00803277601360211,0.00282932672251331,No,NA,NA,P22935,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin binding [GO:0030332]; retinal binding [GO:0016918]; retinoic acid binding [GO:0001972]; retinol binding [GO:0019841]; embryonic forelimb morphogenesis [GO:0035115]; positive regulation of collateral sprouting [GO:0048672]; regulation of retinoic acid receptor signaling pathway [GO:0048385]; retinoic acid biosynthetic process [GO:0002138]; retinoic acid metabolic process [GO:0042573],NA,NA,NA
CHOYP_RABX5.1.2.m.26033,-0.00150954721865322,-0.0106422234813189,No,NA,NA,O18973,NA,NA,NA,early endosome [GO:0005769]; recycling endosome [GO:0055037]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; endocytosis [GO:0006897]; protein transport [GO:0015031],NA,NA,NA
CHOYP_RAC1.1.3.m.20870,0.021844309762495,-0.00974483713028847,No,NA,NA,Q9QX22,NA,NA,NA,cytoplasm [GO:0005737]; S-adenosyl-L-methionine binding [GO:1904047]; thiopurine S-methyltransferase activity [GO:0008119]; drug metabolic process [GO:0017144],NA,NA,NA
CHOYP_RAC1.1.3.m.20871,-0.00459202929052454,0.0145451707231259,No,NA,NA,Q6RUV5,NA,NA,NA,actin filament [GO:0005884]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]; trans-Golgi network [GO:0005802]; ATPase binding [GO:0051117]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; histone deacetylase binding [GO:0042826]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; Rab GTPase binding [GO:0017137]; Rho GDP-dissociation inhibitor binding [GO:0051022]; thioesterase binding [GO:0031996]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; bone resorption [GO:0045453]; cell motility [GO:0048870]; cell projection assembly [GO:0030031]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; chemotaxis [GO:0006935]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of respiratory burst [GO:0060263]; Rho protein signal transduction [GO:0007266]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446],NA,NA,NA
CHOYP_RAC1.2.3.m.23406,-0.0226658712643031,0.0103194414324397,No,NA,NA,Q6RUV5,NA,NA,NA,actin filament [GO:0005884]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]; trans-Golgi network [GO:0005802]; ATPase binding [GO:0051117]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; histone deacetylase binding [GO:0042826]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; Rab GTPase binding [GO:0017137]; Rho GDP-dissociation inhibitor binding [GO:0051022]; thioesterase binding [GO:0031996]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; bone resorption [GO:0045453]; cell motility [GO:0048870]; cell projection assembly [GO:0030031]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; chemotaxis [GO:0006935]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of respiratory burst [GO:0060263]; Rho protein signal transduction [GO:0007266]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446],NA,NA,NA
CHOYP_RADI.1.2.m.2373,0.0137365284153627,0.00812614073284395,No,NA,NA,P26043,NA,NA,NA,apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell tip [GO:0051286]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; cortical actin cytoskeleton [GO:0030864]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; midbody [GO:0030496]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; stereocilium [GO:0032420]; T-tubule [GO:0030315]; actin binding [GO:0003779]; ATPase binding [GO:0051117]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; apical protein localization [GO:0045176]; barbed-end actin filament capping [GO:0051016]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to thyroid hormone stimulus [GO:0097067]; establishment of endothelial barrier [GO:0061028]; establishment of protein localization [GO:0045184]; microvillus assembly [GO:0030033]; negative regulation of adherens junction organization [GO:1903392]; negative regulation of cell size [GO:0045792]; negative regulation of GTPase activity [GO:0034260]; negative regulation of homotypic cell-cell adhesion [GO:0034111]; positive regulation of cell migration [GO:0030335]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to early endosome [GO:1902966]; protein localization to plasma membrane [GO:0072659]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of GTPase activity [GO:0043087]; regulation of organelle assembly [GO:1902115]; regulation of ruffle assembly [GO:1900027],NA,NA,NA
CHOYP_RADI.2.2.m.22446,-0.011503071759478,-0.00343803854921847,No,NA,NA,E1BBQ2,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; protein localization to plasma membrane [GO:0072659],NA,NA,NA
CHOYP_RAEL1.1.1.m.40419,0.00209974482289854,-0.0182543158928611,No,NA,NA,A5GFN6,NA,NA,NA,cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; mitotic spindle pole [GO:0097431]; nuclear pore [GO:0005643]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to organic cyclic compound [GO:0071407]; mRNA export from nucleus [GO:0006406]; regulation of mitotic spindle organization [GO:0060236]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972],NA,NA,NA
CHOYP_RAGP1.1.1.m.64037,-0.0163696957659398,-0.00504620760657195,No,NA,NA,P46060,NA,NA,NA,aggresome [GO:0016235]; axon cytoplasm [GO:1904115]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; dendrite [GO:0030425]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; cadherin binding [GO:0045296]; GTPase activator activity [GO:0005096]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; activation of GTPase activity [GO:0090630]; cellular response to vasopressin [GO:1904117]; negative regulation of protein export from nucleus [GO:0046826]; response to axon injury [GO:0048678]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_RALA.1.4.m.8443,-0.0120052378085164,0.0212175027813806,No,NA,NA,P48555,NA,NA,NA,cleavage furrow [GO:0032154]; Flemming body [GO:0090543]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; PDZ domain binding [GO:0030165]; border follicle cell migration [GO:0007298]; defense response to Gram-negative bacterium [GO:0050829]; dorsal closure [GO:0007391]; innate immune response [GO:0045087]; negative regulation of innate immune response [GO:0045824]; negative regulation of JNK cascade [GO:0046329]; R3/R4 cell fate commitment [GO:0007464]; Ras protein signal transduction [GO:0007265]; regulation of cell morphogenesis [GO:0022604]; regulation of Notch signaling pathway [GO:0008593],NA,NA,NA
CHOYP_RALA.4.4.m.26414,-0.00513712471397507,0.00974296388400715,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RAN.1.3.m.3468,-0.0163244532181024,0.00159777118147835,No,NA,NA,H9D1R1,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; electron transfer activity [GO:0009055]; protein-disulfide reductase (glutathione) activity [GO:0019153]; cell redox homeostasis [GO:0045454]; defense response to virus [GO:0051607]; oxidation-reduction process [GO:0055114]; viral process [GO:0016032],NA,NA,NA
CHOYP_RAN.3.3.m.59027,-0.0172000267759337,0.00487771360766721,No,NA,NA,A0MZ67,NA,NA,NA,axon [GO:0030424]; axonal growth cone [GO:0044295]; cell leading edge [GO:0031252]; cytosol [GO:0005829]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; actin filament binding [GO:0051015]; cell adhesion molecule binding [GO:0050839]; actin filament bundle retrograde transport [GO:0061573]; axonogenesis [GO:0007409]; Cdc42 protein signal transduction [GO:0032488]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; endoplasmic reticulum polarization [GO:0061163]; netrin-activated signaling pathway [GO:0038007]; positive regulation of axon extension [GO:0045773]; positive regulation of neuron migration [GO:2001224]; Ras protein signal transduction [GO:0007265]; regulation of establishment of cell polarity [GO:2000114]; substrate-dependent cell migration; cell extension [GO:0006930],NA,NA,NA
CHOYP_RANB9.1.2.m.40766,-0.00724210185837638,-0.00487894457456435,No,NA,NA,A1L252,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; retina development in camera-type eye [GO:0060041],NA,NA,NA
CHOYP_RANGRF.1.2.m.18930,-0.0139463541060936,-0.00293415693756241,No,NA,NA,A3KPP3,NA,NA,NA,nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; heart contraction [GO:0060047]; heart looping [GO:0001947]; protein transport [GO:0015031],NA,NA,NA
CHOYP_RAS.1.1.m.57089,-0.0105138554370134,0.0109217826533938,No,NA,NA,P23175,NA,NA,NA,host cell plasma membrane [GO:0020002]; membrane [GO:0016020]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_RAS3.1.1.m.15706,-0.00716094909089202,0.011602815991649,No,NA,NA,Q640R7,NA,NA,NA,cell junction [GO:0030054]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; Rap protein signal transduction [GO:0032486],NA,NA,NA
CHOYP_RAVR1.1.1.m.62572,-0.0192526105004598,-0.00707345654698658,No,NA,NA,Q9HCJ3,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_RB3GP.1.2.m.53902,0.0105626115832538,0.0049996710844217,No,NA,NA,Q642R9,NA,NA,NA,cytoplasm [GO:0005737]; GTPase activator activity [GO:0005096],NA,NA,NA
CHOYP_RB6I2.2.2.m.65652,-0.00867415611188743,0.00592337408315217,No,NA,NA,Q99MI1,NA,NA,NA,cytoplasm [GO:0005737]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; IkappaB kinase complex [GO:0008385]; membrane [GO:0016020]; postsynaptic density [GO:0014069]; presynaptic active zone cytoplasmic component [GO:0098831]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; PDZ domain binding [GO:0030165]; Rab GTPase binding [GO:0017137]; structural constituent of presynaptic active zone [GO:0098882]; voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels [GO:0099635]; I-kappaB phosphorylation [GO:0007252]; protein transport [GO:0015031]; retrograde transport; endosome to Golgi [GO:0042147]; synaptic vesicle priming [GO:0016082],NA,NA,NA
CHOYP_RBBP4.1.1.m.62913,0.00677400311036513,0.000412665089348038,No,NA,NA,Q60972,NA,NA,NA,CAF-1 complex [GO:0033186]; cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; NURF complex [GO:0016589]; protein-containing complex [GO:0032991]; DNA-dependent ATPase activity [GO:0008094]; histone deacetylase binding [GO:0042826]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cell cycle [GO:0007049]; chromatin assembly [GO:0031497]; chromatin remodeling [GO:0006338]; DNA replication [GO:0006260]; DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336],NA,NA,NA
CHOYP_RBCC1.1.2.m.7288,-0.00142971047078669,-0.00917318399798537,No,NA,NA,Q9ESK9,NA,NA,NA,Atg1/ULK1 kinase complex [GO:1990316]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; lysosome [GO:0005764]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; protein kinase binding [GO:0019901]; protein-containing complex scaffold activity [GO:0032947]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of peroxisome [GO:0030242]; cell cycle [GO:0007049]; glycophagy [GO:0061723]; heart development [GO:0007507]; liver development [GO:0001889]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of cell size [GO:0045793]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein phosphorylation [GO:0001934]; reticulophagy [GO:0061709],NA,NA,NA
CHOYP_RBEL1.1.1.m.174,-0.00227228992713845,-0.0194692688970062,No,NA,NA,Q3YEC7,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525],NA,NA,NA
CHOYP_RBM10.2.2.m.59955,-0.00359806130232353,-0.00906128591201506,No,NA,NA,A4IGK4,NA,NA,NA,nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; spliceosomal complex assembly [GO:0000245],NA,NA,NA
CHOYP_RBM19.1.2.m.28228,0.00190581620391656,0.00192951417220774,No,NA,NA,Q9Y4C8,NA,NA,NA,chromosome [GO:0005694]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; mRNA cis splicing; via spliceosome [GO:0045292]; multicellular organism development [GO:0007275]; positive regulation of embryonic development [GO:0040019]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],NA,NA,NA
CHOYP_RBM20.1.2.m.2222,-0.00976071689792581,0.00633142111301278,No,NA,NA,Q8K310,NA,NA,NA,cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; zinc ion binding [GO:0008270]; activation of innate immune response [GO:0002218]; blastocyst formation [GO:0001825]; heart valve development [GO:0003170]; innate immune response [GO:0045087]; posttranscriptional regulation of gene expression [GO:0010608]; ventricular septum development [GO:0003281],NA,NA,NA
CHOYP_RBM22.1.1.m.43645,-0.00562864216119595,0.00168303781142671,No,NA,NA,Q5ZM16,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; metal ion binding [GO:0046872]; pre-mRNA binding [GO:0036002]; U6 snRNA binding [GO:0017070]; cellular response to drug [GO:0035690]; mRNA cis splicing; via spliceosome [GO:0045292]; positive regulation of RNA splicing [GO:0033120]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_RBM25.1.2.m.41094,-0.0135100481809309,-0.00901535272381144,No,NA,NA,B2RY56,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; mRNA binding [GO:0003729]; apoptotic process [GO:0006915]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of apoptotic process [GO:0042981]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_RBM39.1.1.m.19427,-0.00805676247038424,0.00991029812807446,No,NA,NA,Q5RC80,NA,NA,NA,nuclear speck [GO:0016607]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_RBMX.1.1.m.26723,-0.00256404720072494,0.00104932267802875,No,NA,NA,Q7ZWA3,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; commitment complex [GO:0000243]; extracellular exosome [GO:0070062]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530]; chromatin binding [GO:0003682]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cellular response to interleukin-1 [GO:0071347]; membrane protein ectodomain proteolysis [GO:0006509]; mRNA splicing; via spliceosome [GO:0000398]; multicellular organism development [GO:0007275]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; positive regulation of mRNA splicing; via spliceosome [GO:0048026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_RBP6.1.2.m.6061,0.0200694243646584,-0.0110194424181476,No,NA,NA,Q9VVE5,NA,NA,NA,cytoplasm [GO:0005737]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; stem cell development [GO:0048864],NA,NA,NA
CHOYP_RBSK.1.1.m.17187,0.0141364764465868,0.00932237050687053,No,NA,NA,Q9H477,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; ribokinase activity [GO:0004747]; carbohydrate phosphorylation [GO:0046835]; D-ribose catabolic process [GO:0019303]; pentose-phosphate shunt [GO:0006098],NA,NA,NA
CHOYP_RBX1A.1.1.m.63168,-0.00132164656493133,-0.00922836664354236,No,NA,NA,P62878,NA,NA,NA,anaphase-promoting complex [GO:0005680]; Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul3-RING ubiquitin ligase complex [GO:0031463]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; Cul5-RING ubiquitin ligase complex [GO:0031466]; Cul7-RING ubiquitin ligase complex [GO:0031467]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nuclear SCF ubiquitin ligase complex [GO:0043224]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]; VCB complex [GO:0030891]; cullin family protein binding [GO:0097602]; eukaryotic initiation factor 4E binding [GO:0008190]; NEDD8 transferase activity [GO:0019788]; protein-containing complex binding [GO:0044877]; transcription factor binding [GO:0008134]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270]; DNA repair [GO:0006281]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein monoubiquitination [GO:0006513]; protein neddylation [GO:0045116]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_RCC1.1.1.m.15249,0.00716794450605175,-0.00443981967761077,No,NA,NA,P18754,NA,NA,NA,chromatin [GO:0000785]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; nucleosomal DNA binding [GO:0031492]; nucleosome binding [GO:0031491]; protein heterodimerization activity [GO:0046982]; Ran GTPase binding [GO:0008536]; Ran guanyl-nucleotide exchange factor activity [GO:0005087]; sulfate binding [GO:0043199]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic spindle organization [GO:0007052]; protein heterotetramerization [GO:0051290]; regulation of mitotic nuclear division [GO:0007088]; spindle assembly [GO:0051225]; viral process [GO:0016032],NA,NA,NA
CHOYP_RCL1.1.1.m.7474,0.000686232728993107,-0.0107331332691118,No,NA,NA,Q9JJT0,NA,NA,NA,nucleolus [GO:0005730]; endoribonuclease activity [GO:0004521]; endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000447]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_RCOM_1886900.1.1.m.11248,-0.0221867757475679,0.000124007842016449,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RD23B.1.1.m.38952,-0.0152138027651018,-0.0172175544914475,No,NA,NA,P54727,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; XPC complex [GO:0071942]; damaged DNA binding [GO:0003684]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; single-stranded DNA binding [GO:0003697]; ubiquitin binding [GO:0043130]; cellular response to interleukin-7 [GO:0098761]; embryonic organ development [GO:0048568]; global genome nucleotide-excision repair [GO:0070911]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair; DNA damage recognition [GO:0000715]; nucleotide-excision repair; preincision complex assembly [GO:0006294]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein folding [GO:0006457]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_RDH13.1.3.m.10433,0.00243312602691096,-0.0236285366148608,No,NA,NA,Q8NBN7,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; NADP-retinol dehydrogenase activity [GO:0052650]; eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574],NA,NA,NA
CHOYP_RED.1.2.m.8931,-0.00847364066705717,-0.0134548168347959,No,NA,NA,Q9Z1M8,NA,NA,NA,cytoplasm [GO:0005737]; mitotic spindle pole [GO:0097431]; nuclear chromosome [GO:0000228]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; identical protein binding [GO:0042802]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA splicing; via spliceosome [GO:0000398]; protein localization to kinetochore [GO:0034501],NA,NA,NA
CHOYP_RED1.1.2.m.60684,-0.0107873336090505,-0.00308044733067975,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RED1.2.2.m.61084,-0.00517073813728388,0.00543230628821714,No,NA,NA,Q91ZS8,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251]; adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; facial nerve morphogenesis [GO:0021610]; hypoglossal nerve morphogenesis [GO:0021618]; innervation [GO:0060384]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; muscle tissue morphogenesis [GO:0060415]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; neuromuscular process controlling posture [GO:0050884]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of mRNA processing [GO:0050685]; positive regulation of viral genome replication [GO:0045070]; regulation of cell cycle [GO:0051726]; RNA processing [GO:0006396]; spinal cord ventral commissure morphogenesis [GO:0021965],NA,NA,NA
CHOYP_RELN.3.4.m.48195,0.0109831386632706,-5.5206001472805e-05,No,NA,NA,P58751,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; lipoprotein particle receptor binding [GO:0070325]; metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell morphogenesis involved in differentiation [GO:0000904]; cellular response to dexamethasone stimulus [GO:0071549]; central nervous system development [GO:0007417]; cerebral cortex development [GO:0021987]; cerebral cortex tangential migration [GO:0021800]; dentate gyrus development [GO:0021542]; glial cell differentiation [GO:0010001]; hypothalamus development [GO:0021854]; locomotory behavior [GO:0007626]; memory [GO:0007613]; midgut development [GO:0007494]; neuron migration [GO:0001764]; orbitofrontal cortex development [GO:0021769]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; response to amino acid [GO:0043200]; response to axon injury [GO:0048678]; response to corticosterone [GO:0051412]; response to drug [GO:0042493]; response to electrical stimulus [GO:0051602]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542]; response to hormone [GO:0009725]; response to insecticide [GO:0017085]; response to lithium ion [GO:0010226]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to pain [GO:0048265]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; social behavior [GO:0035176]; spinal cord patterning [GO:0021511],NA,NA,NA
CHOYP_RENT1.1.1.m.44133,-0.00360235459866229,-0.0100334413940339,No,NA,NA,Q9EPU0,NA,NA,NA,chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nuclear chromosome; telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; supraspliceosomal complex [GO:0044530]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; zinc ion binding [GO:0008270]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; cell cycle phase transition [GO:0044770]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; dosage compensation by inactivation of X chromosome [GO:0009048]; histone mRNA catabolic process [GO:0071044]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process; endonucleolytic cleavage-dependent decay [GO:0000294]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; positive regulation of mRNA catabolic process [GO:0061014]; regulation of telomere maintenance [GO:0032204]; regulation of translational termination [GO:0006449]; telomere maintenance via semi-conservative replication [GO:0032201],NA,NA,NA
CHOYP_RENT2.1.1.m.50589,0.00281716427072701,0.0126520799833661,No,NA,NA,Q9HAU5,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; animal organ regeneration [GO:0031100]; liver development [GO:0001889]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184],NA,NA,NA
CHOYP_REPS1.1.2.m.35334,0.00554976520671447,-0.00136934882187445,No,NA,NA,O54916,NA,NA,NA,clathrin-coated pit [GO:0005905]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; SH3 domain binding [GO:0017124]; receptor-mediated endocytosis [GO:0006898],NA,NA,NA
CHOYP_RER1.1.1.m.49089,-0.0142607283788869,-0.0219662547509697,No,NA,NA,A5PJ65,NA,NA,NA,endoplasmic reticulum [GO:0005783]; integral component of Golgi membrane [GO:0030173]; protein retention in ER lumen [GO:0006621]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_RFA1.1.1.m.16020,-0.00621000569185084,-0.0196830709021,No,NA,NA,P27694,NA,NA,NA,DNA replication factor A complex [GO:0005662]; nuclear chromosome; telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; site of DNA damage [GO:0090734]; damaged DNA binding [GO:0003684]; G-rich strand telomeric DNA binding [GO:0098505]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; single-stranded telomeric DNA binding [GO:0043047]; base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; DNA damage response; detection of DNA damage [GO:0042769]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair via homologous recombination [GO:0000724]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; G1/S transition of mitotic cell cycle [GO:0000082]; interstrand cross-link repair [GO:0036297]; meiotic cell cycle [GO:0051321]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair; DNA gap filling [GO:0006297]; nucleotide-excision repair; DNA incision [GO:0033683]; nucleotide-excision repair; DNA incision; 5'-to lesion [GO:0006296]; nucleotide-excision repair; preincision complex assembly [GO:0006294]; nucleotide-excision repair; preincision complex stabilization [GO:0006293]; protein localization to chromosome [GO:0034502]; regulation of cellular response to heat [GO:1900034]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; telomere maintenance via telomerase [GO:0007004]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985],NA,NA,NA
CHOYP_RFA2.1.1.m.6290,0.0021424265950258,0.0118099922703768,No,NA,NA,Q62193,NA,NA,NA,chromatin [GO:0000785]; chromosome; telomeric region [GO:0000781]; condensed nuclear chromosome [GO:0000794]; DNA replication factor A complex [GO:0005662]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; site of double-strand break [GO:0035861]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; G-rich strand telomeric DNA binding [GO:0098505]; protein N-terminus binding [GO:0047485]; protein phosphatase binding [GO:0019903]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase binding [GO:0031625]; base-excision repair [GO:0006284]; DNA replication [GO:0006260]; DNA topological change [GO:0006265]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; heteroduplex formation [GO:0030491]; mismatch repair [GO:0006298]; mitotic G1 DNA damage checkpoint [GO:0031571]; mitotic recombination [GO:0006312]; nucleotide-excision repair [GO:0006289]; positive regulation of helicase activity [GO:0051096]; protein localization to chromosome [GO:0034502]; reciprocal meiotic recombination [GO:0007131]; regulation of DNA damage checkpoint [GO:2000001]; regulation of double-strand break repair via homologous recombination [GO:0010569]; telomere maintenance [GO:0000723]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomerase [GO:0007004],NA,NA,NA
CHOYP_RFC1.1.3.m.8918,0.00944218174030547,-0.018285818840135,No,NA,NA,P35251,NA,NA,NA,cytoplasm [GO:0005737]; DNA replication factor C complex [GO:0005663]; Elg1 RFC-like complex [GO:0031391]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA clamp loader activity [GO:0003689]; DNA clamp unloader activity [GO:0061860]; double-stranded DNA binding [GO:0003690]; enzyme activator activity [GO:0008047]; protein domain specific binding [GO:0019904]; sequence-specific DNA binding [GO:0043565]; DNA clamp unloading [GO:0090618]; DNA damage response; detection of DNA damage [GO:0042769]; DNA-dependent DNA replication [GO:0006261]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleotide-excision repair; DNA gap filling [GO:0006297]; nucleotide-excision repair; DNA incision [GO:0033683]; nucleotide-excision repair; DNA incision; 5'-to lesion [GO:0006296]; positive regulation of transcription; DNA-templated [GO:0045893]; telomere maintenance via semi-conservative replication [GO:0032201]; telomere maintenance via telomerase [GO:0007004]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985],NA,NA,NA
CHOYP_RFC2.1.2.m.12862,-0.0106005492263112,-0.0180796560833598,No,NA,NA,Q6DGR4,NA,NA,NA,,NA,NA,NA
CHOYP_RFC2.1.2.m.12863,-0.0116227384170058,-0.00159477248392869,No,NA,NA,Q641W4,NA,NA,NA,Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA clamp loader activity [GO:0003689]; enzyme binding [GO:0019899]; single-stranded DNA-dependent ATPase activity [GO:0043142]; DNA-dependent DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264],NA,NA,NA
CHOYP_RFC3.1.1.m.48357,-0.00648534366923618,-0.0073425102654091,No,NA,NA,Q8R323,NA,NA,NA,Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleus [GO:0005634]; DNA clamp loader activity [GO:0003689]; single-stranded DNA-dependent ATPase activity [GO:0043142]; DNA replication [GO:0006260]; DNA-dependent DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; response to organophosphorus [GO:0046683],NA,NA,NA
CHOYP_RFIP4.1.2.m.976,0.00863182346872478,-0.00736670886703768,No,NA,NA,Q3LGD4,NA,NA,NA,cleavage furrow [GO:0032154]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; midbody [GO:0030496]; recycling endosome membrane [GO:0055038]; ADP-ribosylation factor binding [GO:0030306]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]; cell cycle [GO:0007049]; cell division [GO:0051301]; endocytic recycling [GO:0032456]; eye morphogenesis [GO:0048592]; regulation of cell cycle [GO:0051726]; regulation of cytokinesis [GO:0032465],NA,NA,NA
CHOYP_RFOX2.1.2.m.24118,-0.0205258826402043,-0.0011248976879157,No,NA,NA,O43251,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; dendrite morphogenesis [GO:0048813]; fibroblast growth factor receptor signaling pathway [GO:0008543]; intracellular estrogen receptor signaling pathway [GO:0030520]; mRNA processing [GO:0006397]; negative regulation of transcription; DNA-templated [GO:0045892]; nervous system development [GO:0007399]; neuromuscular process controlling balance [GO:0050885]; radial glia guided migration of Purkinje cell [GO:0021942]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of cell proliferation [GO:0042127]; regulation of definitive erythrocyte differentiation [GO:0010724]; RNA metabolic process [GO:0016070]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_RFX3.1.1.m.55790,-0.00867628184859725,0.00403404156673768,No,NA,NA,Q0V9K5,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]; cell differentiation [GO:0030154]; cilium-dependent cell motility [GO:0060285]; endocrine pancreas development [GO:0031018]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; regulation of insulin secretion [GO:0050796]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription; DNA-templated [GO:0006355]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_RGD1309762.1.1.m.47917,0.019212944369832,0.00945491371409392,No,NA,NA,Q9Y4D8,NA,NA,NA,integral component of membrane [GO:0016021]; ubiquitin-protein transferase activity [GO:0004842]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006],NA,NA,NA
CHOYP_RGD1310712.1.1.m.16487,0.00236213729318424,-0.0118559633463957,No,NA,NA,Q7ZUV7,NA,NA,NA,nucleus [GO:0005634]; chromatin organization [GO:0006325]; DNA repair [GO:0006281]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_RGD1561408.1.2.m.4308,0.0189760123880106,-0.0141140294902691,No,NA,NA,P15941,NA,NA,NA,apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; nuclear chromatin [GO:0000790]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; p53 binding [GO:0002039]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coregulator activity [GO:0003712]; cytokine-mediated signaling pathway [GO:0019221]; DNA damage response; signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response; signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of transcription by competitive promoter binding [GO:0010944]; O-glycan processing [GO:0016266]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; stimulatory C-type lectin receptor signaling pathway [GO:0002223],NA,NA,NA
CHOYP_RGN.1.1.m.30406,-0.0157568222262549,0.00627380109640907,No,NA,NA,Q6DF62,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]; gluconolactonase activity [GO:0004341]; zinc ion binding [GO:0008270]; cellular calcium ion homeostasis [GO:0006874]; L-ascorbic acid biosynthetic process [GO:0019853]; positive regulation of ATPase activity [GO:0032781]; regulation of calcium-mediated signaling [GO:0050848],NA,NA,NA
CHOYP_RGPA1.1.1.m.50924,0.002141881502666,-0.0138387461994953,No,NA,NA,Q2PPJ7,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982]; activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056],NA,NA,NA
CHOYP_RHDF1.2.3.m.45435,0.00394536801625317,0.00291369700370642,No,NA,NA,Q6PIX5,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; negative regulation of protein secretion [GO:0050709]; proteolysis [GO:0006508]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein secretion [GO:0050708],NA,NA,NA
CHOYP_RHDF1.3.3.m.54744,-0.00150197846723132,0.00810365196539881,No,NA,NA,Q6PJF5,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; growth factor binding [GO:0019838]; negative regulation of protein secretion [GO:0050709]; protein transport [GO:0015031]; proteolysis [GO:0006508]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of protein secretion [GO:0050708],NA,NA,NA
CHOYP_RHG07.1.1.m.14019,-0.00991383463063687,-0.0114242295924688,No,NA,NA,Q923Q2,NA,NA,NA,lipid droplet [GO:0005811]; mitochondrial membrane [GO:0031966]; GTPase activator activity [GO:0005096]; lipid binding [GO:0008289]; cell cycle [GO:0007049]; endothelial cell migration [GO:0043542]; endothelial tube lumen extension [GO:0097498]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of sprouting angiogenesis [GO:1903671]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_RHG17.1.2.m.32099,0.000817901201245362,-0.00465135245007659,No,NA,NA,Q9CYH6,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; endoplasmic reticulum [GO:0005783]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome; large subunit precursor [GO:0030687]; 5S rRNA binding [GO:0008097]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000447]; hematopoietic progenitor cell differentiation [GO:0002244]; mitotic metaphase plate congression [GO:0007080]; protein localization to nucleolus [GO:1902570]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055],NA,NA,NA
CHOYP_RHG18.1.1.m.24618,-0.00589678568163434,0.0164300955733386,No,NA,NA,Q8K0Q5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament polymerization [GO:0030833]; regulation of cell motility [GO:2000145]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264],NA,NA,NA
CHOYP_RHG44.1.1.m.982,-0.000560533512758111,0.00427912747244661,No,NA,NA,Q68EM7,NA,NA,NA,bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]; SH3 domain binding [GO:0017124]; actin filament organization [GO:0007015]; calcium ion regulated exocytosis [GO:0017156]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_RHO.1.1.m.2313,-0.0092934914468183,-0.019471329082388,No,NA,NA,P01122,NA,NA,NA,plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; small GTPase mediated signal transduction [GO:0007264],NA,NA,NA
CHOYP_RHO1.3.3.m.44337,0.00724264717567357,0.0171768708119723,No,NA,NA,Q5ZIN1,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; unfolded protein binding [GO:0051082]; cell cycle [GO:0007049]; cell division [GO:0051301]; developmental process [GO:0032502]; protein folding [GO:0006457],NA,NA,NA
CHOYP_RHO1.3.3.m.44338,-0.00496209606777747,0.0161657608088987,No,NA,NA,P48148,NA,NA,NA,apical cortex [GO:0045179]; cell cortex [GO:0005938]; cell division site [GO:0032153]; cell hair [GO:0070451]; cell-cell contact zone [GO:0044291]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; kinase binding [GO:0019900]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; actin-mediated cell contraction [GO:0070252]; adherens junction maintenance [GO:0034334]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; cell migration [GO:0016477]; cellular protein localization [GO:0034613]; cellularization [GO:0007349]; compound eye morphogenesis [GO:0001745]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; determination of left/right symmetry [GO:0007368]; dorsal closure [GO:0007391]; dorsal closure; leading edge cell differentiation [GO:0046663]; dorsal closure; spreading of leading edge cells [GO:0007395]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; establishment of planar polarity of embryonic epithelium [GO:0042249]; establishment of protein localization [GO:0045184]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; gastrulation involving germ band extension [GO:0010004]; germ-band extension [GO:0007377]; glial cell migration [GO:0008347]; hemocyte migration [GO:0035099]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing hair organization [GO:0035317]; lumen formation; open tracheal system [GO:0035149]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; melanization defense response [GO:0035006]; mitotic actomyosin contractile ring assembly [GO:1903475]; mitotic cytokinesis [GO:0000281]; motor neuron axon guidance [GO:0008045]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; neuroblast proliferation [GO:0007405]; neuron projection morphogenesis [GO:0048812]; open tracheal system development [GO:0007424]; peripheral nervous system development [GO:0007422]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of wound healing [GO:0090303]; posterior midgut invagination [GO:0007374]; protein localization involved in establishment of planar polarity [GO:0090251]; protein localization to adherens junction [GO:0071896]; pseudocleavage involved in syncytial blastoderm formation [GO:0030589]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of axonogenesis [GO:0050770]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; regulation of embryonic cell shape [GO:0016476]; regulation of filopodium assembly [GO:0051489]; regulation of locomotor rhythm [GO:1904059]; regulation of Malpighian tubule size [GO:0035298]; regulation of myoblast fusion [GO:1901739]; regulation of tube length; open tracheal system [GO:0035159]; response to wounding [GO:0009611]; Rho protein signal transduction [GO:0007266]; salivary gland morphogenesis [GO:0007435]; spiracle morphogenesis; open tracheal system [GO:0035277]; tracheal pit formation in open tracheal system [GO:0035202]; ventral furrow formation [GO:0007370]; visual perception [GO:0007601]; wound healing [GO:0042060],NA,NA,NA
CHOYP_RHOM172_0471.1.1.m.60636,0.0098760652631863,0.0199105798380134,No,NA,NA,Q96C23,NA,NA,NA,cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; aldose 1-epimerase activity [GO:0004034]; carbohydrate binding [GO:0030246]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; glucose metabolic process [GO:0006006],NA,NA,NA
CHOYP_RIF1.1.1.m.13682,-0.00444344383613648,-0.00310733066989272,No,NA,NA,E1C2U2,NA,NA,NA,chromosome; telomeric region [GO:0000781]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; female pronucleus [GO:0001939]; male pronucleus [GO:0001940]; nuclear body [GO:0016604]; nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; spindle midzone [GO:0051233]; cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin silencing at telomere [GO:0006348]; DNA repair [GO:0006281]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of histone H3-K9 methylation [GO:0051574]; positive regulation of isotype switching [GO:0045830]; stem cell population maintenance [GO:0019827]; telomere maintenance [GO:0000723]; telomere maintenance in response to DNA damage [GO:0043247],NA,NA,NA
CHOYP_RIMB2.3.5.m.17363,-0.0144310453802484,-0.0211907197170756,No,NA,NA,O15034,NA,NA,NA,cell junction [GO:0030054]; plasma membrane [GO:0005886]; synapse [GO:0045202]; negative regulation of phosphatase activity [GO:0010923]; neuromuscular synaptic transmission [GO:0007274],NA,NA,NA
CHOYP_RINT1.1.1.m.9402,-0.00215655519663885,-0.000882667417608575,No,NA,NA,Q6NUQ1,NA,NA,NA,cytosol [GO:0005829]; Dsl1/NZR complex [GO:0070939]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; cell cycle [GO:0007049]; Golgi organization [GO:0007030]; protein transport [GO:0015031]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of signal transduction involved in mitotic G2 DNA damage checkpoint [GO:1902504]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_RIOK3.1.1.m.54195,0.00123272305554583,-0.0166784178072991,No,NA,NA,Q9DBU3,NA,NA,NA,cytosol [GO:0005829]; preribosome; small subunit precursor [GO:0030688]; ATP binding [GO:0005524]; caspase binding [GO:0089720]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; cellular response to dsDNA [GO:1990786]; cellular response to dsRNA [GO:0071359]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; maturation of SSU-rRNA [GO:0030490]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of MDA-5 signaling pathway [GO:0039534]; negative regulation of protein homooligomerization [GO:0032463]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728],NA,NA,NA
CHOYP_RIPL1.1.1.m.59984,0.00704128401707864,0.00815396139619566,No,NA,NA,D3ZUQ0,NA,NA,NA,centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; dynein light intermediate chain binding [GO:0051959]; protein dimerization activity [GO:0046983]; small GTPase binding [GO:0031267]; cilium assembly [GO:0060271]; epithelial cell morphogenesis [GO:0003382]; protein transport from ciliary membrane to plasma membrane [GO:1903445]; regulation of neuron death [GO:1901214],NA,NA,NA
CHOYP_RIR1.2.2.m.30556,0.00117682200976431,-0.00476602415156743,No,NA,NA,P07742,NA,NA,NA,cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; ribonucleoside-diphosphate reductase complex [GO:0005971]; ATP binding [GO:0005524]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; purine nucleotide binding [GO:0017076]; ribonucleoside-diphosphate reductase activity; thioredoxin disulfide as acceptor [GO:0004748]; cell proliferation in forebrain [GO:0021846]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]; male gonad development [GO:0008584]; mitotic cell cycle [GO:0000278]; protein complex oligomerization [GO:0051259]; protein heterotetramerization [GO:0051290]; pyrimidine nucleobase metabolic process [GO:0006206]; response to ionizing radiation [GO:0010212]; retina development in camera-type eye [GO:0060041],NA,NA,NA
CHOYP_RIR2.1.1.m.19831,0.00275094777090505,-0.0198790537449268,No,NA,NA,P07201,NA,NA,NA,metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity; thioredoxin disulfide as acceptor [GO:0004748]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260],NA,NA,NA
CHOYP_RL10.1.3.m.11695,0.0142469844491086,-0.00285050093869882,No,NA,NA,O61231,NA,NA,NA,cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; neuronal cell body [GO:0043025]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027],NA,NA,NA
CHOYP_RL10A.1.2.m.7633,-0.0141201748924583,-0.00315525082296888,No,NA,NA,Q9N4I4,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; maturation of LSU-rRNA [GO:0000470]; translation [GO:0006412],NA,NA,NA
CHOYP_RL11.2.7.m.12991,0.0100207706186,0.00882904037988469,No,NA,NA,P62914,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; synapse [GO:0045202]; peroxisome proliferator activated receptor binding [GO:0042975]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; protein localization to nucleus [GO:0034504]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412],NA,NA,NA
CHOYP_RL14.2.9.m.10151,0.0202851613139671,0.00601860295765163,No,NA,NA,O46160,NA,NA,NA,ribosome [GO:0005840]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RL17.2.7.m.34420,0.00864494163574478,0.00481455444812587,No,NA,NA,Q8TBZ5,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; positive regulation by host of viral process [GO:0044794]; positive regulation by host of viral release from host cell [GO:0044791],NA,NA,NA
CHOYP_RL17.7.7.m.57535,-0.00146942481785082,-0.0187030129044402,No,NA,NA,Q09JW2,NA,NA,NA,large ribosomal subunit [GO:0015934]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RL18A.1.8.m.12900,0.0137220396577934,-0.0146450981359217,No,NA,NA,Q02543,NA,NA,NA,cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; membrane [GO:0016020]; polysomal ribosome [GO:0042788]; postsynaptic density [GO:0014069]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; response to antineoplastic agent [GO:0097327]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_RL18A.6.8.m.61646,0.00778908207492762,0.0134797026586813,No,NA,NA,Q02543,NA,NA,NA,cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; membrane [GO:0016020]; polysomal ribosome [GO:0042788]; postsynaptic density [GO:0014069]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; response to antineoplastic agent [GO:0097327]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_RL21.1.4.m.19435,0.00209691719796354,0.0087410017219199,No,NA,NA,P49666,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RL22.4.4.m.37418,0.0171546170071047,0.00999289275465578,No,NA,NA,P67985,NA,NA,NA,cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic large ribosomal subunit [GO:0022625]; glutamatergic synapse [GO:0098978]; large ribosomal subunit [GO:0015934]; presynapse [GO:0098793]; heparin binding [GO:0008201]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]; alpha-beta T cell differentiation [GO:0046632]; regulation of translation at presynapse; modulating synaptic transmission [GO:0099577]; translation [GO:0006412],NA,NA,NA
CHOYP_RL23.1.11.m.2901,0.0125395093271596,0.0204406651992425,No,NA,NA,P48159,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit rRNA binding [GO:0070180]; myosin binding [GO:0017022]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181],NA,NA,NA
CHOYP_RL23.4.11.m.13922,0.0223053858680964,0.00835303086561862,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RL23A.3.6.m.31005,0.0183201655674094,0.0106222683387784,No,NA,NA,P62752,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]; large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; TORC2 complex binding [GO:1904841]; cell proliferation [GO:0008283]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412],NA,NA,NA
CHOYP_RL23A.6.6.m.63333,0.00491588973115351,-0.000600714720400962,No,NA,NA,P62752,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]; large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; TORC2 complex binding [GO:1904841]; cell proliferation [GO:0008283]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412],NA,NA,NA
CHOYP_RL24.6.9.m.43123,0.0194700159457163,-0.0117406897407426,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RL24.6.9.m.43124,0.00364778592941831,-0.00872052841558097,No,NA,NA,Q9DFQ7,NA,NA,NA,ribosome [GO:0005840],NA,NA,NA
CHOYP_RL39.1.2.m.5372,0.0065197481554592,-0.00875722032745603,No,NA,NA,Q9D1L0,NA,NA,NA,mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; mitochondrion organization [GO:0007005]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cellular response to hypoxia [GO:1900037],NA,NA,NA
CHOYP_RL39.2.2.m.64898,-0.00791261650881468,0.00618472031452084,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RL4.2.6.m.4480,-0.000909460131307903,-0.00974903523694925,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RL4.2.6.m.4481,0.0105644123916254,-0.00637526340795244,No,NA,NA,P49165,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RL4.6.6.m.66341,-0.00941375899923115,0.0111643108714567,No,NA,NA,P49165,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RL40.1.7.m.3623,0.0068856993468304,-0.0161182591641767,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RL44.1.2.m.28788,0.0053753800556409,-0.00639478551626255,No,NA,NA,P90702,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RL7A.2.6.m.5689,-0.00183351440139716,-0.00285103491425295,No,NA,NA,Q9ESD1,NA,NA,NA,anchored component of plasma membrane [GO:0046658]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; sodium channel regulator activity [GO:0017080]; positive regulation of sodium ion transmembrane transport [GO:1902307]; positive regulation of sodium ion transport [GO:0010765]; transepithelial transport [GO:0070633],NA,NA,NA
CHOYP_RL8.10.10.m.65636,-0.00101260445552188,-0.0208749805841781,No,NA,NA,Q6PBF0,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181],NA,NA,NA
CHOYP_RL8.3.10.m.22753,-0.004230646179664,0.0128746073691571,No,NA,NA,Q90YV7,NA,NA,NA,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; protein localization to nucleus [GO:0034504]; translation [GO:0006412],NA,NA,NA
CHOYP_RL9.4.6.m.43062,0.0123429630002608,0.00529754830982131,No,NA,NA,P50882,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181],NA,NA,NA
CHOYP_RL9.5.6.m.63453,0.00137177515655019,0.00727046412541173,No,NA,NA,P50882,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181],NA,NA,NA
CHOYP_RLA0.3.7.m.42195,-0.0104828851467163,-0.0154571776785127,No,NA,NA,O75689,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; inositol 1;3;4;5 tetrakisphosphate binding [GO:0043533]; metal ion binding [GO:0046872]; phosphatidylinositol bisphosphate binding [GO:1902936]; phosphatidylinositol-3;4;5-trisphosphate binding [GO:0005547]; cell surface receptor signaling pathway [GO:0007166]; regulation of GTPase activity [GO:0043087],NA,NA,NA
CHOYP_RLA0.3.7.m.42196,0.0167645103063684,-0.00470608036975515,No,NA,NA,Q9DG68,NA,NA,NA,ribosome [GO:0005840]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_RLA0.5.7.m.56220,0.00909626566523043,-0.000906344154246493,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RLA1.3.12.m.12071,0.00276827871103516,0.00956292573200427,No,NA,NA,O01359,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_RLA1.5.12.m.15482,0.00694066828852937,-0.0200288658853005,No,NA,NA,O01359,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_RLA1.8.12.m.25631,0.0061563848697164,0.000982274309884554,No,NA,NA,O01359,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_RLP24.2.2.m.51354,0.00117042260741891,-0.0208247658230317,No,NA,NA,Q7ZTZ2,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; assembly of large subunit precursor of preribosome [GO:1902626]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412],NA,NA,NA
CHOYP_RM10.1.2.m.26850,0.00775154010926363,0.00780726605350469,No,NA,NA,Q29NV5,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; ribonucleoprotein complex [GO:1990904]; structural constituent of ribosome [GO:0003735]; ribosome biogenesis [GO:0042254]; translation [GO:0006412],NA,NA,NA
CHOYP_RM11.1.1.m.9390,0.000920025774316151,-0.008428726309534,No,NA,NA,Q9VFJ2,NA,NA,NA,large ribosomal subunit [GO:0015934]; mitochondrial large ribosomal subunit [GO:0005762]; large ribosomal subunit rRNA binding [GO:0070180]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; gene silencing by RNA [GO:0031047]; mitochondrial translation [GO:0032543]; regulation of translation [GO:0006417]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412],NA,NA,NA
CHOYP_RM22.1.1.m.63127,0.0042334131812744,-0.01332617932647,No,NA,NA,Q0VFH6,NA,NA,NA,large ribosomal subunit [GO:0015934]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; ribosome assembly [GO:0042255]; translation [GO:0006412],NA,NA,NA
CHOYP_RM23.1.1.m.173,-0.0225620750305512,0.00998395844512399,No,NA,NA,Q5TUE9,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543],NA,NA,NA
CHOYP_RM37.1.1.m.14517,-0.00967144113005366,-0.0110810869982782,No,NA,NA,Q6AXT0,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RM49.1.1.m.1644,-0.00522964619256489,-0.00036537244693865,No,NA,NA,Q9CQ40,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RM51.1.1.m.12099,0.00389411101331934,-0.0182436178719889,No,NA,NA,Q22438,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412],NA,NA,NA
CHOYP_RMI1.1.1.m.17246,0.00205195042830452,-0.00934116934689427,No,NA,NA,Q9H9A7,NA,NA,NA,nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; RecQ helicase-Topo III complex [GO:0031422]; nucleotide binding [GO:0000166]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; glucose homeostasis [GO:0042593]; multicellular organism growth [GO:0035264]; reduction of food intake in response to dietary excess [GO:0002023]; resolution of meiotic recombination intermediates [GO:0000712]; response to glucose [GO:0009749],NA,NA,NA
CHOYP_RN19A.1.1.m.35894,-0.0151537204309615,0.00791803728652915,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RN213.11.13.m.59720,-0.00536378344745327,-0.00439014702674205,No,NA,NA,A0A0R4IBK5,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_RN213.12.13.m.60577,-0.0157380500062081,-0.0121100950518771,No,NA,NA,A0A0R4IBK5,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_RN213.4.13.m.27716,0.00110839583453131,-0.0187449431415176,No,NA,NA,A0A0R4IBK5,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_RN213.6.13.m.42268,0.00683330230389409,0.00513890879698858,No,NA,NA,A0A0R4IBK5,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_RN213.7.13.m.45975,-0.0135725579708752,0.00388604629968508,No,NA,NA,A0A0R4IBK5,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_RN213.7.13.m.45976,0.00615966897194063,0.00941964587728867,No,NA,NA,E9Q555,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; angiogenesis [GO:0001525]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_RN213.8.13.m.52889,0.0065883263884642,0.0180931628217626,No,NA,NA,A0A0R4IBK5,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_RN45S.2.5.m.14111,0.0172198320606342,0.00161670438126162,No,NA,NA,Q04832,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_RN45S.4.5.m.43162,0.00708406760976027,-0.00344596534580661,No,NA,NA,Q7M3Y3,NA,NA,NA,troponin complex [GO:0005861]; actin binding [GO:0003779]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_RNF17.1.1.m.17312,-0.0131045906532979,-0.00190421166958348,No,NA,NA,Q99MV7,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; multicellular organism development [GO:0007275]; spermatid development [GO:0007286],NA,NA,NA
CHOYP_RNF213.1.4.m.3458,-0.0169591047060434,0.00960206869202777,No,NA,NA,A0A0R4IBK5,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_RNOY.1.3.m.4495,-0.0154628853493931,-0.0131297076203981,No,NA,NA,Q7M456,NA,NA,NA,extracellular region [GO:0005576]; ribonuclease T2 activity [GO:0033897]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_RNOY.3.3.m.58342,-0.0117462903170131,-0.0165155076182865,No,NA,NA,Q7M456,NA,NA,NA,extracellular region [GO:0005576]; ribonuclease T2 activity [GO:0033897]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_RNP1B.1.1.m.59888,-0.00619805169385667,0.0140938360324203,No,NA,NA,Q3KPW1,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_RNZ1.1.1.m.29553,0.00225770545395051,0.00359411559862883,No,NA,NA,Q9H777,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; 3'-tRNA processing endoribonuclease activity [GO:0042781]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_RO60.1.6.m.24126,-0.0122564635609237,-0.00104570260448939,No,NA,NA,O08848,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; metal ion binding [GO:0046872]; misfolded RNA binding [GO:0034336]; RNA binding [GO:0003723]; U2 snRNA binding [GO:0030620]; cilium assembly [GO:0060271]; immune system development [GO:0002520]; response to UV [GO:0009411]; smoothened signaling pathway [GO:0007224],NA,NA,NA
CHOYP_ROA3.2.2.m.11068,-0.01083077542642,-0.00591464991395157,No,NA,NA,P51989,NA,NA,NA,nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397],NA,NA,NA
CHOYP_ROAA.3.6.m.39522,-0.00838250303743612,-0.00311591644042837,No,NA,NA,Q99020,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; presynaptic cytosol [GO:0099523]; ribonucleoprotein complex [GO:1990904]; RNA polymerase II transcription factor complex [GO:0090575]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; epithelial to mesenchymal transition [GO:0001837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_ROCK2.1.1.m.26830,0.01197382290832,0.00450100499042365,No,NA,NA,Q28021,NA,NA,NA,cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; Rho GTPase binding [GO:0017048]; actin cytoskeleton organization [GO:0030036]; positive regulation of centrosome duplication [GO:0010825]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of circadian rhythm [GO:0042752]; Rho protein signal transduction [GO:0007266]; rhythmic process [GO:0048511]; smooth muscle contraction [GO:0006939],NA,NA,NA
CHOYP_RORA.1.2.m.59037,0.00647509441681852,0.00739630559799847,No,NA,NA,P28699,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; retinoic acid receptor signaling pathway [GO:0048384],NA,NA,NA
CHOYP_RPA1.1.2.m.3320,0.00151075453896622,-0.0148874213159278,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RPA1.2.2.m.6583,0.00092046470496515,0.000845567738515317,No,NA,NA,O35134,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; RNA polymerase I activity [GO:0001054]; zinc ion binding [GO:0008270]; negative regulation of protein localization to nucleolus [GO:1904750]; rRNA transcription [GO:0009303],NA,NA,NA
CHOYP_RPA12.1.1.m.48818,-0.00503472487899643,-0.00389421134825123,No,NA,NA,Q9DCG9,NA,NA,NA,nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; protein heterodimerization activity [GO:0046982]; protein methyltransferase activity [GO:0008276]; rRNA (guanine) methyltransferase activity [GO:0016435]; peptidyl-glutamine methylation [GO:0018364]; positive regulation of rRNA processing [GO:2000234]; rRNA (guanine-N7)-methylation [GO:0070476]; tRNA methylation [GO:0030488],NA,NA,NA
CHOYP_RPAB1.1.1.m.11586,-0.0112568720018552,-0.00528254592856343,No,NA,NA,B0BNE2,NA,NA,NA,nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]; RNA polymerase II; core complex [GO:0005665]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383],NA,NA,NA
CHOYP_RPAB3.2.4.m.30639,0.0113189590617122,-0.0128554260162867,No,NA,NA,Q923G2,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase I complex [GO:0005736]; RNA polymerase II; core complex [GO:0005665]; RNA polymerase III complex [GO:0005666]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; single-stranded DNA binding [GO:0003697]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383],NA,NA,NA
CHOYP_RPAC1.1.1.m.36389,0.00361968174403023,-0.000276453471929232,No,NA,NA,P52432,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase III [GO:0006383],NA,NA,NA
CHOYP_RPB1.1.1.m.36612,-0.00175440836717225,-0.0244755408109305,No,NA,NA,P04052,NA,NA,NA,nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; RNA polymerase II; core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_RPB2.1.1.m.38872,0.00356416140700538,0.00163763841528121,No,NA,NA,P30876,NA,NA,NA,membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II; core complex [GO:0005665]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; RNA binding [GO:0003723]; 7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing; via spliceosome [GO:0000398]; regulation of gene silencing by miRNA [GO:0060964]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283],NA,NA,NA
CHOYP_RPB3.1.1.m.45705,-0.00984767254576119,0.00463389064189891,No,NA,NA,P97760,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II; core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_RPC1.1.1.m.16568,-0.0170664601266782,0.00602409582250833,No,NA,NA,Q15637,NA,NA,NA,nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribosome [GO:0005840]; spliceosomal complex [GO:0005681]; identical protein binding [GO:0042802]; pre-mRNA branch point binding [GO:0045131]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; Leydig cell differentiation [GO:0033327]; male sex determination [GO:0030238]; mRNA 3'-splice site recognition [GO:0000389]; mRNA splicing; via spliceosome [GO:0000398]; negative regulation of smooth muscle cell proliferation [GO:0048662]; nuclear body organization [GO:0030575]; regulation of steroid biosynthetic process [GO:0050810]; spliceosomal complex assembly [GO:0000245],NA,NA,NA
CHOYP_RPF2.2.2.m.27891,0.000294956042081947,-0.0134200800644119,No,NA,NA,Q9JJ80,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; 5S rRNA binding [GO:0008097]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; rRNA binding [GO:0019843]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000463]; protein localization to nucleolus [GO:1902570]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273],NA,NA,NA
CHOYP_RPGRB.1.1.m.59104,0.0106313797325501,-0.0134191969610253,No,NA,NA,Q9N1T2,NA,NA,NA,centrosome [GO:0005813]; ciliary basal body [GO:0036064]; Golgi apparatus [GO:0005794]; sperm flagellum [GO:0036126]; guanyl-nucleotide exchange factor activity [GO:0005085]; cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; response to stimulus [GO:0050896]; visual perception [GO:0007601],NA,NA,NA
CHOYP_RPL36.1.1.m.57199,0.00880739200276814,0.00799999943727199,No,NA,NA,P15771,NA,NA,NA,nucleolus [GO:0005730]; ribonucleoprotein complex [GO:1990904]; DNA binding [GO:0003677]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_RPOC1.1.1.m.34397,-0.0154709090846004,-0.0139149857089647,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RPS24.1.8.m.571,0.00987728265252708,0.0198719940376953,No,NA,NA,O42387,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RPS27L.1.1.m.21535,-0.00958631394528158,-0.0243296995960493,No,NA,NA,O01369,NA,NA,NA,mitochondrial respiratory chain complex III [GO:0005750]; mitochondrial electron transport; ubiquinol to cytochrome c [GO:0006122],NA,NA,NA
CHOYP_RPZ3.1.1.m.26308,-0.0162754932522914,0.00484471807773888,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RRAGA.1.1.m.41224,-0.00870336868822855,0.0124697897822936,No,NA,NA,Q63486,NA,NA,NA,cytoplasm [GO:0005737]; EGO complex [GO:0034448]; GATOR1 complex [GO:1990130]; Gtr1-Gtr2 GTPase complex [GO:1990131]; lysosome [GO:0005764]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; phosphoprotein binding [GO:0051219]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; cell death [GO:0008219]; cellular protein localization [GO:0034613]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to starvation [GO:0009267]; modulation by virus of host morphology or physiology [GO:0019048]; negative regulation of autophagy [GO:0010507]; positive regulation of cytolysis [GO:0045919]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; regulation of autophagy [GO:0010506]; regulation of TORC1 signaling [GO:1903432]; response to amino acid [GO:0043200],NA,NA,NA
CHOYP_RREB1.1.1.m.11945,-0.0136477156902836,-0.00452467842553129,No,NA,NA,O57415,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122],NA,NA,NA
CHOYP_RRP1B.1.1.m.21811,0.00495942269930756,-0.0078266418861381,No,NA,NA,Q14684,NA,NA,NA,cytosol [GO:0005829]; euchromatin [GO:0000791]; granular component [GO:0001652]; heterochromatin [GO:0000792]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome; large subunit precursor [GO:0030687]; preribosome; small subunit precursor [GO:0030688]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; apoptotic process [GO:0006915]; cellular response to virus [GO:0098586]; mRNA processing [GO:0006397]; negative regulation of GTPase activity [GO:0034260]; negative regulation of phosphatase activity [GO:0010923]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_RS14.3.6.m.23056,-0.0150544739333821,-0.000219169135278425,No,NA,NA,Q920P5,NA,NA,NA,cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside kinase activity [GO:0019206]; ATP metabolic process [GO:0046034]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142],NA,NA,NA
CHOYP_RS15A.5.11.m.18785,0.0102765404086383,0.0112496967046688,No,NA,NA,Q6XIM8,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS15A.6.11.m.23616,-0.00430894344577715,-0.00631540690244347,No,NA,NA,Q6XIM8,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS16.1.5.m.29365,0.00019561852163312,0.0135202245440867,No,NA,NA,Q98TR7,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS17.10.11.m.58728,-0.0036529134566419,0.00844666879035458,No,NA,NA,Q94519,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; respirasome [GO:0070469]; acyl binding [GO:0000035]; acyl carrier activity [GO:0000036]; phosphopantetheine binding [GO:0031177]; fatty acid biosynthetic process [GO:0006633]; lipid A biosynthetic process [GO:0009245]; mitochondrial electron transport; NADH to ubiquinone [GO:0006120],NA,NA,NA
CHOYP_RS19.3.12.m.15295,0.0222219033683038,-0.00118565868048429,No,NA,NA,Q8ITC3,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS2.2.10.m.5562,0.0171921715289976,-0.0063999555226831,No,NA,NA,Q90YS3,NA,NA,NA,small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS2.7.10.m.39920,0.00205195042830452,-0.00934116934689426,No,NA,NA,Q90YS3,NA,NA,NA,small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS21.1.4.m.13400,0.0146123219114019,0.00249340959373326,No,NA,NA,O14463,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; antioxidant activity [GO:0016209]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; cellular detoxification of hydrogen peroxide [GO:0061692]; cellular response to reactive oxygen species [GO:0034614]; glycerol ether metabolic process [GO:0006662]; hydrogen peroxide catabolic process [GO:0042744]; L-methionine salvage from methionine sulphoxide [GO:1990355]; positive regulation of cellular response to oxidative stress [GO:1900409]; sulfate assimilation; phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379],NA,NA,NA
CHOYP_RS23.1.9.m.12948,-0.00143203545609535,-0.0141624335892711,No,NA,NA,Q86FP7,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; rough endoplasmic reticulum [GO:0005791]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181],NA,NA,NA
CHOYP_RS23.4.9.m.24810,-0.00393660134490682,0.0114298350160962,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RS26.14.15.m.57342,0.00910198112021588,0.0211558283112553,No,NA,NA,P27085,NA,NA,NA,cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181],NA,NA,NA
CHOYP_RS27L.1.4.m.9354,0.0168478990131802,0.00353064954751978,No,NA,NA,Q3T0B7,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; metal ion binding [GO:0046872]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412],NA,NA,NA
CHOYP_RS27L.3.4.m.33064,0.000686232728993107,-0.0107331332691118,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RS3.2.7.m.23037,0.0172415642317095,-0.00849575837993831,No,NA,NA,P62909,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; mitochondrial inner membrane [GO:0005743]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spindle [GO:0005819]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; kinase binding [GO:0019900]; oxidized purine DNA binding [GO:0032357]; oxidized purine nucleobase lesion DNA N-glycosylase activity [GO:0008534]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to nerve growth factor stimulus [GO:1990090]; DNA repair [GO:0006281]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of DNA repair [GO:0045739]; regulation of apoptotic process [GO:0042981]; regulation of translation [GO:0006417]; translation [GO:0006412],NA,NA,NA
CHOYP_RS3.4.7.m.42801,0.00982296002030017,0.0189543421484886,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RS32.1.1.m.57158,-0.0064472037550487,-0.0109799961566072,No,NA,NA,P14314,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; glucosidase II complex [GO:0017177]; intracellular [GO:0005622]; intracellular membrane-bounded organelle [GO:0043231]; calcium ion binding [GO:0005509]; ion channel binding [GO:0044325]; phosphoprotein binding [GO:0051219]; protein kinase C binding [GO:0005080]; cellular protein metabolic process [GO:0044267]; intracellular signal transduction [GO:0035556]; N-glycan processing [GO:0006491]; post-translational protein modification [GO:0043687],NA,NA,NA
CHOYP_RS3A.14.15.m.57763,0.00491588973115351,-0.000600714720400962,No,NA,NA,P49395,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS3A.2.15.m.2682,0.00491588973115351,-0.000600714720400963,No,NA,NA,P49395,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS3A.4.15.m.15366,-0.00734804105921631,0.0135751754995486,No,NA,NA,Q8VE97,NA,NA,NA,nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; hematopoietic progenitor cell differentiation [GO:0002244]; mRNA cis splicing; via spliceosome [GO:0045292]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],NA,NA,NA
CHOYP_RS3A.4.15.m.15367,-0.00499308113187736,-0.00154443210914058,No,NA,NA,P49395,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS3A.8.15.m.27207,-0.00125450248428149,-0.014302938513803,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RS4.10.11.m.60432,-0.000317569152845565,-0.00256708816388484,No,NA,NA,Q4PMB3,NA,NA,NA,ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS4.11.11.m.63584,-0.017063161504829,0.00792732916623732,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RS4.3.11.m.15465,0.0155769858226765,0.0027898374072436,No,NA,NA,Q4PMB3,NA,NA,NA,ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS5.1.2.m.146,0.0178169142627309,-0.000434576833427602,No,NA,NA,P46782,NA,NA,NA,cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; regulation of translational fidelity [GO:0006450]; ribosomal small subunit assembly [GO:0000028]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_RS6.10.12.m.44863,0.020469493201069,-0.00987232679152072,No,NA,NA,Q9BMX5,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS6.5.12.m.23146,-0.0169591047060434,0.00960206869202778,No,NA,NA,O01727,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS6.8.12.m.36342,-0.000991548221004344,0.00789746980603815,No,NA,NA,O61462,NA,NA,NA,ribosome [GO:0005840]; metal ion binding [GO:0046872]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS7.5.9.m.38700,-0.0135725579708752,0.00388604629968508,No,NA,NA,Q969G6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; riboflavin kinase activity [GO:0008531]; apoptotic process [GO:0006915]; FMN biosynthetic process [GO:0009398]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; reactive oxygen species metabolic process [GO:0072593]; riboflavin biosynthetic process [GO:0009231]; riboflavin metabolic process [GO:0006771],NA,NA,NA
CHOYP_RS7.6.9.m.44704,0.017225887441599,0.0161718659615652,No,NA,NA,P02362,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS8.12.14.m.59492,0.00679201245308727,0.00579007505624932,No,NA,NA,Q6ZQ03,NA,NA,NA,nuclear speck [GO:0016607],NA,NA,NA
CHOYP_RS8.8.14.m.44842,0.00333051357464633,0.00115234421213613,No,NA,NA,Q8WQI5,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS9.11.13.m.49921,0.0162030613437255,-0.00326583903965385,No,NA,NA,B4PEU8,NA,NA,NA,nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; small ribosomal subunit [GO:0015935]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS9.8.13.m.41198,0.0153504477332377,-0.0083109115689091,No,NA,NA,P29314,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]; 5.8S rRNA binding [GO:1990932]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]; positive regulation of cell proliferation [GO:0008284]; positive regulation of translational fidelity [GO:0045903]; translation [GO:0006412],NA,NA,NA
CHOYP_RS9.9.13.m.44486,0.0225689727216191,-0.010191423133892,No,NA,NA,P86954,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_RSMB.1.2.m.12400,-0.0042358998533344,-0.00331703801349667,No,NA,NA,Q9N1Q0,NA,NA,NA,cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; SMN-Sm protein complex [GO:0034719]; U1 snRNP [GO:0005685]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U7 snRNP [GO:0005683]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_RSPH4A.1.1.m.15217,0.00441234911841127,-0.00485401949441545,No,NA,NA,Q8BYM7,NA,NA,NA,axoneme [GO:0005930]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; radial spoke [GO:0001534]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341],NA,NA,NA
CHOYP_RSRC2.1.1.m.14844,-0.00897817885178764,0.0187748546764134,No,NA,NA,Q7ZYR8,NA,NA,NA,,NA,NA,NA
CHOYP_RSSA.1.10.m.2054,0.00859943550133495,0.00619393057026705,No,NA,NA,A3RLT6,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412],NA,NA,NA
CHOYP_RSSA.3.10.m.22114,0.00896274248076713,0.00758494178649281,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RSU1.1.1.m.44138,0.00353127971620127,0.00601853990625579,No,NA,NA,Q15404,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_RT10.2.4.m.12766,0.00891202102997927,-0.022502294213171,No,NA,NA,Q9VFB2,NA,NA,NA,mitochondrial small ribosomal subunit [GO:0005763]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412],NA,NA,NA
CHOYP_RT16.1.1.m.16545,0.0067308283584487,-0.00892142299370276,No,NA,NA,P82915,NA,NA,NA,cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543],NA,NA,NA
CHOYP_RTCB.1.2.m.27510,-0.00533591651537075,-0.0208727403108218,No,NA,NA,Q6NZS4,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; RNA ligase (ATP) activity [GO:0003972]; tRNA exon ligation utilizing 2';3' cyclic phosphate of 5'-exon as source of linkage phosphate [GO:0000971]; tRNA splicing; via endonucleolytic cleavage and ligation [GO:0006388],NA,NA,NA
CHOYP_RTEL1.1.1.m.16665,-0.00867468939004008,-0.0130329684403661,No,NA,NA,Q5RJZ1,NA,NA,NA,chromosome; telomeric region [GO:0000781]; nucleus [GO:0005634]; 4 iron; 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; ATP-dependent DNA helicase activity [GO:0004003]; DNA binding [GO:0003677]; DNA polymerase binding [GO:0070182]; metal ion binding [GO:0046872]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; mitotic telomere maintenance via semi-conservative replication [GO:1902990]; negative regulation of DNA recombination [GO:0045910]; negative regulation of t-circle formation [GO:1904430]; negative regulation of telomere maintenance in response to DNA damage [GO:1904506]; positive regulation of telomeric loop disassembly [GO:1904535]; regulation of double-strand break repair via homologous recombination [GO:0010569]; replication fork processing [GO:0031297]; strand displacement [GO:0000732]; telomere maintenance [GO:0000723]; telomere maintenance in response to DNA damage [GO:0043247]; telomeric loop disassembly [GO:0090657],NA,NA,NA
CHOYP_RTF1.1.1.m.10685,-0.00737501476444857,0.00458122649484112,No,NA,NA,A2AQ19,NA,NA,NA,Cdc73/Paf1 complex [GO:0016593]; nucleolus [GO:0005730]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; single-stranded DNA binding [GO:0003697]; blastocyst growth [GO:0001832]; endodermal cell fate commitment [GO:0001711]; histone H3-K4 trimethylation [GO:0080182]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_RTTN.1.3.m.9025,-0.0145097672528456,-0.00970179174778296,No,NA,NA,Q86VV8,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; centriole replication [GO:0007099]; centriole-centriole cohesion [GO:0010457]; ciliary basal body organization [GO:0032053]; determination of left/right symmetry [GO:0007368],NA,NA,NA
CHOYP_RTTN.1.3.m.9026,0.00458156359908036,-0.00463744831006047,No,NA,NA,Q5I0P2,NA,NA,NA,glycine cleavage complex [GO:0005960]; mitochondrion [GO:0005739]; aminomethyltransferase activity [GO:0004047]; enzyme binding [GO:0019899]; glycine decarboxylation via glycine cleavage system [GO:0019464]; protein lipoylation [GO:0009249],NA,NA,NA
CHOYP_RU1C.1.2.m.50387,-0.00914444474807353,0.00593216216903751,No,NA,NA,C3Z1P5,NA,NA,NA,commitment complex [GO:0000243]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; mRNA binding [GO:0003729]; pre-mRNA 5'-splice site binding [GO:0030627]; U1 snRNA binding [GO:0030619]; zinc ion binding [GO:0008270]; mRNA 5'-splice site recognition [GO:0000395]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_RU2A.1.1.m.20848,-0.0167918203889603,-0.0181373577984065,No,NA,NA,P57784,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U2 snRNA binding [GO:0030620]; mRNA splicing; via spliceosome [GO:0000398]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_RUNX1.1.1.m.49526,0.00511349034283068,-0.000756134165320969,No,NA,NA,Q01196,NA,NA,NA,core-binding factor complex [GO:0016513]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; hematopoietic stem cell proliferation [GO:0071425]; hemopoiesis [GO:0030097]; myeloid cell differentiation [GO:0030099]; negative regulation of CD4-positive; alpha-beta T cell differentiation [GO:0043371]; negative regulation of gene expression [GO:0010629]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; peripheral nervous system neuron development [GO:0048935]; positive regulation of angiogenesis [GO:0045766]; positive regulation of CD8-positive; alpha-beta T cell differentiation [GO:0043378]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of B cell receptor signaling pathway [GO:0050855]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cytokine-mediated signaling pathway [GO:0001959]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of keratinocyte differentiation [GO:0045616]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of myeloid cell differentiation [GO:0045637]; regulation of regulatory T cell differentiation [GO:0045589]; regulation of Wnt signaling pathway [GO:0030111],NA,NA,NA
CHOYP_RUVB1.1.1.m.25669,0.00273461964790755,0.0189731251111167,No,NA,NA,Q9DE26,NA,NA,NA,Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; R2TP complex [GO:0097255]; Swr1 complex [GO:0000812]; ATP binding [GO:0005524]; ATP-dependent 5'-3' DNA helicase activity [GO:0043141]; DNA recombination [GO:0006310]; DNA repair [GO:0006281],NA,NA,NA
CHOYP_RUVB2.1.1.m.19005,-0.00439229440049548,-0.0172129463092648,No,NA,NA,Q9DE27,NA,NA,NA,Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; R2TP complex [GO:0097255]; Swr1 complex [GO:0000812]; ATP binding [GO:0005524]; ATP-dependent 5'-3' DNA helicase activity [GO:0043141]; DNA recombination [GO:0006310]; DNA repair [GO:0006281],NA,NA,NA
CHOYP_RXR.1.2.m.45987,-0.00250629589375798,0.0163577972726516,No,NA,NA,Q5I7G2,NA,NA,NA,cytoplasm [GO:0005737]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; retinal binding [GO:0016918]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_S12A2.1.2.m.32137,0.00783556916417333,-0.00133462579785585,No,NA,NA,P55013,NA,NA,NA,integral component of membrane [GO:0016021]; cation:chloride symporter activity [GO:0015377]; potassium ion transport [GO:0006813]; sodium ion transport [GO:0006814],NA,NA,NA
CHOYP_S12A2.2.2.m.39394,0.0111633055903265,-0.00563112730291576,No,NA,NA,P55013,NA,NA,NA,integral component of membrane [GO:0016021]; cation:chloride symporter activity [GO:0015377]; potassium ion transport [GO:0006813]; sodium ion transport [GO:0006814],NA,NA,NA
CHOYP_S26A5.2.2.m.9883,0.0177584467189918,0.000114601374954822,No,NA,NA,P58743,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; oxalate transmembrane transporter activity [GO:0019531]; protein homodimerization activity [GO:0042803]; secondary active sulfate transmembrane transporter activity [GO:0008271]; spectrin binding [GO:0030507]; sulfate transmembrane transporter activity [GO:0015116]; transcription factor binding [GO:0008134]; cochlea development [GO:0090102]; fructose transmembrane transport [GO:0015755]; negative regulation of ion transmembrane transport [GO:0034766]; positive regulation of cell motility [GO:2000147]; positive regulation of cell size [GO:0045793]; protein tetramerization [GO:0051262]; regulation of cell shape [GO:0008360]; regulation of membrane potential [GO:0042391]; response to auditory stimulus [GO:0010996]; response to ischemia [GO:0002931]; response to potassium ion [GO:0035864]; response to salicylic acid [GO:0009751]; response to salt [GO:1902074]; response to thyroid hormone [GO:0097066]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_S28A3.2.3.m.7477,-0.0106050817970751,0.0008456866214353,No,NA,NA,Q9UA35,NA,NA,NA,integral component of plasma membrane [GO:0005887]; nucleoside transmembrane transporter activity [GO:0005337],NA,NA,NA
CHOYP_S30BP.1.1.m.62845,0.00131577011773752,-0.0104334105090439,No,NA,NA,Q9UHR5,NA,NA,NA,intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; apoptotic process [GO:0006915]; positive regulation of cell death [GO:0010942]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_S4A10.3.4.m.28397,0.0216389513551746,0.00333281248325362,No,NA,NA,Q8JZR6,NA,NA,NA,integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; anion:anion antiporter activity [GO:0015301]; inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; bicarbonate transport [GO:0015701]; regulation of intracellular pH [GO:0051453],NA,NA,NA
CHOYP_S4A8.1.1.m.28334,0.00394536801625317,0.00291369700370642,No,NA,NA,Q80ZA5,NA,NA,NA,integral component of plasma membrane [GO:0005887]; antiporter activity [GO:0015297]; inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; bicarbonate transport [GO:0015701]; regulation of intracellular pH [GO:0051453],NA,NA,NA
CHOYP_SAC1.1.1.m.40164,-0.00882839841173926,0.0114889229370992,No,NA,NA,Q6GM29,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; phosphatase activity [GO:0016791]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; phosphatidylinositol dephosphorylation [GO:0046856],NA,NA,NA
CHOYP_SACS.11.17.m.53250,-0.0185732532317732,0.0108860309175823,No,NA,NA,Q9JLC8,NA,NA,NA,cytoplasm [GO:0005737]; low-density lipoprotein particle receptor binding [GO:0050750],NA,NA,NA
CHOYP_SACS.12.17.m.53659,-0.00633187255915798,-0.00448214263527223,No,NA,NA,Q9JLC8,NA,NA,NA,cytoplasm [GO:0005737]; low-density lipoprotein particle receptor binding [GO:0050750],NA,NA,NA
CHOYP_SACS.14.17.m.61817,-0.0046406725485665,-0.00330311205421759,No,NA,NA,Q9NZJ4,NA,NA,NA,axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457],NA,NA,NA
CHOYP_SACS.4.17.m.32398,-0.0109883560091636,0.0137830648487245,No,NA,NA,Q9NZJ4,NA,NA,NA,axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457],NA,NA,NA
CHOYP_SACS.6.17.m.35149,-0.000285825140402367,-0.00253166946948899,No,NA,NA,Q9JLC8,NA,NA,NA,cytoplasm [GO:0005737]; low-density lipoprotein particle receptor binding [GO:0050750],NA,NA,NA
CHOYP_SACS.9.17.m.52781,0.00782324643929276,-0.00638944144876002,No,NA,NA,Q9JLC8,NA,NA,NA,cytoplasm [GO:0005737]; low-density lipoprotein particle receptor binding [GO:0050750],NA,NA,NA
CHOYP_SAE1.1.1.m.46861,-0.000609349036983663,-0.0173672755074556,No,NA,NA,Q8JGT5,NA,NA,NA,SUMO activating enzyme complex [GO:0031510]; ubiquitin-like modifier activating enzyme activity [GO:0008641]; protein sumoylation [GO:0016925],NA,NA,NA
CHOYP_SAE2.1.1.m.59765,0.00154444009908481,0.0145150000884728,No,NA,NA,Q28GH3,NA,NA,NA,cytoplasm [GO:0005737]; SUMO activating enzyme complex [GO:0031510]; acid-amino acid ligase activity [GO:0016881]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; SUMO activating enzyme activity [GO:0019948]; transferase activity [GO:0016740]; protein modification by small protein conjugation [GO:0032446]; protein sumoylation [GO:0016925],NA,NA,NA
CHOYP_SAFB2.2.3.m.30765,-0.00638710668227277,-0.0196613532501773,No,NA,NA,Q14151,NA,NA,NA,cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]; Sertoli cell differentiation [GO:0060008],NA,NA,NA
CHOYP_SAFB2.3.3.m.33384,-0.0187152176963257,0.0141684270940062,No,NA,NA,Q14151,NA,NA,NA,cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]; Sertoli cell differentiation [GO:0060008],NA,NA,NA
CHOYP_SAHH3.2.2.m.51221,0.00918084968328687,-0.0171884368240517,No,NA,NA,Q96HN2,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; neuron projection [GO:0043005]; hydrolase activity [GO:0016787]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine cycle [GO:0033353],NA,NA,NA
CHOYP_SAHHA.1.1.m.62610,0.0201565799363132,-0.00830947541741523,No,NA,NA,P51893,NA,NA,NA,adenosylhomocysteinase activity [GO:0004013]; NAD binding [GO:0051287]; one-carbon metabolic process [GO:0006730]; S-adenosylhomocysteine catabolic process [GO:0019510],NA,NA,NA
CHOYP_SALIVA_1456.1.1.m.19330,-0.0115982935372116,-0.00370767764665271,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SAM9L.1.2.m.51914,-0.00212078832001384,-0.00891837260408134,No,NA,NA,Q5K651,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; endosomal vesicle fusion [GO:0034058],NA,NA,NA
CHOYP_SAMD15.1.1.m.27733,-0.00648343107158511,0.0086316906395448,No,NA,NA,Q95JY5,NA,NA,NA,,NA,NA,NA
CHOYP_SAMH1.10.12.m.55275,-0.0146996313680775,-0.00134250002114082,No,NA,NA,Q9Y3Z3,NA,NA,NA,intracellular [GO:0005622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; dGTP binding [GO:0032567]; dGTPase activity [GO:0008832]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; immune response [GO:0006955]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; somatic hypermutation of immunoglobulin genes [GO:0016446]; type I interferon signaling pathway [GO:0060337],NA,NA,NA
CHOYP_SAMH1.12.12.m.66249,-0.0126034185161126,0.00393886753281114,No,NA,NA,Q6INN8,NA,NA,NA,nucleus [GO:0005634]; site of double-strand break [GO:0035861]; dGTP binding [GO:0032567]; dGTPase activity [GO:0008832]; GTP binding [GO:0005525]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; RNA phosphodiester bond hydrolysis [GO:0090501]; somatic hypermutation of immunoglobulin genes [GO:0016446],NA,NA,NA
CHOYP_SAP.1.2.m.13958,0.0162824819785383,-0.0152007923157063,No,NA,NA,Q12959,NA,NA,NA,apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell projection membrane [GO:0031253]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; intercalated disc [GO:0014704]; lateral loop [GO:0043219]; lateral plasma membrane [GO:0016328]; membrane raft [GO:0045121]; microtubule [GO:0005874]; MPP7-DLG1-LIN7 complex [GO:0097025]; myelin sheath abaxonal region [GO:0035748]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; sarcolemma [GO:0042383]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; guanylate kinase activity [GO:0004385]; ion channel binding [GO:0044325]; ionotropic glutamate receptor binding [GO:0035255]; L27 domain binding [GO:0097016]; mitogen-activated protein kinase kinase binding [GO:0031434]; phosphatase binding [GO:0019902]; phosphoprotein phosphatase activity [GO:0004721]; potassium channel regulator activity [GO:0015459]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein-containing complex scaffold activity [GO:0032947]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; structural constituent of postsynaptic density [GO:0098919]; actin filament organization [GO:0007015]; activation of protein kinase activity [GO:0032147]; amyloid precursor protein metabolic process [GO:0042982]; astral microtubule organization [GO:0030953]; bicellular tight junction assembly [GO:0070830]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion [GO:0098609]; cellular protein-containing complex localization [GO:0034629]; chemical synaptic transmission [GO:0007268]; cortical actin cytoskeleton organization [GO:0030866]; cortical microtubule organization [GO:0043622]; embryonic skeletal system morphogenesis [GO:0048704]; endothelial cell proliferation [GO:0001935]; establishment of centrosome localization [GO:0051660]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; hard palate development [GO:0060022]; immunological synapse formation [GO:0001771]; lens development in camera-type eye [GO:0002088]; MAPK cascade [GO:0000165]; membrane raft organization [GO:0031579]; mitotic cell cycle checkpoint [GO:0007093]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; peristalsis [GO:0030432]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell proliferation [GO:0008284]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of cell shape [GO:0008360]; regulation of membrane potential [GO:0042391]; regulation of myelination [GO:0031641]; regulation of potassium ion export across plasma membrane [GO:1903764]; regulation of potassium ion import [GO:1903286]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903760]; reproductive structure development [GO:0048608]; smooth muscle tissue development [GO:0048745]; T cell activation [GO:0042110]; T cell cytokine production [GO:0002369]; viral process [GO:0016032],NA,NA,NA
CHOYP_SARM1.1.1.m.377,-0.010789303500006,0.00339380218276383,No,NA,NA,Q6IDD9,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; signaling adaptor activity [GO:0035591]; innate immune response [GO:0045087]; negative regulation of MyD88-independent toll-like receptor signaling pathway [GO:0034128]; regulation of neuron death [GO:1901214]; response to axon injury [GO:0048678]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_SARNP.1.1.m.46095,-0.00815168863957116,-0.0118316950164751,No,NA,NA,Q9D1J3,NA,NA,NA,cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcription export complex [GO:0000346]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RS domain binding [GO:0050733]; mRNA export from nucleus [GO:0006406]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_SART1.1.1.m.14398,0.0093971515964243,0.00929060403624328,No,NA,NA,O43290,NA,NA,NA,Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; RNA binding [GO:0003723]; maturation of 5S rRNA [GO:0000481]; mRNA cis splicing; via spliceosome [GO:0045292]; mRNA splicing; via spliceosome [GO:0000398]; positive regulation of cytotoxic T cell differentiation [GO:0045585]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_SASB.2.3.m.37538,0.00678620130084429,0.00878741825264137,No,NA,NA,Q8N0W4,NA,NA,NA,asymmetric; glutamatergic; excitatory synapse [GO:0098985]; cell junction [GO:0030054]; cell surface [GO:0009986]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; spanning component of membrane [GO:0089717]; symmetric; GABA-ergic; inhibitory synapse [GO:0098983]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; chloride ion binding [GO:0031404]; neurexin family protein binding [GO:0042043]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]; adult behavior [GO:0030534]; brainstem development [GO:0003360]; cell-cell junction organization [GO:0045216]; cerebellum development [GO:0021549]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of excitatory postsynaptic potential [GO:0090394]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; organ growth [GO:0035265]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; social behavior [GO:0035176]; synapse organization [GO:0050808]; synaptic vesicle endocytosis [GO:0048488]; vocalization behavior [GO:0071625],NA,NA,NA
CHOYP_SASB.3.3.m.51787,0.00702281584992544,-0.0193886976770866,No,NA,NA,P23953,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; carboxylic ester hydrolase activity [GO:0052689]; hydrolase activity; acting on ester bonds [GO:0016788]; methyl indole-3-acetate esterase activity [GO:0080030]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_SBDS.1.1.m.27786,-0.0108805561258035,0.0204686822367372,No,NA,NA,P70122,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; ribosome binding [GO:0043022]; rRNA binding [GO:0019843]; bone marrow development [GO:0048539]; bone mineralization [GO:0030282]; cell proliferation [GO:0008283]; inner cell mass cell proliferation [GO:0001833]; leukocyte chemotaxis [GO:0030595]; mature ribosome assembly [GO:0042256]; mitotic spindle organization [GO:0007052]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_SBNO1.1.1.m.7257,-0.00620782067641079,-0.00965381811025125,No,NA,NA,A3KN83,NA,NA,NA,nucleus [GO:0005634]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_SBP1.1.2.m.2083,0.0211324605524732,-0.00669993319362863,No,NA,NA,Q569D5,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; methanethiol oxidase activity [GO:0018549]; selenium binding [GO:0008430]; protein transport [GO:0015031],NA,NA,NA
CHOYP_SBP1.2.2.m.49372,0.0136941728847076,0.0185947980349057,No,NA,NA,Q569D5,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; methanethiol oxidase activity [GO:0018549]; selenium binding [GO:0008430]; protein transport [GO:0015031],NA,NA,NA
CHOYP_SC22B.1.1.m.62900,0.0106677262107882,-0.00852950407267039,No,NA,NA,Q6P7L4,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; SNARE complex [GO:0031201]; SNAP receptor activity [GO:0005484]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890]; vesicle fusion with Golgi apparatus [GO:0048280],NA,NA,NA
CHOYP_SC24B.2.2.m.54667,-0.00868496239723008,-0.000832657309590632,No,NA,NA,O95487,NA,NA,NA,COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; zinc ion binding [GO:0008270]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; aorta morphogenesis [GO:0035909]; auditory receptor cell stereocilium organization [GO:0060088]; cargo loading into COPII-coated vesicle [GO:0090110]; cochlear nucleus development [GO:0021747]; COPII vesicle coating [GO:0048208]; coronary artery morphogenesis [GO:0060982]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; lung lobe morphogenesis [GO:0060463]; neural tube closure [GO:0001843]; outflow tract morphogenesis [GO:0003151]; pulmonary artery morphogenesis [GO:0061156]; regulation of cargo loading into COPII-coated vesicle [GO:1901301]; regulation of establishment of planar polarity involved in neural tube closure [GO:0090178],NA,NA,NA
CHOYP_SC24C.1.1.m.9387,0.0169829223438998,-0.010032639004134,No,NA,NA,P53992,NA,NA,NA,COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; SNARE binding [GO:0000149]; zinc ion binding [GO:0008270]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; cargo loading into COPII-coated vesicle [GO:0090110]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_SC31A.1.2.m.8240,0.0156181640749829,-0.00956707519755093,No,NA,NA,Q5F3X8,NA,NA,NA,COPII vesicle coat [GO:0030127]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; structural molecule activity [GO:0005198]; cargo loading into COPII-coated vesicle [GO:0090110]; COPII-coated vesicle budding [GO:0090114]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_SC31A.1.2.m.8241,-0.00757922324757911,-0.00465228215571613,No,NA,NA,O57521,NA,NA,NA,aryl hydrocarbon receptor complex [GO:0034751]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein dimerization activity [GO:0046983]; protein kinase binding [GO:0019901]; unfolded protein binding [GO:0051082]; blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of transforming growth factor beta activation [GO:1901389]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein folding [GO:0006457]; regulation of cellular protein localization [GO:1903827]; response to estrogen [GO:0043627],NA,NA,NA
CHOYP_SC5A9.3.5.m.27017,0.000686232728993107,-0.0107331332691118,No,NA,NA,A8WHP3,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412],NA,NA,NA
CHOYP_SC6A5.3.7.m.20491,0.0177344538214835,-0.00655269228563871,No,NA,NA,Q9Y345,NA,NA,NA,glycinergic synapse [GO:0098690]; integral component of membrane [GO:0016021]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; synaptic transmission; glycinergic [GO:0060012],NA,NA,NA
CHOYP_SC6A5.5.7.m.49357,0.00615966897194063,0.00941964587728867,No,NA,NA,Q9Y345,NA,NA,NA,glycinergic synapse [GO:0098690]; integral component of membrane [GO:0016021]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; synaptic transmission; glycinergic [GO:0060012],NA,NA,NA
CHOYP_SC6A5.7.7.m.62985,0.00678620130084429,0.00878741825264137,No,NA,NA,A7Y2W8,NA,NA,NA,integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; neurotransmitter:sodium symporter activity [GO:0005328],NA,NA,NA
CHOYP_SC6A6.2.2.m.37040,0.00304852626863706,-0.021626409893512,No,NA,NA,P31646,NA,NA,NA,integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; neurotransmitter binding [GO:0042165]; neurotransmitter transport [GO:0006836],NA,NA,NA
CHOYP_SC6A9.4.6.m.26535,0.0173128240715871,-0.00544898144268388,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SC6A9.6.6.m.57818,0.00205195042830453,-0.00934116934689426,No,NA,NA,A7Y2W8,NA,NA,NA,integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; neurotransmitter:sodium symporter activity [GO:0005328],NA,NA,NA
CHOYP_SCAM1.1.1.m.5509,-0.0136280922203442,-0.0165432448286988,No,NA,NA,Q8K021,NA,NA,NA,clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; recycling endosome membrane [GO:0055038]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; zymogen granule membrane [GO:0042589]; protein domain specific binding [GO:0019904]; endocytosis [GO:0006897]; exocytosis [GO:0006887]; protein transport [GO:0015031],NA,NA,NA
CHOYP_SCAPER.1.1.m.34551,-0.0068633035645251,-0.0100166351831236,No,NA,NA,Q9BY12,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_SCE4070.1.1.m.29642,0.0172375216737098,0.00542421460816319,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SCMH1.1.1.m.1166,-0.0179320803420231,0.00256153232775514,No,NA,NA,Q96GD3,NA,NA,NA,chromocenter [GO:0010369]; nucleoplasm [GO:0005654]; anterior/posterior pattern specification [GO:0009952]; chromatin remodeling [GO:0006338]; gene silencing [GO:0016458]; negative regulation of transcription; DNA-templated [GO:0045892]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_SCN1.1.2.m.28878,0.0027395556678437,0.00895567187306473,No,NA,NA,P15390,NA,NA,NA,axon [GO:0030424]; plasma membrane [GO:0005886]; voltage-gated sodium channel complex [GO:0001518]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; cation transport [GO:0006812]; choline transport [GO:0015871]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814],NA,NA,NA
CHOYP_SCOT1.1.1.m.59655,-0.0149263959972353,0.00402137157188206,No,NA,NA,B2GV06,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 3-oxoacid CoA-transferase activity [GO:0008260]; protein homodimerization activity [GO:0042803]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; cellular ketone body metabolic process [GO:0046950]; heart development [GO:0007507]; ketone body catabolic process [GO:0046952]; ketone catabolic process [GO:0042182]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; response to starvation [GO:0042594],NA,NA,NA
CHOYP_SCP.3.12.m.27952,-0.0197030156752928,-0.00112707588534831,No,NA,NA,P02637,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_SCP.6.12.m.50694,0.00205195042830452,-0.00934116934689426,No,NA,NA,P02637,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_SCP.8.12.m.57173,0.0231677478456082,-0.00631895182521154,No,NA,NA,P02637,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_SCP.9.12.m.62606,0.0218451196949217,-0.00415368986973729,No,NA,NA,P02637,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_SCPDL.1.1.m.55687,-0.0170063811774933,0.00287533938333973,No,NA,NA,Q8NBX0,NA,NA,NA,extracellular region [GO:0005576]; lipid droplet [GO:0005811]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; oxidoreductase activity [GO:0016491]; glycolipid biosynthetic process [GO:0009247]; platelet degranulation [GO:0002576],NA,NA,NA
CHOYP_SDA1.1.1.m.12704,0.00087692869958796,-0.0178143659055506,No,NA,NA,Q9NVU7,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; actin cytoskeleton organization [GO:0030036]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055],NA,NA,NA
CHOYP_SDHC.1.1.m.31276,0.00104377269935688,-0.0140079527371406,No,NA,NA,P70097,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex II; succinate dehydrogenase complex (ubiquinone) [GO:0005749]; electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; succinate dehydrogenase activity [GO:0000104]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_SDR16C5.1.1.m.7423,0.00147681955993848,0.00283942413071859,No,NA,NA,Q8N3Y7,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; activating transcription factor binding [GO:0033613]; DNA-binding transcription factor activity [GO:0003700]; retinol dehydrogenase activity [GO:0004745]; transcription factor binding [GO:0008134]; keratinocyte proliferation [GO:0043616]; negative regulation of histone acetylation [GO:0035067]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone deacetylation [GO:0031065]; retinal metabolic process [GO:0042574]; retinol metabolic process [GO:0042572],NA,NA,NA
CHOYP_SEC13.1.1.m.20714,0.00126143472568509,-0.00653133540306744,No,NA,NA,Q5XFW8,NA,NA,NA,COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; protein-containing complex [GO:0032991]; structural molecule activity [GO:0005198]; COPII-coated vesicle budding [GO:0090114]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; mRNA transport [GO:0051028]; positive regulation of TORC1 signaling [GO:1904263]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to plasma membrane [GO:0072659],NA,NA,NA
CHOYP_SEC23B.1.1.m.12147,0.00646954319868798,-0.0185030596465299,No,NA,NA,Q7SZE5,NA,NA,NA,COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270]; cargo loading into COPII-coated vesicle [GO:0090110]; cartilage development [GO:0051216]; embryonic neurocranium morphogenesis [GO:0048702]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; macroautophagy [GO:0016236]; pectoral fin morphogenesis [GO:0035138]; regulation of cell shape [GO:0008360]; regulation of COPII vesicle coating [GO:0003400],NA,NA,NA
CHOYP_SEC23IP.1.1.m.41425,-0.00458761341376996,-0.0206055805701483,No,NA,NA,Q6NZC7,NA,NA,NA,cis-Golgi network [GO:0005801]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum exit site [GO:0070971]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; metal ion binding [GO:0046872]; phospholipase activity [GO:0004620]; acrosome assembly [GO:0001675]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; single fertilization [GO:0007338]; spermatid development [GO:0007286],NA,NA,NA
CHOYP_SEH1.1.1.m.55025,-0.00575726860947768,0.0208635795266065,No,NA,NA,Q6TGU2,NA,NA,NA,condensed chromosome kinetochore [GO:0000777]; lysosomal membrane [GO:0005765]; nuclear pore outer ring [GO:0031080]; Seh1-associated complex [GO:0035859]; structural molecule activity [GO:0005198]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; cellular protein-containing complex localization [GO:0034629]; cellular response to amino acid starvation [GO:0034198]; mitotic metaphase plate congression [GO:0007080]; mRNA transport [GO:0051028]; nuclear pore organization [GO:0006999]; positive regulation of TORC1 signaling [GO:1904263]; protein transport [GO:0015031],NA,NA,NA
CHOYP_SELD.1.2.m.8600,0.00662837842483355,-0.0210318179433472,No,NA,NA,P62716,NA,NA,NA,chromosome; centromeric region [GO:0000775]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; spindle pole [GO:0000922]; metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein serine/threonine phosphatase activity [GO:0004722]; apoptotic mitochondrial changes [GO:0008637]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of microtubule binding [GO:1904528]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein dephosphorylation [GO:0006470]; regulation of gene expression [GO:0010468]; response to endoplasmic reticulum stress [GO:0034976]; response to hydrogen peroxide [GO:0042542]; response to lead ion [GO:0010288],NA,NA,NA
CHOYP_SELJ.1.1.m.21559,-0.00428791854135508,0.00298280016043972,No,NA,NA,P40821,NA,NA,NA,structural constituent of eye lens [GO:0005212],NA,NA,NA
CHOYP_SEM1A.1.2.m.57703,0.00884102642875128,-0.0107794637400876,No,NA,NA,Q26473,NA,NA,NA,integral component of membrane [GO:0016021]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_SEM2A.1.1.m.43497,0.0162368790177356,-0.008632122054737,No,NA,NA,Q9XZC8,NA,NA,NA,extracellular region [GO:0005576]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_SEP11.1.2.m.19430,0.0168223325259831,0.00341973180849868,No,NA,NA,P54359,NA,NA,NA,microtubule cytoskeleton [GO:0015630]; septin complex [GO:0031105]; septin ring [GO:0005940]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803]; protein-containing complex scaffold activity [GO:0032947]; cellularization [GO:0007349]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; growth of a germarium-derived egg chamber [GO:0007295]; imaginal disc development [GO:0007444]; mitotic cytokinesis [GO:0000281]; regulation of cell cycle [GO:0051726],NA,NA,NA
CHOYP_SEPT2.1.1.m.40428,0.00280215156377111,0.0193379400619806,No,NA,NA,Q63ZQ1,NA,NA,NA,ciliary membrane [GO:0060170]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; midbody [GO:0030496]; spindle [GO:0005819]; GTP binding [GO:0005525]; cell cycle [GO:0007049]; cell division [GO:0051301]; cilium assembly [GO:0060271]; smoothened signaling pathway [GO:0007224],NA,NA,NA
CHOYP_SEPT5.1.2.m.11458,0.00507642061017886,0.00994227128045296,No,NA,NA,Q99719,NA,NA,NA,microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; septin complex [GO:0031105]; septin ring [GO:0005940]; synaptic vesicle [GO:0008021]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein-containing complex scaffold activity [GO:0032947]; structural molecule activity [GO:0005198]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; regulation of exocytosis [GO:0017157]; regulation of synaptic vesicle exocytosis [GO:2000300]; synaptic vesicle targeting [GO:0016080],NA,NA,NA
CHOYP_SEPT7.1.1.m.59134,0.00595442687176557,-0.00243410845226606,No,NA,NA,Q5R481,NA,NA,NA,axoneme [GO:0005930]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; midbody [GO:0030496]; motile cilium [GO:0031514]; septin complex [GO:0031105]; spindle [GO:0005819]; GTP binding [GO:0005525]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; cell division [GO:0051301]; cilium assembly [GO:0060271]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_SERB.1.1.m.7242,0.0118907399266478,-0.0058048805132755,No,NA,NA,Q2KHU0,NA,NA,NA,cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; magnesium ion binding [GO:0000287]; phosphatase activity [GO:0016791]; phosphoserine phosphatase activity [GO:0004647]; protein homodimerization activity [GO:0042803]; dephosphorylation [GO:0016311]; L-serine biosynthetic process [GO:0006564]; L-serine metabolic process [GO:0006563],NA,NA,NA
CHOYP_SETD2.1.1.m.25547,0.00239719329776221,0.0104658561572812,No,NA,NA,Q9BYW2,NA,NA,NA,chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; alpha-tubulin binding [GO:0043014]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; protein-lysine N-methyltransferase activity [GO:0016279]; angiogenesis [GO:0001525]; cell migration involved in vasculogenesis [GO:0035441]; coronary vasculature morphogenesis [GO:0060977]; defense response to virus [GO:0051607]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic placenta morphogenesis [GO:0060669]; endodermal cell differentiation [GO:0035987]; forebrain development [GO:0030900]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; mesoderm morphogenesis [GO:0048332]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mismatch repair [GO:0006298]; morphogenesis of a branching structure [GO:0001763]; neural tube closure [GO:0001843]; nucleosome organization [GO:0034728]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; pericardium development [GO:0060039]; positive regulation of interferon-alpha production [GO:0032727]; regulation of cytokinesis [GO:0032465]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of mRNA export from nucleus [GO:0010793]; regulation of protein localization to chromatin [GO:1905634]; regulation of transcription; DNA-templated [GO:0006355]; response to type I interferon [GO:0034340]; stem cell development [GO:0048864]; stem cell differentiation [GO:0048863]; transcription elongation from RNA polymerase II promoter [GO:0006368],NA,NA,NA
CHOYP_SETD3.1.1.m.42582,0.00910960878827376,-0.0165552420837711,No,NA,NA,B1MTJ4,NA,NA,NA,nucleus [GO:0005634]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; transcription coactivator activity [GO:0003713]; histone H3-K36 methylation [GO:0010452]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_SETD6.1.1.m.14704,0.00130395543401007,-0.00354833522645827,No,NA,NA,Q9CWY3,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; NF-kappaB binding [GO:0051059]; protein-lysine N-methyltransferase activity [GO:0016279]; histone lysine methylation [GO:0034968]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; peptidyl-lysine monomethylation [GO:0018026]; regulation of inflammatory response [GO:0050727]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827],NA,NA,NA
CHOYP_SF3A1.1.3.m.41531,-0.0116823979847508,-0.0163996965169569,No,NA,NA,Q15459,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684]; RNA binding [GO:0003723]; mRNA 3'-splice site recognition [GO:0000389]; mRNA processing [GO:0006397]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_SF3A3.1.1.m.50392,0.015392891108044,-0.0149332610476146,No,NA,NA,Q9D554,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; mRNA processing [GO:0006397]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_SF3B1.1.3.m.24001,-0.0101512540635517,-0.023340073647686,No,NA,NA,O57683,NA,NA,NA,spliceosomal complex [GO:0005681]; mRNA binding [GO:0003729]; spliceosomal complex assembly [GO:0000245],NA,NA,NA
CHOYP_SF3B3.1.1.m.45473,-0.00981103460013632,-0.0166631490710363,No,NA,NA,Q15393,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2-type precatalytic spliceosome [GO:0071005]; nucleic acid binding [GO:0003676]; protein-containing complex binding [GO:0044877]; mRNA splicing; via spliceosome [GO:0000398]; negative regulation of protein catabolic process [GO:0042177]; RNA splicing; via transesterification reactions [GO:0000375],NA,NA,NA
CHOYP_SF3B4.1.1.m.14985,0.00739500204614181,0.000271650061830893,No,NA,NA,O14102,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; U2 snRNP [GO:0005686]; U2-type prespliceosome [GO:0071004]; RNA binding [GO:0003723]; mRNA cis splicing; via spliceosome [GO:0045292]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_SF3B5.1.1.m.12205,-0.0145503007913316,-0.00907906976951337,No,NA,NA,Q9VHI4,NA,NA,NA,precatalytic spliceosome [GO:0071011]; SAGA complex [GO:0000124]; U2 snRNP [GO:0005686]; mRNA splicing; via spliceosome [GO:0000398]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_SGPL1.1.1.m.42223,-0.00392549335034709,0.00290736960790165,No,NA,NA,Q8CHN6,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; sphinganine-1-phosphate aldolase activity [GO:0008117]; ameboidal-type cell migration [GO:0001667]; androgen metabolic process [GO:0008209]; apoptotic signaling pathway [GO:0097190]; ceramide metabolic process [GO:0006672]; estrogen metabolic process [GO:0008210]; face morphogenesis [GO:0060325]; fatty acid metabolic process [GO:0006631]; fibroblast migration [GO:0010761]; hemopoiesis [GO:0030097]; kidney development [GO:0001822]; Leydig cell differentiation [GO:0033327]; luteinization [GO:0001553]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic development [GO:0009791]; regulation of multicellular organism growth [GO:0040014]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; spermatogenesis [GO:0007283]; sphingolipid catabolic process [GO:0030149]; sphingolipid metabolic process [GO:0006665]; vasculogenesis [GO:0001570],NA,NA,NA
CHOYP_SGPP1.1.1.m.5606,-0.00808999744702796,-0.00768013040517892,No,NA,NA,Q99P55,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; hydrolase activity [GO:0016787],NA,NA,NA
CHOYP_SH3KBP1.1.1.m.30545,-0.00877503784576522,0.00738334801715699,No,NA,NA,Q96B97,NA,NA,NA,cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]; SH3 domain binding [GO:0017124]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; cell migration [GO:0016477]; cell-cell signaling [GO:0007267]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; membrane organization [GO:0061024]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; regulation of cell shape [GO:0008360],NA,NA,NA
CHOYP_SH3L1.2.5.m.9176,-0.00944124853118937,-0.00545165884879732,No,NA,NA,Q9NFP5,NA,NA,NA,SH3 domain binding [GO:0017124],NA,NA,NA
CHOYP_SHD.1.1.m.20907,0.00781587644832772,0.0157291833304295,No,NA,NA,Q8CG80,NA,NA,NA,phosphotyrosine residue binding [GO:0001784]; apoptotic process [GO:0006915],NA,NA,NA
CHOYP_SHEP.1.1.m.27990,0.0129598613515874,-0.0104085678768168,No,NA,NA,Q5RBD3,NA,NA,NA,cytoplasm [GO:0005737]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_SHLB1.2.2.m.54016,-0.0129823229725947,-0.0152866479319584,No,NA,NA,Q5ZIR1,NA,NA,NA,Golgi membrane [GO:0000139]; mitochondrial outer membrane [GO:0005741]; lipid binding [GO:0008289]; apoptotic process [GO:0006915],NA,NA,NA
CHOYP_SHMT2.1.1.m.10572,-0.0158012863526378,-0.00884410657807241,No,NA,NA,P34897,NA,NA,NA,BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; amino acid binding [GO:0016597]; chromatin binding [GO:0003682]; cobalt ion binding [GO:0050897]; glycine hydroxymethyltransferase activity [GO:0004372]; identical protein binding [GO:0042802]; L-allo-threonine aldolase activity [GO:0008732]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; zinc ion binding [GO:0008270]; cellular response to tetrahydrofolate [GO:1904482]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; one-carbon metabolic process [GO:0006730]; positive regulation of cell proliferation [GO:0008284]; protein homotetramerization [GO:0051289]; protein K63-linked deubiquitination [GO:0070536]; protein tetramerization [GO:0051262]; regulation of aerobic respiration [GO:1903715]; regulation of mitochondrial translation [GO:0070129]; regulation of oxidative phosphorylation [GO:0002082]; response to type I interferon [GO:0034340]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653],NA,NA,NA
CHOYP_SHROOM3.1.1.m.15543,0.00763470728356488,-0.0043923151772132,No,NA,NA,Q27IV2,NA,NA,NA,adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; microtubule [GO:0005874]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; apical protein localization [GO:0045176]; cell morphogenesis [GO:0000902]; cellular pigment accumulation [GO:0043482]; epithelial cell development [GO:0002064]; neural tube closure [GO:0001843]; pattern specification process [GO:0007389]; regulation of cell shape [GO:0008360],NA,NA,NA
CHOYP_SI_CH211.197G15.10.6.7.m.50389,-0.014177681989542,-0.00934202864368685,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SI_CH211.197G15.7.3.3.m.61063,0.0146404182628859,0.00105176514166603,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SI_CH211.250G4.3.1.2.m.7118,0.00853983710955376,0.00376780409300031,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SI_DKEY.21N12.1.1.1.m.65205,-0.00865473198760622,-0.00876867606904613,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SI_DKEY.5N18.1.1.2.m.5489,-0.00853523268593958,-0.0190692063693597,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SI_DKEYP.75B4.10.2.2.m.54469,-0.0121184469779637,-0.00386927984822253,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SI1L1.1.2.m.7671,-0.00965702654163323,-0.00349923674144124,No,NA,NA,Q80TE4,NA,NA,NA,GTPase activator activity [GO:0005096]; regulation of small GTPase mediated signal transduction [GO:0051056],NA,NA,NA
CHOYP_SIK3.1.1.m.8214,0.0159309986364065,-0.00096935992936457,No,NA,NA,Q6P4S6,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; endochondral ossification [GO:0001958]; intracellular signal transduction [GO:0035556]; limb morphogenesis [GO:0035108]; microtubule cytoskeleton organization [GO:0000226]; multicellular organism growth [GO:0035264]; protein phosphorylation [GO:0006468]; regulation of protein localization [GO:0032880]; skeletal system morphogenesis [GO:0048705],NA,NA,NA
CHOYP_SIP.1.1.m.5724,-0.0072893143457512,0.0166561690232676,No,NA,NA,Q3T168,NA,NA,NA,beta-catenin destruction complex [GO:0030877]; cytosol [GO:0005829]; nuclear envelope lumen [GO:0005641]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; S100 protein binding [GO:0044548]; tubulin binding [GO:0015631]; ubiquitin protein ligase binding [GO:0031625]; cellular response to leukemia inhibitory factor [GO:1990830]; heart development [GO:0007507],NA,NA,NA
CHOYP_SIP.1.1.m.5725,-0.0164582124715567,-0.0198250398984755,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SIRT1.1.1.m.9844,0.00852942914631917,-0.0137589842490517,No,NA,NA,Q923E4,NA,NA,NA,axon [GO:0030424]; chromatin [GO:0000785]; chromatin silencing complex [GO:0005677]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; growth cone [GO:0030426]; mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nuclear envelope [GO:0005635]; nuclear euchromatin [GO:0005719]; nuclear heterochromatin [GO:0005720]; nuclear inner membrane [GO:0005637]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; rDNA heterochromatin [GO:0033553]; bHLH transcription factor binding [GO:0043425]; deacetylase activity [GO:0019213]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; histone deacetylase activity [GO:0004407]; HLH domain binding [GO:0043398]; identical protein binding [GO:0042802]; keratin filament binding [GO:1990254]; metal ion binding [GO:0046872]; mitogen-activated protein kinase binding [GO:0051019]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H3-K9 specific) [GO:0046969]; NAD-dependent protein deacetylase activity [GO:0034979]; nuclear hormone receptor binding [GO:0035257]; p53 binding [GO:0002039]; protein C-terminus binding [GO:0008022]; protein deacetylase activity [GO:0033558]; protein domain specific binding [GO:0019904]; protein kinase B binding [GO:0043422]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; angiogenesis [GO:0001525]; behavioral response to starvation [GO:0042595]; cellular glucose homeostasis [GO:0001678]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to ionizing radiation [GO:0071479]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; cellular triglyceride homeostasis [GO:0035356]; cholesterol homeostasis [GO:0042632]; chromatin organization [GO:0006325]; chromatin silencing at rDNA [GO:0000183]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA synthesis involved in DNA repair [GO:0000731]; energy homeostasis [GO:0097009]; establishment of chromatin silencing [GO:0006343]; fatty acid homeostasis [GO:0055089]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; leptin-mediated signaling pathway [GO:0033210]; macrophage cytokine production [GO:0010934]; macrophage differentiation [GO:0030225]; maintenance of chromatin silencing [GO:0006344]; muscle organ development [GO:0007517]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cAMP-dependent protein kinase activity [GO:2000480]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell death [GO:0060548]; negative regulation of cell growth [GO:0030308]; negative regulation of cellular response to testosterone stimulus [GO:2000655]; negative regulation of cellular senescence [GO:2000773]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA damage response; signal transduction by p53 class mediator [GO:0043518]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of gene expression [GO:0010629]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of helicase activity [GO:0051097]; negative regulation of histone H3-K14 acetylation [GO:0071441]; negative regulation of histone H3-K9 trimethylation [GO:1900113]; negative regulation of histone H4-K16 acetylation [GO:2000619]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; negative regulation of phosphorylation [GO:0042326]; negative regulation of prostaglandin biosynthetic process [GO:0031393]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of tumor necrosis factor production [GO:0032720]; ovulation from ovarian follicle [GO:0001542]; peptidyl-lysine acetylation [GO:0018394]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of cell proliferation [GO:0008284]; positive regulation of cellular senescence [GO:2000774]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of chromatin silencing [GO:0031937]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of DNA repair [GO:0045739]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of heart rate [GO:0010460]; positive regulation of histone H3-K9 methylation [GO:0051574]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of macroautophagy [GO:0016239]; positive regulation of macrophage apoptotic process [GO:2000111]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein deacetylation [GO:0090312]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of skeletal muscle cell proliferation [GO:0014858]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of thyroid-stimulating hormone secretion [GO:2000614]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deacetylation [GO:0006476]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; regulation of apoptotic process [GO:0042981]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of brown fat cell differentiation [GO:0090335]; regulation of cell proliferation [GO:0042127]; regulation of endodeoxyribonuclease activity [GO:0032071]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid storage [GO:0010883]; regulation of mitotic cell cycle [GO:0007346]; regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035358]; regulation of protein import into nucleus; translocation [GO:0033158]; regulation of protein serine/threonine kinase activity [GO:0071900]; regulation of smooth muscle cell apoptotic process [GO:0034391]; response to ethanol [GO:0045471]; response to hydrogen peroxide [GO:0042542]; response to insulin [GO:0032868]; response to leptin [GO:0044321]; response to oxidative stress [GO:0006979]; rRNA processing [GO:0006364]; single strand break repair [GO:0000012]; spermatogenesis [GO:0007283]; stress-induced premature senescence [GO:0090400]; transforming growth factor beta receptor signaling pathway [GO:0007179]; triglyceride mobilization [GO:0006642]; UV-damage excision repair [GO:0070914]; white fat cell differentiation [GO:0050872],NA,NA,NA
CHOYP_SIX1.1.2.m.49270,-0.00430894344577715,-0.00631540690244347,No,NA,NA,Q27350,NA,NA,NA,nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; anatomical structure development [GO:0048856]; Bolwig's organ morphogenesis [GO:0001746]; circadian rhythm [GO:0007623]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; entrainment of circadian clock [GO:0009649]; eye-antennal disc morphogenesis [GO:0007455]; glial cell migration [GO:0008347]; negative regulation of transcription; DNA-templated [GO:0045892]; optic lobe placode formation [GO:0001744]; positive regulation of transcription by RNA polymerase II [GO:0045944]; ring gland development [GO:0035271]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_SK2L2.1.1.m.35679,0.0100363127084768,-0.00664413528873024,No,NA,NA,P42285,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; RNA binding [GO:0003723]; maturation of 5.8S rRNA [GO:0000460]; mRNA splicing; via spliceosome [GO:0000398]; RNA catabolic process [GO:0006401]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_SKAP2.1.1.m.63022,-0.000937874954877276,0.0236809337339926,No,NA,NA,Q6PG29,NA,NA,NA,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; B cell activation [GO:0042113],NA,NA,NA
CHOYP_SKIV2L.3.4.m.25390,-0.00310011986737331,-0.00621013057535342,No,NA,NA,Q15477,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; Ski complex [GO:0055087]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; RNA binding [GO:0003723]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; nuclear-transcribed mRNA catabolic process; 3'-5' exonucleolytic nonsense-mediated decay [GO:0070478]; RNA catabolic process [GO:0006401],NA,NA,NA
CHOYP_SLAI2.1.2.m.8777,-0.0144761540799521,-0.00103804731326416,No,NA,NA,Q3MHV6,NA,NA,NA,cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; cytoplasmic microtubule organization [GO:0031122]; microtubule nucleation [GO:0007020]; positive regulation of microtubule polymerization [GO:0031116],NA,NA,NA
CHOYP_SLC31.5.5.m.57886,-0.00735826223243561,-0.00505375846365174,No,NA,NA,Q91WV7,NA,NA,NA,brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; catalytic activity [GO:0003824]; protein heterodimerization activity [GO:0046982]; amino acid transport [GO:0006865]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_SLC34A2.1.2.m.9501,-0.00272070465124879,-0.00780214189691357,No,NA,NA,Q9DBP0,NA,NA,NA,apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; phosphate ion binding [GO:0042301]; protein domain specific binding [GO:0019904]; sodium ion binding [GO:0031402]; sodium-dependent phosphate transmembrane transporter activity [GO:0015321]; sodium:phosphate symporter activity [GO:0005436]; cellular phosphate ion homeostasis [GO:0030643]; in utero embryonic development [GO:0001701]; phosphate ion transport [GO:0006817]; response to estrogen [GO:0043627]; sodium-dependent phosphate transport [GO:0044341],NA,NA,NA
CHOYP_SLC3A1.1.1.m.14892,-0.0143104288569112,0.00309359340615243,No,NA,NA,Q64319,NA,NA,NA,brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; catalytic activity [GO:0003824]; protein heterodimerization activity [GO:0046982]; amino acid transport [GO:0006865]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_SLC40A1.1.1.m.55100,0.0031263251017479,-0.0128492057201074,No,NA,NA,Q9JHI9,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; ferrous iron transmembrane transporter activity [GO:0015093]; identical protein binding [GO:0042802]; iron channel activity [GO:0097689]; iron ion transmembrane transporter activity [GO:0005381]; peptide hormone binding [GO:0017046]; cellular iron ion homeostasis [GO:0006879]; endothelium development [GO:0003158]; iron ion export across plasma membrane [GO:1903988]; iron ion homeostasis [GO:0055072]; iron ion transmembrane transport [GO:0034755]; iron ion transport [GO:0006826]; lymphocyte homeostasis [GO:0002260]; multicellular organismal iron ion homeostasis [GO:0060586]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription from RNA polymerase II promoter in response to iron [GO:0034395]; spleen development [GO:0048536]; spleen trabecula formation [GO:0060345],NA,NA,NA
CHOYP_SLC6A14.1.1.m.43828,-0.0145381956335719,0.00385828856216191,No,NA,NA,Q9Y345,NA,NA,NA,glycinergic synapse [GO:0098690]; integral component of membrane [GO:0016021]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; synaptic transmission; glycinergic [GO:0060012],NA,NA,NA
CHOYP_SLK.1.1.m.59382,0.0122735995334391,-0.0173156290479246,No,NA,NA,Q7SY52,NA,NA,NA,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; cell cycle [GO:0007049]; protein autophosphorylation [GO:0046777]; regulation of lymphocyte migration [GO:2000401]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_SLMAP.2.8.m.897,-0.00816194213372288,0.00497616769060774,No,NA,NA,Q14BN4,NA,NA,NA,integral component of plasma membrane [GO:0005887]; microtubule organizing center [GO:0005815]; sarcolemma [GO:0042383]; smooth endoplasmic reticulum [GO:0005790]; muscle contraction [GO:0006936]; protein localization to plasma membrane [GO:0072659]; regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900825]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of voltage-gated sodium channel activity [GO:1905150],NA,NA,NA
CHOYP_SLX4.1.1.m.278,0.0065883263884642,0.0180931628217626,No,NA,NA,Q8IY92,NA,NA,NA,cell junction [GO:0030054]; chromosome; telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Slx1-Slx4 complex [GO:0033557]; 5'-flap endonuclease activity [GO:0017108]; endodeoxyribonuclease activity [GO:0004520]; enzyme activator activity [GO:0008047]; DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; meiotic DNA double-strand break processing [GO:0000706]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleotide-excision repair [GO:0006289]; positive regulation of t-circle formation [GO:1904431]; resolution of meiotic recombination intermediates [GO:0000712]; response to intra-S DNA damage checkpoint signaling [GO:0072429]; t-circle formation [GO:0090656]; telomeric D-loop disassembly [GO:0061820],NA,NA,NA
CHOYP_SMAD1.2.2.m.60397,-0.0139745792008641,-0.01204949187581,No,NA,NA,Q5R6H7,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; transcription factor complex [GO:0005667]; DEAD/H-box RNA helicase binding [GO:0017151]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; ubiquitin protein ligase binding [GO:0031625]; BMP signaling pathway [GO:0030509]; bone development [GO:0060348]; cardiac muscle contraction [GO:0060048]; cartilage development [GO:0051216]; cellular response to organic cyclic compound [GO:0071407]; embryonic pattern specification [GO:0009880]; erythrocyte differentiation [GO:0030218]; germ cell development [GO:0007281]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast fate commitment [GO:0002051]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [GO:1901522]; protein phosphorylation [GO:0006468]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657],NA,NA,NA
CHOYP_SMAD3.1.1.m.51679,0.00111001282090027,0.00749127480274602,No,NA,NA,P84025,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nuclear chromatin [GO:0000790]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; SMAD protein complex [GO:0071141]; transcription factor complex [GO:0005667]; beta-catenin binding [GO:0008013]; bHLH transcription factor binding [GO:0043425]; chromatin DNA binding [GO:0031490]; co-SMAD binding [GO:0070410]; collagen binding [GO:0005518]; DEAD/H-box RNA helicase binding [GO:0017151]; DNA binding [GO:0003677]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; enzyme binding [GO:0019899]; glucocorticoid receptor binding [GO:0035259]; mineralocorticoid receptor binding [GO:0031962]; phosphatase binding [GO:0019902]; primary miRNA binding [GO:0070878]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; proximal promoter sequence-specific DNA binding [GO:0000987]; R-SMAD binding [GO:0070412]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; transforming growth factor beta receptor binding [GO:0005160]; transforming growth factor beta receptor; pathway-specific cytoplasmic mediator activity [GO:0030618]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097296]; adrenal gland development [GO:0030325]; cell cycle arrest [GO:0007050]; cell-cell junction organization [GO:0045216]; developmental growth [GO:0048589]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic foregut morphogenesis [GO:0048617]; embryonic pattern specification [GO:0009880]; endoderm development [GO:0007492]; evasion or tolerance of host defenses by virus [GO:0019049]; extrinsic apoptotic signaling pathway [GO:0097191]; heart looping [GO:0001947]; immune response [GO:0006955]; immune system development [GO:0002520]; in utero embryonic development [GO:0001701]; lens fiber cell differentiation [GO:0070306]; liver development [GO:0001889]; mesoderm formation [GO:0001707]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of cell growth [GO:0030308]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of inflammatory response [GO:0050728]; negative regulation of lung blood pressure [GO:0061767]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of wound healing [GO:0061045]; nodal signaling pathway [GO:0038092]; osteoblast development [GO:0002076]; paraxial mesoderm morphogenesis [GO:0048340]; pericardium development [GO:0060039]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of bone mineralization [GO:0030501]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta3 production [GO:0032916]; protein stabilization [GO:0050821]; regulation of binding [GO:0051098]; regulation of epithelial cell proliferation [GO:0050678]; regulation of immune response [GO:0050776]; regulation of striated muscle tissue development [GO:0016202]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of transforming growth factor beta2 production [GO:0032909]; response to hypoxia [GO:0001666]; signal transduction involved in regulation of gene expression [GO:0023019]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; somitogenesis [GO:0001756]; T cell activation [GO:0042110]; thyroid gland development [GO:0030878]; transdifferentiation [GO:0060290]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657],NA,NA,NA
CHOYP_SMAD4.3.4.m.13408,-0.00580604426513398,-0.00757360029838516,No,NA,NA,Q1HE26,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_SMARCA5.1.1.m.31708,-0.0151663468207007,-0.0214202125573073,No,NA,NA,O60264,NA,NA,NA,chromatin silencing complex [GO:0005677]; condensed chromosome [GO:0000793]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NURF complex [GO:0016589]; RSF complex [GO:0031213]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; helicase activity [GO:0004386]; nucleosome binding [GO:0031491]; ATP-dependent chromatin remodeling [GO:0043044]; cellular response to leukemia inhibitory factor [GO:1990830]; CENP-A containing nucleosome assembly [GO:0034080]; chromatin remodeling [GO:0006338]; chromatin silencing at rDNA [GO:0000183]; DNA-templated transcription; initiation [GO:0006352]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; positive regulation of gene expression; epigenetic [GO:0045815]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_SMC.3.5.m.51502,-0.00765324058404731,0.0140429998146648,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SMC2.1.4.m.17836,-0.00740314486699975,-0.00922658393159626,No,NA,NA,P50533,NA,NA,NA,chromosome [GO:0005694]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome condensation [GO:0030261],NA,NA,NA
CHOYP_SMC2.1.4.m.17837,0.00678620130084429,0.00878741825264137,No,NA,NA,Q6Q0C0,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; activation of MAPKKK activity [GO:0000185]; apoptotic process [GO:0006915]; Notch signaling pathway [GO:0007219]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of MAPK cascade [GO:0043410]; protein ubiquitination [GO:0016567]; ribosomal large subunit assembly [GO:0000027],NA,NA,NA
CHOYP_SMC3.1.1.m.65133,-0.0137644683226201,0.00433220768461983,No,NA,NA,O93309,NA,NA,NA,chromatin [GO:0000785]; chromosome; centromeric region [GO:0000775]; meiotic cohesin complex [GO:0030893]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cell division [GO:0051301]; chromosome organization [GO:0051276]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; regulation of DNA replication [GO:0006275],NA,NA,NA
CHOYP_SMCA4.1.1.m.54020,-0.00173134259529906,-0.0112896648229554,No,NA,NA,A7Z019,NA,NA,NA,nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chromatin binding [GO:0003682]; helicase activity [GO:0004386]; histone binding [GO:0042393]; RNA binding [GO:0003723]; ATP-dependent chromatin remodeling [GO:0043044]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_SMG1.1.1.m.46694,0.0147367335912963,-0.00063957189316058,No,NA,NA,Q8BKX6,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; telomeric DNA binding [GO:0042162]; DNA repair [GO:0006281]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol phosphorylation [GO:0046854]; protein autophosphorylation [GO:0046777]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of telomere maintenance [GO:0032204],NA,NA,NA
CHOYP_SMG5.1.1.m.21320,0.00796433518112133,0.00872323062336478,No,NA,NA,Q6ZPY2,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; histone deacetylase binding [GO:0042826]; protein phosphatase 2A binding [GO:0051721]; ribonuclease activity [GO:0004540]; ribonucleoprotein complex binding [GO:0043021]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162]; ubiquitin protein ligase binding [GO:0031625]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; regulation of dephosphorylation [GO:0035303]; regulation of RNA stability [GO:0043487]; regulation of telomere maintenance [GO:0032204]; telomere maintenance via telomerase [GO:0007004],NA,NA,NA
CHOYP_SMG7.1.1.m.21983,-0.00681231924787137,-0.00421093765773844,No,NA,NA,Q5RJH6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; protein phosphatase 2A binding [GO:0051721]; ribonuclease activity [GO:0004540]; ribonucleoprotein complex binding [GO:0043021]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; regulation of RNA stability [GO:0043487]; telomere maintenance via telomerase [GO:0007004],NA,NA,NA
CHOYP_SMG9.1.1.m.2906,0.00205195042830452,-0.00934116934689427,No,NA,NA,B5X165,NA,NA,NA,nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184],NA,NA,NA
CHOYP_SMHD1.1.1.m.47344,0.00328724794143018,0.000767757398074136,No,NA,NA,Q6P5D8,NA,NA,NA,Barr body [GO:0001740]; nuclear chromosome; telomeric region [GO:0000784]; site of double-strand break [GO:0035861]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; protein homodimerization activity [GO:0042803]; dosage compensation by inactivation of X chromosome [GO:0009048]; double-strand break repair [GO:0006302]; heterochromatin organization involved in chromatin silencing [GO:0070868]; inactivation of X chromosome by DNA methylation [GO:0060821]; inactivation of X chromosome by heterochromatin assembly [GO:0060820]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; nose development [GO:0043584]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034],NA,NA,NA
CHOYP_SMOX.1.2.m.3830,-0.00389835695054856,-0.025448443787432,No,NA,NA,Q99K82,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity [GO:0052895]; norspermine:oxygen oxidoreductase activity [GO:0052894]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; spermine:oxygen oxidoreductase (spermidine-forming) activity [GO:0052901]; polyamine catabolic process [GO:0006598]; spermine catabolic process [GO:0046208],NA,NA,NA
CHOYP_SMP_001000.1.1.m.39561,-0.0197627577892642,0.00436354131060353,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SMP_005500.1.1.m.34627,-0.00212078832001384,-0.00891837260408135,No,NA,NA,Q95ZJ1,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation via threonine [GO:0018243],NA,NA,NA
CHOYP_SMP_006860.2.1.4.m.8660,0.0165323712272549,0.0190773619809877,No,NA,NA,A1ZA47,NA,NA,NA,actin cytoskeleton [GO:0015629]; apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cell leading edge [GO:0031252]; focal adhesion [GO:0005925]; muscle tendon junction [GO:0005927]; stress fiber [GO:0001725]; Z disc [GO:0030018]; zonula adherens [GO:0005915]; actin binding [GO:0003779]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; muscle structure development [GO:0061061]; myofibril assembly [GO:0030239]; regulation of cell-matrix adhesion [GO:0001952],NA,NA,NA
CHOYP_SMP_006860.2.2.4.m.24582,-0.00297374081532533,0.00653862571016032,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SMP_006860.2.3.4.m.63036,-0.018424809687862,0.000435018548883449,No,NA,NA,A1ZA47,NA,NA,NA,actin cytoskeleton [GO:0015629]; apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cell leading edge [GO:0031252]; focal adhesion [GO:0005925]; muscle tendon junction [GO:0005927]; stress fiber [GO:0001725]; Z disc [GO:0030018]; zonula adherens [GO:0005915]; actin binding [GO:0003779]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; muscle structure development [GO:0061061]; myofibril assembly [GO:0030239]; regulation of cell-matrix adhesion [GO:0001952],NA,NA,NA
CHOYP_SMP_012720.1.2.m.31152,0.00600844019980797,0.0134423449760777,No,NA,NA,Q9WUM3,NA,NA,NA,actin filament [GO:0005884]; cell leading edge [GO:0031252]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; actin cytoskeleton organization [GO:0030036]; actin filament branching [GO:0090135]; actin filament bundle assembly [GO:0051017]; cell migration [GO:0016477]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; endothelial cell chemotaxis [GO:0035767]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; negative regulation of lamellipodium morphogenesis [GO:2000393]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; positive regulation of lamellipodium morphogenesis [GO:2000394]; protein kinase C signaling [GO:0070528]; protein localization to cell leading edge [GO:1902463]; ruffle organization [GO:0031529]; wound healing [GO:0042060],NA,NA,NA
CHOYP_SMP_012720.2.2.m.34968,0.0100742283140717,0.0116790492499244,No,NA,NA,Q9WUM3,NA,NA,NA,actin filament [GO:0005884]; cell leading edge [GO:0031252]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; actin cytoskeleton organization [GO:0030036]; actin filament branching [GO:0090135]; actin filament bundle assembly [GO:0051017]; cell migration [GO:0016477]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; endothelial cell chemotaxis [GO:0035767]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; negative regulation of lamellipodium morphogenesis [GO:2000393]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; positive regulation of lamellipodium morphogenesis [GO:2000394]; protein kinase C signaling [GO:0070528]; protein localization to cell leading edge [GO:1902463]; ruffle organization [GO:0031529]; wound healing [GO:0042060],NA,NA,NA
CHOYP_SMP_039300.1.1.m.1202,0.0104147859110744,-0.00203880608395096,No,NA,NA,F7H9X2,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; regulation of neuron apoptotic process [GO:0043523],NA,NA,NA
CHOYP_SMP_043120.1.1.m.12494,-0.0111926623849579,0.00647563914589799,No,NA,NA,Q49YE0,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_SMP_045300.1.1.m.927,-0.00948713641615292,0.00372101061700381,No,NA,NA,A1ZA47,NA,NA,NA,actin cytoskeleton [GO:0015629]; apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cell leading edge [GO:0031252]; focal adhesion [GO:0005925]; muscle tendon junction [GO:0005927]; stress fiber [GO:0001725]; Z disc [GO:0030018]; zonula adherens [GO:0005915]; actin binding [GO:0003779]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; muscle structure development [GO:0061061]; myofibril assembly [GO:0030239]; regulation of cell-matrix adhesion [GO:0001952],NA,NA,NA
CHOYP_SMP_048560.1.2.m.58825,-0.0155626199353692,-0.0110472958652777,No,NA,NA,O35115,NA,NA,NA,M band [GO:0031430]; nucleus [GO:0005634]; Z disc [GO:0030018]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription factor binding [GO:0008134]; atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; response to hormone [GO:0009725]; ventricular cardiac muscle cell development [GO:0055015],NA,NA,NA
CHOYP_SMP_051990.1.7.m.327,-0.00123667520132378,0.0142611985674273,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SMP_051990.2.7.m.611,-0.000841166944310304,0.0101540589286486,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SMP_051990.4.7.m.9424,0.0190213329193326,0.00428039838242463,No,NA,NA,Q0E908,NA,NA,NA,cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_SMP_051990.5.7.m.43424,0.00101797061478087,-0.00400528981888488,No,NA,NA,Q0E908,NA,NA,NA,cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_SMP_051990.7.7.m.57569,0.0150788375276484,0.00731439662812986,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SMP_076400.2.2.m.49169,-0.000987688059681454,-0.0068742029394288,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SMP_078690.3.5.m.2272,0.0216578970857447,0.00765755946179638,No,NA,NA,P37397,NA,NA,NA,actin filament [GO:0005884]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; actin binding [GO:0003779]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; protein binding; bridging [GO:0030674]; actomyosin structure organization [GO:0031032]; epithelial cell differentiation [GO:0030855]; negative regulation of ATPase activity [GO:0032780],NA,NA,NA
CHOYP_SMP_078690.4.5.m.41580,-0.0052195420935596,0.00989643900536917,No,NA,NA,P37801,NA,NA,NA,,NA,NA,NA
CHOYP_SMP_082940.1.1.m.3343,-0.0138087567355906,-0.00997560252924249,No,NA,NA,Q9N2W7,NA,NA,NA,mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_SMP_087250.2.2.m.25167,0.0187578424847269,0.0174319859197053,No,NA,NA,P97314,NA,NA,NA,nucleus [GO:0005634]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_SMP_089460.1.1.1.m.34779,0.0138652551998156,-0.00970551310558285,No,NA,NA,Q9VT65,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; border follicle cell migration [GO:0007298]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_SMP_102490.1.2.m.22219,0.00661277155964293,-0.00258107818021843,No,NA,NA,P0C2C1,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_SMP_105540.1.1.m.40275,-0.00585877079552164,-0.0163942195663988,No,NA,NA,Q8JZW5,NA,NA,NA,cell junction [GO:0030054]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211],NA,NA,NA
CHOYP_SMP_137640.1.2.m.40559,0.0112014344609838,0.00515547576122989,No,NA,NA,Q7Z0T3,NA,NA,NA,extracellular region [GO:0005576]; pheromone activity [GO:0005186],NA,NA,NA
CHOYP_SMP_140370.1.1.m.35365,-0.0178959272888594,-0.0165704834937792,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SMP_143090.1.1.m.6805,-0.0225703019344799,-0.00171565865125234,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SMP_147320.1.1.m.27463,0.00364778592941831,-0.00872052841558097,No,NA,NA,Q96M20,NA,NA,NA,cytosol [GO:0005829]; cAMP binding [GO:0030552]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_SMP_148160.1.1.m.11635,-0.0170614117179831,-0.0184133804531806,No,NA,NA,Q9NWH7,NA,NA,NA,extracellular region [GO:0005576]; sperm connecting piece [GO:0097224]; myosin light chain binding [GO:0032027]; cell differentiation [GO:0030154]; motile cilium assembly [GO:0044458]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_SMP_148530.1.1.m.18051,0.0185911742243746,0.00663761208582476,No,NA,NA,P12812,NA,NA,NA,,NA,NA,NA
CHOYP_SMP_149390.1.1.m.8819,-0.0132043560735968,-0.00569859542058828,No,NA,NA,Q8C419,NA,NA,NA,integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor signaling pathway [GO:0007186]; protein localization to plasma membrane [GO:0072659],NA,NA,NA
CHOYP_SMP_149990.1.1.1.m.44960,-0.000433966714541341,-0.0215638115286467,No,NA,NA,Q0E908,NA,NA,NA,cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_SMP_158990.1.1.m.28205,-0.0163950573845959,0.00395327896758426,No,NA,NA,P36609,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_SMP_159010.1.1.1.m.56000,-0.00411766741228614,0.0100843323111719,No,NA,NA,P26818,NA,NA,NA,ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor kinase activity [GO:0004703]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_SMP_159780.1.2.m.41665,0.00042807381418381,0.00578659378525384,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SMP_168770.1.1.m.18618,-0.019645840088888,-0.00192568816438178,No,NA,NA,Q9VF08,NA,NA,NA,TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; instar larval development [GO:0002168]; protein import into mitochondrial matrix [GO:0030150],NA,NA,NA
CHOYP_SMP_171550.1.1.m.44645,-0.0149046356456782,-0.0163380272371608,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SMP_173720.2.3.m.52988,0.0055372613596989,0.0138302283236507,No,NA,NA,Q8CIR4,NA,NA,NA,apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; metal ion transport [GO:0030001]; protein tetramerization [GO:0051262]; response to toxic substance [GO:0009636],NA,NA,NA
CHOYP_SMP_176410.1.1.m.18565,0.000539361144773536,0.00950662783858451,No,NA,NA,Q9UJT9,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]; ubiquitin-protein transferase activity [GO:0004842]; cell division [GO:0051301]; cell proliferation [GO:0008283]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_SMP_194720.1.1.m.53496,0.0176050886641214,0.00933536132564451,No,NA,NA,O02485,NA,NA,NA,,NA,NA,NA
CHOYP_SMRC2.2.2.m.49912,-0.00572857348352559,0.0060241391181893,No,NA,NA,Q8TAQ2,NA,NA,NA,nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; transcription coactivator activity [GO:0003713]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; negative regulation of transcription; DNA-templated [GO:0045892]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_SMRD1.1.2.m.1725,-0.00260747762683954,0.0133599801601371,No,NA,NA,Q61466,NA,NA,NA,intracellular membrane-bounded organelle [GO:0043231]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; chromatin binding [GO:0003682]; protein-containing complex scaffold activity [GO:0032947]; signaling receptor binding [GO:0005102]; cellular response to fatty acid [GO:0071398]; chromatin remodeling [GO:0006338]; chromatin-mediated maintenance of transcription [GO:0048096]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337],NA,NA,NA
CHOYP_SMU1.1.1.m.58635,-0.0157832538175582,-0.00439279524059076,No,NA,NA,Q6NRT3,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; mRNA splicing; via spliceosome [GO:0000398]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],NA,NA,NA
CHOYP_SMYD5.1.1.m.27234,0.00209802524896112,0.00527051281893758,No,NA,NA,Q5ZIZ2,NA,NA,NA,metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168],NA,NA,NA
CHOYP_SNF1A.1.1.m.52779,0.00595495471993747,-0.0157719456096864,No,NA,NA,P54646,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; [acetyl-CoA carboxylase] kinase activity [GO:0050405]; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity [GO:0047322]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; histone serine kinase activity [GO:0035174]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cell cycle arrest [GO:0007050]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; cellular response to oxidative stress [GO:0034599]; cellular response to prostaglandin E stimulus [GO:0071380]; cholesterol biosynthetic process [GO:0006695]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; intracellular signal transduction [GO:0035556]; lipid biosynthetic process [GO:0008610]; macroautophagy [GO:0016236]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of TOR signaling [GO:0032007]; negative regulation of tubulin deacetylation [GO:1904428]; positive regulation of autophagy [GO:0010508]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of glycolytic process [GO:0045821]; positive regulation of macroautophagy [GO:0016239]; positive regulation of peptidyl-lysine acetylation [GO:2000758]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of macroautophagy [GO:0016241]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of stress granule assembly [GO:0062028]; response to muscle activity [GO:0014850]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_SNUT2.1.1.m.19264,-0.0159235584742596,-0.0142969232813744,No,NA,NA,Q3TIX9,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA splicing; via spliceosome [GO:0000398]; protein deubiquitination [GO:0016579]; spliceosomal complex assembly [GO:0000245],NA,NA,NA
CHOYP_SNW1.2.2.m.19563,0.00180950136274906,-0.0183629003289261,No,NA,NA,Q5R7R9,NA,NA,NA,nuclear matrix [GO:0016363]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; nuclear hormone receptor binding [GO:0035257]; retinoic acid receptor binding [GO:0042974]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; vitamin D receptor binding [GO:0042809]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mRNA splicing; via spliceosome [GO:0000398]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of mRNA splicing; via spliceosome [GO:0048026]; positive regulation of neurogenesis [GO:0050769]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of retinoic acid receptor signaling pathway [GO:0048385]; regulation of vitamin D receptor signaling pathway [GO:0070562]; retinoic acid receptor signaling pathway [GO:0048384],NA,NA,NA
CHOYP_SNX2.1.1.m.25425,0.00139539797305003,-0.0117489231027907,No,NA,NA,O60749,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; lamellipodium [GO:0030027]; lysosome [GO:0005764]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; retromer complex [GO:0030904]; retromer; tubulation complex [GO:0030905]; cadherin binding [GO:0045296]; epidermal growth factor receptor binding [GO:0005154]; insulin receptor binding [GO:0005158]; leptin receptor binding [GO:1990460]; phosphatidylinositol binding [GO:0035091]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transferrin receptor binding [GO:1990459]; early endosome to Golgi transport [GO:0034498]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; lamellipodium morphogenesis [GO:0072673]; protein complex oligomerization [GO:0051259]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_SODM.1.2.m.45531,0.0147564606633784,-0.00453232853729316,No,NA,NA,P41976,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; manganese ion binding [GO:0030145]; metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]; age-dependent response to reactive oxygen species [GO:0001315]; aging [GO:0007568]; regulation of transcription by RNA polymerase II [GO:0006357]; superoxide metabolic process [GO:0006801],NA,NA,NA
CHOYP_SODM.2.2.m.62946,0.0131357288513671,-0.00860258778275664,No,NA,NA,Q28709,NA,NA,NA,cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; multivesicular body; internal vesicle [GO:0097487]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; endosome to melanosome transport [GO:0035646]; pigment granule maturation [GO:0048757]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746],NA,NA,NA
CHOYP_SON.1.3.m.26634,0.00185567311353541,-0.0033874309512612,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SORBIDRAFT_04G037735.1.1.m.52863,0.00578216414029149,-0.0100497434713833,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SORBIDRAFT_06G032450.1.1.m.16356,0.00560093499090591,-0.0034982044863299,No,NA,NA,Q7XR46,NA,NA,NA,peroxisome [GO:0005777]; flavin adenine dinucleotide binding [GO:0050660]; norspermine:oxygen oxidoreductase activity [GO:0052894]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; spermine:oxygen oxidoreductase (spermidine-forming) activity [GO:0052901]; polyamine catabolic process [GO:0006598]; spermine catabolic process [GO:0046208]; thermospermine catabolic process [GO:1903602],NA,NA,NA
CHOYP_SORL.1.3.m.4531,0.00660147788540221,-0.0111352639947051,No,NA,NA,P98158,NA,NA,NA,apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023]; steroid hormone receptor binding [GO:0035258]; aging [GO:0007568]; animal organ regeneration [GO:0031100]; coronary artery morphogenesis [GO:0060982]; endocytic hemoglobin import [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; hormone secretion [GO:0046879]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of endopeptidase activity [GO:0010951]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to drug [GO:0042493]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; vitamin metabolic process [GO:0006766],NA,NA,NA
CHOYP_SORL.3.3.m.58779,-0.00438283668670396,0.00222462322507419,No,NA,NA,O88307,NA,NA,NA,early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; integral component of membrane [GO:0016021]; low-density lipoprotein particle [GO:0034362]; membrane [GO:0016020]; multivesicular body [GO:0005771]; neuronal cell body [GO:0043025]; nuclear envelope lumen [GO:0005641]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; ADP-ribosylation factor binding [GO:0030306]; amyloid-beta binding [GO:0001540]; low-density lipoprotein particle binding [GO:0030169]; cell migration [GO:0016477]; cholesterol metabolic process [GO:0008203]; endocytosis [GO:0006897]; lipid transport [GO:0006869]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902960]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902963]; negative regulation of neurofibrillary tangle assembly [GO:1902997]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron death [GO:1901215]; negative regulation of protein binding [GO:0032091]; negative regulation of protein oligomerization [GO:0032460]; negative regulation of tau-protein kinase activity [GO:1902948]; positive regulation of choline O-acetyltransferase activity [GO:1902771]; positive regulation of early endosome to recycling endosome transport [GO:1902955]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to early endosome [GO:1902966]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to Golgi apparatus [GO:0034067]; protein maturation [GO:0051604]; protein retention in Golgi apparatus [GO:0045053]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]; regulation of smooth muscle cell migration [GO:0014910],NA,NA,NA
CHOYP_SOS1.1.1.m.52801,0.0105457964047708,0.0160562368964763,No,NA,NA,Q07890,NA,NA,NA,cytosol [GO:0005829]; nucleosome [GO:0000786]; DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein heterodimerization activity [GO:0046982]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264],NA,NA,NA
CHOYP_SOSB1.1.2.m.1668,-0.00854029571503004,0.0113406977115455,No,NA,NA,Q3SWT1,NA,NA,NA,nucleus [GO:0005634]; SOSS complex [GO:0070876]; single-stranded DNA binding [GO:0003697]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; mitotic cell cycle checkpoint [GO:0007093]; response to ionizing radiation [GO:0010212],NA,NA,NA
CHOYP_SOX2.1.2.m.31411,-0.013866451520291,-0.0172307852804563,No,NA,NA,P48430,NA,NA,NA,cell [GO:0005623]; cytosol [GO:0005829]; nuclear transcription factor complex [GO:0044798]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; miRNA binding [GO:0035198]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; cell cycle arrest [GO:0007050]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; central nervous system development [GO:0007417]; endodermal cell fate specification [GO:0001714]; eye development [GO:0001654]; forebrain development [GO:0030900]; inner ear development [GO:0048839]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; osteoblast differentiation [GO:0001649]; pituitary gland development [GO:0021983]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; regulation of transcription; DNA-templated [GO:0006355]; response to growth factor [GO:0070848]; response to wounding [GO:0009611]; sensory organ precursor cell fate determination [GO:0016360]; somatic stem cell population maintenance [GO:0035019],NA,NA,NA
CHOYP_SP3.1.1.m.9839,0.00486263432069409,-0.0123841731311027,No,NA,NA,Q02446,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_SPAG16.1.1.m.51927,-0.0202355302675273,0.00368364032785459,No,NA,NA,Q8N0X2,NA,NA,NA,axonemal central apparatus [GO:1990716]; axoneme [GO:0005930]; sperm flagellum [GO:0036126]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; sperm axoneme assembly [GO:0007288],NA,NA,NA
CHOYP_SPAG7.1.1.m.66661,0.00205195042830452,-0.00934116934689426,No,NA,NA,Q7SYJ9,NA,NA,NA,nucleic acid binding [GO:0003676],NA,NA,NA
CHOYP_SPAT6.1.1.m.11699,-0.00691419640889627,0.0135875866982426,No,NA,NA,Q3U6K5,NA,NA,NA,extracellular region [GO:0005576]; sperm connecting piece [GO:0097224]; myosin light chain binding [GO:0032027]; cell differentiation [GO:0030154]; motile cilium assembly [GO:0044458]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_SPB3.1.1.m.31072,-0.017545714081859,-0.016871726716559,No,NA,NA,Q5BIR5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; epithelial cell-cell adhesion [GO:0090136]; negative regulation of endopeptidase activity [GO:0010951],NA,NA,NA
CHOYP_SPCA.1.1.m.6746,0.00394536801625317,0.00291369700370642,No,NA,NA,P98194,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calcium-transporting ATPase activity [GO:0005388]; manganese ion binding [GO:0030145]; manganese-transporting ATPase activity [GO:0015410]; metal ion binding [GO:0046872]; proton-exporting ATPase activity; phosphorylative mechanism [GO:0008553]; actin cytoskeleton reorganization [GO:0031532]; ATP hydrolysis coupled cation transmembrane transport [GO:0099132]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cellular calcium ion homeostasis [GO:0006874]; cellular manganese ion homeostasis [GO:0030026]; epidermis development [GO:0008544]; Golgi calcium ion homeostasis [GO:0032468]; Golgi calcium ion transport [GO:0032472]; manganese ion transport [GO:0006828]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123],NA,NA,NA
CHOYP_SPCS.1.1.m.65784,-0.0127269281317152,0.0150901635234551,No,NA,NA,Q803A7,NA,NA,NA,cytoplasm [GO:0005737]; transferase activity; transferring selenium-containing groups [GO:0016785]; tRNA binding [GO:0000049]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; translation [GO:0006412],NA,NA,NA
CHOYP_SPF45.1.1.m.22111,-0.00616994487254728,0.00722948659751263,No,NA,NA,Q96I25,NA,NA,NA,nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; alternative mRNA splicing; via spliceosome [GO:0000380]; DNA repair [GO:0006281]; mRNA splicing; via spliceosome [GO:0000398]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],NA,NA,NA
CHOYP_SPH127.1.1.m.56840,0.0171140644378269,-0.00568173718141233,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SPI2.16.37.m.16200,-0.00161578658493177,0.0173935509064042,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SPI2.25.37.m.28547,0.003475878281059,-0.0254876220304512,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SPI2.29.37.m.30551,0.00944123420086113,-0.0169819350924308,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SPI2.30.37.m.30616,-0.0126323569902992,-0.00719574866287944,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SPI2.8.37.m.4837,-0.00181259232366635,-0.0113668513693379,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SPR.1.3.m.17978,-0.0120372855163306,-0.00917516978380978,No,NA,NA,B0BML7,NA,NA,NA,cytoplasm [GO:0005737]; sepiapterin reductase activity [GO:0004757]; tetrahydrobiopterin biosynthetic process [GO:0006729],NA,NA,NA
CHOYP_SPR.2.3.m.21888,0.00612803509126422,-0.00627376470852415,No,NA,NA,Q8SWR3,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity; post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042],NA,NA,NA
CHOYP_SPT20.1.1.m.35908,0.00716432115675082,-0.0120587453915666,No,NA,NA,Q8TB22,NA,NA,NA,extracellular region [GO:0005576]; catalytic activity [GO:0003824]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_SPT4H.1.1.m.40744,0.00100286197154972,-0.0128224659905652,No,NA,NA,Q6DGQ0,NA,NA,NA,DSIF complex [GO:0032044]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; positive regulation of DNA-templated transcription; elongation [GO:0032786],NA,NA,NA
CHOYP_SPT5H.1.1.m.60053,0.0025948631720076,-0.0174982140765696,No,NA,NA,O00267,NA,NA,NA,DSIF complex [GO:0032044]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; 7-methylguanosine mRNA capping [GO:0006370]; negative regulation of DNA-templated transcription; elongation [GO:0032785]; negative regulation of mRNA polyadenylation [GO:1900364]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription; elongation [GO:0032786]; positive regulation of macroautophagy [GO:0016239]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368],NA,NA,NA
CHOYP_SPT6H.1.1.m.55595,0.00846056599665885,-0.0116357439284937,No,NA,NA,Q7KZ85,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023]; transcriptionally active chromatin [GO:0035327]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723]; blastocyst formation [GO:0001825]; chromatin maintenance [GO:0070827]; chromatin remodeling [GO:0006338]; mRNA processing [GO:0006397]; mRNA transcription by RNA polymerase II [GO:0042789]; mRNA transport [GO:0051028]; negative regulation of histone H3-K27 methylation [GO:0061086]; nucleosome organization [GO:0034728]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of isotype switching [GO:0045191]; regulation of mRNA export from nucleus [GO:0010793]; regulation of mRNA processing [GO:0050684]; regulation of muscle cell differentiation [GO:0051147]; regulation of transcription; DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; viral process [GO:0016032],NA,NA,NA
CHOYP_SPTCA.1.2.m.1905,0.000181159696446167,-0.000260369842516305,No,NA,NA,P13395,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; spectrosome [GO:0045170]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; cytoskeletal protein binding [GO:0008092]; microtubule binding [GO:0008017]; actin filament capping [GO:0051693]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; fusome organization [GO:0045478]; germ-line cyst formation [GO:0048134]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; neuromuscular synaptic transmission [GO:0007274]; oocyte construction [GO:0007308]; ovarian follicle cell development [GO:0030707]; plasma membrane organization [GO:0007009]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807],NA,NA,NA
CHOYP_SPTCA.2.2.m.25615,-0.00786925058837215,0.00760520865089836,No,NA,NA,P13395,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; spectrosome [GO:0045170]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; cytoskeletal protein binding [GO:0008092]; microtubule binding [GO:0008017]; actin filament capping [GO:0051693]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; fusome organization [GO:0045478]; germ-line cyst formation [GO:0048134]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; neuromuscular synaptic transmission [GO:0007274]; oocyte construction [GO:0007308]; ovarian follicle cell development [GO:0030707]; plasma membrane organization [GO:0007009]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807],NA,NA,NA
CHOYP_SQPA.2.2.m.61080,0.00649457360246057,0.00751254086160057,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SR140.1.2.m.11983,0.00343703558504057,0.0117427328209748,No,NA,NA,Q6NV83,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; RNA processing [GO:0006396],NA,NA,NA
CHOYP_SRA1.1.1.m.56432,0.00205195042830452,-0.00934116934689426,No,NA,NA,Q80VJ2,NA,NA,NA,cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; steroid hormone aporeceptor complex [GO:0005831]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; nuclear receptor binding [GO:0016922]; nuclear receptor transcription coactivator activity [GO:0030374]; steroid receptor RNA activator RNA binding [GO:0002153]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cell proliferation [GO:0008283]; cellular response to estrogen stimulus [GO:0071391]; negative regulation of myoblast differentiation [GO:0045662]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_SRAP.10.18.m.43353,0.00615673950805973,-0.0191525160335768,No,NA,NA,Q9Y4F5,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874],NA,NA,NA
CHOYP_SRAP.14.18.m.50950,-0.01671310533388,0.0103900205116696,No,NA,NA,Q9BRZ2,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; RNA binding [GO:0003723]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; interferon-beta production [GO:0032608]; protein K63-linked ubiquitination [GO:0070534]; regulation of type I interferon production [GO:0032479]; response to type I interferon [GO:0034340],NA,NA,NA
CHOYP_SRAP.16.18.m.58654,0.0189626883700517,-0.00700532740907825,No,NA,NA,Q8K561,NA,NA,NA,anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; extracellular region [GO:0005576]; cell-matrix adhesion [GO:0007160]; sensory perception of sound [GO:0007605]; transmission of nerve impulse [GO:0019226],NA,NA,NA
CHOYP_SRC.1.2.m.2503,0.0226567632334604,-0.00787437694626756,No,NA,NA,Q9W596,NA,NA,NA,axon [GO:0030424]; cell projection [GO:0042995]; cytosol [GO:0005829]; dendrite [GO:0030425]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; neuronal cell body [GO:0043025]; synapse [GO:0045202]; actin binding [GO:0003779]; kinase binding [GO:0019900]; microtubule binding [GO:0008017]; tubulin binding [GO:0015631]; axo-dendritic transport [GO:0008088]; axonogenesis [GO:0007409]; compound eye development [GO:0048749]; dendrite development [GO:0016358]; dendrite morphogenesis [GO:0048813]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; nervous system development [GO:0007399]; neurofilament cytoskeleton organization [GO:0060052]; neuromuscular junction development [GO:0007528]; olfactory learning [GO:0008355]; regulation of microtubule depolymerization [GO:0031114]; regulation of synaptic growth at neuromuscular junction [GO:0008582],NA,NA,NA
CHOYP_SRC1.1.1.m.63625,0.0065883263884642,0.0180931628217626,No,NA,NA,P09324,NA,NA,NA,actin filament [GO:0005884]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Golgi apparatus [GO:0005794]; microtubule organizing center [GO:0005815]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; signaling receptor binding [GO:0005102]; cell differentiation [GO:0030154]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; peptidyl-tyrosine autophosphorylation [GO:0038083]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of glucose transmembrane transport [GO:0010827]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_SRC2.1.1.m.6537,0.00656027000833771,0.00127170602229951,No,NA,NA,Q9V9J3,NA,NA,NA,adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; actin filament bundle assembly [GO:0051017]; adherens junction organization [GO:0034332]; apoptotic cell clearance [GO:0043277]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; compound eye development [GO:0048749]; defense response to bacterium [GO:0042742]; dorsal closure [GO:0007391]; dorsal closure; spreading of leading edge cells [GO:0007395]; epithelial cell-cell adhesion [GO:0090136]; imaginal disc fusion; thorax closure [GO:0046529]; imaginal disc-derived wing morphogenesis [GO:0007476]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; open tracheal system development [GO:0007424]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of sevenless signaling pathway [GO:0045874]; protein phosphorylation [GO:0006468]; regulation of synaptic plasticity [GO:0048167]; salivary gland morphogenesis [GO:0007435]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_SRCR12.1.1.m.53668,0.00312637177511709,-0.0128481671114259,No,NA,NA,Q9NR16,NA,NA,NA,external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044],NA,NA,NA
CHOYP_SREC2.7.9.m.44662,0.00394536801625317,0.00291369700370642,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SREC2.9.9.m.66799,0.00784478693593402,0.000660544279086551,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SRFB1.1.2.m.18320,0.00217997094733793,-0.00807271368859912,No,NA,NA,Q5XGC9,NA,NA,NA,90S preribosome [GO:0030686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; maturation of SSU-rRNA [GO:0030490],NA,NA,NA
CHOYP_SRP54.1.2.m.21986,0.00589705295875154,-0.00963824923389337,No,NA,NA,P14576,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; signal recognition particle; endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; drug binding [GO:0008144]; endoplasmic reticulum signal peptide binding [GO:0030942]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribonucleoprotein complex binding [GO:0043021]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614],NA,NA,NA
CHOYP_SRP68.1.1.m.61852,0.00349179964542289,-0.0204519789524704,No,NA,NA,Q9UHB9,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; nucleolus [GO:0005730]; ribosome [GO:0005840]; signal recognition particle [GO:0048500]; signal recognition particle; endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; signal recognition particle binding [GO:0005047]; response to drug [GO:0042493]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614],NA,NA,NA
CHOYP_SRP72.1.1.m.60789,-0.00224080798976023,-0.00670660980539078,No,NA,NA,O76094,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; signal recognition particle [GO:0048500]; signal recognition particle; endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; RNA binding [GO:0003723]; signal recognition particle binding [GO:0005047]; TPR domain binding [GO:0030911]; response to drug [GO:0042493]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; SRP-dependent cotranslational protein targeting to membrane; translocation [GO:0006616],NA,NA,NA
CHOYP_SRPK2.1.1.m.5002,0.0144337751198151,-0.00577652316443644,No,NA,NA,O70551,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; cell differentiation [GO:0030154]; chromosome segregation [GO:0007059]; intracellular signal transduction [GO:0035556]; negative regulation of viral genome replication [GO:0045071]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]; regulation of mRNA processing [GO:0050684]; spliceosomal complex assembly [GO:0000245],NA,NA,NA
CHOYP_SRPX2.1.1.m.37317,0.00223738752752963,-0.00140758654154913,No,NA,NA,Q8TER0,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160],NA,NA,NA
CHOYP_SRSF4.6.6.m.44673,-0.0103213180281321,0.0151210268912765,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SSPO.1.14.m.962,-0.00465350479819893,0.00705361019707702,No,NA,NA,Q8CG65,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_SSPO.11.14.m.53093,-0.0118457622074639,0.00234582307910136,No,NA,NA,Q06852,NA,NA,NA,cell wall [GO:0005618]; extracellular region [GO:0005576]; S-layer [GO:0030115]; carbohydrate binding [GO:0030246]; polysaccharide catabolic process [GO:0000272],NA,NA,NA
CHOYP_SSPO.12.14.m.53188,-0.0200962526949522,0.00692505359597466,No,NA,NA,Q9Y493,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; binding of sperm to zona pellucida [GO:0007339]; cell-cell adhesion [GO:0098609],NA,NA,NA
CHOYP_SSPO.2.14.m.3787,0.00445046671784317,-0.0060272753937889,No,NA,NA,Q28178,NA,NA,NA,cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; platelet alpha granule [GO:0031091]; sarcoplasmic reticulum [GO:0016529]; calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; behavioral response to pain [GO:0048266]; cell adhesion [GO:0007155]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986],NA,NA,NA
CHOYP_SSPO.6.14.m.26542,-0.0122745524994673,0.000926308369389589,No,NA,NA,Q8CG65,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_SSRB.1.2.m.5816,-0.00848235466667615,-0.0137707322807848,No,NA,NA,Q5E9E4,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_SSRP1.1.1.m.19377,-0.0119199061824825,-0.0150452106355953,No,NA,NA,Q04678,NA,NA,NA,chromosome [GO:0005694]; nucleolus [GO:0005730]; DNA binding [GO:0003677]; DNA repair [GO:0006281]; DNA replication [GO:0006260],NA,NA,NA
CHOYP_SSSCA1.1.2.m.25666,-0.000254583925329849,0.0113018291175342,No,NA,NA,O60232,NA,NA,NA,identical protein binding [GO:0042802]; cell division [GO:0051301]; mitotic cell cycle [GO:0000278],NA,NA,NA
CHOYP_SSU72.1.1.m.2079,0.00147853342922354,0.00800962657747013,No,NA,NA,Q5ZJQ7,NA,NA,NA,cytoplasm [GO:0005737]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]; dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; mRNA polyadenylation [GO:0006378]; termination of RNA polymerase II transcription [GO:0006369],NA,NA,NA
CHOYP_ST1C1.1.1.m.45503,-0.00179964758953132,0.011183471007311,No,NA,NA,O75897,NA,NA,NA,cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ethanol catabolic process [GO:0006068]; sulfation [GO:0051923],NA,NA,NA
CHOYP_ST1C4.2.3.m.14628,-0.0110080280457826,0.000630922310557576,No,NA,NA,O75897,NA,NA,NA,cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ethanol catabolic process [GO:0006068]; sulfation [GO:0051923],NA,NA,NA
CHOYP_ST5.1.1.m.54184,0.0065883263884642,0.0180931628217626,No,NA,NA,P78524,NA,NA,NA,Rab guanyl-nucleotide exchange factor activity [GO:0017112]; positive regulation of ERK1 and ERK2 cascade [GO:0070374],NA,NA,NA
CHOYP_STAB2.1.1.m.64132,0.00538629929546804,0.000473423408546151,No,NA,NA,Q8R4U0,NA,NA,NA,cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; hyaluronic acid binding [GO:0005540]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; scavenger receptor activity [GO:0005044]; cell adhesion [GO:0007155]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; endocytosis [GO:0006897],NA,NA,NA
CHOYP_STAR5.2.2.m.39352,0.0181485161162707,0.00776345984060604,No,NA,NA,A1A4M6,NA,NA,NA,bile acid binding [GO:0032052]; cholesterol binding [GO:0015485]; cholesterol transporter activity [GO:0017127]; cholesterol import [GO:0070508],NA,NA,NA
CHOYP_STAT1.1.2.m.1003,-0.000679565351577531,0.0116138232427307,No,NA,NA,P42232,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; glucocorticoid receptor binding [GO:0035259]; protein dimerization activity [GO:0046983]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; acute-phase response [GO:0006953]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hormone stimulus [GO:0032870]; cytokine-mediated signaling pathway [GO:0019221]; development of secondary female sexual characteristics [GO:0046543]; development of secondary male sexual characteristics [GO:0046544]; female pregnancy [GO:0007565]; JAK-STAT cascade [GO:0007259]; JAK-STAT cascade involved in growth hormone signaling pathway [GO:0060397]; lactation [GO:0007595]; lipid storage [GO:0019915]; liver development [GO:0001889]; luteinization [GO:0001553]; mast cell migration [GO:0097531]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of erythrocyte differentiation [GO:0045647]; Peyer's patch development [GO:0048541]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell proliferation [GO:0008284]; positive regulation of cellular component movement [GO:0051272]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-2 biosynthetic process [GO:0045086]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone metabolic process [GO:0042448]; regulation of cell adhesion [GO:0030155]; regulation of epithelial cell differentiation [GO:0030856]; regulation of multicellular organism growth [GO:0040014]; regulation of steroid metabolic process [GO:0019218]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription; DNA-templated [GO:0006355]; response to estradiol [GO:0032355]; response to interleukin-15 [GO:0070672]; response to interleukin-2 [GO:0070669]; response to interleukin-4 [GO:0070670]; response to lipopolysaccharide [GO:0032496]; response to peptide hormone [GO:0043434]; sex differentiation [GO:0007548]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; taurine metabolic process [GO:0019530]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_STERM_3136.1.1.m.53971,-0.00476891178913003,-0.0112251760739146,No,NA,NA,Q5UR67,NA,NA,NA,hydrolase activity; acting on glycosyl bonds [GO:0016798]; metabolic process [GO:0008152],NA,NA,NA
CHOYP_STIM1.1.1.m.13316,0.00851210201991181,-0.00850913627666251,No,NA,NA,P84903,NA,NA,NA,endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; protein-containing complex [GO:0032991]; sarcoplasmic reticulum membrane [GO:0033017]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; microtubule plus-end binding [GO:0051010]; store-operated calcium channel activity [GO:0015279]; activation of store-operated calcium channel activity [GO:0032237]; cellular calcium ion homeostasis [GO:0006874]; detection of calcium ion [GO:0005513]; enamel mineralization [GO:0070166]; myotube differentiation [GO:0014902]; positive regulation of adenylate cyclase activity [GO:0045762]; regulation of calcium ion transport [GO:0051924]; regulation of store-operated calcium entry [GO:2001256]; store-operated calcium entry [GO:0002115],NA,NA,NA
CHOYP_STING.3.3.m.61083,-0.00450420955189307,0.0133201121562837,No,NA,NA,Q86WV6,NA,NA,NA,cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; cyclic-di-GMP binding [GO:0035438]; cyclic-GMP-AMP binding [GO:0061507]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; activation of innate immune response [GO:0002218]; apoptotic process [GO:0006915]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to interferon-beta [GO:0035458]; cellular response to organic cyclic compound [GO:0071407]; cytoplasmic pattern recognition receptor signaling pathway in response to virus [GO:0039528]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; interferon-beta production [GO:0032608]; neutrophil degranulation [GO:0043312]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of protein binding [GO:0032092]; positive regulation of protein import into nucleus; translocation [GO:0033160]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; regulation of inflammatory response [GO:0050727]; regulation of type I interferon production [GO:0032479]; viral process [GO:0016032],NA,NA,NA
CHOYP_STIP1.1.2.m.12856,0.00383420955082793,-0.00390915996414036,No,NA,NA,P31948,NA,NA,NA,chaperone complex [GO:0101031]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; cellular response to interleukin-7 [GO:0098761],NA,NA,NA
CHOYP_STIP1.2.2.m.54723,0.0019866547546802,-0.000107297566674601,No,NA,NA,P31948,NA,NA,NA,chaperone complex [GO:0101031]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; cellular response to interleukin-7 [GO:0098761],NA,NA,NA
CHOYP_STK17A.1.1.m.24446,0.0217077973039906,-0.00649358055927095,No,NA,NA,Q9UEE5,NA,NA,NA,nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; intracellular signal transduction [GO:0035556]; positive regulation of apoptotic process [GO:0043065]; positive regulation of fibroblast apoptotic process [GO:2000271]; protein phosphorylation [GO:0006468]; regulation of reactive oxygen species metabolic process [GO:2000377],NA,NA,NA
CHOYP_STK31.1.1.m.16297,0.00169751179693175,-0.0141447532140762,No,NA,NA,Q9BXU1,NA,NA,NA,acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; nuclease activity [GO:0004518]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; RNA catabolic process [GO:0006401],NA,NA,NA
CHOYP_STK33.1.1.m.8044,-0.0138968402265024,-0.000196564130523527,No,NA,NA,Q924X7,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; mitotic DNA damage checkpoint [GO:0044773]; protein autophosphorylation [GO:0046777]; signal transduction in response to DNA damage [GO:0042770],NA,NA,NA
CHOYP_STRN.MLCK.2.3.m.9348,0.00205195042830452,-0.00934116934689426,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_STRN3.3.5.m.25133,-0.00630083533912645,-0.000362599170612503,No,NA,NA,A5D7H2,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; FAR/SIN/STRIPAK complex [GO:0090443]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; armadillo repeat domain binding [GO:0070016]; calmodulin binding [GO:0005516]; DNA-binding transcription factor activity [GO:0003700]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; Rho GTPase binding [GO:0017048]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_STRUM.1.1.m.42335,-0.00811346052183954,-0.0247825623707272,No,NA,NA,Q5R5P0,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; WASH complex [GO:0071203]; protein transport [GO:0015031],NA,NA,NA
CHOYP_STT3A.1.1.m.40532,-0.00931531533870517,-0.0124771519232785,No,NA,NA,Q2KJI2,NA,NA,NA,integral component of membrane [GO:0016021]; oligosaccharyltransferase III complex [GO:0035000]; dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]; co-translational protein modification [GO:0043686]; protein N-linked glycosylation via asparagine [GO:0018279],NA,NA,NA
CHOYP_STX.1.1.m.30392,0.00205195042830452,-0.00934116934689426,No,NA,NA,Q16932,NA,NA,NA,cell [GO:0005623]; integral component of membrane [GO:0016021]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; intracellular protein transport [GO:0006886]; neurotransmitter transport [GO:0006836]; regulation of exocytosis [GO:0017157]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_STX12.1.1.m.34092,-0.0226634953591803,0.0103471385692035,No,NA,NA,Q86Y82,NA,NA,NA,early endosome membrane [GO:0031901]; endomembrane system [GO:0012505]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; membrane raft [GO:0045121]; phagocytic vesicle [GO:0045335]; phagophore assembly site [GO:0000407]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; vesicle [GO:0031982]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; autophagosome assembly [GO:0000045]; cholesterol efflux [GO:0033344]; intracellular protein transport [GO:0006886]; protein stabilization [GO:0050821]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906],NA,NA,NA
CHOYP_STXB1.1.1.m.56878,-0.0100919908977502,-0.0125985577943329,No,NA,NA,P61765,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; postsynapse [GO:0098794]; presynapse [GO:0098793]; presynaptic active zone membrane [GO:0048787]; protein-containing complex [GO:0032991]; terminal bouton [GO:0043195]; identical protein binding [GO:0042802]; phospholipase binding [GO:0043274]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; axon target recognition [GO:0007412]; cellular response to interferon-gamma [GO:0071346]; developmental process involved in reproduction [GO:0003006]; long-term synaptic depression [GO:0060292]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of SNARE complex assembly [GO:0035544]; negative regulation of synaptic transmission; GABAergic [GO:0032229]; neuromuscular synaptic transmission [GO:0007274]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of exocytosis [GO:0045921]; positive regulation of glutamate secretion; neurotransmission [GO:1903296]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of vesicle docking [GO:0106022]; presynaptic dense core vesicle exocytosis [GO:0099525]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of synaptic vesicle priming [GO:0010807]; regulation of vesicle fusion [GO:0031338]; response to estradiol [GO:0032355]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle priming [GO:0016082]; vesicle docking involved in exocytosis [GO:0006904],NA,NA,NA
CHOYP_STXB5.1.2.m.50466,-0.00318769508789777,0.00628548963471078,No,NA,NA,Q5T5C0,NA,NA,NA,acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extrinsic component of presynaptic membrane [GO:0098888]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; presynaptic cytosol [GO:0099523]; Schaffer collateral - CA1 synapse [GO:0098685]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; exocytosis [GO:0006887]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; synaptic vesicle cycle [GO:0099504],NA,NA,NA
CHOYP_SUCB1.1.1.m.41299,0.0107617639413649,-0.00796922315205718,No,NA,NA,Q9Z2I9,NA,NA,NA,mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase activity [GO:0004774]; succinate metabolic process [GO:0006105]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_SUCB2.1.1.m.7164,-0.00416915260012238,-0.0224039823780393,No,NA,NA,P53590,NA,NA,NA,mitochondrion [GO:0005739]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; succinate-CoA ligase (GDP-forming) activity [GO:0004776]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_SUDX.1.1.m.4577,-0.00845314998535146,0.0101697254726471,No,NA,NA,Q8BZZ3,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; lung development [GO:0030324]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; T cell differentiation [GO:0030217]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_SUIS.2.2.m.16063,0.00364778592941831,-0.00872052841558097,No,NA,NA,O43451,NA,NA,NA,apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821]; alpha-1;4-glucosidase activity [GO:0004558]; amylase activity [GO:0016160]; carbohydrate binding [GO:0030246]; catalytic activity [GO:0003824]; glucan 1;4-alpha-glucosidase activity [GO:0004339]; maltose alpha-glucosidase activity [GO:0032450]; neutrophil degranulation [GO:0043312]; polysaccharide digestion [GO:0044245]; starch catabolic process [GO:0005983],NA,NA,NA
CHOYP_SUOX.1.1.m.32255,0.00876890112525964,-0.00246490897004544,No,NA,NA,Q9VWP4,NA,NA,NA,mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; heme binding [GO:0020037]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; sulfite oxidase activity [GO:0008482]; nitrate assimilation [GO:0042128]; sulfur compound metabolic process [GO:0006790],NA,NA,NA
CHOYP_SUV3.1.1.m.14574,0.00813001556829474,0.00617987185964513,No,NA,NA,Q9VN03,NA,NA,NA,mitochondrial degradosome [GO:0045025]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA duplex unwinding [GO:0032508]; mitochondrial mRNA polyadenylation [GO:0097222]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA processing [GO:0000963]; mitochondrial tRNA processing [GO:0090646]; oxidative phosphorylation [GO:0006119]; positive regulation of mitochondrial translation [GO:0070131]; regulation of mitochondrial mRNA stability [GO:0044528]; respiratory electron transport chain [GO:0022904]; RNA catabolic process [GO:0006401],NA,NA,NA
CHOYP_SVEP1.2.8.m.26503,0.023220420524566,-0.000162535098938499,No,NA,NA,P0C6B8,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_SVIL.1.1.m.1136,-0.0190260181451655,-0.00230170414375668,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SYAC.2.2.m.18500,0.0102522652163237,0.00110257151002164,No,NA,NA,Q8BGQ7,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; Ser-tRNA(Ala) hydrolase activity [GO:0002196]; translation regulator activity [GO:0045182]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; alanyl-tRNA aminoacylation [GO:0006419]; cerebellar Purkinje cell layer development [GO:0021680]; negative regulation of neuron apoptotic process [GO:0043524]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; regulation of cytoplasmic translational fidelity [GO:0140018]; tRNA modification [GO:0006400],NA,NA,NA
CHOYP_SYB.1.3.m.25801,-0.00859891258516779,-0.00408617555724244,No,NA,NA,P35589,NA,NA,NA,cell junction [GO:0030054]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; synaptic vesicle membrane [GO:0030672]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_SYCC.1.1.m.11415,0.00194625074568382,0.00148449388061728,No,NA,NA,Q9ER72,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]; cysteinyl-tRNA aminoacylation [GO:0006423],NA,NA,NA
CHOYP_SYCP2.1.2.m.47476,-0.00726289140193871,-0.0106872702495102,No,NA,NA,Q9CUU3,NA,NA,NA,lateral element [GO:0000800]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; animal organ morphogenesis [GO:0009887]; cell division [GO:0051301]; female meiotic nuclear division [GO:0007143]; fertilization [GO:0009566]; male genitalia morphogenesis [GO:0048808]; male meiotic nuclear division [GO:0007140]; negative regulation of apoptotic process [GO:0043066],NA,NA,NA
CHOYP_SYFA.1.1.m.53256,0.00776037787635647,0.0124707608360011,No,NA,NA,Q1JPX3,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; phenylalanine-tRNA ligase complex [GO:0009328]; ATP binding [GO:0005524]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049]; phenylalanyl-tRNA aminoacylation [GO:0006432]; protein heterotetramerization [GO:0051290],NA,NA,NA
CHOYP_SYFA.1.1.m.53257,-0.0136173909486381,-0.0158291631766005,No,NA,NA,Q08BI9,NA,NA,NA,calcium channel complex [GO:0034704]; integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; uniplex complex [GO:1990246]; calcium channel activity [GO:0005262]; identical protein binding [GO:0042802]; uniporter activity [GO:0015292]; actin filament organization [GO:0007015]; calcium import into the mitochondrion [GO:0036444]; calcium-mediated signaling [GO:0019722]; chordate embryonic development [GO:0043009]; convergent extension involved in gastrulation [GO:0060027]; glucose homeostasis [GO:0042593]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of insulin secretion [GO:0032024]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; protein complex oligomerization [GO:0051259]; regulation of heart contraction [GO:0008016],NA,NA,NA
CHOYP_SYHC.1.1.m.65924,0.00965884904736449,-0.00869579455884135,No,NA,NA,Q61035,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; histidine-tRNA ligase activity [GO:0004821]; identical protein binding [GO:0042802]; histidyl-tRNA aminoacylation [GO:0006427]; mitochondrial translation [GO:0032543],NA,NA,NA
CHOYP_SYMC.1.1.m.18367,0.0130974760205459,0.00239578280877224,No,NA,NA,P56192,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; methionine-tRNA ligase activity [GO:0004825]; tRNA binding [GO:0000049]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to starvation [GO:0009267]; methionyl-tRNA aminoacylation [GO:0006431]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; rRNA transcription [GO:0009303]; tRNA aminoacylation for protein translation [GO:0006418],NA,NA,NA
CHOYP_SYMPK.1.1.m.1791,0.00495581898124344,-0.015084567051638,No,NA,NA,Q92797,NA,NA,NA,bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA polyadenylation [GO:0006378]; mRNA splicing; via spliceosome [GO:0000398]; negative regulation of protein binding [GO:0032091]; positive regulation of protein dephosphorylation [GO:0035307]; termination of RNA polymerase II transcription [GO:0006369],NA,NA,NA
CHOYP_SYNE1.1.1.m.51183,-0.000320426011000542,0.00466402699847506,No,NA,NA,Q8NF91,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynaptic membrane [GO:0045211]; sarcomere [GO:0030017]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; cytoskeletal anchoring at nuclear membrane [GO:0090286]; Golgi organization [GO:0007030]; muscle cell differentiation [GO:0042692]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleus organization [GO:0006997]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_SYNJ1.1.1.m.42275,0.0125201746969659,0.0191159635288239,No,NA,NA,Q8CHC4,NA,NA,NA,clathrin coat [GO:0030118]; clathrin coat of coated pit [GO:0030132]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; membrane coat [GO:0030117]; neuron projection [GO:0043005]; parallel fiber to Purkinje cell synapse [GO:0098688]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic membrane [GO:0097060]; terminal bouton [GO:0043195]; vesicle membrane [GO:0012506]; EH domain binding [GO:1990175]; inositol-1;4;5-trisphosphate 5-phosphatase activity [GO:0052658]; phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol-4;5-bisphosphate 5-phosphatase activity [GO:0004439]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]; brain development [GO:0007420]; inositol phosphate dephosphorylation [GO:0046855]; learning [GO:0007612]; neurotransmitter transport [GO:0006836]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of endosome organization [GO:1904980]; positive regulation of gliogenesis [GO:0014015]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of synaptic vesicle recycling [GO:1903423]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; response to cytokine [GO:0034097]; response to retinoic acid [GO:0032526]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; synaptic vesicle uncoating [GO:0016191],NA,NA,NA
CHOYP_SYPL1.1.1.m.49654,-0.00336984539662947,-0.024524806645196,No,NA,NA,Q16563,NA,NA,NA,extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of synaptic vesicle membrane [GO:0030285]; melanosome [GO:0042470]; secretory granule [GO:0030141]; chemical synaptic transmission [GO:0007268],NA,NA,NA
CHOYP_SYRC.1.2.m.36309,-0.00619099677414438,0.0141682336379013,No,NA,NA,P37880,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; arginyl-tRNA aminoacylation [GO:0006420],NA,NA,NA
CHOYP_SYTC.1.1.m.35709,0.0202215264051755,0.00320983658491703,No,NA,NA,Q9D0R2,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; threonine-tRNA ligase activity [GO:0004829]; threonyl-tRNA aminoacylation [GO:0006435],NA,NA,NA
CHOYP_SYWC.3.5.m.26200,0.0164206510583194,0.0033099246434176,No,NA,NA,P23381,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; kinase inhibitor activity [GO:0019210]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; tryptophan-tRNA ligase activity [GO:0004830]; angiogenesis [GO:0001525]; negative regulation of cell proliferation [GO:0008285]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of gene expression [GO:0010628]; positive regulation of protein complex assembly [GO:0031334]; regulation of angiogenesis [GO:0045765]; regulation of protein ADP-ribosylation [GO:0010835]; translation [GO:0006412]; tRNA aminoacylation for protein translation [GO:0006418]; tryptophanyl-tRNA aminoacylation [GO:0006436],NA,NA,NA
CHOYP_SYWC.4.5.m.36166,0.00721206974079184,0.0207747043641532,No,NA,NA,P17248,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; kinase inhibitor activity [GO:0019210]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; tryptophan-tRNA ligase activity [GO:0004830]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of gene expression [GO:0010628]; positive regulation of protein complex assembly [GO:0031334]; regulation of angiogenesis [GO:0045765]; regulation of protein ADP-ribosylation [GO:0010835]; tryptophanyl-tRNA aminoacylation [GO:0006436],NA,NA,NA
CHOYP_SYWC.5.5.m.54889,0.0200161782955544,0.00893840358445392,No,NA,NA,Q9NQC3,NA,NA,NA,cell projection [GO:0042995]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endoplasmic reticulum tubular network membrane [GO:0098826]; integral component of endoplasmic reticulum membrane [GO:0030176]; intracellular [GO:0005622]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; axonal fasciculation [GO:0007413]; blastocyst formation [GO:0001825]; cardiac epithelial to mesenchymal transition [GO:0060317]; cerebral cortex radial glia guided migration [GO:0021801]; endoplasmic reticulum tubular network formation [GO:0071787]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; endoplasmic reticulum tubular network organization [GO:0071786]; negative regulation of axon extension [GO:0030517]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell growth [GO:0030308]; nuclear pore complex assembly [GO:0051292]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERBB3 signaling pathway [GO:1905580]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of cell migration [GO:0030334],NA,NA,NA
CHOYP_SYYC.1.2.m.23460,-0.00255611601809336,-0.0093988092848383,No,NA,NA,Q6TGS6,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; methionyl glutamyl tRNA synthetase complex [GO:0017102]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; tyrosine-tRNA ligase activity [GO:0004831]; cellular response to DNA damage stimulus [GO:0006974]; tRNA aminoacylation for protein translation [GO:0006418]; tyrosyl-tRNA aminoacylation [GO:0006437],NA,NA,NA
CHOYP_SYYC.2.2.m.58390,0.0123562287204287,0.0229983210199647,No,NA,NA,Q6TGS6,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; methionyl glutamyl tRNA synthetase complex [GO:0017102]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; tyrosine-tRNA ligase activity [GO:0004831]; cellular response to DNA damage stimulus [GO:0006974]; tRNA aminoacylation for protein translation [GO:0006418]; tyrosyl-tRNA aminoacylation [GO:0006437],NA,NA,NA
CHOYP_T23O.5.6.m.52216,0.00780522177982629,0.0156646248472383,No,NA,NA,Q5U4U6,NA,NA,NA,heme binding [GO:0020037]; metal ion binding [GO:0046872]; tryptophan 2;3-dioxygenase activity [GO:0004833]; protein homotetramerization [GO:0051289]; tryptophan catabolic process to kynurenine [GO:0019441],NA,NA,NA
CHOYP_T24B8.5.1.2.m.5660,-0.00455258702829398,-0.0113780893056343,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_T24B8.5.2.2.m.46909,0.0017711567076255,-0.00904274600178593,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_T3HPD.1.2.m.24627,0.0113197025463949,0.000757133938588025,No,NA,NA,Q66II5,NA,NA,NA,hydro-lyase activity [GO:0016836]; trans-L-3-hydroxyproline dehydratase activity [GO:0050346],NA,NA,NA
CHOYP_TAB3.1.1.m.25766,0.00338524315793985,-0.000599916715807153,No,NA,NA,Q99K90,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; heart development [GO:0007507]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein kinase activity [GO:0045860],NA,NA,NA
CHOYP_TACC1.2.2.m.53512,0.0144218944347276,-0.00590088827608212,No,NA,NA,Q6Y685,NA,NA,NA,cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; protein domain specific binding [GO:0019904]; cell division [GO:0051301]; cell proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]; neurogenesis [GO:0022008]; regulation of microtubule-based process [GO:0032886],NA,NA,NA
CHOYP_TACC3.3.3.m.16099,0.0100836433691542,-0.00518996493357416,No,NA,NA,Q9PTG8,NA,NA,NA,cytoplasm [GO:0005737]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]; translation initiation factor binding [GO:0031369]; cell division [GO:0051301]; mitotic spindle organization [GO:0007052]; negative regulation of translation [GO:0017148],NA,NA,NA
CHOYP_TAD2A.1.1.m.27478,-0.00212078832001384,-0.00891837260408135,No,NA,NA,Q5M823,NA,NA,NA,condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; spindle pole [GO:0000922]; unfolded protein binding [GO:0051082]; developmental process [GO:0032502]; protein folding [GO:0006457],NA,NA,NA
CHOYP_TAF1.1.1.m.31656,0.00942767691725956,-0.00278871570016591,No,NA,NA,P21675,NA,NA,NA,MLL1 complex [GO:0071339]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; transcription factor TFIID complex [GO:0005669]; ATP binding [GO:0005524]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; histone acetyltransferase activity [GO:0004402]; kinase activity [GO:0016301]; lysine-acetylated histone binding [GO:0070577]; nuclear hormone receptor binding [GO:0035257]; p53 binding [GO:0002039]; protein heterodimerization activity [GO:0046982]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II sequence-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; TBP-class protein binding [GO:0017025]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; ubiquitin conjugating enzyme activity [GO:0061631]; cell cycle [GO:0007049]; cellular response to ATP [GO:0071318]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; DNA-templated transcription; initiation [GO:0006352]; midbrain development [GO:0030901]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of gene expression [GO:0010629]; negative regulation of protein autoubiquitination [GO:1905524]; negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1903026]; negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage [GO:0010768]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of androgen receptor activity [GO:2000825]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein polyubiquitination [GO:0000209]; protein stabilization [GO:0050821]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription initiation from RNA polymerase II promoter [GO:0060260]; regulation of transcription; DNA-templated [GO:0006355]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription factor catabolic process [GO:0036369]; transcription initiation from RNA polymerase II promoter [GO:0006367]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032],NA,NA,NA
CHOYP_TAF13.1.3.m.20331,-0.012168688043127,0.0195114569797602,No,NA,NA,Q5R9W6,NA,NA,NA,nucleus [GO:0005634]; protein heterodimerization activity [GO:0046982]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_TAF9.1.1.m.10395,0.00159035953927666,-0.0215647126420953,No,NA,NA,A5PJA1,NA,NA,NA,Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; ATPase activity [GO:0016887],NA,NA,NA
CHOYP_TAGL3.1.1.m.31031,0.00946671430884833,0.0226813734550142,No,NA,NA,P37805,NA,NA,NA,actin filament binding [GO:0051015],NA,NA,NA
CHOYP_TALDO.2.2.m.43331,0.00308698520042941,-0.0173763131747374,No,NA,NA,P37837,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; monosaccharide binding [GO:0048029]; sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [GO:0004801]; carbohydrate metabolic process [GO:0005975]; fructose 6-phosphate metabolic process [GO:0006002]; interleukin-12-mediated signaling pathway [GO:0035722]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt; non-oxidative branch [GO:0009052]; xylulose biosynthetic process [GO:0005999],NA,NA,NA
CHOYP_TBA.1.6.m.12217,-0.0101267244015976,-0.00542477794599208,No,NA,NA,P02553,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017],NA,NA,NA
CHOYP_TBA.3.6.m.29936,-0.0227735679510267,0.000991342956712881,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TBA.3.6.m.29937,-0.022496816389458,0.00528284232875842,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TBA.5.6.m.37448,0.000144202036841785,0.010492191896516,No,NA,NA,P02553,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017],NA,NA,NA
CHOYP_TBA1.2.9.m.9962,0.00144476332285765,-0.00838955832131038,No,NA,NA,P06605,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281],NA,NA,NA
CHOYP_TBA1.7.9.m.44107,0.00217997094733793,-0.00807271368859912,No,NA,NA,P06603,NA,NA,NA,astral microtubule [GO:0000235]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; antimicrobial humoral response [GO:0019730]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint [GO:0007094],NA,NA,NA
CHOYP_TBA1A.2.4.m.19573,-0.0115531990600078,-0.0037579190296946,No,NA,NA,P09645,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278],NA,NA,NA
CHOYP_TBA2.1.1.m.955,-0.0155215757439072,-0.00324030310278269,No,NA,NA,P68370,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytoplasmic ribonucleoprotein granule [GO:0036464]; membrane raft [GO:0045121]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; neuromuscular junction [GO:0031594]; recycling endosome [GO:0055037]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; regulation of synapse organization [GO:0050807],NA,NA,NA
CHOYP_TBA3.1.1.m.5111,0.000165904038620519,-0.00358254228664395,No,NA,NA,Q68FR8,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278],NA,NA,NA
CHOYP_TBB.2.7.m.37919,0.0192679303778163,-0.00929869609191303,No,NA,NA,P02554,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; neuron migration [GO:0001764],NA,NA,NA
CHOYP_TBB.5.7.m.60062,0.00394088566356422,-0.000604340542911988,No,NA,NA,P38552,NA,NA,NA,extracellular space [GO:0005615]; carbohydrate binding [GO:0030246]; galactoside binding [GO:0016936],NA,NA,NA
CHOYP_TBB2.1.2.m.45096,-0.0117081665914988,-0.0199307657782672,No,NA,NA,P41937,NA,NA,NA,axonemal microtubule [GO:0005879]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278],NA,NA,NA
CHOYP_TBB2.2.2.m.53000,0.00678620130084429,0.00878741825264137,No,NA,NA,P41387,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017],NA,NA,NA
CHOYP_TBB2.2.2.m.53001,0.00491588973115351,-0.000600714720400963,No,NA,NA,P41937,NA,NA,NA,axonemal microtubule [GO:0005879]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278],NA,NA,NA
CHOYP_TBB2.2.2.m.53003,0.00364778592941831,-0.00872052841558096,No,NA,NA,P41386,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017],NA,NA,NA
CHOYP_TBB4.1.1.m.40048,-0.0135725579708753,0.00388604629968508,No,NA,NA,P11833,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017],NA,NA,NA
CHOYP_TBB4B.1.7.m.12262,0.0078451599537213,-0.00272440024754493,No,NA,NA,P11833,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017],NA,NA,NA
CHOYP_TBB4B.3.7.m.22777,-0.00212078832001384,-0.00891837260408135,No,NA,NA,P43006,NA,NA,NA,axolemma [GO:0030673]; axon [GO:0030424]; cell surface [GO:0009986]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; anion transmembrane transporter activity [GO:0008509]; glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; adult behavior [GO:0030534]; anion transmembrane transport [GO:0098656]; cellular response to extracellular stimulus [GO:0031668]; D-aspartate import across plasma membrane [GO:0070779]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; nervous system development [GO:0007399]; neurotransmitter reuptake [GO:0098810]; positive regulation of glucose import [GO:0046326]; protein homotrimerization [GO:0070207]; response to amino acid [GO:0043200]; response to drug [GO:0042493]; response to light stimulus [GO:0009416]; response to wounding [GO:0009611]; telencephalon development [GO:0021537]; visual behavior [GO:0007632],NA,NA,NA
CHOYP_TBB4B.7.7.m.63980,-0.016151106200142,0.00483369662436441,No,NA,NA,P11833,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017],NA,NA,NA
CHOYP_TBC13.1.1.m.24396,-0.00139975865504235,0.0100200777036393,No,NA,NA,Q9NVG8,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_TBC15.1.1.m.4226,0.0108057438186384,-0.0196312135123154,No,NA,NA,Q9CXF4,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; regulation of GTPase activity [GO:0043087],NA,NA,NA
CHOYP_TBC1D22A.1.1.m.24510,-0.0108982202515191,-0.00378777920749687,No,NA,NA,Q9NU19,NA,NA,NA,cell [GO:0005623]; 14-3-3 protein binding [GO:0071889]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_TBCA.1.1.m.12075,0.0067163384098715,-0.0061615094811181,No,NA,NA,O75347,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleolus [GO:0005730]; beta-tubulin binding [GO:0048487]; chaperone binding [GO:0051087]; RNA binding [GO:0003723]; post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021],NA,NA,NA
CHOYP_TBCD.1.2.m.35202,-0.0177899992460045,-0.00244496604912306,No,NA,NA,Q9BTW9,NA,NA,NA,adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; lateral plasma membrane [GO:0016328]; microtubule [GO:0005874]; beta-tubulin binding [GO:0048487]; chaperone binding [GO:0051087]; GTPase activator activity [GO:0005096]; adherens junction assembly [GO:0034333]; bicellular tight junction assembly [GO:0070830]; cell morphogenesis involved in neuron differentiation [GO:0048667]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of microtubule polymerization [GO:0031115]; post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021],NA,NA,NA
CHOYP_TBCD1.1.1.m.14806,-0.00387998571078248,-0.0154293021397712,No,NA,NA,O60343,NA,NA,NA,cytosol [GO:0005829]; vesicle [GO:0031982]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; cellular response to insulin stimulus [GO:0032869]; intracellular protein transport [GO:0006886]; negative regulation of vesicle fusion [GO:0031339]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_TBCE.1.1.m.14005,0.00139572489317507,0.0115621182025904,No,NA,NA,Q5U508,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; post-chaperonin tubulin folding pathway [GO:0007023],NA,NA,NA
CHOYP_TBCEL.2.2.m.26805,-0.0056617956534708,-0.00873293151345443,No,NA,NA,Q5QJ74,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856],NA,NA,NA
CHOYP_TBG1.1.1.m.28190,-0.0154045421813468,-0.0114399807652956,No,NA,NA,P23258,NA,NA,NA,apical part of cell [GO:0045177]; cell leading edge [GO:0031252]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; gamma-tubulin complex [GO:0000930]; microtubule [GO:0005874]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; polar microtubule [GO:0005827]; recycling endosome [GO:0055037]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200]; ciliary basal body-plasma membrane docking [GO:0097711]; cytoplasmic microtubule organization [GO:0031122]; G2/M transition of mitotic cell cycle [GO:0000086]; meiotic spindle organization [GO:0000212]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle organization [GO:0007052]; regulation of G2/M transition of mitotic cell cycle [GO:0010389],NA,NA,NA
CHOYP_TBL2.1.1.m.29917,0.0070320095307539,-0.00300076073304781,No,NA,NA,Q9Y4P3,NA,NA,NA,endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; phosphoprotein binding [GO:0051219]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; translation initiation factor binding [GO:0031369]; cellular response to glucose starvation [GO:0042149]; cellular response to hypoxia [GO:0071456]; endoplasmic reticulum unfolded protein response [GO:0030968],NA,NA,NA
CHOYP_TBRG4.1.1.m.48213,0.000121768723334823,-0.0221466696836539,No,NA,NA,Q6PA48,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; protein kinase activity [GO:0004672]; cellular respiration [GO:0045333]; mitochondrial mRNA processing [GO:0090615]; mRNA metabolic process [GO:0016071]; regulation of mitochondrial mRNA stability [GO:0044528],NA,NA,NA
CHOYP_TC1DB.1.1.m.22354,-0.0227885287750176,0.00104069262315009,No,NA,NA,A2VDD2,NA,NA,NA,,NA,NA,NA
CHOYP_TCF25.1.1.m.28509,0.000686232728993108,-0.0107331332691118,No,NA,NA,Q8R3L2,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; negative regulation of transcription by RNA polymerase II [GO:0000122],NA,NA,NA
CHOYP_TCFAP2B.2.2.m.11727,-0.0220964658730568,0.00940990435924425,No,NA,NA,P34056,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; anterior neuropore closure [GO:0021506]; basement membrane organization [GO:0071711]; bone morphogenesis [GO:0060349]; cellular response to iron ion [GO:0071281]; cornea development in camera-type eye [GO:0061303]; embryonic body morphogenesis [GO:0010172]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic forelimb morphogenesis [GO:0035115]; embryonic pattern specification [GO:0009880]; epidermis morphogenesis [GO:0048730]; eyelid development in camera-type eye [GO:0061029]; face morphogenesis [GO:0060325]; forebrain neuron development [GO:0021884]; forelimb morphogenesis [GO:0035136]; inner ear morphogenesis [GO:0042472]; keratinocyte development [GO:0003334]; kidney development [GO:0001822]; lens induction in camera-type eye [GO:0060235]; lens morphogenesis in camera-type eye [GO:0002089]; metanephric nephron development [GO:0072210]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; nervous system development [GO:0007399]; neural crest cell development [GO:0014032]; neural tube closure [GO:0001843]; oculomotor nerve formation [GO:0021623]; optic cup structural organization [GO:0003409]; optic vesicle morphogenesis [GO:0003404]; outflow tract morphogenesis [GO:0003151]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cell migration [GO:0030335]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of tooth mineralization [GO:0070172]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of cell differentiation [GO:0045595]; regulation of neuron differentiation [GO:0045664]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription; DNA-templated [GO:0006355]; response to lipopolysaccharide [GO:0032496]; roof of mouth development [GO:0060021]; sensory organ development [GO:0007423]; sensory perception of sound [GO:0007605]; skeletal system morphogenesis [GO:0048705]; skin development [GO:0043588]; sympathetic nervous system development [GO:0048485]; trigeminal nerve development [GO:0021559],NA,NA,NA
CHOYP_TCPB.1.1.m.6398,0.00259863771011773,-0.00967183166380912,No,NA,NA,Q3ZBH0,NA,NA,NA,cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; protein binding involved in protein folding [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; chaperone mediated protein folding independent of cofactor [GO:0051086]; chaperone-mediated protein complex assembly [GO:0051131]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_TCPD.1.1.m.13556,0.00337782272435817,-0.00740464327759122,No,NA,NA,Q2T9X2,NA,NA,NA,chaperonin-containing T-complex [GO:0005832]; cilium [GO:0005929]; melanosome [GO:0042470]; microtubule organizing center [GO:0005815]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457],NA,NA,NA
CHOYP_TCPG.1.1.m.30926,-0.00768076615713766,0.00179440327919095,No,NA,NA,P48605,NA,NA,NA,chaperonin-containing T-complex [GO:0005832]; ATP binding [GO:0005524]; ATPase activity; coupled [GO:0042623]; unfolded protein binding [GO:0051082]; lumen formation; open tracheal system [GO:0035149]; protein folding [GO:0006457]; terminal branching; open tracheal system [GO:0007430],NA,NA,NA
CHOYP_TCPH.1.1.m.7312,-0.0055227809421033,-0.0133467543919003,No,NA,NA,Q5ZJK8,NA,NA,NA,chaperonin-containing T-complex [GO:0005832]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457],NA,NA,NA
CHOYP_TCPQ.1.1.m.57792,0.010063007406972,-0.0130316733674117,No,NA,NA,Q6EE31,NA,NA,NA,cell projection [GO:0042995]; chaperonin-containing T-complex [GO:0005832]; microtubule organizing center [GO:0005815]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457],NA,NA,NA
CHOYP_TCRG1.1.1.m.1150,-0.00630732709002025,-0.0106225154446908,No,NA,NA,Q8CGF7,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; proline-rich region binding [GO:0070064]; RNA polymerase binding [GO:0070063]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription corepressor activity [GO:0003714]; negative regulation of transcription by RNA polymerase II [GO:0000122]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_TDRD1.1.1.m.34821,0.00678620130084428,0.00878741825264137,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TDRD3.1.2.m.3301,-0.00193202771945678,0.0100771000132245,No,NA,NA,Q5ZMS6,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; methylated histone binding [GO:0035064]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; chromatin organization [GO:0006325]; mRNA processing [GO:0006397],NA,NA,NA
CHOYP_TDRD3.2.2.m.8522,0.00217997094733793,-0.00807271368859912,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TEFF2.1.1.m.26857,0.00865801386712038,0.00351477278755258,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TEKT3.1.1.m.37281,-0.0221252427103316,0.00257200684423157,No,NA,NA,A6H782,NA,NA,NA,acrosomal membrane [GO:0002080]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378],NA,NA,NA
CHOYP_TEKT5.1.1.m.60031,-0.0099446471254649,0.00681216999944511,No,NA,NA,A6H782,NA,NA,NA,acrosomal membrane [GO:0002080]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378],NA,NA,NA
CHOYP_TEKT5.1.1.m.60033,-0.0187642404547749,-0.00330100772494373,No,NA,NA,Q9BXF9,NA,NA,NA,acrosomal membrane [GO:0002080]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378],NA,NA,NA
CHOYP_TEMPT.1.3.m.4934,0.0231881512203862,0.00293687491834761,No,NA,NA,Q7Z0T3,NA,NA,NA,extracellular region [GO:0005576]; pheromone activity [GO:0005186],NA,NA,NA
CHOYP_TEMPT.2.3.m.39578,0.01769796113167,0.00214614576359336,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TEMPT.3.3.m.40304,0.00815584260576107,-0.0234781806099163,No,NA,NA,Q7Z0T3,NA,NA,NA,extracellular region [GO:0005576]; pheromone activity [GO:0005186],NA,NA,NA
CHOYP_TEN2.1.2.m.44821,-0.00576311662033174,-0.0144686026990192,No,NA,NA,O61307,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; integral component of plasma membrane [GO:0005887]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; filamin binding [GO:0031005]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cell adhesion [GO:0007155]; chaeta development [GO:0022416]; compound eye corneal lens development [GO:0048058]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; cytoplasmic microtubule organization [GO:0031122]; maintenance of alignment of postsynaptic density and presynaptic active zone [GO:0099559]; maintenance of presynaptic active zone structure [GO:0048790]; motor neuron axon guidance [GO:0008045]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of locomotion [GO:0040017]; postsynaptic membrane organization [GO:0001941]; postsynaptic spectrin-associated cytoskeleton organization [GO:0099190]; presynaptic membrane organization [GO:0097090]; R7 cell development [GO:0045467]; regulation of homotypic cell-cell adhesion [GO:0034110]; regulation of terminal button organization [GO:2000331]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic target attraction [GO:0016200]; synaptic target recognition [GO:0008039]; synaptic vesicle membrane organization [GO:0048499],NA,NA,NA
CHOYP_TENA.5.5.m.43448,0.00394536801625317,0.00291369700370642,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TENS3.2.4.m.45659,0.00977582273333899,0.00664775325174624,No,NA,NA,Q9HBL0,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; actin binding [GO:0003779]; RNA binding [GO:0003723]; cell-substrate junction assembly [GO:0007044]; fibroblast migration [GO:0010761],NA,NA,NA
CHOYP_TENS3.3.4.m.52970,0.0106252595530368,-0.00120787547127603,No,NA,NA,Q9HBL0,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; actin binding [GO:0003779]; RNA binding [GO:0003723]; cell-substrate junction assembly [GO:0007044]; fibroblast migration [GO:0010761],NA,NA,NA
CHOYP_TENS3.4.4.m.60095,0.00907075741437494,0.0110851086956763,No,NA,NA,Q9HBL0,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; actin binding [GO:0003779]; RNA binding [GO:0003723]; cell-substrate junction assembly [GO:0007044]; fibroblast migration [GO:0010761],NA,NA,NA
CHOYP_TENX.1.2.m.12929,0.0178904899100047,0.00292635059243195,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TERA.1.1.m.29200,0.0106477022752861,0.00970307325270929,No,NA,NA,P23787,NA,NA,NA,chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; lipid binding [GO:0008289]; protein-containing complex binding [GO:0044877]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to arsenite ion [GO:1903843]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to heat [GO:0034605]; double-strand break repair [GO:0006302]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; macroautophagy [GO:0016236]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein hexamerization [GO:0034214]; protein N-linked glycosylation via asparagine [GO:0018279]; protein ubiquitination [GO:0016567]; stress granule disassembly [GO:0035617]; translesion synthesis [GO:0019985]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_TEX10.2.3.m.28279,0.0065883263884642,0.0180931628217626,No,NA,NA,Q803M3,NA,NA,NA,MLL1 complex [GO:0071339]; nucleolus [GO:0005730]; Rix1 complex [GO:0097344],NA,NA,NA
CHOYP_TF2AA.1.1.m.50726,-0.00501956685347398,-0.0189979072551146,No,NA,NA,P52655,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; transcription factor TFIIA complex [GO:0005672]; transcription factor TFIID complex [GO:0005669]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; RNA polymerase II repressing transcription factor binding [GO:0001103]; TBP-class protein binding [GO:0017025]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367],NA,NA,NA
CHOYP_TFCP2.1.2.m.11029,-0.0205684901081268,0.0015385094723482,No,NA,NA,Q12800,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; protein C-terminus binding [GO:0008022]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; mRNA transcription by RNA polymerase II [GO:0042789]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_TFG.1.1.m.8487,0.0209336935570604,0.00612621692961461,No,NA,NA,Q92734,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; Golgi membrane [GO:0000139]; identical protein binding [GO:0042802]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123],NA,NA,NA
CHOYP_TFP11.1.1.m.65838,-0.00787345978645446,0.0061660376072426,No,NA,NA,Q66J74,NA,NA,NA,spliceosomal complex [GO:0005681]; nucleic acid binding [GO:0003676]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_TGM1.1.2.m.5148,0.0160933360709949,-0.0035006433515886,No,NA,NA,P52183,NA,NA,NA,plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; peptide cross-linking [GO:0018149],NA,NA,NA
CHOYP_TGME49_066610.1.1.m.2678,0.0103538455446736,-0.000496238543294327,No,NA,NA,O96790,NA,NA,NA,extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of coagulation [GO:0050819],NA,NA,NA
CHOYP_THERJR_2510.1.1.m.38407,0.010086204753535,-0.0182574871255312,No,NA,NA,Q4R4Z9,NA,NA,NA,mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ligase activity [GO:0016874]; fatty acid metabolic process [GO:0006631],NA,NA,NA
CHOYP_THIKA.1.1.m.13333,0.00192113406207734,0.00929443180707926,No,NA,NA,P21775,NA,NA,NA,cytosol [GO:0005829]; peroxisome [GO:0005777]; acetyl-CoA C-acyltransferase activity [GO:0003988]; palmitoyl-CoA oxidase activity [GO:0016401]; fatty acid beta-oxidation [GO:0006635]; phenylacetate catabolic process [GO:0010124]; response to drug [GO:0042493]; response to nutrient [GO:0007584]; response to steroid hormone [GO:0048545],NA,NA,NA
CHOYP_THNS1.1.1.m.28661,0.0122341731826799,-0.00255644798885882,No,NA,NA,Q5R5P3,NA,NA,NA,,NA,NA,NA
CHOYP_THNS2.1.1.m.27131,0.00228746095545229,0.0124548771850771,No,NA,NA,Q5RFE6,NA,NA,NA,lyase activity [GO:0016829],NA,NA,NA
CHOYP_THOC1.1.1.m.62740,-0.00583582403961802,-0.0176167315201136,No,NA,NA,Q8R3N6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nuclear chromosome; telomeric region [GO:0000784]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; THO complex [GO:0000347]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; negative regulation of DNA damage checkpoint [GO:2000002]; negative regulation of isotype switching to IgA isotypes [GO:0048297]; positive regulation of DNA-templated transcription; elongation [GO:0032786]; regulation of DNA recombination [GO:0000018]; regulation of DNA-templated transcription; elongation [GO:0032784]; replication fork processing [GO:0031297]; RNA splicing [GO:0008380]; signal transduction [GO:0007165]; viral mRNA export from host cell nucleus [GO:0046784],NA,NA,NA
CHOYP_THOC2.1.2.m.9631,0.00460745881435494,-0.0172312299861198,No,NA,NA,B2KI97,NA,NA,NA,nuclear speck [GO:0016607]; THO complex [GO:0000347]; RNA binding [GO:0003723]; generation of neurons [GO:0048699]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; neuron development [GO:0048666]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_THOC2.2.2.m.19049,0.00645358075468656,-0.0073803513732886,No,NA,NA,B2KI97,NA,NA,NA,nuclear speck [GO:0016607]; THO complex [GO:0000347]; RNA binding [GO:0003723]; generation of neurons [GO:0048699]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; neuron development [GO:0048666]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_THOC5.1.1.m.12880,-0.00263817932354483,-0.00624365683078405,No,NA,NA,Q5ZJK1,NA,NA,NA,cytoplasm [GO:0005737]; nuclear chromosome [GO:0000228]; THO complex part of transcription export complex [GO:0000445]; mRNA binding [GO:0003729]; cell differentiation [GO:0030154]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of DNA-templated transcription; elongation [GO:0032786]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_THOC7.1.1.m.6771,0.0017991601016549,-0.0136248083175595,No,NA,NA,Q6DGZ3,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; THO complex part of transcription export complex [GO:0000445]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_THOP1.1.1.m.18269,0.00747031246793017,-0.00428384870226027,No,NA,NA,Q8C1A5,NA,NA,NA,mitochondrial intermembrane space [GO:0005758]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; intracellular signal transduction [GO:0035556]; peptide metabolic process [GO:0006518]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_THSD4.1.2.m.36522,0.00415900774608284,-0.00875151112487276,No,NA,NA,Q6ZMP0,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; microfibril [GO:0001527]; extracellular matrix structural constituent [GO:0005201]; peptidase activity [GO:0008233]; elastic fiber assembly [GO:0048251],NA,NA,NA
CHOYP_THSD4.2.2.m.57001,0.00616060716670567,-0.0134695972316105,No,NA,NA,Q3UTY6,NA,NA,NA,extracellular matrix [GO:0031012]; microfibril [GO:0001527]; peptidase activity [GO:0008233]; elastic fiber assembly [GO:0048251],NA,NA,NA
CHOYP_THTR.1.1.m.25923,0.013955551854876,-0.0140482301865552,No,NA,NA,P25324,NA,NA,NA,mitochondrial matrix [GO:0005759]; 5S rRNA binding [GO:0008097]; thiosulfate sulfurtransferase activity [GO:0004792]; rRNA import into mitochondrion [GO:0035928]; rRNA transport [GO:0051029],NA,NA,NA
CHOYP_THTR.1.1.m.25924,-0.0126781278156125,-0.0229486141749679,No,NA,NA,Q95KV7,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial respirasome [GO:0005746]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; apoptotic signaling pathway [GO:0097190]; cellular response to interferon-beta [GO:0035458]; cellular response to retinoic acid [GO:0071300]; extrinsic apoptotic signaling pathway [GO:0097191]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of protein catabolic process [GO:0045732]; protein import into mitochondrial inner membrane [GO:0045039]; reactive oxygen species metabolic process [GO:0072593],NA,NA,NA
CHOYP_THUM1.1.1.m.47876,-0.0169591047060434,0.00960206869202777,No,NA,NA,Q24K03,NA,NA,NA,RNA binding [GO:0003723]; tRNA modification [GO:0006400],NA,NA,NA
CHOYP_THUM3.1.1.m.17928,0.0141160149104561,-0.00783978592389408,No,NA,NA,Q9BV44,NA,NA,NA,cytosol [GO:0005829]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; tRNA (guanine) methyltransferase activity [GO:0016423]; tRNA methylation [GO:0030488],NA,NA,NA
CHOYP_TIAP2.12.13.m.62840,-0.012201334594882,0.00289205676676566,No,NA,NA,Q8JHV9,NA,NA,NA,cytoplasm [GO:0005737]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; protein autoubiquitination [GO:0051865],NA,NA,NA
CHOYP_TIF1A.3.8.m.12841,0.00364778592941831,-0.00872052841558097,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TIF1A.4.8.m.23900,-0.017507422736519,0.0105167897006982,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TIF1A.5.8.m.32570,-0.0169591047060434,0.00960206869202777,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TIM8A.1.1.m.4787,0.00418695004603688,-0.0175982022826381,No,NA,NA,Q90YI5,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; metal ion binding [GO:0046872]; chaperone-mediated protein transport [GO:0072321],NA,NA,NA
CHOYP_TIMP2B.1.1.m.29629,-0.018060770234605,0.0184096042235584,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TIMP3.4.9.m.28669,-0.0207781121683931,-0.00553458432042956,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TIMP3.5.9.m.39776,0.0187872336431528,-0.0129607314629674,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TITIN.1.19.m.2116,0.00394536801625317,0.00291369700370642,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TITIN.19.19.m.66288,0.00996801942325497,-0.00530096181259922,No,NA,NA,Q23551,NA,NA,NA,A band [GO:0031672]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; structural constituent of muscle [GO:0008307]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; muscle contraction [GO:0006936]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_TITIN.4.19.m.19569,0.00643270358792589,0.00677947978016508,No,NA,NA,P20273,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; carbohydrate binding [GO:0030246]; CD4 receptor binding [GO:0042609]; IgM binding [GO:0001791]; protein phosphatase binding [GO:0019903]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102]; B cell activation [GO:0042113]; cell adhesion [GO:0007155]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of calcium-mediated signaling [GO:0050849]; negative regulation of immunoglobulin secretion [GO:0051025]; regulation of B cell proliferation [GO:0030888]; regulation of endocytosis [GO:0030100]; regulation of immune response [GO:0050776],NA,NA,NA
CHOYP_TITIN.6.19.m.31591,0.0129426070770259,0.00318036236870923,No,NA,NA,Q8WZ42,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_TITIN.8.19.m.35861,-0.0117780159811959,0.00167789507988177,No,NA,NA,A2ASS6,NA,NA,NA,A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; telethonin binding [GO:0031433]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_TLE4.1.1.m.19069,-0.0146927221247445,0.00167295113309527,No,NA,NA,Q62441,NA,NA,NA,beta-catenin-TCF complex [GO:1990907]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_TLN1.4.4.m.33719,0.0204341545572702,0.00983278682956298,No,NA,NA,Q9Y490,NA,NA,NA,cell surface [GO:0009986]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166]; cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; cytoskeletal anchoring at plasma membrane [GO:0007016]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; IRE1-mediated unfolded protein response [GO:0036498]; muscle contraction [GO:0006936]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; viral process [GO:0016032],NA,NA,NA
CHOYP_TLN2.1.2.m.5591,-0.00838727720850925,-0.00525211046877794,No,NA,NA,Q9Y4G6,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; synapse [GO:0045202]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; cell-cell junction assembly [GO:0007043]; cytoskeletal anchoring at plasma membrane [GO:0007016],NA,NA,NA
CHOYP_TLR1.1.3.m.1564,-0.00262913880838048,0.00884339527496907,No,NA,NA,Q9Y2C9,NA,NA,NA,Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular [GO:0005622]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Toll-like receptor 2-Toll-like receptor 6 protein complex [GO:0035355]; amyloid-beta binding [GO:0001540]; identical protein binding [GO:0042802]; lipopeptide binding [GO:0071723]; protein heterodimerization activity [GO:0046982]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102]; Toll-like receptor 2 binding [GO:0035663]; transmembrane signaling receptor activity [GO:0004888]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; cell activation [GO:0001775]; cellular response to amyloid-beta [GO:1904646]; cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; defense response to bacterium [GO:0042742]; detection of diacyl bacterial lipopeptide [GO:0042496]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-1 beta secretion [GO:0050702]; microglial cell activation [GO:0001774]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of interleukin-8 secretion [GO:2000483]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; nitric oxide metabolic process [GO:0046209]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-6 biosynthetic process [GO:0045410]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of macrophage activation [GO:0043032]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; signal transduction [GO:0007165]; toll-like receptor 6 signaling pathway [GO:0034150]; toll-like receptor signaling pathway [GO:0002224]; toll-like receptor TLR6:TLR2 signaling pathway [GO:0038124]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666],NA,NA,NA
CHOYP_TM9S4.1.1.m.23520,-0.0140623024923308,-0.00381630232434129,No,NA,NA,Q8BH24,NA,NA,NA,early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; cell adhesion [GO:0007155]; phagocytosis [GO:0006909]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to membrane [GO:0072657]; regulation of intracellular pH [GO:0051453]; response to hypoxia [GO:0001666]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072],NA,NA,NA
CHOYP_TMC3.1.1.m.4078,0.00206473138851016,-0.0050561195677352,No,NA,NA,Q7TQ69,NA,NA,NA,integral component of plasma membrane [GO:0005887]; ion channel activity [GO:0005216]; mechanosensitive ion channel activity [GO:0008381],NA,NA,NA
CHOYP_TMCO4.1.1.m.378,-0.0116143109804211,-0.00894766699156067,No,NA,NA,Q91WU4,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_TMED7.1.3.m.6189,0.0109771296737664,-0.0230299262677615,No,NA,NA,D3ZTX0,NA,NA,NA,COPI-coated vesicle membrane [GO:0030663]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_TMED7.2.3.m.28259,0.0166849485944432,-0.00274893280045314,No,NA,NA,D3ZTX0,NA,NA,NA,COPI-coated vesicle membrane [GO:0030663]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_TMEDA.1.2.m.42794,0.0201040540025456,-0.00509278556288555,No,NA,NA,Q9D1D4,NA,NA,NA,cis-Golgi network [GO:0005801]; COPI-coated vesicle [GO:0030137]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; gamma-secretase complex [GO:0070765]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle membrane [GO:0030658]; zymogen granule membrane [GO:0042589]; protein-containing complex binding [GO:0044877]; syntaxin binding [GO:0019905]; COPI-coated vesicle budding [GO:0035964]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; kidney development [GO:0001822]; protein complex oligomerization [GO:0051259]; regulated exocytosis [GO:0045055]; regulation of amyloid-beta formation [GO:1902003]; response to alkaloid [GO:0043279]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890]; vesicle targeting; to; from or within Golgi [GO:0048199],NA,NA,NA
CHOYP_TMEDA.1.2.m.42795,-0.00475870368836391,-0.0112385645766925,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TMEL_0889.1.2.m.168,0.0150041816889042,0.0180907497399233,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TMEM16.2.2.m.41752,0.00340401892482309,-0.00584417153292222,No,NA,NA,A2AHL1,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983]; calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; detection of mechanical stimulus [GO:0050982]; detection of temperature stimulus [GO:0016048],NA,NA,NA
CHOYP_TMEM2.1.4.m.6314,-0.00953757553378669,-0.0245155769696525,No,NA,NA,A3KPQ7,NA,NA,NA,integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; hyalurononglucosaminidase activity [GO:0004415]; angiogenesis [GO:0001525]; atrioventricular valve formation [GO:0003190]; cardiac muscle tissue morphogenesis [GO:0055008]; cell migration involved in heart formation [GO:0060974]; cell migration to the midline involved in heart development [GO:0003318]; embryonic heart tube morphogenesis [GO:0003143]; endocardial cushion development [GO:0003197]; heart looping [GO:0001947]; hyaluronan catabolic process [GO:0030214]; muscle attachment [GO:0016203]; muscle tissue morphogenesis [GO:0060415]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; regulation of sprouting angiogenesis [GO:1903670],NA,NA,NA
CHOYP_TMEM2.2.4.m.8174,-0.0200480799832498,0.000293179332230325,No,NA,NA,Q5FWI3,NA,NA,NA,integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; hyalurononglucosaminidase activity [GO:0004415]; angiogenesis [GO:0001525]; hyaluronan catabolic process [GO:0030214]; regulation of sprouting angiogenesis [GO:1903670],NA,NA,NA
CHOYP_TMEM2.3.4.m.10491,-0.0223121721998276,0.00692482238516691,No,NA,NA,Q5FWI3,NA,NA,NA,integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; hyalurononglucosaminidase activity [GO:0004415]; angiogenesis [GO:0001525]; hyaluronan catabolic process [GO:0030214]; regulation of sprouting angiogenesis [GO:1903670],NA,NA,NA
CHOYP_TMEM2.4.4.m.28440,0.00573381994950302,0.00171389810744279,No,NA,NA,A3KPQ7,NA,NA,NA,integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; hyalurononglucosaminidase activity [GO:0004415]; angiogenesis [GO:0001525]; atrioventricular valve formation [GO:0003190]; cardiac muscle tissue morphogenesis [GO:0055008]; cell migration involved in heart formation [GO:0060974]; cell migration to the midline involved in heart development [GO:0003318]; embryonic heart tube morphogenesis [GO:0003143]; endocardial cushion development [GO:0003197]; heart looping [GO:0001947]; hyaluronan catabolic process [GO:0030214]; muscle attachment [GO:0016203]; muscle tissue morphogenesis [GO:0060415]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; regulation of sprouting angiogenesis [GO:1903670],NA,NA,NA
CHOYP_TMM98.1.1.m.51750,0.00615966897194063,0.00941964587728867,No,NA,NA,Q6INX1,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_TMO_0856.1.3.m.5045,-0.00484986426887967,0.0189143875827814,No,NA,NA,Q9X6U2,NA,NA,NA,3-hydroxybutyrate dehydrogenase activity [GO:0003858],NA,NA,NA
CHOYP_TNNC.1.1.m.66691,0.00466514767019648,0.0079990572042151,No,NA,NA,Q9BLG0,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_TNNI.3.3.m.56962,-0.00201421745083608,-0.00145279074046283,No,NA,NA,Q7M3Y3,NA,NA,NA,troponin complex [GO:0005861]; actin binding [GO:0003779]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_TNPO1.1.1.m.8874,0.00758989750069881,-0.0180925534636174,No,NA,NA,Q92973,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nucleus [GO:0005634]; nuclear localization sequence binding [GO:0008139]; protein transporter activity [GO:0008565]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; intraciliary transport involved in cilium assembly [GO:0035735]; NLS-bearing protein import into nucleus [GO:0006607]; protein import into nucleus; translocation [GO:0000060]; regulation of mRNA stability [GO:0043488]; ribosomal protein import into nucleus [GO:0006610]; viral process [GO:0016032],NA,NA,NA
CHOYP_TNPO3.1.1.m.11099,-0.00328481884822455,-0.0141936064194747,No,NA,NA,Q9Y5L0,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; nuclear localization sequence binding [GO:0008139]; protein transporter activity [GO:0008565]; signaling receptor activity [GO:0038023]; protein import into nucleus [GO:0006606],NA,NA,NA
CHOYP_TNRC6A.1.2.m.16253,-0.01091341102177,0.00570742263039376,No,NA,NA,Q9HCJ0,NA,NA,NA,cytosol [GO:0005829]; micro-ribonucleoprotein complex [GO:0035068]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; RNA binding [GO:0003723]; gene silencing by miRNA [GO:0035195]; miRNA mediated inhibition of translation [GO:0035278]; negative regulation of gene expression [GO:0010629]; positive regulation of gene expression [GO:0010628]; positive regulation of nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; posttranscriptional gene silencing by RNA [GO:0035194]; regulation of megakaryocyte differentiation [GO:0045652]; Wnt signaling pathway; calcium modulating pathway [GO:0007223],NA,NA,NA
CHOYP_TNRC6A.2.2.m.59802,-0.00722988089921492,0.00394000414061787,No,NA,NA,Q9HCJ0,NA,NA,NA,cytosol [GO:0005829]; micro-ribonucleoprotein complex [GO:0035068]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; RNA binding [GO:0003723]; gene silencing by miRNA [GO:0035195]; miRNA mediated inhibition of translation [GO:0035278]; negative regulation of gene expression [GO:0010629]; positive regulation of gene expression [GO:0010628]; positive regulation of nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; posttranscriptional gene silencing by RNA [GO:0035194]; regulation of megakaryocyte differentiation [GO:0045652]; Wnt signaling pathway; calcium modulating pathway [GO:0007223],NA,NA,NA
CHOYP_TOL2_C08810.1.1.m.6377,-0.0154526967875185,-0.00317788242998231,No,NA,NA,C5BMZ8,NA,NA,NA,carboxyl-O-methyltransferase activity [GO:0010340]; malonyl-CoA methyltransferase activity [GO:0102130]; methyl indole-3-acetate esterase activity [GO:0080030]; biotin biosynthetic process [GO:0009102],NA,NA,NA
CHOYP_TOLIP.1.1.m.57590,0.0166950051505135,0.0089563525919391,No,NA,NA,Q9H0E2,NA,NA,NA,azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; interleukin-1 receptor complex [GO:0045323]; interleukin-18 receptor complex [GO:0045092]; nuclear body [GO:0016604]; perinuclear region of cytoplasm [GO:0048471]; specific granule lumen [GO:0035580]; interleukin-1; type I receptor binding [GO:0005150]; kinase binding [GO:0019900]; SUMO binding [GO:0032183]; Toll-like receptor binding [GO:0035325]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]; autophagy [GO:0006914]; cell-cell signaling [GO:0007267]; epithelial cell differentiation [GO:0030855]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; leukocyte activation [GO:0045321]; neutrophil degranulation [GO:0043312]; phosphorylation [GO:0016310]; positive regulation of protein sumoylation [GO:0033235]; protein localization to endosome [GO:0036010]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_TOLL.1.1.1.m.37581,0.00156324611919973,-0.0179050257605222,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TOM20.1.1.m.11207,0.0111933581181649,-0.00498953499151698,No,NA,NA,Q6DFM9,NA,NA,NA,integral component of mitochondrial outer membrane [GO:0031307]; mitochondrial outer membrane translocase complex [GO:0005742]; mitochondrion targeting sequence binding [GO:0030943]; P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]; mitochondrial outer membrane translocase complex assembly [GO:0070096]; protein import into mitochondrial matrix [GO:0030150]; tRNA import into mitochondrion [GO:0016031],NA,NA,NA
CHOYP_TOMM70A.1.1.m.42370,0.0216029298573497,-0.00764829566598387,No,NA,NA,O94826,NA,NA,NA,extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrial outer membrane translocase complex [GO:0005742]; mitochondrion [GO:0005739]; protein transmembrane transporter activity [GO:0008320]; protein targeting to mitochondrion [GO:0006626],NA,NA,NA
CHOYP_TONSL.1.1.m.18360,-0.00325812880575464,-0.000934259134336629,No,NA,NA,Q8TAQ2,NA,NA,NA,nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; transcription coactivator activity [GO:0003713]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; negative regulation of transcription; DNA-templated [GO:0045892]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_TOP1.5.5.m.61515,-0.00955205246833029,-0.0166025706956737,No,NA,NA,P11387,NA,NA,NA,DNA topoisomerase complex (ATP-hydrolyzing) [GO:0009330]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; perikaryon [GO:0043204]; protein-DNA complex [GO:0032993]; replication fork protection complex [GO:0031298]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA topoisomerase type I activity [GO:0003917]; double-stranded DNA binding [GO:0003690]; protein domain specific binding [GO:0019904]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; supercoiled DNA binding [GO:0097100]; chromatin remodeling [GO:0006338]; chromosome segregation [GO:0007059]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA replication [GO:0006260]; DNA topological change [GO:0006265]; embryonic cleavage [GO:0040016]; peptidyl-serine phosphorylation [GO:0018105]; phosphorylation [GO:0016310]; programmed cell death [GO:0012501]; response to drug [GO:0042493]; viral process [GO:0016032],NA,NA,NA
CHOYP_TOP2B.1.1.m.6674,0.00872132783853188,-0.0188121523327783,No,NA,NA,Q64511,NA,NA,NA,cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; viral integration complex [GO:0019035]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type II (ATP-hydrolyzing) activity [GO:0003918]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein kinase C binding [GO:0005080]; ribonucleoprotein complex binding [GO:0043021]; axonogenesis [GO:0007409]; cell aging [GO:0007569]; cellular response to ATP [GO:0071318]; cellular response to hydrogen peroxide [GO:0070301]; DNA topological change [GO:0006265]; forebrain development [GO:0030900]; mitotic DNA integrity checkpoint [GO:0044774]; neuron migration [GO:0001764]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045870]; resolution of meiotic recombination intermediates [GO:0000712]; sister chromatid segregation [GO:0000819],NA,NA,NA
CHOYP_TOP3B.1.1.m.1654,-0.00333932475441122,-0.012241594763502,No,NA,NA,O95985,NA,NA,NA,condensed chromosome [GO:0000793]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I activity [GO:0003917]; RNA binding [GO:0003723]; chromosome segregation [GO:0007059]; DNA topological change [GO:0006265],NA,NA,NA
CHOYP_TPC2.1.2.m.19378,-0.00779062937638949,-0.00662453574002796,No,NA,NA,A0JMD4,NA,NA,NA,integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; NAADP-sensitive calcium-release channel activity [GO:0072345]; voltage-gated calcium channel activity [GO:0005245]; calcium-mediated signaling [GO:0019722]; regulation of ion transmembrane transport [GO:0034765]; regulation of myotome development [GO:2000290]; skeletal myofibril assembly [GO:0014866]; smooth muscle contraction [GO:0006939],NA,NA,NA
CHOYP_TPM.15.19.m.50851,-0.00724082252079344,0.0107230910261377,No,NA,NA,Q25145,NA,NA,NA,,NA,NA,NA
CHOYP_TPM.17.19.m.63919,0.0159427771680608,0.000640495345005055,No,NA,NA,Q25145,NA,NA,NA,,NA,NA,NA
CHOYP_TPM.18.19.m.66023,-0.0141645742255353,0.000172128437053505,No,NA,NA,Q9GZ71,NA,NA,NA,,NA,NA,NA
CHOYP_TPM.19.19.m.66623,0.0205853476864518,-0.014152715639182,No,NA,NA,P43689,NA,NA,NA,,NA,NA,NA
CHOYP_TPM.6.19.m.12415,0.0133044589799504,0.0218172175146433,No,NA,NA,O02389,NA,NA,NA,,NA,NA,NA
CHOYP_TPM.7.19.m.15554,-0.00835758509749932,-0.0152933294093097,No,NA,NA,Q99020,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; presynaptic cytosol [GO:0099523]; ribonucleoprotein complex [GO:1990904]; RNA polymerase II transcription factor complex [GO:0090575]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; epithelial to mesenchymal transition [GO:0001837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_TPM2.8.8.m.50799,-0.00506796033891114,0.00203065293313671,No,NA,NA,Q25145,NA,NA,NA,,NA,NA,NA
CHOYP_TPP2.1.1.m.24017,0.016778478485063,0.00140291780711229,No,NA,NA,P29144,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; aminopeptidase activity [GO:0004177]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; tripeptidyl-peptidase activity [GO:0008240]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_TPPC3.1.1.m.58563,0.0077953459560206,-0.0176977833674518,No,NA,NA,Q5ZI57,NA,NA,NA,cis-Golgi network membrane [GO:0033106]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; TRAPP complex [GO:0030008]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891],NA,NA,NA
CHOYP_TPPC8.1.1.m.6302,0.0114255405115009,0.00899026131373191,No,NA,NA,Q9Y2L5,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; phagophore assembly site [GO:0000407]; TRAPP complex [GO:0030008]; TRAPPIII protein complex [GO:1990072]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; autophagosome assembly [GO:0000045]; autophagy of peroxisome [GO:0030242]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; protein localization by the Cvt pathway [GO:0032258]; protein localization to phagophore assembly site [GO:0034497],NA,NA,NA
CHOYP_TPR.1.2.m.29645,0.0098037886081445,0.0113851712238274,No,NA,NA,Q5EE04,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; extrinsic component of membrane [GO:0019898]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; chromatin binding [GO:0003682]; heat shock protein binding [GO:0031072]; mitogen-activated protein kinase binding [GO:0051019]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; structural constituent of nuclear pore [GO:0017056]; cell division [GO:0051301]; cellular response to heat [GO:0034605]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein import into nucleus [GO:0006606]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404],NA,NA,NA
CHOYP_TPR.2.2.m.46877,0.00989822361557598,-0.0139339494835335,No,NA,NA,F1MA98,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; extrinsic component of membrane [GO:0019898]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; heat shock protein binding [GO:0031072]; mitogen-activated protein kinase binding [GO:0051019]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; structural constituent of nuclear pore [GO:0017056]; tubulin binding [GO:0015631]; cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404],NA,NA,NA
CHOYP_TR12A.1.2.m.32633,0.00394536801625317,0.00291369700370642,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRA2A.1.1.m.21305,-0.00934820901512209,-0.00846481870870281,No,NA,NA,P62997,NA,NA,NA,nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; positive regulation of mRNA splicing; via spliceosome [GO:0048026]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; response to reactive oxygen species [GO:0000302],NA,NA,NA
CHOYP_TRAP1.1.1.m.60651,0.0115003069257439,-0.0210797099016007,No,NA,NA,Q5XHZ0,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; translational attenuation [GO:0009386],NA,NA,NA
CHOYP_TRD7B.1.1.m.56981,-0.010070173390869,-0.00416891711232893,No,NA,NA,Q5M7P8,NA,NA,NA,cytoplasm [GO:0005737]; ribonucleoprotein granule [GO:0035770]; mRNA binding [GO:0003729]; lens fiber cell differentiation [GO:0070306]; lens morphogenesis in camera-type eye [GO:0002089]; posttranscriptional regulation of gene expression [GO:0010608]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_TRI10.1.1.m.35702,-0.00989845952727507,0.00266329975716995,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRI33.5.8.m.56889,0.0140388453266795,0.0178610187198909,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRI45.13.23.m.35793,0.00394536801625317,0.00291369700370642,No,NA,NA,Q80VI1,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; interferon-beta production [GO:0032608]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral release from host cell [GO:1902187]; protein K63-linked ubiquitination [GO:0070534]; response to type I interferon [GO:0034340],NA,NA,NA
CHOYP_TRI45.18.23.m.48495,0.00364778592941831,-0.00872052841558097,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRI46.2.3.m.61659,-0.00835379665853708,-0.00415869018662741,No,NA,NA,Q6PFY8,NA,NA,NA,cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348],NA,NA,NA
CHOYP_TRI56.4.4.m.61739,-0.00757905454817058,-0.0155898093878537,No,NA,NA,E1BD59,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; interferon-beta production [GO:0032608]; protein K63-linked ubiquitination [GO:0070534]; response to type I interferon [GO:0034340],NA,NA,NA
CHOYP_TRIADDRAFT_19804.1.1.m.8993,-0.00247785961553206,0.0132406943437183,No,NA,NA,A6H603,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_TRIADDRAFT_21078.2.2.m.64279,0.00205195042830452,-0.00934116934689426,No,NA,NA,Q89YT0,NA,NA,NA,deoxyribonuclease IV (phage-T4-induced) activity [GO:0008833]; DNA binding [GO:0003677]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; phosphoric diester hydrolase activity [GO:0008081]; zinc ion binding [GO:0008270]; base-excision repair [GO:0006284],NA,NA,NA
CHOYP_TRIADDRAFT_21752.1.1.m.62548,-0.0115972564795628,-0.00370883933760211,No,NA,NA,P91119,NA,NA,NA,3';5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3';5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cAMP binding [GO:0030552]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; metal ion binding [GO:0046872]; chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; determination of adult lifespan [GO:0008340]; microvillus organization [GO:0032528]; negative regulation of cGMP-mediated signaling [GO:0010754]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; response to alkaline pH [GO:0010446]; response to hydrogen peroxide [GO:0042542],NA,NA,NA
CHOYP_TRIADDRAFT_23075.1.1.m.48886,0.00709811029086768,0.0123990847700343,No,NA,NA,Q9Z223,NA,NA,NA,cytosol [GO:0005829]; molybdopterin synthase complex [GO:0019008]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; molybdopterin synthase activity [GO:0030366]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324],NA,NA,NA
CHOYP_TRIADDRAFT_25769.1.1.m.25945,-0.00876148962758687,0.00344428464545605,No,NA,NA,Q5ZKX1,NA,NA,NA,cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]; endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to vacuole transport [GO:0045324]; protein transport [GO:0015031],NA,NA,NA
CHOYP_TRIADDRAFT_26208.1.1.m.10460,-0.00831136351300825,0.00798916341897081,No,NA,NA,P31029,NA,NA,NA,mitochondrial matrix [GO:0005759]; peroxisomal matrix [GO:0005782]; alanine-glyoxylate transaminase activity [GO:0008453]; amino acid binding [GO:0016597]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; pyridoxal phosphate binding [GO:0030170]; serine-pyruvate transaminase activity [GO:0004760]; signaling receptor binding [GO:0005102]; glycine biosynthetic process; by transamination of glyoxylate [GO:0019265]; glyoxylate catabolic process [GO:0009436]; L-alanine catabolic process [GO:0042853]; L-cysteine catabolic process [GO:0019448]; Notch signaling pathway [GO:0007219]; oxalic acid secretion [GO:0046724],NA,NA,NA
CHOYP_TRIADDRAFT_26518.1.1.m.16475,-2.10219839573102e-05,-0.0134878405576069,No,NA,NA,P83088,NA,NA,NA,Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486],NA,NA,NA
CHOYP_TRIADDRAFT_26633.4.6.m.50465,0.00530216403293426,-0.0211063027333238,No,NA,NA,A2RUV0,NA,NA,NA,integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_TRIADDRAFT_29967.1.1.m.56654,-0.00710376980725611,0.00091148309314284,No,NA,NA,Q55G11,NA,NA,NA,extracellular region [GO:0005576]; ceramidase activity [GO:0102121]; N-acylsphingosine amidohydrolase activity [GO:0017040]; ceramide catabolic process [GO:0046514]; ceramide metabolic process [GO:0006672]; long-chain fatty acid biosynthetic process [GO:0042759]; sphingosine biosynthetic process [GO:0046512],NA,NA,NA
CHOYP_TRIADDRAFT_29994.1.1.m.48948,-0.0147357564359993,-0.0170301189939529,No,NA,NA,P16273,NA,NA,NA,defense response [GO:0006952]; response to biotic stimulus [GO:0009607],NA,NA,NA
CHOYP_TRIADDRAFT_32712.2.4.m.28430,-0.0226626094967056,0.0102519936468988,No,NA,NA,Q7Z0T3,NA,NA,NA,extracellular region [GO:0005576]; pheromone activity [GO:0005186],NA,NA,NA
CHOYP_TRIADDRAFT_32712.3.4.m.44104,-0.0187847148498367,-0.000262200107905653,No,NA,NA,Q7Z0T3,NA,NA,NA,extracellular region [GO:0005576]; pheromone activity [GO:0005186],NA,NA,NA
CHOYP_TRIADDRAFT_32712.4.4.m.44519,0.0220686683596313,-0.0111445479954171,No,NA,NA,Q7Z0T3,NA,NA,NA,extracellular region [GO:0005576]; pheromone activity [GO:0005186],NA,NA,NA
CHOYP_TRIADDRAFT_37121.1.1.m.51940,-0.00563779347375341,-0.0126095134431008,No,NA,NA,Q8BYK4,NA,NA,NA,intracellular [GO:0005622]; photoreceptor inner segment [GO:0001917]; retinol dehydrogenase activity [GO:0004745]; response to stimulus [GO:0050896]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601],NA,NA,NA
CHOYP_TRIADDRAFT_38448.1.1.m.27929,0.0228513964514646,0.000727691488403622,No,NA,NA,Q7Z0T3,NA,NA,NA,extracellular region [GO:0005576]; pheromone activity [GO:0005186],NA,NA,NA
CHOYP_TRIADDRAFT_49883.1.1.m.29857,-0.0224526727030337,-0.00566048880792059,No,NA,NA,Q9QY94,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; metal ion binding [GO:0046872]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; angiogenesis [GO:0001525]; glutamine biosynthetic process [GO:0006542]; protein palmitoylation [GO:0018345]; regulation of endothelial cell migration [GO:0010594]; regulation of sprouting angiogenesis [GO:1903670],NA,NA,NA
CHOYP_TRIADDRAFT_50333.1.1.m.59774,-0.0200683533274712,-0.00789806822573696,No,NA,NA,Q8BHW2,NA,NA,NA,basal plasma membrane [GO:0009925],NA,NA,NA
CHOYP_TRIADDRAFT_51343.2.2.m.65118,0.00558956343895963,-0.00580220494529625,No,NA,NA,Q75JP5,NA,NA,NA,,NA,NA,NA
CHOYP_TRIADDRAFT_52608.1.2.m.25467,-0.00147366879599816,0.00387262062567871,No,NA,NA,Q9UGM3,NA,NA,NA,cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; heparan sulfate binding [GO:1904399]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; signaling pattern recognition receptor activity [GO:0008329]; zymogen binding [GO:0035375]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular protein metabolic process [GO:0044267]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; viral process [GO:0016032],NA,NA,NA
CHOYP_TRIADDRAFT_53531.1.2.m.12127,-0.00437959141164314,-0.0132777038247402,No,NA,NA,P86734,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160],NA,NA,NA
CHOYP_TRIADDRAFT_53596.1.1.m.47642,-0.00264254377309987,-0.0126196692259993,No,NA,NA,Q9NTG1,NA,NA,NA,integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; acrosome reaction [GO:0007340]; detection of mechanical stimulus [GO:0050982],NA,NA,NA
CHOYP_TRIADDRAFT_53677.1.1.m.35290,0.00172736949488502,-0.0142755549580584,No,NA,NA,Q8WWZ7,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; lipid transporter activity [GO:0005319]; cholesterol efflux [GO:0033344]; high-density lipoprotein particle remodeling [GO:0034375]; lipid transport [GO:0006869]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; reverse cholesterol transport [GO:0043691]; transmembrane transport [GO:0055085],NA,NA,NA
CHOYP_TRIADDRAFT_55241.1.1.m.41679,-0.00430894344577715,-0.00631540690244347,No,NA,NA,Q9TU34,NA,NA,NA,axon [GO:0030424]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; rough endoplasmic reticulum [GO:0005791]; sarcoplasmic reticulum [GO:0016529]; secretory granule [GO:0030141]; secretory granule membrane [GO:0030667]; transport vesicle membrane [GO:0030658]; calcium ion binding [GO:0005509]; calcium-release channel activity [GO:0015278]; inositol 1;4;5 trisphosphate binding [GO:0070679]; inositol 1;4;5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; phosphatidylinositol binding [GO:0035091]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; release of sequestered calcium ion into cytosol [GO:0051209],NA,NA,NA
CHOYP_TRIADDRAFT_55525.1.1.m.53631,-0.0190076713371975,-0.00998563742638995,No,NA,NA,P00491,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; intracellular [GO:0005622]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; drug binding [GO:0008144]; nucleoside binding [GO:0001882]; phosphate ion binding [GO:0042301]; purine nucleobase binding [GO:0002060]; purine-nucleoside phosphorylase activity [GO:0004731]; immune response [GO:0006955]; inosine catabolic process [GO:0006148]; interleukin-2 secretion [GO:0070970]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; neutrophil degranulation [GO:0043312]; nicotinamide riboside catabolic process [GO:0006738]; nucleobase-containing compound metabolic process [GO:0006139]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of T cell proliferation [GO:0042102]; purine nucleotide catabolic process [GO:0006195]; purine-containing compound salvage [GO:0043101]; response to drug [GO:0042493]; urate biosynthetic process [GO:0034418],NA,NA,NA
CHOYP_TRIADDRAFT_55768.1.2.m.4473,-0.00166471776658843,0.0159511453212994,No,NA,NA,Q8IZJ3,NA,NA,NA,extracellular space [GO:0005615]; plasma membrane [GO:0005886]; serine-type endopeptidase inhibitor activity [GO:0004867]; eye development [GO:0001654],NA,NA,NA
CHOYP_TRIADDRAFT_55768.2.2.m.14361,0.0191610537933802,-0.0153665183610541,No,NA,NA,Q6YHK3,NA,NA,NA,anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616],NA,NA,NA
CHOYP_TRIADDRAFT_57018.1.2.m.10706,-0.00470144836417181,-0.00168704911474604,No,NA,NA,Q05927,NA,NA,NA,anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; nucleotide catabolic process [GO:0009166],NA,NA,NA
CHOYP_TRIADDRAFT_57086.1.1.m.25271,-0.00500067990417988,-0.0092673458046538,No,NA,NA,Q6C0Y0,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; actin binding [GO:0003779]; actin filament depolymerization [GO:0030042]; cell cycle [GO:0007049]; cell division [GO:0051301],NA,NA,NA
CHOYP_TRIADDRAFT_57945.3.3.m.55640,0.000394976357185308,-0.0217980070664086,No,NA,NA,Q55E58,NA,NA,NA,actomyosin [GO:0042641]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine kinase activity [GO:0004674]; cheating during chimeric sorocarp development [GO:0099139]; mitotic cytokinesis [GO:0000281]; protein dephosphorylation [GO:0006470],NA,NA,NA
CHOYP_TRIADDRAFT_60787.1.1.m.6621,0.00615966897194063,0.00941964587728867,No,NA,NA,Q32N22,NA,NA,NA,RNA polymerase I core factor complex [GO:0070860]; metal ion binding [GO:0046872]; RNA polymerase I CORE element sequence-specific DNA binding [GO:0001164]; RNA polymerase I preinitiation complex assembly [GO:0001188],NA,NA,NA
CHOYP_TRIADDRAFT_61434.1.1.m.8434,0.00405320890913109,-0.0179401907096586,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRIADDRAFT_62546.1.2.m.5483,0.0180227871499376,-0.00215670954827968,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRIADDRAFT_62546.2.2.m.56798,0.00759463530889748,0.0145618698535025,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRIADDRAFT_63204.1.2.m.30701,0.0188087838773513,0.0157393746795257,No,NA,NA,Q9BYV1,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; (R)-3-amino-2-methylpropionate-pyruvate transaminase activity [GO:0047305]; alanine-glyoxylate transaminase activity [GO:0008453]; pyridoxal phosphate binding [GO:0030170]; glycine biosynthetic process; by transamination of glyoxylate [GO:0019265]; glyoxylate catabolic process [GO:0009436]; glyoxylate metabolic process [GO:0046487]; L-alanine catabolic process; by transamination [GO:0019481]; positive regulation of nitric oxide biosynthetic process [GO:0045429],NA,NA,NA
CHOYP_TRIADDRAFT_63204.2.2.m.38038,0.0172118877558036,-0.0106704723143946,No,NA,NA,Q9BYV1,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; (R)-3-amino-2-methylpropionate-pyruvate transaminase activity [GO:0047305]; alanine-glyoxylate transaminase activity [GO:0008453]; pyridoxal phosphate binding [GO:0030170]; glycine biosynthetic process; by transamination of glyoxylate [GO:0019265]; glyoxylate catabolic process [GO:0009436]; glyoxylate metabolic process [GO:0046487]; L-alanine catabolic process; by transamination [GO:0019481]; positive regulation of nitric oxide biosynthetic process [GO:0045429],NA,NA,NA
CHOYP_TRIADDRAFT_63666.3.3.m.57696,-0.00672057013160882,-0.0120550406215736,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRIADDRAFT_64314.1.2.m.9124,0.00427220768342327,-0.0226181324760754,No,NA,NA,Q93T20,NA,NA,NA,NAD(P)H dehydrogenase (quinone) activity [GO:0003955],NA,NA,NA
CHOYP_TRIADDRAFT_64314.2.2.m.54695,-0.00540965827158514,0.0118182746555679,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRIADDRAFT_64367.1.1.m.42126,-0.0169591047060434,0.00960206869202777,No,NA,NA,Q1JPJ2,NA,NA,NA,cytosol [GO:0005829]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]; bradykinin catabolic process [GO:0010815],NA,NA,NA
CHOYP_TRIB2.1.1.m.226,0.00813309266000595,0.00619771034252631,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRIM2.16.59.m.31979,-0.0169591047060434,0.00960206869202778,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRIM2.42.59.m.43682,-0.0125858760495688,0.00789382059383477,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRIM33.1.1.m.36639,0.00544534127744519,-0.00708060110493391,No,NA,NA,Q9UPN9,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; co-SMAD binding [GO:0070410]; DNA binding [GO:0003677]; R-SMAD binding [GO:0070412]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; protein ubiquitination [GO:0016567]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015],NA,NA,NA
CHOYP_TRIM5.1.2.m.60878,0.00205195042830452,-0.00934116934689426,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRIM56.2.2.m.59948,-0.020313208392001,0.00347706243264535,No,NA,NA,E1BD59,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; interferon-beta production [GO:0032608]; protein K63-linked ubiquitination [GO:0070534]; response to type I interferon [GO:0034340],NA,NA,NA
CHOYP_TRIO.1.1.m.49282,-0.0037645329864741,-0.0235721258072226,No,NA,NA,Q0KL02,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; negative regulation of fat cell differentiation [GO:0045599]; regulation of Rho protein signal transduction [GO:0035023],NA,NA,NA
CHOYP_TRIPC.1.1.m.6424,-0.0146653635950255,0.00448921047156602,No,NA,NA,G5E870,NA,NA,NA,nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; thyroid hormone receptor binding [GO:0046966]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; regulation of embryonic development [GO:0045995]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_TRM13.1.1.m.16853,0.00217997094733793,-0.00807271368859912,No,NA,NA,Q8BYH3,NA,NA,NA,metal ion binding [GO:0046872]; tRNA 2'-O-methyltransferase activity [GO:0106050]; tRNA methyltransferase activity [GO:0008175]; tRNA methylation [GO:0030488],NA,NA,NA
CHOYP_TRM5.1.1.m.24347,-0.0135725579708753,0.00388604629968508,No,NA,NA,Q3MHN8,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; tRNA (guanine(37)-N(1))-methyltransferase activity [GO:0052906]; tRNA (guanine-N1-)-methyltransferase activity [GO:0009019]; tRNA methyltransferase activity [GO:0008175]; mitochondrial tRNA methylation [GO:0070901]; tRNA methylation [GO:0030488]; tRNA N1-guanine methylation [GO:0002939],NA,NA,NA
CHOYP_TRMT2A.1.1.m.17768,0.00272505458437259,-0.0108825964182057,No,NA,NA,Q8IZ69,NA,NA,NA,RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]; RNA processing [GO:0006396],NA,NA,NA
CHOYP_TRMT6.1.1.m.8062,0.000284901942911996,-0.0149623735108171,No,NA,NA,Q8CE96,NA,NA,NA,nucleus [GO:0005634]; tRNA (m1A) methyltransferase complex [GO:0031515]; mRNA methylation [GO:0080009]; tRNA methylation [GO:0030488],NA,NA,NA
CHOYP_TRNT1.1.1.m.1512,0.0065883263884642,0.0180931628217626,No,NA,NA,Q8K1J6,NA,NA,NA,mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity [GO:0052929]; CTP:3'-cytidine-tRNA cytidylyltransferase activity [GO:0052928]; CTP:tRNA cytidylyltransferase activity [GO:0052927]; tRNA binding [GO:0000049]; tRNA nucleotidyltransferase activity [GO:0009022]; mitochondrial tRNA 3'-end processing [GO:1990180]; tRNA 3'-terminal CCA addition [GO:0001680]; tRNA processing [GO:0008033],NA,NA,NA
CHOYP_TRPM3.1.7.m.9000,-0.00920347872284989,0.00809643311432822,No,NA,NA,A8DYE2,NA,NA,NA,cation channel complex [GO:0034703]; divalent inorganic cation transmembrane transporter activity [GO:0072509]; intracellular phosphatidylinositol-3;5-bisphosphate-sensitive cation channel activity [GO:0097682]; zinc ion transmembrane transporter activity [GO:0005385]; cation transmembrane transport [GO:0098655]; divalent metal ion transport [GO:0070838]; magnesium ion homeostasis [GO:0010960]; protein tetramerization [GO:0051262]; zinc ion homeostasis [GO:0055069],NA,NA,NA
CHOYP_TRPM3.3.7.m.16169,0.00529524603671739,-0.00680078314421828,No,NA,NA,Q9HCF6,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; calcium ion transmembrane transport [GO:0070588]; cation transport [GO:0006812]; detection of temperature stimulus [GO:0016048]; protein tetramerization [GO:0051262]; sensory perception of temperature stimulus [GO:0050951],NA,NA,NA
CHOYP_TRPM3.7.7.m.59826,0.00535420989584621,-0.00622033802553883,No,NA,NA,Q9HCF6,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; calcium ion transmembrane transport [GO:0070588]; cation transport [GO:0006812]; detection of temperature stimulus [GO:0016048]; protein tetramerization [GO:0051262]; sensory perception of temperature stimulus [GO:0050951],NA,NA,NA
CHOYP_TRRAP.1.2.m.339,0.00859648155458348,-0.0125001717670958,No,NA,NA,Q8I8U7,NA,NA,NA,cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; SAGA complex [GO:0000124]; transcription coregulator activity [GO:0003712]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; histone H3 acetylation [GO:0043966]; mitotic cytokinesis [GO:0000281]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of transcription; DNA-templated [GO:0006355]; transcription; DNA-templated [GO:0006351]; wing disc pattern formation [GO:0035222],NA,NA,NA
CHOYP_TRXR2.1.1.m.10443,-0.00623665375266676,0.00336847885380104,No,NA,NA,Q9JLT4,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; protein homodimerization activity [GO:0042803]; thioredoxin-disulfide reductase activity [GO:0004791]; cell redox homeostasis [GO:0045454]; heart development [GO:0007507]; hemopoiesis [GO:0030097]; response to oxygen radical [GO:0000305],NA,NA,NA
CHOYP_TS101.4.4.m.57290,-0.00237167041359502,0.00427020313390607,No,NA,NA,Q61187,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; microtubule organizing center [GO:0005815]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium-dependent protein binding [GO:0048306]; nuclear receptor transcription coactivator activity [GO:0030374]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; virion binding [GO:0046790]; cell cycle arrest [GO:0007050]; cell differentiation [GO:0030154]; cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; exosomal secretion [GO:1990182]; extracellular transport [GO:0006858]; keratinocyte differentiation [GO:0030216]; negative regulation of cell proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; positive regulation of viral process [GO:0048524]; positive regulation of viral release from host cell [GO:1902188]; protein monoubiquitination [GO:0006513]; protein transport [GO:0015031]; regulation of cell growth [GO:0001558]; regulation of extracellular exosome assembly [GO:1903551]; regulation of MAP kinase activity [GO:0043405]; regulation of viral budding via host ESCRT complex [GO:1903772]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755],NA,NA,NA
CHOYP_TSC1.1.1.m.5136,0.0075704091885751,-0.00775365533958609,No,NA,NA,Q9Z136,NA,NA,NA,actin filament [GO:0005884]; cell cortex [GO:0005938]; cell projection [GO:0042995]; chaperone complex [GO:0101031]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; lipid droplet [GO:0005811]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; TSC1-TSC2 complex [GO:0033596]; ATPase inhibitor activity [GO:0042030]; chaperone binding [GO:0051087]; GTPase activating protein binding [GO:0032794]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; protein N-terminus binding [GO:0047485]; activation of GTPase activity [GO:0090630]; adaptive immune response [GO:0002250]; adult locomotory behavior [GO:0008344]; cardiac muscle cell differentiation [GO:0055007]; cell projection organization [GO:0030030]; cell-matrix adhesion [GO:0007160]; cellular response to oxygen-glucose deprivation [GO:0090650]; cerebral cortex development [GO:0021987]; glucose import [GO:0046323]; hippocampus development [GO:0021766]; kidney development [GO:0001822]; memory T cell differentiation [GO:0043379]; myelination [GO:0042552]; negative regulation of ATPase activity [GO:0032780]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of GTPase activity [GO:0034260]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron projection development [GO:0010977]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of TOR signaling [GO:0032007]; negative regulation of translation [GO:0017148]; neural tube closure [GO:0001843]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of macroautophagy [GO:0016239]; positive regulation of stress fiber assembly [GO:0051496]; potassium ion transport [GO:0006813]; protein heterooligomerization [GO:0051291]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; regulation of focal adhesion assembly [GO:0051893]; regulation of neuron death [GO:1901214]; regulation of phosphoprotein phosphatase activity [GO:0043666]; regulation of protein kinase activity [GO:0045859]; response to insulin [GO:0032868]; rRNA export from nucleus [GO:0006407]; synapse organization [GO:0050808],NA,NA,NA
CHOYP_TSIB_0893.1.1.m.10314,-0.00821433213522154,0.000115312071913897,No,NA,NA,P0AGF9,NA,NA,NA,L-serine ammonia-lyase activity [GO:0003941]; L-threonine ammonia-lyase activity [GO:0004794]; nucleotide binding [GO:0000166]; pyridoxal phosphate binding [GO:0030170]; L-threonine catabolic process to propionate [GO:0070689],NA,NA,NA
CHOYP_TSN3.1.1.m.57074,0.00217997094733793,-0.00807271368859912,No,NA,NA,Q6NWG0,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; cell surface receptor signaling pathway [GO:0007166]; multicellular organism development [GO:0007275]; pigmentation [GO:0043473],NA,NA,NA
CHOYP_TSP_00320.1.1.m.7280,-0.00636201176612921,0.00393517507878606,No,NA,NA,Q2HJC9,NA,NA,NA,cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; neuronal ribonucleoprotein granule [GO:0071598]; nuclear speck [GO:0016607]; double-stranded DNA binding [GO:0003690]; ribonucleoprotein complex binding [GO:0043021]; activation of innate immune response [GO:0002218]; alternative mRNA splicing; via spliceosome [GO:0000380]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; neuron projection development [GO:0031175]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of type I interferon production [GO:0032481]; regulation of dendrite morphogenesis [GO:0048814]; regulation of RNA splicing [GO:0043484],NA,NA,NA
CHOYP_TSP_02835.1.1.m.26375,-0.0155020910749703,-0.00991861770589,No,NA,NA,O01814,NA,NA,NA,nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; fatty acid binding [GO:0005504],NA,NA,NA
CHOYP_TSP_03740.1.1.m.61194,0.0210783397549984,-0.00851515883385378,No,NA,NA,P24367,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; protein-containing complex [GO:0032991]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; unfolded protein binding [GO:0051082]; chaperone-mediated protein folding [GO:0061077]; negative regulation of collagen fibril organization [GO:1904027]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026],NA,NA,NA
CHOYP_TSP_06726.1.1.m.7470,-0.00799576045592471,-0.00236876818270713,No,NA,NA,Q3ZBG5,NA,NA,NA,axon [GO:0030424]; chaperone complex [GO:0101031]; dendritic microtubule [GO:1901588]; adenyl-nucleotide exchange factor activity [GO:0000774]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; tau protein binding [GO:0048156]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of protein binding [GO:0032091]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein processing [GO:0010954]; protein metabolic process [GO:0019538]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_TSP_07884.1.1.m.41175,0.00394536801625317,0.00291369700370642,No,NA,NA,Q96KE9,NA,NA,NA,cytosol [GO:0005829]; neurogenesis [GO:0022008]; post-translational protein modification [GO:0043687],NA,NA,NA
CHOYP_TSP_09282.1.1.m.18814,-0.0128580710060039,-0.00563409123422761,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TSP_10783.1.2.m.5651,0.0065883263884642,0.0180931628217626,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TSP_10831.1.1.m.47028,-0.0226396408678544,0.0101542639119165,No,NA,NA,Q18206,NA,NA,NA,extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; molting cycle; collagen and cuticulin-based cuticle [GO:0018996]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_TSP1.1.1.m.43967,0.00678620130084429,0.00878741825264137,No,NA,NA,P30151,NA,NA,NA,eukaryotic translation elongation factor 1 complex [GO:0005853]; translation elongation factor activity [GO:0003746],NA,NA,NA
CHOYP_TSPAN18A.2.2.m.50689,0.00703889607451694,-0.00415492252668526,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TSSC1.1.1.m.66470,-0.00156529661681824,-0.00774132036353419,No,NA,NA,Q6DUZ9,NA,NA,NA,,NA,NA,NA
CHOYP_TT30A.1.1.m.28332,-0.014077714264508,-0.00147530526797913,No,NA,NA,Q6INU8,NA,NA,NA,axonemal microtubule [GO:0005879]; cilium [GO:0005929]; transporter activity [GO:0005215]; intraciliary transport [GO:0042073]; protein polyglutamylation [GO:0018095],NA,NA,NA
CHOYP_TT39C.1.1.m.6317,0.00491588973115351,-0.000600714720400961,No,NA,NA,Q8N584,NA,NA,NA,,NA,NA,NA
CHOYP_TTC1.1.2.m.53162,-0.000326727305886641,-0.0163588216682494,No,NA,NA,Q3ZBR5,NA,NA,NA,cytosol [GO:0005829],NA,NA,NA
CHOYP_TTC12.1.1.m.14571,0.00011230781048104,-0.0125317976530634,No,NA,NA,Q9H892,NA,NA,NA,centrosome [GO:0005813],NA,NA,NA
CHOYP_TTC14.1.1.m.54084,-0.00225317952895796,0.000789324528208947,No,NA,NA,Q9CSP9,NA,NA,NA,nucleic acid binding [GO:0003676],NA,NA,NA
CHOYP_TTC28.1.1.m.51607,0.0087979495797135,0.00723965437810208,No,NA,NA,Q96AY4,NA,NA,NA,cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922]; kinase binding [GO:0019900]; cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346],NA,NA,NA
CHOYP_TTC38.1.1.m.27111,0.0153790249855749,-0.0105925882681982,No,NA,NA,A3KPN8,NA,NA,NA,,NA,NA,NA
CHOYP_TTC4.1.1.m.16365,0.00272199896280724,-0.0150933407268764,No,NA,NA,O95801,NA,NA,NA,,NA,NA,NA
CHOYP_TTC8.1.1.m.35457,-0.0117045621157787,0.0151893957717712,No,NA,NA,Q8TAM2,NA,NA,NA,BBSome [GO:0034464]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytosol [GO:0005829]; non-motile cilium [GO:0097730]; RNA polymerase II repressing transcription factor binding [GO:0001103]; cilium assembly [GO:0060271]; establishment of anatomical structure orientation [GO:0048560]; non-motile cilium assembly [GO:1905515]; protein transport [GO:0015031]; sensory processing [GO:0050893],NA,NA,NA
CHOYP_TTHERM_00599920.1.1.m.38926,0.00491588973115351,-0.000600714720400962,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TTL11.1.1.m.51011,-0.00212078832001384,-0.00891837260408135,No,NA,NA,Q6DIB5,NA,NA,NA,cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; complement component C1q binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast migration [GO:0051451]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_TTL12.1.1.m.6226,0.0153111810618367,-0.00258876091682342,No,NA,NA,Q3UDE2,NA,NA,NA,ATP binding [GO:0005524]; cellular protein modification process [GO:0006464],NA,NA,NA
CHOYP_TTN.2.9.m.17508,0.0065883263884642,0.0180931628217626,No,NA,NA,A2ASS6,NA,NA,NA,A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; telethonin binding [GO:0031433]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_TUT4.2.2.m.35505,-0.00796845272163563,0.0130125572622958,No,NA,NA,Q5TAX3,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleolus [GO:0005730]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; RNA uridylyltransferase activity [GO:0050265]; zinc ion binding [GO:0008270]; miRNA catabolic process [GO:0010587]; miRNA metabolic process [GO:0010586]; negative regulation of transposition; RNA-mediated [GO:0010526]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; oocyte maturation [GO:0001556]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; pre-miRNA processing [GO:0031054]; RNA 3' uridylation [GO:0071076]; RNA 3'-end processing [GO:0031123]; stem cell population maintenance [GO:0019827],NA,NA,NA
CHOYP_TVAG_008910.1.4.m.27225,0.00364778592941831,-0.00872052841558097,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_008910.2.4.m.37672,0.00217997094733793,-0.00807271368859912,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_012450.7.8.m.63509,-0.0120063849896392,-0.0008490849720115,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_020440.14.21.m.33137,0.00678620130084429,0.00878741825264137,No,NA,NA,P16157,NA,NA,NA,axolemma [GO:0030673]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_TVAG_087170.4.8.m.31291,0.00481559408396538,0.00783069609842799,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_087170.6.8.m.41156,-0.0041773132504905,-0.0165912451188287,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_087500.3.4.m.52917,-0.00775513546592108,0.00610948792136781,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_087500.4.4.m.60594,0.00653972277109614,-0.000361627005949535,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_098350.1.1.m.14015,0.00615966897194063,0.00941964587728867,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_106580.1.1.m.44429,0.019778002185641,-0.0137352820186708,No,NA,NA,H2A0M0,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_TVAG_110290.2.8.m.6221,-0.00513120360336767,0.00897258604975136,No,NA,NA,Q14980,NA,NA,NA,cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; chromosome [GO:0005694]; cortical microtubule [GO:0055028]; cytoplasm [GO:0005737]; cytoplasmic microtubule bundle [GO:1905720]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extrinsic component of plasma membrane [GO:0019897]; Golgi membrane [GO:0000139]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; microtubule bundle [GO:0097427]; microtubule minus-end [GO:0036449]; microtubule plus-end [GO:0035371]; mitotic spindle [GO:0072686]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole [GO:0097431]; neuronal cell body [GO:0043025]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; spindle pole centrosome [GO:0031616]; disordered domain specific binding [GO:0097718]; dynein complex binding [GO:0070840]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; microtubule plus-end binding [GO:0051010]; phosphatidylinositol binding [GO:0035091]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198]; tubulin binding [GO:0015631]; anastral spindle assembly [GO:0055048]; astral microtubule organization [GO:0030953]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; meiotic cell cycle [GO:0051321]; microtubule bundle formation [GO:0001578]; nucleus organization [GO:0006997]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of chromosome separation [GO:1905820]; positive regulation of hair follicle development [GO:0051798]; positive regulation of intracellular transport [GO:0032388]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of mitotic spindle elongation [GO:1902846]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of protein localization to spindle pole body [GO:1902365]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236],NA,NA,NA
CHOYP_TVAG_117920.1.1.m.65694,0.00858669665434248,-0.00257767549409974,No,NA,NA,Q4UMH6,NA,NA,NA,guanosine tetraphosphate metabolic process [GO:0015969],NA,NA,NA
CHOYP_TVAG_127540.1.10.m.21803,0.00678620130084429,0.00878741825264137,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_166520.1.2.m.37665,0.00520565898313766,0.00257946416052501,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_168130.1.2.m.10205,-0.0222718116365482,0.010654779964199,No,NA,NA,O00461,NA,NA,NA,cis-Golgi network [GO:0005801]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; transport vesicle [GO:0030133],NA,NA,NA
CHOYP_TVAG_193760.1.4.m.10065,0.00887523500131194,-0.00941359339404075,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_199400.1.1.m.52426,-0.0169591047060434,0.00960206869202777,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_216960.2.4.m.29368,-0.00993627311666223,-0.0150815956691529,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_268110.1.13.m.574,0.0109909159455919,-0.00652644303669652,No,NA,NA,Q96SN8,NA,NA,NA,cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]; mitotic spindle pole [GO:0097431]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]; calmodulin binding [GO:0005516]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; transcription regulatory region DNA binding [GO:0044212]; tubulin binding [GO:0015631]; brain development [GO:0007420]; centriole replication [GO:0007099]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment of mitotic spindle orientation [GO:0000132]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule organizing center organization [GO:0031023]; negative regulation of centriole replication [GO:0046600]; negative regulation of neuron differentiation [GO:0045665]; neurogenesis [GO:0022008]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]; regulation of neuron differentiation [GO:0045664],NA,NA,NA
CHOYP_TVAG_268110.13.13.m.65590,0.012319292226827,0.0233317307986079,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_283050.1.1.m.65542,0.00362526635968507,0.000263477112938699,No,NA,NA,O75832,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA damage response; signal transduction by p53 class mediator [GO:0043518]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; post-translational protein modification [GO:0043687]; proteasome regulatory particle assembly [GO:0070682]; protein deubiquitination [GO:0016579],NA,NA,NA
CHOYP_TVAG_286470.1.2.m.41541,-0.0105001198235392,0.00169243891680256,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_313830.1.4.m.32667,-0.00212078832001384,-0.00891837260408135,No,NA,NA,Q9VCA8,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; M band [GO:0031430]; Z disc [GO:0030018]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; antimicrobial humoral response [GO:0019730]; compound eye photoreceptor cell differentiation [GO:0001751]; flight [GO:0060361]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy of mitochondrion [GO:1903147]; sarcomere organization [GO:0045214]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_TVAG_355490.1.22.m.8202,0.0118682918349257,0.00322256049335053,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_355490.12.22.m.45126,0.00217997094733793,-0.00807271368859912,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_355490.15.22.m.47579,-0.0150680398702719,-0.0173921042468917,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_355490.16.22.m.50235,-0.00434283718457535,-0.0081645211287316,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_355490.19.22.m.56184,-0.00405570469847323,0.0102484140640778,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_355490.2.22.m.9582,-0.00123667118152368,-0.00772922865389194,No,NA,NA,P49454,NA,NA,NA,axoneme [GO:0005930]; centrosome [GO:0005813]; chromosome; centromeric region [GO:0000775]; ciliary basal body [GO:0036064]; ciliary transition fiber [GO:0097539]; condensed chromosome outer kinetochore [GO:0000940]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; spindle [GO:0005819]; spindle pole [GO:0000922]; chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; transcription factor binding [GO:0008134]; cell differentiation [GO:0030154]; cell division [GO:0051301]; cell proliferation [GO:0008283]; chromosome segregation [GO:0007059]; DNA biosynthetic process [GO:0071897]; kidney development [GO:0001822]; kinetochore assembly [GO:0051382]; metaphase plate congression [GO:0051310]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint [GO:0007094]; muscle organ development [GO:0007517]; negative regulation of transcription; DNA-templated [GO:0045892]; protein transport [GO:0015031]; regulation of cell cycle [GO:0051726]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of striated muscle tissue development [GO:0016202]; response to drug [GO:0042493]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_TVAG_355490.3.22.m.9919,0.0065883263884642,0.0180931628217626,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_355490.4.22.m.10865,0.000336712187399209,-0.0187396584015592,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_355490.5.22.m.11608,-0.00884864369930238,-0.01165563629927,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_355490.6.22.m.13410,-0.016920473263654,-0.00358142966813997,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_355490.7.22.m.16997,0.00431319655798367,0.0042076700108841,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_399490.1.3.m.7885,0.00615966897194063,0.00941964587728867,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_399490.2.3.m.26257,-0.00614462251090636,0.0195507521494923,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_407710.2.4.m.6401,-0.0141674036860379,0.0112443850626439,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_407710.4.4.m.62673,0.0203168617033753,0.001978945140583,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_410100.4.6.m.41037,-0.0166302664278706,-0.00497137622175822,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_417100.1.2.m.19129,0.00479504329905782,-0.00986917166254194,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_480920.2.3.m.38258,0.00561150807635947,-0.00396682910789086,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TWF1.1.1.m.62154,0.00488690702690669,0.0100964309446307,No,NA,NA,Q91YR1,NA,NA,NA,actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium [GO:0030175]; myofibril [GO:0030016]; perinuclear region of cytoplasm [GO:0048471]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; actin filament depolymerization [GO:0030042]; barbed-end actin filament capping [GO:0051016]; negative regulation of actin filament polymerization [GO:0030837]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of neuron projection development [GO:0010976]; regulation of actin phosphorylation [GO:0043538]; regulation of lamellipodium assembly [GO:0010591]; sequestering of actin monomers [GO:0042989],NA,NA,NA
CHOYP_TXN4A.1.2.m.59542,-0.000922398509689539,0.00559891551867159,No,NA,NA,P83877,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_TXND3.1.4.m.3505,-0.0190972135236512,0.00373081266292242,No,NA,NA,Q95YJ5,NA,NA,NA,cell [GO:0005623]; nucleoside diphosphate kinase activity [GO:0004550]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228],NA,NA,NA
CHOYP_TXND3.2.4.m.21415,-0.0175358816754898,0.014112824371765,No,NA,NA,P90666,NA,NA,NA,cell [GO:0005623]; nucleoside diphosphate kinase activity [GO:0004550]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228],NA,NA,NA
CHOYP_TXND3.4.4.m.64014,0.021350150516943,-0.0115043531710046,No,NA,NA,P90666,NA,NA,NA,cell [GO:0005623]; nucleoside diphosphate kinase activity [GO:0004550]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228],NA,NA,NA
CHOYP_TXNDC9.1.1.m.22863,-0.0185578247331148,0.000182747022259442,No,NA,NA,O18883,NA,NA,NA,cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; cell redox homeostasis [GO:0045454],NA,NA,NA
CHOYP_TYRO.1.1.m.38876,0.0203896043063122,-0.0108249842139981,No,NA,NA,P86952,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_TYRO1.2.6.m.42960,0.00584937082253515,-0.0259600309185081,No,NA,NA,H2A0L1,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_TYRO1.5.6.m.44175,0.00205195042830452,-0.00934116934689426,No,NA,NA,H2A0L0,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_TYRO1.6.6.m.44318,0.0221970096880489,-0.0132064875812458,No,NA,NA,H2A0L0,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_U2AF2.1.1.m.30416,0.00293725749723685,-0.00662847619549621,No,NA,NA,Q24562,NA,NA,NA,commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U2-type prespliceosome [GO:0071004]; U2AF [GO:0089701]; mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; nuclear export [GO:0051168]; positive regulation of RNA export from nucleus [GO:0046833]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_U5S1.1.1.m.49230,-0.00831675221333498,-0.0244826745937674,No,NA,NA,Q15029,NA,NA,NA,Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; U5 snRNA binding [GO:0030623]; cellular response to drug [GO:0035690]; mRNA processing [GO:0006397]; mRNA splicing; via spliceosome [GO:0000398]; response to cocaine [GO:0042220]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_U728.1.1.m.63184,-0.0155463135669397,-0.0134593529513474,No,NA,NA,B6LS00,NA,NA,NA,,NA,NA,NA
CHOYP_UAFA.3.8.m.34702,-0.000761422643624678,0.0125361732502562,No,NA,NA,P11137,NA,NA,NA,apical distal dendrite [GO:0150014]; axon hillock [GO:0043203]; axon initial segment [GO:0043194]; basal dendrite [GO:0097441]; CA3 pyramidal cell dendrite [GO:0097442]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; dendritic branch [GO:0044307]; dendritic filopodium [GO:1902737]; dendritic growth cone [GO:0044294]; dendritic shaft [GO:0043198]; distal dendrite [GO:0150002]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear periphery [GO:0034399]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]; primary dendrite [GO:0150001]; proximal dendrite [GO:1990635]; proximal neuron projection [GO:1990769]; calmodulin binding [GO:0005516]; dystroglycan binding [GO:0002162]; microtubule binding [GO:0008017]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]; axonogenesis [GO:0007409]; cellular response to organic substance [GO:0071310]; central nervous system neuron development [GO:0021954]; dendrite development [GO:0016358]; dendrite morphogenesis [GO:0048813]; establishment of cell polarity [GO:0030010]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of axon extension [GO:0030517]; negative regulation of microtubule binding [GO:1904527]; negative regulation of microtubule motor activity [GO:2000575]; negative regulation of microtubule polymerization [GO:0031115]; neuron projection development [GO:0031175]; positive regulation of anterograde dense core granule transport [GO:1901953]; positive regulation of anterograde synaptic vesicle transport [GO:1903744]; regulation of cellular protein localization [GO:1903827]; regulation of microtubule polymerization [GO:0031113]; regulation of organelle transport along microtubule [GO:1902513],NA,NA,NA
CHOYP_UAFA.6.8.m.45002,-0.0108645321027268,-0.00449426636117819,No,NA,NA,P11137,NA,NA,NA,apical distal dendrite [GO:0150014]; axon hillock [GO:0043203]; axon initial segment [GO:0043194]; basal dendrite [GO:0097441]; CA3 pyramidal cell dendrite [GO:0097442]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; dendritic branch [GO:0044307]; dendritic filopodium [GO:1902737]; dendritic growth cone [GO:0044294]; dendritic shaft [GO:0043198]; distal dendrite [GO:0150002]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear periphery [GO:0034399]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]; primary dendrite [GO:0150001]; proximal dendrite [GO:1990635]; proximal neuron projection [GO:1990769]; calmodulin binding [GO:0005516]; dystroglycan binding [GO:0002162]; microtubule binding [GO:0008017]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]; axonogenesis [GO:0007409]; cellular response to organic substance [GO:0071310]; central nervous system neuron development [GO:0021954]; dendrite development [GO:0016358]; dendrite morphogenesis [GO:0048813]; establishment of cell polarity [GO:0030010]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of axon extension [GO:0030517]; negative regulation of microtubule binding [GO:1904527]; negative regulation of microtubule motor activity [GO:2000575]; negative regulation of microtubule polymerization [GO:0031115]; neuron projection development [GO:0031175]; positive regulation of anterograde dense core granule transport [GO:1901953]; positive regulation of anterograde synaptic vesicle transport [GO:1903744]; regulation of cellular protein localization [GO:1903827]; regulation of microtubule polymerization [GO:0031113]; regulation of organelle transport along microtubule [GO:1902513],NA,NA,NA
CHOYP_UB2D2.1.1.m.56387,0.00611348559690171,-0.010052584893191,No,NA,NA,P62840,NA,NA,NA,ATP binding [GO:0005524]; transferase activity [GO:0016740]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_UB2G2.1.1.m.7534,-0.0112761937352606,0.00124225861663206,No,NA,NA,Q5RF84,NA,NA,NA,ATP binding [GO:0005524]; ubiquitin-protein transferase activity [GO:0004842]; protein K48-linked ubiquitination [GO:0070936]; protein N-linked glycosylation via asparagine [GO:0018279]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_UB2R2.1.1.m.18979,-0.00856673703717516,0.00296327677696244,No,NA,NA,Q8CFI2,NA,NA,NA,cytosol [GO:0005829]; nuclear speck [GO:0016607]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle [GO:0007049]; cellular response to interferon-beta [GO:0035458]; negative regulation of cAMP-mediated signaling [GO:0043951]; positive regulation of inclusion body assembly [GO:0090261]; positive regulation of neuron apoptotic process [GO:0043525]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBA1.2.2.m.30036,0.0028831277524959,0.0197916417810556,No,NA,NA,Q5U300,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; desmosome [GO:0030057]; endosome membrane [GO:0010008]; heterochromatin [GO:0000792]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; rough endoplasmic reticulum membrane [GO:0030867]; ATP binding [GO:0005524]; ubiquitin activating enzyme activity [GO:0004839]; cellular response to DNA damage stimulus [GO:0006974]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_UBA3.1.1.m.59856,0.00371116501209973,-0.00903488054633778,No,NA,NA,Q8C878,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; acid-amino acid ligase activity [GO:0016881]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; NEDD8 activating enzyme activity [GO:0019781]; nuclear receptor binding [GO:0016922]; protein heterodimerization activity [GO:0046982]; endomitotic cell cycle [GO:0007113]; mitotic cell cycle [GO:0000278]; negative regulation of transcription; DNA-templated [GO:0045892]; protein modification by small protein conjugation [GO:0032446]; protein neddylation [GO:0045116]; regulation of cell cycle [GO:0051726],NA,NA,NA
CHOYP_UBA5.1.2.m.8624,0.0136888252732074,-0.0136546300095662,No,NA,NA,A7MAZ3,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; UFM1 activating enzyme activity [GO:0071566]; neuromuscular process [GO:0050905]; protein K69-linked ufmylation [GO:1990592]; protein modification by small protein conjugation [GO:0032446]; protein ufmylation [GO:0071569]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; response to endoplasmic reticulum stress [GO:0034976],NA,NA,NA
CHOYP_UBA6.3.4.m.53927,0.00961801275003642,-0.00934440411755598,No,NA,NA,Q8C7R4,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; FAT10 activating enzyme activity [GO:0019780]; ubiquitin activating enzyme activity [GO:0004839]; amygdala development [GO:0021764]; dendritic spine development [GO:0060996]; hippocampus development [GO:0021766]; learning [GO:0007612]; locomotory behavior [GO:0007626]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBA6.4.4.m.63770,-0.00114504536470547,-0.00735706243339185,No,NA,NA,A0AVT1,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; FAT10 activating enzyme activity [GO:0019780]; ubiquitin activating enzyme activity [GO:0004839]; amygdala development [GO:0021764]; dendritic spine development [GO:0060996]; hippocampus development [GO:0021766]; learning [GO:0007612]; locomotory behavior [GO:0007626]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBC12.1.1.m.51806,0.00141018418646686,-0.0113576199412671,No,NA,NA,Q6P8D9,NA,NA,NA,ATP binding [GO:0005524]; NEDD8 transferase activity [GO:0019788]; ubiquitin-protein transferase activity [GO:0004842]; cellular protein modification process [GO:0006464]; protein neddylation [GO:0045116],NA,NA,NA
CHOYP_UBC2.1.3.m.24138,0.0030724662550445,0.0118645230569651,No,NA,NA,P35129,NA,NA,NA,chromosome [GO:0005694]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBC9B.1.1.m.10688,0.00174909326487801,0.0218178269249947,No,NA,NA,Q9DDJ0,NA,NA,NA,nucleus [GO:0005634]; ATP binding [GO:0005524]; SUMO conjugating enzyme activity [GO:0061656]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; definitive hemopoiesis [GO:0060216]; embryonic heart tube elongation [GO:0036306]; heart looping [GO:0001947]; protein sumoylation [GO:0016925],NA,NA,NA
CHOYP_UBCD1.1.2.m.50237,-0.00688942552280483,-0.00132430482162917,No,NA,NA,P62840,NA,NA,NA,ATP binding [GO:0005524]; transferase activity [GO:0016740]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_UBCD2.1.1.m.54558,-0.0121155900232872,-0.00901535303554604,No,NA,NA,P52485,NA,NA,NA,ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; lipid storage [GO:0019915]; protein polyubiquitination [GO:0000209],NA,NA,NA
CHOYP_UBCP1.1.1.m.7721,-0.010153528617351,-0.00936054489174222,No,NA,NA,Q641F1,NA,NA,NA,nucleus [GO:0005634]; phosphoprotein phosphatase activity [GO:0004721],NA,NA,NA
CHOYP_UBD2A.1.1.m.63050,-0.00958822388841078,0.00923612016893268,No,NA,NA,Q6IP57,NA,NA,NA,,NA,NA,NA
CHOYP_UBE2A.1.1.m.48761,0.00394766871453337,-0.0138042733925981,No,NA,NA,Q9Z255,NA,NA,NA,chromatin [GO:0000785]; HULC complex [GO:0033503]; nuclear chromatin [GO:0000790]; XY body [GO:0001741]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; blastocyst hatching [GO:0001835]; DNA repair [GO:0006281]; histone H2A ubiquitination [GO:0033522]; in utero embryonic development [GO:0001701]; maternal process involved in female pregnancy [GO:0060135]; positive regulation of cell proliferation [GO:0008284]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to UV [GO:0009411],NA,NA,NA
CHOYP_UBE2C.1.1.m.55757,-0.00197310243132633,-0.0202598195655309,No,NA,NA,P56616,NA,NA,NA,anaphase-promoting complex [GO:0005680]; ATP binding [GO:0005524]; transferase activity [GO:0016740]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; exit from mitosis [GO:0010458]; free ubiquitin chain polymerization [GO:0010994]; protein K11-linked ubiquitination [GO:0070979]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBE2H.1.1.m.49863,-0.018669741546993,-0.000668583778699547,No,NA,NA,P62257,NA,NA,NA,ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBE2N.1.1.m.62056,-0.0060005859385869,-0.00661228466112675,No,NA,NA,Q5R7J6,NA,NA,NA,cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; UBC13-MMS2 complex [GO:0031372]; UBC13-UEV1A complex [GO:0035370]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; DNA double-strand break processing [GO:0000729]; double-strand break repair via homologous recombination [GO:0000724]; histone ubiquitination [GO:0016574]; positive regulation of DNA repair [GO:0045739]; positive regulation of histone modification [GO:0031058]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; postreplication repair [GO:0006301]; protein K63-linked ubiquitination [GO:0070534]; regulation of histone ubiquitination [GO:0033182]; T cell receptor signaling pathway [GO:0050852]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBE2Z.1.1.m.61760,-0.0135725579708753,0.00388604629968508,No,NA,NA,Q66KB0,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; ubiquitin conjugating enzyme activity [GO:0061631]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBE4A.2.2.m.59113,0.00210223727657445,-0.00895305289671259,No,NA,NA,A5PKG6,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ubiquitin-ubiquitin ligase activity [GO:0034450]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_UBE4B.1.1.m.11223,-0.00338017847374296,0.00232665595587112,No,NA,NA,Q9ES00,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; unfolded protein binding [GO:0051082]; cellular protein catabolic process [GO:0044257]; granzyme-mediated apoptotic signaling pathway [GO:0008626]; neuron projection development [GO:0031175]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein folding [GO:0006457]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to endoplasmic reticulum stress [GO:0034976]; response to UV [GO:0009411]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; ventricular trabecula myocardium morphogenesis [GO:0003222],NA,NA,NA
CHOYP_UBL4A.2.2.m.18059,0.00253690118323149,0.00420271405912517,No,NA,NA,A4QND0,NA,NA,NA,BAT3 complex [GO:0071818]; cytosol [GO:0005829]; nucleus [GO:0005634]; tail-anchored membrane protein insertion into ER membrane [GO:0071816],NA,NA,NA
CHOYP_UBL5.3.5.m.41673,-0.00755280846344544,0.00404629338883428,No,NA,NA,Q791B0,NA,NA,NA,cytoplasm [GO:0005737]; cellular protein modification process [GO:0006464],NA,NA,NA
CHOYP_UBP10.1.1.m.10603,0.000178350472979442,-0.0216159792633667,No,NA,NA,Q6DIJ4,NA,NA,NA,cytoplasm [GO:0005737]; early endosome [GO:0005769]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; ion channel binding [GO:0044325]; p53 binding [GO:0002039]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; autophagy [GO:0006914]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to interleukin-1 [GO:0071347]; DNA damage response; signal transduction by p53 class mediator [GO:0030330]; DNA repair [GO:0006281]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; protein deubiquitination [GO:0016579]; regulation of autophagy [GO:0010506]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBP15.4.4.m.56615,0.0150984704977191,-0.000403491357892816,No,NA,NA,Q9R085,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; BMP signaling pathway [GO:0030509]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; monoubiquitinated protein deubiquitination [GO:0035520]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; protein deubiquitination [GO:0016579]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBP19.1.1.m.55642,-0.00060418881324088,-0.0144009154487495,No,NA,NA,O94966,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; Hsp90 protein binding [GO:0051879]; Lys48-specific deubiquitinase activity [GO:1990380]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of skeletal muscle tissue development [GO:0048642]; positive regulation of cell cycle process [GO:0090068]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of cellular response to hypoxia [GO:1900037]; regulation of ERAD pathway [GO:1904292]; regulation of protein stability [GO:0031647]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_UBP20.2.2.m.51412,-0.0102564906022329,-0.0231558386571306,No,NA,NA,Q9Y2K6,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; cysteine-type endopeptidase activity [GO:0004197]; G protein-coupled receptor binding [GO:0001664]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; zinc ion binding [GO:0008270]; endocytosis [GO:0006897]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBP24.1.1.m.54945,0.0155856955329284,-0.0184875815892979,No,NA,NA,Q9UPU5,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBP25.1.1.m.61531,-0.00485947843499144,-0.0144720367227921,No,NA,NA,P57080,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; ATPase binding [GO:0051117]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of ERAD pathway [GO:1904293]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBP32.1.1.m.56373,0.00447220620886629,-0.00410601632029031,No,NA,NA,Q8NFA0,NA,NA,NA,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBP34.1.1.m.55124,-0.0186053010606755,-0.00952301340999945,No,NA,NA,Q70CQ2,NA,NA,NA,cytosol [GO:0005829]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_UBP47.1.2.m.66121,-0.0147354331860586,-0.00889006990220752,No,NA,NA,Q8BY87,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitinyl hydrolase activity [GO:0101005]; WD40-repeat domain binding [GO:0071987]; base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; protein deubiquitination [GO:0016579]; regulation of protein stability [GO:0031647]; response to drug [GO:0042493]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBP47.2.2.m.66754,-0.00214063877806962,-0.0214911115004156,No,NA,NA,A4II09,NA,NA,NA,eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex; eIF3e [GO:0071540]; eukaryotic translation initiation factor 3 complex; eIF3m [GO:0071541]; multi-eIF complex [GO:0043614]; mRNA binding [GO:0003729]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; translation reinitiation [GO:0002188],NA,NA,NA
CHOYP_UBP48.1.1.m.25564,-0.00496101544160361,-0.00547320805739738,No,NA,NA,Q86UV5,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBQL4.1.1.m.37426,0.00034059568583829,-0.0252564869156385,No,NA,NA,Q8R317,NA,NA,NA,aggresome [GO:0016235]; autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; intermediate filament binding [GO:0019215]; kinase binding [GO:0019900]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein domain specific binding [GO:0019904]; signaling receptor binding [GO:0005102]; aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; macroautophagy [GO:0016236]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_UBQL4.1.1.m.37429,-0.0194456841255077,-0.00533373002133883,No,NA,NA,Q6DEB4,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; phosphatase inhibitor activity [GO:0019212]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]; cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278],NA,NA,NA
CHOYP_UBR2.2.2.m.54412,-0.0145742205128518,-0.00966984611161233,No,NA,NA,Q6WKZ8,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; leucine binding [GO:0070728]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to leucine [GO:0071233]; chromatin silencing [GO:0006342]; histone H2A ubiquitination [GO:0033522]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transposition [GO:0010529]; protein ubiquitination [GO:0016567]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596],NA,NA,NA
CHOYP_UBR3.1.1.m.43346,0.00319362378554431,-0.0135630032363441,No,NA,NA,Q5U430,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; ubiquitin ligase complex [GO:0000151]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; embryo development ending in birth or egg hatching [GO:0009792]; in utero embryonic development [GO:0001701]; olfactory behavior [GO:0042048]; protein ubiquitination [GO:0016567]; sensory perception of smell [GO:0007608]; suckling behavior [GO:0001967]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596],NA,NA,NA
CHOYP_UBR4.1.1.m.34997,-0.00519090963278302,0.00574184472561891,No,NA,NA,Q5T4S7,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; calmodulin binding [GO:0005516]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; neutrophil degranulation [GO:0043312]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032],NA,NA,NA
CHOYP_UBR5.1.1.m.44200,-0.00942179419107936,-0.015569161064006,No,NA,NA,Q80TP3,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; negative regulation of interleukin-17 secretion [GO:1905077]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; positive regulation of protein import into nucleus; translocation [GO:0033160]; progesterone receptor signaling pathway [GO:0050847]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; regulation of protein stability [GO:0031647],NA,NA,NA
CHOYP_UBR7.1.1.m.7300,-0.0102389372421149,-0.00188432364044862,No,NA,NA,Q8N806,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_UBS3B.1.1.m.43636,0.00471461995130058,-0.0105233284430932,No,NA,NA,Q8TF42,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; phosphatase activity [GO:0016791]; phosphoprotein binding [GO:0051219]; protein tyrosine phosphatase activity [GO:0004725]; ubiquitin protein ligase binding [GO:0031625]; collagen-activated signaling pathway [GO:0038065]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; negative regulation of bone resorption [GO:0045779]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of signal transduction [GO:0009968]; peptidyl-tyrosine dephosphorylation [GO:0035335]; platelet aggregation [GO:0070527]; regulation of osteoclast differentiation [GO:0045670]; regulation of protein binding [GO:0043393]; regulation of release of sequestered calcium ion into cytosol [GO:0051279],NA,NA,NA
CHOYP_UBXN4.1.1.m.22642,0.00956003048303325,0.012601488160707,No,NA,NA,Q5R4I3,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_UBXN7.1.1.m.64349,-0.00549454049499065,0.00121998940597374,No,NA,NA,Q5REY7,NA,NA,NA,nuclear body [GO:0016604]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; transcription factor binding [GO:0008134]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625],NA,NA,NA
CHOYP_UCHL.1.1.m.29303,-0.00163316766954877,0.00645900196929586,No,NA,NA,O01391,NA,NA,NA,cytoplasm [GO:0005737]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UCHL5.2.2.m.46419,-0.00613640441753582,0.00892454920791673,No,NA,NA,Q9WUP7,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; Ino80 complex [GO:0031011]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; endopeptidase inhibitor activity [GO:0004866]; proteasome binding [GO:0070628]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; forebrain morphogenesis [GO:0048853]; lateral ventricle development [GO:0021670]; midbrain development [GO:0030901]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; protein deubiquitination [GO:0016579]; regulation of proteasomal protein catabolic process [GO:0061136]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UCK2.1.1.m.6328,-0.00277708836999381,-0.000372317804059865,No,NA,NA,B1H116,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; uridine kinase activity [GO:0004849]; CMP salvage [GO:0006238]; CTP salvage [GO:0044211]; UMP salvage [GO:0044206],NA,NA,NA
CHOYP_UFC1.1.2.m.6917,0.00369521868510183,0.00512990013973315,No,NA,NA,A7SM54,NA,NA,NA,UFM1 transferase activity [GO:0071568]; protein K69-linked ufmylation [GO:1990592],NA,NA,NA
CHOYP_UFD1L.1.1.m.43606,-0.00843048377133571,-0.00235851334458218,No,NA,NA,Q92890,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; UFD1-NPL4 complex [GO:0036501]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; ATPase binding [GO:0051117]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ER-associated misfolded protein catabolic process [GO:0071712]; error-free translesion synthesis [GO:0070987]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; retrograde protein transport; ER to cytosol [GO:0030970]; skeletal system development [GO:0001501]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UFL1.1.1.m.20000,0.0155529189757212,-0.00477088563719281,No,NA,NA,Q4R367,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; UFM1 transferase activity [GO:0071568]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein ubiquitination [GO:0031397]; protein K69-linked ufmylation [GO:1990592]; protein ufmylation [GO:0071569]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146],NA,NA,NA
CHOYP_UFSP2.1.1.m.36906,0.0129722622356472,-0.0218976987938866,No,NA,NA,Q9NUQ7,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; thiolester hydrolase activity [GO:0016790]; UFM1 hydrolase activity [GO:0071567]; proteolysis [GO:0006508]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146],NA,NA,NA
CHOYP_UGGG1.1.1.m.59266,0.00273828993495747,-0.0243697374295808,No,NA,NA,Q9JLA3,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; UDP-glucose:glycoprotein glucosyltransferase activity [GO:0003980]; unfolded protein binding [GO:0051082]; 'de novo' posttranslational protein folding [GO:0051084]; ER-associated misfolded protein catabolic process [GO:0071712]; protein folding [GO:0006457]; protein N-linked glycosylation via asparagine [GO:0018279],NA,NA,NA
CHOYP_UGPA.1.1.m.49579,0.0142506532034688,-0.00328085275536411,No,NA,NA,Q07130,NA,NA,NA,cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; UTP:glucose-1-phosphate uridylyltransferase activity [GO:0003983]; glycogen metabolic process [GO:0005977]; UDP-glucose metabolic process [GO:0006011],NA,NA,NA
CHOYP_UHRF1.1.1.m.10935,0.00766593899622272,0.0075780780073805,No,NA,NA,B6CHA3,NA,NA,NA,euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nuclear chromatin [GO:0000790]; replication fork [GO:0005657]; hemi-methylated DNA-binding [GO:0044729]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; histone ubiquitination [GO:0016574]; maintenance of DNA methylation [GO:0010216]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein autoubiquitination [GO:0051865]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UN45B.1.1.m.19072,-0.0021993553224201,-0.00424349210464787,No,NA,NA,D7REX8,NA,NA,NA,cytosol [GO:0005829]; Z disc [GO:0030018]; Hsp90 protein binding [GO:0051879]; cardiac muscle tissue development [GO:0048738]; chaperone-mediated protein folding [GO:0061077]; lens development in camera-type eye [GO:0002088]; muscle fiber development [GO:0048747]; myofibril assembly [GO:0030239]; skeletal muscle tissue development [GO:0007519],NA,NA,NA
CHOYP_UNC.89.1.2.m.1625,0.00312634405286648,-0.0128487940600689,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_UNC22.2.2.m.50516,0.00487541702279799,-0.00815397613809773,No,NA,NA,Q23551,NA,NA,NA,A band [GO:0031672]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; structural constituent of muscle [GO:0008307]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; muscle contraction [GO:0006936]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_UNC89.1.19.m.7848,-0.00115345029083027,-0.0149778803135115,No,NA,NA,A8T6P4,NA,NA,NA,cortical actin cytoskeleton [GO:0030864]; perinuclear region of cytoplasm [GO:0048471]; transport vesicle [GO:0030133]; actin binding [GO:0003779]; metal ion binding [GO:0046872]; myosin binding [GO:0017022]; Rab GTPase binding [GO:0017137]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_UNC89.15.19.m.55545,0.0110630101569232,0.00400426495984385,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_UNC89.16.19.m.57422,-0.00430894344577715,-0.00631540690244347,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_URIC.1.2.m.35940,0.00217997094733793,-0.00807271368859912,No,NA,NA,P09118,NA,NA,NA,peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; urate oxidase activity [GO:0004846]; purine nucleobase catabolic process [GO:0006145]; urate catabolic process [GO:0019628],NA,NA,NA
CHOYP_URIC.2.2.m.54754,-0.00305327000169985,-0.0174558394253375,No,NA,NA,P09118,NA,NA,NA,peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; urate oxidase activity [GO:0004846]; purine nucleobase catabolic process [GO:0006145]; urate catabolic process [GO:0019628],NA,NA,NA
CHOYP_USH1C.1.1.m.30582,0.0125924403632861,0.0175907795449547,No,NA,NA,Q9Y6N9,NA,NA,NA,apical part of cell [GO:0045177]; brush border [GO:0005903]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; microvillus [GO:0005902]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202]; actin filament binding [GO:0051015]; spectrin binding [GO:0030507]; actin filament bundle assembly [GO:0051017]; brush border assembly [GO:1904970]; cellular protein-containing complex assembly [GO:0034622]; equilibrioception [GO:0050957]; G2/M transition of mitotic cell cycle [GO:0000086]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; parallel actin filament bundle assembly [GO:0030046]; photoreceptor cell maintenance [GO:0045494]; protein localization to microvillus [GO:1904106]; regulation of microvillus length [GO:0032532]; retinal cone cell development [GO:0046549]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_USO1.1.11.m.6354,0.0213890290954917,-0.00476093060862495,No,NA,NA,Q9Z1Z0,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; ER to Golgi transport vesicle membrane [GO:0012507]; fibrillar center [GO:0001650]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; perinuclear region of cytoplasm [GO:0048471]; protein transporter activity [GO:0008565]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi vesicle docking [GO:0048211]; intracellular protein transport [GO:0006886]; membrane fusion [GO:0061025]; transcytosis [GO:0045056]; vesicle fusion with Golgi apparatus [GO:0048280],NA,NA,NA
CHOYP_USO1.11.11.m.64787,0.00394536801625317,0.00291369700370642,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_USO1.2.11.m.12785,-0.00693355988956327,0.002565124476331,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_USP2.1.1.m.44411,0.0129947752406265,-0.0136886577887186,No,NA,NA,H2A0M5,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_USP36.1.2.m.17402,0.00205195042830452,-0.00934116934689426,No,NA,NA,B1AQJ2,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; histone deubiquitination [GO:0016578]; negative regulation of macroautophagy [GO:0016242]; nucleolus organization [GO:0007000]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of protein stability [GO:0031647]; regulation of rRNA processing [GO:2000232]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UT14A.1.1.m.44047,0.00704997257517343,0.0236254091878466,No,NA,NA,Q3T0Q8,NA,NA,NA,nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_UTP20.2.4.m.1508,-0.00430894344577715,-0.00631540690244347,No,NA,NA,O75691,NA,NA,NA,90S preribosome [GO:0030686]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; preribosome; small subunit precursor [GO:0030688]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000472]; negative regulation of cell proliferation [GO:0008285]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_UUR10_0415.1.1.m.64919,0.0229773605022072,-0.00839837110027504,No,NA,NA,B8I6E7,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation initiation factor activity [GO:0003743],NA,NA,NA
CHOYP_VA0D1.1.2.m.31117,-0.00796195785138308,0.00201102679665563,No,NA,NA,Q9W4P5,NA,NA,NA,plasma membrane [GO:0005886]; plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; vacuolar proton-transporting V-type ATPase; V0 domain [GO:0000220]; proton-transporting ATPase activity; rotational mechanism [GO:0046961]; ATP hydrolysis coupled proton transport [GO:0015991]; cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; regulation of Notch signaling pathway [GO:0008593]; terminal branching; open tracheal system [GO:0007430]; vacuolar acidification [GO:0007035],NA,NA,NA
CHOYP_VAC14.1.1.m.31290,0.00448709860573269,-0.00402547685037932,No,NA,NA,Q66L58,NA,NA,NA,endosome membrane [GO:0010008]; extrinsic component of vacuolar membrane [GO:0000306]; PAS complex [GO:0070772]; phosphatidylinositol biosynthetic process [GO:0006661],NA,NA,NA
CHOYP_VASP.1.1.m.15245,0.00290251906233988,-0.00186840577211536,No,NA,NA,Q2TA49,NA,NA,NA,bicellular tight junction [GO:0005923]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium membrane [GO:0031527]; focal adhesion [GO:0005925]; lamellipodium membrane [GO:0031258]; actin binding [GO:0003779]; profilin binding [GO:0005522]; SH3 domain binding [GO:0017124]; actin polymerization or depolymerization [GO:0008154]; axon guidance [GO:0007411]; neural tube closure [GO:0001843]; positive regulation of actin filament polymerization [GO:0030838]; protein homotetramerization [GO:0051289],NA,NA,NA
CHOYP_VATA.1.1.m.44460,-0.00277068423065471,-0.0080432774823535,No,NA,NA,P38606,NA,NA,NA,apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; proton-transporting two-sector ATPase complex [GO:0016469]; proton-transporting V-type ATPase; V1 domain [GO:0033180]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; proton-transporting ATPase activity; rotational mechanism [GO:0046961]; ATP hydrolysis coupled proton transport [GO:0015991]; ATP metabolic process [GO:0046034]; cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; insulin receptor signaling pathway [GO:0008286]; ion transmembrane transport [GO:0034220]; regulation of macroautophagy [GO:0016241]; transferrin transport [GO:0033572],NA,NA,NA
CHOYP_VATB.1.2.m.33785,0.0177868636885333,0.000292850839581298,No,NA,NA,P31401,NA,NA,NA,proton-transporting V-type ATPase; V1 domain [GO:0033180]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; ATP hydrolysis coupled proton transport [GO:0015991]; ATP metabolic process [GO:0046034],NA,NA,NA
CHOYP_VATB.2.2.m.62084,-0.0192099052378888,-0.0176093807196516,No,NA,NA,Q8IYT3,NA,NA,NA,,NA,NA,NA
CHOYP_VATC1.1.1.m.38693,-0.0128942443721461,0.000518602333676457,No,NA,NA,Q5XH14,NA,NA,NA,proton-transporting V-type ATPase; V1 domain [GO:0033180]; proton transmembrane transporter activity [GO:0015078]; ATP hydrolysis coupled proton transport [GO:0015991],NA,NA,NA
CHOYP_VATD.2.2.m.64245,-0.00793075393217012,-0.0067474289162014,No,NA,NA,Q5RCS8,NA,NA,NA,centrosome [GO:0005813]; cilium [GO:0005929]; proton-transporting V-type ATPase complex [GO:0033176]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; cilium assembly [GO:0060271]; ion transport [GO:0006811]; protein localization to cilium [GO:0061512],NA,NA,NA
CHOYP_VATE.1.1.m.21420,-0.00292865493436432,0.00599588629147144,No,NA,NA,P54611,NA,NA,NA,plasma membrane [GO:0005886]; plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; vacuolar proton-transporting V-type ATPase; V1 domain [GO:0000221]; proton-transporting ATPase activity; rotational mechanism [GO:0046961]; apical protein localization [GO:0045176]; ATP hydrolysis coupled proton transport [GO:0015991]; liquid clearance; open tracheal system [GO:0035002]; terminal branching; open tracheal system [GO:0007430],NA,NA,NA
CHOYP_VATG.1.2.m.4407,0.00260894914308972,0.0110583732181344,No,NA,NA,Q25532,NA,NA,NA,apical plasma membrane [GO:0016324]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; proton transmembrane transport [GO:1902600],NA,NA,NA
CHOYP_VAV2.1.3.m.40262,-0.00978396773012467,0.0130581033998528,No,NA,NA,P52735,NA,NA,NA,cytosol [GO:0005829]; plasma membrane [GO:0005886]; epidermal growth factor receptor binding [GO:0005154]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphotyrosine residue binding [GO:0001784]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; angiogenesis [GO:0001525]; cell migration [GO:0016477]; ephrin receptor signaling pathway [GO:0048013]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; G protein-coupled receptor signaling pathway [GO:0007186]; lamellipodium assembly [GO:0030032]; platelet activation [GO:0030168]; positive regulation of apoptotic process [GO:0043065]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; regulation of cell size [GO:0008361]; regulation of GTPase activity [GO:0043087]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],NA,NA,NA
CHOYP_VAV2.3.3.m.62875,0.0066739396871538,-0.0079472284279258,No,NA,NA,P52735,NA,NA,NA,cytosol [GO:0005829]; plasma membrane [GO:0005886]; epidermal growth factor receptor binding [GO:0005154]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphotyrosine residue binding [GO:0001784]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; angiogenesis [GO:0001525]; cell migration [GO:0016477]; ephrin receptor signaling pathway [GO:0048013]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; G protein-coupled receptor signaling pathway [GO:0007186]; lamellipodium assembly [GO:0030032]; platelet activation [GO:0030168]; positive regulation of apoptotic process [GO:0043065]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; regulation of cell size [GO:0008361]; regulation of GTPase activity [GO:0043087]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],NA,NA,NA
CHOYP_VDE.1.1.m.30310,-0.00654014529154394,0.0145254852710903,No,NA,NA,Q40251,NA,NA,NA,chloroplast thylakoid membrane [GO:0009535]; violaxanthin de-epoxidase activity [GO:0046422],NA,NA,NA
CHOYP_VIGLN.1.2.m.34766,0.0167196572293404,0.00583939993491248,No,NA,NA,Q00341,NA,NA,NA,cytosol [GO:0005829]; high-density lipoprotein particle [GO:0034364]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; lipid binding [GO:0008289]; RNA binding [GO:0003723]; cholesterol metabolic process [GO:0008203]; high-density lipoprotein particle clearance [GO:0034384]; lipid transport [GO:0006869],NA,NA,NA
CHOYP_VIGLN.2.2.m.61191,-0.00466738778546464,-0.0220292086177575,No,NA,NA,Q61733,NA,NA,NA,mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; protein domain specific binding [GO:0019904]; structural constituent of ribosome [GO:0003735],NA,NA,NA
CHOYP_VIP2.1.1.m.54883,-0.0169591047060434,0.00960206869202777,No,NA,NA,Q9VR59,NA,NA,NA,cytosol [GO:0005829]; 5-diphosphoinositol pentakisphosphate 3-kinase activity [GO:0102092]; ATP binding [GO:0005524]; diphosphoinositol-pentakisphosphate kinase activity [GO:0033857]; inositol heptakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1;3;4;5;6-pentakisphosphate kinase activity [GO:0000827]; inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958],NA,NA,NA
CHOYP_VIR.1.1.m.51105,0.00315938351943035,-0.000659692562299156,No,NA,NA,A2AIV2,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; mRNA alternative polyadenylation [GO:0110104]; mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; multicellular organism development [GO:0007275]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_VMA5A.1.1.m.24860,0.00678620130084429,0.00878741825264137,No,NA,NA,O00534,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634],NA,NA,NA
CHOYP_VMP1.1.1.m.34831,0.00364778592941831,-0.00872052841558096,No,NA,NA,Q6INE8,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774],NA,NA,NA
CHOYP_VOLCADRAFT_121426.1.1.m.43175,-0.00832207442335569,0.00536142022837691,No,NA,NA,Q9Y6K8,NA,NA,NA,cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside kinase activity [GO:0019206]; ADP biosynthetic process [GO:0006172]; ATP metabolic process [GO:0046034]; dADP biosynthetic process [GO:0006173]; nucleobase-containing small molecule interconversion [GO:0015949]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; pyrimidine ribonucleotide biosynthetic process [GO:0009220],NA,NA,NA
CHOYP_VOLCADRAFT_89567.1.1.m.27272,-0.0196978561260192,-0.0130032074630421,No,NA,NA,Q9Y5Z4,NA,NA,NA,azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; heme binding [GO:0020037]; negative regulation of mitochondrial membrane potential [GO:0010917]; neutrophil degranulation [GO:0043312]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of necrotic cell death [GO:0010940],NA,NA,NA
CHOYP_VOLCADRAFT_93060.1.2.m.3949,0.0117648445845537,0.00190727160412662,No,NA,NA,O96790,NA,NA,NA,extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of coagulation [GO:0050819],NA,NA,NA
CHOYP_VOLCADRAFT_93060.2.2.m.26741,-0.0232673974730088,0.00694516210859433,No,NA,NA,O96790,NA,NA,NA,extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of coagulation [GO:0050819],NA,NA,NA
CHOYP_VP13D.2.3.m.58593,0.00615966897194063,0.00941964587728867,No,NA,NA,Q96GQ7,NA,NA,NA,chromosome [GO:0005694]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_VP33.1.2.m.1058,0.0155031404923277,0.0199528103306661,No,NA,NA,Q16943,NA,NA,NA,cell junction [GO:0030054]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; synapse [GO:0045202],NA,NA,NA
CHOYP_VP33A.1.1.m.58311,-0.00655099148980514,0.00691473297721048,No,NA,NA,Q63615,NA,NA,NA,autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; protein-containing complex binding [GO:0044877]; protein transport [GO:0015031]; regulation of lysosomal lumen pH [GO:0035751]; vesicle docking involved in exocytosis [GO:0006904],NA,NA,NA
CHOYP_VPP1.2.2.m.13421,-0.000303099638507034,-0.00255095246042225,No,NA,NA,Q8C2P3,NA,NA,NA,flavin adenine dinucleotide binding [GO:0050660]; tRNA dihydrouridine synthase activity [GO:0017150],NA,NA,NA
CHOYP_VPRBP.1.1.m.15849,-0.0012427239641016,-0.0143207686910192,No,NA,NA,Q9Y4B6,NA,NA,NA,Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleus [GO:0005634]; ATP binding [GO:0005524]; estrogen receptor binding [GO:0030331]; histone kinase activity (H2A-T120 specific) [GO:1990244]; B cell differentiation [GO:0030183]; cell competition in a multicellular organism [GO:0035212]; histone H2A-T120 phosphorylation [GO:1990245]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein ubiquitination [GO:0016567]; V(D)J recombination [GO:0033151]; viral process [GO:0016032],NA,NA,NA
CHOYP_VPS11.3.3.m.17579,-0.0100565471153872,-0.0178774043000931,No,NA,NA,Q9H270,NA,NA,NA,autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; protein binding; bridging [GO:0030674]; protein domain specific binding [GO:0019904]; syntaxin binding [GO:0019905]; autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of protein targeting to mitochondrion [GO:1903955]; regulation of organelle assembly [GO:1902115]; regulation of protein stability [GO:0031647]; regulation of SNARE complex assembly [GO:0035542]; vesicle docking involved in exocytosis [GO:0006904],NA,NA,NA
CHOYP_VPS18.1.1.m.38708,-0.00135166909720361,-0.0109062904514664,No,NA,NA,P59015,NA,NA,NA,endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; metal ion binding [GO:0046872]; protein binding; bridging [GO:0030674]; apical protein localization [GO:0045176]; bile acid and bile salt transport [GO:0015721]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; endosome to pigment granule transport [GO:0043485]; eye pigmentation [GO:0048069]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; notochord cell vacuolation [GO:0060036]; optokinetic behavior [GO:0007634]; pigment granule maturation [GO:0048757]; regulation of SNARE complex assembly [GO:0035542]; vesicle docking involved in exocytosis [GO:0006904],NA,NA,NA
CHOYP_VPS25.1.1.m.66093,0.00465503072366535,0.0160780824128681,No,NA,NA,Q6NWF4,NA,NA,NA,ESCRT II complex [GO:0000814]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328],NA,NA,NA
CHOYP_VPS35.1.1.m.55447,0.0102783572418747,0.000857455140451606,No,NA,NA,Q2HJG5,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; mitochondrion-derived vesicle [GO:0099073]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; retromer complex [GO:0030904]; retromer; cargo-selective complex [GO:0030906]; tubular endosome [GO:0097422]; D1 dopamine receptor binding [GO:0031748]; protein transporter activity [GO:0008565]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrion to lysosome transport [GO:0099074]; negative regulation of cellular protein localization [GO:1903828]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of neuron death [GO:1901215]; negative regulation of protein homooligomerization [GO:0032463]; neurotransmitter receptor transport; endosome to postsynaptic membrane [GO:0098887]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of Wnt protein secretion [GO:0061357]; protein destabilization [GO:0031648]; protein localization to organelle [GO:0033365]; regulation of dendritic spine maintenance [GO:1902950]; regulation of terminal button organization [GO:2000331]; retrograde transport; endosome to Golgi [GO:0042147]; retrograde transport; endosome to plasma membrane [GO:1990126]; synapse assembly [GO:0007416]; transcytosis [GO:0045056]; vesicle-mediated transport in synapse [GO:0099003]; voluntary musculoskeletal movement [GO:0050882],NA,NA,NA
CHOYP_VPS36.1.1.m.27030,-0.0116864507057211,0.00803420451743399,No,NA,NA,A5PK00,NA,NA,NA,endosome [GO:0005768]; ESCRT II complex [GO:0000814]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; phosphatidylinositol-3-phosphate binding [GO:0032266]; ubiquitin binding [GO:0043130]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328],NA,NA,NA
CHOYP_VPS45.1.1.m.8023,-0.000647855279348736,-0.00701593259559825,No,NA,NA,P97390,NA,NA,NA,endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; synaptic vesicle [GO:0008021]; protein transport [GO:0015031]; vesicle docking involved in exocytosis [GO:0006904],NA,NA,NA
CHOYP_VPS4B.2.2.m.30053,0.0218542271615462,0.0072610591581832,No,NA,NA,Q0VD48,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; Flemming body [GO:0090543]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity; coupled [GO:0042623]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; cholesterol transport [GO:0030301]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; late endosomal microautophagy [GO:0061738]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; negative regulation of cell death [GO:0060548]; negative regulation of exosomal secretion [GO:1903542]; nucleus organization [GO:0006997]; positive regulation of centriole elongation [GO:1903724]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of viral release from host cell [GO:1902188]; potassium ion transport [GO:0006813]; protein depolymerization [GO:0051261]; protein transport [GO:0015031]; regulation of mitotic spindle assembly [GO:1901673]; response to lipid [GO:0033993]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; vacuole organization [GO:0007033]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076],NA,NA,NA
CHOYP_VPS51.1.1.m.43266,-0.00629770309860477,-0.00749404838779654,No,NA,NA,Q155U0,NA,NA,NA,cytosol [GO:0005829]; EARP complex [GO:1990745]; GARP complex [GO:0000938]; membrane [GO:0016020]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; ADP-ribosylation factor binding [GO:0030306]; endocytic recycling [GO:0032456]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; lipid digestion [GO:0044241]; lipid transport [GO:0006869]; lysosomal transport [GO:0007041]; protein transport [GO:0015031]; regulation of phospholipase activity [GO:0010517]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_VPS53.1.1.m.51625,0.010024347228991,-0.00459669585262153,No,NA,NA,Q5ZLD7,NA,NA,NA,cytosol [GO:0005829]; EARP complex [GO:1990745]; endosome membrane [GO:0010008]; GARP complex [GO:0000938]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; endocytic recycling [GO:0032456]; lysosomal transport [GO:0007041]; protein transport [GO:0015031]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_VPS8.1.1.m.51272,0.00521221502324914,-0.0151785887844838,No,NA,NA,Q0P5W1,NA,NA,NA,CORVET complex [GO:0033263]; early endosome [GO:0005769]; metal ion binding [GO:0046872]; endosomal vesicle fusion [GO:0034058],NA,NA,NA
CHOYP_VRK1.1.1.m.10917,0.00600911175330472,-0.0230585891257524,No,NA,NA,Q32PI1,NA,NA,NA,cytoplasm [GO:0005737]; Golgi stack [GO:0005795]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; cell division [GO:0051301]; Golgi disassembly [GO:0090166]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468],NA,NA,NA
CHOYP_VRP.2.4.m.18914,0.0151379861220824,-0.0206936129866238,No,NA,NA,H2A0K6,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_VTA1.1.1.m.36056,0.00677839484016596,0.00690386797734882,No,NA,NA,Q32L63,NA,NA,NA,endosome membrane [GO:0010008]; protein transport [GO:0015031],NA,NA,NA
CHOYP_VWA8.2.3.m.28001,0.000484904290516956,-0.0105368309831318,No,NA,NA,B0R0T1,NA,NA,NA,mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887],NA,NA,NA
CHOYP_VWCE.1.3.m.5007,0.0139430843310469,0.0186852486350215,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_VWDE.5.13.m.28163,0.0114098753827811,0.0100519110769883,No,NA,NA,Q8N2E2,NA,NA,NA,cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856],NA,NA,NA
CHOYP_VWDE.8.13.m.38775,0.00402752467395735,-0.0212191916220216,No,NA,NA,O46581,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; cytochrome-c oxidase activity [GO:0004129],NA,NA,NA
CHOYP_WASP.1.1.m.35786,0.00325434040010107,0.00389726036757607,No,NA,NA,P42768,NA,NA,NA,actin cortical patch [GO:0030479]; actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; site of double-strand break [GO:0035861]; vesicle membrane [GO:0012506]; actin filament binding [GO:0051015]; GTPase regulator activity [GO:0030695]; identical protein binding [GO:0042802]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; Rac GTPase binding [GO:0048365]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267]; actin cortical patch assembly [GO:0000147]; actin cortical patch localization [GO:0051666]; actin filament polymerization [GO:0030041]; actin filament-based movement [GO:0030048]; actin polymerization or depolymerization [GO:0008154]; blood coagulation [GO:0007596]; Cdc42 protein signal transduction [GO:0032488]; cellular response to interferon-gamma [GO:0071346]; defense response [GO:0006952]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; epidermis development [GO:0008544]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; immune response [GO:0006955]; negative regulation of cell motility [GO:2000146]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of actin nucleation [GO:0051127]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of lamellipodium assembly [GO:0010591]; regulation of stress fiber assembly [GO:0051492]; regulation of T cell antigen processing and presentation [GO:0002625]; T cell activation [GO:0042110]; T cell receptor signaling pathway [GO:0050852],NA,NA,NA
CHOYP_WBP11.1.1.m.12849,-0.00318390622641147,0.00987763954483007,No,NA,NA,Q923D5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase regulator activity [GO:0019888]; WW domain binding [GO:0050699]; mRNA cis splicing; via spliceosome [GO:0045292]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_WDHD1.1.1.m.23505,-0.00145902843801608,-0.0106534016146221,No,NA,NA,O13046,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677],NA,NA,NA
CHOYP_WDR1.1.1.m.29076,0.00922716784532765,0.0098720567680975,No,NA,NA,Q9VU68,NA,NA,NA,actomyosin; actin portion [GO:0042643]; cortical actin cytoskeleton [GO:0030864]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin filament depolymerization [GO:0030042]; border follicle cell migration [GO:0007298]; establishment of planar polarity [GO:0001736]; imaginal disc-derived wing hair organization [GO:0035317]; locomotion [GO:0040011]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; positive regulation of actin filament depolymerization [GO:0030836]; regulation of actin filament depolymerization [GO:0030834]; regulation of actin filament polymerization [GO:0030833]; sarcomere organization [GO:0045214],NA,NA,NA
CHOYP_WDR11.2.2.m.58625,0.00415369371528837,-0.0146984081915251,No,NA,NA,Q9BZH6,NA,NA,NA,axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802]; cilium assembly [GO:0060271]; head development [GO:0060322]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; multicellular organism growth [GO:0035264]; regulation of smoothened signaling pathway [GO:0008589]; vesicle tethering to Golgi [GO:0099041],NA,NA,NA
CHOYP_WDR12.1.1.m.13380,-0.00969401847541141,-0.00790972798304647,No,NA,NA,B7PY76,NA,NA,NA,nucleoplasm [GO:0005654]; PeBoW complex [GO:0070545]; preribosome; large subunit precursor [GO:0030687]; ribonucleoprotein complex binding [GO:0043021]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000463],NA,NA,NA
CHOYP_WDR17.1.1.m.17546,3.58832411194404e-05,-0.00298531937448989,No,NA,NA,Q8IZU2,NA,NA,NA,,NA,NA,NA
CHOYP_WDR26.1.1.m.43030,0.00396228205120668,-0.0026588677588338,No,NA,NA,Q28D01,NA,NA,NA,mitochondrion [GO:0005739]; nucleus [GO:0005634],NA,NA,NA
CHOYP_WDR31.2.2.m.65613,0.00364778592941831,-0.00872052841558097,No,NA,NA,Q9JHB4,NA,NA,NA,,NA,NA,NA
CHOYP_WDR37.1.1.m.57561,0.00674343633336044,-0.0160477910218273,No,NA,NA,Q9Y2I8,NA,NA,NA,PeBoW complex [GO:0070545]; preribosome; large subunit precursor [GO:0030687],NA,NA,NA
CHOYP_WDR5.2.3.m.6293,-0.00817753050118237,0.0113267005127306,No,NA,NA,Q5M786,NA,NA,NA,histone acetyltransferase complex [GO:0000123]; MLL1 complex [GO:0071339]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]; histone binding [GO:0042393]; histone H3-K4 methylation [GO:0051568]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982],NA,NA,NA
CHOYP_WDR52.1.1.m.21751,-0.0217372726139505,-0.000754621643983785,No,NA,NA,Q96MT7,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; cilium-dependent cell motility [GO:0060285]; sperm axoneme assembly [GO:0007288],NA,NA,NA
CHOYP_WDR59.4.5.m.55404,-0.000577243107558503,0.0100257879826664,No,NA,NA,Q5ZLG9,NA,NA,NA,GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765]; cellular response to amino acid starvation [GO:0034198]; positive regulation of TOR signaling [GO:0032008],NA,NA,NA
CHOYP_WDR61.1.2.m.7565,-0.0107995226075519,0.0130575825811177,No,NA,NA,Q6P5M2,NA,NA,NA,Cdc73/Paf1 complex [GO:0016593]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; Ski complex [GO:0055087]; transcriptionally active chromatin [GO:0035327]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968],NA,NA,NA
CHOYP_WDR63.1.1.m.21743,-0.0207578047358577,-0.00126329079404558,No,NA,NA,Q8IWG1,NA,NA,NA,dynein complex [GO:0030286]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_WDR70.1.1.m.7199,0.00941365189994574,0.0119461322410556,No,NA,NA,Q0VA16,NA,NA,NA,nucleus [GO:0005634]; site of double-strand break [GO:0035861]; regulation of DNA double-strand break processing [GO:1903775]; regulation of histone H2B conserved C-terminal lysine ubiquitination [GO:2001173],NA,NA,NA
CHOYP_WDR74.1.1.m.19017,-0.00395609933290988,0.00179324217196119,No,NA,NA,Q6RFH5,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome; large subunit precursor [GO:0030687]; blastocyst formation [GO:0001825]; ribosomal large subunit biogenesis [GO:0042273]; RNA metabolic process [GO:0016070]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_WDR75.1.1.m.9234,-0.0027579836119583,0.00627577132543899,No,NA,NA,Q6DFC6,NA,NA,NA,nucleolus [GO:0005730]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_WDR89.1.1.m.30861,0.0100641115331389,-0.00180585330736451,No,NA,NA,Q5RBZ3,NA,NA,NA,,NA,NA,NA
CHOYP_WDR92.1.1.m.12560,-0.0118084754109312,-0.0076655032597201,No,NA,NA,Q29RZ9,NA,NA,NA,ubiquitin binding [GO:0043130]; apoptotic process [GO:0006915],NA,NA,NA
CHOYP_WFIKKN1.1.1.m.28942,-0.0228686158911306,0.00668120463819184,No,NA,NA,P84875,NA,NA,NA,extracellular region [GO:0005576]; metalloendopeptidase inhibitor activity [GO:0008191]; serine-type endopeptidase inhibitor activity [GO:0004867],NA,NA,NA
CHOYP_WHITE.1.1.m.38819,0.00615966897194063,0.00941964587728867,No,NA,NA,P10090,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; integral component of pigment granule membrane [GO:0090740]; pigment granule [GO:0048770]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; 3';5'-cyclic GMP transmembrane-transporting ATPase activity [GO:1905948]; amine transmembrane transporter activity [GO:0005275]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; eye pigment precursor transporter activity [GO:0005395]; guanine-transporting ATPase activity [GO:0008558]; pigment binding [GO:0031409]; aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; cellular biogenic amine biosynthetic process [GO:0042401]; cGMP transport [GO:0070731]; compound eye pigmentation [GO:0048072]; eye pigment metabolic process [GO:0042441]; eye pigment precursor transport [GO:0006856]; gravitaxis [GO:0042332]; histamine uptake [GO:0051615]; male courtship behavior [GO:0008049]; memory [GO:0007613]; ommochrome biosynthetic process [GO:0006727]; transmembrane transport [GO:0055085],NA,NA,NA
CHOYP_WHSC1.1.1.m.15308,-0.00702786907026595,0.00725077481602362,No,NA,NA,O88491,NA,NA,NA,chromatin [GO:0000785]; histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; androgen receptor binding [GO:0050681]; chromatin binding [GO:0003682]; estrogen receptor binding [GO:0030331]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H4-K20 specific) [GO:0042799]; retinoic acid receptor binding [GO:0042974]; retinoid X receptor binding [GO:0046965]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; thyroid hormone receptor binding [GO:0046966]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; gastrulation with mouth forming second [GO:0001702]; histone methylation [GO:0016571]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of histone H3-K36 methylation [GO:0000414]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1903025]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_WIBG.1.1.m.11521,-0.00223159645940384,-0.00137897666405883,No,NA,NA,Q640E9,NA,NA,NA,cytoplasm [GO:0005737]; exon-exon junction complex [GO:0035145]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribosome binding [GO:0043022]; exon-exon junction complex disassembly [GO:1903259]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; positive regulation of translation [GO:0045727],NA,NA,NA
CHOYP_WIPI2.1.2.m.9192,-0.00695280346732165,0.00367001549572199,No,NA,NA,Q5ZHN3,NA,NA,NA,autophagosome [GO:0005776]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; nucleoplasm [GO:0005654]; phagophore assembly site membrane [GO:0034045]; protein-containing complex [GO:0032991]; phosphatidylinositol-3;5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein lipidation involved in autophagosome assembly [GO:0061739]; protein localization to phagophore assembly site [GO:0034497]; xenophagy [GO:0098792],NA,NA,NA
CHOYP_WIPI3.1.1.m.13956,-0.000185136762425758,0.00350879213875284,No,NA,NA,Q5ZL16,NA,NA,NA,cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; lysosome [GO:0005764]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; phosphatidylinositol-3;5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; TSC1-TSC2 complex binding [GO:0062078]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497],NA,NA,NA
CHOYP_WKK_06610.2.2.m.50131,0.00364778592941831,-0.00872052841558096,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_WN10A.1.1.m.28564,0.00217997094733793,-0.00807271368859912,No,NA,NA,Q98SN7,NA,NA,NA,extracellular space [GO:0005615]; frizzled binding [GO:0005109]; camera-type eye photoreceptor cell differentiation [GO:0060219]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cell proliferation [GO:0008283]; cornea development in camera-type eye [GO:0061303]; embryonic camera-type eye formation [GO:0060900]; embryonic forelimb morphogenesis [GO:0035115]; iris morphogenesis [GO:0061072]; lens development in camera-type eye [GO:0002088]; limb development [GO:0060173]; morphogenesis of an epithelial sheet [GO:0002011]; negative regulation of glial cell differentiation [GO:0045686]; negative regulation of neuron differentiation [GO:0045665]; neural retina development [GO:0003407]; neuron differentiation [GO:0030182]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of fibroblast growth factor production [GO:0090270]; retina layer formation [GO:0010842]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_WNK2.1.2.m.38552,0.00709391048335661,-0.00538136266018716,No,NA,NA,P83741,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; ATP binding [GO:0005524]; chloride channel inhibitor activity [GO:0019869]; magnesium ion binding [GO:0000287]; phosphatase binding [GO:0019902]; potassium channel inhibitor activity [GO:0019870]; protein kinase activator activity [GO:0030295]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; cellular response to calcium ion [GO:0071277]; cellular response to chemokine [GO:1990869]; chemokine (C-C motif) ligand 21 signaling pathway [GO:0038116]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; ion transport [GO:0006811]; lymphocyte migration into lymph node [GO:0097022]; negative regulation of cell-cell adhesion mediated by integrin [GO:0033633]; negative regulation of GTPase activity [GO:0034260]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of kinase activity [GO:0033673]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of sodium ion transport [GO:0010766]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of ion transmembrane transporter activity [GO:0032414]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of T cell chemotaxis [GO:0010820]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cellular process [GO:0050794]; regulation of sodium ion transport [GO:0002028]; signal transduction by trans-phosphorylation [GO:0023016]; T cell receptor signaling pathway [GO:0050852],NA,NA,NA
CHOYP_WNT7B.1.2.m.36042,0.00498590840334914,-0.0121976176919574,No,NA,NA,Q3L254,NA,NA,NA,extracellular space [GO:0005615]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to retinoic acid [GO:0071300]; fibroblast proliferation [GO:0048144]; forebrain regionalization [GO:0021871]; lens fiber cell development [GO:0070307]; neuron differentiation [GO:0030182]; positive regulation of JNK cascade [GO:0046330]; stem cell proliferation [GO:0072089]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_WRI_006090.1.1.m.34650,-0.0169591047060434,0.00960206869202777,No,NA,NA,Q8N7Z5,NA,NA,NA,,NA,NA,NA
CHOYP_XCASPASE.7.1.4.m.26576,-0.0118425947050871,0.00658408191705708,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_XDH.1.3.m.46824,-0.0143521485035203,-0.0216888089325713,No,NA,NA,P47990,NA,NA,NA,cytosol [GO:0005829]; peroxisome [GO:0005777]; 2 iron; 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; hypoxanthine dehydrogenase activity [GO:0070674]; iron ion binding [GO:0005506]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; urate biosynthetic process [GO:0034418]; xanthine catabolic process [GO:0009115],NA,NA,NA
CHOYP_XDH.2.3.m.53113,-9.10371983330525e-05,-0.00434932330941572,No,NA,NA,P47990,NA,NA,NA,cytosol [GO:0005829]; peroxisome [GO:0005777]; 2 iron; 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; hypoxanthine dehydrogenase activity [GO:0070674]; iron ion binding [GO:0005506]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; urate biosynthetic process [GO:0034418]; xanthine catabolic process [GO:0009115],NA,NA,NA
CHOYP_XDH.3.3.m.55146,-0.00244754967994263,0.00205729978177646,No,NA,NA,P47989,NA,NA,NA,cytosol [GO:0005829]; extracellular space [GO:0005615]; peroxisome [GO:0005777]; sarcoplasmic reticulum [GO:0016529]; 2 iron; 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; protein homodimerization activity [GO:0042803]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; lactation [GO:0007595]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; negative regulation of vasculogenesis [GO:2001213]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; purine nucleotide catabolic process [GO:0006195]; xanthine catabolic process [GO:0009115],NA,NA,NA
CHOYP_XFIN.1.4.m.606,0.0065883263884642,0.0180931628217626,No,NA,NA,Q99KE8,NA,NA,NA,nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; multicellular organism development [GO:0007275]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mRNA splicing; via spliceosome [GO:0048026]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of gene expression [GO:0010468],NA,NA,NA
CHOYP_XIAP.1.7.m.6021,-0.0197428447754488,-0.010070584308196,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_XPF.1.1.m.14801,-0.00603391733409497,-0.0219017664563257,No,NA,NA,Q6GQN4,NA,NA,NA,nucleolus [GO:0005730]; apoptotic process [GO:0006915]; cell cycle [GO:0007049],NA,NA,NA
CHOYP_XPO1.1.1.m.31560,-0.0110646128299844,-0.0136310579161265,No,NA,NA,Q80U96,NA,NA,NA,annulate lamellae [GO:0005642]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; nuclear export signal receptor activity [GO:0005049]; protein domain specific binding [GO:0019904]; protein transporter activity [GO:0008565]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; mRNA transport [GO:0051028]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; regulation of centrosome duplication [GO:0010824]; regulation of protein catabolic process [GO:0042176]; regulation of protein export from nucleus [GO:0046825]; response to drug [GO:0042493]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056],NA,NA,NA
CHOYP_XPO2.1.1.m.50289,0.000376021596291075,-0.0194713763603129,No,NA,NA,Q8AY73,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; Ran GTPase binding [GO:0008536]; body fluid secretion [GO:0007589]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_XPO5.1.1.m.14207,-0.00159300956539792,-0.0250441952289219,No,NA,NA,Q9HAV4,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; micro-ribonucleoprotein complex [GO:0035068]; nuclear RNA export factor complex [GO:0042272]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA nuclear export complex [GO:0042565]; mRNA binding [GO:0003729]; nuclear export signal receptor activity [GO:0005049]; pre-miRNA binding [GO:0070883]; protein transporter activity [GO:0008565]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; tRNA binding [GO:0000049]; miRNA metabolic process [GO:0010586]; positive regulation of RNA interference [GO:1900370]; pre-miRNA export from nucleus [GO:0035281]; protein export from nucleus [GO:0006611]; regulation of protein export from nucleus [GO:0046825],NA,NA,NA
CHOYP_XPO6.1.1.m.15288,-0.000800461161124381,-0.00868717562258218,No,NA,NA,Q96QU8,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein transporter activity [GO:0008565]; Ran GTPase binding [GO:0008536]; protein export from nucleus [GO:0006611],NA,NA,NA
CHOYP_XPP1.1.2.m.16748,0.013615787572867,-0.0112438650534144,No,NA,NA,Q9NQW7,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]; bradykinin catabolic process [GO:0010815]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_XPP1.2.2.m.38696,-0.00538049054390351,0.00217783511970316,No,NA,NA,Q9NQW7,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]; bradykinin catabolic process [GO:0010815]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_XRN2.1.1.m.13943,-0.0106878522296944,-0.0119670950681033,No,NA,NA,Q5ZIP4,NA,NA,NA,aggresome [GO:0016235]; nucleolus [GO:0005730]; 5'-3' exonuclease activity [GO:0008409]; 5'-3' exoribonuclease activity [GO:0004534]; metal ion binding [GO:0046872]; transcription termination site sequence-specific DNA binding [GO:0001147]; DNA catabolic process; exonucleolytic [GO:0000738]; DNA-templated transcription; termination [GO:0006353]; mRNA processing [GO:0006397]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_Y003.1.1.m.31014,0.00803875468917854,0.00177637172284421,No,NA,NA,Q6R7B4,NA,NA,NA,,NA,NA,NA
CHOYP_Y022.1.1.m.30669,0.00634508297151094,-0.00673739343950175,No,NA,NA,Q6R7K1,NA,NA,NA,host cell membrane [GO:0033644]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_Y0417.2.2.m.29395,-0.00100866337649718,-0.0151638641118922,No,NA,NA,F1LNI5,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; cell cycle [GO:0007049],NA,NA,NA
CHOYP_Y045.1.1.m.43767,0.0210139511766984,-0.00299435347300524,No,NA,NA,Q502K3,NA,NA,NA,,NA,NA,NA
CHOYP_Y054.1.1.m.9666,-0.00566900511765649,0.00360817963008541,No,NA,NA,Q6R7G0,NA,NA,NA,host cell membrane [GO:0033644]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_Y061.1.1.m.29896,0.00751553304113039,0.00653196977493729,No,NA,NA,Q6R7G4,NA,NA,NA,,NA,NA,NA
CHOYP_Y071.1.1.m.29248,0.0065883263884642,0.0180931628217626,No,NA,NA,Q6R7F6,NA,NA,NA,host cell membrane [GO:0033644]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_Y077.1.1.m.27629,0.00364778592941831,-0.00872052841558097,No,NA,NA,Q6R7F2,NA,NA,NA,host cell membrane [GO:0033644]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_Y0777.3.3.m.60141,0.00843696658553944,-0.00189304261552865,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_Y1004.1.1.m.18927,-0.00458288662386492,0.00939777721457759,No,NA,NA,P34501,NA,NA,NA,cell-matrix adhesion [GO:0007160],NA,NA,NA
CHOYP_Y118.1.1.m.30002,-0.00773964940347976,0.0140450325141501,No,NA,NA,Q6R796,NA,NA,NA,metal ion binding [GO:0046872],NA,NA,NA
CHOYP_Y7557.3.3.m.42713,0.0149179147962031,0.0185145971658651,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_YAHB.1.1.m.25422,0.00184732012394363,0.0224748839800557,No,NA,NA,P42297,NA,NA,NA,,NA,NA,NA
CHOYP_YAP.1.2.m.23386,-0.00312775920222833,-0.0130643725504712,No,NA,NA,Q1L8J7,NA,NA,NA,chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; cartilage development [GO:0051216]; cilium assembly [GO:0060271]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; endoderm development [GO:0007492]; fin regeneration [GO:0031101]; heart formation [GO:0060914]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; pancreas development [GO:0031016]; positive regulation of glutamate-ammonia ligase activity [GO:1905480]; posterior lateral line development [GO:0048916]; pronephric duct development [GO:0039022]; regulation of organ growth [GO:0046620]; retinal pigment epithelium development [GO:0003406],NA,NA,NA
CHOYP_YAP.2.2.m.62060,0.00227470186844712,0.00784339433173956,No,NA,NA,Q1L8J7,NA,NA,NA,chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; cartilage development [GO:0051216]; cilium assembly [GO:0060271]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; endoderm development [GO:0007492]; fin regeneration [GO:0031101]; heart formation [GO:0060914]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; pancreas development [GO:0031016]; positive regulation of glutamate-ammonia ligase activity [GO:1905480]; posterior lateral line development [GO:0048916]; pronephric duct development [GO:0039022]; regulation of organ growth [GO:0046620]; retinal pigment epithelium development [GO:0003406],NA,NA,NA
CHOYP_YBOXH.2.4.m.3352,-0.00844344471578531,-0.019882969738479,No,NA,NA,P86854,NA,NA,NA,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_YDJC.1.1.m.4244,0.00823405000782894,-0.0140515277381152,No,NA,NA,A2BIR6,NA,NA,NA,hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_YETS2.1.1.m.302,-0.0025483701132575,-0.0147144345581626,No,NA,NA,Q9ULM3,NA,NA,NA,Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; mitotic spindle [GO:0072686]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; histone binding [GO:0042393]; modification-dependent protein binding [GO:0140030]; TBP-class protein binding [GO:0017025]; histone H3 acetylation [GO:0043966]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892],NA,NA,NA
CHOYP_YG31B.1.3.m.6174,-0.00887552362427124,-0.00676430271011466,No,NA,NA,Q7LHG5,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]; aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition; RNA-mediated [GO:0032197],NA,NA,NA
CHOYP_YG31B.2.3.m.9011,-0.00699852042490584,0.00501554465690768,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_YL086.1.1.m.33481,-0.0169591047060434,0.00960206869202778,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_YL58.1.1.m.35411,0.00205195042830452,-0.00934116934689426,No,NA,NA,A5D7H5,NA,NA,NA,cytoplasmic stress granule [GO:0010494]; dendrite [GO:0030425]; exon-exon junction complex [GO:0035145]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; intracellular mRNA localization [GO:0008298]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_YL8A.1.1.m.29604,-0.0129049608687173,-0.0203803410107073,No,NA,NA,Q9UTA8,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; trans-aconitate 3-methyltransferase activity [GO:0046547]; cellular detoxification [GO:1990748],NA,NA,NA
CHOYP_YLPM1.1.2.m.17086,-0.00390770480386276,-0.00812552678599675,No,NA,NA,P0CB49,NA,NA,NA,nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227],NA,NA,NA
CHOYP_YMS5.1.1.m.5494,0.00909290388958882,-0.0258620798590968,No,NA,NA,P34501,NA,NA,NA,cell-matrix adhesion [GO:0007160],NA,NA,NA
CHOYP_YNY5.2.4.m.50761,0.00837527067579088,0.00508139102790473,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_YQK4.2.2.m.31850,-0.0147911554152032,0.00801695812784643,No,NA,NA,Q09288,NA,NA,NA,defense response to Gram-negative bacterium [GO:0050829]; regulation of antimicrobial humoral response [GO:0002759]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_YS11.1.1.m.30657,-0.00590704384174253,-0.00911796161661324,No,NA,NA,Q9W0Y2,NA,NA,NA,gamma-glutamylaminecyclotransferase activity [GO:0061929]; transferase activity; transferring acyl groups [GO:0016746]; cellular modified amino acid catabolic process [GO:0042219],NA,NA,NA
CHOYP_YTDC1.1.2.m.56405,0.00615966897194063,0.00941964587728867,No,NA,NA,Q9H2Y7,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]; insulin receptor signaling pathway [GO:0008286],NA,NA,NA
CHOYP_ZADH2.1.3.m.13137,0.00405746977658124,0.00504253646375131,No,NA,NA,Q8BGC4,NA,NA,NA,mitochondrion [GO:0005739]; peroxisome [GO:0005777]; 13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; zinc ion binding [GO:0008270]; negative regulation of fat cell differentiation [GO:0045599],NA,NA,NA
CHOYP_ZBTB5.4.4.m.42642,0.00405626903222453,0.00612054155646961,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ZC11A.1.1.m.60722,0.0095553180132712,0.0134510160845671,No,NA,NA,Q6NZF1,NA,NA,NA,cell [GO:0005623]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; poly(A)+ mRNA export from nucleus [GO:0016973],NA,NA,NA
CHOYP_ZC3H18.1.1.m.8085,-0.00226865286261043,-0.00551507763878711,No,NA,NA,Q86VM9,NA,NA,NA,nuclear speck [GO:0016607]; protein-containing complex [GO:0032991]; metal ion binding [GO:0046872]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_ZC3H4.1.1.m.57516,-0.0169591047060434,0.00960206869202778,No,NA,NA,P61129,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; negative regulation of transcription; DNA-templated [GO:0045892],NA,NA,NA
CHOYP_ZC3HA.1.1.m.27569,-0.0169591047060434,0.00960206869202778,No,NA,NA,Q8R205,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],NA,NA,NA
CHOYP_ZC3HDC1L.1.1.m.44413,-0.00845082951742162,-0.0117274303464717,No,NA,NA,Q9H0J9,NA,NA,NA,nucleus [GO:0005634]; metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_ZCCHC8.1.1.m.18098,-0.0129714592949183,-0.0126719625302957,No,NA,NA,Q5F3D1,NA,NA,NA,nucleoplasm [GO:0005654]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_ZDHHC17.1.1.m.29726,-0.0169591047060434,0.00960206869202777,No,NA,NA,Q8IUH5,NA,NA,NA,aggresome [GO:0016235]; cell junction [GO:0030054]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; presynaptic membrane [GO:0042734]; identical protein binding [GO:0042802]; magnesium ion transmembrane transporter activity [GO:0015095]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; lipoprotein transport [GO:0042953]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein palmitoylation [GO:0018345],NA,NA,NA
CHOYP_ZEB2.1.1.m.29733,-0.0141392315364209,0.000564793718899285,No,NA,NA,Q9UDV7,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]; negative regulation of transcription; DNA-templated [GO:0045892]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_ZF_BBOX_RING_.1.3.10.m.29555,0.00678620130084429,0.00878741825264137,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ZF_BBOX_RING_.1.5.10.m.34434,0.0124638125681646,0.0183830272439477,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ZF_U1LIKE_.10.1.1.m.18971,-0.0116742685857743,0.00272578546944642,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ZFP37.1.4.m.10878,-0.0222840268572413,0.000493370867285973,No,NA,NA,Q6GQR8,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_ZFP37.3.4.m.48467,0.0090415371949759,0.00125001105908164,No,NA,NA,A2T812,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_ZFR.1.1.m.57469,-0.000218146509194439,-0.000993747874559291,No,NA,NA,Q96KR1,NA,NA,NA,chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_ZFY27.1.1.m.31417,0.00364778592941831,-0.00872052841558097,No,NA,NA,Q6P7B7,NA,NA,NA,axon [GO:0030424]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum tubular network [GO:0071782]; growth cone membrane [GO:0032584]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; recycling endosome membrane [GO:0055038]; metal ion binding [GO:0046872]; protein self-association [GO:0043621]; endoplasmic reticulum tubular network formation [GO:0071787]; neuron projection development [GO:0031175]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of axon extension [GO:0045773]; protein localization to plasma membrane [GO:0072659]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_ZGC_113208.1.1.m.15618,0.00450149557621657,-0.00394418186886511,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ZGC_113625.1.2.m.2855,-0.000632841853979496,-0.00969448376234785,No,NA,NA,Q8NHV1,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; GTP metabolic process [GO:0046039],NA,NA,NA
CHOYP_ZGC_136858.1.1.m.51274,0.0134597057064795,0.0077803471345753,No,NA,NA,Q9USY1,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; hydrolase activity; acting on glycosyl bonds [GO:0016798]; metal ion binding [GO:0046872]; pseudouridine kinase activity [GO:0050225]; pseudouridylate synthase activity [GO:0004730]; pseudouridine synthesis [GO:0001522]; pyrimidine nucleoside metabolic process [GO:0006213],NA,NA,NA
CHOYP_ZGC_171566.1.1.m.22181,-0.0191517521013941,0.00202347607840768,No,NA,NA,Q9Z0L8,NA,NA,NA,cytosol [GO:0005829]; extracellular space [GO:0005615]; lysosome [GO:0005764]; melanosome [GO:0042470]; vacuole [GO:0005773]; gamma-glutamyl-peptidase activity [GO:0034722]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to insulin [GO:0032868]; response to zinc ion [GO:0010043]; tetrahydrofolylpolyglutamate metabolic process [GO:0046900],NA,NA,NA
CHOYP_ZGC_73273.1.1.m.18633,-0.00375802353902207,-0.00723540301484217,No,NA,NA,Q9QY93,NA,NA,NA,cytosol [GO:0005829]; dCTP diphosphatase activity [GO:0047840]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; pyrimidine deoxyribonucleotide binding [GO:0032556]; pyrophosphatase activity [GO:0016462]; dCTP catabolic process [GO:0006253]; DNA protection [GO:0042262]; nucleoside triphosphate catabolic process [GO:0009143]; protein homotetramerization [GO:0051289],NA,NA,NA
CHOYP_ZGC_92203.1.1.m.55468,0.00922375846982787,-0.00112307176287564,No,NA,NA,Q9HCU5,NA,NA,NA,endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nucleus [GO:0005634]; DNA binding [GO:0003677]; GTPase activator activity [GO:0005096]; GTPase binding [GO:0051020]; guanyl-nucleotide exchange factor activity [GO:0005085]; Sar guanyl-nucleotide exchange factor activity [GO:0005090]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; IRE1-mediated unfolded protein response [GO:0036498]; protein exit from endoplasmic reticulum [GO:0032527]; protein secretion [GO:0009306]; regulation of COPII vesicle coating [GO:0003400],NA,NA,NA
CHOYP_ZIP.1.1.m.15785,0.000247191980315697,0.0174644413577414,No,NA,NA,Q99323,NA,NA,NA,actomyosin contractile ring [GO:0005826]; apical cortex [GO:0045179]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell-cell contact zone [GO:0044291]; cilium [GO:0005929]; cleavage furrow [GO:0032154]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; myosin complex [GO:0016459]; myosin II complex [GO:0016460]; unconventional myosin complex [GO:0016461]; Z disc [GO:0030018]; actin binding [GO:0003779]; ATP binding [GO:0005524]; ATPase activity; coupled [GO:0042623]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; anterior midgut development [GO:0007496]; border follicle cell migration [GO:0007298]; cellular response to mechanical stimulus [GO:0071260]; compartment boundary maintenance [GO:0060289]; cuticle pattern formation [GO:0035017]; dorsal closure [GO:0007391]; dorsal closure; amnioserosa morphology change [GO:0046664]; dorsal closure; leading edge cell differentiation [GO:0046663]; dorsal closure; spreading of leading edge cells [GO:0007395]; establishment of neuroblast polarity [GO:0045200]; establishment of planar polarity [GO:0001736]; eye-antennal disc morphogenesis [GO:0007455]; head involution [GO:0008258]; imaginal disc-derived wing hair organization [GO:0035317]; left/right axis specification [GO:0070986]; maintenance of protein location in cell [GO:0032507]; Malpighian tubule morphogenesis [GO:0007443]; mitotic cytokinesis [GO:0000281]; morphogenesis of an epithelial fold [GO:0060571]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; myosin II filament assembly [GO:0031036]; ommatidial rotation [GO:0016318]; ovarian follicle cell migration [GO:0007297]; positive regulation of border follicle cell migration [GO:1903688]; protein complex oligomerization [GO:0051259]; regulation of myoblast fusion [GO:1901739]; regulation of tube length; open tracheal system [GO:0035159]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; spiracle morphogenesis; open tracheal system [GO:0035277]; wound healing [GO:0042060],NA,NA,NA
CHOYP_ZMY11.1.1.m.3621,-0.00537676206600216,-0.00787884189150662,No,NA,NA,Q8R5C8,NA,NA,NA,chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; defense response to virus [GO:0051607]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of JNK cascade [GO:0046329]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243],NA,NA,NA
CHOYP_ZN207.1.1.m.6909,-0.00775500724237062,0.00913778470554969,No,NA,NA,Q7ZXV8,NA,NA,NA,condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle matrix [GO:1990047]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; nucleic acid binding [GO:0003676]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; microtubule polymerization [GO:0046785]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; mitotic spindle assembly checkpoint [GO:0007094]; protein stabilization [GO:0050821]; regulation of chromosome segregation [GO:0051983],NA,NA,NA
CHOYP_ZN330.1.2.m.7843,0.00530947068835417,-0.0043043416580837,No,NA,NA,Q9VAU9,NA,NA,NA,chromosome; centromeric region [GO:0000775]; midbody [GO:0030496]; nucleolus [GO:0005730]; zinc ion binding [GO:0008270]; larval lymph gland hemopoiesis [GO:0035167],NA,NA,NA
CHOYP_ZN521.2.3.m.13584,0.0031262185010823,-0.0128513116951255,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ZN568.1.1.m.61611,0.00678620130084428,0.00878741825264137,No,NA,NA,P08043,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_ZN609.1.1.m.44387,-0.0106008168418323,0.000841816411619987,No,NA,NA,O15014,NA,NA,NA,integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; muscle organ development [GO:0007517]; positive regulation of neuron migration [GO:2001224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of myoblast proliferation [GO:2000291]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_ZN622.1.1.m.2103,-0.00459544402456289,-0.00157507436178845,No,NA,NA,Q91VY9,NA,NA,NA,cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome; large subunit precursor [GO:0030687]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; ribosomal large subunit biogenesis [GO:0042273],NA,NA,NA
CHOYP_ZN706.1.2.m.11926,0.00843766005429271,-0.0170466908791455,No,NA,NA,Q5ZMM5,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription; DNA-templated [GO:0045892]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_ZN729.1.1.m.13702,0.0074804382989752,-0.00220477068001902,No,NA,NA,P52740,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_ZNF184.1.1.m.59420,-0.013606352365635,-0.00264520404952123,No,NA,NA,Q76KX8,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_ZNF259.1.1.m.10424,-0.00192009627032827,-0.00881007841872919,No,NA,NA,Q62384,NA,NA,NA,axon [GO:0030424]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; Gemini of coiled bodies [GO:0097504]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; SMN complex [GO:0032797]; receptor tyrosine kinase binding [GO:0030971]; translation initiation factor binding [GO:0031369]; zinc ion binding [GO:0008270]; apoptotic process involved in development [GO:1902742]; axon development [GO:0061564]; Cajal body organization [GO:0030576]; cellular response to epidermal growth factor stimulus [GO:0071364]; DNA endoreduplication [GO:0042023]; inner cell mass cell proliferation [GO:0001833]; microtubule cytoskeleton organization [GO:0000226]; mRNA processing [GO:0006397]; negative regulation of motor neuron apoptotic process [GO:2000672]; positive regulation of gene expression [GO:0010628]; positive regulation of growth [GO:0045927]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071931]; pre-mRNA catabolic process [GO:1990261]; regulation of myelination [GO:0031641]; RNA splicing [GO:0008380]; spinal cord development [GO:0021510]; trophectodermal cell proliferation [GO:0001834],NA,NA,NA
CHOYP_ZNF382.1.1.m.21527,-0.00323327224762166,0.0130649706717484,No,NA,NA,Q5T5D7,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_ZNF43.1.1.m.6773,0.00217997094733793,-0.00807271368859912,No,NA,NA,A8MTY0,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_ZNF510.1.1.m.10853,0.00394536801625317,0.00291369700370642,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ZNF624.1.1.m.45743,0.000308659789425945,0.000699519851337131,No,NA,NA,Q6ZNA1,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_ZNF85.1.1.m.65738,-0.00016778875431506,-0.0113374694611753,No,NA,NA,Q8BIQ3,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_ZNRD1.1.2.m.7107,-0.00838306041201656,-0.0041343187641087,No,NA,NA,Q6MFY5,NA,NA,NA,RNA polymerase I complex [GO:0005736]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; mRNA cleavage [GO:0006379]; termination of RNA polymerase I transcription [GO:0006363],NA,NA,NA
CHOYP_ZW10.1.1.m.35287,0.00513609129744787,-0.0217087440974091,No,NA,NA,O54692,NA,NA,NA,condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; Dsl1/NZR complex [GO:0070939]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; nucleus [GO:0005634]; RZZ complex [GO:1990423]; spindle pole [GO:0000922]; cell division [GO:0051301]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; mitotic cell cycle checkpoint [GO:0007093]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint [GO:0007094]; protein localization to kinetochore [GO:0034501]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003]; regulation of exit from mitosis [GO:0007096],NA,NA,NA
CHOYP_ZYRO0F11880G.1.1.m.7082,-0.0151353495365185,-0.0191682244368997,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
K1C10_HUMAN,-0.0127916176263901,-0.0179702693447056,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
K1C15_SHEEP,-0.0124812753308996,-0.00673807483530233,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
K1C9_HUMAN,-0.016003875105601,-0.0169352115308584,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
K1M1_SHEEP,-0.00212078832001384,-0.00891837260408135,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
K22E_HUMAN,-0.0122152300262012,-0.0193816915031826,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
K2C1_HUMAN,-0.0186525777136413,-0.0102005382987765,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
KRUC_SHEEP,-0.000342807862481966,-0.0111446854586756,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
LYSC_CHICK,-0.0131604698983382,-0.00184431421406909,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
LYSC_HUMAN,0.00678620130084429,0.00878741825264137,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
NEDD8_HUMAN,0.00621932399009787,0.00593315386098933,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
TRFL_HUMAN,0.00678620130084429,0.00878741825264137,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
TRYP_PIG,0.0131484096690156,-0.00338712191901207,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
